hsa:645954;SVILP1;supervillin pseudogene 1
hsa:283711;UBE2CP4;ubiquitin-conjugating enzyme E2C pseudogene 4
hsa:400645;RBM22P1,FLJ45994;RNA binding motif protein 22 pseudogene 1
hsa:100128416;;RAB28, member RAS oncogene family pseudogene
hsa:8551;INE2,NCRNA00011;inactivation escape 2 (non-protein coding)
hsa:728658;RPL13AP5,RPL13A_8_1086,bA196N24.2;ribosomal protein L13a pseudogene 5
hsa:100124412;FAM138E,F379;family with sequence similarity 138, member E
hsa:407835;;mitogen-activated protein kinase kinase 2 pseudogene
hsa:84054;PCDHB19P,PCDH-PSI5,PCDHB19;protocadherin beta 19 pseudogene
hsa:654835;FAM138C,F379;family with sequence similarity 138, member C
hsa:360155;CYCSP52,HC6,HCP2;cytochrome c, somatic pseudogene 52
hsa:677784;FAM138D,F379;family with sequence similarity 138, member D
hsa:644649;;apolipoprotein O pseudogene
hsa:260341;TFAMP1,MTTF1,TCF6L1;transcription factor A, mitochondrial pseudogene 1
hsa:83955;NACAP1;nascent-polypeptide-associated complex alpha polypeptide pseudogene 1
hsa:613037;;nuclear pore complex interacting protein pseudogene
hsa:100303749;;LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae) pseudogene
hsa:1197;CLK2P;CDC-like kinase 2, pseudogene
hsa:376412;RNF126P1;ring finger protein 126 pseudogene 1
hsa:400322;HERC2P2,D15F37S3,MN7;hect domain and RLD 2 pseudogene 2
hsa:79469;DLEU2L,BCMSUNL;deleted in lymphocytic leukemia 2-like
hsa:118432;RPL29P2,RPL29_10_1510;ribosomal protein L29 pseudogene 2
hsa:140771;SMCR5,NCRNA00034;Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)
hsa:100131561;FKSG29;FKSG29
hsa:647033;PA2G4P4,PA2G4L1;proliferation-associated 2G4 pseudogene 4
hsa:25787;DGCR9,DGS-A;DiGeorge syndrome critical region gene 9
hsa:649946;RPL23AP64,RPL23A_25_1182;ribosomal protein L23a pseudogene 64
hsa:728963;RPS15AP10,RPS15A_4_42;ribosomal protein S15a pseudogene 10
hsa:606724;;coronin, actin binding protein, 1A pseudogene
hsa:440359;YBX3P1,CSDAP1;Y box binding protein 3 pseudogene 1
hsa:388242;;coiled-coil domain containing 101 pseudogene
hsa:613038;;coiled-coil domain containing 101 pseudogene
hsa:474338;SUMO1P3;SUMO1 pseudogene 3
hsa:730668;;dynein heavy chain -like pseudogene
hsa:54661;PCDHB17,ME4,PCDH-psi1;protocadherin beta 17 pseudogene
hsa:54660;PCDHB18,PCDH-psi2;protocadherin beta 18 pseudogene
hsa:100151643;KRTAP20-4,KAP20.4;keratin associated protein 20-4
hsa:729633;MRS2P2;MRS2 magnesium homeostasis factor homolog (S. cerevisiae) pseudogene 2
hsa:387841;RPL13AP20,RPL13A_9_1211;ribosomal protein L13a pseudogene 20
hsa:442720;EIF3IP1,RG208K23;eukaryotic translation initiation factor 3, subunit I pseudogene 1
hsa:389033;;placenta-specific 9 pseudogene
hsa:100129424;RPL19P12,RPL19_4_829;ribosomal protein L19 pseudogene 12
hsa:100132103;FAM66E;family with sequence similarity 66, member E
hsa:347694;ECEL1P2,ECEL2;endothelin converting enzyme-like 1, pseudogene 2
hsa:286367;;FP944
hsa:729096;BMS1P4,BMS1LP4;BMS1 pseudogene 4
hsa:79166;LILRP2,CD85m,ILT10,LILRA5;leukocyte immunoglobulin-like receptor pseudogene 2
hsa:641311;RPL31P11,RPL31_1_108;ribosomal protein L31 pseudogene 11
hsa:7302;TYRO3P;TYRO3P protein tyrosine kinase pseudogene
hsa:359821;MRPL42P5;mitochondrial ribosomal protein L42 pseudogene 5
hsa:100131205;RPL21P28,RPL21_8_160;ribosomal protein L21 pseudogene 28
hsa:347746;PAR-SN;paternally expressed transcript PAR-SN
hsa:441818;WBP11P1,HsT3017;WW domain binding protein 11 pseudogene 1
hsa:401127;;WD repeat domain 5 pseudogene
hsa:222901;RPL23P8,RPL23_4_790;ribosomal protein L23 pseudogene 8
hsa:340198;IFITM4P,dJ377H14.5;interferon induced transmembrane protein 4 pseudogene
hsa:441455;;makorin ring finger protein 1 pseudogene
hsa:256355;RPS2P32,RPS2_14_794;ribosomal protein S2 pseudogene 32
hsa:2713;GK3P,GKP3,GKTB;glycerol kinase 3 pseudogene
hsa:646243;CXADRP2;coxsackie virus and adenovirus receptor pseudogene 2
hsa:83956;RACGAP1P,FKSG42;Rac GTPase activating protein 1 pseudogene
hsa:345630;FBLL1;fibrillarin-like 1
hsa:441454;;prothymosin, alpha pseudogene
hsa:403340;MGC70870;C-terminal binding protein 2 pseudogene
hsa:653653;;adaptor-related protein complex 1, sigma 2 subunit pseudogene
hsa:283922;;pyruvate dehydrogenase phosphatase regulatory subunit pseudogene
hsa:7152;TOP1P2;topoisomerase (DNA) I pseudogene 2
hsa:728495;FAM74A3;family with sequence similarity 74, member A3
hsa:644172;;mitogen-activated protein kinase 8 interacting protein 1 pseudogene
hsa:171423;PDIA3P,ERp60,GRP58P;protein disulfide isomerase family A, member 3 pseudogene
hsa:401507;FAM74A1;family with sequence similarity 74, member A1
hsa:649395;;tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide pseudogene
hsa:650226;;ankyrin repeat domain 26 pseudogene
hsa:6791;AURKAPS1,AurAps1,STK6P;aurora kinase A pseudogene 1
hsa:23574;PRG1;p53-responsive gene 1
hsa:145241;ADAM21P1,ADAM21P;ADAM metallopeptidase domain 21 pseudogene 1
hsa:100335030;;FGFR1 oncogene partner 2 pseudogene
hsa:8123;PAR5,D15S226E;Prader-Willi/Angelman syndrome-5
hsa:647859;;occludin pseudogene
hsa:401135;SYT14L,CHR415SYT,SYTDEP;synaptotagmin XIV-like
hsa:100101116;TTTY1B;testis-specific transcript, Y-linked 1B (non-protein coding)
hsa:100101117;TTTY2B;testis-specific transcript, Y-linked 2B (non-protein coding)
hsa:100101121;TTTY23B;testis-specific transcript, Y-linked 23B (non-protein coding)
hsa:492303;GEMIN8P4;gem (nuclear organelle) associated protein 8 pseudogene 4
hsa:442245;GSTM2P1;glutathione S-transferase mu 2 (muscle) pseudogene 1
hsa:93164;HTR7P1,HTR7P;5-hydroxytryptamine (serotonin) receptor 7 pseudogene 1
hsa:6458;SH3GL1P1,CNSA-P1,SH3GLP1;SH3-domain GRB2-like 1 pseudogene 1
hsa:400058;MKRN9P,MKRN5,MKRN9,MKRNP6,RNF65,ZNF127L3;makorin ring finger protein 9, pseudogene
hsa:6459;SH3GL1P2,CNSA-P2,SH3GLP2;SH3-domain GRB2-like 1 pseudogene 2
hsa:728402;TPI1P3;triosephosphate isomerase 1 pseudogene 3
hsa:3580;CXCR2P1,CXCR2P,IL8RBP;chemokine (C-X-C motif) receptor 2 pseudogene 1
hsa:286102;TMED10P1,TMED10P,Tmp21-II;transmembrane emp24-like trafficking protein 10 (yeast) pseudogene 1
hsa:9366;RAB9BP1,RAB9P1;RAB9B, member RAS oncogene family pseudogene 1
hsa:352887;GYG2P1,GYG2P;glycogenin 2 pseudogene 1
hsa:644511;RPL13AP6,RPL13A_7_1096,bA348N5.5;ribosomal protein L13a pseudogene 6
hsa:619190;FDPSL2A,FDPSP2,FPSL2,FDPSL2;MGC44478
hsa:100133144;UBE2Q2P3;ubiquitin-conjugating enzyme E2Q family member 2 pseudogene 3
hsa:56120;PCDHGB8P,PCDH-PSI3;protocadherin gamma subfamily B, 8 pseudogene
hsa:441502;RPS26P11,RPS26L1,RPS26_22_1784,bA366E13.1;ribosomal protein S26 pseudogene 11
hsa:149992;ANKRD30BP2,C21orf99,CT85,CTSP-1,CTSP1;ankyrin repeat domain 30B pseudogene 2
hsa:730152;GSTA7P,GSTAP2;glutathione S-transferase alpha 7, pseudogene
hsa:100379220;TMED11P;transmembrane emp24 protein transport domain containing 11, pseudogene
hsa:390705;;protein phosphatase 2, regulatory subunit B'', beta pseudogene
hsa:442132;;golgin A6 family-like 1 pseudogene
hsa:642236;;FSHD region gene 1 pseudogene
hsa:645339;SNRPD2P2;small nuclear ribonucleoprotein D2 pseudogene 2
hsa:728377;;Rho guanine nucleotide exchange factor (GEF) 5 pseudogene
hsa:100132352;;FSHD region gene 1 pseudogene
hsa:729970;;hCG2028352-like
hsa:100131635;;hCG1645011-like
hsa:168741;PER4;period homolog 3 (Drosophila) pseudogene
hsa:80316;PPP1R2P9,I-4;protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9
hsa:441089;CRSP8P;mediator complex subunit 27 pseudogene
hsa:644145;;exocyst complex component 1 pseudogene
hsa:643486;;bromodomain, testis-specific pseudogene
hsa:643036;SLED1;proteoglycan 3 pseudogene
hsa:440888;ACTR3BP2,FKSG73;ARP3 actin-related protein 3 homolog B (yeast) pseudogene 2
hsa:388503;C3P1,CPLP;complement component 3 precursor pseudogene
hsa:645682;POU5F1P4,POU5FLC1;POU class 5 homeobox 1 pseudogene 4
hsa:642559;POU5F1P3,OTF3L,POU5F1L,POU5FLC12;POU class 5 homeobox 1 pseudogene 3
hsa:728024;;chromosome X open reading frame 56 pseudogene
hsa:55545;MSX2P1,HPX5,HSHPX5,MSX2P;msh homeobox 2 pseudogene 1
hsa:7151;TOP1P1;topoisomerase (DNA) I pseudogene 1
hsa:145165;ST13P4,FAM10A4,FAM10A4P;suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 4
hsa:303;ANXA2P1,ANX2L1,ANX2P1,LPC2A;annexin A2 pseudogene 1
hsa:100133234;SBF1P1;SET binding factor 1 pseudogene 1
hsa:100288527;REXO1L2P;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 2 (pseudogene)
hsa:253724;GNN;Grp94 neighboring nucleotidase pseudogene
hsa:100500773;;serine/arginine-rich splicing factor 3 pseudogene
hsa:100133315;;transient receptor potential cation channel, subfamily C, member 2-like
hsa:391037;SKINTL,SKINT1,SKINTP;Skint-like, pseudogene
hsa:100289017;MOXD2P,MOXD2;monooxygenase, DBH-like 2, pseudogene
hsa:344405;PRORSD1P,NCRNA00117,PRDXDD1P,Prdxdd1,Ybakd1;prolyl-tRNA synthetase associated domain containing 1, pseudogene
hsa:729522;AACSP1,AACSL;acetoacetyl-CoA synthetase pseudogene 1
hsa:246182;AKR7A2P1,AFARP1;aldo-keto reductase family 7, member A2 pseudogene 1
hsa:3453;IFNA22P,IFNAP22;interferon, alpha 22, pseudogene
hsa:2498;FTH1P3,FTHL3,FTHL3P;ferritin, heavy polypeptide 1 pseudogene 3
hsa:160313;KRT19P2;keratin 19 pseudogene 2
hsa:646214;;p21 protein (Cdc42/Rac)-activated kinase 2 pseudogene
hsa:494127;;NFYC pseudogene
hsa:220429;CTAGE10P;CTAGE family, member 10, pseudogene
hsa:286495;TTC3P1,RNF105L,TTC3L;tetratricopeptide repeat domain 3 pseudogene 1
hsa:664709;HNRNPA1P10,HNRPA1L-2;heterogeneous nuclear ribonucleoprotein A1 pseudogene 10
hsa:128102;HSD3BP4;hydroxy-delta-5-steroid dehydrogenase, 3 beta, pseudogene 4
hsa:5301;PIN1P1,PIN1L;peptidylprolyl cis/trans isomerase, NIMA-interacting 1 pseudogene 1
hsa:91353;IGLL3P,16.1,IGLL3;immunoglobulin lambda-like polypeptide 3, pseudogene
hsa:389834;;ankyrin repeat domain 57 pseudogene
hsa:100287846;;patched 1 pseudogene
hsa:644165;BCRP3,BCR3,BCRL3,BCRL6;breakpoint cluster region pseudogene 3
hsa:305;ANXA2P3,ANX2L3,ANX2P3,LIP2,LPC2C;annexin A2 pseudogene 3
hsa:246754;MTVR2;mouse mammary tumor virus receptor homolog 2
hsa:402176;RPL21P44,RPL21_17_477;ribosomal protein L21 pseudogene 44
hsa:646201;BASP1P1;brain abundant, membrane attached signal protein 1 pseudogene 1
hsa:728739;;programmed cell death 2 pseudogene
hsa:286016;TPI1P2;triosephosphate isomerase 1 pseudogene 2
hsa:100287632;;selenoprotein K pseudogene
hsa:1720;;dihydrofolate reductase pseudogene
hsa:100131257;;zinc finger protein 655 pseudogene
hsa:646278;;programmed cell death 6 interacting protein pseudogene
hsa:392232;;transient receptor potential cation channel, subfamily A, member 1 pseudogene
hsa:150967;PKI55;DKFZp434H1419
hsa:728619;ASB9P1;ankyrin repeat and SOCS box containing 9 pseudogene 1
hsa:649264;CES5AP1;carboxylesterase 5A pseudogene 1
hsa:5969;REG1P,REGL,RS;regenerating islet-derived 1 pseudogene
hsa:100101120;TTTY7B,NCRNA00215;testis-specific transcript, Y-linked 7B (non-protein coding)
hsa:22973;LAMB2P1,LAMB2L;laminin, beta 2 pseudogene 1
hsa:6043;SNORA63,E3,E3-2,RNE3,RNU107;small nucleolar RNA, H/ACA box 63
hsa:677806;SNORA20,ACA20;small nucleolar RNA, H/ACA box 20
hsa:652965;SNORA48,ACA48;small nucleolar RNA, H/ACA box 48
hsa:100113380;SNORD125;small nucleolar RNA, C/D box 125
hsa:654319;SNORA5A,ACA5,ACA5A/B/C;small nucleolar RNA, H/ACA box 5A
hsa:677833;SNORA54,ACA54;small nucleolar RNA, H/ACA box 54
hsa:692072;SNORD5,mgh28S-2410;small nucleolar RNA, C/D box 5
hsa:654320;SNORA8,ACA8;small nucleolar RNA, H/ACA box 8
hsa:677834;SNORA55,ACA55;small nucleolar RNA, H/ACA box 55
hsa:654321;SNORA75,U23;small nucleolar RNA, H/ACA box 75
hsa:654322;SNORA13,ACA13;small nucleolar RNA, H/ACA box 13
hsa:26797;SNORD52,RNU52,U52;small nucleolar RNA, C/D box 52
hsa:677837;SNORA60,ACA60;small nucleolar RNA, H/ACA box 60
hsa:677838;SNORA61,ACA61;small nucleolar RNA, H/ACA box 61
hsa:619498;SNORD74,U74,Z18;small nucleolar RNA, C/D box 74
hsa:26851;SNORD3B-1,RNU3A1,U3a,U3b1,U3b2;small nucleolar RNA, C/D box 3B-1
hsa:100113385;SNORD121B;small nucleolar RNA, C/D box 121B
hsa:780852;SNORD3B-2,U3-2B,U3b2;small nucleolar RNA, C/D box 3B-2
hsa:100113379;SNORD121A;small nucleolar RNA, C/D box 121A
hsa:26769;SNORD81,RNU104,U81,Z23;small nucleolar RNA, C/D box 81
hsa:26770;SNORD79,RNU103,U79,Z22;small nucleolar RNA, C/D box 79
hsa:26774;SNORD80,RNU100,U80,Z15;small nucleolar RNA, C/D box 80
hsa:677844;SNORA78,ACA64;small nucleolar RNA, H/ACA box 78
hsa:692195;SNORD75,U75;small nucleolar RNA, C/D box 75
hsa:677845;SNORA79,ACA65;small nucleolar RNA, H/ACA box 79
hsa:100113392;SNORD11B;small nucleolar RNA, C/D box 11B
hsa:692196;SNORD76,U76;small nucleolar RNA, C/D box 76
hsa:677882;SNORA59B,ACA59;small nucleolar RNA, H/ACA box 59B
hsa:692200;SNORD85,HBII-251;small nucleolar RNA, C/D box 85
hsa:100113378;SNORD119;small nucleolar RNA, C/D box 119
hsa:692197;SNORD77,U77;small nucleolar RNA, C/D box 77
hsa:692202;SNORD88A,HBII-180A;small nucleolar RNA, C/D box 88A
hsa:692198;SNORD78,U78;small nucleolar RNA, C/D box 78
hsa:692203;SNORD88B,HBII-180B;small nucleolar RNA, C/D box 88B
hsa:692204;SNORD88C,HBII-180C;small nucleolar RNA, C/D box 88C
hsa:26788;SNORD60,RNU60,U60;small nucleolar RNA, C/D box 60
hsa:692205;SNORD89,HBII-289;small nucleolar RNA, C/D box 89
hsa:26789;SNORD59A,RNU59,U59;small nucleolar RNA, C/D box 59A
hsa:26792;SNORD57,RNU57,U57;small nucleolar RNA, C/D box 57
hsa:692207;SNORD91A,HBII-296a;small nucleolar RNA, C/D box 91A
hsa:26793;SNORD56,RNU56,U56;small nucleolar RNA, C/D box 56
hsa:692208;SNORD91B,HBII-296b;small nucleolar RNA, C/D box 91B
hsa:26796;SNORD53,RNU53,U53;small nucleolar RNA, C/D box 53
hsa:692209;SNORD92,HBII-316;small nucleolar RNA, C/D box 92
hsa:692073;SNORA16A,ACA16;small nucleolar RNA, H/ACA box 16A
hsa:692210;SNORD93,HBII-336;small nucleolar RNA, C/D box 93
hsa:319139;SNORD56B,RNU56B;small nucleolar RNA, C/D box 56B
hsa:692211;SNORD98,HBII-419;small nucleolar RNA, C/D box 98
hsa:26800;SNORD49A,RNU49,U49,U49A;small nucleolar RNA, C/D box 49A
hsa:692212;SNORD99,HBII-420;small nucleolar RNA, C/D box 99
hsa:26802;SNORD47,RNU47,U47;small nucleolar RNA, C/D box 47
hsa:692214;SNORD111,HBII-82;small nucleolar RNA, C/D box 111
hsa:26804;SNORD45B,RNU45B,U45b;small nucleolar RNA, C/D box 45B
hsa:26805;SNORD45A,RNU45A,U45a;small nucleolar RNA, C/D box 45A
hsa:574040;SNORA6,ACA6;small nucleolar RNA, H/ACA box 6
hsa:26810;SNORD41,RNU41,U41;small nucleolar RNA, C/D box 41
hsa:6090;RNY5,Y5;RNA, Ro-associated Y5
hsa:26784;SNORA64,RNU64,U64;small nucleolar RNA, H/ACA box 64
hsa:574042;SNORA10,ACA10;small nucleolar RNA, H/ACA box 10
hsa:677824;SNORA43,ACA43;small nucleolar RNA, H/ACA box 43
hsa:677795;SNORA5B,ACA5b;small nucleolar RNA, H/ACA box 5B
hsa:677797;SNORA7B,ACA7B;small nucleolar RNA, H/ACA box 7B
hsa:677816;SNORA35,HBI-36;small nucleolar RNA, H/ACA box 35
hsa:100302738;RNU6-21;RNA, U6 small nuclear 21
hsa:677842;SNORA76,ACA62;small nucleolar RNA, H/ACA box 76
hsa:677846;SNORA80,ACA67;small nucleolar RNA, H/ACA box 80
hsa:100147744;RNU7-1,RNU7,U7.1;RNA, U7 small nuclear 1
hsa:100302741;RNU6-15;RNA, U6 small nuclear 15
hsa:100302742;RNU6-42;RNA, U6 small nuclear 42
hsa:100302743;SNORA80B,ACA67B;small nucleolar RNA, H/ACA box 80B
hsa:6080;SNORA73A,E1,E1-7,E1b,RNE1,RNU17A,U17A;small nucleolar RNA, H/ACA box 73A
hsa:692075;SNORD6,mgh28S-2412;small nucleolar RNA, C/D box 6
hsa:26791;SNORD58A,RNU58A,U58a;small nucleolar RNA, C/D box 58A
hsa:26790;SNORD58B,RNU58B,U58b;small nucleolar RNA, C/D box 58B
hsa:26771;SNORD102,RNU102,Z18;small nucleolar RNA, C/D box 102
hsa:26835;RNU4-1,RNU4A,RNU4B2,U4,U4BL;RNA, U4 small nuclear 1
hsa:619499;SNORA27,ACA27;small nucleolar RNA, H/ACA box 27
hsa:100124542;SNORA11E;small nucleolar RNA, H/ACA box 11E
hsa:692225;SNORD94,U94;small nucleolar RNA, C/D box 94
hsa:692226;SNORD96B,U96b;small nucleolar RNA, C/D box 96B
hsa:677818;SNORA36B,ACA36b;small nucleolar RNA, H/ACA box 36B
hsa:692227;SNORD104,U104;small nucleolar RNA, C/D box 104
hsa:319103;SNORD8,RNU6C,mgU6-53;small nucleolar RNA, C/D box 8
hsa:100126798;SNAR-A1,SNAR-A53113498;small ILF3/NF90-associated RNA A1
hsa:652966;SNORD10,mgU6-77;small nucleolar RNA, C/D box 10
hsa:100126780;SNAR-G1;small ILF3/NF90-associated RNA G1
hsa:100126799;SNAR-A2,SNAR-A53129250;small ILF3/NF90-associated RNA A2
hsa:100126781;SNAR-F;small ILF3/NF90-associated RNA F
hsa:100126800;SNAR-A12,SNAR-A53102747;small ILF3/NF90-associated RNA A12
hsa:684959;SNORA25,ACA25;small nucleolar RNA, H/ACA box 25
hsa:26766;RNU105C,E1-5,E1-6;RNA, U105C small nucleolar
hsa:26795;SNORD54,RNU54,U54;small nucleolar RNA, C/D box 54
hsa:619505;SNORA21,ACA21;small nucleolar RNA, H/ACA box 21
hsa:692053;SNORD9,mgU6-53B;small nucleolar RNA, C/D box 9
hsa:692106;SNORD65,HBII-135;small nucleolar RNA, C/D box 65
hsa:692157;SNORA16B,U98b;small nucleolar RNA, H/ACA box 16B
hsa:692158;SNORA57,U99;small nucleolar RNA, H/ACA box 57
hsa:692110;SNORD70,HBII-234;small nucleolar RNA, C/D box 70
hsa:6085;RNY3,HY3,Y3;RNA, Ro-associated Y3
hsa:692111;SNORD71,HBII-239,MIRN768,hsa-mir-768;small nucleolar RNA, C/D box 71
hsa:6086;RNY4,HY4,Y4;RNA, Ro-associated Y4
hsa:100169951;SNAR-A3;small ILF3/NF90-associated RNA A3
hsa:100169956;SNAR-A4;small ILF3/NF90-associated RNA A4
hsa:26815;SNORD36A,RNU36A,U36a;small nucleolar RNA, C/D box 36A
hsa:100169959;SNAR-A13;small ILF3/NF90-associated RNA A13
hsa:26863;RNU1-5,RNU1P1,RNU1P9,U1.15,U1P101,U1P15;RNA, U1 small nuclear 5
hsa:100170218;SNAR-C2;small ILF3/NF90-associated RNA C2
hsa:100170219;SNAR-C4;small ILF3/NF90-associated RNA C4
hsa:692223;SNORD97,U97;small nucleolar RNA, C/D box 97
hsa:100170223;SNAR-C5;small ILF3/NF90-associated RNA C5
hsa:267010;RNU12,RNU12-1,RNU12L,RNU12P,dJ222E13.7;RNA, U12 small nuclear
hsa:100170225;SNAR-C1;small ILF3/NF90-associated RNA C1
hsa:100170226;SNAR-C3;small ILF3/NF90-associated RNA C3
hsa:692107;SNORD66,HBII-142;small nucleolar RNA, C/D box 66
hsa:26834;RNU4-2,RNU4-1B,RNU4B1,RNU4C,U4A,U4b,U4c;RNA, U4 small nuclear 2
hsa:677828;SNORA47,HBI-115;small nucleolar RNA, H/ACA box 47
hsa:677832;SNORA53,ACA53;small nucleolar RNA, H/ACA box 53
hsa:9304;SNORD22,RNU22,U22;small nucleolar RNA, C/D box 22
hsa:9297;SNORD29,RNU29,U29;small nucleolar RNA, C/D box 29
hsa:6044;SNORA62,E2,E2-1,RNE2,RNU108;small nucleolar RNA, H/ACA box 62
hsa:9298;SNORD31,RNU31,U31;small nucleolar RNA, C/D box 31
hsa:9299;SNORD30,RNU30,U30;small nucleolar RNA, C/D box 30
hsa:9300;SNORD28,RNU28,U28;small nucleolar RNA, C/D box 28
hsa:9301;SNORD27,RNU27,U27;small nucleolar RNA, C/D box 27
hsa:9302;SNORD26,RNU26,U26;small nucleolar RNA, C/D box 26
hsa:8944;SNORD73A,RNU73,RNU73A,U73,U73a;small nucleolar RNA, C/D box 73A
hsa:9303;SNORD25,RNU25,U25;small nucleolar RNA, C/D box 25
hsa:26772;SNORD4B,RNU101B,Z17B;small nucleolar RNA, C/D box 4B
hsa:677885;SNORA59A,ACA59;small nucleolar RNA, H/ACA box 59A
hsa:26768;RNU105A,105A,E1c;RNA, U105A small nucleolar
hsa:85388;SNORD14B,RNU14B,U14,U14B;small nucleolar RNA, C/D box 14B
hsa:26773;SNORD4A,RNU101A,Z17A,mgh18S-121;small nucleolar RNA, C/D box 4A
hsa:26778;SNORA70,DXS648E,RNU70,U70;small nucleolar RNA, H/ACA box 70
hsa:727676;SNORD118,U8;small nucleolar RNA, C/D box 118
hsa:26780;SNORA68,RNU68,U68;small nucleolar RNA, H/ACA box 68
hsa:26824;RNU11,U11;RNA, U11 small nuclear
hsa:26808;SNORD42B,RNU42B,U42B;small nucleolar RNA, C/D box 42B
hsa:94162;SNORD38A,RNU38A,U38A;small nucleolar RNA, C/D box 38A
hsa:26809;SNORD42A,RNU42A,U42,U42A;small nucleolar RNA, C/D box 42A
hsa:94163;SNORD38B,RNU38B,U38B;small nucleolar RNA, C/D box 38B
hsa:26813;SNORD36C,RNU36C,U36c;small nucleolar RNA, C/D box 36C
hsa:692235;SNORD103B,U103B;small nucleolar RNA, C/D box 103B
hsa:26814;SNORD36B,RNU36B,U36b;small nucleolar RNA, C/D box 36B
hsa:26816;SNORD35A,RNU35,RNU35A,U35;small nucleolar RNA, C/D box 35A
hsa:619562;SNORA3,ACA3;small nucleolar RNA, H/ACA box 3
hsa:26817;SNORD34,RNU34,U34;small nucleolar RNA, C/D box 34
hsa:26775;SNORA72,RNU72,U72;small nucleolar RNA, H/ACA box 72
hsa:26818;SNORD33,RNU33,U33;small nucleolar RNA, C/D box 33
hsa:619563;SNORA7A,ACA7;small nucleolar RNA, H/ACA box 7A
hsa:26819;SNORD32A,RNU32,U32,U32A;small nucleolar RNA, C/D box 32A
hsa:619564;SNORD72,HBII-240;small nucleolar RNA, C/D box 72
hsa:26822;SNORD14A,RNU14,RNU14A,U14,U14-S13-5;small nucleolar RNA, C/D box 14A
hsa:619565;SNORA52,ACA52;small nucleolar RNA, H/ACA box 52
hsa:26811;SNORD55,RNU39,RNU55,SNORD39,U39,U55;small nucleolar RNA, C/D box 55
hsa:26820;SNORD24,RNU24,U24;small nucleolar RNA, C/D box 24
hsa:619567;SNORD2,R39B,SNR39B;small nucleolar RNA, C/D box 2
hsa:94161;SNORD46,RNU40,RNU46,U40,U46;small nucleolar RNA, C/D box 46
hsa:619568;SNORA4,ACA4;small nucleolar RNA, H/ACA box 4
hsa:114599;SNORD15B,RNU15B,U15B;small nucleolar RNA, C/D box 15B
hsa:26798;SNORD51,RNU51,U51;small nucleolar RNA, C/D box 51
hsa:619569;SNORA41,ACA41;small nucleolar RNA, H/ACA box 41
hsa:619570;SNORD95,U95;small nucleolar RNA, C/D box 95
hsa:619571;SNORD96A,U96A;small nucleolar RNA, C/D box 96A
hsa:26765;SNORD12C,E2,E2-1,E3,RNU106,SNORD106,U106;small nucleolar RNA, C/D box 12C
hsa:100151684;RNU6ATAC,RNU6ATAC1,U6ATAC;RNA, U6atac small nuclear (U12-dependent splicing)
hsa:100169952;SNAR-A5;small ILF3/NF90-associated RNA A5
hsa:100169953;SNAR-A7;small ILF3/NF90-associated RNA A7
hsa:100169954;SNAR-A11;small ILF3/NF90-associated RNA A11
hsa:100169955;SNAR-A9;small ILF3/NF90-associated RNA A9
hsa:100169957;SNAR-A6;small ILF3/NF90-associated RNA A6
hsa:100169958;SNAR-A8;small ILF3/NF90-associated RNA A8
hsa:100170216;SNAR-A10;small ILF3/NF90-associated RNA A10
hsa:100170217;SNAR-B2;small ILF3/NF90-associated RNA B2
hsa:606500;SNORD68,HBII-202;small nucleolar RNA, C/D box 68
hsa:692084;SNORD13,RNU13,U13;small nucleolar RNA, C/D box 13
hsa:100170224;SNAR-B1;small ILF3/NF90-associated RNA B1
hsa:692057;SNORD12,HBII-99,MIR1259,MIRN1259;small nucleolar RNA, C/D box 12
hsa:692085;SNORD45C,U45C;small nucleolar RNA, C/D box 45C
hsa:692058;SNORD11,HBII-95;small nucleolar RNA, C/D box 11
hsa:692087;SNORD49B,U49B;small nucleolar RNA, C/D box 49B
hsa:692063;SNORA32,ACA32;small nucleolar RNA, H/ACA box 32
hsa:692086;SNORD17,HBI-43;small nucleolar RNA, C/D box 17
hsa:780853;SNORD3C,U3-3;small nucleolar RNA, C/D box 3C
hsa:692090;SNORD59B,U59B;small nucleolar RNA, C/D box 59B
hsa:780854;SNORD3D,U3-4;small nucleolar RNA, C/D box 3D
hsa:692091;SNORD23,HBII-115;small nucleolar RNA, C/D box 23
hsa:26869;RNU1-3,HSD4,RNU1G3;RNA, U1 small nuclear 3
hsa:692092;SNORD32B,U32B;small nucleolar RNA, C/D box 32B
hsa:692093;SNORD62B,U62,U62B;small nucleolar RNA, C/D box 62B
hsa:677829;SNORA49,ACA49;small nucleolar RNA, H/ACA box 49
hsa:595097;SNORD16,U16;small nucleolar RNA, C/D box 16
hsa:26870;RNU1-2,RNU1C1,RNU1C2,U1C1,U1C21;RNA, U1 small nuclear 2
hsa:595098;SNORD18A,U18A;small nucleolar RNA, C/D box 18A
hsa:595099;SNORD18B,U18B;small nucleolar RNA, C/D box 18B
hsa:595100;SNORD18C,U18C;small nucleolar RNA, C/D box 18C
hsa:100170221;SNAR-H,snaR-2;small ILF3/NF90-associated RNA H
hsa:100312957;RNU1-6;RNA, U1 small nuclear 6
hsa:100170222;SNAR-I,snaR-3;small ILF3/NF90-associated RNA I
hsa:26865;RNU1-7;RNA, U1 small nuclear 7
hsa:677793;SNORA2A,ACA2A;small nucleolar RNA, H/ACA box 2A
hsa:677794;SNORA2B,ACA2b;small nucleolar RNA, H/ACA box 2B
hsa:677798;SNORA9,ACA9;small nucleolar RNA, H/ACA box 9
hsa:26866;RNU1-8;RNA, U1 small nuclear 8
hsa:26806;SNORD44,RNU44,U44;small nucleolar RNA, C/D box 44
hsa:26864;RNU1-9;RNA, U1 small nuclear 9
hsa:26812;SNORD37,RNU37,U37;small nucleolar RNA, C/D box 37
hsa:6060;RNU1-4,HSD2,HSD5,HSD6,HSD7,RNU1,RNU1D2,RNU1E2,RNU1F1,RNU1G1,RNU1G2,U1B2,U1D2,U1E2,U1F;RNA, U1 small nuclear 4
hsa:677803;SNORA15,ACA15;small nucleolar RNA, H/ACA box 15
hsa:677804;SNORA17,ACA17;small nucleolar RNA, H/ACA box 17
hsa:677805;SNORA18,ACA18;small nucleolar RNA, H/ACA box 18
hsa:100036563;SNORD115-24,HBII-52-24;small nucleolar RNA, C/D box 115-24
hsa:677807;SNORA22,ACA22;small nucleolar RNA, H/ACA box 22
hsa:677808;SNORA23,ACA23;small nucleolar RNA, H/ACA box 23
hsa:677809;SNORA24,ACA24;small nucleolar RNA, H/ACA box 24
hsa:677811;SNORA28,ACA28;small nucleolar RNA, H/ACA box 28
hsa:677812;SNORA29,ACA29;small nucleolar RNA, H/ACA box 29
hsa:677814;SNORA31,ACA31;small nucleolar RNA, H/ACA box 31
hsa:677815;SNORA34,ACA34;small nucleolar RNA, H/ACA box 34
hsa:6082;SNORD20,RNU20,U20;small nucleolar RNA, C/D box 20
hsa:26767;RNU105B,105B,E1-2;RNA, U105B small nucleolar
hsa:677820;SNORA38,ACA38;small nucleolar RNA, H/ACA box 38
hsa:677821;SNORA39,ACA39;small nucleolar RNA, H/ACA box 39
hsa:677792;SNORA1,ACA1;small nucleolar RNA, H/ACA box 1
hsa:26781;SNORA67,RNU67,U67;small nucleolar RNA, H/ACA box 67
hsa:677822;SNORA40,ACA40;small nucleolar RNA, H/ACA box 40
hsa:594837;SNORD101,U101;small nucleolar RNA, C/D box 101
hsa:100113393;SNORD12B;small nucleolar RNA, C/D box 12B
hsa:594838;SNORD100,HBII-429;small nucleolar RNA, C/D box 100
hsa:26786;SNORD62A,RNU62,U62,U62A;small nucleolar RNA, C/D box 62A
hsa:100113389;SNORD127;small nucleolar RNA, C/D box 127
hsa:100191063;SNAR-A14;small ILF3/NF90-associated RNA A14
hsa:677825;SNORA44,ACA44;small nucleolar RNA, H/ACA box 44
hsa:26821;SNORA74A,RNU19,U19;small nucleolar RNA, H/ACA box 74A
hsa:594839;SNORA33,ACA33;small nucleolar RNA, H/ACA box 33
hsa:100170228;SNAR-G2;small ILF3/NF90-associated RNA G2
hsa:677827;SNORA46,ACA46;small nucleolar RNA, H/ACA box 46
hsa:100124534;SNORA84;small nucleolar RNA, H/ACA box 84
hsa:100113391;SNORD126,MIR1201,MIRN1201;small nucleolar RNA, C/D box 126
hsa:641451;SNORA19,ACA19;small nucleolar RNA, H/ACA box 19
hsa:677830;SNORA50,ACA50;small nucleolar RNA, H/ACA box 50
hsa:7686;MKRN7P,MKRNP3,ZNF127L5,dJ981L23.2;makorin ring finger protein 7, pseudogene
hsa:100170227;SNAR-D;small ILF3/NF90-associated RNA D
hsa:29065;ASAP1-IT1,ASAP1-IT,ASAP1IT,ASAP1IT1,DDEF1IT1,HSPC054,NCRNA00050;ASAP1 intronic transcript 1 (non-protein coding)
hsa:9288;TAAR3,GPR57,GPR58,TAAR2;trace amine associated receptor 3 (gene/pseudogene)
hsa:93556;EGFEM1P,C3orf50,NCRNA00259;EGF-like and EMI domain containing 1, pseudogene
hsa:3116;HLA-DPB2,DP2B,DPB2,DPbeta2,HLA-DP2B;major histocompatibility complex, class II, DP beta 2 (pseudogene)
hsa:56663;VTRNA1-2,HVG2,VAULTRC2,VR2,hvg-2;vault RNA 1-2
hsa:56662;VTRNA1-3,HVG3,VAULTRC3,VR3,hvg-3;vault RNA 1-3
hsa:26255;PTTG3P,PTTG3,rcPTTG1;pituitary tumor-transforming 3, pseudogene
hsa:644314;MT1IP,MT1,MT1I,MTE;metallothionein 1I, pseudogene
hsa:7146;TNXA,D6S103E,HXBL,TNX,XA;tenascin XA (pseudogene)
hsa:442211;ATP6V0CP3;ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c pseudogene 3
hsa:100616530;;tospeak
hsa:619383;SCARNA9,Z32,mgU2-19/30;small Cajal body-specific RNA 9
hsa:677766;SCARNA2,HBII-382,mgU2-25/61;small Cajal body-specific RNA 2
hsa:100124533;SCARNA27;small Cajal body-specific RNA 27
hsa:692148;SCARNA10,U85;small Cajal body-specific RNA 10
hsa:692149;SCARNA14,U100;small Cajal body-specific RNA 14
hsa:677679;SCARNA3,HBI-100;small Cajal body-specific RNA 3
hsa:677681;SCARNA20,ACA66;small Cajal body-specific RNA 20
hsa:677763;SCARNA21,ACA68;small Cajal body-specific RNA 21
hsa:677767;SCARNA7,U90;small Cajal body-specific RNA 7
hsa:677768;SCARNA13,U93;small Cajal body-specific RNA 13
hsa:677770;SCARNA22,ACA11;small Cajal body-specific RNA 22
hsa:677772;SCARNA6,U88;small Cajal body-specific RNA 6
hsa:677773;SCARNA23,ACA12;small Cajal body-specific RNA 23
hsa:677776;SCARNA8,U92;small Cajal body-specific RNA 8
hsa:677778;SCARNA15,ACA45;small Cajal body-specific RNA 15
hsa:677780;SCARNA11,ACA57;small Cajal body-specific RNA 11
hsa:677781;SCARNA16,ACA47;small Cajal body-specific RNA 16
hsa:677769;SCARNA17,U91;small Cajal body-specific RNA 17
hsa:677774;SCARNA1,ACA35;small Cajal body-specific RNA 1
hsa:653162;RPSAP9,LAMR1P9,RPSA_20_986;ribosomal protein SA pseudogene 9
hsa:284232;ANKRD20A9P;ankyrin repeat domain 20 family, member A9, pseudogene
hsa:171220;DSTNP2;destrin (actin depolymerizing factor) pseudogene 2
hsa:83869;TTTY14,CYorf14,NCRNA00137,NCRNA00185,PRO2834,TTY14;testis-specific transcript, Y-linked 14 (non-protein coding)
hsa:441046;GUSBP5,GYPELOC441046;glucuronidase, beta pseudogene 5
hsa:642006;GUSBP10;glucuronidase, beta pseudogene 10
hsa:100130673;;phosphoribosyl pyrophosphate synthetase 2 pseudogene
hsa:3311;HSPA7,HSP70B;heat shock 70kDa protein 7 (HSP70B)
hsa:222699;TOB2P1,TOB2P,TOB4p,p373c6.3;transducer of ERBB2, 2 pseudogene 1
hsa:677836;SNORA58,ACA58;small nucleolar RNA, H/ACA box 58
hsa:644189;;acyl-CoA thioesterase 4 pseudogene
hsa:23782;AP1B1P1,ADTB1L1,dJ127L4.2;adaptor-related protein complex 1, beta 1 subunit pseudogene 1
hsa:348926;FAM86EP;family with sequence similarity 86, member A pseudogene
hsa:653113;FAM86FP;family with sequence similarity 86, member A pseudogene
hsa:677819;SNORA37,ACA37;small nucleolar RNA, H/ACA box 37
hsa:387254;SLC7A5P2,IMAA,MMAA;solute carrier family 7 (amino acid transporter light chain, L system), member 5 pseudogene 2
hsa:85389;SNORD14C;small nucleolar RNA, C/D box 14C
hsa:26785;SNORD63,RNU63,U63;small nucleolar RNA, C/D box 63
hsa:677843;SNORA77,ACA63;small nucleolar RNA, H/ACA box 77
hsa:85390;SNORD14D;small nucleolar RNA, C/D box 14D
hsa:85391;SNORD14E;small nucleolar RNA, C/D box 14E
hsa:100652931;;RNA binding motif protein, Y-linked, family 1, member B pseudogene
hsa:606551;UBE2MP1;ubiquitin-conjugating enzyme E2M pseudogene 1
hsa:401980;;4933406M09Rik pseudogene
hsa:26829;RNU5E-1,RNU5E,U5E;RNA, U5E small nuclear 1
hsa:26828;RNU5F-1,RNU5F,U5F;RNA, U5F small nuclear 1
hsa:26831;RNU5A-1,RNU5,RNU5A,RNU5C,U5A,U5B1;RNA, U5A small nuclear 1
hsa:26830;RNU5D-1,RNU5D,U5DL,U5DS;RNA, U5D small nuclear 1
hsa:1590;CYP21A1P,CYP21A,CYP21P,P450c21A;cytochrome P450, family 21, subfamily A, polypeptide 1 pseudogene
hsa:119437;CTAGE7P,CTAGE7,CTAGEP,bA500G10.2,rcCTAGE5;CTAGE family, member 7, pseudogene
hsa:399746;ACTR3BP5,FKSG74;ARP3 actin-related protein 3 homolog B (yeast) pseudogene 5
hsa:641373;NRON,NCRNA00194;non-protein coding RNA, repressor of NFAT
hsa:93668;HPYR1,HPRG1,LINC00027,NCRNA00027;Helicobacter pylori responsive 1 (non-protein coding)
hsa:100422903;MIR4288;microRNA 4288
hsa:6029;RN7SL1,7L1a,7SL,RN7SL,RNSRP1;RNA, 7SL, cytoplasmic 1
hsa:7696;ZNF137P,ZNF137,pHZ-30;zinc finger protein 137, pseudogene
hsa:4213;MEIS3P1,MEIS3,MEIS4,MRG2;Meis homeobox 3 pseudogene 1
hsa:6719;SRD5A1P1,SRD5AP1;steroid-5-alpha-reductase, alpha polypeptide 1 pseudogene 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha pseudogene)
hsa:6066;RNU2-1,RNU2,U2;RNA, U2 small nuclear 1
hsa:6084;RNY1,HY1,Y1;RNA, Ro-associated Y1
hsa:245;ALOX12P2,ALOX12E;arachidonate 12-lipoxygenase pseudogene 2
hsa:114760;TTTY3,LINC00121,NCRNA00121,TTTY3A,TTY3;testis-specific transcript, Y-linked 3 (non-protein coding)
hsa:257357;BRWD1-IT2,C21orf87,NCRNA00257;BRWD1 intronic transcript 2 (non-protein coding)
hsa:440072;LINC00167,C11orf37,NCRNA00167;long intergenic non-protein coding RNA 167
hsa:60439;TTTY2,NCRNA00109,TTY2,lINC00109;testis-specific transcript, Y-linked 2 (non-protein coding)
hsa:649159;LINC00273,NCRNA00273,TOP;long intergenic non-protein coding RNA 273
hsa:283267;LINC00294,NCRNA00294;long intergenic non-protein coding RNA 294
hsa:205251;LINC00116,NCRNA00116;long intergenic non-protein coding RNA 116
hsa:359822;KCNIP4-IT1,NCRNA00099,UM9(5),UM9-5;KCNIP4 intronic transcript 1 (non-protein coding)
hsa:79854;LINC00115,NCRNA00115;long intergenic non-protein coding RNA 115
hsa:64433;LINC00244,C7orf4,NCRNA00244;long intergenic non-protein coding RNA 244
hsa:64735;LINC00254,C16orf32,NCRNA00254;long intergenic non-protein coding RNA 254
hsa:64493;LINC00235,C16orf10,NCRNA00235;long intergenic non-protein coding RNA 235
hsa:6083;SNORD21,RNU21,U21;small nucleolar RNA, C/D box 21
hsa:10151;HNRNPA3P1,D10S102,FBRNP,HNRPA3,HNRPA3P1;heterogeneous nuclear ribonucleoprotein A3 pseudogene 1
hsa:1057;CELP,CELL,cell1,cell2,cell3;carboxyl ester lipase pseudogene
hsa:441543;TTTY6B,LINC00128,NCRNA00128,TTTY6,TTY6;testis-specific transcript, Y-linked 6B (non-protein coding)
hsa:440184;LINC00238,C14orf53,NCRNA00238;long intergenic non-protein coding RNA 238
hsa:80035;ANP32A-IT1,C15orf28,HsT18971,NCRNA00321;ANP32A intronic transcript 1 (non-protein coding)
hsa:8552;INE1,NCRNA00010;inactivation escape 1 (non-protein coding)
hsa:100551499;LINC00159,C21orf44,NCRNA00159;long intergenic non-protein coding RNA 159
hsa:8847;DLEU2,1B4,BCMSUN,DLB2,LEU2,LINC00022,MIR15AHG,NCRNA00022,RFP2OS,TRIM13OS;deleted in lymphocytic leukemia 2 (non-protein coding)
hsa:474150;TTTY4C,LINC00125,NCRNA00125;testis-specific transcript, Y-linked 4C (non-protein coding)
hsa:474149;TTTY4B,LINC00124,NCRNA00124;testis-specific transcript, Y-linked 4B (non-protein coding)
hsa:8511;MMP23A,MIFR,MIFR-1,MMP21;matrix metallopeptidase 23A (pseudogene)
hsa:79992;AGPAT4-IT1,C6orf59,NCRNA00241;AGPAT4 intronic transcript 1 (non-protein coding)
hsa:29034;CPS1-IT1,CPS1-IT,CPS1IT,CPS1IT1,PRO0132;CPS1 intronic transcript 1 (non-protein coding)
hsa:26787;SNORD61,HBII-342,RNU61,U61;small nucleolar RNA, C/D box 61
hsa:26782;SNORA66,RNU66,U66;small nucleolar RNA, H/ACA box 66
hsa:26799;SNORD50A,RNU50,U50;small nucleolar RNA, C/D box 50A
hsa:54441;STAG3L1,STAG3L2,STAG3L3;stromal antigen 3-like 1
hsa:23629;BRD7P3,BP75;bromodomain containing 7 pseudogene 3
hsa:27160;INGX,ING1-like,ING2;inhibitor of growth family, X-linked, pseudogene
hsa:26247;OR2L1P,HSHTPCRX02,HTPCRX02,OR2L1,OR2L7P;olfactory receptor, family 2, subfamily L, member 1 pseudogene
hsa:25826;SNORD82,RNU82,U82,Z25;small nucleolar RNA, C/D box 82
hsa:53844;COPG2IT1,CIT1,COPG2AS,DKFZP761N09121,NCRNA00170;COPG2 imprinted transcript 1 (non-protein coding)
hsa:26779;SNORA69,RNU69,U69,U69A;small nucleolar RNA, H/ACA box 69
hsa:26184;OR1F2P,OLFMF2,OR16-3,OR1F11,OR1F2,OR1F3P,hg91;olfactory receptor, family 1, subfamily F, member 2
hsa:26226;FBXW4P1,FBW3,FBXW3,SHFM3P1;F-box and WD repeat domain containing 4 pseudogene 1
hsa:11209;MST1P2,MSPL-1,MSPL-2,MSPL-3,MSPL1,MSPL2,MSPL3,MSTP1,MSTP2,MSTP3;macrophage stimulating 1 (hepatocyte growth factor-like) pseudogene 2
hsa:26807;SNORD43,RNU43,U43;small nucleolar RNA, C/D box 43
hsa:56664;VTRNA1-1,HVG1,VAULTRC1,VR1,hvg-1,vRNA;vault RNA 1-1
hsa:26343;OR5E1P,HSTPCR24,OR5E1,TPCR24;olfactory receptor, family 5, subfamily E, member 1 pseudogene
hsa:10821;OR7E12P,HG1058,OR11-3,OR7E58P,OR7E79P,OR7E81P,OST021;olfactory receptor, family 7, subfamily E, member 12 pseudogene
hsa:83864;TTTY9A,NCRNA00131,TTTY9,TTY9;testis-specific transcript, Y-linked 9A (non-protein coding)
hsa:114814;GNRHR2,GnRH-II-R;gonadotropin-releasing hormone (type 2) receptor 2
hsa:139538;VENTXP1,CT18,NA88A,VENTX2P1;VENT homeobox pseudogene 1
hsa:89883;OR6W1P,OR6W1,sdolf;olfactory receptor, family 6, subfamily W, member 1 pseudogene
hsa:118433;RPL23AP7,RPL23AL1,RPL23A_6_267,bA395L14.9;ribosomal protein L23a pseudogene 7
hsa:119369;NUDT9P1,C10orf98,bA56M3.1;nudix (nucleoside diphosphate linked moiety X)-type motif 9 pseudogene 1
hsa:128854;TSPY26P,TSPYL3,bA392M18.1;testis specific protein, Y-linked 26, pseudogene
hsa:139420;SMEK3P,FLFL3P,smk1;SMEK homolog 3, suppressor of mek1 (Dictyostelium) pseudogene
hsa:81343;OR10V2P;olfactory receptor, family 10, subfamily V, member 2 pseudogene
hsa:148898;C1orf213;chromosome 1 open reading frame 213
hsa:114758;CSPG4P1Y,CSPG4LY,CSPG4LYP1,CSPG4P1,CSPG4PY1;chondroitin sulfate proteoglycan 4 pseudogene 1, Y-linked
hsa:155060;;AI894139 pseudogene
hsa:84832;ANKRD36BP1,ANKRD26L1,ANKRD36BL1;ankyrin repeat domain 36B pseudogene 1
hsa:84996;C21orf119;chromosome 21 open reading frame 119
hsa:219525;OR5AK4P,PJCG3;olfactory receptor, family 5, subfamily AK, member 4 pseudogene
hsa:155400;NSUN5P1,NSUN5B,WBSCR20B;NOP2/Sun domain family, member 5 pseudogene 1
hsa:84559;GOLGA2P2Y,GOLGA2LY,GOLGA2LY1,GOLGA2P2;golgin A2 pseudogene 2, Y-linked
hsa:79686;LINC00341,C14orf139,NCRNA00341;long intergenic non-protein coding RNA 341
hsa:116936;RNU86,U82,U86;RNA, U86 small nucleolar
hsa:116937;SNORD83A,RNU83A,U83A;small nucleolar RNA, C/D box 83A
hsa:116938;SNORD83B,RNU83B,U83B;small nucleolar RNA, C/D box 83B
hsa:85495;RPPH1,H1RNA;ribonuclease P RNA component H1
hsa:128872;HMGB3P1,HMG4L,HMGB3L1,dJ18C9.3;high mobility group box 3 pseudogene 1
hsa:202299;C5orf27,FIS;chromosome 5 open reading frame 27
hsa:81893;SLC7A5P1,DC49,LAT1-3TM,MLAS,hLAT1-3TM;solute carrier family 7 (amino acid transporter light chain, L system), member 5 pseudogene 1
hsa:80039;FAM106A;family with sequence similarity 106, member A
hsa:206426;PIP5K1P1;phosphatidylinositol-4-phosphate 5-kinase, type I, pseudogene 1
hsa:138649;ANKRD19P,ANKRD19,bA526D8.2;ankyrin repeat domain 19, pseudogene
hsa:388965;FUNDC2P2;FUN14 domain containing 2 pseudogene 2
hsa:252949;TTTY17A,NCRNA00140,TTTY17;testis-specific transcript, Y-linked 17A (non-protein coding)
hsa:401010;;nucleolar complex associated 2 homolog (S. cerevisiae) pseudogene
hsa:378706;RN7SL2,7L1C,7L30.1,7SL1c,RNSRP2;RNA, 7SL, cytoplasmic 2
hsa:283487;LINC00346,C13orf29,NCRNA00346;long intergenic non-protein coding RNA 346
hsa:376693;RPS10P7,RPS10_2_147;ribosomal protein S10 pseudogene 7
hsa:266971;PIPSL,PIP5K1L1,PIP5K1P3,PSMD4P2,bA429H9.1;PIP5K1A and PSMD4-like, pseudogene
hsa:389705;;chromosome 4 open reading frame 27 pseudogene
hsa:283687;C15orf37;chromosome 15 open reading frame 37
hsa:388762;OR2M1P,JCG10,OR2M1,OST037;olfactory receptor, family 2, subfamily M, member 1 pseudogene
hsa:374650;GOLGA6L5,GOLGA6L8;golgin A6 family-like 5 (pseudogene)
hsa:284942;RPL23AP82,RPL23A_43_1761;ribosomal protein L23a pseudogene 82
hsa:401509;ZNF658B;zinc finger protein 658B, pseudogene
hsa:401634;GOLGA2P3Y,GOLGA2LY2,GOLGA2P3;golgin A2 pseudogene 3, Y-linked
hsa:391518;VENTXP7,HPX42,VENTX1;VENT homeobox pseudogene 7
hsa:360132;FKBP9L;FK506 binding protein 9-like
hsa:339044;PKD1P1,HG1;polycystic kidney disease 1 (autosomal dominant) pseudogene 1
hsa:390539;OR4N3P,OR15-2;olfactory receptor, family 4, subfamily N, member 3 pseudogene
hsa:375260;WASH2P,FAM39B;WAS protein family homolog 2 pseudogene
hsa:246181;AKR7L,AFAR3,AFB1-AR3,AKR7A4;aldo-keto reductase family 7-like
hsa:400892;BCRP2,BCR-2,BCR2,BCRL2;breakpoint cluster region pseudogene 2
hsa:339483;MTMR9LP,MTMR9L;myotubularin related protein 9-like, pseudogene
hsa:401428;OR2A20P,OR2A20;olfactory receptor, family 2, subfamily A, member 20 pseudogene
hsa:348254;CCDC144CP,CCDC144C;coiled-coil domain containing 144C, pseudogene
hsa:283102;KRT8P41;keratin 8 pseudogene 41
hsa:387751;GVINP1,GVIN1,GVIN1P,VLIG-1,VLIG1;GTPase, very large interferon inducible pseudogene 1
hsa:677835;SNORA56,ACA56;small nucleolar RNA, H/ACA box 56
hsa:677841;SNORA74B,U19-2;small nucleolar RNA, H/ACA box 74B
hsa:677847;SNORA81,HBI-61;small nucleolar RNA, H/ACA box 81
hsa:574446;MIR511-2,MIRN511-2,MIR511-1,MIRN511-1;microRNA 511-2
hsa:653492;PSG10P,PSG10,PSG12;pregnancy specific beta-1-glycoprotein 10, pseudogene
hsa:441251;SPDYE7P;speedy homolog E7 (Xenopus laevis), pseudogene
hsa:441295;OR2A9P,FKSG35,HSDJ0798C17,OR2A19,OR2A22P,OR2A9;olfactory receptor, family 2, subfamily A, member 9 pseudogene
hsa:440297;;chondroitin sulfate proteoglycan 4 pseudogene
hsa:692088;SNORD50B,U50',U50B;small nucleolar RNA, C/D box 50B
hsa:677796;SNORA5C,ACA5c;small nucleolar RNA, H/ACA box 5C
hsa:641648;SNORD87,HBII-276,U87;small nucleolar RNA, C/D box 87
hsa:728609;SDHAP3,SDHACL,SDHAL;succinate dehydrogenase complex, subunit A, flavoprotein pseudogene 3
hsa:440253;WHAMMP2,WHAMML2,WHDC1L2;WAS protein homolog associated with actin, golgi membranes and microtubules pseudogene 2
hsa:645996;NAP1L6;nucleosome assembly protein 1-like 6
hsa:503645;DPRXP4;divergent-paired related homeobox pseudogene 4
hsa:677765;SCARNA18,U109;small Cajal body-specific RNA 18
hsa:503640;ARGFXP2;arginine-fifty homeobox pseudogene 2
hsa:729171;ANKRD20A8P,ANKRD20B;ankyrin repeat domain 20 family, member A8, pseudogene
hsa:728743;;zinc finger protein pseudogene
hsa:646300;COL6A4P2,COL6A4;collagen, type VI, alpha 4 pseudogene 2
hsa:677777;SCARNA12,U89;small Cajal body-specific RNA 12
hsa:693235;MIR92B,MIRN92B,hsa-mir-92b;microRNA 92b
hsa:645683;RPL13AP3,RPL13A_11_1370;ribosomal protein L13a pseudogene 3
hsa:644936;;actin, beta pseudogene
hsa:653635;WASH7P,FAM39F,WASH5P;WAS protein family homolog 7 pseudogene
hsa:693153;MIR568,MIRN568,hsa-mir-568;microRNA 568
hsa:693167;MIR582,MIRN582,hsa-mir-582;microRNA 582
hsa:653114;FAM74A2;family with sequence similarity 74, member A2
hsa:554206;;leucine carboxyl methyltransferase 1 pseudogene
hsa:693128;MIR548B,MIRN548B;microRNA 548b
hsa:693177;MIR592,MIRN592,hsa-mir-592;microRNA 592
hsa:728773;PABPC1P2,PABP2,PABP4,PABPCP2,PABPCP4;poly(A) binding protein, cytoplasmic 1 pseudogene 2
hsa:730092;RRN3P1;RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene 1
hsa:693205;MIR620,MIRN620,hsa-mir-620;microRNA 620
hsa:440672;NUDT4P1,NUDT4P2;nudix (nucleoside diphosphate linked moiety X)-type motif 4 pseudogene 1
hsa:693224;MIR639,MIRN639,hsa-mir-639;microRNA 639
hsa:693227;MIR642A,MIR642,MIRN642,hsa-mir-642,hsa-mir-642a;microRNA 642a
hsa:440482;ANKRD20A5P,ANKRD20A5;ankyrin repeat domain 20 family, member A5, pseudogene
hsa:646999;;akirin 1 pseudogene
hsa:677799;SNORA11,SNORA11A,U107;small nucleolar RNA, H/ACA box 11
hsa:677800;SNORA12,U108;small nucleolar RNA, H/ACA box 12
hsa:677801;SNORA14A,ACA14a;small nucleolar RNA, H/ACA box 14A
hsa:677802;SNORA14B,ACA14b;small nucleolar RNA, H/ACA box 14B
hsa:677817;SNORA36A,ACA36;small nucleolar RNA, H/ACA box 36A
hsa:474152;TTTY17C,NCRNA00142;testis-specific transcript, Y-linked 17C (non-protein coding)
hsa:647288;CTAGE11P;CTAGE family, member 11, pseudogene
hsa:653166;OR1D4,OR17-30;olfactory receptor, family 1, subfamily D, member 4 (gene/pseudogene)
hsa:677826;SNORA45,ACA3-2;small nucleolar RNA, H/ACA box 45
hsa:644619;INTS4L2;integrator complex subunit 4-like 2
hsa:100423011;MIR3138;microRNA 3138
hsa:100129396;FAM106CP,FAM106C;family with sequence similarity 106, member C pseudogene
hsa:100049076;GUSBP9;glucuronidase, beta pseudogene 9
hsa:100131816;UBE2DNL;ubiquitin-conjugating enzyme E2D N-terminal like (pseudogene)
hsa:100423016;MIR3159;microRNA 3159
hsa:100533990;APOC4-APOC2;APOC4-APOC2 readthrough
hsa:100313892;MIR761,hsa-mir-761;microRNA 761
hsa:100130849;;phosphorylase kinase, gamma 1 (muscle) pseudogene
hsa:100302156;MIR1229,MIRN1229,hsa-mir-1229;microRNA 1229
hsa:100528022;BLOC1S1-RDH5;BLOC1S1-RDH5 readthrough
hsa:643201;;centrosomal protein 192kDa pseudogene
hsa:100422904;MIR3193;microRNA 3193
hsa:100526831;SLX1B-SULT1A4;SLX1B-SULT1A4 readthrough
hsa:100423014;MIR3196;microRNA 3196
hsa:100124541;SNORA11D;small nucleolar RNA, H/ACA box 11D
hsa:100528031;FKBP1A-SDCBP2;FKBP1A-SDCBP2 readthrough (non-protein coding)
hsa:100422940;MIR4305;microRNA 4305
hsa:100532742;PIR-FIGF;PIR-FIGF readthrough
hsa:791115;PWRN2,NCRNA00199;Prader-Willi region non-protein coding RNA 2
hsa:100129534;;small nuclear ribonucleoprotein polypeptide N pseudogene
hsa:100288637;;OTU domain containing 7A pseudogene
hsa:100423020;MIR4258;microRNA 4258
hsa:100533955;SENP3-EIF4A1;SENP3-EIF4A1 readthrough
hsa:100422968;MIR4251;microRNA 4251
hsa:100313938;MIR548G,MIRN548G,hsa-mir-548g;microRNA 548g
hsa:100313884;MIR548H4,MIR548H-4,MIRN548H4,hsa-mir-548h-4;microRNA 548h-4
hsa:100302214;MIR1277,MIRN1277,hsa-mir-1277;microRNA 1277
hsa:100422874;MIR4279;microRNA 4279
hsa:100132923;FAM66D;family with sequence similarity 66, member D
hsa:100302112;MIR1284,MIRN1284,hsa-mir-1284;microRNA 1284
hsa:100422872;MIR1244-3;microRNA 1244-3
hsa:100423024;MIR1270-2;microRNA 1270-2
hsa:100422834;MIR1302-10;microRNA 1302-10
hsa:100302119;MIR1538,MIRN1538,hsa-mir-1538;microRNA 1538
hsa:100302195;MIR320C2,MIR320C-2,MIRN320C2,hsa-mir-320c-2;microRNA 320c-2
hsa:100616193;MIR4453;microRNA 4453
hsa:100337616;CSN1S2BP,CSN1S2B;casein alpha s2-like B, pseudogene
hsa:100126320;MIR920,MIRN920,hsa-mir-920;microRNA 920
hsa:100302278;MIR1302-2,MIRN1302-2,hsa-mir-1302-2;microRNA 1302-2
hsa:100302285;MIR1244-1,MIR1244,MIRN1244,hsa-mir-1244,hsa-mir-1244-1;microRNA 1244-1
hsa:100302179;MIR1270-1,MIR1270,MIRN1270,hsa-mir-1270,hsa-mir-1270-1;microRNA 1270-1
hsa:100129354;NRADDP;neurotrophin receptor associated death domain, pseudogene
hsa:100500908;MIR3613;microRNA 3613
hsa:100271835;;LIMS3-LOC440895 readthrough
hsa:100630923;;LOC100289561-PRKRIP1 readthrough
hsa:100628560;MIR3155B,hsa-mir-3155b;microRNA mir-3155b
hsa:100506759;OR7E37P,OR7E48P,OST193,hg533;olfactory receptor, family 7, subfamily E, member 37 pseudogene
hsa:100616121;MIR1268B;microRNA 1268b
hsa:100500851;MIR3918;microRNA 3918
hsa:100302274;MIR1178,MIRN1178,hsa-mir-1178;microRNA 1178
hsa:100302283;MIR1227,MIRN1227,hsa-mir-1227;microRNA 1227
hsa:100616250;MIR3960;microRNA 3960
hsa:100126339;MIR941-2,MIRN941-2;microRNA 941-2
hsa:100126330;MIR941-4,MIRN941-4;microRNA 941-4
hsa:100500843;MIR3922;microRNA 3922
hsa:441208;ZNRF2P1;zinc and ring finger 2 pseudogene 1
hsa:100616266;MIR4733;microRNA 4733
hsa:100126329;MIR941-1,MIRN941-1;microRNA 941-1
hsa:100126352;MIR941-3,MIRN941-3;microRNA 941-3
hsa:100271874;ZNRF2P2;zinc and ring finger 2 pseudogene 2
hsa:100036564;SNORD115-27,HBII-52-27;small nucleolar RNA, C/D box 115-27
hsa:100036565;SNORD115-28,HBII-52-28;small nucleolar RNA, C/D box 115-28
hsa:100036566;SNORD115-45,HBII-52-45,SNORD115-48;small nucleolar RNA, C/D box 115-45
hsa:100036567;SNORD115-47,HBII-52-46,HBII-52-47;small nucleolar RNA, C/D box 115-47
hsa:100616490;MIR4706;microRNA 4706
hsa:56969;RPL23AP32,RPL23A_9_220;ribosomal protein L23a pseudogene 32
hsa:100302220;MIR1293,MIRN1293,hsa-mir-1293;microRNA 1293
hsa:692108;SNORD67,HBII-166;small nucleolar RNA, C/D box 67
hsa:100124516;SNORD58C,U58;small nucleolar RNA, C/D box 58C
hsa:55855;FAM45B,HT011;family with sequence similarity 45, member A pseudogene
hsa:728039;SSR4P1,C21orf122,PRED57,PRED90;signal sequence receptor, delta pseudogene 1
hsa:100132464;FAM99B;family with sequence similarity 99, member B (non-protein coding)
hsa:304;ANXA2P2,ANX2L2,ANX2P2,LPC2B;annexin A2 pseudogene 2
hsa:440081;DDX12P,CHLR2,DDX12;DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12, pseudogene
hsa:3262;HPVC1,HPV18E5L,PE5L;human papillomavirus (type 18) E5 central sequence-like 1
hsa:100302268;MIR1285-2,MIRN1285-2,hsa-mir-1285-2;microRNA 1285-2
hsa:100616500;MIR4683;microRNA 4683
hsa:645158;CBX3P2;chromobox homolog 3 pseudogene 2
hsa:693180;MIR595,MIRN595,hsa-mir-595;microRNA 595
hsa:94158;CDRT15P1,CDRT15P;CMT1A duplicated region transcript 15 pseudogene 1
hsa:440299;DNM1P41,DNM1DN11-6,DNM1DN11.6,DNM1DN11@;DNM1 pseudogene 41
hsa:140678;MLLT10P1,MLLT10L,bA348I14.3;myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila);translocated to, 10 pseudogene 1
hsa:644694;CDRT15P2,CDRT15L1;CMT1A duplicated region transcript 15 pseudogene 2
hsa:780851;SNORD3A,RNU3,U3;small nucleolar RNA, C/D box 3A
hsa:100313769;MIR320B2,MIR320B-2,MIRN320B2;microRNA 320b-2
hsa:29931;LINC00312,ERR-10,ERR10,LOH3CR2A,NAG-7,NCRNA00312;long intergenic non-protein coding RNA 312
hsa:100313921;MIR548E,MIRN548E,hsa-mir-548e;microRNA 548e
hsa:387319;HIST1H2APS1,H2AFSP,bA317E16.5;histone cluster 1, H2a, pseudogene 1
hsa:723972;ANP32AP1;acidic (leucine-rich) nuclear phosphoprotein 32 family, member A pseudogene 1
hsa:100526820;CAHM,LINC00468;colon adenocarcinoma hypermethylated (non-protein coding)
hsa:724027;MIR657,MIRN657,hsa-mir-657;microRNA 657
hsa:100422915;MIR3065;microRNA 3065
hsa:100302229;MIR1250,MIRN1250,hsa-mir-1250;microRNA 1250
hsa:390756;OR3A4P,OLFRA05,OLFRA06,OR17-13,OR17-16,OR17-24,OR17-25,OR24,OR25,OR3A4,OR3A5P;olfactory receptor, family 3, subfamily A, member 4 pseudogene
hsa:129790;C7orf13,MY040;chromosome 7 open reading frame 13
hsa:767846;PFN1P2,C1orf152,COAS3;profilin 1 pseudogene 2
hsa:100302152;MIR548N,MIRN548N,hsa-mir-548n;microRNA 548n
hsa:100302287;MIR548H3,MIR548H-3,MIRN548H3,hsa-mir-548h-3;microRNA 548h-3
hsa:100422922;MIR1972-2;microRNA 1972-2
hsa:100302243;MIR1972-1,MIR1972,hsa-mir-1972,hsa-mir-1972-1;microRNA 1972-1
hsa:100313773;MIR548H2,MIR548H-2,MIRN548H2;microRNA 548h-2
hsa:100500863;MIR548AA1;microRNA 548aa-1
hsa:100500819;MIR3609;microRNA 3609
hsa:100113402;SNORD111B,MIR3647;small nucleolar RNA, C/D box 111B
hsa:100422873;MIR4297;microRNA 4297
hsa:100616409;MIR4711;microRNA 4711
hsa:100422910;MIR2861,BMND15,MIRN2861;microRNA 2861
hsa:692234;SNORD103A,U103;small nucleolar RNA, C/D box 103A
hsa:100132417;FCGR1C,CD64c,FCRIC,IGFR1,IGFRC;Fc fragment of IgG, high affinity Ic, receptor (CD64), pseudogene
hsa:338429;SNORD109B,HBII-438B;small nucleolar RNA, C/D box 109B
hsa:338433;SNORD115-1,HBII-52-1,RNHBII52;small nucleolar RNA, C/D box 115-1
hsa:338427;SNORD108,HBII-437;small nucleolar RNA, C/D box 108
hsa:26776;SNORA71B,RNU71B,U71b;small nucleolar RNA, H/ACA box 71B
hsa:347686;SNORD64,HBII-13;small nucleolar RNA, C/D box 64
hsa:338428;SNORD109A,HBII-438A;small nucleolar RNA, C/D box 109A
hsa:6081;SNORA73B,RNU17B,U17B;small nucleolar RNA, H/ACA box 73B
hsa:26777;SNORA71A,RNU71A,U71a;small nucleolar RNA, H/ACA box 71A
hsa:692199;SNORD84,U84;small nucleolar RNA, C/D box 84
hsa:100113390;SNORD124;small nucleolar RNA, C/D box 124
hsa:100113384;SNORD123;small nucleolar RNA, C/D box 123
hsa:677839;SNORA71C,U71c;small nucleolar RNA, H/ACA box 71C
hsa:677840;SNORA71D,U71d;small nucleolar RNA, H/ACA box 71D
hsa:692206;SNORD90,HBII-295;small nucleolar RNA, C/D box 90
hsa:100113382;SNORD105B;small nucleolar RNA, C/D box 105B
hsa:767577;SNORD114-1,14q(II-1);small nucleolar RNA, C/D box 114-1
hsa:767578;SNORD114-2,14q(II-2);small nucleolar RNA, C/D box 114-2
hsa:767579;SNORD114-3,14q(II-3);small nucleolar RNA, C/D box 114-3
hsa:767580;SNORD114-4,14q(II-4);small nucleolar RNA, C/D box 114-4
hsa:767581;SNORD114-5,14q(II-5);small nucleolar RNA, C/D box 114-5
hsa:692215;SNORD112,14q(0);small nucleolar RNA, C/D box 112
hsa:767582;SNORD114-6,14q(II-6);small nucleolar RNA, C/D box 114-6
hsa:767583;SNORD114-7,14q(II-7);small nucleolar RNA, C/D box 114-7
hsa:767584;SNORD114-8,14q(II-8);small nucleolar RNA, C/D box 114-8
hsa:767585;SNORD114-9,14q(II-9);small nucleolar RNA, C/D box 114-9
hsa:100033437;SNORD115-2,HBII-52-2;small nucleolar RNA, C/D box 115-2
hsa:100033440;SNORD115-3,HBII-52-3;small nucleolar RNA, C/D box 115-3
hsa:100033441;SNORD115-4,HBII-52-4;small nucleolar RNA, C/D box 115-4
hsa:100033442;SNORD115-5,HBII-52-5;small nucleolar RNA, C/D box 115-5
hsa:100033443;SNORD115-6,HBII-52-6;small nucleolar RNA, C/D box 115-6
hsa:100033444;SNORD115-7,HBII-52-7;small nucleolar RNA, C/D box 115-7
hsa:100033445;SNORD115-8,HBII-52-8;small nucleolar RNA, C/D box 115-8
hsa:100033446;SNORD115-9,HBII-52-9;small nucleolar RNA, C/D box 115-9
hsa:100033447;SNORD115-10,HBII-52-10;small nucleolar RNA, C/D box 115-10
hsa:100033448;SNORD115-11,HBII-52-11;small nucleolar RNA, C/D box 115-11
hsa:100033449;SNORD115-12,HBII-52-12;small nucleolar RNA, C/D box 115-12
hsa:100033450;SNORD115-13,HBII-52-13;small nucleolar RNA, C/D box 115-13
hsa:100033451;SNORD115-14,HBII-52-14;small nucleolar RNA, C/D box 115-14
hsa:100033453;SNORD115-15,HBII-52-15;small nucleolar RNA, C/D box 115-15
hsa:100033454;SNORD115-16,HBII-52-16;small nucleolar RNA, C/D box 115-16
hsa:100033455;SNORD115-17,HBII-52-17;small nucleolar RNA, C/D box 115-17
hsa:100033456;SNORD115-18,HBII-52-18;small nucleolar RNA, C/D box 115-18
hsa:100033458;SNORD115-19,HBII-52-19;small nucleolar RNA, C/D box 115-19
hsa:100033603;SNORD115-21,HBII-52-21;small nucleolar RNA, C/D box 115-21
hsa:100033460;SNORD115-20,HBII-52-20;small nucleolar RNA, C/D box 115-20
hsa:767588;SNORD114-10,14q(II-10);small nucleolar RNA, C/D box 114-10
hsa:100033799;SNORD115-22,HBII-52-22;small nucleolar RNA, C/D box 115-22
hsa:767589;SNORD114-11,14q(II-11);small nucleolar RNA, C/D box 114-11
hsa:100033800;SNORD115-23,HBII-52-23;small nucleolar RNA, C/D box 115-23
hsa:767590;SNORD114-12,14q(II-12);small nucleolar RNA, C/D box 114-12
hsa:767591;SNORD114-13,14q(II-13);small nucleolar RNA, C/D box 114-13
hsa:767592;SNORD114-14,14q(II-14);small nucleolar RNA, C/D box 114-14
hsa:100033413;SNORD116-1,HBII-85-1,PWCR1;small nucleolar RNA, C/D box 116-1
hsa:767593;SNORD114-15,14q(II-15);small nucleolar RNA, C/D box 114-15
hsa:100033414;SNORD116-2,HBII-85-2;small nucleolar RNA, C/D box 116-2
hsa:767594;SNORD114-16,14q(II-16);small nucleolar RNA, C/D box 114-16
hsa:100033415;SNORD116-3,HBII-85-3;small nucleolar RNA, C/D box 116-3
hsa:767595;SNORD114-17,14q(II-17);small nucleolar RNA, C/D box 114-17
hsa:100033416;SNORD116-4,HBII-85-4;small nucleolar RNA, C/D box 116-4
hsa:767596;SNORD114-18,14q(II-18);small nucleolar RNA, C/D box 114-18
hsa:100033417;SNORD116-5,HBII-85-5;small nucleolar RNA, C/D box 116-5
hsa:767597;SNORD114-19,14q(II-19);small nucleolar RNA, C/D box 114-19
hsa:100033418;SNORD116-6,HBII-85-6;small nucleolar RNA, C/D box 116-6
hsa:767598;SNORD114-20,14q(II-20);small nucleolar RNA, C/D box 114-20
hsa:100033419;SNORD116-7,HBII-85-7;small nucleolar RNA, C/D box 116-7
hsa:767599;SNORD114-21,14q(II-21);small nucleolar RNA, C/D box 114-21
hsa:100033420;SNORD116-8,HBII-85-8;small nucleolar RNA, C/D box 116-8
hsa:767600;SNORD114-22,14q(II-22);small nucleolar RNA, C/D box 114-22
hsa:100033421;SNORD116-9,HBII-85-9;small nucleolar RNA, C/D box 116-9
hsa:767603;SNORD114-23,14q(II-23);small nucleolar RNA, C/D box 114-23
hsa:100033422;SNORD116-10,HBII-85-10;small nucleolar RNA, C/D box 116-10
hsa:767604;SNORD114-24,14q(II-24);small nucleolar RNA, C/D box 114-24
hsa:692229;SNORD105,U105;small nucleolar RNA, C/D box 105
hsa:767605;SNORD114-25,14q(II-25);small nucleolar RNA, C/D box 114-25
hsa:767606;SNORD114-26,14q(II-26);small nucleolar RNA, C/D box 114-26
hsa:767608;SNORD114-27,14q(II-27);small nucleolar RNA, C/D box 114-27
hsa:767609;SNORD114-28,14q(II-28);small nucleolar RNA, C/D box 114-28
hsa:767610;SNORD114-29,14q(II-29);small nucleolar RNA, C/D box 114-29
hsa:767611;SNORD114-30,14q(II-30);small nucleolar RNA, C/D box 114-30
hsa:767612;SNORD114-31,14q(II-31);small nucleolar RNA, C/D box 114-31
hsa:677848;SNORD1A,R38A,snR38A;small nucleolar RNA, C/D box 1A
hsa:677849;SNORD1B,R38B,snR38B;small nucleolar RNA, C/D box 1B
hsa:677850;SNORD1C,R38C,snR38C;small nucleolar RNA, C/D box 1C
hsa:100033801;SNORD115-25,HBII-52-25;small nucleolar RNA, C/D box 115-25
hsa:100033802;SNORD115-26,HBII-52-26;small nucleolar RNA, C/D box 115-26
hsa:100033803;SNORD115-29,HBII-52-29;small nucleolar RNA, C/D box 115-29
hsa:100033804;SNORD115-30,HBII-52-30;small nucleolar RNA, C/D box 115-30
hsa:100033805;SNORD115-31,HBII-52-31;small nucleolar RNA, C/D box 115-31
hsa:100033806;SNORD115-32,HBII-52-32;small nucleolar RNA, C/D box 115-32
hsa:100033807;SNORD115-33,HBII-52-33;small nucleolar RNA, C/D box 115-33
hsa:100033808;SNORD115-34,HBII-52-34;small nucleolar RNA, C/D box 115-34
hsa:100033809;SNORD115-35,HBII-52-35;small nucleolar RNA, C/D box 115-35
hsa:100033810;SNORD115-36,HBII-52-36;small nucleolar RNA, C/D box 115-36
hsa:100033811;SNORD115-37,HBII-52-37;small nucleolar RNA, C/D box 115-37
hsa:100033812;SNORD115-38,HBII-52-38;small nucleolar RNA, C/D box 115-38
hsa:100033813;SNORD115-39,HBII-52-39;small nucleolar RNA, C/D box 115-39
hsa:100033814;SNORD115-40,HBII-52-40;small nucleolar RNA, C/D box 115-40
hsa:100033815;SNORD115-41,HBII-52-41;small nucleolar RNA, C/D box 115-41
hsa:100033816;SNORD115-42,HBII-52-42;small nucleolar RNA, C/D box 115-42
hsa:100033817;SNORD115-43,HBII-52-43;small nucleolar RNA, C/D box 115-43
hsa:100033818;SNORD115-44,HBII-52-44;small nucleolar RNA, C/D box 115-44
hsa:100033821;SNORD116-29,HBII-85-29;small nucleolar RNA, C/D box 116-29
hsa:100033820;SNORD116-28,HBII-85-28;small nucleolar RNA, C/D box 116-28
hsa:100033822;SNORD115-48,HBII-52-48;small nucleolar RNA, C/D box 115-48
hsa:100033439;SNORD116-27,HBII-85-27;small nucleolar RNA, C/D box 116-27
hsa:100033423;SNORD116-11,HBII-85-11;small nucleolar RNA, C/D box 116-11
hsa:767561;SNORD113-1,14q(I-1);small nucleolar RNA, C/D box 113-1
hsa:100033424;SNORD116-12,HBII-85-12;small nucleolar RNA, C/D box 116-12
hsa:767562;SNORD113-2,14q(I-2);small nucleolar RNA, C/D box 113-2
hsa:767563;SNORD113-3,14q(I-3);small nucleolar RNA, C/D box 113-3
hsa:767564;SNORD113-4,14q(I-4);small nucleolar RNA, C/D box 113-4
hsa:767566;SNORD113-6,14q(I-6);small nucleolar RNA, C/D box 113-6
hsa:767565;SNORD113-5,14q(I-5);small nucleolar RNA, C/D box 113-5
hsa:767567;SNORD113-7,14q(I-7);small nucleolar RNA, C/D box 113-7
hsa:100033426;SNORD116-14,HBII-85-14;small nucleolar RNA, C/D box 116-14
hsa:100033427;SNORD116-15,HBII-85-15;small nucleolar RNA, C/D box 116-15
hsa:767568;SNORD113-8,14q(I-8);small nucleolar RNA, C/D box 113-8
hsa:100033428;SNORD116-16,HBII-85-16;small nucleolar RNA, C/D box 116-16
hsa:767569;SNORD113-9,14q(I-9);small nucleolar RNA, C/D box 113-9
hsa:100033425;SNORD116-13,HBII-85-13;small nucleolar RNA, C/D box 116-13
hsa:100033429;SNORD116-17,HBII-85-17;small nucleolar RNA, C/D box 116-17
hsa:100033430;SNORD116-18,HBII-85-18;small nucleolar RNA, C/D box 116-18
hsa:727708;SNORD116-19,HBII-85-19;small nucleolar RNA, C/D box 116-19
hsa:100033431;SNORD116-20,HBII-85-20;small nucleolar RNA, C/D box 116-20
hsa:100033432;SNORD116-21,HBII-85-21;small nucleolar RNA, C/D box 116-21
hsa:100033433;SNORD116-22,HBII-85-22;small nucleolar RNA, C/D box 116-22
hsa:100033434;SNORD116-23,HBII-85-23;small nucleolar RNA, C/D box 116-23
hsa:100033435;SNORD116-24,HBII-85-24;small nucleolar RNA, C/D box 116-24
hsa:100033436;SNORD116-25,HBII-85-25;small nucleolar RNA, C/D box 116-25
hsa:100033438;SNORD116-26,HBII-85-26;small nucleolar RNA, C/D box 116-26
hsa:100422849;MIR548T;microRNA 548t
hsa:595101;;smg-1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) pseudogene
hsa:100132832;PMS2P9,PMS2LP1,PMS2L17;PMS2 postmeiotic segregation increased 2 (S. cerevisiae) pseudogene
hsa:100130000;;phosphodiesterase 4D interacting protein pseudogene
hsa:440461;;Rho GTPase activating protein 27 pseudogene
hsa:729080;;glycine cleavage system protein H (aminomethyl carrier) pseudogene
hsa:641746;;glycine cleavage system protein H (aminomethyl carrier) pseudogene
hsa:100101490;PSIMCT-1;malignant T cell amplified sequence 1 pseudogene
hsa:641367;;cyclin Y-like 1 pseudogene
hsa:643387;;TAR DNA binding protein pseudogene
hsa:339240;;keratin 17 pseudogene
hsa:440354;;smg-1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) pseudogene
hsa:729739;;peptidylprolyl isomerase A (cyclophilin A) pseudogene
hsa:91380;SNORD107,HBII-436;small nucleolar RNA, C/D box 107
hsa:100616342;MIR4638;microRNA 4638
hsa:100616426;MIR4694;microRNA 4694
hsa:442454;UQCRBP1;ubiquinol-cytochrome c reductase binding protein pseudogene 1
hsa:100616118;MIR4486;microRNA 4486
hsa:100422980;MIR4323;microRNA 4323
hsa:389906;;zinc finger protein 839 pseudogene
hsa:440925;;uncharacterized LOC440925
hsa:642361;;uncharacterized LOC642361
hsa:439994;LINC00863;uncharacterized LOC439994
hsa:100272217;;uncharacterized LOC100272217
hsa:389791;;uncharacterized LOC389791
hsa:100129917;;uncharacterized LOC100129917
hsa:283663;;uncharacterized LOC283663
hsa:728323;;uncharacterized LOC728323
hsa:100134317;;uncharacterized LOC100134317
hsa:55056;;uncharacterized protein FLJ10038
hsa:100505776;;uncharacterized LOC100505776
hsa:100499194;;uncharacterized LOC100499194
hsa:100188947;;uncharacterized LOC100188947
hsa:148231;FLJ25328;uncharacterized LOC148231
hsa:100128787;;uncharacterized LOC100128787
hsa:100128993;;uncharacterized LOC100128993
hsa:100288748;;uncharacterized LOC100288748
hsa:400027;;uncharacterized LOC400027
hsa:100289230;;uncharacterized LOC100289230
hsa:100499489;;uncharacterized LOC100499489
hsa:143666;;uncharacterized LOC143666
hsa:79857;FLJ13224;uncharacterized LOC79857
hsa:84815;;uncharacterized protein MGC12916
hsa:90784;;uncharacterized LOC90784
hsa:85009;MGC16025;uncharacterized LOC85009
hsa:90834;;uncharacterized protein BC001742
hsa:100128288;;uncharacterized LOC100128288
hsa:340094;;uncharacterized LOC340094
hsa:100130899;;uncharacterized LOC100130899
hsa:145474;;uncharacterized LOC145474
hsa:400940;;uncharacterized LOC400940
hsa:389332;;uncharacterized LOC389332
hsa:92973;FP588;uncharacterized LOC92973
hsa:150197;;uncharacterized LOC150197
hsa:91450;;uncharacterized LOC91450
hsa:349196;;uncharacterized LOC349196
hsa:100129148;;uncharacterized LOC100129148
hsa:100129034;;uncharacterized LOC100129034
hsa:100128361;;uncharacterized LOC100128361
hsa:100190986;;uncharacterized LOC100190986
hsa:646903;;uncharacterized LOC646903
hsa:644656;;uncharacterized LOC644656
hsa:255512;;uncharacterized LOC255512
hsa:284454;;uncharacterized LOC284454
hsa:100775107;LUST;RBM5 antisense RNA
hsa:100240734;;uncharacterized LOC100240734
hsa:338758;;uncharacterized LOC338758
hsa:100132273;NDUFA6-AS1;uncharacterized LOC100132273
hsa:731656;;uncharacterized LOC731656
hsa:100506548;;uncharacterized LOC100506548
hsa:645644;FLJ42627;uncharacterized LOC645644
hsa:54508;;uncharacterized FLJ11235
hsa:100270804;;uncharacterized LOC100270804
hsa:100216545;;uncharacterized LOC100216545
hsa:100129617;;uncharacterized LOC100129617
hsa:400752;;uncharacterized LOC400752
hsa:153910;;uncharacterized LOC153910
hsa:285548;;uncharacterized LOC285548
hsa:202781;;uncharacterized LOC202781
hsa:100216546;;uncharacterized LOC100216546
hsa:388553;;uncharacterized LOC388553
hsa:84789;;uncharacterized protein MGC2889
hsa:100126784;;uncharacterized LOC100126784
hsa:152217;;uncharacterized LOC152217
hsa:100192386;FLJ16779;uncharacterized LOC100192386
hsa:100128822;;uncharacterized LOC100128822
hsa:100287834;;uncharacterized LOC100287834
hsa:283174;;uncharacterized LOC283174
hsa:100506025;;uncharacterized LOC100506025
hsa:100009676;;uncharacterized LOC100009676
hsa:100507217;;uncharacterized LOC100507217
hsa:284578;;uncharacterized LOC284578
hsa:284648;;uncharacterized LOC284648
hsa:100129794;;uncharacterized LOC100129794
hsa:100506714;;uncharacterized LOC100506714
hsa:100272228;;uncharacterized LOC100272228
hsa:148696;;uncharacterized LOC148696
hsa:100505666;;uncharacterized LOC100505666
hsa:80094;FLJ14107;uncharacterized LOC80094
hsa:401321;;uncharacterized LOC401321
hsa:284688;;uncharacterized LOC284688
hsa:100506801;;uncharacterized LOC100506801
hsa:90246;;uncharacterized LOC90246
hsa:144486;;uncharacterized LOC144486
hsa:100192379;PP12613;uncharacterized LOC100192379
hsa:94023;DKFZp566F0947;uncharacterized LOC94023
hsa:648987;;uncharacterized LOC648987
hsa:100289361;;uncharacterized LOC100289361
hsa:375196;;uncharacterized LOC375196
hsa:100750325;RCAN3AS;RCAN3 antisense
hsa:100129550;;uncharacterized LOC100129550
hsa:100630918;;uncharacterized LOC100630918
hsa:222029;DKFZp434L192;uncharacterized protein DKFZp434L192
hsa:200058;;uncharacterized protein FLJ23867
hsa:100289511;;uncharacterized LOC100289511
hsa:401105;FLJ42393,AVPC1948;uncharacterized LOC401105
hsa:100505633;;uncharacterized LOC100505633
hsa:100131496;;uncharacterized LOC100131496
hsa:100272216;;uncharacterized LOC100272216
hsa:79015;;uncharacterized LOC79015
hsa:100270746;;uncharacterized LOC100270746
hsa:286437;;uncharacterized LOC286437
hsa:54553;;uncharacterized protein DKFZP434I0714
hsa:100134229;;uncharacterized LOC100134229
hsa:100289341;;uncharacterized LOC100289341
hsa:282997;PDCD4-AS1;PDCD4 antisense RNA 1
hsa:388692;;uncharacterized LOC388692
hsa:100506124;;uncharacterized LOC100506124
hsa:643763;UG0898H09;uncharacterized LOC643763
hsa:728752;;uncharacterized LOC728752
hsa:150384;CN5H6.4;uncharacterized LOC150384
hsa:256880;;uncharacterized LOC256880
hsa:146512;;uncharacterized protein FLJ30679
hsa:100507634;;uncharacterized LOC100507634
hsa:100128573;;uncharacterized LOC100128573
hsa:145845;;uncharacterized LOC145845
hsa:641515;;uncharacterized LOC641515
hsa:100287042;;uncharacterized LOC100287042
hsa:100130238;;uncharacterized LOC100130238
hsa:26077;DKFZP434H168;uncharacterized LOC26077
hsa:100506730;;uncharacterized LOC100506730
hsa:222161;;uncharacterized protein DKFZp586I1420
hsa:646471;;uncharacterized LOC646471
hsa:643210;FLJ40292;uncharacterized LOC643210
hsa:150185;;uncharacterized LOC150185
hsa:100130992;;uncharacterized LOC100130992
hsa:100129269;;uncharacterized LOC100129269
hsa:100132356;;uncharacterized LOC100132356
hsa:100130557;;uncharacterized LOC100130557
hsa:158696;;uncharacterized LOC158696
hsa:100288846;;uncharacterized LOC100288846
hsa:100133331;;uncharacterized LOC100133331
hsa:729609;;uncharacterized LOC729609
hsa:100129726;;uncharacterized LOC100129726
hsa:100507547;;uncharacterized LOC100507547
hsa:84849;;uncharacterized protein MGC16142
hsa:283070;;uncharacterized LOC283070
hsa:100507117;;uncharacterized LOC100507117
hsa:170949;DEFT1P,DEFQ1,DEFT1;defensin, theta 1 pseudogene
hsa:729041;;fatty acid amide hydrolase pseudogene
hsa:388152;;uncharacterized LOC388152
hsa:341056;;SUMO1 activating enzyme subunit 1 pseudogene
hsa:100507472;;uncharacterized LOC100507472
hsa:100126338;MIR937,MIRN937,hsa-mir-937;microRNA 937
hsa:162632;USP32P1;ubiquitin specific peptidase 32 pseudogene 1
hsa:390660;;FLJ00317 protein
hsa:282566;LINC00515,C21orf71,PRED21;long intergenic non-protein coding RNA 515
hsa:80215;RUNX1-IT1,C21orf96;RUNX1 intronic transcript 1 (non-protein coding)
hsa:27099;SND1-IT1,C7orf54,NAG8,NSG-X;SND1 intronic transcript 1 (non-protein coding)
hsa:280655;IGBP1P1,C14orf19;immunoglobulin (CD79A) binding protein 1 pseudogene 1
hsa:256369;LINC00521,C14orf48,c14_5713;long intergenic non-protein coding RNA 521
hsa:83957;FRMD8P1;FERM domain containing 8 pseudogene 1
hsa:728622;SKP1P2,SKP1B,p19B;S-phase kinase-associated protein 1 pseudogene 2
hsa:100302256;MIR1180,MIRN1180,hsa-mir-1180;microRNA 1180
hsa:23591;FAM215A,APR-2,C17orf88,LINC00530;family with sequence similarity 215, member A (non-protein coding)
hsa:147525;LINC00526,C18orf18,HsT959;long intergenic non-protein coding RNA 526
hsa:440926;H3F3AP4,p13;H3 histone, family 3A, pseudogene 4
hsa:646096;CHEK2P2;checkpoint kinase 2 pseudogene 2
hsa:440104;TMEM198B;transmembrane protein 198B, pseudogene
hsa:387316;VN1R10P,FKSG83,VNR6I1P,b24o18.2,hs6V1-1p;vomeronasal 1 receptor 10 pseudogene
hsa:81571;MIR600HG,C9orf45,NCRNA00287;MIR600 host gene (non-protein coding)
hsa:100130342;SCGB2B3P,C2B,SCGB4A3P;secretoglobin, family 2B, member 3, pseudogene
hsa:100422860;MIR4292;microRNA 4292
hsa:26826;RNU6-2,RNU6B,U6;RNA, U6 small nuclear 2
hsa:100422832;MIR3191;microRNA 3191
hsa:100302188;MIR1243,MIRN1243,hsa-mir-1243;microRNA 1243
hsa:100313886;MIR2116;microRNA 2116
hsa:6023;RMRP,CHH,NME1,RMRPR,RRP2;RNA component of mitochondrial RNA processing endoribonuclease
hsa:768213;MIR671,MIRN671,hsa-mir-671;microRNA 671
hsa:26783;SNORA65,RNU65,U65;small nucleolar RNA, H/ACA box 65
hsa:100130934;ZNF663;zinc finger protein 663
hsa:349114;LINC00265,NCRNA00265;long intergenic non-protein coding RNA 265
hsa:284581;;uncharacterized LOC284581
hsa:440894;;uncharacterized LOC440894
hsa:57234;LINC00869,FAM91A2;long intergenic non-protein coding RNA 869
hsa:84719;LINC00260,C1orf217,NCRNA00260;long intergenic non-protein coding RNA 260
hsa:440352;SNX29P2,RUNDC2C;sorting nexin 29 pseudogene 2
hsa:157247;;uncharacterized protein MGC27345
hsa:26832;RNU5B-1,RNU5B,RNU5B-1P,U5B1;RNA, U5B small nuclear 1
hsa:647190;RPS16P5,RPS16_3_702;ribosomal protein S16 pseudogene 5
hsa:80868;HCG4B,HCG4P6,HCGIV-06,HCGIV-6,HCGIV.5,bCX67J3.3,bPG309N1.1,bQB90C11.3;HLA complex group 4B (non-protein coding)
hsa:54435;HCG4,HCG4P10,HCGIV-10,HCGIV.9;HLA complex group 4 (non-protein coding)
hsa:100130386;LINC00552;long intergenic non-protein coding RNA 552
hsa:100130964;;ADAM metallopeptidase domain 3A-like
hsa:651430;FLJ38576;uncharacterized LOC651430
hsa:729683;;uncharacterized LOC729683
hsa:400500;BCAR4;breast cancer anti-estrogen resistance 4 (non-protein coding)
hsa:646719;;uncharacterized LOC646719
hsa:100289092;;uncharacterized LOC100289092
hsa:100289150;FAM197Y5;family with sequence similarity 197, Y-linked, member 5
hsa:171391;NS3BP;NS3BP
hsa:359806;PCNAP1,p1PCNA;proliferating cell nuclear antigen pseudogene 1
hsa:692213;SNORD110,HBII-55;small nucleolar RNA, C/D box 110
hsa:373861;HILS1;histone linker H1 domain, spermatid-specific 1, pseudogene
hsa:100132831;;A20-binding inhibitor of NF-kappaB activation 2 pseudogene
hsa:100302138;MIR1292,MIRN1292,hsa-mir-1292;microRNA 1292
hsa:100131626;;uncharacterized LOC100131626
hsa:100130148;MAPT-IT1;MAPT intronic transcript 1 (non-protein coding)
hsa:100652853;HP07349;uncharacterized LOC100652853
hsa:286140;RNF5P1;ring finger protein 5, E3 ubiquitin protein ligase pseudogene 1
hsa:379013;RNF138P1;ring finger protein 138, E3 ubiquitin protein ligase pseudogene 1
hsa:100616154;MIR4466;microRNA 4466
hsa:439934;LINC00575,C4orf11;long intergenic non-protein coding RNA 575
hsa:100862692;DIP2A-IT1;DIP2A intronic transcript 1 (non-protein coding)
hsa:10819;OR7E14P,OR11-5,OR7E151P;olfactory receptor, family 7, subfamily E, member 14 pseudogene
hsa:8587;OR7E2P,OR11-6,OR7E143P,OR7E51P,OR7E52P,OR7F2P,OST245,hg94;olfactory receptor, family 7, subfamily E, member 2 pseudogene
hsa:649352;;ubiquitin carboxyl-terminal hydrolase 17-like protein 2-like
hsa:692201;SNORD86,U86;small nucleolar RNA, C/D box 86
hsa:677831;SNORA51,ACA51;small nucleolar RNA, H/ACA box 51
hsa:677813;SNORA30,ACA30;small nucleolar RNA, H/ACA box 30
hsa:55073;LRRC37A4P,LRRC37A4;leucine rich repeat containing 37, member A4, pseudogene
hsa:650368;;asparagine-linked glycosylation 1-like pseudogene
hsa:6079;SNORD15A,RNU15A,SNORNA,U15A;small nucleolar RNA, C/D box 15A
hsa:100286922;;DnaJ (Hsp40) homolog, subfamily B, member 3 pseudogene
hsa:337873;HIST2H2BC,H2B/t,HIST2H2BD;histone cluster 2, H2bc (pseudogene)
hsa:387646;LRRC37A6P;leucine rich repeat containing 37, member A6, pseudogene
hsa:100128285;DNM1P35,DNM1DN8-2,DNM1DN8.2,DNM1DN8@,FKSG88;DNM1 pseudogene 35
hsa:100133957;;uncharacterized LOC100133957
hsa:26102;DKFZP434A062;uncharacterized LOC26102
hsa:29797;POM121L8P,DKFZp434K191;POM121 transmembrane nucleoporin-like 8 pseudogene
hsa:25812;POM121L1P,POM121L1;POM121 transmembrane nucleoporin-like 1, pseudogene
hsa:266697;POM121L4P;POM121 transmembrane nucleoporin-like 4 pseudogene
hsa:401233;HTATSF1P2;HIV-1 Tat specific factor 1 pseudogene 2
hsa:693161;MIR576,MIRN576,hsa-mir-576;microRNA 576
hsa:693144;MIR559,MIRN559,hsa-mir-559;microRNA 559
hsa:474383;F8A2;coagulation factor VIII-associated 2
hsa:474384;F8A3;coagulation factor VIII-associated 3
hsa:26689;OR4D1,OR17-23,OR4D3,OR4D4P,TPCR16;olfactory receptor, family 4, subfamily D, member 1
hsa:8388;OR1E2,OR17-135,OR17-93,OR1E4,OR1E7,OST529;olfactory receptor, family 1, subfamily E, member 2
hsa:26493;OR8B8,TPCR85;olfactory receptor, family 8, subfamily B, member 8
hsa:440051;KRTAP5-11,KRTAP5-5,KRTAP5-6,KRTAP5.11;keratin associated protein 5-11
hsa:23520;ANP32C,PP32R1;acidic (leucine-rich) nuclear phosphoprotein 32 family, member C
hsa:504189;OR8U8;olfactory receptor, family 8, subfamily U, member 8
hsa:494197;SPANXN5,CT11.10,SPANX-N5;SPANX family, member N5
hsa:390999;PRAMEF12;PRAME family member 12
hsa:388759;C1orf229;chromosome 1 open reading frame 229
hsa:126370;OR1I1,OR19-20,OR1I1P,OR1I1Q;olfactory receptor, family 1, subfamily I, member 1
hsa:2307;FOXS1,FKHL18,FREAC10;forkhead box S1
hsa:387266;KRTAP5-3,KRTAP5-9,KRTAP5.3;keratin associated protein 5-3
hsa:402665;IGLON5;IgLON family member 5
hsa:441150;C6orf226;chromosome 6 open reading frame 226
hsa:127059;OR2M5,OR2M5P;olfactory receptor, family 2, subfamily M, member 5
hsa:11007;CCDC85B,DIPA;coiled-coil domain containing 85B
hsa:119749;OR4C46;olfactory receptor, family 4, subfamily C, member 46
hsa:26341;OR5H1,HSHTPCRX14,HTPCRX14;olfactory receptor, family 5, subfamily H, member 1
hsa:440050;KRTAP5-7,KRTAP5-3,KRTAP5.7;keratin associated protein 5-7
hsa:2297;FOXD1,FKHL8,FREAC4;forkhead box D1
hsa:353333;KRTAP10-10,KAP10.10,KAP18.10,KRTAP18-10,KRTAP18.10;keratin associated protein 10-10
hsa:645191;LINGO3,LERN2,LRRN6B;leucine rich repeat and Ig domain containing 3
hsa:343505;NBPF7;neuroblastoma breakpoint family, member 7
hsa:390326;OR6C76;olfactory receptor, family 6, subfamily C, member 76
hsa:401994;OR14I1,OR5BU1,OR5BU1P;olfactory receptor, family 14, subfamily I, member 1
hsa:3228;HOXC12,HOC3F,HOX3,HOX3F;homeobox C12
hsa:337973;KRTAP19-6,KAP19.6;keratin associated protein 19-6
hsa:1068;CETN1,CEN1,CETN;centrin, EF-hand protein, 1
hsa:337966;KRTAP6-1,C21orf103,KAP6.1;keratin associated protein 6-1
hsa:256892;OR51F1,OR11-21,OR51F1P;olfactory receptor, family 51, subfamily F, member 1
hsa:337967;KRTAP6-2,KAP6.2;keratin associated protein 6-2
hsa:337969;KRTAP19-2,KAP19.2;keratin associated protein 19-2
hsa:337971;KRTAP19-4,KAP19.4;keratin associated protein 19-4
hsa:353515;XKRY2,XKRYP7;XK, Kell blood group complex subunit-related, Y-linked 2
hsa:388818;KRTAP26-1;keratin associated protein 26-1
hsa:257236;CCDC96;coiled-coil domain containing 96
hsa:254783;OR6C74;olfactory receptor, family 6, subfamily C, member 74
hsa:219968;OR5B21;olfactory receptor, family 5, subfamily B, member 21
hsa:283365;OR6C6;olfactory receptor, family 6, subfamily C, member 6
hsa:344657;LRRIQ4,LRRC64;leucine-rich repeats and IQ motif containing 4
hsa:254950;KRTAP15-1,KAP15.1;keratin associated protein 15-1
hsa:390323;OR6C75;olfactory receptor, family 6, subfamily C, member 75
hsa:390327;OR6C70;olfactory receptor, family 6, subfamily C, member 70
hsa:378951;RBMY1J;RNA binding motif protein, Y-linked, family 1, member J
hsa:388931;MFSD2B;major facilitator superfamily domain containing 2B
hsa:441308;OR4F21,OR4F21P;olfactory receptor, family 4, subfamily F, member 21
hsa:5455;POU3F3,BRN1,OTF8;POU class 3 homeobox 3
hsa:390874;ONECUT3,OC3;one cut homeobox 3
hsa:8933;FAM127A,CXX1,MAR8C,MART8C,Mar8,Mart8;family with sequence similarity 127, member A
hsa:441518;FAM127C,CXX1c,MAR8B;family with sequence similarity 127, member C
hsa:403274;OR5H15;olfactory receptor, family 5, subfamily H, member 15
hsa:403277;OR5K3;olfactory receptor, family 5, subfamily K, member 3
hsa:403278;OR5K4;olfactory receptor, family 5, subfamily K, member 4
hsa:403282;OR6C65;olfactory receptor, family 6, subfamily C, member 65
hsa:503834;DPRX;divergent-paired related homeobox
hsa:653275;CFC1B;cripto, FRL-1, cryptic family 1B
hsa:23401;FRAT2;frequently rearranged in advanced T-cell lymphomas 2
hsa:10670;RRAGA,FIP-1,FIP1,RAGA;Ras-related GTP binding A
hsa:121456;SLC9A7P1;solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7 pseudogene 1
hsa:440804;RIMBP3B,RIM-BP3.2,RIM-BP3.B,RIMBP3.2;RIMS binding protein 3B
hsa:387775;SLC22A10,OAT5,hOAT5;solute carrier family 22, member 10
hsa:391211;OR2G6;olfactory receptor, family 2, subfamily G, member 6
hsa:146177;VWA3A;von Willebrand factor A domain containing 3A
hsa:375616;KCP,CRIM2,KCP1,NET67;kielin/chordin-like protein
hsa:643988;C1orf233;chromosome 1 open reading frame 233
hsa:442721;LMOD2,C-LMOD;leiomodin 2 (cardiac)
hsa:124925;SEZ6;seizure related 6 homolog (mouse)
hsa:653545;DUX4L5;double homeobox 4 like 5
hsa:162073;ITPRIPL2;inositol 1,4,5-trisphosphate receptor interacting protein-like 2
hsa:388743;CAPN8,nCL-2;calpain 8 (EC:3.4.22.53)
hsa:56129;PCDHB7,PCDH-BETA7;protocadherin beta 7
hsa:140625;ACTRT2,ARPM2,ARPT2,Arp-T2,HARPM2;actin-related protein T2
hsa:613227;HIGD1C,GM921;HIG1 hypoxia inducible domain family, member 1C
hsa:26148;C10orf12;chromosome 10 open reading frame 12
hsa:337970;KRTAP19-3,GTRHP,KAP19.3;keratin associated protein 19-3
hsa:80728;ARHGAP39,CrGAP,Vilse;Rho GTPase activating protein 39
hsa:284992;CCDC150;coiled-coil domain containing 150
hsa:140947;C5orf20,DCNP1;chromosome 5 open reading frame 20
hsa:83443;SF3B5,SF3b10,Ysf3;splicing factor 3b, subunit 5, 10kDa
hsa:393046;OR2A5,OR2A11P,OR2A26,OR2A8,OR7-138,OR7-141;olfactory receptor, family 2, subfamily A, member 5
hsa:392391;OR5C1,OR5C2P,OR9-31,OR9-F;olfactory receptor, family 5, subfamily C, member 1
hsa:81392;OR2AE1,OR2AE2;olfactory receptor, family 2, subfamily AE, member 1
hsa:6248;RSC1A1,RS1;regulatory solute carrier protein, family 1, member 1
hsa:11317;RBPJL,RBP-L,RBPSUHL,SUH,SUHL;recombination signal binding protein for immunoglobulin kappa J region-like
hsa:245973;ATP6V1C2,ATP6C2,VMA5;ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 (EC:3.6.3.14)
hsa:340784;HMX3,NKX-5.1,NKX5.1,Nkx5-1;H6 family homeobox 3
hsa:57717;PCDHB16,ME1,PCDH-BETA16,PCDH3X,PCDHB8a;protocadherin beta 16
hsa:3754;KCNF1,IK8,KCNF,KV5.1,kH1;potassium voltage-gated channel, subfamily F, member 1
hsa:93650;ACPT;acid phosphatase, testicular (EC:3.1.3.2)
hsa:728936;NBPF16,AG3;neuroblastoma breakpoint family, member 16
hsa:504190;OR8U9;olfactory receptor, family 8, subfamily U, member 9
hsa:200765;TIGD1,EEYORE;tigger transposable element derived 1
hsa:6725;SRMS,C20orf148,SRM,dJ697K14.1;src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (EC:2.7.10.2)
hsa:85290;KRTAP4-3,KAP4.3;keratin associated protein 4-3
hsa:81300;OR4P4,OR4P3P;olfactory receptor, family 4, subfamily P, member 4
hsa:390181;OR5AK2;olfactory receptor, family 5, subfamily AK, member 2
hsa:391192;OR2L3;olfactory receptor, family 2, subfamily L, member 3
hsa:391194;OR2M2,OR2M2Q,OST423;olfactory receptor, family 2, subfamily M, member 2
hsa:57469;PNMAL2;paraneoplastic Ma antigen family-like 2
hsa:112970;KTI12,RP11-91A18.3,TOT4;KTI12 homolog, chromatin associated (S. cerevisiae)
hsa:85443;DCLK3,CLR,DCAMKL3,DCDC3C,DCK3;doublecortin-like kinase 3 (EC:2.7.11.1)
hsa:113763;C7orf29;chromosome 7 open reading frame 29
hsa:219870;OR10G9,OR10G10P;olfactory receptor, family 10, subfamily G, member 9
hsa:64582;GPR135,HUMNPIIY20;G protein-coupled receptor 135
hsa:219986;OR4D11,OR4D11P;olfactory receptor, family 4, subfamily D, member 11
hsa:11166;SOX21,SOX25;SRY (sex determining region Y)-box 21
hsa:138802;OR13C8,OR37H,OR9-10;olfactory receptor, family 13, subfamily C, member 8
hsa:23270;TSPYL4,dJ486I3.2;TSPY-like 4
hsa:391189;OR11L1;olfactory receptor, family 11, subfamily L, member 1
hsa:643832;GAGE10;G antigen 10
hsa:2636;GBX1;gastrulation brain homeobox 1
hsa:170961;ANKRD24;ankyrin repeat domain 24
hsa:140701;ABHD16B,C20orf135,dJ591C20.1;abhydrolase domain containing 16B
hsa:120065;OR5P2,JCG3,JCG4;olfactory receptor, family 5, subfamily P, member 2
hsa:26534;OR10G2,OR14-41;olfactory receptor, family 10, subfamily G, member 2
hsa:128372;OR6N1,OR1-22;olfactory receptor, family 6, subfamily N, member 1
hsa:85293;KRTAP3-3,KAP3.3,KRTAP3.3;keratin associated protein 3-3
hsa:84694;GJA10,CX62,RP11-63K6.6;gap junction protein, alpha 10, 62kDa
hsa:26595;OR8B2,OR11-309,OR11-310;olfactory receptor, family 8, subfamily B, member 2
hsa:149699;GTSF1L,C20orf65,FAM112A,dJ1028D15.4;gametocyte specific factor 1-like
hsa:254879;OR2T6,OR2T6P,OR2T9,OST703;olfactory receptor, family 2, subfamily T, member 6
hsa:254786;OR6C3,OST709;olfactory receptor, family 6, subfamily C, member 3
hsa:341416;OR6C2,OR6C67;olfactory receptor, family 6, subfamily C, member 2
hsa:81050;OR5AC2,HSA1;olfactory receptor, family 5, subfamily AC, member 2
hsa:50838;TAS2R13,T2R13,TRB3;taste receptor, type 2, member 13
hsa:57479;PRR12,KIAA1205;proline rich 12
hsa:219417;OR8U1;olfactory receptor, family 8, subfamily U, member 1
hsa:401667;OR51A2;olfactory receptor, family 51, subfamily A, member 2
hsa:79501;OR4F5;olfactory receptor, family 4, subfamily F, member 5
hsa:85316;BAGE5,CT2.5;B melanoma antigen family, member 5
hsa:85317;BAGE4,CT2.4,MLL3P;B melanoma antigen family, member 4
hsa:134391;GPR151,GALR4,GALRL,GPCR,PGR7;G protein-coupled receptor 151
hsa:337882;KRTAP19-1,KAP19.1;keratin associated protein 19-1
hsa:85376;RIMBP3,RIM-BP3,RIM-BP3.1,RIM-BP3.A,RIMBP3.1,RIMBP3A;RIMS binding protein 3
hsa:26246;OR2L2,HSHTPCRH07,HTPCRH07,OR1-48,OR2L12,OR2L4P;olfactory receptor, family 2, subfamily L, member 2
hsa:55766;H2AFJ,H2AJ;H2A histone family, member J
hsa:131583;FAM43A;family with sequence similarity 43, member A
hsa:51224;TCEB3B,ELOA2,HsT832,TCEB3L;transcription elongation factor B polypeptide 3B (elongin A2)
hsa:343173;OR2T3;olfactory receptor, family 2, subfamily T, member 3
hsa:120114;FAT3,CDHF15,CDHR10;FAT tumor suppressor homolog 3 (Drosophila)
hsa:84078;KBTBD7;kelch repeat and BTB (POZ) domain containing 7
hsa:89890;KBTBD6;kelch repeat and BTB (POZ) domain containing 6
hsa:22997;IGSF9B;immunoglobulin superfamily, member 9B
hsa:414061;DNAJB3,HCG3;DnaJ (Hsp40) homolog, subfamily B, member 3
hsa:2850;GPR27,SREB1;G protein-coupled receptor 27
hsa:343172;OR2T8,OR2T8P;olfactory receptor, family 2, subfamily T, member 8
hsa:338675;OR5AP2,OR9J1;olfactory receptor, family 5, subfamily AP, member 2
hsa:59285;CACNG6;calcium channel, voltage-dependent, gamma subunit 6
hsa:644524;NKX2-4,NKX2.4,NKX2D;NK2 homeobox 4
hsa:26071;FAM127B,CXX1b,MAR8A;family with sequence similarity 127, member B
hsa:83895;KRTAP1-5,KAP1.5,KRTAP1.5;keratin associated protein 1-5
hsa:81099;OR4F17,OR4F11P,OR4F18,OR4F19;olfactory receptor, family 4, subfamily F, member 17
hsa:158055;C9orf163,RP11-413M3.11;chromosome 9 open reading frame 163
hsa:64110;MAGEF1;melanoma antigen family F, 1
hsa:83897;KRTAP3-2,KAP3.2,KRTAP3.2;keratin associated protein 3-2
hsa:27245;AHDC1,CL23945,DJ159A19.3,RP1-159A19.1;AT hook, DNA binding motif, containing 1
hsa:219487;OR5M11,OR11-199;olfactory receptor, family 5, subfamily M, member 11
hsa:388407;C17orf82;chromosome 17 open reading frame 82
hsa:337880;KRTAP11-1,HACL-1,HACL1,KAP11.1;keratin associated protein 11-1
hsa:150353;DNAJB7,DJ5,HSC3;DnaJ (Hsp40) homolog, subfamily B, member 7
hsa:83755;KRTAP4-12,KAP4.12,KRTAP4.12;keratin associated protein 4-12
hsa:56130;PCDHB6,PCDH-BETA6;protocadherin beta 6
hsa:284071;C17orf104;chromosome 17 open reading frame 104
hsa:401387;LRRD1;leucine-rich repeats and death domain containing 1
hsa:100302185;MIR1204,hsa-mir-1204;microRNA 1204
hsa:390010;NKX1-2,C10orf121,NKX-1.1,bB238F13.2;NK1 homeobox 2
hsa:353219;KAAG1,RU2AS;kidney associated antigen 1
hsa:79729;SH3D21,C1orf113;SH3 domain containing 21
hsa:285051;C2orf61;chromosome 2 open reading frame 61
hsa:55779;WDR52;WD repeat domain 52
hsa:55001;TTC22;tetratricopeptide repeat domain 22
hsa:727940;RHOXF2B;Rhox homeobox family, member 2B
hsa:729877;TBC1D3H;TBC1 domain family, member 3H
hsa:9704;DHX34,DDX34,HRH1;DEAH (Asp-Glu-Ala-His) box polypeptide 34 (EC:3.6.4.13)
hsa:112937;GLB1L3;galactosidase, beta 1-like 3
hsa:100288287;KRTAP22-2,KAP22.2;keratin associated protein 22-2
hsa:9625;AATK,AATYK,AATYK1,LMR1,LMTK1,p35BP;apoptosis-associated tyrosine kinase (EC:2.7.11.1)
hsa:51301;GCNT4,C2GNT3;glucosaminyl (N-acetyl) transferase 4, core 2 (EC:2.4.1.102)
hsa:653489;RGPD3,RGP3;RANBP2-like and GRIP domain containing 3
hsa:401097;C3orf80;chromosome 3 open reading frame 80
hsa:139741;ACTRT1,AIP1,ARIP1,ARPT1,HSD27;actin-related protein T1
hsa:10586;MAB21L2;mab-21-like 2 (C. elegans)
hsa:494332;MIR383,MIRN383,hsa-mir-383;microRNA 383
hsa:222234;FAM185A;family with sequence similarity 185, member A
hsa:728224;KRTAP4-8,KAP4.8,KRTAP4.8;keratin associated protein 4-8
hsa:693147;MIR562,MIRN562,hsa-mir-562;microRNA 562
hsa:27184;DISC2,DISC1-AS1,DISC1OS,NCRNA00015;disrupted in schizophrenia 2 (non-protein coding)
hsa:100126343;MIR874,MIRN874,hsa-mir-874;microRNA 874
hsa:390084;OR56A5,OR56A5P;olfactory receptor, family 56, subfamily A, member 5
hsa:727851;RGPD8,RANBP2L1,RGP8,RanBP2alpha;RANBP2-like and GRIP domain containing 8
hsa:139628;FOXR2,FOXN6;forkhead box R2
hsa:150221;RIMBP3C,RIM-BP3.3,RIMBP3.3;RIMS binding protein 3C
hsa:157773;C8orf48;chromosome 8 open reading frame 48
hsa:1768;DNAH6,DNHL1,Dnahc6,HL-2,HL2;dynein, axonemal, heavy chain 6
hsa:80000;GREB1L,C18orf6,KIAA1772;growth regulation by estrogen in breast cancer-like
hsa:392862;GRID2IP,DELPHILIN;glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein
hsa:163479;FNDC7,RP11-293A10.2;fibronectin type III domain containing 7
hsa:653544;DUX4L6;double homeobox 4 like 6
hsa:94086;HSPB9,CT51;heat shock protein, alpha-crystallin-related, B9
hsa:390061;OR51Q1;olfactory receptor, family 51, subfamily Q, member 1
hsa:375248;ANKRD36,UNQ2430;ankyrin repeat domain 36
hsa:4115;MAGEB4,CT3.6;melanoma antigen family B, 4
hsa:164118;TTC24;tetratricopeptide repeat domain 24
hsa:22996;TTC39A,C1orf34,DEME-6;tetratricopeptide repeat domain 39A
hsa:100170220;SNAR-E;small ILF3/NF90-associated RNA E
hsa:150709;ANKAR;ankyrin and armadillo repeat containing
hsa:340578;DCAF12L2,WDR40C;DDB1 and CUL4 associated factor 12-like 2
hsa:135398;C6orf141;chromosome 6 open reading frame 141
hsa:442229;SLC25A51P1,MCART3P,bA707M13.1;solute carrier family 25, member 51 pseudogene 1
hsa:337879;KRTAP8-1,KAP8.1;keratin associated protein 8-1
hsa:353131;LCE1A,LEP1;late cornified envelope 1A
hsa:353137;LCE1F,LEP6;late cornified envelope 1F
hsa:170463;SSBP4;single stranded DNA binding protein 4
hsa:100130827;SGK110;putative uncharacterized serine/threonine-protein kinase SgK110-like (EC:2.7.11.1)
hsa:408050;NOMO3,Nomo;NODAL modulator 3
hsa:25938;HEATR5A,C14orf125;HEAT repeat containing 5A
hsa:26100;WIPI2,ATG18B,Atg21,WIPI-2;WD repeat domain, phosphoinositide interacting 2
hsa:441869;ANKRD65;ankyrin repeat domain 65
hsa:7289;TULP3,TUBL3;tubby like protein 3
hsa:283643;C14orf80;chromosome 14 open reading frame 80
hsa:644150;WIPF3,CR16;WAS/WASL interacting protein family, member 3
hsa:55057;AIM1L,CRYBG2;absent in melanoma 1-like
hsa:100287898;TTC34;tetratricopeptide repeat domain 34
hsa:4675;NAP1L3,MB20,NPL3;nucleosome assembly protein 1-like 3
hsa:441459;ANKRD18B,bA255A11.3,bA255A11.5;ankyrin repeat domain 18B
hsa:93661;CAPZA3,CAPPA3,Gsg3;capping protein (actin filament) muscle Z-line, alpha 3
hsa:728577;CNTNAP3B;contactin associated protein-like 3B
hsa:54454;ATAD2B;ATPase family, AAA domain containing 2B
hsa:100302160;MIR1233-1,MIR1233,MIRN1233,hsa-mir-1233,hsa-mir-1233-1;microRNA 1233-1
hsa:57636;ARHGAP23;Rho GTPase activating protein 23
hsa:442900;MIR326,MIRN326,hsa-mir-326;microRNA 326
hsa:22902;RUFY3,RIPX,SINGAR1;RUN and FYVE domain containing 3
hsa:343099;CCDC18,NY-SAR-41,dJ717I23.1;coiled-coil domain containing 18
hsa:541565;C8orf58;chromosome 8 open reading frame 58
hsa:125704;FAM69C,C18orf51;family with sequence similarity 69, member C
hsa:100190940;;uncharacterized LOC100190940
hsa:432369;ATP5EP2;ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit pseudogene 2
hsa:146880;;Rho GTPase activating protein 27 pseudogene
hsa:100113404;LINC00583,C9orf146;long intergenic non-protein coding RNA 583
hsa:100132724;DCAF13P3;DDB1 and CUL4 associated factor 13 pseudogene 3
hsa:100652883;ALOX15P1,ALOX15P;arachidonate 15-lipoxygenase pseudogene 1
hsa:728882;FAM182B;family with sequence similarity 182, member B
hsa:100129583;FAM47E;family with sequence similarity 47, member E
hsa:353164;TAS2R42,T2R24,T2R55,TAS2R55,hT2R55;taste receptor, type 2, member 42
hsa:389857;CENPVP1,CENPVL1,PRR6L1;centromere protein V pseudogene 1
hsa:100302242;MIR1236,MIRN1236,hsa-mir-1236;microRNA 1236
hsa:100302124;MIR1288,MIRN1288,hsa-mir-1288;microRNA 1288
hsa:403315;FAM92A1P2,FAM92A3;family with sequence similarity 92, member A3
hsa:441495;CENPVP2;centromere protein V pseudogene 2
hsa:25786;DGCR11,DGS-D;DiGeorge syndrome critical region gene 11 (non-protein coding)
hsa:26222;DGCR10,DGS-B;DiGeorge syndrome critical region gene 10 (non-protein coding)
hsa:493812;HCG11,bK14H9.3;HLA complex group 11 (non-protein coding)
hsa:414765;HCG25,dJ1033B10.16;HLA complex group 25 (non-protein coding)
hsa:50839;TAS2R10,T2R10,TRB2;taste receptor, type 2, member 10
hsa:222894;FERD3L,N-TWIST,NATO3,NTWIST,bHLHa31;Fer3-like (Drosophila)
hsa:84616;KRTAP4-4,KAP4.13,KAP4.4,KRTAP4-13,KRTAP4.13,KRTAP4.4;keratin associated protein 4-4
hsa:341567;H1FNT,H1T2;H1 histone family, member N, testis-specific
hsa:11250;GPR45,PSP24,PSP24(ALPHA),PSP24A;G protein-coupled receptor 45
hsa:353323;KRTAP12-2,KAP12.2,KRTAP12.2;keratin associated protein 12-2
hsa:2579;GAGE7,AL4,CT4.7,GAGE-7;G antigen 7
hsa:353332;KRTAP12-1,KAP12.1,KRTAP12.1;keratin associated protein 12-1
hsa:388730;TMEM81,HC3107,KVLA2788,UNQ2788;transmembrane protein 81
hsa:353132;LCE1B,LEP2,SPRL2A;late cornified envelope 1B
hsa:220382;FAM181B;family with sequence similarity 181, member B
hsa:2712;GK2,GKP2,GKTA;glycerol kinase 2 (EC:2.7.1.30)
hsa:337974;KRTAP19-7,KAP19.7;keratin associated protein 19-7
hsa:337975;KRTAP20-1,KAP20.1;keratin associated protein 20-1
hsa:337976;KRTAP20-2,KAP20.2;keratin associated protein 20-2
hsa:574;BAGE,BAGE1,CT2.1;B melanoma antigen
hsa:337977;KRTAP21-1,KAP21.1;keratin associated protein 21-1
hsa:337979;KRTAP22-1,KAP22.1;keratin associated protein 22-1
hsa:284827;KRTAP13-4,KAP13.4;keratin associated protein 13-4
hsa:26130;GAPVD1,GAPEX5,RAP6;GTPase activating protein and VPS9 domains 1
hsa:390212;GPR152,PGR5;G protein-coupled receptor 152
hsa:83896;KRTAP3-1,KAP3.1,KRTAP3.1;keratin associated protein 3-1
hsa:8324;FZD7,FzE3;frizzled family receptor 7
hsa:85280;KRTAP9-4,KAP9.4,KRTAP9.4;keratin associated protein 9-4
hsa:161291;TMEM30B,CDC50B;transmembrane protein 30B
hsa:124565;SLC38A10;solute carrier family 38, member 10
hsa:151050;KANSL1L,C2orf67,MSL1v2;KAT8 regulatory NSL complex subunit 1-like
hsa:84256;FLYWCH1;FLYWCH-type zinc finger 1
hsa:347475;CCDC160;coiled-coil domain containing 160
hsa:359845;FAM101B;family with sequence similarity 101, member B
hsa:646625;PRHOXNB,URAD;parahox cluster neighbor (EC:4.1.1.n1)
hsa:439915;KRTAP5-5,KRTAP5-11,KRTAP5.5;keratin associated protein 5-5
hsa:729767;CEACAM18;carcinoembryonic antigen-related cell adhesion molecule 18
hsa:391002;PRAMEF8;PRAME family member 8
hsa:493861;EID3,NS4EB,NSE4B,NSMCE4B;EP300 interacting inhibitor of differentiation 3
hsa:284194;LGALS9B;lectin, galactoside-binding, soluble, 9B
hsa:55209;SETD5;SET domain containing 5
hsa:646424;SPINK8;serine peptidase inhibitor, Kazal type 8 (putative)
hsa:57481;;KIAA1210
hsa:219972;MPEG1,MPG1,MPS1,Mpg-1;macrophage expressed 1
hsa:55747;FAM21B,FAM21A,bA98I6.1;family with sequence similarity 21, member B
hsa:50840;TAS2R14,T2R14,TRB1;taste receptor, type 2, member 14
hsa:254050;LRRC43;leucine rich repeat containing 43
hsa:389813;C9orf172;chromosome 9 open reading frame 172
hsa:386675;KRTAP10-7,KAP10.7,KAP18.7,KRTAP18-7;keratin associated protein 10-7
hsa:339291;LRRC30;leucine rich repeat containing 30
hsa:339778;C2orf70;chromosome 2 open reading frame 70
hsa:388327;C17orf100;chromosome 17 open reading frame 100
hsa:25763;CXorf27,HIP17,HYPM;chromosome X open reading frame 27
hsa:57593;EBF4,COE4,O/E-4;early B-cell factor 4
hsa:643803;KRTAP24-1,KAP24.1;keratin associated protein 24-1
hsa:253314;EIF4E1B;eukaryotic translation initiation factor 4E family member 1B
hsa:728621;CCDC30,PFD6L,PFDN6L;coiled-coil domain containing 30
hsa:728929;TCEB3CL,HsT828;transcription elongation factor B polypeptide 3C-like
hsa:728299;KRTAP19-8;keratin associated protein 19-8
hsa:643314;;KIAA0754
hsa:337978;KRTAP21-2,KAP21.2;keratin associated protein 21-2
hsa:81872;KRTAP2-1,KAP2.1A,KRTAP2.1A;keratin associated protein 2-1
hsa:57597;BAHCC1,BAHD2;BAH domain and coiled-coil containing 1
hsa:4342;MOS,MSV;v-mos Moloney murine sarcoma viral oncogene homolog (EC:2.7.11.1)
hsa:337959;KRTAP13-2,KAP13-2;keratin associated protein 13-2
hsa:139604;MAGEB16;melanoma antigen family B, 16
hsa:56624;ASAH2,BCDase,HNAC1,LCDase,N-CDase,NCDase;N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 (EC:3.5.1.23)
hsa:643311;CT47B1,CT47.13,CT47A13;cancer/testis antigen family 47, member B1
hsa:284428;MBD3L5;methyl-CpG binding domain protein 3-like 5
hsa:347744;C6orf52;chromosome 6 open reading frame 52
hsa:285782;CAGE1,CT3,CT95,CTAG3,bA69L16.7;cancer antigen 1
hsa:643338;C15orf62;chromosome 15 open reading frame 62
hsa:339541;C1orf228,NCRNA00082,p40;chromosome 1 open reading frame 228
hsa:388963;C2orf81,hCG40743;chromosome 2 open reading frame 81
hsa:116349;C5orf55;chromosome 5 open reading frame 55
hsa:57692;MAGEE1,DAMAGE,HCA1;melanoma antigen family E, 1
hsa:342346;C16orf96;chromosome 16 open reading frame 96
hsa:51184;GPN3,ATPBD1C;GPN-loop GTPase 3;K06883
hsa:100170841;C17orf96;chromosome 17 open reading frame 96
hsa:283152;CCDC153;coiled-coil domain containing 153
hsa:158830;CXorf65;chromosome X open reading frame 65
hsa:552889;ATXN7L3B;ataxin 7-like 3B
hsa:337878;KRTAP7-1,KAP7.1;keratin associated protein 7-1 (gene/pseudogene)
hsa:162083;C16orf82,TNT;chromosome 16 open reading frame 82
hsa:100130742;LRRC69;leucine rich repeat containing 69
hsa:10880;ACTL7B,Tact1;actin-like 7B
hsa:126917;IFFO2;intermediate filament family orphan 2
hsa:221438;TREML5P,TLT5,TREML2P,TREML2P1;triggering receptor expressed on myeloid cells-like 5, pseudogene
hsa:100170765;C19orf69;chromosome 19 open reading frame 69
hsa:442444;FAM47C;family with sequence similarity 47, member C
hsa:442590;SPDYE5;speedy homolog E5 (Xenopus laevis)
hsa:100129271;C1orf68,LEP7,XP32;chromosome 1 open reading frame 68
hsa:65998;C11orf95;chromosome 11 open reading frame 95
hsa:390205;LRRC10B;leucine rich repeat containing 10B
hsa:647309;GMNC,GEMC1;geminin coiled-coil domain containing
hsa:23285;;KIAA1107
hsa:643854;CTAGE9;CTAGE family, member 9
hsa:387885;CCDC42B;coiled-coil domain containing 42B
hsa:653656;MBD3L4;methyl-CpG binding domain protein 3-like 4
hsa:9852;EPM2AIP1;EPM2A (laforin) interacting protein 1
hsa:729597;SPDYE6;speedy homolog E6 (Xenopus laevis)
hsa:343578;ARHGAP40,C20orf95,dJ1100H13.4;Rho GTPase activating protein 40
hsa:100288323;KRTAP21-3;keratin associated protein 21-3
hsa:121006;FAM186A;family with sequence similarity 186, member A
hsa:81870;KRTAP9-9,KAP9.5,KAP9.9,KRTAP9-5,KRTAP9.9;keratin associated protein 9-9
hsa:100132386;KRTAP4-9,KAP4.9;keratin associated protein 4-9
hsa:54429;TAS2R5,T2R5;taste receptor, type 2, member 5
hsa:50836;TAS2R8,T2R8,TRB5;taste receptor, type 2, member 8
hsa:84826;SFT2D3;SFT2 domain containing 3
hsa:259286;TAS2R40,GPR60,T2R40,T2R58;taste receptor, type 2, member 40
hsa:94107;TMEM203,HBEBP1;transmembrane protein 203
hsa:56131;PCDHB4,PCDH-BETA4;protocadherin beta 4
hsa:56132;PCDHB3,PCDH-BETA3;protocadherin beta 3
hsa:56133;PCDHB2,PCDH-BETA2;protocadherin beta 2
hsa:50837;TAS2R7,T2R7,TRB4;taste receptor, type 2, member 7
hsa:401666;OR51A4;olfactory receptor, family 51, subfamily A, member 4
hsa:59351;PBOV1,UC28,UROC28,dJ171N11.2;prostate and breast cancer overexpressed 1
hsa:54972;TMEM132A,GBP,HSPA5BP1;transmembrane protein 132A
hsa:317705;VN1R5,V1RL5;vomeronasal 1 receptor 5 (gene/pseudogene)
hsa:171169;SPACA4,SAMP14;sperm acrosome associated 4
hsa:388199;PRR25,gs64;proline rich 25
hsa:10343;PKDREJ;polycystic kidney disease (polycystin) and REJ homolog (sperm receptor for egg jelly homolog, sea urchin)
hsa:400736;PRAMEF13;PRAME family member 13
hsa:5509;PPP1R3D,PPP1R6;protein phosphatase 1, regulatory subunit 3D (EC:3.1.3.16)
hsa:645369;TMEM200C,TTMA;transmembrane protein 200C
hsa:654348;PRAMEF16;PRAME family member 16
hsa:387849;REP15,RAB15EP;RAB15 effector protein
hsa:741;ZNHIT2,C11orf5,FON;zinc finger, HIT-type containing 2
hsa:29930;PCDHB1,PCDH-BETA1;protocadherin beta 1
hsa:24147;FJX1;four jointed box 1 (Drosophila)
hsa:84144;SYDE2,RP11-33E12.1;synapse defective 1, Rho GTPase, homolog 2 (C. elegans)
hsa:92552;ATXN3L,MJDL;ataxin 3-like (EC:3.4.19.12)
hsa:138429;PIP5KL1,PIPKH,bA203J24.5;phosphatidylinositol-4-phosphate 5-kinase-like 1 (EC:2.7.1.68)
hsa:136306;SVOPL;SVOP-like
hsa:191585;PLAC4,C21orf115,PRED78;placenta-specific 4
hsa:730130;TMEM229A;transmembrane protein 229A
hsa:401474;SAMD12;sterile alpha motif domain containing 12
hsa:100131902;KRTAP25-1,KAP25.1;keratin associated protein 25-1
hsa:375316;RBM44;RNA binding motif protein 44
hsa:389152;PRR23C;proline rich 23C
hsa:729627;PRR23A;proline rich 23A
hsa:144448;TSPAN19;tetraspanin 19
hsa:728464;METTL24,C6orf186,dJ71D21.2;methyltransferase like 24
hsa:643905;PRR21;proline rich 21
hsa:768239;PSAPL1;prosaposin-like 1 (gene/pseudogene)
hsa:50651;SLC45A1,DNB5;solute carrier family 45, member 1
hsa:10638;SPHAR,RP4-803J11.4;S-phase response (cyclin related)
hsa:147699;PPM1N;protein phosphatase, Mg2+/Mn2+ dependent, 1N (putative) (EC:3.1.3.16)
hsa:170394;PWWP2B,PWWP2,RP11-273H7.1,bA432J24.1,pp8607;PWWP domain containing 2B
hsa:647174;SERPINE3;serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 3
hsa:317662;FAM149B1,KIAA0974;family with sequence similarity 149, member B1
hsa:100132403;FAM157B;family with sequence similarity 157, member B
hsa:606495;CYB5RL;cytochrome b5 reductase-like (EC:1.6.2.2)
hsa:56252;YLPM1,C14orf170,ZAP113,ZAP3;YLP motif containing 1
hsa:100287534;killer cell immunoglobulin-like receptor 2DL4-like
hsa:643641;ZNF862;zinc finger protein 862
hsa:645922;S100A7L2,S100a7b;S100 calcium binding protein A7-like 2
hsa:338949;TMEM202;transmembrane protein 202
hsa:100128553;CTAGE4,cTAGE-4;CTAGE family, member 4
hsa:645843;TMEM14E;transmembrane protein 14E
hsa:645414;PRAMEF19;PRAME family member 19
hsa:139599;MAGEE2,HCA3;melanoma antigen family E, 2
hsa:342918;C19orf81;chromosome 19 open reading frame 81
hsa:641455;POTEM,ACT,P704P,POTE14beta;POTE ankyrin domain family, member M
hsa:100381270;ZBED6,MGR;zinc finger, BED-type containing 6
hsa:341346;SMCO2,C12orf70;single-pass membrane protein with coiled-coil domains 2
hsa:91181;NUP210L,RP11-144B19.1;nucleoporin 210kDa-like
hsa:441932;OR2W5,OR2W5P,OST722;olfactory receptor, family 2, subfamily W, member 5
hsa:728318;KRTAP9-1,KAP9.1,KRTAP9L3;keratin associated protein 9-1
hsa:730005;SEC14L6;SEC14-like 6 (S. cerevisiae)
hsa:100289678;ZNF783;zinc finger family member 783
hsa:146861;SLC35G3,AMAC1,TMEM21A;solute carrier family 35, member G3
hsa:389856;USP27X,USP22L,USP27;ubiquitin specific peptidase 27, X-linked (EC:3.4.19.12)
hsa:728137;TSPY3;testis specific protein, Y-linked 3
hsa:100462981;MTRNR2L2,HN2;MT-RNR2-like 2
hsa:219537;SMTNL1,CHASM;smoothelin-like 1
hsa:100170229;SRRM5,ZNF576;serine/arginine repetitive matrix 5
hsa:389161;ANKUB1,C3orf16;ankyrin repeat and ubiquitin domain containing 1
hsa:646960;PRSS56,MCOP6;protease, serine, 56
hsa:147664;ERVV-1,ENVV1,ERVV-2,HERV-V1;endogenous retrovirus group V, member 1
hsa:349633;C11orf34,PLET1;chromosome 11 open reading frame 34
hsa:728591;CCDC169,C13orf38;coiled-coil domain containing 169
hsa:342979;PALM3;paralemmin 3
hsa:57730;ANKRD36B,KIAA1641;ankyrin repeat domain 36B
hsa:57224;NHSL1,C6orf63;NHS-like 1
hsa:378948;RBMY1B;RNA binding motif protein, Y-linked, family 1, member B
hsa:147645;VSIG10L;V-set and immunoglobulin domain containing 10 like
hsa:729396;GAGE12J,GAGE11;G antigen 12J
hsa:94026;POM121L2,POM121-L,POM121L;POM121 transmembrane nucleoporin-like 2
hsa:647024;C6orf132,bA7K24.2;chromosome 6 open reading frame 132
hsa:220213;OTUD1,DUBA7,OTDC1;OTU domain containing 1
hsa:9836;LCMT2,PPM2,TYW4;leucine carboxyl methyltransferase 2
hsa:23148;NACAD;NAC alpha domain containing
hsa:100128327;BET3L,TRAPPC3L,bA259P20.2;BET3 like (S. cerevisiae)
hsa:653606;PRAMEF22,PRAMEF3L;PRAME family member 22
hsa:4674;NAP1L2,BPX;nucleosome assembly protein 1-like 2
hsa:85291;KRTAP4-2,KAP4.2,KRTAP4.2;keratin associated protein 4-2
hsa:255783;PRR24;proline rich 24
hsa:200035;NUDT17;nudix (nucleoside diphosphate linked moiety X)-type motif 17
hsa:81871;KRTAP4-6,KAP4.15,KAP4.6,KRTAP4-15,KRTAP4.15;keratin associated protein 4-6
hsa:56160;NDNL2,HCA4,MAGEG1,MAGEL3,NSE3,NSMCE3;necdin-like 2
hsa:280657;SSX6,SSXP2,dJ54B20.1,psiSSX2;synovial sarcoma, X breakpoint 6 (pseudogene)
hsa:2679;GGT3P,GGT3;gamma-glutamyltransferase 3 pseudogene
hsa:81698;LINC00597,C15orf5;long intergenic non-protein coding RNA 597
hsa:100885780;VWC2L-IT1;VWC2L intronic transcript 1 (non-protein coding)
hsa:100885781;LINC00348;long intergenic non-protein coding RNA 348
hsa:386679;KRTAP10-2,KAP10.2,KAP18-2,KAP18.2,KRTAP10.2,KRTAP18-2,KRTAP18.2;keratin associated protein 10-2
hsa:161779;PGBD4;piggyBac transposable element derived 4
hsa:166815;TIGD2;tigger transposable element derived 2
hsa:51093;RRNAD1,C1orf66,CGI-41;ribosomal RNA adenine dimethylase domain containing 1
hsa:283345;RPL13P5,RPL13-2,RPL13L,RPL13_4_1199,RRPL13L;ribosomal protein L13 pseudogene 5
hsa:85294;KRTAP2-4,KAP2.1B,KAP2.4,KRTAP2.4;keratin associated protein 2-4
hsa:123745;PLA2G4E;phospholipase A2, group IVE (EC:3.1.1.4)
hsa:83901;KRTAP9-8,KAP9.8,KRTAP9.8;keratin associated protein 9-8
hsa:100132476;KRTAP4-7,KAP4.7,KRTAP4.7;keratin associated protein 4-7
hsa:283238;SLC22A24,NET46;solute carrier family 22, member 24
hsa:441177;LINC00602;long intergenic non-protein coding RNA 602
hsa:100329109;GCSHP3;glycine cleavage system protein H (aminomethyl carrier) pseudogene 3
hsa:55293;UEVLD,ATTP,UEV3;UEV and lactate/malate dehyrogenase domains
hsa:100861522;LINC00489;long intergenic non-protein coding RNA 489
hsa:100616436;MIR4449;microRNA 4449
hsa:100873761;RNU6-52;RNA, U6 small nuclear 52
hsa:100873740;RNU6-6;RNA, U6 small nuclear 6
hsa:100873763;RNU6-55;RNA, U6 small nuclear 55
hsa:100873741;RNU6-8;RNA, U6 small nuclear 8
hsa:100873745;RNU6-10;RNA, U6 small nuclear 10
hsa:100873764;RNU6-56;RNA, U6 small nuclear 56
hsa:100873746;RNU6-14;RNA, U6 small nuclear 14
hsa:100873765;RNU6-57;RNA, U6 small nuclear 57
hsa:100873753;RNU6-16;RNA, U6 small nuclear 16
hsa:100873766;RNU6-58;RNA, U6 small nuclear 58
hsa:100873754;RNU6-19;RNA, U6 small nuclear 19
hsa:100873767;RNU6-59;RNA, U6 small nuclear 59
hsa:100873768;RNU6-63;RNA, U6 small nuclear 63
hsa:100873755;RNU6-23;RNA, U6 small nuclear 23
hsa:100873769;RNU6-64;RNA, U6 small nuclear 64
hsa:100873756;RNU6-28;RNA, U6 small nuclear 28
hsa:100873747;RNU6-30;RNA, U6 small nuclear 30
hsa:100873770;RNU6-66;RNA, U6 small nuclear 66
hsa:100873771;RNU6-67;RNA, U6 small nuclear 67
hsa:100873748;RNU6-33;RNA, U6 small nuclear 33
hsa:100873772;RNU6-68;RNA, U6 small nuclear 68
hsa:100873749;RNU6-34;RNA, U6 small nuclear 34
hsa:100873750;RNU6-35;RNA, U6 small nuclear 35
hsa:100873773;RNU6-69;RNA, U6 small nuclear 69
hsa:100873757;RNU6-36;RNA, U6 small nuclear 36
hsa:100873774;RNU6-71;RNA, U6 small nuclear 71
hsa:100873775;RNU6-72;RNA, U6 small nuclear 72
hsa:100873758;RNU6-39;RNA, U6 small nuclear 39
hsa:100873759;RNU6-45;RNA, U6 small nuclear 45
hsa:100873776;RNU6-75;RNA, U6 small nuclear 75
hsa:100873777;RNU6-76;RNA, U6 small nuclear 76
hsa:100873760;RNU6-46;RNA, U6 small nuclear 46
hsa:100873778;RNU6-78;RNA, U6 small nuclear 78
hsa:100873779;RNU6-79;RNA, U6 small nuclear 79
hsa:100873780;RNU6-81;RNA, U6 small nuclear 81
hsa:100873781;RNU6-82;RNA, U6 small nuclear 82
hsa:100873782;RNU6-83;RNA, U6 small nuclear 83
hsa:100500910;MIR3670-1,MIR3670,hsa-mir-3670-1;microRNA 3670-1
hsa:100616155;MIR4536-1,MIR4536,hsa-mir-4536-1;microRNA 4536-1
hsa:100861504;LINC00538,Yiya;long intergenic non-protein coding RNA 538
hsa:100302273;MIR1254-1,MIR1254,MIRN1254,hsa-mir-1254,hsa-mir-1254-1;microRNA 1254-1
hsa:100873962;LINC00278,NCRNA00278;long intergenic non-protein coding RNA 278
hsa:100616394;MIR4444-1,MIR4444,hsa-mir-4444-1;microRNA 4444-1
hsa:100616123;MIR4436B1,MIR4436B,hsa-mir-4436b-1;microRNA 4436b-1
hsa:100422893;MIR3154;microRNA 3154
hsa:100616379;MIR4511;microRNA 4511
hsa:100422835;MIR3183;microRNA 3183
hsa:100500865;MIR3936;microRNA 3936
hsa:100616271;MIR4637;microRNA 4637
hsa:100422899;MIR3190;microRNA 3190
hsa:100616221;MIR4662A;microRNA 4662a
hsa:100616335;MIR2964A;microRNA 2964a
hsa:100422871;MIR3117;microRNA 3117
hsa:100616343;MIR4677;microRNA 4677
hsa:100422859;MIR3136;microRNA 3136
hsa:100422896;MIR3140;microRNA 3140
hsa:100423012;MIR3177;microRNA 3177
hsa:100500907;MIR3150B;microRNA 3150b
hsa:100500904;MIR3942;microRNA 3942
hsa:100616481;MIR4423;microRNA 4423
hsa:100616441;MIR4474;microRNA 4474
hsa:51198;C9orf53,bA149I2.3;chromosome 9 open reading frame 53
hsa:414212;GLUD1P7,GLUDP7,bA342C24.3;glutamate dehydrogenase 1 pseudogene 7
hsa:90586;AOC4;amine oxidase, copper containing 3 (vascular adhesion protein 1) pseudogene
hsa:406953;MIR18A,MIR18,MIRN18,MIRN18A,hsa-mir-18,hsa-mir-18a,miR-18,miRNA18A;microRNA 18a
hsa:406980;MIR19B1,MIRN19B1,miR-19b-1,miRNA19B1;microRNA 19b-1
hsa:497049;FLJ25758;MAP/microtubule affinity-regulating kinase 1 pseudogene
hsa:100506898;MAGOH2;mago-nashi homolog 2 (pseudogene)
hsa:388499;;lysophospholipase II pseudogene
hsa:390732;CES1P2;carboxylesterase 1 pseudogene
hsa:100874370;CACNA1C-IT3;CACNA1C intronic transcript 3 (non-protein coding)
hsa:100288805;HYDIN2,HYDINP1;HYDIN2, axonemal central pair apparatus protein (pseudogene)
hsa:285601;GPR150,PGR11;G protein-coupled receptor 150
hsa:386685;KRTAP10-12,KAP10.12,KRTAP18-12,KRTAP18.12;keratin associated protein 10-12
hsa:220388;CCDC89;coiled-coil domain containing 89
hsa:84636;GPR174;G protein-coupled receptor 174
hsa:337960;KRTAP13-3,KAP13.3;keratin associated protein 13-3
hsa:337963;KRTAP23-1,KAP23.1;keratin associated protein 23-1
hsa:126272;EID2B,EID-3;EP300 interacting inhibitor of differentiation 2B
hsa:386672;KRTAP10-4,KAP10.4,KAP18-4,KRTAP10.4,KRTAP18-4,KRTAP18.4;keratin associated protein 10-4
hsa:643812;KRTAP27-1;keratin associated protein 27-1
hsa:646962;HRCT1,LGLL338,PRO537,UNQ338;histidine rich carboxyl terminus 1
hsa:642423;;uncharacterized LOC642423
hsa:80111;C3orf36;chromosome 3 open reading frame 36
hsa:8705;B3GALT4,BETA3GALT4,GALT2,GALT4;UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 (EC:2.4.1.62)
hsa:222183;SRRM3;serine/arginine repetitive matrix 3
hsa:729528;PRAMEF14;PRAME family member 14
hsa:645425;PRAMEF20;PRAME family member 20
hsa:197135;PATL2,Pat1a,hPat1a;protein associated with topoisomerase II homolog 2 (yeast)
hsa:22928;SEPHS2,SPS2,SPS2b;selenophosphate synthetase 2 (EC:2.7.9.3)
hsa:120379;PIH1D2;PIH1 domain containing 2
hsa:648740;ACTG1P4,ACTGP4;actin, gamma 1 pseudogene 4
hsa:729862;LSP1P3;lymphocyte-specific protein 1 pseudogene 3
hsa:440041;TRIM51HP;tripartite motif-containing 51H, pseudogene
hsa:100874126;LINC00331,NCRNA00331;long intergenic non-protein coding RNA 331
hsa:283416;C12orf61;chromosome 12 open reading frame 61
hsa:285800;PRR18;proline rich 18
hsa:54551;MAGEL2,NDNL1,nM15;MAGE-like 2
hsa:283116;TRIM49B;tripartite motif containing 49B
hsa:266812;NAP1L5,DRLM;nucleosome assembly protein 1-like 5
hsa:406960;MIR184,EDICT,MIRN184,miR-184;microRNA 184
hsa:79605;PGBD5;piggyBac transposable element derived 5
hsa:693160;MIR575,MIRN575,hsa-mir-575;microRNA 575
hsa:100302197;MIR1306,MIRN1306,hsa-mir-1306;microRNA 1306
hsa:100616479;MIR4635;microRNA 4635
hsa:100846992;MIR548AW;microRNA 548aw
hsa:693162;MIR577,MIRN577,hsa-mir-577;microRNA 577
hsa:100302174;MIR1307,MIRN1307,hsa-mir-1307;microRNA 1307
hsa:100500842;MIR3652;microRNA 3652
hsa:100847034;MIR5683;microRNA 5683
hsa:100616326;MIR4636;microRNA 4636
hsa:693163;MIR578,MIRN578,hsa-mir-578;microRNA 578
hsa:100313822;MIR513B,MIRN513B;microRNA 513b
hsa:100847071;MIR5684;microRNA 5684
hsa:693164;MIR579,MIRN579,hsa-mir-579;microRNA 579
hsa:100302114;MIR513C,MIRN513C,hsa-mir-513c;microRNA 513c
hsa:100500804;MIR3654;microRNA 3654
hsa:100616269;MIR4639;microRNA 4639
hsa:100847063;MIR548AX;microRNA 548ax
hsa:693166;MIR581,MIRN581,hsa-mir-581;microRNA 581
hsa:100302171;MIR1321,MIRN1321,hsa-mir-1321;microRNA 1321
hsa:100500820;MIR3655;microRNA 3655
hsa:100616237;MIR4640;microRNA 4640
hsa:100847075;MIR5685;microRNA 5685
hsa:407002;MIR219-1,MIRN219-1,MRI219-1,mir-219;microRNA 219-1
hsa:693168;MIR583,MIRN583,hsa-mir-583;microRNA 583
hsa:100500840;MIR3656;microRNA 3656
hsa:100616178;MIR4641;microRNA 4641
hsa:100847082;MIR5692C1;microRNA 5692c-1
hsa:100500889;MIR3657;microRNA 3657
hsa:100616352;MIR4642;microRNA 4642
hsa:100847017;MIR5692C2;microRNA 5692c-2
hsa:693125;MIR548A1,MIRN548A1;microRNA 548a-1
hsa:100302250;MIR1197,MIRN1197,hsa-mir-1197;microRNA 1197
hsa:100500832;MIR3658;microRNA 3658
hsa:100616174;MIR4643;microRNA 4643
hsa:100847019;MIR5687;microRNA 5687
hsa:693171;MIR586,MIRN586,hsa-mir-586;microRNA 586
hsa:100302212;MIR1324,MIRN1324,hsa-mir-1324;microRNA 1324
hsa:100500801;MIR3659;microRNA 3659
hsa:100616430;MIR4644;microRNA 4644
hsa:100847077;MIR5688;microRNA 5688
hsa:693172;MIR587,MIRN587,hsa-mir-587;microRNA 587
hsa:100302258;MIR1469,MIRN1469,hsa-mir-1469;microRNA 1469
hsa:100500825;MIR3660;microRNA 3660
hsa:100847091;MIR5681B;microRNA 5681b
hsa:100616285;MIR4645;microRNA 4645
hsa:693173;MIR588,MIRN588,hsa-mir-588;microRNA 588
hsa:100302127;MIR1470,MIRN1470,hsa-mir-1470;microRNA 1470
hsa:100500905;MIR3661;microRNA 3661
hsa:100616230;MIR4646;microRNA 4646
hsa:100846998;MIR5689;microRNA 5689
hsa:693126;MIR548A2,MIRN548A2;microRNA 548a-2
hsa:100302126;MIR1471,MIRN1471,hsa-mir-1471;microRNA 1471
hsa:100500880;MIR3662;microRNA 3662
hsa:100616124;MIR4647;microRNA 4647
hsa:100847048;MIR5690;microRNA 5690
hsa:100302139;MIR1537,MIRN1537,hsa-mir-1537;microRNA 1537
hsa:693174;MIR589,MIRN589,hsa-mir-589;microRNA 589
hsa:100500893;MIR3663;microRNA 3663
hsa:100847015;MIR5691;microRNA 5691
hsa:100616346;MIR4649;microRNA 4649
hsa:406905;MIR1-2,MIRN1-2,hsa-mir-1-2,miRNA1-2;microRNA 1-2
hsa:693133;MIR550A1,MIR550-1,MIRN550-1,hsa-mir-550a-1;microRNA 550a-1
hsa:100302257;MIR1539,MIRN1539,hsa-mir-1539;microRNA 1539
hsa:100500844;MIR3664;microRNA 3664
hsa:100847066;MIR5692A1;microRNA 5692a-1
hsa:100616310;MIR4650-1;microRNA 4650-1
hsa:693134;MIR550A2,MIR550-2,MIRN550-2,hsa-mir-550a-2;microRNA 550a-2
hsa:100302238;MIR103B1,MIR103-1AS,MIRN103-1AS,hsa-mir-103-1-as;microRNA 103b-1
hsa:100500861;MIR3665;microRNA 3665
hsa:100616331;MIR4650-2;microRNA 4650-2
hsa:100847038;MIR5692A2;microRNA 5692a-2
hsa:100500896;MIR3666;microRNA 3666
hsa:100302282;MIR103B2,MIR103-2-AS,MIR103-2AS,MIRN103-2AS,hsa-mir-103-2-as;microRNA 103b-2
hsa:100616270;MIR4651;microRNA 4651
hsa:100847047;MIR4666B;microRNA 4666b
hsa:693176;MIR591,MIRN591,hsa-mir-591;microRNA 591
hsa:100313896;MIR320D1,MIR320D-1,MIRN320D1;microRNA 320d-1
hsa:100500882;MIR3667;microRNA 3667
hsa:100616206;MIR4652;microRNA 4652
hsa:100847003;MIR5693;microRNA 5693
hsa:100302169;MIR320D2,MIR320D-2,MIRN320D2,hsa-mir-320d-2;microRNA 320d-2
hsa:100500879;MIR3668;microRNA 3668
hsa:100616117;MIR4653;microRNA 4653
hsa:100847064;MIR5694;microRNA 5694
hsa:693181;MIR596,MIRN596,hsa-mir-596;microRNA 596
hsa:100302183;MIR1825,MIRN1825,hsa-mir-1825;microRNA 1825
hsa:100616386;MIR4654;microRNA 4654
hsa:693182;MIR597,MIRN597,hsa-mir-597;microRNA 597
hsa:100500854;MIR3671;microRNA 3671
hsa:100302217;MIR1827,MIRN1827,hsa-mir-1827;microRNA 1827
hsa:100616160;MIR4655;microRNA 4655
hsa:100847007;MIR5696;microRNA 5696
hsa:406908;MIR124-2,MIRN124-2,MIRN124A2;microRNA 124-2
hsa:693183;MIR598,MIRN598,hsa-mir-598;microRNA 598
hsa:100500869;MIR3672;microRNA 3672
hsa:100616465;MIR4656;microRNA 4656
hsa:100847055;MIR5697;microRNA 5697
hsa:693184;MIR599,MIRN599,hsa-mir-599;microRNA 599
hsa:100302210;MIR1909,MIRN1909,hsa-mir-1909;microRNA 1909
hsa:100500912;MIR3674;microRNA 3674
hsa:100616393;MIR4657;microRNA 4657
hsa:100847024;MIR5698;microRNA 5698
hsa:100302261;MIR1910,MIRN1910,hsa-mir-1910;microRNA 1910
hsa:100500876;MIR3675;microRNA 3675
hsa:100616439;MIR4658;microRNA 4658
hsa:100847086;MIR5699;microRNA 5699
hsa:406915;MIR128-1,MIR128A,MIRN128-1,MIRN128A;microRNA 128-1
hsa:693186;MIR601,MIRN601,hsa-mir-601;microRNA 601
hsa:100302222;MIR1911,MIRN1911,hsa-mir-1911;microRNA 1911
hsa:100500892;MIR3676;microRNA 3676
hsa:100616348;MIR4659A;microRNA 4659a
hsa:100847031;MIR5700;microRNA 5700
hsa:100302144;MIR1912,MIRN1912,hsa-mir-1912;microRNA 1912
hsa:693187;MIR602,MIRN602,hsa-mir-602;microRNA 602
hsa:100500812;MIR3677;microRNA 3677
hsa:100847060;MIR5701-1;microRNA 5701-1
hsa:100616350;MIR4660;microRNA 4660
hsa:693188;MIR603,MIRN603,hsa-mir-603;microRNA 603
hsa:100302141;MIR1913,MIRN1913,hsa-mir-1913;microRNA 1913
hsa:100500841;MIR3678;microRNA 3678
hsa:100616245;MIR4661;microRNA 4661
hsa:100847053;MIR5702;microRNA 5702
hsa:693189;MIR604,MIRN604,hsa-mir-604;microRNA 604
hsa:100302137;MIR1914,MIRN1914,hsa-mir-1914;microRNA 1914
hsa:100500878;MIR3679;microRNA 3679
hsa:100847081;MIR5703;microRNA 5703
hsa:693191;MIR606,MIRN606,hsa-mir-606;microRNA 606
hsa:100500917;MIR3680-1,MIR3680,hsa-mir-3680-1;microRNA 3680-1
hsa:100616372;MIR4659B;microRNA 4659b
hsa:100847013;MIR5692B;microRNA 5692b
hsa:693192;MIR607,MIRN607,hsa-mir-607;microRNA 607
hsa:100500884;MIR3681;microRNA 3681
hsa:100616260;MIR4663;microRNA 4663
hsa:100847040;MIR5704;microRNA 5704
hsa:100302190;MIR1976,hsa-mir-1976;microRNA 1976
hsa:100500850;MIR3682;microRNA 3682
hsa:100616255;MIR4662B;microRNA 4662b
hsa:100847027;MIR5705;microRNA 5705
hsa:693194;MIR609,MIRN609,hsa-mir-609;microRNA 609
hsa:100302260;MIR2052,hsa-mir-2052;microRNA 2052
hsa:100500886;MIR3683;microRNA 3683
hsa:100616318;MIR4664;microRNA 4664
hsa:100847085;MIR5706;microRNA 5706
hsa:406930;MIR138-2,MIRN138-2;microRNA 138-2
hsa:100302225;MIR2053,hsa-mir-2053;microRNA 2053
hsa:100500867;MIR3684;microRNA 3684
hsa:100616288;MIR4665;microRNA 4665
hsa:100847032;MIR5707;microRNA 5707
hsa:100500802;MIR3685;microRNA 3685
hsa:100616308;MIR4666A,MIR4666,hsa-mir-4666a;microRNA 4666a
hsa:100847056;MIR5708;microRNA 5708
hsa:693197;MIR612,MIRN612,hsa-mir-612;microRNA 612
hsa:100302224;MIR2110,hsa-mir-2110;microRNA 2110
hsa:100500839;MIR3686;microRNA 3686
hsa:100616214;MIR4667;microRNA 4667
hsa:100847005;MIR5701-2;microRNA 5701-2
hsa:693198;MIR613,MIRN613,hsa-mir-613;microRNA 613
hsa:100313839;MIR2114;microRNA 2114
hsa:100500815;MIR3687;microRNA 3687
hsa:100616114;MIR4668;microRNA 4668
hsa:693199;MIR614,MIRN614,hsa-mir-614;microRNA 614
hsa:100500881;MIR3688-1,MIR3688;microRNA 3688-1
hsa:100313840;MIR2115;microRNA 2115
hsa:693201;MIR616,MIRN616,hsa-mir-616;microRNA 616
hsa:100313779;MIR2117;microRNA 2117
hsa:100500846;MIR3689A;microRNA 3689a
hsa:100616236;MIR4669;microRNA 4669
hsa:693129;MIR548C,MIRN548C;microRNA 548c
hsa:100313841;MIR548Q;microRNA 548q
hsa:100500894;MIR3690;microRNA 3690
hsa:100616351;MIR4670;microRNA 4670
hsa:693202;MIR617,MIRN617,hsa-mir-617;microRNA 617
hsa:100313842;MIR2276;microRNA 2276
hsa:100616380;MIR4671;microRNA 4671
hsa:100500900;MIR3691;microRNA 3691
hsa:693203;MIR618,MIRN618,hsa-mir-618;microRNA 618
hsa:100313887;MIR2277;microRNA 2277
hsa:100500899;MIR3692;microRNA 3692
hsa:100616429;MIR4672;microRNA 4672
hsa:100313780;MIR2278;microRNA 2278
hsa:693204;MIR619,MIRN619,hsa-mir-619;microRNA 619
hsa:100500855;MIR3713;microRNA 3713
hsa:100616110;MIR2681;microRNA 2681
hsa:100616242;MIR4673;microRNA 4673
hsa:100500913;MIR3714;microRNA 3714
hsa:100616301;MIR4674;microRNA 4674
hsa:100616452;MIR2682;microRNA 2682
hsa:100500852;MIR3180-4;microRNA 3180-4
hsa:100616383;MIR4675;microRNA 4675
hsa:693208;MIR623,MIRN623,hsa-mir-623;microRNA 623
hsa:100500916;MIR3180-5;microRNA 3180-5
hsa:100313843;MIR711,hsa-mir-711;microRNA 711
hsa:100616286;MIR4676;microRNA 4676
hsa:693209;MIR624,MIRN624,hsa-mir-624;microRNA 624
hsa:100313781;MIR718,hsa-mir-718;microRNA 718
hsa:100500835;MIR3907;microRNA 3907
hsa:100422969;MIR2909;microRNA 2909
hsa:100500906;MIR3689B;microRNA 3689b
hsa:100616296;MIR4678;microRNA 4678
hsa:406914;MIR127,MIRN127,miRNA127;microRNA 127
hsa:693211;MIR626,MIRN626,hsa-mir-626;microRNA 626
hsa:100422866;MIR3115;microRNA 3115
hsa:100500909;MIR3908;microRNA 3908
hsa:100616128;MIR4679-1;microRNA 4679-1
hsa:693212;MIR627,MIRN627,hsa-mir-627;microRNA 627
hsa:100422902;MIR3116-1;microRNA 3116-1
hsa:100500826;MIR3909;microRNA 3909
hsa:100616192;MIR4679-2;microRNA 4679-2
hsa:693213;MIR628,MIRN628,hsa-mir-628;microRNA 628
hsa:100422946;MIR3116-2;microRNA 3116-2
hsa:100500821;MIR3910-1;microRNA 3910-1
hsa:100616113;MIR4680;microRNA 4680
hsa:693215;MIR630,MIRN630,hsa-mir-630;microRNA 630
hsa:100500872;MIR3911;microRNA 3911
hsa:100616398;MIR4681;microRNA 4681
hsa:693216;MIR631,MIRN631,hsa-mir-631;microRNA 631
hsa:100423008;MIR3118-1;microRNA 3118-1
hsa:100500831;MIR3912;microRNA 3912
hsa:100616322;MIR4682;microRNA 4682
hsa:100500903;MIR3913-1;microRNA 3913-1
hsa:100422949;MIR3118-2;microRNA 3118-2
hsa:100616391;MIR4684;microRNA 4684
hsa:100422844;MIR3118-3;microRNA 3118-3
hsa:100500868;MIR3913-2;microRNA 3913-2
hsa:100616482;MIR4685;microRNA 4685
hsa:643707;GOLGA6L4;golgin A6 family-like 4
hsa:693219;MIR634,MIRN634,hsa-mir-634;microRNA 634
hsa:100422839;MIR3119-1;microRNA 3119-1
hsa:100500836;MIR3914-1;microRNA 3914-1
hsa:100616126;MIR4686;microRNA 4686
hsa:693220;MIR635,MIRN635,hsa-mir-635;microRNA 635
hsa:100423010;MIR3119-2;microRNA 3119-2
hsa:100616453;MIR4687;microRNA 4687
hsa:100500915;MIR3915;microRNA 3915
hsa:406961;MIR185,MIRN185,miR-185;microRNA 185
hsa:100500920;MIR3914-2;microRNA 3914-2
hsa:100616437;MIR1343;microRNA 1343
hsa:406962;MIR186,MIRN186,miR-186;microRNA 186
hsa:693222;MIR637,MIRN637,hsa-mir-637;microRNA 637
hsa:100500849;MIR3916;microRNA 3916
hsa:100423032;MIR3121;microRNA 3121
hsa:100616368;MIR4688;microRNA 4688
hsa:406964;MIR188,MIRN188,miR-188;microRNA 188
hsa:100422947;MIR3122;microRNA 3122
hsa:100500808;MIR3917;microRNA 3917
hsa:100616421;MIR4689;microRNA 4689
hsa:406965;MIR190A,MIR190,MIRN190,hsa-mir-190a,miR-190;microRNA 190a
hsa:693225;MIR640,MIRN640,hsa-mir-640;microRNA 640
hsa:100422856;MIR3123;microRNA 3123
hsa:100500803;MIR3919;microRNA 3919
hsa:100616292;MIR4690;microRNA 4690
hsa:693226;MIR641,MIRN641,hsa-mir-641;microRNA 641
hsa:100422879;MIR3124;microRNA 3124
hsa:100616403;MIR4691;microRNA 4691
hsa:100422862;MIR548S;microRNA 548s
hsa:693228;MIR643,MIRN643,hsa-mir-643;microRNA 643
hsa:100500823;MIR3920;microRNA 3920
hsa:100616410;MIR4692;microRNA 4692
hsa:693229;MIR644A,MIR644,MIRN644,hsa-mir-644,hsa-mir-644a;microRNA 644a
hsa:100422986;MIR3125;microRNA 3125
hsa:100500859;MIR3921;microRNA 3921
hsa:100616457;MIR4693;microRNA 4693
hsa:693230;MIR645,MIRN645,hsa-mir-645;microRNA 645
hsa:100423030;MIR3126;microRNA 3126
hsa:100500877;MIR3923;microRNA 3923
hsa:100616120;MIR4695;microRNA 4695
hsa:693231;MIR646,MIRN646,hsa-mir-646;microRNA 646
hsa:100422928;MIR3127;microRNA 3127
hsa:100500902;MIR3910-2;microRNA 3910-2
hsa:100616402;MIR4696;microRNA 4696
hsa:693232;MIR647,MIRN647,hsa-mir-647;microRNA 647
hsa:100422824;MIR3128;microRNA 3128
hsa:100500834;MIR3924;microRNA 3924
hsa:100616119;MIR4697;microRNA 4697
hsa:100422908;MIR3129;microRNA 3129
hsa:693233;MIR648,MIRN648,hsa-mir-648;microRNA 648
hsa:100500885;MIR3925;microRNA 3925
hsa:100616486;MIR4698;microRNA 4698
hsa:693234;MIR649,MIRN649,hsa-mir-649;microRNA 649
hsa:100422993;MIR3130-1,MIR3130-3;microRNA 3130-1
hsa:100500870;MIR3926-1;microRNA 3926-1
hsa:100616133;MIR4699;microRNA 4699
hsa:406956;MIR181B2,MIRN181B2;microRNA 181b-2
hsa:100423002;MIR3130-2,MIR3130-4;microRNA 3130-2
hsa:100500898;MIR3927;microRNA 3927
hsa:723779;MIR651,MIRN651,hsa-mir-651;microRNA 651
hsa:100422957;MIR3131;microRNA 3131
hsa:100500887;MIR676,hsa-mir-676;microRNA 676
hsa:100616262;MIR4701;microRNA 4701
hsa:406970;MIR194-2,MIRN194-2;microRNA 194-2
hsa:100423039;MIR3132;microRNA 3132
hsa:100500838;MIR3926-2;microRNA 3926-2
hsa:100616400;MIR3198-2;microRNA 3198-2
hsa:693130;MIR548D1,MIRN548D1;microRNA 548d-1
hsa:100422942;MIR3133;microRNA 3133
hsa:100500901;MIR3928;microRNA 3928
hsa:100616423;MIR4703;microRNA 4703
hsa:724031;MIR661,MIRN661,hsa-mir-661;microRNA 661
hsa:100422933;MIR378B;microRNA 378b
hsa:100616205;MIR4704;microRNA 4704
hsa:100500864;MIR3929;microRNA 3929
hsa:407031;MIR30C1,MIRN30C1;microRNA 30c-1
hsa:100422990;MIR3134;microRNA 3134
hsa:724032;MIR662,MIRN662,hsa-mir-662;microRNA 662
hsa:100500873;MIR3934;microRNA 3934
hsa:100616239;MIR4705;microRNA 4705
hsa:693131;MIR548D2,MIRN548D2;microRNA 548d-2
hsa:100422901;MIR3135A,MIR3135,hsa-mir-3135a;microRNA 3135a
hsa:100500891;MIR3935;microRNA 3935
hsa:100616176;MIR4708;microRNA 4708
hsa:406894;MIR101-2,MIRN101-2;microRNA 101-2
hsa:693123;MIR449B,MIRN449B;microRNA 449b
hsa:100422864;MIR544B;microRNA 544b
hsa:100500822;MIR3937;microRNA 3937
hsa:100616211;MIR4709;microRNA 4709
hsa:724023;MIR653,MIRN653,hsa-mir-653;microRNA 653
hsa:100422926;MIR3137;microRNA 3137
hsa:100500875;MIR3938;microRNA 3938
hsa:100616173;MIR3545;microRNA 3545
hsa:693121;MIR411,MIRN411,hsa-mir-411;microRNA 411
hsa:100500919;MIR548Y;microRNA 548y
hsa:100423017;MIR3139;microRNA 3139
hsa:100616300;MIR4710;microRNA 4710
hsa:724024;MIR654,MIRN654,hsa-mir-654;microRNA 654
hsa:100422950;MIR3141;microRNA 3141
hsa:100500857;MIR3939;microRNA 3939
hsa:100616396;MIR4712;microRNA 4712
hsa:724025;MIR655,MIRN655,hsa-mir-655;microRNA 655
hsa:407023;MIR299,MIRN299;microRNA 299
hsa:100422938;MIR3142;microRNA 3142
hsa:100500888;MIR3940;microRNA 3940
hsa:100500866;MIR3941;microRNA 3941
hsa:100422934;MIR3143;microRNA 3143
hsa:100616432;MIR4714;microRNA 4714
hsa:693132;MIR549,MIRN549,hsa-mir-549;microRNA 549
hsa:100422884;MIR548U;microRNA 548u
hsa:100616474;MIR4715;microRNA 4715
hsa:724028;MIR658,MIRN658,hsa-mir-658;microRNA 658
hsa:407022;MIR296,MIRN296,miRNA296;microRNA 296
hsa:100422951;MIR3144;microRNA 3144
hsa:100500829;MIR3943;microRNA 3943
hsa:100616332;MIR4716;microRNA 4716
hsa:724029;MIR659,MIRN659,hsa-mir-659;microRNA 659
hsa:100423001;MIR3145;microRNA 3145
hsa:100500911;MIR3944;microRNA 3944
hsa:100616238;MIR3529;microRNA 3529
hsa:724030;MIR660,MIRN660,hsa-mir-660;microRNA 660
hsa:100422821;MIR1273C;microRNA 1273c
hsa:100616241;MIR4717;microRNA 4717
hsa:100500818;MIR3945;microRNA 3945
hsa:407016;MIR26A2,MIRN26A2;microRNA 26a-2
hsa:100422967;MIR3146;microRNA 3146
hsa:100500807;MIR374C;microRNA 374c
hsa:100616195;MIR4718;microRNA 4718
hsa:100422939;MIR3147;microRNA 3147
hsa:100500845;MIR642B;microRNA 642b
hsa:100616172;MIR4719;microRNA 4719
hsa:574030;MIR362,MIRN362,hsa-mir-362;microRNA 362
hsa:768212;MIR758,MIRN758,hsa-mir-758;microRNA 758
hsa:100500883;MIR550B1;microRNA 550b-1
hsa:100422850;MIR548V;microRNA 548v
hsa:100616150;MIR4720;microRNA 4720
hsa:100302251;MIR1264,MIRN1264,hsa-mir-1264;microRNA 1264
hsa:100422876;MIR3148;microRNA 3148
hsa:100500830;MIR550B2;microRNA 550b-2
hsa:100616256;MIR4721;microRNA 4721
hsa:768214;MIR668,MIRN668,hsa-mir-668;microRNA 668
hsa:100422964;MIR3150A,MIR3150;microRNA 3150a
hsa:100500856;MIR548Z;microRNA 548z
hsa:100616167;MIR4722;microRNA 4722
hsa:100126356;MIR365B,MIR365-2,MIRN365-2,hsa-mir-365b;microRNA 365b
hsa:100616354;MIR550A3;microRNA 550a-3
hsa:100500895;MIR548AA2;microRNA 548aa-2
hsa:100616466;MIR4520B;microRNA 4520b
hsa:768215;MIR767,MIRN767,hsa-mir-767;microRNA 767
hsa:100422869;MIR3152;microRNA 3152
hsa:100616190;MIR548O2;microRNA 548o-2
hsa:100616388;MIR4723;microRNA 4723
hsa:100616217;MIR1254-2;microRNA 1254-2
hsa:100422936;MIR3153;microRNA 3153
hsa:100616273;MIR451B;microRNA 451b
hsa:100616247;MIR151B;microRNA 151b
hsa:100616201;MIR378D1;microRNA 378d-1
hsa:100616248;MIR4724;microRNA 4724
hsa:100302117;MIR320B1,MIR320B-1,MIRN320B1,hsa-mir-320b-1;microRNA 320b-1
hsa:100616498;MIR378E;microRNA 378e
hsa:100422989;MIR3155A,MIR3155,hsa-mir-3155a;microRNA 3155a
hsa:100616449;MIR4725;microRNA 4725
hsa:100616455;MIR548H5;microRNA 548h-5
hsa:100422988;MIR3156-1;microRNA 3156-1
hsa:100616153;MIR4726;microRNA 4726
hsa:442914;MIR369,MIR369-3,MIRN369,MIRN369-3,hsa-mir-369;microRNA 369
hsa:100422892;MIR3157;microRNA 3157
hsa:100616336;MIR548AB;microRNA 548ab
hsa:100616416;MIR4727;microRNA 4727
hsa:100302115;MIR1468,MIRN1468,hsa-mir-1468;microRNA 1468
hsa:100616489;MIR4417;microRNA 4417
hsa:100422900;MIR3158-1;microRNA 3158-1
hsa:100616132;MIR4728;microRNA 4728
hsa:100423033;MIR3158-2;microRNA 3158-2
hsa:100302255;MIR1323,MIRN1323,hsa-mir-1323;microRNA 1323
hsa:100616433;MIR4418;microRNA 4418
hsa:100616204;MIR4729;microRNA 4729
hsa:100422827;MIR3160-1;microRNA 3160-1
hsa:100616177;MIR4419A;microRNA 4419a
hsa:100616359;MIR4730;microRNA 4730
hsa:768216;MIR454,MIRN454,hsa-mir-454;microRNA 454
hsa:100422825;MIR3160-2;microRNA 3160-2
hsa:100616492;MIR378F;microRNA 378f
hsa:100616125;MIR4731;microRNA 4731
hsa:442919;MIR374A,MIRN374,MIRN374A,hsa-mir-374;microRNA 374a
hsa:100302209;MIR1185-2,MIRN1185-2,hsa-mir-1185-2;microRNA 1185-2
hsa:100616164;MIR4420;microRNA 4420
hsa:100423000;MIR3161;microRNA 3161
hsa:100616385;MIR4732;microRNA 4732
hsa:100313923;MIR449C;microRNA 449c
hsa:100422880;MIR3162;microRNA 3162
hsa:100616203;MIR4734;microRNA 4734
hsa:100616189;MIR4421;microRNA 4421
hsa:100302265;MIR1283-1,MIRN1283-1,hsa-mir-1283-1;microRNA 1283-1
hsa:100423029;MIR3163;microRNA 3163
hsa:100616363;MIR4735;microRNA 4735
hsa:100616272;MIR4422;microRNA 4422
hsa:494326;MIR377,MIRN377,hsa-mir-377;microRNA 377
hsa:100422846;MIR3164;microRNA 3164
hsa:768217;MIR769,MIRN769,hsa-mir-769;microRNA 769
hsa:100616220;MIR4736;microRNA 4736
hsa:768218;MIR766,MIRN766,hsa-mir-766;microRNA 766
hsa:100616321;MIR378G;microRNA 378g
hsa:100422953;MIR3165;microRNA 3165
hsa:100616210;MIR4737;microRNA 4737
hsa:494328;MIR379,MIRN379,hsa-mir-379;microRNA 379
hsa:100616169;MIR378D2;microRNA 378d-2
hsa:100423040;MIR3166;microRNA 3166
hsa:100616328;MIR4424;microRNA 4424
hsa:100616387;MIR3064;microRNA 3064
hsa:494329;MIR380,MIR380-3p,MIRN380,hsa-mir-380;microRNA 380
hsa:100302157;MIR1185-1,MIRN1185-1,hsa-mir-1185-1;microRNA 1185-1
hsa:100422991;MIR1260B;microRNA 1260b
hsa:100616365;MIR4425;microRNA 4425
hsa:100616282;MIR4738;microRNA 4738
hsa:100313837;MIR762,hsa-mir-762;microRNA 762
hsa:100616345;MIR4426;microRNA 4426
hsa:100616170;MIR4739;microRNA 4739
hsa:494331;MIR382,MIRN382,hsa-mir-382;microRNA 382
hsa:100422878;MIR3168;microRNA 3168
hsa:768219;MIR802,MIRN802,hsa-mir-802;microRNA 802
hsa:100616390;MIR4427;microRNA 4427
hsa:100616294;MIR4740;microRNA 4740
hsa:100313777;MIR670,hsa-mir-670;microRNA 670
hsa:100422973;MIR3169;microRNA 3169
hsa:100616141;MIR4428;microRNA 4428
hsa:100616139;MIR4741;microRNA 4741
hsa:100302153;MIR1298,MIRN1298,hsa-mir-1298;microRNA 1298
hsa:442908;MIR340,MIRN340,hsa-mir-340;microRNA 340
hsa:100422881;MIR3170;microRNA 3170
hsa:100616469;MIR4429;microRNA 4429
hsa:100616468;MIR4742;microRNA 4742
hsa:100302164;MIR2113,hsa-mir-2113;microRNA 2113
hsa:442902;MIR330,MIRN330,hsa-mir-330;microRNA 330
hsa:100422981;MIR3173;microRNA 3173
hsa:100616136;MIR4430;microRNA 4430
hsa:100616366;MIR4743;microRNA 4743
hsa:100422837;MIR1193;microRNA 1193
hsa:100616475;MIR548AD;microRNA 548ad
hsa:100616420;MIR4744;microRNA 4744
hsa:100313778;MIR759,hsa-mir-759;microRNA 759
hsa:574410;MIR323B,MIR453,MIRN453,hsa-mir-453;microRNA 323b
hsa:100616357;MIR3591;microRNA 3591
hsa:100616431;MIR4431;microRNA 4431
hsa:768220;MIR765,MIRN765,hsa-mir-765;microRNA 765
hsa:100422935;MIR3118-4;microRNA 3118-4
hsa:100616473;MIR4432;microRNA 4432
hsa:100616459;MIR4745;microRNA 4745
hsa:768222;MIR770,MIRN770,hsa-mir-770;microRNA 770
hsa:100422841;MIR3174;microRNA 3174
hsa:100616265;MIR4433;microRNA 4433
hsa:100616371;MIR4746;microRNA 4746
hsa:442891;MIR135B,MIRN135B;microRNA 135b
hsa:100422995;MIR3175;microRNA 3175
hsa:100616419;MIR4434;microRNA 4434
hsa:100616337;MIR4747;microRNA 4747
hsa:100616499;MIR4435-1;microRNA 4435-1
hsa:100423037;MIR3176;microRNA 3176
hsa:100616425;MIR4748;microRNA 4748
hsa:442903;MIR331,MIRN331,hsa-mir-331;microRNA 331
hsa:100126341;MIR891A,MIRN891A;microRNA 891a
hsa:100616399;MIR4436A;microRNA 4436a
hsa:100616313;MIR4749;microRNA 4749
hsa:442898;MIR324,MIRN324,hsa-mir-324;microRNA 324
hsa:100126297;MIR300,MIRN300,hsa-mir-300;microRNA 300
hsa:100422974;MIR3178;microRNA 3178
hsa:100616341;MIR4435-2;microRNA 4435-2
hsa:100616314;MIR4750;microRNA 4750
hsa:442907;MIR339,MIRN339,hsa-mir-339;microRNA 339
hsa:100422960;MIR3179-1;microRNA 3179-1
hsa:100616213;MIR4437;microRNA 4437
hsa:100616483;MIR4751;microRNA 4751
hsa:100126301;MIR509-2,MIRN509-2;microRNA 509-2
hsa:100422870;MIR3180-1;microRNA 3180-1
hsa:100616305;MIR548AE1;microRNA 548ae-1
hsa:100616171;MIR4752;microRNA 4752
hsa:100126302;MIR450B,MIRN450B;microRNA 450b
hsa:100422956;MIR3180-2;microRNA 3180-2
hsa:100616339;MIR548AE2;microRNA 548ae-2
hsa:100616224;MIR4753;microRNA 4753
hsa:100126303;MIR890,MIRN890,hsa-mir-890;microRNA 890
hsa:100616375;MIR4438;microRNA 4438
hsa:100422886;MIR3179-2;microRNA 3179-2
hsa:100616185;MIR371B;microRNA 371b
hsa:100126304;MIR891B,MIRN891B;microRNA 891b
hsa:442910;MIR345,MIRN345,hsa-mir-345;microRNA 345
hsa:100422836;MIR3180-3;microRNA 3180-3
hsa:100616168;MIR4754;microRNA 4754
hsa:100616207;MIR4439;microRNA 4439
hsa:100126306;MIR888,MIRN888,hsa-mir-888;microRNA 888
hsa:100423006;MIR3179-3;microRNA 3179-3
hsa:100616397;MIR4440;microRNA 4440
hsa:100616434;MIR4755;microRNA 4755
hsa:494333;MIR384,MIRN384,hsa-mir-384;microRNA 384
hsa:100126307;MIR892B,MIRN892B;microRNA 892b
hsa:100422923;MIR548W;microRNA 548w
hsa:100616493;MIR4441;microRNA 4441
hsa:494334;MIR422A,MIRN422A;microRNA 422a
hsa:100616134;MIR499B,MIR499A,hsa-mir-499b;microRNA 499b
hsa:100126308;MIR541,MIRN541,hsa-mir-541;microRNA 541
hsa:100422853;MIR3182;microRNA 3182
hsa:100616477;MIR4442;microRNA 4442
hsa:100616225;MIR4756;microRNA 4756
hsa:100126345;MIR889,MIRN889,hsa-mir-889;microRNA 889
hsa:100616407;MIR4443;microRNA 4443
hsa:100616307;MIR4757;microRNA 4757
hsa:100126309;MIR875,MIRN875,hsa-mir-875;microRNA 875
hsa:100423003;MIR3184;microRNA 3184
hsa:100616340;MIR4758;microRNA 4758
hsa:100126310;MIR876,MIRN876,hsa-mir-876;microRNA 876
hsa:100422978;MIR3185;microRNA 3185
hsa:100616243;MIR4759;microRNA 4759
hsa:100616129;MIR4445;microRNA 4445
hsa:100422944;MIR3186;microRNA 3186
hsa:100616476;MIR4446;microRNA 4446
hsa:100616148;MIR4760;microRNA 4760
hsa:100126311;MIR147B,MIRN147B;microRNA 147b
hsa:100616485;MIR4447;microRNA 4447
hsa:100422907;MIR3156-2;microRNA 3156-2
hsa:100616414;MIR4761;microRNA 4761
hsa:100126346;MIR190B,MIRN190B;microRNA 190b
hsa:554212;MIR448,MIRN448,hsa-mir-448,miRNA448;microRNA 448
hsa:100422854;MIR3187;microRNA 3187
hsa:100616253;MIR4762;microRNA 4762
hsa:100616127;MIR4448;microRNA 4448
hsa:100422833;MIR3188;microRNA 3188
hsa:100126313;MIR744,MIRN744,hsa-mir-744;microRNA 744
hsa:100616143;MIR4763;microRNA 4763
hsa:100422943;MIR3189;microRNA 3189
hsa:100126334;MIR885,MIRN885,hsa-mir-885;microRNA 885
hsa:100616450;MIR548AG1;microRNA 548ag-1
hsa:100616295;MIR4764;microRNA 4764
hsa:554214;MIR450A1,MIRN450,MIRN450-1,MIRN450A-1,MIRN450A1,hsa-mir-450;microRNA 450a-1
hsa:100126314;MIR877,MIRN877,hsa-mir-877,miRNA877;microRNA 877
hsa:100422913;MIR320E;microRNA 320e
hsa:100616440;MIR548AG2;microRNA 548ag-2
hsa:100616219;MIR4765;microRNA 4765
hsa:100126347;MIR887,MIRN887,hsa-mir-887;microRNA 887
hsa:100422875;MIR3192;microRNA 3192
hsa:100616299;MIR4450;microRNA 4450
hsa:574034;MIR433,MIRN433,hsa-mir-433,miRNA433;microRNA 433
hsa:100616283;MIR4766;microRNA 4766
hsa:100126315;MIR665,MIRN665,hsa-mir-665;microRNA 665
hsa:100616254;MIR548AH;microRNA 548ah
hsa:100422889;MIR3194;microRNA 3194
hsa:100616467;MIR4767;microRNA 4767
hsa:574408;MIR329-1,MIRN329-1;microRNA 329-1
hsa:100126316;MIR873,MIRN873,hsa-mir-873;microRNA 873
hsa:100423018;MIR3156-3;microRNA 3156-3
hsa:100616349;MIR4451;microRNA 4451
hsa:100616249;MIR4768;microRNA 4768
hsa:574409;MIR329-2,MIRN329-2;microRNA 329-2
hsa:100422890;MIR3118-5;microRNA 3118-5
hsa:100616463;MIR4452;microRNA 4452
hsa:100616147;MIR4769;microRNA 4769
hsa:100126317;MIR374B,MIRN374B;microRNA 374b
hsa:100422920;MIR548X;microRNA 548x
hsa:100616373;MIR4770;microRNA 4770
hsa:574412;MIR452,MIRN452,hsa-mir-452;microRNA 452
hsa:100126348;MIR760,MIRN760,hsa-mir-760;microRNA 760
hsa:100423023;MIR3197;microRNA 3197
hsa:100616111;MIR4455;microRNA 4455
hsa:100616370;MIR4771-1;microRNA 4771-1
hsa:100126318;MIR301B,MIRN301B;microRNA 301b
hsa:100616381;MIR4456;microRNA 4456
hsa:100423025;MIR3198-1,MIR3198;microRNA 3198-1
hsa:100616165;MIR4771-2;microRNA 4771-2
hsa:574433;MIR412,MIRN412,hsa-mir-412;microRNA 412
hsa:100126319;MIR216B,MIRN216B;microRNA 216b
hsa:100616235;MIR4457;microRNA 4457
hsa:100423034;MIR3199-1;microRNA 3199-1
hsa:100616157;MIR4772;microRNA 4772
hsa:100422998;MIR3199-2;microRNA 3199-2
hsa:100126336;MIR208B,MIRN208B;microRNA 208b
hsa:100616142;MIR4458;microRNA 4458
hsa:100616392;MIR4773-1;microRNA 4773-1
hsa:100422912;MIR3200;microRNA 3200
hsa:100126349;MIR921,MIRN921,hsa-mir-921;microRNA 921
hsa:100616233;MIR4459;microRNA 4459
hsa:100616418;MIR4773-2;microRNA 4773-2
hsa:100422916;MIR3201;microRNA 3201
hsa:100616325;MIR4460;microRNA 4460
hsa:619553;MIR484,MIRN484,hsa-mir-484;microRNA 484
hsa:100126323;MIR924,MIRN924,hsa-mir-924;microRNA 924
hsa:100422847;MIR514B;microRNA 514b
hsa:100616209;MIR4461;microRNA 4461
hsa:100616361;MIR4775;microRNA 4775
hsa:100422987;MIR3202-1;microRNA 3202-1
hsa:100616306;MIR378H;microRNA 378h
hsa:100616267;MIR4776-1;microRNA 4776-1
hsa:100422877;MIR3202-2;microRNA 3202-2
hsa:100126350;MIR933,MIRN933,hsa-mir-933;microRNA 933
hsa:100616218;MIR3135B;microRNA 3135b
hsa:100616472;MIR4776-2;microRNA 4776-2
hsa:619555;MIR487A,MIRN487,MIRN487A,hsa-mir-487;microRNA 487a
hsa:100126324;MIR934,MIRN934,hsa-mir-934;microRNA 934
hsa:100422909;MIR4295;microRNA 4295
hsa:100616413;MIR4462;microRNA 4462
hsa:100616317;MIR4777;microRNA 4777
hsa:574441;MIR488,MIRN488,hsa-mir-488;microRNA 488
hsa:100126325;MIR935,MIRN935,hsa-mir-935;microRNA 935
hsa:100616389;MIR4463;microRNA 4463
hsa:100423041;MIR4296;microRNA 4296
hsa:100616464;MIR4778;microRNA 4778
hsa:100126326;MIR936,MIRN936,hsa-mir-936;microRNA 936
hsa:574442;MIR489,MIRN489,hsa-mir-489;microRNA 489
hsa:100422867;MIR378C;microRNA 378c
hsa:100616109;MIR4464;microRNA 4464
hsa:100616159;MIR4779;microRNA 4779
hsa:100422843;MIR4293;microRNA 4293
hsa:100616447;MIR4780;microRNA 4780
hsa:100616347;MIR548AI;microRNA 548ai
hsa:574444;MIR491,MIRN491,hsa-mir-491;microRNA 491
hsa:100616191;MIR548AJ1;microRNA 548aj-1
hsa:100422895;MIR4294;microRNA 4294
hsa:100126328;MIR940,MIRN940,hsa-mir-940;microRNA 940
hsa:100422855;MIR4301;microRNA 4301
hsa:100616315;MIR4781;microRNA 4781
hsa:100616252;MIR548AJ2;microRNA 548aj-2
hsa:574448;MIR202,MIRN202,hsa-mir-202;microRNA 202
hsa:100423026;MIR4299;microRNA 4299
hsa:100126331;MIR942,MIRN942,hsa-mir-942;microRNA 942
hsa:100616180;MIR4465;microRNA 4465
hsa:100616208;MIR4782;microRNA 4782
hsa:574449;MIR492,MIRN492,hsa-mir-492;microRNA 492
hsa:100126332;MIR943,MIRN943,hsa-mir-943;microRNA 943
hsa:100423021;MIR4298;microRNA 4298
hsa:100616187;MIR4783;microRNA 4783
hsa:100616367;MIR4467;microRNA 4467
hsa:100126340;MIR944,MIRN944,hsa-mir-944;microRNA 944
hsa:100422823;MIR4300;microRNA 4300
hsa:100616226;MIR4468;microRNA 4468
hsa:100616378;MIR4784;microRNA 4784
hsa:574451;MIR432,MIRN432,hsa-mir-432;microRNA 432
hsa:100302235;MIR1179,MIRN1179,hsa-mir-1179;microRNA 1179
hsa:100422931;MIR4304;microRNA 4304
hsa:100616364;MIR4785;microRNA 4785
hsa:100302213;MIR1181,MIRN1181,hsa-mir-1181;microRNA 1181
hsa:100422897;MIR4302;microRNA 4302
hsa:100616324;MIR1245B;microRNA 1245b
hsa:100616484;MIR4470;microRNA 4470
hsa:100302132;MIR1182,MIRN1182,hsa-mir-1182;microRNA 1182
hsa:100422924;MIR4303;microRNA 4303
hsa:100616451;MIR4471;microRNA 4471
hsa:100616360;MIR2467;microRNA 2467
hsa:574454;MIR496,MIRN496,hsa-mir-496;microRNA 496
hsa:100302122;MIR1183,MIRN1183,hsa-mir-1183;microRNA 1183
hsa:100422861;MIR4306;microRNA 4306
hsa:100616268;MIR4472-1;microRNA 4472-1
hsa:100616417;MIR4786;microRNA 4786
hsa:100302111;MIR1184-1,MIR1184,MIRN1184,hsa-mir-1184,hsa-mir-1184-1;microRNA 1184-1
hsa:100422954;MIR4309;microRNA 4309
hsa:100616309;MIR4472-2;microRNA 4472-2
hsa:100616138;MIR4787;microRNA 4787
hsa:100188847;MIR1225,MIRN1225;microRNA 1225
hsa:100423019;MIR4307;microRNA 4307
hsa:100616281;MIR4788;microRNA 4788
hsa:100616229;MIR4473;microRNA 4473
hsa:100422984;MIR4308;microRNA 4308
hsa:100302232;MIR1226,MIRN1226,hsa-mir-1226;microRNA 1226
hsa:100616395;MIR4789;microRNA 4789
hsa:574458;MIR512-1,MIRN512-1;microRNA 512-1
hsa:100616289;MIR4475;microRNA 4475
hsa:100423013;MIR4310;microRNA 4310
hsa:100616334;MIR4790;microRNA 4790
hsa:574459;MIR512-2,MIRN512-2;microRNA 512-2
hsa:100616456;MIR4476;microRNA 4476
hsa:100422905;MIR4311;microRNA 4311
hsa:100616291;MIR4791;microRNA 4791
hsa:100422971;MIR4312;microRNA 4312
hsa:100616184;MIR4477A;microRNA 4477a
hsa:100302196;MIR1234,MIRN1234,hsa-mir-1234;microRNA 1234
hsa:100616194;MIR4477B;microRNA 4477b
hsa:100423035;MIR4313;microRNA 4313
hsa:100616112;MIR4793;microRNA 4793
hsa:574462;MIR515-1,MIRN515-1;microRNA 515-1
hsa:100302280;MIR1237,MIRN1237,hsa-mir-1237;microRNA 1237
hsa:100423004;MIR4315-1;microRNA 4315-1
hsa:100616312;MIR4478;microRNA 4478
hsa:100616338;MIR4794;microRNA 4794
hsa:574463;MIR519E,MIRN519E;microRNA 519e
hsa:100302226;MIR1238,MIRN1238,hsa-mir-1238;microRNA 1238
hsa:100616333;MIR3689C;microRNA 3689c
hsa:100422851;MIR4316;microRNA 4316
hsa:100616161;MIR4795;microRNA 4795
hsa:574464;MIR520F,MIRN520F;microRNA 520f
hsa:100302113;MIR1200,MIRN1200,hsa-mir-1200;microRNA 1200
hsa:100422983;MIR4314;microRNA 4314
hsa:100616302;MIR548X2;microRNA 548x-2
hsa:100616166;MIR4796;microRNA 4796
hsa:574465;MIR515-2,MIRN515-2;microRNA 515-2
hsa:100302259;MIR1202,MIRN1202,hsa-mir-1202;microRNA 1202
hsa:100616131;MIR3689D1;microRNA 3689d-1
hsa:100422857;MIR4318;microRNA 4318
hsa:100616216;MIR4797;microRNA 4797
hsa:100302211;MIR1203,MIRN1203,hsa-mir-1203;microRNA 1203
hsa:100616344;MIR3689D2;microRNA 3689d-2
hsa:574467;MIR520A,MIRN520A;microRNA 520a
hsa:100616471;MIR4798;microRNA 4798
hsa:100313824;MIR663B,MIRN663B;microRNA 663b
hsa:100616460;MIR3689E;microRNA 3689e
hsa:100422865;MIR4320;microRNA 4320
hsa:100616246;MIR4799;microRNA 4799
hsa:574468;MIR526B,MIRN526B;microRNA 526b
hsa:100422840;MIR4317;microRNA 4317
hsa:100616212;MIR3689F;microRNA 3689f
hsa:100616303;MIR3688-2;microRNA 3688-2
hsa:100874137;LINC00351;long intergenic non-protein coding RNA 351
hsa:100302161;MIR1205,MIRN1205,hsa-mir-1205;microRNA 1205
hsa:100422925;MIR4322;microRNA 4322
hsa:100616358;MIR4800;microRNA 4800
hsa:100616480;MIR4479;microRNA 4479
hsa:100616274;MIR4802;microRNA 4802
hsa:574472;MIR518F,MIRN518F;microRNA 518f
hsa:100302281;MIR1208,MIRN1208,hsa-mir-1208;microRNA 1208
hsa:100422976;MIR4256;microRNA 4256
hsa:100616151;MIR4480;microRNA 4480
hsa:100616377;MIR4803;microRNA 4803
hsa:100313914;MIR548J,MIRN548J,hsa-mir-548j;microRNA 548j
hsa:100616320;MIR4481;microRNA 4481
hsa:100422997;MIR4257;microRNA 4257
hsa:100616152;MIR4804;microRNA 4804
hsa:100302118;MIR1286,MIRN1286,hsa-mir-1286;microRNA 1286
hsa:100422894;MIR4260;microRNA 4260
hsa:100616323;MIR4482-1,MIR4482,hsa-mir-4482-1;microRNA 4482-1
hsa:100847049;MIR4999;microRNA 4999
hsa:406882;MIRLET7A2,LET7A2,MIRNLET7A2,let-7a-2;microRNA let-7a-2
hsa:574475;MIR526A1,MIRN526A-1,MIRN526A1;microRNA 526a-1
hsa:100422914;MIR4253;microRNA 4253
hsa:100846995;MIR5000;microRNA 5000
hsa:100616162;MIR4483;microRNA 4483
hsa:100302125;MIR1289-1,MIRN1289-1,hsa-mir-1289-1;microRNA 1289-1
hsa:100423028;MIR4254;microRNA 4254
hsa:100616327;MIR4484;microRNA 4484
hsa:100847037;MIR5001;microRNA 5001
hsa:574477;MIR518C,MIRN518C;microRNA 518c
hsa:100302134;MIR1289-2,MIRN1289-2,hsa-mir-1289-2;microRNA 1289-2
hsa:100422898;MIR4255;microRNA 4255
hsa:100847021;MIR5002;microRNA 5002
hsa:100422975;MIR4252;microRNA 4252
hsa:100616222;MIR4487;microRNA 4487
hsa:100847029;MIR5003;microRNA 5003
hsa:100302221;MIR1291,MIRN1291,hsa-mir-1291;microRNA 1291
hsa:100422883;MIR4325;microRNA 4325
hsa:100616470;MIR4488;microRNA 4488
hsa:100847012;MIR5004;microRNA 5004
hsa:406887;MIRLET7E,MIRNLET7E,hsa-let-7e,let-7e;microRNA let-7e
hsa:100313770;MIR548K,MIRN548K;microRNA 548k
hsa:100422945;MIR4326;microRNA 4326
hsa:100847068;MIR548AO;microRNA 548ao
hsa:100616284;MIR4489;microRNA 4489
hsa:406888;MIRLET7F1,LET7F1,MIRNLET7F1,let-7f-1;microRNA let-7f-1
hsa:574481;MIR521-2,MIRN521-2;microRNA 521-2
hsa:100302181;MIR1294,MIRN1294,hsa-mir-1294;microRNA 1294
hsa:100422891;MIR4327;microRNA 4327
hsa:100616215;MIR548AL;microRNA 548al
hsa:406889;MIRLET7F2,LET7F2,MIRNLET7F2,let-7f-2;microRNA let-7f-2
hsa:574482;MIR520D,MIRN520D;microRNA 520d
hsa:100302178;MIR1295A,MIR1295,MIRN1295,hsa-mir-1295,hsa-mir-1295a;microRNA 1295a
hsa:100616186;MIR4490;microRNA 4490
hsa:100422929;MIR4261;microRNA 4261
hsa:100847026;MIR5006;microRNA 5006
hsa:100422863;MIR4265;microRNA 4265
hsa:100616330;MIR4491;microRNA 4491
hsa:100846996;MIR5007;microRNA 5007
hsa:574484;MIR520G,MIRN520G;microRNA 520g
hsa:100302167;MIR1299,MIRN1299,hsa-mir-1299;microRNA 1299
hsa:100423027;MIR4266;microRNA 4266
hsa:100616376;MIR4492;microRNA 4492
hsa:406981;MIR19B2,MIRN19B2,miR-19b-2;microRNA 19b-2
hsa:574485;MIR516B2,MIRN516-3,MIRN516B-2,MIRN516B2;microRNA 516b-2
hsa:100302275;MIR548L,MIRN548L,hsa-mir-548l;microRNA 548l
hsa:100422994;MIR4267;microRNA 4267
hsa:100616319;MIR4493;microRNA 4493
hsa:100847072;MIR5008;microRNA 5008
hsa:574486;MIR526A2,MIRN526A-2,MIRN526A2;microRNA 526a-2
hsa:100302227;MIR1302-1,MIRN1302-1,hsa-mir-1302-1;microRNA 1302-1
hsa:100422996;MIR4262;microRNA 4262
hsa:100616478;MIR4494;microRNA 4494
hsa:100846993;MIR5009;microRNA 5009
hsa:574487;MIR518E,MIRN518E;microRNA 518e
hsa:100302128;MIR1302-3,MIRN1302-3,hsa-mir-1302-3;microRNA 1302-3
hsa:100616287;MIR4495;microRNA 4495
hsa:100423036;MIR2355;microRNA 2355
hsa:100847046;MIR5010;microRNA 5010
hsa:574488;MIR518A1,MIRN518A-1,MIRN518A1;microRNA 518a-1
hsa:100302130;MIR1302-4,MIRN1302-4,hsa-mir-1302-4;microRNA 1302-4
hsa:100422959;MIR4268;microRNA 4268
hsa:100616240;MIR4496;microRNA 4496
hsa:100847002;MIR5011;microRNA 5011
hsa:574489;MIR518D,MIRN518D;microRNA 518d
hsa:100302146;MIR1302-5,MIRN1302-5,hsa-mir-1302-5;microRNA 1302-5
hsa:100423043;MIR4269;microRNA 4269
hsa:100616408;MIR5047;microRNA 5047
hsa:100616454;MIR4497;microRNA 4497
hsa:574490;MIR516B1,MIRN516-4,MIRN516B-1,MIRN516B1;microRNA 516b-1
hsa:100422965;MIR4263;microRNA 4263
hsa:100302140;MIR1302-6,MIRN1302-6,hsa-mir-1302-6;microRNA 1302-6
hsa:100616179;MIR4498;microRNA 4498
hsa:100847044;MIR5087;microRNA 5087
hsa:574491;MIR518A2,MIRN518A-2,MIRN518A2;microRNA 518a-2
hsa:100422888;MIR4264;microRNA 4264
hsa:100302147;MIR1302-7,MIRN1302-7,hsa-mir-1302-7;microRNA 1302-7
hsa:100616298;MIR4419B;microRNA 4419b
hsa:100847074;MIR5088;microRNA 5088
hsa:574492;MIR517C,MIRN517C;microRNA 517c
hsa:100302223;MIR1302-8,MIRN1302-8,hsa-mir-1302-8;microRNA 1302-8
hsa:100422868;MIR4270;microRNA 4270
hsa:100847067;MIR5089;microRNA 5089
hsa:100616304;MIR4499;microRNA 4499
hsa:100302284;MIR1303,MIRN1303,hsa-mir-1303;microRNA 1303
hsa:100422952;MIR4271;microRNA 4271
hsa:100616182;MIR4500;microRNA 4500
hsa:100847073;MIR5090;microRNA 5090
hsa:574494;MIR521-1,MIRN521-1;microRNA 521-1
hsa:100302240;MIR1304,MIRN1304,hsa-mir-1304;microRNA 1304
hsa:100422941;MIR4272;microRNA 4272
hsa:100616137;MIR4501;microRNA 4501
hsa:100847023;MIR5091;microRNA 5091
hsa:574495;MIR522,MIRN522,hsa-mir-522;microRNA 522
hsa:100422955;MIR4273;microRNA 4273
hsa:100302270;MIR1305,MIRN1305,hsa-mir-1305;microRNA 1305
hsa:100616227;MIR4502;microRNA 4502
hsa:100847039;MIR5092;microRNA 5092
hsa:100302192;MIR548F1,MIR548F-1,MIRN548F1,hsa-mir-548f-1;microRNA 548f-1
hsa:100616280;MIR4503;microRNA 4503
hsa:100423042;MIR4276;microRNA 4276
hsa:100847022;MIR5093;microRNA 5093
hsa:574497;MIR527,MIRN527,hsa-mir-527;microRNA 527
hsa:100422937;MIR4275;microRNA 4275
hsa:100313771;MIR548F2,MIR548F-2,MIRN548F2,hsa-mir-548f-2;microRNA 548f-2
hsa:100616261;MIR4504;microRNA 4504
hsa:100847059;MIR5094;microRNA 5094
hsa:574498;MIR516A1,MIRN516-1,MIRN516A-1,MIRN516A1;microRNA 516a-1
hsa:100302159;MIR548F3,MIR548F-3,MIRN548F3,hsa-mir-548f-3;microRNA 548f-3
hsa:100422826;MIR4274;microRNA 4274
hsa:100616158;MIR4505;microRNA 4505
hsa:100616458;MIR5095;microRNA 5095
hsa:574499;MIR516A2,MIRN516-2,MIRN516A-2,MIRN516A2;microRNA 516a-2
hsa:100422962;MIR4281;microRNA 4281
hsa:100313895;MIR548F4,MIR548F-4,MIRN548F4,hsa-mir-548f-4;microRNA 548f-4
hsa:100616140;MIR4506;microRNA 4506
hsa:100616156;MIR1273F;microRNA 1273f
hsa:100302239;MIR548F5,MIR548F-5,MIRN548F5,hsa-mir-548f-5;microRNA 548f-5
hsa:100422966;MIR4277;microRNA 4277
hsa:100616495;MIR2392;microRNA 2392
hsa:100616145;MIR1273G;microRNA 1273g
hsa:100422999;MIR4278;microRNA 4278
hsa:100616135;MIR4507;microRNA 4507
hsa:100616427;MIR5096;microRNA 5096
hsa:574502;MIR500A,MIR500,MIRN500,hsa-mir-500,hsa-mir-500a;microRNA 500a
hsa:100422887;MIR4280;microRNA 4280
hsa:100847036;MIR5186;microRNA 5186
hsa:100616275;MIR4508;microRNA 4508
hsa:574503;MIR501,MIRN501,hsa-mir-501;microRNA 501
hsa:100302145;MIR1247,MIRN1247,hsa-mir-1247;microRNA 1247
hsa:100423005;MIR4282;microRNA 4282
hsa:100616223;MIR4509-1;microRNA 4509-1
hsa:100847090;MIR5187;microRNA 5187
hsa:100422858;MIR4285;microRNA 4285
hsa:100302143;MIR1248,MIRN1248,hsa-mir-1248;microRNA 1248
hsa:100616228;MIR4509-2;microRNA 4509-2
hsa:100847004;MIR5188;microRNA 5188
hsa:574505;MIR450A2,MIRN450-2,MIRN450A-2,MIRN450A2;microRNA 450a-2
hsa:100302149;MIR1249,MIRN1249,hsa-mir-1249;microRNA 1249
hsa:100422917;MIR4283-1;microRNA 4283-1
hsa:100616382;MIR4509-3;microRNA 4509-3
hsa:100847057;MIR5189;microRNA 5189
hsa:100302289;MIR1251,MIRN1251,hsa-mir-1251;microRNA 1251
hsa:100422948;MIR4284;microRNA 4284
hsa:100847080;MIR5190;microRNA 5190
hsa:100616293;MIR4510;microRNA 4510
hsa:100302208;MIR1253,MIRN1253,hsa-mir-1253;microRNA 1253
hsa:100422982;MIR4286;microRNA 4286
hsa:100847050;MIR5191;microRNA 5191
hsa:407025;MIR29B2,MIRN29B2,mir-29b-2;microRNA 29b-2
hsa:100422828;MIR4287;microRNA 4287
hsa:100616149;MIR4512;microRNA 4512
hsa:100847087;MIR5192;microRNA 5192
hsa:406896;MIR103A2,MIR103-2,MIRN103-2;microRNA 103a-2
hsa:574509;MIR513A1,MIRN513-1,MIRN513A1;microRNA 513a-1
hsa:100302193;MIR1255A,MIRN1255A,hsa-mir-1255a;microRNA 1255a
hsa:100423015;MIR4289;microRNA 4289
hsa:100616183;MIR4513;microRNA 4513
hsa:100847079;MIR5193;microRNA 5193
hsa:574510;MIR513A2,MIRN513-2,MIRN513A-2,MIRN513A2,hsa-mir-513a-2;microRNA 513a-2
hsa:100302155;MIR1256,MIRN1256,hsa-mir-1256;microRNA 1256
hsa:100422963;MIR4290;microRNA 4290
hsa:100616181;MIR4514;microRNA 4514
hsa:100847051;MIR5194;microRNA 5194
hsa:406897;MIR105-1,MIRN105-1;microRNA 105-1
hsa:100302168;MIR1257,MIRN1257,hsa-mir-1257;microRNA 1257
hsa:100422927;MIR4291;microRNA 4291
hsa:100616404;MIR4515;microRNA 4515
hsa:406898;MIR105-2,MIRN105-2;microRNA 105-2
hsa:574512;MIR507,MIRN507,hsa-mir-507;microRNA 507
hsa:100423009;MIR4329;microRNA 4329
hsa:100616258;MIR4516;microRNA 4516
hsa:100847070;MIR5196;microRNA 5196
hsa:100302236;MIR1260A,MIR1260,MIRN1260,hsa-mir-1260,hsa-mir-1260a;microRNA 1260a
hsa:100422930;MIR4330;microRNA 4330
hsa:100616487;MIR4517;microRNA 4517
hsa:100846991;MIR5197;microRNA 5197
hsa:406951;MIR16-2,MIRN16-2,mir-16-3;microRNA 16-2
hsa:100422911;MIR500B;microRNA 500b
hsa:100616405;MIR4518;microRNA 4518
hsa:100847033;MIR4436B2;microRNA 4436b-2
hsa:574515;MIR510,MIRN510,hsa-mir-510;microRNA 510
hsa:100422932;MIR4328;microRNA 4328
hsa:100302279;MIR1262,MIRN1262,hsa-mir-1262;microRNA 1262
hsa:100616231;MIR4519;microRNA 4519
hsa:574516;MIR514A1,MIR514-1,MIRN514-1,hsa-mir-514a-1;microRNA 514a-1
hsa:100302148;MIR1263,MIRN1263,hsa-mir-1263;microRNA 1263
hsa:100616401;MIR4520A;microRNA 4520a
hsa:100422985;MIR1184-2;microRNA 1184-2
hsa:100846994;MIR3670-2;microRNA 3670-2
hsa:574517;MIR514A2,MIR514-2,MIRN514-2,hsa-mir-514a-2;microRNA 514a-2
hsa:100313772;MIR548M,MIRN548M;microRNA 548m
hsa:100422977;MIR1184-3;microRNA 1184-3
hsa:100616406;MIR4521;microRNA 4521
hsa:100847041;MIR3680-2;microRNA 3680-2
hsa:574518;MIR514A3,MIR514-3,MIRN514-3,hsa-mir-514a-3;microRNA 514a-3
hsa:100302116;MIR1265,MIRN1265,hsa-mir-1265;microRNA 1265
hsa:100422845;MIR1233-2;microRNA 1233-2
hsa:100616494;MIR1269B;microRNA 1269b
hsa:100847008;MIR4524B;microRNA 4524b
hsa:100313829;MIR548O,MIRN548O;microRNA 548o
hsa:100422885;MIR1244-2;microRNA 1244-2
hsa:100616277;MIR4522;microRNA 4522
hsa:619556;MIR455,MIRN455,hsa-mir-455;microRNA 455
hsa:100302202;MIR1266,MIRN1266,hsa-mir-1266;microRNA 1266
hsa:100422831;MIR1302-9;microRNA 1302-9
hsa:100616122;MIR4523;microRNA 4523
hsa:100847014;MIR5100;microRNA 5100
hsa:664612;MIR539,MIRN539,hsa-mir-539;microRNA 539
hsa:100302286;MIR1267,MIRN1267,hsa-mir-1267;microRNA 1267
hsa:100422919;MIR1302-11;microRNA 1302-11
hsa:100616316;MIR4524A,MIR4524,hsa-mir-4524a;microRNA 4524a
hsa:664613;MIR544A,MIR544,MIRN544,hsa-mir-544,hsa-mir-544a;microRNA 544a
hsa:100302233;MIR1268A,MIR1268,MIRN1268,hsa-mir-1268,hsa-mir-1268a;microRNA 1268a
hsa:100422906;MIR3118-6;microRNA 3118-6
hsa:100616196;MIR4525;microRNA 4525
hsa:100847078;MIR548AQ;microRNA 548aq
hsa:664614;MIR545,MIRN545,hsa-mir-545;microRNA 545
hsa:100422848;MIR4283-2;microRNA 4283-2
hsa:100302177;MIR1269A,MIR1269,MIRN1269,hsa-mir-1269,hsa-mir-1269a;microRNA 1269a
hsa:100616130;MIR4526;microRNA 4526
hsa:100847035;MIR548AR;microRNA 548ar
hsa:407033;MIR30D,MIRN30D;microRNA 30d
hsa:664615;MIR376A2,MIR376A-2,MIRN376A-2,MIRN376A2;microRNA 376a-2
hsa:100302184;MIR1272,MIRN1272,hsa-mir-1272;microRNA 1272
hsa:100422961;MIR4315-2;microRNA 4315-2
hsa:100616264;MIR4527;microRNA 4527
hsa:100847092;MIR548AS;microRNA 548as
hsa:100302165;MIR1273A,MIR1273,MIRN1273,hsa-mir-1273,hsa-mir-1273a;microRNA 1273a
hsa:100500853;MIR3605;microRNA 3605
hsa:100616290;MIR4529;microRNA 4529
hsa:100847000;MIR5579;microRNA 5579
hsa:100313830;MIR548H1,MIR548H-1,MIRN548H1;microRNA 548h-1
hsa:100500837;MIR3606;microRNA 3606
hsa:100616163;MIR4530;microRNA 4530
hsa:100847052;MIR644B;microRNA 644b
hsa:407044;MIR7-2,MIRN7-2,hsa-mir-7-2,mir-7-2;microRNA 7-2
hsa:693137;MIR552,MIRN552,hsa-mir-552;microRNA 552
hsa:100500805;MIR3607;microRNA 3607
hsa:100616355;MIR4531;microRNA 4531
hsa:407045;MIR7-3,MIRN7-3,hsa-mir-7-3,mir-7-3;microRNA 7-3
hsa:100847076;MIR5580;microRNA 5580
hsa:693138;MIR553,MIRN553,hsa-mir-553;microRNA 553
hsa:100302121;MIR1276,MIRN1276,hsa-mir-1276;microRNA 1276
hsa:100616353;MIR4532;microRNA 4532
hsa:100847010;MIR5581;microRNA 5581
hsa:693139;MIR554,MIRN554,hsa-mir-554;microRNA 554
hsa:100313774;MIR302E,MIRN302E;microRNA 302e
hsa:100500890;MIR3611;microRNA 3611
hsa:100616362;MIR4533;microRNA 4533
hsa:100847030;MIR548AT;microRNA 548at
hsa:693140;MIR555,MIRN555,hsa-mir-555;microRNA 555
hsa:100302131;MIR302F,MIRN302F,hsa-mir-302f;microRNA 302f
hsa:100500817;MIR3612;microRNA 3612
hsa:100616146;MIR4534;microRNA 4534
hsa:100847020;MIR5582;microRNA 5582
hsa:693141;MIR556,MIRN556,hsa-mir-556;microRNA 556
hsa:100302288;MIR548P,MIRN548P,hsa-mir-548p;microRNA 548p
hsa:100616259;MIR378I;microRNA 378i
hsa:100500827;MIR3614;microRNA 3614
hsa:100847025;MIR5583-1;microRNA 5583-1
hsa:693142;MIR557,MIRN557,hsa-mir-557;microRNA 557
hsa:100302204;MIR548I1,MIR548I-1,MIRN548I1,hsa-mir-548i-1;microRNA 548i-1
hsa:100500847;MIR3615;microRNA 3615
hsa:100616415;MIR4535;microRNA 4535
hsa:100846997;MIR5583-2;microRNA 5583-2
hsa:693143;MIR558,MIRN558,hsa-mir-558;microRNA 558
hsa:100302277;MIR548I2,MIR548I-2,MIRN548I2,hsa-mir-548i-2;microRNA 548i-2
hsa:100500814;MIR3616;microRNA 3616
hsa:100847089;MIR5584;microRNA 5584
hsa:100616428;MIR548AM;microRNA 548am
hsa:693146;MIR561,MIRN561,hsa-mir-561;microRNA 561
hsa:100302186;MIR548I3,MIR548I-3,MIRN548I3,hsa-mir-548i-3;microRNA 548i-3
hsa:100500897;MIR3617;microRNA 3617
hsa:100616251;MIR1587;microRNA 1587
hsa:100847018;MIR5585;microRNA 5585
hsa:693148;MIR563,MIRN563,hsa-mir-563;microRNA 563
hsa:100302191;MIR548I4,MIR548I-4,MIRN548I4,hsa-mir-548i-4;microRNA 548i-4
hsa:100500860;MIR3618;microRNA 3618
hsa:100847088;MIR5586;microRNA 5586
hsa:100616144;MIR548AN;microRNA 548an
hsa:100302163;MIR1278,MIRN1278,hsa-mir-1278;microRNA 1278
hsa:100616278;MIR4540;microRNA 4540
hsa:100500828;MIR3619;microRNA 3619
hsa:100847028;MIR5587;microRNA 5587
hsa:693151;MIR566,MIRN566,hsa-mir-566;microRNA 566
hsa:100302182;MIR1279,MIRN1279,hsa-mir-1279;microRNA 1279
hsa:100500809;MIR23C,hsa-mir-23c;microRNA 23c
hsa:100847045;MIR548AU;microRNA 548au
hsa:100616188;MIR3972;microRNA 3972
hsa:100302237;MIR1281,MIRN1281,hsa-mir-1281;microRNA 1281
hsa:693152;MIR567,MIRN567,hsa-mir-567;microRNA 567
hsa:100500810;MIR3620;microRNA 3620
hsa:100847009;MIR1295B;microRNA 1295b
hsa:100616311;MIR3973;microRNA 3973
hsa:693136;MIR551B,MIRN551B;microRNA 551b
hsa:100302254;MIR1282,MIRN1282,hsa-mir-1282;microRNA 1282
hsa:100500811;MIR3621;microRNA 3621
hsa:100616279;MIR3974;microRNA 3974
hsa:100847093;MIR5589;microRNA 5589
hsa:100302205;MIR1283-2,MIRN1283-2,hsa-mir-1283-2;microRNA 1283-2
hsa:693154;MIR569,MIRN569,hsa-mir-569;microRNA 569
hsa:100500858;MIR3622A;microRNA 3622a
hsa:100847069;MIR5590;microRNA 5590
hsa:100616257;MIR3975;microRNA 3975
hsa:693155;MIR570,MIRN570,hsa-mir-570;microRNA 570
hsa:100302136;MIR1252,MIRN1252,hsa-mir-1252;microRNA 1252
hsa:100500871;MIR3622B;microRNA 3622b
hsa:100616244;MIR3976;microRNA 3976
hsa:100847065;MIR5591;microRNA 5591
hsa:100313806;MIR1255B1,MIR1255B-1,MIRN1255B1;microRNA 1255b-1
hsa:100500813;MIR3646;microRNA 3646
hsa:100616297;MIR3977;microRNA 3977
hsa:100847083;MIR548AV;microRNA 548av
hsa:693157;MIR572,MIRN572,hsa-mir-572;microRNA 572
hsa:100313835;MIR1255B2,MIR1255B-2,MIRN1255B2,hsa-mir-1255b-2;microRNA 1255b-2
hsa:100616491;MIR3978;microRNA 3978
hsa:100500862;MIR3648;microRNA 3648
hsa:100847001;MIR5680;microRNA 5680
hsa:693158;MIR573,MIRN573,hsa-mir-573;microRNA 573
hsa:100616175;MIR4633;microRNA 4633
hsa:100500816;MIR3649;microRNA 3649
hsa:100847058;MIR5681A;microRNA 5681a
hsa:100302234;MIR664,MIRN664,hsa-mir-664;microRNA 664
hsa:100500824;MIR3650;microRNA 3650
hsa:100847043;MIR5682;microRNA 5682
hsa:100616202;MIR4634;microRNA 4634
hsa:497259;C18orf61;uncharacterized LOC497259
hsa:100874392;ANKRD20A12P;ankyrin repeat domain 20 family, member A12, pseudogene
hsa:574470;MIR525,MIRN525,hsa-mir-525;microRNA 525
hsa:574471;MIR523,MIRN523,hsa-mir-523;microRNA 523
hsa:100302170;MIR1206,MIRN1206,hsa-mir-1206;microRNA 1206
hsa:100422979;MIR4324;microRNA 4324
hsa:100616488;MIR548AK;microRNA 548ak
hsa:100616435;MIR4801;microRNA 4801
hsa:100874168;LINC00433;long intergenic non-protein coding RNA 433
hsa:100874173;LINC00443;long intergenic non-protein coding RNA 443
hsa:100861554;LINC00563;long intergenic non-protein coding RNA 563
hsa:100101266;HAVCR1P1;hepatitis A virus cellular receptor 1 pseudogene 1
hsa:711;ERC2-IT1,C1orf1,C3orf51,Po42;ERC2 intronic transcript 1 (non-protein coding)
hsa:100874175;LINC00446;long intergenic non-protein coding RNA 446
hsa:100861555;LINC00565;long intergenic non-protein coding RNA 565
hsa:3136;HLA-H,HLAHP;major histocompatibility complex, class I, H (pseudogene)
hsa:23359;FAM189A1,TMEM228;family with sequence similarity 189, member A1
hsa:690;BTF3P11,BTF3L1,HUMBTFB,OCIF,OPG,TNFRSF11B;basic transcription factor 3 pseudogene 11
hsa:692109;SNORD69,HBII-210;small nucleolar RNA, C/D box 69
hsa:151325;MYADML;myeloid-associated differentiation marker-like (pseudogene)
hsa:100874139;LINC00353;long intergenic non-protein coding RNA 353
hsa:378805;FLJ43663;uncharacterized LOC378805
hsa:80070;ADAMTS20,ADAM-TS20,ADAMTS-20,GON-1;ADAM metallopeptidase with thrombospondin type 1 motif, 20
hsa:100113381;SNORD19B;small nucleolar RNA, C/D box 19B
hsa:57653;;LOC100499484-C9orf174 readthrough
hsa:100302246;MIR1301,MIRN1301,hsa-mir-1301;microRNA 1301
hsa:406895;MIR103A1,MIR103-1,MIRN103-1;microRNA 103a-1
hsa:677810;SNORA26,HBI-6;small nucleolar RNA, H/ACA box 26
hsa:442896;MIR302D,MIRN302D;microRNA 302d
hsa:100874326;DSCAM-IT1,zag4;DSCAM intronic transcript 1 (non-protein coding)
hsa:100874300;SYNJ2-IT1;SYNJ2 intronic transcript 1 (non-protein coding)
hsa:100874309;EPN2-IT1;EPN2 intronic transcript 1 (non-protein coding)
hsa:100874275;EMCN-IT3;EMCN intronic transcript 3 (non-protein coding)
hsa:100874052;LINC00534;long intergenic non-protein coding RNA 534
hsa:100874188;LINC00571;long intergenic non-protein coding RNA 571
hsa:100874179;LINC00457;long intergenic non-protein coding RNA 457
hsa:122706;PSMB11,BETA5T;proteasome (prosome, macropain) subunit, beta type, 11 (EC:3.4.25.1)
hsa:100126351;MIR939,MIRN939,hsa-mir-939;microRNA 939
hsa:401258;RAB44,RASD3,RASL13,dJ431A14.3;RAB44, member RAS oncogene family
hsa:645090;CXorf30;chromosome X open reading frame 30
hsa:131544;CRYBG3,DKFZp667G2110;beta-gamma crystallin domain containing 3
hsa:100288615;WHAMMP1,WHDC1P1;WAS protein homolog associated with actin, golgi membranes and microtubules pseudogene 1
hsa:100507674;MARK2P9;MAP/microtubule affinity-regulating kinase 2 pseudogene 9
hsa:100616668;TPTE2P5;transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 5
hsa:26030;PLEKHG3,ARHGEF43,KIAA0599;pleckstrin homology domain containing, family G (with RhoGef domain) member 3
hsa:646658;SYNDIG1L,CAPUCIN,DSPC1,IFITMD4,TMEM90A;synapse differentiation inducing 1-like
hsa:285527;FRYL,KIAA0826;FRY-like
hsa:693214;MIR629,MIRN629,hsa-mir-629;microRNA 629
hsa:414778;HCG17,LINC00046,NCRNA00046;HLA complex group 17 (non-protein coding)
hsa:54064;LINC00160,C21orf52,NCRNA00160;long intergenic non-protein coding RNA 160
hsa:55370;PPP4R1L,C20orf192,PRO1085;protein phosphatase 4, regulatory subunit 1-like
hsa:100169989;DBIL5P2,ELP1P;diazepam binding inhibitor-like 5 pseudogene 2
hsa:100462953;MINOS1P1,CG012,N4BP2L2-IT,N4BP2L2-IT1,N4BP2L2IT1;mitochondrial inner membrane organizing system 1 pseudogene 1
hsa:132241;RPL32P3;ribosomal protein L32 pseudogene 3
hsa:100131454;DBIL5P,ELP2P;diazepam binding inhibitor-like 5, pseudogene
hsa:392364;;nuclear pore associated protein 1 pseudogene
hsa:729603;;calcium binding protein P22 pseudogene
hsa:100158262;SCARNA9L;small Cajal body-specific RNA 9-like
hsa:100124536;SNORA38B;small nucleolar RNA, H/ACA box 38B
hsa:100124535;SNORA36C;small nucleolar RNA, H/ACA box 36C
hsa:100379141;SNORA70D,U70D;small nucleolar RNA, H/ACA box 70D
hsa:100124538;SNORA70C,U70C;small nucleolar RNA, H/ACA box 70C
hsa:100124539;SNORA11B;small nucleolar RNA, H/ACA box 11B
hsa:100124540;SNORA11C;small nucleolar RNA, H/ACA box 11C
hsa:100337591;SNORA70F,U70F;small nucleolar RNA, H/ACA box 70F
hsa:100379250;SNORA70E,U70E;small nucleolar RNA, H/ACA box 70E
hsa:100379132;SNORA70G,U70G;small nucleolar RNA, H/ACA box 70G
hsa:100124537;SNORA70B;small nucleolar RNA, H/ACA box 70B
hsa:492311;IGIP,C5orf53;IgA-inducing protein homolog (Bos taurus)
hsa:83900;KRTAP9-3,KAP9.3,KRTAP9.3;keratin associated protein 9-3
hsa:26167;PCDHB5,PCDH-BETA5;protocadherin beta 5
hsa:81557;MAGED4B;melanoma antigen family D, 4B
hsa:407037;MIR320A,MIRN320,MIRN320A,hsa-mir-320a;microRNA 320a
hsa:752014;CEMP1,CP-23,CP23;cementum protein 1
hsa:758;MPPED1,239AB,C22orf1,FAM1A;metallophosphoesterase domain containing 1
hsa:1004;CDH6,CAD6,KCAD;cadherin 6, type 2, K-cadherin (fetal kidney)
hsa:1265;CNN2;calponin 2
hsa:342;APOC1P1;apolipoprotein C-I pseudogene 1
hsa:416;ARSF,ASF;arylsulfatase F (EC:3.1.6.-)
hsa:2749;GLUD1P3,C10orf102,Em:AC022400.11,GLUDP3,RP11-574K11.12;glutamate dehydrogenase 1 pseudogene 3
hsa:1203;CLN5,NCL;ceroid-lipofuscinosis, neuronal 5
hsa:247;ALOX15B,15-LOX-2;arachidonate 15-lipoxygenase, type B (EC:1.13.11.33)
hsa:344;APOC2,APO-CII,APOC-II;apolipoprotein C-II
hsa:1260;CNGA2,CNCA,CNCA1,CNG2,OCNC1,OCNCALPHA,OCNCa;cyclic nucleotide gated channel alpha 2
hsa:1262;CNGA4,CNCA2,CNG-4,CNG4,CNG5,CNGB2,OCNC2,OCNCBETA,OCNCb;cyclic nucleotide gated channel alpha 4
hsa:29;ABR,MDB;active BCR-related
hsa:631;BFSP1,CP115,CP94,LIFL-H;beaded filament structural protein 1, filensin
hsa:513;ATP5D;ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit (EC:3.6.1.14)
hsa:757;TMEM50B,C21orf4,HCVP7TP3;transmembrane protein 50B
hsa:388394;RPRML;reprimo-like
hsa:389247;;uncharacterized LOC389247
hsa:399833;SPRNP1;shadow of prion protein homolog (zebrafish) pseudogene 1
hsa:577;BAI3;brain-specific angiogenesis inhibitor 3
hsa:100134368;;uncharacterized LOC100134368
hsa:734;OSGIN2,C8orf1,hT41;oxidative stress induced growth inhibitor family member 2
hsa:534;ATP6V1G2,ATP6G,ATP6G2,NG38,VMA10;ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 (EC:3.6.3.14)
hsa:1339;COX6A2,COX6AH,COXVIAH;cytochrome c oxidase subunit VIa polypeptide 2 (EC:1.9.3.1)
hsa:164;AP1G1,ADTG,CLAPG1;adaptor-related protein complex 1, gamma 1 subunit
hsa:533;ATP6V0B,ATP6F,HATPL,VMA16;ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b (EC:3.6.3.14)
hsa:1318;SLC31A2,COPT2,CTR2,hCTR2;solute carrier family 31 (copper transporters), member 2
hsa:963;CD53,MOX44,TSPAN25;CD53 molecule
hsa:606;NBEAP1,BCL8,BCL8A;neurobeachin pseudogene 1
hsa:905;CCNT2,CYCT2;cyclin T2
hsa:689;BTF3,BETA-NAC,BTF3a,BTF3b,NACB;basic transcription factor 3
hsa:1469;CST1;cystatin SN
hsa:786;CACNG1,CACNLG;calcium channel, voltage-dependent, gamma subunit 1
hsa:1678;TIMM8A,DDP,DDP1,DFN1,MTS,TIM8;translocase of inner mitochondrial membrane 8 homolog A (yeast)
hsa:1447;CSN2,CASB;casein beta
hsa:1556;CYP2B7P1,CYP2B,CYP2B7,CYP2B7P;cytochrome P450, family 2, subfamily B, polypeptide 7 pseudogene 1
hsa:1486;CTBS,CTB;chitobiase, di-N-acetyl- (EC:3.2.1.-)
hsa:1416;CRYBB2P1,CRYB2B;crystallin, beta B2 pseudogene 1
hsa:1518;CTSL1P8;cathepsin L1 pseudogene 8
hsa:1517;CTSL1P2,CTSLL2;cathepsin L1 pseudogene 2
hsa:1842;ECM2;extracellular matrix protein 2, female organ and adipocyte specific
hsa:1802;DPH2,DPH2L2;DPH2 homolog (S. cerevisiae)
hsa:830;CAPZA2,CAPPA2,CAPZ;capping protein (actin filament) muscle Z-line, alpha 2
hsa:1838;DTNB;dystrobrevin, beta
hsa:1102;RCBTB2,CHC1L;regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2
hsa:693185;MIR600,MIRN600,hsa-mir-600;microRNA 600
hsa:100302290;MIR1973,hsa-mir-1973;microRNA 1973
hsa:693206;MIR621,MIRN621,hsa-mir-621;microRNA 621
hsa:2189;FANCG,FAG,XRCC9;Fanconi anemia, complementation group G
hsa:2568;GABRP;gamma-aminobutyric acid (GABA) A receptor, pi
hsa:2013;EMP2,XMP;epithelial membrane protein 2
hsa:2529;FUT7,FucT-VII;fucosyltransferase 7 (alpha (1,3) fucosyltransferase) (EC:2.4.1.-)
hsa:2256;FGF11,FHF3;fibroblast growth factor 11
hsa:2515;ADAM2,CRYN1,CRYN2,CT15,FTNB,PH-30b,PH30;ADAM metallopeptidase domain 2
hsa:2282;FKBP1AP1,FKBP12,FKBP1P1;FK506 binding protein 1A, 12kDa pseudogene 1
hsa:2003;ELK2AP,ELK2,ELK2.1,ELK2P1;ELK2A, member of ETS oncogene family, pseudogene
hsa:2123;EVI2A,EVDA,EVI-2A,EVI2;ecotropic viral integration site 2A
hsa:2196;FAT2,CDHF8,CDHR9,HFAT2,MEGF1;FAT tumor suppressor homolog 2 (Drosophila)
hsa:2014;EMP3,YMP;epithelial membrane protein 3
hsa:1995;ELAVL3,HUC,HUCL,PLE21;ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)
hsa:2849;GPR26;G protein-coupled receptor 26
hsa:2681;GGTA1P,GGTA,GGTA1,GLYT2,a1/3GTP;glycoprotein, alpha-galactosyltransferase 1 pseudogene
hsa:2874;GPS2,AMF-1;G protein pathway suppressor 2
hsa:2974;GUCY1B2,GC-SB2;guanylate cyclase 1, soluble, beta 2 (pseudogene)
hsa:3281;HSBP1,NPC-A-13;heat shock factor binding protein 1
hsa:3386;ICAM4,CD242,LW;intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)
hsa:2793;GNGT2,G-GAMMA-8,G-GAMMA-C,GNG8,GNG9,GNGT8;guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2
hsa:2651;GCNT2,CCAT,GCNT2C,GCNT5,IGNT,II,NACGT1,NAGCT1,ULG3,bA360O19.2,bA421M1.1;glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) (EC:2.4.1.150)
hsa:3218;HOXB8,HOX2,HOX2D,Hox-2.4;homeobox B8
hsa:3321;IGSF3,EWI-3,V8;immunoglobulin superfamily, member 3
hsa:3139;HLA-L,HLA-92,HLA92,HLAL;major histocompatibility complex, class I, L (pseudogene)
hsa:2622;GAS8,GAS11;growth arrest-specific 8
hsa:2880;GPX5;glutathione peroxidase 5 (epididymal androgen-related protein) (EC:1.11.1.9)
hsa:2620;GAS2;growth arrest-specific 2
hsa:3227;HOXC11,HOX3H;homeobox C11
hsa:3200;HOXA3,HOX1,HOX1E;homeobox A3
hsa:3128;HLA-DRB6;major histocompatibility complex, class II, DR beta 6 (pseudogene)
hsa:2842;GPR19;G protein-coupled receptor 19
hsa:2787;GNG5;guanine nucleotide binding protein (G protein), gamma 5
hsa:2981;GUCA2B,GCAP-II,UGN;guanylate cyclase activator 2B (uroguanylin)
hsa:5369;PMCHL1;pro-melanin-concentrating hormone-like 1, pseudogene
hsa:5370;PMCHL2;pro-melanin-concentrating hormone-like 2, pseudogene
hsa:4660;PPP1R12B,MYPT2,PP1bp55;protein phosphatase 1, regulatory subunit 12B (EC:3.1.3.53)
hsa:3788;KCNS2,KV9.2;potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2
hsa:4112;MAGEB1,CT3.1,DAM10,MAGE-Xp,MAGEL1;melanoma antigen family B, 1
hsa:5412;UBL3,HCG-1,PNSC1;ubiquitin-like 3
hsa:4711;NDUFB5,CISGDH,SGDH;NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16kDa (EC:1.6.5.3 1.6.99.3)
hsa:5355;PLP2,A4,A4LSB;proteolipid protein 2 (colonic epithelium-enriched)
hsa:4500;MT1L,MT1,MT1R,MTF;metallothionein 1L (gene/pseudogene)
hsa:3800;KIF5C,KINN,NKHC,NKHC-2,NKHC2;kinesin family member 5C
hsa:4943;TBC1D25,MG81,OATL1;TBC1 domain family, member 25
hsa:5283;PIGH,GPI-H;phosphatidylinositol glycan anchor biosynthesis, class H (EC:2.4.1.198)
hsa:4807;NHLH1,HEN1,NSCL,NSCL1,bHLHa35;nescient helix loop helix 1
hsa:4637;MYL6,ESMLC,LC17,LC17-GI,LC17-NM,LC17A,LC17B,MLC-3,MLC1SM,MLC3NM,MLC3SM;myosin, light chain 6, alkali, smooth muscle and non-muscle
hsa:4861;NPAS1,MOP5,PASD5,bHLHe11;neuronal PAS domain protein 1
hsa:5212;VIT;vitrin
hsa:5616;PRKY,PRKXP3,PRKYP;protein kinase, Y-linked, pseudogene
hsa:5051;PAFAH2,HSD-PLA2;platelet-activating factor acetylhydrolase 2, 40kDa (EC:3.1.1.47)
hsa:4714;NDUFB8,ASHI,CI-ASHI;NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa
hsa:3671;ISLR,HsT17563;immunoglobulin superfamily containing leucine-rich repeat
hsa:3783;KCNN4,IK1,IKCA1,KCA4,KCa3.1,SK4,hIKCa1,hKCa4,hSK4;potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
hsa:4888;NPY6R,NPY1RL,PP2,Y2B;neuropeptide Y receptor Y6 (pseudogene)
hsa:3888;KRT82,HB2,Hb-2,KRTHB2;keratin 82
hsa:3841;KPNA5,IPOA6,SRP6;karyopherin alpha 5 (importin alpha 6)
hsa:5436;POLR2G,RPB19,RPB7,hRPB19,hsRPB7;polymerase (RNA) II (DNA directed) polypeptide G (EC:2.7.7.6)
hsa:4858;NOVA2,ANOVA,NOVA3;neuro-oncological ventral antigen 2
hsa:3881;KRT31,HA1,Ha-1,KRTHA1,hHa1;keratin 31
hsa:5471;PPAT,ATASE,GPAT,PRAT;phosphoribosyl pyrophosphate amidotransferase (EC:2.4.2.14)
hsa:5382;PMS2P4,PMS2L4,PMS6;postmeiotic segregation increased 2 pseudogene 4
hsa:4710;NDUFB4,B15,CI-B15;NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa (EC:1.6.5.3 1.6.99.3)
hsa:5673;PSG5,FL-NCA-3,PSG;pregnancy specific beta-1-glycoprotein 5
hsa:4603;MYBL1,A-MYB,AMYB;v-myb myeloblastosis viral oncogene homolog (avian)-like 1
hsa:4107;MAGEA8,CT1.8,MAGE8;melanoma antigen family A, 8
hsa:4184;SMCP,HSMCSGEN1,MCS,MCSP;sperm mitochondria-associated cysteine-rich protein
hsa:4336;MOBP;myelin-associated oligodendrocyte basic protein
hsa:4677;NARS,ASNRS,NARS1;asparaginyl-tRNA synthetase (EC:6.1.1.22)
hsa:3884;KRT33B,HA3II,Ha-3II,K33B,KRTHA3A,KRTHA3B,hHa3-II;keratin 33B
hsa:4114;MAGEB3,CT3.5;melanoma antigen family B, 3
hsa:3883;KRT33A,HA3I,Ha-3I,K33A,KRTHA3A,Krt1-3,hHa3-I;keratin 33A
hsa:4207;MEF2BNB-MEF2B,LOC729991-MEF2B,MEF2B;MEF2BNB-MEF2B readthrough
hsa:4438;MSH4;mutS homolog 4 (E. coli)
hsa:5790;PTPRCAP,CD45-AP,LPAP;protein tyrosine phosphatase, receptor type, C-associated protein
hsa:4695;NDUFA2,B8,CD14,CIB8;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa
hsa:4917;NTN3,NTN2L;netrin 3
hsa:5379;PMS2P1,PMS2L1,PMS2L13,PMS2L6,PMS2L7,PMS2L8,PMS3,PMS8,PMSR1,PMSR2;postmeiotic segregation increased 2 pseudogene 1
hsa:3653;IPW,NCRNA00002;imprinted in Prader-Willi syndrome (non-protein coding)
hsa:3910;LAMA4,LAMA3,LAMA4*-1;laminin, alpha 4
hsa:3797;KIF3C;kinesin family member 3C
hsa:4818;NKG7,GIG1,GMP-17,p15-TIA-1;natural killer cell group 7 sequence
hsa:5874;RAB27B,C25KG;RAB27B, member RAS oncogene family
hsa:5680;PSG11,PSBG-11,PSBG-13,PSG13,PSG14;pregnancy specific beta-1-glycoprotein 11
hsa:5638;PRRG1,PRGP1;proline rich Gla (G-carboxyglutamic acid) 1
hsa:5639;PRRG2,PRGP2;proline rich Gla (G-carboxyglutamic acid) 2
hsa:3755;KCNG1,K13,KCNG,KV6.1,kH2;potassium voltage-gated channel, subfamily G, member 1
hsa:5863;RGL2,HKE1.5,KE1.5,RAB2L;ral guanine nucleotide dissociation stimulator-like 2
hsa:4728;NDUFS8,CI-23k,CI23KD,TYKY;NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3)
hsa:4642;MYO1D,myr4;myosin ID
hsa:3982;LIM2,MP17,MP19;lens intrinsic membrane protein 2, 19kDa
hsa:5352;PLOD2,LH2,TLH;procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (EC:1.14.11.4)
hsa:4694;NDUFA1,CI-MWFE,MWFE,ZNF183;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa (EC:1.6.99.3)
hsa:5597;MAPK6,ERK3,HsT17250,PRKM6,p97MAPK;mitogen-activated protein kinase 6 (EC:2.7.11.24)
hsa:5201;PFDN1,PDF,PFD1;prefoldin subunit 1
hsa:4104;MAGEA5,CT1.5,MAGE5,MAGEA4;melanoma antigen family A, 5
hsa:4707;NDUFB1,CI-MNLL,CI-SGDH,MNLL;NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa
hsa:6094;ROM1,ROM,ROSP1,RP7,TSPAN23;retinal outer segment membrane protein 1
hsa:6705;SPRR2F;small proline-rich protein 2F
hsa:6729;SRP54;signal recognition particle 54kDa
hsa:7141;TNP1,TP1;transition protein 1 (during histone to protamine replacement)
hsa:7955;STL;six-twelve leukemia
hsa:7104;TM4SF4,ILTMP,il-TMP;transmembrane 4 L six family member 4
hsa:6676;SPAG4,CT127,SUN4;sperm associated antigen 4
hsa:6734;SRPR,DP,Sralpha;signal recognition particle receptor (docking protein)
hsa:6618;SNAPC2,PTFDELTA,SNAP45;small nuclear RNA activating complex, polypeptide 2, 45kDa
hsa:7379;UPK2,UP2,UPII;uroplakin 2
hsa:6860;SYT4,HsT1192;synaptotagmin IV
hsa:7069;THRSP,LPGP1,Lpgp,S14,SPOT14,THRP;thyroid hormone responsive
hsa:7286;TUFT1;tuftelin 1
hsa:6838;SURF6,RRP14;surfeit 6
hsa:8079;MLF2,NTN4;myeloid leukemia factor 2
hsa:7802;DNALI1,P28,dJ423B22.5,hp28;dynein, axonemal, light intermediate chain 1
hsa:6588;SLN;sarcolipin
hsa:6629;SNRPB2,Msl1;small nuclear ribonucleoprotein polypeptide B
hsa:7504;XK,KX,MCLDS,X1k,XKR1;X-linked Kx blood group (McLeod syndrome)
hsa:7620;ZNF69,Cos5;zinc finger protein 69
hsa:7179;TPTE,CT44,PTEN2;transmembrane phosphatase with tensin homology (EC:3.1.3.48)
hsa:7355;SLC35A2,UGALT,UGAT,UGT,UGT1,UGT2,UGTL;solute carrier family 35 (UDP-galactose transporter), member A2
hsa:6706;SPRR2G;small proline-rich protein 2G
hsa:6988;TCTA;T-cell leukemia translocation altered
hsa:6674;SPAG1,HSD-3.8,SP75,TPIS;sperm associated antigen 1
hsa:6758;SSX5;synovial sarcoma, X breakpoint 5
hsa:6748;SSR4,TRAPD;signal sequence receptor, delta
hsa:6636;SNRPF,SMF,Sm-F,snRNP-F;small nuclear ribonucleoprotein polypeptide F
hsa:7311;UBA52,CEP52,HUBCEP52,L40,RPL40;ubiquitin A-52 residue ribosomal protein fusion product 1
hsa:7059;THBS3,TSP3;thrombospondin 3
hsa:7380;UPK3A,UP3A,UPIII,UPIIIA,UPK3;uroplakin 3A
hsa:6704;SPRR2E;small proline-rich protein 2E
hsa:6627;SNRPA1,Lea1;small nuclear ribonucleoprotein polypeptide A'
hsa:7110;TMF1,ARA160,TMF;TATA element modulatory factor 1
hsa:6815;STYX;serine/threonine/tyrosine interacting protein
hsa:6702;SPRR2C;small proline-rich protein 2C (pseudogene)
hsa:6643;SNX2,TRG-9;sorting nexin 2
hsa:7164;TPD52L1,D53,hD53;tumor protein D52-like 1
hsa:8001;GLRA3;glycine receptor, alpha 3
hsa:7411;VBP1,PFD3,PFDN3,VBP-1;von Hippel-Lindau binding protein 1
hsa:6829;SUPT5H,SPT5,SPT5H,Tat-CT1;suppressor of Ty 5 homolog (S. cerevisiae)
hsa:339622;;uncharacterized LOC339622
hsa:7783;ZP2,ZPA,Zp-2;zona pellucida glycoprotein 2 (sperm receptor)
hsa:6884;TAF13,TAF(II)18,TAF2K,TAFII-18,TAFII18;TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa
hsa:7221;TRPC2;transient receptor potential cation channel, subfamily C, member 2, pseudogene
hsa:280659;SSX8;synovial sarcoma, X breakpoint 8
hsa:7812;CSDE1,D1S155E,RP5-1000E10.3,UNR;cold shock domain containing E1, RNA-binding
hsa:7754;ZNF204P,ZNF184-Lp,ZNF204,ZNF315P,b24o18.1;zinc finger protein 204, pseudogene
hsa:6992;PPP1R11,HCG-V,HCGV,IPP3,TCTE5,TCTEX5;protein phosphatase 1, regulatory (inhibitor) subunit 11 (EC:3.1.3.16)
hsa:283788;;FSHD region gene 1 pseudogene
hsa:6619;SNAPC3,PTFbeta,SNAP50;small nuclear RNA activating complex, polypeptide 3, 50kDa
hsa:7782;SLC30A4,ZNT4;solute carrier family 30 (zinc transporter), member 4
hsa:100500918;MIR3651;microRNA 3651
hsa:6167;RPL37,L37;ribosomal protein L37
hsa:100500833;MIR3653;microRNA 3653
hsa:6315;ATXN8OS,KLHL1AS,NCRNA00003,SCA8;ATXN8 opposite strand (non-protein coding)
hsa:6039;RNASE6,RNS6,RNasek6;ribonuclease, RNase A family, k6
hsa:4062;LY6H,NMLY6;lymphocyte antigen 6 complex, locus H
hsa:4061;LY6E,RIG-E,RIGE,SCA-2,SCA2,TSA-1;lymphocyte antigen 6 complex, locus E
hsa:6227;RPS21,S21;ribosomal protein S21
hsa:5507;PPP1R3C,PPP1R5;protein phosphatase 1, regulatory subunit 3C
hsa:6161;RPL32,L32;ribosomal protein L32
hsa:4250;SCGB2A2,MGB1,UGB2;secretoglobin, family 2A, member 2
hsa:5718;PSMD12,Rpn5,p55;proteasome (prosome, macropain) 26S subunit, non-ATPase, 12
hsa:5238;PGM3,AGM1,PAGM,PGM_3;phosphoglucomutase 3 (EC:5.4.2.3)
hsa:6210;RPS15A,S15a;ribosomal protein S15a
hsa:4259;MGST3,GST-III;microsomal glutathione S-transferase 3 (EC:2.5.1.18)
hsa:2958;GTF2A2,HsT18745,TF2A2,TFIIA;general transcription factor IIA, 2, 12kDa
hsa:4071;TM4SF1,H-L6,L6,M3S1,TAAL6;transmembrane 4 L six family member 1
hsa:6302;TSPAN31,SAS;tetraspanin 31
hsa:9397;NMT2;N-myristoyltransferase 2 (EC:2.3.1.97)
hsa:8703;B4GALT3,beta4Gal-T3;UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 (EC:2.4.1.90 2.4.1.38)
hsa:9044;BTAF1,MOT1,TAF(II)170,TAF172,TAFII170;BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae)
hsa:8310;ACOX3;acyl-CoA oxidase 3, pristanoyl (EC:1.3.3.6)
hsa:9348;NDST3,HSST3;N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 (EC:2.8.2.8)
hsa:8892;EIF2B2,EIF-2Bbeta,EIF2B;eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa
hsa:8869;ST3GAL5,SATI,SIAT9,SIATGM3S,ST3GalV;ST3 beta-galactoside alpha-2,3-sialyltransferase 5 (EC:2.4.99.9)
hsa:8721;EDF1,EDF-1,MBF1;endothelial differentiation-related factor 1
hsa:8576;STK16,KRCT,MPSK,PKL12,TSF1;serine/threonine kinase 16 (EC:2.7.11.1 2.7.10.2)
hsa:8562;DENR,DRP,DRP1,SMAP-3;density-regulated protein
hsa:8731;RNMT,MET,RG7MT1,hCMT1c;RNA (guanine-7-) methyltransferase (EC:2.1.1.56)
hsa:8821;INPP4B;inositol polyphosphate-4-phosphatase, type II, 105kDa (EC:3.1.3.66)
hsa:8787;RGS9,PERRS,RGS9L;regulator of G-protein signaling 9
hsa:9517;SPTLC2,HSN1C,LCB2,LCB2A,NSAN1C,SPT2,hLCB2a;serine palmitoyltransferase, long chain base subunit 2 (EC:2.3.1.50)
hsa:8514;KCNAB2,AKR6A5,HKvbeta2,HKvbeta2.1,HKvbeta2.2,KCNA2B,KV-BETA-2;potassium voltage-gated channel, shaker-related subfamily, beta member 2
hsa:9583;ENTPD4,LALP70,LAP70,LYSAL1,NTPDase-4,UDPase;ectonucleoside triphosphate diphosphohydrolase 4 (EC:3.6.1.6)
hsa:9246;UBE2L6,RIG-B,UBCH8;ubiquitin-conjugating enzyme E2L 6 (EC:6.3.2.19)
hsa:8708;B3GALT1,beta3Gal-T1;UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 (EC:2.4.1.179)
hsa:9452;ITM2A,BRICD2A,E25A;integral membrane protein 2A
hsa:8789;FBP2;fructose-1,6-bisphosphatase 2 (EC:3.1.3.11)
hsa:100616424;MIR4707;microRNA 4707
hsa:8509;NDST2,HSST2,NST2;N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2 (EC:2.8.2.8)
hsa:9144;SYNGR2;synaptogyrin 2
hsa:8420;SNHG3,NCRNA00014,RNU17C,RNU17D,U17HG,U17HG-A,U17HG-AB;small nucleolar RNA host gene 3 (non-protein coding)
hsa:8992;ATP6V0E1,ATP6H,ATP6V0E,M9.2,Vma21,Vma21p;ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 (EC:3.6.3.14)
hsa:8520;HAT1,KAT1;histone acetyltransferase 1 (EC:2.3.1.48)
hsa:9391;CIAO1,CIA1,WDR39;cytosolic iron-sulfur protein assembly 1
hsa:9262;STK17B,DRAK2;serine/threonine kinase 17b (EC:2.7.11.1)
hsa:9117;SEC22C,SEC22L3;SEC22 vesicle trafficking protein homolog C (S. cerevisiae)
hsa:8852;AKAP4,AKAP_82,AKAP-4,AKAP82,CT99,FSC1,HI,PRKA4,hAKAP82,p82;A kinase (PRKA) anchor protein 4
hsa:9550;ATP6V1G1,ATP6G,ATP6G1,ATP6GL,ATP6J,Vma10;ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 (EC:3.6.3.14)
hsa:9556;C14orf2,MP68,PLPM;chromosome 14 open reading frame 2
hsa:8435;SOAT2,ACACT2,ACAT2,ARGP2;sterol O-acyltransferase 2 (EC:2.3.1.26)
hsa:9167;COX7A2L,COX7AR,COX7RP,EB1,SIG81;cytochrome c oxidase subunit VIIa polypeptide 2 like
hsa:8458;TTF2,HuF2;transcription termination factor, RNA polymerase II
hsa:8269;TMEM187,CXorf12,DXS9878E,ITBA1;transmembrane protein 187
hsa:9364;RAB28;RAB28, member RAS oncogene family
hsa:9580;SOX13,ICA12,Sox-13;SRY (sex determining region Y)-box 13
hsa:8270;LAGE3,CVG5,DXS9879E,DXS9951E,ESO3,ITBA2;L antigen family, member 3
hsa:9443;MED7,ARC34,CRSP33,CRSP9;mediator complex subunit 7
hsa:8999;CDKL2,KKIAMRE,P56;cyclin-dependent kinase-like 2 (CDC2-related kinase) (EC:2.7.11.22)
hsa:8906;AP1G2,G2AD;adaptor-related protein complex 1, gamma 2 subunit
hsa:8825;LIN7A,LIN-7A,LIN7,MALS-1,TIP-33,VELI1;lin-7 homolog A (C. elegans)
hsa:8664;EIF3D,EIF3S7,eIF3-p66,eIF3-zeta;eukaryotic translation initiation factor 3, subunit D
hsa:9189;ZBED1,ALTE,DREF,TRAMP,hDREF;zinc finger, BED-type containing 1
hsa:9130;FAM50A,9F,DXS9928E,HXC-26,HXC26,XAP5;family with sequence similarity 50, member A
hsa:9354;UBE4A,E4,UBOX2,UFD2;ubiquitination factor E4A
hsa:9196;KCNAB3,AKR6A9,KCNA3.1B,KCNA3B,KV-BETA-3;potassium voltage-gated channel, shaker-related subfamily, beta member 3
hsa:8624;PSMG1,C21LRP,DSCR2,LRPC21,PAC-1,PAC1;proteasome (prosome, macropain) assembly chaperone 1
hsa:8424;BBOX1,BBH,BBOX,G-BBH,gamma-BBH;butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 (EC:1.14.11.1)
hsa:100616263;MIR4485;microRNA 4485
hsa:8436;SDPR,CAVIN2,PS-p68,SDR,cavin-2;serum deprivation response
hsa:8303;SNN;stannin
hsa:8273;SLC10A3,DXS253E,P3;solute carrier family 10 (sodium/bile acid cotransporter family), member 3
hsa:8612;PPAP2C,LPP2,PAP-2c,PAP2-g;phosphatidic acid phosphatase type 2C (EC:3.1.3.4)
hsa:8418;CMAHP,CMAH,CSAH;cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene
hsa:8541;PPFIA3,LPNA3;protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3
hsa:8938;BAIAP3,BAP3;BAI1-associated protein 3
hsa:9585;KIF20B,CT90,KRMP1,MPHOSPH1,MPP-1,MPP1;kinesin family member 20B
hsa:9028;RHBDL1,RHBDL,RRP;rhomboid, veinlet-like 1 (Drosophila) (EC:3.4.21.105)
hsa:9623;TCL1B,SYN-1,TML1;T-cell leukemia/lymphoma 1B
hsa:8455;ATRN,DPPT-L,MGCA;attractin
hsa:9546;APBA3,MGC:15815,X11L2,mint3;amyloid beta (A4) precursor protein-binding, family A, member 3
hsa:9087;TMSB4Y,TB4Y;thymosin beta 4, Y-linked
hsa:9238;TBRG4,CPR2,FASTKD4;transforming growth factor beta regulator 4
hsa:9129;PRPF3,HPRP3,HPRP3P,PRP3,Prp3p,RP18;PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae)
hsa:9256;BZRAP1,PBR-IP,PRAX-1,PRAX1,RIM-BP1,RIMBP1;benzodiazapine receptor (peripheral) associated protein 1
hsa:8642;DCHS1,CDH25,CDHR6,FIB1,PCDH16;dachsous 1 (Drosophila)
hsa:8544;PIR;pirin (iron-binding nuclear protein) (EC:1.13.11.24);K06911
hsa:9420;CYP7B1,CBAS3,CP7B,SPG5A;cytochrome P450, family 7, subfamily B, polypeptide 1 (EC:1.14.13.100)
hsa:8559;PRPF18,PRP18,hPrp18;PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae)
hsa:8785;MATN4,HE6WCR54;matrilin 4
hsa:9340;GLP2R;glucagon-like peptide 2 receptor
hsa:8681;JMJD7-PLA2G4B,HsT16992,cPLA2-beta;JMJD7-PLA2G4B readthrough
hsa:8302;KLRC4,NKG2-F,NKG2F;killer cell lectin-like receptor subfamily C, member 4
hsa:9755;TBKBP1,ProSAPiP2,SINTBAD;TBK1 binding protein 1
hsa:10651;MTX2;metaxin 2
hsa:10609;LEPREL4,NO55,NOL55,SC65;leprecan-like 4
hsa:10446;LRRN2,FIGLER7,GAC1,LRANK1,LRRN5;leucine rich repeat neuronal 2
hsa:10473;HMGN4,HMG17L3,NHC;high mobility group nucleosomal binding domain 4
hsa:10246;SLC17A2,NPT3;solute carrier family 17 (sodium phosphate), member 2
hsa:10311;DSCR3,DCRA,DSCRA;Down syndrome critical region gene 3
hsa:9679;FAM53B,KIAA0140,RP11-12J10.2,bA12J10.2;family with sequence similarity 53, member B
hsa:10141;C4orf6,aC1;chromosome 4 open reading frame 6
hsa:9824;ARHGAP11A;Rho GTPase activating protein 11A
hsa:10233;LRRC23,LRPB7;leucine rich repeat containing 23
hsa:10230;NBR2,NCRNA00192;neighbor of BRCA1 gene 2 (non-protein coding)
hsa:10302;SNAPC5,SNAP19;small nuclear RNA activating complex, polypeptide 5, 19kDa
hsa:10420;TESK2;testis-specific kinase 2 (EC:2.7.12.1)
hsa:10608;MXD4,MAD4,MST149,MSTP149,bHLHc12;MAX dimerization protein 4
hsa:10149;GPR64,EDDM6,HE6,TM7LN2;G protein-coupled receptor 64
hsa:10607;TBL3,SAZD,UTP13;transducin (beta)-like 3
hsa:10548;TM9SF1,HMP70,MP70;transmembrane 9 superfamily member 1
hsa:10369;CACNG2,MRD10;calcium channel, voltage-dependent, gamma subunit 2
hsa:9904;RBM19;RNA binding motif protein 19
hsa:9629;CLCA3P,CLCA3;chloride channel accessory 3, pseudogene
hsa:9917;FAM20B,gxk1;family with sequence similarity 20, member B
hsa:10455;ECI2,ACBD2,DRS-1,DRS1,HCA88,PECI,dJ1013A10.3;enoyl-CoA delta isomerase 2 (EC:5.3.3.8)
hsa:10627;MYL12A,MLCB,MRCL3,MRLC3,MYL2B;myosin, light chain 12A, regulatory, non-sarcomeric
hsa:10720;UGT2B11;UDP glucuronosyltransferase 2 family, polypeptide B11 (EC:2.4.1.17)
hsa:10008;KCNE3,HOKPP,HYPP,MiRP2;potassium voltage-gated channel, Isk-related family, member 3
hsa:9741;LAPTM4A,HUMORF13,LAPTM4,MBNT,Mtrp;lysosomal protein transmembrane 4 alpha
hsa:10098;TSPAN5,NET-4,NET4,TM4SF9,TSPAN-5;tetraspanin 5
hsa:10391;CORO2B,CLIPINC;coronin, actin binding protein, 2B
hsa:9870;;KIAA0317
hsa:10169;SERF2,4F5REL,FAM2C,H4F5REL,HsT17089;small EDRK-rich factor 2
hsa:10817;FRS3,FRS2B,FRS2beta,SNT-2,SNT2;fibroblast growth factor receptor substrate 3
hsa:10234;LRRC17,P37NB;leucine rich repeat containing 17
hsa:10716;TBR1,TBR-1,TES-56;T-box, brain, 1
hsa:10205;MPZL2,EVA,EVA1;myelin protein zero-like 2
hsa:9929;JOSD1,dJ508I15.2;Josephin domain containing 1 (EC:3.4.19.12)
hsa:10069;RWDD2B,C21orf6;RWD domain containing 2B
hsa:10629;TAF6L,PAF65A;TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa
hsa:10175;CNIH,CNIH1,CNIL,TGAM77;cornichon homolog (Drosophila)
hsa:10066;SCAMP2;secretory carrier membrane protein 2
hsa:9926;LPGAT1,FAM34A,FAM34A1,NET8;lysophosphatidylglycerol acyltransferase 1
hsa:9633;MTL5,CXCDC2,MTLT,TESMIN;metallothionein-like 5, testis-specific (tesmin)
hsa:10052;GJC1,CX45,GJA7;gap junction protein, gamma 1, 45kDa
hsa:10434;LYPLA1,APT-1,LPL1,LYSOPLA,hAPT1;lysophospholipase I (EC:3.1.1.5 3.1.2.-)
hsa:10199;MPHOSPH10,CT90,MPP10,MPP10P;M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein)
hsa:9764;;KIAA0513
hsa:10813;UTP14A,NYCO16,SDCCAG16,dJ537K23.3;UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast)
hsa:9906;SLC35E2;solute carrier family 35, member E2
hsa:10653;SPINT2,DIAR3,HAI-2,HAI2,Kop,PB;serine peptidase inhibitor, Kunitz type, 2
hsa:9637;FEZ2,HUM3CL;fasciculation and elongation protein zeta 2 (zygin II)
hsa:9808;;KIAA0087
hsa:10286;BCAS2,DAM1,SPF27,Snt309;breast carcinoma amplified sequence 2
hsa:10597;TRAPPC2P1,MIP-2A,SEDLP,SEDLP1;trafficking protein particle complex 2 pseudogene 1
hsa:9674;;KIAA0040
hsa:9747;FAM115A;family with sequence similarity 115, member A
hsa:10559;SLC35A1,CDG2F,CMPST,CST,hCST;solute carrier family 35 (CMP-sialic acid transporter), member A1
hsa:10423;CDIPT,PIS,PIS1;CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC:2.7.8.11)
hsa:9717;SEC14L5,PRELID4B;SEC14-like 5 (S. cerevisiae)
hsa:9913;SUPT7L,SPT7L,STAF65,STAF65(gamma),STAF65G,SUPT7H;suppressor of Ty 7 (S. cerevisiae)-like
hsa:10557;RPP38;ribonuclease P/MRP 38kDa subunit (EC:3.1.26.5)
hsa:10535;RNASEH2A,AGS4,JUNB,RNASEHI,RNHIA,RNHL;ribonuclease H2, subunit A (EC:3.1.26.4)
hsa:10289;EIF1B,GC20;eukaryotic translation initiation factor 1B
hsa:10147;SUGP2,SFRS14;SURP and G patch domain containing 2
hsa:10218;ANGPTL7,AngX,CDT6,RP4-647M16.2,dJ647M16.1;angiopoietin-like 7
hsa:10099;TSPAN3,TM4-A,TM4SF8,TSPAN-3;tetraspanin 3
hsa:9729;RP3-403A15.2;KIAA0408
hsa:10681;GNB5,GB5;guanine nucleotide binding protein (G protein), beta 5
hsa:9697;TRAM2;translocation associated membrane protein 2
hsa:9949;AMMECR1,AMMERC1;Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1
hsa:10278;EFS,CAS3,CASS3,EFS1,EFS2,HEFS,SIN;embryonal Fyn-associated substrate
hsa:10217;CTDSPL,C3orf8,HYA22,PSR1,RBSP3,SCP3;CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like (EC:3.1.3.16)
hsa:10143;CLEC3A,CLECSF1;C-type lectin domain family 3, member A
hsa:10778;ZNF271,HZF7,ZNFEB;zinc finger protein 271
hsa:9718;ECE2;endothelin converting enzyme 2 (EC:3.4.24.71)
hsa:10214;SSX3,CT5.3;synovial sarcoma, X breakpoint 3
hsa:10748;KLRAP1,KLRA#,KLRA1,LY49L,Ly-49L,Ly49;killer cell lectin-like receptor subfamily A pseudogene 1
hsa:9716;AQR,IBP160,fSAP164;aquarius homolog (mouse)
hsa:10184;LHFPL2;lipoma HMGIC fusion partner-like 2
hsa:10640;EXOC5,HSEC10,PRO1912,SEC10,SEC10L1,SEC10P;exocyst complex component 5
hsa:10422;UBAC1,GBDR1,RP11-432J22.3,UBADC1;UBA domain containing 1
hsa:10435;CDC42EP2,BORG1,CEP2;CDC42 effector protein (Rho GTPase binding) 2
hsa:10430;TMEM147,NIFIE14;transmembrane protein 147
hsa:10025;MED16,DRIP92,THRAP5,TRAP95;mediator complex subunit 16
hsa:9631;NUP155,N155;nucleoporin 155kDa
hsa:10236;HNRNPR,HNRPR,hnRNP_R,hnRNP-R;heterogeneous nuclear ribonucleoprotein R
hsa:10618;TGOLN2,TGN38,TGN46,TGN48,TGN51,TTGN2;trans-golgi network protein 2
hsa:9818;NUPL1,PRO2463;nucleoporin like 1
hsa:10742;RAI2;retinoic acid induced 2
hsa:9920;KBTBD11,KLHDC7C;kelch repeat and BTB (POZ) domain containing 11
hsa:10478;SLC25A17,PMP34;solute carrier family 25 (mitochondrial carrier;peroxisomal membrane protein, 34kDa), member 17
hsa:9811;CTIF,Gm672,KIAA0427;CBP80/20-dependent translation initiation factor
hsa:9720;CCDC144A;coiled-coil domain containing 144A
hsa:9834;C14orf110,FAM30A;KIAA0125
hsa:9948;WDR1,AIP1,NORI-1;WD repeat domain 1
hsa:100129405;MSTO2P,MSTO2;misato homolog 2 pseudogene
hsa:9746;CLSTN3,CDHR14,CSTN3,alcbeta;calsyntenin 3
hsa:9796;PHYHIP,DYRK1AP3,PAHX-AP,PAHXAP1;phytanoyl-CoA 2-hydroxylase interacting protein
hsa:10652;YKT6;YKT6 v-SNARE homolog (S. cerevisiae)
hsa:10126;DNAL4,PIG27;dynein, axonemal, light chain 4
hsa:9701;PPP6R2,KIAA0685,PP6R2,SAP190,SAPS2;protein phosphatase 6, regulatory subunit 2
hsa:10650;SLMO1,C18orf43,HFL-EDDG1,PRELID3A;slowmo homolog 1 (Drosophila)
hsa:10244;RABEPK,RAB9P40,bA65N13.1,p40;Rab9 effector protein with kelch motifs
hsa:10775;POP4,RPP29;processing of precursor 4, ribonuclease P/MRP subunit (S. cerevisiae) (EC:3.1.26.5)
hsa:9886;RHOBTB1;Rho-related BTB domain containing 1
hsa:10476;ATP5H,ATPQ;ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d (EC:3.6.1.14)
hsa:11158;RABL2B;RAB, member of RAS oncogene family-like 2B
hsa:11102;RPP14,P14;ribonuclease P/MRP 14kDa subunit (EC:3.1.26.5)
hsa:10917;BTNL3,BTNLR;butyrophilin-like 3
hsa:11138;TBC1D8,AD3,HBLP1,TBC1D8A,VRP;TBC1 domain family, member 8 (with GRAM domain)
hsa:10905;MAN1A2,MAN1B;mannosidase, alpha, class 1A, member 2 (EC:3.2.1.113)
hsa:11264;PXMP4,PMP24;peroxisomal membrane protein 4, 24kDa
hsa:11230;PRAF2;PRA1 domain family, member 2
hsa:10865;ARID5A,MRF-1,MRF1,RP11-363D14;AT rich interactive domain 5A (MRF1-like)
hsa:11056;DDX52,HUSSY19,ROK1;DEAD (Asp-Glu-Ala-Asp) box polypeptide 52 (EC:3.6.4.13)
hsa:11182;SLC2A6,GLUT6,GLUT9,HSA011372;solute carrier family 2 (facilitated glucose transporter), member 6
hsa:11227;GALNT5,GALNAC-T5;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) (EC:2.4.1.41)
hsa:10944;C11orf58,IMAGE145052,SMAP;chromosome 11 open reading frame 58
hsa:11068;CYB561D2,101F6,TSP10;cytochrome b561 family, member D2
hsa:10936;GPR75,GPRchr2,WI31133;G protein-coupled receptor 75
hsa:10900;RUNDC3A,RAP2IP,RPIP-8,RPIP8;RUN domain containing 3A
hsa:11098;PRSS23,SIG13,SPUVE,ZSIG13;protease, serine, 23
hsa:11077;HSF2BP;heat shock transcription factor 2 binding protein
hsa:11112;HIBADH,NS5ATP1;3-hydroxyisobutyrate dehydrogenase (EC:1.1.1.31)
hsa:10867;TSPAN9,NET-5,NET5,PP1057;tetraspanin 9
hsa:10876;EDDM3A,EP3A,FAM12A,HE3-ALPHA,HE3A,HE3ALPHA;epididymal protein 3A
hsa:11051;NUDT21,CFIM25,CPSF5;nudix (nucleoside diphosphate linked moiety X)-type motif 21
hsa:11142;PKIG;protein kinase (cAMP-dependent, catalytic) inhibitor gamma
hsa:10882;C1QL1,C1QRF,C1QTNF14,CRF;complement component 1, q subcomponent-like 1
hsa:11105;PRDM7,PFM4,ZNF910;PR domain containing 7 (EC:2.1.1.43)
hsa:11147;HHLA3;HERV-H LTR-associating 3
hsa:11332;ACOT7,ACH1,ACT,BACH,CTE-II,LACH,LACH1,RP1-120G22.10,hBACH;acyl-CoA thioesterase 7 (EC:3.1.2.2)
hsa:11247;NXPH4,NPH4;neurexophilin 4
hsa:11159;RABL2A;RAB, member of RAS oncogene family-like 2A
hsa:11101;ATE1;arginyltransferase 1 (EC:2.3.2.8)
hsa:10879;SMR3B,P-B,PBII,PRL3,PROL3,SMR1B;submaxillary gland androgen regulated protein 3B
hsa:11042;SMA5;glucuronidase, beta pseudogene
hsa:11070;TMEM115,PL6;transmembrane protein 115
hsa:11336;EXOC3,SEC6,SEC6L1,Sec6p;exocyst complex component 3
hsa:10983;CCNI,CYC1,CYI;cyclin I
hsa:10985;GCN1L1,GCN1,GCN1L,PRIC295;GCN1 general control of amino-acid synthesis 1-like 1 (yeast)
hsa:11272;PRR4,LPRP,PROL4;proline rich 4 (lacrimal)
hsa:11063;SOX30;SRY (sex determining region Y)-box 30
hsa:11228;RASSF8,C12orf2,HOJ1;Ras association (RalGDS/AF-6) domain family (N-terminal) member 8
hsa:11015;KDELR3,ERD2L3;KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3
hsa:11019;LIAS,LAS,LIP1,LS,PDHLD;lipoic acid synthetase (EC:2.8.1.8)
hsa:11157;LSM6,YDR378C;LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae)
hsa:10994;ILVBL,209L8,AHAS,ILV2H;ilvB (bacterial acetolactate synthase)-like (EC:2.2.1.-)
hsa:11282;MGAT4B,GNT-IV,GNT-IVB;mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B (EC:2.4.1.145)
hsa:11257;TP53TG1,LINC00096,NCRNA00096,P53TG1,P53TG1-D,TP53AP1;TP53 target 1 (non-protein coding)
hsa:11072;DUSP14,MKP-L,MKP6;dual specificity phosphatase 14 (EC:3.1.3.16 3.1.3.48)
hsa:10966;RAB40B,RAR,SEC4L;RAB40B, member RAS oncogene family
hsa:10903;MTMR11,CRA,RP11-212K13.1;myotubularin related protein 11
hsa:11061;LECT1,BRICD3,CHM-I,CHM1,MYETS1;leukocyte cell derived chemotaxin 1
hsa:11014;KDELR2,ELP-1,ERD2.2;KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2
hsa:11212;PROSC;proline synthetase co-transcribed homolog (bacterial);K06997
hsa:11328;FKBP9,FKBP60,FKBP63,PPIase;FK506 binding protein 9, 63 kDa (EC:5.2.1.8)
hsa:642826;BMS1P6,BMS1LP6,bA302K17.2;BMS1 pseudogene 6
hsa:255031;FLJ35390;uncharacterized LOC255031
hsa:222223;KIAA1324L,EIG121L;KIAA1324-like
hsa:285622;NBPF22P;neuroblastoma breakpoint family, member 22, pseudogene
hsa:23597;ACOT9,ACATE2,MT-ACT48,MTACT48;acyl-CoA thioesterase 9
hsa:23555;TSPAN15,2700063A19Rik,NET-7,NET7,TM4SF15;tetraspanin 15
hsa:646813;;DEAH (Asp-Glu-Ala-His) box polypeptide 9 pseudogene
hsa:23507;LRRC8B,TA-LRRP,TALRRP;leucine rich repeat containing 8 family, member B
hsa:23399;CTDNEP1,DULLARD,HSA011916,NET56;CTD nuclear envelope phosphatase 1 (EC:3.1.3.16)
hsa:23142;DCUN1D4;DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae)
hsa:22952;CYP2G1P,CYP2G1,CYP2G2P,CYP2GP1;cytochrome P450, family 2, subfamily G, polypeptide 1 pseudogene
hsa:23074;UHRF1BP1L,SHIP164;UHRF1 binding protein 1-like
hsa:23015;GOLGA8A,GM88;golgin A8 family, member A
hsa:23023;TMCC1;transmembrane and coiled-coil domain family 1
hsa:23349;RP11-392A14.4;KIAA1045
hsa:23138;N4BP3,LZTS4;NEDD4 binding protein 3
hsa:23614;PPY2;pancreatic polypeptide 2
hsa:23091;ZC3H13,KIAA0853;zinc finger CCCH-type containing 13
hsa:23251;;KIAA1024
hsa:23585;TMEM50A,IFNRC,SMP1;transmembrane protein 50A
hsa:23313;C22orf9;KIAA0930
hsa:23466;CBX6;chromobox homolog 6
hsa:23480;SEC61G,SSS1;Sec61 gamma subunit
hsa:22865;SLITRK3;SLIT and NTRK-like family, member 3
hsa:23548;TTC33,OSRF;tetratricopeptide repeat domain 33
hsa:22913;RALY,HNRPCL2,P542;RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse))
hsa:23648;SSBP3,CSDP,SSDP,SSDP1;single stranded DNA binding protein 3
hsa:23396;PIP5K1C,LCCS3,PIP5K-GAMMA,PIP5Kgamma,PIPKIg_v4;phosphatidylinositol-4-phosphate 5-kinase, type I, gamma (EC:2.7.1.68)
hsa:23080;AVL9,KIAA0241;AVL9 homolog (S. cerevisiase)
hsa:23474;ETHE1,HSCO,YF13H12;ethylmalonic encephalopathy 1
hsa:23243;ANKRD28,PITK,PPP1R65;ankyrin repeat domain 28
hsa:23232;TBC1D12;TBC1 domain family, member 12
hsa:23642;SNHG1,LINC00057,NCRNA00057,U22HG,UHG;small nucleolar RNA host gene 1 (non-protein coding)
hsa:23333;DPY19L1;dpy-19-like 1 (C. elegans)
hsa:23463;ICMT,HSTE14,MST098,MSTP098,PCCMT,PCMT,PPMT;isoprenylcysteine carboxyl methyltransferase (EC:2.1.1.100)
hsa:23022;PALLD,CGI151,MYN,PNCA1,SIH002;palladin, cytoskeletal associated protein
hsa:23546;SYNGR4;synaptogyrin 4
hsa:23350;U2SURP,SR140,fSAPa;U2 snRNP-associated SURP domain containing
hsa:23217;ZFR2,KIAA1086;zinc finger RNA binding protein 2
hsa:23219;FBXO28,CENP-30,Fbx28;F-box protein 28
hsa:23207;PLEKHM2,RP11-169K16.1,SKIP;pleckstrin homology domain containing, family M (with RUN domain) member 2
hsa:23658;LSM5,YER146W;LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae)
hsa:23205;ACSBG1,BG,BG1,BGM,GR-LACS,LPD;acyl-CoA synthetase bubblegum family member 1 (EC:6.2.1.3)
hsa:23588;KLHDC2,HCLP-1,LCP;kelch domain containing 2
hsa:23366;;KIAA0895
hsa:23434;C3orf27,GR6;chromosome 3 open reading frame 27
hsa:23483;TGDS,SDR2E1,TDPGD;TDP-glucose 4,6-dehydratase (EC:4.2.1.46)
hsa:23094;SIPA1L3,SPAL3;signal-induced proliferation-associated 1 like 3
hsa:23550;PSD4,EFA6B,TIC;pleckstrin and Sec7 domain containing 4
hsa:23379;;KIAA0947
hsa:23306;TMEM194A,TMEM194;transmembrane protein 194A
hsa:23615;PYY2;peptide YY, 2 (pseudogene)
hsa:23031;MAST3;microtubule associated serine/threonine kinase 3 (EC:2.7.11.1)
hsa:22983;MAST1,SAST,SAST170;microtubule associated serine/threonine kinase 1 (EC:2.7.11.1)
hsa:22993;HMGXB3,HMGX3,SMF;HMG box domain containing 3
hsa:23033;DOPEY1,KIAA1117,dJ202D23.2;dopey family member 1
hsa:23450;SF3B3,RSE1,SAP130,SF3b130,STAF130;splicing factor 3b, subunit 3, 130kDa
hsa:23125;CAMTA2;calmodulin binding transcription activator 2
hsa:23473;CAPN7,CALPAIN7,PALBH;calpain 7
hsa:23353;SUN1,UNC84A;Sad1 and UNC84 domain containing 1
hsa:23492;CBX7;chromobox homolog 7
hsa:22986;SORCS3,SORCS;sortilin-related VPS10 domain containing receptor 3
hsa:25966;C2CD2,C21orf25,C21orf258,TMEM24L;C2 calcium-dependent domain containing 2
hsa:26231;LRRC29,FBL9,FBXL9;leucine rich repeat containing 29
hsa:25854;FAM149A,MSTP119;family with sequence similarity 149, member A
hsa:27437;HSFY1P1,CECR8,HSFYL1,HSFYP1,NCRNA00016;heat shock transcription factor, Y-linked 1 pseudogene 1
hsa:27439;CECR6;cat eye syndrome chromosome region, candidate 6
hsa:25798;BRI3,I3;brain protein I3
hsa:28981;IFT81,CDV-1,CDV-1R,CDV1,CDV1R;intraflagellar transport 81 homolog (Chlamydomonas)
hsa:26062;HYALP1,HYAL6;hyaluronoglucosaminidase pseudogene 1
hsa:26070;DKFZP434K028;uncharacterized LOC26070
hsa:25912;C1orf43,NICE-3,NS5ATP4,S863-3;chromosome 1 open reading frame 43
hsa:27124;INPP5J,INPP5,PIB5PA,PIPP;inositol polyphosphate-5-phosphatase J (EC:3.1.3.56)
hsa:29068;ZBTB44,BTBD15,HSPC063,ZNF851;zinc finger and BTB domain containing 44
hsa:27258;LSM3,SMX4,USS2,YLR438C;LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae)
hsa:27333;GOLIM4,GIMPC,GOLPH4,GPP130,P138;golgi integral membrane protein 4
hsa:25962;fSAP121;KIAA1429
hsa:25789;TMEM59L,BSMAP,C19orf4;transmembrane protein 59-like
hsa:27341;RRP7A,BK126B4.3,CGI-96;ribosomal RNA processing 7 homolog A (S. cerevisiae)
hsa:26230;TIAM2,STEF,TIAM-2;T-cell lymphoma invasion and metastasis 2
hsa:26220;DGCR5,LINC00037,NCRNA00037;DiGeorge syndrome critical region gene 5 (non-protein coding)
hsa:26157;GIMAP2,HIMAP2,IMAP2;GTPase, IMAP family member 2
hsa:26050;SLITRK5,LRRC11,bA364G4.2;SLIT and NTRK-like family, member 5
hsa:27284;SULT1B1,ST1B1,ST1B2,SULT1B2;sulfotransferase family, cytosolic, 1B, member 1 (EC:2.8.2.-)
hsa:27091;CACNG5;calcium channel, voltage-dependent, gamma subunit 5
hsa:27292;DIMT1,DIM1,DIMT1L,HSA9761,HUSSY5;DIM1 dimethyladenosine transferase 1 homolog (S. cerevisiae) (EC:2.1.1.183)
hsa:25774;GSTTP1,HS322B1A;glutathione S-transferase theta pseudogene 1
hsa:26083;TBC1D29;TBC1 domain family, member 29
hsa:28983;TMPRSS11E,DESC1,TMPRSS11E2;transmembrane protease, serine 11E (EC:3.4.21.-)
hsa:27145;FILIP1,FILIP;filamin A interacting protein 1
hsa:28954;REM1,GD:REM,GES,REM;RAS (RAD and GEM)-like GTP-binding 1
hsa:27079;RPUSD2,C15orf19,C18B11;RNA pseudouridylate synthase domain containing 2
hsa:25822;DNAJB5,Hsc40;DnaJ (Hsp40) homolog, subfamily B, member 5
hsa:27254;CSDC2,PIPPIN,dJ347H13.2;cold shock domain containing C2, RNA binding
hsa:27286;SRPX2,BPP,CBPS,PMGX,RESDX,SRPUL;sushi-repeat containing protein, X-linked 2
hsa:25845;PP7080;uncharacterized LOC25845
hsa:26059;ERC2,CAST,CAST1,ELKSL,SPBC110,Spc110;ELKS/RAB6-interacting/CAST family member 2
hsa:27442;CECR3;cat eye syndrome chromosome region, candidate 3 (non-protein coding)
hsa:26138;LINC00588,C8orf71;long intergenic non-protein coding RNA 588
hsa:27098;CLUL1,RA337M;clusterin-like 1 (retinal)
hsa:27293;SMPDL3B,ASML3B;sphingomyelin phosphodiesterase, acid-like 3B
hsa:27128;CYTH4,CYT4,DJ63G5.1,PSCD4;cytohesin 4
hsa:26091;HERC4;HECT and RLD domain containing E3 ubiquitin protein ligase 4
hsa:24142;NAT6,FUS-2,FUS2;N-acetyltransferase 6 (GCN5-related) (EC:2.3.1.-)
hsa:26032;SUSD5;sushi domain containing 5
hsa:26261;FBXO24,FBX24;F-box protein 24
hsa:25775;C22orf24,HSN44A4A;chromosome 22 open reading frame 24
hsa:25817;FAM19A5,QLLK5208,TAFA-5,TAFA5,UNQ5208;family with sequence similarity 19 (chemokine (C-C motif)-like), member A5
hsa:26579;MYEOV,OCIM;myeloma overexpressed (in a subset of t(11;14) positive multiple myelomas)
hsa:25796;PGLS,6PGL;6-phosphogluconolactonase (EC:3.1.1.31)
hsa:27097;TAF5L,PAF65B;TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa
hsa:24148;PRPF6,ANT-1,ANT1,C20orf14,Prp6,TOM,U5-102K,hPrp6;PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae)
hsa:25879;DCAF13,GM83,WDSOF1;DDB1 and CUL4 associated factor 13
hsa:27012;KCNV1,HNKA,KCNB3,KV2.3,KV8.1;potassium channel, subfamily V, member 1
hsa:27004;TCL6,TNG1,TNG2;T-cell leukemia/lymphoma 6 (non-protein coding)
hsa:25940;FAM98A;family with sequence similarity 98, member A
hsa:29070;CCDC113;coiled-coil domain containing 113
hsa:26469;PTPN18,BDP1,PTP-HSCF;protein tyrosine phosphatase, non-receptor type 18 (brain-derived) (EC:3.1.3.48)
hsa:26984;SEC22A,SEC22L2;SEC22 vesicle trafficking protein homolog A (S. cerevisiae)
hsa:25884;CHRDL2,BNF1,CHL2,FKSG37;chordin-like 2
hsa:28231;SLCO4A1,OATP-E,OATP1,OATP4A1,OATPE,OATPRP1,POAT,SLC21A12;solute carrier organic anion transporter family, member 4A1
hsa:26205;GMEB2,P79PIF,PIF79;glucocorticoid modulatory element binding protein 2
hsa:28966;SNX24,PRO1284;sorting nexin 24
hsa:25859;PART1,NCRNA00206;prostate androgen-regulated transcript 1 (non-protein coding)
hsa:25891;PAMR1,DKFZP586H2123,RAMP;peptidase domain containing associated with muscle regeneration 1
hsa:26235;FBXL4,FBL4,FBL5;F-box and leucine-rich repeat protein 4
hsa:27236;ARFIP1,HSU52521;ADP-ribosylation factor interacting protein 1
hsa:26128;KBP,TTC20;KIAA1279
hsa:28952;CCDC22,CXorf37;coiled-coil domain containing 22
hsa:26284;ERAL1,ERA,ERAL1A,H-ERA,HERA-A,HERA-B;Era G-protein-like 1 (E. coli)
hsa:26995;TRUB2,CLONE24922,RP11-339B21.1;TruB pseudouridine (psi) synthase homolog 2 (E. coli)
hsa:25778;DSTYK,DustyPK,RIP5,RIPK5;dual serine/threonine and tyrosine protein kinase (EC:2.7.12.1)
hsa:25927;CNRIP1,C2orf32,CRIP1;cannabinoid receptor interacting protein 1
hsa:25972;UNC50,GMH1,UNCL,URP;unc-50 homolog (C. elegans)
hsa:28974;C19orf53,LYDG10;chromosome 19 open reading frame 53
hsa:26260;FBXO25,FBX25;F-box protein 25
hsa:29035;C16orf72,PRO0149;chromosome 16 open reading frame 72
hsa:26576;SRPK3,MSSK-1,MSSK1,STK23;SRSF protein kinase 3 (EC:2.7.11.1)
hsa:25903;OLFML2B,RP11-227F8.1;olfactomedin-like 2B
hsa:28978;TMEM14A,C6orf73;transmembrane protein 14A
hsa:27106;ARRDC2,CLONE24945;arrestin domain containing 2
hsa:25949;SYF2,CBPIN,NTC31,P29,fSAP29;SYF2 homolog, RNA splicing factor (S. cerevisiae)
hsa:27146;FAM184B;family with sequence similarity 184, member B
hsa:26257;NKX2-8,NKX2.8,NKX2H,Nkx2-9;NK2 homeobox 8
hsa:25900;IFFO1,HOM-TES-103,IFFO;intermediate filament family orphan 1
hsa:26297;SERGEF,DELGEF,Gnefr;secretion regulating guanine nucleotide exchange factor
hsa:26301;GBGT1,A3GALNT,FS,UNQ2513;globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (EC:2.4.1.88)
hsa:26093;CCDC9;coiled-coil domain containing 9
hsa:27296;TP53TG5,C20orf10,CLG01;TP53 target 5
hsa:26953;RANBP6;RAN binding protein 6
hsa:27290;SPINK4,PEC-60,PEC60;serine peptidase inhibitor, Kazal type 4
hsa:51050;PI15,CRISP8,P24TI,P25TI;peptidase inhibitor 15
hsa:56902;PNO1,KHRBP1,RRP20;partner of NOB1 homolog (S. cerevisiae)
hsa:55180;LINS,LINS1,WINS1;lines homolog (Drosophila)
hsa:53344;CHIC1,BRX;cysteine-rich hydrophobic domain 1
hsa:51122;COMMD2;COMM domain containing 2
hsa:55760;DHX32,DDX32,DHLP1;DEAH (Asp-Glu-Ala-His) box polypeptide 32 (EC:3.6.4.13)
hsa:56994;CHPT1,CPT,CPT1;choline phosphotransferase 1 (EC:2.7.8.2)
hsa:57710;RP11-46A10.3;KIAA1614
hsa:56906;THAP10;THAP domain containing 10
hsa:55362;TMEM63B,C6orf110,RP3-421H19.2;transmembrane protein 63B
hsa:54797;MED18,p28b;mediator complex subunit 18
hsa:55113;XKR8,RP11-460I13.3,XRG8;XK, Kell blood group complex subunit-related family, member 8
hsa:29937;NENF,CIR2,SCIRP10,SPUF;neudesin neurotrophic factor
hsa:54921;CHTF8,CTF8,DERPC;CTF8, chromosome transmission fidelity factor 8 homolog (S. cerevisiae)
hsa:55144;LRRC8D,LRRC5;leucine rich repeat containing 8 family, member D
hsa:54072;LINC00158,C21orf42,NCRNA00158;long intergenic non-protein coding RNA 158
hsa:55336;FBXL8,FBL8;F-box and leucine-rich repeat protein 8
hsa:57587;;KIAA1430
hsa:55314;TMEM144;transmembrane protein 144
hsa:54067;C21orf49;chromosome 21 open reading frame 49
hsa:51054;PLEKHA8P1,PLEKHA9;pleckstrin homology domain containing, family A member 8 pseudogene 1
hsa:29895;MYLPF,HUMMLC2B,MRLC2,MYL11;myosin light chain, phosphorylatable, fast skeletal muscle
hsa:51524;TMEM138;transmembrane protein 138
hsa:57061;HYMAI,NCRNA00020;hydatidiform mole associated and imprinted (non-protein coding)
hsa:54531;MIER2,KIAA1193,Mi-er2;mesoderm induction early response 1, family member 2
hsa:57699;CPNE5,COPN5,CPN5;copine V
hsa:57461;ISY1,FSAP33;ISY1 splicing factor homolog (S. cerevisiae)
hsa:55176;SEC61A2;Sec61 alpha 2 subunit (S. cerevisiae)
hsa:54991;C1orf159;chromosome 1 open reading frame 159
hsa:55127;HEATR1,BAP28,UTP10;HEAT repeat containing 1
hsa:55539;KCNQ1DN,BWRT,HSA404617;KCNQ1 downstream neighbor (non-protein coding)
hsa:55922;NKRF,ITBA4,NRF;NFKB repressing factor
hsa:51098;IFT52,C20orf9,CGI-53,NGD2,NGD5,dJ1028D15.1;intraflagellar transport 52 homolog (Chlamydomonas)
hsa:57696;DDX55;DEAD (Asp-Glu-Ala-Asp) box polypeptide 55 (EC:3.6.4.13)
hsa:51678;MPP6,PALS2,VAM-1,VAM1,p55T;membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6)
hsa:55028;C17orf80,HLC-8,MIG3,SPEP1;chromosome 17 open reading frame 80
hsa:56882;CDC42SE1,SCIP1,SPEC1;CDC42 small effector 1
hsa:54754;NUTMF,FAM22F;NUT family member 2F
hsa:57536;;KIAA1328
hsa:51000;SLC35B3,C6orf196,PAPST2;solute carrier family 35, member B3
hsa:51318;MRPL35,L35mt,MRP-L35;mitochondrial ribosomal protein L35
hsa:56659;KCNK13,K2p13.1,THIK-1,THIK1;potassium channel, subfamily K, member 13
hsa:54457;TAF7L,CT40,TAF2Q;TAF7-like RNA polymerase II, TATA box binding protein (TBP)-associated factor, 50kDa
hsa:57589;CIP150,bA207C16.1;KIAA1432
hsa:51368;TEX264,SIG11,ZSIG11;testis expressed 264
hsa:50624;CUZD1,ERG-1,UO-44;CUB and zona pellucida-like domains 1
hsa:54766;BTG4,PC3B;B-cell translocation gene 4
hsa:54108;CHRAC1,CHARC1,CHARC15,CHRAC-1,CHRAC-15,CHRAC15,YCL1;chromatin accessibility complex 1
hsa:51075;TMX2,PDIA12,PIG26,TXNDC14;thioredoxin-related transmembrane protein 2
hsa:55890;GPRC5C,RAIG-3,RAIG3;G protein-coupled receptor, family C, group 5, member C
hsa:55248;TMEM206,C1orf75,RP11-384C4.5;transmembrane protein 206
hsa:55356;SLC22A15,FLIPT1,PRO34686;solute carrier family 22, member 15
hsa:51267;CLEC1A,CLEC1;C-type lectin domain family 1, member A
hsa:55301;OLAH,AURA1,SAST,THEDC1;oleoyl-ACP hydrolase (EC:3.1.2.14)
hsa:57482;;KIAA1211
hsa:51005;AMDHD2;amidohydrolase domain containing 2 (EC:3.5.1.25)
hsa:54942;FAM206A,C9orf6,CG-8;family with sequence similarity 206, member A
hsa:56683;C21orf59,C21orf48;chromosome 21 open reading frame 59
hsa:54094;C21orf15;chromosome 21 open reading frame 15
hsa:54621;VSIG10;V-set and immunoglobulin domain containing 10
hsa:51412;ACTL6B,ACTL6,BAF53B;actin-like 6B
hsa:56114;PCDHGA1,PCDH-GAMMA-A1;protocadherin gamma subfamily A, 1
hsa:56271;BEX4,BEXL1;brain expressed, X-linked 4
hsa:55793;FAM63A,RP11-316M1.5;family with sequence similarity 63, member A
hsa:55410;NCRNA00185,CYorf14,PRO2834;non-protein coding RNA 185
hsa:56935;SMCO4,C11orf75,FN5;single-pass membrane protein with coiled-coil domains 4
hsa:54834;GDAP2,MACROD3,dJ776P7.1;ganglioside induced differentiation associated protein 2
hsa:55285;RBM41;RNA binding motif protein 41
hsa:51213;LUZP4,CT-28,CT-8,CT28,HOM-TES-85;leucine zipper protein 4
hsa:51693;TRAPPC2L,HSPC176;trafficking protein particle complex 2-like
hsa:55701;ARHGEF40,SOLO;Rho guanine nucleotide exchange factor (GEF) 40
hsa:54915;YTHDF1,C20orf21;YTH domain family, member 1
hsa:57691;;KIAA1586
hsa:29107;NXT1,MTR2,P15;NTF2-like export factor 1
hsa:55187;VPS13D;vacuolar protein sorting 13 homolog D (S. cerevisiae)
hsa:53828;FXYD4,CHIF;FXYD domain containing ion transport regulator 4
hsa:51104;ABHD17B,C9orf77,FAM108B1,RP11-409O11.2;abhydrolase domain containing 17B
hsa:56005;C19orf10,EUROIMAGE1875335,IL25,IL27,IL27w,R33729_1,SF20;chromosome 19 open reading frame 10
hsa:55573;CDV3,H41;CDV3 homolog (mouse)
hsa:54521;WDR44,RAB11BP,RPH11;WD repeat domain 44
hsa:51236;FAM203A,BRP16,C8orf30A;family with sequence similarity 203, member A
hsa:54529;ASNSD1,NBLA00058,NS3TP1;asparagine synthetase domain containing 1
hsa:29926;GMPPA;GDP-mannose pyrophosphorylase A (EC:2.7.7.13)
hsa:51060;TXNDC12,AG1,AGR1,ERP16,ERP18,ERP19,PDIA16,TLP19,hAG-1,hTLP19;thioredoxin domain containing 12 (endoplasmic reticulum) (EC:1.8.4.2)
hsa:51090;PLLP,PMLP,TM4SF11;plasmolipin
hsa:51134;CCDC41,NY-REN-58;coiled-coil domain containing 41
hsa:56751;BARHL1;BarH-like homeobox 1
hsa:54939;COMMD4;COMM domain containing 4
hsa:55238;SLC38A7,SNAT7;solute carrier family 38, member 7
hsa:54539;NDUFB11,CI-ESSS,ESSS,NP17.3,Np15,P17.3;NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa
hsa:29097;CNIH4;cornichon homolog 4 (Drosophila)
hsa:50613;UBQLN3,TUP-1;ubiquilin 3
hsa:55228;PNMAL1;paraneoplastic Ma antigen family-like 1
hsa:54987;C1orf123;chromosome 1 open reading frame 123
hsa:51390;AIG1,AIG-1,dJ95L4.1;androgen-induced 1
hsa:57189;LCHN,PRO2561;KIAA1147
hsa:53838;C11orf24,DM4E3;chromosome 11 open reading frame 24
hsa:51052;PRLH,PRH,PRRP;prolactin releasing hormone
hsa:54681;P4HTM,EGLN4,HIFPH4,P4H-TM,PH-4,PH4,PHD4;prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum)
hsa:55631;LRRC40,dJ677H15.1;leucine rich repeat containing 40
hsa:51335;NGRN,DSC92;neugrin, neurite outgrowth associated
hsa:51315;KRCC1,CHBP2;lysine-rich coiled-coil 1
hsa:29114;TAGLN3,NP22,NP25;transgelin 3
hsa:56833;SLAMF8,BLAME,CD353,SBBI42;SLAM family member 8
hsa:57700;FAM160B1,KIAA1600,bA106M7.3;family with sequence similarity 160, member B1
hsa:55103;RALGPS2,dJ595C2.1;Ral GEF with PH domain and SH3 binding motif 2
hsa:51285;RASL12,RIS;RAS-like, family 12
hsa:56262;LRRC8A,AGM5,LRRC8;leucine rich repeat containing 8 family, member A
hsa:29767;TMOD2,N-TMOD,NTMOD;tropomodulin 2 (neuronal)
hsa:51194;IPO11,RanBP11;importin 11
hsa:56919;DHX33,DDX33;DEAH (Asp-Glu-Ala-His) box polypeptide 33 (EC:3.6.4.13)
hsa:56901;NDUFA4L2,NUOMS;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2
hsa:56905;C15orf39;chromosome 15 open reading frame 39
hsa:54682;MANSC1,9130403P13Rik,LOH12CR3;MANSC domain containing 1 (EC:3.2.1.14)
hsa:56967;C14orf132,C14orf88;chromosome 14 open reading frame 132
hsa:57647;DHX37,DDX37;DEAH (Asp-Glu-Ala-His) box polypeptide 37 (EC:3.6.4.13)
hsa:29989;OBP2B,hOBPIIb;odorant binding protein 2B
hsa:56944;OLFML3,HNOEL-iso,OLF44;olfactomedin-like 3
hsa:55313;CPPED1,CSTP1;calcineurin-like phosphoesterase domain containing 1 (EC:3.1.-.-)
hsa:55707;NECAP2;NECAP endocytosis associated 2
hsa:56260;C8orf44;chromosome 8 open reading frame 44
hsa:57210;SLC45A4;solute carrier family 45, member 4
hsa:29999;FSCN3;fascin homolog 3, actin-bundling protein, testicular (Strongylocentrotus purpuratus)
hsa:54058;C21orf58;chromosome 21 open reading frame 58
hsa:51293;CD320,8D6,8D6A,TCBLR;CD320 molecule
hsa:51009;DERL2,F-LAN-1,F-LANa,FLANa;derlin 2
hsa:55017;C14orf119;chromosome 14 open reading frame 119
hsa:55721;IQCC,RP4-622L5.6;IQ motif containing C
hsa:51068;NMD3;NMD3 homolog (S. cerevisiae)
hsa:53371;NUP54;nucleoporin 54kDa
hsa:54491;FAM105A,NET20;family with sequence similarity 105, member A
hsa:57577;;KIAA1407
hsa:29991;OBP2A,OBP,OBP2C,OBPIIa,hOBPIIa;odorant binding protein 2A
hsa:55350;VNN3,HSA238982;vanin 3
hsa:56241;SUSD2,BK65A6.2;sushi domain containing 2
hsa:55680;RUFY2,RABIP4R,ZFYVE13;RUN and FYVE domain containing 2
hsa:57622;LRFN1,SALM2;leucine rich repeat and fibronectin type III domain containing 1
hsa:55083;KIF26B;kinesin family member 26B
hsa:56256;SERTAD4,DJ667H12.2;SERTA domain containing 4
hsa:29105;C16orf80,EVORF,GTL3,fSAP23;chromosome 16 open reading frame 80
hsa:54470;ARMCX6;armadillo repeat containing, X-linked 6
hsa:54558;SPATA6,HASH,SRF-1,SRF1;spermatogenesis associated 6
hsa:51716;CES1P1,CES1A2,CES1A3,CES4,CESR,PCE-3;carboxylesterase 1 pseudogene 1
hsa:56339;METTL3,IME4,M6A,MT-A70,Spo8;methyltransferase like 3 (EC:2.1.1.62)
hsa:51108;METTL9,DREV,DREV1,PAP1;methyltransferase like 9
hsa:54906;FAM208B,C10orf18,bA318E3.2;family with sequence similarity 208, member B
hsa:55529;TMEM55A;transmembrane protein 55A (EC:3.1.3.78)
hsa:55268;ECHDC2;enoyl CoA hydratase domain containing 2
hsa:57002;YAE1D1,C7orf36;Yae1 domain containing 1
hsa:55727;BTBD7,FUP1;BTB (POZ) domain containing 7
hsa:51409;HEMK1,HEMK,MTQ1;HemK methyltransferase family member 1
hsa:51207;DUSP13,BEDP,DUSP13A,DUSP13B,MDSP,SKRP4,TMDP;dual specificity phosphatase 13 (EC:3.1.3.16 3.1.3.48)
hsa:55110;MAGOHB,MGN2,mago,magoh;mago-nashi homolog B (Drosophila)
hsa:55530;SVOP;SV2 related protein homolog (rat)
hsa:51439;FAM8A1,AHCP;family with sequence similarity 8, member A1
hsa:55592;GOLGA2P5,GOLGA2B,GOLGA2L1;golgin A2 pseudogene 5
hsa:55208;DCUN1D2,C13orf17;DCN1, defective in cullin neddylation 1, domain containing 2 (S. cerevisiae)
hsa:55891;LENEP,LEP503;lens epithelial protein
hsa:54346;UNC93A,Unc-93A,dJ366N23.1,dJ366N23.2;unc-93 homolog A (C. elegans)
hsa:55076;TMEM45A,DERP7;transmembrane protein 45A
hsa:54886;LPPR1,PRG-3;lipid phosphate phosphatase-related protein type 1
hsa:56342;PPAN,BXDC3,SSF,SSF-1,SSF1,SSF2;peter pan homolog (Drosophila)
hsa:57648;;KIAA1522
hsa:29092;LINC00339,HSPC157,NCRNA00339;long intergenic non-protein coding RNA 339
hsa:57291;DANCR,ANCR,KIAA0114,SNHG13;differentiation antagonizing non-protein coding RNA
hsa:57226;LYRM2,DJ122O8.2;LYR motif containing 2
hsa:54870;QRICH1;glutamine-rich 1
hsa:51186;WBP5,TCEAL9;WW domain binding protein 5
hsa:55841;WWC3,BM042;WWC family member 3
hsa:55299;BRIX1,BRIX,BXDC2;BRX1, biogenesis of ribosomes, homolog (S. cerevisiae)
hsa:55267;C22orf26;chromosome 22 open reading frame 26
hsa:55780;C6orf70,dJ266L20.3;chromosome 6 open reading frame 70
hsa:51582;AZIN1,OAZI,OAZIN,ODC1L;antizyme inhibitor 1
hsa:51760;SYT17;synaptotagmin XVII
hsa:55653;BCAS4,CNOL;breast carcinoma amplified sequence 4
hsa:53820;DSCR6,RIPPLY3;Down syndrome critical region gene 6
hsa:54850;FBXL12,Fbl12;F-box and leucine-rich repeat protein 12
hsa:54557;SGTB,SGT2;small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta
hsa:54733;SLC35F2,HSNOV1;solute carrier family 35, member F2
hsa:55916;NXT2,P15-2;nuclear transport factor 2-like export factor 2
hsa:54867;TMEM214;transmembrane protein 214
hsa:54946;SLC41A3,SLC41A1-L2;solute carrier family 41, member 3
hsa:55437;STRADB,ALS2CR2,CALS-21,ILPIP,ILPIPA,PAPK;STE20-related kinase adaptor beta
hsa:54976;C20orf27;chromosome 20 open reading frame 27
hsa:51585;PCF11;PCF11, cleavage and polyadenylation factor subunit, homolog (S. cerevisiae)
hsa:51233;C22orf43;chromosome 22 open reading frame 43
hsa:57529;RGAG1,MAR9,MART9;retrotransposon gag domain containing 1
hsa:51626;DYNC2LI1,D2LIC,LIC3;dynein, cytoplasmic 2, light intermediate chain 1
hsa:57508;INTS2,INT2,KIAA1287;integrator complex subunit 2
hsa:57231;SNX14,RGS-PX2;sorting nexin 14
hsa:60313;GPBP1L1,RP11-767N6.1;GC-rich promoter binding protein 1-like 1
hsa:55791;LRIF1,C1orf103,RIF1,RP11-96K19.1;ligand dependent nuclear receptor interacting factor 1
hsa:57405;SPC25,SPBC25,hSpc25;SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae)
hsa:58478;ENOPH1,E1,MASA,MST145;enolase-phosphatase 1 (EC:3.1.3.77)
hsa:57151;LYZL6,LYC1,PRO1485,TKAL754,UNQ754;lysozyme-like 6 (EC:3.2.1.17)
hsa:29125;C11orf21;chromosome 11 open reading frame 21
hsa:55088;C10orf118;chromosome 10 open reading frame 118
hsa:54626;HES2,bHLHb40;hairy and enhancer of split 2 (Drosophila)
hsa:55030;FBXO34,Fbx34;F-box protein 34
hsa:60592;SCOC,SCOCO;short coiled-coil protein
hsa:55974;SLC50A1,HsSWEET1,RAG1AP1,SCP,SWEET1,slv;solute carrier family 50 (sugar transporter), member 1
hsa:63931;MRPS14,DJ262D12.2,HSMRPS14,MRP-S14,S14mt;mitochondrial ribosomal protein S14
hsa:65117;RSRC2;arginine/serine-rich coiled-coil 2
hsa:58510;PRODH2,HSPOX1;proline dehydrogenase (oxidase) 2 (EC:1.5.99.8)
hsa:54475;NLE1,Nle;notchless homolog 1 (Drosophila)
hsa:51133;KCTD3,NY-REN-45;potassium channel tetramerisation domain containing 3
hsa:64595;TTTY15,NCRNA00138;testis-specific transcript, Y-linked 15 (non-protein coding)
hsa:65988;ZNF747;zinc finger protein 747
hsa:51663;ZFR,ZFR1;zinc finger RNA binding protein
hsa:55761;TTC17;tetratricopeptide repeat domain 17
hsa:57213;SPRYD7,C13orf1,CLLD6;SPRY domain containing 7
hsa:51303;FKBP11,FKBP19;FK506 binding protein 11, 19 kDa (EC:5.2.1.8)
hsa:54456;MOV10L1,CHAMP,DJ402G11.8;Mov10l1, Moloney leukemia virus 10-like 1, homolog (mouse) (EC:3.6.4.13)
hsa:65999;LRRC61,HSPC295;leucine rich repeat containing 61
hsa:54718;BTN2A3P,BTN2A3;butyrophilin, subfamily 2, member A3, pseudogene
hsa:65997;RASL11B;RAS-like, family 11, member B
hsa:54780;NSMCE4A,C10orf86,NS4EA,NSE4A;non-SMC element 4 homolog A (S. cerevisiae)
hsa:64940;STAG3L4;stromal antigen 3-like 4
hsa:29099;COMMD9;COMM domain containing 9
hsa:57664;PLEKHA4,PEPP1;pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4
hsa:64645;HIAT1;hippocampus abundant transcript 1
hsa:63932;CXorf56;chromosome X open reading frame 56
hsa:58486;ZBED5,Buster1;zinc finger, BED-type containing 5
hsa:64981;MRPL34,L34mt;mitochondrial ribosomal protein L34
hsa:60674;GAS5,NCRNA00030,SNHG2;growth arrest-specific 5 (non-protein coding)
hsa:55070;DET1;de-etiolated homolog 1 (Arabidopsis)
hsa:29799;YPEL1;yippee-like 1 (Drosophila)
hsa:57824;HMHB1,HB-1,HLA-HB1;histocompatibility (minor) HB-1
hsa:58475;MS4A7,4SPAN2,CD20L4,CFFM4,MS4A8;membrane-spanning 4-domains, subfamily A, member 7
hsa:54555;DDX49,R27090_2;DEAD (Asp-Glu-Ala-Asp) box polypeptide 49 (EC:3.6.4.13)
hsa:54952;TRNAU1AP,PRO1902,RP4-669K10.4,SECP43,TRSPAP1;tRNA selenocysteine 1 associated protein 1
hsa:51326;ARL17A,ARF1P2,ARL17P1;ADP-ribosylation factor-like 17A
hsa:55108;BSDC1;BSD domain containing 1
hsa:55466;DNAJA4,MST104,MSTP104,PRO1472;DnaJ (Hsp40) homolog, subfamily A, member 4
hsa:56964;WDR93;WD repeat domain 93
hsa:64860;ARMCX5;armadillo repeat containing, X-linked 5
hsa:57476;GRAMD1B;GRAM domain containing 1B
hsa:54143;LINC00308,C21orf74,NCRNA00308;long intergenic non-protein coding RNA 308
hsa:65996;MGC2752;CENPB DNA-binding domains containing 1 pseudogene
hsa:64926;RASAL3;RAS protein activator like 3
hsa:59284;CACNG7;calcium channel, voltage-dependent, gamma subunit 7
hsa:51616;TAF9B,DN-7,DN7,TAF9L,TAFII31L,TFIID-31;TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31kDa
hsa:51195;RAPGEFL1,Link-GEFII;Rap guanine nucleotide exchange factor (GEF)-like 1
hsa:64184;EDDM3B,EP3B,FAM12B,HE3-BETA,HE3B;epididymal protein 3B
hsa:57182;ANKRD50;ankyrin repeat domain 50
hsa:55262;C7orf43;chromosome 7 open reading frame 43
hsa:65084;TMEM135,PMP52;transmembrane protein 135
hsa:63920;C5orf54,Buster3;chromosome 5 open reading frame 54
hsa:54918;CMTM6,CKLFSF6,PRO2219;CKLF-like MARVEL transmembrane domain containing 6
hsa:64793;CEP85,CCDC21;centrosomal protein 85kDa
hsa:59084;ENPP5;ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)
hsa:65121;PRAMEF1;PRAME family member 1
hsa:58485;TRAPPC1,BET5,MUM2;trafficking protein particle complex 1
hsa:60487;TRMT11,C6orf75,MDS024,TRM11,TRMT11-1;tRNA methyltransferase 11 homolog (S. cerevisiae) (EC:2.1.1.-)
hsa:58528;RRAGD,RAGD,bA11D8.2.1;Ras-related GTP binding D
hsa:51146;A4GNT,alpha4GnT;alpha-1,4-N-acetylglucosaminyltransferase
hsa:54965;PIGX;phosphatidylinositol glycan anchor biosynthesis, class X
hsa:54502;RBM47,NET18;RNA binding motif protein 47
hsa:55229;PANK4;pantothenate kinase 4 (EC:2.7.1.33)
hsa:60467;BPESC1,NCRNA00187;blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding)
hsa:63914;C6orf164,dJ102H19.4;chromosome 6 open reading frame 164
hsa:60493;FASTKD5,dJ1187M17.5;FAST kinase domains 5
hsa:56521;DNAJC12,JDP1;DnaJ (Hsp40) homolog, subfamily C, member 12
hsa:51398;WDR83OS,C19orf56,PTD008;WD repeat domain 83 opposite strand
hsa:29798;C2orf27A,C2orf27,C2orf27B;chromosome 2 open reading frame 27A
hsa:66000;TMEM108,CT124;transmembrane protein 108
hsa:57228;SMAGP,hSMAGP;small cell adhesion glycoprotein
hsa:57520;HECW2,NEDL2;HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2
hsa:54980;C2orf42;chromosome 2 open reading frame 42
hsa:57456;;KIAA1143
hsa:51149;C5orf45;chromosome 5 open reading frame 45
hsa:51690;LSM7,YNL147W;LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae)
hsa:57095;PITHD1,C1orf128,HT014,RP5-886K2.4,TXNL1CL;PITH (C-terminal proteasome-interacting domain of thioredoxin-like) domain containing 1
hsa:54841;BIVM;basic, immunoglobulin-like variable motif containing
hsa:57348;TTYH1;tweety homolog 1 (Drosophila)
hsa:54587;MXRA8;matrix-remodelling associated 8
hsa:65056;GPBP1,GPBP,SSH6,VASCULIN;GC-rich promoter binding protein 1
hsa:64080;RBKS,RBSK;ribokinase (EC:2.7.1.15)
hsa:55218;EXD2,C14orf114,EXDL2;exonuclease 3'-5' domain containing 2
hsa:64800;EFCAB6,DJBP,HSCBCIP1,dJ185D5.1;EF-hand calcium binding domain 6
hsa:60559;SPCS3,PRO3567,SPC22/23,SPC3,YLR066W;signal peptidase complex subunit 3 homolog (S. cerevisiae)
hsa:29951;PDZRN4,LNX4,SAMCAP3L;PDZ domain containing ring finger 4
hsa:64091;POPDC2,POP2;popeye domain containing 2
hsa:55100;WDR70;WD repeat domain 70
hsa:63939;FAM217B,C20orf177,dJ551D2.5;family with sequence similarity 217, member B
hsa:54089;LINC00112,C21orf22,NCRNA00112;long intergenic non-protein coding RNA 112
hsa:55227;LRRC1,LANO,dJ523E19.1;leucine rich repeat containing 1
hsa:65989;DLK2,EGFL9;delta-like 2 homolog (Drosophila)
hsa:57472;CNOT6,CCR4;CCR4-NOT transcription complex, subunit 6
hsa:54951;COMMD8;COMM domain containing 8
hsa:59353;TMEM35;transmembrane protein 35
hsa:64747;MFSD1,SMAP4;major facilitator superfamily domain containing 1
hsa:55689;YEATS2;YEATS domain containing 2
hsa:54752;FNDC8;fibronectin type III domain containing 8
hsa:64215;DNAJC1,DNAJL1,ERdj1,HTJ1,MTJ1;DnaJ (Hsp40) homolog, subfamily C, member 1
hsa:55999;NXF4;nuclear RNA export factor 4 pseudogene
hsa:51125;GOLGA7,GCP16,GOLGA3AP1,GOLGA7A,HSPC041;golgin A7
hsa:51665;ASB1,ASB-1;ankyrin repeat and SOCS box containing 1
hsa:64748;LPPR2,PRG4;lipid phosphate phosphatase-related protein type 2 (EC:3.1.3.4)
hsa:55287;TMEM40;transmembrane protein 40
hsa:56245;C21orf62,B37,C21orf120,PRED81;chromosome 21 open reading frame 62
hsa:51513;ETV7,TEL-2,TEL2,TELB;ets variant 7
hsa:51440;HPCAL4,HLP4;hippocalcin like 4
hsa:56941;C3orf37;chromosome 3 open reading frame 37
hsa:57795;FAM5B,BRINP2,DBCCR1L2,RP5-1026E2.1;family with sequence similarity 5, member B
hsa:54629;FAM63B;family with sequence similarity 63, member B
hsa:54093;SETD4,C21orf18,C21orf27;SET domain containing 4
hsa:63899;NSUN3,MST077;NOP2/Sun domain family, member 3 (EC:2.1.1.-)
hsa:55048;VPS37C;vacuolar protein sorting 37 homolog C (S. cerevisiae)
hsa:64431;ACTR6,ARP6,HSPC281,MSTP136,hARP6,hARPX;ARP6 actin-related protein 6 homolog (yeast)
hsa:64108;RTP4,IFRG28;receptor (chemosensory) transporter protein 4
hsa:56650;CLDND1,C3orf4,GENX-3745;claudin domain containing 1
hsa:54465;ETAA1,ETAA16;Ewing tumor-associated antigen 1
hsa:57415;C3orf14;chromosome 3 open reading frame 14
hsa:64129;TINAGL1,ARG1,LCN7,LIECG3,TINAGRP;tubulointerstitial nephritis antigen-like 1
hsa:51065;RPS27L;ribosomal protein S27-like
hsa:51290;ERGIC2,Erv41,PTX1,cd002;ERGIC and golgi 2
hsa:54967;CXorf48,BJHCC20A,CT55;chromosome X open reading frame 48
hsa:51442;VGLL1,TDU,VGL1;vestigial like 1 (Drosophila)
hsa:29889;GNL2,HUMAUANTIG,NGP1,Ngp-1;guanine nucleotide binding protein-like 2 (nucleolar)
hsa:64232;MS4A5,CD20-L2,CD20L2,TETM4;membrane-spanning 4-domains, subfamily A, member 5
hsa:54020;SLC37A1,G3PP;solute carrier family 37 (glycerol-3-phosphate transporter), member 1
hsa:54676;GTPBP2;GTP binding protein 2
hsa:54762;GRAMD1C;GRAM domain containing 1C
hsa:65265;C8orf33;chromosome 8 open reading frame 33
hsa:60343;FAM3A,2.19,DLD,DXS560S,XAP-7;family with sequence similarity 3, member A
hsa:54957;TXNL4B,DLP,Dim2;thioredoxin-like 4B
hsa:64518;TEKT3;tektin 3
hsa:54619;CCNJ,bA690P14.1;cyclin J
hsa:55702;CCDC94;coiled-coil domain containing 94
hsa:64063;PRSS22,BSSP-4,hBSSP-4;protease, serine, 22
hsa:57466;SCAF4,SFRS15,SRA4;SR-related CTD-associated factor 4
hsa:55090;MED9,MED25;mediator complex subunit 9
hsa:57611;ISLR2,LINX;immunoglobulin superfamily containing leucine-rich repeat 2
hsa:64425;POLR1E,PAF53,PRAF1,RP11-405L18.3;polymerase (RNA) I polypeptide E, 53kDa
hsa:55640;FLVCR2,C14orf58,CCT,EPV,FLVCRL14q,MFSD7C,PVHH;feline leukemia virus subgroup C cellular receptor family, member 2
hsa:51316;PLAC8,C15,onzin;placenta-specific 8
hsa:51307;FAM53C,C5orf6;family with sequence similarity 53, member C
hsa:58526;MID1IP1,G12-like,MIG12,S14R,STRAIT11499,THRSPL;MID1 interacting protein 1
hsa:64743;WDR13,MG21;WD repeat domain 13
hsa:57092;PCNP;PEST proteolytic signal containing nuclear protein
hsa:29915;HCFC2,HCF-2,HCF2;host cell factor C2
hsa:30815;ST6GALNAC6,RP11-203J24.3,SIAT7F,ST6GALNACVI;ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6
hsa:60494;CCDC81;coiled-coil domain containing 81
hsa:60677;CELF6,BRUNOL6;CUGBP, Elav-like family member 6
hsa:51611;DPH5,CGI-30,HSPC143,NPD015;DPH5 homolog (S. cerevisiae) (EC:2.1.1.98)
hsa:63901;FAM111A;family with sequence similarity 111, member A
hsa:65991;FUNDC2,DC44,HCBP6,HCC3,PD03104;FUN14 domain containing 2
hsa:60686;C14orf93;chromosome 14 open reading frame 93
hsa:54866;PPP1R14D,CPI17-like,GBPI-1,GBPI1;protein phosphatase 1, regulatory (inhibitor) subunit 14D
hsa:51463;GPR89B,GPHR,GPR89,SH120;G protein-coupled receptor 89B
hsa:64319;FBRS,FBS,FBS1;fibrosin
hsa:51666;ASB4,ASB-4;ankyrin repeat and SOCS box containing 4
hsa:55633;TBC1D22B,C6orf197,RP4-744I24.2,dJ744I24.2;TBC1 domain family, member 22B
hsa:64417;C5orf28;chromosome 5 open reading frame 28
hsa:54490;UGT2B28;UDP glucuronosyltransferase 2 family, polypeptide B28 (EC:2.4.1.17)
hsa:56548;CHST7,C6ST-2;carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 (EC:2.8.2.17)
hsa:51661;FKBP7,FKBP23,PPIase;FK506 binding protein 7 (EC:5.2.1.8)
hsa:221584;ZSCAN12P1,ZNF187p1,ZNF305P1,ZNF96L1,ZNF96P1,ZSCAN12L1,dJ313I6.7;zinc finger and SCAN domain containing 12 pseudogene 1
hsa:79940;LINC00472,C6orf155,dJ288M22.3;long intergenic non-protein coding RNA 472
hsa:93082;NEURL3,LINCR;neuralized homolog 3 (Drosophila) pseudogene
hsa:81563;C1orf21,PIG13;chromosome 1 open reading frame 21
hsa:83992;CTTNBP2,C7orf8,CORTBP2,Orf4;cortactin binding protein 2
hsa:81796;SLCO5A1,OATP-J,OATP-RP4,OATP5A1,OATPRP4,SLC21A15;solute carrier organic anion transporter family, member 5A1
hsa:92359;CRB3;crumbs homolog 3 (Drosophila)
hsa:90634;N4BP2L1,CG018;NEDD4 binding protein 2-like 1
hsa:91860;CALML4,NY-BR-20;calmodulin-like 4
hsa:84809;CROCCP2,CROCCL1;ciliary rootlet coiled-coil, rootletin pseudogene 2
hsa:84950;PRPF38A,Prp38,RP5-965L7.1;PRP38 pre-mRNA processing factor 38 (yeast) domain containing A
hsa:79629;OCEL1,FWP009,S863-9;occludin/ELL domain containing 1
hsa:79838;TMC5;transmembrane channel-like 5
hsa:79998;ANKRD53;ankyrin repeat domain 53
hsa:89796;NAV1,POMFIL3,STEERIN1,UNC53H1;neuron navigator 1
hsa:79095;C9orf16;chromosome 9 open reading frame 16
hsa:84946;LTV1,C6orf93,dJ468K18.4;LTV1 homolog (S. cerevisiae)
hsa:84179;MFSD7;major facilitator superfamily domain containing 7
hsa:84852;ATP1A1OS,C1orf203;ATP1A1 opposite strand
hsa:83442;SH3BGRL3,SH3BP-1,TIP-B1;SH3 domain binding glutamic acid-rich protein like 3
hsa:83861;RSPH3,RSHL2,RSP3,dJ111C20.1;radial spoke 3 homolog (Chlamydomonas)
hsa:84771;DDX11L2;DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 like 2
hsa:390561;HERC2P10;hect domain and RLD 2 pseudogene 10
hsa:83868;TTTY13,NCRNA00136,TTY13;testis-specific transcript, Y-linked 13 (non-protein coding)
hsa:84645;C22orf23,EVG1,dJ1039K5.6;chromosome 22 open reading frame 23
hsa:84222;TMEM191A,TMEM191AP;transmembrane protein 191A (pseudogene)
hsa:85352;;KIAA1644
hsa:80823;BHLHB9,p60TRP;basic helix-loop-helix domain containing, class B, 9
hsa:84131;CEP78,C9orf81,IP63;centrosomal protein 78kDa
hsa:79847;TMEM180,C10orf77,bA18I14.8;transmembrane protein 180
hsa:83863;TTTY5,LINC00126,NCRNA00126,TTY5;testis-specific transcript, Y-linked 5 (non-protein coding)
hsa:91319;DERL3,C22orf14,IZP6,LLN2,derlin-3;derlin 3
hsa:79919;C2orf54;chromosome 2 open reading frame 54
hsa:92856;IMP4,BXDC4;IMP4, U3 small nucleolar ribonucleoprotein, homolog (yeast)
hsa:79922;MRM1;mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae)
hsa:91695;RRP7B,dJ222E13.2;ribosomal RNA processing 7 homolog B (S. cerevisiae)
hsa:79863;RBFA,C18orf22,HsT169;ribosome binding factor A (putative)
hsa:84435;GPR123;G protein-coupled receptor 123
hsa:112936;VPS26B,Pep8b;vacuolar protein sorting 26 homolog B (S. pombe)
hsa:113091;PTH2,TIP39;parathyroid hormone 2
hsa:79867;TCTN2,C12orf38,MKS8,TECT2;tectonic family member 2
hsa:84440;RAB11FIP4,RAB11-FIP4;RAB11 family interacting protein 4 (class II)
hsa:79906;MORN1;MORN repeat containing 1
hsa:84069;PLEKHN1,RP11-54O7.7;pleckstrin homology domain containing, family N member 1
hsa:79144;PPDPF,C20orf149,dJ697K14.9,exdpf;pancreatic progenitor cell differentiation and proliferation factor homolog (zebrafish)
hsa:84216;TMEM117;transmembrane protein 117
hsa:84193;SETD3,C14orf154;SET domain containing 3 (EC:2.1.1.43)
hsa:84970;C1orf94;chromosome 1 open reading frame 94
hsa:84247;LDOC1L,Mar6,Mart6,dJ1033E15.2;leucine zipper, down-regulated in cancer 1-like
hsa:79089;TMUB2;transmembrane and ubiquitin-like domain containing 2
hsa:94005;PIGS;phosphatidylinositol glycan anchor biosynthesis, class S
hsa:85481;PSKH2;protein serine kinase H2 (EC:2.7.11.1)
hsa:81577;GFOD2;glucose-fructose oxidoreductase domain containing 2
hsa:80740;LY6G6C,C6orf24,G6c,NG24;lymphocyte antigen 6 complex, locus G6C
hsa:84912;SLC35B4,YEA,YEA4;solute carrier family 35, member B4
hsa:85329;LGALS12,GAL12,GRIP1;lectin, galactoside-binding, soluble, 12
hsa:93643;TJAP1,PILT,TJP4;tight junction associated protein 1 (peripheral)
hsa:79413;ZBED2;zinc finger, BED-type containing 2
hsa:84296;GINS4,SLD5;GINS complex subunit 4 (Sld5 homolog)
hsa:84620;ST6GAL2,SIAT2,ST6GalII;ST6 beta-galactosamide alpha-2,6-sialyltranferase 2 (EC:2.4.99.1)
hsa:85395;FAM207A,C21orf70;family with sequence similarity 207, member A
hsa:83931;STK40,RP11-268J15.4,SHIK,SgK495;serine/threonine kinase 40 (EC:2.7.11.1)
hsa:92482;BBIP1,BBIP10,NCRNA00081,bA348N5.3;BBSome interacting protein 1
hsa:81533;ITFG1,TIP;integrin alpha FG-GAP repeat containing 1
hsa:83690;CRISPLD1,CRISP10,LCRISP1;cysteine-rich secretory protein LCCL domain containing 1
hsa:83890;SPATA9,NYD-SP16;spermatogenesis associated 9
hsa:85025;TMEM60,C7orf35;transmembrane protein 60
hsa:80013;FAM188A,C10orf97,CARP,DERP5,MST126,RP11-394I23.1,my042;family with sequence similarity 188, member A
hsa:112597;LINC00152,C2orf59,NCRNA00152;long intergenic non-protein coding RNA 152
hsa:92249;;uncharacterized LOC92249
hsa:79169;C1orf35,MMTAG2,hMMTAG2;chromosome 1 open reading frame 35
hsa:92129;RIPPLY1;ripply1 homolog (zebrafish)
hsa:84640;USP38,HP43.8KD;ubiquitin specific peptidase 38 (EC:3.4.19.12)
hsa:83941;TM2D1,BBP;TM2 domain containing 1
hsa:79639;TMEM53,NET4;transmembrane protein 53
hsa:90326;THAP3;THAP domain containing, apoptosis associated protein 3
hsa:80011;FAM192A,C16orf94,CDA018,NIP30;family with sequence similarity 192, member A
hsa:90864;SPSB3,C16orf31,SSB3;splA/ryanodine receptor domain and SOCS box containing 3
hsa:84656;GLYR1,BM045,HIBDL,N-PAC,NP60;glyoxylate reductase 1 homolog (Arabidopsis)
hsa:79136;LY6G6E,C6orf22,G6e;lymphocyte antigen 6 complex, locus G6E (pseudogene)
hsa:85014;TMEM141,RP11-216L13.7;transmembrane protein 141
hsa:79007;DBNDD1;dysbindin (dystrobrevin binding protein 1) domain containing 1
hsa:91893;FDXACB1;ferredoxin-fold anticodon binding domain containing 1
hsa:84536;C21orf67,C21orf69,PRED54;chromosome 21 open reading frame 67
hsa:84176;MYH16,MHC20,MYH16P,MYH5;myosin, heavy chain 16 pseudogene
hsa:79946;C10orf95;chromosome 10 open reading frame 95
hsa:79315;OR7E91P;olfactory receptor, family 7, subfamily E, member 91 pseudogene
hsa:84844;PHF5A,INI,Rds3,SAP14b,SF3b14b,bK223H9.2;PHD finger protein 5A
hsa:84219;WDR24,C16orf21,JFP7;WD repeat domain 24
hsa:91419;XRCC6BP1,KUB3;XRCC6 binding protein 1 (EC:3.4.24.-)
hsa:93429;DKFZp434J0226;uncharacterized LOC93429
hsa:84272;YIPF4,FinGER4;Yip1 domain family, member 4
hsa:83594;NUDT12;nudix (nucleoside diphosphate linked moiety X)-type motif 12 (EC:3.6.1.22)
hsa:84848;;uncharacterized protein MGC16121
hsa:79622;SNRNP25,C16orf33;small nuclear ribonucleoprotein 25kDa (U11/U12)
hsa:84502;JPH4,JP4,JPHL1;junctophilin 4
hsa:85360;SYDE1,7h3;synapse defective 1, Rho GTPase, homolog 1 (C. elegans)
hsa:83889;WDR87,NYD-SP11;WD repeat domain 87
hsa:83604;TMEM47,BCMP1,TM4SF10;transmembrane protein 47
hsa:79665;DHX40,DDX40,PAD;DEAH (Asp-Glu-Ala-His) box polypeptide 40 (EC:3.6.4.13)
hsa:84561;SLC12A8,CCC9;solute carrier family 12 (potassium/chloride transporters), member 8
hsa:84326;C16orf13;chromosome 16 open reading frame 13
hsa:80739;C6orf25,G6b,NG31;chromosome 6 open reading frame 25
hsa:80231;CXorf21;chromosome X open reading frame 21
hsa:84279;PRADC1,C2orf7,PAP21;protease-associated domain containing 1
hsa:81554;WBSCR16;Williams-Beuren syndrome chromosome region 16
hsa:90011;KIR3DX1,KIR3DL0,LENG12;killer cell immunoglobulin-like receptor, three domains, X1
hsa:79627;OGFRL1,dJ331H24.1;opioid growth factor receptor-like 1
hsa:84648;LCE3D,LEP16,SPRL6A,SPRL6B;late cornified envelope 3D
hsa:85569;GALP;galanin-like peptide
hsa:84677;DSCR8,C21orf65,CT25.1a,CT25.1b,MMA-1,MMA-1a,MMA-1b,MMA1,MTAG2;Down syndrome critical region gene 8
hsa:83544;DNAL1,C14orf168,CILD16;dynein, axonemal, light chain 1
hsa:84923;FAM104A;family with sequence similarity 104, member A
hsa:93109;TMEM44;transmembrane protein 44
hsa:79611;ACSS3;acyl-CoA synthetase short-chain family member 3 (EC:6.2.1.1)
hsa:92369;SPSB4,SSB-4,SSB4;splA/ryanodine receptor domain and SOCS box containing 4
hsa:83982;IFI27L2,FAM14A,ISG12B,TLH29;interferon, alpha-inducible protein 27-like 2
hsa:79745;CLIP4,RSNL2;CAP-GLY domain containing linker protein family, member 4
hsa:91948;;uncharacterized LOC91948
hsa:94236;DNAJA1P5,HEJ1;DnaJ (Hsp40) homolog, subfamily A, member 1 pseudogene 5
hsa:84301;DDI2,RP4-680D5.5;DNA-damage inducible 1 homolog 2 (S. cerevisiae)
hsa:90141;EFCAB11,C14orf143;EF-hand calcium binding domain 11
hsa:79173;C19orf57;chromosome 19 open reading frame 57
hsa:80023;NRSN2,C20orf98,dJ1103G7.6;neurensin 2
hsa:112840;WDR89,C14orf150;WD repeat domain 89
hsa:90231;;KIAA2013
hsa:79176;FBXL15,FBXO37,Fbl15,JET,PSD;F-box and leucine-rich repeat protein 15
hsa:93432;;maltase-glucoamylase (alpha-glucosidase) pseudogene
hsa:81615;TMEM163,DC29,SV31;transmembrane protein 163
hsa:79019;CENPM,C22orf18,CENP-M,PANE1,bK250D10.2;centromere protein M
hsa:83450;LRRC48;leucine rich repeat containing 48
hsa:84249;PSD2;pleckstrin and Sec7 domain containing 2
hsa:80008;TMEM156;transmembrane protein 156
hsa:84960;PARF,RP11-216L13.9,bA216L13.7;KIAA1984
hsa:113157;RPLP0P2,RPLP0L2,RPLP0_3_1146;ribosomal protein, large, P0 pseudogene 2
hsa:84316;LSMD1,PFAAP2;LSM domain containing 1
hsa:84672;TTTY6,LINC00127,NCRNA00127,TTTY6A,TTY6;testis-specific transcript, Y-linked 6 (non-protein coding)
hsa:84910;TMEM87B;transmembrane protein 87B
hsa:93436;ARMC6,R30923_1;armadillo repeat containing 6
hsa:80237;ELL3;elongation factor RNA polymerase II-like 3
hsa:89944;GLB1L2,MST114,MSTP114;galactosidase, beta 1-like 2 (EC:3.2.1.23)
hsa:79979;TRMT2B,CXorf34,dJ341D10.3;tRNA methyltransferase 2 homolog B (S. cerevisiae) (EC:2.1.1.35)
hsa:90025;UBE3D,C6orf157,H10BH,UBE2CBP,YJR141W;ubiquitin protein ligase E3D (EC:6.3.2.-)
hsa:83862;TMEM120A,NET29,TMPIT;transmembrane protein 120A
hsa:93622;;Morf4 family associated protein 1-like 1 pseudogene
hsa:90378;SAMD1;sterile alpha motif domain containing 1
hsa:90499;FAM95A;uncharacterized LOC90499
hsa:81629;TSSK3,SPOGA3,STK22C,STK22D,TSK3;testis-specific serine kinase 3 (EC:2.7.11.1)
hsa:80022;MYO15B,MYO15BP;myosin XVB pseudogene
hsa:89846;FGD3,ZFYVE5;FYVE, RhoGEF and PH domain containing 3
hsa:84807;NFKBID,IkappaBNS,TA-NFKBH;nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta
hsa:89927;C16orf45;chromosome 16 open reading frame 45
hsa:90809;TMEM55B,C14orf9;transmembrane protein 55B (EC:3.1.3.78)
hsa:90580;C19orf52;chromosome 19 open reading frame 52
hsa:113452;TMEM54,BCLP,CAC-1,CAC1;transmembrane protein 54
hsa:90407;TMEM41A,2900010K02Rik;transmembrane protein 41A
hsa:83877;TM2D2,BLP1;TM2 domain containing 2
hsa:90379;DCAF15,C19orf72;DDB1 and CUL4 associated factor 15
hsa:84981;MIR22HG,C17orf91;MIR22 host gene (non-protein coding)
hsa:79104;MEG8,Bsr,Irm,LINC00024,NCRNA00024,Rian;maternally expressed 8 (non-protein coding)
hsa:83734;ATG10,APG10,APG10L,pp12616;autophagy related 10
hsa:85016;C11orf70;chromosome 11 open reading frame 70
hsa:80789;INTS5,INT5,KIAA1698;integrator complex subunit 5
hsa:80020;FOXRED2,ERFAD;FAD-dependent oxidoreductase domain containing 2
hsa:113178;SCAMP4,SCAMP-4;secretory carrier membrane protein 4
hsa:84552;PARD6G,PAR-6G,PAR6gamma;par-6 partitioning defective 6 homolog gamma (C. elegans)
hsa:81031;SLC2A10,ATS,GLUT10;solute carrier family 2 (facilitated glucose transporter), member 10
hsa:79637;ARMC7;armadillo repeat containing 7
hsa:79025;C20orf195;chromosome 20 open reading frame 195
hsa:79800;ALS2CR8,CARF,NYD-SP24;amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8
hsa:83608;C18orf21,HsT3108,PNAS-131,XTP13;chromosome 18 open reading frame 21
hsa:84836;ABHD14B,CIB;abhydrolase domain containing 14B (EC:3.-.-.-)
hsa:79839;CCDC102B,ACY1L,AN,C18orf14,HsT1731;coiled-coil domain containing 102B
hsa:79804;DEIN;Nbla00301
hsa:79846;C7orf63;chromosome 7 open reading frame 63
hsa:84074;QRICH2;glutamine rich 2
hsa:90506;LRRC46;leucine rich repeat containing 46
hsa:85865;GTPBP10,ObgH2;GTP-binding protein 10 (putative)
hsa:84899;TMTC4;transmembrane and tetratricopeptide repeat containing 4
hsa:90843;TCEAL8;transcription elongation factor A (SII)-like 8
hsa:83849;SYT15,CHR10SYT,sytXV;synaptotagmin XV
hsa:91614;DEPDC7,TR2,dJ85M6.4;DEP domain containing 7
hsa:83866;TTTY11,NCRNA00134,TTY11;testis-specific transcript, Y-linked 11 (non-protein coding)
hsa:84057;MND1,GAJ;meiotic nuclear divisions 1 homolog (S. cerevisiae)
hsa:79411;GLB1L;galactosidase, beta 1-like
hsa:96610;;BMS1 homolog, ribosome assembly protein (yeast) pseudogene
hsa:83989;FAM172A,C5orf21;family with sequence similarity 172, member A
hsa:79573;TTC13;tetratricopeptide repeat domain 13
hsa:79794;C12orf49;chromosome 12 open reading frame 49
hsa:91050;CCDC149;coiled-coil domain containing 149
hsa:80318;GKAP1,GKAP42;G kinase anchoring protein 1
hsa:84973;SNHG7,NCRNA00061;small nucleolar RNA host gene 7 (non-protein coding)
hsa:84791;LINC00467,C1orf97,RP11-318L16.3;long intergenic non-protein coding RNA 467
hsa:89777;SERPINB12,YUKOPIN;serpin peptidase inhibitor, clade B (ovalbumin), member 12
hsa:84895;FAM73B,C9orf54;family with sequence similarity 73, member B
hsa:79600;TCTN1,JBTS13,TECT1;tectonic family member 1
hsa:80349;WDR61,REC14,SKI8;WD repeat domain 61
hsa:93034;NT5C1B,AIRP,CN-IB,CN1B;5'-nucleotidase, cytosolic IB (EC:3.1.3.5)
hsa:89882;TPD52L3,NYDSP25,hD55;tumor protein D52-like 3
hsa:84518;CNFN,PLAC8L2;cornifelin
hsa:84504;NKX6-2,GTX,NKX6.2,NKX6B;NK6 homeobox 2
hsa:90416;C15orf57,CCDC32;chromosome 15 open reading frame 57
hsa:79037;PVRIG,C7orf15;poliovirus receptor related immunoglobulin domain containing
hsa:79571;GCC1,GCC1P,GCC88;GRIP and coiled-coil domain containing 1
hsa:94015;TTYH2,C17orf29;tweety homolog 2 (Drosophila)
hsa:81558;FAM117A;family with sequence similarity 117, member A
hsa:79022;TMEM106C;transmembrane protein 106C
hsa:83876;MRO,B29,C18orf3;maestro
hsa:79607;FAM118B;family with sequence similarity 118, member B
hsa:79852;EPHX3,ABHD9;epoxide hydrolase 3
hsa:80173;IFT74,CCDC2,CMG-1,CMG1;intraflagellar transport 74 homolog (Chlamydomonas)
hsa:84986;ARHGAP19;Rho GTPase activating protein 19
hsa:85371;;KIAA1656 protein
hsa:84288;EFCAB2;EF-hand calcium binding domain 2
hsa:92691;TMEM169;transmembrane protein 169
hsa:79815;NIPAL2,NPAL2;NIPA-like domain containing 2
hsa:79077;DCTPP1,RS21C6,XTP3TPA;dCTP pyrophosphatase 1 (EC:3.6.1.12)
hsa:112703;FAM71E1;family with sequence similarity 71, member E1
hsa:94150;CDRT7,LINC00025,NCRNA00025;CMT1A duplicated region transcript 7 (non-protein coding)
hsa:90693;CCDC126;coiled-coil domain containing 126
hsa:89765;RSPH1,RSP44,RSPH10A,TSA2,TSGA2;radial spoke head 1 homolog (Chlamydomonas)
hsa:79760;GEMIN7,SIP3;gem (nuclear organelle) associated protein 7
hsa:83638;C11orf68,BLES03,P5326;chromosome 11 open reading frame 68
hsa:79064;TMEM223;transmembrane protein 223
hsa:80154;AGSK1;golgin subfamily A member 2-like
hsa:85028;SNHG12,C1orf79,LINC00100,NCRNA00100,RP4-669K10.5;small nucleolar RNA host gene 12 (non-protein coding)
hsa:79098;C1orf116,SARG;chromosome 1 open reading frame 116
hsa:79716;NPEPL1,bA261P9.2;aminopeptidase-like 1
hsa:84164;ASCC2,ASC1p100,p100;activating signal cointegrator 1 complex subunit 2
hsa:83655;LINC00208,C8orf14,NCRNA00208,VIR35;long intergenic non-protein coding RNA 208
hsa:113691;TUBA3FP;tubulin, alpha 3f, pseudogene
hsa:84064;HDHD2,3110052N05Rik;haloacid dehalogenase-like hydrolase domain containing 2
hsa:84717;HDGFRP2,HDGF2;hepatoma-derived growth factor-related protein 2
hsa:79956;ERMP1,FXNA,KIAA1815,bA207C16.3;endoplasmic reticulum metallopeptidase 1
hsa:79033;ERI3,PINT1,PRNPIP;ERI1 exoribonuclease family member 3
hsa:91433;RCCD1;RCC1 domain containing 1
hsa:85013;TMEM128;transmembrane protein 128
hsa:78994;PRR14;proline rich 14
hsa:83719;YPEL3;yippee-like 3 (Drosophila)
hsa:81691;exonuclease NEF-sp
hsa:83878;USHBP1,AIEBP,MCC2;Usher syndrome 1C binding protein 1
hsa:80255;SLC35F5;solute carrier family 35, member F5
hsa:80262;C16orf70,C16orf6,LIN10,lin-10;chromosome 16 open reading frame 70
hsa:90355;C5orf30;chromosome 5 open reading frame 30
hsa:90768;MGC45800;uncharacterized LOC90768
hsa:92714;ARRDC1;arrestin domain containing 1
hsa:80313;LRRC27;leucine rich repeat containing 27
hsa:89894;TMEM116;transmembrane protein 116
hsa:81849;ST6GALNAC5,SIAT7E,ST6GalNAcV;ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5
hsa:83787;ARMC10,PNAS-112,PNAS112,SVH;armadillo repeat containing 10
hsa:84366;PRAC,C17orf92;prostate cancer susceptibility candidate
hsa:84886;C1orf198;chromosome 1 open reading frame 198
hsa:89849;ATG16L2,ATG16B,WDR80;autophagy related 16-like 2 (S. cerevisiae)
hsa:79785;RERGL;RERG/RAS-like
hsa:112714;TUBA3E;tubulin, alpha 3e
hsa:81833;SPACA1,SAMP32;sperm acrosome associated 1
hsa:81551;STMN4,RB3;stathmin-like 4
hsa:93010;B3GNT7,beta3GnT7;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7
hsa:81853;TMEM14B;transmembrane protein 14B
hsa:113402;SFT2D1,C6orf83,pRGR1;SFT2 domain containing 1
hsa:90007;MIDN;midnolin
hsa:91300;R3HDM4,C19orf22;R3H domain containing 4
hsa:79097;TRIM48,RNF101;tripartite motif containing 48
hsa:83795;KCNK16,K2p16.1,TALK-1,TALK1;potassium channel, subfamily K, member 16
hsa:84548;TMEM185A,CXorf13,FAM11A,FRAXF;transmembrane protein 185A
hsa:80124;VCPIP1,DUBA3,VCIP135;valosin containing protein (p97)/p47 complex interacting protein 1
hsa:79696;ZC2HC1C,C14orf140,FAM164C;zinc finger, C2HC-type containing 1C
hsa:91977;MYOZ3,CS-3,CS3,FRP3;myozenin 3
hsa:78996;C7orf49,MRI;chromosome 7 open reading frame 49
hsa:81543;LRRC3,C21orf102;leucine rich repeat containing 3
hsa:79986;ZNF702P,ZNF702;zinc finger protein 702, pseudogene
hsa:90557;CCDC74A;coiled-coil domain containing 74A
hsa:79667;;uncharacterized FLJ13197
hsa:85474;LBX2;ladybird homeobox 2
hsa:84318;CCDC77;coiled-coil domain containing 77
hsa:84163;GTF2IRD2,FP630,GTF2IRD2A;GTF2I repeat domain containing 2
hsa:121506;ERP27,C12orf46,PDIA8;endoplasmic reticulum protein 27
hsa:80301;PLEKHO2,PLEKHQ1,PP1628,pp9099;pleckstrin homology domain containing, family O member 2
hsa:139324;HDX,CXorf43,D030011N01Rik;highly divergent homeobox
hsa:150771;ITPRIPL1,KIAA1754L;inositol 1,4,5-trisphosphate receptor interacting protein-like 1
hsa:122553;TRAPPC6B,TPC6;trafficking protein particle complex 6B
hsa:91687;CENPL,C1orf155,CENP-L,RP3-383J4.1,dJ383J4.3;centromere protein L
hsa:138199;C9orf41;chromosome 9 open reading frame 41
hsa:146212;KCTD19;potassium channel tetramerisation domain containing 19
hsa:200172;SLFNL1;schlafen-like 1
hsa:161635;CSNK1A1P1,CSNK1A1P;casein kinase 1, alpha 1 pseudogene 1
hsa:144699;FBXL14,Fbl14;F-box and leucine-rich repeat protein 14
hsa:124751;KRBA2;KRAB-A domain containing 2
hsa:165530;CLEC4F,CLECSF13,KCLR;C-type lectin domain family 4, member F
hsa:130574;LYPD6;LY6/PLAUR domain containing 6
hsa:116362;RBP7,CRBP4,CRBPIV;retinol binding protein 7, cellular
hsa:129303;TMEM150A,TM6P1,TMEM150;transmembrane protein 150A
hsa:150000;ABCC13,C21orf73,PRED6;ATP-binding cassette, sub-family C (CFTR/MRP), member 13, pseudogene
hsa:147093;;uncharacterized LOC147093
hsa:130814;PQLC3,C2orf22;PQ loop repeat containing 3
hsa:84230;LRRC8C,AD158,FAD158;leucine rich repeat containing 8 family, member C
hsa:114569;MAL2;mal, T-cell differentiation protein 2 (gene/pseudogene)
hsa:154089;;uncharacterized protein MGC34034
hsa:79763;ISOC2;isochorismatase domain containing 2
hsa:127602;DNAH14,C1orf67,Dnahc14,HL-18,HL18;dynein, axonemal, heavy chain 14
hsa:132203;SNTN,S100A1L,S100AL,sentan;sentan, cilia apical structure protein
hsa:148145;;uncharacterized LOC148145
hsa:147179;WIPF2,WICH,WIRE;WAS/WASL interacting protein family, member 2
hsa:146439;CCDC64B,BICDR-2;coiled-coil domain containing 64B
hsa:118924;FRA10AC1,C10orf4,F26C11.1-like,FRA10A;fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1
hsa:146378;C16orf92;chromosome 16 open reading frame 92
hsa:130813;C2orf50;chromosome 2 open reading frame 50
hsa:148753;FAM163A,C1orf76,NDSP,RP11-12M5.2;family with sequence similarity 163, member A
hsa:158381;ATP8B5P,FetA;ATPase, class I, type 8B, member 5, pseudogene
hsa:170958;ZNF525;zinc finger protein 525
hsa:133619;PRRC1;proline-rich coiled-coil 1
hsa:202915;TMEM184A;transmembrane protein 184A
hsa:170626;XAGE3,CT12.3a,CT12.3b,GAGED4,PLAC6,XAGE-3,pp9012;X antigen family, member 3
hsa:120103;SLC36A4,PAT4;solute carrier family 36 (proton/amino acid symporter), member 4
hsa:125488;TTC39C,C18orf17,HsT2697;tetratricopeptide repeat domain 39C
hsa:84167;C19orf44;chromosome 19 open reading frame 44
hsa:84324;SARNP,CIP29,HCC1,HSPC316,THO1;SAP domain containing ribonucleoprotein
hsa:116211;TM4SF19;transmembrane 4 L six family member 19
hsa:122416;ANKRD9;ankyrin repeat domain 9
hsa:154215;NKAIN2,FAM77B,NKAIP2,TCBA,TCBA1;Na+/K+ transporting ATPase interacting 2
hsa:119032;C10orf32,RP11-753C18.6;chromosome 10 open reading frame 32
hsa:128346;C1orf162;chromosome 1 open reading frame 162
hsa:154197;PNLDC1;poly(A)-specific ribonuclease (PARN)-like domain containing 1
hsa:199786;FAM129C,BCNP1;family with sequence similarity 129, member C
hsa:128497;SPATA25,C20orf165,TSG23,dJ337O18.8;spermatogenesis associated 25
hsa:91316;GUSBP11;glucuronidase, beta pseudogene 11
hsa:90806;ANGEL2,KIAA0759L;angel homolog 2 (Drosophila)
hsa:197196;LINC00311,NCRNA00311,TMEM148;long intergenic non-protein coding RNA 311
hsa:80055;PGAP1,Bst1,ISPD3024;post-GPI attachment to proteins 1
hsa:200634;KRTCAP3,KCP3,MRV222,PRO9898;keratinocyte associated protein 3
hsa:140881;DEFB129,C20orf87,DEFB-29,DEFB29,bA530N10.3,hBD-29;defensin, beta 129
hsa:84808;C1orf170,RP11-54O7.8;chromosome 1 open reading frame 170
hsa:149708;WFDC5,PRG5,WAP1,dJ211D12.5;WAP four-disulfide core domain 5
hsa:126789;PUSL1;pseudouridylate synthase-like 1
hsa:83867;TTTY12,NCRNA00135,TTY11,TTY12;testis-specific transcript, Y-linked 12 (non-protein coding)
hsa:114036;LINC00310,C21orf82,NCRNA00310;long intergenic non-protein coding RNA 310
hsa:140836;BANF2,BAF-L,BAF2,BAFL,C20orf179;barrier to autointegration factor 2
hsa:129446;XIRP2,CMYA3;xin actin-binding repeat containing 2
hsa:84100;ARL6,BBS3,RP55;ADP-ribosylation factor-like 6
hsa:91464;ISX,Pix-1,RAXLX;intestine-specific homeobox
hsa:83692;CD99L2,CD99B,MIC2L1;CD99 molecule-like 2
hsa:89839;ARHGAP11B,B'-T,FAM7B1;Rho GTPase activating protein 11B
hsa:199899;LINC00466;long intergenic non-protein coding RNA 466
hsa:200933;FBXO45,Fbx45;F-box protein 45
hsa:170393;C10orf91,RP11-432J24.4,bA432J24.4;chromosome 10 open reading frame 91
hsa:155051;CRYGN;crystallin, gamma N
hsa:145942;TMCO5A,TMCO5;transmembrane and coiled-coil domains 5A
hsa:123775;C16orf46;chromosome 16 open reading frame 46
hsa:146849;CCDC42,CCDC42A;coiled-coil domain containing 42
hsa:128977;C22orf39;chromosome 22 open reading frame 39
hsa:144110;TMEM86A;transmembrane protein 86A
hsa:134549;SHROOM1,APXL2;shroom family member 1
hsa:147947;ZNF542;zinc finger protein 542
hsa:114785;MBD6;methyl-CpG binding domain protein 6
hsa:158763;ARHGAP36;Rho GTPase activating protein 36
hsa:196913;C14orf183;chromosome 14 open reading frame 183
hsa:123036;TC2N,C14orf47,C2CD1,MTAC2D1,Tac2-N;tandem C2 domains, nuclear
hsa:127687;C1orf122,ALAESM;chromosome 1 open reading frame 122
hsa:201780;SLC10A4,P4;solute carrier family 10 (sodium/bile acid cotransporter family), member 4
hsa:144402;CPNE8;copine VIII
hsa:157627;LINC00599,Rncr3;long intergenic non-protein coding RNA 599
hsa:138162;C9orf116,PIERCE1,RbEST47;chromosome 9 open reading frame 116
hsa:158248;TTC16;tetratricopeptide repeat domain 16
hsa:138724;C9orf131;chromosome 9 open reading frame 131
hsa:116437;;uncharacterized LOC116437
hsa:196475;RMST,LINC00054,NCRMS,NCRNA00054;rhabdomyosarcoma 2 associated transcript (non-protein coding)
hsa:147968;CAPN12;calpain 12
hsa:145389;SLC38A6,NAT-1;solute carrier family 38, member 6
hsa:129642;MBOAT2,LPCAT4,OACT2;membrane bound O-acyltransferase domain containing 2 (EC:2.3.1.51 2.3.1.n7)
hsa:128853;DUSP15,VHY;dual specificity phosphatase 15 (EC:3.1.3.16 3.1.3.48)
hsa:81688;C6orf62,Nbla00237,XTP12,dJ30M3.2;chromosome 6 open reading frame 62
hsa:115761;ARL11,ARLTS1;ADP-ribosylation factor-like 11
hsa:84189;SLITRK6;SLIT and NTRK-like family, member 6
hsa:80059;LRRTM4;leucine rich repeat transmembrane neuronal 4
hsa:113230;;uncharacterized LOC113230
hsa:116123;FMO9P;flavin containing monooxygenase 9 pseudogene
hsa:150677;OTOS,OTOSP;otospiralin
hsa:162515;SLC16A11,MCT11;solute carrier family 16, member 11 (monocarboxylic acid transporter 11)
hsa:122509;IFI27L1,FAM14B,ISG12C;interferon, alpha-inducible protein 27-like 1
hsa:163778;SPRR4;small proline-rich protein 4
hsa:92400;RBM18;RNA binding motif protein 18
hsa:196968;DNM1P46,C15orf51,DNM1DN14.2,DNM1DN14@;DNM1 pseudogene 46
hsa:132321;C4orf33;chromosome 4 open reading frame 33
hsa:114960;TSGA13;testis specific, 13
hsa:164284;APCDD1L;adenomatosis polyposis coli down-regulated 1-like
hsa:79929;MAP6D1,MAPO6D1,SL21;MAP6 domain containing 1
hsa:158801;NKAPP1,CXorf42;NFKB activating protein pseudogene 1
hsa:201798;TIGD4;tigger transposable element derived 4
hsa:114041;C21orf88;chromosome 21 open reading frame 88
hsa:165055;CCDC138;coiled-coil domain containing 138
hsa:117153;MIA2;melanoma inhibitory activity 2
hsa:205860;TRIML2,SPRYD6;tripartite motif family-like 2
hsa:116068;LYSMD3;LysM, putative peptidoglycan-binding, domain containing 3
hsa:169966;FAM46D,CT1.26,CT112;family with sequence similarity 46, member D
hsa:199720;GGN;gametogenetin
hsa:165082;GPR113,PGR23,hGPCR37;G protein-coupled receptor 113
hsa:124637;CYB5D1;cytochrome b5 domain containing 1
hsa:114825;PWWP2A,MST101;PWWP domain containing 2A
hsa:196792;FAM24B;family with sequence similarity 24, member B
hsa:140686;WFDC3,WAP14,dJ447F3.3;WAP four-disulfide core domain 3
hsa:201456;FBXO15,FBX15;F-box protein 15
hsa:123346;HIGD2B,HIGD2BP;HIG1 hypoxia inducible domain family, member 2B
hsa:151011;SEPT10;septin 10
hsa:170589;GPHA2,A2,GPA2,ZSIG51;glycoprotein hormone alpha 2
hsa:150275;CCDC117,dJ366L4.1;coiled-coil domain containing 117
hsa:146712;B3GNTL1,B3GNT8;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1 (EC:2.4.1.-)
hsa:124222;PAQR4;progestin and adipoQ receptor family member IV
hsa:140870;WFDC6,C20orf171,WAP6,dJ461P17.11;WAP four-disulfide core domain 6
hsa:121457;IKBIP,IKIP;IKBKB interacting protein
hsa:150776;;sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3) pseudogene
hsa:166863;RBM46,CT68;RNA binding motif protein 46
hsa:153218;SPINK13,HBVDNAPTP1,HESPINTOR,LiESP6,SPINK5L3;serine peptidase inhibitor, Kazal type 13 (putative)
hsa:158376;;uncharacterized LOC158376
hsa:150297;C22orf42,dJ90G24.6;chromosome 22 open reading frame 42
hsa:127247;ASB17,Asb-17;ankyrin repeat and SOCS box containing 17
hsa:148109;FAM187B,TMEM162;family with sequence similarity 187, member B
hsa:149373;;uncharacterized LOC149373
hsa:154449;;uncharacterized LOC154449
hsa:201651;;arylacetamide deacetylase (esterase) pseudogene
hsa:79656;BEND5,C1orf165;BEN domain containing 5
hsa:126567;C2CD4C,FAM148C,KIAA1957,NLF3;C2 calcium-dependent domain containing 4C
hsa:201799;TMEM154;transmembrane protein 154
hsa:137994;LETM2;leucine zipper-EF-hand containing transmembrane protein 2
hsa:115399;LRRC56;leucine rich repeat containing 56
hsa:116372;LYPD1,LYPDC1,PHTS;LY6/PLAUR domain containing 1
hsa:134553;C5orf24;chromosome 5 open reading frame 24
hsa:116441;TM4SF18,L6D;transmembrane 4 L six family member 18
hsa:149483;CCDC17;coiled-coil domain containing 17
hsa:170082;TCEANC;transcription elongation factor A (SII) N-terminal and central domain containing
hsa:161394;SAMD15,C14orf174,FAM15A;sterile alpha motif domain containing 15
hsa:115265;DDIT4L,REDD2,Rtp801L;DNA-damage-inducible transcript 4-like
hsa:148203;ZNF738;zinc finger protein 738
hsa:200185;KRTCAP2,KCP2;keratinocyte associated protein 2
hsa:116179;TGM7,TGMZ;transglutaminase 7 (EC:2.3.2.13)
hsa:202151;RANBP3L;RAN binding protein 3-like
hsa:399715;;uncharacterized LOC399715
hsa:201255;LRRC45;leucine rich repeat containing 45
hsa:170371;C10orf128;chromosome 10 open reading frame 128
hsa:114043;C21orf90;chromosome 21 open reading frame 90
hsa:151174;;uncharacterized LOC151174
hsa:117155;CATSPER2;cation channel, sperm associated 2
hsa:140711;TLDC2,C20orf118,dJ132F21.2;TBC/LysM-associated domain containing 2
hsa:145853;C15orf61;chromosome 15 open reading frame 61
hsa:135932;TMEM139;transmembrane protein 139
hsa:203076;C8orf74;chromosome 8 open reading frame 74
hsa:160492;IFLTD1,PAS1C1;intermediate filament tail domain containing 1
hsa:152404;IGSF11,BT-IgSF,CT119,CXADRL1,Igsf13,VSIG3;immunoglobulin superfamily, member 11
hsa:145837;;uncharacterized LOC145837
hsa:155370;SBDSP1,SBDSP;Shwachman-Bodian-Diamond syndrome pseudogene 1
hsa:147184;TMEM99;transmembrane protein 99
hsa:149175;MANEAL,RP11-109P14.3;mannosidase, endo-alpha-like (EC:3.2.1.130)
hsa:79962;DNAJC22,wus;DnaJ (Hsp40) homolog, subfamily C, member 22
hsa:146481;;FSHD region gene 2 family, member C pseudogene
hsa:149047;;uncharacterized MGC27382
hsa:170370;FAM170B,C10orf73;family with sequence similarity 170, member B
hsa:203328;SUSD3;sushi domain containing 3
hsa:150935;;uncharacterized LOC150935
hsa:127003;C1orf194;chromosome 1 open reading frame 194
hsa:129852;C2orf73;chromosome 2 open reading frame 73
hsa:146325;C16orf11;chromosome 16 open reading frame 11
hsa:79883;PODNL1,SLRR5B;podocan-like 1
hsa:130367;SGPP2,SPP2;sphingosine-1-phosphate phosphatase 2
hsa:196472;FAM71C;family with sequence similarity 71, member C
hsa:151171;;uncharacterized LOC151171
hsa:149111;CNIH3,CNIH-3;cornichon homolog 3 (Drosophila)
hsa:150379;PNPLA5,GS2L,dJ388M5,dJ388M5.4;patatin-like phospholipase domain containing 5
hsa:148709;;actin pseudogene
hsa:84058;WDR54;WD repeat domain 54
hsa:136541;PRSS58,PRSS1,TRY1,TRYX3,UNQ2540;protease, serine, 58 (EC:3.4.21.4)
hsa:158062;LCN6,LCN5,UNQ643,hLcn5;lipocalin 6
hsa:159371;SLC35G1,C10orf60,TMEM20;solute carrier family 35, member G1
hsa:144817;LINC00330,NCRNA00330;long intergenic non-protein coding RNA 330
hsa:140700;SAMD10,C20orf136,dJ591C20,dJ591C20.7;sterile alpha motif domain containing 10
hsa:126638;RPTN;repetin
hsa:149473;CCDC24,RP5-1198O20.2;coiled-coil domain containing 24
hsa:132204;SYNPR,SPO;synaptoporin
hsa:92270;ATP6AP1L;ATPase, H+ transporting, lysosomal accessory protein 1-like
hsa:149069;DCDC2B;doublecortin domain containing 2B
hsa:158160;HSD17B7P2,HSD17B7,Hsd17b_2,bA291L22.1;hydroxysteroid (17-beta) dehydrogenase 7 pseudogene 2
hsa:124044;SPATA2L,C16orf76,tamo;spermatogenesis associated 2-like
hsa:124641;OVCA2;ovarian tumor suppressor candidate 2
hsa:145820;;uncharacterized LOC145820
hsa:153918;ZC2HC1B,C6orf94,FAM164B,dJ468K18.5;zinc finger, C2HC-type containing 1B
hsa:196549;EEF1DP3;eukaryotic translation elongation factor 1 delta pseudogene 3
hsa:115825;WDFY2,PROF,RP11-147H23.1,WDF2,ZFYVE22;WD repeat and FYVE domain containing 2
hsa:159013;CXorf38;chromosome X open reading frame 38
hsa:196074;METTL15,METT5D1;methyltransferase like 15 (EC:2.1.1.-)
hsa:152015;ROPN1B;rhophilin associated tail protein 1B
hsa:147166;TRIM16L,TRIM70;tripartite motif containing 16-like
hsa:3347;HTN3,HIS2,HTN2,HTN5;histatin 3
hsa:124801;LSM12,PNAS-135;LSM12 homolog (S. cerevisiae)
hsa:171586;ABHD3,LABH3;abhydrolase domain containing 3
hsa:124491;TMEM170A,TMEM170;transmembrane protein 170A
hsa:79982;DNAJB14,EGNR9427,PRO34683;DnaJ (Hsp40) homolog, subfamily B, member 14
hsa:128826;C20orf166,dJ353C17.1;chromosome 20 open reading frame 166
hsa:148137;C19orf55;chromosome 19 open reading frame 55
hsa:132949;AASDH,ACSF4,LYS2,NRPS1098,NRPS998;aminoadipate-semialdehyde dehydrogenase (EC:6.2.1.-)
hsa:127733;UBXN10,UBXD3;UBX domain protein 10
hsa:196996;GRAMD2;GRAM domain containing 2
hsa:90271;LINC00263,C10orf75,NCRNA00263;long intergenic non-protein coding RNA 263
hsa:118812;MORN4,C10orf83,bA548K23.4;MORN repeat containing 4
hsa:158572;;uncharacterized LOC158572
hsa:89885;FATE1,CT43,FATE;fetal and adult testis expressed 1
hsa:131909;FAM172BP,FAM172B;family with sequence similarity 172, member B pseudogene
hsa:113277;TMEM106A;transmembrane protein 106A
hsa:140875;LINC00028,C20orf93,NCRNA00028,dJ1093G12.6;long intergenic non-protein coding RNA 28
hsa:158798;AKAP14,AKAP28,PRKA14;A kinase (PRKA) anchor protein 14
hsa:118421;LINC00161,C21orf100,NCRNA00161;long intergenic non-protein coding RNA 161
hsa:120224;TMEM45B;transmembrane protein 45B
hsa:131408;FAM131A,C3orf40,FLAT715,PRO1378;family with sequence similarity 131, member A
hsa:79669;C3orf52,TTMP;chromosome 3 open reading frame 52
hsa:84070;FAM186B,C12orf25;family with sequence similarity 186, member B
hsa:84727;SPSB2,GRCC9,SSB2;splA/ryanodine receptor domain and SOCS box containing 2
hsa:153571;C5orf38,CEI,IRX2NB;chromosome 5 open reading frame 38
hsa:84926;SPRYD3;SPRY domain containing 3 (EC:2.7.1.112)
hsa:151556;GPR155,DEP.7,DEPDC3,PGR22;G protein-coupled receptor 155
hsa:135927;C7orf34,ctm-1;chromosome 7 open reading frame 34
hsa:138241;C9orf85;chromosome 9 open reading frame 85
hsa:84312;BRMS1L,BRMS1;breast cancer metastasis-suppressor 1-like
hsa:128869;PIGU,CDC91L1,GAB1;phosphatidylinositol glycan anchor biosynthesis, class U
hsa:118425;GDEP,PCAN1;gene differentially expressed in prostate
hsa:143471;PSMA8,PSMA7L;proteasome (prosome, macropain) subunit, alpha type, 8 (EC:3.4.25.1)
hsa:147685;C19orf18;chromosome 19 open reading frame 18
hsa:122622;ADSSL1;adenylosuccinate synthase like 1 (EC:6.3.4.4)
hsa:137814;NKX2-6,CSX2,NKX2F,NKX4-2;NK2 homeobox 6
hsa:130340;AP1S3;adaptor-related protein complex 1, sigma 3 subunit
hsa:164237;WFDC13,C20orf138,WAP13,dJ601O1.3;WAP four-disulfide core domain 13
hsa:84258;SYT3,SytIII;synaptotagmin III
hsa:150147;C21orf128;chromosome 21 open reading frame 128
hsa:150135;LINC00479,C21orf129;long intergenic non-protein coding RNA 479
hsa:124149;ANKRD26P1;ankyrin repeat domain 26 pseudogene 1
hsa:148170;CDC42EP5,Borg3,CEP5;CDC42 effector protein (Rho GTPase binding) 5
hsa:146760;RTN4RL1,NGRH2,NgR3;reticulon 4 receptor-like 1
hsa:151234;SULT1C2P1,SULT1C1P;sulfotransferase family, cytosolic, 1C, member 2 pseudogene 1
hsa:196383;RILPL2,RLP2;Rab interacting lysosomal protein-like 2
hsa:140733;MACROD2,C20orf133;MACRO domain containing 2
hsa:78986;DUSP26,DUSP24,LDP-4,MKP8,NATA1,SKRP3;dual specificity phosphatase 26 (putative) (EC:3.1.3.16 3.1.3.48)
hsa:145200;LINC00239,C14orf72,NCRNA00239;long intergenic non-protein coding RNA 239
hsa:164592;CCDC116;coiled-coil domain containing 116
hsa:144776;LINC00410;long intergenic non-protein coding RNA 410
hsa:145447;ABHD12B,BEM46L3,C14orf29,c14_5314;abhydrolase domain containing 12B
hsa:139201;MAP2K4P1;mitogen-activated protein kinase kinase 4 pseudogene 1
hsa:113000;RPUSD1,C16orf40,RLUCL;RNA pseudouridylate synthase domain containing 1
hsa:85457;;KIAA1737
hsa:118426;LOH12CR1,LOH1CR12;loss of heterozygosity, 12, chromosomal region 1
hsa:151278;CCDC140;coiled-coil domain containing 140
hsa:136895;C7orf31;chromosome 7 open reading frame 31
hsa:114819;CROCCP3,CROCCL2,dJ798A10.2;ciliary rootlet coiled-coil, rootletin pseudogene 3
hsa:83888;FGFBP2,HBP17RP,KSP37;fibroblast growth factor binding protein 2
hsa:114824;PNMA5;paraneoplastic Ma antigen family member 5
hsa:160897;GPR180,ITR;G protein-coupled receptor 180
hsa:90050;FAM181A,C14orf152;family with sequence similarity 181, member A
hsa:140687;GCNT7,C20orf105,dJ1153D9.2,gcnt;glucosaminyl (N-acetyl) transferase family member 7 (EC:2.4.1.-)
hsa:199745;THAP8;THAP domain containing 8
hsa:153642;ARSK,TSULF;arylsulfatase family, member K
hsa:132851;SPATA4,SPEF1B,TSARG2;spermatogenesis associated 4
hsa:124411;ZNF720;zinc finger protein 720
hsa:196993;CT62;cancer/testis antigen 62
hsa:147746;HIPK4;homeodomain interacting protein kinase 4 (EC:2.7.11.1)
hsa:144195;SLC2A14,GLUT14,SLC2A3P3;solute carrier family 2 (facilitated glucose transporter), member 14
hsa:149950;;uncharacterized LOC149950
hsa:133874;C5orf58;chromosome 5 open reading frame 58
hsa:148523;C1orf51;chromosome 1 open reading frame 51
hsa:199964;TMEM61;transmembrane protein 61
hsa:152877;FAM53A,DNTNP;family with sequence similarity 53, member A
hsa:152065;C3orf22;chromosome 3 open reading frame 22
hsa:159162;RBMY2FP;RNA binding motif protein, Y-linked, family 2, member F pseudogene
hsa:151056;PLB1,PLB,PLB/LIP,hPLB;phospholipase B1 (EC:3.1.1.5 3.1.1.4)
hsa:139065;SLITRK4;SLIT and NTRK-like family, member 4
hsa:81929;SEH1L,SEC13L,SEH1A,SEH1B,Seh1;SEH1-like (S. cerevisiae)
hsa:137886;UBXN2B,p37;UBX domain protein 2B
hsa:79006;METRN,C16orf23,c380A1.2;meteorin, glial cell differentiation regulator
hsa:93953;ACRC,NAAR1;acidic repeat containing
hsa:84259;DCUN1D5;DCN1, defective in cullin neddylation 1, domain containing 5 (S. cerevisiae)
hsa:148932;MOB3C,MOB1E,MOBKL2C;MOB kinase activator 3C
hsa:145501;ISM2,TAIL1,THSD3;isthmin 2 homolog (zebrafish)
hsa:139231;FAM199X,CXorf39;family with sequence similarity 199, X-linked
hsa:145783;;uncharacterized LOC145783
hsa:152742;;uncharacterized LOC152742
hsa:158314;LINC00475,C9orf44;long intergenic non-protein coding RNA 475
hsa:155382;VPS37D,WBSCR24;vacuolar protein sorting 37 homolog D (S. cerevisiae)
hsa:139793;PAGE3,CT16.6,GAGED1,PAGE-3;P antigen family, member 3 (prostate associated)
hsa:113802;HENMT1,C1orf59,HEN1;HEN1 methyltransferase homolog 1 (Arabidopsis) (EC:2.1.1.n8)
hsa:199953;TMEM201,NET5;transmembrane protein 201
hsa:140680;C20orf96,dJ1103G7.2;chromosome 20 open reading frame 96
hsa:146223;CMTM4,CKLFSF4;CKLF-like MARVEL transmembrane domain containing 4
hsa:153684;;uncharacterized LOC153684
hsa:138240;C9orf57,RP11-346E17.3;chromosome 9 open reading frame 57
hsa:202865;C7orf33;chromosome 7 open reading frame 33
hsa:140597;TCEAL2,MY0876G05,my048;transcription elongation factor A (SII)-like 2
hsa:151195;CCNYL1;cyclin Y-like 1
hsa:121599;SPIC,SPI-C;Spi-C transcription factor (Spi-1/PU.1 related)
hsa:122046;TEX26,C13orf26;testis expressed 26
hsa:126382;NR2C2AP,TRA16;nuclear receptor 2C2-associated protein
hsa:116966;WDR17;WD repeat domain 17
hsa:151647;FAM19A4,TAFA-4,TAFA4;family with sequence similarity 19 (chemokine (C-C motif)-like), member A4
hsa:147650;LINC00085,NCRNA00085,SPACA6;long intergenic non-protein coding RNA 85
hsa:117157;SH2D1B,EAT2;SH2 domain containing 1B
hsa:162427;FAM134C;family with sequence similarity 134, member C
hsa:140873;C20orf173,dJ477O4.4;chromosome 20 open reading frame 173
hsa:149685;ADIG,SMAF1;adipogenin
hsa:125931;CEACAM20,UNQ9366;carcinoembryonic antigen-related cell adhesion molecule 20
hsa:148304;C1orf74;chromosome 1 open reading frame 74
hsa:149840;C20orf196;chromosome 20 open reading frame 196
hsa:78992;YIPF2,FinGER2;Yip1 domain family, member 2
hsa:121268;RHEBL1,RHEBL1c;Ras homolog enriched in brain like 1
hsa:130872;AHSA2,Hch1;AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast)
hsa:83742;MARVELD1,GB14,MARVD1,MRVLDC1,RP11-548K23.8,bA548K23.8;MARVEL domain containing 1
hsa:202051;SPATA24,CCDC161,T6441;spermatogenesis associated 24
hsa:116138;KLHDC3,PEAS,RP1-20C7.3,dJ20C7.3;kelch domain containing 3
hsa:170627;XAGE5,CT12.5,GAGED5,XAGE-5;X antigen family, member 5
hsa:149934;NCOR1P1,C20orf191,bB329D4.2;nuclear receptor corepressor 1 pseudogene 1
hsa:150992;LINC00309,NCRNA00309;long intergenic non-protein coding RNA 309
hsa:158435;;uncharacterized LOC158435
hsa:79020;C7orf25;chromosome 7 open reading frame 25
hsa:140838;NANP,C20orf147,HDHD4,dJ694B14.3;N-acetylneuraminic acid phosphatase (EC:3.1.3.29)
hsa:148789;B3GALNT2,B3GalNAc-T2;beta-1,3-N-acetylgalactosaminyltransferase 2 (EC:2.4.1.-)
hsa:128602;C20orf85,LLC1,bA196N14.1;chromosome 20 open reading frame 85
hsa:151188;ARL6IP6,AIP-6,PFAAP1;ADP-ribosylation-like factor 6 interacting protein 6
hsa:155368;WBSCR27;Williams Beuren syndrome chromosome region 27
hsa:133060;OTOP1;otopetrin 1
hsa:130026;ICA1L,ALS2CR14,ALS2CR15;islet cell autoantigen 1,69kDa-like
hsa:124535;HSF5,HSF_5,HSTF_5;heat shock transcription factor family member 5
hsa:130612;TMEM198,TMEM198A;transmembrane protein 198
hsa:117285;DEFB118,C20orf63,DEFB-18,ESC42,ESP13.6;defensin, beta 118
hsa:149466;C1orf210;chromosome 1 open reading frame 210
hsa:143941;TTC36,HBP21;tetratricopeptide repeat domain 36
hsa:200772;;uncharacterized LOC200772
hsa:116238;TLCD1;TLC domain containing 1
hsa:123970;C16orf78;chromosome 16 open reading frame 78
hsa:149830;PRNT,M8;prion protein (testis specific)
hsa:80851;SH3BP5L;SH3-binding domain protein 5-like
hsa:91608;RASL10B,RRP17,VTS58635;RAS-like, family 10, member B
hsa:152118;C3orf79;chromosome 3 open reading frame 79
hsa:90701;SEC11C,SEC11L3,SPC21,SPCS4C;SEC11 homolog C (S. cerevisiae) (EC:3.4.21.89)
hsa:161247;FITM1,FIT1;fat storage-inducing transmembrane protein 1
hsa:143678;C11orf94;chromosome 11 open reading frame 94
hsa:127829;ARL8A,ARL10B,GIE2;ADP-ribosylation factor-like 8A
hsa:89822;KCNK17,K2p17.1,TALK-2,TALK2,TASK-4,TASK4;potassium channel, subfamily K, member 17
hsa:130940;CCDC148;coiled-coil domain containing 148
hsa:151473;SLC16A14,MCT14;solute carrier family 16, member 14 (monocarboxylic acid transporter 14)
hsa:114928;GPRASP2,GASP2;G protein-coupled receptor associated sorting protein 2
hsa:124790;HEXIM2;hexamethylene bis-acetamide inducible 2
hsa:157848;NKX6-3,NKX6.3;NK6 homeobox 3
hsa:150726;FBXO41,FBX41;F-box protein 41
hsa:126669;SHE,RP11-350G8.8;Src homology 2 domain containing E
hsa:79963;ABCA11P,ABCA11,EST1133530;ATP-binding cassette, sub-family A (ABC1), member 11, pseudogene
hsa:196394;AMN1;antagonist of mitotic exit network 1 homolog (S. cerevisiae)
hsa:202459;OSTCP1,DC2L,OSTCL;oligosaccharyltransferase complex subunit pseudogene 1
hsa:84255;SLC37A3;solute carrier family 37 (glycerol-3-phosphate transporter), member 3
hsa:80256;FAM214B,KIAA1539,P1.11659_5,RP11-182N22.6,bA182N22.6;family with sequence similarity 214, member B
hsa:137797;LYPD2,LYPDC2,UNQ430;LY6/PLAUR domain containing 2
hsa:148413;;uncharacterized LOC148413
hsa:115110;;uncharacterized LOC115110
hsa:155006;TMEM213;transmembrane protein 213
hsa:157556;C8orf56;chromosome 8 open reading frame 56
hsa:127795;C1orf87;chromosome 1 open reading frame 87
hsa:130535;KCTD18,6530404F10Rik;potassium channel tetramerisation domain containing 18
hsa:127343;DMBX1,MBX,OTX3,PAXB;diencephalon/mesencephalon homeobox 1
hsa:152078;C3orf55;chromosome 3 open reading frame 55
hsa:140902;R3HDML,dJ881L22.3;R3H domain containing-like
hsa:149134;;uncharacterized LOC149134
hsa:85455;DISP2,DISPB,HsT16908;dispatched homolog 2 (Drosophila)
hsa:114984;FLYWCH2;FLYWCH family member 2
hsa:142913;CFL1P1,CFLP1;cofilin 1 (non-muscle) pseudogene 1
hsa:126661;CCDC163P,C1orf231;coiled-coil domain containing 163, pseudogene
hsa:124976;SPNS2;spinster homolog 2 (Drosophila)
hsa:124808;CCDC43;coiled-coil domain containing 43
hsa:164091;PAQR7,MPRA,PGLP,mSR;progestin and adipoQ receptor family member VII
hsa:158056;MAMDC4,AEGP;MAM domain containing 4
hsa:114932;MRFAP1L1;Morf4 family associated protein 1-like 1
hsa:159163;RBMY1F,YRRM2;RNA binding motif protein, Y-linked, family 1, member F
hsa:123920;CMTM3,BNAS2,CKLFSF3;CKLF-like MARVEL transmembrane domain containing 3
hsa:202018;TAPT1,CMVFR;transmembrane anterior posterior transformation 1
hsa:152578;;uncharacterized LOC152578
hsa:134353;LSM11;LSM11, U7 small nuclear RNA associated
hsa:144742;;uncharacterized LOC144742
hsa:114821;SCAND3,ZFP38-L,ZNF305P2,ZNF452,dJ1186N24.3;SCAN domain containing 3
hsa:84954;MPND;MPN domain containing
hsa:160419;C12orf50;chromosome 12 open reading frame 50
hsa:116093;DIRC1;disrupted in renal carcinoma 1
hsa:89837;ULK4P3,D-X,FAM7A3;unc-51-like kinase 4 (C. elegans) pseudogene 3
hsa:142679;DUSP19,DUSP17,LMWDSP3,SKRP1,TS-DSP1;dual specificity phosphatase 19 (EC:3.1.3.16 3.1.3.48)
hsa:200150;PLD5,PLDC;phospholipase D family, member 5
hsa:151525;WDSUB1,UBOX6,WDSAM1;WD repeat, sterile alpha motif and U-box domain containing 1
hsa:151477;LINC00471,C2orf52;long intergenic non-protein coding RNA 471
hsa:126364;LRRC25,MAPA;leucine rich repeat containing 25
hsa:150244;ZDHHC8P1,ZDHHC8P;zinc finger, DHHC-type containing 8 pseudogene 1
hsa:127391;TMCO2,dJ39G22.2;transmembrane and coiled-coil domains 2
hsa:159686;CCDC147,C10orf80,bA127L20.4,bA127L20.5,bA554P13.1;coiled-coil domain containing 147
hsa:131616;TMEM42;transmembrane protein 42
hsa:148252;DIRAS1,Di-Ras1,GBTS1,RIG;DIRAS family, GTP-binding RAS-like 1
hsa:150082;LCA5L,C21orf13;Leber congenital amaurosis 5-like
hsa:83714;NRIP2;nuclear receptor interacting protein 2
hsa:150159;SLC9B1,NHA1,NHEDC1;solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1
hsa:158035;LINC00032,C9orf14,NCRNA00032;long intergenic non-protein coding RNA 32
hsa:196051;PPAPDC1A,DPPL2,PPAPDC1;phosphatidic acid phosphatase type 2 domain containing 1A (EC:3.1.3.4)
hsa:125965;COX6B2,COXVIB2,CT59;cytochrome c oxidase subunit VIb polypeptide 2 (testis)
hsa:140707;BRI3BP,BNAS1,HCCR-1,HCCR-2,HCCRBP-1,KG19;BRI3 binding protein
hsa:192134;B3GNT6,B3Gn-T6,IMAGE:4907098;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase) (EC:2.4.1.149)
hsa:154872;;uncharacterized protein LOC154872
hsa:150472;CBWD2;COBW domain containing 2
hsa:132200;C3orf49;chromosome 3 open reading frame 49
hsa:151475;;uncharacterized LOC151475
hsa:151613;TTC14,DRDL5813,PRO19630;tetratricopeptide repeat domain 14
hsa:127703;C1orf216;chromosome 1 open reading frame 216
hsa:134466;ZNF300P1;zinc finger protein 300 pseudogene 1
hsa:152225;;uncharacterized LOC152225
hsa:148641;SLC35F3;solute carrier family 35, member F3
hsa:147172;LRRC37BP1,LRRC37B2;leucine rich repeat containing 37B pseudogene 1
hsa:127262;TPRG1L,FAM79A,RP11-46F15.3,h-mover,mover;tumor protein p63 regulated 1-like
hsa:153396;TMEM161B,FLB3342,PRO1313;transmembrane protein 161B
hsa:114908;TMEM123,KCT3,PORIMIN,PORMIN;transmembrane protein 123
hsa:200420;ALMS1P,ALMS1L;Alstrom syndrome 1 pseudogene
hsa:126308;MOB3A,MOB1C,MOBKL2A,moblak;MOB kinase activator 3A
hsa:207107;SFTA1P,SFTPF;surfactant associated 1, pseudogene
hsa:162494;RHBDL3,RHBDL4,VRHO;rhomboid, veinlet-like 3 (Drosophila) (EC:3.4.21.105)
hsa:113655;MFSD3;major facilitator superfamily domain containing 3
hsa:133491;C5orf47;chromosome 5 open reading frame 47
hsa:162461;TMEM92;transmembrane protein 92
hsa:142686;ASB14;ankyrin repeat and SOCS box containing 14
hsa:114625;ERMAP,PRO2801,RD,SC;erythroblast membrane-associated protein (Scianna blood group)
hsa:144809;FAM216B,C13orf30;family with sequence similarity 216, member B
hsa:145978;LINC00052,NCRNA00052,TMEM83;long intergenic non-protein coding RNA 52
hsa:153770;PLAC8L1;PLAC8-like 1
hsa:94009;SERHL,BK126B4.1,BK126B4.2,HS126B42,dJ222E13.1;serine hydrolase-like
hsa:151254;ALS2CR11;amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11
hsa:146862;UNC45B,CMYA4,SMUNC45,UNC45;unc-45 homolog B (C. elegans)
hsa:170622;COMMD6,Acrg;COMM domain containing 6
hsa:196743;PAOX,PAO;polyamine oxidase (exo-N4-amino) (EC:1.5.3.13)
hsa:150568;;uncharacterized LOC150568
hsa:115273;RAB42,RP4-669K10.6;RAB42, member RAS oncogene family
hsa:79183;TTPAL,C20orf121;tocopherol (alpha) transfer protein-like
hsa:126767;AADACL3;arylacetamide deacetylase-like 3 (EC:3.1.1.-)
hsa:135154;C6orf57;chromosome 6 open reading frame 57
hsa:128218;TMEM125;transmembrane protein 125
hsa:168975;CNBD1;cyclic nucleotide binding domain containing 1
hsa:199870;FAM76A;family with sequence similarity 76, member A
hsa:143379;C10orf82;chromosome 10 open reading frame 82
hsa:128272;ARHGEF19,WGEF;Rho guanine nucleotide exchange factor (GEF) 19
hsa:142940;TRUB1,PUS4;TruB pseudouridine (psi) synthase homolog 1 (E. coli)
hsa:143501;C11orf40,NOV1;chromosome 11 open reading frame 40
hsa:132946;ARL9;ADP-ribosylation factor-like 9
hsa:123722;FSD2,RP11-127F21,SPRYD1;fibronectin type III and SPRY domain containing 2
hsa:193629;LINC00189,C21orf109,NCRNA00189;long intergenic non-protein coding RNA 189
hsa:128817;CSTL1,CTES1,RCET11,dJ322G13.4;cystatin-like 1
hsa:154761;;family with sequence similarity 115, member C pseudogene
hsa:150290;DUSP18,DSP18,DUSP20,LMWDSP20,bK963H5.1;dual specificity phosphatase 18 (EC:3.1.3.16 3.1.3.48)
hsa:152573;SHISA3,hShisa3;shisa homolog 3 (Xenopus laevis)
hsa:192668;CYS1;cystin 1
hsa:79706;PRKRIP1,C114,KRBOX3;PRKR interacting protein 1 (IL11 inducible)
hsa:136853;SRCRB4D,S4D-SRCRB,SRCRB-S4D,SSC4D;scavenger receptor cysteine rich domain containing, group B (4 domains)
hsa:139067;SPANXN3,CT11.8,SPANX-N3;SPANX family, member N3
hsa:139081;MAGEC3,CT7.2,HCA2,MAGE-C3,MAGEC4;melanoma antigen family C, 3
hsa:124842;TMEM132E;transmembrane protein 132E
hsa:199223;TTC21A,STI2;tetratricopeptide repeat domain 21A
hsa:93426;SYCE1,C10orf94,CT76;synaptonemal complex central element protein 1
hsa:80019;UBTD1;ubiquitin domain containing 1
hsa:146513;;uncharacterized LOC146513
hsa:115811;IQCD,4933433C09Rik;IQ motif containing D
hsa:163688;CALML6,CAGLP;calmodulin-like 6
hsa:144423;GLT1D1;glycosyltransferase 1 domain containing 1 (EC:2.4.-.-)
hsa:134728;IRAK1BP1,AIP70,SIMPL;interleukin-1 receptor-associated kinase 1 binding protein 1
hsa:149951;COMMD7,C20orf92,dJ1085F17.3;COMM domain containing 7
hsa:202658;TRIM39-RPP21,TRIM39R;TRIM39-RPP21 readthrough
hsa:197003;;uncharacterized protein MGC15885
hsa:117156;SCGB3A2,LU103,PNSP1,UGRP1,pnSP-1;secretoglobin, family 3A, member 2
hsa:158747;MOSPD2;motile sperm domain containing 2
hsa:147710;IGSF23;immunoglobulin superfamily, member 23
hsa:157739;TDH,SDR14E1P;L-threonine dehydrogenase
hsa:118670;FAM24A;family with sequence similarity 24, member A
hsa:79157;MFSD11,ET;major facilitator superfamily domain containing 11
hsa:157381;;uncharacterized LOC157381
hsa:200407;CREG2;cellular repressor of E1A-stimulated genes 2
hsa:127845;GOLT1A,CGI-141,GOT1,HMFN1187,RP11-203F10.3,YMR292W;golgi transport 1A
hsa:146279;TEKT5;tektin 5
hsa:203197;C9orf91,RP11-402G3.2;chromosome 9 open reading frame 91
hsa:124274;GPR139,GPRg1,PGR3;G protein-coupled receptor 139
hsa:140832;WFDC10A,C20orf146,WAP10,dJ688G8.3;WAP four-disulfide core domain 10A
hsa:134111;UBE2QL1;ubiquitin-conjugating enzyme E2Q family-like 1 (EC:6.3.2.19)
hsa:120863;DEPDC4,DEP.4;DEP domain containing 4
hsa:116832;RPL39L,RPL39L1;ribosomal protein L39-like
hsa:126823;KLHDC9,KARCA1;kelch domain containing 9
hsa:123355;LRRC28;leucine rich repeat containing 28
hsa:153733;CCDC112,MBC1;coiled-coil domain containing 112
hsa:201283;AMZ2P1;archaelysin family metallopeptidase 2 pseudogene 1
hsa:167681;PRSS35,C6orf158,dJ223E3.1;protease, serine, 35
hsa:122945;NOXRED1,C14orf148;NADP-dependent oxidoreductase domain containing 1
hsa:139728;PNCK,BSTK3,CaMK1b;pregnancy up-regulated non-ubiquitously expressed CaM kinase (EC:2.7.11.17)
hsa:125875;CLDND2;claudin domain containing 2
hsa:145946;SPATA8,SRG8;spermatogenesis associated 8
hsa:152519;NIPAL1,NPAL1;NIPA-like domain containing 1
hsa:151313;FAHD2B;fumarylacetoacetate hydrolase domain containing 2B
hsa:84314;TMEM107,GRVS638,PRO1268;transmembrane protein 107
hsa:84553;FAXC,C6orf168,dJ273F20;failed axon connections homolog (Drosophila)
hsa:151484;;uncharacterized LOC151484
hsa:157697;ERICH1;glutamate-rich 1
hsa:125981;ACER1,ALKCDase1,ASAH3;alkaline ceramidase 1 (EC:3.5.1.23)
hsa:219855;SLC37A2,pp11662;solute carrier family 37 (glycerol-3-phosphate transporter), member 2
hsa:219445;OR7E5P,OR11-12,OR11-156,OR7F5P;olfactory receptor, family 7, subfamily E, member 5 pseudogene
hsa:221718;LINC00518,C6orf218;long intergenic non-protein coding RNA 518
hsa:220594;USP32P2,TL132;ubiquitin specific peptidase 32 pseudogene 2
hsa:220979;C10orf25;chromosome 10 open reading frame 25
hsa:221079;ARL5B,ARL8;ADP-ribosylation factor-like 5B
hsa:220047;CCDC83;coiled-coil domain containing 83
hsa:219285;SAMD9L,C7orf6,DRIF2,UEF1;sterile alpha motif domain containing 9-like
hsa:220963;SLC16A9,C10orf36,MCT9;solute carrier family 16, member 9 (monocarboxylic acid transporter 9)
hsa:220729;;succinate dehydrogenase complex, subunit A, flavoprotein (Fp) pseudogene
hsa:219854;TMEM218;transmembrane protein 218
hsa:221960;CCZ1B,C7orf28B,H_NH0577018.2;CCZ1 vacuolar protein trafficking and biogenesis associated homolog B (S. cerevisiae)
hsa:219348;PLAC9;placenta-specific 9
hsa:221786;FAM200A,C7orf38;family with sequence similarity 200, member A
hsa:220108;FAM124A;family with sequence similarity 124A
hsa:221914;GPC2;glypican 2
hsa:221491;C6orf1,LBH;chromosome 6 open reading frame 1
hsa:219738;C10orf35;chromosome 10 open reading frame 35
hsa:219995;MS4A15;membrane-spanning 4-domains, subfamily A, member 15
hsa:220832;FABP5P3,FABP5L3;fatty acid binding protein 5 pseudogene 3
hsa:221468;TMEM217,C6orf128,dJ355M6.2;transmembrane protein 217
hsa:220002;CYB561A3,CYBASC3,LCYTB;cytochrome b561 family, member A3
hsa:219539;YPEL4;yippee-like 4 (Drosophila)
hsa:221061;FAM171A1,C10orf38;family with sequence similarity 171, member A1
hsa:219902;TMEM136;transmembrane protein 136
hsa:222865;TMEM130;transmembrane protein 130
hsa:221756;MGC39372;serpin peptidase inhibitor, clade B (ovalbumin), member 9 pseudogene
hsa:221122;;uncharacterized LOC221122
hsa:222235;FBXL13,Fbl13;F-box and leucine-rich repeat protein 13
hsa:220323;OAF,NS5ATP13TP2;OAF homolog (Drosophila)
hsa:221409;SPATS1,DDIP,SPATA8,SRSP1;spermatogenesis associated, serine-rich 1
hsa:221955;DAGLB,DAGLBETA,KCCR13L;diacylglycerol lipase, beta (EC:3.1.1.-)
hsa:219899;TBCEL,El,LRRC35;tubulin folding cofactor E-like
hsa:221303;FAM162B,C6orf189,bA86F4.2;family with sequence similarity 162, member B
hsa:222658;KCTD20,C6orf69,dJ108K11.3;potassium channel tetramerisation domain containing 20
hsa:283970;PDXDC2P,PDXDC2;pyridoxal-dependent decarboxylase domain containing 2, pseudogene
hsa:284023;;uncharacterized LOC284023
hsa:284802;FRG1B,C20orf80,bA348I14.2;FSHD region gene 1 family, member B
hsa:283677;C15orf60;chromosome 15 open reading frame 60
hsa:257407;C2orf72;chromosome 2 open reading frame 72
hsa:254559;;uncharacterized LOC254559
hsa:284800;FAM182A,C20orf91,bB329D4.1;family with sequence similarity 182, member A
hsa:284100;;tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide pseudogene
hsa:255025;;uncharacterized LOC255025
hsa:285629;;uncharacterized LOC285629
hsa:256356;GK5;glycerol kinase 5 (putative) (EC:2.7.1.30)
hsa:284207;METRNL;meteorin, glial cell differentiation regulator-like
hsa:285740;;uncharacterized LOC285740
hsa:283651;HMGN2P46,C15orf21,D-PCa-2;high mobility group nucleosomal binding domain 2 pseudogene 46
hsa:285768;;uncharacterized LOC285768
hsa:285033;;uncharacterized LOC285033
hsa:283761;;uncharacterized LOC283761
hsa:284422;C19orf77;chromosome 19 open reading frame 77
hsa:283860;LINC00304,C16orf81,NCRNA00304;long intergenic non-protein coding RNA 304
hsa:283871;PGP;phosphoglycolate phosphatase (EC:3.1.3.18)
hsa:284749;LINC00494;long intergenic non-protein coding RNA 494
hsa:285588;EFCAB9;EF-hand calcium binding domain 9
hsa:286094;;uncharacterized LOC286094
hsa:245937;DEFB124,DEFB-24;defensin, beta 124
hsa:254170;FBXO33,BMND12,Fbx33,c14_5247;F-box protein 33
hsa:284365;MGC45922;uncharacterized LOC284365
hsa:283585;;uncharacterized LOC283585
hsa:286442;;uncharacterized LOC286442
hsa:286410;ATP11C,ATPIG,ATPIQ;ATPase, class VI, type 11C (EC:3.6.3.1)
hsa:285941;C7orf71;chromosome 7 open reading frame 71
hsa:285888;CNPY1;canopy 1 homolog (zebrafish)
hsa:259283;MDS2;myelodysplastic syndrome 2 translocation associated
hsa:252954;TTTY22,NCRNA00147;testis-specific transcript, Y-linked 22 (non-protein coding)
hsa:266919;LINC00307,D21S2091E,NCRNA00307;long intergenic non-protein coding RNA 307
hsa:285547;;uncharacterized LOC285547
hsa:252955;TTTY23,NCRNA00148;testis-specific transcript, Y-linked 23 (non-protein coding)
hsa:284836;LINC00319,C21orf125,NCRNA00319,PRED49;long intergenic non-protein coding RNA 319
hsa:246119;TTTY10,NCRNA00133,TTY10;testis-specific transcript, Y-linked 10 (non-protein coding)
hsa:283683;;uncharacterized LOC283683
hsa:260434;PYDC1,ASC2,POP1,PYC1;PYD (pyrin domain) containing 1
hsa:256714;MAP7D2;MAP7 domain containing 2
hsa:245940;DEFB130,DEFB-30,DEFB130L;defensin, beta 130
hsa:286828;CSN1S2AP,CSN1S2A;casein alpha s2-like A, pseudogene
hsa:284835;LINC00323,C21orf130,NCRNA00323,PRED42;long intergenic non-protein coding RNA 323
hsa:252951;TTTY20,NCRNA00145;testis-specific transcript, Y-linked 20 (non-protein coding)
hsa:284344;;uncharacterized LOC284344
hsa:286557;RBMY1A3P;RNA binding motif protein, Y-linked, family 1, member A3 pseudogene
hsa:284551;;uncharacterized LOC284551
hsa:252952;TTTY19,NCRNA00144;testis-specific transcript, Y-linked 19 (non-protein coding)
hsa:284788;;uncharacterized LOC284788
hsa:252950;TTTY18,NCRNA00143;testis-specific transcript, Y-linked 18 (non-protein coding)
hsa:285758;;uncharacterized LOC285758
hsa:284424;MIR7-3HG,C19orf30,LINC00306,NCRNA00306,PGSF1;MIR7-3 host gene (non-protein coding)
hsa:284798;;uncharacterized LOC284798
hsa:259217;HSPA12A;heat shock 70kDa protein 12A
hsa:283948;NHLRC4;NHL repeat containing 4
hsa:252948;TTTY16,NCRNA00139;testis-specific transcript, Y-linked 16 (non-protein coding)
hsa:256309;CCDC110,CT52,KM-HN-1,KMHN1;coiled-coil domain containing 110
hsa:245911;DEFB108B;defensin, beta 108B
hsa:284116;KRT42P;keratin 42 pseudogene
hsa:284613;CYB561D1;cytochrome b561 family, member D1
hsa:283768;GOLGA8G;golgin A8 family, member G
hsa:285386;TPRG1,FAM79B;tumor protein p63 regulated 1
hsa:283332;;uncharacterized LOC283332
hsa:283726;FAM154B;family with sequence similarity 154, member B
hsa:283404;LINC00592;long intergenic non-protein coding RNA 592
hsa:283673;LINC00277,NCRNA00277,TMEM84;long intergenic non-protein coding RNA 277
hsa:254228;FAM26E,C6orf188,dJ493F7.3;family with sequence similarity 26, member E
hsa:284029;LINC00324,C17orf44,NCRNA00324;long intergenic non-protein coding RNA 324
hsa:266675;BEST4,VMD2L2;bestrophin 4
hsa:317760;ADAM20P1,C14orf55;ADAM metallopeptidase domain 20 pseudogene 1
hsa:317649;EIF4E3;eukaryotic translation initiation factor 4E family member 3
hsa:245935;DEFB122,DEFB-22,DEFB122P;defensin, beta 122 (pseudogene)
hsa:284467;FAM19A3,TAFA-3,TAFA3;family with sequence similarity 19 (chemokine (C-C motif)-like), member A3
hsa:255027;MPV17L,M-LPH,MLPH1,MLPH2,MPV17L1;MPV17 mitochondrial membrane protein-like
hsa:253044;;uncharacterized LOC253044
hsa:245711;SPDYA,RINGO3,RINGOA,SPDY1,SPY1;speedy homolog A (Xenopus laevis)
hsa:286186;;uncharacterized LOC286186
hsa:286114;;uncharacterized LOC286114
hsa:284632;;uncharacterized LOC284632
hsa:284131;ENDOV;endonuclease V (EC:3.1.-.-)
hsa:286101;ZNF252P,ZNF252;zinc finger protein 252, pseudogene
hsa:286083;;uncharacterized LOC286083
hsa:266917;;D21S2088E
hsa:285641;SLC36A3,PAT3,TRAMD2,tramdorin2;solute carrier family 36 (proton/amino acid symporter), member 3
hsa:283011;FLJ37201;tigger transposable element derived 2 pseudogene
hsa:285577;;uncharacterized LOC285577
hsa:284085;KRT18P55;keratin 18 pseudogene 55
hsa:258010;SVIP;small VCP/p97-interacting protein
hsa:286467;;family with sequence similarity 195, member A pseudogene
hsa:245912;DEFB109P1,DEFB-9,DEFB109,DEFB109A;defensin, beta 109, pseudogene 1
hsa:284009;;uncharacterized LOC284009
hsa:283299;;uncharacterized LOC283299
hsa:284615;ANKRD34A,ANKRD34;ankyrin repeat domain 34A
hsa:254099;;uncharacterized LOC254099
hsa:246122;TTTY7,CLONE795723,LINC00129,NCRNA00129,TTTY7A,TTTY7B,TTY7;testis-specific transcript, Y-linked 7 (non-protein coding)
hsa:266747;RGL4,Rgr;ral guanine nucleotide dissociation stimulator-like 4
hsa:255812;SDHAP1,SDHAL1,SDHALP1;succinate dehydrogenase complex, subunit A, flavoprotein pseudogene 1
hsa:286451;YIPF6,FinGER6;Yip1 domain family, member 6
hsa:285540;;uncharacterized LOC285540
hsa:283710;;uncharacterized LOC283710
hsa:284865;;uncharacterized LOC284865
hsa:255167;;uncharacterized LOC255167
hsa:283876;;uncharacterized protein FLJ39639
hsa:286238;;uncharacterized LOC286238
hsa:284837;;uncharacterized LOC284837
hsa:285958;SNHG15,C7orf40;small nucleolar RNA host gene 15 (non-protein coding)
hsa:246312;C21orf91-OT1,D21S2089E,NCRNA00285;C21orf91 overlapping transcript 1 (non-protein coding)
hsa:255654;;uncharacterized LOC255654
hsa:284759;SIRPB2,PTPN1L,PTPNS1L3,dJ776F14.2;signal-regulatory protein beta 2
hsa:286059;;tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain pseudogene
hsa:285419;;uncharacterized LOC285419
hsa:286177;;uncharacterized LOC286177
hsa:284276;;uncharacterized LOC284276
hsa:286184;;uncharacterized LOC286184
hsa:260294;NSUN5P2,NOL1R2,NSUN5C,WBSCR20B,WBSCR20C;NOP2/Sun domain family, member 5 pseudogene 2
hsa:284233;CYP4F35P;cytochrome P450, family 4, subfamily F, polypeptide 35, pseudogene
hsa:285759;;uncharacterized FLJ34503
hsa:283129;C11orf85;chromosome 11 open reading frame 85
hsa:286189;;uncharacterized LOC286189
hsa:284379;;solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 pseudogene
hsa:283578;TMED8,FAM15B;transmembrane emp24 protein transport domain containing 8
hsa:255275;MYADML2;myeloid-associated differentiation marker-like 2
hsa:255330;NUP210P1,C3orf46;nucleoporin 210kDa pseudogene 1
hsa:284185;LINC00482,C17orf55;long intergenic non-protein coding RNA 482
hsa:285819;;uncharacterized LOC285819
hsa:286190;;uncharacterized LOC286190
hsa:317716;BPIFA4P,BASE;BPI fold containing family A, member 4, pseudogene
hsa:255426;RASGEF1C;RasGEF domain family, member 1C
hsa:286370;;uncharacterized LOC286370
hsa:285878;;uncharacterized LOC285878
hsa:266740;MAGEA2B,MAGE2,MAGEA2;melanoma antigen family A, 2B
hsa:284729;ESPNP,RP1-163M9.1,dJ1182A14.1;espin pseudogene
hsa:254158;CXorf58;chromosome X open reading frame 58
hsa:337875;HIST2H2BA;histone cluster 2, H2ba (pseudogene)
hsa:260436;FDCSP,C4orf7,FDC-SP;follicular dendritic cell secreted protein
hsa:284612;SYPL2,MG29;synaptophysin-like 2
hsa:286133;SCARA5,NET33,Tesr;scavenger receptor class A, member 5 (putative)
hsa:257396;;uncharacterized LOC257396
hsa:283422;C12orf36;chromosome 12 open reading frame 36
hsa:256281;NUDT14,UGPP,UGPPase;nudix (nucleoside diphosphate linked moiety X)-type motif 14 (EC:3.6.1.45)
hsa:254272;TBC1D28;TBC1 domain family, member 28
hsa:254910;LCE5A,LEP18,SPRL5A;late cornified envelope 5A
hsa:259234;DSCR10;Down syndrome critical region gene 10 (non-protein coding)
hsa:284950;;uncharacterized LOC284950
hsa:284412;;uncharacterized LOC284412
hsa:285961;SEPT7L,CDC10L,bA291L22.2,SEPT7P9;septin 7-like
hsa:285501;;uncharacterized LOC285501
hsa:283629;TSSK4,C14orf20,STK22E,TSK-4,TSK4,TSSK5;testis-specific serine kinase 4 (EC:2.7.11.1)
hsa:255130;;uncharacterized LOC255130
hsa:280664;WFDC10B,WAP12;WAP four-disulfide core domain 10B
hsa:246705;LINC00314,C21orf94,NCRNA00314;long intergenic non-protein coding RNA 314
hsa:285000;;uncharacterized LOC285000
hsa:333929;SNAI3,SMUC,SNAIL3,ZNF293,Zfp293;snail homolog 3 (Drosophila)
hsa:283143;;uncharacterized LOC283143
hsa:284573;LINC00303,C1orf157,NCRNA00303;long intergenic non-protein coding RNA 303
hsa:246329;STAC3;SH3 and cysteine rich domain 3
hsa:326342;EMR4P,EMR4,FIRE,GPR127,PGR16;egf-like module containing, mucin-like, hormone receptor-like 4 pseudogene
hsa:286499;FAM133A,CT115;family with sequence similarity 133, member A
hsa:255349;TMEM211,bA9F11.1;transmembrane protein 211
hsa:283693;;actin, alpha 2, smooth muscle, aorta pseudogene
hsa:284293;HMSD,ACC-6,C18orf53,HSMD-v;histocompatibility (minor) serpin domain containing
hsa:285084;;uncharacterized LOC285084
hsa:256586;LYSMD2;LysM, putative peptidoglycan-binding, domain containing 2
hsa:257415;FAM133B;family with sequence similarity 133, member B
hsa:284751;;uncharacterized LOC284751
hsa:246176;GAS2L2,GAR17;growth arrest-specific 2 like 2
hsa:286122;C8orf31;chromosome 8 open reading frame 31
hsa:255919;CNEP1R1,C16orf69,NEP1-R1,TMEM188,TMP125;CTD nuclear envelope phosphatase 1 regulatory subunit 1
hsa:283507;SUGT1P3,SUGT1L1;suppressor of G2 allele of SKP1 (S. cerevisiae) pseudogene 3
hsa:266655;LINC00094,LP2477,NCRNA00094,bA374P20.3;long intergenic non-protein coding RNA 94
hsa:284801;;uncharacterized LOC284801
hsa:283688;;uncharacterized LOC283688
hsa:254240;BPIFC,BPIL2;BPI fold containing family C
hsa:245913;DEFB110,DEFB-10,DEFB-11,DEFB111;defensin, beta 110 locus
hsa:246213;SLC17A8,DFNA25,VGLUT3;solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8
hsa:246126;TXLNG2P,CYorf15A,CYorf15B;taxilin gamma 2, pseudogene
hsa:283982;LINC00469,C17orf54;long intergenic non-protein coding RNA 469
hsa:255374;MBLAC1;metallo-beta-lactamase domain containing 1 (EC:3.-.-.-)
hsa:245927;DEFB113,DEFB-13;defensin, beta 113
hsa:245929;DEFB115,DEFB-15;defensin, beta 115
hsa:245930;DEFB116,DEFB-16;defensin, beta 116
hsa:286411;RP1-177G6.2;uncharacterized LOC286411
hsa:283521;LINC00282,NCRNA00282;long intergenic non-protein coding RNA 282
hsa:253128;LINC00612,C12orf33;long intergenic non-protein coding RNA 612
hsa:283130;SLC25A45;solute carrier family 25, member 45
hsa:286554;BCORP1,BCORL2;BCL6 corepressor pseudogene 1
hsa:286343;LURAP1L,C9orf150,bA3L8.2;leucine rich adaptor protein 1-like
hsa:284756;C20orf197,RP5-1017F8.1;chromosome 20 open reading frame 197
hsa:253573;;uncharacterized LOC253573
hsa:284593;FAM41C;family with sequence similarity 41, member C
hsa:284080;;uncharacterized LOC284080
hsa:284889;;uncharacterized LOC284889
hsa:284067;C17orf105;chromosome 17 open reading frame 105
hsa:285550;FAM200B;family with sequence similarity 200, member B
hsa:283403;;uncharacterized LOC283403
hsa:285126;DNAJC5G,CSP-gamma;DnaJ (Hsp40) homolog, subfamily C, member 5 gamma
hsa:283038;;uncharacterized LOC283038
hsa:326343;MT1DP,MTM;metallothionein 1D, pseudogene
hsa:285382;C3orf70;chromosome 3 open reading frame 70
hsa:283491;OR7E156P;olfactory receptor, family 7, subfamily E, member 156 pseudogene
hsa:283731;;uncharacterized LOC283731
hsa:283177;;uncharacterized LOC283177
hsa:255411;;uncharacterized LOC255411
hsa:284933;;uncharacterized LOC284933
hsa:256471;MFSD8,CLN7;major facilitator superfamily domain containing 8
hsa:285962;FLJ40852;uncharacterized LOC285962
hsa:283025;C10orf40;chromosome 10 open reading frame 40
hsa:283194;;uncharacterized LOC283194
hsa:284395;;uncharacterized LOC284395
hsa:284129;SLC26A11;solute carrier family 26, member 11
hsa:285972;;uncharacterized LOC285972
hsa:255082;CASC2,C10orf5;cancer susceptibility candidate 2 (non-protein coding)
hsa:245936;DEFB123,DEFB-23,ESC42-RELD;defensin, beta 123
hsa:283208;P4HA3;prolyl 4-hydroxylase, alpha polypeptide III (EC:1.14.11.2)
hsa:283335;;uncharacterized LOC283335
hsa:267002;PGBD2;piggyBac transposable element derived 2
hsa:283432;LINC00485;long intergenic non-protein coding RNA 485
hsa:257358;;uncharacterized LOC257358
hsa:338005;LINC00221,C14orf98,NCRNA00221;long intergenic non-protein coding RNA 221
hsa:283375;SLC39A5,LZT-Hs7,ZIP5;solute carrier family 39 (metal ion transporter), member 5
hsa:284047;CCDC144B;coiled-coil domain containing 144B (pseudogene)
hsa:286076;BREA2;breast cancer estrogen-induced apoptosis 2
hsa:285889;;uncharacterized LOC285889
hsa:283150;FOXR1,FOXN5;forkhead box R1
hsa:283219;KCTD21,KCASH2;potassium channel tetramerisation domain containing 21
hsa:284677;C1orf204;chromosome 1 open reading frame 204
hsa:283856;;uncharacterized LOC283856
hsa:286135;;uncharacterized LOC286135
hsa:283914;;uncharacterized LOC283914
hsa:283875;LINC00514;long intergenic non-protein coding RNA 514
hsa:285593;;uncharacterized LOC285593
hsa:280658;SSX7;synovial sarcoma, X breakpoint 7
hsa:285627;;uncharacterized LOC285627
hsa:285172;FAM126B,HYCC2;family with sequence similarity 126, member B
hsa:285847;;uncharacterized LOC285847
hsa:253970;SFTA3,SFTPH;surfactant associated 3
hsa:283867;;uncharacterized LOC283867
hsa:285908;LINC00174,NCRNA00174;long intergenic non-protein coding RNA 174
hsa:283440;;uncharacterized LOC283440
hsa:284083;C17orf47;chromosome 17 open reading frame 47
hsa:338004;LINC00226,C14orf97,NCRNA00226;long intergenic non-protein coding RNA 226
hsa:285955;SPDYE1,Ringo1,SPDYE,WBSCR19;speedy homolog E1 (Xenopus laevis)
hsa:284114;TMEM102,CBAP;transmembrane protein 102
hsa:253018;HCG27,bCX101P6.9,bPG299F13.9,bQB115I13.2;HLA complex group 27 (non-protein coding)
hsa:284338;PRR19;proline rich 19
hsa:285193;DUSP28,DUSP26,VHP;dual specificity phosphatase 28 (EC:3.1.3.16 3.1.3.48)
hsa:283461;C12orf40;chromosome 12 open reading frame 40
hsa:284739;LINC00176,NCRNA00176,PRR17;long intergenic non-protein coding RNA 176
hsa:283197;LINC00301,C11orf64,NCRNA00301;long intergenic non-protein coding RNA 301
hsa:285313;IGSF10,CMF608;immunoglobulin superfamily, member 10
hsa:284385;;uncharacterized LOC284385
hsa:283755;HERC2P3,D15F37S4;hect domain and RLD 2 pseudogene 3
hsa:319101;KRT73,IRT6IRS3,K6IRS3,KRT6IRS3;keratin 73
hsa:283480;FGF14-IT1;FGF14 intronic transcript 1 (non-protein coding)
hsa:255119;C4orf22;chromosome 4 open reading frame 22
hsa:286183;NKAIN3,FAM77D;Na+/K+ transporting ATPase interacting 3
hsa:285492;;uncharacterized FLJ35424
hsa:253039;;uncharacterized LOC253039
hsa:284661;;uncharacterized LOC284661
hsa:284367;SIGLEC17P,HSPC078,SIGLECP2,SIGLECP3;sialic acid binding Ig-like lectin 17, pseudogene
hsa:283554;GPR137C,TM7SF1L2;G protein-coupled receptor 137C
hsa:254128;;uncharacterized LOC254128
hsa:245934;DEFB121,ESC42RELC;defensin, beta 121
hsa:254013;METTL20,C12orf72;methyltransferase like 20
hsa:245938;DEFB125,DEFB-25;defensin, beta 125
hsa:254187;TSGA10IP,FAM161C;testis specific, 10 interacting protein
hsa:285148;IAH1;isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae)
hsa:285231;FBXW12,FBW12,FBXO12,FBXO35;F-box and WD repeat domain containing 12
hsa:255798;C3orf43,SMCO1;chromosome 3 open reading frame 43
hsa:286187;PPP1R42,LRRC67,TLLR,dtr;protein phosphatase 1, regulatory subunit 42
hsa:285045;LINC00486;long intergenic non-protein coding RNA 486
hsa:255220;TXNDC8,SPTRX-3,TRX6,bA427L11.2;thioredoxin domain containing 8 (spermatozoa)
hsa:246721;POLR2J2,HRPB11B,RPB11b1;polymerase (RNA) II (DNA directed) polypeptide J2
hsa:259239;WFDC11,WAP11;WAP four-disulfide core domain 11
hsa:285370;LINC00606;long intergenic non-protein coding RNA 606
hsa:285735;LINC00326,NCRNA00326;long intergenic non-protein coding RNA 326
hsa:284186;TMEM105;transmembrane protein 105
hsa:400123;LINC00548;long intergenic non-protein coding RNA 548
hsa:340542;BEX5,NGFRAP1L1;brain expressed, X-linked 5
hsa:100505817;;uncharacterized LOC100505817
hsa:100329135;TRPC5OS,TRPC5-AS1;TRPC5 opposite strand
hsa:100141515;C17orf99;chromosome 17 open reading frame 99
hsa:401172;;FLJ33360 protein
hsa:644838;;uncharacterized LOC644838
hsa:388372;CCL4L2,AT744.2,CCL4L,SCYA4L;chemokine (C-C motif) ligand 4-like 2
hsa:375061;FAM89A,C1orf153,RP11-423F24.2;family with sequence similarity 89, member A
hsa:731779;;uncharacterized LOC731779
hsa:374393;FAM111B,CANP;family with sequence similarity 111, member B
hsa:100499405;;uncharacterized LOC100499405
hsa:100534599;ISY1-RAB43;ISY1-RAB43 readthrough
hsa:100505875;;uncharacterized LOC100505875
hsa:440956;IQCF6;IQ motif containing F6
hsa:643723;;uncharacterized LOC643723
hsa:100507351;;uncharacterized LOC100507351
hsa:445815;PALM2-AKAP2,AKAP2;PALM2-AKAP2 readthrough
hsa:643853;TMPPE;transmembrane protein with metallophosphoesterase domain (EC:3.1.-.-)
hsa:387895;;uncharacterized LOC387895
hsa:643441;;uncharacterized LOC643441
hsa:342125;TMC3;transmembrane channel-like 3
hsa:442523;DPY19L2P4;dpy-19-like 2 pseudogene 4 (C. elegans)
hsa:100130776;;uncharacterized LOC100130776
hsa:348761;;uncharacterized LOC348761
hsa:414149;ACBD7,bA455B2.2;acyl-CoA binding domain containing 7
hsa:344875;COL6A4P1,COL6A4,COL6A4P,DIVA,DVWA,VWA6;collagen, type VI, alpha 4 pseudogene 1
hsa:100130889;PSORS1C3,AB023059.1,NCRNA00196;psoriasis susceptibility 1 candidate 3 (non-protein coding)
hsa:100507091;;uncharacterized LOC100507091
hsa:440600;;uncharacterized LOC440600
hsa:100528018;ARL2-SNX15;ARL2-SNX15 readthrough
hsa:387978;C14orf23,c14_5148;chromosome 14 open reading frame 23
hsa:375189;PFN4;profilin family, member 4
hsa:388165;UBE2Q2P1,UBE2QP1;ubiquitin-conjugating enzyme E2Q family member 2 pseudogene 1
hsa:643401;;uncharacterized LOC643401
hsa:339123;JMJD8,C16orf20;jumonji domain containing 8
hsa:342898;SYCN,INSSA1,SYL;syncollin
hsa:729085;FAM198A,C3orf41;family with sequence similarity 198, member A
hsa:339822;;uncharacterized LOC339822
hsa:100132979;GOLGA8DP,GOLGA8D;golgin A8 family, member D, pseudogene
hsa:100507391;;uncharacterized LOC100507391
hsa:100133985;;uncharacterized LOC100133985
hsa:400710;;FLJ26850 protein
hsa:100528019;HSPB2-C11orf52;HSPB2-C11orf52 readthrough (non-protein coding)
hsa:100133050;;glucuronidase, beta pseudogene
hsa:731275;;uncharacterized LOC731275
hsa:729737;;uncharacterized LOC729737
hsa:728806;NSFP1,NSFP;N-ethylmaleimide-sensitive factor pseudogene 1
hsa:388942;;uncharacterized LOC388942
hsa:375133;PI4KAP2;phosphatidylinositol 4-kinase, catalytic, alpha pseudogene 2
hsa:440508;CLEC4GP1;C-type lectin domain family 4, member G pseudogene 1
hsa:441461;;uncharacterized LOC441461
hsa:440452;TBC1D3P2;TBC1 domain family, member 3 pseudogene 2
hsa:388815;LINC00478,C21orf34,C21orf35,FLJ38295;long intergenic non-protein coding RNA 478
hsa:100289561;;uncharacterized LOC100289561
hsa:387066;SNHG5,C6orf160,LINC00044,NCRNA00044,U50HG,bA33E24.2;small nucleolar RNA host gene 5 (non-protein coding)
hsa:100289473;;cytoskeleton associated protein 2-like pseudogene
hsa:728215;FAM155A;family with sequence similarity 155, member A
hsa:100128782;LINC00476,C9orf130,NAG11;long intergenic non-protein coding RNA 476
hsa:100506585;;uncharacterized LOC100506585
hsa:100316904;SAP25;Sin3A-associated protein, 25kDa
hsa:399806;FLJ41350;uncharacterized LOC399806
hsa:348995;NUP43,bA350J20.1,p42;nucleoporin 43kDa
hsa:401565;FAM166A;family with sequence similarity 166, member A
hsa:100507032;;uncharacterized LOC100507032
hsa:348738;C2orf48;chromosome 2 open reading frame 48
hsa:100506668;;uncharacterized LOC100506668
hsa:100506599;;uncharacterized LOC100506599
hsa:414777;HCG18;HLA complex group 18 (non-protein coding)
hsa:440117;;uncharacterized LOC440117
hsa:728989;;phosphodiesterase 4D interacting protein pseudogene
hsa:100533111;ZNF670-ZNF695;ZNF670-ZNF695 readthrough
hsa:100533483;DYX1C1-CCPG1;DYX1C1-CCPG1 readthrough (non-protein coding)
hsa:100507173;;uncharacterized LOC100507173
hsa:100506229;;uncharacterized LOC100506229
hsa:100506384;;uncharacterized LOC100506384
hsa:100507557;;uncharacterized LOC100507557
hsa:503693;LOH12CR2,LOH2CR12;loss of heterozygosity, 12, chromosomal region 2 (non-protein coding)
hsa:728411;GUSBP1;glucuronidase, beta pseudogene 1
hsa:100129482;ZNF37BP,KOX21,ZNF37B;zinc finger protein 37B, pseudogene
hsa:100507194;;uncharacterized LOC100507194
hsa:441009;;uncharacterized LOC441009
hsa:339505;;uncharacterized LOC339505
hsa:100132708;CYP4F30P,C2orf14;cytochrome P450, family 4, subfamily F, polypeptide 30, pseudogene
hsa:100422737;;uncharacterized LOC100422737
hsa:100526737;RBM14-RBM4,COAZ;RBM14-RBM4 readthrough
hsa:343637;RSPO4,C20orf182,CRISTIN4;R-spondin 4
hsa:100505648;;uncharacterized LOC100505648
hsa:100505659;;uncharacterized LOC100505659
hsa:100534611;TM4SF19-TCTEX1D2;TM4SF19-TCTEX1D2 readthrough
hsa:439996;IFIT1B,IFIT1L,bA149I23.6;interferon-induced protein with tetratricopeptide repeats 1B
hsa:100506082;;uncharacterized LOC100506082
hsa:729515;TMEM242,BM033,C6orf35;transmembrane protein 242
hsa:375743;PTAR1;protein prenyltransferase alpha subunit repeat containing 1
hsa:100507334;;two pore channel 3 pseudogene
hsa:643923;;uncharacterized LOC643923
hsa:338785;KRT79,K6L,KRT6L;keratin 79
hsa:100507043;LINC00617;long intergenic non-protein coding RNA 617
hsa:441191;RNF216P1,RNF216L,hCG2040556;ring finger protein 216 pseudogene 1
hsa:401399;PRRT4;proline-rich transmembrane protein 4
hsa:390916;NUDT19,RP2;nudix (nucleoside diphosphate linked moiety X)-type motif 19
hsa:100507027;M1;uncharacterized LOC100507027
hsa:100507433;;uncharacterized LOC100507433
hsa:100506178;;uncharacterized LOC100506178
hsa:338657;CCDC84;coiled-coil domain containing 84
hsa:440288;;uncharacterized LOC440288
hsa:729506;;uncharacterized LOC729506
hsa:728606;;uncharacterized LOC728606
hsa:340073;;uncharacterized LOC340073
hsa:339593;;uncharacterized LOC339593
hsa:338817;;uncharacterized LOC338817
hsa:340107;;uncharacterized LOC340107
hsa:442582;STAG3L2,STAG3L1,STAG3L3;stromal antigen 3-like 2
hsa:440028;;uncharacterized LOC440028
hsa:339145;FAM92B;family with sequence similarity 92, member B
hsa:353189;SLCO4C1,OATP-H,OATP-M1,OATP4C1,OATPX,PRO2176,SLC21A20;solute carrier organic anion transporter family, member 4C1
hsa:728568;C12orf73;chromosome 12 open reading frame 73
hsa:646762;;uncharacterized LOC646762
hsa:399818;METTL10,C10orf138,Em:AC068896.3;methyltransferase like 10
hsa:340357;;uncharacterized LOC340357
hsa:100534612;C1QTNF3-AMACR;C1QTNF3-AMACR readthrough
hsa:729614;FLJ37453;uncharacterized LOC729614
hsa:650794;MIPEPP3,LINC00539;mitochondrial intermediate peptidase pseudogene 3
hsa:100294145;;uncharacterized LOC100294145
hsa:100506050;;uncharacterized LOC100506050
hsa:100506305;;uncharacterized LOC100506305
hsa:344658;SAMD7;sterile alpha motif domain containing 7
hsa:100132565;GOLGA8F;golgin A8 family, member F
hsa:100128505;;uncharacterized LOC100128505
hsa:645884;RPS7P5,RPS7_2_183;ribosomal protein S7 pseudogene 5
hsa:100527960;HEATR8-TTC4;HEATR8-TTC4 readthrough
hsa:100271832;;uncharacterized LOC100271832
hsa:100288432;;uncharacterized LOC100288432
hsa:415117;STX19;syntaxin 19
hsa:399706;LINC00200,C10orf139,NCRNA00200,RP11-529L18.1;long intergenic non-protein coding RNA 200
hsa:440423;SUZ12P1,SUZ12P;suppressor of zeste 12 homolog pseudogene 1
hsa:440533;PSG8,PSG1;pregnancy specific beta-1-glycoprotein 8
hsa:100292680;;uncharacterized LOC100292680
hsa:100505738;;uncharacterized LOC100505738
hsa:730183;;uncharacterized LOC730183
hsa:404550;C16orf74;chromosome 16 open reading frame 74
hsa:100507362;;uncharacterized LOC100507362
hsa:342527;SMTNL2;smoothelin-like 2
hsa:386627;FLJ38109;uncharacterized LOC386627
hsa:100499227;;uncharacterized LOC100499227
hsa:399474;TMEM200B,TTMB;transmembrane protein 200B
hsa:340075;ARSI;arylsulfatase family, member I
hsa:401535;C9orf170;chromosome 9 open reading frame 170
hsa:100507299;;uncharacterized LOC100507299
hsa:100130880;;uncharacterized LOC100130880
hsa:100379345;MIR181A2HG;MIR181A2 host gene (non-protein coding)
hsa:100129066;UNQ6494;uncharacterized LOC100129066
hsa:653712;;intraflagellar transport 122 homolog (Chlamydomonas) pseudogene
hsa:100529855;ZNF625-ZNF20;ZNF625-ZNF20 readthrough
hsa:400891;;chromosome 14 open reading frame 166B pseudogene
hsa:339874;;uncharacterized LOC339874
hsa:389765;;kinesin family member 27 pseudogene
hsa:338661;TMEM225,PMP22CD;transmembrane protein 225
hsa:100529097;RPL36A-HNRNPH2;RPL36A-HNRNPH2 readthrough
hsa:388550;CEACAM22P;carcinoembryonic antigen-related cell adhesion molecule 2, pseudogene
hsa:728716;;uncharacterized LOC728716
hsa:644997;C1orf200;chromosome 1 open reading frame 200
hsa:339344;MYPOP,P42pop;Myb-related transcription factor, partner of profilin
hsa:387590;TPTEP1,psiTPTE22;transmembrane phosphatase with tensin homology pseudogene 1
hsa:100130418;CECR7,SAHL1;cat eye syndrome chromosome region, candidate 7 (non-protein coding)
hsa:100132111;;uncharacterized LOC100132111
hsa:619455;SPANXA2-OT1,CXorf18;SPANXA2 overlapping transcript 1 (non-protein coding)
hsa:439916;LINC00615,C12orf37;long intergenic non-protein coding RNA 615
hsa:440823;MIAT,C22orf35,GOMAFU,LINC00066,NCRNA00066,RNCR2;myocardial infarction associated transcript (non-protein coding)
hsa:440419;TBC1D3P5;TBC1 domain family, member 3 pseudogene 5
hsa:100132101;HERC2P7;hect domain and RLD 2 pseudogene 7
hsa:400512;FLJ21408;uncharacterized LOC400512
hsa:100506469;;uncharacterized LOC100506469
hsa:645513;;uncharacterized LOC645513
hsa:344595;;uncharacterized LOC344595
hsa:378807;CATSPER4;cation channel, sperm associated 4
hsa:345757;FAM174A,TMEM157,UNQ1912;family with sequence similarity 174, member A
hsa:339665;SLC35E4;solute carrier family 35, member E4
hsa:360030;NANOGNB;NANOG neighbor homeobox
hsa:100505687;;uncharacterized LOC100505687
hsa:100506207;;uncharacterized LOC100506207
hsa:441897;PGCP1;progastricsin (pepsinogen C) pseudogene 1
hsa:339184;CCDC144NL;coiled-coil domain containing 144 family, N-terminal like
hsa:643376;BTBD18;BTB (POZ) domain containing 18
hsa:100302640;;uncharacterized LOC100302640
hsa:100506321;;uncharacterized LOC100506321
hsa:340390;;KIAA1875
hsa:100128239;;uncharacterized LOC100128239
hsa:100129961;;uncharacterized LOC100129961
hsa:768096;HAR1A,HAR1F,LINC00064,NCRNA00064;highly accelerated region 1A (non-protein coding)
hsa:339568;;uncharacterized LOC339568
hsa:768097;HAR1B,HAR1R,LINC00065,NCRNA00065;highly accelerated region 1B (non-protein coding)
hsa:100271849;MEF2B,RSRFR2;myocyte enhancer factor 2B
hsa:100507254;;uncharacterized LOC100507254
hsa:408187;SPINK14,SPINK5L2;serine peptidase inhibitor, Kazal type 14 (putative)
hsa:643180;CCT6P3,CCT6-3P;chaperonin containing TCP1, subunit 6 (zeta) pseudogene 3
hsa:100192420;FLJ41941;uncharacterized LOC100192420
hsa:729689;FAM90A2P;family with sequence similarity 90, member A2 pseudogene
hsa:100529240;ZNF816-ZNF321P,ZNF816-ZNF321;ZNF816-ZNF321P readthrough
hsa:100131096;;uncharacterized LOC100131096
hsa:441212;RP9P;retinitis pigmentosa 9 pseudogene
hsa:387911;C1QTNF9B,CTRP9B;C1q and tumor necrosis factor related protein 9B
hsa:653238;GTF2H2B;general transcription factor IIH, polypeptide 2B (pseudogene)
hsa:441601;;septin 7 pseudogene
hsa:441172;FLJ46906;uncharacterized LOC441172
hsa:595135;PGM5P2;phosphoglucomutase 5 pseudogene 2
hsa:388335;TMEM220;transmembrane protein 220
hsa:641638;SNHG6,HBII-276HG,NCRNA00058,U87HG;small nucleolar RNA host gene 6 (non-protein coding)
hsa:389207;GRXCR1,DFNB25;glutaredoxin, cysteine rich 1
hsa:642280;ZNF876P;zinc finger protein 876, pseudogene
hsa:377841;ENTPD8,GLSR2492,NTPDase-8,UNQ2492;ectonucleoside triphosphate diphosphohydrolase 8 (EC:3.6.1.5)
hsa:100132735;;uncharacterized LOC100132735
hsa:388555;IGFL3,UNQ483;IGF-like family member 3
hsa:339535;;uncharacterized LOC339535
hsa:100132707;;uncharacterized LOC100132707
hsa:375940;FLJ46361;deleted in malignant brain tumors 1 pseudogene
hsa:440518;;golgin A2 pseudogene
hsa:339230;CCDC137;coiled-coil domain containing 137
hsa:400696;LGALS17A;Charcot-Leyden crystal protein pseudogene
hsa:339788;;uncharacterized LOC339788
hsa:399670;RPL13AP17,RPL13A_6_816;ribosomal protein L13a pseudogene 17
hsa:100532724;NPHP3-ACAD11;NPHP3-ACAD11 readthrough
hsa:100506083;;uncharacterized LOC100506083
hsa:645455;CEP170P1,CEP170L,FAM68B,KIAA0470L;centrosomal protein 170kDa pseudogene 1
hsa:440563;;heterogeneous nuclear ribonucleoprotein C-like
hsa:100134259;;uncharacterized LOC100134259
hsa:554202;MIR31HG;MIR31 host gene (non-protein coding)
hsa:724102;SNHG4,NCRNA00059,U19H;small nucleolar RNA host gene 4 (non-protein coding)
hsa:100506655;;uncharacterized LOC100506655
hsa:100505676;;uncharacterized LOC100505676
hsa:399761;BMS1P5,BMS1LP5;BMS1 pseudogene 5
hsa:644844;PHGR1;proline/histidine/glycine-rich 1
hsa:642929;;general transcription factor II, i pseudogene
hsa:100507205;;uncharacterized LOC100507205
hsa:100506134;;uncharacterized LOC100506134
hsa:348645;C22orf34;chromosome 22 open reading frame 34
hsa:100529207;RAD51L3-RFFL;RAD51L3-RFFL readthrough
hsa:100533195;FAM24B-CUZD1;FAM24B-CUZD1 readthrough
hsa:339166;;uncharacterized LOC339166
hsa:400221;FLJ22447;uncharacterized LOC400221
hsa:340146;SLC35D3,FRCL1,bA55K22.3;solute carrier family 35, member D3
hsa:340074;;uncharacterized LOC340074
hsa:100506755;MIR497HG;mir-497-195 cluster host gene (non-protein coding)
hsa:100131234;;familial acute myelogenous leukemia related factor
hsa:100288198;;uncharacterized LOC100288198
hsa:100192426;;uncharacterized LOC100192426
hsa:100131726;HCCC11,HCCC11_v1,HCCC11_v2;HCC-related HCC-C11_v3
hsa:728613;;programmed cell death 6 pseudogene
hsa:100131320;;uncharacterized LOC100131320
hsa:441054;C4orf47;chromosome 4 open reading frame 47
hsa:399744;;uncharacterized LOC399744
hsa:643719;SCGB1B2P,SCGB4A1P;secretoglobin, family 1B, member 2, pseudogene
hsa:388333;SPDYE4;speedy homolog E4 (Xenopus laevis)
hsa:448835;LCE6A,C1orf44;late cornified envelope 6A
hsa:100287225;;uncharacterized LOC100287225
hsa:642938;FAM196A,C10orf141;family with sequence similarity 196, member A
hsa:374387;;uncharacterized DKFZp779M0652
hsa:646938;;TBC1 domain family, member 2B pseudogene
hsa:344758;GPR149,IEDA,PGR10;G protein-coupled receptor 149
hsa:374491;TPTE2P6;transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 6
hsa:348825;TPRXL;tetra-peptide repeat homeobox-like
hsa:401052;;uncharacterized LOC401052
hsa:339803;;uncharacterized LOC339803
hsa:100188893;TOMM6,OBTP;translocase of outer mitochondrial membrane 6 homolog (yeast)
hsa:402573;C7orf61;chromosome 7 open reading frame 61
hsa:342666;LRRC37A11P;leucine rich repeat containing 37, member A11, pseudogene
hsa:374618;TEX9;testis expressed 9
hsa:100507462;;uncharacterized LOC100507462
hsa:389634;;uncharacterized LOC389634
hsa:100131551;;uncharacterized LOC100131551
hsa:347853;TBX10,TBX13,TBX7;T-box 10
hsa:400624;;FLJ45079 protein
hsa:339669;TEX33,C22orf33,EAN57,cE81G9.2;testis expressed 33
hsa:389043;;uncharacterized LOC389043
hsa:100131347;;RAD52 motif 1 pseudogene
hsa:100507537;;uncharacterized LOC100507537
hsa:735301;SNHG9,NCRNA00062;small nucleolar RNA host gene 9 (non-protein coding)
hsa:388849;;uncharacterized LOC388849
hsa:404217;CTXN1,CTXN;cortexin 1
hsa:100507244;;uncharacterized LOC100507244
hsa:375341;C3orf62;chromosome 3 open reading frame 62
hsa:339005;WHAMMP3,WHAMML1,WHDC1L1;WAS protein homolog associated with actin, golgi membranes and microtubules pseudogene 3
hsa:613212;CTXN3,KABE;cortexin 3
hsa:100131047;;uncharacterized LOC100131047
hsa:389320;C5orf48;chromosome 5 open reading frame 48
hsa:100133612;;uncharacterized LOC100133612
hsa:653501;;zinc finger protein 658 pseudogene
hsa:449493;DEFA10P;defensin, alpha 10 pseudogene
hsa:643406;;uncharacterized LOC643406
hsa:100128420;;uncharacterized LOC100128420
hsa:100507489;;uncharacterized LOC100507489
hsa:375295;;uncharacterized LOC375295
hsa:440434;;aminopeptidase puromycin sensitive pseudogene
hsa:389558;FAM180A,UNQ1940;family with sequence similarity 180, member A
hsa:399669;ZNF321P,ZNF321;zinc finger protein 321, pseudogene
hsa:100532726;NDUFC2-KCTD14;NDUFC2-KCTD14 readthrough
hsa:100507387;;uncharacterized LOC100507387
hsa:128439;SNHG11,C20orf198,LINC00101,NCRNA00101;small nucleolar RNA host gene 11 (non-protein coding)
hsa:389649;C8orf86;chromosome 8 open reading frame 86
hsa:401138;AMTN,UNQ689;amelotin
hsa:389524;GTF2IRD2B;GTF2I repeat domain containing 2B
hsa:100527963;PMF1-BGLAP,PMF1;PMF1-BGLAP readthrough
hsa:100302692;FTX,LINC00182,MIR374AHG,NCRNA00182;FTX transcript, XIST regulator (non-protein coding)
hsa:100507373;;uncharacterized LOC100507373
hsa:374354;NHLRC2;NHL repeat containing 2
hsa:440560;PRAMEF11,RP5-845O24.2;PRAME family member 11
hsa:641365;LINC00616;long intergenic non-protein coding RNA 616
hsa:389831;;uncharacterized LOC389831
hsa:100507584;;uncharacterized LOC100507584
hsa:375690;WASH5P;WAS protein family homolog 5 pseudogene
hsa:441687;TEX21P;testis expressed 21, pseudogene
hsa:399827;;FLJ46300 protein
hsa:440955;TMEM89;transmembrane protein 89
hsa:648691;;uncharacterized LOC648691
hsa:387837;CLEC12B,UNQ5782;C-type lectin domain family 12, member B
hsa:100130298;;hCG1816373-like
hsa:497661;C18orf32;chromosome 18 open reading frame 32
hsa:403339;DEFB133;defensin, beta 133
hsa:100125556;FAM86JP;family with sequence similarity 86, member A pseudogene
hsa:389715;FAM205B,C9orf144;transmembrane protein C9orf144B pseudogene
hsa:100131211;TMEM194B;transmembrane protein 194B
hsa:554251;FBXO48;F-box protein 48
hsa:728724;;hCG1814486
hsa:100288069;;general transcription factor IIi pseudogene
hsa:641649;TMEM91,DSPC3,IFITMD6;transmembrane protein 91
hsa:445372;TRIM6-TRIM34,IFP1,RNF21,TRIM34;TRIM6-TRIM34 readthrough
hsa:643224;TUBBP5;tubulin, beta pseudogene 5
hsa:374918;IGFL1,APRG644,UNQ644;IGF-like family member 1
hsa:401074;;uncharacterized LOC401074
hsa:100506804;;uncharacterized LOC100506804
hsa:729375;FAM86HP;family with sequence similarity 86, member A pseudogene
hsa:642987;TMEM232;transmembrane protein 232
hsa:441501;FLJ46446;uncharacterized LOC441501
hsa:100128398;;uncharacterized LOC100128398
hsa:401983;ZNF847P,gm127;zinc finger protein 847, pseudogene
hsa:100528030;POC1B-GALNT4;POC1B-GALNT4 readthrough
hsa:439921;MXRA7,PS1TP1,TMAP1;matrix-remodelling associated 7
hsa:728264;MIR143HG;MIR143 host gene (non-protein coding)
hsa:100507066;;uncharacterized LOC100507066
hsa:400629;TEX19;testis expressed 19
hsa:338862;LINC00550;long intergenic non-protein coding RNA 550
hsa:644873;FLJ33630;uncharacterized LOC644873
hsa:100128164;;four and a half LIM domains 1 pseudogene
hsa:100533179;UBE2F-SCLY;UBE2F-SCLY readthrough
hsa:374955;SPATA21,spergen-2,spergen2;spermatogenesis associated 21
hsa:388574;FLJ43681;ribosomal protein L23a pseudogene
hsa:100294720;NHEG1;neuroblastoma highly expressed 1
hsa:100652739;;uncharacterized LOC100652739
hsa:440300;;chondroitin sulfate proteoglycan 4 pseudogene
hsa:348751;FONG;uncharacterized LOC348751
hsa:100529067;SERF2-C15ORF63;SERF2-C15orf63 readthrough
hsa:440896;;uncharacterized LOC440896
hsa:643432;TSG1;tumor suppressor TSG1
hsa:388796;;uncharacterized LOC388796
hsa:400793;C1orf226;chromosome 1 open reading frame 226
hsa:554226;ANKRD30BL,ANKRD30BP3,NCRNA00164;ankyrin repeat domain 30B-like
hsa:400941;LINC00487;long intergenic non-protein coding RNA 487
hsa:100128750;;uncharacterized LOC100128750
hsa:399959;MIR100HG;mir-100-let-7a-2 cluster host gene (non-protein coding)
hsa:728233;PI4KAP1;phosphatidylinositol 4-kinase, catalytic, alpha pseudogene 1
hsa:347735;SERINC2,PRO0899,TDE2,TDE2L;serine incorporator 2
hsa:100130451;;uncharacterized LOC100130451
hsa:100505806;;uncharacterized LOC100505806
hsa:401613;DKFZp686D0853;uncharacterized LOC401613
hsa:100527964;;uncharacterized LOC100527964
hsa:100131138;;uncharacterized LOC100131138
hsa:340745;LRIT2,LRRC22;leucine-rich repeat, immunoglobulin-like and transmembrane domains 2
hsa:401337;FLJ45974;uncharacterized LOC401337
hsa:389119;FAM212A,C3orf54,INKA1;family with sequence similarity 212, member A
hsa:100133286;;uncharacterized LOC100133286
hsa:408029;C2orf27B;chromosome 2 open reading frame 27B
hsa:388948;;uncharacterized LOC388948
hsa:375035;SFT2D2,UNQ512,dJ747L4.C1.2;SFT2 domain containing 2
hsa:548644;POLR2J3,POLR2J2,RPB11b1,RPB11b2;polymerase (RNA) II (DNA directed) polypeptide J3
hsa:729911;;uncharacterized LOC729911
hsa:100652768;;uncharacterized LOC100652768
hsa:441204;;uncharacterized LOC441204
hsa:440173;;uncharacterized LOC440173
hsa:343069;HNRNPCL1,HNRPCL1;heterogeneous nuclear ribonucleoprotein C-like 1
hsa:441094;FLJ42709;uncharacterized LOC441094
hsa:440910;;uncharacterized LOC440910
hsa:400073;C12orf76;chromosome 12 open reading frame 76
hsa:340591;CA5BP1,CA5BL,CA5BP,PRO2325;carbonic anhydrase VB pseudogene 1
hsa:100288346;;uncharacterized LOC100288346
hsa:400735;PRAMEF4,RP5-845O24.6;PRAME family member 4
hsa:100505716;;uncharacterized LOC100505716
hsa:100652770;;uncharacterized LOC100652770
hsa:100130275;;uncharacterized LOC100130275
hsa:100128554;;uncharacterized LOC100128554
hsa:400657;;uncharacterized LOC400657
hsa:100130155;;uncharacterized LOC100130155
hsa:729975;FLJ30403;uncharacterized LOC729975
hsa:100130093;;uncharacterized LOC100130093
hsa:401177;;uncharacterized LOC401177
hsa:389084;C2orf82,UNQ830;chromosome 2 open reading frame 82
hsa:100652791;;uncharacterized LOC100652791
hsa:414926;LINC00593,C15orf50;long intergenic non-protein coding RNA 593
hsa:100526664;LY75-CD302;LY75-CD302 readthrough
hsa:100130449;PP14571;uncharacterized LOC100130449
hsa:619351;LINC00589,C8orf75;long intergenic non-protein coding RNA 589
hsa:100129316;;uncharacterized LOC100129316
hsa:401134;;uncharacterized LOC401134
hsa:400798;C1orf220;chromosome 1 open reading frame 220
hsa:652968;GATSL3;GATS protein-like 3
hsa:399668;LINC00086,NCRNA00086;long intergenic non-protein coding RNA 86
hsa:347732;CATSPER3,CACRC;cation channel, sperm associated 3
hsa:100128593;;uncharacterized LOC100128593
hsa:401081;FLJ22763;uncharacterized LOC401081
hsa:100093630;SNHG8,LINC00060,NCRNA00060;small nucleolar RNA host gene 8 (non-protein coding)
hsa:100506776;;uncharacterized LOC100506776
hsa:414152;C10orf105;chromosome 10 open reading frame 105
hsa:791114;PWRN1,NCRNA00198;Prader-Willi region non-protein coding RNA 1
hsa:677779;LINC00488,C3orf66;long intergenic non-protein coding RNA 488
hsa:731424;;uncharacterized LOC731424
hsa:338811;FAM19A2,TAFA-2,TAFA2;family with sequence similarity 19 (chemokine (C-C motif)-like), member A2
hsa:340017;;uncharacterized LOC340017
hsa:390213;DOC2GP;double C2-like domains, gamma, pseudogene
hsa:100526740;ATP5J2-PTCD1;ATP5J2-PTCD1 readthrough
hsa:100129460;DPY19L1P1;dpy-19-like 1 pseudogene 1 (C. elegans)
hsa:400759;GBP1P1;guanylate binding protein 1, interferon-inducible pseudogene 1
hsa:100128496;C20orf78,dJ1068E13.1;chromosome 20 open reading frame 78
hsa:100287879;;uncharacterized LOC100287879
hsa:401260;FLJ41649;uncharacterized LOC401260
hsa:100133091;;uncharacterized LOC100133091
hsa:348840;ANKRD18DP;ankyrin repeat domain 18D, pseudogene
hsa:554203;JPX,ENOX,LINC00183,NCRNA00183;JPX transcript, XIST activator (non-protein coding)
hsa:440278;CATSPER2P1;cation channel, sperm associated 2 pseudogene 1
hsa:375387;LRRC33,GARPL1,UNQ3030;leucine rich repeat containing 33
hsa:440519;ZNF724P;zinc finger protein 724, pseudogene
hsa:389136;VGLL3,VGL-3,VGL3;vestigial like 3 (Drosophila)
hsa:100134938;UPK3BL,UPLP;uroplakin 3B-like
hsa:643733;;caspase 4, apoptosis-related cysteine peptidase pseudogene
hsa:493754;;RAB guanine nucleotide exchange factor (GEF) 1 pseudogene
hsa:100359394;LINC00102,NCRNA00102;long intergenic non-protein coding RNA 102
hsa:388524;RPSAP58,RPSA_30_1642;ribosomal protein SA pseudogene 58
hsa:344967;;acyl-CoA thioesterase 7 pseudogene
hsa:642819;ZNF487P,KRBO1,ZNF487;zinc finger protein 487, pseudogene
hsa:440362;HERC2P4,D16F37S5;hect domain and RLD 2 pseudogene 4
hsa:401237;LINC00340;long intergenic non-protein coding RNA 340
hsa:400961;PAIP2B;poly(A) binding protein interacting protein 2B
hsa:100130855;;uncharacterized LOC100130855
hsa:653316;FAM153C,NY-REN-7-like;family with sequence similarity 153, member C, pseudogene
hsa:100506713;;uncharacterized LOC100506713
hsa:348801;LNP1;leukemia NUP98 fusion partner 1
hsa:440799;P2RX6P;purinergic receptor P2X, ligand-gated ion channel, 6 pseudogene
hsa:440700;;carbonic anhydrase XIV (CA14) pseudogene
hsa:391267;ANKRD20A11P,C21orf81;ankyrin repeat domain 20 family, member A11, pseudogene
hsa:100132215;;uncharacterized LOC100132215
hsa:344905;ATP13A5;ATPase type 13A5 (EC:3.6.3.-)
hsa:100533952;;RBAK-LOC389458 readthrough
hsa:440225;NF1P2,NF1HHS;neurofibromin 1 pseudogene 2
hsa:402779;;uncharacterized LOC402779
hsa:654817;NCF1C,SH3PXD1C;neutrophil cytosolic factor 1C pseudogene
hsa:728228;;uncharacterized LOC728228
hsa:574016;CLLU1OS;chronic lymphocytic leukemia up-regulated 1 opposite strand
hsa:100133445;;uncharacterized LOC100133445
hsa:401082;FLJ25363;uncharacterized LOC401082
hsa:100506388;;uncharacterized LOC100506388
hsa:493911;PHOSPHO2;phosphatase, orphan 2 (EC:3.1.3.74)
hsa:347365;ITIH6,ITIH5L,UNQ6369,dJ14O9.1;inter-alpha-trypsin inhibitor heavy chain family, member 6
hsa:100506840;IQCF4;IQ motif containing F5 pseudogene
hsa:400761;FLJ27354;uncharacterized LOC400761
hsa:100130950;;uncharacterized LOC100130950
hsa:401039;;FLJ43879 protein
hsa:374819;LRRC37A3,LRRC37A;leucine rich repeat containing 37, member A3
hsa:399815;;chromosome 10 open reading frame 88 pseudogene
hsa:619207;;scavenger receptor protein family member
hsa:728081;LINC00290,NCRNA00290;long intergenic non-protein coding RNA 290
hsa:400685;;uncharacterized LOC400685
hsa:440248;HERC2P9;hect domain and RLD 2 pseudogene 9
hsa:399697;CTXN2;cortexin 2
hsa:100507156;;uncharacterized LOC100507156
hsa:100652781;SNX29P1,RUNDC2B,RUNDC2L;sorting nexin 29 pseudogene 1
hsa:100507135;SPG20OS,C13orf43;SPG20 opposite strand
hsa:645434;;uncharacterized LOC645434
hsa:100271722;;uncharacterized LOC100271722
hsa:440561;PRAMEF6;PRAME family member 6
hsa:400654;;uncharacterized LOC400654
hsa:100130894;;uncharacterized LOC100130894
hsa:100288123;;uncharacterized LOC100288123
hsa:645700;ZNF890P;zinc finger protein 890, pseudogene
hsa:100505768;;uncharacterized LOC100505768
hsa:401320;;uncharacterized LOC401320
hsa:404636;FAM45A;family with sequence similarity 45, member A
hsa:494143;CHAC2;ChaC, cation transport regulator homolog 2 (E. coli)
hsa:100130954;;uncharacterized LOC100130954
hsa:387923;SERP2,C13orf21,RP11-269C23.1,bA269C23.1;stress-associated endoplasmic reticulum protein family member 2
hsa:400548;;uncharacterized LOC400548
hsa:653160;;uncharacterized LOC653160
hsa:100534012;TNFAIP8L2-SCNM1;TNFAIP8L2-SCNM1 readthrough
hsa:727910;TLCD2;TLC domain containing 2
hsa:644554;;uncharacterized LOC644554
hsa:400533;FLJ26245;uncharacterized LOC400533
hsa:653399;GSTTP2;glutathione S-transferase theta pseudogene 2
hsa:100529251;CKLF-CMTM1;CKLF-CMTM1 readthrough
hsa:347487;CXorf66;chromosome X open reading frame 66
hsa:642345;MIR4500HG;MIR4500 host gene (non-protein coding)
hsa:644076;GLYCAM1;glycosylation dependent cell adhesion molecule 1 (pseudogene)
hsa:379025;FLJ31306;uncharacterized LOC379025
hsa:441058;MGC39584;uncharacterized LOC441058
hsa:730227;;uncharacterized LOC730227
hsa:100288778;;WAS protein family homolog 1 pseudogene
hsa:606293;KLKP1,KARMA,KLK31P,KRSP1,PsiKLK1,YKLK1;kallikrein pseudogene 1
hsa:352954;GATS,STAG3OS;GATS, stromal antigen 3 opposite strand
hsa:402483;FLJ45340;uncharacterized LOC402483
hsa:392459;CXXC1P1,CXorf25,NCRNA00236;CXXC finger protein 1 pseudogene 1
hsa:100130700;;uncharacterized LOC100130700
hsa:641516;KC6;keratoconus gene 6
hsa:404785;POTEG,A26C2,ACTBL1,CT104.4,POTE-14,POTE14,POTE14alpha,POTE22;POTE ankyrin domain family, member G
hsa:389124;IQCF5;IQ motif containing F5
hsa:100130015;;5-hydroxyisourate hydrolase pseudogene
hsa:729956;SHISA7;shisa homolog 7 (Xenopus laevis)
hsa:728858;C12orf71;chromosome 12 open reading frame 71
hsa:440224;CXADRP3;coxsackie virus and adenovirus receptor pseudogene 3
hsa:415056;;uncharacterized LOC415056
hsa:400087;FLJ37505;uncharacterized LOC400087
hsa:388011;C14orf64;chromosome 14 open reading frame 64
hsa:100506990;;uncharacterized LOC100506990
hsa:646626;;uncharacterized LOC646626
hsa:100131691;;uncharacterized LOC100131691
hsa:400046;FLJ41278;uncharacterized LOC400046
hsa:728192;LINC00460;long intergenic non-protein coding RNA 460
hsa:100532731;COMMD3-BMI1;COMMD3-BMI1 readthrough
hsa:388789;LINC00493;long intergenic non-protein coding RNA 493
hsa:339168;TMEM95,UNQ9390;transmembrane protein 95
hsa:646508;FAM90A27P;family with sequence similarity 90, member A27, pseudogene
hsa:646329;;uncharacterized LOC646329
hsa:100302652;GPR75-ASB3;GPR75-ASB3 readthrough
hsa:613210;DEFB136,DEFB137;defensin, beta 136
hsa:645367;GGT8P,GGT1P1;gamma-glutamyltransferase 8 pseudogene
hsa:100188949;LINC00426;long intergenic non-protein coding RNA 426
hsa:100131067;;uncharacterized LOC100131067
hsa:100302691;LINC00184,HANC,NCRNA00184;long intergenic non-protein coding RNA 184
hsa:100507206;;uncharacterized LOC100507206
hsa:374443;;C-type lectin domain family 2, member D pseudogene
hsa:339967;TMPRSS11A,ECRG1;transmembrane protease, serine 11A
hsa:388182;FLJ42289;uncharacterized LOC388182
hsa:440356;;uncharacterized LOC440356
hsa:391004;PRAMEF17;PRAME family member 17
hsa:552891;DNAJC25-GNG10;DNAJC25-GNG10 readthrough
hsa:100526760;ABHD14A-ACY1;ABHD14A-ACY1 readthrough (non-protein coding)
hsa:100128675;;uncharacterized LOC100128675
hsa:643236;TMEM72,C10orf127,KSP37,bA285G1.3;transmembrane protein 72
hsa:343521;TCTEX1D4;Tctex1 domain containing 4
hsa:401106;FLJ34208;uncharacterized LOC401106
hsa:387723;;uncharacterized LOC387723
hsa:401253;LINC00336,C6orf227,NCRNA00336;long intergenic non-protein coding RNA 336
hsa:100134868;;uncharacterized LOC100134868
hsa:644669;;ankyrin repeat domain 30B pseudogene
hsa:100505841;;zinc finger protein 474-like
hsa:390992;HES3,bHLHb43;hairy and enhancer of split 3 (Drosophila)
hsa:387036;GUSBP2,GUSBL1,GUSBP4,SMA3-L,SMAC3L,SMAC3L2,b55C20.1,bA239L20.1,bA239L20.5,bGLU-Lp;glucuronidase, beta pseudogene 2
hsa:400569;MED11;mediator complex subunit 11
hsa:440556;FLJ42875;uncharacterized LOC440556
hsa:552859;LINC00251,C8orf25,NCRNA00251;long intergenic non-protein coding RNA 251
hsa:100169752;;uncharacterized LOC100169752
hsa:100507410;;uncharacterized LOC100507410
hsa:340508;;growth arrest-specific 2 like 1 pseudogene
hsa:100101938;ANKRD26P3,LINC00414;ankyrin repeat domain 26 pseudogene 3
hsa:338651;;uncharacterized LOC338651
hsa:347404;LANCL3;LanC lantibiotic synthetase component C-like 3 (bacterial)
hsa:387097;C6orf147;chromosome 6 open reading frame 147
hsa:388719;LINC00272,C1orf120,NCRNA00272,RP1-223H12.3;long intergenic non-protein coding RNA 272
hsa:100128076;;protein tyrosine phosphatase pseudogene
hsa:340113;;uncharacterized LOC340113
hsa:400084;;uncharacterized LOC400084
hsa:387065;HMGA1P7,HMGA1L7;high mobility group AT-hook 1 pseudogene 7
hsa:401335;C7orf65;chromosome 7 open reading frame 65
hsa:550112;;uncharacterized LOC550112
hsa:100507600;;uncharacterized LOC100507600
hsa:474343;SPIN2B,SPIN-2,SPIN2_duplicate,dJ323P24.2;spindlin family, member 2B
hsa:652972;LRRC37A5P,C9orf29;leucine rich repeat containing 37, member A5, pseudogene
hsa:339302;CPLX4,CPX-IV,CPXIV;complexin 4
hsa:100130017;FTLP10;ferritin, light polypeptide pseudogene 10
hsa:503569;;uncharacterized protein FLJ35946
hsa:375519;GJB7,CX25,bA136M9.1,connexin25;gap junction protein, beta 7, 25kDa
hsa:729991;MEF2BNB;MEF2B neighbor
hsa:400655;;uncharacterized LOC400655
hsa:400578;KRT16P2;keratin 16 pseudogene 2
hsa:339977;LRRC66;leucine rich repeat containing 66
hsa:100271846;ERVV-2,ENVV2,HERV-V2;endogenous retrovirus group V, member 2
hsa:727982;;uncharacterized LOC727982
hsa:340206;TREML3P,TLT3,TREML3;triggering receptor expressed on myeloid cells-like 3, pseudogene
hsa:100302736;TMED7-TICAM2,TAG;TMED7-TICAM2 readthrough
hsa:100652999;;uncharacterized LOC100652999
hsa:401109;;uncharacterized LOC401109
hsa:100529211;C17orf61-PLSCR3;C17orf61-PLSCR3 readthrough
hsa:440040;;glutamate receptor, metabotropic 5 pseudogene
hsa:401898;ZNF833P,ZNF833;zinc finger protein 833, pseudogene
hsa:100129213;SLC39A12-AS1;uncharacterized LOC100129213
hsa:729220;FLJ45513;uncharacterized LOC729220
hsa:388695;LYSMD1,RP11-68I18.5;LysM, putative peptidoglycan-binding, domain containing 1
hsa:100130264;;uncharacterized LOC100130264
hsa:339807;;uncharacterized LOC339807
hsa:100133461;;uncharacterized LOC100133461
hsa:100652909;;uncharacterized LOC100652909
hsa:100131564;;uncharacterized LOC100131564
hsa:100289187;;transmembrane protein 225-like
hsa:374860;ANKRD30B,NY-BR-1.1;ankyrin repeat domain 30B
hsa:339501;PRSS38,MPN2;protease, serine, 38
hsa:339231;ARL16;ADP-ribosylation factor-like 16
hsa:400043;;uncharacterized LOC400043
hsa:400620;;uncharacterized LOC400620
hsa:541471;;uncharacterized LOC541471
hsa:441631;TSPAN11,VSSW1971;tetraspanin 11
hsa:646600;C3orf65;chromosome 3 open reading frame 65
hsa:100233156;;tektin 4 pseudogene
hsa:728378;POTEF,A26C1B,ACTB,POTE2alpha,POTEACTIN;POTE ankyrin domain family, member F
hsa:100506451;;uncharacterized LOC100506451
hsa:342096;GOLGA6A,GLP,GOLGA6;golgin A6 family, member A
hsa:100505929;C21orf37;chromosome 21 open reading frame 37
hsa:342900;LEUTX;leucine twenty homeobox
hsa:647087;C7orf73,PL-5283;chromosome 7 open reading frame 73
hsa:646405;TPTE2P1;transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 1
hsa:100506123;;uncharacterized LOC100506123
hsa:100144602;;uncharacterized LOC100144602
hsa:728053;BMS1P1,BMS1LP1,bA556L1.3;BMS1 pseudogene 1
hsa:388722;C1orf53;chromosome 1 open reading frame 53
hsa:401288;LINC00242,C6orf122,NCRNA00242,dJ266L20.5;long intergenic non-protein coding RNA 242
hsa:497634;LINC00293,BEYLA,NCRNA00293;long intergenic non-protein coding RNA 293
hsa:338963;;epididymal protein pseudogene
hsa:338799;;uncharacterized LOC338799
hsa:643677;CCDC168,C13orf40;coiled-coil domain containing 168
hsa:374887;YJEFN3;YjeF N-terminal domain containing 3
hsa:100506368;;uncharacterized LOC100506368
hsa:731223;;uncharacterized LOC731223
hsa:100287114;LINC00421;long intergenic non-protein coding RNA 421
hsa:100499484;;SUGT1-1300002K09Rik pseudogene
hsa:349152;DPY19L2P2;dpy-19-like 2 pseudogene 2 (C. elegans)
hsa:643623;;uncharacterized LOC643623
hsa:653479;MRPL45P2;mitochondrial ribosomal protein L45 pseudogene 2
hsa:100129083;;uncharacterized LOC100129083
hsa:100507300;;uncharacterized LOC100507300
hsa:727758;ROCK1P1;Rho-associated, coiled-coil containing protein kinase 1 pseudogene 1
hsa:730112;FAM166B;family with sequence similarity 166, member B
hsa:100287792;;uncharacterized LOC100287792
hsa:645121;CCNI2;cyclin I family, member 2
hsa:100534589;HOXA10-HOXA9;HOXA10-HOXA9 readthrough
hsa:100533970;P2RX5-TAX1BP3;P2RX5-TAX1BP3 readthrough
hsa:343450;KCNT2,KCa4.2,SLICK,SLO2.1;potassium channel, subfamily T, member 2
hsa:729966;;uncharacterized LOC729966
hsa:100526767;RNF103-CHMP3,RNF103-VPS24;RNF103-CHMP3 readthrough
hsa:100526833;SEPT5-GP1BB;SEPT5-GP1BB readthrough
hsa:402778;IFITM10,DSPA3;interferon induced transmembrane protein 10
hsa:643770;;uncharacterized LOC643770
hsa:100289495;;uncharacterized LOC100289495
hsa:378825;LINC00162,C21orf113,NCRNA00162,NLC1-C,NLC1C,PRED74;long intergenic non-protein coding RNA 162
hsa:730811;;uncharacterized LOC730811
hsa:100508120;;uncharacterized LOC100508120
hsa:100128252;;uncharacterized LOC100128252
hsa:100144603;;uncharacterized transcript
hsa:100288079;;microtubule-associated protein 1 light chain 3 beta pseudogene
hsa:100507321;ERVK13-1;endogenous retrovirus group K13, member 1
hsa:441194;PMS2CL,PMS2P13;PMS2 C-terminal like pseudogene
hsa:100288911;;uncharacterized LOC100288911
hsa:340168;DPPA5,ESG1;developmental pluripotency associated 5
hsa:401720;FIGNL2;fidgetin-like 2
hsa:100129046;;uncharacterized LOC100129046
hsa:728310;GOLGA6L7P,GOLGA6L7;golgin A6 family-like 7, pseudogene
hsa:439927;C1orf180;chromosome 1 open reading frame 180
hsa:100289462;DEFB4B,DEFB4P;defensin, beta 4B
hsa:100129055;;cyclin Y-like pseudogene
hsa:646168;;uncharacterized LOC646168
hsa:400680;;uncharacterized LOC400680
hsa:653319;KIAA0895L;KIAA0895-like
hsa:100505893;SLIT2-IT1;SLIT2 intronic transcript 1 (non-protein coding)
hsa:100132288;TEKT4P2,MAFIPL,TEKT4P;tektin 4 pseudogene 2
hsa:100507384;;uncharacterized LOC100507384
hsa:767557;SYS1-DBNDD2,C20orf169-DBNDD2;SYS1-DBNDD2 readthrough (non-protein coding)
hsa:100129138;;THAP domain containing, apoptosis associated protein 3 pseudogene
hsa:650655;ABCA17P,ABCA17;ATP-binding cassette, sub-family A (ABC1), member 17, pseudogene
hsa:100129250;TOPORS-AS1,C9orf133;uncharacterized LOC100129250
hsa:340596;LHFPL1;lipoma HMGIC fusion partner-like 1
hsa:340811;AKR1CL1;aldo-keto reductase family 1, member C-like 1
hsa:728012;;uncharacterized LOC728012
hsa:646324;LINC00607;long intergenic non-protein coding RNA 607
hsa:100144604;;uncharacterized LOC100144604
hsa:728084;;uncharacterized LOC728084
hsa:100506795;;uncharacterized LOC100506795
hsa:400839;FLJ33581;uncharacterized LOC400839
hsa:399829;;uncharacterized LOC399829
hsa:100499183;;uncharacterized LOC100499183
hsa:401563;C9orf139;chromosome 9 open reading frame 139
hsa:100505624;;uncharacterized LOC100505624
hsa:100131655;;uncharacterized LOC100131655
hsa:440387;CTRB2;chymotrypsinogen B2 (EC:3.4.21.1)
hsa:399821;FLJ37035;uncharacterized LOC399821
hsa:100505474;;uncharacterized LOC100505474
hsa:387486;LINC00320,C21orf131,NCRNA00320,PRED14;long intergenic non-protein coding RNA 320
hsa:652276;;potassium channel tetramerisation domain containing 5 pseudogene
hsa:401884;MGC57346;uncharacterized LOC401884
hsa:664701;ZNF826P,ZNF826;zinc finger protein 826, pseudogene
hsa:647121;EMBP1;embigin pseudogene 1
hsa:654434;LINC00338,C17orf86,NCRNA00338;long intergenic non-protein coding RNA 338
hsa:728730;;uncharacterized LOC728730
hsa:619434;LINC00051,C8orf43,NCRNA00051;long intergenic non-protein coding RNA 51
hsa:642864;SRG7;spermatogenesis-related protein 7
hsa:100128881;;uncharacterized LOC100128881
hsa:389023;;uncharacterized LOC389023
hsa:448831;FRG2,FRG2A;FSHD region gene 2
hsa:100423062;IGLL5;immunoglobulin lambda-like polypeptide 5
hsa:100133172;FAM66A;family with sequence similarity 66, member A
hsa:100288486;DDX11L9;DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 like 9
hsa:343068;PRAMEF5;PRAME family member 5
hsa:340204;CLPSL1,C6orf127,ESP32,dJ510O8.6;colipase-like 1
hsa:100132077;;uncharacterized LOC100132077
hsa:497189;TIFAB;TRAF-interacting protein with forkhead-associated domain, family member B
hsa:654346;LGALS9C;lectin, galactoside-binding, soluble, 9C
hsa:100129464;CXorf28;chromosome X open reading frame 28
hsa:386607;ZFP91-CNTF;ZFP91-CNTF readthrough (non-protein coding)
hsa:100505540;;uncharacterized LOC100505540
hsa:100129858;;uncharacterized LOC100129858
hsa:100526693;ARPC4-TTLL3;ARPC4-TTLL3 readthrough
hsa:100505545;;uncharacterized LOC100505545
hsa:389538;;MGC72080 pseudogene
hsa:100129620;;uncharacterized LOC100129620
hsa:100130705;;uncharacterized LOC100130705
hsa:100505912;;uncharacterized LOC100505912
hsa:339666;;uncharacterized LOC339666
hsa:100130987;;uncharacterized LOC100130987
hsa:100506085;;uncharacterized LOC100506085
hsa:654429;LRTM2;leucine-rich repeats and transmembrane domains 2
hsa:554223;;histocompatibility antigen-related
hsa:100101267;POM121C,POM121-2;POM121 transmembrane nucleoporin C
hsa:644444;TMEM30C,CDC50C;transmembrane protein 30C
hsa:646024;RAET1K;retinoic acid early transcript 1K pseudogene
hsa:441161;OOEP,C6orf156,FLOPED,HOEP19,KHDC2;oocyte expressed protein
hsa:100131897;FAM196B,C5orf57;family with sequence similarity 196, member B
hsa:100130357;;uncharacterized LOC100130357
hsa:388533;KRTDAP,KDAP,UNQ467;keratinocyte differentiation-associated protein
hsa:641977;SEPT7P2,SEPT13,SEPT7B;septin 7 pseudogene 2
hsa:441666;;zinc finger protein 91 pseudogene
hsa:100268168;;uncharacterized LOC100268168
hsa:613209;DEFB135,DEFB136;defensin, beta 135
hsa:100506314;;uncharacterized LOC100506314
hsa:646396;REREP3;arginine-glutamic acid dipeptide (RE) repeats pseudogene 3
hsa:654433;;uncharacterized LOC654433
hsa:347918;EP400NL;EP400 N-terminal like
hsa:440078;FAM66C;family with sequence similarity 66, member C
hsa:348021;LINC00442;long intergenic non-protein coding RNA 442
hsa:642852;;uncharacterized LOC642852
hsa:100505876;;uncharacterized LOC100505876
hsa:339906;PRSS42,TESSP2;protease, serine, 42 (EC:3.4.21.-)
hsa:440854;CAPN14;calpain 14 (EC:3.4.22.-)
hsa:100505964;;uncharacterized LOC100505964
hsa:100287177;;uncharacterized LOC100287177
hsa:401103;FLJ46066;uncharacterized LOC401103
hsa:440498;HSBP1L1;heat shock factor binding protein 1-like 1
hsa:387267;KRTAP5-4,KRTAP5.4;keratin associated protein 5-4
hsa:644316;FLJ43315;asparagine synthetase pseudogene
hsa:100533184;ARHGAP19-SLIT1;ARHGAP19-SLIT1 readthrough
hsa:100534592;URGCP-MRPS24;URGCP-MRPS24 readthrough
hsa:100288974;;BMS1 homolog, ribosome assembly protein (yeast) pseudogene
hsa:100129345;;uncharacterized LOC100129345
hsa:100506054;;uncharacterized LOC100506054
hsa:100127888;;uncharacterized LOC100127888
hsa:647323;;uncharacterized LOC647323
hsa:100505622;;uncharacterized LOC100505622
hsa:100287036;;uncharacterized LOC100287036
hsa:100287569;LINC00173,NCRNA00173;long intergenic non-protein coding RNA 173
hsa:401014;DKFZp686O1327;uncharacterized LOC401014
hsa:100288181;;uncharacterized LOC100288181
hsa:374969;CCDC23;coiled-coil domain containing 23
hsa:100527949;GIMAP1-GIMAP5;GIMAP1-GIMAP5 readthrough
hsa:100532735;INO80B-WBP1;INO80B-WBP1 readthrough
hsa:100505658;;uncharacterized LOC100505658
hsa:100288122;;uncharacterized LOC100288122
hsa:728939;PDZK1P1;PDZ domain containing 1 pseudogene 1
hsa:341359;SYT10;synaptotagmin X
hsa:100532736;C1orf151-NBL1;C1orf151-NBL1 readthrough
hsa:728175;;uncharacterized LOC728175
hsa:100130581;;uncharacterized LOC100130581
hsa:388272;C16orf87;chromosome 16 open reading frame 87
hsa:646268;;hCG1654703
hsa:100128770;;uncharacterized LOC100128770
hsa:348378;FAM159A,PRO7171,WWLS2783;family with sequence similarity 159, member A
hsa:401232;DKFZP686I15217;uncharacterized LOC401232
hsa:100506421;;uncharacterized LOC100506421
hsa:728537;;uncharacterized LOC728537
hsa:339442;;uncharacterized LOC339442
hsa:100505495;;uncharacterized LOC100505495
hsa:339834;CCDC36,CT74;coiled-coil domain containing 36
hsa:340441;POTEA,A26A1,CT104.3,POTE-8,POTE8;POTE ankyrin domain family, member A
hsa:574538;;uncharacterized LOC574538
hsa:100130539;;uncharacterized LOC100130539
hsa:100271702;;uncharacterized LOC100271702
hsa:730971;FLJ36777;uncharacterized LOC730971
hsa:100507053;;uncharacterized LOC100507053
hsa:729950;;uncharacterized LOC729950
hsa:100131289;;uncharacterized LOC100131289
hsa:645027;EVPLL;envoplakin-like
hsa:347517;RAB41;RAB41, member RAS oncogene family
hsa:100288966;;POTE ankyrin domain family member D-like
hsa:375323;LHFPL4;lipoma HMGIC fusion partner-like 4
hsa:100528007;C10orf32-AS3MT;C10orf32-AS3MT readthrough
hsa:100506274;;uncharacterized LOC100506274
hsa:388960;C2orf78,COG5373,hCG1989538;chromosome 2 open reading frame 78
hsa:644809;C15orf56;chromosome 15 open reading frame 56
hsa:100130771;EFCAB10;EF-hand calcium binding domain 10
hsa:100506243;KRBOX1;KRAB box domain containing 1
hsa:100506071;;uncharacterized LOC100506071
hsa:100505782;;uncharacterized LOC100505782
hsa:387496;RASL11A;RAS-like, family 11, member A
hsa:100132916;FAM159B;family with sequence similarity 159, member B
hsa:339298;;uncharacterized LOC339298
hsa:100507527;THEG5;testis highly expressed protein 5
hsa:100505715;;uncharacterized LOC100505715
hsa:642366;;uncharacterized LOC642366
hsa:404734;ANKHD1-EIF4EBP3,MASK-BP3,MASK-BP3ARF;ANKHD1-EIF4EBP3 readthrough
hsa:100534593;STX16-NPEPL1;STX16-NPEPL1 readthrough (non-protein coding)
hsa:389257;LRRC14B;leucine rich repeat containing 14B
hsa:400121;LINC00547;long intergenic non-protein coding RNA 547
hsa:375513;GUSBP4,C6orf216,GUSBL2,SMA3-L,SMAC3L,b55C20.2;glucuronidase, beta pseudogene 4
hsa:344901;OSTN,MUSCLIN;osteocrin
hsa:728448;PPIEL,PPIEP1;peptidylprolyl isomerase E-like pseudogene
hsa:100505835;;uncharacterized LOC100505835
hsa:100287314;;uncharacterized LOC100287314
hsa:494119;SPANXN2,CT11.7,SPANX-N2;SPANX family, member N2
hsa:692312;PPAN-P2RY11;PPAN-P2RY11 readthrough
hsa:401463;;uncharacterized LOC401463
hsa:100529257;SYNJ2BP-COX16;SYNJ2BP-COX16 readthrough
hsa:340654;LIPM,LIPL3,bA304I5.1;lipase, family member M
hsa:100507424;;uncharacterized LOC100507424
hsa:100534595;HNRNPUL2-BSCL2;HNRNPUL2-BSCL2 readthrough
hsa:646019;CBY3;chibby homolog 3 (Drosophila)
hsa:100289019;;uncharacterized LOC100289019
hsa:440456;PLEKHM1P;pleckstrin homology domain containing, family M (with RUN domain) member 1 pseudogene
hsa:401492;FLJ41200;uncharacterized LOC401492
hsa:645212;;uncharacterized LOC645212
hsa:442028;;uncharacterized LOC442028
hsa:100506844;;uncharacterized LOC100506844
hsa:440970;;uncharacterized LOC440970
hsa:100130452;;uncharacterized LOC100130452
hsa:390651;OR4F13P,GPCRLTM7;olfactory receptor, family 4, subfamily F, member 13 pseudogene
hsa:100526825;INMT-FAM188B;INMT-FAM188B readthrough (non-protein coding)
hsa:100506474;;uncharacterized LOC100506474
hsa:100287015;;uncharacterized LOC100287015
hsa:400952;;putative uncharacterized protein UNQ6975/PRO21958
hsa:388364;TMIGD1,TMIGD,UNQ9372;transmembrane and immunoglobulin domain containing 1
hsa:100188953;LINC00092,NCRNA00092,bA346B7.1;long intergenic non-protein coding RNA 92
hsa:401282;DKFZp451B082;uncharacterized LOC401282
hsa:375719;AQP7P1,bA251O17.3;aquaporin 7 pseudogene 1
hsa:100130967;C6orf99,yR211F11.1;chromosome 6 open reading frame 99
hsa:100526794;NT5C1B-RDH14;NT5C1B-RDH14 readthrough
hsa:100505918;;uncharacterized LOC100505918
hsa:399844;FLJ45445;uncharacterized LOC399844
hsa:100506394;GAS6-AS2;uncharacterized LOC100506394
hsa:441432;AQP7P3,AQPap-3;aquaporin 7 pseudogene 3
hsa:100132146;;uncharacterized LOC100132146
hsa:100526694;MSANTD3-TMEFF1,C9orf3-TMEFF1,C9orf30-TMEFF1;MSANTD3-TMEFF1 readthrough
hsa:100169851;PATE3,HEL-127,PATE-DJ;prostate and testis expressed 3
hsa:100505761;;uncharacterized LOC100505761
hsa:100038246;TLX1NB,APT-B7,TD1,TDI;TLX1 neighbor
hsa:642924;LINC00535;long intergenic non-protein coding RNA 535
hsa:730101;;uncharacterized LOC730101
hsa:100505695;;uncharacterized LOC100505695
hsa:643837;;uncharacterized LOC643837
hsa:645840;TXNRD3NB,TR2IT1,TXNRD3IT1,TXNRD3NT1;thioredoxin reductase 3 neighbor
hsa:449520;GGNBP1;gametogenetin binding protein 1 (pseudogene)
hsa:100128338;;uncharacterized LOC100128338
hsa:442497;;uncharacterized LOC442497
hsa:389206;BEND4,CCDC4;BEN domain containing 4
hsa:340286;FAM183B;acyloxyacyl hydrolase (neutrophil)
hsa:440603;BCL2L15,Bfk,C1orf178;BCL2-like 15
hsa:100129427;;uncharacterized LOC100129427
hsa:401089;C3orf72;chromosome 3 open reading frame 72
hsa:387628;KGFLP1;fibroblast growth factor 7 pseudogene
hsa:730102;;quinone oxidoreductase-like protein 2 pseudogene
hsa:100528016;TMX2-CTNND1;TMX2-CTNND1 readthrough (non-protein coding)
hsa:100505619;;uncharacterized LOC100505619
hsa:100506013;;uncharacterized LOC100506013
hsa:100505839;SH3PXD2A-AS1;SH3PXD2A antisense RNA 1
hsa:440895;;two pore channel 3 pseudogene
hsa:100505478;;uncharacterized LOC100505478
hsa:391322;;D-dopachrome tautomerase-like
hsa:100506035;;uncharacterized LOC100506035
hsa:100129931;;uncharacterized LOC100129931
hsa:100507140;;uncharacterized LOC100507140
hsa:100128531;;uncharacterized LOC100128531
hsa:100287814;LINC00582;long intergenic non-protein coding RNA 582
hsa:353135;LCE1E,LEP5;late cornified envelope 1E
hsa:387111;LINC00222,C6orf181,NCRNA00222,dJ354J5.2;long intergenic non-protein coding RNA 222
hsa:730441;;trypsin X3 pseudogene
hsa:100289137;FAM95C;uncharacterized LOC100289137
hsa:401136;TMPRSS11BNL;TMPRSS11B N terminal-like
hsa:100126791;EGOT,EGO,NCRNA00190;eosinophil granule ontogeny transcript (non-protein coding)
hsa:645528;LINC00264,C10orf50,NCRNA00264,bA128B16.2;long intergenic non-protein coding RNA 264
hsa:388514;CYP4F24P;cytochrome P450, family 4, subfamily F, polypeptide 24, pseudogene
hsa:100506874;;uncharacterized LOC100506874
hsa:649133;;uncharacterized LOC649133
hsa:400932;FLJ46257;uncharacterized LOC400932
hsa:645687;LINC00520,C14orf34;long intergenic non-protein coding RNA 520
hsa:400360;C15orf54;chromosome 15 open reading frame 54
hsa:441581;FRG2B;FSHD region gene 2 family, member B
hsa:375444;C5orf34;chromosome 5 open reading frame 34
hsa:730091;;uncharacterized LOC730091
hsa:100128264;;uncharacterized LOC100128264
hsa:440905;;uncharacterized LOC440905
hsa:100289656;;Dexi homolog (mouse) pseudogene
hsa:729444;;uncharacterized LOC729444
hsa:100287029;DDX11L10,DDX11L1,DDX11P;DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 like 10
hsa:401242;;uncharacterized LOC401242
hsa:441374;FLJ42969;uncharacterized LOC441374
hsa:100131998;RRN3P3;RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene 3
hsa:100289650;;uncharacterized LOC100289650
hsa:100506895;;uncharacterized LOC100506895
hsa:494558;;uncharacterized LOC494558
hsa:400927;;TPTE and PTEN homologous inositol lipid phosphatase pseudogene
hsa:100527950;GJA9-MYCBP;GJA9-MYCBP readthrough
hsa:100505989;;uncharacterized LOC100505989
hsa:389123;IQCF2;IQ motif containing F2
hsa:100131434;;uncharacterized LOC100131434
hsa:374470;C12orf42;chromosome 12 open reading frame 42
hsa:574414;PRR9;proline rich 9
hsa:100506136;;uncharacterized LOC100506136
hsa:645249;;uncharacterized LOC645249
hsa:441307;FLJ44511;uncharacterized LOC441307
hsa:100526837;EEF1E1-MUTED;EEF1E1-MUTED readthrough
hsa:100506195;;uncharacterized LOC100506195
hsa:340348;TSPAN33,PEN;tetraspanin 33
hsa:392399;LCN9,9230102I19Rik;lipocalin 9
hsa:692099;FAM86DP,FAM86D;family with sequence similarity 86, member D, pseudogene
hsa:401577;CD99P1,CD99L1,CXYorf12,MIC2R,NCRNA00103;CD99 molecule pseudogene 1
hsa:440044;SLC22A20,Oat6;solute carrier family 22, member 20
hsa:729967;MORN2,BLOCK27,MOPT;MORN repeat containing 2
hsa:100128682;;uncharacterized LOC100128682
hsa:441027;TMEM150C;transmembrane protein 150C
hsa:399881;HNRNPKP3;heterogeneous nuclear ribonucleoprotein K pseudogene 3
hsa:441025;;uncharacterized LOC441025
hsa:100131094;;uncharacterized LOC100131094
hsa:100130872;;uncharacterized LOC100130872
hsa:100131532;;uncharacterized LOC100131532
hsa:100506963;;uncharacterized LOC100506963
hsa:339416;ANKRD45,CT117,RP3-436N22.4;ankyrin repeat domain 45
hsa:401164;;uncharacterized LOC401164
hsa:360200;TMPRSS9;transmembrane protease, serine 9
hsa:100507651;;uncharacterized LOC100507651
hsa:730159;;uncharacterized LOC730159
hsa:152815;THAP6;THAP domain containing 6
hsa:100129722;;uncharacterized LOC100129722
hsa:645949;;uncharacterized LOC645949
hsa:100506343;;uncharacterized LOC100506343
hsa:653857;ACTR3C,ARP11;ARP3 actin-related protein 3 homolog C (yeast)
hsa:100506122;;uncharacterized LOC100506122
hsa:100507564;;uncharacterized LOC100507564
hsa:400999;FLJ42351;uncharacterized LOC400999
hsa:494551;WEE2,WEE1B;WEE1 homolog 2 (S. pombe) (EC:2.7.10.2)
hsa:645355;;uncharacterized LOC645355
hsa:100506241;;uncharacterized protein FLJ39582-like
hsa:440335;;uncharacterized LOC440335
hsa:347088;GPR144,PGR24;G protein-coupled receptor 144
hsa:751071;METTL12,U99HG;methyltransferase like 12 (EC:2.1.1.-)
hsa:399726;C10orf114,bA418C1.3;chromosome 10 open reading frame 114
hsa:388135;C15orf59;chromosome 15 open reading frame 59
hsa:401508;FAM74A4;family with sequence similarity 74, member A4
hsa:401027;C2orf66,UNQ6411;chromosome 2 open reading frame 66
hsa:400946;FLJ12334;uncharacterized LOC400946
hsa:100507632;;uncharacterized LOC100507632
hsa:643414;LIPK,LIPL2,bA186O14.2;lipase, family member K
hsa:386757;SLC6A10P,CT-2,CT2,SLC6A10,SLC6A10pB;solute carrier family 6 (neurotransmitter transporter, creatine), member 10, pseudogene
hsa:100132247;;nuclear pore complex interacting protein related gene
hsa:100216479;;uncharacterized LOC100216479
hsa:440594;FLJ31662;uncharacterized LOC440594
hsa:339487;ZBTB8OS,ARCH,ARCH2;zinc finger and BTB domain containing 8 opposite strand
hsa:100506190;;uncharacterized LOC100506190
hsa:100506710;;endogenous Bornavirus-like nucleoprotein 2 pseudogene
hsa:100507463;;uncharacterized LOC100507463
hsa:727956;SDHAP2,SDHAL2,SDHALP2;succinate dehydrogenase complex, subunit A, flavoprotein pseudogene 2
hsa:401397;;uncharacterized LOC401397
hsa:100130417;;uncharacterized LOC100130417
hsa:100130691;;uncharacterized LOC100130691
hsa:728431;;uncharacterized LOC728431
hsa:389812;LCN15,PRO6093,UNQ2541;lipocalin 15
hsa:100289673;;phosphoglycerate mutase family member 5 pseudogene
hsa:347527;ARSH,sulfatase;arylsulfatase family, member H
hsa:342667;STAC2,24b2,24b2/STAC2;SH3 and cysteine rich domain 2
hsa:654816;NCF1B,NCF-1B,SH3PXD1B;neutrophil cytosolic factor 1B pseudogene
hsa:399693;;uncharacterized MGC50722
hsa:340543;TCEAL5;transcription elongation factor A (SII)-like 5
hsa:100132891;;uncharacterized LOC100132891
hsa:642968;FAM163B,C9orf166;family with sequence similarity 163, member B
hsa:100507266;;uncharacterized LOC100507266
hsa:100129935;;lectin, galactoside-binding, soluble, 14 pseudogene
hsa:100533997;MAGEA10-MAGEA5,CT1.5;MAGEA10-MAGEA5 readthrough
hsa:400619;LINC00511;long intergenic non-protein coding RNA 511
hsa:387742;FAM99A;family with sequence similarity 99, member A (non-protein coding)
hsa:401303;ZNF815P,ZNF815;zinc finger protein 815, pseudogene
hsa:643253;CCT6P1,CCT6-5P,CCT6AP1;chaperonin containing TCP1, subunit 6 (zeta) pseudogene 1
hsa:353134;LCE1D,LEP4;late cornified envelope 1D
hsa:401375;GTF2IRD2P1,GTF2IRD2P;GTF2I repeat domain containing 2 pseudogene 1
hsa:790955;C11orf83,CCDS41658.1,UNQ655;chromosome 11 open reading frame 83
hsa:441328;FAM90A10P,FAM90A10;putative protein FAM90A10
hsa:2970;GTF2IP1,WBSCR7;general transcription factor IIi, pseudogene 1
hsa:790952;ESRG,HESRG;embryonic stem cell related (non-protein coding)
hsa:8512;MBL1P,COLEC3P,MBL1P1;mannose-binding lectin (protein A) 1, pseudogene
hsa:64593;RBMY3AP,RBMY3P,RBMY4P,SPATA14;RNA binding motif protein, Y-linked, family 3, member A pseudogene
hsa:284123;FAM27L;family with sequence similarity 27-like
hsa:152302;CIDECP,CICE;cell death-inducing DFFA-like effector c pseudogene
hsa:94115;CGB8;chorionic gonadotropin, beta polypeptide 8
hsa:729156;GTF2IRD1P1;GTF2I repeat domain containing 1 pseusogene 1
hsa:26239;LCE2B,LEP10,SPRL1B,XP5;late cornified envelope 2B
hsa:1564;CYP2D7P1,CYP2D,CYP2D7,CYP2D7AP,CYP2D@,P450C2D,P450DB1;cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 1
hsa:285966;FAM115C,FAM139A;family with sequence similarity 115, member C
hsa:653657;MBD3L3;methyl-CpG binding domain protein 3-like 3
hsa:80086;TUBA4B,TUBA4;tubulin, alpha 4b (pseudogene)
hsa:100130476;;uncharacterized LOC100130476
hsa:729234;FAHD2CP;fumarylacetoacetate hydrolase domain containing 2C, pseudogene
hsa:548321;FAM27A,FAM27A1,bA7G23.5;family with sequence similarity 27, member A
hsa:159125;RBMY2EP;RNA binding motif protein, Y-linked, family 2, member E pseudogene
hsa:163720;CYP4Z2P;cytochrome P450, family 4, subfamily Z, polypeptide 2 pseudogene
hsa:148713;PTPRVP,ESP,OST-PTP,PTPRV;protein tyrosine phosphatase, receptor type, V, pseudogene
hsa:728758;PIN4P1;protein (peptidylprolyl cis/trans isomerase) NIMA-interacting, 4 pseudogene 1
hsa:203429;FAM226A,CXorf50,LINC00246A,NCRNA00246,NCRNA00246A;family with sequence similarity 226, member A (non-protein coding)
hsa:728066;FAM133DP;family with sequence similarity 133, member A pseudogene
hsa:401629;FAM224B,LINC00230B,NCRNA00230B;family with sequence similarity 224, member B (non-protein coding)
hsa:401630;FAM224A,LINC00230A,NCRNA00230A;family with sequence similarity 224, member A (non-protein coding)
hsa:221442;ADCY10P1;adenylate cyclase 10 (soluble) pseudogene 1
hsa:401331;RASA4CP,RASA4P;RAS p21 protein activator 4C, pseudogene
hsa:728640;FAM133CP;family with sequence similarity 133, member A pseudogene
hsa:100306975;NDUFAF4P1;NADH dehydrogenase (ubiquinone) complex I, assembly factor 4 pseudogene 1
hsa:390226;GUCY2EP,GC-E,GCD,GUCY2E;guanylate cyclase 2E, pseudogene
hsa:729799;SEC14L1P1;SEC14-like 1 pseudogene 1
hsa:641298;SMG1P1;smg-1 homolog, phosphatidylinositol 3-kinase-related kinase pseudogene 1
hsa:286333;FAM225A,C9orf109,LINC00256A,NCRNA00256A;family with sequence similarity 225, member A (non-protein coding)
hsa:100132967;FAM223A,CXorf52,LINC00204A,NCRNA00204,NCRNA00204A,SPCX;family with sequence similarity 223, member A (non-protein coding)
hsa:653687;FAM226B,CXorf50B,LINC00246B,NCRNA00246B;family with sequence similarity 226, member B (non-protein coding)
hsa:286967;FAM223B,CXorf52,CXorf52B,LINC00204B,NCRNA00204B;family with sequence similarity 223, member B (non-protein coding)
hsa:57180;ACTR3B,ARP11,ARP3BETA;ARP3 actin-related protein 3 homolog B (yeast)
hsa:100286979;ANAPC1P1;anaphase promoting complex subunit 1 pseudogene 1
hsa:5414;SEPT4,ARTS,BRADEION,CE5B3,H5,MART,PNUTL2,SEP4,hCDCREL-2;septin 4
hsa:7993;UBXN8,D8S2298E,REP8,UBXD6;UBX domain protein 8
hsa:407051;MIR9-3,MIRN9-3,hsa-mir-9-3,miRNA9-3;microRNA 9-3
hsa:255057;C19orf26,DOS;chromosome 19 open reading frame 26
hsa:9179;AP4M1,CPSQ3,MU-4,MU-ARP2,SPG50;adaptor-related protein complex 4, mu 1 subunit
hsa:9724;UTP14C,2700066J21Rik,KIAA0266,UTP14B;UTP14, U3 small nucleolar ribonucleoprotein, homolog C (yeast)
hsa:10109;ARPC2,ARC34,PNAS-139,p34-Arc;actin related protein 2/3 complex, subunit 2, 34kDa
hsa:10881;ACTL7A;actin-like 7A
hsa:100271836;;smg-1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) pseudogene
hsa:92521;SPECC1,CYTSB,HCMOGT-1,HCMOGT1,NSP;sperm antigen with calponin homology and coiled-coil domains 1
hsa:389073;C2orf80;chromosome 2 open reading frame 80
hsa:574450;MIR493,MIRN493,hsa-mir-493;microRNA 493
hsa:112616;CMTM7,CKLFSF7;CKLF-like MARVEL transmembrane domain containing 7
hsa:100885775;BANCR,LINC00586;BRAF-activated non-protein coding RNA
hsa:5475;PPEF1,PP7,PPEF,PPP7C,PPP7CA;protein phosphatase, EF-hand calcium binding domain 1 (EC:3.1.3.16)
hsa:131873;COL6A6;collagen, type VI, alpha 6
hsa:81873;ARPC5L,ARC16-2;actin related protein 2/3 complex, subunit 5-like
hsa:26057;ANKRD17,GTAR,NY-BR-16;ankyrin repeat domain 17
hsa:100302218;MIR1285-1,MIRN1285-1,hsa-mir-1285-1;microRNA 1285-1
hsa:3004;GZMM,LMET1,MET1;granzyme M (lymphocyte met-ase 1)
hsa:338567;KCNK18,K2p18.1,MGR13,TRESK,TRESK-2,TRESK2,TRIK;potassium channel, subfamily K, member 18
hsa:1747;DLX3,AI4,TDO;distal-less homeobox 3
hsa:407055;MIR99A,MIRN99A;microRNA 99a
hsa:100874184;LINC00502;long intergenic non-protein coding RNA 502
hsa:100526739;APITD1-CORT;APITD1-CORT readthrough
hsa:100093631;;general transcription factor II, i, pseudogene
hsa:100423031;MIR4321;microRNA 4321
hsa:100874377;SMIM2-IT1,C13orf44-IT1;SMIM2 intronic transcript 1 (non-protein coding)
hsa:391001;PRAMEF21;PRAME family member 21
hsa:645974;PABPC1L2B,RBM32B;poly(A) binding protein, cytoplasmic 1-like 2B
hsa:340529;PABPC1L2A,RBM32A;poly(A) binding protein, cytoplasmic 1-like 2A
hsa:414260;LINC00619,C10orf136,bA168P8.1;long intergenic non-protein coding RNA 619
hsa:727837;SSX2B,CT5.2b;synovial sarcoma, X breakpoint 2B
hsa:7809;BSND,BART,DFNB73;Bartter syndrome, infantile, with sensorineural deafness (Barttin)
hsa:11334;TUSC2,C3orf11,FUS1,PAP,PDAP2;tumor suppressor candidate 2
hsa:4820;NKTR,p104;natural killer-tumor recognition sequence (EC:5.2.1.8)
hsa:81576;CCDC130;coiled-coil domain containing 130
hsa:128153;SPATA17,IQCH,MSRG-11,MSRG11,RP11-144C20.1;spermatogenesis associated 17
hsa:8804;CREG1,CREG;cellular repressor of E1A-stimulated genes 1
hsa:3222;HOXC5,CP11,HOX3,HOX3D;homeobox C5
hsa:85012;TCEAL3;transcription elongation factor A (SII)-like 3
hsa:79921;TCEAL4,NPD017;transcription elongation factor A (SII)-like 4
hsa:25911;DPCD;deleted in primary ciliary dyskinesia homolog (mouse)
hsa:23580;CDC42EP4,BORG4,CEP4,KAIA1777;CDC42 effector protein (Rho GTPase binding) 4
hsa:346689;KLRG2,CLEC15B;killer cell lectin-like receptor subfamily G, member 2
hsa:10250;SRRM1,160-KD,POP101,SRM160;serine/arginine repetitive matrix 1
hsa:6873;TAF2,CIF150,TAF2B,TAFII150;TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa
hsa:6160;RPL31,L31;ribosomal protein L31
hsa:85403;EAF1;ELL associated factor 1
hsa:84196;USP48,RAP1GA1,USP31;ubiquitin specific peptidase 48 (EC:3.4.19.12)
hsa:8667;EIF3H,EIF3S3,eIF3-gamma,eIF3-p40;eukaryotic translation initiation factor 3, subunit H
hsa:22862;FNDC3A,FNDC3,HUGO,bA203I16.1,bA203I16.5;fibronectin type III domain containing 3A
hsa:8266;UBL4A,DX254E,DXS254E,G6PD,GDX,GET5,MDY2,TMA24,UBL4;ubiquitin-like 4A
hsa:5064;PALM;paralemmin
hsa:22905;EPN2,EHB21;epsin 2
hsa:128864;C20orf144,dJ63M2.6;chromosome 20 open reading frame 144
hsa:94056;SYAP1;synapse associated protein 1
hsa:100287362;PRSS46,TESSP6;protease, serine, 46
hsa:54680;ZNHIT6,BCD1,C1orf181,NY-BR-75;zinc finger, HIT-type containing 6
hsa:205428;C3orf58,DIA1;chromosome 3 open reading frame 58
hsa:116969;ART5,ARTC5;ADP-ribosyltransferase 5 (EC:2.4.2.31)
hsa:51367;POP5,HSPC004,RPP2,RPP20,hPop5;processing of precursor 5, ribonuclease P/MRP subunit (S. cerevisiae) (EC:3.1.26.5)
hsa:57408;LRTM1;leucine-rich repeats and transmembrane domains 1
hsa:5208;PFKFB2,PFK-2/FBPase-2;6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 (EC:2.7.1.105 3.1.3.46)
hsa:8819;SAP30;Sin3A-associated protein, 30kDa
hsa:26037;SIPA1L1,E6TP1;signal-induced proliferation-associated 1 like 1
hsa:84128;WDR75,NET16,UTP17;WD repeat domain 75
hsa:8689;KRT36,HA6,KRTHA6,hHa6;keratin 36
hsa:55808;ST6GALNAC1,HSY11339,SIAT7A,ST6GalNAcI,STYI;ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (EC:2.4.99.3)
hsa:10489;LRRC41,MUF1,RP4-636H5.2;leucine rich repeat containing 41
hsa:7106;TSPAN4,NAG-2,NAG2,TETRASPAN,TM4SF7,TSPAN-4;tetraspanin 4
hsa:6152;RPL24,L24;ribosomal protein L24
hsa:221481;ARMC12,C6orf81;armadillo repeat containing 12
hsa:80346;REEP4,C8orf20;receptor accessory protein 4
hsa:337972;KRTAP19-5,KAP19.5;keratin associated protein 19-5
hsa:23630;KCNE1L,KCNE5;KCNE1-like
hsa:79414;LRFN3,FIGLER1,SALM4;leucine rich repeat and fibronectin type III domain containing 3
hsa:23551;RASD2,MGC:4834,Rhes,TEM2;RASD family, member 2
hsa:25901;CCDC28A,C6orf80,CCRL1AP;coiled-coil domain containing 28A
hsa:4034;LRCH4,LRN,LRRN1,LRRN4,PP14183;leucine-rich repeats and calponin homology (CH) domain containing 4
hsa:8497;PPFIA4;protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4
hsa:93380;MMGT1,EMC5,TMEM32;membrane magnesium transporter 1
hsa:83899;KRTAP9-2,KAP9.2,KRTAP9.2;keratin associated protein 9-2
hsa:4248;MGAT3,GNT-III,GNT3;mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase (EC:2.4.1.144)
hsa:25957;PNISR,C6orf111,HSPC306,RP11-98I9.2,SFRS18,SRrp130,bA98I9.2;PNN-interacting serine/arginine-rich protein
hsa:57532;NUFIP2,182-FIP,82-FIP,FIP-82;nuclear fragile X mental retardation protein interacting protein 2
hsa:55147;RBM23,CAPERbeta,RNPC4;RNA binding motif protein 23
hsa:11135;CDC42EP1,BORG5,CEP1,MSE55;CDC42 effector protein (Rho GTPase binding) 1
hsa:26173;INTS1,INT1,NET28;integrator complex subunit 1
hsa:84726;PRRC2B,BAT2L,BAT2L1,KIAA0515,LQFBS-1;proline-rich coiled-coil 2B
hsa:51096;UTP18,CGI-48,WDR50;UTP18 small subunit (SSU) processome component homolog (yeast)
hsa:100422882;MIR3120;microRNA 3120
hsa:26015;RPAP1;RNA polymerase II associated protein 1
hsa:100500914;MIR3610;microRNA 3610
hsa:26855;RNU2-2,RNU2B,U2;RNA, U2 small nuclear 2
hsa:149478;BTBD19;BTB (POZ) domain containing 19
hsa:100616115;MIR4469;microRNA 4469
hsa:23223;RRP12,KIAA0690;ribosomal RNA processing 12 homolog (S. cerevisiae)
hsa:26750;RPS6KC1,RPK118,humS6PKh1;ribosomal protein S6 kinase, 52kDa, polypeptide 1 (EC:2.7.11.1)
hsa:1047;CLGN;calmegin
hsa:342865;VSTM2B;V-set and transmembrane domain containing 2B
hsa:2138;EYA1,BOP,BOR,BOS1;eyes absent homolog 1 (Drosophila) (EC:3.1.3.48)
hsa:57488;ESYT2,CHR2SYT,E-Syt2,FAM62B;extended synaptotagmin-like protein 2
hsa:23376;UFL1,KIAA0776,Maxer,NLBP,RCAD,RP3-393D12.1;UFM1-specific ligase 1
hsa:5198;PFAS,FGAMS,FGARAT,PURL;phosphoribosylformylglycinamidine synthase (EC:6.3.5.3)
hsa:130589;GALM,IBD1;galactose mutarotase (aldose 1-epimerase) (EC:5.1.3.3)
hsa:8443;GNPAT,DAP-AT,DAPAT,DHAPAT;glyceronephosphate O-acyltransferase (EC:2.3.1.42)
hsa:84549;MAK16,MAK16L,RBM13;MAK16 homolog (S. cerevisiae)
hsa:8623;ASMTL,ASMTLX,ASMTLY,ASTML;acetylserotonin O-methyltransferase-like
hsa:93487;MAPK1IP1L,C14orf32,MISS,c14_5346;mitogen-activated protein kinase 1 interacting protein 1-like
hsa:55787;TXLNG,CXorf15,ELRG,FIAT,LSR5;taxilin gamma
hsa:51759;C9orf78,HCA59,HSPC220,bA409K20.3;chromosome 9 open reading frame 78
hsa:157657;C8orf37,CORD16,RP64,smalltalk;chromosome 8 open reading frame 37
hsa:9120;SLC16A6,MCT6,MCT7;solute carrier family 16, member 6 (monocarboxylic acid transporter 7)
hsa:56849;TCEAL7,MPMGp800C04260Q003;transcription elongation factor A (SII)-like 7
hsa:55802;DCP1A,HSA275986,Nbla00360,SMAD4IP1,SMIF;DCP1 decapping enzyme homolog A (S. cerevisiae)
hsa:23160;WDR43,NET12,UTP5;WD repeat domain 43
hsa:91750;LIN52,C14orf46,c14_5549;lin-52 homolog (C. elegans)
hsa:8760;CDS2;CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 (EC:2.7.7.41)
hsa:83853;ROPN1L,ASP,RSPH11;rhophilin associated tail protein 1-like
hsa:55970;GNG12;guanine nucleotide binding protein (G protein), gamma 12
hsa:8672;EIF4G3,eIF-4G_3,eIF4G_3,eIF4GII;eukaryotic translation initiation factor 4 gamma, 3
hsa:55339;WDR33,NET14,WDC146;WD repeat domain 33
hsa:54802;TRIT1,IPT,MOD5;tRNA isopentenyltransferase 1 (EC:2.5.1.75)
hsa:3613;IMPA2;inositol(myo)-1(or 4)-monophosphatase 2 (EC:3.1.3.25)
hsa:23255;SOGA2,CCDC165,KIAA0802;SOGA family member 2
hsa:84847;LINC00525;long intergenic non-protein coding RNA 525
hsa:730262;PPIAL4E,COAS2;peptidylprolyl isomerase A (cyclophilin A)-like 4E
hsa:4253;CTAGE5,MEA6,MGEA,MGEA11,MGEA6;CTAGE family, member 5
hsa:161497;STRC,DFNB16;stereocilin
hsa:9134;CCNE2,CYCE2;cyclin E2
hsa:8824;CES2,CE-2,CES2A1,PCE-2,iCE;carboxylesterase 2 (EC:3.1.1.1 3.1.1.84 3.1.1.56)
hsa:145645;C15orf43;chromosome 15 open reading frame 43
hsa:10785;WDR4,TRM82,TRMT82;WD repeat domain 4
hsa:23059;CLUAP1,FAP22;clusterin associated protein 1
hsa:406891;MIRLET7I,LET7I,MIRNLET7I,hsa-let-7i;microRNA let-7i
hsa:407056;MIR99B,MIRN99B;microRNA 99b
hsa:130576;LYPD6B,CT116,LYPD7;LY6/PLAUR domain containing 6B
hsa:10296;MAEA,EMLP,EMP,GID9,HLC-10,PIG5;macrophage erythroblast attacher
hsa:64777;RMND5B,GID2,GID2B;required for meiotic nuclear division 5 homolog B (S. cerevisiae)
hsa:28986;MAGEH1,APR-1,APR1,MAGEH;melanoma antigen family H, 1
hsa:504191;OR9G9;olfactory receptor, family 9, subfamily G, member 9
hsa:541578;CXorf40B;chromosome X open reading frame 40B
hsa:26206;SPAG8,BS-84,HSD-1,SMP1,SPAG3,hSMP-1;sperm associated antigen 8
hsa:199834;LCE4A,LEP8,SPRL4A;late cornified envelope 4A
hsa:100652857;TMCO5B;transmembrane and coiled-coil domains 5B, pseudogene
hsa:693127;MIR548A3,MIRN548A3;microRNA 548a-3
hsa:139221;MUM1L1;melanoma associated antigen (mutated) 1-like 1
hsa:728343;NXF2B,bA353J17.1;nuclear RNA export factor 2B
hsa:644242;LINC00622;long intergenic non-protein coding RNA 622
hsa:79100;LINC00626;long intergenic non-protein coding RNA 626
hsa:127841;LINC00628;long intergenic non-protein coding RNA 628
hsa:56963;RGMA,RGM;RGM domain family, member A
hsa:127534;GJB4,CX30.3,EKV;gap junction protein, beta 4, 30.3kDa
hsa:23440;OTP;orthopedia homeobox
hsa:347745;PAR4;Prader-Willi/Angelman region gene 4
hsa:90632;LINC00473,C6orf176,bA142J11.1;long intergenic non-protein coding RNA 473
hsa:149998;LIPI,CT17,LPDL,PLA1C;lipase, member I (EC:2.7.11.30)
hsa:8228;PNPLA4,DXS1283E,GS2,iPLA2eta;patatin-like phospholipase domain containing 4 (EC:3.1.1.3)
hsa:100526836;BLOC1S5-TXNDC5,MUTED-TXNDC5;BLOC1S5-TXNDC5 readthrough (non-protein coding)
hsa:100287765;LINC00630;long intergenic non-protein coding RNA 630
hsa:100506757;LINC00629;long intergenic non-protein coding RNA 629
hsa:1373;CPS1,CPSASE1;carbamoyl-phosphate synthase 1, mitochondrial (EC:6.3.4.16)
hsa:1365;CLDN3,C7orf1,CPE-R2,CPETR2,HRVP1,RVP1;claudin 3
hsa:145567;TTC7B,TTC7L1,c14_5685;tetratricopeptide repeat domain 7B
hsa:116135;LRRC3B,LRP15;leucine rich repeat containing 3B
hsa:724022;MIR652,MIRN652,hsa-mir-652;microRNA 652
hsa:406883;MIRLET7A3,LET7A3,MIRNLET7A3,let-7a-3;microRNA let-7a-3
hsa:406977;MIR199A2,MIR-199-s,MIRN199A2;microRNA 199a-2
hsa:693156;MIR571,MIRN571,hsa-mir-571;microRNA 571
hsa:144404;TMEM120B;transmembrane protein 120B
hsa:149297;FAM78B;family with sequence similarity 78, member B
hsa:347862;PDDC1;Parkinson disease 7 domain containing 1
hsa:644139;PIRT;phosphoinositide-interacting regulator of transient receptor potential channels
hsa:158809;MAGEB6,CT3.4,MAGE-B6,MAGEB6A;melanoma antigen family B, 6
hsa:4201;MEA1,HYS,MEA;male-enhanced antigen 1
hsa:390616;ANKRD34C;ankyrin repeat domain 34C
hsa:84975;MFSD5;major facilitator superfamily domain containing 5
hsa:64839;FBXL17,FBXO13,Fbl17,Fbx13;F-box and leucine-rich repeat protein 17
hsa:130560;SPATA3,TSARG1;spermatogenesis associated 3
hsa:25847;ANAPC13,APC13,SWM1;anaphase promoting complex subunit 13
hsa:339453;TMEM240,C1orf70;transmembrane protein 240
hsa:5986;RFNG;RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase (EC:2.4.1.222)
hsa:399888;FAM180B;family with sequence similarity 180, member B
hsa:126003;TRAPPC5,TRS31;trafficking protein particle complex 5
hsa:63908;NAPB,SNAP-BETA,SNAPB;N-ethylmaleimide-sensitive factor attachment protein, beta
hsa:392255;GDF6,BMP13,CDMP2,KFM,KFS,KFS1,KFSL,MCOP4,MCOPCB6,SCDO4,SGM1;growth differentiation factor 6
hsa:79640;C22orf46;chromosome 22 open reading frame 46
hsa:55623;THUMPD1;THUMP domain containing 1
hsa:55204;GOLPH3L,GPP34R;golgi phosphoprotein 3-like
hsa:340533;;KIAA2022
hsa:126668;TDRD10;tudor domain containing 10
hsa:7851;MALL,BENE;mal, T-cell differentiation protein-like
hsa:344387;CDKL4;cyclin-dependent kinase-like 4 (EC:2.7.11.22)
hsa:55266;TMEM19;transmembrane protein 19
hsa:767558;LUZP6,MPD6,MTPNUT;leucine zipper protein 6
hsa:113829;SLC35A4;solute carrier family 35, member A4
hsa:79005;SCNM1;sodium channel modifier 1
hsa:286436;H2BFM;H2B histone family, member M
hsa:80034;CSRNP3,FAM130A2,PPP1R73,TAIP-2,TAIP2;cysteine-serine-rich nuclear protein 3
hsa:90522;YIF1B,FinGER8;Yip1 interacting factor homolog B (S. cerevisiae)
hsa:10251;SPRY3,HSPRY3,spry-3;sprouty homolog 3 (Drosophila)
hsa:83786;FRMD8;FERM domain containing 8
hsa:64168;NECAB1,EFCBP1,STIP-1;N-terminal EF-hand calcium binding protein 1
hsa:220032;GDPD4,GDE6;glycerophosphodiester phosphodiesterase domain containing 4
hsa:23014;FBXO21,FBX21;F-box protein 21
hsa:200539;ANKRD23,DARP,MARP3;ankyrin repeat domain 23
hsa:84337;ELOF1,ELF1;elongation factor 1 homolog (S. cerevisiae)
hsa:159090;FAM122B,SPACIA2;family with sequence similarity 122B
hsa:83445;GSG1;germ cell associated 1
hsa:55588;MED29,IXL;mediator complex subunit 29
hsa:92305;TMEM129,D4S2561E;transmembrane protein 129
hsa:10078;TSSC4;tumor suppressing subtransferable candidate 4
hsa:285855;RPL7L1,dJ475N16.4;ribosomal protein L7-like 1
hsa:8629;JRK,JH8;jerky homolog (mouse)
hsa:54943;DNAJC28,C21orf55,C21orf78;DnaJ (Hsp40) homolog, subfamily C, member 28
hsa:51481;VCX3A,VCX-8r,VCX-A,VCX3,VCX8R,VCXA;variable charge, X-linked 3A
hsa:338324;S100A7A,NICE-2,S100A15,S100A7L1,S100A7f;S100 calcium binding protein A7A
hsa:283471;TMPRSS12;transmembrane (C-terminal) protease, serine 12
hsa:51077;FCF1,Bka,C14orf111,UTP24;FCF1 small subunit (SSU) processome component homolog (S. cerevisiae)
hsa:10089;KCNK7,K2p7.1,TWIK3;potassium channel, subfamily K, member 7
hsa:100008587;RNA5-8S5,RN5-8S1;RNA, 5.8S ribosomal 5
hsa:100008588;RNA18S5,RN18S1;RNA, 18S ribosomal 5
hsa:100169751;RNA5S1,RN5S1;RNA, 5S ribosomal 1
hsa:100169753;RNA5S2,RN5S2;RNA, 5S ribosomal 2
hsa:100169754;RNA5S3,RN5S3;RNA, 5S ribosomal 3
hsa:100169755;RNA5S4,RN5S4;RNA, 5S ribosomal 4
hsa:100169756;RNA5S5,RN5S5;RNA, 5S ribosomal 5
hsa:100169757;RNA5S6,RN5S6;RNA, 5S ribosomal 6
hsa:100169758;RNA5S7,RN5S7;RNA, 5S ribosomal 7
hsa:100169759;RNA5S8,RN5S8;RNA, 5S ribosomal 8
hsa:100169761;RNA5S10,RN5S10;RNA, 5S ribosomal 10
hsa:100169760;RNA5S9,RN5S9;RNA, 5S ribosomal 9
hsa:100169762;RNA5S11,RN5S11;RNA, 5S ribosomal 11
hsa:100169763;RNA5S12,RN5S12;RNA, 5S ribosomal 12
hsa:100169764;RNA5S13,RN5S13;RNA, 5S ribosomal 13
hsa:100169765;RNA5S14,RN5S14;RNA, 5S ribosomal 14
hsa:100169766;RNA5S15,RN5S15;RNA, 5S ribosomal 15
hsa:100169767;RNA5S16,RN5S16;RNA, 5S ribosomal 16
hsa:100169768;RNA5S17,RN5S17;RNA, 5S ribosomal 17
hsa:100288687;DUX4L;double homeobox 4-like
hsa:94030;LRRC4B,HSM,LRIG4;leucine rich repeat containing 4B
hsa:100008589;RNA28S5,RN28S1;RNA, 28S ribosomal 5
hsa:51526;C20orf111,HSPC207,Osr1,Perit1,dJ1183I21.1;chromosome 20 open reading frame 111
hsa:339674;LINC00634,BK250D10.8;long intergenic non-protein coding RNA 634
hsa:100861532;RNA45S5,RN45S;RNA, 45S pre-ribosomal 5
hsa:100885864;RNA5SP244,RN5S244;RNA, 5S ribosomal pseudogene 244
hsa:100887740;RNA5SP411,RN5S411;RNA, 5S ribosomal pseudogene 411
hsa:151658;LINC00635;long intergenic non-protein coding RNA 635
hsa:100129027;;uncharacterized LOC100129027
hsa:643160;CYMP;chymosin pseudogene
hsa:100131814;LINC00271,C6orf217,NCRNA00271;long intergenic non-protein coding RNA 271
hsa:9992;KCNE2,ATFB4,LQT5,LQT6,MIRP1;potassium voltage-gated channel, Isk-related family, member 2
hsa:4724;NDUFS4,AQDQ,CI-18;NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase)
hsa:283349;RASSF3,RASSF5;Ras association (RalGDS/AF-6) domain family member 3
hsa:9528;TMEM59,C1orf8,HSPC001;transmembrane protein 59
hsa:574508;MIR505,MIRN505,hsa-mir-505;microRNA 505
hsa:283553;LINC00640;long intergenic non-protein coding RNA 640
hsa:100506334;LINC00649;long intergenic non-protein coding RNA 649
hsa:283624;LINC00641;long intergenic non-protein coding RNA 641
hsa:283547;LINC00639;long intergenic non-protein coding RNA 639
hsa:100505967;LINC00645;long intergenic non-protein coding RNA 645
hsa:100506433;LINC00648;long intergenic non-protein coding RNA 648
hsa:646113;LINC00643;long intergenic non-protein coding RNA 643
hsa:400238;LINC00642;long intergenic non-protein coding RNA 642
hsa:196872;LINC00638;long intergenic non-protein coding RNA 638
hsa:145216;LINC00637;long intergenic non-protein coding RNA 637
hsa:100507629;LINC00658;long intergenic non-protein coding RNA 658
hsa:29075;LINC00652,HSPC072;long intergenic non-protein coding RNA 652
hsa:647979;LINC00657;long intergenic non-protein coding RNA 657
hsa:200261;LINC00656;long intergenic non-protein coding RNA 656
hsa:100652730;LINC00659;long intergenic non-protein coding RNA 659
hsa:149837;LINC00654;long intergenic non-protein coding RNA 654
hsa:643355;;uncharacterized LOC643355
hsa:126536;LINC00661;long intergenic non-protein coding RNA 661
hsa:284440;LINC00663;long intergenic non-protein coding RNA 663
hsa:148189;LINC00662;long intergenic non-protein coding RNA 662
hsa:100506930;LINC00665;long intergenic non-protein coding RNA 665
hsa:80763;C12orf39;chromosome 12 open reading frame 39
hsa:10047;CST8,CRES,CTES5;cystatin 8 (cystatin-related epididymal specific)
hsa:642569;TRIM53AP,TRIM53,TRIM53P,TRIM80P;tripartite motif containing 53A, pseudogene
hsa:284618;RUSC1-AS1,C1orf104,RP11-21N7.3;RUSC1 antisense RNA 1
hsa:80161;ASMTL-AS1,ASMTL-AS,ASMTLAS,CXYorf2,NCRNA00105;ASMTL antisense RNA 1
hsa:286103;ZNF252P-AS1,C8orf77;ZNF252P antisense RNA 1
hsa:285224;DNAJB8-AS1;DNAJB8 antisense RNA 1
hsa:125144;C17orf76-AS1,C17orf45,NCRNA00188,TSAP19;C17orf76 antisense RNA 1
hsa:100507086;DLG1-AS1;DLG1 antisense RNA 1
hsa:100874204;ALDH1L1-AS1;ALDH1L1 antisense RNA 1
hsa:100132163;PHKA2-AS1;PHKA2 antisense RNA 1
hsa:100874042;HM13-AS1;HM13 antisense RNA 1
hsa:100506046;GAS5-AS1;GAS5 antisense RNA 1
hsa:100885776;UGDH-AS1;UGDH antisense RNA 1
hsa:100505881;MAGI2-AS3;MAGI2 antisense RNA 3
hsa:554201;CCDC148-AS1;CCDC148 antisense RNA 1
hsa:404744;NPSR1-AS1,AAA1;NPSR1 antisense RNA 1
hsa:339751;MLK7-AS1;MLK7 antisense RNA 1
hsa:84850;GLIS3-AS1,C9orf70;GLIS3 antisense RNA 1
hsa:100128025;WWTR1-AS1;WWTR1 antisense RNA 1
hsa:401431;ATP6V0E2-AS1;ATP6V0E2 antisense RNA 1
hsa:100874083;KCNAB1-AS2;KCNAB1 antisense RNA 2
hsa:100874084;KCNAB1-AS1;KCNAB1 antisense RNA 1
hsa:100873997;KCNQ5-AS1;KCNQ5 antisense RNA 1
hsa:644660;RAD21-AS1,C8orf81,NCRNA00255;RAD21 antisense RNA 1
hsa:100533182;SEC24B-AS1,1/2-SBSRNA4;SEC24B antisense RNA 1
hsa:100506540;SPTY2D1-AS1;SPTY2D1 antisense RNA 1
hsa:100499177;THAP9-AS1;THAP9 antisense RNA 1
hsa:649446;DLGAP1-AS1,HsT914;DLGAP1 antisense RNA 1
hsa:284649;SMG7-AS1,DKFZP564C196;SMG7 antisense RNA 1
hsa:55853;IDI2-AS1,C10orf110,IDI2-AS;IDI2 antisense RNA 1
hsa:100134015;UBOX5-AS1;UBOX5 antisense RNA 1
hsa:283314;C1RL-AS1,MATL2963;C1RL antisense RNA 1
hsa:360205;HOXB-AS5,C17orf93,HOXB13-AS1,NCRNA00253,PRAC2;HOXB cluster antisense RNA 5
hsa:10408;MYCNOS,MYCN-AS1,NCYM,NYCM;MYCN opposite strand/antisense RNA
hsa:100286844;BCDIN3D-AS1;BCDIN3D antisense RNA 1
hsa:100505854;RSBN1L-AS1;RSBN1L antisense RNA 1
hsa:414201;ZNF32-AS3,C10orf44,ZNF32-OT1,bA402L1.3;ZNF32 antisense RNA 3
hsa:100885777;PCCA-AS1;PCCA antisense RNA 1
hsa:349408;TLR8-AS1;TLR8 antisense RNA 1
hsa:100131208;SNAP25-AS1;SNAP25 antisense RNA 1
hsa:93654;ST7-AS2,ST7AS2,ST7OT2;ST7 antisense RNA 2
hsa:386597;RNF144A-AS1;RNF144A antisense RNA 1
hsa:100873945;HLTF-AS1;HLTF antisense RNA 1
hsa:340544;MORF4L2-AS1;MORF4L2 antisense RNA 1
hsa:100128788;SRRM2-AS1;SRRM2 antisense RNA 1
hsa:100628315;DNM3OS,DNM3-AS1,MIR199A2HG;DNM3 opposite strand/antisense RNA
hsa:100302739;PCNA-AS1,PCNA-AS,PCNAAS;PCNA antisense RNA 1
hsa:100507404;TMLHE-AS1;TMLHE antisense RNA 1
hsa:100302740;FAS-AS1,FAS-AS,FASAS,SAF;FAS antisense RNA 1
hsa:100505681;NAPA-AS1;NAPA antisense RNA 1
hsa:339290;LINC00667;long intergenic non-protein coding RNA 667
hsa:100505894;TMEM161B-AS1;TMEM161B antisense RNA 1
hsa:144571;A2M-AS1;A2M antisense RNA 1
hsa:552860;SAMD12-AS1,C8orf26,NCRNA00252;SAMD12 antisense RNA 1
hsa:100873922;ZFX-AS1;ZFX antisense RNA 1
hsa:100379571;BACE1-AS,BACE1-AS1,BACE1AS,FJ573250,NCRNA00177;BACE1 antisense RNA
hsa:439931;THAP7-AS1;THAP7 antisense RNA 1
hsa:100505975;ENO1-AS1;ENO1 antisense RNA 1
hsa:283392;TRHDE-AS1;TRHDE antisense RNA 1
hsa:100128640;ACVR2B-AS1;ACVR2B antisense RNA 1
hsa:100129196;MATN1-AS1;MATN1 antisense RNA 1
hsa:91149;RAPGEF4-AS1;RAPGEF4 antisense RNA 1
hsa:100188954;DNMBP-AS1,NCRNA00093,bA287G8.2;DNMBP antisense RNA 1
hsa:100862679;NAALADL2-AS3;NAALADL2 antisense RNA 3
hsa:100233209;PCED1B-AS1;PCED1B antisense RNA 1
hsa:730198;MEIS1-AS3;MEIS1 antisense RNA 3
hsa:100131213;ZNF503-AS2,C10orf41,NCRNA00245;ZNF503 antisense RNA 2
hsa:339929;LPP-AS2;LPP antisense RNA 2
hsa:100507524;ARHGEF26-AS1;ARHGEF26 antisense RNA 1
hsa:100289373;UBAC2-AS1;UBAC2 antisense RNA 1
hsa:100134713;NDUFB2-AS1;NDUFB2 antisense RNA 1
hsa:594842;HAS2-AS1,HAS2-AS,HAS2AS,HASNT,NCRNA00077;HAS2 antisense RNA 1
hsa:100288730;PAN3-AS1;PAN3 antisense RNA 1
hsa:100316868;HOTTIP,HOXA-AS6,HOXA13-AS1,NCRNA00213;HOXA distal transcript antisense RNA
hsa:400236;FOXN3-AS1;FOXN3 antisense RNA 1
hsa:100507470;GRID1-AS1;GRID1 antisense RNA 1
hsa:285103;CCDC74B-AS1;CCDC74B antisense RNA 1
hsa:285796;PACRG-AS1;PACRG antisense RNA 1
hsa:152641;WWC2-AS2,C4orf38;WWC2 antisense RNA 2
hsa:283165;KIRREL3-AS3,NCRNA00288,PRR10;KIRREL3 antisense RNA 3
hsa:116933;CLRN1-AS1,CLRN1OS,UCRP;CLRN1 antisense RNA 1
hsa:151534;LBX2-AS1;LBX2 antisense RNA 1
hsa:100874016;SYNPR-AS1;SYNPR antisense RNA 1
hsa:650669;GAS6-AS1;GAS6 antisense RNA 1
hsa:692224;FBXO22-AS1,FBXO22OS,FISTC1OS,HsT18082,NCRNA00053;FBXO22 antisense RNA 1
hsa:414197;ZNF32-AS1,ZNF32OS1,bA402L1.8;ZNF32 antisense RNA 1
hsa:100289410;MCF2L-AS1;MCF2L antisense RNA 1
hsa:100131193;KIAA1984-AS1;KIAA1984 antisense RNA 1
hsa:414208;ZNF32-AS2,ZNF32OS2,b402L1.7;ZNF32 antisense RNA 2
hsa:319085;ITPK1-AS1,C14orf85,ITPK1-AS,ITPK1AS,NCRNA00203;ITPK1 antisense RNA 1
hsa:100113386;UCKL1-AS1,UCKL1-AS,UCKL1AS,UCKL1OS;UCKL1 antisense RNA 1
hsa:100885782;MYO16-AS1;MYO16 antisense RNA 1
hsa:55472;RBM12B-AS1,C8orf39;RBM12B antisense RNA 1
hsa:80072;HEXA-AS1,C15orf34;HEXA antisense RNA 1
hsa:100505746;ITGB2-AS1;ITGB2 antisense RNA 1
hsa:100874208;NDFIP2-AS1;NDFIP2 antisense RNA 1
hsa:100130522;PARD6G-AS1;PARD6G antisense RNA 1
hsa:9383;TSIX,LINC00013,NCRNA00013,XIST-AS,XIST-AS1,XISTAS;TSIX transcript, XIST antisense RNA
hsa:100128811;GPR158-AS1;GPR158 antisense RNA 1
hsa:100874207;ST3GAL6-AS1;ST3GAL6 antisense RNA 1
hsa:150538;SATB2-AS1;SATB2 antisense RNA 1
hsa:100128191;TMPO-AS1;TMPO antisense RNA 1
hsa:100507423;MKNK1-AS1;MKNK1 antisense RNA 1
hsa:404201;WDFY3-AS2,C4orf12,FBI4,NCRNA00247;WDFY3 antisense RNA 2
hsa:317751;MESTIT1,MEST-AS1,MEST-IT,MEST-IT1,NCRNA00040,PEG1-AS;MEST intronic transcript 1, antisense RNA
hsa:100129662;FGF13-AS1;FGF13 antisense RNA 1
hsa:339926;EHHADH-AS1;EHHADH antisense RNA 1
hsa:100874102;HS6ST2-AS1;HS6ST2 antisense RNA 1
hsa:100505538;RBM26-AS1;RBM26 antisense RNA 1
hsa:149775;GNAS-AS1,GNAS-AS,GNAS1AS,GNASAS,NCRNA00075,NESP-AS,NESPAS,SANG;GNAS antisense RNA 1
hsa:100526771;TMPRSS4-AS1;TMPRSS4 antisense RNA 1
hsa:100131117;ZBTB20-AS1;ZBTB20 antisense RNA 1
hsa:220930;ZEB1-AS1;ZEB1 antisense RNA 1
hsa:100130717;CECR5-AS1,CECR4,NCRNA00017;CECR5 antisense RNA 1
hsa:348808;NPHP3-AS1,NCRNA00119;NPHP3 antisense RNA 1
hsa:54075;CHODL-AS1,C21orf39,NCRNA00157;CHODL antisense RNA 1
hsa:400643;LINC00668;long intergenic non-protein coding RNA 668
hsa:100302401;RASAL2-AS1;RASAL2 antisense RNA 1
hsa:9597;SMAD5-AS1,DAMS,SMAD5AS,SMAD5OS;SMAD5 antisense RNA 1
hsa:100190939;TPT1-AS1;TPT1 antisense RNA 1
hsa:93653;ST7-AS1,ST7AS1,ST7OT1;ST7 antisense RNA 1
hsa:100873969;GPC5-AS1;GPC5 antisense RNA 1
hsa:729082;OIP5-AS1,cyrano;OIP5 antisense RNA 1
hsa:51275;MAPKAPK5-AS1,C12orf47;MAPKAPK5 antisense RNA 1
hsa:100128126;STAU2-AS1;STAU2 antisense RNA 1
hsa:100873973;GPC6-AS2;GPC6 antisense RNA 2
hsa:100192378;ZFHX4-AS1;ZFHX4 antisense RNA 1
hsa:283104;SBF2-AS1;SBF2 antisense RNA 1
hsa:100131176;WDR86-AS1;WDR86 antisense RNA 1
hsa:146336;SSTR5-AS1;SSTR5 antisense RNA 1
hsa:100129387;GABPB1-AS1;GABPB1 antisense RNA 1
hsa:148046;CIRBP-AS1,C19orf23;CIRBP antisense RNA 1
hsa:729723;DNAJC27-AS1;DNAJC27 antisense RNA 1
hsa:196047;EMX2OS,EMX2-AS1,NCRNA00045;EMX2 opposite strand/antisense RNA
hsa:286002;SLC26A4-AS1;SLC26A4 antisense RNA 1
hsa:100132774;KDM4A-AS1;KDM4A antisense RNA 1
hsa:100507178;SLFNL1-AS1;SLFNL1 antisense RNA 1
hsa:100874190;SAMSN1-AS1;SAMSN1 antisense RNA 1
hsa:414245;DNAJC9-AS1,C10orf103,bA537A6.3;DNAJC9 antisense RNA 1
hsa:729178;STXBP5-AS1;STXBP5 antisense RNA 1
hsa:100506428;CBR3-AS1,PlncRNA-1;CBR3 antisense RNA 1
hsa:100287227;TIPARP-AS1;TIPARP antisense RNA 1
hsa:572558;PGM5-AS1;PGM5 antisense RNA 1
hsa:100189589;DCTN1-AS1;DCTN1 antisense RNA 1
hsa:100287216;SH3RF3-AS1;SH3RF3 antisense RNA 1
hsa:283888;IL21R-AS1;IL21R antisense RNA 1
hsa:100873932;DPYD-AS1;DPYD antisense RNA 1
hsa:201477;DLGAP1-AS3;DLGAP1 antisense RNA 3
hsa:100506492;DSCAM-AS1,M41;DSCAM antisense RNA 1
hsa:100873935;MTOR-AS1;MTOR antisense RNA 1
hsa:100874032;PRRT3-AS1;PRRT3 antisense RNA 1
hsa:92070;CTBP1-AS1,C4orf42;CTBP1 antisense RNA 1
hsa:283592;FAM181A-AS1,C14orf86;FAM181A antisense RNA 1
hsa:100303728;SLC25A5-AS1;SLC25A5 antisense RNA 1
hsa:399876;NAV2-AS4;NAV2 antisense RNA 4
hsa:100507218;RNF157-AS1;RNF157 antisense RNA 1
hsa:100505678;STARD4-AS1;STARD4 antisense RNA 1
hsa:100506779;BZRAP1-AS1;BZRAP1 antisense RNA 1
hsa:221883;HOXA11-AS,HOXA-AS5,HOXA11-AS1,HOXA11AS,HOXA11S,NCRNA00076;HOXA11 antisense RNA
hsa:100874203;COL4A2-AS1;COL4A2 antisense RNA 1
hsa:388428;AATK-AS1;AATK antisense RNA 1
hsa:641518;LEF1-AS1;LEF1 antisense RNA 1
hsa:253264;ZNF503-AS1;ZNF503 antisense RNA 1
hsa:153469;JAKMIP2-AS1;JAKMIP2 antisense RNA 1
hsa:317648;NOP14-AS1,C4orf10,RES4-24;NOP14 antisense RNA 1
hsa:641364;SLC7A11-AS1;SLC7A11 antisense RNA 1
hsa:641467;TSC22D1-AS1;TSC22D1 antisense RNA 1
hsa:114915;EPB41L4A-AS1,C5orf26,NCRNA00219,TIGA1;EPB41L4A antisense RNA 1
hsa:100132618;ZRANB2-AS1;ZRANB2 antisense RNA 1
hsa:645431;FUT8-AS1;FUT8 antisense RNA 1
hsa:100509894;CPB2-AS1;CPB2 antisense RNA 1
hsa:283738;NTRK3-AS1;NTRK3 antisense RNA 1
hsa:645591;LHFPL3-AS1;LHFPL3 antisense RNA 1
hsa:285512;FAM13A-AS1,FAM13A1OS,FAM13AOS,NCRNA00039;FAM13A antisense RNA 1
hsa:100507475;IDH1-AS1;IDH1 antisense RNA 1
hsa:723809;LHFPL3-AS2;LHFPL3 antisense RNA 2
hsa:100506462;SRD5A3-AS1;SRD5A3 antisense RNA 1
hsa:100873954;SNRK-AS1;SNRK antisense RNA 1
hsa:100507392;FLI1-AS1;FLI1 antisense RNA 1
hsa:100126270;FMR1-AS1,ASFMR1,FMR1-AS,FMR1AS,FMR4;FMR1 antisense RNA 1
hsa:284576;LEMD1-AS1;LEMD1 antisense RNA 1
hsa:285194;LSAMP-AS3,LSAMP-AS1,NCRNA00295;LSAMP antisense RNA 3
hsa:100129845;PCOLCE-AS1;PCOLCE antisense RNA 1
hsa:100506765;IGSF11-AS1;IGSF11 antisense RNA 1
hsa:100379661;GRIK1-AS2,C21orf41,NCRNA00258;GRIK1 antisense RNA 2
hsa:100885796;SLC9A9-AS1;SLC9A9 antisense RNA 1
hsa:100507589;NAGPA-AS1;NAGPA antisense RNA 1
hsa:283089;WDR11-AS1;WDR11 antisense RNA 1
hsa:340037;PRR7-AS1;PRR7 antisense RNA 1
hsa:284408;ZNF790-AS1;ZNF790 antisense RNA 1
hsa:100874231;SPATA13-AS1;SPATA13 antisense RNA 1
hsa:100873965;MED4-AS1,MED4-AS;MED4 antisense RNA 1
hsa:100750247;HIF1A-AS2,3'aHIF-1A,aHIF;HIF1A antisense RNA 2
hsa:100129827;MRVI1-AS1;MRVI1 antisense RNA 1
hsa:144481;SOCS2-AS1;SOCS2 antisense RNA 1
hsa:100169890;PEG3-AS1,APEG3,NCRNA00155,PEG3-AS,PEG3AS;PEG3 antisense RNA 1
hsa:65072;CFLAR-AS1,ALS2CR10;CFLAR antisense RNA 1
hsa:145438;FRMD6-AS1,C14orf82;FRMD6 antisense RNA 1
hsa:100652846;CACNA1C-AS1;CACNA1C antisense RNA 1
hsa:100506649;PXN-AS1;PXN antisense RNA 1
hsa:100133545;MRPL23-AS1;MRPL23 antisense RNA 1
hsa:100286938;VPS13A-AS1;VPS13A antisense RNA 1
hsa:100505483;PRKAG2-AS1;PRKAG2 antisense RNA 1
hsa:100287559;ADPGK-AS1;ADPGK antisense RNA 1
hsa:80862;ZNRD1-AS1,C6orf12,HTEX4,NCRNA00171,ZNRD1-AS,ZNRD1AS;ZNRD1 antisense RNA 1
hsa:100506660;DDX11-AS1;DDX11 antisense RNA 1
hsa:404266;HOXB-AS3;HOXB cluster antisense RNA 3
hsa:100379249;BOK-AS1,BOK-AS,BOKAS,NAToB,NCRNA00151;BOK antisense RNA 1
hsa:100303491;ZEB2-AS1,ZEB2-AS,ZEB2AS,ZEB2NAT;ZEB2 antisense RNA 1
hsa:100628307;DIO2-AS1;DIO2 antisense RNA 1
hsa:100507297;TMEM44-AS1;TMEM44 antisense RNA 1
hsa:400508;CRYM-AS1,NCRNA00169;CRYM antisense RNA 1
hsa:100506033;PTOV1-AS1;PTOV1 antisense RNA 1
hsa:285954;INHBA-AS1;INHBA antisense RNA 1
hsa:100506555;PVRL3-AS1;PVRL3 antisense RNA 1
hsa:283303;MRGPRG-AS1,C11orf36,HSD-40;MRGPRG antisense RNA 1
hsa:503538;A1BG-AS1,A1BG-AS,A1BGAS,NCRNA00181;A1BG antisense RNA 1
hsa:100506866;TTN-AS1;TTN antisense RNA 1
hsa:644246;KANSL1-AS1;KANSL1 antisense RNA 1
hsa:100873982;ABCC5-AS1;ABCC5 antisense RNA 1
hsa:100506068;DACT3-AS1;DACT3 antisense RNA 1
hsa:678655;CD27-AS1;CD27 antisense RNA 1
hsa:51352;WT1-AS,WIT-1,WIT1,WT1-AS1,WT1AS,dJ74J1.1;WT1 antisense RNA
hsa:150291;MORC2-AS1,C22orf27,NCRNA00325;MORC2 antisense RNA 1
hsa:253868;C20orf166-AS1,C20orf200,NCRNA00335;C20orf166 antisense RNA 1
hsa:100129716;ARRDC3-AS1;ARRDC3 antisense RNA 1
hsa:100302650;BRE-AS1;BRE antisense RNA 1
hsa:100874053;JRKL-AS1;JRKL antisense RNA 1
hsa:100506783;HOXD-AS2;HOXD cluster antisense RNA 2
hsa:154860;FEZF1-AS1;FEZF1 antisense RNA 1
hsa:100287902;LGALS8-AS1;LGALS8 antisense RNA 1
hsa:100133311;HOXA-AS3;HOXA cluster antisense RNA 3
hsa:29018;FOXN3-AS2;FOXN3 antisense RNA 2
hsa:100874195;DIAPH3-AS1;DIAPH3 antisense RNA 1
hsa:100505536;ISM1-AS1;ISM1 antisense RNA 1
hsa:439941;FER1L6-AS1,C8orf54;FER1L6 antisense RNA 1
hsa:100379174;MACROD2-AS1,NCRNA00186;MACROD2 antisense RNA 1
hsa:100505641;FGD5-AS1;FGD5 antisense RNA 1
hsa:84983;FAM222A-AS1;FAM222A antisense RNA 1
hsa:283460;HNF1A-AS1,C12orf27,NCRNA00262;HNF1A antisense RNA 1
hsa:284215;DLGAP1-AS5;DLGAP1 antisense RNA 5
hsa:642976;GRIK1-AS1,C21orf9,GRIK1-AS,GRIK1AS,NCRNA00110;GRIK1 antisense RNA 1
hsa:100873976;CNTN4-AS2;CNTN4 antisense RNA 2
hsa:440584;SLC2A1-AS1;SLC2A1 antisense RNA 1
hsa:255193;CSNK1G2-AS1,C19orf34;CSNK1G2 antisense RNA 1
hsa:645676;ASH1L-AS1;ASH1L antisense RNA 1
hsa:282706;DAOA-AS1,DAOA-AS,DAOAAS,G30;DAOA antisense RNA 1
hsa:400960;PCBP1-AS1;PCBP1 antisense RNA 1
hsa:100507495;SDCBP2-AS1;SDCBP2 antisense RNA 1
hsa:285154;CYP1B1-AS1,C2orf58;CYP1B1 antisense RNA 1
hsa:114044;MCM3AP-AS1,C21orf85,MCM3AP-AS,MCM3APAS,MCM3APASB,NCRNA00031;MCM3AP antisense RNA 1
hsa:255480;TBX5-AS1;TBX5 antisense RNA 1
hsa:100507057;MFI2-AS1;MFI2 antisense RNA 1
hsa:100507062;PSMD6-AS2;PSMD6 antisense RNA 2
hsa:100507567;RAB11B-AS1;RAB11B antisense RNA 1
hsa:100507064;TEX26-AS1,LINC00447;TEX26 antisense RNA 1
hsa:642394;ADARB2-AS1,C10orf109,NCRNA00168,bA466B20.1;ADARB2 antisense RNA 1
hsa:122525;C14orf28,DRIP-1,DRIP1,c14_5270;chromosome 14 open reading frame 28
hsa:100507240;VWA8-AS1;VWA8 antisense RNA 1 (head to head)
hsa:404665;CACTIN-AS1,C19orf29-AS1,C19orf29OS;CACTIN antisense RNA 1
hsa:400617;KCNJ2-AS1;KCNJ2 antisense RNA 1 (head to head)
hsa:80054;CEBPA-AS1;CEBPA antisense RNA 1 (head to head)
hsa:400604;TOB1-AS1;TOB1 antisense RNA 1
hsa:164380;CST13P,CSTT,CTES6;cystatin 13, pseudogene
hsa:92659;MAFG-AS1;MAFG antisense RNA 1 (head to head)
hsa:388387;LINC00671;long intergenic non-protein coding RNA 671
hsa:386758;ZNF582-AS1;ZNF582 antisense RNA 1 (head to head)
hsa:147727;ILF3-AS1;ILF3 antisense RNA 1 (head to head)
hsa:284034;LINC00670;long intergenic non-protein coding RNA 670
hsa:55449;DHRS4-AS1,AS1DHRS4,C14orf167;DHRS4 antisense RNA 1
hsa:283932;FBXL19-AS1,NCRNA00095;FBXL19 antisense RNA 1 (head to head)
hsa:54510;PCDH18,PCDH68L;protocadherin 18
hsa:285668;C5orf64;chromosome 5 open reading frame 64
hsa:92105;INTS4,INT4,MST093;integrator complex subunit 4
hsa:81491;GPR63,PSP24(beta),PSP24B;G protein-coupled receptor 63
hsa:57713;SFMBT2;Scm-like with four mbt domains 2
hsa:23266;LPHN2,CIRL2,CL2,LEC1,LPHH1;latrophilin 2
hsa:9628;RGS6,GAP;regulator of G-protein signaling 6
hsa:284111;SLC13A5,NACT;solute carrier family 13 (sodium-dependent citrate transporter), member 5
hsa:83591;THAP2;THAP domain containing, apoptosis associated protein 2
hsa:376844;SDC4P;syndecan 4 pseudogene
hsa:10866;HCP5,6S2650E,D6S2650E,P5-1;HLA complex P5 (non-protein coding)
hsa:653190;ABCC6P1;ATP-binding cassette, sub-family C, member 6 pseudogene 1
hsa:220115;TPTE2P3,TPTEps1;transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 3
hsa:84931;;uncharacterized LOC84931
hsa:29774;POM121L9P,DKFZP434P211,UNQ2565;POM121 transmembrane nucleoporin-like 9, pseudogene
hsa:730013;ABCC6P2;ATP-binding cassette, sub-family C, member 6 pseudogene 2
hsa:5383;PMS2P5,PMS2L5,PMS7;postmeiotic segregation increased 2 pseudogene 5
hsa:642846;;DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11-like
hsa:646074;POM121L10P;POM121 transmembrane nucleoporin-like 10, pseudogene
hsa:388910;LINC00207,NCRNA00207;long intergenic non-protein coding RNA 207
hsa:100302746;NCRUPAR,NCRNA00193,ncR-uPAR;non-protein coding RNA, upstream of F2R/PAR1
hsa:10360;NPM3,PORMIN,TMEM123;nucleophosmin/nucleoplasmin 3
hsa:284340;CXCL17,DMC,Dcip1,UNQ473,VCC-1,VCC1;chemokine (C-X-C motif) ligand 17
hsa:7425;VGF;VGF nerve growth factor inducible
hsa:56246;MRAP,B27,C21orf61,FALP,FGD2,GCCD2;melanocortin 2 receptor accessory protein
hsa:2192;FBLN1,FBLN,FIBL1;fibulin 1
hsa:1039;CDR2,CDR62,Yo;cerebellar degeneration-related protein 2, 62kDa
hsa:8321;FZD1;frizzled family receptor 1
hsa:574038;MIR431,MIRN431,hsa-mir-431,miRNA431;microRNA 431
hsa:574435;MIR376B,MIRN376B;microRNA 376b
hsa:574480;MIR519D,MIRN519D;microRNA 519d
hsa:100302219;MIR1245A,MIR1245,MIRN1245,hsa-mir-1245,hsa-mir-1245a;microRNA 1245a
hsa:406975;MIR198,MIRN198,miR-198;microRNA 198
hsa:693135;MIR551A,MIRN551A;microRNA 551a
hsa:693221;MIR636,MIRN636,hsa-mir-636;microRNA 636
hsa:100133991;MAP3K14-AS1;MAP3K14 antisense RNA 1
hsa:100505576;LINC00672;long intergenic non-protein coding RNA 672
hsa:100190938;RAMP2-AS1;RAMP2 antisense RNA 1
hsa:100499466;LINC00674;long intergenic non-protein coding RNA 674
hsa:100289255;LINC00675;long intergenic non-protein coding RNA 675
hsa:100499467;LINC00673;long intergenic non-protein coding RNA 673
hsa:259240;WFDC9,WAP9,dJ688G8.2;WAP four-disulfide core domain 9
hsa:128488;WFDC12,C20orf122,SWAM2,WAP2,dJ211D12.4;WAP four-disulfide core domain 12
hsa:64396;GMCL1P1,GCL,GMCL1L,GMCL2;germ cell-less, spermatogenesis associated 1 pseudogene 1
hsa:100652772;;uncharacterized LOC100652772
hsa:8755;ADAM6,C14orf96,tMDCIV;ADAM metallopeptidase domain 6, pseudogene
hsa:8759;ADAM1A,ADAM1,ADAM1P,FTNAP,Ftna,PH-30a;ADAM metallopeptidase domain 1A, pseudogene
hsa:255926;ADAM5,ADAM5P,TMDCII;ADAM metallopeptidase domain 5, pseudogene
hsa:390858;OACYLP,ACYL3P;O-acyltransferase like, pseudogene
hsa:9082;XKRY,XKRY1;XK, Kell blood group complex subunit-related, Y-linked
hsa:8331;HIST1H2AJ,H2A/E,H2AFE,dJ160A22.4;histone cluster 1, H2aj
hsa:85318;BAGE3,CT2.3;B melanoma antigen family, member 3
hsa:387273;KRTAP5-10,KRTAP5.10;keratin associated protein 5-10
hsa:26095;PTPN20B,bA42B19.1;protein tyrosine phosphatase, non-receptor type 20B (EC:3.1.3.48)
hsa:3167;HMX2,H6L,Nkx5-2;H6 family homeobox 2
hsa:57630;SH3RF1,POSH,RNF142,SH3MD2;SH3 domain containing ring finger 1
hsa:259293;TAS2R30,T2R30,T2R47,TAS2R47;taste receptor, type 2, member 30
hsa:650293;;seven transmembrane helix receptor
hsa:728819;;hCG1645220
hsa:150786;WTH3DI;RAB6C-like
hsa:64693;CTAGE1,CT21.1,CT21.2,CTAGE,CTAGE-1,CTAGE-2;cutaneous T-cell lymphoma-associated antigen 1
hsa:127707;KLHDC7A,RP11-422P22.2;kelch domain containing 7A
hsa:594840;ZFAT-AS1,NCRNA00070,SAS-ZFAT,ZFAT-AS,ZFATAS;ZFAT antisense RNA 1
hsa:677771;SCARNA4,ACA26;small Cajal body-specific RNA 4
hsa:56269;IRGC,CINEMA,IFGGE,IRGC1,Iigp5,R30953_1;immunity-related GTPase family, cinema
hsa:58160;NFE4,NF-E4;transcription factor NF-E4
hsa:100036519;FOXD4L2;forkhead box D4-like 2
hsa:400818;NBPF9,AE01,NBPF10;neuroblastoma breakpoint family, member 9
hsa:440567;UQCRHL;ubiquinol-cytochrome c reductase hinge protein-like
hsa:677823;SNORA42,ACA42;small nucleolar RNA, H/ACA box 42
hsa:80028;FBXL18,Fbl18;F-box and leucine-rich repeat protein 18
hsa:337985;KRTAP20-3,KAP19D,KAP20.3,KRTAP19P4;keratin associated protein 20-3
hsa:642587;MIR205HG,LINC00510;MIR205 host gene (non-protein coding)
hsa:91646;TDRD12,ECAT8;tudor domain containing 12
hsa:84629;TNRC18,CAGL79,TNRC18A;trinucleotide repeat containing 18
hsa:649330;;heterogeneous nuclear ribonucleoprotein C-like
hsa:131920;TMEM207,UNQ846;transmembrane protein 207
hsa:1617;DAZ1,DAZ,SPGY;deleted in azoospermia 1
hsa:126075;CCDC159;coiled-coil domain containing 159
hsa:56776;FMN2;formin 2
hsa:349136;WDR86;WD repeat domain 86
hsa:58483;LINC00474,C9orf27,EST-YD1;long intergenic non-protein coding RNA 474
hsa:100288814;;uncharacterized LOC100288814
hsa:391114;OR6K3,OR1-18;olfactory receptor, family 6, subfamily K, member 3
hsa:389840;MAP3K15,ASK3,bA723P2.3;mitogen-activated protein kinase kinase kinase 15 (EC:2.7.11.25)
hsa:79893;GGNBP2,DIF-3,DIF3,LCRG1,LZK1,ZFP403,ZNF403;gametogenetin binding protein 2
hsa:643037;;uncharacterized LOC643037
hsa:728689;EIF3CL;eukaryotic translation initiation factor 3, subunit C-like
hsa:2086;ERV3-1,ERV-R,ERV3,ERVR,HERV-R,HERVR,envR;endogenous retrovirus group 3, member 1
hsa:100288524;;forkhead box L1-like
hsa:387763;C11orf96,AG2;chromosome 11 open reading frame 96
hsa:646862;;uncharacterized LOC646862
hsa:126374;WTIP;Wilms tumor 1 interacting protein
hsa:100133267;;defensin, beta 130-like
hsa:402160;;uncharacterized LOC402160
hsa:51252;FAM178B;family with sequence similarity 178, member B
hsa:100128124;HGC6.3;uncharacterized LOC100128124
hsa:729020;rcRPE
hsa:728945;PPIAL4F;peptidylprolyl isomerase A (cyclophilin A)-like 4F
hsa:100132994;CXorf49B;chromosome X open reading frame 49B
hsa:10071;MUC12,MUC-11,MUC-12,MUC11;mucin 12, cell surface associated
hsa:345895;RSPH4A,CILD11,RSHL3,RSPH6B,dJ412I7.1;radial spoke head 4 homolog A (Chlamydomonas)
hsa:100129636;;uncharacterized LOC100129636
hsa:100130348;;uncharacterized LOC100130348
hsa:730087;ZNF726;zinc finger protein 726
hsa:100129239;CXorf51A,CXorf51;chromosome X open reading frame 51A
hsa:100129924;;uncharacterized LOC100129924
hsa:146429;SLC22A31;solute carrier family 22, member 31
hsa:140776;SMCR9;Smith-Magenis syndrome chromosome region, candidate 9
hsa:387522;TMEM189-UBE2V1,CROC-1B,CROC1B,KUA-UEV;TMEM189-UBE2V1 readthrough
hsa:100129216;;beta-defensin 131-like
hsa:100129520;;testis expressed sequence 13-like
hsa:100288255;;FSHD region gene 2-like
hsa:645426;TMEM191C;transmembrane protein 191C
hsa:200958;MUC20,MUC-20;mucin 20, cell surface associated
hsa:100126337;MIR509-3,MIRN509-3;microRNA 509-3
hsa:574513;MIR508,MIRN508,hsa-mir-508;microRNA 508
hsa:574514;MIR509-1,MIRN509,MIRN509-1,hsa-mir-509;microRNA 509-1
hsa:6205;RPS11,S11;ribosomal protein S11
hsa:27095;TRAPPC3,BET3;trafficking protein particle complex 3
hsa:5675;PSG6,PSBG-10,PSBG-12,PSBG-6,PSG10,PSGGB;pregnancy specific beta-1-glycoprotein 6
hsa:1456;CSNK1G3,CKI-gamma_3,CSNK1G3L;casein kinase 1, gamma 3 (EC:2.7.11.1)
hsa:339862;;uncharacterized LOC339862
hsa:57657;HCN3;hyperpolarization activated cyclic nucleotide-gated potassium channel 3
hsa:442901;MIR328,MIRN328,hsa-mir-328;microRNA 328
hsa:574456;MIR497,MIRN497,hsa-mir-497;microRNA 497
hsa:406974;MIR197,MIRN197,miR-197,miRNA197;microRNA 197
hsa:406940;MIR148A,MIRN148,MIRN148A,hsa-mir-148;microRNA 148a
hsa:59274;MESDC1;mesoderm development candidate 1
hsa:11202;KLK8,HNP,NP,NRPN,PRSS19,TADG14;kallikrein-related peptidase 8 (EC:3.4.21.118)
hsa:6504;SLAMF1,CD150,CDw150,SLAM;signaling lymphocytic activation molecule family member 1
hsa:60401;EDA2R,EDA-A2R,EDAA2R,TNFRSF27,XEDAR;ectodysplasin A2 receptor
hsa:353143;LCE3B,LEP14;late cornified envelope 3B
hsa:219541;MED19,DT2P1G7,LCMR1;mediator complex subunit 19
hsa:30848;CTAG2,CAMEL,CT2,CT6.2,CT6.2a,CT6.2b,ESO2,LAGE-1,LAGE2B;cancer/testis antigen 2
hsa:23556;PIGN,MCAHS,MCAHS1,MCD4,MDC4,PIG-N;phosphatidylinositol glycan anchor biosynthesis, class N
hsa:406997;MIR215,MIRN215,miRNA215,mir-215;microRNA 215
hsa:652995;UCA1,CUDR,LINC00178,NCRNA00178;urothelial cancer associated 1 (non-protein coding)
hsa:406918;MIR129-2,MIR-129b,MIRN129-2,mir-129-2;microRNA 129-2
hsa:406983;MIR200A,MIRN200A;microRNA 200a
hsa:100126342;MIR892A,MIRN892A;microRNA 892a
hsa:554213;MIR449A,MIRN449,MIRN449A,hsa-mir-449;microRNA 449a
hsa:574411;MIR451A,MIR451,MIRN451,hsa-mir-451,hsa-mir-451a;microRNA 451a
hsa:693169;MIR584,MIRN584,hsa-mir-584;microRNA 584
hsa:100302276;MIR1290,MIRN1290,hsa-mir-1290;microRNA 1290
hsa:406967;MIR192,MIRN192,miR-192,miRNA192;microRNA 192
hsa:406917;MIR129-1,MIR-129b,MIRN129-1;microRNA 129-1
hsa:406978;MIR199B,MIRN199B,mir-199b;microRNA 199b
hsa:100526773;EPPIN-WFDC6,SPINLW1-WFDC6;EPPIN-WFDC6 readthrough
hsa:653390;RRN3P2;RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene 2
hsa:83592;AKR1E2,AKR1CL2,AKRDC1,LoopADR,hTSP,htAKR;aldo-keto reductase family 1, member E2 (EC:1.1.1.263)
hsa:63946;DMRTC2;DMRT-like family C2
hsa:63950;DMRTA2;DMRT-like family A2
hsa:100616116;MIR4648;microRNA 4648
hsa:100616438;MIR4632;microRNA 4632
hsa:10895;PPBPP2,PPBPL2,SPBPBP;pro-platelet basic protein pseudogene 2
hsa:55179;FAIM,FAIM1;Fas apoptotic inhibitory molecule
hsa:10741;RBBP9,BOG,RBBP10;retinoblastoma binding protein 9;K07002
hsa:9957;HS3ST1,3OST,3OST1;heparan sulfate (glucosamine) 3-O-sulfotransferase 1 (EC:2.8.2.23)
hsa:6991;TCTE3,TCTEX1D3;t-complex-associated-testis-expressed 3
hsa:51006;SLC35C2,BA394O2.1,C20orf5,CGI-15,OVCOV1;solute carrier family 35, member C2
hsa:9819;TSC22D2,TILZ4a,TILZ4b,TILZ4c;TSC22 domain family, member 2
hsa:219938;SPATA19,CT132,SPAS1,spergen1;spermatogenesis associated 19
hsa:56660;KCNK12,K2p12.1,THIK-2,THIK2;potassium channel, subfamily K, member 12
hsa:347516;DGAT2L6,DC3;diacylglycerol O-acyltransferase 2-like 6
hsa:1389;CREBL2;cAMP responsive element binding protein-like 2
hsa:259294;TAS2R19,MSTP058,T2R19,T2R23,T2R48,TAS2R23,TAS2R48;taste receptor, type 2, member 19
hsa:80305;TRABD,LP6054,PP2447;TraB domain containing
hsa:1783;DYNC1LI2,DNCLI2,LIC2;dynein, cytoplasmic 1, light intermediate chain 2
hsa:57613;;KIAA1467
hsa:359787;DPPA3,STELLA;developmental pluripotency associated 3
hsa:145748;LYSMD4;LysM, putative peptidoglycan-binding, domain containing 4
hsa:55732;C1orf112,RP1-97P20.1;chromosome 1 open reading frame 112
hsa:1797;DOM3Z,DOM3L,NG6,RAI1;dom-3 homolog Z (C. elegans)
hsa:91057;CCDC34,NY-REN-41,RAMA3;coiled-coil domain containing 34
hsa:8515;ITGA10,PRO827;integrin, alpha 10
hsa:28955;DEXI,MYLE;Dexi homolog (mouse)
hsa:65122;PRAMEF2,DJ845O24.3,RP5-845O24.1;PRAME family member 2
hsa:124152;IQCK;IQ motif containing K
hsa:25770;C22orf31,HS747E2A,bK747E2.1;chromosome 22 open reading frame 31
hsa:346606;MOGAT3,DC7,DGAT2L7,MGAT3;monoacylglycerol O-acyltransferase 3 (EC:2.3.1.20 2.3.1.22)
hsa:1762;DMWD,D19S593E,DMR-N9,DMRN9,gene59;dystrophia myotonica, WD repeat containing
hsa:123283;TARSL2;threonyl-tRNA synthetase-like 2 (EC:6.1.1.3)
hsa:245972;ATP6V0D2,ATP6D2,VMA6;ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 (EC:3.6.3.14)
hsa:26039;SS18L1,CREST,LP2261;synovial sarcoma translocation gene on chromosome 18-like 1
hsa:79074;C2orf49,asw;chromosome 2 open reading frame 49
hsa:154907;C7orf66;chromosome 7 open reading frame 66
hsa:23554;TSPAN12,EVR5,NET-2,NET2,TM4SF12;tetraspanin 12
hsa:338398;TAS2R60,T2R56,T2R60;taste receptor, type 2, member 60
hsa:80168;MOGAT2,DGAT2L5,MGAT2;monoacylglycerol O-acyltransferase 2 (EC:2.3.1.22)
hsa:9739;SETD1A,KMT2F,Set1,Set1A;SET domain containing 1A (EC:2.1.1.43)
hsa:126353;C19orf21;chromosome 19 open reading frame 21
hsa:5348;FXYD1,PLM;FXYD domain containing ion transport regulator 1
hsa:56676;ASCL3,HASH3,SGN1,bHLHa42;achaete-scute complex homolog 3 (Drosophila)
hsa:644815;FAM83G;family with sequence similarity 83, member G
hsa:10915;TCERG1,CA150,TAF2S,Urn1;transcription elongation regulator 1
hsa:9147;NEMF,NY-CO-1,SDCCAG1;nuclear export mediator factor
hsa:8645;KCNK5,K2p5.1,TASK-2,TASK2;potassium channel, subfamily K, member 5
hsa:200844;C3orf67;chromosome 3 open reading frame 67
hsa:128861;BPIFA3,C20orf71,SPLUNC3;BPI fold containing family A, member 3
hsa:54726;OTUD4,DUBA6,HIN1,HSHIN1;OTU domain containing 4
hsa:25963;TMEM87A;transmembrane protein 87A
hsa:86;ACTL6A,ACTL6,ARPN-BETA,Arp4,BAF53A,INO80K;actin-like 6A
hsa:132989;C4orf36;chromosome 4 open reading frame 36
hsa:147339;C18orf25,ARKL1;chromosome 18 open reading frame 25
hsa:80830;APOL6,APOL-VI,APOLVI;apolipoprotein L, 6
hsa:284274;SMIM21,C18orf62;small integral membrane protein 21
hsa:55660;PRPF40A,FBP-11,FBP11,FLAF1,FNBP3,HIP-10,HIP10,HYPA,NY-REN-6,Prp40;PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae)
hsa:163747;C1orf177;chromosome 1 open reading frame 177
hsa:158405;;KIAA1958
hsa:10786;SLC17A3,NPT4;solute carrier family 17 (sodium phosphate), member 3
hsa:131149;OTOL1,C1QTNF15;otolin 1
hsa:10268;RAMP3;receptor (G protein-coupled) activity modifying protein 3
hsa:79933;SYNPO2L;synaptopodin 2-like
hsa:23505;TMEM131,CC28,PRO1048,RW1,YR-23;transmembrane protein 131
hsa:222662;LHFPL5,DFNB67,TMHS,dJ510O8.8;lipoma HMGIC fusion partner-like 5
hsa:11170;FAM107A,DRR1,TU3A;family with sequence similarity 107, member A
hsa:282966;C10orf53;chromosome 10 open reading frame 53
hsa:220359;TIGD3;tigger transposable element derived 3
hsa:5281;PIGF;phosphatidylinositol glycan anchor biosynthesis, class F (EC:2.7.8.1)
hsa:22911;WDR47;WD repeat domain 47
hsa:126755;LRRC38,RP4-597A16.1;leucine rich repeat containing 38
hsa:55092;TMEM51,C1orf72;transmembrane protein 51
hsa:9875;URB1,C21orf108,NPA1;URB1 ribosome biogenesis 1 homolog (S. cerevisiae)
hsa:92293;TMEM132C;transmembrane protein 132C
hsa:114827;FHAD1;forkhead-associated (FHA) phosphopeptide binding domain 1
hsa:219527;LRRC55;leucine rich repeat containing 55
hsa:120400;NXPE1,FAM55A;neurexophilin and PC-esterase domain family, member 1
hsa:79780;CCDC82,HSPC048;coiled-coil domain containing 82
hsa:84925;DIRC2,RCC4;disrupted in renal carcinoma 2
hsa:9600;PITPNM1,DRES9,NIR2,PITPNM,RDGB,RDGB1,RDGBA,RDGBA1,Rd9;phosphatidylinositol transfer protein, membrane-associated 1
hsa:51188;SS18L2,KIAA-iso;synovial sarcoma translocation gene on chromosome 18-like 2
hsa:55719;FAM178A,C10orf6;family with sequence similarity 178, member A
hsa:9853;RUSC2,Iporin;RUN and SH3 domain containing 2
hsa:3834;KIF25,KNSL3;kinesin family member 25
hsa:57001;ACN9;ACN9 homolog (S. cerevisiae)
hsa:23029;RBM34;RNA binding motif protein 34
hsa:7798;LUZP1,LUZP;leucine zipper protein 1
hsa:54516;MTRF1L,HMRF1L,MRF1L,mtRF1a;mitochondrial translational release factor 1-like
hsa:79905;TMC7;transmembrane channel-like 7
hsa:9095;TBX19,TBS19,TPIT,dJ747L4.1;T-box 19
hsa:4238;MFAP3;microfibrillar-associated protein 3
hsa:158833;AWAT1,DGA2,DGAT2L3;acyl-CoA wax alcohol acyltransferase 1 (EC:2.3.1.75)
hsa:128859;BPIFB6,BPIL3,LPLUNC6;BPI fold containing family B, member 6
hsa:23161;SNX13,RGS-PX1;sorting nexin 13
hsa:57089;ENTPD7,LALP1,RP11-483F11.1;ectonucleoside triphosphate diphosphohydrolase 7 (EC:3.6.1.-)
hsa:387890;TMEM233,DSPB2,IFITMD2;transmembrane protein 233
hsa:53346;TM6SF1;transmembrane 6 superfamily member 1
hsa:9711;RUBICON;KIAA0226
hsa:55509;BATF3,JDP1,JUNDM1,SNFT;basic leucine zipper transcription factor, ATF-like 3
hsa:203611;CDY2B,CDY;chromodomain protein, Y-linked, 2B (EC:2.3.1.48)
hsa:10491;CRTAP,CASP,LEPREL3,OI7;cartilage associated protein
hsa:136319;MTPN,GCDP,V-1;myotrophin
hsa:353144;LCE3C,LEP15,SPRL3A;late cornified envelope 3C
hsa:5794;PTPRH,SAP1;protein tyrosine phosphatase, receptor type, H (EC:3.1.3.48)
hsa:9617;MTRF1,MRF1,MTTRF1,RF1;mitochondrial translational release factor 1
hsa:55871;CBWD1,COBP;COBW domain containing 1
hsa:25807;RHBDD3,C22orf3,HS984G1A,PTAG;rhomboid domain containing 3
hsa:56180;MOSPD1,DJ473B4;motile sperm domain containing 1
hsa:29802;VPREB3,8HS20,N27C7-2;pre-B lymphocyte 3
hsa:26224;FBXL3,FBL3,FBL3A,FBXL3A;F-box and leucine-rich repeat protein 3
hsa:7260;TSSC1;tumor suppressing subtransferable candidate 1
hsa:1687;DFNA5,ICERE-1;deafness, autosomal dominant 5
hsa:51705;EMCN,EMCN2,MUC14;endomucin
hsa:3839;KPNA3,IPOA4,SRP1,SRP1gamma,SRP4,hSRP1;karyopherin alpha 3 (importin alpha 4)
hsa:55654;TMEM127;transmembrane protein 127
hsa:7367;UGT2B17,UDPGT2B17;UDP glucuronosyltransferase 2 family, polypeptide B17 (EC:2.4.1.17)
hsa:9015;TAF1A,MGC:17061,RAFI48,SL1,TAFI48;TATA box binding protein (TBP)-associated factor, RNA polymerase I, A, 48kDa
hsa:63970;TP53AIP1,P53AIP1;tumor protein p53 regulated apoptosis inducing protein 1
hsa:28227;PPP2R3B,NYREN8,PPP2R3L,PPP2R3LY,PR48;protein phosphatase 2, regulatory subunit B'', beta
hsa:221711;SYCP2L,C6orf177,NO145,dJ62D2.1;synaptonemal complex protein 2-like
hsa:6474;SHOX2,OG12,OG12X,SHOT;short stature homeobox 2
hsa:151258;SLC38A11,AVT2;solute carrier family 38, member 11
hsa:8403;SOX14,SOX28;SRY (sex determining region Y)-box 14
hsa:729857;RGPD2,NUP358,RANBP2L2,RGP2;RANBP2-like and GRIP domain containing 2
hsa:221416;C6orf223;chromosome 6 open reading frame 223
hsa:3196;TLX2,HOX11L1,NCX;T-cell leukemia homeobox 2
hsa:56672;AKIP1,BCA3,C11orf17;A kinase (PRKA) interacting protein 1
hsa:8895;CPNE3,CPN3,PRO1071;copine III
hsa:29970;SCHIP1,SCHIP-1;schwannomin interacting protein 1
hsa:10279;PRSS16,TSSP;protease, serine, 16 (thymus)
hsa:27345;KCNMB4;potassium large conductance calcium-activated channel, subfamily M, beta member 4
hsa:23484;LEPROTL1,HSPC112,Vps55,my047;leptin receptor overlapping transcript-like 1
hsa:84938;ATG4C,APG4-C,APG4C,AUTL1,AUTL3;autophagy related 4C, cysteine peptidase
hsa:81611;ANP32E,LANP-L,LANPL;acidic (leucine-rich) nuclear phosphoprotein 32 family, member E
hsa:388324;INCA1;inhibitor of CDK, cyclin A1 interacting protein 1
hsa:4242;MFNG;MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase (EC:2.4.1.222)
hsa:84812;PLCD4;phospholipase C, delta 4 (EC:3.1.4.11)
hsa:27075;TSPAN13,NET-6,NET6,TM4SF13;tetraspanin 13
hsa:7092;TLL1,ASD6,TLL;tolloid-like 1 (EC:3.4.24.-)
hsa:85313;PPIL4,HDCME13P;peptidylprolyl isomerase (cyclophilin)-like 4 (EC:5.2.1.8)
hsa:10842;PPP1R17,C7orf16,GSBS;protein phosphatase 1, regulatory subunit 17
hsa:285643;KIF4B;kinesin family member 4B
hsa:644961;;actin, gamma 1 pseudogene
hsa:728656;DMRTC1B;DMRT-like family C1B
hsa:400931;MIRLET7BHG,RP4-695O20__B.10;MIRLET7B host gene (non-protein coding)
hsa:100886964;PTCSC3;papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding)
hsa:84790;TUBA1C,TUBA6,bcm948;tubulin, alpha 1c
hsa:388939;C2orf71;chromosome 2 open reading frame 71
hsa:5496;PPM1G,PP2CG,PP2CGAMMA,PPP2CG;protein phosphatase, Mg2+/Mn2+ dependent, 1G (EC:3.1.3.16)
hsa:145781;GCOM1,GRINL1A,Gcom2,MYZAP,MYZAP-POLR2M,gcom;GRINL1A complex locus 1
hsa:51298;THEG,CT56,THEG1;theg spermatid protein
hsa:3420;IDH3B,H-IDHB,RP46;isocitrate dehydrogenase 3 (NAD+) beta (EC:1.1.1.41)
hsa:57819;LSM2,C6orf28,G7B,YBL026W,snRNP;LSM2 homolog, U6 small nuclear RNA associated (S. cerevisiae)
hsa:134121;C5orf49;chromosome 5 open reading frame 49
hsa:9467;SH3BP5,SAB,SH3BP-5;SH3-domain binding protein 5 (BTK-associated)
hsa:388341;FAM211A,C17orf76;family with sequence similarity 211, member A
hsa:401491;FLJ35024;uncharacterized LOC401491
hsa:219557;C7orf62;chromosome 7 open reading frame 62
hsa:374986;FAM73A;family with sequence similarity 73, member A
hsa:11024;LILRA1,CD85I,LIR-6,LIR6;leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1
hsa:167359;NIM1;serine/threonine-protein kinase NIM1 (EC:2.7.11.1)
hsa:406912;MIR125B2,MIRN125B2;microRNA 125b-2
hsa:407034;MIR30E,MIRN30E;microRNA 30e
hsa:554210;MIR429,MIRN429,hsa-mir-429;microRNA 429
hsa:574436;MIR485,MIRN485,hsa-mir-485;microRNA 485
hsa:574496;MIR519A1,MIRN519A-1,MIRN519A1;microRNA 519a-1
hsa:574500;MIR519A2,MIRN519A-2,MIRN519A2;microRNA 519a-2
hsa:26007;DAK,NET45;dihydroxyacetone kinase 2 homolog (S. cerevisiae) (EC:2.7.1.29 4.6.1.15 2.7.1.28)
hsa:158835;AWAT2,ARAT,DC4,DGAT2L4,MFAT,WS;acyl-CoA wax alcohol acyltransferase 2 (EC:2.3.1.75 2.3.1.76)
hsa:11185;INMT,TEMT;indolethylamine N-methyltransferase (EC:2.1.1.49 2.1.1.96)
hsa:9609;RAB36;RAB36, member RAS oncogene family
hsa:9191;DEDD,CASP8IP1,DEDD1,DEFT,FLDED1;death effector domain containing
hsa:163732;CITED4;Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
hsa:121642;ALKBH2,ABH2;alkB, alkylation repair homolog 2 (E. coli) (EC:1.14.11.33)
hsa:10950;BTG3,ANA,TOB5,TOB55,TOFA;BTG family, member 3
hsa:129049;SGSM1,RUTBC2;small G protein signaling modulator 1
hsa:255231;MCOLN2,TRP-ML2,TRPML2;mucolipin 2
hsa:84002;B3GNT5,B3GN-T5,beta3Gn-T5;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 (EC:2.4.1.206)
hsa:3568;IL5RA,CD125,CDw125,HSIL5R3,IL5R;interleukin 5 receptor, alpha
hsa:29122;PRSS50,CT20,TSP50;protease, serine, 50
hsa:4983;OPHN1,ARHGAP41,MRX60,OPN1;oligophrenin 1
hsa:406916;MIR128-2,MIR128B,MIRN128-2,MIRN128B,mir-128b;microRNA 128-2
hsa:574031;MIR363,MIR-363,MIRN363,hsa-mir-363;microRNA 363
hsa:619552;MIR483,MIRN483,hsa-mir-483;microRNA 483
hsa:100616448;MIR4792,miR-4792;microRNA 4792
hsa:407020;MIR28,MIRN28,hsa-mir-28,miR-28;microRNA 28
hsa:440131;LINC00544;long intergenic non-protein coding RNA 544
hsa:283481;FGF14-AS2;FGF14 antisense RNA 2
hsa:286042;FAM86B3P;family with sequence similarity 86, member A pseudogene
hsa:116828;N4BP2L2-IT2,CG030;N4BPL2 intronic transcript 2 (non-protein coding)
hsa:94027;CGB7,CG-beta-a,CGB6;chorionic gonadotropin, beta polypeptide 7
hsa:285834;HCG22,PBMUCL2;HLA complex group 22 (non-protein coding)
hsa:5634;PRPS2,PRSII;phosphoribosyl pyrophosphate synthetase 2 (EC:2.7.6.1)
hsa:267020;ATP5L2,ATP5K2;ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G2
hsa:23412;COMMD3,BUP,C10orf8;COMM domain containing 3
hsa:8871;SYNJ2,INPP5H;synaptojanin 2 (EC:3.1.3.36)
hsa:283953;TMEM114;transmembrane protein 114
hsa:2186;BPTF,FAC1,FALZ,NURF301;bromodomain PHD finger transcription factor
hsa:344454;AOX2P,AOH2,AOX2;aldehyde oxidase 2 pseudogene
hsa:487;ATP2A1,ATP2A,SERCA1;ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 (EC:3.6.3.8)
hsa:4826;NNAT,Peg5;neuronatin
hsa:84707;BEX2,BEX1,DJ79P11.1;brain expressed X-linked 2
hsa:5721;PSME2,PA28B,PA28beta,REGbeta;proteasome (prosome, macropain) activator subunit 2 (PA28 beta)
hsa:889;KRIT1,CAM,CCM1;KRIT1, ankyrin repeat containing
hsa:8653;DDX3Y,DBY;DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked (EC:3.6.4.13)
hsa:4588;MUC6,MUC-6;mucin 6, oligomeric mucus/gel-forming
hsa:100126355;MIR365A,MIR365-1,MIRN365-1,hsa-mir-365a;microRNA 365a
hsa:442911;MIR346,MIRN346,hsa-mir-346,miR-346,miRNA346;microRNA 346
hsa:406993;MIR211,MIRN211,mir-211;microRNA 211
hsa:100133308;RSU1P2;Ras suppressor protein 1 pseudogene 2
hsa:100996455;;uncharacterized LOC100996455
hsa:112487;DTD2,C14orf126;D-tyrosyl-tRNA deacylase 2 (putative)
hsa:100996291;;uncharacterized LOC100996291
hsa:100996307;;uncharacterized LOC100996307
hsa:256646;NUTM1,C15orf55,FAM22H,NUT;NUT midline carcinoma, family member 1
hsa:100287722;AP4B1-AS1;AP4B1 antisense RNA 1
hsa:23145;SSPO,SCO-spondin;SCO-spondin homolog (Bos taurus)
hsa:5537;PPP6C,PP6,PP6C;protein phosphatase 6, catalytic subunit (EC:3.1.3.16)
hsa:340515;;uncharacterized LOC340515
hsa:10857;PGRMC1,HPR6.6,MPR;progesterone receptor membrane component 1
hsa:9166;EBAG9,EB9,PDAF,RCAS1;estrogen receptor binding site associated, antigen, 9
hsa:874;CBR3,SDR21C2,hCBR3;carbonyl reductase 3 (EC:1.1.1.184)
hsa:57393;TMEM27,NX-17,NX17;transmembrane protein 27
hsa:56311;ANKRD7,TSA806;ankyrin repeat domain 7
hsa:23641;LDOC1,BCUR1,Mar7,Mart7;leucine zipper, down-regulated in cancer 1
hsa:221938;MMD2,PAQR10;monocyte to macrophage differentiation-associated 2
hsa:9046;DOK2,p56DOK,p56dok-2;docking protein 2, 56kDa
hsa:406943;MIR152,MIRN152;microRNA 152
hsa:406945;MIR153-2,MIRN153-2;microRNA 153-2
hsa:100422992;MIR3151;microRNA 3151
hsa:100302175;MIR1207,MIRN1207,hsa-mir-1207;microRNA 1207
hsa:140464;PISRT1,NCRNA00195;polled intersex syndrome regulated transcript 1 (non-protein coding RNA)
hsa:574473;MIR520B,MIRN520B;microRNA 520b
hsa:729176;;katanin p80 subunit B-like 1 pseudogene
hsa:91452;ACBD5;acyl-CoA binding domain containing 5
hsa:100073347;MIMT1,LINC00067,MIM1,NCRNA00067;MER1 repeat containing imprinted transcript 1 (non-protein coding)
hsa:147429;AQP4-AS1,C18orf16,CHST9-AS1;AQP4 antisense RNA 1
hsa:55018;LINC00483,C17orf73;long intergenic non-protein coding RNA 483
hsa:388007;SERPINA13P,SERPINA13,UNQ6121;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 13, pseudogene
hsa:2310;FOXO3B,FKHRL1P1,ZNF286C;forkhead box O3B pseudogene
hsa:140880;CST11,CST8L,CTES2,SC13,dJ322G13.6;cystatin 11
hsa:1876;E2F6,E2F-6;E2F transcription factor 6
hsa:116159;CYYR1,C21orf95;cysteine/tyrosine-rich 1
hsa:1774;DNASE1L1,DNAS1L1,DNASEX,DNL1L,G4.8,XIB;deoxyribonuclease I-like 1 (EC:3.1.21.-)
hsa:932;MS4A3,CD20L,HTM4;membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific)
hsa:9249;DHRS3,DD83.1,RDH17,Rsdr1,SDR1,SDR16C1,retSDR1;dehydrogenase/reductase (SDR family) member 3 (EC:1.1.1.300)
hsa:9023;CH25H,C25H;cholesterol 25-hydroxylase (EC:1.14.99.38)
hsa:57134;MAN1C1,HMIC,MAN1A3,MAN1C,pp6318;mannosidase, alpha, class 1C, member 1 (EC:3.2.1.113)
hsa:119395;CALHM3,FAM26A,bA225H22.7;calcium homeostasis modulator 3
hsa:55105;GPATCH2,CT110,GPATC2,PPP1R30,RP11-361K17.1;G patch domain containing 2
hsa:641700;ECSCR,ARIA,ECSM2;endothelial cell surface expressed chemotaxis and apoptosis regulator
hsa:285605;DTWD2;DTW domain containing 2
hsa:58489;ABHD17C,FAM108C1;abhydrolase domain containing 17C
hsa:407738;FAM19A1,TAFA-1,TAFA1;family with sequence similarity 19 (chemokine (C-C motif)-like), member A1
hsa:729786;GOLGA8CP,GOLGA8C;golgin A8 family, member C, pseudogene
hsa:390535;GOLGA8EP,GOLGA8E;golgin A8 family, member E, pseudogene
hsa:283796;GOLGA8I,GOLGA8IP,GOLGA9P;golgin A8 family, member I
hsa:100616234;MIR4454;microRNA 4454
hsa:9671;WSCD2;WSC domain containing 2
hsa:7103;TSPAN8,CO-029,TM4SF3;tetraspanin 8
hsa:54579;UGT1A5,UDPGT,UDPGT_1-5,UGT1E;UDP glucuronosyltransferase 1 family, polypeptide A5 (EC:2.4.1.17)
hsa:6780;STAU1,STAU;staufen, RNA binding protein, homolog 1 (Drosophila)
hsa:6836;SURF4,ERV29;surfeit 4
hsa:25956;SEC31B,SEC31B-1,SEC31L2;SEC31 homolog B (S. cerevisiae)
hsa:389158;PLSCR5;phospholipid scramblase family, member 5
hsa:161753;ODF3L1;outer dense fiber of sperm tails 3-like 1
hsa:654790;PCP4L1,IQM1;Purkinje cell protein 4 like 1
hsa:196483;FAM86A;family with sequence similarity 86, member A
hsa:166752;FREM3;FRAS1 related extracellular matrix 3
hsa:4722;NDUFS3,CI-30;NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3)
hsa:375449;MAST4;microtubule associated serine/threonine kinase family member 4 (EC:2.7.11.1)
hsa:57549;IGSF9,FP18798,IGSF9A,Nrt1;immunoglobulin superfamily, member 9
hsa:64922;LRRC19;leucine rich repeat containing 19
hsa:2987;GUK1,GMK;guanylate kinase 1 (EC:2.7.4.8)
hsa:284451;ODF3L2,C19orf19;outer dense fiber of sperm tails 3-like 2
hsa:9792;SERTAD2,Sei-2,TRIP-Br2;SERTA domain containing 2
hsa:115650;TNFRSF13C,BAFF-R,BAFFR,BROMIX,CD268,CVID4,prolixin;tumor necrosis factor receptor superfamily, member 13C
hsa:54544;CRCT1,C1orf42,NICE-1;cysteine-rich C-terminal 1
hsa:653075;GOLGA8T;golgin A8 family, member T
hsa:653061;GOLGA8S;golgin A8 family, member S
hsa:401124;DTHD1;death domain containing 1
hsa:166647;GPR125,PGR21,TEM5L;G protein-coupled receptor 125
hsa:28971;AAMDC,C11orf67,CK067;adipogenesis associated, Mth938 domain containing
hsa:646450;ARIH2OS,C3orf71;ariadne homolog 2 opposite strand
hsa:100132911;DPH3P1,C20orf143,DPH3B,ZCSL1,dJ885L7.5;DPH3, KTI11 homolog (S. cerevisiae) pseudogene 1
hsa:440957;SMIM4,C3orf78;small integral membrane protein 4
hsa:645836;USP17L3,USP17B,USP17F;ubiquitin specific peptidase 17-like family member 3
hsa:401447;USP17L1P,USP17L1;ubiquitin specific peptidase 17-like family member 1, pseudogene
hsa:391622;USP17L6P,DUB4,USP17L6,vDUB4;ubiquitin specific peptidase 17-like family member 6, pseudogene
hsa:200504;GKN2,BRICD1B,GDDR,PRO813,TFIZ1,VLTI465;gastrokine 2
hsa:283870;BRICD5,C16orf79;BRICHOS domain containing 5
hsa:100526830;SLX1A-SULT1A3;SLX1A-SULT1A3 readthrough (non-protein coding)
hsa:100529209;RNASEK-C17orf49;RNASEK-C17orf49 readthrough (non-protein coding)
hsa:100529145;TEN1-CDK3,C17orf106-CDK3;TEN1-CDK3 readthrough (non-protein coding)
hsa:646023;ADORA2A-AS1,C22orf45;ADORA2A antisense RNA 1
hsa:339201;ASB16-AS1,C17orf65;ASB16 antisense RNA 1
hsa:204962;SLC44A5,CTL5;solute carrier family 44, member 5
hsa:55615;PRR5,FLJ20185k,PP610,PROTOR-1,PROTOR1;proline rich 5 (renal)
hsa:221035;REEP3,C10orf74;receptor accessory protein 3
hsa:80758;PRR7;proline rich 7 (synaptic)
hsa:149420;PDIK1L,CLIK1L,STK35L2;PDLIM1 interacting kinase 1 like (EC:2.7.11.1)
hsa:57763;ANKRA2,ANKRA;ankyrin repeat, family A (RFXANK-like), 2
hsa:24139;EML2,ELP70,EMAP-2,EMAP2;echinoderm microtubule associated protein like 2
hsa:3038;HAS3;hyaluronan synthase 3 (EC:2.4.1.212)
hsa:79415;C17orf62;chromosome 17 open reading frame 62
hsa:5625;PRODH,HSPOX2,PIG6,POX,PRODH1,PRODH2,TP53I6;proline dehydrogenase (oxidase) 1 (EC:1.5.99.8)
hsa:9909;DENND4B,KIAA0476;DENN/MADD domain containing 4B
hsa:11341;SCRG1,SCRG-1;stimulator of chondrogenesis 1
hsa:8896;BUD31,Cwc14,EDG-2,EDG2,G10,YCR063W,fSAP17;BUD31 homolog (S. cerevisiae)
hsa:128653;C20orf141,dJ860F19.4;chromosome 20 open reading frame 141
hsa:64766;S100PBP,S100PBPR;S100P binding protein
hsa:64854;USP46;ubiquitin specific peptidase 46 (EC:3.4.19.12)
hsa:79652;TMEM204,C16orf30,CLP24;transmembrane protein 204
hsa:148327;CREB3L4,AIBZIP,ATCE1,CREB3,CREB4,JAL,hJAL;cAMP responsive element binding protein 3-like 4
hsa:9723;SEMA3E,M-SEMAH,M-SemaK,SEMAH,coll-5;sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
hsa:53336;CPXCR1,CT77;CPX chromosome region, candidate 1
hsa:160;AP2A1,ADTAA,AP2-ALPHA,CLAPA1;adaptor-related protein complex 2, alpha 1 subunit
hsa:81789;TIGD6;tigger transposable element derived 6
hsa:26511;CHIC2,BTL;cysteine-rich hydrophobic domain 2
hsa:9987;HNRPDL,HNRNP,JKTBP,JKTBP2,laAUF1;heterogeneous nuclear ribonucleoprotein D-like
hsa:553158;PRR5-ARHGAP8;PRR5-ARHGAP8 readthrough
hsa:153743;PPP1R2P3;protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 3
hsa:574445;MIR511-1,MIRN511-1,MIR511-2,MIRN511-2;microRNA 511-1
hsa:391257;SUMO1P1,PIC1L,UBL2,UBL6;SUMO1 pseudogene 1
hsa:400794;;uncharacterized LOC400794
hsa:388714;FMO6P,FMO6;flavin containing monooxygenase 6 pseudogene
hsa:84236;RHBDD1,RRP4;rhomboid domain containing 1 (EC:3.4.21.105)
hsa:100505753;KRTAP16-1,KAP16.1;keratin associated protein 16-1
hsa:644100;ARL14EPL;ADP-ribosylation factor-like 14 effector protein-like
hsa:648791;PPP1R3G;protein phosphatase 1, regulatory subunit 3G
hsa:284418;FAM71E2,C19orf16;family with sequence similarity 71, member E2
hsa:100507055;LRCOL1;leucine rich colipase-like 1
hsa:347411;MPC1L;mitochondrial pyruvate carrier 1-like
hsa:375190;FAM228B;family with sequence similarity 228, member B
hsa:100507050;TPBGL;trophoblast glycoprotein-like
hsa:728419;USP17L30;ubiquitin specific peptidase 17-like family member 30
hsa:100130890;TSTD3;thiosulfate sulfurtransferase (rhodanese)-like domain containing 3
hsa:728373;USP17L25;ubiquitin specific peptidase 17-like family member 25
hsa:728369;USP17L24;ubiquitin specific peptidase 17-like family member 24
hsa:728379;USP17L26;ubiquitin specific peptidase 17-like family member 26
hsa:728393;USP17L27;ubiquitin specific peptidase 17-like family member 27
hsa:728400;USP17L28;ubiquitin specific peptidase 17-like family member 28
hsa:728405;USP17L29;ubiquitin specific peptidase 17-like family member 29
hsa:348174;CLEC18A,MRCL,MRCL1,MRLP2;C-type lectin domain family 18, member A
hsa:646627;LYPD8;LY6/PLAUR domain containing 8
hsa:100507096;GIMD1;GIMAP family P-loop NTPase domain containing 1
hsa:120376;C11orf93;chromosome 11 open reading frame 93
hsa:256006;ANKRD31;ankyrin repeat domain 31
hsa:347127;SPATA31D5P,FAM75D5,FAM75D5P;SPATA31 subfamily D, member 5, pseudogene
hsa:84461;NEURL4;neuralized homolog 4 (Drosophila)
hsa:56954;NIT2;nitrilase family, member 2 (EC:3.5.1.3)
hsa:65990;FAM173A,C16orf24;family with sequence similarity 173, member A
hsa:338339;CLEC4D,CLEC-6,CLEC6,CLECSF8,MCL,MPCL;C-type lectin domain family 4, member D
hsa:693195;MIR610,MIRN610,hsa-mir-610;microRNA 610
hsa:494323;MIR361,MIRN361,hsa-mir-361;microRNA 361
hsa:574457;MIR181D,MIRN181D;microRNA 181d
hsa:574504;MIR502,MIRN502,hsa-mir-502;microRNA 502
hsa:574511;MIR506,MIRN506,hsa-mir-506;microRNA 506
hsa:149620;CHIAP2;chitinase, acidic pseudogene 2
hsa:2861;GPR37,EDNRBL,PAELR,hET(B)R-LP;G protein-coupled receptor 37 (endothelin receptor type B-like)
hsa:90639;COX19;cytochrome c oxidase assembly homolog 19 (S. cerevisiae)
hsa:285521;COX18,COX18HS;cytochrome c oxidase assembly homolog 18 (yeast)
hsa:6341;SCO1,SCOD1;SCO1 cytochrome c oxidase assembly protein;K07152
hsa:389895;;chromosome 16 open reading frame 72-like
hsa:100505826;STK4-AS1;STK4 antisense RNA 1 (head to head)
hsa:100506696;KDM5B-AS1,ncRNA-a2;KDM5B antisense RNA 1 (head to head)
hsa:100507466;ATPBD4-AS1;ATPBD4 antisense RNA 1 (head to head)
hsa:100132677;BSN-AS2;BSN antisense RNA 2 (head to head)
hsa:64150;DIO3OS,C14orf134,DIO3-AS1,DIO3-OS,NCRNA00041;DIO3 opposite strand/antisense RNA (head to head)
hsa:642946;FLVCR1-AS1,LQK1,NCRNA00292;FLVCR1 antisense RNA 1 (head to head)
hsa:100507171;BOLA3-AS1;BOLA3 antisense RNA 1 (head to head)
hsa:653483;MLLT4-AS1,C6orf124,HGC6.4,dJ431P23.3;MLLT4 antisense RNA 1 (head to head)
hsa:78998;RHPN1-AS1,C8orf51;RHPN1 antisense RNA 1 (head to head)
hsa:440465;BAIAP2-AS1;BAIAP2 antisense RNA 1 (head to head)
hsa:285456;RPL34-AS1;RPL34 antisense RNA 1 (head to head)
hsa:11260;XPOT,XPO3;exportin, tRNA
hsa:649;BMP1,OI13,PCOLC,PCP,PCP2,TLD;bone morphogenetic protein 1 (EC:3.4.24.19)
hsa:84837;ARHGAP5-AS1,C14orf128;ARHGAP5 antisense RNA 1 (head to head)
hsa:100861510;LRRC3-AS1;LRRC3 antisense RNA 1 (head to head)
hsa:100309464;OTX2-AS1,OTX2OS1;OTX2 antisense RNA 1 (head to head)
hsa:283981;LINC00685,CXYorf10,NCRNA00107,PPP2R3B-AS1;long intergenic non-protein coding RNA 685
hsa:401588;ZNF674-AS1;ZNF674 antisense RNA 1 (head to head)
hsa:100775104;KLHL7-AS1,PLATAK;KLHL7 antisense RNA 1 (head to head)
hsa:84793;FOXD2-AS1;FOXD2 antisense RNA 1 (head to head)
hsa:100129361;;chromosome X open reading frame 69-like
hsa:348249;CCL15-CCL14;CCL15-CCL14 readthrough (non-protein coding)
hsa:647060;SPATA31A1,C9orf36,C9orf36A,FAM75A1;SPATA31 subfamily A, member 1
hsa:727830;SPATA31A3,FAM75A3;SPATA31 subfamily A, member 3
hsa:727905;SPATA31A5,FAM75A5;SPATA31 subfamily A, member 5
hsa:10024;TROAP,TASTIN;trophinin associated protein
hsa:54964;C1orf56,MENT,RP11-316M1.9;chromosome 1 open reading frame 56
hsa:10057;ABCC5,ABC33,EST277145,MOAT-C,MOATC,MRP5,SMRP,pABC11;ATP-binding cassette, sub-family C (CFTR/MRP), member 5
hsa:1677;DFFB,CAD,CPAN,DFF-40,DFF2,DFF40;DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
hsa:63027;SLC22A23,C6orf85;solute carrier family 22, member 23
hsa:9860;LRIG2,LIG-2,LIG2,UFS2;leucine-rich repeats and immunoglobulin-like domains 2
hsa:23647;ARFIP2,POR1;ADP-ribosylation factor interacting protein 2
hsa:9400;RECQL5,RECQ5;RecQ protein-like 5 (EC:3.6.4.12)
hsa:55012;PPP2R3C,C14orf10,G4-1,G5pr;protein phosphatase 2, regulatory subunit B'', gamma
hsa:387357;THEMIS,C6orf190,C6orf207,GASP,SPOT,TSEPA,bA325O24.3,bA325O24.4;thymocyte selection associated
hsa:84315;MON1A,SAND1;MON1 homolog A (yeast)
hsa:55765;C1orf106;chromosome 1 open reading frame 106
hsa:4013;VWA5A,BCSC-1,BCSC1,LOH11CR2A;von Willebrand factor A domain containing 5A
hsa:54675;CRLS1,C20orf155,CLS,CLS1,GCD10,dJ967N21.6;cardiolipin synthase 1
hsa:693193;MIR608,MIRN608,hsa-mir-608;microRNA 608
hsa:442894;MIR302B,MIRN302B;microRNA 302b
hsa:442895;MIR302C,MIRN302C;microRNA 302c
hsa:10301;DLEU1,BCMS,DLB1,DLEU2,LEU1,LEU2,LINC00021,NCRNA00021,XTP6;deleted in lymphocytic leukemia 1 (non-protein coding)
hsa:100126327;MIR938,MIRN938,hsa-mir-938;microRNA 938
hsa:574461;MIR520E,MIRN520E;microRNA 520e
hsa:79970;ZNF767;zinc finger family member 767
hsa:23439;ATP1B4;ATPase, Na+/K+ transporting, beta 4 polypeptide
hsa:27077;B9D1,B9,EPPB9,MKS9,MKSR1;B9 protein domain 1
hsa:7190;HSP90B2P,GRP94P1,GRP94b,HSP,HSPCP2,TRA1P1,TRAP1;heat shock protein 90kDa beta (Grp94), member 2, pseudogene
hsa:644096;SDHAF1,LYRM8;succinate dehydrogenase complex assembly factor 1
hsa:51441;YTHDF2,HGRG8,NY-REN-2;YTH domain family, member 2
hsa:353299;RGSL1,RGSL,RGSL2;regulator of G-protein signaling like 1
hsa:285973;ATG9B,APG9L2,NOS3AS,SONE;autophagy related 9B
hsa:80063;ATF7IP2,MCAF2;activating transcription factor 7 interacting protein 2
hsa:64231;MS4A6A,4SPAN3,4SPAN3.2,CD20L3,MS4A6,MST090,MSTP090;membrane-spanning 4-domains, subfamily A, member 6A
hsa:51338;MS4A4A,4SPAN1,CD20-L1,CD20L1,MS4A4,MS4A7;membrane-spanning 4-domains, subfamily A, member 4A
hsa:201140;DHRS7C,SDR32C2;dehydrogenase/reductase (SDR family) member 7C (EC:1.1.-.-)
hsa:64149;C17orf75,NJMU-R1;chromosome 17 open reading frame 75
hsa:54777;TTC40,C10orf123,C10orf124,C10orf92,C10orf93,RP13-137A17.3,bA288G11.4,bA288G11.5,bB137A17.2,bB137A17.3;tetratricopeptide repeat domain 40
hsa:9537;TP53I11,PIG11;tumor protein p53 inducible protein 11
hsa:10421;CD2BP2,FWP010,LIN1,PPP1R59,Snu40,U5-52K;CD2 (cytoplasmic tail) binding protein 2
hsa:5636;PRPSAP2,PAP41;phosphoribosyl pyrophosphate synthetase-associated protein 2
hsa:157574;FBXO16,FBX16;F-box protein 16
hsa:8751;ADAM15,MDC15;ADAM metallopeptidase domain 15
hsa:27039;PKD2L2,TRPP5;polycystic kidney disease 2-like 2
hsa:643669;;uncharacterized LOC643669
hsa:100130480;;uncharacterized LOC100130480
hsa:266629;SEC14L3,TAP2;SEC14-like 3 (S. cerevisiae)
hsa:22901;ARSG;arylsulfatase G
hsa:100127983;;uncharacterized LOC100127983
hsa:100505679;;uncharacterized LOC100505679
hsa:26223;FBXL21,FBL3B,FBXL3B,FBXL3P,Fbl21;F-box and leucine-rich repeat protein 21 (gene/pseudogene)
hsa:219833;C11orf45;chromosome 11 open reading frame 45
hsa:285242;HTR3E,5-HT3-E,5-HT3E,5-HT3c1;5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
hsa:653333;FAM86B2;family with sequence similarity 86, member B2
hsa:126526;C19orf47;chromosome 19 open reading frame 47
hsa:730094;C16orf52;chromosome 16 open reading frame 52
hsa:84293;FAM213A,C10orf58,PAMM;family with sequence similarity 213, member A
hsa:9128;PRPF4,HPRP4,HPRP4P,PRP4,Prp4p;PRP4 pre-mRNA processing factor 4 homolog (yeast)
hsa:10092;ARPC5,ARC16,dJ127C7.3,p16-Arc;actin related protein 2/3 complex, subunit 5, 16kDa
hsa:347442;DCAF8L2,WDR42C;DDB1 and CUL4 associated factor 8-like 2
hsa:54929;TMEM161A,AROS-29;transmembrane protein 161A
hsa:125111;GJD3,CX31.9,Cx30.2,GJA11,GJC1;gap junction protein, delta 3, 31.9kDa
hsa:27134;TJP3,ZO-3,ZO3;tight junction protein 3
hsa:474344;GIMAP6,IAN-2,IAN-6,IAN2,IAN6;GTPase, IMAP family member 6
hsa:100129654;TCF24,TCF-24,bHLHa25;transcription factor 24
hsa:55035;NOL8,C9orf34,NOP132,bA62C3.3,bA62C3.4;nucleolar protein 8
hsa:79134;TMEM185B,FAM11B;transmembrane protein 185B
hsa:2762;GMDS,GMD,SDR3E1;GDP-mannose 4,6-dehydratase (EC:4.2.1.47)
hsa:100506581;C16orf95;chromosome 16 open reading frame 95
hsa:129563;DIS3L2,FAM6A,PRLMNS;DIS3 mitotic control homolog (S. cerevisiae)-like 2
hsa:64847;SPATA20,SSP411,Tisp78;spermatogenesis associated 20
hsa:646498;;uncharacterized LOC646498
hsa:202134;FAM153B;family with sequence similarity 153, member B
hsa:163259;DENND2C,dJ1156J9.1;DENN/MADD domain containing 2C
hsa:145788;FLJ27352;uncharacterized LOC145788
hsa:147646;;uncharacterized LOC147646
hsa:100529144;CORO7-PAM16;CORO7-PAM16 readthrough
hsa:124739;USP43;ubiquitin specific peptidase 43 (EC:3.4.19.12)
hsa:23334;SZT2,C1orf84,KIAA0467,RP11-506B15.3,SZT2A,SZT2B;seizure threshold 2 homolog (mouse)
hsa:100507003;;uncharacterized LOC100507003
hsa:9692;MRPP3;KIAA0391
hsa:26693;OR2V1,OR2V1P,OST265;olfactory receptor, family 2, subfamily V, member 1
hsa:374973;TEX38,ATPAF1-AS1,C1orf223,THEG4;testis expressed 38
hsa:9442;MED27,CRAP34,CRSP34,CRSP8,TRAP37;mediator complex subunit 27
hsa:100127206;KIAA1024L;KIAA1024-like
hsa:79731;NARS2,SLM5,asnRS;asparaginyl-tRNA synthetase 2, mitochondrial (putative) (EC:6.1.1.22)
hsa:729059;;uncharacterized LOC729059
hsa:257019;FRMD3,4.1O,EPB41L4O,EPB41LO,P410;FERM domain containing 3
hsa:100129480;C3orf83,MKRN2-AS1;uncharacterized LOC100129480
hsa:51380;CSAD,CSD,PCAP;cysteine sulfinic acid decarboxylase (EC:4.1.1.29)
hsa:494514;C18orf56;chromosome 18 open reading frame 56
hsa:83882;TSPAN10,OCSP;tetraspanin 10
hsa:146547;PRSS36;protease, serine, 36
hsa:79948;LPPR3,LPR3,PRG-2,PRG2;lipid phosphate phosphatase-related protein type 3 (EC:3.1.3.4)
hsa:158358;;KIAA2026
hsa:115353;LRRC42,dJ167A19.4;leucine rich repeat containing 42
hsa:10393;ANAPC10,APC10,DOC1;anaphase promoting complex subunit 10
hsa:10840;ALDH1L1,10-FTHFDH,10-fTHF,FDH,FTHFD;aldehyde dehydrogenase 1 family, member L1 (EC:1.5.1.6)
hsa:2804;GOLGB1,GCP,GCP372,GOLIM1;golgin B1
hsa:100131755;ARMCX4,CXorf35;armadillo repeat containing, X-linked 4
hsa:83697;SLC4A9,AE4;solute carrier family 4, sodium bicarbonate cotransporter, member 9
hsa:200959;GABRR3;gamma-aminobutyric acid (GABA) A receptor, rho 3
hsa:197342;EME2,SLX2B,gs125;essential meiotic endonuclease 1 homolog 2 (S. pombe)
hsa:10896;OCLM,TISR;oculomedin
hsa:494141;;solute carrier family 25, member 51 pseudogene
hsa:285407;ALG1L9P;asparagine-linked glycosylation 1-like 9, pseudogene
hsa:9252;RPS6KA5,MSK1,MSPK1,RLPK;ribosomal protein S6 kinase, 90kDa, polypeptide 5 (EC:2.7.11.1)
hsa:55508;SLC35E3,BLOV1;solute carrier family 35, member E3
hsa:4649;MYO9A;myosin IXA
hsa:84798;C19orf48;chromosome 19 open reading frame 48
hsa:57722;IGDCC4,DDM36,NOPE;immunoglobulin superfamily, DCC subclass, member 4
hsa:55094;GPATCH1,ECGP,GPATC1;G patch domain containing 1
hsa:344148;NCKAP5,ERIH1,ERIH2,NAP5;NCK-associated protein 5
hsa:138639;PTPDC1,PTP9Q22;protein tyrosine phosphatase domain containing 1 (EC:3.1.3.48)
hsa:4883;NPR3,ANP-C,ANPR-C,ANPRC,C5orf23,GUCY2B,NPR-C,NPRC;natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C)
hsa:10260;DENND4A,IRLB,MYCPBP;DENN/MADD domain containing 4A
hsa:245806;VGLL2,VGL2,VITO1;vestigial like 2 (Drosophila)
hsa:56169;GSDMC,MLZE;gasdermin C
hsa:4990;SIX6,MCOPCT2,OPTX2,Six9;SIX homeobox 6
hsa:83643;CCDC3;coiled-coil domain containing 3
hsa:55297;CCDC91,p56;coiled-coil domain containing 91
hsa:9477;MED20,PRO0213,TRFP;mediator complex subunit 20
hsa:654364;NME1-NME2,NM23-LV,NMELV;NME1-NME2 readthrough (EC:2.7.4.6)
hsa:90488;C12orf23;chromosome 12 open reading frame 23
hsa:8846;ALKBH1,ABH,ABH1,ALKBH,alkB,hABH;alkB, alkylation repair homolog 1 (E. coli) (EC:4.2.99.18 1.14.11.33)
hsa:23381;SMG5,EST1B,LPTS-RP1,LPTSRP1,SMG-5;smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans)
hsa:23272;FAM208A,C3orf63,RAP140,se89-1;family with sequence similarity 208, member A
hsa:220107;DLEU7;deleted in lymphocytic leukemia, 7
hsa:114659;LRRC37B;leucine rich repeat containing 37B
hsa:11181;TREH,TRE,TREA;trehalase (brush-border membrane glycoprotein) (EC:3.2.1.28)
hsa:57333;RCN3,RLP49;reticulocalbin 3, EF-hand calcium binding domain
hsa:84283;TMEM79;transmembrane protein 79
hsa:205717;;KIAA2018
hsa:113730;KLHDC7B;kelch domain containing 7B
hsa:83930;STARD3NL,MENTHO;STARD3 N-terminal like
hsa:389668;XKR9,XRG9;XK, Kell blood group complex subunit-related family, member 9
hsa:729582;DIRC3;disrupted in renal carcinoma 3
hsa:100507257;MEG9,LINC00584;maternally expressed 9 (non-protein coding)
hsa:283459;GATC,15E1.2;glutamyl-tRNA(Gln) amidotransferase, subunit C
hsa:340547;VSIG1,1700062D20Rik,GPA34,dJ889N15.1;V-set and immunoglobulin domain containing 1
hsa:26123;TCTN3,C10orf61,JBTS18,OFD4,TECT3;tectonic family member 3
hsa:10325;RRAGB,RAGB,bA465E19.1;Ras-related GTP binding B
hsa:6732;SRPK1,SFRSK1;SRSF protein kinase 1 (EC:2.7.11.1)
hsa:25902;MTHFD1L,FTHFSDC1,MTC1THFS,dJ292B18.2;methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like (EC:6.3.4.3)
hsa:962;CD48,BCM1,BLAST,BLAST1,MEM-102,SLAMF2,hCD48,mCD48;CD48 molecule
hsa:10768;AHCYL1,DCAL,IRBIT,PRO0233,XPVKONA;adenosylhomocysteinase-like 1 (EC:3.3.1.1)
hsa:50834;TAS2R1,T2R1,TRB7;taste receptor, type 2, member 1
hsa:10637;LEFTY1,LEFTB,LEFTYB;left-right determination factor 1
hsa:23677;SH3BP4,BOG25,TTP;SH3-domain binding protein 4
hsa:407047;MIR9-2,MIRN9-2,hsa-mir-9-2,miRNA9-2;microRNA 9-2
hsa:100126333;MIR708,MIRN708,hsa-mir-708;microRNA 708
hsa:101060798;;aldo-keto reductase family 1 member C2-like
hsa:100128356;;protein transactivated by hepatitis B virus E antigen
hsa:100507059;LINC00703;long intergenic non-protein coding RNA 703
hsa:100652988;LINC00702;long intergenic non-protein coding RNA 702
hsa:642422;;uncharacterized LOC642422
hsa:100288619;;uncharacterized LOC100288619
hsa:729668;;golgin A6 family, member A pseudogene
hsa:283080;C10orf126,bA492M23.1;chromosome 10 open reading frame 126
hsa:100507531;LINC00836;long intergenic non-protein coding RNA 836
hsa:100289455;;uncharacterized LOC100289455
hsa:100507445;;uncharacterized LOC100507445
hsa:100509635;;uncharacterized LOC100509635
hsa:101060107;ARL5B-AS1;ARL5B antisense RNA 1
hsa:100507347;VIM-AS1;VIM antisense RNA 1
hsa:100507163;LINC00709;long intergenic non-protein coding RNA 709
hsa:100507143;LINC00708;long intergenic non-protein coding RNA 708
hsa:100652997;LINC00706;long intergenic non-protein coding RNA 706
hsa:399716;;uncharacterized protein DKFZp667F0711
hsa:100132159;CALML3-AS1;CALML3 antisense RNA 1
hsa:340895;C10orf112,bA265G8.2;chromosome 10 open reading frame 112
hsa:100505601;PARD3-AS1;PARD3 antisense RNA 1
hsa:100505502;;putative UPF0607 protein FLJ37424-like
hsa:100996668;;uncharacterized LOC100996668
hsa:100507663;;uncharacterized LOC100507663
hsa:283028;;uncharacterized LOC283028
hsa:100506853;;uncharacterized LOC100506853
hsa:100506769;C10orf71-AS1;C10orf71 antisense RNA 1
hsa:195977;ANTXRL;anthrax toxin receptor-like
hsa:100507008;LINC00844;long intergenic non-protein coding RNA 844
hsa:100507058;LINC00845;long intergenic non-protein coding RNA 845
hsa:100996629;LINC00849;long intergenic non-protein coding RNA 849
hsa:729815;;uncharacterized LOC729815
hsa:100131132;;uncharacterized LOC100131132
hsa:100996797;;uncharacterized LOC100996797
hsa:100653137;cadherin-23-like
hsa:100130698;;uncharacterized LOC100130698
hsa:100133190;ADIRF-AS1;ADIRF antisense RNA 1
hsa:100505561;LINC00866;long intergenic non-protein coding RNA 866
hsa:100507633;TNKS2-AS1;TNKS2 antisense RNA 1 (head to head)
hsa:100132116;ACTA2-AS1;ACTA2 antisense RNA 1
hsa:100130887;;uncharacterized LOC100130887
hsa:404216;C10orf85;chromosome 10 open reading frame 85
hsa:100506126;LINC00867;long intergenic non-protein coding RNA 867
hsa:100505890;SORCS3-AS1;SORCS3 antisense RNA 1
hsa:100505869;CCDC147-AS1;CCDC147 antisense RNA 1 (head to head)
hsa:414269;CYP17A1-AS1,CYP17A1OS,bA753C18.3;CYP17A1 antisense RNA 1
hsa:100506255;;uncharacterized LOC100506255
hsa:387720;;uncharacterized LOC387720
hsa:100506057;;uncharacterized LOC100506057
hsa:100289424;;uncharacterized LOC100289424
hsa:692247;;uncharacterized LOC692247
hsa:100506518;;uncharacterized LOC100506518
hsa:100131262;;uncharacterized LOC100131262
hsa:4586;MUC5AC,MUC5,TBM,leB;mucin 5AC, oligomeric mucus/gel-forming
hsa:100505570;;uncharacterized LOC100505570
hsa:100505870;;uncharacterized LOC100505870
hsa:100506101;;uncharacterized LOC100506101
hsa:100506238;;uncharacterized LOC100506238
hsa:100506258;;uncharacterized LOC100506258
hsa:100507417;;uncharacterized LOC100507417
hsa:399886;FLJ41423;uncharacterized LOC399886
hsa:100507261;;uncharacterized LOC100507261
hsa:100996875;;uncharacterized LOC100996875
hsa:100507144;;uncharacterized LOC100507144
hsa:101060148;;uncharacterized LOC101060148
hsa:100507109;;uncharacterized LOC100507109
hsa:100506675;;uncharacterized LOC100506675
hsa:100508408;;uncharacterized LOC100508408
hsa:100506352;;uncharacterized LOC100506352
hsa:100131381;;uncharacterized LOC100131381
hsa:100508736;;uncharacterized LOC100508736
hsa:340990;OTOG,DFNB18B,OTGN,mlemp;otogelin
hsa:100287413;;uncharacterized LOC100287413
hsa:100129473;;uncharacterized LOC100129473
hsa:399900;;uncharacterized LOC399900
hsa:100507521;;uncharacterized LOC100507521
hsa:100996453;;uncharacterized LOC100996453
hsa:101059993;;uncharacterized LOC101059993
hsa:100505834;;uncharacterized LOC100505834
hsa:100009613;ANO1-AS2,C11orf78,NCRNA00224;ANO1 antisense RNA 2 (head to head)
hsa:100506282;;uncharacterized LOC100506282
hsa:100996578;;uncharacterized LOC100996578
hsa:100506113;;uncharacterized LOC100506113
hsa:100287896;;uncharacterized LOC100287896
hsa:100506020;ARAP1-AS2;ARAP1 antisense RNA 2
hsa:100131392;tripartite motif-containing protein 49-like protein 1-like
hsa:729173;;uncharacterized LOC729173
hsa:100507077;;uncharacterized LOC100507077
hsa:84796;;uncharacterized MGC13053
hsa:100509413;;uncharacterized LOC100509413
hsa:100049615;SKCG-1;sporadic kidney cancer gene 1
hsa:100131541;;uncharacterized LOC100131541
hsa:100129203;;uncharacterized LOC100129203
hsa:403312;MGC39545;uncharacterized LOC403312
hsa:100130428;;IGYY565
hsa:100507283;;uncharacterized LOC100507283
hsa:100507145;;uncharacterized LOC100507145
hsa:100507165;;uncharacterized LOC100507165
hsa:338667;;uncharacterized LOC338667
hsa:100507431;;uncharacterized LOC100507431
hsa:100507450;C11orf39;chromosome 11 open reading frame 39
hsa:100653217;;neurotrimin-like
hsa:100653275;;uncharacterized LOC100653275
hsa:646543;;uncharacterized LOC646543
hsa:100130507;;uncharacterized LOC100130507
hsa:100507548;;uncharacterized LOC100507548
hsa:100507560;;uncharacterized LOC100507560
hsa:100507511;;uncharacterized LOC100507511
hsa:100128816;;ACAH3104
hsa:100129223;;uncharacterized LOC100129223
hsa:100130219;;uncharacterized LOC100130219
hsa:100049716;;uncharacterized LOC100049716
hsa:100509976;;uncharacterized LOC100509976
hsa:100127974;;uncharacterized LOC100127974
hsa:100653000;;uncharacterized LOC100653000
hsa:101060038;;uncharacterized LOC101060038
hsa:100506226;;uncharacterized LOC100506226
hsa:100996472;;uncharacterized LOC100996472
hsa:100996477;;uncharacterized LOC100996477
hsa:100506606;;uncharacterized LOC100506606
hsa:101060821;;alpha-2-macroglobulin-P-like
hsa:645177;;uncharacterized LOC645177
hsa:100509445;;uncharacterized LOC100509445
hsa:100507855;adenylate kinase isoenzyme 4,mitochondrial-like
hsa:100506684;;uncharacterized LOC100506684
hsa:100288798;;uncharacterized LOC100288798
hsa:100505923;;uncharacterized LOC100505923
hsa:100506125;;uncharacterized LOC100506125
hsa:100293962;;uncharacterized LOC100293962
hsa:100509541;;uncharacterized LOC100509541
hsa:100509764;;uncharacterized LOC100509764
hsa:100130083;HBCBP;HBcAg-binding protein
hsa:100507363;;uncharacterized LOC100507363
hsa:100507330;;uncharacterized LOC100507330
hsa:100507175;;uncharacterized LOC100507175
hsa:100129940;;uncharacterized LOC100129940
hsa:100507065;;uncharacterized LOC100507065
hsa:100506869;;uncharacterized LOC100506869
hsa:100653022;PP12719;uncharacterized LOC100653022
hsa:196446;MYRFL,C12orf15,C12orf28,bcm1377;myelin regulatory factor-like
hsa:100652933;IGANRP;uncharacterized LOC100652933
hsa:100505645;;uncharacterized LOC100505645
hsa:100507616;;uncharacterized LOC100507616
hsa:100507594;;uncharacterized LOC100507594
hsa:100507559;;uncharacterized LOC100507559
hsa:100507498;;uncharacterized LOC100507498
hsa:100507484;;uncharacterized LOC100507484
hsa:100508329;;uncharacterized LOC100508329
hsa:100506465;;uncharacterized LOC100506465
hsa:100506551;;uncharacterized LOC100506551
hsa:100128895;;uncharacterized LOC100128895
hsa:100506691;;uncharacterized LOC100506691
hsa:101060751;;nucleoside diphosphate kinase B-like
hsa:100996679;;uncharacterized LOC100996679
hsa:100996671;;uncharacterized LOC100996671
hsa:732360;;G/T mismatch-specific thymine DNA glycosylase-like
hsa:100293704;;uncharacterized LOC100293704
hsa:100128840;;uncharacterized LOC100128840
hsa:100508384;;uncharacterized LOC100508384
hsa:100996246;;uncharacterized LOC100996246
hsa:338797;;uncharacterized LOC338797
hsa:100506978;;uncharacterized LOC100506978
hsa:100652856;;uncharacterized LOC100652856
hsa:100652865;LINC00539;long intergenic non-protein coding RNA 539
hsa:100506622;LINC00540;long intergenic non-protein coding RNA 540
hsa:100506680;SACS-AS1;SACS antisense RNA 1
hsa:100507040;LINC00427;long intergenic non-protein coding RNA 427
hsa:100132234;LINC00543;long intergenic non-protein coding RNA 543
hsa:100506997;;uncharacterized LOC100506997
hsa:440132;LINC00545;long intergenic non-protein coding RNA 545
hsa:100507099;FRY-AS1;FRY antisense RNA 1
hsa:100507114;LINC00445;long intergenic non-protein coding RNA 445
hsa:100996395;;uncharacterized LOC100996395
hsa:79024;SMIM2,C13orf44;small integral membrane protein 2
hsa:100996416;;uncharacterized LOC100996416
hsa:100507398;INTS6-AS1;INTS6 antisense RNA 1
hsa:644623;TPTE2P2;transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 2
hsa:440137;FLJ31945;uncharacterized LOC440137
hsa:647166;LINC00371;long intergenic non-protein coding RNA 371
hsa:100507428;LINC00458;long intergenic non-protein coding RNA 458
hsa:100288208;;uncharacterized LOC100288208
hsa:100505518;;uncharacterized LOC100505518
hsa:100129307;;UPF0607 protein ENSP00000383144-like
hsa:100996267;;uncharacterized LOC100996267
hsa:100505494;ANKRD10-IT1;ANKRD10 intronic transcript 1 (non-protein coding)
hsa:100507654;;uncharacterized LOC100507654
hsa:100289274;DNAJC3-AS1;DNAJC3 antisense RNA 1 (head to head)
hsa:100505996;LINC00403;long intergenic non-protein coding RNA 403
hsa:100506016;;uncharacterized LOC100506016
hsa:100506063;;uncharacterized LOC100506063
hsa:400169;DKFZp451A211;uncharacterized LOC400169
hsa:100507747;;uncharacterized LOC100507747
hsa:643365;LINC00452;long intergenic non-protein coding RNA 452
hsa:100508046;;uncharacterized LOC100508046
hsa:100507513;;uncharacterized LOC100507513
hsa:100505758;PRMT5-AS1;PRMT5 antisense RNA 1
hsa:100128908;;uncharacterized LOC100128908
hsa:728755;;uncharacterized LOC728755
hsa:100506004;;uncharacterized LOC100506004
hsa:100996589;;uncharacterized LOC100996589
hsa:100506110;;uncharacterized LOC100506110
hsa:100506157;;uncharacterized LOC100506157
hsa:100996613;;uncharacterized LOC100996613
hsa:100506412;;uncharacterized LOC100506412
hsa:100506446;;uncharacterized LOC100506446
hsa:100506499;;uncharacterized LOC100506499
hsa:100996664;;uncharacterized LOC100996664
hsa:283588;;uncharacterized LOC283588
hsa:100506792;;uncharacterized LOC100506792
hsa:100128075;;uncharacterized LOC100128075
hsa:100506718;;uncharacterized LOC100506718
hsa:100506731;;uncharacterized LOC100506731
hsa:100996280;;uncharacterized LOC100996280
hsa:100506700;;uncharacterized LOC100506700
hsa:283575;;uncharacterized LOC283575
hsa:100506498;;uncharacterized LOC100506498
hsa:100506476;;uncharacterized LOC100506476
hsa:100506411;;uncharacterized LOC100506411
hsa:100653021;;uncharacterized LOC100653021
hsa:100507277;;uncharacterized LOC100507277
hsa:100507242;;uncharacterized LOC100507242
hsa:100507108;;uncharacterized LOC100507108
hsa:100996339;;uncharacterized LOC100996339
hsa:100130815;;uncharacterized LOC100130815
hsa:100133207;;uncharacterized LOC100133207
hsa:100506999;;uncharacterized LOC100506999
hsa:100288160;;esophagus cancer-related gene-2 interaction susceptibility protein
hsa:100996805;;uncharacterized LOC100996805
hsa:100128343;;uncharacterized LOC100128343
hsa:642131;;uncharacterized LOC642131
hsa:100653243;;uncharacterized LOC100653243
hsa:100506948;;uncharacterized LOC100506948
hsa:100130111;;uncharacterized LOC100130111
hsa:100653133;;U3 small nucleolar ribonucleoprotein protein MPP10-like
hsa:100505573;;uncharacterized LOC100505573
hsa:100507568;;uncharacterized LOC100507568
hsa:100507480;;uncharacterized LOC100507480
hsa:100289090;;uncharacterized LOC100289090
hsa:101060036;;uncharacterized LOC101060036
hsa:145694;;uncharacterized LOC145694
hsa:100128979;;uncharacterized LOC100128979
hsa:100506530;;uncharacterized LOC100506530
hsa:100996876;;uncharacterized LOC100996876
hsa:100129973;;uncharacterized LOC100129973
hsa:100996299;;uncharacterized LOC100996299
hsa:100652954;;uncharacterized LOC100652954
hsa:100506059;;uncharacterized LOC100506059
hsa:646670;;uncharacterized LOC646670
hsa:255180;;uncharacterized FLJ38723
hsa:100129540;;uncharacterized LOC100129540
hsa:441728;;golgin-like
hsa:440292;;uncharacterized LOC440292
hsa:100505616;;uncharacterized LOC100505616
hsa:100507079;;uncharacterized LOC100507079
hsa:100507166;;uncharacterized LOC100507166
hsa:643797;;AGVR6190
hsa:100996653;;uncharacterized LOC100996653
hsa:400454;UNQ9370;IFMQ9370
hsa:100996663;;uncharacterized LOC100996663
hsa:100291699;;A disintegrin and metalloproteinase with thrombospondin motifs 7-like
hsa:100652749;;uncharacterized LOC100652749
hsa:100507325;;uncharacterized LOC100507325
hsa:644192;NR2F2-AS1;NR2F2 antisense RNA 1
hsa:100507288;;uncharacterized LOC100507288
hsa:100507311;;uncharacterized LOC100507311
hsa:100128108;;uncharacterized LOC100128108
hsa:145757;;uncharacterized LOC145757
hsa:440313;;uncharacterized LOC440313
hsa:100996869;;UPF0621 protein B-like
hsa:100507759;;uncharacterized LOC100507759
hsa:100507803;;uncharacterized LOC100507803
hsa:100996332;;uncharacterized LOC100996332
hsa:100289283;;uncharacterized LOC100289283
hsa:100506928;;uncharacterized LOC100506928
hsa:100996344;;uncharacterized LOC100996344
hsa:100996366;;uncharacterized LOC100996366
hsa:100507092;;uncharacterized LOC100507092
hsa:100128371;;Derived by automated computational analysis using gene prediction method: GNOMON. Supporting evidence includes similarity to: 1 Protein
hsa:101060778;;uncharacterized LOC101060778
hsa:101060782;;creatine transporter-like
hsa:162137;;uncharacterized protein MGC34800
hsa:100505948;;uncharacterized LOC100505948
hsa:100505692;FTO-IT1;FTO intronic transcript 1 (non-protein coding)
hsa:100996338;;uncharacterized LOC100996338
hsa:100996345;;uncharacterized LOC100996345
hsa:100132339;;uncharacterized LOC100132339
hsa:100505722;;uncharacterized LOC100505722
hsa:100996353;;uncharacterized LOC100996353
hsa:388282;;uncharacterized LOC388282
hsa:100132529;;uncharacterized LOC100132529
hsa:100506105;;uncharacterized LOC100506105
hsa:388289;C16orf47;chromosome 16 open reading frame 47
hsa:654780;;SFPQ
hsa:100996430;;uncharacterized LOC100996430
hsa:100996425;;uncharacterized LOC100996425
hsa:100506542;;uncharacterized LOC100506542
hsa:100129215;;uncharacterized LOC100129215
hsa:400553;;uncharacterized LOC400553
hsa:339059;;uncharacterized protein FLJ40448
hsa:642452;;uncharacterized LOC642452
hsa:100129697;;uncharacterized LOC100129697
hsa:100507918;;uncharacterized LOC100507918
hsa:642533;;uncharacterized LOC642533
hsa:100996810;;uncharacterized LOC100996810
hsa:100506183;;uncharacterized LOC100506183
hsa:100507303;;uncharacterized LOC100507303
hsa:100996845;;uncharacterized LOC100996845
hsa:100287301;GS52;uncharacterized LOC100287301
hsa:100130285;;uncharacterized LOC100130285
hsa:100287175;;uncharacterized LOC100287175
hsa:101060747;;3-phosphoinositide-dependent protein kinase 1-like
hsa:100996788;;uncharacterized LOC100996788
hsa:100507378;;uncharacterized LOC100507378
hsa:100507419;;uncharacterized LOC100507419
hsa:100507458;;uncharacterized LOC100507458
hsa:440337;;uncharacterized LOC440337
hsa:100287598;;uncharacterized LOC100287598
hsa:100287628;;uncharacterized LOC100287628
hsa:100505564;;uncharacterized LOC100505564
hsa:642696;FLJ32790;hCG1983896
hsa:388210;;uncharacterized LOC388210
hsa:400511;FLJ45256;uncharacterized LOC400511
hsa:283887;;uncharacterized LOC283887
hsa:100506705;;uncharacterized LOC100506705
hsa:100506371;;uncharacterized LOC100506371
hsa:100996816;;uncharacterized LOC100996816
hsa:100288728;;uncharacterized LOC100288728
hsa:100506974;;uncharacterized LOC100506974
hsa:400576;;uncharacterized FLJ45831
hsa:100996842;;uncharacterized LOC100996842
hsa:101060767;;putative uncharacterized protein FLJ46089-like
hsa:100507131;;uncharacterized LOC100507131
hsa:100996906;;F-box/WD repeat-containing protein 10-like
hsa:100131943;;uncharacterized LOC100131943
hsa:339260;;uncharacterized LOC339260
hsa:400590;;uncharacterized LOC400590
hsa:100506418;;uncharacterized LOC100506418
hsa:100506596;;uncharacterized LOC100506596
hsa:101060080;;uncharacterized LOC101060080
hsa:100506629;;uncharacterized LOC100506629
hsa:100506643;;uncharacterized LOC100506643
hsa:100652927;;uncharacterized LOC100652927
hsa:100134267;;keratin-associated protein 4-8-like
hsa:101059954;;uncharacterized LOC101059954
hsa:100505620;;uncharacterized LOC100505620
hsa:100996526;;uncharacterized LOC100996526
hsa:100287808;;uncharacterized LOC100287808
hsa:100996563;;uncharacterized LOC100996563
hsa:100506295;;uncharacterized LOC100506295
hsa:100506325;;uncharacterized LOC100506325
hsa:100506373;;uncharacterized LOC100506373
hsa:100288866;;uncharacterized LOC100288866
hsa:100506609;;uncharacterized LOC100506609
hsa:440446;;uncharacterized FLJ42842
hsa:100506863;CLTC-IT1,PRO0456;CLTC intronic transcript 1 (non-protein coding)
hsa:100996660;;uncharacterized LOC100996660
hsa:100506882;;uncharacterized LOC100506882
hsa:100996784;;chorionic somatomammotropin hormone-like
hsa:100509290;;DEAH (Asp-Glu-Ala-His) box polypeptide 40 pseudogene
hsa:100507191;;uncharacterized LOC100507191
hsa:100134391;;uncharacterized LOC100134391
hsa:400618;FLJ37644;uncharacterized LOC400618
hsa:100507002;;uncharacterized LOC100507002
hsa:100996374;;uncharacterized LOC100996374
hsa:100507425;;uncharacterized LOC100507425
hsa:100652929;HP09025;uncharacterized LOC100652929
hsa:644767;FLJ44838;uncharacterized LOC644767
hsa:100507440;;uncharacterized LOC100507440
hsa:100128105;;uncharacterized LOC100128105
hsa:400627;;FLJ46026 protein
hsa:100129503;PP13;uncharacterized LOC100129503
hsa:100507520;;uncharacterized LOC100507520
hsa:100507494;;uncharacterized LOC100507494
hsa:100505970;HEXDC-IT1;HEXDC intronic transcript 1 (non-protein coding)
hsa:100652823;;uncharacterized LOC100652823
hsa:100505592;;uncharacterized LOC100505592
hsa:84777;DLGAP1-AS2;DLGAP1 antisense RNA 2
hsa:100287082;;uncharacterized LOC100287082
hsa:646000;SLC35G4,AMAC1L1;solute carrier family 35, member G4
hsa:100509487;;uncharacterized LOC100509487
hsa:342850;ANKRD62,DKFZp779B1634;ankyrin repeat domain 62
hsa:100996324;;uncharacterized LOC100996324
hsa:101060862;;uncharacterized LOC101060862
hsa:100652778;;uncharacterized LOC100652778
hsa:100506837;;uncharacterized LOC100506837
hsa:100506821;;uncharacterized LOC100506821
hsa:100996400;;uncharacterized LOC100996400
hsa:100506787;;uncharacterized LOC100506787
hsa:100128893;;uncharacterized LOC100128893
hsa:100127909;;uncharacterized LOC100127909
hsa:84322;C18orf12,HEIL1,HsT2508;chromosome 18 open reading frame 12
hsa:100132501;;uncharacterized LOC100132501
hsa:642484;FLJ45743;uncharacterized LOC642484
hsa:100130938;;uncharacterized LOC100130938
hsa:100996669;;uncharacterized LOC100996669
hsa:100509315;;uncharacterized LOC100509315
hsa:100505797;;uncharacterized LOC100505797
hsa:100505853;;uncharacterized LOC100505853
hsa:400660;LINC00683;long intergenic non-protein coding RNA 683
hsa:400661;;FLJ44881
hsa:645321;;uncharacterized LOC645321
hsa:284241;;uncharacterized protein FLJ25715
hsa:100506070;;uncharacterized LOC100506070
hsa:100129831;;EPWW6493
hsa:646457;C19orf67;chromosome 19 open reading frame 67
hsa:100507353;;uncharacterized LOC100507353
hsa:100996288;;uncharacterized LOC100996288
hsa:100505555;;uncharacterized LOC100505555
hsa:100507535;;uncharacterized LOC100507535
hsa:100287160;;uncharacterized LOC100287160
hsa:101060810;;zinc finger protein 737-like
hsa:400682;;zinc finger protein 100-like
hsa:100128139;;uncharacterized LOC100128139
hsa:100996349;;testis-expressed sequence 264 protein-like
hsa:374890;;uncharacterized LOC374890
hsa:100129543;ZNF730;zinc finger protein 730
hsa:100132815;;importin 5 pseudogene
hsa:101060817;;glycine cleavage system H protein, mitochondrial-like
hsa:100505851;;uncharacterized LOC100505851
hsa:100996381;;uncharacterized LOC100996381
hsa:101060187;;putative uncharacterized protein FLJ25328-like
hsa:100996925;;uncharacterized LOC100996925
hsa:100996665;;uncharacterized LOC100996665
hsa:100996672;;uncharacterized LOC100996672
hsa:100996681;;uncharacterized LOC100996681
hsa:100293044;;uncharacterized LOC100293044
hsa:100652911;;uncharacterized LOC100652911
hsa:728485;;uncharacterized LOC728485
hsa:100507342;;uncharacterized LOC100507342
hsa:400692;;uncharacterized LOC400692
hsa:100507486;;uncharacterized LOC100507486
hsa:100507646;;uncharacterized LOC100507646
hsa:100505585;;uncharacterized LOC100505585
hsa:100505639;;uncharacterized LOC100505639
hsa:100132272;;uncharacterized LOC100132272
hsa:400706;;uncharacterized LOC400706
hsa:723805;;interleukin-like
hsa:100505754;;uncharacterized LOC100505754
hsa:100506114;;uncharacterized LOC100506114
hsa:390956;;peptidyl-prolyl cis-trans isomerase A-like
hsa:100996417;;uncharacterized LOC100996417
hsa:100506374;;uncharacterized LOC100506374
hsa:100288142;NBPF20;neuroblastoma breakpoint family member
hsa:728802;;myomegalin-like
hsa:100505824;;uncharacterized LOC100505824
hsa:100509195;;uncharacterized LOC100509195
hsa:100293748;;putative neuroblastoma breakpoint family member 6-like protein-like
hsa:148645;LINC00337,C1orf211,NCRNA00337;long intergenic non-protein coding RNA 337
hsa:100130071;;GSQS6193
hsa:100505887;;uncharacterized LOC100505887
hsa:100996592;;uncharacterized LOC100996592
hsa:100129476;;uncharacterized LOC100129476
hsa:100506022;;uncharacterized LOC100506022
hsa:645010;FLJ16126;uncharacterized LOC645010
hsa:727721;;uncharacterized LOC727721
hsa:100996521;;uncharacterized LOC100996521
hsa:100507670;;uncharacterized LOC100507670
hsa:339400;FLG-AS1;FLG antisense RNA 1
hsa:100131107;;UPF0607 protein ENSP00000383783-like
hsa:100287049;;uncharacterized LOC100287049
hsa:100505799;;uncharacterized LOC100505799
hsa:100505785;KIRREL-IT1;KIRREL intronic transcript 1 (non-protein coding)
hsa:100996595;;uncharacterized LOC100996595
hsa:100128751;;INM04
hsa:100147773;;uncharacterized LOC100147773
hsa:100505828;;uncharacterized LOC100505828
hsa:100506775;;uncharacterized LOC100506775
hsa:100652834;;uncharacterized LOC100652834
hsa:100996636;;uncharacterized LOC100996636
hsa:100509205;;uncharacterized LOC100509205
hsa:100506206;;uncharacterized LOC100506206
hsa:400797;LINC00083,NCRNA00083;long intergenic non-protein coding RNA 83
hsa:100506128;;uncharacterized LOC100506128
hsa:100505991;;uncharacterized LOC100505991
hsa:100127910;;uncharacterized LOC100127910
hsa:100287813;;uncharacterized LOC100287813
hsa:647215;MROH3P,C1orf81;maestro heat-like repeat family member 3, pseudogene
hsa:100505650;;uncharacterized LOC100505650
hsa:574431;C1orf147;chromosome 1 open reading frame 147
hsa:100506161;;uncharacterized LOC100506161
hsa:100509303;;uncharacterized LOC100509303
hsa:100506899;;uncharacterized LOC100506899
hsa:100506443;ITPKB-IT1;ITPKB intronic transcript 1 (non-protein coding)
hsa:100996486;;uncharacterized LOC100996486
hsa:100996502;;uncharacterized LOC100996502
hsa:574432;C1orf148;chromosome 1 open reading frame 148
hsa:101060766;;uncharacterized LOC101060766
hsa:100130249;PP2672;uncharacterized LOC100130249
hsa:100506915;CHRM3-AS2;CHRM3 antisense RNA 2
hsa:100506929;;uncharacterized LOC100506929
hsa:440742;;uncharacterized LOC440742
hsa:400743;;uncharacterized LOC400743
hsa:644083;;uncharacterized LOC644083
hsa:100996511;;uncharacterized LOC100996511
hsa:100287934;;uncharacterized LOC100287934
hsa:646567;OSTCP2;oligosaccharyltransferase complex subunit pseudogene 2
hsa:100127947;;uncharacterized LOC100127947
hsa:100996496;;uncharacterized LOC100996496
hsa:101059975;;uncharacterized LOC101059975
hsa:374987;NEXN-AS1,C1orf118;NEXN antisense RNA 1
hsa:400756;;uncharacterized LOC400756
hsa:100507664;;uncharacterized LOC100507664
hsa:100996570;;uncharacterized LOC100996570
hsa:100507652;;uncharacterized LOC100507652
hsa:619518;C1orf191,MST128;chromosome 1 open reading frame 191
hsa:100996847;;uncharacterized LOC100996847
hsa:199897;;uncharacterized LOC199897
hsa:400728;FAM87B;family with sequence similarity 87, member B
hsa:284600;;uncharacterized LOC284600
hsa:100506376;TTLL10-AS1;TTLL10 antisense RNA 1
hsa:101060082;;uncharacterized LOC101060082
hsa:339457;C1orf222;chromosome 1 open reading frame 222
hsa:100996583;;uncharacterized LOC100996583
hsa:100506029;;uncharacterized LOC100506029
hsa:100506051;;uncharacterized LOC100506051
hsa:100506007;;uncharacterized LOC100506007
hsa:730081;;uncharacterized LOC730081
hsa:100996635;;uncharacterized LOC100996635
hsa:100996630;;uncharacterized LOC100996630
hsa:100505940;;uncharacterized LOC100505940
hsa:100132240;;uncharacterized LOC100132240
hsa:100996620;;uncharacterized LOC100996620
hsa:100505840;;uncharacterized LOC100505840
hsa:149351;;uncharacterized LOC149351
hsa:100505821;;uncharacterized LOC100505821
hsa:100996868;;uncharacterized LOC100996868
hsa:100506257;;uncharacterized LOC100506257
hsa:100506392;;uncharacterized LOC100506392
hsa:100996251;;uncharacterized LOC100996251
hsa:100506459;;uncharacterized LOC100506459
hsa:100506478;;uncharacterized LOC100506478
hsa:100996263;;uncharacterized LOC100996263
hsa:128322;;nuclear transport factor 2-like
hsa:100996587;;uncharacterized LOC100996587
hsa:284561;;uncharacterized LOC284561
hsa:100509378;;uncharacterized LOC100509378
hsa:100507459;;uncharacterized LOC100507459
hsa:100653194;signal-regulatory protein beta-1 isoform 3-like
hsa:388780;;uncharacterized LOC388780
hsa:728450;LINC00687,C20orf61,dJ1012F16.1;long intergenic non-protein coding RNA 687
hsa:100505515;;uncharacterized LOC100505515
hsa:100996658;;uncharacterized LOC100996658
hsa:100996673;;uncharacterized LOC100996673
hsa:100505651;;uncharacterized LOC100505651
hsa:100653231;signal-regulatory protein beta-1-like
hsa:100509860;;uncharacterized LOC100509860
hsa:100652902;;uncharacterized LOC100652902
hsa:100505664;;uncharacterized LOC100505664
hsa:100505683;;uncharacterized LOC100505683
hsa:100289308;;uncharacterized LOC100289308
hsa:100996695;;uncharacterized LOC100996695
hsa:400841;;FLJ45832 protein
hsa:554250;GDF5OS;growth differentiation factor 5 opposite strand
hsa:100996873;;uncharacterized LOC100996873
hsa:100505663;;uncharacterized LOC100505663
hsa:100128988;;uncharacterized LOC100128988
hsa:100130157;;uncharacterized LOC100130157
hsa:100128028;;uncharacterized LOC100128028
hsa:100505983;;uncharacterized LOC100505983
hsa:101060004;;uncharacterized LOC101060004
hsa:100506053;;uncharacterized LOC100506053
hsa:100506069;;uncharacterized LOC100506069
hsa:100506115;;uncharacterized LOC100506115
hsa:100506175;;uncharacterized LOC100506175
hsa:100130156;;uncharacterized LOC100130156
hsa:100506470;;uncharacterized LOC100506470
hsa:729296;;uncharacterized LOC729296
hsa:100506348;;uncharacterized LOC100506348
hsa:100652930;;uncharacterized LOC100652930
hsa:79160;;uncharacterized MGC4294
hsa:400850;;uncharacterized FLJ44790
hsa:100128310;;uncharacterized LOC100128310
hsa:100131174;;uncharacterized LOC100131174
hsa:100505735;;uncharacterized LOC100505735
hsa:149650;;uncharacterized protein FLJ32154
hsa:100509861;;uncharacterized LOC100509861
hsa:100996831;;uncharacterized LOC100996831
hsa:100134423;;uncharacterized LOC100134423
hsa:100505973;;uncharacterized LOC100505973
hsa:100652994;;uncharacterized LOC100652994
hsa:150051;;uncharacterized LOC150051
hsa:400863;LINC00650;long intergenic non-protein coding RNA 650
hsa:101060027;;uncharacterized LOC101060027
hsa:388820;;uncharacterized LOC388820
hsa:100506369;;uncharacterized LOC100506369
hsa:100506403;;uncharacterized LOC100506403
hsa:100996609;;uncharacterized LOC100996609
hsa:101060815;;uncharacterized LOC101060815
hsa:400867;;FLJ45139 protein
hsa:100126693;LINC00322,C21orf136,NCRNA00322;long intergenic non-protein coding RNA 322
hsa:400870;;FLJ41733 protein
hsa:54083;LRRC3DN,C21orf30;LRRC3 downstream neighbor (non-protein coding)
hsa:100505727;;uncharacterized LOC100505727
hsa:246704;LINC00315,C21orf93,NCRNA00315;long intergenic non-protein coding RNA 315
hsa:388830;LINC00316,C21orf111,NCRNA00316,PRED59;long intergenic non-protein coding RNA 316
hsa:100505827;;uncharacterized LOC100505827
hsa:100509196;;putative uncharacterized protein encoded by LINC00205-like
hsa:100653149;;uncharacterized LOC100653149
hsa:642633;;uncharacterized LOC642633
hsa:200298;LINC00528,C22orf37;long intergenic non-protein coding RNA 528
hsa:100996342;;uncharacterized LOC100996342
hsa:100292922;;ankyrin repeat domain-containing protein 30B-like
hsa:100652736;;uncharacterized LOC100652736
hsa:100287576;;uncharacterized LOC100287576
hsa:373856;USP41;ubiquitin specific peptidase 41
hsa:101060781;;uncharacterized LOC101060781
hsa:101060787;;putative uncharacterized protein ENSP00000383309-like
hsa:100653309;;uncharacterized LOC100653309
hsa:100996780;;phosphatidylinositol 4-kinase alpha-like
hsa:100286925;;uncharacterized LOC100286925
hsa:649179;PRAMEF24P,PRAMEL;PRAME family member 24, pseudogene
hsa:388882;;uncharacterized LOC388882
hsa:100507580;;uncharacterized LOC100507580
hsa:100996404;;uncharacterized LOC100996404
hsa:100507599;;uncharacterized LOC100507599
hsa:646513;;VLGN1945
hsa:100506075;;uncharacterized LOC100506075
hsa:84843;;uncharacterized protein MGC15705
hsa:54944;;uncharacterized protein FLJ20464
hsa:100996793;;uncharacterized LOC100996793
hsa:100131802;;uncharacterized LOC100131802
hsa:100506271;;uncharacterized LOC100506271
hsa:100131530;;uncharacterized LOC100131530
hsa:100996460;;uncharacterized LOC100996460
hsa:100506544;;uncharacterized LOC100506544
hsa:100134361;;uncharacterized LOC100134361
hsa:100996817;;putative POM121-like protein 1-like
hsa:100506679;;uncharacterized LOC100506679
hsa:100506695;;uncharacterized LOC100506695
hsa:100506737;;uncharacterized LOC100506737
hsa:100506813;;uncharacterized LOC100506813
hsa:642757;FLJ32756;uncharacterized LOC642757
hsa:100128818;;LPEQ6126
hsa:100506877;;uncharacterized LOC100506877
hsa:100996524;;uncharacterized LOC100996524
hsa:100506917;;uncharacterized LOC100506917
hsa:727944;;uncharacterized LOC727944
hsa:100996637;;uncharacterized LOC100996637
hsa:100508751;;uncharacterized LOC100508751
hsa:100292909;;uncharacterized LOC100292909
hsa:100506014;;uncharacterized LOC100506014
hsa:100506216;;uncharacterized LOC100506216
hsa:100506299;;uncharacterized LOC100506299
hsa:100506317;;uncharacterized LOC100506317
hsa:100996549;;uncharacterized LOC100996549
hsa:100996551;;uncharacterized LOC100996551
hsa:100506405;;uncharacterized LOC100506405
hsa:100506457;;uncharacterized LOC100506457
hsa:100131373;;uncharacterized LOC100131373
hsa:100507562;;uncharacterized LOC100507562
hsa:100507630;;uncharacterized LOC100507630
hsa:100131510;;uncharacterized LOC100131510
hsa:100505736;;uncharacterized LOC100505736
hsa:403150;;uncharacterized protein FLJ31356
hsa:100505774;;uncharacterized LOC100505774
hsa:100996902;;uncharacterized LOC100996902
hsa:100506047;;uncharacterized LOC100506047
hsa:100130502;;uncharacterized LOC100130502
hsa:100506108;SIX3-AS1;SIX3 antisense RNA 1
hsa:440862;FLJ41757;uncharacterized LOC440862
hsa:644093;;hCG2040054
hsa:100506235;;uncharacterized LOC100506235
hsa:100506300;;uncharacterized LOC100506300
hsa:100129434;;uncharacterized LOC100129434
hsa:100506934;;uncharacterized LOC100506934
hsa:100996924;;uncharacterized LOC100996924
hsa:100507006;;uncharacterized LOC100507006
hsa:100996770;;uncharacterized LOC100996770
hsa:100507073;;uncharacterized LOC100507073
hsa:101060019;;uncharacterized LOC101060019
hsa:100996448;;uncharacterized LOC100996448
hsa:100507113;ZNF638-IT1;ZNF638 intronic transcript 1 (non-protein coding)
hsa:100652991;;uncharacterized LOC100652991
hsa:100507201;;uncharacterized LOC100507201
hsa:100996478;;uncharacterized LOC100996478
hsa:100996506;;all-trans-retinol 13,14-reductase-like
hsa:730268;;anaphase-promoting complex subunit 1-like
hsa:101060760;;uncharacterized LOC101060760
hsa:100509620;;aquaporin-7-like
hsa:150759;LINC00342,NCRNA00342;long intergenic non-protein coding RNA 342
hsa:100506036;;uncharacterized LOC100506036
hsa:100506473;;uncharacterized LOC100506473
hsa:644617;;uncharacterized LOC644617
hsa:100128131;;uncharacterized LOC100128131
hsa:100131131;;AHPA9419
hsa:100506328;;uncharacterized LOC100506328
hsa:100506286;;uncharacterized LOC100506286
hsa:150577;;uncharacterized LOC150577
hsa:100134365;;uncharacterized LOC100134365
hsa:100996919;;putative T-cell surface glycoprotein CD8 beta-2 chain-like
hsa:729121;;uncharacterized LOC729121
hsa:729164;;hCG1732469
hsa:400997;;uncharacterized FLJ44006
hsa:100128130;;uncharacterized LOC100128130
hsa:100505634;;uncharacterized LOC100505634
hsa:284958;NT5DC4;5'-nucleotidase domain containing 4
hsa:100653334;;COBW domain-containing protein 1-like
hsa:100653336;;uncharacterized LOC100653336
hsa:100506797;;uncharacterized LOC100506797
hsa:100506748;;uncharacterized LOC100506748
hsa:101060103;;uncharacterized LOC101060103
hsa:100996820;;POTE ankyrin domain family member I-like
hsa:151121;;uncharacterized LOC151121
hsa:100131492;;PP12901
hsa:100506922;;uncharacterized LOC100506922
hsa:339760;;uncharacterized LOC339760
hsa:100996884;;putative fatty acyl-CoA reductase 2-like protein FLJ43933-like
hsa:100996887;;tubulin alpha-3E chain-like
hsa:100505498;;uncharacterized LOC100505498
hsa:100128406;AZFP;AML-associated zinc finger protein
hsa:100507460;;uncharacterized LOC100507460
hsa:100507474;;uncharacterized LOC100507474
hsa:440915;POTEKP,ACT,ACTBL3,POTE2delta,POTEK;POTE ankyrin domain family, member K, pseudogene
hsa:339742;FAM201B;family with sequence similarity 201, member B
hsa:101060825;;uncharacterized LOC101060825
hsa:150596;;uncharacterized protein FLJ32955
hsa:100996579;;uncharacterized LOC100996579
hsa:643072;;uncharacterized LOC643072
hsa:285141;ERICH2;glutamate-rich 2
hsa:100128905;;uncharacterized LOC100128905
hsa:100506923;;uncharacterized LOC100506923
hsa:100506993;;uncharacterized LOC100506993
hsa:100996866;;uncharacterized LOC100996866
hsa:729224;;uncharacterized LOC729224
hsa:101059946;;uncharacterized LOC101059946
hsa:100507554;;uncharacterized LOC100507554
hsa:729770;;uncharacterized LOC729770
hsa:654841;;uncharacterized LOC654841
hsa:100507948;;Derived by automated computational analysis using gene prediction method: GNOMON. Supporting evidence includes similarity to: 98 ESTs
hsa:339766;MROH2A,HEATR7B1;maestro heat-like repeat family member 2A
hsa:101060142;;uncharacterized LOC101060142
hsa:100506749;AGAP1-IT1;AGAP1 intronic transcript 1 (non-protein coding)
hsa:93463;;uncharacterized LOC93463
hsa:401040;;uncharacterized FLJ45964
hsa:100128563;;uncharacterized LOC100128563
hsa:728208;;uncharacterized LOC728208
hsa:285095;;uncharacterized LOC285095
hsa:100509490;;uncharacterized LOC100509490
hsa:100996616;;uncharacterized LOC100996616
hsa:442075;;uncharacterized LOC442075
hsa:100996542;;uncharacterized LOC100996542
hsa:100996539;ITPR1-AS1;ITPR1 antisense RNA 1 (head to head)
hsa:100508226;;HHSL751
hsa:151877;MAGI1-IT1;MAGI1 intronic transcript 1 (non-protein coding)
hsa:246734;NPCDR1,NPCDRG,NPCR;nasopharyngeal carcinoma, down-regulated 1
hsa:101059937;;uncharacterized LOC101059937
hsa:101059928;;uncharacterized LOC101059928
hsa:100996916;;uncharacterized LOC100996916
hsa:100129060;;uncharacterized LOC100129060
hsa:474171;STGC3;uncharacterized STGC3
hsa:100506651;;uncharacterized LOC100506651
hsa:100506637;PRKAR2A-AS1;PRKAR2A antisense RNA 1
hsa:101060195;;rRNA-processing protein FCF1 homolog
hsa:100996656;;uncharacterized LOC100996656
hsa:100506319;;uncharacterized LOC100506319
hsa:100506301;LINC00694;long intergenic non-protein coding RNA 694
hsa:100506275;KRBOX1-AS1;KRBOX1 antisense RNA 1
hsa:389102;YPLR6490,PRO21339;uncharacterized LOC389102
hsa:100509621;;uncharacterized LOC100509621
hsa:100996624;;uncharacterized LOC100996624
hsa:100505947;;uncharacterized LOC100505947
hsa:100505877;UBE2E2-AS1;UBE2E2 antisense RNA 1 (head to head)
hsa:100505786;;uncharacterized LOC100505786
hsa:100996597;LINC00690;long intergenic non-protein coding RNA 690
hsa:100293612;;uncharacterized LOC100293612
hsa:100128644;;LMNE6487
hsa:100133039;;uncharacterized LOC100133039
hsa:729756;PRSS44,TESSP-4,TESSP4;protease, serine, 44
hsa:100287063;;uncharacterized LOC100287063
hsa:100653071;;cartilage-associated protein-like
hsa:101059963;;uncharacterized LOC101059963
hsa:100996321;;uncharacterized LOC100996321
hsa:100506815;FOXP1-IT1;FOXP1 intronic transcript 1 (non-protein coding)
hsa:100506865;;uncharacterized LOC100506865
hsa:728290;;uncharacterized LOC728290
hsa:100506944;;uncharacterized LOC100506944
hsa:100996791;;uncharacterized LOC100996791
hsa:100996310;;uncharacterized LOC100996310
hsa:100506724;LSAMP-AS4;LSAMP antisense RNA 4
hsa:100129297;;uncharacterized LOC100129297
hsa:151760;;uncharacterized LOC151760
hsa:100506377;;uncharacterized LOC100506377
hsa:100132481;;uncharacterized LOC100132481
hsa:100506907;;uncharacterized LOC100506907
hsa:644662;;uncharacterized LOC644662
hsa:285311;C3orf56;chromosome 3 open reading frame 56
hsa:100505920;;uncharacterized LOC100505920
hsa:100505902;;uncharacterized LOC100505902
hsa:101060141;;uncharacterized LOC101060141
hsa:100508227;;uncharacterized LOC100508227
hsa:100505729;;uncharacterized LOC100505729
hsa:100505710;;uncharacterized LOC100505710
hsa:100508383;;uncharacterized LOC100508383
hsa:100996494;;uncharacterized LOC100996494
hsa:100996490;;uncharacterized LOC100996490
hsa:100505609;;uncharacterized LOC100505609
hsa:100505547;;uncharacterized LOC100505547
hsa:100507661;;uncharacterized LOC100507661
hsa:100996456;;uncharacterized LOC100996456
hsa:100996447;;uncharacterized LOC100996447
hsa:100507556;;putative uncharacterized protein NCRNA00269-like
hsa:100507461;;uncharacterized LOC100507461
hsa:100507447;;uncharacterized LOC100507447
hsa:440982;FLJ30375;uncharacterized LOC440982
hsa:100507291;;uncharacterized LOC100507291
hsa:100507274;;uncharacterized LOC100507274
hsa:100507224;;uncharacterized LOC100507224
hsa:100507210;;uncharacterized LOC100507210
hsa:100996371;;uncharacterized LOC100996371
hsa:100507134;;uncharacterized LOC100507134
hsa:442092;ARVP6125;uncharacterized LOC442092
hsa:100996834;;uncharacterized LOC100996834
hsa:100507033;;uncharacterized LOC100507033
hsa:100128262;;uncharacterized LOC100128262
hsa:100129516;;uncharacterized LOC100129516
hsa:100996363;;uncharacterized LOC100996363
hsa:401114;;FLJ35816 protein
hsa:285463;;uncharacterized LOC285463
hsa:100507150;;uncharacterized LOC100507150
hsa:100507376;;uncharacterized LOC100507376
hsa:389199;;uncharacterized LOC389199
hsa:100996623;;uncharacterized LOC100996623
hsa:100507930;;uncharacterized LOC100507930
hsa:100506048;;uncharacterized LOC100506048
hsa:100508631;;uncharacterized LOC100508631
hsa:100996859;;uncharacterized LOC100996859
hsa:100506827;;uncharacterized LOC100506827
hsa:643783;USP46-AS1;USP46 antisense RNA 1
hsa:100507160;;uncharacterized LOC100507160
hsa:100996918;;uncharacterized LOC100996918
hsa:100507388;;uncharacterized LOC100507388
hsa:100505946;;uncharacterized LOC100505946
hsa:100506253;;uncharacterized LOC100506253
hsa:100996628;;uncharacterized LOC100996628
hsa:100131826;;TSSP3028
hsa:100996863;;putative uncharacterized protein C4orf12-like
hsa:100507012;;uncharacterized LOC100507012
hsa:100507209;;uncharacterized LOC100507209
hsa:285556;;uncharacterized LOC285556
hsa:100996694;;uncharacterized LOC100996694
hsa:100507487;;uncharacterized LOC100507487
hsa:100507528;LINC00613;long intergenic non-protein coding RNA 613
hsa:100996903;;uncharacterized LOC100996903
hsa:100507639;;uncharacterized LOC100507639
hsa:100128055;SMARCA5-AS1;SMARCA5 antisense RNA 1
hsa:100505491;;uncharacterized LOC100505491
hsa:100505596;;uncharacterized LOC100505596
hsa:100505685;;uncharacterized LOC100505685
hsa:100996286;;uncharacterized LOC100996286
hsa:100505784;;uncharacterized LOC100505784
hsa:100506107;;uncharacterized LOC100506107
hsa:100506154;;uncharacterized LOC100506154
hsa:100509240;;uncharacterized LOC100509240
hsa:100996305;;uncharacterized LOC100996305
hsa:100506272;;uncharacterized LOC100506272
hsa:345051;;hCG38984
hsa:391722;;uncharacterized LOC391722
hsa:554045;DUX4L9,DUX4C;double homeobox 4 like 9
hsa:100506791;;uncharacterized LOC100506791
hsa:100506766;;uncharacterized LOC100506766
hsa:100288152;;uncharacterized LOC100288152
hsa:100996897;;uncharacterized LOC100996897
hsa:100996904;;uncharacterized LOC100996904
hsa:100506858;;uncharacterized LOC100506858
hsa:100505845;ROPN1L-AS1;ROPN1L antisense RNA 1
hsa:100133299;;GALI1870
hsa:401176;;uncharacterized LOC401176
hsa:646652;;integral membrane glycoprotein-like
hsa:439936;C5orf17;chromosome 5 open reading frame 17
hsa:100996421;;uncharacterized LOC100996421
hsa:401180;;uncharacterized LOC401180
hsa:100506406;;uncharacterized LOC100506406
hsa:100861519;GDNF-AS1,GDNFOS;GDNF antisense RNA 1 (head to head)
hsa:100506475;EGFLAM-AS2;EGFLAM antisense RNA 2
hsa:100506495;LIFR-AS1;LIFR antisense RNA 1
hsa:100506639;;uncharacterized LOC100506639
hsa:100996444;;uncharacterized LOC100996444
hsa:100506674;;uncharacterized LOC100506674
hsa:643977;FLJ32255;uncharacterized LOC643977
hsa:100287592;;uncharacterized LOC100287592
hsa:100506329;;uncharacterized LOC100506329
hsa:441072;FLJ31104;uncharacterized LOC441072
hsa:100509780;;uncharacterized LOC100509780
hsa:100996645;;uncharacterized LOC100996645
hsa:100506526;;uncharacterized LOC100506526
hsa:100996319;;uncharacterized LOC100996319
hsa:728769;;uncharacterized LOC728769
hsa:645079;FLJ41309;uncharacterized LOC645079
hsa:100505878;;uncharacterized LOC100505878
hsa:100505949;;uncharacterized LOC100505949
hsa:729040;;uncharacterized LOC729040
hsa:100505994;;uncharacterized LOC100505994
hsa:100130172;;uncharacterized LOC100130172
hsa:100506219;;uncharacterized LOC100506219
hsa:100506102;;uncharacterized LOC100506102
hsa:728586;;hCG1981531
hsa:100505811;;uncharacterized LOC100505811
hsa:100129233;;uncharacterized LOC100129233
hsa:100505822;;uncharacterized LOC100505822
hsa:728093;;putative POM121-like protein 1-like
hsa:255187;;hCG1980447
hsa:100505636;;uncharacterized LOC100505636
hsa:100128482;;uncharacterized LOC100128482
hsa:100128059;;uncharacterized LOC100128059
hsa:100507267;;uncharacterized LOC100507267
hsa:100133106;;VCEW9374
hsa:728095;;uncharacterized LOC728095
hsa:101060007;;uncharacterized LOC101060007
hsa:644994;C5orf50;chromosome 5 open reading frame 50
hsa:728145;;uncharacterized LOC728145
hsa:100128340;;uncharacterized LOC100128340
hsa:100996419;;uncharacterized LOC100996419
hsa:100996424;;uncharacterized LOC100996424
hsa:100652782;;uncharacterized LOC100652782
hsa:100507546;;uncharacterized LOC100507546
hsa:100507602;;uncharacterized LOC100507602
hsa:642316;FLJ43763;uncharacterized LOC642316
hsa:100653247;;dual specificity protein phosphatase 22-like
hsa:100507336;;uncharacterized LOC100507336
hsa:100507506;;uncharacterized LOC100507506
hsa:497048;;KU-MEL-3
hsa:100129033;;QIQN5815
hsa:100129461;;uncharacterized LOC100129461
hsa:100506091;;uncharacterized LOC100506091
hsa:100506288;;uncharacterized LOC100506288
hsa:100506379;;uncharacterized LOC100506379
hsa:100506631;;uncharacterized LOC100506631
hsa:100506647;;uncharacterized LOC100506647
hsa:100506885;;uncharacterized LOC100506885
hsa:100653086;;uncharacterized LOC100653086
hsa:100129195;;uncharacterized LOC100129195
hsa:100507399;HCG8,HCGVIII,HCGVIII-1;HLA complex group 8
hsa:401247;LINC00243,C6orf214,NCRNA00243,bQB10J12.2,bQB230F21.2;long intergenic non-protein coding RNA 243
hsa:100996357;;uncharacterized LOC100996357
hsa:100287329;;uncharacterized LOC100287329
hsa:100653005;;uncharacterized LOC100653005
hsa:100507672;;uncharacterized LOC100507672
hsa:100505530;FLJ45825;uncharacterized LOC100505530
hsa:100505550;;uncharacterized LOC100505550
hsa:651302;ZNF192P1,ZNF389,ZNF389P,dJ265C24.4;zinc finger protein 192 pseudogene 1
hsa:100996809;;HLA class II histocompatibility antigen, DR beta 3 chain-like
hsa:101060779;;HLA class II histocompatibility antigen, DRB1-10 beta chain-like
hsa:100506188;;uncharacterized LOC100506188
hsa:101060775;;uncharacterized LOC101060775
hsa:401264;FLJ37798;uncharacterized LOC401264
hsa:100505985;;uncharacterized LOC100505985
hsa:100505862;;uncharacterized LOC100505862
hsa:100509542;;uncharacterized LOC100509542
hsa:100505711;;uncharacterized LOC100505711
hsa:100505697;;uncharacterized LOC100505697
hsa:100505635;;uncharacterized LOC100505635
hsa:100996481;;DNA primase large subunit-like
hsa:100996552;;uncharacterized LOC100996552
hsa:100507367;;uncharacterized LOC100507367
hsa:100507381;KCNQ5-IT1;KCNQ5 intronic transcript 1 (non-protein coding)
hsa:100506851;;uncharacterized LOC100506851
hsa:100506908;;uncharacterized LOC100506908
hsa:100506926;;uncharacterized LOC100506926
hsa:100507024;;uncharacterized LOC100507024
hsa:100505519;;uncharacterized LOC100505519
hsa:100505475;SYNE1-AS1;SYNE1 antisense RNA 1
hsa:101060008;;uncharacterized LOC101060008
hsa:100507477;;uncharacterized LOC100507477
hsa:100507406;;uncharacterized LOC100507406
hsa:644135;;uncharacterized LOC644135
hsa:100507308;;uncharacterized LOC100507308
hsa:100507136;;uncharacterized LOC100507136
hsa:100506496;;uncharacterized LOC100506496
hsa:441167;;hCG1820801
hsa:100287612;;uncharacterized LOC100287612
hsa:100506389;;uncharacterized LOC100506389
hsa:100506276;;uncharacterized LOC100506276
hsa:100287366;OSTM1-AS1;OSTM1 antisense RNA 1
hsa:100506165;;uncharacterized LOC100506165
hsa:100996852;;non-histone chromosomal protein HMG-17-like
hsa:401281;FLJ27255;uncharacterized LOC401281
hsa:100505705;SDIM1;stress responsive DNAJB4 interacting membrane protein 1
hsa:729658;;uncharacterized LOC729658
hsa:101060837;;uncharacterized LOC101060837
hsa:100505879;KIF25-AS1,C6orf54,HGC6.1.1,NCRNA00300;KIF25 antisense RNA 1
hsa:441179;;uncharacterized LOC441179
hsa:401286;;uncharacterized LOC401286
hsa:100505903;;uncharacterized LOC100505903
hsa:100507642;;uncharacterized LOC100507642
hsa:100131372;;uncharacterized LOC100131372
hsa:100996269;;uncharacterized LOC100996269
hsa:100128653;;uncharacterized LOC100128653
hsa:401296;;uncharacterized LOC401296
hsa:100128374;;uncharacterized LOC100128374
hsa:100996298;;uncharacterized LOC100996298
hsa:100129484;;uncharacterized LOC100129484
hsa:100288594;;uncharacterized LOC100288594
hsa:100505863;;uncharacterized LOC100505863
hsa:100505904;;uncharacterized LOC100505904
hsa:100505921;;uncharacterized LOC100505921
hsa:100505938;;uncharacterized LOC100505938
hsa:100506098;;uncharacterized LOC100506098
hsa:541472;;uncharacterized LOC541472
hsa:401312;;uncharacterized LOC401312
hsa:100506236;;uncharacterized LOC100506236
hsa:100996355;;uncharacterized LOC100996355
hsa:100506289;;uncharacterized LOC100506289
hsa:285943;HOXA-AS2;HOXA cluster antisense RNA 2
hsa:100506516;;uncharacterized LOC100506516
hsa:55025;;uncharacterized FLJ20712
hsa:100506725;;uncharacterized LOC100506725
hsa:402481;PP13004;uncharacterized LOC402481
hsa:401317;;uncharacterized LOC401317
hsa:644086;;uncharacterized LOC644086
hsa:100996411;;uncharacterized LOC100996411
hsa:100127950;HECW1-IT1;HECW1 intronic transcript 1 (non-protein coding)
hsa:100996654;;uncharacterized LOC100996654
hsa:730378;;uncharacterized LOC730378
hsa:730376;;uncharacterized LOC730376
hsa:101060139;;uncharacterized LOC101060139
hsa:401357;;uncharacterized LOC401357
hsa:100653233;;uncharacterized LOC100653233
hsa:100509247;;protein FAM27E2-like
hsa:100996407;;uncharacterized LOC100996407
hsa:644794;;uncharacterized LOC644794
hsa:100996437;;uncharacterized LOC100996437
hsa:100289098;;uncharacterized LOC100289098
hsa:84214;DKFZP434F142;uncharacterized DKFZp434F142
hsa:100996798;;uncharacterized LOC100996798
hsa:100996422;;uncharacterized LOC100996422
hsa:100507468;;uncharacterized LOC100507468
hsa:100996815;;uncharacterized LOC100996815
hsa:101060822;;probable E3 ubiquitin-protein ligase DTX2-like
hsa:101059910;;uncharacterized LOC101059910
hsa:644975;FLJ30064;uncharacterized LOC644975
hsa:613126;;uncharacterized LOC613126
hsa:100505913;;uncharacterized LOC100505913
hsa:101060861;;uncharacterized LOC101060861
hsa:101060797;;mucin-3A-like
hsa:100506527;;uncharacterized LOC100506527
hsa:100996615;;uncharacterized LOC100996615
hsa:100996872;;uncharacterized LOC100996872
hsa:100506881;;uncharacterized LOC100506881
hsa:100506860;;uncharacterized LOC100506860
hsa:100996787;;uncharacterized LOC100996787
hsa:100506682;;uncharacterized LOC100506682
hsa:100506664;;uncharacterized LOC100506664
hsa:100996795;;uncharacterized LOC100996795
hsa:100996266;;uncharacterized LOC100996266
hsa:100506489;;uncharacterized LOC100506489
hsa:100287664;TSRM;zinc finger domain-related protein TSRM
hsa:100996249;;uncharacterized LOC100996249
hsa:100506413;;uncharacterized LOC100506413
hsa:100506312;;uncharacterized LOC100506312
hsa:100129703;NAG20;NAG20
hsa:100130609;PP12708;uncharacterized LOC100130609
hsa:653739;;uncharacterized LOC653739
hsa:100130169;;uncharacterized LOC100130169
hsa:100507507;;uncharacterized LOC100507507
hsa:100508781;;protein FAM115A-like
hsa:100294033;;protein FAM115A-like
hsa:100507538;;uncharacterized LOC100507538
hsa:644090;;uncharacterized LOC644090
hsa:100996388;;uncharacterized LOC100996388
hsa:100506557;;uncharacterized LOC100506557
hsa:100506458;;putative uncharacterized protein LOC65996-like
hsa:100506380;;uncharacterized LOC100506380
hsa:389602;;uncharacterized LOC389602
hsa:100506302;;uncharacterized LOC100506302
hsa:157693;FAM87A;family with sequence similarity 87, member A
hsa:389607;;uncharacterized LOC389607
hsa:401442;;uncharacterized LOC401442
hsa:100507435;;uncharacterized LOC100507435
hsa:100131395;;uncharacterized LOC100131395
hsa:100507530;;uncharacterized LOC100507530
hsa:606553;C8orf49;chromosome 8 open reading frame 49
hsa:100129129;;uncharacterized LOC100129129
hsa:100131275;NSAP11;nervous system abundant protein 11
hsa:100133995;;uncharacterized LOC100133995
hsa:729732;;uncharacterized LOC729732
hsa:100507071;;uncharacterized LOC100507071
hsa:100507207;;uncharacterized LOC100507207
hsa:100507222;;uncharacterized LOC100507222
hsa:100507439;;uncharacterized LOC100507439
hsa:100507420;;uncharacterized LOC100507420
hsa:100507403;;uncharacterized LOC100507403
hsa:100996474;;uncharacterized LOC100996474
hsa:100507481;;uncharacterized LOC100507481
hsa:100505775;;uncharacterized LOC100505775
hsa:100507464;;uncharacterized LOC100507464
hsa:100507516;;uncharacterized LOC100507516
hsa:286178;;uncharacterized LOC286178
hsa:100505501;;uncharacterized LOC100505501
hsa:100505532;;uncharacterized LOC100505532
hsa:100505613;;uncharacterized LOC100505613
hsa:101060153;;uncharacterized LOC101060153
hsa:100505739;;uncharacterized LOC100505739
hsa:100129098;;uncharacterized LOC100129098
hsa:442388;SDR16C6P,SDR16C6;short chain dehydrogenase/reductase family 16C, member 6, pseudogene
hsa:100288310;;uncharacterized LOC100288310
hsa:100996348;;uncharacterized LOC100996348
hsa:100507258;;uncharacterized LOC100507258
hsa:100506342;;uncharacterized LOC100506342
hsa:100506351;;uncharacterized LOC100506351
hsa:100506365;;uncharacterized LOC100506365
hsa:100132183;FP6628;uncharacterized LOC100132183
hsa:100506538;;uncharacterized LOC100506538
hsa:286149;;uncharacterized LOC286149
hsa:100506558;;uncharacterized LOC100506558
hsa:100506652;;uncharacterized LOC100506652
hsa:401472;;FLJ45248 protein
hsa:100506753;;uncharacterized LOC100506753
hsa:100996462;;uncharacterized LOC100996462
hsa:100130232;;LP2209
hsa:100506861;;uncharacterized LOC100506861
hsa:100507018;;uncharacterized LOC100507018
hsa:100507056;CCAT1;colon cancer associated transcript 1 (non-protein coding)
hsa:641384;TMEM75;transmembrane protein 75
hsa:100507101;;uncharacterized LOC100507101
hsa:100507162;;uncharacterized LOC100507162
hsa:401478;;FLJ45872 protein
hsa:100131910;;uncharacterized LOC100131910
hsa:100129596;;uncharacterized LOC100129596
hsa:100996662;;uncharacterized LOC100996662
hsa:100287098;;uncharacterized LOC100287098
hsa:100507316;;uncharacterized LOC100507316
hsa:100509263;;uncharacterized protein LOC100509263
hsa:730098;;uncharacterized LOC730098
hsa:114224;;uncharacterized protein PRO2852
hsa:548324;C9orf133,GVQW1,TIGD1L2;chromosome 9 open reading frame 133
hsa:100509484;;uncharacterized LOC100509484
hsa:158295;;uncharacterized MGC24103
hsa:648570;;uncharacterized LOC648570
hsa:100506331;;uncharacterized LOC100506331
hsa:100506304;;uncharacterized LOC100506304
hsa:29044;C9orf38;chromosome 9 open reading frame 38
hsa:100506189;;uncharacterized LOC100506189
hsa:751816;DSERG1;Down syndrome encephalopathy related protein 1
hsa:392288;;microtubule-associated proteins 1A/1B light chain 3B-like
hsa:100130458;;uncharacterized LOC100130458
hsa:647044;FAM220BP,C9orf51,bA392E22.4;family with sequence similarity 220, member B, pseudogene
hsa:100126582;;uncharacterized LOC100126582
hsa:100509638;;protein FAM27D1-like
hsa:100509686;;protein FAM27D1-like
hsa:100996870;;uncharacterized LOC100996870
hsa:100996885;;putative uncharacterized protein FLJ45355-like
hsa:100507540;;uncharacterized LOC100507540
hsa:100506414;;uncharacterized LOC100506414
hsa:100996796;;protein FAM75D1-like
hsa:404770;SPATA31B1,C9orf36B,FAM75B,bA388B24.2;SPATA31 subfamily B, member 1
hsa:100506897;DAPK1-IT1;DAPK1 intronic transcript 1 (non-protein coding)
hsa:100506912;;uncharacterized LOC100506912
hsa:100996508;;uncharacterized LOC100996508
hsa:100653206;;uncharacterized LOC100653206
hsa:100507009;;uncharacterized LOC100507009
hsa:100996917;;putative uncharacterized protein UNQ6494/PRO21346-like
hsa:100128909;;uncharacterized LOC100128909
hsa:100507103;;uncharacterized LOC100507103
hsa:100507137;FP2234;uncharacterized LOC100507137
hsa:100996557;;uncharacterized LOC100996557
hsa:100507364;;uncharacterized LOC100507364
hsa:101060023;;uncharacterized LOC101060023
hsa:100507319;;uncharacterized LOC100507319
hsa:100507449;;uncharacterized LOC100507449
hsa:100507438;;uncharacterized LOC100507438
hsa:100287922;ANKRD18CP;ankyrin repeat domain 18C, pseudogene
hsa:100133204;C9orf147,bA32M23.3;chromosome 9 open reading frame 147
hsa:100505588;;uncharacterized LOC100505588
hsa:100505986;;uncharacterized LOC100505986
hsa:100128077;;uncharacterized LOC100128077
hsa:401554;;FLJ46836 protein
hsa:256158;HMCN2;hemicentin 2
hsa:138948;DBH-AS1,NCRNA00118;DBH antisense RNA 1
hsa:100130548;;uncharacterized LOC100130548
hsa:100506532;;uncharacterized LOC100506532
hsa:100506620;;uncharacterized LOC100506620
hsa:100129999;;uncharacterized LOC100129999
hsa:100652835;RBSG2;retinoblastoma-specific gene 2
hsa:100188917;ESP33;uncharacterized locus ESP33
hsa:401561;;FP7915 protein
hsa:100130547;;uncharacterized LOC100130547
hsa:651337;;uncharacterized LOC651337
hsa:101060829;;voltage-dependent N-type calcium channel subunit alpha-1B-like
hsa:100996822;;RNA-binding motif protein, Y chromosome, family 1 member F/J-like
hsa:100996825;;IQ motif and SEC7 domain-containing protein 3-like
hsa:100653113;;uncharacterized LOC100653113
hsa:650267;;double homeobox protein 4-like
hsa:100996843;;ATP-sensitive inward rectifier potassium channel 12-like
hsa:100131514;;uncharacterized LOC100131514
hsa:100289124;FAM27E2;family with sequence similarity 27, member E2
hsa:100134409;;double homeobox protein 4-like
hsa:101060792;;uncharacterized LOC101060792
hsa:652119;;double homeobox protein 4-like protein 4-like
hsa:100508782;;inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1-like
hsa:101060846;;protein FAM104B-like
hsa:100134173;;dead end protein homolog 1-like
hsa:100996819;;phosphoserine phosphatase-like
hsa:100996839;;putative uncharacterized protein FLJ46235-like
hsa:100996844;;mucin-3A-like
hsa:101060756;;uncharacterized LOC101060756
hsa:101060769;;tektin-4 like protein LOC389833-like
hsa:651536;immunoglobulin iota chain-like
hsa:100653225;;ovostatin homolog 2-like
hsa:101060789;;low affinity immunoglobulin gamma Fc region receptor III-A-like
hsa:729218;;uncharacterized LOC729218
hsa:100996888;;putative uncharacterized protein FLJ11871-like
hsa:100653251;;ankyrin repeat domain-containing protein SOWAHC-like
hsa:100128002;;uncharacterized LOC100128002
hsa:100996920;;uncharacterized LOC100996920
hsa:100134216;;uncharacterized LOC100134216
hsa:100996779;;protein FRG1-like
hsa:652586;;double homeobox protein 4-like protein 4-like
hsa:100134091;;protein FRG1B-like
hsa:100996862;;ankyrin repeat domain-containing protein 36A-like
hsa:101060794;;protein USP6-like 2-like
hsa:100507312;;uncharacterized LOC100507312
hsa:100034248;;uncharacterized LOC100034248
hsa:101060835;HLA class II histocompatibility antigen,DQ beta 1 chain-like
hsa:100509457;HLA class II histocompatibility antigen,DQ alpha 1 chain-like
hsa:101060854;;protein FAM27E2-like
hsa:100996792;;dual specificity mitogen-activated protein kinase kinase 3-like
hsa:100292669;;double homeobox protein 4-like protein 2-like
hsa:101060770;;uncharacterized LOC101060770
hsa:101060813;;uncharacterized LOC101060813
hsa:79999;;uncharacterized LOC79999
hsa:100132913;;uncharacterized LOC100132913
hsa:100996782;;mediator of RNA polymerase II transcription subunit 18-like
hsa:100653292;;putative HERC2-like protein 3-like
hsa:100996890;;uncharacterized LOC100996890
hsa:440570;;uncharacterized LOC440570
hsa:651959;;FSHD region gene 2-like
hsa:101060859;;putative tripartite motif-containing protein 53-like
hsa:101060866;;uncharacterized LOC101060866
hsa:100653166;;uncharacterized LOC100653166
hsa:101060754;;complement C4-B-like
hsa:100507395;;uncharacterized LOC100507395
hsa:100996909;;anaphase-promoting complex subunit 1-like
hsa:100506610;;uncharacterized LOC100506610
hsa:100506630;;uncharacterized LOC100506630
hsa:645864;MAGEB17;melanoma antigen family B, 17
hsa:101060750;;inosine-5'-monophosphate dehydrogenase 1-like
hsa:100506641;;uncharacterized LOC100506641
hsa:101060753;;chromosome transmission fidelity protein 8 homolog isoform 2-like
hsa:441493;;uncharacterized LOC441493
hsa:203414;CXorf24;chromosome X open reading frame 24
hsa:100129860;;uncharacterized LOC100129860
hsa:340602;CXorf67;chromosome X open reading frame 67
hsa:139629;XAGE-4;XAGE-4 protein
hsa:100129291;;uncharacterized LOC100129291
hsa:100128574;ARMCX3-AS1;ARMCX3 antisense RNA 1
hsa:84443;FRMPD3;FERM and PDZ domain containing 3
hsa:100996848;;FERM and PDZ domain-containing protein 3-like
hsa:100126447;;uncharacterized LOC100126447
hsa:100287728;;uncharacterized LOC100287728
hsa:100506790;;uncharacterized LOC100506790
hsa:100996830;;uncharacterized LOC100996830
hsa:645188;;uncharacterized LOC645188
hsa:100507199;;uncharacterized LOC100507199
hsa:101060772;;paraneoplastic antigen-like protein 6B-like
hsa:100509091;;extracellular matrix protein 2-like
hsa:648761;;uncharacterized LOC648761
hsa:101059949;;coiled-coil domain-containing protein 29-like
hsa:100509646;;PTPN13-like protein, Y-linked-like
hsa:100134822;;uncharacterized LOC100134822
hsa:100653348;;uncharacterized LOC100653348
hsa:100653358;;putative uncharacterized protein C20orf69-like
hsa:100996768;;putative uncharacterized protein FLJ46235-like
hsa:100134663;;uncharacterized LOC100134663
hsa:101060742;;putative uncharacterized protein FLJ46348-like
hsa:100287894;;uncharacterized LOC100287894
hsa:101060745;;putative uncharacterized protein FLJ46235-like
hsa:101060147;;uncharacterized LOC101060147
hsa:100996365;;uncharacterized LOC100996365
hsa:285905;INTS4L1;integrator complex subunit 4-like 1
hsa:101060178;;uncharacterized LOC101060178
hsa:653375;;RCC1-like G exchanging factor-like
hsa:101060740;;mucin-3A-like
hsa:100134040;;uncharacterized LOC100134040
hsa:100510007;;uncharacterized LOC100510007
hsa:100506534;;uncharacterized LOC100506534
hsa:100996442;;uncharacterized LOC100996442
hsa:100506504;;uncharacterized LOC100506504
hsa:100996614;;putative uncharacterized protein encoded by LINC00596-like
hsa:100506310;;uncharacterized protein C1orf167-like
hsa:284498;C1orf167;chromosome 1 open reading frame 167
hsa:729368;PRAMEF23,PRAMEF5L;PRAME family member 23
hsa:441873;PRAMEF25;PRAME family member 25-like
hsa:645359;;PRAME family member
hsa:100506533;;putative uncharacterized protein FLJ35883-like
hsa:100133301;;UPF0627 protein ENSP00000364708
hsa:729574;;UPF0627 protein ENSP00000341061/ENSP00000339743
hsa:729587;;UPF0627 protein ENSP00000341061/ENSP00000339743-like
hsa:729516;PRAMEF24;putative PRAME family member 24
hsa:101060085;;uncharacterized LOC101060085
hsa:646262;LACTBL1;lactamase, beta-like 1
hsa:400768;;uncharacterized LOC400768
hsa:100996702;;putative uncharacterized protein FLJ36116-like
hsa:100132074;FOXO6;forkhead box O6
hsa:100996301;;uncharacterized LOC100996301
hsa:100505741;SPATA1,SP-2,SPAP1;spermatogenesis associated 1
hsa:100996318;;uncharacterized LOC100996318
hsa:730256;;uncharacterized LOC730256
hsa:100996575;NBPF8P,NBPF8;neuroblastoma breakpoint family member 3-like
hsa:100996517;;vesicle-trafficking protein SEC22b-like
hsa:100506011;;uncharacterized LOC100506011
hsa:101059961;;neuroblastoma breakpoint family member 21-like
hsa:149013;NBPF12,COAS1,KIAA1245;neuroblastoma breakpoint family, member 12
hsa:101059980;;neuroblastoma breakpoint family member 20-like
hsa:100996529;;uncharacterized LOC100996529
hsa:100505794;;uncharacterized LOC100505794
hsa:100132999;;uncharacterized LOC100132999
hsa:100996555;;uncharacterized LOC100996555
hsa:642691;FLJ37786;uncharacterized LOC642691
hsa:644634;;UPF0627 protein ENSP00000358171-like
hsa:100996516;;uncharacterized LOC100996516
hsa:100506546;;uncharacterized LOC100506546
hsa:100506636;;uncharacterized LOC100506636
hsa:101059970;;liprin-alpha-2-like
hsa:101059976;;uncharacterized LOC101059976
hsa:100287497;;uncharacterized LOC100287497
hsa:100288102;;uncharacterized LOC100288102
hsa:100506571;;uncharacterized LOC100506571
hsa:100505955;;putative uncharacterized protein FLJ44672-like
hsa:101060009;;uncharacterized LOC101060009
hsa:441124;;uncharacterized LOC441124
hsa:728728;;putative uncharacterized protein encoded by LINC00174-like
hsa:101060022;;uncharacterized LOC101060022
hsa:100129094;BTNL10,BUTR1;butyrophilin-like 10
hsa:101060028;;uncharacterized LOC101060028
hsa:100996568;;uncharacterized LOC100996568
hsa:100130097;;kinesin-like protein family member 6-like
hsa:728597;DCDC2C;doublecortin domain containing 2C
hsa:100996394;;uncharacterized LOC100996394
hsa:100996537;;uncharacterized LOC100996537
hsa:650157;;peptidyl-prolyl cis-trans isomerase A-like
hsa:100652774;;putative uncharacterized protein UNQ3029/PRO9830-like
hsa:100652775;;uncharacterized protein HP11026
hsa:100130921;;uncharacterized LOC100130921
hsa:100506088;;uncharacterized LOC100506088
hsa:100506891;;uncharacterized LOC100506891
hsa:100874048;DGUOK-AS1;DGUOK antisense RNA 1
hsa:101060017;;uncharacterized LOC101060017
hsa:400986;ANKRD36C;ankyrin repeat domain 36C
hsa:100996535;;uncharacterized LOC100996535
hsa:100506076;;uncharacterized LOC100506076
hsa:100996606;;uncharacterized LOC100996606
hsa:100506563;;uncharacterized LOC100506563
hsa:100507581;;uncharacterized LOC100507581
hsa:646802;CYP4F43P;cytochrome P450, family 4, subfamily F, polypeptide 43, pseudogene
hsa:100288897;;fatty acyl-CoA reductase 2-like
hsa:100996685;;putative uncharacterized protein ENSP00000272607-like
hsa:101060198;;MARVEL domain-containing protein 1-like
hsa:646915;ZNF806;zinc finger protein 806
hsa:100652824;;uncharacterized LOC100652824
hsa:100996693;;CAVP-target protein-like
hsa:100996253;;uncharacterized LOC100996253
hsa:440934;;uncharacterized LOC440934
hsa:151176;FAM132B,C1QTNF15,CTRP15;family with sequence similarity 132, member B
hsa:100996584;;uncharacterized LOC100996584
hsa:100287387;;uncharacterized LOC100287387
hsa:285097;;uncharacterized FLJ38379
hsa:728763;;rootletin-like
hsa:100996546;;putative uncharacterized protein FLJ46541-like
hsa:100288831;SRGAP3-AS3;SRGAP3 antisense RNA 3
hsa:100505836;;uncharacterized LOC100505836
hsa:101060160;DDTP1;D-dopachrome tautomerase pseudogene 1
hsa:285346;ZNF852;zinc finger protein 852
hsa:100996661;;uncharacterized LOC100996661
hsa:100652807;;putative uncharacterized protein C3orf53-like
hsa:729454;DSTNP4;destrin (actin depolymerizing factor) pseudogene 4
hsa:401068;;uncharacterized LOC401068
hsa:100996350;;double homeobox protein 4-like protein 4-like
hsa:100287852;;protein FAM136A-like
hsa:100132731;;uncharacterized LOC100132731
hsa:100287290;;cytokine receptor CRL2
hsa:440993;;uncharacterized LOC440993
hsa:101060069;;Derived by automated computational analysis using gene prediction method: GNOMON. Supporting evidence includes similarity to: 1 mRNA, 71 ESTs
hsa:101060079;;uncharacterized LOC101060079
hsa:100507054;;uncharacterized LOC100507054
hsa:389197;C4orf50;chromosome 4 open reading frame 50
hsa:100996632;;uncharacterized LOC100996632
hsa:729175;;uncharacterized LOC729175
hsa:727738;AREGB;amphiregulin B
hsa:100507306;;uncharacterized LOC100507306
hsa:152586;;glycosyltransferase 54 domain-containing protein
hsa:285423;;uncharacterized LOC285423
hsa:101059914;;protein FAM218A-like
hsa:731282;;uncharacterized LOC731282
hsa:101059947;;uncharacterized LOC101059947
hsa:100996325;;uncharacterized LOC100996325
hsa:100128508;;PP12100
hsa:100506217;;putative POM121-like protein 1-like
hsa:100996452;;uncharacterized LOC100996452
hsa:653082;ZDHHC11B,DHHC-11B;zinc finger, DHHC-type containing 11B
hsa:100652783;;putative POM121-like protein 1-like
hsa:100506903;;putative POM121-like protein 1-like
hsa:728637;;uncharacterized LOC728637
hsa:101060024;;uncharacterized LOC101060024
hsa:100996485;;uncharacterized LOC100996485
hsa:441098;;putative POM121-like protein 1-like
hsa:100652758;;uncharacterized LOC100652758
hsa:100507161;;putative uncharacterized protein NCRNA00269-like
hsa:100996385;;uncharacterized LOC100996385
hsa:100507427;;uncharacterized LOC100507427
hsa:100996446;;uncharacterized LOC100996446
hsa:101060059;;uncharacterized LOC101060059
hsa:100286914;;putative uncharacterized protein C20orf69-like
hsa:100506431;;B2 RNA
hsa:100506681;JARID2-AS1;JARID2 antisense RNA 1
hsa:100996300;;zinc finger protein ENSP00000375192-like
hsa:401261;;FLJ38717 protein
hsa:100652766;;dystonin-like
hsa:100996497;LINC00680;uncharacterized LOC100996497
hsa:266553;OFCC1,MRDS1;orofacial cleft 1 candidate 1
hsa:100507172;;uncharacterized LOC100507172
hsa:100996634;;transmembrane protein FLJ37396-like
hsa:100996641;;coiled-coil domain-containing protein 162-like
hsa:100996290;;uncharacterized LOC100996290
hsa:729995;;hCG1817208
hsa:389422;C6orf183,bA487F23.3;chromosome 6 open reading frame 183
hsa:100652953;60S ribosomal protein L30-like
hsa:100132858;;putative protein FAM157B-like
hsa:100128364;;uncharacterized LOC100128364
hsa:100996433;;uncharacterized LOC100996433
hsa:101060133;;myosin regulatory light chain 10-like
hsa:100131017;ZNF316,MZF-3,ZNF853;zinc finger protein 316
hsa:101060138;zinc finger protein 316-like
hsa:100996459;;uncharacterized LOC100996459
hsa:100128326;;putative uncharacterized protein FLJ92257-like
hsa:100507369;;putative uncharacterized protein encoded by LINC00174-like
hsa:100996261;;putative uncharacterized protein FLJ46348-like
hsa:100996271;;putative uncharacterized protein FLJ46348-like
hsa:100996278;;putative uncharacterized protein FLJ46348-like
hsa:101060183;;putative uncharacterized protein encoded by LINC00174-like
hsa:100287294;;equilibrative nucleoside transporter 4-like
hsa:100287633;;protein FAM27E2-like
hsa:100996380;;putative uncharacterized protein FLJ46348-like
hsa:100996451;;uncharacterized LOC100996451
hsa:100505669;;uncharacterized LOC100505669
hsa:100288807;;putative speedy protein-like protein 2-like
hsa:100505767;;putative speedy protein-like protein 2-like
hsa:100996527;;uncharacterized LOC100996527
hsa:100996577;;putative uncharacterized protein encoded by LINC00269-like
hsa:100271927;RASA4B;RAS p21 protein activator 4B
hsa:100506937;;uncharacterized LOC100506937
hsa:101060128;;putative uncharacterized protein encoded by LINC00174-like
hsa:100996392;;putative uncharacterized protein FLJ46348-like
hsa:100996408;;putative uncharacterized protein FLJ46348-like
hsa:100996423;;putative uncharacterized protein FLJ46348-like
hsa:100996428;;putative uncharacterized protein FLJ46348-like
hsa:100996372;;putative uncharacterized protein FLJ46348-like
hsa:101060161;;putative uncharacterized protein FLJ44672-like
hsa:441239;;uncharacterized LOC441239
hsa:100132581;SPDYE9P;speedy homolog E9 (Xenopus laevis), pseudogene
hsa:101059921;;uncharacterized LOC101059921
hsa:4584;MUC3A,MUC-3A,MUC3;mucin 3A, cell surface associated
hsa:646409;DGAT2L7P,DGAT2L7;diacylglycerol O-acyltransferase 2-like 7, pseudogene
hsa:100996677;;uncharacterized LOC100996677
hsa:101060011;;putative IQ and AAA domain-containing protein 1-like
hsa:100996700;;putative uncharacterized protein encoded by LINC00269-like
hsa:100996256;;uncharacterized LOC100996256
hsa:101060029;;putative IQ and AAA domain-containing protein 1-like
hsa:100996426;;putative uncharacterized protein encoded by LINC00269-like
hsa:100996445;;uncharacterized LOC100996445
hsa:100996633;;uncharacterized LOC100996633
hsa:100131608;;uncharacterized LOC100131608
hsa:100132046;;uncharacterized LOC100132046
hsa:100996519;;transmembrane protein C8orf5-like
hsa:619423;FAM85A;family with sequence similarity 85, member A
hsa:100133251;;uncharacterized LOC100133251
hsa:101059959;;uncharacterized LOC101059959
hsa:101059966;;uncharacterized LOC101059966
hsa:100287313;;uncharacterized LOC100287313
hsa:100996304;;uncharacterized LOC100996304
hsa:100287651;;lipoxygenase homology domain-containing protein 1-like
hsa:100288562;REXO1L7P;exonuclease GOR-like
hsa:100996398;;uncharacterized LOC100996398
hsa:100996457;;uncharacterized LOC100996457
hsa:392275;SMPD5;sphingomyelin phosphodiesterase 5
hsa:728071;FAM203B,BRP16L,C8orf30B;family with sequence similarity 203, member B
hsa:377711;;HEAT repeat-containing protein 7A-like
hsa:100996667;;uncharacterized LOC100996667
hsa:101060026;;coiled-coil domain-containing protein 29-like
hsa:100132439;FAM27E4,FAM27E4P;family with sequence similarity 27, member E4
hsa:100505781;;protein FAM27D1-like
hsa:100507284;;uncharacterized LOC100507284
hsa:100287333;FAM27E1;family with sequence similarity 27, member E1
hsa:100287368;;protein FAM27D1-like
hsa:724094;FAM27D1;family with sequence similarity 27, member D1
hsa:100996612;;putative UPF0633 protein LOC554249-like
hsa:100132249;;uncharacterized LOC100132249
hsa:100132004;;uncharacterized LOC100132004
hsa:100996689;;uncharacterized LOC100996689
hsa:403323;;uncharacterized protein FLJ20444
hsa:100132154;;putative ankyrin repeat domain-containing protein 30B-like
hsa:100996489;;uncharacterized LOC100996489
hsa:100996482;;putative uncharacterized protein encoded by LINC00269-like
hsa:100996487;;putative uncharacterized protein C9orf63-like
hsa:100652913;;uncharacterized LOC100652913
hsa:728026;;prothymosin alpha-like
hsa:100996601;;uncharacterized LOC100996601
hsa:401550;TTLL11-IT1,C9orf148;TTLL11 intronic transcript 1 (non-protein coding)
hsa:51145;;erythrocyte transmembrane protein
hsa:100506119;;uncharacterized LOC100506119
hsa:100996250;;uncharacterized LOC100996250
hsa:100506667;;uncharacterized LOC100506667
hsa:100996287;;uncharacterized LOC100996287
hsa:101060175;;hemicentin-2-like
hsa:414196;CELF2-AS1,C10orf31;CELF2 antisense RNA 1
hsa:439951;;uncharacterized LOC439951
hsa:100507213;USP6NL-IT1;USP6NL intronic transcript 1 (non-protein coding)
hsa:100289151;DCLRE1CP1;DNA cross-link repair 1C pseudogene 1
hsa:101060092;macrophage mannose receptor 1-like
hsa:101060101;;transmembrane protein 236-like
hsa:101060163;;MAM and LDL-receptor class A domain-containing protein C10orf112-like
hsa:101060171;ARMC4P1;armadillo repeat containing 4 pseudogene 1
hsa:100996605;;putative calcium-sensing receptor-like 1-like
hsa:414194;CCNYL2,C10orf21,bA178A10.2;cyclin Y-like 2
hsa:100996642;;poly(ADP-ribose) glycohydrolase-like
hsa:653252;TIMM23B,TIMM23,bA592B15.7;translocase of inner mitochondrial membrane 23 homolog B (yeast)
hsa:100996610;;putative uncharacterized protein LOC65996-like
hsa:100652748;LINC00843;long intergenic non-protein coding RNA 843
hsa:100652732;;coiled-coil and C2 domain-containing protein 2A-like
hsa:101060155;;uncharacterized LOC101060155
hsa:100996346;;uncharacterized LOC100996346
hsa:728065;;uncharacterized LOC728065
hsa:100996618;;uncharacterized LOC100996618
hsa:101060179;;uncharacterized LOC101060179
hsa:101059906;;collagen alpha-1(IV) chain-like
hsa:101059911;;mucin-5AC-like
hsa:101059934;;uncharacterized LOC101059934
hsa:643680;MS4A4E;membrane-spanning 4-domains, subfamily A, member 4E
hsa:100996467;;metastasis-associated lung adenocarcinoma transcript 1-like
hsa:100505504;;uncharacterized LOC100505504
hsa:100996505;;uncharacterized LOC100996505
hsa:100996515;;uncharacterized LOC100996515
hsa:100131539;ZNF705E;zinc finger protein 705E
hsa:100287837;;uncharacterized LOC100287837
hsa:100506127;;putative uncharacterized protein FLJ37770-like
hsa:399940;TRIM51EP;tripartite motif-containing 51E, pseudogene
hsa:728588;MS4A18;membrane-spanning 4-domains, subfamily A, member 18
hsa:100127946;;uncharacterized LOC100127946
hsa:100128242;;uncharacterized LOC100128242
hsa:729305;;uncharacterized LOC729305
hsa:644277;;uncharacterized LOC644277
hsa:100506870;;uncharacterized LOC100506870
hsa:100996646;;uncharacterized LOC100996646
hsa:100996356;;uncharacterized LOC100996356
hsa:100996378;;uncharacterized LOC100996378
hsa:728715;;ovostatin homolog 2-like
hsa:101060047;;uncharacterized LOC101060047
hsa:144203;OVOS2;ovostatin 2
hsa:408186;OVOS;ovostatin
hsa:100506248;;prothymosin alpha-like
hsa:100507195;;uncharacterized LOC100507195
hsa:374467;C12orf63;chromosome 12 open reading frame 63
hsa:283463;MUC19,MUC-19;mucin 19, oligomeric
hsa:728503;;uncharacterized LOC728503
hsa:144535;C12orf55;chromosome 12 open reading frame 55
hsa:100996254;;uncharacterized LOC100996254
hsa:100996317;;uncharacterized LOC100996317
hsa:100996701;;uncharacterized LOC100996701
hsa:100128276;;uncharacterized LOC100128276
hsa:100996573;;uncharacterized LOC100996573
hsa:101060200;zinc finger protein 891-like
hsa:100996347;;uncharacterized LOC100996347
hsa:100874259;SLC25A30-AS1;SLC25A30 antisense RNA 1
hsa:100996412;;uncharacterized LOC100996412
hsa:647264;;uncharacterized LOC647264
hsa:100507612;LINC00402;long intergenic non-protein coding RNA 402
hsa:100996470;;uncharacterized LOC100996470
hsa:220416;LRRC63;leucine rich repeat containing 63
hsa:731932;;uncharacterized LOC731932
hsa:100506859;;serine/threonine-protein kinase Nek5-like
hsa:440157;;uncharacterized LOC440157
hsa:101059917;;uncharacterized LOC101059917
hsa:100506303;;uncharacterized LOC100506303
hsa:642477;FLJ39632;uncharacterized LOC642477
hsa:100506237;NKX2-1-AS1;NKX2-1 antisense RNA 1
hsa:101059952;;uncharacterized LOC101059952
hsa:101059957;;tetratricopeptide repeat protein 6-like
hsa:100506358;;uncharacterized LOC100506358
hsa:100506972;;uncharacterized protein C14orf113-like
hsa:100288144;;uncharacterized LOC100288144
hsa:100507437;;uncharacterized LOC100507437
hsa:100288568;;uncharacterized LOC100288568
hsa:100507650;C14orf164;chromosome 14 open reading frame 164
hsa:319089;TTC6,C14orf25,NCRNA00291;tetratricopeptide repeat domain 6
hsa:101060117;;uncharacterized LOC101060117
hsa:100287399;;POTE ankyrin domain family member B-like
hsa:100996331;;POTE ankyrin domain family member B-like
hsa:440233;;putative golgin subfamily A member 6-like protein 6-like
hsa:101060115;;putative transmembrane protein ENSP00000320207-like
hsa:100996599;;putative transmembrane protein FLJ36131-like
hsa:283685;GOLGA6L2,CT105;golgin A6 family-like 2
hsa:100996625;;putative transmembrane protein FLJ36131-like
hsa:645202;;golgin A6 family-like
hsa:100996644;;putative transmembrane protein FLJ36131-like
hsa:653720;GOLGA8M;golgin A8 family, member M
hsa:101059991;;golgin subfamily A member 6-like protein 2-like
hsa:653073;GOLGA8J;golgin A8 family, member J
hsa:101059918;;golgin subfamily A member 8-like protein 2-like
hsa:728498;GOLGA8H,GOLGA6L11;golgin A8 family, member H
hsa:101059939;;uncharacterized LOC101059939
hsa:100996675;;putative uncharacterized protein DKFZp434L187-like
hsa:653125;GOLGA8K;golgin A8 family, member K
hsa:728047;GOLGA8O;golgin A8 family, member O
hsa:643699;GOLGA8R;golgin A8 family, member R
hsa:100996255;;uncharacterized LOC100996255
hsa:101059984;;formin-1-like
hsa:100505534;;uncharacterized LOC100505534
hsa:100133746;;uncharacterized LOC100133746
hsa:100996413;;uncharacterized LOC100996413
hsa:732265;;COMM domain-containing protein 4-like
hsa:730058;;UPF0621 protein C-like
hsa:100996492;;uncharacterized LOC100996492
hsa:643696;;uncharacterized LOC643696
hsa:727751;;uncharacterized LOC727751
hsa:100133220;GOLGA6L3;golgin A6 family-like 3
hsa:400464;;uncharacterized LOC400464
hsa:100996528;;uncharacterized LOC100996528
hsa:197350;CASP16,CASP14L;caspase 16, apoptosis-related cysteine peptidase (putative)
hsa:100287538;;uncharacterized LOC100287538
hsa:400499;;uncharacterized LOC400499
hsa:100129781;;uncharacterized LOC100129781
hsa:642778;;nuclear pore complex-interacting protein-like 1-like
hsa:642799;;nuclear pore complex-interacting protein-like 1-like
hsa:100288332;;NPIP-like protein 1-like
hsa:101059938;;nuclear pore complex-interacting protein-like
hsa:101059953;;nuclear pore complex-interacting protein-like
hsa:100996242;;uncharacterized LOC100996242
hsa:101059979;;uncharacterized LOC101059979
hsa:440345;61E3.4;nuclear pore complex interacting protein-like
hsa:100996268;;uncharacterized LOC100996268
hsa:100996277;;uncharacterized LOC100996277
hsa:101059992;;uncharacterized LOC101059992
hsa:101059994;;uncharacterized LOC101059994
hsa:728888;;nuclear pore complex-interacting protein-like 3-like
hsa:100652740;C16orf98;chromosome 16 open reading frame 98
hsa:100289574;;HECT and RLD domain containing E3 ubiquitin protein ligase 2 pseudogene
hsa:100507221;;uncharacterized LOC100507221
hsa:653562;;sodium- and chloride-dependent creatine transporter 1-like
hsa:100652777;;group 10 secretory phospholipase A2-like
hsa:728741;;uncharacterized LOC728741
hsa:728734;;nuclear pore complex-interacting protein-like 2-like
hsa:100507607;;nuclear pore complex-interacting protein-like 2-like
hsa:101060129;;uncharacterized LOC101060129
hsa:388436;;uncharacterized LOC388436
hsa:100996259;FAM106B;protein FAM106B-like
hsa:100996282;;uncharacterized LOC100996282
hsa:96597;TBC1D27;TBC1 domain family, member 27
hsa:100505724;KRTAP9-7,KAP9.7,KRTAP9L1;keratin associated protein 9-7
hsa:645460;FLJ44342;uncharacterized LOC645460
hsa:100996273;;uncharacterized LOC100996273
hsa:100132174;;uncharacterized LOC100132174
hsa:100996295;;uncharacterized LOC100996295
hsa:100507608;KRTAP9-6,KAP9.6,KRTAP9.6,KRTAP9L2;keratin associated protein 9-6
hsa:100507656;;uncharacterized LOC100507656
hsa:100996368;;uncharacterized LOC100996368
hsa:100505909;;uncharacterized LOC100505909
hsa:100996382;;uncharacterized LOC100996382
hsa:652991;SKOR2,CORL2,FUSSEL18;SKI family transcriptional corepressor 2
hsa:646778;;uncharacterized LOC646778
hsa:100996274;;uncharacterized LOC100996274
hsa:100506089;;uncharacterized LOC100506089
hsa:100996289;;uncharacterized LOC100996289
hsa:648044;;guanine nucleotide binding protein (G protein), gamma 12-like
hsa:100996314;;putative uncharacterized protein FLJ26174-like
hsa:100505594;;uncharacterized LOC100505594
hsa:101060181;;zinc finger protein ZnFP12-like
hsa:79860;;uncharacterized protein FLJ21369
hsa:100652943;;putative uncharacterized protein FLJ38264-like
hsa:374920;C19orf68;chromosome 19 open reading frame 68
hsa:729974;RFPL4AL1;ret finger protein-like 4A-like 1
hsa:101059922;;uncharacterized LOC101059922
hsa:100506634;;hepatocellular carcinoma-associated antigen HCA25a
hsa:100996440;;uncharacterized LOC100996440
hsa:100129800;ZNF807,ZNF181P1,ZNF807P;zinc finger protein 807
hsa:100652741;;protein capicua homolog
hsa:100287477;zinc finger protein 420-like
hsa:646698;ZSCAN5D,ZNF495D;zinc finger and SCAN domain containing 5D
hsa:100996518;;putative uncharacterized protein PRO0628-like
hsa:100291105;;uncharacterized LOC100291105
hsa:100996602;;uncharacterized LOC100996602
hsa:388795;EFCAB8;EF-hand calcium binding domain 8
hsa:728671;;uncharacterized LOC728671
hsa:140731;ANKRD60,C20orf86,bA196N14.3;ankyrin repeat domain 60
hsa:100505771;;uncharacterized LOC100505771
hsa:100128998;C20orf181,dJ824A14.1;chromosome 20 open reading frame 181
hsa:441956;;uncharacterized LOC441956
hsa:100996571;;tigger transposable element-derived protein 1-like
hsa:101060041;;uncharacterized LOC101060041
hsa:101060037;;uncharacterized LOC101060037
hsa:100996619;;uncharacterized LOC100996619
hsa:100288336;;Putative uncharacterized protein ENSP00000383251
hsa:728441;GGT2,GGT,GGT_2;gamma-glutamyltransferase 2
hsa:100996335;;uncharacterized LOC100996335
hsa:100996337;;transmembrane protein 191B-like
hsa:100652894;;uncharacterized LOC100652894
hsa:100652901;;uncharacterized LOC100652901
hsa:100507657;;uncharacterized LOC100507657
hsa:101059981;;putative uncharacterized protein FLJ23865-like
hsa:100506562;;protein LLP homolog
hsa:729461;;uncharacterized LOC729461
hsa:101060018;;uncharacterized LOC101060018
hsa:284861;FAM230B;family with sequence similarity 230, member B
hsa:100132705;;immunoglobulin superfamily member 3-like
hsa:100996556;CA15P3;carbonic anhydrase XV, pseudogene 3
hsa:100652871;;glutathione S-transferase theta-4-like
hsa:100996594;;glutathione S-transferase theta-4-like
hsa:100996598;;uncharacterized LOC100996598
hsa:164714;TTLL8;tubulin tyrosine ligase-like family, member 8
hsa:100506453;;uncharacterized LOC100506453
hsa:100506502;;uncharacterized LOC100506502
hsa:100506661;;uncharacterized LOC100506661
hsa:441528;;uncharacterized LOC441528
hsa:729162;;uncharacterized LOC729162
hsa:401589;;uncharacterized LOC401589
hsa:101060193;;G antigen family D member 3-like
hsa:100996279;;putative uncharacterized protein encoded by LINC00269-like
hsa:101059915;;uncharacterized LOC101059915
hsa:100132304;;uncharacterized LOC100132304
hsa:100506745;;protein shisa-5-like
hsa:100996631;;T-complex protein 11 homolog
hsa:100996648;;T-complex protein 11 homolog
hsa:100506901;;uncharacterized LOC100506901
hsa:101060167;;uncharacterized LOC101060167
hsa:100996525;;uncharacterized LOC100996525
hsa:728513;PNMA6B;paraneoplastic Ma antigen family member 6B
hsa:100996465;;putative lung carcinoma-associated protein 10-like
hsa:649238;;putative paraneoplastic antigen-like protein 6B-like
hsa:100533178;CYorf17;chromosome Y open reading frame 17
hsa:101060136;;BCL-6 corepressor-like
hsa:101060140;;testis-specific Y-encoded protein 2-like
hsa:100506543;;uncharacterized LOC100506543
hsa:100996292;;hydrocephalus-inducing protein homolog
hsa:100996431;;uncharacterized LOC100996431
hsa:100287163;;zinc finger protein 717-like
hsa:100996464;zinc finger protein 84-like
hsa:100287515;zinc finger protein 26-like
hsa:90462;;zinc finger protein 605-like
hsa:100505874;;uncharacterized LOC100505874
hsa:100288355;;double homeobox protein 4-like
hsa:100288398;;double homeobox protein 4-like
hsa:100288433;;double homeobox protein 4-like
hsa:100288494;;double homeobox protein 4-like
hsa:100288593;;double homeobox protein 4-like
hsa:100288657;;double homeobox protein 4-like
hsa:100289038;;von Willebrand factor-like
hsa:100289097;;protein FRG1-like
hsa:100996283;;uncharacterized LOC100996283
hsa:100996302;;uncharacterized LOC100996302
hsa:100652869;;uncharacterized LOC100652869
hsa:100129836;COL4A2-AS2;COL4A2 antisense RNA 2
hsa:100996276;;uncharacterized LOC100996276
hsa:100507534;;uncharacterized LOC100507534
hsa:100996329;;putative uncharacterized protein FLJ42384-like
hsa:101060062;;uncharacterized LOC101060062
hsa:100505942;;uncharacterized LOC100505942
hsa:100506735;;uncharacterized LOC100506735
hsa:729159;;UPF0607 protein ENSP00000381418-like
hsa:100996499;;uncharacterized LOC100996499
hsa:440348;NPIPL2,A-761H5.4;nuclear pore complex interacting protein-like 2
hsa:100289580;;uncharacterized LOC100289580
hsa:100996541;FAM157C;putative protein FAM157C-like
hsa:101059936;;uncharacterized LOC101059936
hsa:100506347;;uncharacterized LOC100506347
hsa:100996554;;uncharacterized LOC100996554
hsa:100996328;;uncharacterized LOC100996328
hsa:101060166;;putative uncharacterized protein UNQ9165/PRO28630-like
hsa:390877;adenylate kinase isoenzyme 1-like
hsa:729458;;methyl-CpG-binding domain protein 3-like 2-like
hsa:100996405;;uncharacterized LOC100996405
hsa:100287166;;uncharacterized LOC100287166
hsa:100289375;;protein FAM27E2-like
hsa:642643;;uncharacterized LOC642643
hsa:727983;;putative POM121-like protein 1-like
hsa:100996432;;paternally-expressed gene 3 protein-like
hsa:100996369;;cadherin EGF LAG seven-pass G-type receptor 1-like
hsa:100506454;;uncharacterized LOC100506454
hsa:100996401;;transmembrane protein 191B-like
hsa:100132900;;immunoglobulin superfamily member 3-like
hsa:100289087;TSPY10;testis specific protein, Y-linked 10
hsa:100289188;FAM197Y4;family with sequence similarity 197, Y-linked, member 4
hsa:100132506;FAM197Y3;family with sequence similarity 197, Y-linked, member 3
hsa:100289265;FAM197Y1;family with sequence similarity 197, Y-linked, member 1
hsa:100132932;FAM197Y9;family with sequence similarity 197, Y-linked, member 9
hsa:100133077;;uncharacterized LOC100133077
hsa:100132055;FAM157C;family with sequence similarity 157, member C
hsa:100505993;TMEM210;transmembrane protein 210
hsa:400879;;uncharacterized LOC400879
hsa:728127;AGAP10,CTGLF7,bA144G6.2;ArfGAP with GTPase domain, ankyrin repeat and PH domain 10
hsa:100506191;;uncharacterized LOC100506191
hsa:100996574;;uncharacterized LOC100996574
hsa:100996567;ANTXRLP1;anthrax toxin receptor-like pseudogene 1
hsa:100996504;;uncharacterized LOC100996504
hsa:100996522;;uncharacterized LOC100996522
hsa:100288646;;putative uncharacterized protein C20orf69-like
hsa:441402;;contactin associated protein-like 3 pseudogene
hsa:101059935;;coiled-coil domain-containing protein 29-like
hsa:728013;CBWD7;COBW domain containing 7
hsa:100996312;;uncharacterized LOC100996312
hsa:100131997;FAM27E3;family with sequence similarity 27, member E3
hsa:644249;;uncharacterized LOC644249
hsa:100132859;;protein FAM27E2-like
hsa:728841;NBPF8,NBPF21;neuroblastoma breakpoint family, member 8
hsa:100996643;;monofunctional C1-tetrahydrofolate synthase, mitochondrial-like
hsa:100505630;;uncharacterized LOC100505630
hsa:100287798;FAM197Y8;family with sequence similarity 197, Y-linked, member 8
hsa:100287826;FAM197Y7;family with sequence similarity 197, Y-linked, member 7
hsa:100287859;FAM197Y6;family with sequence similarity 197, Y-linked, member 6
hsa:100996473;;uncharacterized LOC100996473
hsa:100996547;;uncharacterized LOC100996547
hsa:100996626;;proline-rich nuclear receptor coactivator 2-like
hsa:100996657;serine/arginine-rich splicing factor 10-like
hsa:100289079;;60S ribosomal protein L36-like
hsa:100996341;;putative uncharacterized protein FLJ11871-like
hsa:101060081;;carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2-like
hsa:100132336;;GDNF family receptor alpha-2-like
hsa:100996383;;uncharacterized LOC100996383
hsa:100996390;;protein FAM163B-like
hsa:100996396;;ADAMTS-like protein 2-like
hsa:101060165;;uncharacterized LOC101060165
hsa:100271840;;uncharacterized LOC100271840
hsa:100505543;;uncharacterized LOC100505543
hsa:101059908;;uncharacterized LOC101059908
hsa:100133046;KIR3DL3;killer cell immunoglobulin-like receptor three domains long cytoplasmic tail 3
hsa:100506173;1060P11.3;killer cell immunoglobulin-like receptor, three domains, pseudogene
hsa:727787;;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like
hsa:100653034;;uncharacterized LOC100653034
hsa:100507709;HLA class II histocompatibility antigen,DRB1-7 beta chain-like
hsa:100507714;HLA class II histocompatibility antigen,DRB1-7 beta chain-like
hsa:100996707;;putative uncharacterized protein C6orf214-like
hsa:100294341;;ADP-ribosylation factor-like protein 17-like
hsa:100996709;;ADP-ribosylation factor-like protein 17-like
hsa:100294336;;dead end protein homolog 1-like
hsa:100996710;;c-Jun-amino-terminal kinase-interacting protein 1-like
hsa:100996730;;D(1B) dopamine receptor-like
hsa:554282;FAM72C;family with sequence similarity 72, member C
hsa:100996732;;uncharacterized LOC100996732
hsa:100996734;;D(1B) dopamine receptor-like
hsa:100996735;;uncharacterized LOC100996735
hsa:100996740;;uncharacterized LOC100996740
hsa:100996741;;UPF0627 protein ENSP00000358171-like
hsa:101060237;;uncharacterized LOC101060237
hsa:100996754;;peptidyl-prolyl cis-trans isomerase A-like 4G-like
hsa:100996756;;uncharacterized LOC100996756
hsa:101060238;;neuroblastoma breakpoint family member 14-like
hsa:101060202;;neuroblastoma breakpoint family member 20-like
hsa:100996761;;myomegalin-like
hsa:100996764;;uncharacterized LOC100996764
hsa:100996711;;uncharacterized LOC100996711
hsa:100996713;;uncharacterized LOC100996713
hsa:101060215;;uncharacterized LOC101060215
hsa:100996715;;uncharacterized LOC100996715
hsa:100996752;;uncharacterized LOC100996752
hsa:100996763;;uncharacterized LOC100996763
hsa:100996717;;neurogenic locus notch homolog protein 2-like
hsa:101060226;;neuroblastoma breakpoint family member
hsa:101060235;;thymosin beta-15B-like
hsa:101060236;;developmental pluripotency-associated protein 3-like
hsa:101060208;;cancer/testis antigen family 45 member A3-like
hsa:101060210;;cancer/testis antigen family 45 member A2-like
hsa:101060211;;cancer/testis antigen family 45 member A3-like
hsa:101060230;;melanoma-associated antigen 12-like
hsa:101060231;;chondrosarcoma-associated gene 2/3 protein-like
hsa:101060233;medium-wave-sensitive opsin 1-like
hsa:101060234;;testis-specific protein TEX28-like
hsa:100510710;;glucosylceramidase-like
hsa:100653056;;putative POM121-like protein 1-like
hsa:100653058;;putative POM121-like protein 1-like
hsa:100653059;;putative POM121-like protein 1-like
hsa:100653060;;putative POM121-like protein 1-like
hsa:100653061;;beta-glucuronidase-like protein SMA4-like
hsa:100510701;;uncharacterized LOC100510701
hsa:100132202;;golgin subfamily A member 6-like protein 1-like
hsa:100653057;;liver carboxylesterase 1-like
hsa:101060212;;uncharacterized LOC101060212
hsa:100510707;;TBC1 domain family member 3H-like
hsa:100653049;keratin,type I cuticular Ha4-like
hsa:101060229;;zinc finger protein 486-like
hsa:100653067;;putative killer cell immunoglobulin-like receptor like protein KIR3DP1-like
hsa:100653052;;putative killer cell immunoglobulin-like receptor like protein KIR3DP1-like
hsa:101060228;;killer cell immunoglobulin-like receptor 3DS1-like
hsa:100653050;;killer cell immunoglobulin-like receptor 2DL2-like
hsa:100996743;;killer cell immunoglobulin-like receptor 3DL2-like
hsa:100653068;;putative killer cell immunoglobulin-like receptor like protein KIR3DP1-like
hsa:100996725;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like
hsa:100996720;;uncharacterized LOC100996720
hsa:100996721;;UPF0627 protein ENSP00000358171-like
hsa:100996723;;uncharacterized LOC100996723
hsa:100996724;myomegalin-like
hsa:100996746;;putative speedy protein E8-like
hsa:101060203;;putative speedy protein E8-like
hsa:101060204;;postmeiotic segregation increased 4-like protein-like
hsa:100996749;;postmeiotic segregation increased 4-like protein-like
hsa:101060205;;postmeiotic segregation increased 4-like protein-like
hsa:100996753;;postmeiotic segregation increased 4-like protein-like
hsa:100996758;neuropeptide Y receptor type 4-like
hsa:100996760;;uncharacterized LOC100996760
hsa:100996718;olfactory receptor 9G1-like
hsa:100996747;;40S ribosomal protein S26-like
hsa:100996748;;uncharacterized LOC100996748
hsa:100996750;;keratin-associated protein 4-7-like
hsa:100996762;;keratin-associated protein 9-2-like
hsa:101060660;olfactory receptor 4F6-like
hsa:101060494;;uncharacterized LOC101060494
hsa:101060300;;uncharacterized LOC101060300
hsa:101060318;eukaryotic translation initiation factor 1A,X-chromosomal-like
hsa:101060339;;rootletin-like
hsa:101060378;;uncharacterized LOC101060378
hsa:101060384;;UPF0627 protein ENSP00000341061/ENSP00000339743-like
hsa:101060536;;uncharacterized LOC101060536
hsa:101060288;;PRAME family member 9/15-like
hsa:101060295;;PRAME family member 9/15-like
hsa:101060301;;heterogeneous nuclear ribonucleoprotein C-like 1-like
hsa:101060308;;PRAME family member 9/15-like
hsa:101060347;;hepatocyte growth factor-like protein-like
hsa:101060363;;peptidyl-prolyl cis-trans isomerase A-like
hsa:101060387;;uncharacterized LOC101060387
hsa:101060442;;calcium-binding mitochondrial carrier protein SCaMC-1-like
hsa:101060456;;uncharacterized LOC101060456
hsa:101060463;;myomegalin-like
hsa:101060632;;coiled-coil domain-containing protein 29-like
hsa:101060645;;uncharacterized LOC101060645
hsa:101060656;;protein FAM72D-like
hsa:101060664;;uncharacterized LOC101060664
hsa:101060672;;neuroblastoma breakpoint family member 14-like
hsa:642441;;uncharacterized LOC642441
hsa:101060698;;uncharacterized LOC101060698
hsa:101060345;;ankyrin repeat domain-containing protein 35-like
hsa:101060362;;neuroblastoma breakpoint family member 20-like
hsa:101060372;dimethylaniline monooxygenase [N-oxide-forming] 5-like
hsa:101060402;gap junction alpha-8 protein-like
hsa:101060409;;nucleoside diphosphate-linked moiety X motif 17-like
hsa:101060415;;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like
hsa:101060422;integrin alpha-10-like
hsa:101060431;E3 SUMO-protein ligase PIAS3-like
hsa:101060460;DNA-directed RNA polymerase III subunit RPC3-like
hsa:101060478;E3 ubiquitin-protein ligase RNF115-like
hsa:101060487;;ankyrin repeat domain-containing protein 34A-like
hsa:101060503;;thioredoxin-interacting protein-like
hsa:101060511;5'-AMP-activated protein kinase subunit beta-2-like
hsa:101060525;hemojuvelin-like
hsa:101060541;RNA-binding protein 8A-like
hsa:101060547;LIX1-like protein-like
hsa:101060555;DNA-directed RNA polymerase III subunit RPC7-like
hsa:101060561;;protein disulfide-isomerase A3-like
hsa:101060567;peroxisomal membrane protein 11B-like
hsa:101060582;;myomegalin-like
hsa:101060613;gap junction alpha-5 protein-like
hsa:101060623;;gonadotropin-releasing hormone II receptor-like
hsa:101060629;CD160 antigen-like
hsa:101060636;;Golgi pH regulator B-like
hsa:101060646;;neuroblastoma breakpoint family member 1-like
hsa:101060666;;uncharacterized LOC101060666
hsa:101060676;;uncharacterized LOC101060676
hsa:101060683;;neurogenic locus notch homolog protein 2-like
hsa:101060692;;neuroblastoma breakpoint family member 14-like
hsa:101060699;;hydrocephalus-inducing protein homolog
hsa:101060722;;uncharacterized LOC101060722
hsa:101060281;;vesicular, overexpressed in cancer, prosurvival protein 1-like
hsa:101060285;;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like
hsa:101060298;;neuroblastoma breakpoint family member 1-like
hsa:101060475;;D(1B) dopamine receptor-like
hsa:101060518;;peptidyl-prolyl cis-trans isomerase A-like 4A/B/C-like
hsa:101060524;;D(1B) dopamine receptor-like
hsa:101060531;;neuroblastoma breakpoint family member 21-like
hsa:101060562;;uncharacterized LOC101060562
hsa:101060568;;UPF0627 protein ENSP00000358171-like
hsa:101060579;;uncharacterized LOC101060579
hsa:101060590;;uncharacterized LOC101060590
hsa:101060595;;uncharacterized LOC101060595
hsa:101060601;;chromodomain-helicase-DNA-binding protein 1-like
hsa:101060684;;neuroblastoma breakpoint family member 20-like
hsa:101060700;;B-cell CLL/lymphoma 9 protein-like
hsa:101060704;lysophosphatidic acid phosphatase type 6-like
hsa:101060723;;peptidyl-prolyl cis-trans isomerase A-like 4G-like
hsa:101060247;;Golgi pH regulator B-like
hsa:101060260;;uncharacterized LOC101060260
hsa:101060268;;uncharacterized LOC101060268
hsa:101060270;;uncharacterized LOC101060270
hsa:101060291;myomegalin-like
hsa:101060344;;uncharacterized LOC101060344
hsa:101060353;;myomegalin-like
hsa:101060398;;uncharacterized LOC101060398
hsa:101060404;;uncharacterized LOC101060404
hsa:101060425;;UPF0627 protein ENSP00000358171-like
hsa:101060659;;uncharacterized LOC101060659
hsa:101060677;;uncharacterized LOC101060677
hsa:101060693;;uncharacterized LOC101060693
hsa:101060242;;uncharacterized LOC101060242
hsa:101060254;;myomegalin-like
hsa:101060261;;uncharacterized LOC101060261
hsa:101060302;;uncharacterized LOC101060302
hsa:101060315;;neurogenic locus notch homolog protein 2-like
hsa:101060626;;F-box only protein 25-like
hsa:101060657;;uncharacterized LOC101060657
hsa:101060385;;uncharacterized LOC101060385
hsa:101060391;;uncharacterized LOC101060391
hsa:101060423;;uncharacterized LOC101060423
hsa:101060545;ribose-5-phosphate isomerase-like
hsa:101060554;;ankyrin repeat domain-containing protein 36C-like
hsa:101060614;;MAL-like protein-like
hsa:101060667;;uncharacterized LOC101060667
hsa:101060710;;uncharacterized LOC101060710
hsa:101060091;;uncharacterized LOC101060091
hsa:653269;POTEI,POTE2beta;POTE ankyrin domain family, member I
hsa:101060673;;uncharacterized LOC101060673
hsa:101060680;;uncharacterized LOC101060680
hsa:101060571;;uncharacterized LOC101060571
hsa:642891;CHL1-AS2;CHL1 antisense RNA 2
hsa:440981;;phospholipid scramblase-like
hsa:646730;;uncharacterized LOC646730
hsa:101060650;;uncharacterized LOC101060650
hsa:101060498;;uncharacterized LOC101060498
hsa:101060314;;uncharacterized LOC101060314
hsa:101060397;;uncharacterized LOC101060397
hsa:101060375;;putative POM121-like protein 1-like
hsa:101060382;;putative POM121-like protein 1-like
hsa:101060439;;ras-related protein Rap-1b-like protein-like
hsa:101060516;;putative POM121-like protein 1-like
hsa:101060519;;putative beta-glucuronidase-like protein FLJ75429-like
hsa:101060527;;baculoviral IAP repeat-containing protein 1-like
hsa:101060534;;putative POM121-like protein 1-like
hsa:101060539;;putative POM121-like protein 1-like
hsa:101060558;;putative POM121-like protein 1-like
hsa:101060244;;uncharacterized LOC101060244
hsa:101060495;;uncharacterized LOC101060495
hsa:101060681;;tenascin-X-like
hsa:101060688;;uncharacterized LOC101060688
hsa:101060264;;uncharacterized LOC101060264
hsa:101060333;;uncharacterized LOC101060333
hsa:101060246;;putative uncharacterized protein KIF25-AS1-like
hsa:101060341;;uncharacterized LOC101060341
hsa:101060380;;putative uncharacterized protein FLJ46348-like
hsa:101060444;;uncharacterized LOC101060444
hsa:101060474;;putative uncharacterized protein FLJ46235-like
hsa:101060276;;uncharacterized LOC101060276
hsa:101060283;;putative speedy protein E8-like
hsa:402269;;equilibrative nucleoside transporter 4-like
hsa:101060496;;putative uncharacterized protein FLJ46348-like
hsa:101060599;;postmeiotic segregation increased 4-like protein-like
hsa:101060605;;postmeiotic segregation increased 4-like protein-like
hsa:101060622;;uncharacterized LOC101060622
hsa:101060628;;uncharacterized LOC101060628
hsa:101060689;;protein FAM115C-like
hsa:101060696;;cutaneous T-cell lymphoma-associated antigen 4-like
hsa:101060702;olfactory receptor 2A1/2A42-like
hsa:101060717;;uncharacterized LOC101060717
hsa:392843;IQCA1P1,IQCA1L,TCAG_9762;IQ motif containing with AAA domain 1 pseudogene 1
hsa:101060316;;rho guanine nucleotide exchange factor 5-like
hsa:101060307;;protein FAM87B-like
hsa:101060357;;uncharacterized LOC101060357
hsa:101060621;;putative protein FAM90A8P-like
hsa:101060627;;uncharacterized LOC101060627
hsa:101060654;;uncharacterized LOC101060654
hsa:101060662;;uncharacterized LOC101060662
hsa:101060540;;exonuclease GOR-like
hsa:101060371;;exonuclease GOR-like
hsa:101060445;;uncharacterized LOC101060445
hsa:101060591;;putative UPF0633 protein MGC21881-like
hsa:101060259;;protein FAM27D1-like
hsa:101060414;;uncharacterized LOC101060414
hsa:101060493;;uncharacterized LOC101060493
hsa:101060560;;forkhead box protein D4-like 6-like
hsa:101060578;;COBW domain-containing protein 5-like
hsa:101060641;;putative uncharacterized protein UNQ6494/PRO21346-like
hsa:101060446;;neuropeptide Y receptor type 4-like
hsa:101060462;;uncharacterized LOC101060462
hsa:101060467;;putative heterogeneous nuclear ribonucleoprotein A1-like 3-like
hsa:101060581;;arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like
hsa:101060675;;poly(ADP-ribose) glycohydrolase-like
hsa:101060691;;uncharacterized LOC101060691
hsa:101060609;;uncharacterized LOC101060609
hsa:101060625;;uncharacterized LOC101060625
hsa:101060719;;uncharacterized LOC101060719
hsa:101060277;;glycine N-acyltransferase-like protein 1-like
hsa:101060335;;protein RCC2-like
hsa:101060408;;glutaredoxin-like protein C5orf63-like
hsa:101060510;;60S ribosomal protein L31-like
hsa:101060670;;chitobiosyldiphosphodolichol beta-mannosyltransferase-like
hsa:101060262;;tripartite motif-containing protein 49-like protein 1-like
hsa:101060319;;uncharacterized LOC101060319
hsa:101060432;;uncharacterized LOC101060432
hsa:101060720;;uncharacterized LOC101060720
hsa:101060265;;ovostatin homolog 2-like
hsa:101060311;;probable ATP-dependent RNA helicase DDX11-like
hsa:101060443;;uncharacterized LOC101060443
hsa:101060427;;uncharacterized LOC101060427
hsa:101060453;;fatty acid-binding protein, epidermal-like
hsa:101060458;;peptidyl-prolyl cis-trans isomerase A-like
hsa:100996441;;uncharacterized protein LOC100996441
hsa:101060526;;uncharacterized LOC101060526
hsa:101060548;;uncharacterized LOC101060548
hsa:101060553;;uncharacterized LOC101060553
hsa:101060565;;uncharacterized LOC101060565
hsa:101060615;;uncharacterized LOC101060615
hsa:101060712;;uncharacterized LOC101060712
hsa:101060448;;putative neurofibromin 1-like protein 4/6-like
hsa:101060488;;uncharacterized LOC101060488
hsa:101060706;;uncharacterized LOC101060706
hsa:101060716;;POTE ankyrin domain family member B-like
hsa:81787;DKFZP547L112;uncharacterized protein DKFZp547L112
hsa:101060563;;uncharacterized LOC101060563
hsa:101060569;;U3 small nucleolar ribonucleoprotein protein MPP10-like
hsa:101060580;;uncharacterized LOC101060580
hsa:101060588;;uncharacterized LOC101060588
hsa:101060661;;uncharacterized LOC101060661
hsa:101060703;;uncharacterized LOC101060703
hsa:101060257;;uncharacterized LOC101060257
hsa:101060393;;nuclear pore complex-interacting protein-like 1-like
hsa:101060412;;nuclear pore complex-interacting protein-like
hsa:101060429;;polycystin-1-like
hsa:101060433;;pyridoxal-dependent decarboxylase domain-containing protein 1-like
hsa:100288162;;uncharacterized LOC100288162
hsa:101060497;;uncharacterized LOC101060497
hsa:101060521;DNA-directed RNA polymerase III subunit RPC5-like
hsa:101060557;;von Willebrand factor A domain-containing protein 3A-like
hsa:101060564;;nuclear pore complex-interacting protein-like 3-like
hsa:101060570;eukaryotic elongation factor 2 kinase-like
hsa:101060576;;putative NPIP-like protein LOC100132247-like
hsa:101060589;;serine/threonine-protein kinase SMG1-like
hsa:101060596;;serine/threonine-protein kinase SMG1-like
hsa:101060604;;putative L-type amino acid transporter 1-like protein IMAA-like
hsa:101060624;;uncharacterized LOC101060624
hsa:101060634;;uncharacterized LOC101060634
hsa:101060649;;uncharacterized LOC101060649
hsa:101060652;;uncharacterized LOC101060652
hsa:101060714;sulfotransferase 1A3/1A4-like
hsa:101060729;structure-specific endonuclease subunit SLX1-like
hsa:101060252;;bolA-like protein 2-like
hsa:101060275;;putative NPIP-like protein LOC100132247-like
hsa:101060350;;ectonucleotide pyrophosphatase/phosphodiesterase family member 7-like
hsa:101060360;;apolipophorins-like
hsa:101060373;;nodal modulator 1-like
hsa:101060386;;serine/threonine-protein kinase SMG1-like
hsa:101060394;;putative NPIP-like protein LOC100132247-like
hsa:101060399;;cerebellar degeneration-related protein 2-like
hsa:101060405;;RNA polymerase I-specific transcription initiation factor RRN3-like
hsa:101060410;;serine/threonine-protein kinase SMG1-like
hsa:101060416;;serine/threonine-protein kinase SMG1-like
hsa:101060424;;otoancorin-like
hsa:101060434;;NPIP-like protein LOC729602-like
hsa:101060449;;putative NPIP-like protein LOC613037-like
hsa:101060455;;serine/threonine-protein kinase SMG1-like
hsa:101060459;;uncharacterized LOC101060459
hsa:101060465;;putative NPIP-like protein LOC613037-like
hsa:400539;;FLJ27243 protein
hsa:101060253;;nuclear pore complex-interacting protein-like 2-like
hsa:101060480;;putative uncharacterized protein FLJ46089-like
hsa:101060544;;uncharacterized LOC101060544
hsa:101060546;;uncharacterized LOC101060546
hsa:101060607;;keratin, type I cytoskeletal 16-like
hsa:101060267;c-C motif chemokine 3-like
hsa:101060271;c-C motif chemokine 18-like
hsa:101060278;c-C motif chemokine 4-like
hsa:101060287;;TBC1 domain family member 3G-like
hsa:101060303;;TBC1 domain family member 3G-like
hsa:101060321;;TBC1 domain family member 3H-like
hsa:101060348;;puromycin-sensitive aminopeptidase-like protein-like
hsa:101060351;;TBC1 domain family member 3G-like
hsa:101060376;;TBC1 domain family member 3F-like
hsa:101060389;;TBC1 domain family member 3F-like
hsa:101060403;;TBC1 domain family member 3G-like
hsa:101060421;;TBC1 domain family member 3F-like
hsa:101060440;;TBC1 domain family member 3F-like
hsa:101060471;;puromycin-sensitive aminopeptidase-like protein-like
hsa:101060489;;TBC1 domain family member 3F-like
hsa:101060506;;TBC1 domain family member 3G-like
hsa:101060522;;puromycin-sensitive aminopeptidase-like protein-like
hsa:101060620;;c-Jun-amino-terminal kinase-interacting protein 1-like
hsa:646021;;uncharacterized LOC646021
hsa:101060367;;TBC1 domain family member 3H-like
hsa:339192;;uncharacterized LOC339192
hsa:101060400;;uncharacterized LOC101060400
hsa:101060406;;uncharacterized LOC101060406
hsa:101060457;;RNA polymerase II transcription factor SIII subunit A3-like
hsa:101060464;;RNA polymerase II transcription factor SIII subunit A3-like
hsa:101060468;;RNA polymerase II transcription factor SIII subunit A3-like
hsa:101060473;;uncharacterized LOC101060473
hsa:101060542;;uncharacterized LOC101060542
hsa:101060417;;zinc finger protein 486-like
hsa:388559;ZNF888;zinc finger protein 888
hsa:101060551;;uncharacterized LOC101060551
hsa:101060395;;uncharacterized LOC101060395
hsa:101060407;;uncharacterized LOC101060407
hsa:101060430;;putative uncharacterized protein encoded by LINC00205-like
hsa:101060483;;uncharacterized LOC101060483
hsa:101060466;;putative POM121-like protein 1-like
hsa:101060472;;breakpoint cluster region protein-like
hsa:101060682;;gamma-glutamyltranspeptidase 2-like
hsa:101060690;;uncharacterized LOC101060690
hsa:101060697;;uncharacterized LOC101060697
hsa:101060718;;uncharacterized LOC101060718
hsa:101060328;;uncharacterized LOC101060328
hsa:101060528;;uncharacterized LOC101060528
hsa:101060533;;uncharacterized LOC101060533
hsa:101060305;;testis-specific protein TEX28-like
hsa:101060317;;paraneoplastic antigen-like protein 6B-like
hsa:101060361;;mucin-16-like
hsa:101060411;;uncharacterized LOC101060411
hsa:101060508;;hemicentin-2-like
hsa:101060514;;dynein heavy chain 7, axonemal-like
hsa:101060574;;uncharacterized LOC101060574
hsa:101060651;;uncharacterized LOC101060651
hsa:51507;RTFDC1,C20orf43,CDAO5,HSPC164,SHUJUN-3;replication termination factor 2 domain containing 1
hsa:83598;LRRC2-AS1,LUZP3,LUZP3P,LUZPP1;LRRC2 antisense RNA 1
hsa:140893;RBBP8NL,C20orf151;RBBP8 N-terminal like
hsa:64343;AZI2,AZ2,NAP1,TILP;5-azacytidine induced 2
hsa:392196;;ubiquitin specific peptidase 17-like family member 2 pseudogene
hsa:389633;FAM90A25P;family with sequence similarity 90, member A7 pseudogene
hsa:619343;ERICH1-AS1,C8orf68;ERICH1 antisense RNA 1
hsa:390963;ZNF818P,ZNF818;zinc finger protein 818, pseudogene
hsa:414216;BMS1P2,BMS1LP2;BMS1 pseudogene 2
hsa:84210;ANKRD20A1,ANKRD20A;ankyrin repeat domain 20 family, member A1
hsa:10485;C1orf61,CROC4;chromosome 1 open reading frame 61
hsa:253725;FAM21C,FAM21A,VPEF;family with sequence similarity 21, member C
hsa:374666;WASH3P,FAM39DP;WAS protein family homolog 3 pseudogene
hsa:5387;PMS2P3,PMS2L3,PMS2L9,PMS5,PMSR3;postmeiotic segregation increased 2 pseudogene 3
hsa:414927;MGC34796;sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase) pseudogene
hsa:1620;DBC1,BRINP1,DBCCR1,FAM5A;deleted in bladder cancer 1
hsa:29982;NRBF2,COPR1,COPR2,NRBF-2;nuclear receptor binding factor 2
hsa:440243;;putative golgin subfamily A member 6-like
hsa:347454;SOWAHD,ANKRD58;sosondowah ankyrin repeat domain family member D
hsa:8537;BCAS1,AIBC1,NABC1;breast carcinoma amplified sequence 1
hsa:375791;C9orf169;chromosome 9 open reading frame 169
hsa:136242;PRSS37,TRYX2;protease, serine, 37
hsa:22798;LAMB4;laminin, beta 4
hsa:57644;MYH7B,MHC14,MYH14;myosin, heavy chain 7B, cardiac muscle, beta
hsa:389337;ARHGEF37;Rho guanine nucleotide exchange factor (GEF) 37
hsa:100191040;C2CD4D,FAM148D;C2 calcium-dependent domain containing 4D
hsa:53942;CNTN5,HNB-2s,NB-2;contactin 5
hsa:80003;PCNXL2;pecanex-like 2 (Drosophila)
hsa:387733;IFITM5,BRIL,DSPA1,Hrmp1,OI5,fragilis4;interferon induced transmembrane protein 5
hsa:340120;ANKRD34B,DP58;ankyrin repeat domain 34B
hsa:5662;PSD,EFA6,EFA6A,PSD1,TYL;pleckstrin and Sec7 domain containing
hsa:164045;HFM1,MER3,RP11-539G11.1,SEC63D1,Si-11,Si-11-6,helicase;HFM1, ATP-dependent DNA helicase homolog (S. cerevisiae) (EC:3.6.4.12)
hsa:128025;WDR64;WD repeat domain 64
hsa:341880;SLC35F4,C14orf36,c14_5373;solute carrier family 35, member F4
hsa:64005;MYO1G,HA2,MHAG;myosin IG
hsa:100130988;C7orf72;chromosome 7 open reading frame 72
hsa:256957;C17orf66;chromosome 17 open reading frame 66
hsa:389676;C8orf87;chromosome 8 open reading frame 87
hsa:400120;SERTM1,C13orf36;serine-rich and transmembrane domain containing 1
hsa:79658;ARHGAP10,GRAF2,PS-GAP,PSGAP;Rho GTPase activating protein 10
hsa:90342;FER1L5;fer-1-like 5 (C. elegans)
hsa:143872;ARHGAP42,GRAF3;Rho GTPase activating protein 42
hsa:343263;MYBPHL;myosin binding protein H-like
hsa:9884;LRRC37A;leucine rich repeat containing 37A
hsa:84626;KRBA1;KRAB-A domain containing 1
hsa:441272;SPDYE3;speedy homolog E3 (Xenopus laevis)
hsa:254439;C11orf86;chromosome 11 open reading frame 86
hsa:474170;LRRC37A2;leucine rich repeat containing 37, member A2
hsa:92806;CENPBD1;CENPB DNA-binding domains containing 1
hsa:400823;FAM177B;family with sequence similarity 177, member B
hsa:387787;LIPT2;lipoyl(octanoyl) transferase 2 (putative) (EC:2.3.1.181)
hsa:54852;PAQR5,MPRG;progestin and adipoQ receptor family member V
hsa:440836;ODF3B,ODF3L3;outer dense fiber of sperm tails 3B
hsa:403284;OR6C68;olfactory receptor, family 6, subfamily C, member 68
hsa:440295;GOLGA6L9;golgin A6 family-like 9
hsa:55236;UBA6,E1-L2,MOP-4,UBE1L2;ubiquitin-like modifier activating enzyme 6
hsa:84455;EFCAB7,RP4-534K7.1;EF-hand calcium binding domain 7
hsa:285331;CCDC66;coiled-coil domain containing 66
hsa:84465;MEGF11;multiple EGF-like-domains 11
hsa:54103;PION,GSAP;pigeon homolog (Drosophila)
hsa:389177;TMEM212;transmembrane protein 212
hsa:29062;WDR91;WD repeat domain 91
hsa:115948;CCDC151;coiled-coil domain containing 151
hsa:401409;RAB19,RAB19B;RAB19, member RAS oncogene family
hsa:64591;TSPY2,TSPYQ1;testis specific protein, Y-linked 2
hsa:440087;SMCO3,C12orf69;single-pass membrane protein with coiled-coil domains 3
hsa:137392;FAM92A1;family with sequence similarity 92, member A1
hsa:92196;DAPL1;death associated protein-like 1
hsa:256643;CXorf23;chromosome X open reading frame 23
hsa:55814;BDP1,HSA238520,TAF3B1,TFC5,TFIIIB'',TFIIIB150,TFIIIB90,TFNR;B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB
hsa:144568;A2ML1,CPAMD9;alpha-2-macroglobulin-like 1
hsa:124599;CD300LB,CD300b,CLM-7,CLM7,CMRF35-A2,IREM-3,IREM3,TREM-5,TREM5;CD300 molecule-like family member b
hsa:90835;C16orf93;chromosome 16 open reading frame 93
hsa:130074;FAM168B,MANI;family with sequence similarity 168, member B
hsa:23240;TMEM131L;KIAA0922
hsa:2765;GML,LY6DL;glycosylphosphatidylinositol anchored molecule like
hsa:441081;;POM121 membrane glycoprotein (rat) pseudogene
hsa:9470;EIF4E2,4E-LP,4EHP,EIF4EL3,IF4e;eukaryotic translation initiation factor 4E family member 2
hsa:9338;TCEAL1,SIIR,p21,pp21;transcription elongation factor A (SII)-like 1
hsa:6757;SSX2,CT5.2a,HD21,HOM-MEL-40,SSX;synovial sarcoma, X breakpoint 2
hsa:28959;TMEM176B,LR8;transmembrane protein 176B
hsa:9465;AKAP7,AKAP15,AKAP18;A kinase (PRKA) anchor protein 7
hsa:285704;RGMB,DRAGON;RGM domain family, member B
hsa:9592;IER2,ETR101;immediate early response 2
hsa:10228;STX6;syntaxin 6
hsa:407019;MIR27B,MIR-27b,MIRN27B,miRNA27B;microRNA 27b
hsa:693210;MIR625,MIRN625,hsa-mir-625;microRNA 625
hsa:494330;MIR381,MIRN381,hsa-mir-381;microRNA 381
hsa:407017;MIR26B,MIRN26B,hsa-mir-26b,miR-26b;microRNA 26b
hsa:407048;MIR92A1,MIR92-1,MIRN92-1,MIRN92A-1,MIRN92A1,miRNA92-1;microRNA 92a-1
hsa:574447;MIR146B,MIRN146B,miRNA146B;microRNA 146b
hsa:407052;MIR95,MIRN95,hsa-mir-95,miR-95;microRNA 95
hsa:100126354;MIR297,MIRN297,hsa-mir-297;microRNA 297
hsa:100507582;BHLHE40-AS1;BHLHE40 antisense RNA 1
hsa:441155;;zinc finger CCCH-type domain-containing-like
hsa:100126296;MIR298,MIRN298,hsa-mir-298;microRNA 298
hsa:55194;EVA1B,C1orf78,FAM176B,RP11-268J15.2;eva-1 homolog B (C. elegans)
hsa:84141;EVA1A,FAM176A,TMEM166;eva-1 homolog A (C. elegans)
hsa:399665;FAM102A,C9orf132,EEIG1,SYM-3A,bA203J24.7;family with sequence similarity 102, member A
hsa:441733;PRKXP1;protein kinase, X-linked, pseudogene 1
hsa:402415;XKRX,XKR2,XPLAC,XRG2;XK, Kell blood group complex subunit-related, X-linked
hsa:85315;PAQR8,C6orf33,LMPB1,MPRB;progestin and adipoQ receptor family member VIII
hsa:449491;DEFA8P,DEFAP1;defensin, alpha 8 pseudogene
hsa:449492;DEFA9P,DEFAP2;defensin, alpha 9 pseudogene
hsa:729252;KRT16P1,KRT14P,KRT16P;keratin 16 pseudogene 1
hsa:574029;DUSP5P1,DUSP5P,RP4-621O15.2;dual specificity phosphatase 5 pseudogene 1
hsa:724068;DEFA11P,DEFAP3;defensin, alpha 11 pseudogene
hsa:161159;ACTN1-AS1,C14orf84;ACTN1 antisense RNA 1
hsa:643955;ZNF733P,ZNF733;zinc finger protein 733, pseudogene
hsa:440944;SETD5-AS1,THUMPD3-AS1;SETD5 antisense RNA 1
hsa:100288428;LMCD1-AS1;LMCD1 antisense RNA 1 (head to head)
hsa:114796;PSMG3-AS1;PSMG3 antisense RNA 1 (head to head)
hsa:81854;ZNF205-AS1;ZNF205 antisense RNA 1
hsa:100616356;MIR4774;microRNA 4774
hsa:100507500;EGFR-AS1;EGFR antisense RNA 1
hsa:220906;WAC-AS1;WAC antisense RNA 1 (head to head)
hsa:1587;ADAM3A,ADAM3,CYRN1,tMDCI;ADAM metallopeptidase domain 3A (pseudogene)
hsa:219347;TMEM254-AS1;TMEM254 antisense RNA 1
hsa:145663;GATM-AS1;GATM antisense RNA 1
hsa:202020;TAPT1-AS1;TAPT1 antisense RNA 1 (head to head)
hsa:197187;SNAI3-AS1;SNAI3 antisense RNA 1
hsa:154822;LINC00689;long intergenic non-protein coding RNA 689
hsa:8688;KRT37,HA7,K37,KRTHA7;keratin 37
hsa:50831;TAS2R3,T2R3;taste receptor, type 2, member 3
hsa:10390;CEPT1;choline/ethanolamine phosphotransferase 1 (EC:2.7.8.2 2.7.8.1)
hsa:1038;CDR1,CDR,CDR34,CDR62A;cerebellar degeneration-related protein 1, 34kDa
hsa:30012;TLX3,HOX11L2,RNX;T-cell leukemia homeobox 3
hsa:55520;ELAC1,D29;elaC homolog 1 (E. coli) (EC:3.1.26.11)
hsa:10632;ATP5L,ATP5JG;ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G (EC:3.6.1.14)
hsa:9240;PNMA1,MA1;paraneoplastic Ma antigen 1
hsa:254122;SNX32,SNX6B;sorting nexin 32
hsa:25871;C3orf17,NET17;chromosome 3 open reading frame 17
hsa:128061;C1orf131;chromosome 1 open reading frame 131
hsa:130502;TTC32;tetratricopeptide repeat domain 32
hsa:8399;PLA2G10,GXPLA2,GXSPLA2,SPLA2;phospholipase A2, group X (EC:3.1.1.4)
hsa:1665;DHX15,DBP1,DDX15,HRH2,PRP43,PRPF43,PrPp43p;DEAH (Asp-Glu-Ala-His) box polypeptide 15 (EC:3.6.4.13)
hsa:197258;FUK,1110046B12Rik;fucokinase (EC:2.7.1.52)
hsa:121551;BTBD11;BTB (POZ) domain containing 11
hsa:10190;TXNDC9,APACD,PHLP3;thioredoxin domain containing 9
hsa:83935;TMEM133;transmembrane protein 133
hsa:6769;STAC,STAC1;SH3 and cysteine rich domain
hsa:386682;KRTAP10-3,KAP10.3,KAP18-3,KAP18.3,KRTAP10.3,KRTAP18-3,KRTAP18.3;keratin associated protein 10-3
hsa:386680;KRTAP10-5,KAP10.5,KAP18-5,KAP18.5,KRTAP10.5,KRTAP18-5,KRTAP18.1,KRTAP18.5;keratin associated protein 10-5
hsa:157724;SLC7A13,AGT-1,AGT1,XAT2;solute carrier family 7 (anionic amino acid transporter), member 13
hsa:23140;ZZEF1,ZZZ4;zinc finger, ZZ-type with EF-hand domain 1
hsa:5822;PWP2,EHOC-17,PWP2H,UTP1;PWP2 periodic tryptophan protein homolog (yeast)
hsa:284355;TPRX1,TPRX;tetra-peptide repeat homeobox 1
hsa:27112;FAM155B,CXorf63,TED,TMEM28,bB57D9.1;family with sequence similarity 155, member B
hsa:10004;NAALADL1,I100,NAALADASEL;N-acetylated alpha-linked acidic dipeptidase-like 1 (EC:3.4.17.21)
hsa:9639;ARHGEF10,GEF10;Rho guanine nucleotide exchange factor (GEF) 10
hsa:56903;PAPOLB,PAPT,TPAP;poly(A) polymerase beta (testis specific) (EC:2.7.7.19)
hsa:22977;AKR7A3,AFAR2;aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)
hsa:50833;TAS2R16,T2R16;taste receptor, type 2, member 16
hsa:84569;LYZL1,KAAG648,LYC2,PRO1278,bA534G20.1;lysozyme-like 1 (EC:3.2.1.17)
hsa:7813;EVI5,NB4S;ecotropic viral integration site 5
hsa:4857;NOVA1,Nova-1;neuro-oncological ventral antigen 1
hsa:55700;MAP7D1,PARCC1,RPRC1;MAP7 domain containing 1
hsa:200879;LIPH,AH,ARWH2,LAH2,LPDLR,PLA1B,mPA-PLA1;lipase, member H (EC:2.7.11.30)
hsa:5042;PABPC3,PABP3,PABPL3,tPABP;poly(A) binding protein, cytoplasmic 3
hsa:142684;RAB40A,RAR2,RAR2A;RAB40A, member RAS oncogene family
hsa:79870;BAALC;brain and acute leukemia, cytoplasmic
hsa:90313;TP53I13,DSCP1;tumor protein p53 inducible protein 13
hsa:83401;ELOVL3,CIG-30,CIG30;ELOVL fatty acid elongase 3 (EC:2.3.1.199)
hsa:245802;MS4A6E;membrane-spanning 4-domains, subfamily A, member 6E
hsa:56926;NCLN,NET59;nicalin
hsa:51334;PRR16,DSC54;proline rich 16
hsa:3743;KCNA7,HAK6,KV1.7;potassium voltage-gated channel, shaker-related subfamily, member 7
hsa:23753;SDF2L1;stromal cell-derived factor 2-like 1
hsa:10534;SSSCA1,p27;Sjogren syndrome/scleroderma autoantigen 1
hsa:79833;GEMIN6;gem (nuclear organelle) associated protein 6
hsa:9450;LY86,MD-1,MMD-1,dJ80N2.1;lymphocyte antigen 86
hsa:55608;ANKRD10;ankyrin repeat domain 10
hsa:84239;ATP13A4;ATPase type 13A4 (EC:3.6.3.-)
hsa:147463;ANKRD29;ankyrin repeat domain 29
hsa:10766;TOB2,TOB4,TOBL,TROB2;transducer of ERBB2, 2
hsa:3656;IRAK2,IRAK-2;interleukin-1 receptor-associated kinase 2
hsa:2806;GOT2,KAT4,KATIV,mitAAT;glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) (EC:2.6.1.1 2.6.1.7)
hsa:80021;TMEM62;transmembrane protein 62
hsa:148398;SAMD11;sterile alpha motif domain containing 11
hsa:55567;DNAH3,DLP3,DNAHC3B,Hsadhc3;dynein, axonemal, heavy chain 3
hsa:1089;CEACAM4,CGM7,CGM7_HUMAN,NCA;carcinoembryonic antigen-related cell adhesion molecule 4
hsa:8444;DYRK3,DYRK5,RED,REDK,hYAK3-2;dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 (EC:2.7.12.1)
hsa:10799;RPP40,RNASEP1,bA428J1.3;ribonuclease P/MRP 40kDa subunit (EC:3.1.26.5)
hsa:164153;UBL4B;ubiquitin-like 4B
hsa:81488;POLR2M,GCOM1,GRINL1A,Gdown,Gdown1;polymerase (RNA) II (DNA directed) polypeptide M
hsa:92255;LMBRD2;LMBR1 domain containing 2
hsa:57595;PDZD4,LU1,PDZK4,PDZRN4L;PDZ domain containing 4
hsa:91298;C12orf29;chromosome 12 open reading frame 29
hsa:126147;NTN5;netrin 5
hsa:7348;UPK1B,TSPAN20,UPIB,UPK1;uroplakin 1B
hsa:146562;C16orf71;chromosome 16 open reading frame 71
hsa:84135;UTP15,NET21;UTP15, U3 small nucleolar ribonucleoprotein, homolog (S. cerevisiae)
hsa:3950;LECT2,chm-II,chm2;leukocyte cell-derived chemotaxin 2
hsa:8487;GEMIN2,SIP1,SIP1-delta;gem (nuclear organelle) associated protein 2
hsa:10992;SF3B2,Cus1,SAP145,SF3B145,SF3b1,SF3b150;splicing factor 3b, subunit 2, 145kDa
hsa:10761;PLAC1,CT92;placenta-specific 1
hsa:23560;GTPBP4,CRFG,NGB,NOG1;GTP binding protein 4
hsa:55003;PAK1IP1,MAK11,PIP1,RP11-421M1.5,WDR84,bA421M1.5,hPIP1;PAK1 interacting protein 1
hsa:770;CA11,CARPX1;carbonic anhydrase XI
hsa:9064;MAP3K6,ASK2,MAPKKK6,MEKK6;mitogen-activated protein kinase kinase kinase 6 (EC:2.7.11.25)
hsa:56850;GRIPAP1,GRASP-1;GRIP1 associated protein 1
hsa:26609;VCX,VCX-10r,VCX-B1,VCX1,VCX10R,VCXB1;variable charge, X-linked
hsa:5121;PCP4,PEP-19;Purkinje cell protein 4
hsa:4664;NAB1;NGFI-A binding protein 1 (EGR1 binding protein 1)
hsa:8712;PAGE1,AL5,CT16.3,GAGE-9,GAGEB1,PAGE-1;P antigen family, member 1 (prostate associated)
hsa:9760;TOX,TOX1;thymocyte selection-associated high mobility group box
hsa:55137;FIGN;fidgetin
hsa:1448;CSN3,CSN10,CSNK,KCA;casein kappa
hsa:202243;CCDC125,KENAE;coiled-coil domain containing 125
hsa:57478;USP31;ubiquitin specific peptidase 31 (EC:3.4.19.12)
hsa:79575;ABHD8;abhydrolase domain containing 8
hsa:132320;SCLT1,CAP-1A,CAP1A,hCAP-1A;sodium channel and clathrin linker 1
hsa:92370;ACPL2;acid phosphatase-like 2 (EC:3.1.3.2)
hsa:158293;FAM120AOS,C9orf10OS;family with sequence similarity 120A opposite strand
hsa:9543;IGDCC3,HsT18880,PUNC;immunoglobulin superfamily, DCC subclass, member 3
hsa:203102;ADAM32;ADAM metallopeptidase domain 32
hsa:22802;CLCA4,CaCC,CaCC2;chloride channel accessory 4
hsa:9749;PHACTR2,C6orf56;phosphatase and actin regulator 2
hsa:386618;KCTD4,bA321C24.3;potassium channel tetramerisation domain containing 4
hsa:441490;FTH1P18,FTHL18;ferritin, heavy polypeptide 1 pseudogene 18
hsa:79153;GDPD3;glycerophosphodiester phosphodiesterase domain containing 3
hsa:23120;ATP10B,ATPVB;ATPase, class V, type 10B (EC:3.6.3.1)
hsa:23539;SLC16A8,MCT3,REMP;solute carrier family 16, member 8 (monocarboxylic acid transporter 3)
hsa:283897;C16orf54;chromosome 16 open reading frame 54
hsa:388951;TSPYL6;TSPY-like 6
hsa:137868;SGCZ,ZSG1;sarcoglycan, zeta
hsa:64711;HS3ST6,HS3ST5;heparan sulfate (glucosamine) 3-O-sulfotransferase 6 (EC:2.8.2.23)
hsa:84698;CAPS2;calcyphosine 2
hsa:56965;PARP6,ARTD17,PARP-6-B1,PARP-6-C,pART17;poly (ADP-ribose) polymerase family, member 6 (EC:2.4.2.30)
hsa:55138;FAM90A1;family with sequence similarity 90, member A1
hsa:389336;C5orf46;chromosome 5 open reading frame 46
hsa:83851;SYT16,CHR14SYT,SYT14L,Strep14,syt14r,yt14r;synaptotagmin XVI
hsa:115708;TRMT61A,C14orf172,GCD14,Gcd14p,TRM61,hTRM61;tRNA methyltransferase 61 homolog A (S. cerevisiae) (EC:2.1.1.220)
hsa:6568;SLC17A1,NAPI-1,NPT-1,NPT1;solute carrier family 17 (sodium phosphate), member 1
hsa:54969;C4orf27;chromosome 4 open reading frame 27
hsa:10106;CTDSP2,OS4,PSR2,SCP2;CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 (EC:3.1.3.16)
hsa:339779;C2orf53;chromosome 2 open reading frame 53
hsa:4300;MLLT3,AF9,YEATS3;myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila);translocated to, 3
hsa:285525;YIPF7,FinGER9;Yip1 domain family, member 7
hsa:84752;B3GNT9;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9
hsa:401562;LCNL1;lipocalin-like 1
hsa:201965;RWDD4,FAM28A,RWDD4A;RWD domain containing 4
hsa:140775;SMCR8;Smith-Magenis syndrome chromosome region, candidate 8
hsa:9389;SLC22A14,OCTL2,OCTL4,ORCTL4;solute carrier family 22, member 14
hsa:159195;USP54,C10orf29,bA137L10.3,bA137L10.4;ubiquitin specific peptidase 54
hsa:139135;PASD1,CT63,OXTES1;PAS domain containing 1
hsa:84658;EMR3;egf-like module containing, mucin-like, hormone receptor-like 3
hsa:339175;METTL2A,METTL2;methyltransferase like 2A
hsa:251;ALPPL2,ALPG,ALPPL,GCAP;alkaline phosphatase, placental-like 2 (EC:3.1.3.1)
hsa:729759;OR4F29,OR7-21;olfactory receptor, family 4, subfamily F, member 29
hsa:222008;VSTM2A,VSTM2;V-set and transmembrane domain containing 2A
hsa:386681;KRTAP10-8,KAP10.8,KRTAP18-8,KRTAP18.8;keratin associated protein 10-8
hsa:57830;KRTAP5-8,KRTAP5-2,KRTAP5.8,UHSKerB;keratin associated protein 5-8
hsa:91749;MFSD4B,NaGLT1;KIAA1919
hsa:6534;SLC6A7,PROT;solute carrier family 6 (neurotransmitter transporter, L-proline), member 7
hsa:51560;RAB6B;RAB6B, member RAS oncogene family
hsa:64427;TTC31;tetratricopeptide repeat domain 31
hsa:165545;DQX1;DEAQ box RNA-dependent ATPase 1 (EC:3.6.4.12)
hsa:55150;C19orf73;chromosome 19 open reading frame 73
hsa:55039;TRMT12,TRM12,TYW2;tRNA methyltransferase 12 homolog (S. cerevisiae)
hsa:53345;TM6SF2;transmembrane 6 superfamily member 2
hsa:132332;TMEM155;transmembrane protein 155
hsa:55002;TMCO3,C13orf11;transmembrane and coiled-coil domains 3
hsa:27076;LYPD3,C4.4A;LY6/PLAUR domain containing 3
hsa:286256;LCN12;lipocalin 12
hsa:1770;DNAH9,DNAH17L,DNEL1,DYH9,Dnahc9,HL-20,HL20;dynein, axonemal, heavy chain 9
hsa:121053;C12orf45;chromosome 12 open reading frame 45
hsa:389792;IER5L,bA247A12.2;immediate early response 5-like
hsa:8666;EIF3G,EIF3-P42,EIF3S4,eIF3-delta,eIF3-p44;eukaryotic translation initiation factor 3, subunit G
hsa:6839;SUV39H1,KMT1A,MG44,SUV39H;suppressor of variegation 3-9 homolog 1 (Drosophila) (EC:2.1.1.43)
hsa:84520;C14orf142,PNAS-127;chromosome 14 open reading frame 142
hsa:401498;TMEM215;transmembrane protein 215
hsa:121643;FOXN4;forkhead box N4
hsa:2124;EVI2B,CD361,D17S376,EVDB;ecotropic viral integration site 2B
hsa:259295;TAS2R20,T2R20,T2R49,T2R56,TAS2R49;taste receptor, type 2, member 20
hsa:417;ART1,ART2,ARTC1,CD296,RT6;ADP-ribosyltransferase 1 (EC:2.4.2.31)
hsa:10745;PHTF1,PHTF;putative homeodomain transcription factor 1
hsa:144453;BEST3,VMD2L3;bestrophin 3
hsa:285464;CRIPAK;cysteine-rich PAK1 inhibitor
hsa:9329;GTF3C4,KAT12,TFIII90,TFIIIC290,TFIIIC90,TFIIICDELTA;general transcription factor IIIC, polypeptide 4, 90kDa (EC:2.3.1.48)
hsa:54876;DCAF16,C4orf30;DDB1 and CUL4 associated factor 16
hsa:345062;PRSS48,ESSPL;protease, serine, 48 (EC:3.4.21.-)
hsa:503497;MS4A13;membrane-spanning 4-domains, subfamily A, member 13
hsa:150165;XKR3,XRG3,XTES;XK, Kell blood group complex subunit-related family, member 3
hsa:153478;PLEKHG4B;pleckstrin homology domain containing, family G (with RhoGef domain) member 4B
hsa:387601;SLC22A25,HIMTP,UST6;solute carrier family 22, member 25
hsa:408263;FNDC9,C5orf40;fibronectin type III domain containing 9
hsa:116285;ACSM1,BUCS1,MACS1;acyl-CoA synthetase medium-chain family member 1 (EC:6.2.1.2)
hsa:440097;DBX2;developing brain homeobox 2
hsa:3846;KRTAP5-9,KRN1,KRTAP5-1,KRTAP5.9;keratin associated protein 5-9
hsa:84734;FAM167B,C1orf90;family with sequence similarity 167, member B
hsa:285596;FAM153A,NY-REN-7;family with sequence similarity 153, member A
hsa:9567;GTPBP1,GP-1,GP1,HSPC018;GTP binding protein 1
hsa:79762;C1orf115,RP11-322F10.4;chromosome 1 open reading frame 115
hsa:55785;FGD6,ZFYVE24;FYVE, RhoGEF and PH domain containing 6
hsa:339512;C1orf110;chromosome 1 open reading frame 110
hsa:54893;MTMR10;myotubularin related protein 10
hsa:56063;TMEM234,AASL548,C1orf91,PRO1105,RP4-622L5,dJ622L5.7;transmembrane protein 234
hsa:139818;DOCK11,ACG,ZIZ2,bB128O4.1;dedicator of cytokinesis 11
hsa:160518;DENND5B;DENN/MADD domain containing 5B
hsa:388115;C15orf52;chromosome 15 open reading frame 52
hsa:64788;LMF1,C16orf26,HMFN1876,JFP11,TMEM112,TMEM112A;lipase maturation factor 1
hsa:550631;CCDC157;coiled-coil domain containing 157
hsa:196441;ZFC3H1,CCDC131,PSRC2;zinc finger, C3H1-type containing
hsa:402055;SRRD,HC/HCC,SRR1L;SRR1 domain containing
hsa:389383;CLPSL2,C6orf126,UNQ3045,dJ510O8.5;colipase-like 2
hsa:155184;SLC2A7,GLUT7;solute carrier family 2 (facilitated glucose transporter), member 7
hsa:197335;WDR90,C16orf15,C16orf16,C16orf17,C16orf18,C16orf19;WD repeat domain 90
hsa:51018;RRP15,KIAA0507;ribosomal RNA processing 15 homolog (S. cerevisiae)
hsa:55153;SDAD1;SDA1 domain containing 1
hsa:25907;TMEM158,BBP,RIS1,p40BBP;transmembrane protein 158 (gene/pseudogene)
hsa:55246;CCDC25;coiled-coil domain containing 25
hsa:84182;FAM188B,C7orf67;family with sequence similarity 188, member B
hsa:259287;TAS2R41,T2R41,T2R59;taste receptor, type 2, member 41
hsa:90019;SYT8;synaptotagmin VIII
hsa:5714;PSMD8,HIP6,HYPF,Nin1p,Rpn12,S14,p31;proteasome (prosome, macropain) 26S subunit, non-ATPase, 8
hsa:55040;EPN3;epsin 3
hsa:55751;TMEM184C,TMEM34;transmembrane protein 184C
hsa:25834;MGAT4C,GNTIVH,HGNT-IV-H;mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) (EC:2.4.1.145)
hsa:956;ENTPD3,CD39L3,HB6,NTPDase-3;ectonucleoside triphosphate diphosphohydrolase 3 (EC:3.6.1.5)
hsa:9119;KRT75,K6HF,KB18,PFB;keratin 75
hsa:120793;OR56A4,OR11-49;olfactory receptor, family 56, subfamily A, member 4
hsa:285282;RABL3;RAB, member of RAS oncogene family-like 3
hsa:7479;WNT8B;wingless-type MMTV integration site family, member 8B
hsa:3886;KRT35,HA5,Ha-5,KRTHA5,hHa5;keratin 35
hsa:199675;C19orf59,MCEMP1;chromosome 19 open reading frame 59
hsa:386674;KRTAP10-6,KAP10.6,KAP18.6,KRTAP18-6,KRTAP18.6;keratin associated protein 10-6
hsa:126248;WDR88,PQWD;WD repeat domain 88
hsa:54466;SPIN2A,DXF34,RP3-323P24.2,SPIN2,dJ323P24.1;spindlin family, member 2A
hsa:50617;ATP6V0A4,A4,ATP6N1B,ATP6N2,RDRTA2,RTA1C,RTADR,STV1,VPH1,VPP2;ATPase, H+ transporting, lysosomal V0 subunit a4 (EC:3.6.3.14)
hsa:146853;C17orf50;chromosome 17 open reading frame 50
hsa:285513;GPRIN3,GRIN3;GPRIN family member 3
hsa:89932;PAPLN;papilin, proteoglycan-like sulfated glycoprotein
hsa:144577;C12orf66;chromosome 12 open reading frame 66
hsa:23116;FAM179B,KIAA0423;family with sequence similarity 179, member B
hsa:79939;SLC35E1;solute carrier family 35, member E1
hsa:143684;FAM76B;family with sequence similarity 76, member B
hsa:117532;TMC2,C20orf145,dJ686C3.3;transmembrane channel-like 2
hsa:122616;C14orf79;chromosome 14 open reading frame 79
hsa:150737;TTC30B,IFT70,fleer;tetratricopeptide repeat domain 30B
hsa:85462;FHDC1;FH2 domain containing 1
hsa:286319;TUSC1,TSG-9,TSG9;tumor suppressor candidate 1
hsa:166378;SPATA5,AFG2,SPAF;spermatogenesis associated 5
hsa:284339;TMEM145;transmembrane protein 145
hsa:79269;DCAF10,WDR32;DDB1 and CUL4 associated factor 10
hsa:65987;KCTD14;potassium channel tetramerisation domain containing 14
hsa:27288;RBMXL2,HNRNPG-T,HNRNPGT,HNRPGT;RNA binding motif protein, X-linked-like 2
hsa:5286;PIK3C2A,CPK,PI3-K-C2(ALPHA),PI3-K-C2A;phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha (EC:2.7.1.154)
hsa:22826;DNAJC8,HSPC331,SPF31;DnaJ (Hsp40) homolog, subfamily C, member 8
hsa:114787;GPRIN1,GRIN1;G protein regulated inducer of neurite outgrowth 1
hsa:9882;TBC1D4,AS160;TBC1 domain family, member 4
hsa:85442;KNDC1,C10orf23,RASGEF2,bB439H18.3;kinase non-catalytic C-lobe domain (KIND) containing 1
hsa:10827;FAM114A2,133K02,C5orf3;family with sequence similarity 114, member A2
hsa:6953;TCP10,TCP10A;t-complex 10
hsa:159963;SLC5A12,SMCT2;solute carrier family 5 (sodium/glucose cotransporter), member 12
hsa:29765;TMOD4,SK-TMOD;tropomodulin 4 (muscle)
hsa:168090;C6orf118,bA85G2.1,dJ416F21.2;chromosome 6 open reading frame 118
hsa:84220;RGPD5,BS-63,BS63,RGP5;RANBP2-like and GRIP domain containing 5
hsa:728635;DHRS4L1,SDR25C4;dehydrogenase/reductase (SDR family) member 4 like 1
hsa:339768;ESPNL;espin-like
hsa:79828;METTL8,TIP;methyltransferase like 8
hsa:51340;CRNKL1,CLF,CRN,Clf1,HCRN,MSTP021,SYF3;crooked neck pre-mRNA splicing factor-like 1 (Drosophila)
hsa:8608;RDH16,RODH-4,SDR9C8;retinol dehydrogenase 16 (all-trans)
hsa:29902;FAM216A,C12orf24,HSU79274;family with sequence similarity 216, member A
hsa:160140;C11orf65;chromosome 11 open reading frame 65
hsa:27023;FOXB1,FKH5,HFKH-5;forkhead box B1
hsa:123591;C15orf27;chromosome 15 open reading frame 27
hsa:285093;CXXC11,C2orf85;CXXC finger protein 11
hsa:54868;TMEM104;transmembrane protein 104
hsa:149499;LRRC71,C1orf92,RP11-356J7.1;leucine rich repeat containing 71
hsa:79742;CXorf36,4930578C19Rik,DIA1R,EPQL1862,PRO3743,bA435K1.1;chromosome X open reading frame 36
hsa:388886;FAM211B,C22orf36;family with sequence similarity 211, member B
hsa:122618;PLD4,C14orf175;phospholipase D family, member 4 (EC:3.1.4.4)
hsa:10380;BPNT1,PIP;3'(2'), 5'-bisphosphate nucleotidase 1 (EC:3.1.3.7)
hsa:142685;ASB15;ankyrin repeat and SOCS box containing 15
hsa:2996;GYPE,GPE,MNS,MiIX;glycophorin E (MNS blood group)
hsa:135458;HUS1B,RP11-532F6.1;HUS1 checkpoint homolog b (S. pombe)
hsa:4814;NINJ1,NIN1,NINJURIN;ninjurin 1
hsa:81616;ACSBG2,BGR,BRGL,PRTD-NY3,PRTDNY3;acyl-CoA synthetase bubblegum family member 2 (EC:6.2.1.3)
hsa:22891;ZNF365,Su48,UAN,ZNF365D;zinc finger protein 365
hsa:114990;VASN,SLITL2;vasorin
hsa:25840;METTL7A,AAM-B;methyltransferase like 7A
hsa:138474;TAF1L,TAF2A2;TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 210kDa-like
hsa:337968;KRTAP6-3,KAP6.3;keratin associated protein 6-3
hsa:64090;GAL3ST2,GAL3ST-2,GP3ST;galactose-3-O-sulfotransferase 2
hsa:54468;MIOS;missing oocyte, meiosis regulator, homolog (Drosophila)
hsa:55211;DPPA4,2410091M23Rik;developmental pluripotency associated 4
hsa:79591;C10orf76;chromosome 10 open reading frame 76
hsa:342574;KRT27,KRT25C;keratin 27
hsa:23037;PDZD2,AIPC,PAPIN,PDZK3,PIN1;PDZ domain containing 2
hsa:55119;PRPF38B,NET1,RP11-293A10.1;PRP38 pre-mRNA processing factor 38 (yeast) domain containing B
hsa:85289;KRTAP4-5,KAP4.5,KRTAP4.5;keratin associated protein 4-5
hsa:83741;TFAP2D,TFAP2BL1;transcription factor AP-2 delta (activating enhancer binding protein 2 delta)
hsa:131965;METTL6;methyltransferase like 6 (EC:2.1.1.-)
hsa:129530;LYG1,SALW1939;lysozyme G-like 1
hsa:55561;CDC42BPG,DMPK2,HSMDPKIN,KAPPA-200,MRCKG,MRCKgamma;CDC42 binding protein kinase gamma (DMPK-like) (EC:2.7.11.1)
hsa:63897;HEATR6,ABC1;HEAT repeat containing 6
hsa:89792;GAL3ST3,GAL3ST-3,GAL3ST2;galactose-3-O-sulfotransferase 3
hsa:56673;C11orf16;chromosome 11 open reading frame 16
hsa:63910;SLC17A9,C20orf59;solute carrier family 17, member 9
hsa:55337;C19orf66;chromosome 19 open reading frame 66
hsa:54537;FAM35A,FAM35A1,bA163M19.1;family with sequence similarity 35, member A
hsa:260429;PRSS33,EOS;protease, serine, 33
hsa:81626;SHCBP1L,C1orf14,GE36;SHC SH2-domain binding protein 1-like
hsa:1953;MEGF6,EGFL3;multiple EGF-like-domains 6
hsa:23215;PRRC2C,BAT2-iso,BAT2D1,BAT2L2,XTP2;proline-rich coiled-coil 2C
hsa:147965;FAM98C;family with sequence similarity 98, member C
hsa:389677;RBM12B,MGC:33837;RNA binding motif protein 12B
hsa:148741;ANKRD35;ankyrin repeat domain 35
hsa:169981;SPIN3,SPIN-3,bA445O16.1;spindlin family, member 3
hsa:80007;C10orf88;chromosome 10 open reading frame 88
hsa:286753;TUSC5,DSPB1,IFITMD3,LOST1;tumor suppressor candidate 5
hsa:79874;RABEP2,FRA;rabaptin, RAB GTPase binding effector protein 2
hsa:80176;SPSB1,SSB-1,SSB1;splA/ryanodine receptor domain and SOCS box containing 1
hsa:6874;TAF4,TAF2C,TAF2C1,TAF4A,TAFII130,TAFII135;TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa
hsa:9242;MSC,ABF-1,ABF1,MYOR,bHLHa22;musculin
hsa:23645;PPP1R15A,GADD34;protein phosphatase 1, regulatory subunit 15A
hsa:3882;KRT32,HA2,HKA2,KRTHA2,hHa2;keratin 32
hsa:84769;MPV17L2,FKSG24;MPV17 mitochondrial membrane protein-like 2
hsa:51347;TAOK3,DPK,JIK,MAP3K18;TAO kinase 3 (EC:2.7.11.1)
hsa:338699;ANKRD42,SARP;ankyrin repeat domain 42
hsa:29950;SERTAD1,SEI1,TRIP-Br1;SERTA domain containing 1
hsa:54707;GPN2,ATPBD1B;GPN-loop GTPase 2;K06883
hsa:55020;TTC38;tetratricopeptide repeat domain 38
hsa:79004;CUEDC2,C10orf66,bA18I14.5;CUE domain containing 2
hsa:155435;RBM33,PRR8;RNA binding motif protein 33
hsa:55174;INTS10,C8orf35,INT10;integrator complex subunit 10
hsa:58986;TMEM8A,M83,TMEM6,TMEM8;transmembrane protein 8A
hsa:9182;RASSF9,P-CIP1,PAMCI,PCIP1;Ras association (RalGDS/AF-6) domain family (N-terminal) member 9
hsa:171546;SPTSSA,C14orf147,SSSPTA;serine palmitoyltransferase, small subunit A
hsa:140738;TMEM37,PR,PR1;transmembrane protein 37
hsa:116255;MOGAT1,DGAT2L,DGAT2L1,MGAT1;monoacylglycerol O-acyltransferase 1 (EC:2.3.1.22)
hsa:79927;FAM110D,GRRP1,RP11-96L14.5;family with sequence similarity 110, member D
hsa:10200;MPHOSPH6,MPP,MPP-6,MPP6;M-phase phosphoprotein 6
hsa:259285;TAS2R39,T2R39,T2R57;taste receptor, type 2, member 39
hsa:54826;GIN1,GIN-1,TGIN1,ZH2C2;gypsy retrotransposon integrase 1
hsa:346288;SEPT14;septin 14
hsa:126321;MFSD12,C19orf28,PP3501;major facilitator superfamily domain containing 12
hsa:79680;C22orf29,BOP;chromosome 22 open reading frame 29
hsa:401546;C9orf152,bA470J20.2;chromosome 9 open reading frame 152
hsa:58503;PROL1,BPLP,PRL1,opiorphin;proline rich, lacrimal 1
hsa:152940;C4orf45;chromosome 4 open reading frame 45
hsa:25831;HECTD1;HECT domain containing E3 ubiquitin protein ligase 1
hsa:259290;TAS2R31,T2R31,T2R44,T2R53,TAS2R44;taste receptor, type 2, member 31
hsa:57685;CACHD1,RP4-655E10.1,VWCD1;cache domain containing 1
hsa:9480;ONECUT2,OC-2,OC2;one cut homeobox 2
hsa:170680;PSORS1C2,C6orf17,SPR1;psoriasis susceptibility 1 candidate 2
hsa:79616;CCNJL;cyclin J-like
hsa:55716;LMBR1L,LIMR;limb region 1 homolog (mouse)-like
hsa:143888;KDELC2;KDEL (Lys-Asp-Glu-Leu) containing 2
hsa:8732;RNGTT,CAP1A,HCE,HCE1,hCAP;RNA guanylyltransferase and 5'-phosphatase (EC:2.7.7.50 3.1.3.33)
hsa:154743;C7orf60;chromosome 7 open reading frame 60
hsa:10186;LHFP;lipoma HMGIC fusion partner (EC:3.6.5.4)
hsa:80745;THUMPD2,C2orf8;THUMP domain containing 2
hsa:55511;SAGE1,CT14,SAGE;sarcoma antigen 1
hsa:6545;SLC7A4,CAT-4,CAT4,HCAT3,VH;solute carrier family 7 (orphan transporter), member 4
hsa:259292;TAS2R46,T2R46,T2R54;taste receptor, type 2, member 46
hsa:25992;SNED1,SST3,Snep;sushi, nidogen and EGF-like domains 1
hsa:391059;FRRS1,SDFR2,SDR2;ferric-chelate reductase 1
hsa:65244;SPATS2,P59SCR,SCR59,SPATA10;spermatogenesis associated, serine-rich 2
hsa:283849;EXOC3L1,EXOC3L;exocyst complex component 3-like 1
hsa:548645;DNAJC25,bA16L21.2.1;DnaJ (Hsp40) homolog, subfamily C, member 25
hsa:79896;THNSL1,TSH1;threonine synthase-like 1 (S. cerevisiae)
hsa:135886;WBSCR28;Williams-Beuren syndrome chromosome region 28
hsa:22836;RHOBTB3;Rho-related BTB domain containing 3
hsa:55231;CCDC87;coiled-coil domain containing 87
hsa:10307;APBB3,FE65L2,SRA;amyloid beta (A4) precursor protein-binding, family B, member 3
hsa:153643;FAM81B;family with sequence similarity 81, member B
hsa:113174;SAAL1,SPACIA1;serum amyloid A-like 1
hsa:114336;CGB2;chorionic gonadotropin, beta polypeptide 2
hsa:7108;TM7SF2,ANG1,DHCR14A,NET47;transmembrane 7 superfamily member 2 (EC:1.3.1.70)
hsa:286336;FAM78A,C9orf59;family with sequence similarity 78, member A
hsa:285368;PRRT3;proline-rich transmembrane protein 3
hsa:401137;C4orf40;chromosome 4 open reading frame 40
hsa:81552;VOPP1,ECOP,GASP;vesicular, overexpressed in cancer, prosurvival protein 1
hsa:6703;SPRR2D;small proline-rich protein 2D
hsa:161502;C15orf26;chromosome 15 open reading frame 26
hsa:6819;SULT1C2,ST1C1,ST1C2,SULT1C1,humSULTC2;sulfotransferase family, cytosolic, 1C, member 2 (EC:2.8.2.-)
hsa:256394;SERPINA11;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11
hsa:5239;PGM5,PGMRP;phosphoglucomutase 5
hsa:1101;CHAD,SLRR4A;chondroadherin
hsa:5671;PSG3;pregnancy specific beta-1-glycoprotein 3
hsa:10721;POLQ,POLH,PRO0327;polymerase (DNA directed), theta (EC:2.7.7.7)
hsa:389400;GFRAL,C6orf144,GRAL,UNQ9356,bA360D14.1;GDNF family receptor alpha like
hsa:29113;C6orf15,STG;chromosome 6 open reading frame 15
hsa:26005;C2CD3;C2 calcium-dependent domain containing 3
hsa:158427;TSTD2,C9orf97;thiosulfate sulfurtransferase (rhodanese)-like domain containing 2
hsa:196410;METTL7B,ALDI;methyltransferase like 7B
hsa:285429;DCAF4L1,WDR21B;DDB1 and CUL4 associated factor 4-like 1
hsa:64863;METTL4,HsT661;methyltransferase like 4
hsa:9851;;KIAA0753
hsa:10266;RAMP2;receptor (G protein-coupled) activity modifying protein 2
hsa:9352;TXNL1,TRP32,TXL-1,TXNL,Txl;thioredoxin-like 1
hsa:284348;LYPD5,PRO4356;LY6/PLAUR domain containing 5
hsa:92104;TTC30A;tetratricopeptide repeat domain 30A
hsa:9914;ATP2C2,SPCA2;ATPase, Ca++ transporting, type 2C, member 2 (EC:3.6.3.8)
hsa:57156;TMEM63C,C14orf171;transmembrane protein 63C
hsa:10235;RASGRP2,CALDAG-GEFI,CDC25L;RAS guanyl releasing protein 2 (calcium and DAG-regulated)
hsa:257062;CATSPERD,TMEM146;catsper channel auxiliary subunit delta
hsa:84953;MICALCL,Ebitein1;MICAL C-terminal like
hsa:80157;CWH43,CWH43-C;cell wall biogenesis 43 C-terminal homolog (S. cerevisiae)
hsa:727832;GOLGA6L6;golgin A6 family-like 6
hsa:729420;C13orf45;chromosome 13 open reading frame 45
hsa:286207;C9orf117;chromosome 9 open reading frame 117
hsa:51634;RBMX2,CGI-79;RNA binding motif protein, X-linked 2
hsa:50853;VILL;villin-like
hsa:23383;MAU2,KIAA0892,MAU2L,SCC4,mau-2;MAU2 chromatid cohesion factor homolog (C. elegans)
hsa:80178;C16orf59;chromosome 16 open reading frame 59
hsa:221393;GPR115,PGR18;G protein-coupled receptor 115
hsa:29100;TMEM208;transmembrane protein 208
hsa:140258;KRTAP13-1,KAP13.1,KRTAP13.1;keratin associated protein 13-1
hsa:353149;TBC1D26;TBC1 domain family, member 26
hsa:83894;TTC29,NYD-SP14,TBPP2A;tetratricopeptide repeat domain 29
hsa:84641;HIATL1;hippocampus abundant transcript-like 1
hsa:283777;FAM169B;family with sequence similarity 169, member B
hsa:90525;SHF;Src homology 2 domain containing F
hsa:169611;OLFML2A,PRO34319;olfactomedin-like 2A
hsa:80183;KIAA0226L,C13orf18;KIAA0226-like
hsa:653583;PHLDB3;pleckstrin homology-like domain, family B, member 3
hsa:64853;AIDA,C1orf80,RP11-378J18.7;axin interactor, dorsalization associated
hsa:51249;TMEM69,C1orf154,RP11-767N6.4;transmembrane protein 69
hsa:6814;STXBP3,MUNC18-3,MUNC18C,PSP,UNC-18C;syntaxin binding protein 3
hsa:79802;HHIPL2,KIAA1822L;HHIP-like 2
hsa:127670;TEDDM1,EDDM9,Epdd1,HE9,RP1-223H12.2,TMEM45C;transmembrane epididymal protein 1
hsa:158931;TCEAL6,Tceal3;transcription elongation factor A (SII)-like 6
hsa:9889;ZBED4;zinc finger, BED-type containing 4
hsa:129831;RBM45,DRB1;RNA binding motif protein 45
hsa:22832;C6orf84,QN1;KIAA1009
hsa:5678;PSG9,PS34,PSBG-11,PSBG-9,PSG11,PSGII;pregnancy specific beta-1-glycoprotein 9
hsa:728242;XAGE2B;X antigen family, member 2B
hsa:79913;ACTR5,Arp5,INO80M;ARP5 actin-related protein 5 homolog (yeast)
hsa:10322;SMYD5,NN8-4AG,RAI15,RRG1,ZMYND23;SMYD family member 5
hsa:133482;SLCO6A1,CT48,GST,OATP6A1,OATPY;solute carrier organic anion transporter family, member 6A1
hsa:93035;PKHD1L1,PKHDL1;polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1
hsa:118442;GPR62,GPCR8,KPG_005;G protein-coupled receptor 62
hsa:29909;GPR171,H963;G protein-coupled receptor 171
hsa:80207;OPA3,MGA3;optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)
hsa:346653;FAM71F2,FAM137B;family with sequence similarity 71, member F2
hsa:55234;SMU1,BWD,RP11-54K16.3,SMU-1,fSAP57;smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans)
hsa:80099;C7orf69;chromosome 7 open reading frame 69
hsa:55324;ABCF3,EST201864;ATP-binding cassette, sub-family F (GCN20), member 3
hsa:400451;FAM174B;family with sequence similarity 174, member B
hsa:51071;DERA,DEOC;deoxyribose-phosphate aldolase (putative) (EC:4.1.2.4)
hsa:125997;MBD3L2;methyl-CpG binding domain protein 3-like 2
hsa:112609;MRAP2,C6orf117,RP11-51G5.2,bA51G5.2;melanocortin 2 receptor accessory protein 2
hsa:56171;DNAH7;dynein, axonemal, heavy chain 7
hsa:112611;RWDD2A,RWDD2,dJ747H23.2;RWD domain containing 2A
hsa:23317;DNAJC13,RME8;DnaJ (Hsp40) homolog, subfamily C, member 13
hsa:414332;LCN10;lipocalin 10
hsa:374739;TEPP;testis, prostate and placenta expressed
hsa:84060;RBM48,C7orf64,DKFZP564O0523,HSPC304;RNA binding motif protein 48
hsa:386678;KRTAP10-11,KAP10.11,KAP18.11,KRTAP18-11,KRTAP18.11;keratin associated protein 10-11
hsa:388284;C16orf86;chromosome 16 open reading frame 86
hsa:54112;GPR88,STRG;G protein-coupled receptor 88
hsa:84065;TMEM222,C1orf160;transmembrane protein 222
hsa:9552;SPAG7,ACRP,FSA-1;sperm associated antigen 7
hsa:130355;C2orf76,AIM29;chromosome 2 open reading frame 76
hsa:317781;DDX51;DEAD (Asp-Glu-Ala-Asp) box polypeptide 51 (EC:3.6.4.13)
hsa:80205;CHD9,AD013,CReMM,KISH2,PRIC320;chromodomain helicase DNA binding protein 9 (EC:3.6.4.12)
hsa:9905;SGSM2,RUTBC1;small G protein signaling modulator 2
hsa:144608;C12orf60;chromosome 12 open reading frame 60
hsa:57614;HsT3308,HsT885;KIAA1468
hsa:63947;DMRTC1;DMRT-like family C1
hsa:246330;PELI3;pellino E3 ubiquitin protein ligase family member 3
hsa:22936;ELL2;elongation factor, RNA polymerase II, 2
hsa:25876;SPEF1,C20orf28,CLAMP,SPEF1A;sperm flagellar 1
hsa:222166;C7orf41,Ells1;chromosome 7 open reading frame 41
hsa:1122;CHML,REP2;choroideremia-like (Rab escort protein 2)
hsa:118932;ANKRD22;ankyrin repeat domain 22
hsa:54566;EPB41L4B,CG1,EHM2;erythrocyte membrane protein band 4.1 like 4B
hsa:286046;XKR6,C8orf21,C8orf5,C8orf7,XRG6;XK, Kell blood group complex subunit-related family, member 6
hsa:284018;C17orf58;chromosome 17 open reading frame 58
hsa:55296;TBC1D19;TBC1 domain family, member 19
hsa:139886;SPIN4;spindlin family, member 4
hsa:199920;C1orf168;chromosome 1 open reading frame 168
hsa:57642;COL20A1,bA261N11.4;collagen, type XX, alpha 1
hsa:165215;FAM171B,KIAA1946;family with sequence similarity 171, member B
hsa:55082;ARGLU1;arginine and glutamate rich 1
hsa:30850;CDR2L,HUMPPA;cerebellar degeneration-related protein 2-like
hsa:750;C16orf3;chromosome 16 open reading frame 3
hsa:6861;SYT5;synaptotagmin V
hsa:84654;SPZ1,NYD-TSP1;spermatogenic leucine zipper 1
hsa:27340;UTP20,DRIM;UTP20, small subunit (SSU) processome component, homolog (yeast)
hsa:93589;CACNA2D4,RCD4;calcium channel, voltage-dependent, alpha 2/delta subunit 4
hsa:153657;TTC23L,MC25-1;tetratricopeptide repeat domain 23-like
hsa:121952;METTL21EP,METTL21CP1;methyltransferase like 21E, pseudogene
hsa:221749;PXDC1,C6orf145;PX domain containing 1
hsa:51659;GINS2,HSPC037,PSF2,Pfs2;GINS complex subunit 2 (Psf2 homolog)
hsa:121355;GTSF1,FAM112B;gametocyte specific factor 1
hsa:49856;WRAP73,WDR8;WD repeat containing, antisense to TP73
hsa:392509;ARL13A,ARL13,dJ341D10.2;ADP-ribosylation factor-like 13A
hsa:122664;TPPP2,C14orf8,P18,p25beta;tubulin polymerization-promoting protein family member 2
hsa:83743;GRWD1,CDW4,GRWD,RRB1,WDR28;glutamate-rich WD repeat containing 1
hsa:132141;IQCF1;IQ motif containing F1
hsa:8530;CST7,CMAP;cystatin F (leukocystatin)
hsa:147920;IGFL2,UNQ645,VPRI645;IGF-like family member 2
hsa:123099;DEGS2,C14orf66,DES2,FADS8;delta(4)-desaturase, sphingolipid 2
hsa:9153;SLC28A2,CNT2,HCNT2,HsT17153,SPNT1;solute carrier family 28 (sodium-coupled nucleoside transporter), member 2
hsa:80975;TMPRSS5,SPINESIN;transmembrane protease, serine 5 (EC:3.4.21.-)
hsa:7288;TULP2,CT65,TUBL2;tubby like protein 2
hsa:8417;STX7;syntaxin 7
hsa:2051;EPHB6,HEP;EPH receptor B6 (EC:2.7.10.1)
hsa:338328;GPIHBP1,GPI-HBP1;glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1
hsa:401944;LDLRAD2;low density lipoprotein receptor class A domain containing 2
hsa:55276;PGM2;phosphoglucomutase 2 (EC:5.4.2.2 5.4.2.7)
hsa:83479;DDX59,ZNHIT5;DEAD (Asp-Glu-Ala-Asp) box polypeptide 59 (EC:3.6.4.13)
hsa:54033;RBM11;RNA binding motif protein 11
hsa:8540;AGPS,ADAP-S,ADAS,ADHAPS,ADPS,ALDHPSY;alkylglycerone phosphate synthase (EC:2.5.1.26)
hsa:64978;MRPL38,L38MT,MRP-L3,MRP-L38,RPML3;mitochondrial ribosomal protein L38
hsa:340527;NHSL2;NHS-like 2
hsa:117195;MRGPRX3,GPCR,MRGX3,SNSR1,SNSR2;MAS-related GPR, member X3
hsa:284697;BTBD8;BTB (POZ) domain containing 8
hsa:51806;CALML5,CLSP;calmodulin-like 5
hsa:79981;FRMD1,bA164L23.1;FERM domain containing 1
hsa:80741;LY6G5C,C6orf20,G5C,LY6G5CA,LY6G5CB,NG33;lymphocyte antigen 6 complex, locus G5C
hsa:79935;CNTD2;cyclin N-terminal domain containing 2
hsa:353174;ZACN,L2,LGICZ,LGICZ1,ZAC,ZAC1;zinc activated ligand-gated ion channel
hsa:140886;PABPC5,PABP5;poly(A) binding protein, cytoplasmic 5
hsa:25948;KBTBD2,BKLHD1;kelch repeat and BTB (POZ) domain containing 2
hsa:10045;SH2D3A,NSP1;SH2 domain containing 3A
hsa:254778;C8orf46;chromosome 8 open reading frame 46
hsa:5002;SLC22A18,BWR1A,BWSCR1A,HET,IMPT1,ITM,ORCTL2,SLC22A1L,TSSC5,p45-BWR1A;solute carrier family 22, member 18
hsa:669;BPGM,DPGM;2,3-bisphosphoglycerate mutase (EC:3.1.3.13 5.4.2.1 5.4.2.4)
hsa:10610;ST6GALNAC2,SAITL1,SIAT7,SIAT7B,SIATL1,ST6GalNAII,STHM;ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (EC:2.4.99.7)
hsa:148808;MFSD4,UNQ3064;major facilitator superfamily domain containing 4
hsa:144193;AMDHD1;amidohydrolase domain containing 1 (EC:3.5.2.7)
hsa:744;MPPED2,239FB,C11orf8;metallophosphoesterase domain containing 2
hsa:23109;DDN;dendrin
hsa:122970;ACOT4,PTE-Ib,PTE1B,PTE2B;acyl-CoA thioesterase 4 (EC:3.1.2.2)
hsa:8483;CILP,CILP-1,HsT18872;cartilage intermediate layer protein, nucleotide pyrophosphohydrolase
hsa:4956;ODF1,CT133,HSPB10,ODF,ODF2,ODF27,ODFP,ODFPG,ODFPGA,ODFPGB,RT7,SODF;outer dense fiber of sperm tails 1
hsa:127002;ATXN7L2;ataxin 7-like 2
hsa:340419;RSPO2,CRISTIN2;R-spondin 2
hsa:340562;SATL1;spermidine/spermine N1-acetyl transferase-like 1
hsa:150864;FAM117B,ALS2CR13;family with sequence similarity 117, member B
hsa:79675;FASTKD1;FAST kinase domains 1
hsa:497190;CLEC18B,MRCL2;C-type lectin domain family 18, member B
hsa:55341;LSG1;large subunit GTPase 1 homolog (S. cerevisiae)
hsa:11046;SLC35D2,HFRC1,SQV7L,UGTrel8,hfrc;solute carrier family 35, member D2
hsa:399823;FOXI2;forkhead box I2
hsa:83473;KATNAL2;katanin p60 subunit A-like 2 (EC:3.6.4.3)
hsa:55116;TMEM39B;transmembrane protein 39B
hsa:84696;ABHD1,LABH1;abhydrolase domain containing 1
hsa:142827;C10orf129,ACSM6,bA310E22.3;chromosome 10 open reading frame 129 (EC:6.2.1.2)
hsa:23247;;KIAA0556
hsa:6563;SLC14A1,HUT11,HsT1341,JK,RACH1,RACH2,UT-B1,UT1,UTE;solute carrier family 14 (urea transporter), member 1 (Kidd blood group)
hsa:51101;ZC2HC1A,C8orf70,FAM164A;zinc finger, C2HC-type containing 1A
hsa:353116;RILPL1,GOSPEL,RLP1;Rab interacting lysosomal protein-like 1
hsa:1849;DUSP7,MKPX,PYST2;dual specificity phosphatase 7 (EC:3.1.3.16 3.1.3.48)
hsa:3889;KRT83,HB3,Hb-3,KRTHB3;keratin 83
hsa:51350;KRT76,HUMCYT2A,KRT2B,KRT2P;keratin 76
hsa:339896;GADL1;glutamate decarboxylase-like 1
hsa:57003;CCDC47,MSTP041;coiled-coil domain containing 47
hsa:192666;KRT24,K24,KA24;keratin 24
hsa:93081;TEX30,C13orf27;testis expressed 30
hsa:284325;C19orf54;chromosome 19 open reading frame 54
hsa:84102;SLC41A2,SLC41A1-L1;solute carrier family 41, member 2
hsa:27013;CNPPD1,C2orf24,CGI-57;cyclin Pas1/PHO80 domain containing 1
hsa:142910;LIPJ,LIPL1,bA425M17.2;lipase, family member J
hsa:79137;FAM134A,C2orf17;family with sequence similarity 134, member A
hsa:51313;FAM198B,AD036,C4orf18;family with sequence similarity 198, member B
hsa:23102;TBC1D2B;TBC1 domain family, member 2B
hsa:2523;FUT1,H,HH,HSC;fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) (EC:2.4.1.69)
hsa:84250;ANKRD32,BRCTD1,BRCTx;ankyrin repeat domain 32
hsa:84948;TIGD5;tigger transposable element derived 5
hsa:25864;ABHD14A,DORZ1;abhydrolase domain containing 14A
hsa:146852;ODF4,CT134,CT136,OPPO1;outer dense fiber of sperm tails 4
hsa:400566;C17orf97;chromosome 17 open reading frame 97
hsa:84253;GARNL3,bA356B19.1;GTPase activating Rap/RanGAP domain-like 3
hsa:79801;SHCBP1,PAL;SHC SH2-domain binding protein 1
hsa:58511;DNASE2B,DLAD;deoxyribonuclease II beta (EC:3.1.22.1)
hsa:256815;C10orf67;chromosome 10 open reading frame 67
hsa:115572;FAM46B,RP11-344H11.8;family with sequence similarity 46, member B
hsa:387856;C12orf68;chromosome 12 open reading frame 68
hsa:124773;C17orf64;chromosome 17 open reading frame 64
hsa:389208;TMPRSS11F;transmembrane protease, serine 11F
hsa:84680;ACCS,ACS,PHACS;1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)
hsa:219621;C10orf107,bA63A2.1;chromosome 10 open reading frame 107
hsa:79730;NSUN7;NOP2/Sun domain family, member 7
hsa:10570;DPYSL4,CRMP3,DRP-4,ULIP4;dihydropyrimidinase-like 4
hsa:84897;TBRG1,NIAM,TB-5;transforming growth factor beta regulator 1
hsa:79912;PYROXD1;pyridine nucleotide-disulphide oxidoreductase domain 1 (EC:1.8.1.-)
hsa:85478;CCDC65,NYD-SP28;coiled-coil domain containing 65
hsa:9857;CEP350,CAP350,GM133;centrosomal protein 350kDa
hsa:56654;NPDC1,CAB,CAB-,CAB-1,CAB1,NPDC-1;neural proliferation, differentiation and control, 1
hsa:6397;SEC14L1,PRELID4A,SEC14L;SEC14-like 1 (S. cerevisiae)
hsa:117196;MRGPRX4,GPCR,MRGX4,SNSR6;MAS-related GPR, member X4
hsa:222487;GPR97,PB99,PGR26;G protein-coupled receptor 97
hsa:91289;LMF2,TMEM112B,TMEM153;lipase maturation factor 2
hsa:54785;C17orf59,PRO2472;chromosome 17 open reading frame 59
hsa:284353;NKPD1;NTPase, KAP family P-loop domain containing 1
hsa:374454;KRT77,K1B,KRT1B;keratin 77
hsa:84804;MFSD9;major facilitator superfamily domain containing 9
hsa:4884;NPTX1,NP1;neuronal pentraxin I
hsa:10050;SLC17A4,KAIA2138;solute carrier family 17 (sodium phosphate), member 4
hsa:84865;CCDC142;coiled-coil domain containing 142
hsa:92749;DRC1,C2orf39,CCDC164;dynein regulatory complex subunit 1 homolog (Chlamydomonas)
hsa:79853;TM4SF20,PRO994,TCCE518;transmembrane 4 L six family member 20
hsa:79983;POF1B,POF,POF2B;premature ovarian failure, 1B
hsa:246744;STH,MAPTIT;saitohin
hsa:4037;LRP3;low density lipoprotein receptor-related protein 3
hsa:256691;MAMDC2;MAM domain containing 2
hsa:259236;TMIE,DFNB6;transmembrane inner ear
hsa:84075;FSCB,C14orf155;fibrous sheath CABYR binding protein
hsa:162681;C18orf54,LAS2;chromosome 18 open reading frame 54
hsa:283455;KSR2;kinase suppressor of ras 2
hsa:64180;DPEP3,MBD3;dipeptidase 3 (EC:3.4.13.19)
hsa:9390;SLC22A13,OAT10,OCTL1,OCTL3,ORCTL-3,ORCTL3;solute carrier family 22 (organic anion transporter), member 13
hsa:3161;HMMR,CD168,IHABP,RHAMM;hyaluronan-mediated motility receptor (RHAMM)
hsa:9881;TRANK1,LBA1;tetratricopeptide repeat and ankyrin repeat containing 1
hsa:60370;AVPI1,PP5395,RP11-548K23.7,VIP32,VIT32;arginine vasopressin-induced 1
hsa:144132;DNHD1,C11orf47,CCDC35,DHCD1,DNHD1L;dynein heavy chain domain 1
hsa:79734;KCTD17;potassium channel tetramerisation domain containing 17
hsa:130132;RFTN2,C2orf11,Raftlin-2;raftlin family member 2
hsa:494188;FBXO47;F-box protein 47
hsa:286148;DPY19L4;dpy-19-like 4 (C. elegans)
hsa:81562;LMAN2L,VIPL;lectin, mannose-binding 2-like
hsa:54221;SNTG2,G2SYN,SYN5;syntrophin, gamma 2
hsa:150248;C22orf15,N27C7-3;chromosome 22 open reading frame 15
hsa:55161;TMEM33,1600019D15Rik,SHINC3;transmembrane protein 33
hsa:221223;CES5A,CAUXIN,CES4C1,CES5,CES7;carboxylesterase 5A (EC:3.1.1.1)
hsa:85026;C9orf37;chromosome 9 open reading frame 37
hsa:344892;RTP2;receptor (chemosensory) transporter protein 2
hsa:130827;TMEM182;transmembrane protein 182
hsa:147111;NOTUM;notum pectinacetylesterase homolog (Drosophila)
hsa:64599;GIGYF1,GYF1,PERQ1;GRB10 interacting GYF protein 1
hsa:119467;CLRN3,TMEM12,USH3AL1;clarin 3
hsa:100130733;LRRC70,SLRN;leucine rich repeat containing 70
hsa:5450;POU2AF1,BOB1,OBF-1,OBF1,OCAB;POU class 2 associating factor 1
hsa:10136;CELA3A,ELA3,ELA3A;chymotrypsin-like elastase family, member 3A (EC:3.4.21.70)
hsa:374877;C19orf45;chromosome 19 open reading frame 45
hsa:253152;EPHX4,ABHD7,EPHXRP;epoxide hydrolase 4
hsa:128646;SIRPD,PTPNS1L2,dJ576H24.4;signal-regulatory protein delta
hsa:55013;CCDC109B;coiled-coil domain containing 109B
hsa:9293;GPR52;G protein-coupled receptor 52
hsa:84984;CEP19,C3orf34;centrosomal protein 19kDa
hsa:54830;NUP62CL;nucleoporin 62kDa C-terminal like
hsa:92922;CCDC102A;coiled-coil domain containing 102A
hsa:167838;TXLNB,C6orf198,LST001,MDP77,dJ522B19.2;taxilin beta
hsa:169166;SNX31;sorting nexin 31
hsa:147719;LYPD4,SMR;LY6/PLAUR domain containing 4
hsa:85509;MBD3L1,MBD3L;methyl-CpG binding domain protein 3-like 1
hsa:153579;BTNL9,BTN3,VDLS1900;butyrophilin-like 9
hsa:8518;IKBKAP,DYS,ELP1,FD,IKAP,IKI3,TOT1;inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
hsa:283284;IGSF22;immunoglobulin superfamily, member 22
hsa:2918;GRM8,GLUR8,GPRC1H,MGLUR8,mGlu8;glutamate receptor, metabotropic 8
hsa:338773;TMEM119;transmembrane protein 119
hsa:63906;GPATCH3,GPATC3;G patch domain containing 3
hsa:167410;LIX1,C5orf11;Lix1 homolog (chicken)
hsa:56961;SHD;Src homology 2 domain containing transforming protein D
hsa:139170;DCAF12L1,KIAA1892L,WDR40B;DDB1 and CUL4 associated factor 12-like 1
hsa:84342;COG8,CDG2H,DOR1;component of oligomeric golgi complex 8
hsa:146723;C17orf77;chromosome 17 open reading frame 77
hsa:9947;MAGEC1,CT7,CT7.1;melanoma antigen family C, 1
hsa:63904;DUSP21,LMWDSP21;dual specificity phosphatase 21 (EC:3.1.3.16 3.1.3.48)
hsa:92346;C1orf105;chromosome 1 open reading frame 105
hsa:54663;WDR74;WD repeat domain 74
hsa:128822;CST9,CLM,CTES7A;cystatin 9 (testatin)
hsa:9871;SEC24D;SEC24 family, member D (S. cerevisiae)
hsa:220081;FAM194B;family with sequence similarity 194, member B
hsa:255252;LRRC57;leucine rich repeat containing 57
hsa:152503;SH3D19,EBP,EVE1,Kryn,SH3P19;SH3 domain containing 19
hsa:8449;DHX16,DBP2,DDX16,PRO2014,PRP8,PRPF2,Prp2;DEAH (Asp-Glu-Ala-His) box polypeptide 16 (EC:3.6.4.13)
hsa:164684;WBP2NL,PAWP;WBP2 N-terminal like
hsa:653240;KRTAP4-11,KAP4.11,KAP4.14,KRTAP4-14,KRTAP4.14;keratin associated protein 4-11
hsa:120935;CCDC38;coiled-coil domain containing 38
hsa:124817;CNTD1,CNTD;cyclin N-terminal domain containing 1
hsa:119548;PNLIPRP3;pancreatic lipase-related protein 3 (EC:3.1.1.3)
hsa:28972;SPCS1,SPC1,SPC12,YJR010C-A;signal peptidase complex subunit 1 homolog (S. cerevisiae) (EC:3.4.-.-)
hsa:146923;RUNDC1;RUN domain containing 1
hsa:64651;CSRNP1,AXUD1,CSRNP-1,FAM130B,TAIP-3,URAX1;cysteine-serine-rich nuclear protein 1
hsa:1352;COX10;cytochrome c oxidase assembly homolog 10 (yeast) (EC:2.5.1.-)
hsa:164127;C1orf65,RP11-76K24.1;chromosome 1 open reading frame 65
hsa:79070;KDELC1,EP58,KDEL1;KDEL (Lys-Asp-Glu-Leu) containing 1
hsa:55024;BANK1,BANK;B-cell scaffold protein with ankyrin repeats 1
hsa:414236;C10orf55,bA417O11.3;chromosome 10 open reading frame 55
hsa:84940;CORO6;coronin 6
hsa:284680;C1orf111,RP11-565P22.3;chromosome 1 open reading frame 111
hsa:55322;C5orf22;chromosome 5 open reading frame 22
hsa:151516;ASPRV1,MUNO,SASP,SASPase,Taps;aspartic peptidase, retroviral-like 1
hsa:55195;C14orf105;chromosome 14 open reading frame 105
hsa:219681;ARMC3,CT81,KU-CT-1;armadillo repeat containing 3
hsa:284382;ACTL9;actin-like 9
hsa:148870;CCDC27;coiled-coil domain containing 27
hsa:153745;FAM71B;family with sequence similarity 71, member B
hsa:57467;HHATL,C3orf3,GUP1,MBOAT3,MSTP002,OACT3;hedgehog acyltransferase-like
hsa:387707;CC2D2B,C10orf130,bA248J23.4;coiled-coil and C2 domain containing 2B
hsa:55281;TMEM140;transmembrane protein 140
hsa:414899;BLID,BRCC2;BH3-like motif containing, cell death inducer
hsa:5257;PHKB;phosphorylase kinase, beta (EC:2.7.11.19)
hsa:84918;LRP11,MANSC3,bA350J20.3;low density lipoprotein receptor-related protein 11
hsa:92092;ZC3HAV1L,C7orf39;zinc finger CCCH-type, antiviral 1-like
hsa:160777;CCDC60;coiled-coil domain containing 60
hsa:266743;NPAS4,Le-PAS,NXF,PASD10,bHLHe79;neuronal PAS domain protein 4
hsa:388969;C2orf68;chromosome 2 open reading frame 68
hsa:93190;C1orf158;chromosome 1 open reading frame 158
hsa:343035;RD3,C1orf36,LCA12;retinal degeneration 3
hsa:344752;AADACL2;arylacetamide deacetylase-like 2
hsa:8636;SSNA1,N14,NA-14,NA14;Sjogren syndrome nuclear autoantigen 1
hsa:222659;PXT1,STEPP;peroxisomal, testis specific 1
hsa:9210;BMP15,GDF9B,ODG2,POF4;bone morphogenetic protein 15
hsa:91373;UAP1L1,RP11-229P13.18;UDP-N-acetylglucosamine pyrophosphorylase 1-like 1
hsa:57585;CRAMP1L,HN1L,TCE4;Crm, cramped-like (Drosophila)
hsa:9816;URB2,KIAA0133,NET10,NPA2;URB2 ribosome biogenesis 2 homolog (S. cerevisiae)
hsa:151871;DPPA2,CT100,ECAT15-2,PESCRG1;developmental pluripotency associated 2
hsa:84830;ADTRP,AIG1L,C6orf105,dJ413H6.1;androgen-dependent TFPI-regulating protein
hsa:27283;TINAG,TIN-AG;tubulointerstitial nephritis antigen
hsa:6305;SBF1,DENND7A,MTMR5;SET binding factor 1
hsa:79977;GRHL2,BOM,DFNA28,TFCP2L3;grainyhead-like 2 (Drosophila)
hsa:55325;UFSP2,C4orf20;UFM1-specific peptidase 2 (EC:3.4.22.-)
hsa:23357;ANGEL1,KIAA0759;angel homolog 1 (Drosophila)
hsa:442213;PTCHD4,C6orf138,dJ402H5.2;patched domain containing 4
hsa:29841;GRHL1,LBP32,MGR,NH32,TFCP2L2;grainyhead-like 1 (Drosophila)
hsa:118491;TTC18;tetratricopeptide repeat domain 18
hsa:151531;UPP2,UDRPASE2,UP2,UPASE2;uridine phosphorylase 2 (EC:2.4.2.3)
hsa:134285;TMEM171,PRP2;transmembrane protein 171
hsa:55343;SLC35C1,CDG2C,FUCT1;solute carrier family 35, member C1
hsa:200132;TCTEX1D1,RP11-266I14.2;Tctex1 domain containing 1
hsa:285877;POM121L12;POM121 transmembrane nucleoporin-like 12
hsa:84522;JAGN1,GL009;jagunal homolog 1 (Drosophila)
hsa:256130;TMEM196;transmembrane protein 196
hsa:220042;C11orf82,noxin;chromosome 11 open reading frame 82
hsa:56918;C2orf83;chromosome 2 open reading frame 83
hsa:145497;C14orf166B;chromosome 14 open reading frame 166B
hsa:79174;CRELD2;cysteine-rich with EGF-like domains 2
hsa:222553;SLC35F1,C6orf169,dJ230I3.1;solute carrier family 35, member F1
hsa:9626;GUCA1C,GCAP3;guanylate cyclase activator 1C
hsa:2070;EYA4,CMD1J,DFNA10;eyes absent homolog 4 (Drosophila) (EC:3.1.3.48)
hsa:157983;C9orf66,RP11-59O6.1;chromosome 9 open reading frame 66
hsa:401940;PRAMEF3;PRAME family member 3
hsa:253143;PRR14L,C22orf30;proline rich 14-like
hsa:206412;C6orf163;chromosome 6 open reading frame 163
hsa:84294;UTP23,C8orf53;UTP23, small subunit (SSU) processome component, homolog (yeast)
hsa:203522;DDX26B;DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26B
hsa:401;PHOX2A,ARIX,CFEOM2,FEOM2,NCAM2,PMX2A;paired-like homeobox 2a
hsa:9413;FAM189A2,C9orf61,RP11-548B3.1,X123;family with sequence similarity 189, member A2
hsa:201176;ARHGAP27,CAMGAP1,PP905,SH3D20,SH3P20;Rho GTPase activating protein 27
hsa:92799;SHKBP1,Sb1;SH3KBP1 binding protein 1
hsa:205327;C2orf69;chromosome 2 open reading frame 69
hsa:6745;SSR1,TRAPA;signal sequence receptor, alpha
hsa:283385;MORN3;MORN repeat containing 3
hsa:85027;SMIM3,C5orf62,MST150,NID67;small integral membrane protein 3
hsa:79668;PARP8,ARTD16,pART16;poly (ADP-ribose) polymerase family, member 8 (EC:2.4.2.30)
hsa:60672;MIIP,IIP45;migration and invasion inhibitory protein
hsa:122011;CSNK1A1L,CK1;casein kinase 1, alpha 1-like (EC:2.7.11.1)
hsa:66002;CYP4F12,F22329_1;cytochrome P450, family 4, subfamily F, polypeptide 12 (EC:1.14.14.1)
hsa:55577;NAGK,GNK,HSA242910;N-acetylglucosamine kinase (EC:2.7.1.59)
hsa:9855;FARP2,FIR,FRG,PLEKHC3;FERM, RhoGEF and pleckstrin domain protein 2
hsa:222643;UNC5CL,MUXA,ZUD;unc-5 homolog C (C. elegans)-like
hsa:27042;DIEXF,C1orf107,DEF,DJ434O14.5,UTP25;digestive organ expansion factor homolog (zebrafish)
hsa:84968;PNMA6A,MA6,PNMA6;paraneoplastic Ma antigen family member 6A
hsa:255043;TMEM86B;transmembrane protein 86B (EC:3.3.2.2 3.3.2.5)
hsa:26002;MOXD1,MOX,PRO5780,dJ248E1.1;monooxygenase, DBH-like 1
hsa:161142;FAM71D,C14orf54;family with sequence similarity 71, member D
hsa:50801;KCNK4,K2p4.1,TRAAK,TRAAK1;potassium channel, subfamily K, member 4
hsa:10103;TSPAN1,NET1,TM4C,TM4SF;tetraspanin 1
hsa:2657;GDF1,DORV,DTGA3;growth differentiation factor 1
hsa:92689;FAM114A1,Noxp20;family with sequence similarity 114, member A1
hsa:162387;MFSD6L;major facilitator superfamily domain containing 6-like
hsa:5670;PSG2,CEA,PSBG2,PSG1;pregnancy specific beta-1-glycoprotein 2
hsa:29903;CCDC106,HSU79303,ZNF581;coiled-coil domain containing 106
hsa:79570;NKAIN1,FAM77C;Na+/K+ transporting ATPase interacting 1
hsa:119678;OR52E2;olfactory receptor, family 52, subfamily E, member 2
hsa:79694;MANEA,ENDO,hEndo;mannosidase, endo-alpha (EC:3.2.1.130)
hsa:283248;RCOR2;REST corepressor 2
hsa:168391;GALNTL5,GALNT15;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5
hsa:170063;CXorf22;chromosome X open reading frame 22
hsa:158724;FAM47A;family with sequence similarity 47, member A
hsa:161;AP2A2,ADTAB,CLAPA2,HIP-9,HIP9,HYPJ;adaptor-related protein complex 2, alpha 2 subunit
hsa:170679;PSORS1C1,C6orf16,SEEK1;psoriasis susceptibility 1 candidate 1
hsa:79630;C1orf54;chromosome 1 open reading frame 54
hsa:55846;ITFG2,MDS028;integrin alpha FG-GAP repeat containing 2
hsa:7374;UNG,DGU,HIGM4,HIGM5,UDG,UNG1,UNG15,UNG2;uracil-DNA glycosylase (EC:3.2.2.27)
hsa:8715;NOL4,CT125,NOLP;nucleolar protein 4
hsa:57168;ASPHD2;aspartate beta-hydroxylase domain containing 2
hsa:51804;SIX4,AREC3;SIX homeobox 4
hsa:80342;TRAF3IP3,DJ434O14.3,T3JAM;TRAF3 interacting protein 3
hsa:6332;SCN7A,NaG,Nav2.1,Nav2.2,SCN6A;sodium channel, voltage-gated, type VII, alpha subunit
hsa:120071;GYLTL1B,LARGE2;glycosyltransferase-like 1B
hsa:122258;SPACA7,C13orf28;sperm acrosome associated 7
hsa:149345;SHISA4,C1orf40,TMEM58;shisa homolog 4 (Xenopus laevis)
hsa:22822;PHLDA1,DT1P1B11,PHRIP,TDAG51;pleckstrin homology-like domain, family A, member 1
hsa:387700;SLC16A12,CJMG,MCT12;solute carrier family 16, member 12 (monocarboxylic acid transporter 12)
hsa:56834;GPR137,C11orf4,GPR137A,TM7SF1L1;G protein-coupled receptor 137
hsa:126695;C1orf172,RP11-344H11.3;chromosome 1 open reading frame 172
hsa:23245;ASTN2,bA67K19.1;astrotactin 2
hsa:57489;ODF2L,RP5-977L11.1,dJ977L11.1;outer dense fiber of sperm tails 2-like
hsa:2994;GYPB,CD235b,GPB,GPB.NY,GYPHe.NY,GpMiIII,HGpMiIII,HGpMiVI,HGpMiX,MNS,PAS-3,SS;glycophorin B (MNS blood group)
hsa:80233;C17orf70,FAAP100;chromosome 17 open reading frame 70
hsa:10677;AVIL,ADVIL,DOC6,p92;advillin
hsa:54520;CCDC93;coiled-coil domain containing 93
hsa:4701;NDUFA7,B14.5a;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa
hsa:91683;SYT12,SYT11,sytXII;synaptotagmin XII
hsa:255762;PDZD9,C16orf65;PDZ domain containing 9
hsa:133746;JMY,WHDC1L3;junction mediating and regulatory protein, p53 cofactor
hsa:22995;CEP152,MCPH4,MCPH9,SCKL5;centrosomal protein 152kDa
hsa:441381;LRRC24,LRRC14OS;leucine rich repeat containing 24
hsa:151354;FAM84A,NSE1,PP11517;family with sequence similarity 84, member A
hsa:6723;SRM,PAPT,SPDSY,SPS1,SRML1;spermidine synthase (EC:2.5.1.16)
hsa:338692;ANKRD13D;ankyrin repeat domain 13 family, member D
hsa:84961;FBXL20,Fbl2,Fbl20;F-box and leucine-rich repeat protein 20
hsa:339448;C1orf174,RP13-531C17.2;chromosome 1 open reading frame 174
hsa:26262;TSPAN17,FBX23,FBXO23,TM4SF17;tetraspanin 17 (EC:3.6.5.3)
hsa:9868;TOMM70A;translocase of outer mitochondrial membrane 70 homolog A (S. cerevisiae)
hsa:79078;C1orf50;chromosome 1 open reading frame 50
hsa:254958;REXO1L1,GOR;REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 1 (EC:3.1.-.-)
hsa:90139;TSPAN18,TSPAN;tetraspanin 18
hsa:8674;VAMP4,VAMP-4,VAMP24;vesicle-associated membrane protein 4
hsa:285180;RUFY4;RUN and FYVE domain containing 4
hsa:441282;AKR1B15,AKR1B10L;aldo-keto reductase family 1, member B15
hsa:387509;GPR153,PGR1;G protein-coupled receptor 153
hsa:149647;FAM71A,RP11-338C15.4;family with sequence similarity 71, member A
hsa:283598;C14orf177;chromosome 14 open reading frame 177
hsa:51163;DBR1;debranching enzyme homolog 1 (S. cerevisiae)
hsa:375607;NAT16,C7orf52;N-acetyltransferase 16 (GCN5-related, putative)
hsa:201305;SPNS3;spinster homolog 3 (Drosophila)
hsa:171177;RHOV,ARHV,CHP,WRCH2;ras homolog family member V
hsa:256329;C11orf35;chromosome 11 open reading frame 35
hsa:55798;METTL2B,METL,METTL2,METTL2A,PSENIP1;methyltransferase like 2B
hsa:399947;C11orf87,LOH11CR1A;chromosome 11 open reading frame 87
hsa:222826;FAM217A,C6orf146;family with sequence similarity 217, member A
hsa:10046;MAMLD1,CG1,CXorf6,F18,HYSP2;mastermind-like domain containing 1
hsa:84103;C4orf17;chromosome 4 open reading frame 17
hsa:158297;FAM154A,C9orf138;family with sequence similarity 154, member A
hsa:4616;GADD45B,GADD45BETA,MYD118;growth arrest and DNA-damage-inducible, beta
hsa:10424;PGRMC2,DG6,PMBP;progesterone receptor membrane component 2
hsa:25849;PARM1,Cipar1,DKFZP564O0823,PARM-1,WSC4;prostate androgen-regulated mucin-like protein 1
hsa:116236;ABHD15;abhydrolase domain containing 15 (EC:3.1.1.-)
hsa:10368;CACNG3;calcium channel, voltage-dependent, gamma subunit 3
hsa:83446;CCDC70;coiled-coil domain containing 70
hsa:60598;KCNK15,K2p15.1,KCNK11,KCNK14,KT3.3,TASK-5,TASK5,dJ781B1.1;potassium channel, subfamily K, member 15
hsa:23654;PLXNB2,MM1,Nbla00445,PLEXB2,dJ402G11.3;plexin B2
hsa:222611;GPR111,PGR20,hGPCR35;G protein-coupled receptor 111
hsa:165100;C2orf57;chromosome 2 open reading frame 57
hsa:167555;FAM151B,UNQ9217;family with sequence similarity 151, member B
hsa:84942;WDR73;WD repeat domain 73
hsa:4109;MAGEA10,CT1.10,MAGE10;melanoma antigen family A, 10
hsa:284805;C20orf203;chromosome 20 open reading frame 203
hsa:151648;SGOL1,NY-BR-85,SGO,Sgo1;shugoshin-like 1 (S. pombe)
hsa:84138;SLC7A6OS;solute carrier family 7, member 6 opposite strand
hsa:100132526;FGD5P1;FYVE, RhoGEF and PH domain containing 5 pseudogene 1
hsa:53615;MBD3;methyl-CpG binding domain protein 3
hsa:146330;FBXL16,C16orf22,Fbl16,c380A1.1;F-box and leucine-rich repeat protein 16
hsa:664618;HSP90AB4P,HSP90Bd;heat shock protein 90kDa alpha (cytosolic), class B member 4, pseudogene
hsa:493900;TMEM9B-AS1,C11orf18;TMEM9B antisense RNA 1
hsa:731220;RFX8;RFX family member 8, lacking RFX DNA binding domain
hsa:83607;AMMECR1L;AMMECR1-like
hsa:23269;MGA,MAD5,MXD5;MGA, MAX dimerization protein
hsa:4752;NEK3,HSPK36;NIMA-related kinase 3 (EC:2.7.11.1)
hsa:7404;UTY,UTY1;ubiquitously transcribed tetratricopeptide repeat containing, Y-linked
hsa:341676;NEK5;NIMA-related kinase 5 (EC:2.7.11.1)
hsa:285359;PDCL3P4;phosducin-like 3 pseudogene 4
hsa:152024;LINC00691;long intergenic non-protein coding RNA 691
hsa:172;AFG3L1P,AFG3,AFG3L1;AFG3 ATPase family member 3-like 1 (S. cerevisiae), pseudogene
hsa:284069;FAM171A2;family with sequence similarity 171, member A2
hsa:9911;TMCC2,HUCEP11;transmembrane and coiled-coil domain family 2
hsa:84056;KATNAL1;katanin p60 subunit A-like 1 (EC:3.6.4.3)
hsa:147991;DPY19L3;dpy-19-like 3 (C. elegans)
hsa:56892;C8orf4,TC-1,TC1;chromosome 8 open reading frame 4
hsa:414157;C10orf62,bA548K23.1;chromosome 10 open reading frame 62
hsa:9725;TMEM63A,KIAA0792;transmembrane protein 63A
hsa:65260;SELRC1,C1orf163;Sel1 repeat containing 1
hsa:90332;EXOC3L2,XTP7;exocyst complex component 3-like 2
hsa:57097;PARP11,ARTD11,C12orf6;poly (ADP-ribose) polymerase family, member 11 (EC:2.4.2.30)
hsa:170062;FAM47B;family with sequence similarity 47, member B
hsa:23167;EFR3A;EFR3 homolog A (S. cerevisiae)
hsa:79057;PRRG3,PRGP3,TMG3;proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane)
hsa:341019;DCDC1;doublecortin domain containing 1
hsa:7268;TTC4;tetratricopeptide repeat domain 4
hsa:79626;TNFAIP8L2,TIPE2;tumor necrosis factor, alpha-induced protein 8-like 2
hsa:55771;PRR11;proline rich 11
hsa:79774;GRTP1,TBC1D6;growth hormone regulated TBC protein 1
hsa:55622;TTC27;tetratricopeptide repeat domain 27
hsa:58513;EPS15L1,EPS15R;epidermal growth factor receptor pathway substrate 15-like 1
hsa:126868;MAB21L3,C1orf161,RP5-1185H19.1;mab-21-like 3 (C. elegans)
hsa:160298;C11orf42;chromosome 11 open reading frame 42
hsa:333926;PPM1J,PP2CZ,PP2Czeta,PPP2CZ;protein phosphatase, Mg2+/Mn2+ dependent, 1J (EC:3.1.3.16)
hsa:145483;FAM161B,C14orf44,c14_5547;family with sequence similarity 161, member B
hsa:85444;LRRCC1,CLERC,SAP2,VFL1;leucine rich repeat and coiled-coil centrosomal protein 1
hsa:343563;OR2T29;olfactory receptor, family 2, subfamily T, member 29
hsa:27257;LSM1,CASM,YJL124C;LSM1 homolog, U6 small nuclear RNA associated (S. cerevisiae)
hsa:3849;KRT2,CK-2e,K2e,KRT2A,KRT2E,KRTE;keratin 2
hsa:80213;TM2D3,BLP2;TM2 domain containing 3
hsa:9778;;KIAA0232
hsa:65979;PHACTR4;phosphatase and actin regulator 4
hsa:389125;MUSTN1,MUSTANG;musculoskeletal, embryonic nuclear protein 1
hsa:83694;RPS6KL1;ribosomal protein S6 kinase-like 1 (EC:2.7.11.1)
hsa:11248;NXPH3,NPH3;neurexophilin 3
hsa:441476;C9orf173;chromosome 9 open reading frame 173
hsa:56128;PCDHB8,PCDH-BETA8,PCDH3I;protocadherin beta 8
hsa:25844;YIPF3,C6orf109,FinGER3,KLIP1,dJ337H4.3;Yip1 domain family, member 3
hsa:388121;TNFAIP8L3;tumor necrosis factor, alpha-induced protein 8-like 3
hsa:8756;ADAM7,ADAM_7,ADAM-7,EAPI,GP-83,GP83;ADAM metallopeptidase domain 7
hsa:139322;APOOL,CXorf33,FAM121A,UNQ8193;apolipoprotein O-like
hsa:83656;C8orf12;chromosome 8 open reading frame 12
hsa:692076;SNORD7,Z30,mgU6-47;small nucleolar RNA, C/D box 7
hsa:26827;RNU6-1,RNU6,RNU6A,U6;RNA, U6 small nuclear 1
hsa:388507;ZNF788;zinc finger family member 788
hsa:80209;PROSER1,C13orf23;proline and serine rich 1
hsa:254263;CNIH2,CNIH-2,Cnil;cornichon homolog 2 (Drosophila)
hsa:57820;CCNB1IP1,C14orf18,HEI10;cyclin B1 interacting protein 1, E3 ubiquitin protein ligase
hsa:9375;TM9SF2,P76;transmembrane 9 superfamily member 2
hsa:245932;DEFB119,DEFB-19,DEFB-20,DEFB120,ESC42-RELA,ESC42-RELB;defensin, beta 119
hsa:25766;PRPF40B,HYPC;PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)
hsa:9538;EI24,EPG4,PIG8,TP53I8;etoposide induced 2.4
hsa:26024;PTCD1;pentatricopeptide repeat domain 1
hsa:285326;LINC00692;long intergenic non-protein coding RNA 692
hsa:3636;INPPL1,OPSMD,SHIP2;inositol polyphosphate phosphatase-like 1 (EC:3.1.3.86)
hsa:8694;DGAT1,ARAT,ARGP1,DGAT;diacylglycerol O-acyltransferase 1 (EC:2.3.1.20 2.3.1.76)
hsa:84971;ATG4D,APG4-D,APG4D,AUTL4;autophagy related 4D, cysteine peptidase
hsa:7136;TNNI2,AMCD2B,DA2B,FSSV,fsTnI;troponin I type 2 (skeletal, fast)
hsa:3885;KRT34,HA4,Ha-4,KRTHA4,hHa4;keratin 34
hsa:10411;RAPGEF3,CAMP-GEFI,EPAC,EPAC1,HSU79275,bcm910;Rap guanine nucleotide exchange factor (GEF) 3
hsa:10550;ARL6IP5,DERP11,GTRAP3-18,JWA,PRAF3,addicsin,hp22,jmx;ADP-ribosylation-like factor 6 interacting protein 5
hsa:54971;BANP,BEND1,SMAR1,SMARBP1;BTG3 associated nuclear protein
hsa:200845;KCTD6,KCASH3;potassium channel tetramerisation domain containing 6
hsa:60506;NYX,CLRP,CSNB1,CSNB1A,CSNB4,NBM1;nyctalopin
hsa:6877;TAF5,TAF2D,TAFII100;TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 100kDa
hsa:26254;OPTC,OPT;opticin
hsa:6690;SPINK1,PCTT,PSTI,Spink3,TATI,TCP;serine peptidase inhibitor, Kazal type 1
hsa:6590;SLPI,ALK1,ALP,BLPI,HUSI,HUSI-I,MPI,WAP4,WFDC4;secretory leukocyte peptidase inhibitor
hsa:407000;MIR218-1,MIRN218-1,mir-218-1;microRNA 218-1
hsa:114761;TTTY4,LINC00123,NCRNA00123,TTTY4A,TTY4;testis-specific transcript, Y-linked 4 (non-protein coding)
hsa:406949;MIR15B,MIRN15B,hsa-mir-15b,miR-15b;microRNA 15b
hsa:406923;MIR133A2,MIRN133A2;microRNA 133a-2
hsa:284702;HNRNPU-AS1,C1orf199,NCRNA00201;HNRNPU antisense RNA 1
hsa:693217;MIR632,MIRN632,hsa-mir-632;microRNA 632
hsa:10255;HCG9,HCGIX,HCGIX4;HLA complex group 9 (non-protein coding)
hsa:100313838;MIR764,hsa-mir-764;microRNA 764
hsa:442899;MIR325,MIRN325,hsa-mir-325;microRNA 325
hsa:494335;MIR423,MIRN423,hsa-mir-423;microRNA 423
hsa:100302158;MIR1231,MIRN1231,hsa-mir-1231;microRNA 1231
hsa:574479;MIR517A,MIRN517A;microRNA 517a
hsa:574483;MIR517B,MIRN517B;microRNA 517b
hsa:407049;MIR92A2,MIRN92-2,MIRN92A-2,MIRN92A2;microRNA 92a-2
hsa:442906;MIR338,MIRN338,hsa-mir-338;microRNA 338
hsa:693159;MIR574,MIRN574,hsa-mir-574;microRNA 574
hsa:440952;EIF1B-AS1;EIF1B antisense RNA 1
hsa:162605;KRT28,KRT25D;keratin 28
hsa:414243;LINC00595,C10orf101;long intergenic non-protein coding RNA 595
hsa:100874123;ZNRF3-AS1;ZNRF3 antisense RNA 1
hsa:100874056;NLGN4Y-AS1,NLGN4Y-AS,NLGN4YAS;NLGN4Y antisense RNA 1
hsa:100874323;HOXA-AS4;HOXA cluster antisense RNA 4
hsa:100874286;NRG1-IT3;NRG1 intronic transcript 3 (non-protein coding)
hsa:100874185;FRMD6-AS2;FRMD6 antisense RNA 2
hsa:100874090;SLC6A1-AS1;SLC6A1 antisense RNA 1
hsa:202181;;SUMO-interacting motifs containing 1 pseudogene
hsa:100874093;BRWD1-AS1;BRWD1 antisense RNA 1
hsa:100874158;LINC00398;long intergenic non-protein coding RNA 398
hsa:100874239;ARHGAP26-AS1;ARHGAP26 antisense RNA 1
hsa:100874051;LZTS1-AS1;LZTS1 antisense RNA 1
hsa:100874021;MAGI2-AS2;MAGI2 antisense RNA 2
hsa:100874212;MYCBP2-AS1;MYCBP2 antisense RNA 1
hsa:100874027;TPRG1-AS2;TPRG1 antisense RNA 2
hsa:100874264;AOAH-IT1;AOAH intronic transcript 1 (non-protein coding)
hsa:100874041;MACC1-AS1;MACC1 antisense RNA 1
hsa:100874361;PPP2R2B-IT1;PPP2R2B intronic transcript 1 (non-protein coding)
hsa:100874330;KCNMB2-IT1;KCNMB2 intronic transcript 1 (non-protein coding)
hsa:100874194;CLDN10-AS1;CLDN10 antisense RNA 1
hsa:100874353;RPS6KA2-IT1;RPS6KA2 intronic transcript 1 (non-protein coding)
hsa:100874196;DIAPH3-AS2,DIPAH3-AS2;DIAPH3 antisense RNA 2
hsa:100874255;RNASEH2B-AS1;RNASEH2B antisense RNA 1
hsa:100874197;EFCAB6-AS1;EFCAB6 antisense RNA 1
hsa:100874282;MLIP-IT1;MLIP intronic transcript 1 (non-protein coding)
hsa:100874342;RNF216-IT1;RNF216 intronic transcript 1 (non-protein coding)
hsa:100874374;ARHGEF38-IT1;ARHGEF38 intronic transcript 1 (non-protein coding)
hsa:414763;LINC00516,C14orf17;long intergenic non-protein coding RNA 516
hsa:100128378;LINC00696,C3orf74;long intergenic non-protein coding RNA 696
hsa:101101776;;ribosome biogenesis protein BMS1 homolog pseudogene
hsa:401093;MBNL1-AS1;MBNL1 antisense RNA 1
hsa:101101772;LINC00601;long intergenic non-protein coding RNA 601
hsa:101101773;LINC00609;long intergenic non-protein coding RNA 609
hsa:285352;KIF9-AS1;KIF9 antisense RNA 1
hsa:101101775;TMEM220-AS1;TMEM220 antisense RNA 1
hsa:2069;EREG,ER;epiregulin
hsa:54896;PQLC2;PQ loop repeat containing 2
hsa:9032;TM4SF5;transmembrane 4 L six family member 5
hsa:345456;PFN3;profilin 3
hsa:9019;MPZL1,MPZL1b,PZR,PZR1b,PZRa,PZRb;myelin protein zero-like 1
hsa:219333;USP12,UBH1,USP12L1;ubiquitin specific peptidase 12 (EC:3.4.19.12)
hsa:219931;TPCN2,SHEP10,TPC2;two pore segment channel 2
hsa:6370;CCL25,Ckb15,SCYA25,TECK;chemokine (C-C motif) ligand 25
hsa:2101;ESRRA,ERR1,ERRa,ERRalpha,ESRL1,NR3B1;estrogen-related receptor alpha
hsa:23005;MAPKBP1,JNKBP-1;mitogen-activated protein kinase binding protein 1
hsa:10568;SLC34A2,NAPI-3B,NAPI-IIb,NPTIIb;solute carrier family 34 (sodium phosphate), member 2
hsa:79879;CCDC134,dJ821D11.3;coiled-coil domain containing 134
hsa:574537;UGT2A2;UDP glucuronosyltransferase 2 family, polypeptide A2 (EC:2.4.1.17)
hsa:6259;RYK,D3S3195,JTK5,JTK5A,RYK1;receptor-like tyrosine kinase (EC:2.7.10.1)
hsa:160728;SLC5A8,AIT,SMCT,SMCT1;solute carrier family 5 (iodide transporter), member 8
hsa:9486;CHST10,HNK-1ST,HNK1ST;carbohydrate sulfotransferase 10
hsa:57192;MCOLN1,MG-2,ML4,MLIV,MST080,TRP-ML1,TRPM-L1,TRPML1;mucolipin 1
hsa:10267;RAMP1;receptor (G protein-coupled) activity modifying protein 1
hsa:57709;SLC7A14;solute carrier family 7 (orphan transporter), member 14
hsa:9743;ARHGAP32,GC-GAP,GRIT,PX-RICS,RICS,p200RhoGAP,p250GAP;Rho GTPase activating protein 32
hsa:9891;NUAK1,ARK5;NUAK family, SNF1-like kinase, 1 (EC:2.7.11.1)
hsa:27289;RND1,ARHS,RHO6,RHOS;Rho family GTPase 1
hsa:220296;HEPACAM,GlialCAM,MLC2A,MLC2B;hepatic and glial cell adhesion molecule
hsa:27287;VENTX,HPX42B,NA88A,VENTX2;VENT homeobox
hsa:8560;DEGS1,DEGS,DEGS-1,DES1,Des-1,FADS7,MLD;delta(4)-desaturase, sphingolipid 1 (EC:1.14.-.-)
hsa:80321;CEP70,BITE;centrosomal protein 70kDa
hsa:727764;MAFIP,MIP,TEKT4P4,pp5644;MAFF interacting protein (pseudogene)
hsa:442897;MIR323A,MIR323,MIRN323,hsa-mir-323,hsa-mir-323a;microRNA 323a
hsa:574476;MIR520C,MIRN520C;microRNA 520c
hsa:407013;MIR24-2,MIRN24-2,miR-24-2,miRNA24-2;microRNA 24-2
hsa:407015;MIR26A1,MIR26A,MIRN26A1;microRNA 26a-1
hsa:26871;RNU1-1,HSD1,HU1-1,RNU1,RNU1A,RNU1A3,RNU1G4,Rnu1a1,U1,U1A1;RNA, U1 small nuclear 1
hsa:407024;MIR29B1,MIRN29B1,miRNA29B1;microRNA 29b-1
hsa:442893;MIR151A,MIR151,MIRN151,hsa-mir-151,hsa-mir-151a;microRNA 151a
hsa:100128023;DPPA2P3;developmental pluripotency associated 2 pseudogene 3
hsa:100506994;PTPRG-AS1;PTPRG antisense RNA 1
hsa:285401;LINC00698;long intergenic non-protein coding RNA 698
hsa:5001;ORC5,ORC5L,ORC5P,ORC5T;origin recognition complex, subunit 5
hsa:22797;TFEC,TCFEC,TFE-C,TFEC-L,TFECL,bHLHe34,hTFEC-L;transcription factor EC
hsa:100130331;;POTE ankyrin domain family, member F pseudogene
hsa:648809;EFTUD1P1,FAM42B,HsT19321;elongation factor Tu GTP binding domain containing 1 pseudogene 1
hsa:10871;CD300C,CLM-6,CMRF-35,CMRF-35A,CMRF35,CMRF35-A1,CMRF35A,CMRF35A1,IGSF16,LIR;CD300c molecule
hsa:56181;MTFR1L,FAM54B,MST116,MSTP116;mitochondrial fission regulator 1-like
hsa:171483;FAM9B,TEX39B;family with sequence similarity 9, member B
hsa:171484;FAM9C,TEX39C;family with sequence similarity 9, member C
hsa:113115;MTFR2,DUFD1,FAM54A;mitochondrial fission regulator 2
hsa:201158;TVP23C,FAM18B2;trans-golgi network vesicle protein 23 homolog C (S. cerevisiae)
hsa:51030;TVP23B,FAM18B,FAM18B1,NPD008,YDR084C;trans-golgi network vesicle protein 23 homolog B (S. cerevisiae)
hsa:170067;SUPT20HL2,FAM48B1,FAM48B2;suppressor of Ty 20 homolog (S. cerevisiae)-like 2
hsa:100130302;SUPT20HL1,FAM48B1;suppressor of Ty 20 homolog (S. cerevisiae)-like 1
hsa:728279;KRTAP2-2,KAP2.2;keratin associated protein 2-2
hsa:27336;HTATSF1,TAT-SF1,dJ196E23.2;HIV-1 Tat specific factor 1
hsa:8499;PPFIA2;protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2
hsa:79993;ELOVL7;ELOVL fatty acid elongase 7 (EC:2.3.1.199)
hsa:100130361;CXorf49,CXorf49B;chromosome X open reading frame 49
hsa:100132341;CLUHP3,C16orf67,KIAA0664L3,KIAA0664P3;clustered mitochondria (cluA/CLU1) homolog pseudogene 3
hsa:23504;RIMBP2,RBP2,RIM-BP2;RIMS binding protein 2
hsa:1431;CS;citrate synthase (EC:2.3.3.1)
hsa:51057;WDPCP,BBS15,C2orf86,FRITZ,FRTZ;WD repeat containing planar cell polarity effector
hsa:4709;NDUFB3,B12,CI-B12;NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa
hsa:6253;RTN2,NSP2,NSPL1,NSPLI,SPG12;reticulon 2
hsa:1209;CLPTM1;cleft lip and palate associated transmembrane protein 1
hsa:9229;DLGAP1,DAP-1,DAP-1-ALPHA,DAP-1-BETA,GKAP,SAPAP1,hGKAP;discs, large (Drosophila) homolog-associated protein 1
hsa:274;BIN1,AMPH2,AMPHL,SH3P9;bridging integrator 1
hsa:9985;REC8,HR21spB,REC8L1,Rec8p;REC8 homolog (yeast)
hsa:9554;SEC22B,ERS-24,SEC22L1;SEC22 vesicle trafficking protein homolog B (S. cerevisiae) (gene/pseudogene)
hsa:9086;EIF1AY;eukaryotic translation initiation factor 1A, Y-linked
hsa:3776;KCNK2,K2p2.1,TPKC1,TREK,TREK-1,TREK1,hTREK-1c,hTREK-1e;potassium channel, subfamily K, member 2
hsa:2941;GSTA4,GSTA4-4,GTA4;glutathione S-transferase alpha 4 (EC:2.5.1.18)
hsa:26873;OPLAH,5-Opase,OPLA,OPLAHD;5-oxoprolinase (ATP-hydrolysing) (EC:3.5.2.9)
hsa:1719;DHFR,DHFRP1,DYR;dihydrofolate reductase (EC:1.5.1.3)
hsa:8777;MPDZ,MUPP1;multiple PDZ domain protein
hsa:788;SLC25A20,CAC,CACT;solute carrier family 25 (carnitine/acylcarnitine translocase), member 20
hsa:8446;DUSP11,PIR1;dual specificity phosphatase 11 (RNA/RNP complex 1-interacting) (EC:3.1.3.16 3.1.3.48)
hsa:10261;IGSF6,DORA;immunoglobulin superfamily, member 6
hsa:9522;SCAMP1,SCAMP,SCAMP37;secretory carrier membrane protein 1
hsa:223117;SEMA3D,Sema-Z2,coll-2;sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D
hsa:8613;PPAP2B,Dri42,LPP3,PAP2B,VCIP;phosphatidic acid phosphatase type 2B (EC:3.1.3.4)
hsa:4725;NDUFS5,CI-15k,CI15K;NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)
hsa:9016;SLC25A14,BMCP1,UCP5;solute carrier family 25 (mitochondrial carrier, brain), member 14
hsa:8839;WISP2,CCN5,CT58,CTGF-L;WNT1 inducible signaling pathway protein 2
hsa:8993;PGLYRP1,PGLYRP,PGRP,PGRP-S,PGRPS,TAG7,TNFSF3L;peptidoglycan recognition protein 1
hsa:135935;NOBOX,OG-2,OG2,OG2X,POF5,TCAG_12042;NOBOX oogenesis homeobox
hsa:8468;FKBP6,FKBP36,PPIase;FK506 binding protein 6, 36kDa (EC:5.2.1.8)
hsa:79634;SCRN3,SES3;secernin 3
hsa:348120;CT60;cancer/testis antigen 60 (non-protein coding)
hsa:404663;CT49,TAG;cancer/testis antigen 49 (non-protein coding)
hsa:647107;CT64;cancer/testis antigen 64 (non-protein coding)
hsa:116535;MRGPRF,GPR140,GPR168,MRGF,RTA;MAS-related GPR, member F
hsa:91409;CCDC74B;coiled-coil domain containing 74B
hsa:339456;TMEM52;transmembrane protein 52
hsa:144097;C11orf84;chromosome 11 open reading frame 84
hsa:55861;DBNDD2,C20orf35,CK1BP,HSMNP1;dysbindin (dystrobrevin binding protein 1) domain containing 2
hsa:284106;CISD3,Miner2;CDGSH iron sulfur domain 3
hsa:148003;LGALS16;lectin, galactoside-binding, soluble, 16
hsa:130888;FBXO36,Fbx36;F-box protein 36
hsa:284427;SLC25A41,APC4;solute carrier family 25, member 41
hsa:6168;RPL37A,L37A;ribosomal protein L37a
hsa:27005;USP21,USP16,USP23;ubiquitin specific peptidase 21 (EC:3.4.19.12)
hsa:6141;RPL18,L18;ribosomal protein L18
hsa:6747;SSR3,TRAPG;signal sequence receptor, gamma (translocon-associated protein gamma)
hsa:440270;GOLGA8B,GOLGA5;golgin A8 family, member B
hsa:64648;SPANXD,CT11.4,SPANX-C,SPANX-D,dJ171K16.1;SPANX family, member D
hsa:9502;XAGE2,CT12.2,GAGED3,XAGE-2;X antigen family, member 2
hsa:1033;CDKN3,CDI1,CIP2,KAP,KAP1;cyclin-dependent kinase inhibitor 3 (EC:3.1.3.16 3.1.3.48)
hsa:22932;POMZP3,POM-ZP3,POM121;POM121 and ZP3 fusion
hsa:150590;C2orf15;chromosome 2 open reading frame 15
hsa:255758;TCTEX1D2;Tctex1 domain containing 2
hsa:29901;SAC3D1,HSU79266,SHD1;SAC3 domain containing 1
hsa:115098;CCDC124;coiled-coil domain containing 124
hsa:10591;DNPH1,C6orf108,RCL,RP3-330M21.3,dJ330M21.3;2'-deoxynucleoside 5'-phosphate N-hydrolase 1
hsa:414919;C8orf82;chromosome 8 open reading frame 82
hsa:653486;;secretoglobin, family 1C, member 1-like
hsa:389362;PSMG4,C6orf86,PAC4,bA506K6.2;proteasome (prosome, macropain) assembly chaperone 4
hsa:200726;;hCG1657980
hsa:146822;CDRT15;CMT1A duplicated region transcript 15
hsa:121273;C12orf54,HSD-29,HSD-30;chromosome 12 open reading frame 54
hsa:5279;PIGC,GPI2;phosphatidylinositol glycan anchor biosynthesis, class C (EC:2.4.1.198)
hsa:128077;LIX1L;Lix1 homolog (mouse)-like
hsa:55586;MIOX,ALDRL6;myo-inositol oxygenase (EC:1.13.99.1)
hsa:6171;RPL41,L41;ribosomal protein L41
hsa:647310;TEX22;testis expressed 22
hsa:401466;C8orf59;chromosome 8 open reading frame 59
hsa:1350;COX7C;cytochrome c oxidase subunit VIIc (EC:1.9.3.1)
hsa:8045;RASSF7,C11orf13,HRAS1,HRC1;Ras association (RalGDS/AF-6) domain family (N-terminal) member 7
hsa:9789;SPCS2;signal peptidase complex subunit 2 homolog (S. cerevisiae) (EC:3.4.-.-)
hsa:80135;RPF1,BXDC5,RP11-118B23.1;ribosome production factor 1 homolog (S. cerevisiae)
hsa:11017;SNRNP27,27K,RY1;small nuclear ribonucleoprotein 27kDa (U4/U6.U5)
hsa:51118;UTP11L,CGI94;UTP11-like, U3 small nucleolar ribonucleoprotein, (yeast)
hsa:91408;BTF3L4;basic transcription factor 3-like 4
hsa:256472;TMEM151A,TMEM151;transmembrane protein 151A
hsa:283971;CLEC18C,MRCL,MRCL3;C-type lectin domain family 18, member C
hsa:256710;GLIPR1L1,ALKN2972,PRO7434;GLI pathogenesis-related 1 like 1
hsa:84418;CYSTM1,C5orf32;cysteine-rich transmembrane module containing 1
hsa:51239;ANKRD39;ankyrin repeat domain 39
hsa:91368;CDKN2AIPNL;CDKN2A interacting protein N-terminal like
hsa:85319;BAGE2,CT2.2;B melanoma antigen family, member 2
hsa:4635;MYL4,ALC1,AMLC,GT1;myosin, light chain 4, alkali;atrial, embryonic
hsa:55251;PCMTD2,C20orf36;protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2
hsa:653129;PTPN20A,CT126,PTPN20B,bA142I17.1,hPTPN20;protein tyrosine phosphatase, non-receptor type 20A (EC:3.1.3.48)
hsa:221143;N6AMT2,ESP13;N-6 adenine-specific DNA methyltransferase 2 (putative)
hsa:2219;FCN1,FCNM;ficolin (collagen/fibrinogen domain containing) 1
hsa:80167;C4orf29;chromosome 4 open reading frame 29
hsa:51622;CCZ1,C7orf28A,CCZ1A,H_DJ1163J12.2;CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae)
hsa:9533;POLR1C,RPA39,RPA40,RPA5,RPAC1,TCS3;polymerase (RNA) I polypeptide C, 30kDa
hsa:55425;LSR7,RP11-245H20.2,bA245H20.2;KIAA1704
hsa:147011;PROCA1;protein interacting with cyclin A1
hsa:84134;TOMM40L,RP11-297K8.10,TOMM40B;translocase of outer mitochondrial membrane 40 homolog (yeast)-like
hsa:11333;PDAP1,HASPP28,PAP,PAP1;PDGFA associated protein 1
hsa:3512;IGJ,IGCJ,JCH;immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides
hsa:100506688;;uncharacterized LOC100506688
hsa:51596;CUTA,ACHAP,C6orf82;cutA divalent cation tolerance homolog (E. coli)
hsa:10791;VAMP5;vesicle-associated membrane protein 5
hsa:128414;NKAIN4,C20orf58,FAM77A,bA261N11.2;Na+/K+ transporting ATPase interacting 4
hsa:440699;LRRC52;leucine rich repeat containing 52
hsa:653220;XAGE1B,CT12.1,CT12.1B,CTP9,GAGED2;X antigen family, member 1B
hsa:64979;MRPL36,BRIP1,L36mt,MRP-L36,PRPL36,RPMJ;mitochondrial ribosomal protein L36
hsa:339855;KY;kyphoscoliosis peptidase
hsa:10245;TIMM17B,DXS9822,TIM17B;translocase of inner mitochondrial membrane 17 homolog B (yeast)
hsa:163154;PRR22;proline rich 22
hsa:445329;SULT1A4,HAST3,M-PST,ST1A3/ST1A4,TL-PST;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4 (EC:2.8.2.1)
hsa:123207;C15orf40;chromosome 15 open reading frame 40
hsa:8611;PPAP2A,LLP1a,LPP1,PAP-2a,PAP2,PAP2a2,PAP2alpha2,PAPalpha1;phosphatidic acid phosphatase type 2A (EC:3.1.3.4)
hsa:27089;UQCRQ,QCR8,QP-C,QPC,UQCR7;ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa (EC:1.10.2.2)
hsa:100133053;CXorf51B;chromosome X open reading frame 51B
hsa:55859;BEX1,BEX2,HBEX2,HGR74-h;brain expressed, X-linked 1
hsa:4849;CNOT3,LENG2,NOT3,NOT3H;CCR4-NOT transcription complex, subunit 3
hsa:475;ATOX1,ATX1,HAH1;ATX1 antioxidant protein 1 homolog (yeast) (EC:6.2.1.2)
hsa:440400;RNASEK;ribonuclease, RNase K (EC:3.1.-.-)
hsa:654341;TBC1D3G;TBC1 domain family, member 3G
hsa:148014;TTC9B;tetratricopeptide repeat domain 9B
hsa:146227;BEAN1,BEAN,SCA31;brain expressed, associated with NEDD4, 1
hsa:100533496;TVP23C-CDRT4,FAM18B2-CDRT4;TVP23C-CDRT4 readthrough
hsa:653067;XAGE1E,CT12.1,CT12.1E,CTP9,GAGED2;X antigen family, member 1E
hsa:644041;C18orf63,DKFZP781G0119;chromosome 18 open reading frame 63
hsa:8972;MGAM,MG,MGA;maltase-glucoamylase (alpha-glucosidase) (EC:3.2.1.20 3.2.1.3)
hsa:1443;CSH2,CS-2,CSB,hCS-B;chorionic somatomammotropin hormone 2
hsa:8926;SNURF;SNRPN upstream reading frame
hsa:150223;YDJC;YdjC homolog (bacterial)
hsa:56061;UBFD1,UBPH;ubiquitin family domain containing 1
hsa:692094;MSMP,PSMP;microseminoprotein, prostate associated
hsa:84889;SLC7A3,ATRC3,CAT-3,CAT3;solute carrier family 7 (cationic amino acid transporter, y+ system), member 3
hsa:221336;BEND6,C6orf65,bA203B9.1;BEN domain containing 6
hsa:4821;NKX2-2,NKX2.2,NKX2B;NK2 homeobox 2
hsa:10073;SNUPN,KPNBL,RNUT1,Snurportin1;snurportin 1
hsa:728392;;uncharacterized LOC728392
hsa:146456;TMED6,PRO34237,SPLL9146;transmembrane emp24 protein transport domain containing 6
hsa:81575;APOLD1,VERGE;apolipoprotein L domain containing 1
hsa:4696;NDUFA3,B9,CI-B9;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa
hsa:9441;MED26,CRSP7,CRSP70;mediator complex subunit 26
hsa:84218;TBC1D3F,TBC1D3;TBC1 domain family, member 3F
hsa:79843;FAM124B;family with sequence similarity 124B
hsa:284184;C17orf89;chromosome 17 open reading frame 89
hsa:374291;NDUFS7,CI-20,CI-20KD,MY017,PSST;NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3)
hsa:414318;C9orf106,bA65J3.5;chromosome 9 open reading frame 106
hsa:9721;GPRIN2,GRIN2,KIAA0514;G protein regulated inducer of neurite outgrowth 2
hsa:55071;C9orf40;chromosome 9 open reading frame 40
hsa:91151;TIGD7,Sancho;tigger transposable element derived 7
hsa:4717;NDUFC1,KFYI;NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa
hsa:645104;CLRN2;clarin 2
hsa:375307;C2orf62;chromosome 2 open reading frame 62
hsa:10281;DSCR4,DCRB,DSCRB;Down syndrome critical region gene 4
hsa:4726;NDUFS6,CI-13kA,CI-13kD-A,CI13KDA;NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3)
hsa:100190949;C5orf52;chromosome 5 open reading frame 52
hsa:10094;ARPC3,ARC21,p21-Arc;actin related protein 2/3 complex, subunit 3, 21kDa
hsa:100288797;TMEM239;transmembrane protein 239
hsa:3963;LGALS7,GAL7,LGALS7A;lectin, galactoside-binding, soluble, 7
hsa:51259;TMEM216,CORS2,MKS2;transmembrane protein 216
hsa:2786;GNG4;guanine nucleotide binding protein (G protein), gamma 4
hsa:388381;C17orf98;chromosome 17 open reading frame 98
hsa:51562;MBIP;MAP3K12 binding inhibitory protein 1
hsa:100130301;;uncharacterized LOC100130301
hsa:285016;FAM150B,PRO1097,RGPG542;family with sequence similarity 150, member B
hsa:2788;GNG7;guanine nucleotide binding protein (G protein), gamma 7
hsa:3904;LAIR2,CD306;leukocyte-associated immunoglobulin-like receptor 2
hsa:81623;DEFB126,C20orf8,DEFB-26,DEFB26,ESP13.2,bA530N10.1,hBD-26;defensin, beta 126
hsa:644186;SYCE3,C22orf41,THEG2;synaptonemal complex central element protein 3
hsa:80759;KHDC1,C6orf148,NDG1,bA257K9.4;KH homology domain containing 1
hsa:400668;PRSS57,PRSSL1,UNQ782;protease, serine, 57
hsa:100287466;PNMA6D;paraneoplastic Ma antigen family member 6D
hsa:63877;FAM204A,C10orf84,bA319I23.1;family with sequence similarity 204, member A
hsa:65078;RTN4R,NGR,NOGOR;reticulon 4 receptor
hsa:51282;SCAND1,RAZ1,SDP1;SCAN domain containing 1
hsa:84262;PSMG3,C7orf48,PAC3;proteasome (prosome, macropain) assembly chaperone 3
hsa:85285;KRTAP4-1,KAP4.1,KAP4.10,KRTAP4-10,KRTAP4.10;keratin associated protein 4-1
hsa:340526;RGAG4,6430402L03Rik,MAR5,MART5;retrotransposon gag domain containing 4
hsa:55957;LIN37,F25965,ZK418.4,lin-37;lin-37 homolog (C. elegans)
hsa:79002;C19orf43,fSAP18;chromosome 19 open reading frame 43
hsa:8395;PIP5K1B,MSS4,STM7;phosphatidylinositol-4-phosphate 5-kinase, type I, beta (EC:2.7.1.68)
hsa:80148;PQLC1;PQ loop repeat containing 1
hsa:286257;C9orf142;chromosome 9 open reading frame 142
hsa:5224;PGAM2,GSD10,PGAM-M,PGAMM;phosphoglycerate mutase 2 (muscle) (EC:3.1.3.13 5.4.2.1 5.4.2.4)
hsa:643802;;u3 small nucleolar ribonucleoprotein protein MPP10-like
hsa:387695;C10orf99,UNQ1833;chromosome 10 open reading frame 99
hsa:55049;C19orf60;chromosome 19 open reading frame 60
hsa:80833;APOL3,APOLIII,CG121;apolipoprotein L, 3
hsa:54960;GEMIN8,FAM51A1;gem (nuclear organelle) associated protein 8
hsa:80775;TMEM177;transmembrane protein 177
hsa:5554;PRH1,PA;proline-rich protein HaeIII subfamily 1
hsa:480;ATP1A4,ATP1A1,ATP1AL2;ATPase, Na+/K+ transporting, alpha 4 polypeptide (EC:3.6.3.9)
hsa:728833;FAM72D,GCUD2;family with sequence similarity 72, member D
hsa:64776;C11orf1;chromosome 11 open reading frame 1
hsa:55342;STRBP,ILF3L,SPNR,p74;spermatid perinuclear RNA binding protein
hsa:10870;HCST,DAP10,KAP10,PIK3AP;hematopoietic cell signal transducer
hsa:9410;SNRNP40,40K,HPRP8BP,PRP8BP,PRPF8BP,RP11-490K7.3,SPF38,WDR57;small nuclear ribonucleoprotein 40kDa (U5)
hsa:65094;JMJD4;jumonji domain containing 4
hsa:9232;PTTG1,EAP1,HPTTG,PTTG,TUTR1;pituitary tumor-transforming 1
hsa:728269;MAGEA9B;melanoma antigen family A, 9B
hsa:554235;ASPDH;aspartate dehydrogenase domain containing (EC:1.4.1.21)
hsa:144347;FAM101A;family with sequence similarity 101, member A
hsa:26022;TMEM98;transmembrane protein 98
hsa:196415;C12orf77;chromosome 12 open reading frame 77
hsa:157927;C9orf62;chromosome 9 open reading frame 62
hsa:441871;PRAMEF7;PRAME family member 7
hsa:343070;PRAMEF9;PRAME family member 9
hsa:138255;C9orf135;chromosome 9 open reading frame 135
hsa:10469;TIMM44,TIM44;translocase of inner mitochondrial membrane 44 homolog (yeast)
hsa:100528064;NEDD8-MDP1;NEDD8-MDP1 readthrough
hsa:203562;TMEM31;transmembrane protein 31
hsa:84270;C9orf89,BinCARD,bA370F5.1;chromosome 9 open reading frame 89
hsa:200916;RPL22L1;ribosomal protein L22-like 1
hsa:100506144;ZMYM6NB;ZMYM6 neighbor
hsa:51480;VCX2,VCX-2r,VCX2R,VCXB;variable charge, X-linked 2
hsa:9254;CACNA2D2,CACNA2D,LUAC11.1;calcium channel, voltage-dependent, alpha 2/delta subunit 2
hsa:541468;LURAP1,C1orf190,LRAP35a,LRP35A;leucine rich adaptor protein 1
hsa:374395;TMEM179B;transmembrane protein 179B
hsa:26227;PHGDH,3-PGDH,3PGDH,PDG,PGAD,PGD,PGDH,SERA;phosphoglycerate dehydrogenase (EC:1.1.1.95)
hsa:203062;TSNARE1;t-SNARE domain containing 1
hsa:80777;CYB5B,CYB5-M,CYPB5M,OMB5;cytochrome b5 type B (outer mitochondrial membrane)
hsa:653619;PRAMEF15;PRAME family member 15
hsa:85452;;KIAA1751
hsa:147199;SCGB1C1,RYD5;secretoglobin, family 1C, member 1
hsa:552900;BOLA2,BOLA2A,My016;bolA homolog 2 (E. coli)
hsa:83541;FAM110A,C20orf55,F10,bA371L19.3;family with sequence similarity 110, member A
hsa:132864;CPEB2,CPE-BP2,CPEB-2,hCPEB-2;cytoplasmic polyadenylation element binding protein 2
hsa:27018;NGFRAP1,BEX3,Bex,DXS6984E,HGR74,NADE;nerve growth factor receptor (TNFRSF16) associated protein 1
hsa:81553;FAM49A;family with sequence similarity 49, member A
hsa:5691;PSMB3,HC10-II;proteasome (prosome, macropain) subunit, beta type, 3 (EC:3.4.25.1)
hsa:26225;ARL5A,ARFLP5,ARL5;ADP-ribosylation factor-like 5A
hsa:55286;C4orf19;chromosome 4 open reading frame 19
hsa:29081;METTL5,HSPC133;methyltransferase like 5
hsa:10248;POP7,0610037N12Rik,RPP2,RPP20;processing of precursor 7, ribonuclease P/MRP subunit (S. cerevisiae) (EC:3.1.26.5)
hsa:55534;MAML3,CAGH3,ERDA3,GDN,MAM-2,MAM2,TNRC3;mastermind-like 3 (Drosophila)
hsa:5688;PSMA7,C6,HSPC,RC6-1,XAPC7;proteasome (prosome, macropain) subunit, alpha type, 7 (EC:3.4.25.1)
hsa:284098;PIGW,Gwt1;phosphatidylinositol glycan anchor biosynthesis, class W
hsa:203447;NRK,NESK;Nik related kinase (EC:2.7.11.1)
hsa:198437;C20orf201;chromosome 20 open reading frame 201
hsa:653519;GPR89A,GPR89B,UNQ192;G protein-coupled receptor 89A
hsa:29080;CCDC59,BR22,TAP26;coiled-coil domain containing 59
hsa:441519;CT45A3,CT45-3,CT45.3,RP13-36C9.1;cancer/testis antigen family 45, member A3
hsa:8707;B3GALT2,BETA3GALT2,GLCT2,beta3Gal-T2;UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2
hsa:284611;FAM102B,SYM-3B;family with sequence similarity 102, member B
hsa:64598;MOSPD3,CDS3,NET30;motile sperm domain containing 3
hsa:404203;SPINK6,BUSI2,UNQ844;serine peptidase inhibitor, Kazal type 6
hsa:2791;GNG11,GNGT11;guanine nucleotide binding protein (G protein), gamma 11
hsa:11313;LYPLA2,APT-2,DJ886K2.4;lysophospholipase II (EC:3.1.1.5)
hsa:5367;PMCH,MCH;pro-melanin-concentrating hormone
hsa:29946;SERTAD3,RBT1;SERTA domain containing 3
hsa:4708;NDUFB2,AGGG,CI-AGGG;NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa (EC:1.6.5.3 1.6.99.3)
hsa:9532;BAG2,BAG-2,dJ417I1.2;BCL2-associated athanogene 2
hsa:286297;;uncharacterized LOC286297
hsa:100289509;;uncharacterized LOC100289509
hsa:84673;TTTY8,LINC00130,NCRNA00130,TTY8;testis-specific transcript, Y-linked 8 (non-protein coding)
hsa:654412;FAM138B,F379,bA395L14.6;family with sequence similarity 138, member B
hsa:285189;PLGLA,PLGLA1,PLGP2,PRGA;plasminogen-like A
hsa:50858;TTTY1,LINC00033,NCRNA00033,TTY1;testis-specific transcript, Y-linked 1 (non-protein coding)
hsa:100132596;XGPY2,XG,XGPY;Xg pseudogene, Y-linked 2
hsa:152195;NUDT16P1,NUDT16P;nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene 1
hsa:158228;FAM201A,C9orf122;family with sequence similarity 201, member A
hsa:100288570;;glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast) pseudogene
hsa:442578;STAG3L3,STAG3L1,STAG3L2;stromal antigen 3-like 3
hsa:645166;;lymphocyte-specific protein 1 pseudogene
hsa:252946;FAM197Y2,CYorf16,FAM197Y2P;family with sequence similarity 197, Y-linked, member 2, pseudogene
hsa:653513;;phosphodiesterase 4D interacting protein pseudogene
hsa:100133669;;uncharacterized LOC100133669
hsa:729467;HSD52;uncharacterized LOC729467
hsa:100288842;;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 pseudogene
hsa:100101115;TTTY21B;testis-specific transcript, Y-linked 21B (non-protein coding)
hsa:100129075;KTN1-AS1,C14orf33;KTN1 antisense RNA 1
hsa:85001;;uncharacterized protein MGC16275
hsa:414235;PRR26,C10orf108;proline rich 26
hsa:150622;;uncharacterized LOC150622
hsa:285692;;uncharacterized LOC285692
hsa:644128;RPL23AP53,RPL23A_20_869;ribosomal protein L23a pseudogene 53
hsa:100507501;;uncharacterized LOC100507501
hsa:285484;;uncharacterized LOC285484
hsa:645332;FAM86C2P;family with sequence similarity 86, member A pseudogene
hsa:729338;CETN4P;centrin EF-hand protein 4, pseudogene
hsa:653786;;otoancorin pseudogene
hsa:378828;LINC00317,C21orf117,NCRNA00317,PRED89;long intergenic non-protein coding RNA 317
hsa:100132741;;uncharacterized LOC100132741
hsa:285150;FLJ33534;uncharacterized LOC285150
hsa:728855;LINC00623;long intergenic non-protein coding RNA 623
hsa:400456;;uncharacterized LOC400456
hsa:389741;;uncharacterized locus MGC21881
hsa:100131733;USP30-AS1;USP30 antisense RNA 1
hsa:204010;RPSAP52,RPSA_17_1251;ribosomal protein SA pseudogene 52
hsa:100506472;;uncharacterized LOC100506472
hsa:728407;;poly (ADP-ribose) glycohydrolase pseudogene
hsa:26082;DKFZP434L187;uncharacterized LOC26082
hsa:100498859;;uncharacterized LOC100498859
hsa:389458;;uncharacterized LOC389458
hsa:728554;;THO complex 3 pseudogene
hsa:400709;SIGLEC16,SIGLECP16,Siglec-P16;sialic acid binding Ig-like lectin 16 (gene/pseudogene)
hsa:124871;;uncharacterized FLJ40194
hsa:150142;ZNF295-AS1,C21orf121,NCRNA00318;ZNF295 antisense RNA 1
hsa:151009;;uncharacterized LOC151009
hsa:150381;;uncharacterized LOC150381
hsa:727924;;uncharacterized LOC727924
hsa:100132781;;cyclin Y-like 1 pseudogene
hsa:440704;;uncharacterized LOC440704
hsa:100506436;SPAG5-AS1;SPAG5 antisense RNA 1
hsa:54090;LINC00111,C21orf21,NCRNA00111;long intergenic non-protein coding RNA 111
hsa:100129407;LINC00684,DMRTC1-AS1;long intergenic non-protein coding RNA 684
hsa:645784;ANKRD36BP2;ankyrin repeat domain 36B pseudogene 2
hsa:151507;MSL3P1,MSL3L2;male-specific lethal 3 homolog (Drosophila) pseudogene 1
hsa:100287083;DEFT1P2;defensin, theta 1 pseudogene 2
hsa:100128176;;uncharacterized LOC100128176
hsa:100134869;UBE2Q2P2,UBE2QP2;ubiquitin-conjugating enzyme E2Q family member 2 pseudogene 2
hsa:654466;KGFLP2;keratinocyte growth factor-like protein 2
hsa:646743;;uncharacterized LOC646743
hsa:201617;LINC00870;uncharacterized LOC201617
hsa:644596;LINC00087,NCRNA00087;long intergenic non-protein coding RNA 87
hsa:541473;;FK506 binding protein 6, 36kDa pseudogene
hsa:550643;;uncharacterized LOC550643
hsa:440101;FLJ12825;uncharacterized LOC440101
hsa:26238;C6orf123,HGC6.2,RP3-431P23.4,dJ431P23.4;chromosome 6 open reading frame 123
hsa:100128890;FAM66B,FAM66E;family with sequence similarity 66, member B
hsa:644945;KRT16P3;keratin 16 pseudogene 3
hsa:100506233;;uncharacterized LOC100506233
hsa:654342;;lymphocyte-specific protein 1 pseudogene
hsa:641702;FAM138F,F379;family with sequence similarity 138, member F
hsa:728875;;uncharacterized LOC728875
hsa:389517;SPDYE8P;speedy homolog E8 (Xenopus laevis), pseudogene
hsa:100506677;AA06,AA02,AA04,AA05;uncharacterized LOC100506677
hsa:285266;ENTPD3-AS1;ENTPD3 antisense RNA 1
hsa:399972;FLJ39051;uncharacterized LOC399972
hsa:727699;LINC00163,C21orf134,NCRNA00163,NLC1-A,NLC1A;long intergenic non-protein coding RNA 163
hsa:100129597;LINC00462;long intergenic non-protein coding RNA 462
hsa:100506211;MIR210HG;MIR210 host gene (non-protein coding)
hsa:425057;TTTY9B,NCRNA00132,TTTY9,TTTY9A,TTY9;testis-specific transcript, Y-linked 9B (non-protein coding)
hsa:100133205;LINC00240,C6orf41,NCRNA00240,bA373D17.1;long intergenic non-protein coding RNA 240
hsa:727849;;golgin A2 pseudogene
hsa:100505978;;uncharacterized LOC100505978
hsa:574036;SERTAD4-AS1,C1orf133;SERTAD4 antisense RNA 1
hsa:285074;;anaphase promoting complex subunit 1 pseudogene
hsa:286359;;uncharacterized LOC286359
hsa:285205;LINC00636;long intergenic non-protein coding RNA 636
hsa:5380;PMS2L2,PMS4,PMS2P2;postmeiotic segregation increased 2-like 2 pseudogene
hsa:100131366;LINC00605;long intergenic non-protein coding RNA 605
hsa:100132948;FAM27C,FAM27A3,bA374M1.5;family with sequence similarity 27, member C
hsa:100133121;FAM27B,FAM27A2,bA12A20.3;family with sequence similarity 27, member B
hsa:154754;PRSS3P2,T6,TRY6;protease, serine, 3 pseudogene 2
hsa:100129518;;uncharacterized LOC100129518
hsa:150527;TISP43;uncharacterized LOC150527
hsa:84278;HIATL2;hippocampus abundant transcript-like 2
hsa:100288380;ULK4P2,D-X,FAM7A2;unc-51-like kinase 4 (C. elegans) pseudogene 2
hsa:100287102;DDX11L1;DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 like 1
hsa:100506826;MYLK-AS1;MYLK antisense RNA 1
hsa:401149;FLJ14186;uncharacterized LOC401149
hsa:100286793;;uncharacterized LOC100286793
hsa:440900;;uncharacterized LOC440900
hsa:114038;LINC00313,C21orf84,NCRNA00313;long intergenic non-protein coding RNA 313
hsa:100132287;;uncharacterized LOC100132287
hsa:100306951;PITPNA-AS1;PITPNA antisense RNA 1
hsa:100133161;;uncharacterized LOC100133161
hsa:283902;HTA;uncharacterized LOC283902
hsa:100287704;;uncharacterized LOC100287704
hsa:100302526;FAM41AY2;family with sequence similarity 41, member A, Y-linked 2
hsa:147804;TPM3P9;tropomyosin 3 pseudogene 9
hsa:442524;DPY19L2P3;dpy-19-like 2 pseudogene 3 (C. elegans)
hsa:441394;SUGT1P1,SGT1P,SUGT1P,bA255A11.1;suppressor of G2 allele of SKP1 (S. cerevisiae) pseudogene 1
hsa:100128946;;uncharacterized LOC100128946
hsa:645638;;WDNM1-like pseudogene
hsa:767811;H2BFXP;H2B histone family, member X, pseudogene
hsa:441317;FAM90A7P,FAM90A7;putative protein FAM90A7
hsa:400958;;uncharacterized LOC400958
hsa:641517;DEFB109P1B,DEF109P1B,DEFB109;defensin, beta 109, pseudogene 1B
hsa:645752;;golgin A6 family, member A pseudogene
hsa:474148;TTTY3B,LNCRNA00122,NCRNA00122;testis-specific transcript, Y-linked 3B (non-protein coding)
hsa:284124;;uncharacterized FLJ36000
hsa:90024;FLJ20021;uncharacterized LOC90024
hsa:253962;CACNA1G-AS1;CACNA1G antisense RNA 1
hsa:257203;DSCR9,NCRNA00038;Down syndrome critical region gene 9 (non-protein coding)
hsa:100507250;;uncharacterized LOC100507250
hsa:100507412;;uncharacterized LOC100507412
hsa:474151;TTTY17B,NCRNA00141;testis-specific transcript, Y-linked 17B (non-protein coding)
hsa:100128385;FAM225B,C9orf110,LINC00256B,NCRNA00256B;family with sequence similarity 225, member B (non-protein coding)
hsa:79798;ARMC5;armadillo repeat containing 5
hsa:100861540;CYP3A7-CYP3AP1,CYP3A7-3AP1,CYP3A7.1L;CYP3A7-CYP3AP1 readthrough
hsa:8225;GTPBP6,PGPL;GTP binding protein 6 (putative)
hsa:285598;ARL10,ARL10A;ADP-ribosylation factor-like 10
hsa:387921;NHLRC3;NHL repeat containing 3
hsa:100862671;;uncharacterized LOC100862671
hsa:353514;LILRA5,CD85,CD85F,ILT-11,ILT11,LILRB7,LIR-9,LIR9;leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5
hsa:147798;TMC4;transmembrane channel-like 4
hsa:653219;XAGE1A,CT12.1,CT12.1A,CTP9,GAGED2,XAGE1;X antigen family, member 1A
hsa:219956;OR9Q1;olfactory receptor, family 9, subfamily Q, member 1
hsa:9615;GDA,CYPIN,GUANASE,NEDASIN;guanine deaminase (EC:3.5.4.3)
hsa:84068;SLC10A7,C4orf13,P7;solute carrier family 10 (sodium/bile acid cotransporter family), member 7
hsa:79758;DHRS12,SDR40C1;dehydrogenase/reductase (SDR family) member 12
hsa:219670;ENKUR,C10orf63;enkurin, TRPC channel interacting protein
hsa:667;DST,BP240,BPA,BPAG1,CATX-15,CATX15,D6S1101,DMH,DT,HSAN6,MACF2;dystonin
hsa:100144595;;uncharacterized LOC100144595
hsa:79917;MAGIX,JM10,PDZX;MAGI family member, X-linked
hsa:10990;LILRB5,CD85C,LIR-8,LIR8;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5
hsa:256021;;uncharacterized LOC256021
hsa:445571;CBWD3,bA561O23.1;COBW domain containing 3
hsa:100653515;;differential display clone 8
hsa:60625;DHX35,C20orf15,DDX35,KAIA0875;DEAH (Asp-Glu-Ala-His) box polypeptide 35 (EC:3.6.4.13)
hsa:196463;PLBD2,P76;phospholipase B domain containing 2
hsa:441864;TARM1,OLT-2;T cell-interacting, activating receptor on myeloid cells 1
hsa:3823;KLRC3,NKG2-E,NKG2E;killer cell lectin-like receptor subfamily C, member 3
hsa:1791;DNTT,TDT;deoxynucleotidyltransferase, terminal (EC:2.7.7.31)
hsa:100885850;PTGES3L-AARSD1;PTGES3L-AARSD1 readthrough;K07050
hsa:26526;TSPAN16,TM-8,TM4-B,TM4SF16;tetraspanin 16
hsa:128821;CST9L,CTES7B,bA218C14.1;cystatin 9-like
hsa:25823;TPSG1,PRSS31,TMT,trpA;tryptase gamma 1 (EC:3.4.21.59)
hsa:114801;TMEM200A,KIAA1913,TTMA,TTMC;transmembrane protein 200A
hsa:100861437;NARR;nine-amino acid residue-repeats
hsa:8412;BCAR3,NSP2,SH2D3B;breast cancer anti-estrogen resistance 3
hsa:58498;MYL7,MYL2A,MYLC2A;myosin, light chain 7, regulatory
hsa:401647;GOLGA7B,C10orf132,C10orf133,bA451M19.3,bA459F3.4;golgin A7 family, member B
hsa:9162;DGKI,DGK-IOTA;diacylglycerol kinase, iota (EC:2.7.1.107)
hsa:6183;MRPS12,MPR-S12,MT-RPS12,RPMS12,RPS12,RPSM12;mitochondrial ribosomal protein S12
hsa:390595;UBAP1L,UBAP-1L;ubiquitin associated protein 1-like
hsa:81569;ACTL8,CT57;actin-like 8
hsa:55863;TMEM126B;transmembrane protein 126B
hsa:143241;DYDC1,DPY30D1;DPY30 domain containing 1
hsa:642597;C18orf42;chromosome 18 open reading frame 42
hsa:729993;SHISA9,CKAMP44;shisa homolog 9 (Xenopus laevis)
hsa:114823;LENG8,pp13842;leukocyte receptor cluster (LRC) member 8
hsa:51241;COX16,C14orf112;COX16 cytochrome c oxidase assembly homolog (S. cerevisiae)
hsa:643847;PGA4,PGA3,PGA5;pepsinogen 4, group I (pepsinogen A) (EC:3.4.23.1)
hsa:27233;SULT1C4,SULT1C,SULT1C2;sulfotransferase family, cytosolic, 1C, member 4 (EC:2.8.2.-)
hsa:10263;CDK2AP2,DOC-1R,p14;cyclin-dependent kinase 2 associated protein 2
hsa:154790;CLEC2L;C-type lectin domain family 2, member L
hsa:56981;PRDM11,PFM8;PR domain containing 11
hsa:100861412;FSBP;fibrinogen silencer binding protein
hsa:63905;MANBAL;mannosidase, beta A, lysosomal-like
hsa:158434;;uncharacterized LOC158434
hsa:11092;C9orf9;chromosome 9 open reading frame 9
hsa:644414;DEFB131,DEFB-31;defensin, beta 131
hsa:388813;;uncharacterized protein ENSP00000383407-like
hsa:100862662;ALDH1L1-AS2;ALDH1L1 antisense RNA 2
hsa:645520;FAM138A,F379;family with sequence similarity 138, member A
hsa:100133920;;uncharacterized LOC100133920
hsa:252953;TTTY21,NCRNA00146;testis-specific transcript, Y-linked 21 (non-protein coding)
hsa:100874058;COX10-AS1,COX10-AS,COX10AS;COX10 antisense RNA 1
hsa:100874018;EPN2-AS1;EPN2 antisense RNA 1
hsa:153163;MGC32805;uncharacterized LOC153163
hsa:286023;;uncharacterized FLJ40288
hsa:727915;;uncharacterized LOC727915
hsa:399923;FLJ42102;uncharacterized LOC399923
hsa:728463;;uncharacterized LOC728463
hsa:100874171;LINC00439;long intergenic non-protein coding RNA 439
hsa:100130935;CSAG4;CSAG family, member 4 (pseudogene)
hsa:100874147;LINC00366;long intergenic non-protein coding RNA 366
hsa:100505812;;uncharacterized LOC100505812
hsa:100885798;LINC00210,NCRNA00210;long intergenic non-protein coding RNA 210
hsa:100287010;;uncharacterized LOC100287010
hsa:100874150;LINC00379;long intergenic non-protein coding RNA 379
hsa:100132078;;uncharacterized LOC100132078
hsa:144920;LINC00343,NCRNA00343;long intergenic non-protein coding RNA 343
hsa:100101118;TTTY8B,NCRNA00217;testis-specific transcript, Y-linked 8B (non-protein coding)
hsa:100874237;CACNA2D3-AS1;CACNA2D3 antisense RNA 1
hsa:100129175;;uncharacterized LOC100129175
hsa:100862680;LINC00507;long intergenic non-protein coding RNA 507
hsa:100507577;;uncharacterized LOC100507577
hsa:101055625;;uncharacterized LOC101055625
hsa:100133123;;uncharacterized LOC100133123
hsa:100093698;;unknown transcript
hsa:84820;POLR2J4,RPB11-phi;polymerase (RNA) II (DNA directed) polypeptide J4, pseudogene
hsa:400684;;uncharacterized LOC400684
hsa:400558;;uncharacterized LOC400558
hsa:653188;GUSBP3;glucuronidase, beta pseudogene 3
hsa:644248;;uncharacterized LOC644248
hsa:643648;;uncharacterized LOC643648
hsa:729987;;uncharacterized LOC729987
hsa:728342;;uncharacterized LOC728342
hsa:283214;;uncharacterized LOC283214
hsa:100130744;;uncharacterized LOC100130744
hsa:401497;;uncharacterized LOC401497
hsa:100861520;POU6F2-AS1;POU6F2 antisense RNA 1
hsa:283587;;uncharacterized LOC283587
hsa:100874054;LINC00568,ncRNA-a1;long intergenic non-protein coding RNA 568
hsa:100874206;OSBPL10-AS1;OSBPL10 antisense RNA 1
hsa:100133036;FAM95B1;family with sequence similarity 95, member B1
hsa:101054525;;progesterone receptor antisense RNA
hsa:283692;;uncharacterized LOC283692
hsa:100887750;MRPS31P5,MRPS31P3;mitochondrial ribosomal protein S31 pseudogene 5
hsa:100874200;ARHGEF3-AS1;ARHGEF3 antisense RNA 1
hsa:284757;;uncharacterized LOC284757
hsa:646282;AZGP1P1;alpha-2-glycoprotein 1, zinc-binding pseudogene 1
hsa:100874236;COL18A1-AS2;COL18A1 antisense RNA 2
hsa:285762;;uncharacterized LOC285762
hsa:100887754;LINC00359;long intergenic non-protein coding RNA 359
hsa:93655;ST7-OT3,NCRNA00026,ST7,ST7OT3;ST7 overlapping transcript 3 (non-protein coding)
hsa:647476;FLJ20518;FSHD region gene 2 family, member C pseudogene
hsa:149086;;ornithine decarboxylase 1 pseudogene
hsa:140849;LINC00266-1,C20orf69,NCRNA00266,NCRNA00266-1,bA476I15.3;long intergenic non-protein coding RNA 266-1
hsa:100874064;PCDH9-AS2;PCDH9 antisense RNA 2
hsa:724087;CXorf31;chromosome X open reading frame 31
hsa:349160;;uncharacterized LOC349160
hsa:100240735;;uncharacterized LOC100240735
hsa:642426;;uncharacterized LOC642426
hsa:100874074;DLEU7-AS1;DLEU7 antisense RNA 1
hsa:100874086;PCDH9-AS3;PCDH9 antisense RNA 3
hsa:401557;;uncharacterized LOC401557
hsa:100113403;LINC00577,C6orf220,dJ439I14.1;long intergenic non-protein coding RNA 577
hsa:100873939;LNX1-AS1;LNX1 antisense RNA 1
hsa:100874127;LINC00332,NCRNA00332;long intergenic non-protein coding RNA 332
hsa:441242;;uncharacterized LOC441242
hsa:100873955;LNX1-AS2;LNX1 antisense RNA 2
hsa:100887755;LINC00651;long intergenic non-protein coding RNA 651
hsa:283483;LINC00551;long intergenic non-protein coding RNA 551
hsa:100859921;LINC00536;long intergenic non-protein coding RNA 536
hsa:441116;;FLJ16171 protein
hsa:100873941;OPA1-AS1;OPA1 antisense RNA 1
hsa:100750225;PCAT1,PCAT-1;prostate cancer associated transcript 1 (non-protein coding)
hsa:100873942;PHEX-AS1;PHEX antisense RNA 1
hsa:100852410;ZRANB2-AS2;ZRANB2 antisense RNA 2 (head to head)
hsa:100874234;CACNA1C-AS4;CACNA1C antisense RNA 4
hsa:100874243;PRICKLE2-AS3;PRICKLE2 antisense RNA 3
hsa:100874249;DENND5B-AS1;DENND5B antisense RNA 1
hsa:100852408;EGFLAM-AS4;EGFLAM antisense RNA 4
hsa:100874366;HOXC-AS5;HOXC cluster antisense RNA 5
hsa:100862704;LINC00441;long intergenic non-protein coding RNA 441
hsa:441369;FLJ46284;uncharacterized LOC441369
hsa:100873989;GRM5-AS1;GRM5 antisense RNA 1
hsa:550113;;uncharacterized LOC550113
hsa:100873946;VAV3-AS1;VAV3 antisense RNA 1
hsa:100873948;NREP-AS1;NREP antisense RNA 1
hsa:100861402;CERS6-AS1;CERS6 antisense RNA 1
hsa:100874012;NAV2-AS5;NAV2 antisense RNA 5
hsa:280660;SSX9;synovial sarcoma, X breakpoint 9
hsa:100885795;LARS2-AS1;LARS2 antisense RNA 1
hsa:554236;DPY19L2P1;dpy-19-like 2 pseudogene 1 (C. elegans)
hsa:619344;C8orf69;uncharacterized LOC619344
hsa:55000;TUG1,LINC00080,NCRNA00080,TI-227H;taurine upregulated 1 (non-protein coding)
hsa:100533464;PRH1-PRR4,PRH1;PRH1-PRR4 readthrough
hsa:100129515;LINC00633;long intergenic non-protein coding RNA 633
hsa:100874242;PRICKLE2-AS2;PRICKLE2 antisense RNA 2
hsa:100128568;;uncharacterized LOC100128568
hsa:100287596;DDX11L5;DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 like 5
hsa:728040;;hCG1813624
hsa:89838;ULK4P1,D-X,FAM7A1;unc-51-like kinase 4 (C. elegans) pseudogene 1
hsa:100506100;;uncharacterized LOC100506100
hsa:100874107;MTUS2-AS1;MTUS2 antisense RNA 1
hsa:100874047;LINC00499;long intergenic non-protein coding RNA 499
hsa:100505865;;uncharacterized LOC100505865
hsa:388685;;uncharacterized FLJ39739
hsa:399753;;uncharacterized LOC399753
hsa:221262;CCDC162P,C6orf184,C6orf185,CCDC162,bA425D10.3,bA425D10.7;coiled-coil domain containing 162, pseudogene
hsa:644990;THRB-AS1;THRB antisense RNA 1
hsa:100874114;CCDC13-AS1;CCDC13 antisense RNA 1
hsa:100506060;;SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) pseudogene
hsa:100132062;;uncharacterized LOC100132062
hsa:574407;C1orf145;chromosome 1 open reading frame 145
hsa:100750326;HTT-AS1,HTTAS;HTT antisense RNA 1 (head to head)
hsa:340618;FAM41AY1,FAM41AY;family with sequence similarity 41, member A, Y-linked 1
hsa:100873983;MAGI1-AS1;MAGI1 antisense RNA 1
hsa:100874182;LINC00424;long intergenic non-protein coding RNA 424
hsa:100862728;UPK1A-AS1;UPK1A antisense RNA 1
hsa:100287948;GM140;uncharacterized LOC100287948
hsa:158257;MIRLET7DHG;MIRLET7D host gene (non-protein coding)
hsa:647946;LINC00669;long intergenic non-protein coding RNA 669
hsa:326332;FLJ31813;FAM21B pseudogene
hsa:644759;TMPRSS11GP;transmembrane protease, serine 11G, pseudogene
hsa:100874187;LINC00559;long intergenic non-protein coding RNA 559
hsa:100874055;LINC00570,ncRNA-a5;long intergenic non-protein coding RNA 570
hsa:728798;FRMPD2P1,FRMPD2L1,PDZD5A,PDZK5A,yX59F3.2;FERM and PDZ domain containing 2 pseudogene 1
hsa:100874198;SHANK2-AS1;SHANK2 antisense RNA 1
hsa:100874029;WDR52-AS1;WDR52 antisense RNA 1
hsa:254896;;uncharacterized LOC254896
hsa:399708;LINC00701;long intergenic non-protein coding RNA 701
hsa:282980;LINC00700;long intergenic non-protein coding RNA 700
hsa:100287072;;ribosomal protein S6 kinase, 70kDa, polypeptide 1 pseudogene
hsa:100507034;PITRM1-AS1;PITRM1 antisense RNA 1
hsa:726;CAPN5,HTRA3,nCL-3;calpain 5
hsa:51751;HIGD1B,CLST11240,CLST11240-15;HIG1 hypoxia inducible domain family, member 1B
hsa:100507127;LINC00707;long intergenic non-protein coding RNA 707
hsa:439949;PRKCQ-AS1;PRKCQ antisense RNA 1
hsa:389932;AKR1C6P,TAKR;aldo-keto reductase family 1, member C6, pseudogene
hsa:399717;GATA3-AS1;GATA3 antisense RNA 1
hsa:100885779;LINC-ROR,lincRNA-RoR;long intergenic non-protein coding RNA, regulator of reprogramming
hsa:389333;PROB1,C5orf65;proline-rich basic protein 1
hsa:401494;PTPLAD2,HACD4;protein tyrosine phosphatase-like A domain containing 2 (EC:4.2.1.134)
hsa:9945;GFPT2,GFAT2;glutamine-fructose-6-phosphate transaminase 2 (EC:2.6.1.16)
hsa:653808;ZG16,JCLN,JCLN1,ZG16A;zymogen granule protein 16
hsa:55237;VRTN,C14orf115,vertnin;vertebrae development associated
hsa:55806;HR,ALUNC,AU,HSA277165,MUHH,MUHH1;hair growth associated
hsa:91461;PKDCC,SGK493,Vlk;protein kinase domain containing, cytoplasmic
hsa:653645;TBC1D3P1-DHX40P1,DHX40P,DHX40P1,TBC1D3P1;TBC1D3P1-DHX40P1 readthrough transcribed pseudogene
hsa:441263;DTX2P1-UPK3BP1-PMS2P11,PMS2L11,PMS2P11,PMSR6;DTX2P1-UPK3BP1-PMS2P11 readthrough transcribed pseudogene
hsa:439950;CELF2-AS2;CELF2 antisense RNA 2
hsa:219731;PROSER2-AS1;PROSER2 antisense RNA 1
hsa:23783;ANKRD62P1-PARP4P3,ADPRTL4,PARP4P3;ANKRD62P1-PARP4P3 readthrough transcribed pseudogene
hsa:254312;LINC00710;long intergenic non-protein coding RNA 710
hsa:388611;CD164L2,UNQ6122;CD164 sialomucin-like 2
hsa:7358;UGDH,GDH,UDP-GlcDH,UDPGDH,UGD;UDP-glucose 6-dehydrogenase (EC:1.1.1.22)
hsa:55532;SLC30A10,HMDPC,ZNT10,ZNT8,ZRC1,ZnT-10;solute carrier family 30, member 10
hsa:9973;CCS;copper chaperone for superoxide dismutase
hsa:445347;TARP,CD3G,TCRG,TCRGC1,TCRGC2;TCR gamma alternate reading frame protein
hsa:2315;MLANA,MART-1,MART1;melan-A
hsa:50832;TAS2R4,T2R4;taste receptor, type 2, member 4
hsa:2619;GAS1;growth arrest-specific 1
hsa:8099;CDK2AP1,DOC1,DORC1,ST19,doc-1,p12DOC-1;cyclin-dependent kinase 2 associated protein 1
hsa:8724;SNX3,Grd19,MCOPS8,SDP3;sorting nexin 3
hsa:8807;IL18RAP,ACPL,CD218b,CDw218b,IL18RB;interleukin 18 receptor accessory protein
hsa:5173;PDYN,ADCA,PENKB,SCA23;prodynorphin
hsa:4867;NPHP1,JBTS4,NPH1,SLSN1;nephronophthisis 1 (juvenile)
hsa:405753;DUOXA2,SIMNIPHOM,TDH5;dual oxidase maturation factor 2
hsa:10254;STAM2,Hbp,STAM2A,STAM2B;signal transducing adaptor molecule (SH3 domain and ITAM motif) 2
hsa:9997;SCO2,SCO1L;SCO2 cytochrome c oxidase assembly protein;K07152
hsa:9873;FCHSD2,NWK,SH3MD3;FCH and double SH3 domains 2
hsa:923;CD6,TP120;CD6 molecule
hsa:5493;PPL;periplakin
hsa:255061;TAC4,EK,HK-1,HK1,PPT-C;tachykinin 4 (hemokinin)
hsa:9141;PDCD5,TFAR19;programmed cell death 5
hsa:785;CACNB4,CAB4,CACNLB4,EA5,EIG9,EJM,EJM4,EJM6;calcium channel, voltage-dependent, beta 4 subunit
hsa:389376;SFTA2,GSGL541,SFTPG,UNQ541;surfactant associated 2
hsa:23576;DDAH1,DDAH;dimethylarginine dimethylaminohydrolase 1 (EC:3.5.3.18)
hsa:9399;STOML1,SLP-1,STORP,hUNC-24;stomatin (EPB72)-like 1
hsa:8089;YEATS4,4930573H17Rik,B230215M10Rik,GAS41,NUBI-1,YAF9;YEATS domain containing 4
hsa:338382;RAB7B,RAB7;RAB7B, member RAS oncogene family
hsa:257;ALX3,FND1;ALX homeobox 3
hsa:9573;GDF3,KFS3,MCOP7,MCOPCB6;growth differentiation factor 3
hsa:442909;MIR342,MIRN342,hsa-mir-342;microRNA 342
hsa:442904;MIR335,MIRN335,hsa-mir-335,miRNA335;microRNA 335
hsa:574474;MIR518B,MIRN518B;microRNA 518b
hsa:693200;MIR615,MIRN615,hsa-mir-615;microRNA 615
hsa:100302142;MIR1246,MIRN1246,hsa-mir-1246;microRNA 1246
hsa:406987;MIR204,MIRN204,miRNA204;microRNA 204
hsa:124045;C16orf55;chromosome 16 open reading frame 55
hsa:100130075;;SUZ RNA binding domain containing 1 pseudogene
hsa:10490;VTI1B,VTI1,VTI1-LIKE,VTI1L,VTI2,v-SNARE,vti1-rp1;vesicle transport through interaction with t-SNAREs 1B
hsa:9503;XAGE1D,CT12.1,CT12.1D,CTP9;X antigen family, member 1D
hsa:143187;VTI1A,MVti1,VTI1RP2,Vti1-rp2;vesicle transport through interaction with t-SNAREs 1A
hsa:79699;ZYG11B,ZYG11;zyg-11 family member B, cell cycle regulator
hsa:51602;NOP58,NOP5,NOP5/NOP58;NOP58 ribonucleoprotein
hsa:51491;NOP16,HSPC111,HSPC185;NOP16 nucleolar protein
hsa:8780;RIOK3,SUDD;RIO kinase 3 (EC:2.7.11.1)
hsa:79674;VEPH1,MELT,VEPH;ventricular zone expressed PH domain-containing 1
hsa:8615;USO1,P115,TAP,VDP;USO1 vesicle transport factor
hsa:440590;ZYG11A,ZYG11;zyg-11 family member A, cell cycle regulator
hsa:55781;RIOK2,RIO2;RIO kinase 2 (EC:2.7.11.1)
hsa:115209;OMA1,2010001O09Rik,DAB1,MPRP-1,YKR087C,ZMPOMA1;OMA1 zinc metallopeptidase homolog (S. cerevisiae)
hsa:8602;NOP14,C4orf9,NOL14,RES425,UTP2;NOP14 nucleolar protein
hsa:55651;NHP2,DKCB2,NHP2P,NOLA2;NHP2 ribonucleoprotein
hsa:83732;RIOK1,AD034,RRP10,bA288G3.1;RIO kinase 1 (EC:2.7.11.1)
hsa:55505;NOP10,DKCB1,NOLA3,NOP10P;NOP10 ribonucleoprotein
hsa:8733;GPAA1,GAA1,hGAA1;glycosylphosphatidylinositol anchor attachment 1
hsa:404093;CUEDC1;CUE domain containing 1
hsa:26280;IL1RAPL2,IL-1R9,IL1R9,IL1RAPL-2,TIGIRR-1;interleukin 1 receptor accessory protein-like 2
hsa:10497;UNC13B,MUNC13,UNC13,Unc13h2;unc-13 homolog B (C. elegans)
hsa:7301;TYRO3,BYK,Dtk,RSE,Sky,Tif;TYRO3 protein tyrosine kinase (EC:2.7.10.1)
hsa:8720;MBTPS1,PCSK8,S1P,SKI-1;membrane-bound transcription factor peptidase, site 1 (EC:3.4.21.112)
hsa:9379;NRXN2;neurexin 2
hsa:1437;CSF2,GMCSF;colony stimulating factor 2 (granulocyte-macrophage)
hsa:51617;HMP19;HMP19 protein
hsa:7252;TSHB,TSH-B,TSH-BETA;thyroid stimulating hormone, beta
hsa:81846;SBF2,CMT4B2,DENND7B,MTMR13;SET binding factor 2
hsa:407001;MIR218-2,MIRN218-2,mir-218-2;microRNA 218-2
hsa:693170;MIR585,MIRN585,hsa-mir-585;microRNA 585
hsa:100192204;PPIAP30;peptidylprolyl isomerase A (cyclophilin A) pseudogene 30
hsa:128989;TANGO2,C22orf25;transport and golgi organization 2 homolog (Drosophila)
hsa:124540;MSI2,MSI2H;musashi RNA-binding protein 2
hsa:5356;PLRG1,Cwc1,PRL1,PRP46,PRPF46,TANGO4;pleiotropic regulator 1
hsa:401236;STMND1;stathmin domain containing 1
hsa:100287482;SMKR1;small lysine-rich protein 1
hsa:5244;ABCB4,ABC21,GBD1,ICP3,MDR2,MDR2/3,MDR3,PFIC-3,PGY3;ATP-binding cassette, sub-family B (MDR/TAP), member 4 (EC:3.6.3.44)
hsa:8459;TPST2,TANGO13B;tyrosylprotein sulfotransferase 2 (EC:2.8.2.20)
hsa:79613;TANGO6,TMCO7;transport and golgi organization 6 homolog (Drosophila)
hsa:116150;NUS1,C6orf68,MGC:7199,NgBR,TANGO14;nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)
hsa:100128098;ST8SIA6-AS1;ST8SIA6 antisense RNA 1
hsa:146771;TCAM1P,TCAM1;testicular cell adhesion molecule 1, pseudogene
hsa:124221;PRSS30P,Disp,TMPRSS8,TMPRSS8P;protease, serine, 30, pseudogene
hsa:64220;STRA6,MCOPCB8,MCOPS9;stimulated by retinoic acid 6
hsa:4593;MUSK;muscle, skeletal, receptor tyrosine kinase (EC:2.7.10.1)
hsa:27328;PCDH11X,PCDH-X,PCDH11,PCDHX;protocadherin 11 X-linked
hsa:10558;SPTLC1,HSAN,HSAN1,HSN1,LBC1,LCB1,SPT1,SPTI,hLCB1;serine palmitoyltransferase, long chain base subunit 1 (EC:2.3.1.50)
hsa:23114;NFASC,NF,NRCAML;neurofascin
hsa:51554;CCRL1,CC-CKR-11,CCBP2,CCR-11,CCR10,CCR11,CCX_CKR,CCX-CKR,CKR-11,PPR1,VSHK1;chemokine (C-C motif) receptor-like 1
hsa:535;ATP6V0A1,ATP6N1,ATP6N1A,Stv1,VPP1,Vph1,a1;ATPase, H+ transporting, lysosomal V0 subunit a1 (EC:3.6.3.14)
hsa:9627;SNCAIP,SYPH1,Sph1;synuclein, alpha interacting protein
hsa:8991;SELENBP1,LPSB,SBP56,SP56,hSBP;selenium binding protein 1
hsa:23478;SEC11A,1810012E07Rik,SEC11L1,SPC18,SPCS4A,sid2895;SEC11 homolog A (S. cerevisiae) (EC:3.4.21.89)
hsa:643911;CRNDE,LINC00180,NCRNA00180;colorectal neoplasia differentially expressed (non-protein coding)
hsa:8799;PEX11B,PEX11-BETA,PEX14B;peroxisomal biogenesis factor 11 beta
hsa:100528021;ST20-MTHFS;ST20-MTHFS readthrough
hsa:388276;C16orf97;chromosome 16 open reading frame 97
hsa:100507203;SMLR1;small leucine-rich protein 1
hsa:9847;C2CD5,CDP138,KIAA0528;C2 calcium-dependent domain containing 5
hsa:375056;MIA3,ARNT,D320,TANGO,TANGO1,UNQ6077;melanoma inhibitory activity family, member 3
hsa:100527943;TGIF2-C20orf24;TGIF2-C20orf24 readthrough
hsa:401388;C7orf76;chromosome 7 open reading frame 76
hsa:100526842;RPL17-C18orf32;RPL17-C18orf32 readthrough
hsa:10480;EIF3M,B5,PCID1,TANGO7,hfl-B5;eukaryotic translation initiation factor 3, subunit M (EC:3.6.5.3)
hsa:100128071;FAM229A;family with sequence similarity 229, member A
hsa:100287718;ANKRD66;ankyrin repeat domain 66
hsa:55055;ZWILCH,KNTC1AP,hZwilch;zwilch kinetochore protein
hsa:100500938;CCDC179;coiled-coil domain containing 179
hsa:10667;FARS2,COXPD14,FARS1,HSPC320,PheRS,dJ520B18.2;phenylalanyl-tRNA synthetase 2, mitochondrial (EC:6.1.1.20)
hsa:9183;ZW10,HZW10,KNTC1AP;zw10 kinetochore protein
hsa:147670;SMIM17;small integral membrane protein 17
hsa:388419;BTBD17,BTBD17A,LGALS3BPL,TANGO10A;BTB (POZ) domain containing 17
hsa:8460;TPST1,TANGO13A;tyrosylprotein sulfotransferase 1 (EC:2.8.2.20)
hsa:4604;MYBPC1,LCCS4,MYBPCC,MYBPCS;myosin binding protein C, slow type
hsa:100128511;NEBL-AS1;NEBL antisense RNA 1
hsa:390003;GUCY2GP,GUCY2G;guanylate cyclase 2G, pseudogene
hsa:100533181;FXYD6-FXYD2;FXYD6-FXYD2 readthrough
hsa:100533467;BIVM-ERCC5;BIVM-ERCC5 readthrough
hsa:55450;CAMK2N1,PRO1489,RP11-401M16.1;calcium/calmodulin-dependent protein kinase II inhibitor 1
hsa:100847016;MIR5695;microRNA 5695
hsa:81689;ISCA1,HBLD2,ISA1,RP11-507D14.2,hIscA;iron-sulfur cluster assembly 1 homolog (S. cerevisiae) (EC:2.7.7.52)
hsa:54869;EPS8L1,DRC3,EPS8R1;EPS8-like 1
hsa:79574;EPS8L3,EPS8R3;EPS8-like 3
hsa:80761;UPK3B,P35,UP3B,UPIIIB;uroplakin 3B
hsa:64787;EPS8L2,EPS8R2;EPS8-like 2
hsa:10913;EDAR,DL,ECTD10A,ECTD10B,ED1R,ED3,ED5,EDA-A1R,EDA1R,EDA3,HRM1;ectodysplasin A receptor
hsa:128178;EDARADD,ECTD11A,ECTD11B,ED3,EDA3;EDAR-associated death domain
hsa:84944;MAEL,CT128,RP11-102C16.1,SPATA35;maelstrom spermatogenic transposon silencer
hsa:3891;KRT85,ECTD4,HB5,Hb-5,KRTHB5,hHb5;keratin 85
hsa:132014;IL17RE;interleukin 17 receptor E
hsa:100126299;VTRNA2-1,CBL-3,CBL3,MIR886,MIRN886,VTRNA2,hsa-mir-886,hvg-5,nc886;vault RNA 2-1
hsa:220070;SHANK2-AS3,C11orf76;SHANK2 antisense RNA 3
hsa:387644;LINC00202-1,C10orf51,LINC00202,NCRNA00202,bB27G4.1;long intergenic non-protein coding RNA 202-1
hsa:1856;DVL2;dishevelled, dsh homolog 2 (Drosophila)
hsa:201164;PLD6,ZUC;phospholipase D family, member 6 (EC:3.1.4.4)
hsa:260293;CYP4X1,CYPIVX1;cytochrome P450, family 4, subfamily X, polypeptide 1 (EC:1.14.14.1)
hsa:727957;MROH1,HEATR7A;maestro heat-like repeat family member 1
hsa:57171;DOLPP1,LSFR2;dolichyl pyrophosphate phosphatase 1 (EC:3.6.1.43)
hsa:642475;MROH6,C8orf73;maestro heat-like repeat family member 6
hsa:133558;MROH2B,HEATR7B2;maestro heat-like repeat family member 2B
hsa:84695;LOXL3,LOXL;lysyl oxidase-like 3
hsa:745;MYRF,C11orf9,MRF,Ndt80,pqn-47;myelin regulatory factor
hsa:550;AUP1;ancient ubiquitous protein 1
hsa:80133;MROH9,ARMC11,C1orf129;maestro heat-like repeat family member 9
hsa:374977;MROH7,C1orf175,HEATR8;maestro heat-like repeat family member 7
hsa:14;AAMP;angio-associated, migratory cell protein
hsa:79090;TRAPPC6A,TRS33;trafficking protein particle complex 6A
hsa:79143;MBOAT7,BB1,LENG4,LPIAT,LRC4,MBOA7,OACT7,hMBOA-7;membrane bound O-acyltransferase domain containing 7 (EC:2.3.1.n4)
hsa:203413;CXorf61,CT83,KK-LC-1,KKLC1;chromosome X open reading frame 61
hsa:283171;C11orf44;chromosome 11 open reading frame 44
hsa:3357;HTR2B,5-HT(2B),5-HT2B;5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
hsa:56940;DUSP22,JKAP,JSP1,LMWDSP2,MKPX,VHX;dual specificity phosphatase 22 (EC:3.1.3.16 3.1.3.48)
hsa:1399;CRKL;v-crk sarcoma virus CT10 oncogene homolog (avian)-like
hsa:2571;GAD1,CPSQ1,GAD,SCP;glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15)
hsa:28232;SLCO3A1,OATP-D,OATP3A1,OATPD,SLC21A11;solute carrier organic anion transporter family, member 3A1
hsa:26088;GGA1;golgi-associated, gamma adaptin ear containing, ARF binding protein 1
hsa:9922;IQSEC1,ARF-GEP100,ARFGEP100,BRAG2,GEP100;IQ motif and Sec7 domain 1
hsa:3697;ITIH1,H1P,IATIH,IGHEP1,ITI-HC1,ITIH,SHAP;inter-alpha-trypsin inhibitor heavy chain 1
hsa:3073;HEXA,TSD;hexosaminidase A (alpha polypeptide) (EC:3.2.1.52)
hsa:57369;GJD2,CX36,GJA9;gap junction protein, delta 2, 36kDa
hsa:3592;IL12A,CLMF,IL-12A,NFSK,NKSF1,P35;interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)
hsa:1073;CFL2,NEM7;cofilin 2 (muscle)
hsa:5890;RAD51B,R51H2,RAD51L1,REC2;RAD51 homolog B (S. cerevisiae)
hsa:6843;VAMP1,SYB1,VAMP-1;vesicle-associated membrane protein 1 (synaptobrevin 1)
hsa:5422;POLA1,POLA,p180;polymerase (DNA directed), alpha 1, catalytic subunit (EC:2.7.7.7)
hsa:79370;BCL2L14,BCLG;BCL2-like 14 (apoptosis facilitator)
hsa:26277;TINF2,DKCA3,TIN2;TERF1 (TRF1)-interacting nuclear factor 2
hsa:64806;IL25,IL17E;interleukin 25
hsa:5368;PNOC,PPNOC;prepronociceptin
hsa:3561;IL2RG,CD132,CIDX,IL-2RG,IMD4,P64,SCIDX,SCIDX1;interleukin 2 receptor, gamma
hsa:3595;IL12RB2;interleukin 12 receptor, beta 2
hsa:8676;STX11,FHL4,HLH4,HPLH4;syntaxin 11
hsa:343641;TGM6,SCA35,TG6,TGM3L,TGY,dJ734P14.3;transglutaminase 6 (EC:2.3.2.13)
hsa:8887;TAX1BP1,CALCOCO3,T6BP,TXBP151;Tax1 (human T-cell leukemia virus type I) binding protein 1
hsa:219736;STOX1,C10orf24,PEE4;storkhead box 1
hsa:2207;FCER1G,FCRG;Fc fragment of IgE, high affinity I, receptor for;gamma polypeptide
hsa:5532;PPP3CB,CALNA2,CALNB,CNA2,PP2Bbeta;protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16)
hsa:6683;SPAST,ADPSP,FSP2,SPG4;spastin (EC:3.6.4.3)
hsa:6092;ROBO2,SAX3;roundabout, axon guidance receptor, homolog 2 (Drosophila)
hsa:117289;TAGAP,ARHGAP47,IDDM21,TAGAP1;T-cell activation RhoGTPase activating protein
hsa:336;APOA2,Apo-AII,ApoA-II,apoAII;apolipoprotein A-II
hsa:51477;ISYNA1,INO1,INOS,IPS,IPS_1,IPS-1;inositol-3-phosphate synthase 1 (EC:5.5.1.4)
hsa:10590;SCGN,CALBL,DJ501N12.8,SECRET,SEGN,setagin;secretagogin, EF-hand calcium binding protein
hsa:921;CD5,LEU1,T1;CD5 molecule
hsa:57531;HACE1;HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
hsa:10007;GNPDA1,GNP1,GNPDA,GNPI,GPI,HLN;glucosamine-6-phosphate deaminase 1 (EC:3.5.99.6)
hsa:334;APLP2,APLP-2,APPH,APPL2,CDEBP;amyloid beta (A4) precursor-like protein 2
hsa:57448;BIRC6,APOLLON,BRUCE;baculoviral IAP repeat containing 6
hsa:1489;CTF1,CT-1,CT1;cardiotrophin 1
hsa:1839;HBEGF,DTR,DTS,DTSF,HEGFL;heparin-binding EGF-like growth factor
hsa:313;AOAH;acyloxyacyl hydrolase (neutrophil) (EC:3.1.1.77)
hsa:3467;IFNW1;interferon, omega 1
hsa:2863;GPR39;G protein-coupled receptor 39
hsa:3660;IRF2,IRF-2;interferon regulatory factor 2
hsa:11346;SYNPO;synaptopodin
hsa:10257;ABCC4,EST170205,MOAT-B,MOATB,MRP4;ATP-binding cassette, sub-family C (CFTR/MRP), member 4
hsa:219770;GJD4,CX40.1,RP11-425A6.2;gap junction protein, delta 4, 40.1kDa
hsa:115727;RASGRP4;RAS guanyl releasing protein 4
hsa:22881;ANKRD6;ankyrin repeat domain 6
hsa:1173;AP2M1,AP50,CLAPM1,mu2;adaptor-related protein complex 2, mu 1 subunit
hsa:4343;MOV10,fSAP113,gb110;Mov10, Moloney leukemia virus 10, homolog (mouse) (EC:3.6.4.13)
hsa:10273;STUB1,CHIP,HSPABP2,NY-CO-7,SDCCAG7,UBOX1;STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
hsa:23552;CDK20,CCRK,CDCH,P42,PNQALRE;cyclin-dependent kinase 20 (EC:2.7.11.22)
hsa:6233;RPS27A,CEP80,S27A,UBA80,UBC,UBCEP1,UBCEP80;ribosomal protein S27a
hsa:23043;TNIK;TRAF2 and NCK interacting kinase (EC:2.7.11.1)
hsa:10951;CBX1,CBX,HP1-BETA,HP1Hs-beta,HP1Hsbeta,M31,MOD1,p25beta;chromobox homolog 1
hsa:6529;SLC6A1,GABATHG,GABATR,GAT1;solute carrier family 6 (neurotransmitter transporter, GABA), member 1
hsa:9481;SLC25A27,UCP4;solute carrier family 25, member 27
hsa:3698;ITIH2,H2P,SHAP;inter-alpha-trypsin inhibitor heavy chain 2
hsa:116071;BATF2,SARI;basic leucine zipper transcription factor, ATF-like 2
hsa:5210;PFKFB4;6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (EC:2.7.1.105 3.1.3.46)
hsa:9049;AIP,ARA9,FKBP16,FKBP37,SMTPHN,XAP-2,XAP2;aryl hydrocarbon receptor interacting protein
hsa:4151;MB,PVALB;myoglobin
hsa:65267;WNK3,PRKWNK3;WNK lysine deficient protein kinase 3 (EC:2.7.11.1)
hsa:22883;CLSTN1,ALC-ALPHA,CDHR12,CSTN1,PIK3CD,XB31alpha,alcalpha1,alcalpha2;calsyntenin 1
hsa:169355;IDO2,INDOL1;indoleamine 2,3-dioxygenase 2 (EC:1.13.11.52)
hsa:7305;TYROBP,DAP12,KARAP,PLOSL;TYRO protein tyrosine kinase binding protein
hsa:79602;ADIPOR2,ACDCR2,PAQR2;adiponectin receptor 2
hsa:59340;HRH4,AXOR35,BG26,GPCR105,GPRv53,H4,H4R,HH4R;histamine receptor H4
hsa:5607;MAP2K5,HsT17454,MAPKK5,MEK5,PRKMK5;mitogen-activated protein kinase kinase 5 (EC:2.7.12.2)
hsa:11201;POLI,RAD30B,RAD3OB;polymerase (DNA directed) iota (EC:2.7.7.7)
hsa:4055;LTBR,CD18,D12S370,LT-BETA-R,TNF-R-III,TNFCR,TNFR-RP,TNFR2-RP,TNFR3,TNFRSF3;lymphotoxin beta receptor (TNFR superfamily, member 3)
hsa:2954;GSTZ1,GSTZ1-1,MAAI,MAI;glutathione S-transferase zeta 1 (EC:2.5.1.18 5.2.1.2)
hsa:30008;EFEMP2,ARCL1B,FBLN4,MBP1,UPH1;EGF containing fibulin-like extracellular matrix protein 2
hsa:50615;IL21R,CD360,NILR;interleukin 21 receptor
hsa:145264;SERPINA12,OL-64;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
hsa:28512;NKIRAS1,KBRAS1,kappaB-Ras1;NFKB inhibitor interacting Ras-like 1
hsa:8890;EIF2B4,EIF-2B,EIF2B,EIF2Bdelta;eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa
hsa:51455;REV1,REV1L;REV1, polymerase (DNA directed)
hsa:5310;PKD1,PBP,Pc-1,TRPP1;polycystic kidney disease 1 (autosomal dominant)
hsa:5889;RAD51C,BROVCA3,FANCO,RAD51L2;RAD51 homolog C (S. cerevisiae)
hsa:6658;SOX3,GHDX,MRGH,PHP,PHPX,SOXB;SRY (sex determining region Y)-box 3
hsa:5494;PPM1A,PP2C-ALPHA,PP2CA,PP2Calpha;protein phosphatase, Mg2+/Mn2+ dependent, 1A (EC:3.1.3.16)
hsa:4287;ATXN3,AT3,ATX3,JOS,MJD,MJD1,SCA3;ataxin 3 (EC:3.4.19.12)
hsa:9423;NTN1,NTN1L;netrin 1
hsa:9698;PUM1,HSPUM,PUMH,PUMH1,PUML1;pumilio homolog 1 (Drosophila)
hsa:6857;SYT1,P65,SVP65,SYT;synaptotagmin I
hsa:9401;RECQL4,RECQ4;RecQ protein-like 4 (EC:3.6.4.12)
hsa:1861;TOR1A,DQ2,DYT1;torsin family 1, member A (torsin A)
hsa:1141;CHRNB2,EFNL3,nAChRB2;cholinergic receptor, nicotinic, beta 2 (neuronal)
hsa:1820;ARID3A,BRIGHT,DRIL1,DRIL3,E2FBP1;AT rich interactive domain 3A (BRIGHT-like)
hsa:10087;COL4A3BP,CERT,CERTL,GPBP,STARD11;collagen, type IV, alpha 3 (Goodpasture antigen) binding protein (EC:2.7.11.1)
hsa:205;AK4,AK3,AK3L1,AK3L2;adenylate kinase 4 (EC:2.7.4.3)
hsa:60526;C2orf43;chromosome 2 open reading frame 43
hsa:145270;PRIMA1,PRIMA;proline rich membrane anchor 1
hsa:151242;PPP1R1C,IPP5;protein phosphatase 1, regulatory (inhibitor) subunit 1C
hsa:2572;GAD2,GAD65;glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) (EC:4.1.1.15)
hsa:27115;PDE7B,bA472E5.1;phosphodiesterase 7B (EC:3.1.4.17)
hsa:9055;PRC1,ASE1;protein regulator of cytokinesis 1
hsa:640;BLK,MODY11;B lymphoid tyrosine kinase (EC:2.7.10.2)
hsa:51083;GAL,GAL-GMAP,GALN,GLNN,GMAP;galanin/GMAP prepropeptide
hsa:2527;FUT5,FUC-TV;fucosyltransferase 5 (alpha (1,3) fucosyltransferase) (EC:2.4.1.65)
hsa:325;APCS,PTX2,SAP;amyloid P component, serum
hsa:200734;SPRED2,Spred-2;sprouty-related, EVH1 domain containing 2
hsa:25926;NOL11;nucleolar protein 11
hsa:6275;S100A4,18A2,42A,CAPL,FSP1,MTS1,P9KA,PEL98;S100 calcium binding protein A4
hsa:8131;NPRL3,C16orf35,CGTHBA,HS-40,MARE,NPR3,RMD11;nitrogen permease regulator-like 3 (S. cerevisiae)
hsa:51684;SUFU,PRO1280,SUFUH,SUFUXL;suppressor of fused homolog (Drosophila)
hsa:6091;ROBO1,DUTT1,SAX3;roundabout, axon guidance receptor, homolog 1 (Drosophila)
hsa:11251;PTGDR2,CD294,CRTH2,DL1R,DP2,GPR44;prostaglandin D2 receptor 2
hsa:84072;HORMAD1,CT46,NOHMA;HORMA domain containing 1
hsa:8814;CDKL1,KKIALRE,P42;cyclin-dependent kinase-like 1 (CDC2-related kinase) (EC:2.7.11.22)
hsa:5926;ARID4A,RBBP-1,RBBP1,RBP-1,RBP1;AT rich interactive domain 4A (RBP1-like)
hsa:8522;GAS7,MLL/GAS7;growth arrest-specific 7
hsa:51586;MED15,ARC105,CAG7A,CTG7A,PCQAP,TIG-1,TIG1,TNRC7;mediator complex subunit 15
hsa:51311;TLR8,CD288;toll-like receptor 8
hsa:6527;SLC5A4,DJ90G24.4,SAAT1,SGLT3;solute carrier family 5 (low affinity glucose cotransporter), member 4
hsa:153090;DAB2IP,AF9Q34,AIP1,DIP1/2;DAB2 interacting protein
hsa:27165;GLS2,GA,GLS,LGA,hLGA;glutaminase 2 (liver, mitochondrial) (EC:3.5.1.2)
hsa:4208;MEF2C,C5DELq14.3,DEL5q14.3;myocyte enhancer factor 2C
hsa:6416;MAP2K4,JNKK,JNKK1,MAPKK4,MEK4,MKK4,PRKMK4,SAPKK-1,SAPKK1,SEK1,SERK1;mitogen-activated protein kinase kinase 4 (EC:2.7.12.2)
hsa:93659;CGB5,HCG;chorionic gonadotropin, beta polypeptide 5
hsa:26960;NBEA,BCL8B,LYST2;neurobeachin
hsa:1307;COL16A1,447AA;collagen, type XVI, alpha 1
hsa:1241;LTB4R,BLT1,BLTR,CMKRL1,GPR16,LTB4R1,LTBR1,P2RY7,P2Y7;leukotriene B4 receptor
hsa:661;POLR3D,BN51T,RPC4,RPC53,TSBN51;polymerase (RNA) III (DNA directed) polypeptide D, 44kDa (EC:2.7.7.6)
hsa:64109;CRLF2,CRL2,CRLF2Y,TSLPR;cytokine receptor-like factor 2
hsa:124590;USH1G,ANKS4A,SANS;Usher syndrome 1G (autosomal recessive)
hsa:54900;LAX1,LAX;lymphocyte transmembrane adaptor 1
hsa:6554;SLC10A1,NTCP;solute carrier family 10 (sodium/bile acid cotransporter family), member 1
hsa:222545;GPRC6A,GPCR,bA86F4.3;G protein-coupled receptor, family C, group 6, member A
hsa:6947;TCN1,TC-1,TC1,TCI;transcobalamin I (vitamin B12 binding protein, R binder family)
hsa:1915;EEF1A1,CCS-3,CCS3,EE1A1,EEF-1,EEF1A,EF-Tu,EF1A,GRAF-1EF,HNGC:16303,LENG7,PTI1,eEF1A-1;eukaryotic translation elongation factor 1 alpha 1
hsa:5449;POU1F1,CPHD1,GHF-1,PIT1,POU1F1a,Pit-1;POU class 1 homeobox 1
hsa:11126;CD160,BY55,NK1,NK28;CD160 molecule
hsa:22953;P2RX2,P2X2;purinergic receptor P2X, ligand-gated ion channel, 2
hsa:63916;ELMO2,CED-12,CED12,ELMO-2;engulfment and cell motility 2
hsa:11167;FSTL1,FRP,FSL1;follistatin-like 1
hsa:333;APLP1,APLP;amyloid beta (A4) precursor-like protein 1
hsa:974;CD79B,AGM6,B29,IGB;CD79b molecule, immunoglobulin-associated beta
hsa:6755;SSTR5,SS-5-R;somatostatin receptor 5
hsa:2717;GLA,GALA;galactosidase, alpha (EC:3.2.1.22)
hsa:375704;ENHO,C9orf165,UNQ470;energy homeostasis associated
hsa:3291;HSD11B2,AME,AME1,HSD11K,HSD2,SDR9C3;hydroxysteroid (11-beta) dehydrogenase 2 (EC:1.1.1.146)
hsa:9066;SYT7,IPCA-7,IPCA7,PCANAP7,SYT-VII,SYTVII;synaptotagmin VII
hsa:1060;CENPC1,CENP-C,CENPC,MIF2,hcp-4;centromere protein C 1
hsa:407008;MIR223,MIRN223,miRNA223,mir-223;microRNA 223
hsa:442913;MIR376C,MIR368,MIRN368,MIRN376C,hsa-mir-368,miRNA368;microRNA 376c
hsa:494325;MIR376A1,MIR376A-1,MIRN376A,MIRN376A-1,MIRN376A1;microRNA 376a-1
hsa:442905;MIR337,MIRN337,hsa-mir-337;microRNA 337
hsa:100302201;MIR1228,MIRN1228,hsa-mir-1228;microRNA 1228
hsa:391627;USP17L9P,RS447,USP17,USP17A,USP17H,USP17I,USP17J,USP17K,USP17L,USP17M;ubiquitin specific peptidase 17-like family member 9, pseudogene
hsa:5820;PVT1,LINC00079,NCRNA00079;Pvt1 oncogene (non-protein coding)
hsa:407014;MIR25,MIRN25,hsa-mir-25,miR-25;microRNA 25
hsa:407029;MIR30A,MIRN30A;microRNA 30a
hsa:2984;GUCY2C,DIAR6,GUC2C,MECIL,MUCIL,STAR;guanylate cyclase 2C (heat stable enterotoxin receptor) (EC:4.6.1.2)
hsa:10715;CERS1,LAG1,LASS1,UOG1;ceramide synthase 1
hsa:5456;POU3F4,BRAIN-4,BRN-4,BRN4,DFN3,DFNX2,OCT-9,OTF-9,OTF9;POU class 3 homeobox 4
hsa:100419868;ZNF33BP1;zinc finger protein 33B pseudogene 1
hsa:84856;LINC00839;long intergenic non-protein coding RNA 839
hsa:387647;PTCHD3P1;patched domain containing 3 pseudogene 1
hsa:100507605;LINC00837;long intergenic non-protein coding RNA 837
hsa:100505583;LINC00838;long intergenic non-protein coding RNA 838
hsa:731789;LINC00202-2;long intergenic non-protein coding RNA 202-2
hsa:79654;HECTD3,RP11-69J16.1;HECT domain containing E3 ubiquitin protein ligase 3
hsa:92736;OTOP2;otopetrin 2
hsa:122961;ISCA2,HBLD1,ISA2,c14_5557;iron-sulfur cluster assembly 2 homolog (S. cerevisiae)
hsa:80115;BAIAP2L2;BAI1-associated protein 2-like 2
hsa:133957;CCDC127;coiled-coil domain containing 127
hsa:126859;AXDND1,C1orf125,RP11-215I23.2;axonemal dynein light chain domain containing 1
hsa:55253;TYW1,RSAFD1,TYW1A,YPL207W;tRNA-yW synthesizing protein 1 homolog (S. cerevisiae)
hsa:79856;SNX22;sorting nexin 22
hsa:83547;RILP;Rab interacting lysosomal protein
hsa:80127;CCDC176,C14orf45;coiled-coil domain containing 176
hsa:100144748;KLLN,CWS4,KILLIN;killin, p53-regulated DNA replication inhibitor
hsa:83983;TSSK6,CT72,SSTK,TSSK4;testis-specific serine kinase 6 (EC:2.7.11.1)
hsa:9253;NUMBL,CAG3A,CTG3a,NBL,NUMB-R,NUMBLIKE,NUMBR,TNRC23;numb homolog (Drosophila)-like
hsa:8204;NRIP1,RIP140;nuclear receptor interacting protein 1
hsa:2168;FABP1,FABPL,L-FABP;fatty acid binding protein 1, liver
hsa:83667;SESN2,HI95,SES2,SEST2;sestrin 2
hsa:83461;CDCA3,GRCC8,TOME-1;cell division cycle associated 3
hsa:158983;H2BFWT;H2B histone family, member W, testis-specific
hsa:1675;CFD,ADIPSIN,ADN,DF,PFD;complement factor D (adipsin) (EC:3.4.21.46)
hsa:7172;TPMT;thiopurine S-methyltransferase (EC:2.1.1.67)
hsa:9104;RGN,GNL,RC,SMP30;regucalcin (senescence marker protein-30) (EC:3.1.1.17)
hsa:5826;ABCD4,ABC41,EST352188,MAHCJ,P70R,P79R,PMP69,PXMP1L;ATP-binding cassette, sub-family D (ALD), member 4
hsa:5947;RBP1,CRABP-I,CRBP,CRBP1,CRBPI,RBPC;retinol binding protein 1, cellular
hsa:5948;RBP2,CRABP-II,CRBP2,CRBPII,RBPC2;retinol binding protein 2, cellular
hsa:3184;HNRNPD,AUF1,AUF1A,HNRPD,P37,hnRNPD0;heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
hsa:7270;TTF1,TTF-1,TTF-I;transcription termination factor, RNA polymerase I
hsa:3155;HMGCL,HL;3-hydroxymethyl-3-methylglutaryl-CoA lyase (EC:4.1.3.4)
hsa:6785;ELOVL4,ADMD,CT118,ISQMR,STGD2,STGD3;ELOVL fatty acid elongase 4 (EC:2.3.1.199)
hsa:3572;IL6ST,CD130,CDW130,GP130,IL-6RB;interleukin 6 signal transducer (gp130, oncostatin M receptor)
hsa:10158;PDZK1IP1,DD96,MAP17,RP1-18D14.5,SPAP;PDZK1 interacting protein 1
hsa:10068;IL18BP,IL18BPa;interleukin 18 binding protein
hsa:10924;SMPDL3A,ASM3A,ASML3a,yR36GH4.1;sphingomyelin phosphodiesterase, acid-like 3A
hsa:844;CASQ1,CASQ,PDIB1;calsequestrin 1 (fast-twitch, skeletal muscle)
hsa:23581;CASP14;caspase 14, apoptosis-related cysteine peptidase
hsa:4689;NCF4,NCF,P40PHOX,SH3PXD4;neutrophil cytosolic factor 4, 40kDa
hsa:7520;XRCC5,KARP-1,KARP1,KU80,KUB2,Ku86,NFIV;X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
hsa:10083;USH1C,AIE-75,DFNB18,DFNB18A,NY-CO-37,NY-CO-38,PDZ-45,PDZ-73,PDZ-73/NY-CO-38,PDZ73,ush1cpst;Usher syndrome 1C (autosomal recessive, severe)
hsa:4703;NEB,NEB177D,NEM2;nebulin
hsa:1300;COL10A1;collagen, type X, alpha 1
hsa:10979;FERMT2,KIND2,MIG2,PLEKHC1,UNC112,UNC112B,mig-2;fermitin family member 2
hsa:50507;NOX4,KOX,KOX-1,RENOX;NADPH oxidase 4 (EC:1.6.3.-)
hsa:186;AGTR2,AT2,ATGR2,MRX88;angiotensin II receptor, type 2
hsa:9377;COX5A,COX,COX-VA,VA;cytochrome c oxidase subunit Va (EC:1.9.3.1)
hsa:54487;DGCR8,C22orf12,DGCRK6,Gy1,pasha;DiGeorge syndrome critical region gene 8
hsa:10845;CLPX;ClpX caseinolytic peptidase X homolog (E. coli)
hsa:7434;VIPR2,C16DUPq36.3,DUP7q36.3,PACAP-R-3,PACAP-R3,VIP-R-2,VPAC2,VPAC2R,VPCAP2R;vasoactive intestinal peptide receptor 2
hsa:4046;LSP1,WP34,pp52;lymphocyte-specific protein 1
hsa:7477;WNT7B;wingless-type MMTV integration site family, member 7B
hsa:80854;SETD7,KMT7,SET7,SET7/9,SET9;SET domain containing (lysine methyltransferase) 7 (EC:2.1.1.43)
hsa:5149;PDE6H,ACHM6,RCD3;phosphodiesterase 6H, cGMP-specific, cone, gamma (EC:3.1.4.35)
hsa:727897;MUC5B,MG1,MUC-5B,MUC5,MUC9;mucin 5B, oligomeric mucus/gel-forming
hsa:4693;NDP,EVR2,FEVR,ND;Norrie disease (pseudoglioma)
hsa:84162;FSA,Tweek;KIAA1109
hsa:152816;C4orf26;chromosome 4 open reading frame 26
hsa:57124;CD248,CD164L1,TEM1;CD248 molecule, endosialin
hsa:284004;HEXDC;hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing (EC:3.2.1.52)
hsa:29101;SSU72,HSPC182,PNAS-120;SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae) (EC:3.1.3.16)
hsa:6579;SLCO1A2,OATP,OATP-A,OATP1A2,SLC21A3;solute carrier organic anion transporter family, member 1A2
hsa:5650;KLK7,PRSS6,SCCE,hK7;kallikrein-related peptidase 7 (EC:3.4.21.117)
hsa:23400;ATP13A2,CLN12,HSA9947,KRPPD,PARK9;ATPase type 13A2 (EC:3.6.3.8)
hsa:151888;BTLA,BTLA1,CD272;B and T lymphocyte associated
hsa:63874;ABHD4,ABH4;abhydrolase domain containing 4
hsa:4284;MIP,AQP0,LIM1,MIP26,MP26;major intrinsic protein of lens fiber (EC:1.11.1.6)
hsa:5585;PKN1,DBK,PAK-1,PAK1,PKN,PKN-ALPHA,PRK1,PRKCL1;protein kinase N1 (EC:2.7.11.13)
hsa:4056;LTC4S;leukotriene C4 synthase (EC:4.4.1.20)
hsa:27443;CECR2;cat eye syndrome chromosome region, candidate 2
hsa:221937;FOXK1,FOXK1L;forkhead box K1
hsa:8914;TIMELESS,TIM,TIM1,hTIM;timeless circadian clock
hsa:57010;CABP4,CSNB2B;calcium binding protein 4
hsa:55624;POMGNT1,GNTI.2,GnT_I.2,LGMD2O,MDDGA3,MDDGB3,MDDGC3,MEB,MGAT1.2,gnT-I.2;protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase
hsa:54982;CLN6,CLN4A,HsT18960,nclf;ceroid-lipofuscinosis, neuronal 6, late infantile, variant
hsa:22887;FOXJ3;forkhead box J3
hsa:5653;KLK6,Bssp,Klk7,PRSS18,PRSS9,SP59,hK6;kallikrein-related peptidase 6
hsa:55638;SYBU,GOLSYN,OCSYN,SNPHL;syntabulin (syntaxin-interacting)
hsa:51094;ADIPOR1,ACDCR1,CGI45,PAQR1,TESBP1A;adiponectin receptor 1
hsa:262;AMD1,ADOMETDC,AMD,SAMDC;adenosylmethionine decarboxylase 1 (EC:4.1.1.50)
hsa:6891;TAP2,ABC18,ABCB3,APT2,D6S217E,PSF-2,PSF2,RING11;transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
hsa:10023;FRAT1;frequently rearranged in advanced T-cell lymphomas
hsa:72;ACTG2,ACT,ACTA3,ACTE,ACTL3,ACTSG;actin, gamma 2, smooth muscle, enteric
hsa:26278;SACS,ARSACS,DNAJC29;spastic ataxia of Charlevoix-Saguenay (sacsin)
hsa:55507;GPRC5D;G protein-coupled receptor, family C, group 5, member D
hsa:1515;CTSL2,CATL2,CTSU,CTSV;cathepsin L2 (EC:3.4.22.43)
hsa:203;AK1;adenylate kinase 1 (EC:2.7.4.3)
hsa:7726;TRIM26,AFP,RNF95,ZNF173;tripartite motif containing 26
hsa:3170;FOXA2,HNF3B,TCF3B;forkhead box A2
hsa:6279;S100A8,60B8AG,CAGA,CFAG,CGLA,CP-10,L1Ag,MA387,MIF,MRP8,NIF,P8;S100 calcium binding protein A8
hsa:54805;CNNM2,ACDP2;cyclin M2
hsa:9989;PPP4R1,MEG1,PP4(Rmeg),PP4R1;protein phosphatase 4, regulatory subunit 1
hsa:975;CD81,CVID6,S5.7,TAPA1,TSPAN28;CD81 molecule
hsa:23107;MRPS27,MRP-S27,S27mt;mitochondrial ribosomal protein S27
hsa:133308;SLC9B2,NHA2,NHE10,NHEDC2;solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2
hsa:9584;RBM39,CAPER,CAPERalpha,FSAP59,HCC1,RNPC2;RNA binding motif protein 39
hsa:5629;PROX1;prospero homeobox 1
hsa:9306;SOCS6,CIS-4,CIS4,HSPC060,SOCS-4,SOCS-6,SOCS4,SSI4,STAI4,STATI4;suppressor of cytokine signaling 6
hsa:824;CAPN2,CANP2,CANPL2,CANPml,mCANP;calpain 2, (m/II) large subunit (EC:3.4.22.53)
hsa:9077;DIRAS3,ARHI,NOEY2;DIRAS family, GTP-binding RAS-like 3
hsa:9942;XYLB;xylulokinase homolog (H. influenzae) (EC:2.7.1.17)
hsa:922;CD5L,AIM,API6,PRO229,SP-ALPHA,Spalpha;CD5 molecule-like
hsa:9372;ZFYVE9,MADHIP,NSP,SARA,SMADIP;zinc finger, FYVE domain containing 9
hsa:839;CASP6,MCH2;caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59)
hsa:51426;POLK,DINB1,DINP,POLQ;polymerase (DNA directed) kappa (EC:2.7.7.7)
hsa:83733;SLC25A18,GC2;solute carrier family 25 (glutamate carrier), member 18
hsa:23644;EDC4,GE1,Ge-1,HEDL5,HEDLS,RCD-8,RCD8;enhancer of mRNA decapping 4
hsa:4129;MAOB;monoamine oxidase B (EC:1.4.3.4)
hsa:3202;HOXA5,HOX1,HOX1.3,HOX1C;homeobox A5
hsa:4885;NPTX2,NARP,NP-II,NP2;neuronal pentraxin II
hsa:406924;MIR134,MIRN134;microRNA 134
hsa:406927;MIR136,MIRN136,miRNA136;microRNA 136
hsa:407026;MIR29C,MIRN29C,miRNA29C;microRNA 29c
hsa:574033;MIR18B,MIRN18B,hsa-mir-18b;microRNA 18b
hsa:100151683;RNU4ATAC,MOPD1,RNU4ATAC1,TALS,U4ATAC;RNA, U4atac small nuclear (U12-dependent splicing)
hsa:125050;RN7SK,7SK;RNA, 7SK small nuclear
hsa:100302172;MIR1258,MIRN1258,hsa-mir-1258;microRNA 1258
hsa:693149;MIR564,MIRN564,hsa-mir-564;microRNA 564
hsa:9684;LRRC14,LRRC14A;leucine rich repeat containing 14
hsa:101059948;;uncharacterized LOC101059948
hsa:286749;STON1-GTF2A1L,SALF;STON1-GTF2A1L readthrough
hsa:256126;SYCE2,CESC1;synaptonemal complex central element protein 2
hsa:140699;MROH8,C20orf131,C20orf132,dJ621N11.3,dJ621N11.4;maestro heat-like repeat family member 8
hsa:9103;FCGR2C,CD32,CD32C,CDW32,FCG2,FCRIIC,IGFR2;Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)
hsa:29956;CERS2,L3,LASS2,SP260,TMSG1;ceramide synthase 2
hsa:55911;APOBR,APOB100R,APOB48R;apolipoprotein B receptor
hsa:22828;SCAF8,RBM16;SR-related CTD-associated factor 8
hsa:133383;SETD9,C5orf35;SET domain containing 9
hsa:729025;SLC15A5;solute carrier family 15, member 5
hsa:100526772;TMEM110-MUSTN1;TMEM110-MUSTN1 readthrough
hsa:338442;HCAR2,GPR109A,HCA2,HM74a,HM74b,NIACR1,PUMAG,Puma-g;hydroxycarboxylic acid receptor 2
hsa:100506627;DCDC5;doublecortin domain containing 5
hsa:253582;TMEM244,C6orf191,bA174C7.4;transmembrane protein 244
hsa:7920;ABHD16A,BAT5,D6S82E,NG26,PP199;abhydrolase domain containing 16A
hsa:100505385;IQCJ-SCHIP1;IQCJ-SCHIP1 readthrough
hsa:283450;HECTD4,C12orf51;HECT domain containing E3 ubiquitin protein ligase 4 (EC:6.3.2.-)
hsa:100527978;TMEM56-RWDD3;TMEM56-RWDD3 readthrough
hsa:162540;SPPL2C,IMP5;signal peptide peptidase like 2C
hsa:100526783;C15orf38-AP3S2;C15orf38-AP3S2 readthrough
hsa:28984;RGCC,C13orf15,RGC-32,RGC32,bA157L14.2;regulator of cell cycle
hsa:58512;DLGAP3,DAP3,SAPAP3;discs, large (Drosophila) homolog-associated protein 3
hsa:79817;MOB3B,C9orf35,MOB1D,MOBKL2B;MOB kinase activator 3B
hsa:542767;C1QTNF9B-AS1,PCOTH;C1QTNF9B antisense RNA 1
hsa:56267;CCBL2,KAT3,KATIII,RP4-531M19.2;cysteine conjugate-beta lyase 2 (EC:2.6.1.7 4.4.1.13 2.6.1.63)
hsa:121793;TEX29,C13orf16,bA474D23.1;testis expressed 29
hsa:30816;ERVW-1,ENV,ENVW,ERVWE1,HERV-7q,HERV-W-ENV,HERV7Q,HERVW,HERVWENV;endogenous retrovirus group W, member 1
hsa:168455;CCDC71L,C7orf74;coiled-coil domain containing 71-like
hsa:100526761;CCDC169-SOHLH2,C13orf38-SOHLH2;CCDC169-SOHLH2 readthrough
hsa:80817;CEP44,KIAA1712,PS1TP3;centrosomal protein 44kDa
hsa:8564;KMO,dJ317G22.1;kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) (EC:1.14.13.9)
hsa:100533183;ZNF664-FAM101A;protein FAM101A
hsa:100505549;;uncharacterized LOC100505549
hsa:79363;RSG1,C1orf89;REM2 and RAB-like small GTPase 1
hsa:55668;GPATCH2L,C14orf118;G patch domain containing 2-like
hsa:55321;TMEM74B,C20orf46;transmembrane protein 74B
hsa:391356;PTRHD1,C2orf79;peptidyl-tRNA hydrolase domain containing 1 (EC:3.1.1.29)
hsa:387119;CEP85L,C6orf204,NY-BR-15,bA57K17.2;centrosomal protein 85kDa-like
hsa:100507341;SMIM18;small integral membrane protein 18
hsa:403257;OR4C45;olfactory receptor, family 4, subfamily C, member 45
hsa:84319;CMSS1,C3orf26;cms1 ribosomal small subunit homolog (yeast)
hsa:54908;SPDL1,CCDC99;spindle apparatus coiled-coil protein 1
hsa:100526835;FPGT-TNNI3K;FPGT-TNNI3K readthrough
hsa:79603;CERS4,LASS4,Trh1;ceramide synthase 4
hsa:100528017;SAA2-SAA4;SAA2-SAA4 readthrough
hsa:57212;TP73-AS1,KIAA0495,PDAM;TP73 antisense RNA 1
hsa:503519;;uncharacterized LOC503519
hsa:339942;H1FX-AS1,C3orf47;H1FX antisense RNA 1
hsa:6998;TDGF1P3,CR-3,CRIPTO,CRIPTO-3,CRIPTO3,TDGF1,TDGF2,TDGF3;teratocarcinoma-derived growth factor 1 pseudogene 3
hsa:406926;MIR135A2,MIRN135-2,MIRN135A2;microRNA 135a-2
hsa:400804;C1orf140;uncharacterized LOC400804
hsa:693207;MIR622,MIRN622,hsa-mir-622;microRNA 622
hsa:100616369;MIR4713;microRNA 4713
hsa:724026;MIR656,MIRN656,hsa-mir-656;microRNA 656
hsa:100187716;MIR1224,MIRN1224;microRNA 1224
hsa:400242;DICER1-AS1,DICER1-AS;DICER1 antisense RNA 1
hsa:400866;LINC00114,C21orf24,NCRNA00114;long intergenic non-protein coding RNA 114
hsa:389641;;uncharacterized LOC389641
hsa:653677;SEC1P,SEC1;secretory blood group 1, pseudogene
hsa:440119;FLJ31485;uncharacterized LOC440119
hsa:729013;;uncharacterized LOC729013
hsa:80069;LINC00574,C6orf208,RP1-266L20.3,dJ182D15.1;long intergenic non-protein coding RNA 574
hsa:729177;;uncharacterized LOC729177
hsa:100422829;MIR4319;microRNA 4319
hsa:284998;;uncharacterized LOC284998
hsa:63930;;uncharacterized LOC63930
hsa:283601;LINC00523,C14orf70;long intergenic non-protein coding RNA 523
hsa:285987;DLX6-AS1,DLX6-AS,DLX6AS,Evf-2,NCRNA00212;DLX6 antisense RNA 1
hsa:121838;LINC00284,NCRNA00284;long intergenic non-protein coding RNA 284
hsa:54088;LINC00113,C21orf23,NCRNA00113;long intergenic non-protein coding RNA 113
hsa:144360;LINC00477,C12orf67,FAM191B;long intergenic non-protein coding RNA 477
hsa:100302228;MIR1261,MIRN1261,hsa-mir-1261;microRNA 1261
hsa:221241;LINC00305,C18orf20,HsT1235,NCRNA00305;long intergenic non-protein coding RNA 305
hsa:56651;LINC00470,C18orf2;long intergenic non-protein coding RNA 470
hsa:163742;SLC25A3P1;solute carrier family 25 (mitochondrial carrier;phosphate carrier), member 3 pseudogene 1
hsa:406939;MIR147A,MIR147,MIRN147,hsa-mir-147a;microRNA 147a
hsa:100302123;MIR1275,MIRN1275,hsa-mir-1275;microRNA 1275
hsa:100506746;;uncharacterized LOC100506746
hsa:7850;IL1R2,CD121b,CDw121b,IL-1R-2,IL-1RT-2,IL-1RT2,IL1R2c,IL1RB;interleukin 1 receptor, type II
hsa:6640;SNTA1,LQT12,SNT1,TACIP1,dJ1187J4.5;syntrophin, alpha 1
hsa:1056;CEL,BAL,BSDL,BSSL,CELL,CEase,FAP,FAPP,LIPA,MODY8;carboxyl ester lipase (EC:3.1.1.13 3.1.1.3)
hsa:140850;DEFB127,C20orf73,DEF-27,DEFB-27,DEFB27,bA530N10.2,hBD-27;defensin, beta 127
hsa:8111;GPR68,GPR12A,OGR1;G protein-coupled receptor 68
hsa:100506311;HOTAIRM1,HOXA-AS1,HOXA1-AS1,NCRNA00179;HOXA transcript antisense RNA, myeloid-specific 1
hsa:340706;VWA2,AMACO,CCSP-2,NET42;von Willebrand factor A domain containing 2
hsa:93621;MRFAP1,PAM14,PGR1;Morf4 family associated protein 1
hsa:8344;HIST1H2BE,H2B.h,H2B/h,H2BFH,dJ221C16.8;histone cluster 1, H2be
hsa:10317;B3GALT5,B3GalT-V,B3GalTx,B3T5,GLCT5,beta3Gal-T5;UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5
hsa:51187;RSL24D1,C15orf15,HRP-L30-iso,L30,RLP24,RPL24,RPL24L,TVAS3;ribosomal L24 domain containing 1
hsa:5763;PTMS,ParaT;parathymosin
hsa:25984;KRT23,CK23,HAIK1,K23;keratin 23 (histone deacetylase inducible)
hsa:8345;HIST1H2BH,H2B/j,H2BFJ;histone cluster 1, H2bh
hsa:4676;NAP1L4,NAP1L4b,NAP2,NAP2L,hNAP2;nucleosome assembly protein 1-like 4
hsa:11080;DNAJB4,DNAJW,DjB4,HLJ1;DnaJ (Hsp40) homolog, subfamily B, member 4
hsa:8346;HIST1H2BI,H2B/k,H2BFK;histone cluster 1, H2bi
hsa:58497;PRUNE,DRES-17,DRES17,HTCD37;prune homolog (Drosophila) (EC:3.6.1.1)
hsa:4215;MAP3K3,MAPKKK3,MEKK3;mitogen-activated protein kinase kinase kinase 3 (EC:2.7.11.25)
hsa:8347;HIST1H2BC,H2B.1,H2B/l,H2BFL,dJ221C16.3;histone cluster 1, H2bc
hsa:2564;GABRE;gamma-aminobutyric acid (GABA) A receptor, epsilon
hsa:3995;FADS3,CYB5RP,LLCDL3;fatty acid desaturase 3 (EC:1.14.19.-)
hsa:56929;FEM1C,EUROIMAGE686608,EUROIMAGE783647,FEM1A;fem-1 homolog c (C. elegans)
hsa:5097;PCDH1,PC42,PCDH42;protocadherin 1
hsa:8348;HIST1H2BO,H2B.2,H2B/n,H2BFN,dJ193B12.2;histone cluster 1, H2bo
hsa:29124;LGALS13,GAL13,PLAC8,PP13;lectin, galactoside-binding, soluble, 13 (EC:3.1.1.5)
hsa:8349;HIST2H2BE,GL105,H2B,H2B.1,H2BFQ,H2BGL105,H2BQ;histone cluster 2, H2be
hsa:92747;BPIFB1,C20orf114,LPLUNC1;BPI fold containing family B, member 1
hsa:79171;RBM42;RNA binding motif protein 42
hsa:219409;GSX1,GSH1,Gsh-1;GS homeobox 1
hsa:89872;AQP10,AQPA_HUMAN;aquaporin 10
hsa:26355;FAM162A,C3orf28,E2IG5,HGTD-P;family with sequence similarity 162, member A
hsa:55647;RAB20;RAB20, member RAS oncogene family
hsa:566;AZU1,AZAMP,AZU,CAP37,HBP,HUMAZUR,NAZC;azurocidin 1
hsa:27240;SIT1,RP11-331F9.5,SIT,SIT-R;signaling threshold regulating transmembrane adaptor 1
hsa:28970;C11orf54,PTD012;chromosome 11 open reading frame 54
hsa:55130;ARMC4;armadillo repeat containing 4
hsa:56125;PCDHB11,ME2,PCDH-BETA11;protocadherin beta 11
hsa:51097;SCCPDH,NET11,RP11-439E19.2;saccharopine dehydrogenase (putative) (EC:1.5.1.9)
hsa:4735;SEPT2,DIFF6,NEDD5,Pnutl3,hNedd5;septin 2
hsa:253959;RALGAPA1,GARNL1,GRIPE,TULIP1;Ral GTPase activating protein, alpha subunit 1 (catalytic)
hsa:53407;STX18,Ufe1;syntaxin 18
hsa:51605;TRMT6,GCD10,Gcd10p;tRNA methyltransferase 6 homolog (S. cerevisiae)
hsa:23769;FLRT1;fibronectin leucine rich transmembrane protein 1
hsa:55132;LARP1B,LARP2;La ribonucleoprotein domain family, member 1B
hsa:11172;INSL6,RIF1;insulin-like 6
hsa:7879;RAB7A,PRO2706,RAB7;RAB7A, member RAS oncogene family
hsa:6119;RPA3,REPA3;replication protein A3, 14kDa
hsa:400916;CHCHD10,C22orf16,N27C7-4;coiled-coil-helix-coiled-coil-helix domain containing 10
hsa:9783;RIMS3,NIM3,RIM3;regulating synaptic membrane exocytosis 3
hsa:29958;DMGDH,DMGDHD,ME2GLYDH;dimethylglycine dehydrogenase (EC:1.5.8.4)
hsa:29985;SLC39A3,ZIP3;solute carrier family 39 (zinc transporter), member 3
hsa:3843;IPO5,IMB3,KPNB3,Pse1,RANBP5,imp5;importin 5
hsa:57214;CCSP1,TMEM2L;KIAA1199
hsa:90121;TSR2,DT1P1A10,WGG1;TSR2, 20S rRNA accumulation, homolog (S. cerevisiae)
hsa:51294;PCDH12,VE-cadherin-2,VECAD2;protocadherin 12
hsa:79085;SLC25A23,APC2,MCSC2,SCaMC-3;solute carrier family 25 (mitochondrial carrier;phosphate carrier), member 23
hsa:4953;ODC1,ODC;ornithine decarboxylase 1 (EC:4.1.1.17)
hsa:54497;HEATR5B;HEAT repeat containing 5B
hsa:29960;FTSJ2,FJH1,MRM2;FtsJ RNA methyltransferase homolog 2 (E. coli) (EC:2.1.1.-)
hsa:80856;LNP,Ul,ulnaless;KIAA1715
hsa:5745;PTH1R,PFE,PTHR,PTHR1;parathyroid hormone 1 receptor
hsa:51001;MTERFD1,mTERF3;MTERF domain containing 1
hsa:29785;CYP2S1;cytochrome P450, family 2, subfamily S, polypeptide 1 (EC:1.14.14.1)
hsa:51458;RHCG,C15orf6,PDRC2,RHGK,SLC42A3;Rh family, C glycoprotein
hsa:810;CALML3,CLP;calmodulin-like 3
hsa:7318;UBA7,D8,UBA1B,UBE1L,UBE2;ubiquitin-like modifier activating enzyme 7
hsa:81572;PDRG1,C20orf126,PDRG;p53 and DNA-damage regulated 1
hsa:284723;SLC25A34,RP11-169K16.2;solute carrier family 25, member 34
hsa:2585;GALK2,GK2;galactokinase 2 (EC:2.7.1.157)
hsa:23225;NUP210,GP210,POM210;nucleoporin 210kDa
hsa:25828;TXN2,MT-TRX,MTRX,TRX2;thioredoxin 2
hsa:516;ATP5G1,ATP5A,ATP5G;ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)
hsa:64897;C12orf43;chromosome 12 open reading frame 43
hsa:65975;STK33;serine/threonine kinase 33 (EC:2.7.11.1)
hsa:53632;PRKAG3,AMPKG3;protein kinase, AMP-activated, gamma 3 non-catalytic subunit
hsa:4608;MYBPH;myosin binding protein H
hsa:23013;SPEN,HIAA0929,MINT,RBM15C,SHARP;spen homolog, transcriptional regulator (Drosophila)
hsa:116092;DNTTIP1,C20orf167,Tdif1,dJ447F3.4;deoxynucleotidyltransferase, terminal, interacting protein 1
hsa:55752;SEPT11;septin 11
hsa:10484;SEC23A,CLSD;Sec23 homolog A (S. cerevisiae)
hsa:4102;MAGEA3,CT1.3,HIP8,HYPD,MAGE3,MAGEA6;melanoma antigen family A, 3
hsa:10549;PRDX4,AOE37-2,PRX-4;peroxiredoxin 4 (EC:1.11.1.15)
hsa:222171;PRR15;proline rich 15
hsa:4108;MAGEA9,CT1.9,MAGE9;melanoma antigen family A, 9
hsa:10495;ENOX2,APK1,COVA1,tNOX;ecto-NOX disulfide-thiol exchanger 2
hsa:5729;PTGDR,AS1,ASRT1,DP,DP1,PTGDR1;prostaglandin D2 receptor (DP)
hsa:1132;CHRM4,HM4,M4R;cholinergic receptor, muscarinic 4
hsa:23632;CA14,CAXiV;carbonic anhydrase XIV (EC:4.2.1.1)
hsa:1119;CHKA,CHK,CK,CKI,EK;choline kinase alpha (EC:2.7.1.32 2.7.1.82)
hsa:55867;SLC22A11,OAT4,hOAT4;solute carrier family 22 (organic anion/urate transporter), member 11
hsa:3083;HGFAC,HGFA;HGF activator (EC:3.4.21.-)
hsa:8859;STK19,D6S60,D6S60E,G11,HLA-RP1,RP1;serine/threonine kinase 19 (EC:2.7.11.1)
hsa:23105;FSTL4;follistatin-like 4
hsa:28962;OSTM1,GIPN,GL,OPTB5;osteopetrosis associated transmembrane protein 1
hsa:10388;SYCP2,SCP2;synaptonemal complex protein 2
hsa:2180;ACSL1,ACS1,FACL1,FACL2,LACS,LACS1,LACS2;acyl-CoA synthetase long-chain family member 1 (EC:6.2.1.3)
hsa:79190;IRX6,IRX-3,IRX7,IRXB3;iroquois homeobox 6
hsa:91734;IDI2,IPPI2;isopentenyl-diphosphate delta isomerase 2 (EC:5.3.3.2)
hsa:56904;SH3GLB2,PP6569,PP9455,RRIG1;SH3-domain GRB2-like endophilin B2
hsa:482;ATP1B2,AMOG;ATPase, Na+/K+ transporting, beta 2 polypeptide (EC:3.6.3.9)
hsa:6423;SFRP2,FRP-2,SARP1,SDF-5;secreted frizzled-related protein 2
hsa:7408;VASP;vasodilator-stimulated phosphoprotein
hsa:57704;GBA2;glucosidase, beta (bile acid) 2 (EC:3.2.1.45)
hsa:94235;GNG8;guanine nucleotide binding protein (G protein), gamma 8
hsa:1810;DR1,NC2,NC2-BETA;down-regulator of transcription 1, TBP-binding (negative cofactor 2)
hsa:3669;ISG20,CD25,HEM45;interferon stimulated exonuclease gene 20kDa (EC:3.1.13.1)
hsa:117531;TMC1,DFNA36,DFNB11,DFNB7;transmembrane channel-like 1
hsa:6252;RTN1,NSP;reticulon 1
hsa:653;BMP5;bone morphogenetic protein 5
hsa:9791;PTDSS1,PSS1,PSSA;phosphatidylserine synthase 1 (EC:2.7.8.29)
hsa:2980;GUCA2A,GCAP-I,GUCA2,STARA;guanylate cyclase activator 2A (guanylin)
hsa:284948;SH2D6;SH2 domain containing 6
hsa:64976;MRPL40,MRP-L22,MRPL22,NLVCF,URIM;mitochondrial ribosomal protein L40
hsa:57687;VAT1L;vesicle amine transport protein 1 homolog (T. californica)-like
hsa:88455;ANKRD13A,ANKRD13,NY-REN-25;ankyrin repeat domain 13A
hsa:51573;GDE1,363E6.2,MIR16;glycerophosphodiester phosphodiesterase 1 (EC:3.1.4.44)
hsa:4809;NHP2L1,15.5K,FA-1,FA1,NHPX,OTK27,SNRNP15-5,SNU13,SPAG12,SSFA1;NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae)
hsa:56920;SEMA3G,sem2;sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G
hsa:28957;MRPS28,MRP-S28,MRP-S35,MRPS35;mitochondrial ribosomal protein S28
hsa:10945;KDELR1,ERD2,ERD2.1,HDEL,PM23;KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1
hsa:6945;MLX,MAD7,MXD7,TCFL4,bHLHd13;MLX, MAX dimerization protein
hsa:25819;CCRN4L,CCR4L,NOC;CCR4 carbon catabolite repression 4-like (S. cerevisiae)
hsa:143458;LDLRAD3,LRAD3;low density lipoprotein receptor class A domain containing 3
hsa:65992;DDRGK1,C20orf116,UFBP1,dJ1187M17.3;DDRGK domain containing 1
hsa:84669;USP32,NY-REN-60,USP10;ubiquitin specific peptidase 32 (EC:3.4.19.12)
hsa:57035;C1orf63,DJ465N24.2.1,NPD014,RP3-465N24.4;chromosome 1 open reading frame 63
hsa:51155;HN1,ARM2,HN1A;hematological and neurological expressed 1
hsa:65993;MRPS34,MRP-S12,MRP-S34,MRPS12;mitochondrial ribosomal protein S34
hsa:6753;SSTR3;somatostatin receptor 3
hsa:92609;TIMM50,TIM50,TIM50L;translocase of inner mitochondrial membrane 50 homolog (S. cerevisiae)
hsa:23760;PITPNB,PI-TP-beta,PtdInsTP,VIB1B;phosphatidylinositol transfer protein, beta
hsa:23339;VPS39,TLP,VAM6,hVam6p;vacuolar protein sorting 39 homolog (S. cerevisiae)
hsa:5922;RASA2,GAP1M;RAS p21 protein activator 2
hsa:10634;GAS2L1,GAR22;growth arrest-specific 2 like 1
hsa:51429;SNX9,MST155,MSTP155,SDP1,SH3PX1,SH3PXD3A,WISP;sorting nexin 9
hsa:5130;PCYT1A,CCTA,CT,CTA,CTPCT,PCYT1;phosphate cytidylyltransferase 1, choline, alpha (EC:2.7.7.15)
hsa:5016;OVGP1,CHIT5,EGP,MUC9,OGP;oviductal glycoprotein 1, 120kDa
hsa:57646;USP28;ubiquitin specific peptidase 28 (EC:3.4.19.12)
hsa:51726;DNAJB11,ABBP-2,ABBP2,DJ9,Dj-9,EDJ,ERdj3,ERj3,ERj3p,PRO1080,UNQ537,hDj-9;DnaJ (Hsp40) homolog, subfamily B, member 11
hsa:11187;PKP3;plakophilin 3
hsa:55323;LARP6,ACHN;La ribonucleoprotein domain family, member 6
hsa:92610;TIFA,T2BP,T6BP,TIFAA;TRAF-interacting protein with forkhead-associated domain
hsa:483;ATP1B3,ATPB-3,CD298;ATPase, Na+/K+ transporting, beta 3 polypeptide (EC:3.6.3.9)
hsa:91647;ATPAF2,ATP12,ATP12p,MC5DN1;ATP synthase mitochondrial F1 complex assembly factor 2
hsa:84528;RHOXF2,CT107,PEPP-2,PEPP2,THG1;Rhox homeobox family, member 2
hsa:10513;APPBP2,HS.84084,PAT1;amyloid beta precursor protein (cytoplasmic tail) binding protein 2
hsa:134429;STARD4;StAR-related lipid transfer (START) domain containing 4
hsa:26160;IFT172,SLB,osm-1,wim;intraflagellar transport 172 homolog (Chlamydomonas)
hsa:7453;WARS,GAMMA-2,IFI53,IFP53;tryptophanyl-tRNA synthetase (EC:6.1.1.2)
hsa:4236;MFAP1;microfibrillar-associated protein 1
hsa:54212;SNTG1,G1SYN,SYN4;syntrophin, gamma 1
hsa:1130;LYST,CHS,CHS1;lysosomal trafficking regulator
hsa:10814;CPLX2,921-L,CPX-2,CPX2,Hfb1;complexin 2
hsa:7290;HIRA,DGCR1,TUP1,TUPLE1;HIR histone cell cycle regulation defective homolog A (S. cerevisiae)
hsa:26499;PLEK2;pleckstrin 2
hsa:51112;TRAPPC12,TTC-15,TTC15;trafficking protein particle complex 12
hsa:54554;WDR5B;WD repeat domain 5B
hsa:6938;TCF12,HEB,HTF4,HsT17266,bHLHb20;transcription factor 12
hsa:23770;FKBP8,FKBP38,FKBPr38;FK506 binding protein 8, 38kDa (EC:5.2.1.8)
hsa:10242;KCNMB2;potassium large conductance calcium-activated channel, subfamily M, beta member 2
hsa:900;CCNG1,CCNG;cyclin G1
hsa:29959;NRBP1,BCON3,MADM,MUDPNP,NRBP;nuclear receptor binding protein 1
hsa:397;ARHGDIB,D4,GDIA2,GDID4,LYGDI,Ly-GDI,RAP1GN1,RhoGDI2;Rho GDP dissociation inhibitor (GDI) beta
hsa:26575;RGS17,RGS-17,RGSZ2,hRGS17;regulator of G-protein signaling 17
hsa:81932;HDHD3,2810435D12Rik,C9orf158;haloacid dehalogenase-like hydrolase domain containing 3
hsa:83752;LONP2,LONP,LONPL;lon peptidase 2, peroxisomal
hsa:3396;ICT1,DS-1,DS1;immature colon carcinoma transcript 1 (EC:3.1.1.29)
hsa:5816;PVALB,D22S749;parvalbumin
hsa:56259;CTNNBL1,C20orf33,NAP,NYD-SP19,P14L,PP8304,dJ633O20.1;catenin, beta like 1
hsa:55589;BMP2K,BIKE;BMP2 inducible kinase (EC:2.7.11.1)
hsa:79864;C11orf63;chromosome 11 open reading frame 63
hsa:23649;POLA2;polymerase (DNA directed), alpha 2, accessory subunit
hsa:50;ACO2,ACONM,ICRD;aconitase 2, mitochondrial (EC:4.2.1.3)
hsa:23097;CDK19,CDC2L6,CDK11,bA346C16.3;cyclin-dependent kinase 19 (EC:2.7.11.22)
hsa:147323;STARD6;StAR-related lipid transfer (START) domain containing 6
hsa:65059;RAPH1,ALS2CR18,ALS2CR9,LPD,PREL-2,PREL2,RMO1,RalGDS/AF-6;Ras association (RalGDS/AF-6) and pleckstrin homology domains 1
hsa:79820;CATSPERB,C14orf161,CatSper(beta);catsper channel auxiliary subunit beta
hsa:2358;FPR2,ALXR,FMLP-R-II,FMLPX,FPR2A,FPRH1,FPRH2,FPRL1,HM63,LXA4R;formyl peptide receptor 2
hsa:1645;AKR1C1,2-ALPHA-HSD,20-ALPHA-HSD,C9,DD1,DD1/DD2,DDH,DDH1,H-37,HAKRC,HBAB,MBAB;aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112)
hsa:341032;C11orf53;chromosome 11 open reading frame 53
hsa:259230;SGMS1,MOB,MOB1,SMS1,TMEM23,hmob33;sphingomyelin synthase 1 (EC:2.7.8.27)
hsa:10162;LPCAT3,C3F,LPCAT,LPLAT_5,LPSAT,MBOAT5,OACT5,nessy;lysophosphatidylcholine acyltransferase 3 (EC:2.3.1.23 2.3.1.n6)
hsa:147744;TMEM190,MDAC1;transmembrane protein 190
hsa:9955;HS3ST3A1,30ST3A1,3OST3A1;heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 (EC:2.8.2.30)
hsa:26063;DECR2,PDCR,SDR17C1;2,4-dienoyl CoA reductase 2, peroxisomal (EC:1.3.1.34)
hsa:1519;CTSO,CTSO1;cathepsin O (EC:3.4.22.42)
hsa:9953;HS3ST3B1,30ST3B1,3OST3B1;heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 (EC:2.8.2.30)
hsa:26240;FAM50B,D6S2654E,X5L;family with sequence similarity 50, member B
hsa:81033;KCNH6,ERG2,HERG2,Kv11.2;potassium voltage-gated channel, subfamily H (eag-related), member 6
hsa:10153;CEBPZ,CBF,CBF2,HSP-CBF,NOC1;CCAAT/enhancer binding protein (C/EBP), zeta
hsa:8208;CHAF1B,CAF-1,CAF-IP60,CAF1,CAF1A,CAF1P60,MPHOSPH7,MPP7;chromatin assembly factor 1, subunit B (p60)
hsa:84277;DNAJC30,WBSCR18;DnaJ (Hsp40) homolog, subfamily C, member 30
hsa:94033;FTMT,MTF;ferritin mitochondrial (EC:1.16.3.1)
hsa:8886;DDX18,MrDb;DEAD (Asp-Glu-Ala-Asp) box polypeptide 18 (EC:3.6.4.13)
hsa:114571;SLC22A9,HOAT4,OAT4,OAT7,UST3H,ust3;solute carrier family 22 (organic anion transporter), member 9
hsa:221830;TWISTNB;TWIST neighbor
hsa:2191;FAP,DPPIV,FAPA;fibroblast activation protein, alpha
hsa:23299;BICD2,bA526D8.1;bicaudal D homolog 2 (Drosophila)
hsa:51651;PTRH2,BIT1,PTH2;peptidyl-tRNA hydrolase 2 (EC:3.1.1.29)
hsa:10113;PREB,SEC12;prolactin regulatory element binding
hsa:22801;ITGA11,HsT18964;integrin, alpha 11
hsa:23387;SIK3,QSK,SIK-3;SIK family kinase 3 (EC:2.7.11.1)
hsa:29882;ANAPC2,APC2,RP11-350O14.5;anaphase promoting complex subunit 2
hsa:9416;DDX23,PRPF28,U5-100K,U5-100KD,prp28;DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 (EC:3.6.4.13)
hsa:81490;PTDSS2,PSS2;phosphatidylserine synthase 2 (EC:2.7.8.29)
hsa:23082;PPRC1,PRC,RP11-302K17.6;peroxisome proliferator-activated receptor gamma, coactivator-related 1
hsa:5576;PRKAR2A,PKR2,PRKAR2;protein kinase, cAMP-dependent, regulatory, type II, alpha (EC:2.7.11.1)
hsa:51639;SF3B14,HSPC175,Ht006,P14,SAP14,SF3B14a;splicing factor 3B, 14 kDa subunit
hsa:686;BTD;biotinidase (EC:3.5.1.12)
hsa:204474;PDILT,PDIA7;protein disulfide isomerase-like, testis expressed
hsa:84271;POLDIP3,PDIP46,SKAR;polymerase (DNA-directed), delta interacting protein 3
hsa:84896;ATAD1,AFDC1,THORASE;ATPase family, AAA domain containing 1 (EC:3.6.1.3)
hsa:8419;BFSP2,CP47,CP49,LIFL-L,PHAKOSIN;beaded filament structural protein 2, phakinin
hsa:7781;SLC30A3,ZNT3;solute carrier family 30 (zinc transporter), member 3
hsa:63826;SRR,ILV1,ISO1;serine racemase (EC:4.3.1.17 5.1.1.18 4.3.1.18)
hsa:54517;PUS7;pseudouridylate synthase 7 homolog (S. cerevisiae) (EC:4.2.1.70)
hsa:56945;MRPS22,C3orf5,COXPD5,GIBT,MRP-S22,RPMS22;mitochondrial ribosomal protein S22
hsa:56000;NXF3;nuclear RNA export factor 3
hsa:1329;COX5B,COXVB;cytochrome c oxidase subunit Vb (EC:1.9.3.1)
hsa:113451;ADC,AZI2,ODC-p,ODC1L;arginine decarboxylase (EC:4.1.1.19)
hsa:51542;VPS54,HCC8,SLP-8p,VPS54L,WR,hVps54L;vacuolar protein sorting 54 homolog (S. cerevisiae)
hsa:152579;SCFD2,STXBP1L1;sec1 family domain containing 2
hsa:55303;GIMAP4,IAN-1,IAN1,IMAP4;GTPase, IMAP family member 4
hsa:57821;CCDC181,C1orf114,RP1-206D15.2;coiled-coil domain containing 181
hsa:10920;COPS8,COP9,CSN8,SGN8;COP9 signalosome subunit 8
hsa:1949;EFNB3,EFL6,EPLG8,LERK8;ephrin-B3
hsa:140683;BPIFA2,C20orf70,PSP,SPLUNC2,bA49G10.1;BPI fold containing family A, member 2
hsa:506;ATP5B,ATPMB,ATPSB;ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (EC:3.6.3.14)
hsa:1472;CST4;cystatin S
hsa:8192;CLPP;ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit homolog (E. coli) (EC:3.4.21.92)
hsa:51179;HAO2,GIG16,HAOX2;hydroxyacid oxidase 2 (long chain) (EC:1.1.3.15)
hsa:81502;HM13,H13,IMP1,IMPAS,IMPAS-1,MSTP086,PSENL3,PSL3,SPP,SPPL1,dJ324O17.1;histocompatibility (minor) 13
hsa:5708;PSMD2,P97,Rpn1,S2,TRAP2;proteasome (prosome, macropain) 26S subunit, non-ATPase, 2
hsa:119559;SFXN4,BCRM1;sideroflexin 4
hsa:161514;TBC1D21,MgcRabGAP;TBC1 domain family, member 21
hsa:1264;CNN1,SMCC,Sm-Calp;calponin 1, basic, smooth muscle
hsa:155465;AGR3,AG3,BCMP11,HAG3,PDIA18,hAG-3;anterior gradient 3 homolog (Xenopus laevis)
hsa:55361;PI4K2A,PI4KII,PIK42A,RP11-548K23.6;phosphatidylinositol 4-kinase type 2 alpha (EC:2.7.1.67)
hsa:90427;BMF;Bcl2 modifying factor
hsa:5577;PRKAR2B,PRKAR2,RII-BETA;protein kinase, cAMP-dependent, regulatory, type II, beta (EC:2.7.11.1)
hsa:8764;TNFRSF14,ATAR,CD270,HVEA,HVEM,LIGHTR,TR2;tumor necrosis factor receptor superfamily, member 14
hsa:150684;COMMD1,C2orf5,MURR1;copper metabolism (Murr1) domain containing 1
hsa:79676;OGFOD2;2-oxoglutarate and iron-dependent oxygenase domain containing 2
hsa:8528;DDO,DASOX,DDO-1,DDO-2;D-aspartate oxidase (EC:1.4.3.1)
hsa:9341;VAMP3,CEB;vesicle-associated membrane protein 3
hsa:23271;CAMSAP2,CAMSAP1L1;calmodulin regulated spectrin-associated protein family, member 2
hsa:51566;ARMCX3,ALEX3,dJ545K15.2;armadillo repeat containing, X-linked 3
hsa:8833;GMPS;guanine monphosphate synthetase (EC:6.3.5.2)
hsa:9527;GOSR1,GOLIM2,GOS-28,GOS28,GOS28/P28,GS28,P28;golgi SNAP receptor complex member 1
hsa:51268;PIPOX,LPIPOX;pipecolic acid oxidase (EC:1.5.3.1 1.5.3.7)
hsa:84859;LRCH3;leucine-rich repeats and calponin homology (CH) domain containing 3
hsa:54509;RHOF,ARHF,RIF;ras homolog family member F (in filopodia)
hsa:3617;IMPG1,GP147,IPM150,SPACR;interphotoreceptor matrix proteoglycan 1
hsa:357;SHROOM2,APXL,HSAPXL;shroom family member 2
hsa:10949;HNRNPA0,HNRPA0;heterogeneous nuclear ribonucleoprotein A0
hsa:168537;GIMAP7,IAN7,hIAN7;GTPase, IMAP family member 7
hsa:57721;METTL14;methyltransferase like 14
hsa:10498;CARM1,PRMT4;coactivator-associated arginine methyltransferase 1 (EC:2.1.1.125)
hsa:3726;JUNB,AP-1;jun B proto-oncogene
hsa:4329;ALDH6A1,MMSADHA,MMSDH;aldehyde dehydrogenase 6 family, member A1 (EC:1.2.1.27 1.2.1.18)
hsa:8650;NUMB,C14orf41,S171,c14_5527;numb homolog (Drosophila)
hsa:5966;REL,C-Rel;v-rel reticuloendotheliosis viral oncogene homolog (avian)
hsa:51504;TRMT112,HSPC152,HSPC170,TRM112,TRMT11-2;tRNA methyltransferase 11-2 homolog (S. cerevisiae)
hsa:129684;CNTNAP5,caspr5;contactin associated protein-like 5
hsa:6273;S100A2,CAN19,S100L;S100 calcium binding protein A2
hsa:84651;SPINK7,ECG2,ECRG2;serine peptidase inhibitor, Kazal type 7 (putative)
hsa:2248;FGF3,HBGF-3,INT2;fibroblast growth factor 3
hsa:2049;EPHB3,ETK2,HEK2,TYRO6;EPH receptor B3 (EC:2.7.10.1)
hsa:23193;GANAB,G2AN,GLUII;glucosidase, alpha;neutral AB (EC:3.2.1.84)
hsa:10887;PROKR1,GPR73,GPR73a,PKR1,ZAQ;prokineticin receptor 1
hsa:83483;PLVAP,FELS,PV-1,PV1,gp68;plasmalemma vesicle associated protein
hsa:3150;HMGN1,HMG14;high mobility group nucleosome binding domain 1
hsa:26272;FBXO4,FBX4;F-box protein 4
hsa:11000;SLC27A3,ACSVL3,FATP3,VLCS-3;solute carrier family 27 (fatty acid transporter), member 3 (EC:6.2.1.-)
hsa:115290;FBXO17,FBG4,FBX26,FBXO26,Fbx17;F-box protein 17
hsa:196294;IMMP1L,IMP1,IMP1-LIKE;IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae)
hsa:8263;F8A1,DXS522E,F8A,HAP40;coagulation factor VIII-associated 1
hsa:84618;NT5C1A,CN-I,CN-IA,CN1,CN1A;5'-nucleotidase, cytosolic IA (EC:3.1.3.5)
hsa:170572;HTR3C;5-hydroxytryptamine (serotonin) receptor 3C, ionotropic
hsa:64318;NOC3L,AD24,C10orf117,FAD24;nucleolar complex associated 3 homolog (S. cerevisiae)
hsa:5289;PIK3C3,VPS34,hVps34;phosphatidylinositol 3-kinase, catalytic subunit type 3 (EC:2.7.1.137)
hsa:1444;CSHL1,CS-5,CSHP1,CSL,hCS-L;chorionic somatomammotropin hormone-like 1
hsa:155038;GIMAP8,IAN-9,IAN6,IANT,hIAN6;GTPase, IMAP family member 8
hsa:3702;ITK,EMT,LYK,PSCTK2;IL2-inducible T-cell kinase (EC:2.7.10.2)
hsa:5731;PTGER1,EP1;prostaglandin E receptor 1 (subtype EP1), 42kDa
hsa:7127;TNFAIP2,B94,EXOC3L3;tumor necrosis factor, alpha-induced protein 2
hsa:5982;RFC2,A1,RFC40;replication factor C (activator 1) 2, 40kDa
hsa:90070;LACRT;lacritin
hsa:29922;NME7,MN23H7,nm23-H7;NME/NM23 family member 7 (EC:2.7.4.6)
hsa:57326;PBXIP1,HPIP;pre-B-cell leukemia homeobox interacting protein 1
hsa:1659;DHX8,DDX8,HRH1,PRP22,PRPF22;DEAH (Asp-Glu-Ala-His) box polypeptide 8 (EC:3.6.4.13)
hsa:11047;ADRM1,ARM1,GP110,Rpn13;adhesion regulating molecule 1
hsa:131034;CPNE4,COPN4,CPN4;copine IV
hsa:51669;TMEM66,FOAP-7,SARAF,XTP3;transmembrane protein 66
hsa:6470;SHMT1,CSHMT,SHMT;serine hydroxymethyltransferase 1 (soluble) (EC:2.1.2.1)
hsa:392636;AGMO,TMEM195;alkylglycerol monooxygenase (EC:1.14.16.5)
hsa:54935;DUSP23,DUSP25,LDP-3,MOSP,RP11-190A12.1,VHZ;dual specificity phosphatase 23 (EC:3.1.3.16 3.1.3.48)
hsa:51327;AHSP,EDRF,ERAF;alpha hemoglobin stabilizing protein
hsa:374407;DNAJB13,RSPH16A,TSARG5,TSARG6;DnaJ (Hsp40) homolog, subfamily B, member 13
hsa:55201;MAP1S,BPY2IP1,C19orf5,MAP8,VCY2IP-1,VCY2IP1;microtubule-associated protein 1S
hsa:495;ATP4A,ATP6A;ATPase, H+/K+ exchanging, alpha polypeptide (EC:3.6.3.10)
hsa:90665;TBL1Y,TBL1;transducin (beta)-like 1, Y-linked
hsa:64432;MRPS25,MRP-S25,RPMS25;mitochondrial ribosomal protein S25
hsa:60492;CCDC90B,MDS011,MDS025;coiled-coil domain containing 90B
hsa:56993;TOMM22,1C9-2,MST065,MSTP065,TOM22;translocase of outer mitochondrial membrane 22 homolog (yeast)
hsa:84254;CAMKK1,CAMKKA;calcium/calmodulin-dependent protein kinase kinase 1, alpha (EC:2.7.11.17)
hsa:54102;CLIC6,CLIC1L;chloride intracellular channel 6
hsa:11148;HHLA2,B7H7;HERV-H LTR-associating 2
hsa:399512;SLC25A35;solute carrier family 25, member 35
hsa:2004;ELK3,ERP,NET,SAP2;ELK3, ETS-domain protein (SRF accessory protein 2)
hsa:6767;ST13,AAG2,FAM10A1,FAM10A4,HIP,HOP,HSPABP,HSPABP1,P48,PRO0786,SNC6;suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)
hsa:4836;NMT1,NMT;N-myristoyltransferase 1 (EC:2.3.1.97)
hsa:5092;PCBD1,DCOH,PCBD,PCD,PHS;pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (EC:4.2.1.96)
hsa:253558;LCLAT1,1AGPAT8,AGPAT8,ALCAT1,HSRG1849,LYCAT,UNQ1849;lysocardiolipin acyltransferase 1 (EC:2.3.1.51)
hsa:10477;UBE2E3,UBCH9,UbcM2;ubiquitin-conjugating enzyme E2E 3 (EC:6.3.2.19)
hsa:347736;NME9,NM23-H9,TXL-2,TXL2,TXNDC6;NME/NM23 family member 9
hsa:5031;P2RY6,P2Y6;pyrimidinergic receptor P2Y, G-protein coupled, 6
hsa:56159;TEX11,TGC1,TSGA3;testis expressed 11
hsa:2644;GCHFR,GFRP,HsT16933,P35;GTP cyclohydrolase I feedback regulator
hsa:1857;DVL3;dishevelled, dsh homolog 3 (Drosophila)
hsa:3806;KIR2DS1,CD158H,CD158a,p50.1;killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
hsa:23180;RFTN1,PIB10,PIG9,RAFTLIN;raftlin, lipid raft linker 1
hsa:10247;HRSP12,P14.5,PSP,UK114;heat-responsive protein 12
hsa:7982;ST7,ETS7q,FAM4A,FAM4A1,HELG,RAY1,SEN4,TSG7;suppression of tumorigenicity 7
hsa:55681;SCYL2,CVAK104;SCY1-like 2 (S. cerevisiae)
hsa:53918;PELO,PRO1770;pelota homolog (Drosophila)
hsa:5316;PKNOX1,PREP1,pkonx1c;PBX/knotted 1 homeobox 1
hsa:65981;CAPRIN2,C1QDC1,EEG-1,EEG1,RNG140;caprin family member 2
hsa:131890;GRK7,GPRK7;G protein-coupled receptor kinase 7 (EC:2.7.11.14 2.7.11.16)
hsa:11054;OGFR;opioid growth factor receptor
hsa:3171;FOXA3,FKHH3,HNF3G,TCF3G;forkhead box A3
hsa:140576;S100A16,DT1P1A7,S100F;S100 calcium binding protein A16
hsa:6847;SYCP1,CT8,HOM-TES-14,SCP1;synaptonemal complex protein 1
hsa:5552;SRGN,PPG,PRG,PRG1;serglycin
hsa:84945;ABHD13,BEM46L1,C13orf6,RP11-153I24.2,bA153I24.2;abhydrolase domain containing 13;K06889
hsa:80212;CCDC92;coiled-coil domain containing 92
hsa:10048;RANBP9,BPM-L,BPM90,RANBPM,RanBP7;RAN binding protein 9
hsa:8227;AKAP17A,721P,AKAP-17A,CCDC133,CXYorf3,DXYS155E,PRKA17A,SFRS17A,XE7,XE7Y;A kinase (PRKA) anchor protein 17A
hsa:89953;KLC4,KNSL8,bA387M24.3;kinesin light chain 4
hsa:2873;GPS1,COPS1,CSN1;G protein pathway suppressor 1
hsa:5600;MAPK11,P38B,P38BETA2,PRKM11,SAPK2,SAPK2B,p38-2,p38Beta;mitogen-activated protein kinase 11 (EC:2.7.11.24)
hsa:6296;ACSM3,SA,SAH;acyl-CoA synthetase medium-chain family member 3 (EC:6.2.1.2)
hsa:8798;DYRK4;dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 (EC:2.7.12.1)
hsa:1669;DEFA4,DEF4,HNP-4,HP-4,HP4;defensin, alpha 4, corticostatin
hsa:312;ANXA13,ANX13,ISA;annexin A13
hsa:6694;SPP2,SPP-24,SPP24;secreted phosphoprotein 2, 24kDa
hsa:11066;SNRNP35,HM-1,U1SNRNPBP;small nuclear ribonucleoprotein 35kDa (U11/U12)
hsa:29945;ANAPC4,APC4;anaphase promoting complex subunit 4
hsa:1351;COX8A,COX,COX8,COX8-2,COX8L,VIII,VIII-L;cytochrome c oxidase subunit VIIIA (ubiquitous) (EC:1.9.3.1)
hsa:220082;SPERT,CBY2,NURIT;spermatid associated
hsa:10694;CCT8,C21orf112,Cctq,D21S246,PRED71;chaperonin containing TCP1, subunit 8 (theta)
hsa:4101;MAGEA2,CT1.2,MAGE2,MAGEA2A;melanoma antigen family A, 2
hsa:56977;STOX2;storkhead box 2
hsa:55699;IARS2,ILERS;isoleucyl-tRNA synthetase 2, mitochondrial (EC:6.1.1.5)
hsa:132243;H1FOO,osH1;H1 histone family, member O, oocyte-specific
hsa:55363;HEMGN,EDAG,EDAG-1;hemogen
hsa:389799;C9orf171;chromosome 9 open reading frame 171
hsa:148581;UBE2U,RP4-636O23.1;ubiquitin-conjugating enzyme E2U (putative) (EC:6.3.2.19)
hsa:85453;TSPYL5;TSPY-like 5
hsa:54933;RHBDL2,RRP2;rhomboid, veinlet-like 2 (Drosophila) (EC:3.4.21.105)
hsa:64130;LIN7B,LIN-7B,MALS-2,MALS2,VELI2;lin-7 homolog B (C. elegans)
hsa:84467;FBN3;fibrillin 3
hsa:54996;MARC2,MOSC2,RP11-270A6.1;mitochondrial amidoxime reducing component 2
hsa:80306;MED28,1500003D12Rik,EG1,magicin;mediator complex subunit 28
hsa:868;CBLB,Cbl-b,RNF56;Cbl proto-oncogene, E3 ubiquitin protein ligase B
hsa:60484;HAPLN2,BRAL1;hyaluronan and proteoglycan link protein 2
hsa:11234;HPS5,AIBP63;Hermansky-Pudlak syndrome 5
hsa:3337;DNAJB1,HSPF1,Hdj1,Hsp40,RSPH16B,Sis1;DnaJ (Hsp40) homolog, subfamily B, member 1
hsa:9879;DDX46,PRPF5,Prp5;DEAD (Asp-Glu-Ala-Asp) box polypeptide 46 (EC:3.6.4.13)
hsa:23532;PRAME,CT130,MAPE,OIP-4,OIP4;preferentially expressed antigen in melanoma
hsa:6450;SH3BGR,21-GARP;SH3 domain binding glutamic acid-rich protein
hsa:132954;PDCL2,GCPHLP;phosducin-like 2
hsa:57099;AVEN,PDCD12;apoptosis, caspase activation inhibitor
hsa:1670;DEFA5,DEF5,HD-5;defensin, alpha 5, Paneth cell-specific
hsa:51729;WBP11,NPWBP,SIPP1,WBP-11;WW domain binding protein 11
hsa:3748;KCNC3,KSHIIID,KV3.3,SCA13;potassium voltage-gated channel, Shaw-related subfamily, member 3
hsa:826;CAPNS1,30K,CALPAIN4,CANP,CANPS,CAPN4,CDPS,CSS1;calpain, small subunit 1 (EC:3.4.22.17)
hsa:4191;MDH2,M-MDH,MDH,MGC:3559,MOR1;malate dehydrogenase 2, NAD (mitochondrial) (EC:1.1.1.37)
hsa:11144;DMC1,DMC1H,HsLim15,LIM15,dJ199H16.1;DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast)
hsa:23369;PUM2,PUMH2,PUML2;pumilio homolog 2 (Drosophila)
hsa:54955;C1orf109;chromosome 1 open reading frame 109
hsa:10061;ABCF2,ABC28,EST133090,HUSSY18,M-ABC1;ATP-binding cassette, sub-family F (GCN20), member 2
hsa:56893;UBQLN4,A1U,A1Up,C1orf6,CIP75,UBIN;ubiquilin 4
hsa:8808;IL1RL2,IL-1Rrp2,IL-36R,IL1R-rp2,IL1RRP2;interleukin 1 receptor-like 2
hsa:3581;IL9R,CD129,IL-9R;interleukin 9 receptor
hsa:57497;LRFN2,FIGLER2,KIAA1246,RP11-535K1.2,SALM1;leucine rich repeat and fibronectin type III domain containing 2
hsa:154807;VKORC1L1;vitamin K epoxide reductase complex, subunit 1-like 1
hsa:54665;RSBN1,ROSBIN,RP11-324J2.1;round spermatid basic protein 1
hsa:31;ACACA,ACAC,ACACAD,ACC,ACC1,ACCA;acetyl-CoA carboxylase alpha (EC:6.4.1.2 6.3.4.14)
hsa:151887;CCDC80,DRO1,SSG1,URB,okuribin;coiled-coil domain containing 80
hsa:50649;ARHGEF4,ASEF,ASEF1,GEF4,STM6;Rho guanine nucleotide exchange factor (GEF) 4
hsa:54958;TMEM160;transmembrane protein 160
hsa:60385;TSKS,STK22S1,TSKS1,TSSKS;testis-specific serine kinase substrate
hsa:10577;NPC2,EDDM1,HE1;Niemann-Pick disease, type C2
hsa:55335;NIPSNAP3B,NIPSNAP3;nipsnap homolog 3B (C. elegans)
hsa:3787;KCNS1,KV9.1;potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1
hsa:2251;FGF6,HBGF-6,HST2;fibroblast growth factor 6
hsa:10437;IFI30,GILT,IFI-30,IP30;interferon, gamma-inducible protein 30
hsa:131177;FAM3D,EF7,OIT1;family with sequence similarity 3, member D
hsa:84988;PPP1R16A,MYPT3;protein phosphatase 1, regulatory subunit 16A
hsa:56891;LGALS14,CLC2,PPL13;lectin, galactoside-binding, soluble, 14
hsa:57102;C12orf4;chromosome 12 open reading frame 4
hsa:3765;KCNJ9,GIRK3,KIR3.3;potassium inwardly-rectifying channel, subfamily J, member 9
hsa:10223;GPA33,A33;glycoprotein A33 (transmembrane)
hsa:3191;HNRNPL,HNRPL,hnRNP-L;heterogeneous nuclear ribonucleoprotein L
hsa:54550;NECAB2,EFCBP2;N-terminal EF-hand calcium binding protein 2
hsa:4832;NME3,DR-nm23,NDPK-C,NDPKC,NM23-H3,NM23H3,c371H6.2;NME/NM23 nucleoside diphosphate kinase 3 (EC:2.7.4.6)
hsa:55096;EBLN2,EBLN-2;endogenous Bornavirus-like nucleoprotein 2
hsa:92291;CAPN13;calpain 13
hsa:7414;VCL,CMD1W,CMH15,MVCL;vinculin
hsa:29796;UQCR10,HSPC051,HSPC151,QCR9,UCCR7.2,UCRC;ubiquinol-cytochrome c reductase, complex III subunit X
hsa:150350;ENTHD1,CACNA1I,dJ370M22.3;ENTH domain containing 1
hsa:54617;INO80,INO80A,INOC1,hINO80;INO80 homolog (S. cerevisiae) (EC:3.6.4.12)
hsa:55720;TSR1;TSR1, 20S rRNA accumulation, homolog (S. cerevisiae)
hsa:55599;RNPC3,RBM40,RNP;RNA-binding region (RNP1, RRM) containing 3
hsa:158067;AK8,C9orf98,DDX31,RP11-143F18.1;adenylate kinase 8 (EC:2.7.4.3)
hsa:6036;RNASE2,EDN,RNS2;ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) (EC:3.1.27.5)
hsa:5589;PRKCSH,AGE-R2,G19P1,PCLD,PKCSH,PLD1;protein kinase C substrate 80K-H (EC:2.7.11.1)
hsa:145407;C14orf37,c14_5376;chromosome 14 open reading frame 37
hsa:64708;COPS7B,CSN7B;COP9 signalosome subunit 7B
hsa:83891;SNX25,SBBI31;sorting nexin 25
hsa:222663;SCUBE3,CEGF3;signal peptide, CUB domain, EGF-like 3
hsa:22889;BLOM7,RP11-336K24.1;KIAA0907
hsa:54738;FEV,HSRNAFEV,PET-1;FEV (ETS oncogene family)
hsa:84284;NTPCR,C1orf57,HCR-NTPase,RP4-678E16.2;nucleoside-triphosphatase, cancer-related (EC:3.6.1.15)
hsa:10096;ACTR3,ARP3;ARP3 actin-related protein 3 homolog (yeast)
hsa:9500;MAGED1,DLXIN-1,NRAGE;melanoma antigen family D, 1
hsa:56145;PCDHA3,PCDH-ALPHA3;protocadherin alpha 3
hsa:10361;NPM2;nucleophosmin/nucleoplasmin 2
hsa:5546;PRCC,RCCP1,TPRC;papillary renal cell carcinoma (translocation-associated)
hsa:387758;FIBIN;fin bud initiation factor homolog (zebrafish)
hsa:7984;ARHGEF5,GEF5,P60,TIM,TIM1;Rho guanine nucleotide exchange factor (GEF) 5
hsa:26872;STEAP1,PRSS24,STEAP;six transmembrane epithelial antigen of the prostate 1
hsa:56146;PCDHA2,PCDH-ALPHA2;protocadherin alpha 2
hsa:64746;ACBD3,GCP60,GOCAP1,GOLPH1,PAP7;acyl-CoA binding domain containing 3
hsa:84286;TMEM175;transmembrane protein 175
hsa:6782;HSPA13,STCH;heat shock protein 70kDa family, member 13
hsa:4698;NDUFA5,B13,CI-13KD-B,CI-13kB,NUFM,UQOR13;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa (EC:1.6.5.3 1.6.99.3)
hsa:29083;GTPBP8,HSPC135;GTP-binding protein 8 (putative)
hsa:23101;MCF2L2,ARHGEF22;MCF.2 cell line derived transforming sequence-like 2
hsa:112858;TP53RK,BUD32,C20orf64,Nori-2,Nori-2p,PRPK,dJ101A2;TP53 regulating kinase (EC:2.7.11.1)
hsa:57823;SLAMF7,19A,CD319,CRACC,CS1;SLAM family member 7
hsa:283237;TTC9C;tetratricopeptide repeat domain 9C
hsa:55746;NUP133,hNUP133;nucleoporin 133kDa
hsa:63935;PCIF1,C20orf67;PDX1 C-terminal inhibiting factor 1
hsa:10907;TXNL4A,DIB1,DIM1,HsT161,TXNL4,U5-15kD;thioredoxin-like 4A
hsa:5723;PSPH,PSP,PSPHD;phosphoserine phosphatase (EC:3.1.3.3)
hsa:64840;PORCN,DHOF,FODH,MG61,PORC,PPN,por;porcupine homolog (Drosophila)
hsa:1666;DECR1,DECR,NADPH,SDR18C1;2,4-dienoyl CoA reductase 1, mitochondrial (EC:1.3.1.34)
hsa:57515;SERINC1,TDE1L,TDE2,TMS-2,TMS2;serine incorporator 1
hsa:199974;CYP4Z1,CYP4A20;cytochrome P450, family 4, subfamily Z, polypeptide 1 (EC:1.14.14.1)
hsa:6320;CLEC11A,CLECSF3,LSLCL,P47,SCGF;C-type lectin domain family 11, member A
hsa:54851;ANKRD49,FGIF,GBIF;ankyrin repeat domain 49
hsa:348093;RBPMS2;RNA binding protein with multiple splicing 2
hsa:1501;CTNND2,GT24,NPRAP;catenin (cadherin-associated protein), delta 2
hsa:22845;DOLK,CDG1M,DK,DK1,SEC59,TMEM15;dolichol kinase (EC:2.7.1.108)
hsa:388403;YPEL2;yippee-like 2 (Drosophila)
hsa:90187;EMILIN3,C20orf130,EMILIN5,dJ620E11.4;elastin microfibril interfacer 3
hsa:51141;INSIG2;insulin induced gene 2
hsa:56255;TMX4,DJ971N18.2,PDIA14,TXNDC13;thioredoxin-related transmembrane protein 4
hsa:3070;HELLS,LSH,PASG,SMARCA6;helicase, lymphoid-specific
hsa:83854;ANGPTL6,AGF,ARP5;angiopoietin-like 6
hsa:9380;GRHPR,GLXR,GLYD,PH2;glyoxylate reductase/hydroxypyruvate reductase (EC:1.1.1.79 1.1.1.81)
hsa:9785;DHX38,DDX38,PRP16,PRPF16;DEAH (Asp-Glu-Ala-His) box polypeptide 38 (EC:3.6.4.13)
hsa:23212;RRS1;RRS1 ribosome biogenesis regulator homolog (S. cerevisiae)
hsa:55207;ARL8B,ARL10C,Gie1;ADP-ribosylation factor-like 8B
hsa:3957;LGALS2,HL14;lectin, galactoside-binding, soluble, 2
hsa:90324;CCDC97;coiled-coil domain containing 97
hsa:23234;DNAJC9,HDJC9,JDD1,SB73;DnaJ (Hsp40) homolog, subfamily C, member 9
hsa:81855;SFXN3,BA108L7.2,SFX3;sideroflexin 3
hsa:9587;MAD2L1BP,CMT2,RP1-261G23.6;MAD2L1 binding protein
hsa:11137;PWP1,IEF-SSP-9502;PWP1 homolog (S. cerevisiae)
hsa:126637;TCHHL1,S100A17,THHL1,basalin;trichohyalin-like 1
hsa:118788;PIK3AP1,BCAP,RP11-34E5.3;phosphoinositide-3-kinase adaptor protein 1
hsa:9514;GAL3ST1,CST;galactose-3-O-sulfotransferase 1 (EC:2.8.2.11)
hsa:23518;R3HDM1,R3HDM;R3H domain containing 1
hsa:51302;CYP39A1;cytochrome P450, family 39, subfamily A, polypeptide 1 (EC:1.14.13.99)
hsa:1346;COX7A1,COX7A,COX7AH,COX7AM;cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) (EC:1.9.3.1)
hsa:84647;PLA2G12B,GXIIB,GXIIIsPLA2,PLA2G13;phospholipase A2, group XIIB (EC:3.1.1.4)
hsa:116224;FAM122A,C9orf42;family with sequence similarity 122A
hsa:10457;GPNMB,HGFIN,NMB;glycoprotein (transmembrane) nmb
hsa:23283;CSTF2T,CstF-64T;cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant
hsa:10928;RALBP1,RIP1,RLIP1,RLIP76;ralA binding protein 1
hsa:51411;BIN2,BRAP-1;bridging integrator 2
hsa:5700;PSMC1,P26S4,S4,p56;proteasome (prosome, macropain) 26S subunit, ATPase, 1
hsa:64240;ABCG5,STSL;ATP-binding cassette, sub-family G (WHITE), member 5
hsa:5534;PPP3R1,CALNB1,CNB,CNB1;protein phosphatase 3, regulatory subunit B, alpha (EC:3.1.3.16)
hsa:54360;CYTL1,C17,C4orf4;cytokine-like 1
hsa:51780;KDM3B,5qNCA,C5orf7,JMJD1B,NET22;lysine (K)-specific demethylase 3B
hsa:349667;RTN4RL2,NGRH1,NgR2;reticulon 4 receptor-like 2
hsa:26151;NAT9,EBSP,hNATL;N-acetyltransferase 9 (GCN5-related, putative)
hsa:5273;SERPINB10,PI-10,PI10;serpin peptidase inhibitor, clade B (ovalbumin), member 10
hsa:10376;TUBA1B,K-ALPHA-1;tubulin, alpha 1b
hsa:84993;UBL7,BMSC-UbP,TCBA1;ubiquitin-like 7 (bone marrow stromal cell-derived)
hsa:9980;DOPEY2,21orf5,C21orf5;dopey family member 2
hsa:167826;OLIG3,Bhlhb7,bHLHe20;oligodendrocyte transcription factor 3
hsa:51465;UBE2J1,HSPC153,HSPC205,HSU93243,NCUBE-1,NCUBE1,UBC6,Ubc6p;ubiquitin-conjugating enzyme E2, J1 (EC:6.3.2.19)
hsa:51309;ARMCX1,ALEX1;armadillo repeat containing, X-linked 1
hsa:1459;CSNK2A2,CK2A2,CSNK2A1;casein kinase 2, alpha prime polypeptide (EC:2.7.11.1)
hsa:140679;SLC32A1,VGAT,VIAAT;solute carrier family 32 (GABA vesicular transporter), member 1
hsa:10116;FEM1B,F1A-ALPHA,FIAA;fem-1 homolog b (C. elegans)
hsa:57018;CCNL1,ANIA6A,PRO1073,ania-6a;cyclin L1
hsa:509;ATP5C1,ATP5C,ATP5CL1;ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 (EC:3.6.1.14)
hsa:83658;DYNLRB1,BITH,BLP,DNCL2A,DNLC2A,ROBLD1;dynein, light chain, roadblock-type 1
hsa:84306;PDCD2L;programmed cell death 2-like
hsa:57617;VPS18,PEP3;vacuolar protein sorting 18 homolog (S. cerevisiae)
hsa:10428;CFDP1,BCNT,BUCENTAUR,CENP-29,CP27,SWC5,Yeti,p97;craniofacial development protein 1
hsa:522;ATP5J,ATP5,ATP5A,ATPM,CF6,F6;ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6 (EC:3.6.1.14)
hsa:51733;UPB1,BUP1;ureidopropionase, beta (EC:3.5.1.6)
hsa:54734;RAB39A,RAB39;RAB39A, member RAS oncogene family
hsa:51069;MRPL2,MRP-L14,RPML14;mitochondrial ribosomal protein L2
hsa:51703;ACSL5,ACS2,ACS5,FACL5;acyl-CoA synthetase long-chain family member 5 (EC:6.2.1.3)
hsa:245812;CNPY4,PRAT4B;canopy 4 homolog (zebrafish)
hsa:4762;NEUROG1,AKA,Math4C,NEUROD3,bHLHa6,ngn1;neurogenin 1
hsa:81537;SGPP1,SPPase1;sphingosine-1-phosphate phosphatase 1
hsa:7135;TNNI1,SSTNI,TNN1;troponin I type 1 (skeletal, slow)
hsa:10179;RBM7;RNA binding motif protein 7
hsa:152100;CMC1,C3orf68;COX assembly mitochondrial protein 1 homolog (S. cerevisiae)
hsa:6051;RNPEP;arginyl aminopeptidase (aminopeptidase B) (EC:3.4.11.6)
hsa:91137;SLC25A46;solute carrier family 25, member 46
hsa:5940;RBMY1A1,RBM,RBM1,RBM2,RBMY,RBMY1C,YRRM1,YRRM2;RNA binding motif protein, Y-linked, family 1, member A1
hsa:3816;KLK1,KLKR,Klk6,hK1;kallikrein 1 (EC:3.4.21.35)
hsa:51715;RAB23,HSPC137;RAB23, member RAS oncogene family
hsa:10010;TANK,I-TRAF,TRAF2;TRAF family member-associated NFKB activator
hsa:6120;RPE,RPE2-1;ribulose-5-phosphate-3-epimerase (EC:5.1.3.1)
hsa:376497;SLC27A1,ACSVL5,FATP,FATP1;solute carrier family 27 (fatty acid transporter), member 1
hsa:83641;FAM107B,C10orf45;family with sequence similarity 107, member B
hsa:53905;DUOX1,LNOX1,NOXEF1,THOX1;dual oxidase 1 (EC:1.6.3.1)
hsa:173;AFM,ALB2,ALBA,ALF;afamin
hsa:23195;MDN1;MDN1, midasin homolog (yeast)
hsa:10892;MALT1,MLT,MLT1;mucosa associated lymphoid tissue lymphoma translocation gene 1 (EC:3.4.22.-)
hsa:118881;COMTD1;catechol-O-methyltransferase domain containing 1
hsa:56655;POLE4,YHHQ1,p12;polymerase (DNA-directed), epsilon 4, accessory subunit (EC:2.7.7.7)
hsa:30811;HUNK;hormonally up-regulated Neu-associated kinase (EC:2.7.11.1)
hsa:1069;CETN2,CALT,CEN2;centrin, EF-hand protein, 2
hsa:57609;DIP2B;DIP2 disco-interacting protein 2 homolog B (Drosophila)
hsa:57663;USP29,HOM-TES-84/86;ubiquitin specific peptidase 29 (EC:3.4.19.12)
hsa:23395;LARS2,LEURS;leucyl-tRNA synthetase 2, mitochondrial (EC:6.1.1.4)
hsa:8563;THOC5,C22orf19,Fmip,PK1.3,fSAP79;THO complex 5
hsa:51614;ERGIC3,C20orf47,CGI-54,Erv46,NY-BR-84,PRO0989,SDBCAG84,dJ477O4.2;ERGIC and golgi 3
hsa:10935;PRDX3,AOP-1,AOP1,HBC189,MER5,PRO1748,SP-22,prx-III;peroxiredoxin 3 (EC:1.11.1.15)
hsa:6415;SEPW1,selW;selenoprotein W, 1
hsa:118663;BTBD16,C10orf87;BTB (POZ) domain containing 16
hsa:51228;GLTP;glycolipid transfer protein
hsa:60496;AASDHPPT,AASD-PPT,LYS2,LYS5;aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (EC:2.7.8.-)
hsa:2267;FGL1,HFREP1,HP-041,LFIRE-1,LFIRE1;fibrinogen-like 1
hsa:9360;PPIG,CARS-Cyp,CYP,SCAF10,SRCyp;peptidylprolyl isomerase G (cyclophilin G) (EC:5.2.1.8)
hsa:11059;WWP1,AIP5,Tiul1,hSDRP1;WW domain containing E3 ubiquitin protein ligase 1
hsa:51397;COMMD10,PTD002;COMM domain containing 10
hsa:7319;UBE2A,HHR6A,MRXS30,MRXSN,RAD6A,UBC2;ubiquitin-conjugating enzyme E2A (EC:6.3.2.19)
hsa:23761;PISD,DJ858B16,PSD,PSDC,PSSC,dJ858B16.2;phosphatidylserine decarboxylase (EC:4.1.1.65)
hsa:7320;UBE2B,E2-17kDa,HHR6B,HR6B,RAD6B,UBC2;ubiquitin-conjugating enzyme E2B (EC:6.3.2.19)
hsa:51603;METTL13,5630401D24Rik,KIAA0859,feat;methyltransferase like 13
hsa:220064;ORAOV1,TAOS1;oral cancer overexpressed 1
hsa:85476;GFM1,COXPD1,EFG,EFG1,EFGM,EGF1,GFM,hEFG1;G elongation factor, mitochondrial 1
hsa:55260;TMEM143;transmembrane protein 143
hsa:84941;HSH2D,ALX,HSH2;hematopoietic SH2 domain containing
hsa:7031;TFF1,BCEI,D21S21,HP1.A,HPS2,pNR-2,pS2;trefoil factor 1
hsa:2813;GP2,ZAP75;glycoprotein 2 (zymogen granule membrane)
hsa:80273;GRPEL1,HMGE;GrpE-like 1, mitochondrial (E. coli)
hsa:28990;ASTE1;asteroid homolog 1 (Drosophila)
hsa:265;AMELX,AI1E,AIH1,ALGN,AMG,AMGL,AMGX;amelogenin, X-linked
hsa:55884;WSB2,SBA2;WD repeat and SOCS box containing 2
hsa:2098;ESD,FGH;esterase D (EC:3.1.2.12 3.1.1.56)
hsa:64601;VPS16,hVPS16;vacuolar protein sorting 16 homolog (S. cerevisiae)
hsa:9976;CLEC2B,AICL,CLECSF2,HP10085,IFNRG1;C-type lectin domain family 2, member B
hsa:6123;RPL3L;ribosomal protein L3-like
hsa:51450;PRRX2,PMX2,PRX2;paired related homeobox 2
hsa:11325;DDX42,RHELP,RNAHP,SF3b125;DEAD (Asp-Glu-Ala-Asp) box polypeptide 42 (EC:3.6.4.13)
hsa:90990;KIFC2;kinesin family member C2
hsa:26269;FBXO8,FBS,FBX8;F-box protein 8
hsa:84898;PLXDC2,TEM7R;plexin domain containing 2
hsa:51478;HSD17B7,PRAP,SDR37C1;hydroxysteroid (17-beta) dehydrogenase 7 (EC:1.1.1.62 1.1.1.270)
hsa:129401;NUP35,MP44,NP44,NUP53;nucleoporin 35kDa
hsa:283899;INO80E,CCDC95;INO80 complex subunit E
hsa:117194;MRGPRX2,MRGX2;MAS-related GPR, member X2
hsa:11153;FICD,HIP13,HYPE,UNQ3041;FIC domain containing (EC:2.7.7.n1)
hsa:123169;LEO1,RDL;Leo1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)
hsa:199731;CADM4,IGSF4C,NECL4,Necl-4,TSLL2,synCAM4;cell adhesion molecule 4
hsa:145258;GSC;goosecoid homeobox
hsa:84701;COX4I2,COX4,COX4-2,COX4B,COX4L2,COXIV-2,dJ857M17.2;cytochrome c oxidase subunit IV isoform 2 (lung)
hsa:55729;ATF7IP,AM,MCAF,MCAF1,p621;activating transcription factor 7 interacting protein
hsa:3008;HIST1H1E,H1.4,H1E,H1F4,H1s-4,dJ221C16.5;histone cluster 1, H1e
hsa:6789;STK4,KRS2,MST1,TIIAC,YSK3;serine/threonine kinase 4 (EC:2.7.11.1)
hsa:167;CRISP1,AEGL1,ARP,CRISP-1,HSCRISP1D,HSCRISP1G,HUMARP;cysteine-rich secretory protein 1
hsa:5780;PTPN9,MEG2,PTPMEG2;protein tyrosine phosphatase, non-receptor type 9 (EC:3.1.3.48)
hsa:6492;SIM1,bHLHe14;single-minded homolog 1 (Drosophila)
hsa:57555;NLGN2;neuroligin 2
hsa:2696;GIPR,PGQTL2;gastric inhibitory polypeptide receptor
hsa:23590;PDSS1,COQ1,COQ10D2,DPS,RP13-16H11.3,SPS,TPRT,TPT,TPT_1,hDPS1;prenyl (decaprenyl) diphosphate synthase, subunit 1 (EC:2.5.1.91)
hsa:3010;HIST1H1T,H1FT,H1t,dJ221C16.2;histone cluster 1, H1t
hsa:10462;CLEC10A,CD301,CLECSF13,CLECSF14,HML,HML2,MGL;C-type lectin domain family 10, member A
hsa:284086;NEK8,JCK,NEK12A,NPHP9;NIMA-related kinase 8 (EC:2.7.11.1)
hsa:2931;GSK3A;glycogen synthase kinase 3 alpha (EC:2.7.11.1 2.7.11.26)
hsa:319;APOF,Apo-F,LTIP;apolipoprotein F
hsa:57215;THAP11,CTG-B43a,CTG-B45d,RONIN;THAP domain containing 11
hsa:60626;RIC8A,RIC8;resistance to inhibitors of cholinesterase 8 homolog A (C. elegans)
hsa:255626;HIST1H2BA,H2BFU,STBP,TSH2B,bA317E16.3;histone cluster 1, H2ba
hsa:90826;PRMT10;protein arginine methyltransferase 10 (putative)
hsa:339221;ENPP7,ALK-SMase;ectonucleotide pyrophosphatase/phosphodiesterase 7 (EC:3.1.4.12)
hsa:57645;POGK,BASS2,KRBOX2;pogo transposable element with KRAB domain
hsa:64114;TMBIM1,LFG3,MST100,MSTP100,RECS1;transmembrane BAX inhibitor motif containing 1;K06890
hsa:151790;WDR49;WD repeat domain 49
hsa:153020;RASGEF1B,GPIG4;RasGEF domain family, member 1B
hsa:55813;UTP6,C17orf40,HCA66;UTP6, small subunit (SSU) processome component, homolog (yeast)
hsa:24144;TFIP11,NTR1,Spp382,TIP39,bK445C9.6,hNtr1;tuftelin interacting protein 11
hsa:84336;TMEM101;transmembrane protein 101
hsa:56952;PRTFDC1,HHGP;phosphoribosyl transferase domain containing 1 (EC:2.4.2.8)
hsa:3080;CFHR2,CFHL2,FHR2,HFL3;complement factor H-related 2
hsa:8502;PKP4,p0071;plakophilin 4
hsa:64801;ARV1;ARV1 homolog (S. cerevisiae)
hsa:84681;HINT2,HIT-17;histidine triad nucleotide binding protein 2
hsa:29091;STXBP6,amisyn;syntaxin binding protein 6 (amisyn)
hsa:311;ANXA11,ANX11,CAP50;annexin A11
hsa:163786;SASS6,SAS-6,SAS6;spindle assembly 6 homolog (C. elegans)
hsa:257169;C9orf43;chromosome 9 open reading frame 43
hsa:129880;BBS5;Bardet-Biedl syndrome 5
hsa:51389;RWDD1,PTD013;RWD domain containing 1
hsa:79023;NUP37,p37;nucleoporin 37kDa
hsa:64969;MRPS5,MRP-S5,S5mt;mitochondrial ribosomal protein S5
hsa:7058;THBS2,TSP2;thrombospondin 2
hsa:54810;GIPC2,SEMCAP-2,SEMCAP2;GIPC PDZ domain containing family, member 2
hsa:8339;HIST1H2BG,H2B.1A,H2B/a,H2BFA,dJ221C16.8;histone cluster 1, H2bg
hsa:84299;MIEN1,C17orf37,C35,ORB3,RDX12,XTP4;migration and invasion enhancer 1
hsa:80832;APOL4,APOL-IV,APOLIV;apolipoprotein L, 4
hsa:1945;EFNA4,EFL4,EPLG4,LERK4;ephrin-A4
hsa:339010;POTEB,A26B1,CT104.5,POTE-15,POTE15;POTE ankyrin domain family, member B
hsa:2071;ERCC3,BTF2,GTF2H,RAD25,TFIIH,XPB;excision repair cross-complementing rodent repair deficiency, complementation group 3 (EC:3.6.4.12)
hsa:26273;FBXO3,FBA,FBX3;F-box protein 3
hsa:5905;RANGAP1,Fug1,SD;Ran GTPase activating protein 1
hsa:8545;CGGBP1,CGGBP,p20-CGGBP;CGG triplet repeat binding protein 1
hsa:51348;KLRF1,CLEC5C,NKp80;killer cell lectin-like receptor subfamily F, member 1
hsa:5912;RAP2B;RAP2B, member of RAS oncogene family
hsa:7385;UQCRC2,QCR2,UQCR2;ubiquinol-cytochrome c reductase core protein II (EC:1.10.2.2)
hsa:6632;SNRPD1,HsT2456,SMD1,SNRPD,Sm-D1;small nuclear ribonucleoprotein D1 polypeptide 16kDa
hsa:3208;HPCA,BDR2;hippocalcin
hsa:23627;PRND,DOPPEL,DPL,PrPLP,dJ1068H6.4;prion protein 2 (dublet)
hsa:23593;HEBP2,C6ORF34B,C6orf34,PP23,SOUL;heme binding protein 2
hsa:25961;NUDT13;nudix (nucleoside diphosphate linked moiety X)-type motif 13
hsa:7529;YWHAB,GW128,HS1,KCIP-1,YWHAA;tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide
hsa:1942;EFNA1,B61,ECKLG,EFL1,EPLG1,LERK-1,LERK1,TNFAIP4;ephrin-A1
hsa:5880;RAC2,EN-7,Gx,HSPC022;ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
hsa:23510;KCTD2;potassium channel tetramerisation domain containing 2
hsa:64689;GORASP1,GOLPH5,GRASP65,P65;golgi reassembly stacking protein 1, 65kDa
hsa:57122;NUP107,NUP84;nucleoporin 107kDa
hsa:7455;ZAN;zonadhesin
hsa:705;BYSL,BYSTIN;bystin-like
hsa:11018;TMED1,IL1RL1LG,Il1rl1l,ST2L,Tp24;transmembrane emp24 protein transport domain containing 1
hsa:9663;LPIN2;lipin 2 (EC:3.1.3.4)
hsa:114771;PGLYRP3,PGRP-Ialpha,PGRPIA;peptidoglycan recognition protein 3
hsa:10993;SDS,SDH;serine dehydratase (EC:4.3.1.17 4.3.1.19)
hsa:79890;RIN3;Ras and Rab interactor 3
hsa:80831;APOL5,APOL-V,APOLV;apolipoprotein L, 5
hsa:55669;MFN1,hfzo1,hfzo2;mitofusin 1
hsa:2639;GCDH,ACAD5,GCD;glutaryl-CoA dehydrogenase (EC:1.3.8.6)
hsa:5902;RANBP1,HTF9A;RAN binding protein 1
hsa:57115;PGLYRP4,PGLYRPIbeta,PGRP-Ibeta,PGRPIB;peptidoglycan recognition protein 4
hsa:6733;SRPK2,SFRSK2;SRSF protein kinase 2 (EC:2.7.11.1)
hsa:5375;PMP2,FABP8,M-FABP,MP2,P2;peripheral myelin protein 2
hsa:8076;MFAP5,MAGP2,MP25;microfibrillar associated protein 5
hsa:6251;RSU1,RSP-1;Ras suppressor protein 1
hsa:79109;MAPKAP1,JC310,MIP1,SIN1,SIN1b,SIN1g;mitogen-activated protein kinase associated protein 1
hsa:57575;PCDH10,OL-PCDH,PCDH19;protocadherin 10
hsa:1032;CDKN2D,INK4D,p19,p19-INK4D;cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
hsa:10382;TUBB4A,TUBB4,TUBB5,beta-5;tubulin, beta 4A class IVa
hsa:40;ASIC2,ACCN,ACCN1,ASIC2a,BNC1,BNaC1,MDEG,hBNaC1;acid-sensing (proton-gated) ion channel 2
hsa:79041;TMEM38A,TRIC-A,TRICA;transmembrane protein 38A
hsa:26145;IRF2BP1;interferon regulatory factor 2 binding protein 1
hsa:2837;UTS2R,GPR14,UR-2-R,UTR,UTR2;urotensin 2 receptor
hsa:114786;XKR4,XRG4;XK, Kell blood group complex subunit-related family, member 4
hsa:84343;HPS3,SUTAL;Hermansky-Pudlak syndrome 3
hsa:64241;ABCG8,GBD4,STSL;ATP-binding cassette, sub-family G (WHITE), member 8
hsa:64073;C19orf33,H2RSP,IMUP,IMUP-1,IMUP-2;chromosome 19 open reading frame 33
hsa:84328;LZIC;leucine zipper and CTNNBIP1 domain containing
hsa:83886;PRSS27,CAPH2,MPN;protease, serine 27
hsa:119392;SFR1,C10orf78,MEI5,MEIR5,bA373N18.1;SWI5-dependent recombination repair 1
hsa:80329;ULBP1,RAET1I;UL16 binding protein 1
hsa:84340;GFM2,EF-G2mt,EFG2,MRRF2,MST027,RRF2,RRF2mt,hEFG2,mEF-G_2;G elongation factor, mitochondrial 2
hsa:84842;HPDL,4-HPPD-L,GLOXD1,RP4-534D1.1;4-hydroxyphenylpyruvate dioxygenase-like
hsa:59343;SENP2,AXAM2,SMT3IP2;SUMO1/sentrin/SMT3 specific peptidase 2 (EC:3.4.22.68)
hsa:4296;MAP3K11,MEKK11,MLK-3,MLK3,PTK1,SPRK;mitogen-activated protein kinase kinase kinase 11 (EC:2.7.11.25)
hsa:219927;MRPL21,L21mt,MRP-L21;mitochondrial ribosomal protein L21
hsa:160760;PPTC7,TA-PP2C,TAPP2C;PTC7 protein phosphatase homolog (S. cerevisiae) (EC:3.1.3.16)
hsa:118856;MMP21;matrix metallopeptidase 21
hsa:2326;FMO1;flavin containing monooxygenase 1 (EC:1.14.13.8)
hsa:196264;MPZL3;myelin protein zero-like 3
hsa:339479;FAM5C,BRINP3,DBCCR1L,DBCCR1L1;family with sequence similarity 5, member C
hsa:6620;SNCB;synuclein, beta
hsa:2329;FMO4,FMO2;flavin containing monooxygenase 4 (EC:1.14.13.8)
hsa:83657;DYNLRB2,DNCL2B,DNLC2B,ROBLD2;dynein, light chain, roadblock-type 2
hsa:222068;TMED4,ERS25,HNLF;transmembrane emp24 protein transport domain containing 4
hsa:5814;PURB,PURBETA;purine-rich element binding protein B
hsa:92840;REEP6,C19orf32,DP1L1,TB2L1;receptor accessory protein 6
hsa:64420;SUSD1;sushi domain containing 1
hsa:2733;GLE1,GLE1L,LCCS,LCCS1,hGLE1;GLE1 RNA export mediator homolog (yeast)
hsa:60678;EEFSEC,EFSEC,SELB;eukaryotic elongation factor, selenocysteine-tRNA-specific
hsa:6913;TBX15,TBX14;T-box 15
hsa:66036;MTMR9,C8orf9,LIP-STYX,MTMR8;myotubularin related protein 9
hsa:124935;SLC43A2,LAT4;solute carrier family 43, member 2
hsa:6939;TCF15,EC2,PARAXIS,bHLHa40;transcription factor 15 (basic helix-loop-helix)
hsa:80328;ULBP2,N2DL2,RAET1H;UL16 binding protein 2
hsa:5267;SERPINA4,KAL,KLST,KST,PI-4,PI4,kallistatin;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4
hsa:84901;NFATC2IP,ESC2,NIP45,RAD60;nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 interacting protein
hsa:55365;TMEM176A,GS188,HCA112;transmembrane protein 176A
hsa:6751;SSTR1,SRIF-2,SS-1-R,SS1-R,SS1R;somatostatin receptor 1
hsa:23235;SIK2,LOH11CR1I,QIK,SNF1LK2;salt-inducible kinase 2 (EC:2.7.11.1)
hsa:3310;HSPA6;heat shock 70kDa protein 6 (HSP70B')
hsa:64928;MRPL14,L14mt,L32mt,MRP-L14,MRP-L32,MRPL32,RMPL32,RPML32;mitochondrial ribosomal protein L14
hsa:51608;GET4,C7orf20,CEE,TRC35;golgi to ER traffic protein 4 homolog (S. cerevisiae)
hsa:51706;CYB5R1,B5R.1,B5R1,B5R2,NQO3A2,humb5R2;cytochrome b5 reductase 1 (EC:1.6.2.2)
hsa:5957;RCVRN,RCV1;recoverin
hsa:55915;LANCL2,GPR69B,TASP;LanC lantibiotic synthetase component C-like 2 (bacterial)
hsa:23201;FAM168A,KIAA0280,TCRP1;family with sequence similarity 168, member A
hsa:51373;MRPS17,HSPC011,MRP-S17,RPMS17,S17mt;mitochondrial ribosomal protein S17
hsa:4605;MYBL2,B-MYB,BMYB;v-myb myeloblastosis viral oncogene homolog (avian)-like 2
hsa:2634;GBP2;guanylate binding protein 2, interferon-inducible
hsa:399687;MYO18A,MYSPDZ,SPR210;myosin XVIIIA
hsa:2355;FOSL2,FRA2;FOS-like antigen 2
hsa:90861;HN1L,C16orf34,L11;hematological and neurological expressed 1-like
hsa:636;BICD1,BICD;bicaudal D homolog 1 (Drosophila)
hsa:23203;PMPCA,Alpha-MPP,INPP5E;peptidase (mitochondrial processing) alpha (EC:3.4.24.64)
hsa:6634;SNRPD3,SMD3,Sm-D3;small nuclear ribonucleoprotein D3 polypeptide 18kDa
hsa:64434;NOM1,C7orf3,SGD1;nucleolar protein with MIF4G domain 1
hsa:9858;PPP1R26,KIAA0649;protein phosphatase 1, regulatory subunit 26
hsa:4731;NDUFV3,CI-10k,CI-9KD;NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa (EC:1.6.5.3)
hsa:80727;TTYH3;tweety homolog 3 (Drosophila)
hsa:24140;FTSJ1,CDLIV,MRX44,MRX9,SPB1,TRM7,TRMT7;FtsJ RNA methyltransferase homolog 1 (E. coli) (EC:2.1.1.-)
hsa:23204;ARL6IP1,AIP1,ARL6IP,ARMER;ADP-ribosylation factor-like 6 interacting protein 1
hsa:90316;TGIF2LX,TGIFLX;TGFB-induced factor homeobox 2-like, X-linked
hsa:5917;RARS,ArgRS,DALRD1;arginyl-tRNA synthetase (EC:6.1.1.19)
hsa:93343;MVB12A,CFBP,FAM125A;multivesicular body subunit 12A
hsa:7088;TLE1,ESG,ESG1,GRG1;transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
hsa:2444;FRK,GTK,PTK5,RAK;fyn-related kinase (EC:2.7.10.2)
hsa:84700;MYO18B;myosin XVIIIB
hsa:6890;TAP1,ABC17,ABCB2,APT1,D6S114E,PSF-1,PSF1,RING4,TAP1*0102N,TAP1N;transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
hsa:54059;YBEY,C21orf57;ybeY metallopeptidase (putative)
hsa:26528;DAZAP1;DAZ associated protein 1
hsa:284099;C17orf78;chromosome 17 open reading frame 78
hsa:8548;BLZF1,GOLGIN-45,JEM-1,JEM-1s,JEM1;basic leucine zipper nuclear factor 1
hsa:10955;SERINC3,AIGP1,DIFF33,SBBI99,TDE,TDE1,TMS-1;serine incorporator 3
hsa:134864;TAAR1,RP11-295F4.9,TA1,TAR1,TRAR1;trace amine associated receptor 1
hsa:5535;PPP3R2,PPP3RL;protein phosphatase 3, regulatory subunit B, beta (EC:3.1.3.16)
hsa:2824;GPM6B,M6B;glycoprotein M6B
hsa:283209;PGM2L1,BM32A;phosphoglucomutase 2-like 1 (EC:2.7.1.106)
hsa:64816;CYP3A43;cytochrome P450, family 3, subfamily A, polypeptide 43 (EC:1.14.14.1)
hsa:3346;HTN1,HIS1;histatin 1
hsa:64866;CDCP1,CD318,SIMA135,TRASK;CUB domain containing protein 1
hsa:5991;RFX3,bA32F11.1;regulatory factor X, 3 (influences HLA class II expression)
hsa:51378;ANGPT4,AGP4,ANG-3,ANG4;angiopoietin 4
hsa:55833;UBAP2,UBAP-2,bA176F3.5;ubiquitin associated protein 2
hsa:201161;CENPV,3110013H01Rik,CENP-V,PRR6,p30;centromere protein V
hsa:1615;DARS;aspartyl-tRNA synthetase (EC:6.1.1.12)
hsa:285315;C3orf33,AC3-33;chromosome 3 open reading frame 33
hsa:149563;C1orf64,ERRF,RP11-5P18.4;chromosome 1 open reading frame 64
hsa:7022;TFAP2C,AP2-GAMMA,ERF1,TFAP2G,hAP-2g;transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
hsa:29761;USP25,USP21;ubiquitin specific peptidase 25 (EC:3.4.19.12)
hsa:22981;NINL,NLP,dJ691N24.1;ninein-like
hsa:55316;RSAD1;radical S-adenosyl methionine domain containing 1
hsa:2781;GNAZ;guanine nucleotide binding protein (G protein), alpha z polypeptide
hsa:78988;MRP63,bMRP63;mitochondrial ribosomal protein 63
hsa:138428;PTRH1,C9orf115,PTH1;peptidyl-tRNA hydrolase 1 homolog (S. cerevisiae) (EC:3.1.1.29)
hsa:50852;TRAT1,TCRIM,TRIM;T cell receptor associated transmembrane adaptor 1
hsa:54443;ANLN,Scraps,scra;anillin, actin binding protein
hsa:26354;GNL3,C77032,E2IG3,NNP47,NS;guanine nucleotide binding protein-like 3 (nucleolar)
hsa:3991;LIPE,HSL,LHS;lipase, hormone-sensitive (EC:3.1.1.79)
hsa:23406;COTL1,CLP;coactosin-like 1 (Dictyostelium)
hsa:55872;PBK,CT84,Nori-3,SPK,TOPK;PDZ binding kinase (EC:2.7.12.2)
hsa:55255;WDR41;WD repeat domain 41
hsa:55191;NADSYN1;NAD synthetase 1 (EC:6.3.5.1)
hsa:22879;MON1B,HSRG1,SAND2,SRG1;MON1 homolog B (yeast)
hsa:23568;ARL2BP,BART,BART1;ADP-ribosylation factor-like 2 binding protein
hsa:29015;SLC43A3,EEG1,FOAP-13,PRO1659,SEEEG-1;solute carrier family 43, member 3
hsa:3455;IFNAR2,IFN-R,IFN-alpha-REC,IFNABR,IFNARB;interferon (alpha, beta and omega) receptor 2
hsa:1196;CLK2,hCLK2;CDC-like kinase 2 (EC:2.7.12.1)
hsa:6121;RPE65,LCA2,RP20,mRPE65,rd12,sRPE65;retinal pigment epithelium-specific protein 65kDa (EC:3.1.1.64)
hsa:221613;HIST1H2AA,H2AA,H2AFR,bA317E16.2;histone cluster 1, H2aa
hsa:348303;SELV;selenoprotein V
hsa:3422;IDI1,IPP1,IPPI1;isopentenyl-diphosphate delta isomerase 1 (EC:5.3.3.2)
hsa:131566;DCBLD2,CLCP1,ESDN;discoidin, CUB and LCCL domain containing 2
hsa:83597;RTP3,LTM1,TMEM7;receptor (chemosensory) transporter protein 3
hsa:2637;GBX2;gastrulation brain homeobox 2
hsa:160335;TMTC2,IBDBP1;transmembrane and tetratricopeptide repeat containing 2
hsa:3694;ITGB6;integrin, beta 6
hsa:3695;ITGB7;integrin, beta 7
hsa:65977;PLEKHA3,FAPP1;pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 3
hsa:55810;FOXJ2,FHX;forkhead box J2
hsa:3232;HOXD3,HOX1D,HOX4,HOX4A,Hox-4.1;homeobox D3
hsa:4504;MT3,GIF,GIFB,GRIF,ZnMT3;metallothionein 3
hsa:4332;MNDA,PYHIN3;myeloid cell nuclear differentiation antigen
hsa:79465;ULBP3,RAET1N;UL16 binding protein 3
hsa:23438;HARS2,HARSL,HARSR,HO3,PRLTS2;histidyl-tRNA synthetase 2, mitochondrial (EC:6.1.1.21)
hsa:3224;HOXC8,HOX3,HOX3A;homeobox C8
hsa:5899;RALB;v-ral simian leukemia viral oncogene homolog B (ras related;GTP binding protein)
hsa:55222;LRRC20;leucine rich repeat containing 20
hsa:55240;STEAP3,STMP3,TSAP6,dudlin-2;STEAP family member 3, metalloreductase
hsa:57610;RANBP10;RAN binding protein 10
hsa:8578;SCARF1,SREC,SREC-I,SREC1;scavenger receptor class F, member 1
hsa:9962;SLC23A2,NBTL1,SLC23A1,SVCT2,YSPL2;solute carrier family 23 (nucleobase transporters), member 2
hsa:25825;BACE2,AEPLC,ALP56,ASP1,ASP21,BAE2,CEAP1,DRAP;beta-site APP-cleaving enzyme 2 (EC:3.4.23.45)
hsa:10036;CHAF1A,CAF-1,CAF1,CAF1B,CAF1P150,P150;chromatin assembly factor 1, subunit A (p150)
hsa:4528;MTIF2;mitochondrial translational initiation factor 2
hsa:126205;NLRP8,CLR19.2,NALP8,NOD16,PAN4;NLR family, pyrin domain containing 8
hsa:5396;PRRX1,AGOTC,PHOX1,PMX1,PRX-1,PRX1;paired related homeobox 1
hsa:27131;SNX5;sorting nexin 5
hsa:131368;ZPLD1;zona pellucida-like domain containing 1
hsa:254042;METAP1D,MAP1D,Metap1l;methionyl aminopeptidase type 1D (mitochondrial) (EC:3.4.11.18)
hsa:57142;RTN4,ASY,NI220/250,NOGO,NOGO-A,NOGOC,NSP,NSP-CL,Nbla00271,Nbla10545,Nogo-B,Nogo-C,RTN-X,RTN4-A,RTN4-B1,RTN4-B2,RTN4-C;reticulon 4
hsa:10938;EHD1,H-PAST,HPAST1,PAST,PAST1;EH-domain containing 1
hsa:90956;ADCK2,AARF;aarF domain containing kinase 2
hsa:161829;EXD1,EXDL1;exonuclease 3'-5' domain containing 1
hsa:54363;HAO1,GOX,GOX1,HAOX1;hydroxyacid oxidase (glycolate oxidase) 1 (EC:1.1.3.15)
hsa:43849;KLK12,KLK-L5,KLKL5;kallikrein-related peptidase 12
hsa:152189;CMTM8,CKLFSF8,CKLFSF8-V2;CKLF-like MARVEL transmembrane domain containing 8
hsa:83729;INHBE;inhibin, beta E
hsa:89858;SIGLEC12,S2V,SIGLECL1,SLG,Siglec-XII;sialic acid binding Ig-like lectin 12 (gene/pseudogene)
hsa:8382;NME5,NM23-H5,NM23H5,RSPH23;NME/NM23 family member 5
hsa:23325;SWIP;KIAA1033
hsa:8911;CACNA1I,Cav3.3,ca(v)3.3;calcium channel, voltage-dependent, T type, alpha 1I subunit
hsa:83881;MIXL1,MILD1,MIX,MIXL;Mix paired-like homeobox
hsa:255239;ANKK1,PKK2;ankyrin repeat and kinase domain containing 1 (EC:2.7.11.1)
hsa:127428;TCEANC2,C1orf83,RP4-758J24.3;transcription elongation factor A (SII) N-terminal and central domain containing 2
hsa:2245;FGD1,AAS,FGDY,MRXS16,ZFYVE3;FYVE, RhoGEF and PH domain containing 1
hsa:55213;RCBTB1,CLLD7,CLLL7,GLP,RP11-185C18.1;regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1
hsa:113220;KIF12,RP11-56P10.3;kinesin family member 12
hsa:7360;UGP2,UDPG,UDPGP,UDPGP2,UGP1,UGPP1,UGPP2,pHC379;UDP-glucose pyrophosphorylase 2 (EC:2.7.7.9)
hsa:23194;FBXL7,FBL6,FBL7;F-box and leucine-rich repeat protein 7
hsa:79827;CLMP,ACAM,ASAM;CXADR-like membrane protein
hsa:1662;DDX10,HRH-J8;DEAD (Asp-Glu-Ala-Asp) box polypeptide 10 (EC:3.6.4.13)
hsa:2730;GCLM,GLCLR;glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2)
hsa:27156;RTDR1;rhabdoid tumor deletion region gene 1
hsa:29968;PSAT1,EPIP,PSA,PSAT;phosphoserine aminotransferase 1 (EC:2.6.1.52)
hsa:84446;BRSK1,hSAD1;BR serine/threonine kinase 1 (EC:2.7.11.1 2.7.11.26)
hsa:56897;WRNIP1,RP11-420G6.2,WHIP,bA420G6.2;Werner helicase interacting protein 1
hsa:6837;MED22,MED24,SURF5,surf-5;mediator complex subunit 22
hsa:51292;GMPR2;guanosine monophosphate reductase 2 (EC:1.7.1.7)
hsa:4293;MAP3K9,MEKK9,MLK1,PRKE1;mitogen-activated protein kinase kinase kinase 9 (EC:2.7.11.25)
hsa:338321;NLRP9,CLR19.1,NALP9,NOD6,PAN12;NLR family, pyrin domain containing 9
hsa:285761;DCBLD1,dJ94G16.1;discoidin, CUB and LCCL domain containing 1
hsa:6876;TAGLN,SM22,SMCC,TAGLN1,WS3-10;transgelin
hsa:326340;ZAR1;zygote arrest 1
hsa:136332;LRGUK;leucine-rich repeats and guanylate kinase domain containing
hsa:9149;DYRK1B,MIRK;dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B (EC:2.7.12.1)
hsa:10237;SLC35B1,UGTREL1;solute carrier family 35, member B1
hsa:57053;CHRNA10;cholinergic receptor, nicotinic, alpha 10 (neuronal)
hsa:253190;SERHL2,dJ222E13.1;serine hydrolase-like 2
hsa:84957;RELT,TNFRSF19L,TRLT;RELT tumor necrosis factor receptor
hsa:2021;ENDOG;endonuclease G
hsa:142683;ITLN2,HL-2,HL2;intelectin 2
hsa:113675;SDSL,SDH_2,SDS-RS1,TDH;serine dehydratase-like (EC:4.3.1.17 4.3.1.19)
hsa:257364;SNX33,SH3PX3,SH3PXD3C,SNX30;sorting nexin 33
hsa:6595;SMARCA2,BAF190,BRM,NCBRS,SNF2,SNF2L2,SNF2LA,SWI2,Sth1p,hBRM,hSNF2a;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
hsa:2576;GAGE4,CT4.4;G antigen 4
hsa:150160;CCT8L2,CESK1;chaperonin containing TCP1, subunit 8 (theta)-like 2
hsa:3808;KIR2DS3,NKAT7;killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
hsa:27179;IL36A,FIL1,FIL1(EPSILON),FIL1E,IL-1F6,IL1(EPSILON),IL1F6;interleukin 36, alpha
hsa:145864;HAPLN3,EXLD1,HsT19883;hyaluronan and proteoglycan link protein 3
hsa:327;APEH,AARE,ACPH,APH,D3F15S2,D3S48E,DNF15S2,OPH;N-acylaminoacyl-peptide hydrolase (EC:3.4.19.1)
hsa:27352;SGSM3,MAP,RABGAP5,RUSC3,RUTBC3,RabGAP-5;small G protein signaling modulator 3
hsa:22948;CCT5,CCT-epsilon,CCTE,TCP-1-epsilon;chaperonin containing TCP1, subunit 5 (epsilon)
hsa:4889;NPY5R,NPY5-R,NPYR5,NPYY5-R;neuropeptide Y receptor Y5
hsa:27440;CECR5;cat eye syndrome chromosome region, candidate 5
hsa:55095;SAMD4B,SMGB,hSmaug2;sterile alpha motif domain containing 4B
hsa:284366;KLK9,KLK-L3,KLKL3;kallikrein-related peptidase 9
hsa:57062;DDX24;DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 (EC:3.6.4.13)
hsa:91653;BOC,CDON2;BOC cell adhesion associated, oncogene regulated
hsa:57496;MKL2,MRTF-B,NPD001;MKL/myocardin-like 2
hsa:6300;MAPK12,ERK3,ERK6,P38GAMMA,PRKM12,SAPK-3,SAPK3;mitogen-activated protein kinase 12 (EC:2.7.11.24)
hsa:4597;MVD,FP17780,MPD;mevalonate (diphospho) decarboxylase (EC:4.1.1.33)
hsa:3419;IDH3A;isocitrate dehydrogenase 3 (NAD+) alpha (EC:1.1.1.41)
hsa:3781;KCNN2,KCa2.2,SK2,SKCA2,hSK2;potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
hsa:80765;STARD5;StAR-related lipid transfer (START) domain containing 5
hsa:23584;VSIG2,2210413P10Rik,CTH,CTXL;V-set and immunoglobulin domain containing 2
hsa:79192;IRX1,IRX-5,IRXA1;iroquois homeobox 1
hsa:2831;NPBWR1,GPR7;neuropeptides B/W receptor 1
hsa:2046;EPHA8,EEK,EK3,HEK3;EPH receptor A8 (EC:2.7.10.1)
hsa:6779;STATH,STR;statherin
hsa:7064;THOP1,EP24.15,MEPD_HUMAN,MP78,TOP;thimet oligopeptidase 1 (EC:3.4.24.15)
hsa:3476;IGBP1,ALPHA-4,IBP1;immunoglobulin (CD79A) binding protein 1
hsa:23671;TMEFF2,CT120.2,HPP1,TENB2,TPEF,TR;transmembrane protein with EGF-like and two follistatin-like domains 2
hsa:3237;HOXD11,HOX4,HOX4F;homeobox D11
hsa:84154;RPF2,BXDC1,bA397G5.4;ribosome production factor 2 homolog (S. cerevisiae)
hsa:11329;STK38,NDR,NDR1;serine/threonine kinase 38 (EC:2.7.11.1)
hsa:430;ASCL2,ASH2,HASH2,MASH2,bHLHa45;achaete-scute complex homolog 2 (Drosophila)
hsa:83756;TAS1R3,T1R3;taste receptor, type 1, member 3
hsa:84501;SPIRE2,Spir-2;spire homolog 2 (Drosophila)
hsa:84750;FUT10;fucosyltransferase 10 (alpha (1,3) fucosyltransferase) (EC:2.4.1.69)
hsa:203190;LGI3,LGIL4;leucine-rich repeat LGI family, member 3
hsa:280636;C11orf31,C17orf10,SELH;chromosome 11 open reading frame 31
hsa:7262;PHLDA2,BRW1C,BWR1C,HLDA2,IPL,TSSC3;pleckstrin homology-like domain, family A, member 2
hsa:84498;FAM120B,CCPG,KIAA1838,PGCC1,dJ894D12.1;family with sequence similarity 120B
hsa:8685;MARCO,SCARA2;macrophage receptor with collagenous structure
hsa:873;CBR1,CBR,SDR21C1,hCBR1;carbonyl reductase 1 (EC:1.1.1.189 1.1.1.197 1.1.1.184)
hsa:58189;WFDC1,PS20;WAP four-disulfide core domain 1
hsa:122665;RNASE8;ribonuclease, RNase A family, 8
hsa:4733;DRG1,NEDD3;developmentally regulated GTP binding protein 1
hsa:55799;CACNA2D3,HSA272268;calcium channel, voltage-dependent, alpha 2/delta subunit 3
hsa:64422;ATG3,APG3,APG3-LIKE,APG3L,PC3-96;autophagy related 3
hsa:115416;MALSU1,C7orf30;mitochondrial assembly of ribosomal large subunit 1
hsa:4783;NFIL3,E4BP4,IL3BP1,NF-IL3A,NFIL3A;nuclear factor, interleukin 3 regulated
hsa:196513;DCP1B,DCP1,hDcp1b;DCP1 decapping enzyme homolog B (S. cerevisiae)
hsa:2907;GRINA,HNRGW,LFG1,NMDARA1,TMBIM3;glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding);K06890
hsa:10051;SMC4,CAP-C,CAPC,SMC-4,SMC4L1,hCAP-C;structural maintenance of chromosomes 4
hsa:9320;TRIP12,ULF;thyroid hormone receptor interactor 12
hsa:3626;INHBC,IHBC;inhibin, beta C
hsa:22903;BTBD3,dJ742J24.1;BTB (POZ) domain containing 3
hsa:51166;AADAT,KAT2,KATII;aminoadipate aminotransferase (EC:2.6.1.7 2.6.1.39)
hsa:1775;DNASE1L2,DNAS1L2;deoxyribonuclease I-like 2
hsa:6407;SEMG2,SGII;semenogelin II
hsa:140801;RPL10L,RPL10_5_1358;ribosomal protein L10-like
hsa:54763;ROPN1,CT91,ODF6,RHPNAP1,ROPN1A,ropporin;rhophilin associated tail protein 1
hsa:6605;SMARCE1,BAF57;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1
hsa:56946;C11orf30,EMSY;chromosome 11 open reading frame 30
hsa:6756;SSX1,CT5.1,SSRC;synovial sarcoma, X breakpoint 1
hsa:22820;COPG1,COPG;coatomer protein complex, subunit gamma 1
hsa:1164;CKS2,CKSHS2;CDC28 protein kinase regulatory subunit 2
hsa:7257;TSNAX,TRAX;translin-associated factor X
hsa:116379;IL22RA2,CRF2-10,CRF2-S1,CRF2X,IL-22BP,IL-22RA2;interleukin 22 receptor, alpha 2
hsa:123904;NRN1L,UNQ2446;neuritin 1-like
hsa:1606;DGKA,DAGK,DAGK1,DGK-alpha;diacylglycerol kinase, alpha 80kDa (EC:2.7.1.107)
hsa:10404;CPQ,LDP,PGCP;carboxypeptidase Q (EC:3.4.17.-)
hsa:55178;RNMTL1;RNA methyltransferase like 1 (EC:2.1.1.-)
hsa:4636;MYL5;myosin, light chain 5, regulatory
hsa:7277;TUBA4A,H2-ALPHA,TUBA1;tubulin, alpha 4a
hsa:115827;RAB3C;RAB3C, member RAS oncogene family
hsa:23780;APOL2,APOL-II,APOL3;apolipoprotein L, 2
hsa:9644;SH3PXD2A,FISH,SH3MD1,TKS5;SH3 and PX domains 2A
hsa:115861;NXNL1,RDCVF,TXNL6;nucleoredoxin-like 1
hsa:10776;ARPP19,ARPP-16,ARPP-19,ARPP16,ENSAL;cAMP-regulated phosphoprotein, 19kDa
hsa:81875;ISG20L2;interferon stimulated exonuclease gene 20kDa-like 2
hsa:4324;MMP15,MT2-MMP,MTMMP2,SMCP-2;matrix metallopeptidase 15 (membrane-inserted) (EC:3.4.24.-)
hsa:10363;HMG20A,HMGX1,HMGXB1;high mobility group 20A
hsa:5005;ORM2,AGP-B,AGP-B',AGP2;orosomucoid 2
hsa:29941;PKN3,RP11-545E17.1;protein kinase N3 (EC:2.7.11.13)
hsa:25934;NIPSNAP3A,NIPSNAP4,TASSC;nipsnap homolog 3A (C. elegans)
hsa:29992;PILRA,FDF03;paired immunoglobin-like type 2 receptor alpha
hsa:25923;ATL3;atlastin GTPase 3
hsa:254428;SLC41A1,MgtE;solute carrier family 41, member 1
hsa:10463;SLC30A9,C4orf1,GAC63,HUEL,ZNT9;solute carrier family 30 (zinc transporter), member 9
hsa:27255;CNTN6,NB3;contactin 6
hsa:63948;DMRTB1;DMRT-like family B with proline-rich C-terminal, 1
hsa:54922;RASIP1,RAIN;Ras interacting protein 1
hsa:23061;TBC1D9B;TBC1 domain family, member 9B (with GRAM domain)
hsa:6453;ITSN1,ITSN,SH3D1A,SH3P17;intersectin 1 (SH3 domain protein)
hsa:3672;ITGA1,CD49a,VLA1;integrin, alpha 1
hsa:6165;RPL35A,DBA5,L35A;ribosomal protein L35a
hsa:170392;OIT3,LZP;oncoprotein induced transcript 3
hsa:5431;POLR2B,POL2RB,RPB2,hRPB140,hsRPB2;polymerase (RNA) II (DNA directed) polypeptide B, 140kDa (EC:2.7.7.6)
hsa:5720;PSME1,IFI5111,PA28A,PA28alpha,REGalpha;proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)
hsa:6549;SLC9A2,NHE2;solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2
hsa:9312;KCNB2,KV2.2;potassium voltage-gated channel, Shab-related subfamily, member 2
hsa:6538;SLC6A11,GAT-3,GAT3,GAT4;solute carrier family 6 (neurotransmitter transporter, GABA), member 11
hsa:51435;SCARA3,APC7,CSR,CSR1,MSLR1,MSRL1;scavenger receptor class A, member 3
hsa:57105;CYSLTR2,CYSLT2,CYSLT2R,HG57,HPN321,KPG_011,hGPCR21;cysteinyl leukotriene receptor 2
hsa:8337;HIST2H2AA3,H2A,H2A.2,H2A/O,H2A/q,H2AFO,H2a-615,HIST2H2AA;histone cluster 2, H2aa3
hsa:7378;UPP1,UDRPASE,UP,UPASE,UPP;uridine phosphorylase 1 (EC:2.4.2.3)
hsa:54165;DCUN1D1,DCNL1,DCUN1L1,RP42,SCCRO,SCRO,Tes3;DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae)
hsa:10198;MPHOSPH9,MPP-9,MPP9;M-phase phosphoprotein 9
hsa:7125;TNNC2;troponin C type 2 (fast)
hsa:57453;DSCAML1;Down syndrome cell adhesion molecule like 1
hsa:10017;BCL2L10,BCL-B,Boo,Diva;BCL2-like 10 (apoptosis facilitator)
hsa:150274;HSCB,DNAJC20,HSC20,JAC1,dJ366L4.2;HscB iron-sulfur cluster co-chaperone homolog (E. coli)
hsa:27285;TEKT2,TEKTB1,TEKTIN-T,h-tektin-t;tektin 2 (testicular)
hsa:3988;LIPA,CESD,LAL;lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13)
hsa:199;AIF1,AIF-1,IBA1,IRT-1,IRT1;allograft inflammatory factor 1
hsa:10953;TOMM34,HTOM34P,TOM34,URCC3;translocase of outer mitochondrial membrane 34
hsa:8340;HIST1H2BL,H2B/c,H2BFC,dJ97D16.4;histone cluster 1, H2bl
hsa:56674;TMEM9B,C11orf15;TMEM9 domain family, member B
hsa:81628;TSC22D4,THG-1,THG1,TILZ2;TSC22 domain family, member 4
hsa:5564;PRKAB1,AMPK,HAMPKb;protein kinase, AMP-activated, beta 1 non-catalytic subunit
hsa:84985;FAM83A,BJ-TSA-9;family with sequence similarity 83, member A
hsa:6175;RPLP0,L10E,LP0,P0,PRLP0,RPP0;ribosomal protein, large, P0
hsa:8341;HIST1H2BN,H2B/d,H2BFD;histone cluster 1, H2bn
hsa:54480;CHPF2,CSGLCA-T,CSGlcAT,ChSy-3;chondroitin polymerizing factor 2 (EC:2.4.1.226)
hsa:7458;EIF4H,WBSCR1,WSCR1,eIF-4H;eukaryotic translation initiation factor 4H
hsa:22821;RASA3,GAP1IP4BP,GAPIII;RAS p21 protein activator 3
hsa:9274;BCL7C;B-cell CLL/lymphoma 7C
hsa:8342;HIST1H2BM,H2B/e,H2BFE,dJ160A22.3;histone cluster 1, H2bm
hsa:4700;NDUFA6,B14,CI-B14,LYRM6,NADHB14;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa
hsa:22987;SV2C;synaptic vesicle glycoprotein 2C
hsa:8343;HIST1H2BF,H2B/g,H2BFG;histone cluster 1, H2bf
hsa:10750;GRAP;GRB2-related adaptor protein
hsa:200081;TXLNA,IL14,RP4-622L5.4,TXLN;taxilin alpha
hsa:84317;CCDC115,ccp1;coiled-coil domain containing 115
hsa:5446;PON3;paraoxonase 3 (EC:3.1.1.2 3.1.8.1 3.1.1.81)
hsa:4648;MYO7B;myosin VIIB
hsa:26998;FETUB,16G2,Gugu,IRL685;fetuin B
hsa:84034;EMILIN2,EMILIN-2,FOAP-10;elastin microfibril interfacer 2
hsa:83884;SLC25A2,ORC2,ORNT2;solute carrier family 25 (mitochondrial carrier;ornithine transporter) member 2
hsa:6209;RPS15,RIG,S15;ribosomal protein S15
hsa:79726;WDR59;WD repeat domain 59
hsa:9185;REPS2,POB1;RALBP1 associated Eps domain containing 2
hsa:10777;ARPP21,ARPP-21,R3HDM3,RCS,TARPP;cAMP-regulated phosphoprotein, 21kDa
hsa:10807;SDCCAG3,NY-CO-3;serologically defined colon cancer antigen 3
hsa:50944;SHANK1,SPANK-1,SSTRIP,synamon;SH3 and multiple ankyrin repeat domains 1
hsa:10734;STAG3;stromal antigen 3
hsa:79631;EFTUD1,FAM42A,HsT19294,RIA1;elongation factor Tu GTP binding domain containing 1
hsa:143;PARP4,ADPRTL1,ARTD4,PARP-4,PARPL,PH5P,VAULT3,VPARP,VWA5C,p193;poly (ADP-ribose) polymerase family, member 4 (EC:2.4.2.30)
hsa:161835;FSIP1;fibrous sheath interacting protein 1
hsa:27151;CPAMD8,K-CAP,VIP;C3 and PZP-like, alpha-2-macroglobulin domain containing 8
hsa:4638;MYLK,AAT7,KRP,MLCK,MLCK1,MLCK108,MLCK210,MSTP083,MYLK1,smMLCK;myosin light chain kinase (EC:2.7.11.18)
hsa:363;AQP6,AQP2L,KID;aquaporin 6, kidney specific
hsa:57096;RPGRIP1,CORD13,LCA6,RGI1,RGRIP,RPGRIP,RPGRIP1d;retinitis pigmentosa GTPase regulator interacting protein 1
hsa:165140;OXER1,GPCR,GPR170,TG1019;oxoeicosanoid (OXE) receptor 1
hsa:440279;UNC13C;unc-13 homolog C (C. elegans)
hsa:1400;CRMP1,CRMP-1,DPYSL1,DRP-1,DRP1,ULIP-3;collapsin response mediator protein 1
hsa:6430;SRSF5,HRS,SFRS5,SRP40;serine/arginine-rich splicing factor 5
hsa:25830;SULT4A1,BR-STL-1,BRSTL1,DJ388M5.3,NST,SULTX3,hBR-STL-1;sulfotransferase family 4A, member 1 (EC:2.8.2.-)
hsa:57554;LRRC7,DENSIN;leucine rich repeat containing 7
hsa:55239;OGFOD1,TPA1;2-oxoglutarate and iron-dependent oxygenase domain containing 1 (EC:1.14.11.-)
hsa:54926;UBE2R2,CDC34B,E2-CDC34B,UBC3B;ubiquitin-conjugating enzyme E2R 2 (EC:6.3.2.19)
hsa:252983;STXBP4,Synip;syntaxin binding protein 4
hsa:196374;KRT78,K5B,Kb40;keratin 78
hsa:266727;MDGA1,GPIM,MAMDC3;MAM domain containing glycosylphosphatidylinositol anchor 1
hsa:149371;EXOC8,EXO84,Exo84p,SEC84;exocyst complex component 8
hsa:25790;CCDC19,NESG1;coiled-coil domain containing 19
hsa:54831;BEST2,VMD2L1;bestrophin 2
hsa:10287;RGS19,GAIP,RGSGAIP;regulator of G-protein signaling 19
hsa:23230;VPS13A,CHAC,CHOREIN;vacuolar protein sorting 13 homolog A (S. cerevisiae)
hsa:909;CD1A,CD1,FCB6,HTA1,R4,T6;CD1a molecule
hsa:1121;CHM,DXS540,GGTA,HSD-32,REP-1,TCD;choroideremia (Rab escort protein 1)
hsa:10788;IQGAP2;IQ motif containing GTPase activating protein 2
hsa:5089;PBX2,G17,HOX12,PBX2MHC;pre-B-cell leukemia homeobox 2
hsa:53834;FGFRL1,FGFR5,FHFR;fibroblast growth factor receptor-like 1 (EC:3.2.1.76)
hsa:51244;CCDC174,C3orf19;coiled-coil domain containing 174
hsa:64097;EPB41L4A,EPB41L4,NBL4;erythrocyte membrane protein band 4.1 like 4A
hsa:84612;PARD6B,PAR6B;par-6 partitioning defective 6 homolog beta (C. elegans)
hsa:10873;ME3,NADP-ME;malic enzyme 3, NADP(+)-dependent, mitochondrial (EC:1.1.1.40)
hsa:348094;ANKDD1A;ankyrin repeat and death domain containing 1A
hsa:65985;AACS,ACSF1,SUR-5;acetoacetyl-CoA synthetase (EC:6.2.1.16)
hsa:4145;MATK,CHK,CTK,HHYLTK,HYL,HYLTK,Lsk;megakaryocyte-associated tyrosine kinase (EC:2.7.10.2)
hsa:5630;PRPH,NEF4,PRPH1;peripherin
hsa:6217;RPS16,S16;ribosomal protein S16
hsa:84191;FAM96A;family with sequence similarity 96, member A
hsa:27034;ACAD8,ACAD-8,ARC42;acyl-CoA dehydrogenase family, member 8
hsa:3344;FOXN2,HTLF;forkhead box N2
hsa:1801;DPH1,DPH2L,DPH2L1,OVCA1;DPH1 homolog (S. cerevisiae)
hsa:5217;PFN2,D3S1319E,PFL;profilin 2
hsa:970;CD70,CD27L,CD27LG,TNFSF7;CD70 molecule
hsa:79832;QSER1;glutamine and serine rich 1
hsa:23035;PHLPP2,PHLPPL;PH domain and leucine rich repeat protein phosphatase 2 (EC:3.1.3.16)
hsa:8100;IFT88,D13S1056E,DAF19,TG737,TTC10,hTg737;intraflagellar transport 88 homolog (Chlamydomonas)
hsa:79722;ANKRD55;ankyrin repeat domain 55
hsa:55800;SCN3B,HSA243396,SCNB3;sodium channel, voltage-gated, type III, beta subunit
hsa:347730;LRRTM1;leucine rich repeat transmembrane neuronal 1
hsa:4825;NKX6-1,NKX6.1,NKX6A;NK6 homeobox 1
hsa:388962;BOLA3,MMDS2;bolA homolog 3 (E. coli)
hsa:85320;ABCC11,EWWD,MRP8,WW;ATP-binding cassette, sub-family C (CFTR/MRP), member 11
hsa:8663;EIF3C,EIF3CL,EIF3S8,eIF3-p110;eukaryotic translation initiation factor 3, subunit C
hsa:51032;CELA2B,ELA2B;chymotrypsin-like elastase family, member 2B (EC:3.4.21.71)
hsa:537;ATP6AP1,16A,ATP6IP1,ATP6S1,Ac45,CF2,VATPS1,XAP-3,XAP3;ATPase, H+ transporting, lysosomal accessory protein 1 (EC:3.6.3.14)
hsa:5019;OXCT1,OXCT,SCOT;3-oxoacid CoA transferase 1 (EC:2.8.3.5)
hsa:51761;ATP8A2,ATP,ATPIB,IB,ML-1;ATPase, aminophospholipid transporter, class I, type 8A, member 2 (EC:3.6.3.1)
hsa:57494;RIMKLB,FAM80B,NAAGS,NAAGS-I;ribosomal modification protein rimK-like family member B
hsa:51312;SLC25A37,MFRN,MFRN1,MSC,MSCP,PRO1278,PRO1584,PRO2217;solute carrier family 25 (mitochondrial iron transporter), member 37
hsa:493860;CCDC73,NY-SAR-79;coiled-coil domain containing 73
hsa:55374;TMCO6;transmembrane and coiled-coil domains 6
hsa:80254;CEP63;centrosomal protein 63kDa
hsa:338323;NLRP14,CLR11.2,GC-LRR,NALP14,NOD5,PAN8;NLR family, pyrin domain containing 14
hsa:8883;NAE1,A-116A10.1,APPBP1,ula-1;NEDD8 activating enzyme E1 subunit 1
hsa:54760;PCSK4,PC4,SPC5;proprotein convertase subtilisin/kexin type 4
hsa:1933;EEF1B2,EEF1B,EEF1B1,EF1B;eukaryotic translation elongation factor 1 beta 2
hsa:10114;HIPK3,DYRK6,FIST3,PKY,YAK1;homeodomain interacting protein kinase 3 (EC:2.7.11.1)
hsa:7461;CLIP2,CLIP,CLIP-115,CYLN2,WBSCR3,WBSCR4,WSCR3,WSCR4;CAP-GLY domain containing linker protein 2
hsa:84125;LRRIQ1;leucine-rich repeats and IQ motif containing 1
hsa:8880;FUBP1,FBP,FUBP;far upstream element (FUSE) binding protein 1
hsa:1124;CHN2,ARHGAP3,BCH,CHN2-3,RHOGAP3;chimerin 2
hsa:6795;AURKC,AIE2,AIK3,ARK3,AurC,SPGF5,STK13,aurora-C;aurora kinase C (EC:2.7.11.1)
hsa:725;C4BPB,C4BP;complement component 4 binding protein, beta
hsa:23659;PLA2G15,ACS,GXVPLA2,LLPL,LPLA2,LYPLA3;phospholipase A2, group XV (EC:3.1.1.5)
hsa:23072;HECW1,NEDL1;HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1
hsa:10362;HMG20B,BRAF25,BRAF35,HMGX2,HMGXB2,PP7706,SMARCE1r,SOXL,pp8857;high mobility group 20B
hsa:84560;MT4,MT-4,MT-IV,MTIV;metallothionein 4
hsa:8189;SYMPK,SPK,SYM;symplekin
hsa:16;AARS,CMT2N;alanyl-tRNA synthetase (EC:6.1.1.7)
hsa:56704;JPH1,JP-1,JP1;junctophilin 1
hsa:26512;INTS6,DBI-1,DDX26,DDX26A,DICE1,HDB,INT6,Notchl2;integrator complex subunit 6
hsa:22934;RPIA,RPI;ribose 5-phosphate isomerase A (EC:5.3.1.6)
hsa:54855;FAM46C;family with sequence similarity 46, member C
hsa:2686;GGT7,D20S101,GGT4,GGTL3,GGTL5,dJ18C9.2;gamma-glutamyltransferase 7 (EC:2.3.2.2 3.4.19.13)
hsa:8220;DGCR14,DGCR13,DGS-H,DGS-I,DGSH,DGSI,ES2,Es2el;DiGeorge syndrome critical region gene 14
hsa:541466;CT45A1,CT45,CT45-1,CT45.1;cancer/testis antigen family 45, member A1
hsa:8722;CTSF,CATSF,CLN13;cathepsin F (EC:3.4.22.41)
hsa:10447;FAM3C,ILEI;family with sequence similarity 3, member C
hsa:6329;SCN4A,HOKPP2,HYKPP,HYPP,NAC1A,Na(V)1.4,Nav1.4,SkM1;sodium channel, voltage-gated, type IV, alpha subunit
hsa:57158;JPH2,CMH17,JP-2,JP2;junctophilin 2
hsa:347273;MURC,CAVIN4,cavin-4;muscle-related coiled-coil protein
hsa:327657;SERPINA9,GCET1,SERPINA11,SERPINA11b;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9
hsa:10654;PMVK,HUMPMKI,PMK,PMKA,PMKASE;phosphomevalonate kinase (EC:2.7.4.2)
hsa:84076;TKTL2;transketolase-like 2 (EC:2.2.1.1)
hsa:10445;MCRS1,ICP22BP,INO80Q,MCRS2,MSP58,P78;microspherule protein 1
hsa:7855;FZD5,C2orf31,HFZ5;frizzled family receptor 5
hsa:55612;FERMT1,C20orf42,DTGCU2,KIND1,UNC112A,URP1;fermitin family member 1
hsa:3736;KCNA1,AEMK,EA1,HBK1,HUK1,KV1.1,MBK1,MK1,RBK1;potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
hsa:89795;NAV3,POMFIL1,STEERIN3,unc53H3;neuron navigator 3
hsa:1761;DMRT1,DMT1;doublesex and mab-3 related transcription factor 1
hsa:23436;CELA3B,CBPP,E1,EL-1,ELA3B;chymotrypsin-like elastase family, member 3B (EC:3.4.21.70)
hsa:284001;CCDC57;coiled-coil domain containing 57
hsa:3042;HBM,HBAP2;hemoglobin, mu
hsa:3030;HADHA,ECHA,GBP,HADH,LCEH,LCHAD,MTPA,TP-ALPHA;hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit (EC:4.2.1.17 1.1.1.211)
hsa:7405;UVRAG,DHTX,VPS38,p63;UV radiation resistance associated
hsa:1292;COL6A2,PP3610;collagen, type VI, alpha 2
hsa:204219;CERS3,LASS3;ceramide synthase 3
hsa:79065;ATG9A,APG9L1,MGD3208,mATG9;autophagy related 9A
hsa:26952;SMR3A,P-B1,PBI,PRL5,PROL5;submaxillary gland androgen regulated protein 3A
hsa:94032;CAMK2N2,CAM-KIIN,CAMKIIN;calcium/calmodulin-dependent protein kinase II inhibitor 2
hsa:3212;HOXB2,HOX2,HOX2H,Hox-2.8,K8;homeobox B2
hsa:51700;CYB5R2,B5R.2;cytochrome b5 reductase 2 (EC:1.6.2.2)
hsa:79903;NAA60,HAT4,NAT15;N(alpha)-acetyltransferase 60, NatF catalytic subunit (EC:2.3.1.88 2.3.1.48)
hsa:53339;BTBD1,C15orf1,NS5ATP8;BTB (POZ) domain containing 1
hsa:134266;GRPEL2,Mt-GrpE#2;GrpE-like 2, mitochondrial (E. coli)
hsa:64222;TOR3A,ADIR,ADIR2;torsin family 3, member A
hsa:348180;CTU2,C16orf84,NCS2,UPF0432;cytosolic thiouridylase subunit 2 homolog (S. pombe)
hsa:1733;DIO1,5DI,TXDI1;deiodinase, iodothyronine, type I (EC:1.97.1.10)
hsa:1066;CES1,ACAT,CE-1,CEH,CES2,HMSE,HMSE1,PCE-1,REH,SES1,TGH,hCE-1;carboxylesterase 1 (EC:3.1.1.1 3.1.1.56)
hsa:27349;MCAT,FASN2C,MCT,MT,NET62,fabD;malonyl CoA:ACP acyltransferase (mitochondrial) (EC:2.3.1.39)
hsa:124930;ANKRD13B;ankyrin repeat domain 13B
hsa:7177;TPSAB1,TPS1,TPS2,TPSB1;tryptase alpha/beta 1 (EC:3.4.21.59)
hsa:2339;FNTA,FPTA,PGGT1A,PTAR2;farnesyltransferase, CAAX box, alpha (EC:2.5.1.59 2.5.1.58)
hsa:51451;LCMT1,LCMT,PPMT1;leucine carboxyl methyltransferase 1 (EC:2.1.1.233)
hsa:140823;ROMO1,C20orf52,MTGM,MTGMP,bA353C18.2;reactive oxygen species modulator 1
hsa:91544;UBXN11,COA-1,SOC,SOCI,UBXD5;UBX domain protein 11
hsa:5204;PFDN5,MM-1,MM1,PFD5;prefoldin subunit 5
hsa:84674;CARD6,CINCIN1;caspase recruitment domain family, member 6
hsa:4837;NNMT;nicotinamide N-methyltransferase (EC:2.1.1.1)
hsa:23779;ARHGAP8,BPGAP1,PP610;Rho GTPase activating protein 8
hsa:7326;UBE2G1,E217K,UBC7,UBE2G;ubiquitin-conjugating enzyme E2G 1 (EC:6.3.2.19)
hsa:8174;MADCAM1,MACAM1;mucosal vascular addressin cell adhesion molecule 1
hsa:911;CD1C,BDCA1,CD1,CD1A,R7;CD1c molecule
hsa:112812;FDX1L,FDX2;ferredoxin 1-like
hsa:158401;C9orf84;chromosome 9 open reading frame 84
hsa:27294;DHDH,2DD,HUM2DD;dihydrodiol dehydrogenase (dimeric) (EC:1.3.1.20 1.1.1.179)
hsa:2780;GNAT2,ACHM4,GNATC;guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2
hsa:26502;NARF,IOP2;nuclear prelamin A recognition factor
hsa:10884;MRPS30,MRP-S30,PAP,PDCD9,S30mt;mitochondrial ribosomal protein S30
hsa:266977;GPR110,KPG_012,PGR19,hGPCR36;G protein-coupled receptor 110
hsa:284541;CYP4A22;cytochrome P450, family 4, subfamily A, polypeptide 22 (EC:1.14.15.3)
hsa:28965;SLC27A6,ACSVL2,FACVL2,FATP6,VLCS-H1;solute carrier family 27 (fatty acid transporter), member 6
hsa:128954;GAB4;GRB2-associated binding protein family, member 4
hsa:829;CAPZA1,CAPPA1,CAPZ,CAZ1;capping protein (actin filament) muscle Z-line, alpha 1
hsa:53944;CSNK1G1,CK1gamma1;casein kinase 1, gamma 1 (EC:2.7.11.1)
hsa:80119;PIF1,C15orf20,PIF;PIF1 5'-to-3' DNA helicase homolog (S. cerevisiae) (EC:3.6.4.12)
hsa:57475;PLEKHH1;pleckstrin homology domain containing, family H (with MyTH4 domain) member 1
hsa:25930;PTPN23,HD-PTP,HDPTP,PTP-TD14;protein tyrosine phosphatase, non-receptor type 23 (EC:3.1.3.48)
hsa:4606;MYBPC2,MYBPC,MYBPCF;myosin binding protein C, fast type
hsa:79736;TEFM,C17orf42;transcription elongation factor, mitochondrial
hsa:4247;MGAT2,CDG2A,CDGS2,GLCNACTII,GNT-II,GNT2;mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143)
hsa:1290;COL5A2;collagen, type V, alpha 2
hsa:153443;SRFBP1,BUD22,P49,Rlb1,STRAP,p49/STRAP;serum response factor binding protein 1
hsa:26103;LRIT1,FIGLER9,LRRC21,PAL;leucine-rich repeat, immunoglobulin-like and transmembrane domains 1
hsa:3003;GZMK,TRYP2;granzyme K (granzyme 3;tryptase II) (EC:3.4.21.-)
hsa:6009;RHEB,RHEB2;Ras homolog enriched in brain
hsa:154150;HDGFL1,PWWP1,dJ309H15.1;hepatoma derived growth factor-like 1
hsa:79728;PALB2,FANCN,PNCA3;partner and localizer of BRCA2
hsa:162282;ANKFN1;ankyrin-repeat and fibronectin type III domain containing 1
hsa:144363;LYRM5;LYR motif containing 5
hsa:26118;WSB1,SWIP1,WSB-1;WD repeat and SOCS box containing 1
hsa:26610;ELP4,C11orf19,PAX6NEB,PAXNEB,dJ68P15A.1;elongator acetyltransferase complex subunit 4
hsa:53635;PTOV1,ACID2,PTOV-1;prostate tumor overexpressed 1
hsa:57217;TTC7A,TTC7;tetratricopeptide repeat domain 7A
hsa:1608;DGKG,DAGK3,DGK-GAMMA;diacylglycerol kinase, gamma 90kDa (EC:2.7.1.107)
hsa:11006;LILRB4,CD85K,HM18,ILT3,LILRB5,LIR-5,LIR5;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
hsa:643866;CBLN3,PRO1486;cerebellin 3 precursor
hsa:120;ADD3,ADDL;adducin 3 (gamma)
hsa:10665;C6orf10,TSBP;chromosome 6 open reading frame 10
hsa:57523;NYNRIN,CGIN1,KIAA1305;NYN domain and retroviral integrase containing
hsa:149643;C1orf227;chromosome 1 open reading frame 227
hsa:23341;DNAJC16;DnaJ (Hsp40) homolog, subfamily C, member 16
hsa:11311;VPS45,H1,H1VPS45,VPS45A,VPS45B,VPS54A,VSP45,VSP45A;vacuolar protein sorting 45 homolog (S. cerevisiae)
hsa:2294;FOXF1,ACDMPV,FKHL5,FREAC1;forkhead box F1
hsa:8717;TRADD,Hs.89862;TNFRSF1A-associated via death domain
hsa:51765;MST4,MASK;serine/threonine protein kinase MST4 (EC:2.7.11.1)
hsa:51471;NAT8B,CML2,Hcml2,NAT8BP;N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene)
hsa:5439;POLR2J,POLR2J1,RPB11,RPB11A,RPB11m,hRPB14;polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa (EC:2.7.7.6)
hsa:23063;WAPAL,FOE,KIAA0261,WAPL;wings apart-like homolog (Drosophila)
hsa:55540;IL17RB,CRL4,EVI27,IL17BR,IL17RH1;interleukin 17 receptor B
hsa:5996;RGS1,1R20,BL34,IER1,IR20;regulator of G-protein signaling 1
hsa:116442;RAB39B,MRX72;RAB39B, member RAS oncogene family
hsa:3699;ITIH3,H3P;inter-alpha-trypsin inhibitor heavy chain 3
hsa:131076;CCDC58;coiled-coil domain containing 58
hsa:79767;ELMO3,CED-12,CED12,ELMO-3;engulfment and cell motility 3
hsa:10383;TUBB4B,Beta2,TUBB2,TUBB2C;tubulin, beta 4B class IVb
hsa:57109;REXO4,REX4,XPMC2,XPMC2H;REX4, RNA exonuclease 4 homolog (S. cerevisiae)
hsa:1291;COL6A1,OPLL;collagen, type VI, alpha 1
hsa:26253;CLEC4E,CLECSF9,MINCLE;C-type lectin domain family 4, member E
hsa:51291;GMIP,ARHGAP46;GEM interacting protein
hsa:116842;LEAP2,LEAP-2;liver expressed antimicrobial peptide 2
hsa:10352;WARS2,TrpRS;tryptophanyl tRNA synthetase 2, mitochondrial (EC:6.1.1.2)
hsa:7803;PTP4A1,HH72,PRL-1,PRL1,PTP(CAAX1),PTPCAAX1;protein tyrosine phosphatase type IVA, member 1 (EC:3.1.3.48)
hsa:165679;SPTSSB,ADMP,C3orf57,SSSPTB;serine palmitoyltransferase, small subunit B
hsa:10988;METAP2,MAP2,MNPEP,p67,p67eIF2;methionyl aminopeptidase 2 (EC:3.4.11.18)
hsa:4901;NRL,D14S46E,NRL-MAF,RP27;neural retina leucine zipper
hsa:8736;MYOM1,SKELEMIN;myomesin 1
hsa:6293;VPS52,ARE1,RP5-1033B10,SAC2,SACM2L,dJ1033B10.5;vacuolar protein sorting 52 homolog (S. cerevisiae)
hsa:163404;LPPR5,PAP2,PAP2D,PRG5;lipid phosphate phosphatase-related protein type 5
hsa:54856;GON4L,GON-4,GON4,RP11-243J18.4,YARP;gon-4-like (C. elegans)
hsa:5322;PLA2G5,FRFB,GV-PLA2,PLA2-10,hVPLA(2);phospholipase A2, group V (EC:3.1.1.4)
hsa:4583;MUC2,MLP,MUC-2,SMUC;mucin 2, oligomeric mucus/gel-forming
hsa:23154;NCDN;neurochondrin
hsa:23335;WDR7,TRAG;WD repeat domain 7
hsa:222;ALDH3B2,ALDH8;aldehyde dehydrogenase 3 family, member B2 (EC:1.2.1.5)
hsa:64900;LPIN3,LIPN3L,SMP2,dJ450M14.2,dJ450M14.3,dJ620E11.2;lipin 3 (EC:3.1.3.4)
hsa:23616;SH3BP1,ARHGAP43;SH3-domain binding protein 1
hsa:23179;RGL1,RGL;ral guanine nucleotide dissociation stimulator-like 1
hsa:283748;PLA2G4D,cPLA2delta;phospholipase A2, group IVD (cytosolic) (EC:3.1.1.4)
hsa:221002;RASGEF1A,CG4853;RasGEF domain family, member 1A
hsa:114769;CARD16,COP,COP1,PSEUDO-ICE;caspase recruitment domain family, member 16
hsa:57026;PDXP,CIN,PLP,dJ37E16.5;pyridoxal (pyridoxine, vitamin B6) phosphatase (EC:3.1.3.3 3.1.3.74)
hsa:114793;FMNL2,FHOD2;formin-like 2
hsa:84890;ADO,C10orf22;2-aminoethanethiol (cysteamine) dioxygenase (EC:1.13.11.19)
hsa:6322;SCML1;sex comb on midleg-like 1 (Drosophila)
hsa:5202;PFDN2,PFD2;prefoldin subunit 2
hsa:43847;KLK14,KLK-L6;kallikrein-related peptidase 14
hsa:9098;USP6,HRP1,TRE17,TRE2,Tre-2,USP6-short;ubiquitin specific peptidase 6 (Tre-2 oncogene) (EC:3.4.19.12)
hsa:84232;MAF1;MAF1 homolog (S. cerevisiae)
hsa:51019;CCDC53,CGI-116;coiled-coil domain containing 53
hsa:51699;VPS29,DC15,PEP11;vacuolar protein sorting 29 homolog (S. cerevisiae) (EC:3.1.3.3);K07095
hsa:90249;UNC5A,UNC5H1;unc-5 homolog A (C. elegans)
hsa:254531;LPCAT4,AGPAT7,AYTL3,LPAAT-eta,LPEAT2;lysophosphatidylcholine acyltransferase 4 (EC:2.3.1.51)
hsa:51085;MLXIPL,CHREBP,MIO,MONDOB,WBSCR14,WS-bHLH,bHLHd14;MLX interacting protein-like
hsa:83478;ARHGAP24,FILGAP,RC-GAP72,RCGAP72,p73,p73RhoGAP;Rho GTPase activating protein 24
hsa:3913;LAMB2,LAMS,NPHS5;laminin, beta 2 (laminin S)
hsa:7462;LAT2,LAB,NTAL,WBSCR15,WBSCR5,WSCR5;linker for activation of T cells family, member 2
hsa:57716;PRX,CMT4F;periaxin
hsa:23048;FNBP1,FBP17;formin binding protein 1
hsa:2834;PRLHR,GPR10,GR3,PrRPR;prolactin releasing hormone receptor
hsa:51182;HSPA14,HSP70-4,HSP70L1;heat shock 70kDa protein 14
hsa:84059;GPR98,FEB4,MASS1,USH2B,USH2C,VLGR1,VLGR1b;G protein-coupled receptor 98
hsa:10129;FRY,13CDNA73,214K23.2,C13orf14,CG003,bA207N4.2,bA37E23.1;furry homolog (Drosophila)
hsa:5343;PLGLB1,PLGL,PLGP1,PRGB,PRP-B;plasminogen-like B1
hsa:127943;FCRLB,FCRL2,FCRLM2,FCRLY,FREB-2,FcRY;Fc receptor-like B
hsa:3005;H1F0,H10,H1FV;H1 histone family, member 0
hsa:1267;CNP,CNP1;2',3'-cyclic nucleotide 3' phosphodiesterase (EC:3.1.4.37)
hsa:256364;EML3,ELP95;echinoderm microtubule associated protein like 3
hsa:84816;RTN4IP1,NIMP;reticulon 4 interacting protein 1
hsa:5342;PLGLB2,PLGP1;plasminogen-like B2
hsa:56953;NT5M,dNT-2,dNT2,mdN;5',3'-nucleotidase, mitochondrial (EC:3.1.3.5)
hsa:93377;OPALIN,HTMP10,TMEM10,TMP10;oligodendrocytic myelin paranodal and inner loop protein
hsa:79887;PLBD1;phospholipase B domain containing 1
hsa:10929;SRSF8,SFRS2B,SRP46;serine/arginine-rich splicing factor 8
hsa:64333;ARHGAP9,10C,RGL1;Rho GTPase activating protein 9
hsa:22990;PCNX,PCNXL1;pecanex homolog (Drosophila)
hsa:90624;LYRM7,C5orf31;LYR motif containing 7
hsa:91746;YTHDC1,YT521,YT521-B;YTH domain containing 1
hsa:3131;HLF;hepatic leukemia factor
hsa:92154;MTSS1L,ABBA-1;metastasis suppressor 1-like
hsa:8776;MTMR1;myotubularin related protein 1
hsa:915;CD3D,CD3-DELTA,T3D;CD3d molecule, delta (CD3-TCR complex)
hsa:29966;STRN3,SG2NA;striatin, calmodulin binding protein 3
hsa:140453;MUC17,MUC3;mucin 17, cell surface associated
hsa:79770;TXNDC15,C5orf14,UNQ335;thioredoxin domain containing 15
hsa:154064;RAET1L,ULBP6;retinoic acid early transcript 1L
hsa:55500;ETNK1,EKI,EKI_1,EKI1,Nbla10396;ethanolamine kinase 1 (EC:2.7.1.82)
hsa:124446;TMEM219,IGFBP-3R;transmembrane protein 219
hsa:27068;PPA2,SID6-306;pyrophosphatase (inorganic) 2 (EC:3.6.1.1)
hsa:441549;CDNF,ARMETL1;cerebral dopamine neurotrophic factor
hsa:55686;MREG,DSU,WDT2;melanoregulin
hsa:1622;DBI,ACBD1,ACBP,CCK-RP,EP;diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) (EC:3.4.17.3)
hsa:57602;USP36,DUB1;ubiquitin specific peptidase 36 (EC:3.4.19.12)
hsa:2635;GBP3;guanylate binding protein 3
hsa:64855;FAM129B,C9orf88,MEG-3,MINERVA,OC58,bA356B19.6;family with sequence similarity 129, member B
hsa:55578;SUPT20H,C13,C13orf19,FAM48A,P38IP,SPT20,bA421P11.4;suppressor of Ty 20 homolog (S. cerevisiae)
hsa:10207;INADL,Cipp,PATJ,hINADL;InaD-like (Drosophila)
hsa:25818;KLK5,KLK-L2,KLKL2,SCTE;kallikrein-related peptidase 5
hsa:64066;MMP27,MMP-27;matrix metallopeptidase 27
hsa:9464;HAND2,DHAND2,Hed,Thing2,bHLHa26,dHand;heart and neural crest derivatives expressed 2
hsa:93517;SDR42E1;short chain dehydrogenase/reductase family 42E, member 1 (EC:1.1.1.-)
hsa:124454;EARS2,COXPD12,MSE1;glutamyl-tRNA synthetase 2, mitochondrial (EC:6.1.1.17)
hsa:11259;FILIP1L,DOC-1,DOC1,GIP130,GIP130a,GIP130b,GIP130c,GIP90;filamin A interacting protein 1-like
hsa:79958;DENND1C,FAM31C;DENN/MADD domain containing 1C
hsa:394;ARHGAP5,GFI2,RhoGAP5,p190-B,p190BRhoGAP;Rho GTPase activating protein 5
hsa:51762;RAB8B;RAB8B, member RAS oncogene family
hsa:79066;METTL16,METT10D;methyltransferase like 16 (EC:2.1.1.-)
hsa:6880;TAF9,AK6,CGI-137,CINAP,CIP,MGC:1603,MGC:3647,MGC:5067,TAF2G,TAFII31,TAFII32,TAFIID32,hCINAP;TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa (EC:2.7.4.3)
hsa:2222;FDFT1,DGPT,ERG9,SQS,SS;farnesyl-diphosphate farnesyltransferase 1 (EC:2.5.1.21)
hsa:79875;THSD4,ADAMTSL-6,ADAMTSL6,FVSY9334,PRO34005;thrombospondin, type I, domain containing 4
hsa:92181;UBTD2,DCUBP;ubiquitin domain containing 2
hsa:10056;FARSB,FARSLB,FRSB,PheHB,PheRS;phenylalanyl-tRNA synthetase, beta subunit (EC:6.1.1.20)
hsa:151742;PPM1L,PP2C-epsilon,PP2CE,PPM1-LIKE;protein phosphatase, Mg2+/Mn2+ dependent, 1L (EC:3.1.3.16)
hsa:2352;FOLR3,FR-G,FR-gamma,gamma-hFR;folate receptor 3 (gamma)
hsa:10660;LBX1,HPX-6,HPX6,LBX1H,homeobox;ladybird homeobox 1
hsa:1479;CSTF3,CSTF-77;cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kDa
hsa:8292;COLQ,EAD;collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase
hsa:56927;GPR108,LUSTR2;G protein-coupled receptor 108
hsa:23112;TNRC6B;trinucleotide repeat containing 6B
hsa:220988;HNRNPA3,2610510D13Rik,D10S102,FBRNP,HNRPA3;heterogeneous nuclear ribonucleoprotein A3
hsa:7402;UTRN,DMDL,DRP,DRP1;utrophin
hsa:51776;ZAK,AZK,MLK7,MLT,MLTK,MRK,mlklak,pk;sterile alpha motif and leucine zipper containing kinase AZK (EC:2.7.11.25)
hsa:29888;STRN4,ZIN,zinedin;striatin, calmodulin binding protein 4
hsa:145873;MESP2,SCDO2,bHLHc6;mesoderm posterior 2 homolog (mouse)
hsa:23462;HEY1,BHLHb31,CHF2,HERP2,HESR1,HRT-1,OAF1;hairy/enhancer-of-split related with YRPW motif 1
hsa:50509;COL5A3;collagen, type V, alpha 3
hsa:2565;GABRG1;gamma-aminobutyric acid (GABA) A receptor, gamma 1
hsa:27044;SND1,TDRD11,p100;staphylococcal nuclease and tudor domain containing 1
hsa:150372;NFAM1,CNAIP,bK126B4.4;NFAT activating protein with ITAM motif 1
hsa:26504;CNNM4,ACDP4;cyclin M4
hsa:594855;CPLX3,CPX-III,CPXIII;complexin 3
hsa:64101;LRRC4,NGL-2;leucine rich repeat containing 4
hsa:79748;LMAN1L,ERGIC-53L,ERGL;lectin, mannose-binding, 1 like
hsa:151835;CPNE9;copine family member IX
hsa:50487;PLA2G3,GIII-SPLA2,SPLA2III;phospholipase A2, group III (EC:3.1.1.4)
hsa:9168;TMSB10,MIG12,TB10;thymosin beta 10
hsa:55929;DMAP1,DNMAP1,DNMTAP1,EAF2,MEAF2,SWC4;DNA methyltransferase 1 associated protein 1
hsa:114795;TMEM132B;transmembrane protein 132B
hsa:9308;CD83,BL11,HB15;CD83 molecule
hsa:23493;HEY2,CHF1,GRIDLOCK,GRL,HERP1,HESR2,HRT2,bHLHb32;hairy/enhancer-of-split related with YRPW motif 2
hsa:9578;CDC42BPB,MRCKB;CDC42 binding protein kinase beta (DMPK-like) (EC:2.7.11.1)
hsa:6242;RTKN;rhotekin
hsa:140876;FAM65C,C20orf175,C20orf176,dJ530I15.2,dJ530I15.3;family with sequence similarity 65, member C
hsa:795;S100G,CABP,CABP1,CABP9K,CALB3;S100 calcium binding protein G
hsa:11226;GALNT6,GALNAC-T6,GalNAcT6;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) (EC:2.4.1.41)
hsa:51248;PDZD11,AIPP1,PDZK11,PISP;PDZ domain containing 11
hsa:94160;ABCC12,MRP9;ATP-binding cassette, sub-family C (CFTR/MRP), member 12
hsa:64418;TMEM168;transmembrane protein 168
hsa:85456;TNKS1BP1,TAB182;tankyrase 1 binding protein 1, 182kDa
hsa:125113;KRT222,KA21,KRT222P;keratin 222
hsa:57662;CAMSAP3,KIAA1543,NEZHA;calmodulin regulated spectrin-associated protein family, member 3
hsa:6129;RPL7,L7,humL7-1;ribosomal protein L7
hsa:79902;NUP85,Nup75;nucleoporin 85kDa
hsa:54700;RRN3,A-270G1.2,TIFIA;RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae)
hsa:26020;LRP10,LRP9,MST087;low density lipoprotein receptor-related protein 10
hsa:2792;GNGT1,GNG1;guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1
hsa:4682;NUBP1,NBP,NBP1;nucleotide binding protein 1
hsa:55815;TSNAXIP1,TXI1;translin-associated factor X interacting protein 1
hsa:178;AGL,GDE;amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase (EC:2.4.1.25 3.2.1.33)
hsa:28991;COMMD5,HCARG;COMM domain containing 5
hsa:2299;FOXI1,FKH10,FKHL10,FREAC-6,FREAC6,HFH-3,HFH3;forkhead box I1
hsa:10499;NCOA2,GRIP1,KAT13C,NCoA-2,SRC2,TIF2,bHLHe75;nuclear receptor coactivator 2
hsa:27198;HCAR1,GPR104,GPR81,HCA1,LACR1,TA-GPCR;hydroxycarboxylic acid receptor 1
hsa:3607;FOXK2,ILF,ILF-1,ILF1;forkhead box K2
hsa:26073;POLDIP2,PDIP38,POLD4;polymerase (DNA-directed), delta interacting protein 2
hsa:3916;LAMP1,CD107a,LAMPA,LGP120;lysosomal-associated membrane protein 1
hsa:55190;NUDT11,APS1,ASP1,DIPP3b,DIPP3beta,hDIPP3beta;nudix (nucleoside diphosphate linked moiety X)-type motif 11 (EC:3.6.1.52 3.6.1.60)
hsa:83593;RASSF5,Maxp1,NORE1,NORE1A,NORE1B,RAPL,RASSF3;Ras association (RalGDS/AF-6) domain family member 5
hsa:617;BCS1L,BCS,BCS1,BJS,FLNMS,GRACILE,Hs.6719,PTD,h-BCS;BC1 (ubiquinol-cytochrome c reductase) synthesis-like
hsa:1812;DRD1,DADR,DRD1A;dopamine receptor D1
hsa:79083;MLPH,SLAC2-A;melanophilin
hsa:51226;COPZ2;coatomer protein complex, subunit zeta 2
hsa:65057;ACD,PIP1,PTOP,TINT1,TPP1;adrenocortical dysplasia homolog (mouse)
hsa:9821;RB1CC1,CC1,FIP200;RB1-inducible coiled-coil 1
hsa:51170;HSD17B11,17BHSD11,DHRS8,PAN1B,RETSDR2,SDR16C2;hydroxysteroid (17-beta) dehydrogenase 11 (EC:1.1.1.62)
hsa:389898;UBE2NL,Li174;ubiquitin-conjugating enzyme E2N-like (EC:6.3.2.-)
hsa:23166;STAB1,CLEVER-1,FEEL-1,FELE-1,FEX1,STAB-1;stabilin 1
hsa:56894;AGPAT3,LPAAT-GAMMA1,LPAAT3;1-acylglycerol-3-phosphate O-acyltransferase 3 (EC:2.3.1.51)
hsa:120526;DNAJC24,DPH4,JJJ3,ZCSL3;DnaJ (Hsp40) homolog, subfamily C, member 24
hsa:64927;TTC23,HCC-8;tetratricopeptide repeat domain 23
hsa:9933;HA-8,HLA-HA8,PEN,PUF6,XTP5,hPUF-A;KIAA0020
hsa:2241;FER,FerT,PPP1R74,TYK3;fer (fps/fes related) tyrosine kinase (EC:2.7.10.2)
hsa:51278;IER5,SBBI48;immediate early response 5
hsa:7478;WNT8A,WNT8D;wingless-type MMTV integration site family, member 8A
hsa:124220;ZG16B,EECP,HRPE773,JCLN2,PAUF,PRO1567;zymogen granule protein 16B
hsa:3632;INPP5A,5PTASE;inositol polyphosphate-5-phosphatase, 40kDa (EC:3.1.3.56)
hsa:4298;MLLT1,ENL,LTG19,YEATS1;myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila);translocated to, 1
hsa:899;CCNF,FBX1,FBXO1;cyclin F
hsa:3045;HBD;hemoglobin, delta
hsa:154043;CNKSR3,MAGI1;CNKSR family member 3
hsa:8476;CDC42BPA,MRCK,MRCKA,PK428;CDC42 binding protein kinase alpha (DMPK-like) (EC:2.7.11.1)
hsa:4544;MTNR1B,FGQTL2,MEL-1B-R,MT2;melatonin receptor 1B
hsa:9097;USP14,TGT;ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase) (EC:3.4.19.12)
hsa:26508;HEYL,HESR3,HEY3,HRT3,bHLHb33;hairy/enhancer-of-split related with YRPW motif-like
hsa:353091;RAET1G,ULBP5;retinoic acid early transcript 1G
hsa:55824;PAG1,CBP,PAG;phosphoprotein associated with glycosphingolipid microdomains 1
hsa:113510;HELQ,HEL308;helicase, POLQ-like (EC:3.6.4.12)
hsa:84888;SPPL2A,IMP3,PSL2;signal peptide peptidase like 2A (EC:3.4.23.-)
hsa:4036;LRP2,DBS,GP330;low density lipoprotein receptor-related protein 2
hsa:57605;PITPNM2,NIR-3,NIR3,RDGB2,RDGBA2;phosphatidylinositol transfer protein, membrane-associated 2
hsa:221016;CCDC7,BioT2-A,BioT2-B,BioT2-C,RP11-479G22.1;coiled-coil domain containing 7
hsa:27163;NAAA,ASAHL,PLT;N-acylethanolamine acid amidase (EC:3.5.1.-)
hsa:84267;C9orf64;chromosome 9 open reading frame 64
hsa:57169;ZNFX1;zinc finger, NFX1-type containing 1
hsa:1477;CSTF1,CstF-50,CstFp50;cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kDa
hsa:23139;MAST2,MAST205,MTSSK;microtubule associated serine/threonine kinase 2 (EC:2.7.11.1)
hsa:1310;COL19A1,COL9A1L,D6S228E;collagen, type XIX, alpha 1
hsa:6491;STIL,MCPH7,SIL;SCL/TAL1 interrupting locus
hsa:5544;PRB3,G1,PRG;proline-rich protein BstNI subfamily 3
hsa:64081;PBLD,MAWBP,MAWDBP;phenazine biosynthesis-like protein domain containing;K06998
hsa:23041;MON2;MON2 homolog (S. cerevisiae)
hsa:2020;EN2;engrailed homeobox 2
hsa:157570;ESCO2,2410004I17Rik,EFO2,RBS;establishment of cohesion 1 homolog 2 (S. cerevisiae) (EC:2.3.1.-)
hsa:3914;LAMB3,BM600-125KDA,LAM5,LAMNB1;laminin, beta 3
hsa:57380;MRS2,HPT,MRS2L;MRS2 magnesium homeostasis factor homolog (S. cerevisiae)
hsa:26267;FBXO10,FBX10,PRMT11;F-box protein 10
hsa:342035;GLDN,CLOM,COLM,CRG-L2,CRGL2,UNC-112;gliomedin;K16364 GLDN;gliomedin
hsa:5457;POU4F1,BRN3A,Oct-T1,RDC-1,brn-3A;POU class 4 homeobox 1
hsa:2268;FGR,SRC2,c-fgr,c-src2,p55-Fgr,p55c-fgr,p58-Fgr,p58c-fgr;Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog (EC:2.7.10.2)
hsa:9934;P2RY14,GPR105,P2Y14;purinergic receptor P2Y, G-protein coupled, 14
hsa:1043;CD52,CDW52;CD52 molecule
hsa:154007;SNRNP48,C6orf151,dJ336K20B.1,dJ512B11.2;small nuclear ribonucleoprotein 48kDa (U11/U12)
hsa:526;ATP6V1B2,ATP6B1B2,ATP6B2,HO57,VATB,VPP3,Vma2;ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 (EC:3.6.3.14)
hsa:8718;TNFRSF25,APO-3,DDR3,DR3,LARD,TNFRSF12,TR3,TRAMP,WSL-1,WSL-LR;tumor necrosis factor receptor superfamily, member 25
hsa:341350;OVCH1,OVCH;ovochymase 1
hsa:29855;UBN1,VT,VT4;ubinuclein 1
hsa:9411;ARHGAP29,PARG1,RP11-255E17.1;Rho GTPase activating protein 29
hsa:146754;DNAH2,DNAHC2,DNHD3;dynein, axonemal, heavy chain 2
hsa:1142;CHRNB3;cholinergic receptor, nicotinic, beta 3 (neuronal)
hsa:26135;SERBP1,CHD3IP,HABP4L,PAI-RBP1,PAIRBP1;SERPINE1 mRNA binding protein 1
hsa:2847;MCHR1,GPR24,MCH1R,SLC1;melanin-concentrating hormone receptor 1
hsa:129685;TAF8,43,II,TAF,TAFII-43,TAFII43,TBN;TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 43kDa
hsa:7837;PXDN,D2S448,D2S448E,MG50,PRG2,PXN,VPO;peroxidasin homolog (Drosophila) (EC:1.11.1.7)
hsa:10152;ABI2,ABI-2,ABI2B,AIP-1,AblBP3,SSH3BP2,argBPIA,argBPIB;abl-interactor 2
hsa:5142;PDE4B,DPDE4,PDE4B5,PDEIVB;phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17)
hsa:6905;TBCE,HRD,KCS,KCS1,pac2;tubulin folding cofactor E
hsa:23392;ECM29;KIAA0368
hsa:9859;CEP170,FAM68A,KAB,KIAA0470;centrosomal protein 170kDa
hsa:83858;ATAD3B,AAA-TOB3,TOB3;ATPase family, AAA domain containing 3B
hsa:30849;PIK3R4,VPS15,p150;phosphoinositide-3-kinase, regulatory subunit 4 (EC:2.7.11.1)
hsa:440503;PLIN5,LSDA5,LSDP5,MLDP,OXPAT;perilipin 5
hsa:729359;PLIN4,KIAA1881,S3-12;perilipin 4
hsa:26119;LDLRAP1,ARH,ARH1,ARH2,FHCB1,FHCB2;low density lipoprotein receptor adaptor protein 1
hsa:5655;KLK10,NES1,PRSSL1;kallikrein-related peptidase 10 (EC:3.4.21.35)
hsa:55665;URGCP,URG4;upregulator of cell proliferation
hsa:57512;GPR158,RP11-59G22.1;G protein-coupled receptor 158
hsa:79810;PTCD2;pentatricopeptide repeat domain 2
hsa:5802;PTPRS,PTPSIGMA;protein tyrosine phosphatase, receptor type, S (EC:3.1.3.48)
hsa:23524;SRRM2,300-KD,CWF21,Cwc21,SRL300,SRm300;serine/arginine repetitive matrix 2
hsa:4051;CYP4F3,CPF3,CYP4F,LTB4H;cytochrome P450, family 4, subfamily F, polypeptide 3 (EC:1.14.13.30)
hsa:81618;ITM2C,BRI3,BRICD2C,E25,E25C,ITM3;integral membrane protein 2C
hsa:22837;COBLL1,COBLR1;cordon-bleu WH2 repeat protein-like 1
hsa:7073;TIAL1,TCBP,TIAR;TIA1 cytotoxic granule-associated RNA binding protein-like 1
hsa:9349;RPL23,L23,rpL17;ribosomal protein L23
hsa:10038;PARP2,ADPRT2,ADPRTL2,ADPRTL3,ARTD2,PARP-2,pADPRT-2;poly (ADP-ribose) polymerase 2 (EC:2.4.2.30)
hsa:10809;STARD10,NY-CO-28,PCTP2,SDCCAG28;StAR-related lipid transfer (START) domain containing 10
hsa:64951;MRPS24,MRP-S24,S24mt,bMRP-47,bMRP47;mitochondrial ribosomal protein S24
hsa:56934;CA10,CA-RPX,CARPX,HUCEP-15;carbonic anhydrase X
hsa:51696;HECA,HDC,HDCL,HHDC,dJ225E12.1;headcase homolog (Drosophila)
hsa:26505;CNNM3,ACDP3;cyclin M3
hsa:92126;DSEL,C18orf4;dermatan sulfate epimerase-like
hsa:4665;NAB2,MADER;NGFI-A binding protein 2 (EGR1 binding protein 2)
hsa:3305;HSPA1L,HSP70-1L,HSP70-HOM,HSP70T,hum70t;heat shock 70kDa protein 1-like
hsa:202333;CMYA5,C5orf10,SPRYD2,TRIM76;cardiomyopathy associated 5
hsa:55188;RIC8B,RIC8,hSyn;resistance to inhibitors of cholinesterase 8 homolog B (C. elegans)
hsa:154467;CCDC167,C6orf129,HSPC265;coiled-coil domain containing 167
hsa:54847;SIDT1,B830021E24Rik,SID-1,SID1;SID1 transmembrane family, member 1
hsa:84105;PCBD2,DCOH2,DCOHM,PHS2;pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2 (EC:4.2.1.96)
hsa:92;ACVR2A,ACTRII,ACVR2;activin A receptor, type IIA (EC:2.7.11.30)
hsa:54892;NCAPG2,CAP-G2,LUZP5,MTB,hCAP-G2;non-SMC condensin II complex, subunit G2
hsa:84928;TMEM209,NET31;transmembrane protein 209
hsa:55527;FEM1A,EPRAP;fem-1 homolog a (C. elegans)
hsa:116729;PPP1R27,DYSFIP1;protein phosphatase 1, regulatory subunit 27
hsa:221935;SDK1;sidekick cell adhesion molecule 1
hsa:9001;HAP1,HAP2,HIP5,HLP,hHLP1;huntingtin-associated protein 1
hsa:9951;HS3ST4,3-OST-4,30ST4,3OST4,h3-OST-4;heparan sulfate (glucosamine) 3-O-sulfotransferase 4 (EC:2.8.2.23)
hsa:56948;SDR39U1,C14orf124,HCDI;short chain dehydrogenase/reductase family 39U, member 1;K07071
hsa:81610;FAM83D,C20orf129,CHICA,dJ616B8.3;family with sequence similarity 83, member D
hsa:23397;NCAPH,BRRN1,CAP-H,HCAP-H;non-SMC condensin I complex, subunit H
hsa:23558;WBP2,WBP-2;WW domain binding protein 2
hsa:2814;GP5,CD42d,GPV;glycoprotein V (platelet)
hsa:253943;YTHDF3;YTH domain family, member 3
hsa:55181;SMG8,C17orf71;smg-8 homolog, nonsense mediated mRNA decay factor (C. elegans)
hsa:3855;KRT7,CK7,K2C7,K7,SCL;keratin 7
hsa:54858;PGPEP1,PGP,PGP-I,PGPI,Pcp;pyroglutamyl-peptidase I (EC:3.4.19.3)
hsa:65082;VPS33A;vacuolar protein sorting 33 homolog A (S. cerevisiae)
hsa:55506;H2AFY2,macroH2A2;H2A histone family, member Y2
hsa:283514;SIAH3;siah E3 ubiquitin protein ligase family member 3
hsa:341640;FREM2;FRAS1 related extracellular matrix protein 2
hsa:23657;SLC7A11,CCBR1,xCT;solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
hsa:9231;DLG5,LP-DLG,P-DLG5,PDLG;discs, large homolog 5 (Drosophila)
hsa:10319;LAMC3,OCCM;laminin, gamma 3
hsa:23433;RHOQ,ARHQ,RASL7A,TC10,TC10A;ras homolog family member Q
hsa:2019;EN1;engrailed homeobox 1
hsa:92675;DTD1,C20orf88,DUEB,HARS2,bA379J5.3,bA555E18.1,pqn-68;D-tyrosyl-tRNA deacylase 1 (EC:6.1.1.21)
hsa:283316;CD163L1,CD163B,M160;CD163 molecule-like 1
hsa:79154;DHRS11,ARPG836,SDR24C1;dehydrogenase/reductase (SDR family) member 11
hsa:388531;RGS9BP,PERRS,R9AP,RGS9;regulator of G protein signaling 9 binding protein
hsa:256302;C17orf103,Gtlf3b;chromosome 17 open reading frame 103;K06975
hsa:2327;FMO2,FMO1B1;flavin containing monooxygenase 2 (non-functional) (EC:1.14.13.8)
hsa:55603;FAM46A,C6orf37,XTP11;family with sequence similarity 46, member A
hsa:9940;DLEC1,DLC1,F56;deleted in lung and esophageal cancer 1
hsa:150465;TTL;tubulin tyrosine ligase (EC:6.3.2.25)
hsa:6398;SECTM1,K12;secreted and transmembrane 1
hsa:9107;MTMR6;myotubularin related protein 6
hsa:1937;EEF1G,EF1G,GIG35;eukaryotic translation elongation factor 1 gamma
hsa:3219;HOXB9,HOX-2.5,HOX2,HOX2E;homeobox B9
hsa:4629;MYH11,AAT4,FAA4,SMHC,SMMHC;myosin, heavy chain 11, smooth muscle
hsa:23589;CARHSP1,CRHSP-24,CSDC1;calcium regulated heat stable protein 1, 24kDa
hsa:146691;TOM1L2;target of myb1-like 2 (chicken)
hsa:6234;RPS28,S28;ribosomal protein S28
hsa:729540;RGPD6,RGP6,RGPD7,RanBP2L1,RanBP2L2;RANBP2-like and GRIP domain containing 6
hsa:55898;UNC45A,GC-UNC45,GCUNC-45,GCUNC45,IRO039700,SMAP-1,SMAP1;unc-45 homolog A (C. elegans)
hsa:79625;NDNF,C4orf31;neuron-derived neurotrophic factor
hsa:23604;DAPK2,DRP-1,DRP1;death-associated protein kinase 2 (EC:2.7.11.1)
hsa:6699;SPRR1B,CORNIFIN,GADD33,SPRR1;small proline-rich protein 1B
hsa:80217;WDR96,C10orf79,bA373N18.2;WD repeat domain 96
hsa:170712;COX7B2;cytochrome c oxidase subunit VIIb2 (EC:1.9.3.1)
hsa:84251;SGIP1;SH3-domain GRB2-like (endophilin) interacting protein 1
hsa:148362;BROX,C1orf58,RP11-452F19.1;BRO1 domain and CAAX motif containing
hsa:117159;DCD,AIDD,DCD-1,DSEP,HCAP,PIF;dermcidin
hsa:4358;MPV17,MTDPS6,SYM1;MpV17 mitochondrial inner membrane protein
hsa:9801;MRPL19,L19mt,MRP-L15,MRP-L19,MRPL15,RLX1,RPML15;mitochondrial ribosomal protein L19
hsa:29109;FHOD1,FHOS;formin homology 2 domain containing 1
hsa:6155;RPL27,L27;ribosomal protein L27 (EC:3.6.5.3)
hsa:261729;STEAP2,IPCA1,PCANAP1,PUMPCn,STAMP1,STMP;STEAP family member 2, metalloreductase
hsa:4686;NCBP1,CBP80,NCBP,Sto1;nuclear cap binding protein subunit 1, 80kDa
hsa:4619;MYH1,MYHSA1,MYHa,MyHC-2X/D,MyHC-2x;myosin, heavy chain 1, skeletal muscle, adult
hsa:150763;GPAT2,CT123;glycerol-3-phosphate acyltransferase 2, mitochondrial (EC:2.3.1.15)
hsa:3226;HOXC10,HOX3I;homeobox C10
hsa:114784;CSMD2,dJ1007G16.1,dJ1007G16.2,dJ947L8.1;CUB and Sushi multiple domains 2
hsa:64172;OSGEPL1,Qri7;O-sialoglycoprotein endopeptidase-like 1 (EC:3.4.24.57)
hsa:221322;C6orf170,BROMI,C6orf171,bA301B7.2,bA57L9.1,dJ310J6.1;chromosome 6 open reading frame 170
hsa:283635;FAM177A1,C14orf24;family with sequence similarity 177, member A1
hsa:445582;POTEE,A26C1,A26C1A,CT104.2,POTE-2,POTE2,POTE2gamma;POTE ankyrin domain family, member E
hsa:79884;MAP9,ASAP;microtubule-associated protein 9
hsa:4014;LOR;loricrin
hsa:89866;SEC16B,LZTR2,PGPR-p117,RGPR,SEC16S;SEC16 homolog B (S. cerevisiae)
hsa:26999;CYFIP2,PIR121;cytoplasmic FMR1 interacting protein 2
hsa:6904;TBCD,SSD-1,tfcD;tubulin folding cofactor D
hsa:84661;DPY30,HDPY-30,Saf19;dpy-30 homolog (C. elegans)
hsa:2483;FRG1,FRG1A,FSG1;FSHD region gene 1
hsa:3225;HOXC9,HOX3,HOX3B;homeobox C9
hsa:3166;HMX1,H6,NKX5-3;H6 family homeobox 1
hsa:54974;THG1L,ICF45,IHG-1;tRNA-histidine guanylyltransferase 1-like (S. cerevisiae) (EC:2.7.7.79)
hsa:55671;SMEK1,FLFL1,KIAA2010,PP4R3A,smk-1,smk1;SMEK homolog 1, suppressor of mek1 (Dictyostelium)
hsa:51520;LARS,HSPC192,LARS1,LEURS,LEUS,LRS,PIG44,RNTLS,hr025Cl;leucyl-tRNA synthetase (EC:6.1.1.4)
hsa:57410;SCYL1,GKLP,NKTL,NTKL,P105,TAPK,TEIF,TRAP;SCY1-like 1 (S. cerevisiae)
hsa:7163;TPD52,D52,N8L,PC-1,PrLZ,hD52;tumor protein D52
hsa:2172;FABP6,I-15P,I-BABP,I-BALB,I-BAP,ILBP,ILBP3,ILLBP;fatty acid binding protein 6, ileal
hsa:133690;CAPSL;calcyphosine-like
hsa:23362;PSD3,EFA6R,HCA67;pleckstrin and Sec7 domain containing 3
hsa:1473;CST5;cystatin D
hsa:64802;NMNAT1,LCA9,NMNAT,PNAT1;nicotinamide nucleotide adenylyltransferase 1 (EC:2.7.7.1 2.7.7.18)
hsa:83596;BCL2L12;BCL2-like 12 (proline rich)
hsa:5408;PNLIPRP2,PLRP2;pancreatic lipase-related protein 2 (EC:3.1.1.3 3.1.1.26)
hsa:6903;TBCC,CFC;tubulin folding cofactor C
hsa:5476;CTSA,GLB2,GSL,NGBE,PPCA,PPGB;cathepsin A (EC:3.4.16.5)
hsa:84867;PTPN5,PTPSTEP,STEP;protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) (EC:3.1.3.48)
hsa:63979;FIGNL1;fidgetin-like 1
hsa:3270;HRC;histidine rich calcium binding protein
hsa:2300;FOXL1,FKH6,FKHL11,FREAC7;forkhead box L1
hsa:22916;NCBP2,CBC2,CBP20,NIP1;nuclear cap binding protein subunit 2, 20kDa
hsa:91074;ANKRD30A,NY-BR-1;ankyrin repeat domain 30A
hsa:114800;CCDC85A;coiled-coil domain containing 85A
hsa:23210;JMJD6,PSR,PTDSR,PTDSR1;jumonji domain containing 6 (EC:1.14.11.-)
hsa:54584;GNB1L,DGCRK3,GY2,WDR14,WDVCF;guanine nucleotide binding protein (G protein), beta polypeptide 1-like
hsa:55837;EAPP,BM036,C14orf11;E2F-associated phosphoprotein
hsa:114783;LMTK3,LMR3,TYKLM3;lemur tyrosine kinase 3 (EC:2.7.11.1)
hsa:5406;PNLIP,PL,PNLIPD,PTL;pancreatic lipase (EC:3.1.1.3)
hsa:55160;ARHGEF10L,GrinchGEF;Rho guanine nucleotide exchange factor (GEF) 10-like
hsa:54545;MTMR12,3-PAP,PIP3AP;myotubularin related protein 12
hsa:23446;SLC44A1,CD92,CDW92,CHTL1,CTL1,RP11-287A8.1;solute carrier family 44, member 1
hsa:90993;CREB3L1,OASIS;cAMP responsive element binding protein 3-like 1
hsa:94137;RP1L1,DCDC4B;retinitis pigmentosa 1-like 1
hsa:84539;MCHR2,GPR145,GPRv17,MCH-2R,MCH-R2,MCH2,MCH2R,MCHR-2,SLT;melanin-concentrating hormone receptor 2
hsa:54821;ERCC6L,PICH,RAD26L;excision repair cross-complementing rodent repair deficiency, complementation group 6-like (EC:3.6.4.12)
hsa:132299;OCIAD2;OCIA domain containing 2
hsa:5458;POU4F2,BRN3.2,BRN3B,Brn-3b;POU class 4 homeobox 2
hsa:137362;GOT1L1;glutamic-oxaloacetic transaminase 1-like 1 (EC:2.6.1.1)
hsa:22984;PDCD11,ALG-4,ALG4,NFBP,RRP5;programmed cell death 11
hsa:57731;SPTBN4,QV,SPNB4,SPTBN3;spectrin, beta, non-erythrocytic 4
hsa:92737;DNER,UNQ26,bet;delta/notch-like EGF repeat containing
hsa:1760;DMPK,DM,DM1,DM1PK,DMK,MDPK,MT-PK;dystrophia myotonica-protein kinase (EC:2.7.11.1)
hsa:152;ADRA2C,ADRA2L2,ADRA2RL2,ADRARL2,ALPHA2CAR;adrenoceptor alpha 2C
hsa:127579;DCST2;DC-STAMP domain containing 2
hsa:6553;SLC9A5,NHE5;solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5
hsa:79048;SECISBP2,SBP2;SECIS binding protein 2
hsa:157310;PEBP4,CORK-1,CORK1,GWTM1933,PEBP-4,PRO4408,hPEBP4;phosphatidylethanolamine-binding protein 4
hsa:83451;ABHD11,WBSCR21;abhydrolase domain containing 11
hsa:23729;SHPK,CARKL,SHK;sedoheptulokinase (EC:2.7.1.14)
hsa:3802;KIR2DL1,CD158A,KIR-K64,KIR221,NKAT,NKAT1,p58.1;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
hsa:246269;LACE1,AFG1;lactation elevated 1
hsa:11219;TREX2;three prime repair exonuclease 2 (EC:3.1.11.2)
hsa:22937;SCAP;SREBF chaperone
hsa:27346;TMEM97,MAC30;transmembrane protein 97
hsa:114790;STK11IP,LIP1,LKB1IP,STK11IP1;serine/threonine kinase 11 interacting protein
hsa:55816;DOK5,C20orf180;docking protein 5
hsa:4326;MMP17,MT4-MMP;matrix metallopeptidase 17 (membrane-inserted) (EC:3.4.24.-)
hsa:8631;SKAP1,SCAP1,SKAP55;src kinase associated phosphoprotein 1
hsa:2110;ETFDH,ETFQO,MADD;electron-transferring-flavoprotein dehydrogenase (EC:1.5.5.1)
hsa:6713;SQLE;squalene epoxidase (EC:1.14.13.132)
hsa:5091;PC,PCB;pyruvate carboxylase (EC:6.4.1.1)
hsa:4622;MYH4,MYH2B,MyHC-2B,MyHC-IIb;myosin, heavy chain 4, skeletal muscle
hsa:80122;MAP3K19,RCK,YSK4;mitogen-activated protein kinase kinase kinase 19 (EC:2.7.11.1)
hsa:283951;C16orf91,CCSMST1,gs103;chromosome 16 open reading frame 91
hsa:23531;MMD,MMA,MMD1,PAQR11;monocyte to macrophage differentiation-associated
hsa:374864;CCDC178,C18orf34;coiled-coil domain containing 178
hsa:2193;FARSA,CML33,FARSL,FARSLA,FRSA,PheHA;phenylalanyl-tRNA synthetase, alpha subunit (EC:6.1.1.20)
hsa:4158;MC2R,ACTHR;melanocortin 2 receptor (adrenocorticotropic hormone)
hsa:25802;LMOD1,1D,64kD,D1,SM-LMOD;leiomodin 1 (smooth muscle)
hsa:150084;IGSF5,GSF5,JAM4;immunoglobulin superfamily, member 5
hsa:23158;TBC1D9,MDR1;TBC1 domain family, member 9 (with GRAM domain)
hsa:387755;INSC;inscuteable homolog (Drosophila)
hsa:81617;CAB39L,MO25-BETA,MO2L,bA103J18.3;calcium binding protein 39-like
hsa:924;CD7,GP40,LEU-9,TP41,Tp40;CD7 molecule
hsa:8379;MAD1L1,MAD1,PIG9,TP53I9,TXBP181;MAD1 mitotic arrest deficient-like 1 (yeast)
hsa:114799;ESCO1,A930014I12Rik,CTF,ECO1,EFO1,ESO1;establishment of cohesion 1 homolog 1 (S. cerevisiae)
hsa:55423;SIRPG,CD172g,SIRP-B2,SIRPB2,SIRPgamma,bA77C3.1;signal-regulatory protein gamma
hsa:5586;PKN2,PAK2,PRK2,PRKCL2,PRO2042,Pak-2;protein kinase N2 (EC:2.7.11.13)
hsa:51475;CABP2,DFNB93;calcium binding protein 2
hsa:23542;MAPK8IP2,IB2,JIP2,PRKM8IPL;mitogen-activated protein kinase 8 interacting protein 2
hsa:55259;CASC1,LAS1,PPP1R54;cancer susceptibility candidate 1
hsa:146206;RLTPR,CARMIL2,CARMIL2b,LRRC16C;RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing
hsa:3996;LLGL1,DLG4,HUGL,HUGL-1,HUGL1,LLGL;lethal giant larvae homolog 1 (Drosophila)
hsa:9863;MAGI2,ACVRIP1,AIP-1,AIP1,ARIP1,MAGI-2,SSCAM;membrane associated guanylate kinase, WW and PDZ domain containing 2
hsa:732;C8B;complement component 8, beta polypeptide
hsa:51167;CYB5R4,NCB5OR,RP4-676J13.1,cb5/cb5R,dJ676J13.1;cytochrome b5 reductase 4 (EC:1.6.2.2)
hsa:257194;NEGR1,DMML2433,IGLON4,KILON,Ntra;neuronal growth regulator 1
hsa:124359;CDYL2,PCCP1;chromodomain protein, Y-like 2
hsa:347731;LRRTM3;leucine rich repeat transmembrane neuronal 3
hsa:10541;ANP32B,APRIL,PHAPI2,SSP29;acidic (leucine-rich) nuclear phosphoprotein 32 family, member B
hsa:58157;NGB;neuroglobin
hsa:886;CCKAR,CCK-A,CCK1-R,CCKRA;cholecystokinin A receptor
hsa:60412;EXOC4,SEC8,SEC8L1,Sec8p;exocyst complex component 4
hsa:9114;ATP6V0D1,ATP6D,ATP6DV,P39,VATX,VMA6,VPATPD;ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 (EC:3.6.3.14)
hsa:10678;B3GNT2,B3GN-T2,B3GNT,B3GNT-2,B3GNT1,BETA3GNT,BGNT2,BGnT-2;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 (EC:2.4.1.149)
hsa:10972;TMED10,P24(DELTA),S31I125,S31III125,TMP21,Tmp-21-I,p23;transmembrane emp24-like trafficking protein 10 (yeast)
hsa:152138;PYDC2,POP2,cPOP2;pyrin domain containing 2
hsa:2109;ETFB,MADD;electron-transfer-flavoprotein, beta polypeptide
hsa:1891;ECH1,HPXEL;enoyl CoA hydratase 1, peroxisomal
hsa:84132;USP42;ubiquitin specific peptidase 42 (EC:3.4.19.12)
hsa:57471;ERMN,JN,KIAA1189,ermin;ermin, ERM-like protein
hsa:9807;IP6K1,IHPK1,PiUS;inositol hexakisphosphate kinase 1 (EC:2.7.4.21)
hsa:151449;GDF7,BMP12;growth differentiation factor 7
hsa:5652;PRSS8,CAP1,PROSTASIN;protease, serine, 8
hsa:2128;EVX1;even-skipped homeobox 1
hsa:22976;PAXIP1,CAGF29,PACIP1,PAXIP1L,PTIP,TNRC2;PAX interacting (with transcription-activation domain) protein 1
hsa:2548;GAA,LYAG;glucosidase, alpha;acid (EC:3.2.1.20)
hsa:250;ALPP,ALP,PALP,PLAP,PLAP-1;alkaline phosphatase, placental (EC:3.1.3.1)
hsa:259232;NALCN,CanIon,VGCNL1,bA430M15.1;sodium leak channel, non-selective
hsa:5046;PCSK6,PACE4,SPC4;proprotein convertase subtilisin/kexin type 6
hsa:8662;EIF3B,EIF3-ETA,EIF3-P110,EIF3-P116,EIF3S9,PRT1;eukaryotic translation initiation factor 3, subunit B
hsa:11010;GLIPR1,CRISP7,GLIPR,RTVP1;GLI pathogenesis-related 1
hsa:3204;HOXA7,ANTP,HOX1,HOX1.1,HOX1A;homeobox A7
hsa:6830;SUPT6H,SPT6,SPT6H,emb-5;suppressor of Ty 6 homolog (S. cerevisiae)
hsa:220001;VWCE,URG11,VWC1;von Willebrand factor C and EGF domains
hsa:3681;ITGAD,ADB2,CD11D;integrin, alpha D
hsa:6192;RPS4Y1,RPS4Y,S4;ribosomal protein S4, Y-linked 1
hsa:3615;IMPDH2,IMPD2,IMPDH-II;IMP (inosine 5'-monophosphate) dehydrogenase 2 (EC:1.1.1.205)
hsa:10893;MMP24,MMP-24,MMP25,MT-MMP_5,MT-MMP5,MT5-MMP,MT5MMP,MTMMP5;matrix metallopeptidase 24 (membrane-inserted)
hsa:9969;MED13,ARC250,DRIP250,HSPC221,THRAP1,TRAP240;mediator complex subunit 13
hsa:3768;KCNJ12,IRK-2,IRK2,KCNJN1,Kir2.2,Kir2.2v,hIRK,hIRK1,hkir2.2x,kcnj12x;potassium inwardly-rectifying channel, subfamily J, member 12
hsa:11129;CLASRP,CLASP,SFRS16,SWAP2;CLK4-associating serine/arginine rich protein
hsa:2331;FMOD,SLRR2E;fibromodulin
hsa:163;AP2B1,ADTB2,AP105B,AP2-BETA,CLAPB1;adaptor-related protein complex 2, beta 1 subunit
hsa:3207;HOXA11,HOX1,HOX1I;homeobox A11
hsa:26608;TBL2,WBSCR13,WS-betaTRP;transducin (beta)-like 2
hsa:3696;ITGB8;integrin, beta 8
hsa:23294;ANKS1A,ANKS1;ankyrin repeat and sterile alpha motif domain containing 1A
hsa:79811;SLTM,Met;SAFB-like, transcription modulator
hsa:57727;NCOA5,CIA,bA465L10.6;nuclear receptor coactivator 5
hsa:4223;MEOX2,GAX,MOX2;mesenchyme homeobox 2
hsa:201294;UNC13D,FHL3,HLH3,HPLH3,Munc13-4;unc-13 homolog D (C. elegans)
hsa:116173;CMTM5,CKLFSF5;CKLF-like MARVEL transmembrane domain containing 5
hsa:7388;UQCRH,QCR6,UQCR8;ubiquinol-cytochrome c reductase hinge protein (EC:1.10.2.2)
hsa:9218;VAPA,VAP-33,VAP-A,VAP33,hVAP-33;VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa
hsa:51496;CTDSPL2,HSPC129;CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2 (EC:3.1.3.-)
hsa:5949;RBP3,D10S64,D10S65,D10S66,IRBP,RBPI;retinol binding protein 3, interstitial
hsa:26524;LATS2,KPM;LATS, large tumor suppressor, homolog 2 (Drosophila) (EC:2.7.11.1)
hsa:92259;MRPS36,MRP-S36;mitochondrial ribosomal protein S36
hsa:9382;COG1,CDG2G,LDLB;component of oligomeric golgi complex 1
hsa:29896;TRA2A,AWMS1,HSU53209;transformer 2 alpha homolog (Drosophila)
hsa:64115;C10orf54,B7-H5,B7H5,GI24,PP2135,SISP1;chromosome 10 open reading frame 54
hsa:2250;FGF5,HBGF-5,Smag-82;fibroblast growth factor 5
hsa:116496;FAM129A,C1orf24,NIBAN;family with sequence similarity 129, member A
hsa:135152;B3GAT2,GLCATS;beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) (EC:2.4.1.135)
hsa:10606;PAICS,ADE2,ADE2H1,AIRC,PAIS;phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (EC:6.3.2.6 4.1.1.21)
hsa:257106;ARHGAP30;Rho GTPase activating protein 30
hsa:10249;GLYAT,ACGNAT,CAT,GAT;glycine-N-acyltransferase (EC:2.3.1.13 2.3.1.71)
hsa:6164;RPL34,L34;ribosomal protein L34
hsa:7922;SLC39A7,D6S115E,D6S2244E,H2-KE4,HKE4,KE4,RING5,ZIP7;solute carrier family 39 (zinc transporter), member 7
hsa:91828;EXOC3L4,C14orf73;exocyst complex component 3-like 4
hsa:27036;SIGLEC7,AIRM1,CD328,CDw328,D-siglec,QA79,SIGLEC-7,p75,p75/AIRM1,SIGLEC19P,SIGLECP2;sialic acid binding Ig-like lectin 7
hsa:137872;ADHFE1,ADH8,HOT;alcohol dehydrogenase, iron containing, 1 (EC:1.1.99.24)
hsa:420;ART4,ARTC4,CD297,DO,DOK1;ADP-ribosyltransferase 4 (Dombrock blood group) (EC:2.4.2.31)
hsa:134430;WDR36,GLC1G,TA-WDRP,TAWDRP,UTP21;WD repeat domain 36
hsa:339403;RXFP4,GPCR142,GPR100,RLN3R2,RXFPR4;relaxin/insulin-like family peptide receptor 4
hsa:3550;IK,CSA2,RED;IK cytokine, down-regulator of HLA II
hsa:84978;FRMD5;FERM domain containing 5
hsa:8396;PIP4K2B,PI5P4KB,PIP5K2B,PIP5KIIB,PIP5KIIbeta;phosphatidylinositol-5-phosphate 4-kinase, type II, beta (EC:2.7.1.149)
hsa:23403;FBXO46,20D7-FC4,FBXO34L,Fbx46;F-box protein 46
hsa:221;ALDH3B1,ALDH4,ALDH7;aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5)
hsa:10973;ASCC3,ASC1p200,DJ467N11.1,HELIC1,RNAH,dJ121G13.4,p200;activating signal cointegrator 1 complex subunit 3 (EC:3.6.4.12)
hsa:116151;FAM210B,5A3,C20orf108,dJ1167H4.1;family with sequence similarity 210, member B
hsa:57562;;KIAA1377
hsa:30062;RAX,MCOP3,RX;retina and anterior neural fold homeobox
hsa:345557;PLCXD3;phosphatidylinositol-specific phospholipase C, X domain containing 3
hsa:223;ALDH9A1,ALDH4,ALDH7,ALDH9,E3,TMABADH;aldehyde dehydrogenase 9 family, member A1 (EC:1.2.1.3 1.2.1.19 1.2.1.47)
hsa:23224;SYNE2,EDMD5,NUA,NUANCE,Nesp2,Nesprin-2,SYNE-2,TROPH;spectrin repeat containing, nuclear envelope 2
hsa:375033;PEAR1,JEDI,MEGF12;platelet endothelial aggregation receptor 1
hsa:55031;USP47,TRFP;ubiquitin specific peptidase 47 (EC:3.4.19.12)
hsa:23310;NCAPD3,CAP-D3,hCAP-D3,hHCP-6,hcp-6;non-SMC condensin II complex, subunit D3
hsa:10864;SLC22A7,NLT,OAT2;solute carrier family 22 (organic anion transporter), member 7
hsa:90268;FAM105B;family with sequence similarity 105, member B
hsa:1284;COL4A2,ICH,POREN2;collagen, type IV, alpha 2
hsa:256297;PTF1A,PTF1-p48,bHLHa29;pancreas specific transcription factor, 1a
hsa:139378;GPR112,PGR17,RP1-299I16;G protein-coupled receptor 112
hsa:23596;OPN3,ECPN;opsin 3
hsa:8527;DGKD,DGKdelta,dgkd-2;diacylglycerol kinase, delta 130kDa (EC:2.7.1.107)
hsa:51092;SIDT2;SID1 transmembrane family, member 2
hsa:134147;CMBL,JS-1;carboxymethylenebutenolidase homolog (Pseudomonas) (EC:3.1.-.-)
hsa:9263;STK17A,DRAK1;serine/threonine kinase 17a (EC:2.7.11.1)
hsa:51168;MYO15A,DFNB3,MYO15;myosin XVA
hsa:200403;VWA3B;von Willebrand factor A domain containing 3B
hsa:4110;MAGEA11,CT1.11,MAGE-11,MAGE11,MAGEA-11;melanoma antigen family A, 11
hsa:5453;POU3F1,OCT6,OTF6,SCIP;POU class 3 homeobox 1
hsa:9667;SAFB2;scaffold attachment factor B2
hsa:643834;PGA3,PGA4,PGA5;pepsinogen 3, group I (pepsinogen A) (EC:3.4.23.1)
hsa:387263;C6orf120,bA160E12.4;chromosome 6 open reading frame 120
hsa:51227;PIGP,DCRC,DCRC-S,DSCR5,DSRC;phosphatidylinositol glycan anchor biosynthesis, class P (EC:2.4.1.198)
hsa:9990;SLC12A6,ACCPN,KCC3,KCC3A,KCC3B;solute carrier family 12 (potassium/chloride transporters), member 6
hsa:9736;USP34;ubiquitin specific peptidase 34 (EC:3.4.19.12)
hsa:85479;DNAJC5B,CSP-beta;DnaJ (Hsp40) homolog, subfamily C, member 5 beta
hsa:6344;SCTR,SR;secretin receptor
hsa:55102;ATG2B,C14orf103;autophagy related 2B
hsa:339105;PRSS53,POL3S,UNQ308;protease, serine, 53 (EC:3.4.21.-)
hsa:11224;RPL35,L35;ribosomal protein L35
hsa:6645;SNTB2,D16S2531E,EST25263,SNT2B2,SNT3,SNTL;syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)
hsa:1521;CTSW,LYPN;cathepsin W
hsa:23184;MESDC2,BOCA,MESD;mesoderm development candidate 2
hsa:126204;NLRP13,CLR19.7,NALP13,NOD14,PAN13;NLR family, pyrin domain containing 13
hsa:57568;SIPA1L2,SPAL2;signal-induced proliferation-associated 1 like 2
hsa:51332;SPTBN5,BSPECV,HUBSPECV,HUSPECV;spectrin, beta, non-erythrocytic 5
hsa:7533;YWHAH,YWHA1;tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide
hsa:116228;COX20,FAM36A;COX20 Cox2 chaperone homolog (S. cerevisiae)
hsa:94097;SFXN5,BBG-TCC;sideroflexin 5
hsa:54148;MRPL39,C21orf92,L39mt,MRP-L5,MRPL5,PRED22,PRED66,RPML5;mitochondrial ribosomal protein L39
hsa:55304;SPTLC3,C20orf38,LCB2B,LCB3,SPT3,SPTLC2L,dJ718P11,dJ718P11.1,hLCB2b;serine palmitoyltransferase, long chain base subunit 3 (EC:2.3.1.50)
hsa:27069;GHITM,DERP2,HSPC282,MICS1,PTD010,TMBIM5;growth hormone inducible transmembrane protein
hsa:84261;FBXW9,Fbw9;F-box and WD repeat domain containing 9
hsa:779;CACNA1S,CACNL1A3,CCHL1A3,Cav1.1,HOKPP,HOKPP1,MHS5,TTPP1,hypoPP;calcium channel, voltage-dependent, L type, alpha 1S subunit
hsa:4969;OGN,OG,OIF,SLRR3A;osteoglycin
hsa:9052;GPRC5A,GPCR5A,RAI3,RAIG1;G protein-coupled receptor, family C, group 5, member A
hsa:8942;KYNU;kynureninase (EC:3.7.1.3)
hsa:114898;C1QTNF2,CTRP2,zacrp2;C1q and tumor necrosis factor related protein 2
hsa:51059;FAM135B,C8ORFK32;family with sequence similarity 135, member B
hsa:84084;RAB6C,WTH3;RAB6C, member RAS oncogene family
hsa:10283;CWC27,NY-CO-10,SDCCAG10;CWC27 spliceosome-associated protein homolog (S. cerevisiae) (EC:5.2.1.8)
hsa:7447;VSNL1,HLP3,HPCAL3,HUVISL1,VILIP,VILIP-1;visinin-like 1
hsa:22884;WDR37,RP11-529L18.2;WD repeat domain 37
hsa:5432;POLR2C,RPB3,RPB31,hRPB33,hsRPB3;polymerase (RNA) II (DNA directed) polypeptide C, 33kDa (EC:2.7.7.6)
hsa:154091;SLC2A12,GLUT12,GLUT8;solute carrier family 2 (facilitated glucose transporter), member 12
hsa:3709;ITPR2,IP3R2;inositol 1,4,5-trisphosphate receptor, type 2
hsa:80725;SRCIN1,P140,SNIP;SRC kinase signaling inhibitor 1
hsa:26268;FBXO9,FBX9,NY-REN-57,VCIA1,dJ341E18.2;F-box protein 9
hsa:26190;FBXW2,FBW2,Fwd2,Md6;F-box and WD repeat domain containing 2
hsa:64386;MMP25,MMP-25,MMP20,MMP20A,MMPL1,MT-MMP_6,MT-MMP6,MT6-MMP,MT6MMP,MTMMP6;matrix metallopeptidase 25
hsa:2731;GLDC,GCE,GCSP,HYGN1;glycine dehydrogenase (decarboxylating) (EC:1.4.4.2)
hsa:51154;MRTO4,C1orf33,MRT4,dJ657E11.4;mRNA turnover 4 homolog (S. cerevisiae)
hsa:63923;TNN,TN-W;tenascin N
hsa:131831;FAM194A,C3orf44;family with sequence similarity 194, member A
hsa:64131;XYLT1,PXYLT1,XT-I,XT1,XTI,XYLTI;xylosyltransferase I (EC:2.4.2.26)
hsa:11103;KRR1,HRB2,RIP-1;KRR1, small subunit (SSU) processome component, homolog (yeast)
hsa:79784;MYH14,DFNA4,DFNA4A,MHC16,MYH17,NMHC_II-C,NMHC-II-C,PNMHH,myosin;myosin, heavy chain 14, non-muscle (EC:3.6.4.1)
hsa:50809;HP1BP3,HP1-BP74;heterochromatin protein 1, binding protein 3
hsa:9733;SART3,DSAP1,P100,RP11-13G14,TIP110,p110,p110(nrb);squamous cell carcinoma antigen recognized by T cells 3
hsa:4103;MAGEA4,CT1.4,MAGE-41,MAGE-X2,MAGE4,MAGE4A,MAGE4B;melanoma antigen family A, 4
hsa:162417;NAGS,AGAS,ARGA;N-acetylglutamate synthase (EC:2.3.1.1)
hsa:79642;ARSJ;arylsulfatase family, member J (EC:3.1.6.12)
hsa:4734;NEDD4,NEDD4-1,RPF1;neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase (EC:6.3.2.-)
hsa:50506;DUOX2,LNOX2,NOXEF2,P138-TOX,TDH6,THOX2;dual oxidase 2 (EC:1.6.3.1)
hsa:338872;C1QTNF9,AQL1,C1QTNF9A,CTRP9;C1q and tumor necrosis factor related protein 9
hsa:22917;ZP1;zona pellucida glycoprotein 1 (sperm receptor)
hsa:85449;;KIAA1755
hsa:4130;MAP1A,MAP1L,MTAP1A;microtubule-associated protein 1A
hsa:84274;COQ5;coenzyme Q5 homolog, methyltransferase (S. cerevisiae) (EC:2.1.1.201)
hsa:51300;TIMMDC1,C3orf1;translocase of inner mitochondrial membrane domain containing 1
hsa:54504;CPVL,HVLP;carboxypeptidase, vitellogenic-like
hsa:29943;PADI1,HPAD10,PAD1,PDI,PDI1;peptidyl arginine deiminase, type I (EC:3.5.3.15)
hsa:11064;CNTRL,CEP1,CEP110,FAN,bA165P4.1;centriolin
hsa:79738;BBS10,C12orf58;Bardet-Biedl syndrome 10
hsa:253260;RICTOR,PIA,mAVO3;RPTOR independent companion of MTOR, complex 2
hsa:51286;CEND1,BM88;cell cycle exit and neuronal differentiation 1
hsa:339965;CCDC158;coiled-coil domain containing 158
hsa:79693;YRDC,DRIP3,IRIP,RP11-109P14.4,SUA5;yrdC domain containing (E. coli)
hsa:25873;RPL36,L36;ribosomal protein L36
hsa:80834;TAS1R2,GPR71,T1R2,TR2;taste receptor, type 1, member 2
hsa:3646;EIF3E,EIF3-P48,EIF3S6,INT6,eIF3-p46;eukaryotic translation initiation factor 3, subunit E
hsa:9837;GINS1,PSF1;GINS complex subunit 1 (Psf1 homolog)
hsa:728358;DEFA1B,HNP-1,HP-1,HP1;defensin, alpha 1B
hsa:124626;ZPBP2,ZPBPL;zona pellucida binding protein 2
hsa:225689;MAPK15,ERK7,ERK8;mitogen-activated protein kinase 15 (EC:2.7.11.24)
hsa:11330;CTRC,CLCR,ELA4;chymotrypsin C (caldecrin) (EC:3.4.21.2)
hsa:29087;THYN1,MDS012,MY105,THY28,THY28KD;thymocyte nuclear protein 1
hsa:57639;CCDC146;coiled-coil domain containing 146
hsa:283989;TSEN54,PCH2A,PCH4,SEN54L,sen54;tRNA splicing endonuclease 54 homolog (S. cerevisiae)
hsa:286204;CRB2;crumbs homolog 2 (Drosophila)
hsa:91748;ELMSAN1,C14orf117,C14orf43,LSR68,c14_5541;ELM2 and Myb/SANT-like domain containing 1
hsa:3445;IFNA8,IFN-alphaB;interferon, alpha 8
hsa:2673;GFPT1,CMSTA1,GFA,GFAT,GFAT_1,GFAT1,GFAT1m,GFPT,GFPT1L,MSLG;glutamine--fructose-6-phosphate transaminase 1 (EC:2.6.1.16)
hsa:81609;SNX27,MRT1,MY014;sorting nexin family member 27
hsa:29883;CNOT7,CAF1,hCAF-1;CCR4-NOT transcription complex, subunit 7
hsa:134548;SOWAHA,ANKRD43;sosondowah ankyrin repeat domain family member A
hsa:132112;RTP1;receptor (chemosensory) transporter protein 1
hsa:51702;PADI3,PAD3,PDI3;peptidyl arginine deiminase, type III (EC:3.5.3.15)
hsa:90161;HS6ST2;heparan sulfate 6-O-sulfotransferase 2 (EC:2.8.2.-)
hsa:26330;GAPDHS,GAPD2,GAPDH-2,GAPDS,HSD-35;glyceraldehyde-3-phosphate dehydrogenase, spermatogenic (EC:1.2.1.12)
hsa:25936;NSL1,C1orf48,MIS14;NSL1, MIND kinetochore complex component, homolog (S. cerevisiae)
hsa:10493;VAT1,VATI;vesicle amine transport protein 1 homolog (T. californica)
hsa:1793;DOCK1,DOCK180,ced5;dedicator of cytokinesis 1
hsa:1875;E2F5,E2F-5;E2F transcription factor 5, p130-binding
hsa:2187;FANCB,FA2,FAAP90,FAAP95,FAB,FACB;Fanconi anemia, complementation group B
hsa:4493;MT1E,MT1,MTD;metallothionein 1E
hsa:65124;SOWAHC,ANKRD57,C2orf26;sosondowah ankyrin repeat domain family member C
hsa:283149;BCL9L,BCL9-2,DLNB11;B-cell CLL/lymphoma 9-like
hsa:10959;TMED2,P24A,RNP24,p24;transmembrane emp24 domain trafficking protein 2
hsa:2998;GYS2;glycogen synthase 2 (liver) (EC:2.4.1.11)
hsa:27335;EIF3K,EIF3-p28,EIF3S12,HSPC029,M9,MSTP001,PLAC-24,PLAC24,PRO1474,PTD001;eukaryotic translation initiation factor 3, subunit K
hsa:80853;JHDM1D,KDM7A;jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)
hsa:57085;AGTRAP,ATRAP;angiotensin II receptor-associated protein
hsa:2829;XCR1,CCXCR1,GPR5;chemokine (C motif) receptor 1
hsa:54433;GAR1,NOLA1;GAR1 ribonucleoprotein homolog (yeast)
hsa:8661;EIF3A,EIF3,EIF3S10,P167,TIF32,eIF3-p170,eIF3-theta,p180,p185;eukaryotic translation initiation factor 3, subunit A
hsa:256979;SUN3,SUNC1;Sad1 and UNC84 domain containing 3
hsa:1306;COL15A1;collagen, type XV, alpha 1
hsa:150368;FAM109B,IPIP27B,Ses2;family with sequence similarity 109, member B
hsa:203286;ANKS6,ANKRD14,SAMD6;ankyrin repeat and sterile alpha motif domain containing 6
hsa:80820;EEPD1,HSPC107;endonuclease/exonuclease/phosphatase family domain containing 1
hsa:57480;PLEKHG1,ARHGEF41;pleckstrin homology domain containing, family G (with RhoGef domain) member 1
hsa:57179;p60MONOX;KIAA1191
hsa:144501;KRT80,KB20;keratin 80
hsa:134701;RIPPLY2,C6orf159,dJ237I15.1;ripply2 homolog (zebrafish)
hsa:80772;GLTPD1;glycolipid transfer protein domain containing 1
hsa:641371;ACOT1,ACH2,CTE-1,LACH2;acyl-CoA thioesterase 1 (EC:3.1.2.2)
hsa:118430;MUCL1,SBEM;mucin-like 1
hsa:11280;SCN11A,NAV1.9,NaN,SCN12A,SNS-2;sodium channel, voltage-gated, type XI, alpha subunit
hsa:5710;PSMD4,AF,AF-1,ASF,MCB1,Rpn10,S5A,pUB-R5;proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
hsa:6572;SLC18A3,VACHT;solute carrier family 18 (vesicular acetylcholine), member 3
hsa:27087;B3GAT1,CD57,GLCATP,GLCUATP,HNK1,LEU7,NK-1,NK1;beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) (EC:2.4.1.135)
hsa:29789;OLA1,DOC45,GBP45,GTBP9,GTPBP9;Obg-like ATPase 1;K06942
hsa:56997;ADCK3,ARCA2,CABC1,COQ10D4,COQ8,SCAR9;aarF domain containing kinase 3
hsa:113026;PLCD3;phospholipase C, delta 3 (EC:3.1.4.11)
hsa:4921;DDR2,MIG20a,NTRKR3,TKT,TYRO10;discoidin domain receptor tyrosine kinase 2 (EC:2.7.10.1)
hsa:51668;HSPB11,C1orf41,HSPCO34,IFT25,PP25;heat shock protein family B (small), member 11
hsa:7978;MTERF;mitochondrial transcription termination factor
hsa:2617;GARS,CMT2D,DSMAV,GlyRS,HMN5,SMAD1;glycyl-tRNA synthetase (EC:6.1.1.14)
hsa:6854;SYN2,SYNII,SYNIIa,SYNIIb;synapsin II
hsa:84870;RSPO3,CRISTIN1,PWTSR,THSD2;R-spondin 3
hsa:654463;FER1L6,C8ORFK23;fer-1-like 6 (C. elegans)
hsa:55280;CWF19L1;CWF19-like 1, cell cycle control (S. pombe)
hsa:10818;FRS2,FRS2A,FRS2alpha,SNT,SNT-1,SNT1;fibroblast growth factor receptor substrate 2
hsa:2121;EVC,DWF-1,EVC1,EVCL;Ellis van Creveld syndrome
hsa:79717;PPCS;phosphopantothenoylcysteine synthetase (EC:6.3.2.5)
hsa:64506;CPEB1,CEBP,CPE-BP1,CPEB;cytoplasmic polyadenylation element binding protein 1
hsa:9865;TRIL;TLR4 interactor with leucine-rich repeats
hsa:134829;CLVS2,C6orf212,C6orf213,RLBP1L2,bA160A10.4;clavesin 2
hsa:8428;STK24,MST3,MST3B,STE20,STK3;serine/threonine kinase 24 (EC:2.7.11.1)
hsa:7082;TJP1,ZO-1;tight junction protein 1
hsa:2301;FOXE3,FKHL12,FREAC8;forkhead box E3
hsa:6621;SNAPC4,PTFalpha,SNAP190;small nuclear RNA activating complex, polypeptide 4, 190kDa
hsa:55691;FRMD4A,FRMD4,bA295P9.4;FERM domain containing 4A
hsa:605;BCL7A,BCL7;B-cell CLL/lymphoma 7A
hsa:5987;TRIM27,RFP,RNF76;tripartite motif containing 27
hsa:9771;RAPGEF5,GFR,MR-GEF,REPAC;Rap guanine nucleotide exchange factor (GEF) 5
hsa:1544;CYP1A2,CP12,P3-450,P450(PA);cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1)
hsa:5067;CNTN3,BIG-1,PANG,PCS;contactin 3 (plasmacytoma associated)
hsa:341947;COX8C,COX8-3;cytochrome c oxidase subunit VIIIC
hsa:359948;IRF2BP2;interferon regulatory factor 2 binding protein 2
hsa:9027;NAT8,ATase2,CML1,GLA,Hcml1,TSC501,TSC510;N-acetyltransferase 8 (GCN5-related, putative)
hsa:55763;EXOC1,BM-102,SEC3,SEC3L1,SEC3P;exocyst complex component 1
hsa:5030;P2RY4,NRU,P2P,P2Y4,UNR;pyrimidinergic receptor P2Y, G-protein coupled, 4
hsa:8939;FUBP3,FBP3;far upstream element (FUSE) binding protein 3
hsa:151306;GPBAR1,BG37,GPCR19,GPR131,M-BAR,TGR5;G protein-coupled bile acid receptor 1
hsa:2986;GUCY2F,CYGF,GC-F,GUC2DL,GUC2F,RETGC-2,ROS-GC2;guanylate cyclase 2F, retinal (EC:4.6.1.2)
hsa:1487;CTBP1,BARS;C-terminal binding protein 1
hsa:8899;PRPF4B,PR4H,PRP4,PRP4H,PRP4K,dJ1013A10.1;PRP4 pre-mRNA processing factor 4 homolog B (yeast) (EC:2.7.11.1)
hsa:3633;INPP5B,5PTase;inositol polyphosphate-5-phosphatase, 75kDa (EC:3.1.3.36)
hsa:43;ACHE,ACEE,ARACHE,N-ACHE,YT;acetylcholinesterase (EC:3.1.1.7)
hsa:56832;IFNK,RP11-27J8.1;interferon, kappa
hsa:646480;FABP9,PERF,PERF15,T-FABP;fatty acid binding protein 9, testis
hsa:84063;KIRREL2,FILTRIN,NEPH3,NLG1;kin of IRRE like 2 (Drosophila)
hsa:1135;CHRNA2;cholinergic receptor, nicotinic, alpha 2 (neuronal)
hsa:5797;PTPRM,PTPRL1,R-PTP-MU,RPTPM,RPTPU,hR-PTPu;protein tyrosine phosphatase, receptor type, M (EC:3.1.3.48)
hsa:9687;GREB1;growth regulation by estrogen in breast cancer 1
hsa:9693;RAPGEF2,CNrasGEF,NRAPGEP,PDZ-GEF1,PDZGEF1,RA-GEF,Rap-GEP,nRap_GEP;Rap guanine nucleotide exchange factor (GEF) 2
hsa:79888;LPCAT1,AYTL2,PFAAP3,lpcat;lysophosphatidylcholine acyltransferase 1 (EC:2.3.1.23 2.3.1.67)
hsa:6524;SLC5A2,SGLT2;solute carrier family 5 (sodium/glucose cotransporter), member 2
hsa:9491;PSMF1,PI31;proteasome (prosome, macropain) inhibitor subunit 1 (PI31)
hsa:54674;LRRN3,FIGLER5,NLRR-3,NLRR3;leucine rich repeat neuronal 3
hsa:518;ATP5G3,P3;ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)
hsa:6528;SLC5A5,NIS,TDH1;solute carrier family 5 (sodium iodide symporter), member 5
hsa:9657;IQCB1,NPHP5,PIQ,SLSN5;IQ motif containing B1
hsa:375759;C9orf50;chromosome 9 open reading frame 50
hsa:54535;CCHCR1,C6orf18,HCR,SBP;coiled-coil alpha-helical rod protein 1
hsa:9353;SLIT2,SLIL3,Slit-2;slit homolog 2 (Drosophila)
hsa:84969;TOX2,C20orf100,GCX-1,dJ1108D11.2,dJ495O3.1;TOX high mobility group box family member 2
hsa:4715;NDUFB9,B22,LYRM3,UQOR22;NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa
hsa:51755;CDK12,CRK7,CRKR,CRKRS,hCDK12;cyclin-dependent kinase 12 (EC:2.7.11.23 2.7.11.22)
hsa:79703;C11orf80;chromosome 11 open reading frame 80
hsa:353322;ANKRD37,Lrp2bp;ankyrin repeat domain 37
hsa:23141;ANKLE2,KIAA0692,LEMD7,Lem4;ankyrin repeat and LEM domain containing 2
hsa:3189;HNRNPH3,2H9,HNRPH3;heterogeneous nuclear ribonucleoprotein H3 (2H9)
hsa:23172;FAM175B,ABRO1,KIAA0157;family with sequence similarity 175, member B
hsa:55186;SLC25A36,PNC2;solute carrier family 25 (pyrimidine nucleotide carrier ), member 36
hsa:91351;DDX60L;DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like (EC:3.6.4.13)
hsa:54910;SEMA4C,M-SEMA-F,SEMACL1,SEMAF,SEMAI;sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C
hsa:26056;RAB11FIP5,GAF1,RIP11,pp75;RAB11 family interacting protein 5 (class I)
hsa:163782;KANK4,ANKRD38,RP5-1155K23.5,dJ1078M7.1;KN motif and ankyrin repeat domains 4
hsa:112574;SNX18,SH3PX2,SH3PXD3B,SNAG1;sorting nexin 18
hsa:65008;MRPL1,BM022,L1MT,MRP-L1;mitochondrial ribosomal protein L1
hsa:6875;TAF4B,TAF2C2,TAFII105;TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa
hsa:23250;ATP11A,ATPIH,ATPIS;ATPase, class VI, type 11A (EC:3.6.3.1)
hsa:112942;CCDC104;coiled-coil domain containing 104
hsa:374659;HDDC3,MESH1;HD domain containing 3 (EC:3.1.7.2)
hsa:2204;FCAR,CD89;Fc fragment of IgA, receptor for
hsa:729830;FAM160A1;family with sequence similarity 160, member A1
hsa:3251;HPRT1,HGPRT,HPRT;hypoxanthine phosphoribosyltransferase 1 (EC:2.4.2.8)
hsa:55197;RPRD1A,HsT3101,P15RS;regulation of nuclear pre-mRNA domain containing 1A
hsa:53904;MYO3A,DFNB30;myosin IIIA (EC:2.7.11.1)
hsa:5004;ORM1,AGP-A,AGP1,ORM;orosomucoid 1
hsa:4856;NOV,CCN3,IBP-9,IGFBP-9,IGFBP9,NOVh;nephroblastoma overexpressed
hsa:80071;CCDC15;coiled-coil domain containing 15
hsa:248;ALPI,IAP;alkaline phosphatase, intestinal (EC:3.1.3.1)
hsa:144715;RAD9B;RAD9 homolog B (S. pombe)
hsa:63875;MRPL17,L17mt,LIP2,MRP-L17,MRP-L26,RPL17L,RPML26;mitochondrial ribosomal protein L17
hsa:55602;CDKN2AIP,CARF;CDKN2A interacting protein
hsa:1537;CYC1,UQCR4;cytochrome c-1
hsa:728642;CDK11A,CDC2L2,CDC2L3,CDK11-p110,CDK11-p46,CDK11-p58,PITSLRE,p58GTA;cyclin-dependent kinase 11A (EC:2.7.11.22)
hsa:5305;PIP4K2A,PI5P4KA,PIP5K2A,PIP5KII-alpha,PIP5KIIA,PIPK;phosphatidylinositol-5-phosphate 4-kinase, type II, alpha (EC:2.7.1.149)
hsa:10553;HTATIP2,CC3,SDR44U1,TIP30;HIV-1 Tat interactive protein 2, 30kDa (EC:1.1.1.-)
hsa:9765;ZFYVE16,ENDOFIN,PPP1R69;zinc finger, FYVE domain containing 16
hsa:22795;NID2,NID-2;nidogen 2 (osteonidogen)
hsa:100049587;SIGLEC14;sialic acid binding Ig-like lectin 14
hsa:2077;ERF,PE-2,PE2;Ets2 repressor factor
hsa:54948;MRPL16,L16mt,MRP-L16;mitochondrial ribosomal protein L16
hsa:50856;CLEC4A,CLECSF6,DCIR,DDB27,LLIR;C-type lectin domain family 4, member A
hsa:84659;RNASE7;ribonuclease, RNase A family, 7
hsa:2125;EVPL,EVPK;envoplakin
hsa:7140;TNNT3,TNTF;troponin T type 3 (skeletal, fast)
hsa:125228;FAM210A,C18orf19,HsT2329;family with sequence similarity 210, member A
hsa:51087;YBX2,CONTRIN,CSDA3,DBPC,MSY2;Y box binding protein 2
hsa:2354;FOSB,AP-1,G0S3,GOS3,GOSB;FBJ murine osteosarcoma viral oncogene homolog B
hsa:3727;JUND,AP-1;jun D proto-oncogene
hsa:29088;MRPL15,L15mt,MRP-L15,MRP-L7,RPML7;mitochondrial ribosomal protein L15
hsa:54436;SH3TC1;SH3 domain and tetratricopeptide repeats 1
hsa:55080;TAPBPL,TAPBP-R,TAPBPR;TAP binding protein-like
hsa:6865;TACR2,NK2R,NKNAR,SKR,TAC2R;tachykinin receptor 2
hsa:55052;MRPL20,L20mt,MRP-L20;mitochondrial ribosomal protein L20
hsa:84129;ACAD11,ACAD-11;acyl-CoA dehydrogenase family, member 11
hsa:645;BLVRB,BVRB,FLR,SDR43U1;biliverdin reductase B (flavin reductase (NADPH)) (EC:1.3.1.24 1.5.1.30)
hsa:55172;DNAAF2,C14orf104,CILD10,KTU,PF13;dynein, axonemal, assembly factor 2
hsa:8092;ALX1,CART1,FND3;ALX homeobox 1
hsa:10171;RCL1,RNAC,RPCL1;RNA terminal phosphate cyclase-like 1
hsa:54962;TIPIN;TIMELESS interacting protein
hsa:79590;MRPL24,L24mt,MRP-L18,MRP-L24;mitochondrial ribosomal protein L24
hsa:79741;C10orf68,dJ1104A8.1;chromosome 10 open reading frame 68
hsa:22848;AAK1;AP2 associated kinase 1 (EC:2.7.11.1)
hsa:26586;CKAP2,LB1,TMAP,se20-10;cytoskeleton associated protein 2
hsa:84071;ARMC2,bA787I22.1;armadillo repeat containing 2
hsa:157922;CAMSAP1,PRO2405,bA100C15.1;calmodulin regulated spectrin-associated protein 1
hsa:10962;MLLT11,AF1Q,RP11-316M1.10;myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila);translocated to, 11
hsa:26291;FGF21;fibroblast growth factor 21
hsa:2550;GABBR1,GABABR1,GABBR1-3,GB1,GPRC3A,dJ271M21.1.1,dJ271M21.1.2;gamma-aminobutyric acid (GABA) B receptor, 1
hsa:663;BNIP2,BNIP-2,NIP2;BCL2/adenovirus E1B 19kDa interacting protein 2
hsa:729475;RAD51AP2;RAD51 associated protein 2
hsa:59342;SCPEP1,HSCP1,RISC;serine carboxypeptidase 1
hsa:685;BTC;betacellulin
hsa:22878;TRAPPC8,GSG1,HsT2706,KIAA1012,TRS85;trafficking protein particle complex 8
hsa:55821;ALLC,ALC;allantoicase (EC:3.5.3.4)
hsa:120425;AMICA1,AMICA,CREA7-1,CREA7-4,Gm638,JAML;adhesion molecule, interacts with CXADR antigen 1
hsa:23254;KAZN,KAZ;kazrin, periplakin interacting protein
hsa:256949;KANK3,ANKRD47;KN motif and ankyrin repeat domains 3
hsa:84327;ZBED3;zinc finger, BED-type containing 3
hsa:25759;SHC2,SCK,SHCB,SLI;SHC (Src homology 2 domain containing) transforming protein 2
hsa:654231;OCM,OCM1,OM,ONCM;oncomodulin
hsa:64864;RFX7,RFXDC2;regulatory factor X, 7
hsa:23177;CEP68,KIAA0582;centrosomal protein 68kDa
hsa:201562;PTPLB,HACD2;protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b (EC:4.2.1.134)
hsa:11023;VAX1,MCOPS11;ventral anterior homeobox 1
hsa:3068;HDGF,HMG1L2;hepatoma-derived growth factor
hsa:81573;ANKRD13C,RP4-677H15.5,dJ677H15.3;ankyrin repeat domain 13C
hsa:9172;MYOM2,TTNAP;myomesin 2
hsa:399979;SNX19,CHET8;sorting nexin 19
hsa:284656;EPHA10;EPH receptor A10 (EC:2.7.10.1)
hsa:60558;GUF1,EF-4;GUF1 GTPase homolog (S. cerevisiae)
hsa:11194;ABCB8,EST328128,M-ABC1,MABC1;ATP-binding cassette, sub-family B (MDR/TAP), member 8
hsa:29998;GLTSCR1;glioma tumor suppressor candidate region gene 1
hsa:84643;KIF2B;kinesin family member 2B
hsa:2591;GALNT3,GalNAc-T3,HFTC,HHS;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) (EC:2.4.1.41)
hsa:10989;IMMT,HMP,MINOS2,P87,P87/89,P89,PIG52;inner membrane protein, mitochondrial
hsa:79633;FAT4,CDHF14,CDHR11,FAT-J,FATJ,NBLA00548;FAT tumor suppressor homolog 4 (Drosophila)
hsa:401505;TOMM5,C9orf105,RP11-263I4.1,Tom5,bA613M10.3;translocase of outer mitochondrial membrane 5 homolog (yeast)
hsa:310;ANXA7,ANX7,SNX,SYNEXIN;annexin A7
hsa:23673;STX12,STX13,STX14;syntaxin 12
hsa:64983;MRPL32,L32mt,MRP-L32,bMRP-59b;mitochondrial ribosomal protein L32
hsa:283420;CLEC9A,DNGR1,UNQ9341;C-type lectin domain family 9, member A
hsa:10981;RAB32;RAB32, member RAS oncogene family
hsa:124783;SPATA32,AEP2,C17orf46,TEX34,VAD1.2;spermatogenesis associated 32
hsa:399909;PCNXL3;pecanex-like 3 (Drosophila)
hsa:7224;TRPC5,TRP5;transient receptor potential cation channel, subfamily C, member 5
hsa:4617;MYF5,bHLHc2;myogenic factor 5
hsa:23456;ABCB10,EST20237,M-ABC2,MTABC2;ATP-binding cassette, sub-family B (MDR/TAP), member 10
hsa:3209;HOXA13,HOX1,HOX1J;homeobox A13
hsa:23176;SEPT8,SEP2;septin 8
hsa:401548;SNX30,ATG24A;sorting nexin family member 30
hsa:165257;C1QL2,C1QTNF10,CTRP10;complement component 1, q subcomponent-like 2
hsa:11011;TLK2,HsHPK,PKU-ALPHA;tousled-like kinase 2 (EC:2.7.11.1)
hsa:51177;PLEKHO1,CKIP-1,OC120;pleckstrin homology domain containing, family O member 1
hsa:23508;TTC9,TTC9A;tetratricopeptide repeat domain 9
hsa:579;NKX3-2,BAPX1,NKX3.2,NKX3B,SMMD;NK3 homeobox 2
hsa:268;AMH,MIF,MIS;anti-Mullerian hormone
hsa:23423;TMED3,C15orf22,P24B,p26;transmembrane emp24 protein transport domain containing 3
hsa:54905;CYP2W1;cytochrome P450, family 2, subfamily W, polypeptide 1
hsa:23268;DNMBP,ARHGEF36,TUBA;dynamin binding protein
hsa:2188;FANCF,FAF;Fanconi anemia, complementation group F
hsa:348487;FAM131C,C1orf117,RP11-5P18.9;family with sequence similarity 131, member C
hsa:22864;R3HDM2,PR01365;R3H domain containing 2
hsa:696;BTN1A1,BT,BTN;butyrophilin, subfamily 1, member A1
hsa:2587;GALR1,GALNR,GALNR1;galanin receptor 1
hsa:389816;LRRC26,CAPC,bA350O14.10;leucine rich repeat containing 26
hsa:10443;N4BP2L2,92M18.3,CG005,PFAAP5;NEDD4 binding protein 2-like 2
hsa:60561;RINT1,RINT-1;RAD50 interactor 1
hsa:54853;WDR55;WD repeat domain 55
hsa:59339;PLEKHA2,TAPP2;pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2
hsa:80709;AKNA;AT-hook transcription factor
hsa:3093;UBE2K,E2-25K,HIP2,HYPG,LIG,UBC1;ubiquitin-conjugating enzyme E2K (EC:6.3.2.19)
hsa:5256;PHKA2,GSD9A,PHK,PYK,PYKL,XLG,XLG2;phosphorylase kinase, alpha 2 (liver) (EC:2.7.11.19)
hsa:6000;RGS7;regulator of G-protein signaling 7
hsa:256380;SCML4,dJ47M23.1;sex comb on midleg-like 4 (Drosophila)
hsa:3460;IFNGR2,AF-1,IFGR2,IFNGT1;interferon gamma receptor 2 (interferon gamma transducer 1)
hsa:7363;UGT2B4,HLUG25,UDPGT2B4,UDPGTH1,UGT2B11;UDP glucuronosyltransferase 2 family, polypeptide B4 (EC:2.4.1.17)
hsa:254295;PHYHD1;phytanoyl-CoA dioxygenase domain containing 1
hsa:6005;RHAG,CD241,RH2,RH50A,Rh50,Rh50GP,SLC42A1;Rh-associated glycoprotein
hsa:7827;NPHS2,PDCN,SRN1;nephrosis 2, idiopathic, steroid-resistant (podocin)
hsa:28988;DBNL,ABP1,HIP-55,SH3P7;drebrin-like
hsa:57594;HOMEZ,KIAA1443;homeobox and leucine zipper encoding
hsa:29093;MRPL22,L22mt,MRP-L22,MRP-L25,RPML25;mitochondrial ribosomal protein L22
hsa:27122;DKK3,REIC,RIG;dickkopf 3 homolog (Xenopus laevis)
hsa:440145;MZT1,C13orf37,MOZART1;mitotic spindle organizing protein 1
hsa:116064;LRRC58;leucine rich repeat containing 58
hsa:55034;MOCOS,HMCS,MCS,MOS;molybdenum cofactor sulfurase (EC:2.8.1.9)
hsa:100131187;TSTD1,KAT;thiosulfate sulfurtransferase (rhodanese)-like domain containing 1 (EC:2.8.1.1)
hsa:401152;C4orf3;chromosome 4 open reading frame 3
hsa:109;ADCY3,AC3;adenylate cyclase 3 (EC:4.6.1.1)
hsa:51503;CWC15,C11orf5,Cwf15,HSPC148,ORF5;CWC15 spliceosome-associated protein homolog (S. cerevisiae)
hsa:23233;EXOC6B,SEC15B,SEC15L2;exocyst complex component 6B
hsa:7975;MAFK,NFE2U,P18;v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian)
hsa:64857;PLEKHG2,ARHGEF42,CLG;pleckstrin homology domain containing, family G (with RhoGef domain) member 2
hsa:56647;BCCIP,TOK-1,TOK1;BRCA2 and CDKN1A interacting protein
hsa:54977;SLC25A38;solute carrier family 25, member 38
hsa:23646;PLD3,HU-K4,HUK4;phospholipase D family, member 3 (EC:3.1.4.4)
hsa:100137049;PLA2G4B,HsT16992,cPLA2-beta;phospholipase A2, group IVB (cytosolic) (EC:3.1.1.4)
hsa:9918;NCAPD2,CAP-D2,CNAP1,hCAP-D2;non-SMC condensin I complex, subunit D2
hsa:9440;MED17,CRSP6,CRSP77,DRIP80,TRAP80;mediator complex subunit 17
hsa:58158;NEUROD4,ATH-3,ATH3,Atoh3,MATH-3,bHLHa4;neuronal differentiation 4
hsa:653820;FAM72B,p17;family with sequence similarity 72, member B
hsa:4829;NMBR;neuromedin B receptor
hsa:23075;SWAP70,SWAP-70;SWAP switching B-cell complex 70kDa subunit
hsa:51073;MRPL4,CGI-28,L4mt;mitochondrial ribosomal protein L4
hsa:50632;CALY,DRD1IP,NSG3;calcyon neuron-specific vesicular protein
hsa:79925;SPEF2,CT122,KPL2;sperm flagellar 2
hsa:8820;HESX1,ANF,CPHD5,RPX;HESX homeobox 1
hsa:7047;TGM4,TGP,hTGP;transglutaminase 4 (prostate) (EC:2.3.2.13)
hsa:51633;OTUD6B,DUBA5;OTU domain containing 6B
hsa:3036;HAS1,HAS;hyaluronan synthase 1 (EC:2.4.1.212)
hsa:147906;DACT3,RRR1;dapper, antagonist of beta-catenin, homolog 3 (Xenopus laevis)
hsa:55173;MRPS10,MRP-S10,PNAS-122;mitochondrial ribosomal protein S10
hsa:132671;SPATA18,Mieap,SPETEX1;spermatogenesis associated 18
hsa:201931;TMEM192;transmembrane protein 192
hsa:2525;FUT3,CD174,FT3B,FucT-III,LE,Les;fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) (EC:2.4.1.65)
hsa:83698;CALN1,CABP8;calneuron 1
hsa:3887;KRT81,HB1,Hb-1,KRTHB1,MLN137,ghHkb1,hHAKB2-1;keratin 81
hsa:9022;CLIC3;chloride intracellular channel 3
hsa:222389;BEND7,C10orf30;BEN domain containing 7
hsa:65080;MRPL44,L44MT,MRP-L44;mitochondrial ribosomal protein L44 (EC:3.1.26.-)
hsa:11171;STRAP,MAWD,PT-WD,UNRIP;serine/threonine kinase receptor associated protein
hsa:148223;C19orf25;chromosome 19 open reading frame 25
hsa:51379;CRLF3,CREME-9,CREME9,CRLM9,CYTOR4,FRWS,p48.2;cytokine receptor-like factor 3
hsa:88;ACTN2,CMD1AA;actinin, alpha 2
hsa:118987;PDZD8,PDZK8,bA129M16.2;PDZ domain containing 8
hsa:2531;KDSR,DHSR,FVT1,SDR35C1;3-ketodihydrosphingosine reductase (EC:1.1.1.102)
hsa:57462;NET37;KIAA1161 (EC:3.2.1.-)
hsa:80010;RMI1,BLAP75,C9orf76,FAAP75,RP11-346I8.1;RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae)
hsa:3192;HNRNPU,HNRPU,SAF-A,U21.1,hnRNP_U;heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
hsa:23288;IQCE,1700028P05Rik;IQ motif containing E
hsa:51506;UFC1,HSPC155;ubiquitin-fold modifier conjugating enzyme 1
hsa:148113;CILP2,CLIP-2;cartilage intermediate layer protein 2
hsa:256536;TCERG1L;transcription elongation regulator 1-like
hsa:11067;C10orf10,DEPP,FIG;chromosome 10 open reading frame 10
hsa:3384;ICAM2,CD102;intercellular adhesion molecule 2
hsa:283373;ANKRD52,ANKRD33;ankyrin repeat domain 52
hsa:346389;MACC1,7A5,SH3BP4L;metastasis associated in colon cancer 1
hsa:66037;BOLL,BOULE;bol, boule-like (Drosophila)
hsa:4900;NRGN,RC3,hng;neurogranin (protein kinase C substrate, RC3)
hsa:27074;LAMP3,CD208,DC_LAMP,DC-LAMP,DCLAMP,LAMP,LAMP-3,TSC403;lysosomal-associated membrane protein 3
hsa:51449;PCYOX1,PCL1;prenylcysteine oxidase 1 (EC:1.8.3.5)
hsa:3578;IL9,HP40,IL-9,P40;interleukin 9
hsa:146;ADRA1D,ADRA1,ADRA1A,ADRA1R,ALPHA1,DAR,dJ779E11.2;adrenoceptor alpha 1D
hsa:5719;PSMD13,HSPC027,Rpn9,S11,p40.5;proteasome (prosome, macropain) 26S subunit, non-ATPase, 13
hsa:138046;RALYL,HNRPCL3;RALY RNA binding protein-like
hsa:415;ARSE,ASE,CDPX,CDPX1,CDPXR;arylsulfatase E (chondrodysplasia punctata 1) (EC:3.1.6.1)
hsa:200205;IBA57,C1orf69;IBA57, iron-sulfur cluster assembly homolog (S. cerevisiae);K06980
hsa:91012;CERS5,LASS5,Trh4;ceramide synthase 5
hsa:9772;TMEM94;KIAA0195
hsa:27071;DAPP1,BAM32;dual adaptor of phosphotyrosine and 3-phosphoinositides
hsa:2220;FCN2,EBP-37,FCNL,P35,ficolin-2;ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin)
hsa:1879;EBF1,COE1,EBF,O/E-1,OLF1;early B-cell factor 1
hsa:3306;HSPA2,HSP70-2,HSP70-3;heat shock 70kDa protein 2
hsa:6697;SPR,SDR38C1;sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase) (EC:1.1.1.153)
hsa:157;ADRBK2,BARK2,GRK3;adrenergic, beta, receptor kinase 2 (EC:2.7.11.15)
hsa:5757;PTMA,TMSA;prothymosin, alpha
hsa:400410;ST20,HCCS-1;suppressor of tumorigenicity 20
hsa:128344;PIFO,C1orf88,pitchfork;primary cilia formation
hsa:57697;FANCM,FAAP250,KIAA1596;Fanconi anemia, complementation group M (EC:3.6.4.13)
hsa:51264;MRPL27,L27mt;mitochondrial ribosomal protein L27
hsa:55619;DOCK10,DRIP2,Nbla10300,ZIZ3;dedicator of cytokinesis 10
hsa:54823;SWT1,C1orf26,HsSwt1;SWT1 RNA endoribonuclease homolog (S. cerevisiae)
hsa:10449;ACAA2,DSAEC;acetyl-CoA acyltransferase 2 (EC:2.3.1.16)
hsa:84451;KIAA1804,MLK4,RP5-862P8.2,dJ862P8.3;mixed lineage kinase 4 (EC:2.7.11.25)
hsa:671;BPI,BPIFD1,rBPI;bactericidal/permeability-increasing protein
hsa:664;BNIP3,NIP3;BCL2/adenovirus E1B 19kDa interacting protein 3
hsa:9912;ARHGAP44,NPC-A-10,RICH2;Rho GTPase activating protein 44
hsa:170685;NUDT10,APS2,DIPP3a,hDIPP3alpha;nudix (nucleoside diphosphate linked moiety X)-type motif 10 (EC:3.6.1.52 3.6.1.60)
hsa:728461;CSAG2,CSAG3B,CT24.2,TRAG-3,TRAG3;CSAG family, member 2
hsa:55252;ASXL2,ASXH2;additional sex combs like 2 (Drosophila)
hsa:51265;CDKL3,NKIAMRE;cyclin-dependent kinase-like 3 (EC:2.7.11.22)
hsa:84335;AKT1S1,Lobe,PRAS40;AKT1 substrate 1 (proline-rich)
hsa:57624;NYAP2,KIAA1486;neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2
hsa:57129;MRPL47,L47mt,MRP-L47,NCM1;mitochondrial ribosomal protein L47
hsa:375775;PNPLA7,C9orf111,NTE-R1,NTEL1;patatin-like phospholipase domain containing 7
hsa:5105;PCK1,PEPCK-C,PEPCK1,PEPCKC;phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32)
hsa:90853;SPOCD1;SPOC domain containing 1
hsa:55850;USE1,P31,SLT1;unconventional SNARE in the ER 1 homolog (S. cerevisiae)
hsa:10847;SRCAP,DOMO1,EAF1,FLHS,SWR1;Snf2-related CREBBP activator protein
hsa:29094;LGALSL,GRP;lectin, galactoside-binding-like
hsa:10556;RPP30,TSG15;ribonuclease P/MRP 30kDa subunit (EC:3.1.26.5)
hsa:388662;SLC6A17,NTT4;solute carrier family 6, member 17
hsa:91807;MYLK3,MLCK,MLCK2,caMLCK;myosin light chain kinase 3 (EC:2.7.11.18)
hsa:11069;RAPGEF4,CAMP-GEFII,CGEF2,EPAC2,Nbla00496;Rap guanine nucleotide exchange factor (GEF) 4
hsa:7105;TSPAN6,T245,TM4SF6,TSPAN-6;tetraspanin 6
hsa:64123;ELTD1,ETL,KPG_003;EGF, latrophilin and seven transmembrane domain containing 1
hsa:2870;GRK6,GPRK6;G protein-coupled receptor kinase 6 (EC:2.7.11.16)
hsa:55215;FANCI,KIAA1794;Fanconi anemia, complementation group I
hsa:389015;SLC9A4,NHE4;solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4
hsa:4651;MYO10;myosin X
hsa:390259;BSX,BSX1;brain-specific homeobox
hsa:388698;FLG2,IFPS;filaggrin family member 2
hsa:23244;PDS5A,SCC-112,SCC112;PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae)
hsa:163351;GBP6;guanylate binding protein family, member 6
hsa:57222;ERGIC1,ERGIC-32,ERGIC32,NET24;endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1
hsa:8897;MTMR3,FYVE-DSP1,ZFYVE10;myotubularin related protein 3 (EC:3.1.3.48)
hsa:55062;WIPI1,ATG18,ATG18A,WIPI49;WD repeat domain, phosphoinositide interacting 1
hsa:22858;ICK,ECO,LCK2,MRK;intestinal cell (MAK-like) kinase (EC:2.7.11.22)
hsa:5999;RGS4,RGP4,SCZD9;regulator of G-protein signaling 4
hsa:154796;AMOT;angiomotin
hsa:51642;MRPL48,HSPC290,L48MT,MRP-L48;mitochondrial ribosomal protein L48
hsa:2909;ARHGAP35,GRF-1,GRLF1,P190-A,P190A,p190ARhoGAP,p190RhoGAP;Rho GTPase activating protein 35
hsa:85397;RGS8;regulator of G-protein signaling 8
hsa:3223;HOXC6,CP25,HHO.C8,HOX3,HOX3C;homeobox C6
hsa:4958;OMD,OSAD,SLRR2C;osteomodulin
hsa:127294;MYOM3,RP11-293P20.1;myomesin 3
hsa:6448;SGSH,HSS,MPS3A,SFMD;N-sulfoglucosamine sulfohydrolase (EC:3.10.1.1)
hsa:10687;PNMA2,MA2,MM2,RGAG2;paraneoplastic Ma antigen 2
hsa:285220;EPHA6,EK12,EPA6,PRO57066;EPH receptor A6 (EC:2.7.10.1)
hsa:54532;USP53;ubiquitin specific peptidase 53
hsa:8812;CCNK,CPR4;cyclin K
hsa:6035;RNASE1,RIB1,RNS1;ribonuclease, RNase A family, 1 (pancreatic) (EC:3.1.27.5)
hsa:10396;ATP8A1,ATPASEII,ATPIA,ATPP2;ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 (EC:3.6.3.1)
hsa:128308;MRPL55,AAVG5835,L55nt,MRP-L55,PRO19675;mitochondrial ribosomal protein L55
hsa:4163;MCC,MCC1;mutated in colorectal cancers
hsa:1739;DLG1,DLGH1,SAP-97,SAP97,dJ1061C18.1.1,hdlg;discs, large homolog 1 (Drosophila)
hsa:23150;FRMD4B,6030440G05Rik,GRSP1;FERM domain containing 4B
hsa:90199;WFDC8,C20orf170,WAP8,dJ461P17.1;WAP four-disulfide core domain 8
hsa:286887;KRT6C,K6E,KRT6E;keratin 6C
hsa:3385;ICAM3,CD50,CDW50,ICAM-R;intercellular adhesion molecule 3
hsa:6654;SOS1,GF1,GGF1,GINGF,HGF,NS4;son of sevenless homolog 1 (Drosophila)
hsa:4159;MC3R,BMIQ9,MC3,MC3-R,OB20,OQTL;melanocortin 3 receptor
hsa:3449;IFNA16,IFN-alphaO;interferon, alpha 16
hsa:79572;ATP13A3,AFURS1;ATPase type 13A3
hsa:51253;MRPL37,L37mt,MRP-L2,MRP-L37,MRPL2,RPML2;mitochondrial ribosomal protein L37
hsa:10595;ERN2,IRE1-BETA,IRE1b;endoplasmic reticulum to nucleus signaling 2 (EC:2.7.11.1)
hsa:1611;DAP;death-associated protein
hsa:284415;VSTM1,SIRL1,UNQ3033;V-set and transmembrane domain containing 1
hsa:79966;SCD5,ACOD4,FADS4,HSCD5,SCD2,SCD4;stearoyl-CoA desaturase 5 (EC:1.14.19.1)
hsa:26228;STAP1,BRDG1,STAP-1;signal transducing adaptor family member 1
hsa:56261;GPCPD1,GDE5,GDPD6,PREI4;glycerophosphocholine phosphodiesterase GDE1 homolog (S. cerevisiae) (EC:3.1.4.2)
hsa:168002;DACT2,C6orf116,DAPPER2,DPR2,RP11-503C24.7,bA503C24.7;dapper, antagonist of beta-catenin, homolog 2 (Xenopus laevis)
hsa:26578;OSTF1,OSF,SH3P2,bA235O14.1;osteoclast stimulating factor 1
hsa:5934;RBL2,P130,Rb2;retinoblastoma-like 2 (p130)
hsa:7784;ZP3,ZP3A,ZP3B,ZPC,Zp-3;zona pellucida glycoprotein 3 (sperm receptor)
hsa:6603;SMARCD2,BAF60B,CRACD2,Rsc6p;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2
hsa:56970;ATXN7L3;ataxin 7-like 3
hsa:10487;CAP1,CAP,CAP1-PEN;CAP, adenylate cyclase-associated protein 1 (yeast)
hsa:283377;SPRYD4;SPRY domain containing 4
hsa:2926;GRSF1;G-rich RNA sequence binding factor 1
hsa:128434;VSTM2L,C20orf102,dJ1118M15.2;V-set and transmembrane domain containing 2 like
hsa:11022;TDRKH,TDRD2;tudor and KH domain containing
hsa:145773;FAM81A;family with sequence similarity 81, member A
hsa:26054;SENP6,SSP1,SUSP1;SUMO1/sentrin specific peptidase 6 (EC:3.4.22.68)
hsa:9759;HDAC4,AHO3,BDMR,HA6116,HD4,HDAC-4,HDAC-A,HDACA;histone deacetylase 4 (EC:3.5.1.98)
hsa:3683;ITGAL,CD11A,LFA-1,LFA1A;integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1;alpha polypeptide)
hsa:30846;EHD2,PAST2;EH-domain containing 2
hsa:1755;DMBT1,GP340,muclin;deleted in malignant brain tumors 1
hsa:23307;FKBP15,FKBP133,KIAA0674,PPP1R76;FK506 binding protein 15, 133kDa (EC:5.2.1.8)
hsa:79718;TBL1XR1,C21,DC42,IRA1,TBLR1;transducin (beta)-like 1 X-linked receptor 1
hsa:8803;SUCLA2,A-BETA,MTDPS5,SCS-betaA;succinate-CoA ligase, ADP-forming, beta subunit (EC:6.2.1.5)
hsa:6237;RRAS;related RAS viral (r-ras) oncogene homolog
hsa:147015;DHRS13,SDR7C5;dehydrogenase/reductase (SDR family) member 13
hsa:9655;SOCS5,CIS6,CISH6,Cish5,SOCS-5;suppressor of cytokine signaling 5
hsa:54842;MFSD6,MMR2,hMMR2;major facilitator superfamily domain containing 6
hsa:160857;CCDC122;coiled-coil domain containing 122
hsa:10039;PARP3,ADPRT3,ADPRTL2,ADPRTL3,ARTD3,IRT1,PADPRT-3;poly (ADP-ribose) polymerase family, member 3 (EC:2.4.2.30)
hsa:83758;RBP5,CRBP-III,CRBP3,CRBPIII;retinol binding protein 5, cellular
hsa:133022;TRAM1L1;translocation associated membrane protein 1-like 1
hsa:22989;MYH15;myosin, heavy chain 15
hsa:3151;HMGN2,HMG17;high mobility group nucleosomal binding domain 2
hsa:2559;GABRA6;gamma-aminobutyric acid (GABA) A receptor, alpha 6
hsa:64960;MRPS15,MPR-S15,RPMS15,S15mt;mitochondrial ribosomal protein S15
hsa:83699;SH3BGRL2;SH3 domain binding glutamic acid-rich protein like 2
hsa:128239;IQGAP3;IQ motif containing GTPase activating protein 3
hsa:3134;HLA-F,CDA12,HLA-5.4,HLA-CDA12,HLAF;major histocompatibility complex, class I, F
hsa:377;ARF3;ADP-ribosylation factor 3
hsa:5314;PKHD1,ARPKD,FCYT,TIGM1;polycystic kidney and hepatic disease 1 (autosomal recessive)
hsa:50619;DEF6,IBP,SLAT,SWAP70L;differentially expressed in FDCP 6 homolog (mouse)
hsa:54891;INO80D;INO80 complex subunit D
hsa:10991;SLC38A3,G17,NAT1,SN1;solute carrier family 38, member 3
hsa:4863;NPAT,E14,E14/NPAT,p220;nuclear protein, ataxia-telangiectasia locus
hsa:339761;CYP27C1;cytochrome P450, family 27, subfamily C, polypeptide 1
hsa:1266;CNN3;calponin 3, acidic
hsa:54460;MRPS21,MRP-S21,RPMS21;mitochondrial ribosomal protein S21
hsa:170591;S100Z,Gm625,S100-zeta;S100 calcium binding protein Z
hsa:4131;MAP1B,FUTSCH,MAP5;microtubule-associated protein 1B
hsa:55224;ETNK2,EKI2,HMFT1716;ethanolamine kinase 2 (EC:2.7.1.82)
hsa:2953;GSTT2,GSTT2B;glutathione S-transferase theta 2 (EC:2.5.1.18)
hsa:55061;SUSD4,PRO222;sushi domain containing 4
hsa:158471;PRUNE2,A214N16.3,BMCC1,BNIPXL,C9orf65,KIAA0367,RP11-58J3.2,bA214N16.3;prune homolog 2 (Drosophila)
hsa:219970;GLYATL2,BXMAS2-10,GATF-B;glycine-N-acyltransferase-like 2 (EC:2.3.1.13)
hsa:79632;FAM184A,C6orf60;family with sequence similarity 184, member A
hsa:55672;NBPF1,AB13,AB14,AB23,AD2,NBG,NBPF;neuroblastoma breakpoint family, member 1
hsa:51024;FIS1,TTC11;fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae)
hsa:653689;GSTT2B,GSTT2P;glutathione S-transferase theta 2B (gene/pseudogene) (EC:2.5.1.18)
hsa:79612;NAA16,NARG1L;N(alpha)-acetyltransferase 16, NatA auxiliary subunit
hsa:89797;NAV2,HELAD1,POMFIL2,RAINB1,STEERIN2,UNC53H2;neuron navigator 2 (EC:3.6.4.12)
hsa:6844;VAMP2,SYB2,VAMP-2;vesicle-associated membrane protein 2 (synaptobrevin 2)
hsa:6508;SLC4A3,AE3,SLC2C;solute carrier family 4, anion exchanger, member 3
hsa:51564;HDAC7,HD7A,HDAC7A;histone deacetylase 7 (EC:3.5.1.98)
hsa:84779;NAA11,ARD1B,ARD2,hARD2;N(alpha)-acetyltransferase 11, NatA catalytic subunit (EC:2.3.1.88)
hsa:59277;NTN4,PRO3091;netrin 4
hsa:5447;POR,CPR,CYPOR,P450R;P450 (cytochrome) oxidoreductase (EC:1.6.2.4)
hsa:1455;CSNK1G2,CK1g2;casein kinase 1, gamma 2 (EC:2.7.11.1)
hsa:5434;POLR2E,RPABC1,RPB5,XAP4,hRPB25,hsRPB5;polymerase (RNA) II (DNA directed) polypeptide E, 25kDa (EC:2.7.7.6)
hsa:7143;TNR,TN-R;tenascin R
hsa:143630;UBQLNL;ubiquilin-like
hsa:151651;EFHB;EF-hand domain family, member B
hsa:1580;CYP4B1,CYPIVB1,P-450HP;cytochrome P450, family 4, subfamily B, polypeptide 1 (EC:1.14.14.1)
hsa:1;A1BG,A1B,ABG,GAB,HYST2477;alpha-1-B glycoprotein
hsa:9750;FAM65B,C6orf32,DIFF40,DIFF48,MYONAP,PL48;family with sequence similarity 65, member B
hsa:79747;ADGB,C6orf103;androglobin
hsa:3201;HOXA4,HOX1,HOX1D;homeobox A4
hsa:4135;MAP6,MTAP6,N-STOP,STOP;microtubule-associated protein 6
hsa:1652;DDT,DDCT;D-dopachrome tautomerase (EC:4.1.1.84)
hsa:256764;WDR72,AI2A3;WD repeat domain 72
hsa:64965;MRPS9,MRP-S9,RPMS9,S9mt;mitochondrial ribosomal protein S9
hsa:84749;USP30;ubiquitin specific peptidase 30 (EC:3.4.19.12)
hsa:51076;CUTC,RP11-483F11.3;cutC copper transporter homolog (E. coli)
hsa:133686;NADKD1,C5orf33;NAD kinase domain containing 1
hsa:96764;TGS1,NCOA6IP,PIMT,PIPMT;trimethylguanosine synthase 1 (EC:2.1.1.-)
hsa:2841;GPR18;G protein-coupled receptor 18
hsa:80014;WWC2,BOMB;WW and C2 domain containing 2
hsa:23011;RAB21;RAB21, member RAS oncogene family
hsa:7090;TLE3,ESG,ESG3,GRG3,HsT18976;transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila)
hsa:84839;RAX2,ARMD6,CORD11,QRX,RAXL1;retina and anterior neural fold homeobox 2
hsa:98;ACYP2,ACYM,ACYP;acylphosphatase 2, muscle type (EC:3.6.1.7)
hsa:80017;C14orf159;chromosome 14 open reading frame 159
hsa:2775;GNAO1,G-ALPHA-o,GNAO;guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
hsa:55243;KIRREL,NEPH1;kin of IRRE like (Drosophila)
hsa:10298;PAK4;p21 protein (Cdc42/Rac)-activated kinase 4 (EC:2.7.11.1)
hsa:7005;TEAD3,DTEF-1,ETFR-1,TEAD-3,TEAD5,TEF-5,TEF5;TEA domain family member 3
hsa:1975;EIF4B,EIF-4B,PRO1843;eukaryotic translation initiation factor 4B
hsa:113828;FAM83F;family with sequence similarity 83, member F
hsa:51023;MRPS18C,MRP-S18-1,MRPS18-1;mitochondrial ribosomal protein S18C
hsa:9221;NOLC1,NOPP130,NOPP140,NS5ATP13,P130;nucleolar and coiled-body phosphoprotein 1
hsa:57463;AMIGO1,AMIGO,AMIGO-1;adhesion molecule with Ig-like domain 1
hsa:150468;CKAP2L;cytoskeleton associated protein 2-like
hsa:28973;MRPS18B,C6orf14,HSPC183,HumanS18a,MRP-S18-2,MRPS18-2,PTD017,S18amt;mitochondrial ribosomal protein S18B
hsa:145741;C2CD4A,FAM148A,NLF1;C2 calcium-dependent domain containing 4A
hsa:4082;MARCKS,80K-L,MACS,PKCSL,PRKCSL;myristoylated alanine-rich protein kinase C substrate
hsa:22927;HABP4,IHABP4,Ki-1/57,SERBP1L;hyaluronan binding protein 4
hsa:80258;EFHC2,dJ1158H2.1;EF-hand domain (C-terminal) containing 2
hsa:9737;GPRASP1,GASP,GASP-1,GASP1;G protein-coupled receptor associated sorting protein 1
hsa:10309;CCNO,CCNU,UDG2;cyclin O
hsa:4139;MARK1,MARK,Par-1c,Par1c;MAP/microtubule affinity-regulating kinase 1 (EC:2.7.11.1 2.7.11.26)
hsa:57633;LRRN1,FIGLER3,NLRR-1;leucine rich repeat neuronal 1
hsa:602;BCL3,BCL4,D19S37;B-cell CLL/lymphoma 3
hsa:79713;IGFLR1,TMEM149,U2AF1L4;IGF-like family receptor 1
hsa:57188;ADAMTSL3;ADAMTS-like 3
hsa:92565;FANK1;fibronectin type III and ankyrin repeat domains 1
hsa:126014;OSCAR,PIGR3;osteoclast associated, immunoglobulin-like receptor
hsa:4168;MCF2,ARHGEF21,DBL;MCF.2 cell line derived transforming sequence
hsa:391;RHOG,ARHG;ras homolog family member G
hsa:157285;SGK223,PRAGMIN;homolog of rat pragma of Rnd2 (EC:2.7.10.2)
hsa:159296;NKX2-3,CSX3,NK2.3,NKX2.3,NKX2C,NKX4-3;NK2 homeobox 3
hsa:84959;UBASH3B,STS-1,STS1,TULA-2,p70;ubiquitin associated and SH3 domain containing B (EC:3.1.3.48)
hsa:57455;REXO1,ELOABP1,EloA-BP1,REX1,TCEB3BP1;REX1, RNA exonuclease 1 homolog (S. cerevisiae)
hsa:57578;UNC79,KIAA1409;unc-79 homolog (C. elegans)
hsa:222537;HS3ST5,3-OST-5,3OST5,HS3OST5,NBLA04021;heparan sulfate (glucosamine) 3-O-sulfotransferase 5 (EC:2.8.2.23)
hsa:412;STS,ARSC,ARSC1,ASC,ES,SSDD,XLI;steroid sulfatase (microsomal), isozyme S (EC:3.1.6.2)
hsa:89778;SERPINB11,EPIPIN,SERPIN11;serpin peptidase inhibitor, clade B (ovalbumin), member 11 (gene/pseudogene)
hsa:165631;PARP15,ARTD7,BAL3,pART7;poly (ADP-ribose) polymerase family, member 15 (EC:2.4.2.30)
hsa:26000;TBC1D10B,EPI64B;TBC1 domain family, member 10B
hsa:114794;ELFN2,LRRC62,PPP1R29,dJ63G5.3;extracellular leucine-rich repeat and fibronectin type III domain containing 2
hsa:5079;PAX5,BSAP;paired box 5
hsa:26164;GTPBP5,ObgH1,dJ1005F21.2;GTP binding protein 5 (putative)
hsa:124975;GGT6;gamma-glutamyltransferase 6 (EC:2.3.2.2 3.4.19.13)
hsa:729533;FAM72A,LMPIP;family with sequence similarity 72, member A
hsa:10516;FBLN5,ADCL2,ARCL1A,ARMD3,DANCE,EVEC,FIBL-5,UP50;fibulin 5
hsa:115207;KCTD12,C13orf2,PFET1,PFETIN;potassium channel tetramerisation domain containing 12
hsa:54899;PXK,MONaKA;PX domain containing serine/threonine kinase
hsa:115701;ALPK2,HAK;alpha-kinase 2
hsa:55273;TMEM100;transmembrane protein 100
hsa:116541;MRPL54,L54mt,MRP-L54;mitochondrial ribosomal protein L54
hsa:6898;TAT;tyrosine aminotransferase (EC:2.6.1.5)
hsa:158;ADSL,AMPS,ASASE,ASL;adenylosuccinate lyase (EC:4.3.2.2)
hsa:239;ALOX12,12-LOX,12S-LOX,LOG12;arachidonate 12-lipoxygenase (EC:1.13.11.31)
hsa:2203;FBP1,FBP;fructose-1,6-bisphosphatase 1 (EC:3.1.3.11)
hsa:23173;METAP1,MAP1A,MetAP1A;methionyl aminopeptidase 1 (EC:3.4.11.18)
hsa:55635;DEPDC1,DEP.8,DEPDC1-V2,DEPDC1A,SDP35;DEP domain containing 1
hsa:164656;TMPRSS6,IRIDA;transmembrane protease, serine 6
hsa:26010;SPATS2L,DNAPTP6,SGNP;spermatogenesis associated, serine-rich 2-like
hsa:112464;PRKCDBP,CAVIN3,HSRBC,SRBC,cavin-3;protein kinase C, delta binding protein
hsa:147040;KCTD11,C17orf36,KCASH1,REN,REN/KCTD11;potassium channel tetramerisation domain containing 11
hsa:79156;PLEKHF1,APPD,PHAFIN1,ZFYVE15;pleckstrin homology domain containing, family F (with FYVE domain) member 1
hsa:57460;PPM1H,ARHCL1,NERPP-2C,URCC2;protein phosphatase, Mg2+/Mn2+ dependent, 1H (EC:3.1.3.16)
hsa:55022;PID1,NYGGF4,P-CLI1,PCLI1;phosphotyrosine interaction domain containing 1
hsa:407;ARR3,ARRX;arrestin 3, retinal (X-arrestin)
hsa:7109;TRAPPC10,EHOC-1,EHOC1,GT334,TMEM1,TRS130,TRS30;trafficking protein particle complex 10
hsa:22870;PPP6R1,KIAA1115,PP6R1,SAP190,SAPS1;protein phosphatase 6, regulatory subunit 1
hsa:23623;RUSC1,NESCA;RUN and SH3 domain containing 1
hsa:1767;DNAH5,CILD3,DNAHC5,HL1,KTGNR,PCD;dynein, axonemal, heavy chain 5
hsa:6832;SUPV3L1,SUV3;suppressor of var1, 3-like 1 (S. cerevisiae) (EC:3.6.4.13)
hsa:51701;NLK;nemo-like kinase (EC:2.7.11.24)
hsa:50945;TBX22,CLPA,CPX,TBXX,dJ795G23.1;T-box 22
hsa:10682;EBP,CDPX2,CHO2,CPX,CPXD;emopamil binding protein (sterol isomerase) (EC:5.3.3.5)
hsa:10243;GPHN,GEPH,GPH,GPHRYN,HKPX1;gephyrin (EC:2.10.1.1 2.7.7.75)
hsa:10514;MYBBP1A,P160,PAP2;MYB binding protein (P160) 1a
hsa:220136;CCDC11,HTX6;coiled-coil domain containing 11
hsa:1018;CDK3;cyclin-dependent kinase 3 (EC:2.7.11.22)
hsa:284021;MILR1,Allergin-1,C17orf60,MCA-32,MCA32;mast cell immunoglobulin-like receptor 1
hsa:220;ALDH1A3,ALDH1A6,ALDH6,MCOP8,RALDH3;aldehyde dehydrogenase 1 family, member A3 (EC:1.2.1.5)
hsa:84951;TNS4,CTEN;tensin 4
hsa:3185;HNRNPF,HNRPF,OK/SW-cl.23,mcs94-1;heterogeneous nuclear ribonucleoprotein F
hsa:55783;FTSJD1,AFT,MTr2;FtsJ methyltransferase domain containing 1
hsa:5910;RAP1GDS1,GDS1,SmgGDS;RAP1, GTP-GDP dissociation stimulator 1
hsa:56033;BARX1;BARX homeobox 1
hsa:51011;FAHD2A;fumarylacetoacetate hydrolase domain containing 2A (EC:3.-.-.-)
hsa:1582;CYP8B1,CP8B,CYP12;cytochrome P450, family 8, subfamily B, polypeptide 1 (EC:1.14.13.95)
hsa:139411;PTCHD1;patched domain containing 1
hsa:22904;SBNO2,KIAA0963,SNO,STNO;strawberry notch homolog 2 (Drosophila)
hsa:85366;MYLK2,KMLC,MLCK,MLCK2,skMLCK;myosin light chain kinase 2 (EC:2.7.11.18)
hsa:57107;PDSS2,C6orf210,COQ10D3,DLP1,bA59I9.3,hDLP1;prenyl (decaprenyl) diphosphate synthase, subunit 2 (EC:2.5.1.91)
hsa:7102;TSPAN7,A15,CCG-B7,CD231,DXS1692E,MRX58,MXS1,TALLA-1,TM4SF2,TM4SF2b;tetraspanin 7
hsa:91603;ZNF830,CCDC16,OMCG1,SEL13;zinc finger protein 830
hsa:55007;FAM118A,C22orf8;family with sequence similarity 118, member A
hsa:130399;ACVR1C,ACVRLK7,ALK7;activin A receptor, type IC (EC:2.7.11.30)
hsa:57576;KIF17,KIF17B,KIF3X,KLP-2,OSM-3;kinesin family member 17
hsa:54984;PINX1,LPTL,LPTS;PIN2/TERF1 interacting, telomerase inhibitor 1
hsa:79987;SVEP1,C9orf13,CCP22,POLYDOM,SEL-OB,SELOB;sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1
hsa:2872;MKNK2,GPRK7,MNK2;MAP kinase interacting serine/threonine kinase 2 (EC:2.7.11.1)
hsa:2556;GABRA3;gamma-aminobutyric acid (GABA) A receptor, alpha 3
hsa:3833;KIFC1,HSET,KNSL2;kinesin family member C1
hsa:9170;LPAR2,EDG-4,EDG4,LPA-2,LPA2;lysophosphatidic acid receptor 2
hsa:25989;ULK3;unc-51-like kinase 3 (C. elegans) (EC:2.7.11.1)
hsa:6707;SPRR3;small proline-rich protein 3
hsa:8538;BARX2;BARX homeobox 2
hsa:27147;DENND2A,FAM31D,KIAA1277;DENN/MADD domain containing 2A
hsa:23231;SEL1L3,Sel-1L3;sel-1 suppressor of lin-12-like 3 (C. elegans)
hsa:343413;FCRL6,FcRH6;Fc receptor-like 6
hsa:55333;SYNJ2BP,ARIP2,OMP25;synaptojanin 2 binding protein
hsa:3902;LAG3,CD223;lymphocyte-activation gene 3
hsa:7881;KCNAB1,AKR6A3,KCNA1B,KV-BETA-1,Kvb1.3,hKvBeta3,hKvb3;potassium voltage-gated channel, shaker-related subfamily, beta member 1
hsa:5506;PPP1R3A,GM,PP1G,PPP1R3;protein phosphatase 1, regulatory subunit 3A (EC:3.1.3.16)
hsa:84916;CIRH1A,CIRHIN,NAIC,TEX292,UTP4;cirrhosis, autosomal recessive 1A (cirhin)
hsa:56006;SMG9,C19orf61,F17127_1;smg-9 homolog, nonsense mediated mRNA decay factor (C. elegans)
hsa:58490;RPRD1B,C20orf77,CREPT,NET60,dJ1057B20.2;regulation of nuclear pre-mRNA domain containing 1B
hsa:90668;LRRC16B,C14orf121,CARMIL3,crml-1;leucine rich repeat containing 16B
hsa:339829;CCDC39,CILD14,FAP59;coiled-coil domain containing 39
hsa:57404;CYP20A1,CYP-M;cytochrome P450, family 20, subfamily A, polypeptide 1
hsa:80143;SIKE1,SIKE;suppressor of IKBKE 1
hsa:7317;UBA1,A1S9,A1S9T,A1ST,AMCX1,GXP1,POC20,SMAX2,UBA1A,UBE1,UBE1X;ubiquitin-like modifier activating enzyme 1 (EC:6.3.2.19)
hsa:80145;THOC7,NIF3L1BP1,fSAP24;THO complex 7 homolog (Drosophila)
hsa:3355;HTR1F,5-HT-1F,5-HT1F,5HT6,HTR1EL,MR77;5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled
hsa:63941;NECAB3,APBA2BP,EFCBP3,NIP1,STIP3,SYTIP2,XB51,dJ63M2.4,dJ63M2.5;N-terminal EF-hand calcium binding protein 3
hsa:90523;MLIP,C6orf142;muscular LMNA-interacting protein
hsa:284716;RIMKLA,FAM80A,NAAGS,NAAGS-II;ribosomal modification protein rimK-like family member A
hsa:2742;GLRA2,GLR;glycine receptor, alpha 2
hsa:7390;UROS,UROIIIS;uroporphyrinogen III synthase (EC:4.2.1.75)
hsa:51081;MRPS7,MRP-S,MRP-S7,RP-S7,RPMS7,S7mt,bMRP27a;mitochondrial ribosomal protein S7
hsa:79746;ECHDC3;enoyl CoA hydratase domain containing 3
hsa:10077;TSPAN32,ART1,PHEMX,PHMX,TSSC6;tetraspanin 32
hsa:80219;COQ10B;coenzyme Q10 homolog B (S. cerevisiae)
hsa:11326;VSIG4,CRIg,Z39IG;V-set and immunoglobulin domain containing 4
hsa:286527;TMSB15B,Tbeta15b;thymosin beta 15B
hsa:51258;MRPL51,HSPC241,MRP64,bMRP64;mitochondrial ribosomal protein L51
hsa:10240;MRPS31,IMOGN38,MRP-S31,S31mt;mitochondrial ribosomal protein S31
hsa:5502;PPP1R1A,I1,IPP1;protein phosphatase 1, regulatory (inhibitor) subunit 1A (EC:3.1.3.16)
hsa:8861;LDB1,CLIM2,NLI;LIM domain binding 1
hsa:9715;FAM131B;family with sequence similarity 131, member B
hsa:9646;CTR9,SH2BP1,TSBP,p150,p150TSP;Ctr9, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)
hsa:339398;LINGO4,DAAT9248,LRRN6D,PRO34002;leucine rich repeat and Ig domain containing 4
hsa:341208;HEPHL1;hephaestin-like 1
hsa:3918;LAMC2,B2T,BM600,CSF,EBR2,EBR2A,LAMB2T,LAMNB2;laminin, gamma 2
hsa:91584;PLXNA4,FAYV2820,PLEXA4,PLXNA4A,PLXNA4B,PRO34003;plexin A4
hsa:60560;NAA35,MAK10,bA379P1.1;N(alpha)-acetyltransferase 35, NatC auxiliary subunit
hsa:56243;SKT;KIAA1217
hsa:26155;NOC2L,NET15,NET7,NIR;nucleolar complex associated 2 homolog (S. cerevisiae)
hsa:202;AIM1,CRYBG1,ST4;absent in melanoma 1
hsa:55486;PARL,PSARL,PSARL1,PSENIP2,RHBDS1;presenilin associated, rhomboid-like (EC:3.4.21.105)
hsa:26507;CNNM1,ACDP1,CLP-1;cyclin M1
hsa:57583;TMEM181,GPR178,KIAA1423;transmembrane protein 181
hsa:63922;CHTF18,C16orf41,C321D2.2,C321D2.3,C321D2.4,CHL12,Ctf18,RUVBL;CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae)
hsa:51764;GNG13,G(gamma)13,h2-35;guanine nucleotide binding protein (G protein), gamma 13
hsa:4064;CD180,LY64,Ly78,RP105;CD180 molecule
hsa:54625;PARP14,ARTD8,BAL2,PARP-14,pART8;poly (ADP-ribose) polymerase family, member 14 (EC:2.4.2.30)
hsa:8995;TNFSF18,AITRL,GITRL,TL6,hGITRL;tumor necrosis factor (ligand) superfamily, member 18
hsa:55862;ECHDC1,MMCD,dJ351K20.2;enoyl CoA hydratase domain containing 1 (EC:4.1.1.41 4.1.1.94)
hsa:27237;ARHGEF16,GEF16,NBR;Rho guanine nucleotide exchange factor (GEF) 16
hsa:122402;TDRD9,C14orf75,HIG-1,NET54;tudor domain containing 9 (EC:3.6.4.13)
hsa:9328;GTF3C5,TFIIIC63,TFIIICepsilon,TFiiiC2-63;general transcription factor IIIC, polypeptide 5, 63kDa
hsa:25821;MTO1,COXPD10;mitochondrial translation optimization 1 homolog (S. cerevisiae)
hsa:60314;C12orf10,MST024,MSTP024,MYG,MYG1;chromosome 12 open reading frame 10
hsa:344807;CD200R1L,CD200R2,CD200RLa;CD200 receptor 1-like
hsa:114805;GALNT13,GalNAc-T13,H_NH0187G20.1,WUGSC:H_NH0187G20.1;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13) (EC:2.4.1.41)
hsa:5795;PTPRJ,CD148,DEP1,HPTPeta,R-PTP-ETA,SCC1;protein tyrosine phosphatase, receptor type, J (EC:3.1.3.48)
hsa:400745;SH2D5;SH2 domain containing 5
hsa:23129;PLXND1,PLEXD1;plexin D1
hsa:9777;TM9SF4,dJ836N17.2;transmembrane 9 superfamily protein member 4
hsa:170506;DHX36,DDX36,G4R1,MLEL1,RHAU;DEAH (Asp-Glu-Ala-His) box polypeptide 36 (EC:3.6.4.13)
hsa:81037;CLPTM1L,CRR9;CLPTM1-like
hsa:79080;CCDC86;coiled-coil domain containing 86
hsa:23637;RABGAP1,GAPCENA,RP11-123N4.2,TBC1D11;RAB GTPase activating protein 1
hsa:51650;MRPS33,MRP-S33,PTD003,S33mt;mitochondrial ribosomal protein S33
hsa:90273;CEACAM21,CEACAM3,R29124_1;carcinoembryonic antigen-related cell adhesion molecule 21
hsa:81930;KIF18A,MS-KIF18A;kinesin family member 18A
hsa:80198;MUS81,SLX3;MUS81 endonuclease homolog (S. cerevisiae) (EC:3.1.22.-)
hsa:660;BMX,ETK,PSCTK2,PSCTK3;BMX non-receptor tyrosine kinase (EC:2.7.10.2)
hsa:23252;OTUD3,DUBA4,RP11-460G22.1;OTU domain containing 3
hsa:4794;NFKBIE,IKBE;nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
hsa:10347;ABCA7,ABCA-SSN,ABCX;ATP-binding cassette, sub-family A (ABC1), member 7
hsa:10564;ARFGEF2,BIG2,PVNH2,dJ1164I10.1;ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited)
hsa:84513;PPAPDC1B,DPPL1,HTPAP;phosphatidic acid phosphatase type 2 domain containing 1B (EC:3.1.3.4)
hsa:80201;HKDC1;hexokinase domain containing 1 (EC:2.7.1.1)
hsa:7114;TMSB4X,FX,PTMB4,TB4X,TMSB4;thymosin beta 4, X-linked
hsa:2038;EPB42,PA,SPH5;erythrocyte membrane protein band 4.2
hsa:64785;GINS3,PSF3;GINS complex subunit 3 (Psf3 homolog)
hsa:123876;ACSM2A,A-923A4.1,ACSM2;acyl-CoA synthetase medium-chain family member 2A (EC:6.2.1.2)
hsa:65005;MRPL9,L9mt;mitochondrial ribosomal protein L9
hsa:11141;IL1RAPL1,IL1R8,IL1RAPL,MRX10,MRX21,MRX34,OPHN4,TIGIRR-2;interleukin 1 receptor accessory protein-like 1
hsa:1850;DUSP8,C11orf81,HB5,HVH-5,HVH8;dual specificity phosphatase 8 (EC:3.1.3.16 3.1.3.48)
hsa:7284;TUFM,COXPD4,EF-TuMT,EFTU,P43;Tu translation elongation factor, mitochondrial
hsa:388646;GBP7,GBP4L;guanylate binding protein 7
hsa:6655;SOS2;son of sevenless homolog 2 (Drosophila)
hsa:917;CD3G,CD3-GAMMA,T3G;CD3g molecule, gamma (CD3-TCR complex)
hsa:107;ADCY1,AC1;adenylate cyclase 1 (brain) (EC:4.6.1.1)
hsa:23248;RPRD2,KIAA0460;regulation of nuclear pre-mRNA domain containing 2
hsa:6146;RPL22,EAP,HBP15,HBP15/L22,L22;ribosomal protein L22
hsa:57556;SEMA6A,HT018,SEMA,SEMA6A1,SEMAQ,VIA;sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A
hsa:4909;NTF4,GLC10,GLC1O,NT-4,NT-4/5,NT-5,NT4,NT5,NTF5;neurotrophin 4
hsa:3795;KHK;ketohexokinase (fructokinase) (EC:2.7.1.3)
hsa:83937;RASSF4,AD037;Ras association (RalGDS/AF-6) domain family member 4
hsa:55964;SEPT3,SEP3,bK250D10.3;septin 3
hsa:205564;SENP5;SUMO1/sentrin specific peptidase 5 (EC:3.4.22.68)
hsa:83648;FAM167A,C8orf13,D8S265;family with sequence similarity 167, member A
hsa:768211;RELL1;RELT-like 1
hsa:26515;TIMM10B,FXC1,TIM10B,Tim9b;translocase of inner mitochondrial membrane 10 homolog B (yeast)
hsa:1999;ELF3,EPR-1,ERT,ESE-1,ESX;E74-like factor 3 (ets domain transcription factor, epithelial-specific )
hsa:9770;RASSF2,CENP-34,RASFADIN;Ras association (RalGDS/AF-6) domain family member 2
hsa:3183;HNRNPC,C1,C2,HNRNP,HNRPC,SNRPC;heterogeneous nuclear ribonucleoprotein C (C1/C2)
hsa:5274;SERPINI1,PI12,neuroserpin;serpin peptidase inhibitor, clade I (neuroserpin), member 1
hsa:64600;PLA2G2F;phospholipase A2, group IIF (EC:3.1.1.4)
hsa:254773;LYG2,LYGH;lysozyme G-like 2 (EC:3.2.1.17)
hsa:91133;L3MBTL4,HsT1031;l(3)mbt-like 4 (Drosophila)
hsa:6594;SMARCA1,ISWI,NURF140,SNF2L,SNF2L1,SNF2LB,SNF2LT,SWI,SWI2;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
hsa:54986;ULK4,FAM7C1,REC01035;unc-51-like kinase 4 (C. elegans) (EC:2.7.11.1)
hsa:348235;SKA2,FAM33A;spindle and kinetochore associated complex subunit 2
hsa:84875;PARP10,ARTD10;poly (ADP-ribose) polymerase family, member 10 (EC:2.4.2.30)
hsa:114;ADCY8,AC8,ADCY3,HBAC1;adenylate cyclase 8 (brain) (EC:4.6.1.1)
hsa:4100;MAGEA1,CT1.1,MAGE1;melanoma antigen family A, 1 (directs expression of antigen MZ2-E)
hsa:51095;TRNT1,CCA1,MtCCA;tRNA nucleotidyl transferase, CCA-adding, 1 (EC:2.7.7.72)
hsa:390792;KRT39,CK-39,K39,KA35;keratin 39
hsa:54828;BCAS3,GAOB1,MAAB;breast carcinoma amplified sequence 3
hsa:84226;C2orf16;chromosome 2 open reading frame 16
hsa:1947;EFNB1,CFND,CFNS,EFL3,EPLG2,Elk-L,LERK2;ephrin-B1
hsa:11099;PTPN21,PTPD1,PTPRL10;protein tyrosine phosphatase, non-receptor type 21 (EC:3.1.3.48)
hsa:348158;ACSM2B,ACSM2,HXMA;acyl-CoA synthetase medium-chain family member 2B (EC:6.2.1.2)
hsa:9050;PSTPIP2,MAYP;proline-serine-threonine phosphatase interacting protein 2
hsa:135295;SRSF12,RP11-63L7.3,SFRS13B,SFRS19,SRrp35;serine/arginine-rich splicing factor 12
hsa:152789;JAKMIP1,Gababrbp,JAMIP1,MARLIN1;janus kinase and microtubule interacting protein 1
hsa:9515;STXBP5L,LLGL4;syntaxin binding protein 5-like
hsa:65095;KRI1;KRI1 homolog (S. cerevisiae)
hsa:54854;FAM83E;family with sequence similarity 83, member E
hsa:85459;;KIAA1731
hsa:225;ABCD2,ABC39,ALDL1,ALDR,ALDRP,hALDR;ATP-binding cassette, sub-family D (ALD), member 2
hsa:143884;CWF19L2;CWF19-like 2, cell cycle control (S. pombe)
hsa:54534;MRPL50,MRP-L50;mitochondrial ribosomal protein L50
hsa:148738;HFE2,HFE2A,HJV,JH,RGMC;hemochromatosis type 2 (juvenile)
hsa:157378;TMEM65;transmembrane protein 65
hsa:528;ATP6V1C1,ATP6C,ATP6D,VATC,Vma5;ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 (EC:3.6.3.14)
hsa:6424;SFRP4,FRP-4,FRPHE,sFRP-4;secreted frizzled-related protein 4
hsa:39;ACAT2;acetyl-CoA acetyltransferase 2 (EC:2.3.1.9)
hsa:414301;DDI1;DNA-damage inducible 1 homolog 1 (S. cerevisiae)
hsa:340267;COL28A1,COL28;collagen, type XXVIII, alpha 1
hsa:29899;GPSM2,CMCS,DFNB82,LGN,PINS;G-protein signaling modulator 2
hsa:5255;PHKA1,PHKA;phosphorylase kinase, alpha 1 (muscle) (EC:2.7.11.19)
hsa:127018;LYPLAL1;lysophospholipase-like 1 (EC:3.1.2.-)
hsa:80221;ACSF2,ACSMW,AVYV493;acyl-CoA synthetase family member 2 (EC:6.2.1.-)
hsa:10003;NAALAD2,GCPIII,GPCIII,NAADALASE2,NAALADASE2;N-acetylated alpha-linked acidic dipeptidase 2 (EC:3.4.17.21)
hsa:93058;COQ10A;coenzyme Q10 homolog A (S. cerevisiae)
hsa:222194;RSBN1L;round spermatid basic protein 1-like
hsa:883;CCBL1,GTK,KAT1,KATI;cysteine conjugate-beta lyase, cytoplasmic (EC:2.6.1.64 2.6.1.7 4.4.1.13)
hsa:79876;UBA5,THIFP1,UBE1DC1;ubiquitin-like modifier activating enzyme 5
hsa:219790;RTKN2,PLEKHK1,bA531F24.1;rhotekin 2
hsa:2177;FANCD2,FA-D2,FA4,FACD,FAD,FAD2,FANCD;Fanconi anemia, complementation group D2
hsa:283464;GXYLT1,GLT8D3;glucoside xylosyltransferase 1 (EC:2.4.1.-)
hsa:23137;SMC5,SMC5L1;structural maintenance of chromosomes 5
hsa:222255;ATXN7L1,ATXN7L4;ataxin 7-like 1
hsa:549;AUH;AU RNA binding protein/enoyl-CoA hydratase (EC:4.2.1.18)
hsa:5825;ABCD3,ABC43,PMP70,PXMP1,ZWS2;ATP-binding cassette, sub-family D (ALD), member 3
hsa:126549;ANKLE1,ANKRD41,LEM3,LEMD6;ankyrin repeat and LEM domain containing 1
hsa:84067;FAM160A2,C11orf56;family with sequence similarity 160, member A2
hsa:283229;EFCAB4A,CRACR2B;EF-hand calcium binding domain 4A
hsa:22950;SLC4A1AP;solute carrier family 4 (anion exchanger), member 1, adaptor protein
hsa:55585;UBE2Q1,GTAP,NICE-5,UBE2Q;ubiquitin-conjugating enzyme E2Q family member 1 (EC:6.3.2.19)
hsa:553;AVPR1B,AVPR3;arginine vasopressin receptor 1B
hsa:84109;QRFPR,AQ27,GPR103,SP9155;pyroglutamylated RFamide peptide receptor
hsa:121391;KRT74,HTSS2,K6IRS4,KRT5C,KRT6IRS4;keratin 74
hsa:152206;CCDC13;coiled-coil domain containing 13
hsa:1595;CYP51A1,CP51,CYP51,CYPL1,LDM,P450-14DM,P450L1;cytochrome P450, family 51, subfamily A, polypeptide 1 (EC:1.14.13.70)
hsa:92715;WDR85,C9orf112,RP11-48C7.3,RRT2;WD repeat domain 85
hsa:55112;WDR60;WD repeat domain 60
hsa:57130;ATP13A1,ATP13A;ATPase type 13A1 (EC:3.6.3.8)
hsa:64921;CASD1,C7orf12,NBLA04196;CAS1 domain containing 1
hsa:81928;CABLES2,C20orf150,dJ908M14.2,ik3-2;Cdk5 and Abl enzyme substrate 2
hsa:2042;EPHA3,EK4,ETK,ETK1,HEK,HEK4,TYRO4;EPH receptor A3 (EC:2.7.10.1)
hsa:9495;AKAP5,AKAP75,AKAP79,H21;A kinase (PRKA) anchor protein 5
hsa:57019;CIAPIN1,2810413N20Rik,Anamorsin,DRE2,PRO0915;cytokine induced apoptosis inhibitor 1
hsa:126206;NLRP5,CLR19.8,MATER,NALP5,PAN11,PYPAF8;NLR family, pyrin domain containing 5
hsa:26166;RGS22,PRTD-NY2;regulator of G-protein signaling 22
hsa:3000;GUCY2D,CORD5,CORD6,CYGD,GUC1A4,GUC2D,LCA,LCA1,RCD2,RETGC-1,ROS-GC1,ROSGC,retGC;guanylate cyclase 2D, membrane (retina-specific) (EC:4.6.1.2)
hsa:165186;FAM179A;family with sequence similarity 179, member A
hsa:57540;PTCHD2,DISP3;patched domain containing 2
hsa:26153;KIF26A;kinesin family member 26A
hsa:55591;VEZT,VEZATIN;vezatin, adherens junctions transmembrane protein
hsa:83468;GLT8D2;glycosyltransferase 8 domain containing 2
hsa:166348;KBTBD12,KLHDC6;kelch repeat and BTB (POZ) domain containing 12
hsa:81606;LBH;limb bud and heart development
hsa:220965;FAM13C,FAM13C1;family with sequence similarity 13, member C
hsa:81890;QTRT1,FP3235,TGT,TGUT;queuine tRNA-ribosyltransferase 1 (EC:2.4.2.29)
hsa:93594;WDR67,Gm85;WD repeat domain 67
hsa:79368;FCRL2,CD307b,FCRH2,IFGP4,IRTA4,SPAP1,SPAP1A,SPAP1B,SPAP1C;Fc receptor-like 2
hsa:9425;CDYL,CDYL1;chromodomain protein, Y-like (EC:2.3.1.48)
hsa:200558;APLF,APFL,C2orf13,PALF,Xip1;aprataxin and PNKP like factor (EC:4.2.99.18)
hsa:8621;CDK13,CDC2L,CDC2L5,CHED,hCDK13;cyclin-dependent kinase 13 (EC:2.7.11.23 2.7.11.22)
hsa:29089;UBE2T,PIG50;ubiquitin-conjugating enzyme E2T (putative) (EC:6.3.2.19)
hsa:441151;TMEM151B,C6orf137,TMEM193,bA444E17.5;transmembrane protein 151B
hsa:22949;PTGR1,LTB4DH,PGR1,ZADH3;prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74)
hsa:64781;CERK,LK4,dA59H18.2,dA59H18.3,hCERK;ceramide kinase (EC:2.7.1.138)
hsa:5062;PAK2,PAK65,PAKgamma;p21 protein (Cdc42/Rac)-activated kinase 2 (EC:2.7.11.1)
hsa:27309;ZNF330,HSA6591,NOA36;zinc finger protein 330
hsa:9706;ULK2,ATG1B,Unc51.2;unc-51-like kinase 2 (C. elegans) (EC:2.7.11.1)
hsa:57544;TXNDC16,ERp90,KIAA1344;thioredoxin domain containing 16
hsa:78990;OTUB2,C14orf137,OTB2,OTU2;OTU domain, ubiquitin aldehyde binding 2 (EC:3.4.19.12)
hsa:1741;DLG3,MRX,MRX90,NEDLG,SAP102,XLMR;discs, large homolog 3 (Drosophila)
hsa:83605;CCM2,C7orf22,OSM;cerebral cavernous malformation 2
hsa:126298;IRGQ,IRGQ1;immunity-related GTPase family, Q
hsa:84188;FAR1,MLSTD2,SDR10E1;fatty acyl CoA reductase 1 (EC:1.2.1.n2)
hsa:84457;PHYHIPL;phytanoyl-CoA 2-hydroxylase interacting protein-like
hsa:51014;TMED7,p27;transmembrane emp24 protein transport domain containing 7
hsa:387836;CLEC2A,KACL,PILAR,UNQ5792;C-type lectin domain family 2, member A
hsa:157807;CLVS1,CRALBPL,RLBP1L1;clavesin 1
hsa:84061;MAGT1,IAP,MRX95,OST3B,PRO0756,XMEN,bA217H1.1;magnesium transporter 1
hsa:57524;CASKIN1,ANKS5A;CASK interacting protein 1
hsa:284161;GDPD1,GDE4;glycerophosphodiester phosphodiesterase domain containing 1
hsa:6710;SPTB,EL3,HS2,HSPTB1,SPH2;spectrin, beta, erythrocytic
hsa:57665;RDH14,PAN2,SDR7C4;retinol dehydrogenase 14 (all-trans/9-cis/11-cis) (EC:1.1.1.-)
hsa:200162;SPAG17,PF6,RP4-776P7.2;sperm associated antigen 17
hsa:25878;MXRA5;matrix-remodelling associated 5
hsa:51399;TRAPPC4,HSPC172,PTD009,SBDN,SYNBINDIN,TRS23;trafficking protein particle complex 4
hsa:2235;FECH,EPP,FCE;ferrochelatase (EC:4.99.1.1)
hsa:398;ARHGDIG,RHOGDI-3;Rho GDP dissociation inhibitor (GDI) gamma
hsa:2917;GRM7,GLUR7,GPRC1G,MGLU7,MGLUR7;glutamate receptor, metabotropic 7
hsa:11055;ZPBP,ZPBP1;zona pellucida binding protein
hsa:2664;GDI1,1A,GDIL,MRX41,MRX48,OPHN2,RABGD1A,RABGDIA,XAP-4;GDP dissociation inhibitor 1
hsa:55607;PPP1R9A,NRB1,NRBI,Neurabin-I;protein phosphatase 1, regulatory subunit 9A
hsa:55068;ENOX1,CNOX,PIG38,bA64J21.1,cCNOX;ecto-NOX disulfide-thiol exchanger 1
hsa:55364;IMPACT,RWDD5;impact RWD domain protein
hsa:26287;ANKRD2,ARPP;ankyrin repeat domain 2 (stretch responsive muscle)
hsa:150962;PUS10,CCDC139,DOBI;pseudouridylate synthase 10
hsa:90167;FRMD7,NYS,NYS1,XIPAN;FERM domain containing 7
hsa:4774;NFIA,CTF,NF-I/A,NF1-A,NFI-A,NFI-L;nuclear factor I/A
hsa:10256;CNKSR1,CNK,CNK1,KSR;connector enhancer of kinase suppressor of Ras 1
hsa:1892;ECHS1,SCEH;enoyl CoA hydratase, short chain, 1, mitochondrial (EC:4.2.1.17)
hsa:168451;THAP5;THAP domain containing 5
hsa:23301;EHBP1,HPC12,NACSIN;EH domain binding protein 1
hsa:1120;CHKB,CHETK,CHKL,CK,CKB,CKEKB,EK,EKB,MDCMC;choline kinase beta (EC:2.7.1.32 2.7.1.82)
hsa:9924;PAN2,USP52;PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) (EC:3.1.13.4)
hsa:1297;COL9A1,DJ149L1.1.2,EDM6,MED,STL4;collagen, type IX, alpha 1
hsa:10885;WDR3,DIP2,UTP12;WD repeat domain 3
hsa:117143;TADA1,ADA1,HFI1,RP1-9E21.4,STAF42,TADA1L,hADA1;transcriptional adaptor 1
hsa:80270;HSD3B7,CBAS1,PFIC4,SDR11E3;hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 (EC:1.1.1.181)
hsa:4054;LTBP3,LTBP-3,LTBP2,STHAG6,pp6425;latent transforming growth factor beta binding protein 3
hsa:2169;FABP2,FABPI,I-FABP;fatty acid binding protein 2, intestinal
hsa:6150;MRPL23,L23MRP,RPL23,RPL23L;mitochondrial ribosomal protein L23
hsa:83999;KREMEN1,KREMEN,KRM1;kringle containing transmembrane protein 1
hsa:57519;STARD9;StAR-related lipid transfer (START) domain containing 9
hsa:4146;MATN1,CMP,CRTM;matrilin 1, cartilage matrix protein
hsa:51296;SLC15A3,OCTP,PHT2,PTR3;solute carrier family 15, member 3
hsa:56853;CELF4,BRUNOL-4,BRUNOL4;CUGBP, Elav-like family member 4
hsa:10316;NMUR1,(FM-3),FM-3,FM3,GPC-R,GPR66,NMU1R;neuromedin U receptor 1
hsa:10097;ACTR2,ARP2;ARP2 actin-related protein 2 homolog (yeast)
hsa:894;CCND2,KIAK0002;cyclin D2
hsa:56942;CMC2,2310061C15Rik,C16orf61;COX assembly mitochondrial protein 2 homolog (S. cerevisiae)
hsa:124460;SNX20,SLIC1;sorting nexin 20
hsa:1496;CTNNA2,CAP-R,CAPR,CT114,CTNR;catenin (cadherin-associated protein), alpha 2
hsa:23498;HAAO,3-HAO,HAO;3-hydroxyanthranilate 3,4-dioxygenase (EC:1.13.11.6)
hsa:51719;CAB39,MO25;calcium binding protein 39
hsa:5050;PAFAH1B3,PAFAHG;platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) (EC:3.1.1.47)
hsa:8558;CDK10,PISSLRE;cyclin-dependent kinase 10 (EC:2.7.11.22)
hsa:8659;ALDH4A1,ALDH4,P5CD,P5CDh;aldehyde dehydrogenase 4 family, member A1 (EC:1.5.1.12)
hsa:4779;NFE2L1,LCR-F1,NRF1,TCF11;nuclear factor (erythroid-derived 2)-like 1
hsa:2560;GABRB1;gamma-aminobutyric acid (GABA) A receptor, beta 1
hsa:126626;GABPB2;GA binding protein transcription factor, beta subunit 2
hsa:1990;CELA1,ELA1;chymotrypsin-like elastase family, member 1 (EC:3.4.21.36)
hsa:9331;B4GALT6,B4Gal-T6,beta4Gal-T6;UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 6 (EC:2.4.1.274)
hsa:22866;CNKSR2,CNK2,KSR2,MAGUIN;connector enhancer of kinase suppressor of Ras 2
hsa:10134;BCAP31,6C6-AG,BAP31,CDM,DXS1357E;B-cell receptor-associated protein 31
hsa:55133;SRBD1;S1 RNA binding domain 1
hsa:254048;UBN2;ubinuclein 2
hsa:3142;HLX,HB24,HLX1;H2.0-like homeobox
hsa:3101;HK3,HKIII,HXK3;hexokinase 3 (white cell) (EC:2.7.1.1)
hsa:79016;DDA1,C19orf58,PCIA1;DET1 and DDB1 associated 1
hsa:10326;SIRPB1,CD172b,SIRP-BETA-1;signal-regulatory protein beta 1
hsa:85415;RHPN2,P76RBE,RHOBP;rhophilin, Rho GTPase binding protein 2
hsa:1370;CPN2,ACBP;carboxypeptidase N, polypeptide 2 (EC:3.4.17.3)
hsa:7053;TGM3,TGE;transglutaminase 3 (E polypeptide, protein-glutamine-gamma-glutamyltransferase) (EC:2.3.2.13)
hsa:5864;RAB3A;RAB3A, member RAS oncogene family
hsa:10736;SIX2;SIX homeobox 2
hsa:3163;HMOX2,HO-2;heme oxygenase (decycling) 2 (EC:1.14.99.3)
hsa:10783;NEK6,SID6-1512;NIMA-related kinase 6 (EC:2.7.11.1)
hsa:79877;DCAKD;dephospho-CoA kinase domain containing
hsa:22982;DIP2C,KIAA0934;DIP2 disco-interacting protein 2 homolog C (Drosophila)
hsa:9643;MORF4L2,MORFL2,MRGX;mortality factor 4 like 2
hsa:9392;TGFBRAP1,TRAP-1,TRAP1;transforming growth factor, beta receptor associated protein 1
hsa:5989;RFX1,EFC,RFX;regulatory factor X, 1 (influences HLA class II expression)
hsa:7365;UGT2B10,UDPGT2B10;UDP glucuronosyltransferase 2 family, polypeptide B10 (EC:2.4.1.17)
hsa:388552;BLOC1S3,BLOS3,HPS8,RP;biogenesis of lysosomal organelles complex-1, subunit 3
hsa:29979;UBQLN1,DA41,DSK2,PLIC-1,UBQN,XDRP1;ubiquilin 1
hsa:23624;CBLC,CBL-3,CBL-SL,RNF57;Cbl proto-oncogene, E3 ubiquitin protein ligase C
hsa:57584;ARHGAP21,ARHGAP10;Rho GTPase activating protein 21
hsa:112483;SAT2,SSAT2;spermidine/spermine N1-acetyltransferase family member 2 (EC:2.3.1.57)
hsa:201973;CCDC111;coiled-coil domain containing 111
hsa:25894;PLEKHG4,ARHGEF44,PRTPHN1,SCA4;pleckstrin homology domain containing, family G (with RhoGef domain) member 4
hsa:57758;SCUBE2,CEGB1,CEGF1,CEGP1;signal peptide, CUB domain, EGF-like 2
hsa:3298;HSF2,HSF_2,HSTF_2;heat shock transcription factor 2
hsa:54107;POLE3,CHARAC17,CHRAC17,YBL1,p17;polymerase (DNA directed), epsilon 3, accessory subunit (EC:2.7.7.7)
hsa:64175;LEPRE1,GROS1,OI8,P3H1;leucine proline-enriched proteoglycan (leprecan) 1 (EC:1.14.11.7)
hsa:54843;SYTL2,CHR11SYT,EXO4,SGA72M,SLP2,SLP2A;synaptotagmin-like 2
hsa:57705;WDFY4,C10orf64;WDFY family member 4
hsa:53938;PPIL3,CYPJ;peptidylprolyl isomerase (cyclophilin)-like 3 (EC:5.2.1.8)
hsa:375287;RBM43,C2orf38;RNA binding motif protein 43
hsa:56666;PANX2,PX2,hPANX2;pannexin 2
hsa:55757;UGGT2,HUGT2,UGCGL2,UGT2;UDP-glucose glycoprotein glucosyltransferase 2
hsa:415116;PIM3,pim-3;pim-3 oncogene (EC:2.7.11.1)
hsa:221264;AKD1,AKD2,C6orf199,C6orf224,RP1-70A9.1,dJ70A9.1;adenylate kinase domain containing 1
hsa:10574;CCT7,CCTETA,CCTH,NIP7-1,TCP1ETA;chaperonin containing TCP1, subunit 7 (eta)
hsa:5791;PTPRE,HPTPE,PTPE,R-PTP-EPSILON;protein tyrosine phosphatase, receptor type, E (EC:3.1.3.48)
hsa:285237;C3orf38;chromosome 3 open reading frame 38
hsa:51629;SLC25A39,CGI69;solute carrier family 25, member 39
hsa:27094;KCNMB3,BKBETA3,HBETA3,KCNMB2,KCNMBL,SLOBETA3;potassium large conductance calcium-activated channel, subfamily M beta member 3
hsa:1628;DBP,DABP;D site of albumin promoter (albumin D-box) binding protein
hsa:23592;LEMD3,MAN1;LEM domain containing 3
hsa:10053;AP1M2,AP1-mu2,HSMU1B,MU-1B,MU1B,mu2;adaptor-related protein complex 1, mu 2 subunit
hsa:55843;ARHGAP15,BM046;Rho GTPase activating protein 15
hsa:126326;GIPC3,C19orf64,DFNB15,DFNB72,DFNB95;GIPC PDZ domain containing family, member 3
hsa:84787;SUV420H2,KMT5C;suppressor of variegation 4-20 homolog 2 (Drosophila) (EC:2.1.1.43)
hsa:376267;RAB15;RAB15, member RAS oncogene family
hsa:64084;CLSTN2,ALC-GAMMA,CDHR13,CS2,CSTN2,alcagamma;calsyntenin 2
hsa:26052;DNM3;dynamin 3 (EC:3.6.5.5)
hsa:10998;SLC27A5,ACSB,ACSVL6,BACS,BAL,FACVL3,FATP-5,FATP5,VLACSR,VLCS-H2,VLCSH2;solute carrier family 27 (fatty acid transporter), member 5 (EC:6.2.1.7)
hsa:126402;CCDC105;coiled-coil domain containing 105
hsa:253512;SLC25A30,KMCP1;solute carrier family 25, member 30
hsa:23413;NCS1,FLUP,FREQ;neuronal calcium sensor 1
hsa:6543;SLC8A2,NCX2;solute carrier family 8 (sodium/calcium exchanger), member 2
hsa:64122;FN3K;fructosamine 3 kinase (EC:2.7.1.-)
hsa:55278;QRSL1,GatA;glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1
hsa:7027;TFDP1,DP1,DRTF1,Dp-1;transcription factor Dp-1
hsa:140901;STK35,CLIK1,STK35L1;serine/threonine kinase 35 (EC:2.7.11.1)
hsa:93664;CADPS2;Ca++-dependent secretion activator 2
hsa:84310;C7orf50,YCR016W;chromosome 7 open reading frame 50
hsa:64850;AGXT2L1;alanine-glyoxylate aminotransferase 2-like 1 (EC:4.2.3.2)
hsa:55203;LGI2,LGIL2;leucine-rich repeat LGI family, member 2
hsa:1088;CEACAM8,CD66b,CD67,CGM6,NCA-95;carcinoembryonic antigen-related cell adhesion molecule 8
hsa:761;CA3,CAIII,Car3;carbonic anhydrase III, muscle specific (EC:4.2.1.1)
hsa:26270;FBXO6,FBG2,FBS2,FBX6,Fbx6b;F-box protein 6
hsa:23049;SMG1,61E3.4,ATX,LIP;smg-1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) (EC:2.7.11.1)
hsa:4841;NONO,NMT55,NRB54,P54,P54NRB;non-POU domain containing, octamer-binding
hsa:441024;MTHFD2L;methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like (EC:3.5.4.9 1.5.1.15)
hsa:84542;;KIAA1841
hsa:1522;CTSZ,CTSX;cathepsin Z (EC:3.4.18.1)
hsa:91369;ANKRD40;ankyrin repeat domain 40
hsa:79366;HMGN5,NBP-45,NSBP1;high mobility group nucleosome binding domain 5
hsa:126282;TNFAIP8L1,TIPE1;tumor necrosis factor, alpha-induced protein 8-like 1
hsa:79932;KIAA0319L;KIAA0319-like
hsa:57552;NCEH1,AADACL1,NCEH;neutral cholesterol ester hydrolase 1 (EC:3.1.1.-)
hsa:285175;UNC80,C2orf21,UNC-80;unc-80 homolog (C. elegans)
hsa:4673;NAP1L1,NAP1,NAP1L,NRP;nucleosome assembly protein 1-like 1
hsa:219844;HYLS1,HLS;hydrolethalus syndrome 1
hsa:66004;LYNX1,SLURP2;Ly6/neurotoxin 1
hsa:344018;FIGLA,BHLHC8,FIGALPHA,POF6;folliculogenesis specific basic helix-loop-helix
hsa:6872;TAF1,BA2R,CCG1,CCGS,DYT3,DYT3/TAF1,KAT4,N-TAF1,NSCL2,OF,P250,TAF2A,TAFII250,XDP;TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa (EC:2.7.11.1)
hsa:79849;PDZD3,IKEPP,NHERF4,PDZK2;PDZ domain containing 3
hsa:115350;FCRL1,CD307a,FCRH1,IFGP1,IRTA5;Fc receptor-like 1
hsa:1946;EFNA5,AF1,EFL5,EPLG7,GLC1M,LERK7,RAGS;ephrin-A5
hsa:491;ATP2B2,PMCA2,PMCA2a,PMCA2i;ATPase, Ca++ transporting, plasma membrane 2 (EC:3.6.3.8)
hsa:64795;RMND5A,CTLH,GID2,GID2A,RMD5,p44CTLH;required for meiotic nuclear division 5 homolog A (S. cerevisiae)
hsa:9213;XPR1,SYG1,X3;xenotropic and polytropic retrovirus receptor 1
hsa:1195;CLK1,CLK,CLK/STY,STY;CDC-like kinase 1 (EC:2.7.12.1)
hsa:84873;GPR128;G protein-coupled receptor 128
hsa:1375;CPT1B,CPT1-M,CPT1M,CPTI,CPTI-M,M-CPT1,MCCPT1,MCPT1;carnitine palmitoyltransferase 1B (muscle) (EC:2.3.1.21)
hsa:5250;SLC25A3,PHC,PTP;solute carrier family 25 (mitochondrial carrier;phosphate carrier), member 3
hsa:54884;RETSAT;retinol saturase (all-trans-retinol 13,14-reductase) (EC:1.3.99.23)
hsa:285852;TREML4,TLT-4,TLT4;triggering receptor expressed on myeloid cells-like 4
hsa:115704;EVI5L;ecotropic viral integration site 5-like
hsa:1347;COX7A2,COX7AL,COX7AL1,COXVIIAL,COXVIIa-L,VIIAL;cytochrome c oxidase subunit VIIa polypeptide 2 (liver) (EC:1.9.3.1)
hsa:79047;KCTD15;potassium channel tetramerisation domain containing 15
hsa:115362;GBP5,GBP-5;guanylate binding protein 5
hsa:57619;SHROOM3,APXL3,SHRM,ShrmL;shroom family member 3
hsa:149428;BNIPL,BNIP-S,BNIPL-1,BNIPL-2,BNIPL1,BNIPL2,BNIPS,PP753;BCL2/adenovirus E1B 19kD interacting protein like
hsa:8971;H1FX,H1X;H1 histone family, member X
hsa:54704;PDP1,PDH,PDP,PDPC,PPM2C;pyruvate dehyrogenase phosphatase catalytic subunit 1 (EC:3.1.3.43)
hsa:494115;RBMXL1,RBM1;RNA binding motif protein, X-linked-like 1
hsa:9462;RASAL2,NGAP;RAS protein activator like 2
hsa:57828;CATSPERG,C19orf15;catsper channel auxiliary subunit gamma
hsa:2035;EPB41,4.1R,EL1,HE;erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked)
hsa:339983;NAT8L,CML3,NACED,NAT8-LIKE;N-acetyltransferase 8-like (GCN5-related, putative) (EC:2.3.1.17)
hsa:3338;DNAJC4,DANJC4,HSPF2,MCG18;DnaJ (Hsp40) homolog, subfamily C, member 4
hsa:81579;PLA2G12A,GXII,PLA2G12,ROSSY;phospholipase A2, group XIIA (EC:3.1.1.4)
hsa:115361;GBP4,Mpa2;guanylate binding protein 4
hsa:6158;RPL28,L28;ribosomal protein L28 (EC:3.6.5.3)
hsa:10170;DHRS9,3ALPHA-HSD,RDH-TBE,RDH15,RDHL,RDHTBE,RETSDR8,SDR9C4;dehydrogenase/reductase (SDR family) member 9
hsa:51535;PPHLN1,HSPC232;periphilin 1
hsa:4974;OMG,OMGP;oligodendrocyte myelin glycoprotein
hsa:55536;CDCA7L,JPO2,R1,RAM2;cell division cycle associated 7-like
hsa:1353;COX11,COX11P;cytochrome c oxidase assembly homolog 11 (yeast)
hsa:971;CD72,CD72b,LYB2;CD72 molecule
hsa:9673;SLC25A44,RP11-54H19.3;solute carrier family 25, member 44
hsa:9635;CLCA2,CACC,CACC3,CLCRG2,CaCC-3;chloride channel accessory 2
hsa:55101;ATP5SL;ATP5S-like
hsa:4680;CEACAM6,CD66c,CEAL,NCA;carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
hsa:139341;FUNDC1;FUN14 domain containing 1
hsa:114902;C1QTNF5,CTRP5,LORD;C1q and tumor necrosis factor related protein 5
hsa:55998;NXF5;nuclear RNA export factor 5
hsa:132724;TMPRSS11B;transmembrane protease, serine 11B
hsa:2743;GLRB,HKPX2;glycine receptor, beta
hsa:25814;ATXN10,E46L,HUMEEP,SCA10;ataxin 10
hsa:25890;ABI3BP,NESHBP,TARSH;ABI family, member 3 (NESH) binding protein
hsa:1794;DOCK2;dedicator of cytokinesis 2
hsa:2262;GPC5;glypican 5
hsa:9603;NFE2L3,NRF3;nuclear factor (erythroid-derived 2)-like 3
hsa:6503;SLA,SLA1,SLAP;Src-like-adaptor
hsa:1040;CDS1,CDS;CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 (EC:2.7.7.41)
hsa:83447;SLC25A31,AAC4,ANT4,SFEC35kDa;solute carrier family 25 (mitochondrial carrier;adenine nucleotide translocator), member 31
hsa:8774;NAPG,GAMMASNAP;N-ethylmaleimide-sensitive factor attachment protein, gamma
hsa:78991;PCYOX1L;prenylcysteine oxidase 1 like
hsa:134526;ACOT12,CACH-1,Cach,STARD15,THEAL;acyl-CoA thioesterase 12 (EC:3.1.2.1)
hsa:1607;DGKB,DAGK2,DGK,DGK-BETA;diacylglycerol kinase, beta 90kDa (EC:2.7.1.107)
hsa:148811;PM20D1,Cps1;peptidase M20 domain containing 1 (EC:3.4.17.-)
hsa:167127;UGT3A2;UDP glycosyltransferase 3 family, polypeptide A2 (EC:2.4.1.17)
hsa:7325;UBE2E2,UBCH8;ubiquitin-conjugating enzyme E2E 2 (EC:6.3.2.19)
hsa:55327;LIN7C,LIN-7-C,LIN-7C,MALS-3,MALS3,VELI3;lin-7 homolog C (C. elegans)
hsa:55344;PLCXD1;phosphatidylinositol-specific phospholipase C, X domain containing 1
hsa:399694;SHC4,RaLP,SHCD;SHC (Src homology 2 domain containing) family, member 4
hsa:154865;IQUB;IQ motif and ubiquitin domain containing
hsa:2669;GEM,KIR;GTP binding protein overexpressed in skeletal muscle
hsa:23143;LRCH1,CHDC1,NP81;leucine-rich repeats and calponin homology (CH) domain containing 1
hsa:143162;FRMPD2,PDZD5C,PDZK4,PDZK5C;FERM and PDZ domain containing 2
hsa:26581;DUX5,DUX1;double homeobox 5
hsa:9804;TOMM20,MAS20,MOM19,TOM20;translocase of outer mitochondrial membrane 20 homolog (yeast)
hsa:10969;EBNA1BP2,EBP2,NOBP,P40;EBNA1 binding protein 2
hsa:5209;PFKFB3,IPFK2,PFK2;6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (EC:2.7.1.105 3.1.3.46)
hsa:63893;UBE2O,E2-230K;ubiquitin-conjugating enzyme E2O (EC:6.3.2.19)
hsa:55811;ADCY10,HCA2,RP1-313L4.2,SAC,SACI,Sacy;adenylate cyclase 10 (soluble) (EC:4.6.1.1)
hsa:4650;MYO9B,CELIAC4,MYR5;myosin IXB
hsa:1979;EIF4EBP2,4EBP2,PHASII;eukaryotic translation initiation factor 4E binding protein 2
hsa:6887;TAL2;T-cell acute lymphocytic leukemia 2
hsa:6565;SLC15A2,PEPT2;solute carrier family 15 (H+/peptide transporter), member 2
hsa:171425;CLYBL,CLB,bA134O15.1;citrate lyase beta like
hsa:2554;GABRA1,ECA4,EJM,EJM5;gamma-aminobutyric acid (GABA) A receptor, alpha 1
hsa:53940;FTHL17,CT38;ferritin, heavy polypeptide-like 17
hsa:7866;IFRD2,IFNRP,SKMc15,SM15;interferon-related developmental regulator 2
hsa:9318;COPS2,ALIEN,CSN2,SGN2,TRIP15;COP9 signalosome subunit 2
hsa:7171;TPM4;tropomyosin 4
hsa:212;ALAS2,ALAS-E,ALASE,ANH1,ASB,XLDPP,XLEPP,XLSA;aminolevulinate, delta-, synthase 2 (EC:2.3.1.37)
hsa:84939;MUM1,EXPAND1,HSPC211,MUM-1;melanoma associated antigen (mutated) 1
hsa:163882;CNST,C1orf71,PPP1R64;consortin, connexin sorting protein
hsa:5459;POU4F3,BRN3C,DFNA15;POU class 4 homeobox 3
hsa:1633;DCK;deoxycytidine kinase (EC:2.7.1.74)
hsa:55677;IWS1;IWS1 homolog (S. cerevisiae)
hsa:8178;ELL,C19orf17,ELL1,MEN,PPP1R68;elongation factor RNA polymerase II
hsa:26582;DUX3;double homeobox 3
hsa:60491;NIF3L1,ALS2CR1,CALS-7;NIF3 NGG1 interacting factor 3-like 1 (S. cerevisiae)
hsa:347902;AMIGO2,ALI1,AMIGO-2,DEGA;adhesion molecule with Ig-like domain 2
hsa:7011;TEP1,TLP1,TP1,TROVE1,VAULT2,p240;telomerase-associated protein 1
hsa:1551;CYP3A7,CP37,CYPIIIA7,P450-HFLA;cytochrome P450, family 3, subfamily A, polypeptide 7 (EC:1.14.14.1)
hsa:201134;CEP112,CCDC46,MACOCO;centrosomal protein 112kDa
hsa:114134;SLC2A13,HMIT;solute carrier family 2 (facilitated glucose transporter), member 13
hsa:64225;ATL2,ARL3IP2,ARL6IP2,atlastin2;atlastin GTPase 2
hsa:1539;CYLC2;cylicin, basic protein of sperm head cytoskeleton 2
hsa:10584;COLEC10,CLL1;collectin sub-family member 10 (C-type lectin)
hsa:4354;MPP1,AAG12,DXS552E,EMP55,MRG1,PEMP;membrane protein, palmitoylated 1, 55kDa
hsa:8831;SYNGAP1,MRD5,RASA1,RASA5,SYNGAP;synaptic Ras GTPase activating protein 1
hsa:1436;CSF1R,C-FMS,CD115,CSF-1R,CSFR,FIM2,FMS,HDLS,M-CSF-R;colony stimulating factor 1 receptor (EC:2.7.10.1)
hsa:161823;ADAL;adenosine deaminase-like (EC:3.5.4.-)
hsa:768206;PRCD,RP36;progressive rod-cone degeneration
hsa:7342;UBP1,LBP-1B,LBP-1a,LBP1A,LBP1B;upstream binding protein 1 (LBP-1a)
hsa:222256;CDHR3,CDH28;cadherin-related family member 3
hsa:2975;GTF3C1,TFIIIC,TFIIIC220,TFIIICalpha;general transcription factor IIIC, polypeptide 1, alpha 220kDa
hsa:25959;KANK2,ANKRD25,MXRA3,SIP;KN motif and ankyrin repeat domains 2
hsa:400966;RGPD1,RGP1,RGPD2,RanBP2L2;RANBP2-like and GRIP domain containing 1
hsa:6330;SCN4B,LQT10,Navbeta4;sodium channel, voltage-gated, type IV, beta subunit
hsa:56479;KCNQ5,Kv7.5;potassium voltage-gated channel, KQT-like subfamily, member 5
hsa:2145;EZH1,KMT6B;enhancer of zeste homolog 1 (Drosophila) (EC:2.1.1.43)
hsa:80153;EDC3,LSM16,YJDC,YJEFN2;enhancer of mRNA decapping 3 homolog (S. cerevisiae)
hsa:79816;TLE6,GRG6;transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila)
hsa:25813;SAMM50,OMP85,SAM50,TOB55,TRG-3,YNL026W;sorting and assembly machinery component 50 homolog (S. cerevisiae)
hsa:8816;DCAF5,BCRG2,BCRP2,D14S1461E,WDR22;DDB1 and CUL4 associated factor 5
hsa:92002;FAM58A,STAR;family with sequence similarity 58, member A
hsa:10440;TIMM17A,TIM17,TIM17A;translocase of inner mitochondrial membrane 17 homolog A (yeast)
hsa:8605;PLA2G4C,CPLA2-gamma;phospholipase A2, group IVC (cytosolic, calcium-independent) (EC:3.1.1.4)
hsa:117178;SSX2IP,ADIP;synovial sarcoma, X breakpoint 2 interacting protein
hsa:3340;NDST1,HSST,NST1;N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 (EC:2.8.2.8)
hsa:81035;COLEC12,CLP1,NSR2,SCARA4,SRCL;collectin sub-family member 12
hsa:3441;IFNA4,IFN-alpha4a,INFA4;interferon, alpha 4
hsa:255189;PLA2G4F,PLA2G4FZ;phospholipase A2, group IVF (EC:3.1.1.4)
hsa:123606;NIPA1,FSP3,SPG6;non imprinted in Prader-Willi/Angelman syndrome 1
hsa:4045;LSAMP,IGLON3,LAMP;limbic system-associated membrane protein
hsa:58538;MPP4,ALS2CR5,DLG6;membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4)
hsa:27000;DNAJC2,MPHOSPH11,MPP11,ZRF1,ZUO1;DnaJ (Hsp40) homolog, subfamily C, member 2
hsa:23012;STK38L,NDR2;serine/threonine kinase 38 like (EC:2.7.11.1)
hsa:215;ABCD1,ABC42,ALD,ALDP,AMN;ATP-binding cassette, sub-family D (ALD), member 1
hsa:11276;SYNRG,AP1GBP1,SYNG;synergin, gamma
hsa:25806;VAX2,DRES93;ventral anterior homeobox 2
hsa:9118;INA,NEF5,NF-66,TXBP-1;internexin neuronal intermediate filament protein, alpha
hsa:2618;GART,AIRS,GARS,GARTF,PAIS,PGFT,PRGS;phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase (EC:2.1.2.2 6.3.3.1 6.3.4.13)
hsa:23085;ERC1,Cast2,ELKS,RAB6IP2;ELKS/RAB6-interacting/CAST family member 1
hsa:3238;HOXD12,HOX4H;homeobox D12
hsa:2840;GPR17;G protein-coupled receptor 17
hsa:55897;MESP1,bHLHc5;mesoderm posterior 1 homolog (mouse)
hsa:55856;ACOT13,PNAS-27,THEM2;acyl-CoA thioesterase 13
hsa:5837;PYGM;phosphorylase, glycogen, muscle (EC:2.4.1.1)
hsa:800;CALD1,CDM,H-CAD,HCAD,L-CAD,LCAD,NAG22;caldesmon 1
hsa:5361;PLXNA1,NOV,NOVP,PLEXIN-A1,PLXN1;plexin A1
hsa:79645;EFCAB1;EF-hand calcium binding domain 1
hsa:79075;DSCC1,DCC1;defective in sister chromatid cohesion 1 homolog (S. cerevisiae)
hsa:143879;KBTBD3,BKLHD3;kelch repeat and BTB (POZ) domain containing 3
hsa:5651;TMPRSS15,ENTK,PRSS7;transmembrane protease, serine 15 (EC:3.4.21.9)
hsa:25870;SUMF2,pFGE;sulfatase modifying factor 2
hsa:64116;SLC39A8,BIGM103,LZT-Hs6,ZIP8;solute carrier family 39 (zinc transporter), member 8
hsa:2117;ETV3,METS,PE-1,PE1,bA110J1.4;ets variant 3
hsa:7087;ICAM5,TLCN,TLN;intercellular adhesion molecule 5, telencephalin
hsa:2846;LPAR4,GPR23,LPA4,P2RY9,P2Y5-LIKE,P2Y9;lysophosphatidic acid receptor 4
hsa:2041;EPHA1,EPH,EPHT,EPHT1;EPH receptor A1 (EC:2.7.10.1)
hsa:2588;GALNS,GALNAC6S,GAS,MPS4A;galactosamine (N-acetyl)-6-sulfate sulfatase (EC:3.1.6.4)
hsa:147945;NLRP4,CLR19.5,CT58,NALP4,PAN2,PYPAF4,RNH2;NLR family, pyrin domain containing 4
hsa:5349;FXYD3,MAT8,PLML;FXYD domain containing ion transport regulator 3
hsa:10886;NPFFR2,GPR74,HLWAR77,NPFF2,NPGPR;neuropeptide FF receptor 2
hsa:57458;TMCC3;transmembrane and coiled-coil domain family 3
hsa:204801;NLRP11,CLR19.6,NALP11,NOD17,PAN10,PYPAF6,PYPAF7;NLR family, pyrin domain containing 11
hsa:84919;PPP1R15B,CREP;protein phosphatase 1, regulatory subunit 15B
hsa:6518;SLC2A5,GLUT-5,GLUT5;solute carrier family 2 (facilitated glucose/fructose transporter), member 5
hsa:83856;FSD1L,CCDC10,CSDUFD1,FSD1CL,FSD1NL,MIR1;fibronectin type III and SPRY domain containing 1-like
hsa:160287;LDHAL6A,LDH6A;lactate dehydrogenase A-like 6A (EC:1.1.1.27)
hsa:2566;GABRG2,CAE2,ECA2,GEFSP3;gamma-aminobutyric acid (GABA) A receptor, gamma 2
hsa:29850;TRPM5,LTRPC5,MTR1;transient receptor potential cation channel, subfamily M, member 5
hsa:3960;LGALS4,GAL4,L36LBP;lectin, galactoside-binding, soluble, 4
hsa:84172;POLR1B,RPA135,RPA2,Rpo1-2;polymerase (RNA) I polypeptide B, 128kDa (EC:2.7.7.6)
hsa:83666;PARP9,ARTD9,BAL,BAL1,MGC:7868;poly (ADP-ribose) polymerase family, member 9 (EC:2.4.2.30)
hsa:132612;ADAD1,Tenr;adenosine deaminase domain containing 1 (testis-specific)
hsa:23784;POTEH,A26C3,ACTBL1,CT104.7,POTE22;POTE ankyrin domain family, member H
hsa:259308;FAM205A,C9orf144B;family with sequence similarity 205, member A
hsa:162466;PHOSPHO1;phosphatase, orphan 1 (EC:3.1.3.75)
hsa:219293;ATAD3C;ATPase family, AAA domain containing 3C
hsa:29924;EPN1;epsin 1
hsa:25977;NECAP1;NECAP endocytosis associated 1
hsa:374882;TMEM205,UNQ501;transmembrane protein 205
hsa:134265;AFAP1L1;actin filament associated protein 1-like 1
hsa:2330;FMO5;flavin containing monooxygenase 5 (EC:1.14.13.8)
hsa:139596;UPRT,FUR1,UPP;uracil phosphoribosyltransferase (FUR1) homolog (S. cerevisiae) (EC:2.4.2.9)
hsa:6431;SRSF6,B52,SFRS6,SRP55;serine/arginine-rich splicing factor 6
hsa:339366;ADAMTSL5,THSD6;ADAMTS-like 5
hsa:57157;PHTF2;putative homeodomain transcription factor 2
hsa:50805;IRX4,IRXA3;iroquois homeobox 4
hsa:10157;AASS,LKR/SDH,LKRSDH,LORSDH;aminoadipate-semialdehyde synthase (EC:1.5.1.8 1.5.1.9)
hsa:5965;RECQL,RECQL1,RecQ1;RecQ protein-like (DNA helicase Q1-like) (EC:3.6.4.12)
hsa:57121;LPAR5,GPR92,GPR93,KPG_010,LPA5;lysophosphatidic acid receptor 5
hsa:84229;CCDC135,C16orf50,FAP50;coiled-coil domain containing 135
hsa:170825;GSX2,GSH2;GS homeobox 2
hsa:64077;LHPP,HDHD2B;phospholysine phosphohistidine inorganic pyrophosphate phosphatase (EC:3.6.1.1)
hsa:163933;FAM43B;family with sequence similarity 43, member B
hsa:90390;MED30,MED30S,THRAP6,TRAP25;mediator complex subunit 30
hsa:283537;SLC46A3,FKSG16;solute carrier family 46, member 3
hsa:55753;OGDHL;oxoglutarate dehydrogenase-like (EC:1.2.4.-)
hsa:84881;RPUSD4;RNA pseudouridylate synthase domain containing 4 (EC:5.4.99.12)
hsa:5365;PLXNB3,PLEXB3,PLEXR,PLXN6;plexin B3
hsa:22844;FRMPD1,FRMD2;FERM and PDZ domain containing 1
hsa:642623;UBTFL1,C11orf27,HMGPI;upstream binding transcription factor, RNA polymerase I-like 1
hsa:64881;PCDH20,PCDH13;protocadherin 20
hsa:2963;GTF2F2,BTF4,RAP30,TF2F2,TFIIF;general transcription factor IIF, polypeptide 2, 30kDa (EC:3.6.4.12)
hsa:57561;ARRDC3,TLIMP;arrestin domain containing 3
hsa:55805;LRP2BP;LRP2 binding protein
hsa:7499;XG,PBDX;Xg blood group
hsa:57666;FBRSL1;fibrosin-like 1
hsa:5339;PLEC,EBS1,EBSO,HD1,LGMD2Q,PCN,PLEC1,PLEC1b,PLTN;plectin
hsa:84935;MEDAG,AWMS3,C13orf33,MEDA-4,MEDA4,hAWMS3;mesenteric estrogen-dependent adipogenesis
hsa:115294;PCMTD1;protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1
hsa:339488;TFAP2E,AP2E;transcription factor AP-2 epsilon (activating enhancer binding protein 2 epsilon)
hsa:83933;HDAC10,HD10;histone deacetylase 10 (EC:3.5.1.98)
hsa:152273;FGD5,ZFYVE23;FYVE, RhoGEF and PH domain containing 5
hsa:8019;BRD3,ORFX,RING3L;bromodomain containing 3
hsa:9825;SPATA2,PD1,tamo;spermatogenesis associated 2
hsa:653247;PRB2,IB-9,PRPPRB1,Ps,cP7;proline-rich protein BstNI subfamily 2
hsa:8438;RAD54L,HR54,RAD54A,hHR54,hRAD54;RAD54-like (S. cerevisiae)
hsa:9445;ITM2B,ABRI,BRI,BRI2,BRICD2B,E25B,E3-16,FBD,imBRI2;integral membrane protein 2B
hsa:5357;PLS1;plastin 1
hsa:57030;SLC17A7,BNPI,VGLUT1;solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7
hsa:23471;TRAM1,PNAS8,TRAM,TRAMP;translocation associated membrane protein 1
hsa:7368;UGT8,CGT,UGT4;UDP glycosyltransferase 8 (EC:2.4.1.45)
hsa:30;ACAA1,ACAA,PTHIO,THIO;acetyl-CoA acyltransferase 1 (EC:2.3.1.16)
hsa:114788;CSMD3;CUB and Sushi multiple domains 3
hsa:57864;SLC46A2,Ly110,TSCOT;solute carrier family 46, member 2
hsa:91272;BOD1,FAM44B;biorientation of chromosomes in cell division 1
hsa:133418;EMB;embigin
hsa:55300;PI4K2B,PI4KIIB,PIK42B;phosphatidylinositol 4-kinase type 2 beta (EC:2.7.1.67)
hsa:66035;SLC2A11,GLUT10,GLUT11,SLC2A11-a,SLC2A11-c;solute carrier family 2 (facilitated glucose transporter), member 11
hsa:55924;FAM212B,C1orf183;family with sequence similarity 212, member B
hsa:9419;CRIPT;cysteine-rich PDZ-binding protein
hsa:121260;SLC15A4,PHT1,PTR4;solute carrier family 15, member 4
hsa:10082;GPC6,OMIMD1;glypican 6
hsa:389941;C1QL3,C1QTNF13,C1ql,CTRP13,K100;complement component 1, q subcomponent-like 3
hsa:6949;TCOF1,MFD1,TCS1,treacle;Treacher Collins-Franceschetti syndrome 1
hsa:54206;ERRFI1,GENE-33,MIG-6,MIG6,RALT;ERBB receptor feedback inhibitor 1
hsa:9900;SV2A,SV2;synaptic vesicle glycoprotein 2A
hsa:9071;CLDN10,CPETRL3,OSP-L;claudin 10
hsa:23529;CLCF1,BSF-3,BSF3,CISS2,CLC,NNT-1,NNT1,NR6;cardiotrophin-like cytokine factor 1
hsa:10164;CHST4,GST3,GlcNAc6ST2,HECGLCNAC6ST,LSST;carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4
hsa:10389;SCML2;sex comb on midleg-like 2 (Drosophila)
hsa:3707;ITPKB,IP3-3KB,IP3K,IP3K-B,IP3KB,PIG37;inositol-trisphosphate 3-kinase B (EC:2.7.1.127)
hsa:80309;SPHKAP,SKIP;SPHK1 interactor, AKAP domain containing
hsa:51593;SRRT,ARS2,ASR2,serrate;serrate RNA effector molecule homolog (Arabidopsis)
hsa:27316;RBMX,HNRPG,RBMXP1,RBMXRT,RNMX,hnRNP-G;RNA binding motif protein, X-linked
hsa:144811;LACC1,C13orf31;laccase (multicopper oxidoreductase) domain containing 1
hsa:26281;FGF20,FGF-20;fibroblast growth factor 20
hsa:127731;VWA5B1;von Willebrand factor A domain containing 5B1
hsa:54514;DDX4,VASA;DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 (EC:3.6.4.13)
hsa:51175;TUBE1,TUBE,dJ142L7.2;tubulin, epsilon 1
hsa:4025;LPO,SPO;lactoperoxidase (EC:1.11.1.7)
hsa:94122;SYTL5,slp5;synaptotagmin-like 5
hsa:55346;TCP11L1,dJ85M6.3;t-complex 11, testis-specific-like 1
hsa:2734;GLG1,CFR-1,ESL-1,MG-160,MG160;golgi glycoprotein 1
hsa:56992;KIF15,HKLP2,KNSL7,NY-BR-62;kinesin family member 15
hsa:4058;LTK,TYK1;leukocyte receptor tyrosine kinase (EC:2.7.10.1)
hsa:10509;SEMA4B,SEMAC,SemC;sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B
hsa:80179;MYO19,MYOHD1;myosin XIX
hsa:132720;C4orf32;chromosome 4 open reading frame 32
hsa:84814;PPAPDC3,C9orf67,NET39;phosphatidic acid phosphatase type 2 domain containing 3 (EC:3.1.3.-)
hsa:1355;COX15;cytochrome c oxidase assembly homolog 15 (yeast)
hsa:79799;UGT2A3;UDP glucuronosyltransferase 2 family, polypeptide A3 (EC:2.4.1.17)
hsa:54947;LPCAT2,AYTL1,LysoPAFAT;lysophosphatidylcholine acyltransferase 2 (EC:2.3.1.23 2.3.1.67)
hsa:55515;ASIC4,ACCN4,BNAC4;acid-sensing (proton-gated) ion channel family member 4
hsa:7072;TIA1,TIA-1;TIA1 cytotoxic granule-associated RNA binding protein
hsa:320;APBA1,D9S411E,LIN10,MINT1,X11,X11A,X11ALPHA;amyloid beta (A4) precursor protein-binding, family A, member 1
hsa:5782;PTPN12,PTP-PEST,PTPG1;protein tyrosine phosphatase, non-receptor type 12 (EC:3.1.3.48)
hsa:55171;TBCCD1;TBCC domain containing 1
hsa:51559;NT5DC3,TU12B1-TY,TU12B1TY;5'-nucleotidase domain containing 3
hsa:4589;MUC7,MG2;mucin 7, secreted
hsa:84929;FIBCD1;fibrinogen C domain containing 1
hsa:55257;MRGBP,C20orf20,Eaf7,MRG15BP,URCC4;MRG/MORF4L binding protein
hsa:4753;NELL2,NRP2;NEL-like 2 (chicken)
hsa:79568;C2orf47;chromosome 2 open reading frame 47
hsa:2760;GM2A,GM2-AP,SAP-3;GM2 ganglioside activator
hsa:22947;DUX4,DUX10;double homeobox 4
hsa:55790;CSGALNACT1,CSGalNAcT-1,ChGn,beta4GalNAcT;chondroitin sulfate N-acetylgalactosaminyltransferase 1 (EC:2.4.1.174)
hsa:9472;AKAP6,ADAP100,ADAP6,AKAP100,PRKA6,mAKAP;A kinase (PRKA) anchor protein 6
hsa:9289;GPR56,BFPP,TM7LN4,TM7XN1;G protein-coupled receptor 56
hsa:9111;NMI;N-myc (and STAT) interactor
hsa:321;APBA2,D15S1518E,HsT16821,LIN-10,MGC:14091,MINT2,X11-BETA,X11L;amyloid beta (A4) precursor protein-binding, family A, member 2
hsa:64216;TFB2M,Hkp1,mtTFB2;transcription factor B2, mitochondrial
hsa:372;ARCN1,COPD;archain 1
hsa:56474;CTPS2;CTP synthase 2 (EC:6.3.4.2)
hsa:55214;LEPREL1,MCVD,MLAT4,P3H2;leprecan-like 1 (EC:1.14.11.7)
hsa:83481;EPPK1,EPIPL,EPIPL1;epiplakin 1
hsa:6229;RPS24,DBA3,S24;ribosomal protein S24
hsa:135228;CD109,CPAMD7,RP11-525G3.1;CD109 molecule
hsa:10166;SLC25A15,D13S327,HHH,ORC1,ORNT1;solute carrier family 25 (mitochondrial carrier;ornithine transporter) member 15
hsa:83440;ADPGK,2610017G09Rik,ADP-GK;ADP-dependent glucokinase (EC:2.7.1.147)
hsa:220164;DOK6,DOK5L,HsT3226;docking protein 6
hsa:51768;TM7SF3;transmembrane 7 superfamily member 3
hsa:91875;TTC5,Strap;tetratricopeptide repeat domain 5
hsa:79587;CARS2;cysteinyl-tRNA synthetase 2, mitochondrial (putative) (EC:6.1.1.16)
hsa:57501;;KIAA1257
hsa:6547;SLC8A3,NCX3;solute carrier family 8 (sodium/calcium exchanger), member 3
hsa:2979;GUCA1B,GCAP2,GUCA2,RP48;guanylate cyclase activator 1B (retina)
hsa:2969;GTF2I,BAP135,BTKAP1,DIWS,GTFII-I,IB291,SPIN,TFII-I,WBS,WBSCR6;general transcription factor IIi
hsa:80705;TSGA10,CEP4L,CT79;testis specific, 10
hsa:4729;NDUFV2,CI-24k;NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa (EC:1.6.5.3 1.6.99.3)
hsa:51027;BOLA1;bolA homolog 1 (E. coli)
hsa:92906;HNRPLL,SRRF,hnRNPLL;heterogeneous nuclear ribonucleoprotein L-like
hsa:55601;DDX60;DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 (EC:3.6.4.13)
hsa:80344;DCAF11,PRO2389,WDR23;DDB1 and CUL4 associated factor 11
hsa:53373;TPCN1,TPC1;two pore segment channel 1
hsa:54998;AURKAIP1,AIP,AKIP;aurora kinase A interacting protein 1
hsa:116461;TSEN15,C1orf19,sen15;tRNA splicing endonuclease 15 homolog (S. cerevisiae)
hsa:5372;PMM1,Sec53;phosphomannomutase 1 (EC:5.4.2.8)
hsa:26122;EPC2,EPC-LIKE;enhancer of polycomb homolog 2 (Drosophila)
hsa:10019;SH2B3,IDDM20,LNK;SH2B adaptor protein 3
hsa:11321;GPN1,ATPBD1A,MBDIN,NTPBP,RPAP4,XAB1;GPN-loop GTPase 1;K06883
hsa:84991;RBM17,SPF45;RNA binding motif protein 17
hsa:57468;SLC12A5,KCC2;solute carrier family 12 (potassium/chloride transporter), member 5
hsa:114132;SIGLEC11;sialic acid binding Ig-like lectin 11
hsa:5568;PRKACG,KAPG,PKACg;protein kinase, cAMP-dependent, catalytic, gamma (EC:2.7.11.11)
hsa:494513;DFNB59,PJVK;deafness, autosomal recessive 59
hsa:23181;DIP2A,C21orf106,DIP2;DIP2 disco-interacting protein 2 homolog A (Drosophila)
hsa:9468;PCYT1B,CCTB,CTB;phosphate cytidylyltransferase 1, choline, beta (EC:2.7.7.15)
hsa:2044;EPHA5,CEK7,EHK1,HEK7,TYRO4;EPH receptor A5 (EC:2.7.10.1)
hsa:80162;ATHL1;ATH1, acid trehalase-like 1 (yeast) (EC:3.2.1.-)
hsa:57050;UTP3,CRL1,CRLZ1,SAS10;UTP3, small subunit (SSU) processome component, homolog (S. cerevisiae)
hsa:79677;SMC6,SMC-6,SMC6L1,hSMC6;structural maintenance of chromosomes 6
hsa:85477;SCIN;scinderin
hsa:4800;NFYA,CBF-A,CBF-B,HAP2,NF-YA;nuclear transcription factor Y, alpha
hsa:26053;AUTS2,FBRSL2;autism susceptibility candidate 2
hsa:4723;NDUFV1,CI-51K,CI51KD,UQOR1;NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa (EC:1.6.5.3 1.6.99.3)
hsa:84908;FAM136A;family with sequence similarity 136, member A
hsa:64221;ROBO3,HGPPS,HGPS,RBIG1,RIG1;roundabout, axon guidance receptor, homolog 3 (Drosophila)
hsa:10507;SEMA4D,C9orf164,CD100,M-sema-G,SEMAJ,coll-4;sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
hsa:65217;PCDH15,CDHR15,DFNB23,USH1F;protocadherin-related 15
hsa:2060;EPS15,AF-1P,AF1P,MLLT5;epidermal growth factor receptor pathway substrate 15
hsa:60529;ALX4,FND2,PFM2;ALX homeobox 4
hsa:218;ALDH3A1,ALDH3,ALDHIII;aldehyde dehydrogenase 3 family, member A1 (EC:1.2.1.5)
hsa:2939;GSTA2,GST2,GSTA2-2,GTA2,GTH2;glutathione S-transferase alpha 2 (EC:2.5.1.18)
hsa:55794;DDX28,MDDX28;DEAD (Asp-Glu-Ala-Asp) box polypeptide 28 (EC:3.6.4.13)
hsa:57608;JCAD;KIAA1462
hsa:5081;PAX7,HUP1,PAX7B,RMS2;paired box 7
hsa:130271;PLEKHH2,PLEKHH1L;pleckstrin homology domain containing, family H (with MyTH4 domain) member 2
hsa:3836;KPNA1,IPOA5,NPI-1,RCH2,SRP1;karyopherin alpha 1 (importin alpha 5)
hsa:7274;TTPA,ATTP,AVED,TTP1,alphaTTP;tocopherol (alpha) transfer protein
hsa:57162;PELI1;pellino E3 ubiquitin protein ligase 1
hsa:6924;TCEB3,EloA,SIII,SIII_p110,TCEB3A;transcription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A)
hsa:373156;GSTK1,GST,GST_13-13,GST13,GST13-13,GSTK1-1,hGSTK1;glutathione S-transferase kappa 1 (EC:2.5.1.18)
hsa:56886;UGGT1,HUGT1,UGCGL1,UGT1;UDP-glucose glycoprotein glucosyltransferase 1
hsa:51493;C22orf28,DJ149A16.6,FAAP,RP1-149A16.6;chromosome 22 open reading frame 28 (EC:6.5.1.3)
hsa:152185;SPICE1,CCDC52,SPICE;spindle and centriole associated protein 1
hsa:5635;PRPSAP1,PAP39;phosphoribosyl pyrophosphate synthetase-associated protein 1
hsa:2553;GABPB1,BABPB2,E4TF1,E4TF1-47,E4TF1-53,E4TF1B,GABPB,GABPB2,NRF2B1,NRF2B2;GA binding protein transcription factor, beta subunit 1 (EC:3.2.1.3)
hsa:10605;PAIP1;poly(A) binding protein interacting protein 1
hsa:25780;RASGRP3,GRP3;RAS guanyl releasing protein 3 (calcium and DAG-regulated)
hsa:2940;GSTA3,GSTA3-3,GTA3;glutathione S-transferase alpha 3 (EC:2.5.1.18)
hsa:583;BBS2,BBS;Bardet-Biedl syndrome 2
hsa:91851;CHRDL1,CHL,NRLN1,VOPT,dA141H5.1;chordin-like 1
hsa:5968;REG1B,PSPS2,REGH,REGI-BETA,REGL;regenerating islet-derived 1 beta
hsa:25937;WWTR1,TAZ;WW domain containing transcription regulator 1
hsa:79685;SAP30L,NS4ATP2;SAP30-like
hsa:64838;FNDC4,FRCP1;fibronectin type III domain containing 4
hsa:9790;BMS1,BMS1L;BMS1 homolog, ribosome assembly protein (yeast)
hsa:1087;CEACAM7,CEA,CGM2;carcinoembryonic antigen-related cell adhesion molecule 7
hsa:5967;REG1A,ICRF,P19,PSP,PSPS,PSPS1,PTP,REG;regenerating islet-derived 1 alpha
hsa:152831;KLB,BKL;klotho beta
hsa:9719;ADAMTSL2,GPHYSD1;ADAMTS-like 2
hsa:285600;C5orf36;KIAA0825
hsa:51637;C14orf166,CGI99,CLE,CLE7,LCRP369,RLLM1;chromosome 14 open reading frame 166
hsa:84529;C15orf41,HH114;chromosome 15 open reading frame 41
hsa:91404;SESTD1,SOLO;SEC14 and spectrin domains 1
hsa:5911;RAP2A,K-REV,KREV,RAP2,RbBP-30;RAP2A, member of RAS oncogene family
hsa:196385;DNAH10;dynein, axonemal, heavy chain 10
hsa:152110;NEK10;NIMA-related kinase 10 (EC:2.7.11.1)
hsa:1388;ATF6B,CREB-RP,CREBL1,G13;activating transcription factor 6 beta
hsa:10538;BATF,B-ATF,BATF1,SFA-2,SFA2;basic leucine zipper transcription factor, ATF-like
hsa:57658;CALCOCO1,Cocoa,calphoglin;calcium binding and coiled-coil domain 1
hsa:125115;KRT40,CK-40,K40,KA36;keratin 40
hsa:8439;NSMAF,FAN;neutral sphingomyelinase (N-SMase) activation associated factor
hsa:57325;CSRP2BP,ATAC2,CRP2BP,KAT14,PRO1194,dJ717M23.1;CSRP2 binding protein
hsa:25909;AHCTF1,ELYS,MST108,TMBS62;AT hook containing transcription factor 1
hsa:83639;TEX101,CT131,GTPR867,NYD-SP8,PRO1884,SGRG,TES101RP;testis expressed 101
hsa:3742;KCNA6,HBK2,KV1.6;potassium voltage-gated channel, shaker-related subfamily, member 6
hsa:27102;EIF2AK1,HCR,HRI;eukaryotic translation initiation factor 2-alpha kinase 1 (EC:2.7.11.1)
hsa:27175;TUBG2;tubulin, gamma 2
hsa:79147;FKRP,LGMD2I,MDC1C,MDDGA5,MDDGB5,MDDGC5;fukutin related protein
hsa:5939;RBMS2,SCR3;RNA binding motif, single stranded interacting protein 2
hsa:22980;TCF25,Hulp1,NULP1,PRO2620,hKIAA1049;transcription factor 25 (basic helix-loop-helix)
hsa:79812;MMRN2,EMILIN-3,EMILIN3,ENDOGLYX-1;multimerin 2
hsa:23764;MAFF,U-MAF,hMafF;v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
hsa:58517;RBM25,NET52,RED120,RNPC7,S164,Snu71,fSAP94;RNA binding motif protein 25
hsa:965;CD58,LFA-3,LFA3,ag3;CD58 molecule
hsa:153241;CEP120,CCDC100;centrosomal protein 120kDa
hsa:126074;SWSAP1,C19orf39,SWS1AP1,ZSWIM7AP1;SWIM-type zinc finger 7 associated protein 1
hsa:207063;DHRSX,CXorf11,DHRS5X,DHRS5Y,DHRSXY,DHRSY,SDR46C1;dehydrogenase/reductase (SDR family) X-linked
hsa:1880;GPR183,EBI2;G protein-coupled receptor 183
hsa:6641;SNTB1,59-DAP,A1B,BSYN2,DAPA1B,SNT2,SNT2B1,TIP-43;syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1)
hsa:84541;KBTBD8,TA-KRP;kelch repeat and BTB (POZ) domain containing 8
hsa:89886;SLAMF9,CD2F-10,CD2F10,CD84-H1,CD84H1,SF2001;SLAM family member 9
hsa:10957;PNRC1,B4-2,PNAS-145,PROL2,PRR2;proline-rich nuclear receptor coactivator 1
hsa:114905;C1QTNF7,CTRP7,ZACRP7;C1q and tumor necrosis factor related protein 7
hsa:26146;TRAF3IP1,MIP-T3,MIPT3;TNF receptor-associated factor 3 interacting protein 1
hsa:221662;RBM24,RNPC6,dJ259A10.1;RNA binding motif protein 24
hsa:283383;GPR133,PGR25;G protein-coupled receptor 133
hsa:79768;KATNBL1,C15orf29;katanin p80 subunit B-like 1
hsa:1630;DCC,CRC18,CRCR1,IGDCC1;deleted in colorectal carcinoma
hsa:55225;RAVER2;ribonucleoprotein, PTB-binding 2
hsa:8434;RECK,ST15;reversion-inducing-cysteine-rich protein with kazal motifs
hsa:55089;SLC38A4,ATA3,NAT3,PAAT;solute carrier family 38, member 4
hsa:55200;PLEKHG6,MyoGEF;pleckstrin homology domain containing, family G (with RhoGef domain) member 6
hsa:1293;COL6A3;collagen, type VI, alpha 3
hsa:80790;CMIP,TCMIP;c-Maf inducing protein
hsa:645832;SEBOX,OG-9,OG9,OG9X;SEBOX homeobox
hsa:80351;TNKS2,ARTD6,PARP-5b,PARP-5c,PARP5B,PARP5C,TANK2,TNKL,pART6;tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 (EC:2.4.2.30)
hsa:26751;SH3YL1,RAY;SH3 domain containing, Ysc84-like 1 (S. cerevisiae)
hsa:55023;PHIP,BRWD2,DCAF14,WDR11,ndrp;pleckstrin homology domain interacting protein
hsa:3336;HSPE1,CPN10,EPF,GROES,HSP10;heat shock 10kDa protein 1 (chaperonin 10)
hsa:130540;ALS2CR12;amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12
hsa:23070;FTSJD2,KIAA0082,MTr1,hMTr1;FtsJ methyltransferase domain containing 2 (EC:2.1.1.57)
hsa:91156;IGFN1,EEF1A2BP1;immunoglobulin-like and fibronectin type III domain containing 1
hsa:64208;POPDC3,POP3,RP11-99L11.2,bA355M14.1;popeye domain containing 3
hsa:92344;GORAB,GO,NTKLBP1,SCYL1BP1;golgin, RAB6-interacting
hsa:56986;DTWD1;DTW domain containing 1
hsa:146722;CD300LF,CD300f,CLM-1,CLM1,IREM-1,IREM1,IgSF13,NKIR;CD300 molecule-like family member f
hsa:80324;PUS1,MLASA1;pseudouridylate synthase 1 (EC:5.4.99.12)
hsa:6990;DYNLT3,RP3,TCTE1L,TCTEX1L;dynein, light chain, Tctex-type 3
hsa:84168;ANTXR1,ATR,TEM8;anthrax toxin receptor 1
hsa:2948;GSTM4,GSTM4-4,GTM4;glutathione S-transferase mu 4 (EC:2.5.1.18)
hsa:151295;SLC23A3,E2BP3,SVCT3,Yspl1;solute carrier family 23 (nucleobase transporters), member 3
hsa:9101;USP8,HumORF8,UBPY;ubiquitin specific peptidase 8 (EC:3.4.19.12)
hsa:25975;EGFL6,MAEG,W80;EGF-like-domain, multiple 6
hsa:253559;CADM2,IGSF4D,NECL3,Necl-3,SynCAM_2,synCAM2;cell adhesion molecule 2
hsa:53;ACP2;acid phosphatase 2, lysosomal (EC:3.1.3.2)
hsa:55359;STYK1,NOK,SuRTK106;serine/threonine/tyrosine kinase 1 (EC:2.7.10.2)
hsa:117246;FTSJ3,EPCS3,SPB1;FtsJ homolog 3 (E. coli) (EC:2.1.1.-)
hsa:81619;TSPAN14,DC-TM4F2,TM4SF14;tetraspanin 14
hsa:5783;PTPN13,FAP-1,PNP1,PTP-BAS,PTP-BL,PTP1E,PTPL1,PTPLE,hPTP1E;protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) (EC:3.1.3.48)
hsa:79094;CHAC1;ChaC, cation transport regulator homolog 1 (E. coli)
hsa:79885;HDAC11,HD11;histone deacetylase 11 (EC:3.5.1.98)
hsa:29115;SAP30BP,HCNGP,HTRG,HTRP;SAP30 binding protein
hsa:8907;AP1M1,AP47,CLAPM2,CLTNM,MU-1A;adaptor-related protein complex 1, mu 1 subunit
hsa:2978;GUCA1A,C6orf131,COD3,CORD14,GCAP,GCAP1,GUCA,GUCA1,dJ139D8.6;guanylate cyclase activator 1A (retina)
hsa:79180;EFHD2,SWS1;EF-hand domain family, member D2
hsa:57670;;KIAA1549
hsa:799;CALCR,CRT,CT-R,CTR,CTR1;calcitonin receptor
hsa:55558;PLXNA3,6.3,HSSEXGENE,PLEXIN-A3,PLXN3,PLXN4,SEX,XAP-6;plexin A3
hsa:84365;MKI67IP,NIFK,Nopp34;MKI67 (FHA domain) interacting nucleolar phosphoprotein
hsa:143282;FGFBP3,C10orf13,FGF-BP3;fibroblast growth factor binding protein 3
hsa:55291;PPP6R3,C11orf23,PP6R3,SAP190,SAPL,SAPLa,SAPS3;protein phosphatase 6, regulatory subunit 3
hsa:5090;PBX3;pre-B-cell leukemia homeobox 3
hsa:83696;TRAPPC9,IBP,IKBKBBP,MRT13,NIBP,TRS120;trafficking protein particle complex 9
hsa:138311;FAM69B,C9orf136,pp6977;family with sequence similarity 69, member B
hsa:7323;UBE2D3,E2(17)KB3,UBC4/5,UBCH5C;ubiquitin-conjugating enzyme E2D 3 (EC:6.3.2.19)
hsa:828;CAPS,CAPS1;calcyphosine
hsa:9806;SPOCK2,testican-2;sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2
hsa:25886;POC1A,PIX2,SOFT,WDR51A;POC1 centriolar protein homolog A (Chlamydomonas)
hsa:57596;BEGAIN;brain-enriched guanylate kinase-associated
hsa:390664;C1QTNF8,CTRP8,UNQ5829;C1q and tumor necrosis factor related protein 8
hsa:643664;SLC35G6,AMAC1L3,TMEM21B;solute carrier family 35, member G6
hsa:404672;GTF2H5,C6orf175,TFB5,TFIIH,TGF2H5,TTD,TTD-A,TTDA,bA120J8.2;general transcription factor IIH, polypeptide 5
hsa:9058;SLC13A2,NADC1,NaCT,NaDC-1,SDCT1;solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2
hsa:79918;SETD6;SET domain containing 6
hsa:2526;FUT4,CD15,ELFT,FCT3A,FUC-TIV,FUTIV,LeX,SSEA-1;fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) (EC:2.4.1.-)
hsa:10908;PNPLA6,NTE,NTEMND,SPG39,iPLA2delta,sws;patatin-like phospholipase domain containing 6 (EC:3.1.1.5)
hsa:1133;CHRM5,HM5;cholinergic receptor, muscarinic 5
hsa:6617;SNAPC1,PTFgamma,SNAP43;small nuclear RNA activating complex, polypeptide 1, 43kDa
hsa:23503;ZFYVE26,FYVE-CENT,SPG15;zinc finger, FYVE domain containing 26
hsa:121549;ASCL4,HASH4,bHLHa44;achaete-scute complex homolog 4 (Drosophila)
hsa:84623;KIRREL3,KIRRE,MRD4,NEPH2,PRO4502;kin of IRRE like 3 (Drosophila)
hsa:64282;PAPD5,TRF4-2;PAP associated domain containing 5
hsa:341405;ANKRD33,C12orf7,PANKY;ankyrin repeat domain 33
hsa:79805;VASH2,RP11-275G3.1;vasohibin 2
hsa:55973;BCAP29,BAP29;B-cell receptor-associated protein 29
hsa:91442;C19orf40,FAAP24;chromosome 19 open reading frame 40
hsa:57620;STIM2;stromal interaction molecule 2
hsa:23111;SPG20,SPARTIN,TAHCCP1;spastic paraplegia 20 (Troyer syndrome)
hsa:84706;GPT2,ALT2;glutamic pyruvate transaminase (alanine aminotransferase) 2 (EC:2.6.1.2)
hsa:146779;EFCAB3;EF-hand calcium binding domain 3
hsa:63036;CELA2A,ELA2A,PE-1;chymotrypsin-like elastase family, member 2A (EC:3.4.21.71)
hsa:22999;RIMS1,CORD7,RAB3IP2,RIM,RIM1;regulating synaptic membrane exocytosis 1
hsa:9650;MTFR1,CHPPR,FAM54A2;mitochondrial fission regulator 1
hsa:160428;ALDH1L2,mtFDH;aldehyde dehydrogenase 1 family, member L2 (EC:1.5.1.6)
hsa:80232;WDR26,CDW2,GID7,MIP2;WD repeat domain 26
hsa:54187;NANS,SAS;N-acetylneuraminic acid synthase (EC:2.5.1.56 2.5.1.57)
hsa:79258;MMEL1,MMEL2,NEP2,NEPII,NL1,NL2,SEP;membrane metallo-endopeptidase-like 1 (EC:3.4.24.11)
hsa:7111;TMOD1,D9S57E,ETMOD,TMOD;tropomodulin 1
hsa:22979;EFR3B,KIAA0953;EFR3 homolog B (S. cerevisiae)
hsa:284358;MAMSTR,MASTR;MEF2 activating motif and SAP domain containing transcriptional regulator
hsa:55219;TMEM57,MACOILIN;transmembrane protein 57
hsa:57801;HES4,bHLHb42;hairy and enhancer of split 4 (Drosophila)
hsa:51250;C6orf203,PRED31,RP11-59I9.1;chromosome 6 open reading frame 203
hsa:115752;DIS3L,DIS3L1;DIS3 mitotic control homolog (S. cerevisiae)-like (EC:3.1.13.-)
hsa:51512;GTSE1,B99;G-2 and S-phase expressed 1
hsa:56675;NRIP3,C11orf14,NY-SAR-105;nuclear receptor interacting protein 3
hsa:293;SLC25A6,AAC3,ANT3,ANT3Y;solute carrier family 25 (mitochondrial carrier;adenine nucleotide translocator), member 6
hsa:90102;PHLDB2,LL5b,LL5beta;pleckstrin homology-like domain, family B, member 2
hsa:79869;CPSF7,CFIm59;cleavage and polyadenylation specific factor 7, 59kDa
hsa:54586;EQTN,AFAF,C9orf11,SPACA8,equatorin;equatorin, sperm acrosome associated
hsa:84866;TMEM25;transmembrane protein 25
hsa:8402;SLC25A11,OGC,SLC20A4;solute carrier family 25 (mitochondrial carrier;oxoglutarate carrier), member 11
hsa:11057;ABHD2,HS1-2,LABH2,PHPS1-2;abhydrolase domain containing 2
hsa:11027;LILRA2,CD85H,ILT1,LIR-7,LIR7;leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2
hsa:5303;PIN4,EPVH,PAR14,PAR17;protein (peptidylprolyl cis/trans isomerase) NIMA-interacting, 4 (parvulin) (EC:5.2.1.8)
hsa:716;C1S;complement component 1, s subcomponent (EC:3.4.21.42)
hsa:56478;EIF4ENIF1,4E-T,Clast4;eukaryotic translation initiation factor 4E nuclear import factor 1
hsa:57221;A7322,ARFGEF3,BIG3,C6orf92,PPP1R33,dJ171N11.1;KIAA1244
hsa:4317;MMP8,CLG1,HNC,MMP-8,PMNL-CL;matrix metallopeptidase 8 (neutrophil collagenase) (EC:3.4.24.34)
hsa:2334;AFF2,FMR2,FMR2P,FRAXE,MRX2,OX19;AF4/FMR2 family, member 2
hsa:23092;ARHGAP26,GRAF,GRAF1,OPHN1L,OPHN1L1;Rho GTPase activating protein 26
hsa:9454;HOMER3,HOMER-3,VESL3;homer homolog 3 (Drosophila)
hsa:10890;RAB10;RAB10, member RAS oncogene family
hsa:79792;GSDMD,DF5L,DFNA5L,GSDMDC1;gasdermin D
hsa:27235;COQ2,CL640,COQ10D1;coenzyme Q2 homolog, prenyltransferase (yeast) (EC:2.5.1.39)
hsa:50650;ARHGEF3,GEF3,STA3,XPLN;Rho guanine nucleotide exchange factor (GEF) 3
hsa:5793;PTPRG,HPTPG,PTPG,R-PTP-GAMMA,RPTPG;protein tyrosine phosphatase, receptor type, G (EC:3.1.3.48)
hsa:55758;RCOR3,RP11-318L16.1;REST corepressor 3
hsa:392490;FLJ44635;TPT1-like protein
hsa:84668;FAM126A,DRCTNNB1A,HCC,HLD5,HYCC1;family with sequence similarity 126, member A
hsa:4494;MT1F,MT1;metallothionein 1F
hsa:3801;KIFC3;kinesin family member C3
hsa:79968;WDR76,CDW14;WD repeat domain 76
hsa:51635;DHRS7,SDR34C1,retDSR4,retSDR4;dehydrogenase/reductase (SDR family) member 7
hsa:140735;DYNLL2,DNCL1B,Dlc2,RSPH22;dynein, light chain, LC8-type 2
hsa:340024;SLC6A19,B0AT1,HND;solute carrier family 6 (neutral amino acid transporter), member 19
hsa:57038;RARS2,ArgRS,DALRD2,PCH6,PRO1992,RARSL,dJ382I10.6;arginyl-tRNA synthetase 2, mitochondrial (EC:6.1.1.19)
hsa:54938;SARS2,SARS,SARSM,SERS,SYS,SerRS,SerRSmt,mtSerRS;seryl-tRNA synthetase 2, mitochondrial (EC:6.1.1.11)
hsa:8632;DNAH17,DNAHL1,DNEL2;dynein, axonemal, heavy chain 17
hsa:6599;SMARCC1,BAF155,CRACC1,Rsc8,SRG3,SWI3;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1
hsa:5094;PCBP2,HNRPE2,hnRNP-E2;poly(rC) binding protein 2
hsa:59;ACTA2,AAT6,ACTSA,MYMY5;actin, alpha 2, smooth muscle, aorta
hsa:90353;CTU1,ATPBD3,NCS6;cytosolic thiouridylase subunit 1 homolog (S. pombe)
hsa:23617;TSSK2,DGS-G,SPOGA2,STK22B,TSK2;testis-specific serine kinase 2 (EC:2.7.11.1)
hsa:51002;TPRKB;TP53RK binding protein
hsa:6224;RPS20,S20;ribosomal protein S20
hsa:9898;UBAP2L,NICE-4;ubiquitin associated protein 2-like
hsa:55;ACPP,5'-NT,ACP-3,ACP3,PAP;acid phosphatase, prostate (EC:3.1.3.2 3.1.3.5)
hsa:147183;KRT25,KRT25A;keratin 25
hsa:9842;PLEKHM1,AP162,B2,OPTB6;pleckstrin homology domain containing, family M (with RUN domain) member 1
hsa:112755;STX1B,STX1B1,STX1B2;syntaxin 1B
hsa:126259;TMIGD2,IGPR-1,IGPR1;transmembrane and immunoglobulin domain containing 2
hsa:54622;ARL15,ARFRP2;ADP-ribosylation factor-like 15
hsa:90135;BTBD6,BDPL;BTB (POZ) domain containing 6
hsa:2752;GLUL,GLNS,GS,PIG43,PIG59;glutamate-ammonia ligase (EC:4.1.1.15 6.3.1.2)
hsa:3235;HOXD9,HOX4,HOX4C,Hox-4.3,Hox-5.2;homeobox D9
hsa:153572;IRX2,IRXA2;iroquois homeobox 2
hsa:286097;MICU3,EFHA2;mitochondrial uptake family, member 3
hsa:10956;OS9,ERLEC2,OS-9;osteosarcoma amplified 9, endoplasmic reticulum lectin
hsa:91947;ARRDC4;arrestin domain containing 4
hsa:83953;FCAMR,CD351,FCA/MR;Fc receptor, IgA, IgM, high affinity
hsa:29072;SETD2,HBP231,HIF-1,HIP-1,HYPB,KMT3A,SET2,p231HBP;SET domain containing 2 (EC:2.1.1.43)
hsa:22796;COG2,LDLC;component of oligomeric golgi complex 2
hsa:5990;RFX2;regulatory factor X, 2 (influences HLA class II expression)
hsa:11178;LZTS1,F37,FEZ1;leucine zipper, putative tumor suppressor 1
hsa:84811;BUD13,Cwc26,fSAP71;BUD13 homolog (S. cerevisiae)
hsa:2779;GNAT1,CSNBAD3,GBT1,GNATR;guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1
hsa:79789;CLMN;calmin (calponin-like, transmembrane)
hsa:148423;C1orf52,RP11-234D19.1,gm117;chromosome 1 open reading frame 52
hsa:386724;AMIGO3,AMIGO-3;adhesion molecule with Ig-like domain 3 (EC:2.7.7.13)
hsa:26034;IPCEF1,PIP3-E,RP3-402L9.2;interaction protein for cytohesin exchange factors 1
hsa:162517;FBXO39,Fbx39;F-box protein 39
hsa:79930;DOK3,DOKL;docking protein 3
hsa:375337;TOPAZ1,C3orf77;testis and ovary specific PAZ domain containing 1
hsa:9797;TATDN2;TatD DNase domain containing 2
hsa:1967;EIF2B1,EIF2B,EIF2BA;eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa
hsa:26074;C20orf26,dJ1002M8.3,dJ1178H5.4;chromosome 20 open reading frame 26
hsa:338094;FAM151A,C1orf179;family with sequence similarity 151, member A
hsa:80726;;KIAA1683
hsa:145581;LRFN5,C14orf146,FIGLER8,SALM5;leucine rich repeat and fibronectin type III domain containing 5
hsa:49860;CRNN,C1orf10,DRC1,PDRC1,SEP53;cornulin
hsa:283659;PRTG,IGDCC5;protogenin
hsa:89958;SAPCD2,C9orf140,p42.3;suppressor APC domain containing 2
hsa:11078;TRIOBP,DFNB28,TARA,dJ37E16.4;TRIO and F-actin binding protein
hsa:55754;TMEM30A,C6orf67,CDC50A;transmembrane protein 30A
hsa:64061;TSPYL2,CDA1,CINAP,CTCL,DENTT,HRIHFB2216,NP79,SE204,TSPX;TSPY-like 2
hsa:6569;SLC34A1,FRTS2,NAPI-3,NPHLOP1,NPT2,NPTIIa,SLC11,SLC17A2;solute carrier family 34 (sodium phosphate), member 1
hsa:81030;ZBP1,C20orf183,DAI,DLM-1,DLM1;Z-DNA binding protein 1
hsa:127254;C1orf173,RP11-653A5.1;chromosome 1 open reading frame 173
hsa:170954;PPP1R18,HKMT1098,KIAA1949;protein phosphatase 1, regulatory subunit 18
hsa:51110;LACTB2;lactamase, beta 2
hsa:1114;CHGB,SCG1;chromogranin B (secretogranin 1)
hsa:5148;PDE6G,PDEG,RP57;phosphodiesterase 6G, cGMP-specific, rod, gamma (EC:3.1.4.35)
hsa:11005;SPINK5,LEKTI,LETKI,NETS,NS,VAKTI;serine peptidase inhibitor, Kazal type 5
hsa:3631;INPP4A,INPP4,TVAS1;inositol polyphosphate-4-phosphatase, type I, 107kDa (EC:3.1.3.66)
hsa:1381;CRABP1,CRABP,CRABP-I,CRABPI,RBP5;cellular retinoic acid binding protein 1
hsa:10042;HMGXB4,HMG2L1,HMGBCG,THC211630;HMG box domain containing 4
hsa:123228;SENP8,DEN1,NEDP1,PRSC2;SUMO/sentrin specific peptidase family member 8 (EC:3.4.22.68)
hsa:4891;SLC11A2,DCT1,DMT1,NRAMP2;solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2
hsa:5199;CFP,BFD,PFC,PFD,PROPERDIN;complement factor properdin
hsa:136991;ASZ1,ALP1,ANKL1,C7orf7,CT1.19,GASZ,Orf3;ankyrin repeat, SAM and basic leucine zipper domain containing 1
hsa:93100;NAPRT1,PP3856;nicotinate phosphoribosyltransferase domain containing 1 (EC:2.4.2.11)
hsa:5275;SERPINB13,HSHUR7SEQ,HUR7,PI13,headpin;serpin peptidase inhibitor, clade B (ovalbumin), member 13
hsa:115817;DHRS1,SDR19C1;dehydrogenase/reductase (SDR family) member 1
hsa:78999;LRFN4,FIGLER6,SALM3,SALM3.;leucine rich repeat and fibronectin type III domain containing 4
hsa:51099;ABHD5,CDS,CGI58,IECN2,NCIE2;abhydrolase domain containing 5 (EC:2.3.1.51)
hsa:158521;FMR1NB,CT37,NY-SAR-35,NYSAR35;fragile X mental retardation 1 neighbor
hsa:57477;SHROOM4,SHAP;shroom family member 4
hsa:60528;ELAC2,ELC2,HPC2;elaC homolog 2 (E. coli) (EC:3.1.26.11)
hsa:2799;GNS,G6S;glucosamine (N-acetyl)-6-sulfatase (EC:3.1.6.14)
hsa:4134;MAP4;microtubule-associated protein 4
hsa:4047;LSS,OSC;lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) (EC:5.4.99.7)
hsa:9047;SH2D2A,F2771,SCAP,TSAD,VRAP;SH2 domain containing 2A
hsa:10940;POP1;processing of precursor 1, ribonuclease P/MRP subunit (S. cerevisiae) (EC:3.1.26.5)
hsa:55008;HERC6;HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
hsa:51225;ABI3,NESH,SSH3BP3;ABI family, member 3
hsa:127253;TYW3,C1orf171;tRNA-yW synthesizing protein 3 homolog (S. cerevisiae) (EC:2.1.1.-)
hsa:5018;OXA1L,OXA1;oxidase (cytochrome c) assembly 1-like
hsa:1198;CLK3,PHCLK3,PHCLK3/152;CDC-like kinase 3 (EC:2.7.12.1)
hsa:9908;G3BP2;GTPase activating protein (SH3 domain) binding protein 2
hsa:378;ARF4,ARF2;ADP-ribosylation factor 4
hsa:23213;SULF1,HSULF-1,SULF-1;sulfatase 1
hsa:83590;TMUB1,C7orf21,DULP;transmembrane and ubiquitin-like domain containing 1
hsa:2983;GUCY1B3,GC-S-beta-1,GC-SB3,GUC1B3,GUCB3,GUCSB3,GUCY1B1;guanylate cyclase 1, soluble, beta 3 (EC:4.6.1.2)
hsa:81493;SYNC,SYNC1,SYNCOILIN;syncoilin, intermediate filament protein
hsa:4864;NPC1,NPC;Niemann-Pick disease, type C1
hsa:1562;CYP2C18,CPCI,CYP2C,CYP2C17,P450-6B/29C,P450IIC17;cytochrome P450, family 2, subfamily C, polypeptide 18 (EC:1.14.14.1)
hsa:8406;SRPX,DRS,ETX1,SRPX1;sushi-repeat containing protein, X-linked
hsa:4294;MAP3K10,MEKK10,MLK2,MST;mitogen-activated protein kinase kinase kinase 10 (EC:2.7.11.25)
hsa:5101;PCDH9;protocadherin 9
hsa:23169;SLC35D1,UGTREL7;solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1
hsa:23042;PDXDC1,LP8165;pyridoxal-dependent decarboxylase domain containing 1
hsa:9874;TLK1,PKU-beta;tousled-like kinase 1 (EC:2.7.11.1)
hsa:28992;MACROD1,LRP16;MACRO domain containing 1
hsa:5682;PSMA1,HC2,NU,PROS30;proteasome (prosome, macropain) subunit, alpha type, 1 (EC:3.4.25.1)
hsa:2646;GCKR,FGQTL5,GKRP;glucokinase (hexokinase 4) regulator
hsa:30844;EHD4,PAST4;EH-domain containing 4
hsa:3750;KCND1,KV4.1;potassium voltage-gated channel, Shal-related subfamily, member 1
hsa:64067;NPAS3,MOP6,PASD6,bHLHe12;neuronal PAS domain protein 3
hsa:730755;KRTAP2-3,KAP2.3,KRTAP2.3;keratin associated protein 2-3
hsa:5681;PSKH1;protein serine kinase H1 (EC:2.7.11.1)
hsa:1833;EPYC,DSPG3,PGLB,Pg-Lb,SLRR3B;epiphycan
hsa:9941;EXOG,ENDOGL1,ENDOGL2,ENGL,ENGL-a,ENGL-b,ENGLA,ENGLB;endo/exonuclease (5'-3'), endonuclease G-like (EC:3.1.30.-)
hsa:9690;UBE3C,HECTH2;ubiquitin protein ligase E3C
hsa:735;C9;complement component 9
hsa:23640;HSPBP1,FES1;HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1
hsa:7223;TRPC4,HTRP-4,HTRP4,TRP4;transient receptor potential cation channel, subfamily C, member 4
hsa:66005;CHID1,SI-CLP;chitinase domain containing 1 (EC:3.6.5.4)
hsa:2621;GAS6,AXLLG,AXSF;growth arrest-specific 6
hsa:9805;SCRN1,SES1;secernin 1
hsa:23265;EXOC7,2-5-3p,EX070,EXO70,EXOC1,Exo70p,YJL085W;exocyst complex component 7
hsa:65266;WNK4,PHA2B,PRKWNK4;WNK lysine deficient protein kinase 4 (EC:2.7.11.1)
hsa:345275;HSD17B13,NIIL497,SCDR9,SDR16C3;hydroxysteroid (17-beta) dehydrogenase 13
hsa:117154;DACH2;dachshund homolog 2 (Drosophila)
hsa:6447;SCG5,7B2,P7B2,SGNE1,SgV;secretogranin V (7B2 protein)
hsa:5973;RENBP,RBP,RNBP;renin binding protein (EC:5.1.3.8)
hsa:54596;L1TD1,ECAT11,RP5-1155K23.3;LINE-1 type transposase domain containing 1
hsa:79829;NAA40,NAT11,PATT1;N(alpha)-acetyltransferase 40, NatD catalytic subunit, homolog (S. cerevisiae) (EC:2.3.1.-)
hsa:26958;COPG2,2-COP;coatomer protein complex, subunit gamma 2
hsa:59082;CARD18,ICEBERG,UNQ5804,pseudo-ICE;caspase recruitment domain family, member 18
hsa:9890;LPPR4,LPR4,PHP1,PRG-1,PRG1,RP4-788L13.1;lipid phosphate phosphatase-related protein type 4 (EC:3.1.3.4)
hsa:260425;MAGI3,MAGI-3,RP4-730K3.1,dJ730K3.2;membrane associated guanylate kinase, WW and PDZ domain containing 3
hsa:160418;TMTC3,SMILE;transmembrane and tetratricopeptide repeat containing 3
hsa:26094;DCAF4,WDR21,WDR21A;DDB1 and CUL4 associated factor 4
hsa:28996;HIPK2,PRO0593;homeodomain interacting protein kinase 2 (EC:2.7.11.1)
hsa:1841;DTYMK,CDC8,PP3731,TMPK,TYMK;deoxythymidylate kinase (thymidylate kinase) (EC:2.7.4.9)
hsa:147381;CBLN2;cerebellin 2 precursor
hsa:55140;ELP3,KAT9;elongator acetyltransferase complex subunit 3 (EC:2.3.1.48)
hsa:146956;EME1,MMS4L,SLX2A;essential meiotic endonuclease 1 homolog 1 (S. pombe)
hsa:3857;KRT9,CK-9,EPPK,K9;keratin 9
hsa:253017;TECRL,GPSN2L,SRD5A2L2,TERL;trans-2,3-enoyl-CoA reductase-like
hsa:92241;RCSD1,CAPZIP,MK2S4;RCSD domain containing 1
hsa:55768;NGLY1,PNG1,PNGase;N-glycanase 1 (EC:3.5.1.52)
hsa:51557;LGSN,GLULD1,LGS;lengsin, lens protein with glutamine synthetase domain
hsa:54873;PALMD,C1orf11,PALML;palmdelphin
hsa:55553;SOX6,HSSOX6,SOXD;SRY (sex determining region Y)-box 6
hsa:81544;GDPD5,GDE2,PP1665;glycerophosphodiester phosphodiesterase domain containing 5
hsa:91522;COL23A1;collagen, type XXIII, alpha 1
hsa:9180;OSMR,OSMRB,PLCA1;oncostatin M receptor
hsa:58155;PTBP2,PTB,PTBLP,brPTB,nPTB,nPTB5,nPTB6,nPTB7,nPTB8;polypyrimidine tract binding protein 2
hsa:51569;UFM1,BM-002,C13orf20,bA131P10.1;ubiquitin-fold modifier 1
hsa:57521;RPTOR,KOG1,Mip1;regulatory associated protein of MTOR, complex 1
hsa:148345;C1orf127;chromosome 1 open reading frame 127
hsa:2224;FDPS,FPPS,FPS;farnesyl diphosphate synthase (EC:2.5.1.1 2.5.1.10)
hsa:2965;GTF2H1,BTF2,P62,TFB1,TFIIH;general transcription factor IIH, polypeptide 1, 62kDa
hsa:116841;SNAP47,C1orf142,HEL170,SNAP-47,SVAP1;synaptosomal-associated protein, 47kDa
hsa:51270;TFDP3,CT30,DP4,HCA661;transcription factor Dp family, member 3
hsa:153201;SLC36A2,PAT2,TRAMD1;solute carrier family 36 (proton/amino acid symporter), member 2
hsa:6444;SGCD,35DAG,CMD1L,DAGD,SG-delta,SGCDP,SGD;sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)
hsa:94081;SFXN1;sideroflexin 1
hsa:2800;GOLGA1,golgin-97;golgin A1
hsa:79191;IRX3,IRX-1,IRXB1;iroquois homeobox 3
hsa:64285;RHBDF1,C16orf8,Dist1,EGFR-RS,gene-89,gene-90,hDist1;rhomboid 5 homolog 1 (Drosophila)
hsa:196740;VSTM4,C10orf72;V-set and transmembrane domain containing 4
hsa:79707;NOL9,Grc3,NET6;nucleolar protein 9
hsa:54442;KCTD5;potassium channel tetramerisation domain containing 5
hsa:51438;MAGEC2,CT10,HCA587,MAGEE1;melanoma antigen family C, 2
hsa:58473;PLEKHB1,KPL1,PHR1,PHRET1;pleckstrin homology domain containing, family B (evectins) member 1
hsa:80336;PABPC1L,C20orf119,PABPC1L1,dJ1069P2.3,ePAB;poly(A) binding protein, cytoplasmic 1-like
hsa:57181;SLC39A10,LZT-Hs2;solute carrier family 39 (zinc transporter), member 10
hsa:84334;APOPT1,APOP1,C14orf153;apoptogenic 1, mitochondrial
hsa:440107;PLEKHG7;pleckstrin homology domain containing, family G (with RhoGef domain) member 7
hsa:54872;PIGG,GPI7,LAS21,PRO4405,RLGS1930;phosphatidylinositol glycan anchor biosynthesis, class G
hsa:148867;SLC30A7,ZNT7,ZnT-7,ZnTL2;solute carrier family 30 (zinc transporter), member 7
hsa:54664;TMEM106B;transmembrane protein 106B
hsa:202500;TCTE1,D6S46;t-complex-associated-testis-expressed 1
hsa:2642;GCGR,GGR;glucagon receptor
hsa:122830;NAA30,C14orf35,MAK3,Mak3p,NAT12;N(alpha)-acetyltransferase 30, NatC catalytic subunit (EC:2.3.1.88)
hsa:284359;IZUMO1,IZUMO;izumo sperm-egg fusion 1
hsa:3363;HTR7,5-HT7;5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
hsa:10394;PRG3,MBP2,MBPH;proteoglycan 3
hsa:84439;HHIPL1,KIAA1822,UNQ9245;HHIP-like 1
hsa:112869;CCDC101,SGF29,STAF36;coiled-coil domain containing 101
hsa:112724;RDH13,SDR7C3;retinol dehydrogenase 13 (all-trans/9-cis) (EC:1.1.1.-)
hsa:5527;PPP2R5C,B56G,PR61G;protein phosphatase 2, regulatory subunit B', gamma
hsa:92335;STRADA,LYK5,NY-BR-96,PMSE,STRAD,Stlk;STE20-related kinase adaptor alpha
hsa:55210;ATAD3A;ATPase family, AAA domain containing 3A
hsa:121512;FGD4,CMT4H,FRABP,ZFYVE6;FYVE, RhoGEF and PH domain containing 4
hsa:9513;FXR2,FMR1L2,FXR2P;fragile X mental retardation, autosomal homolog 2
hsa:57128;LYRM4,C6orf149,CGI-203,ISD11;LYR motif containing 4
hsa:23370;ARHGEF18,P114-RhoGEF;Rho/Rac guanine nucleotide exchange factor (GEF) 18
hsa:79618;HMBOX1,HNF1LA,PBHNF;homeobox containing 1
hsa:51324;SPG21,ACP33,GL010,MASPARDIN,MAST;spastic paraplegia 21 (autosomal recessive, Mast syndrome)
hsa:58506;SCAF1,SRA1;SR-related CTD-associated factor 1
hsa:22941;SHANK2,AUTS17,CORTBP1,CTTNBP1,ProSAP1,SHANK,SPANK-3;SH3 and multiple ankyrin repeat domains 2
hsa:54953;C1orf27,ODR4,TTG1,odr-4;chromosome 1 open reading frame 27 (EC:1.1.1.14)
hsa:55131;RBM28;RNA binding motif protein 28
hsa:56203;LMOD3;leiomodin 3 (fetal)
hsa:8506;CNTNAP1,CASPR,CNTNAP,NRXN4,P190;contactin associated protein 1
hsa:79837;PIP4K2C,PIP5K2C;phosphatidylinositol-5-phosphate 4-kinase, type II, gamma (EC:2.7.1.149)
hsa:5462;POU5F1B,OCT4-PG1,OTF3C,OTF3P1,POU5F1P1,POU5F1P4,POU5FLC20,POU5FLC8;POU class 5 homeobox 1B
hsa:153328;SLC25A48,HDMCP;solute carrier family 25, member 48
hsa:2558;GABRA5;gamma-aminobutyric acid (GABA) A receptor, alpha 5
hsa:93492;TPTE2,TPIP;transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 (EC:3.1.3.67)
hsa:84932;RAB2B;RAB2B, member RAS oncogene family
hsa:9319;TRIP13,16E1BP;thyroid hormone receptor interactor 13
hsa:91782;CHMP7;charged multivesicular body protein 7
hsa:257044;C1orf101,RP11-523K4.1;chromosome 1 open reading frame 101
hsa:123879;DCUN1D3,44M2.4;DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae) (EC:3.1.-.-)
hsa:51063;CALHM2,FAM26B;calcium homeostasis modulator 2
hsa:5954;RCN1,PIG20,RCAL,RCN;reticulocalbin 1, EF-hand calcium binding domain
hsa:55226;NAT10,ALP,NET43;N-acetyltransferase 10 (GCN5-related) (EC:2.3.1.-)
hsa:55789;DEPDC1B,BRCC3,XTP1;DEP domain containing 1B
hsa:55902;ACSS2,ACAS2,ACECS,ACS,ACSA,dJ1161H23.1;acyl-CoA synthetase short-chain family member 2 (EC:6.2.1.1)
hsa:51151;SLC45A2,1A1,AIM1,MATP,SHEP5;solute carrier family 45, member 2
hsa:8394;PIP5K1A;phosphatidylinositol-4-phosphate 5-kinase, type I, alpha (EC:2.7.1.68)
hsa:117247;SLC16A10,MCT10,PRO0813,TAT1;solute carrier family 16, member 10 (aromatic amino acid transporter)
hsa:80315;CPEB4;cytoplasmic polyadenylation element binding protein 4
hsa:219402;MTIF3,IF3mt;mitochondrial translational initiation factor 3
hsa:57834;CYP4F11,CYPIVF11;cytochrome P450, family 4, subfamily F, polypeptide 11 (EC:1.14.14.1)
hsa:8031;NCOA4,ARA70,ELE1,PTC3,RFG;nuclear receptor coactivator 4
hsa:56134;PCDHAC2,PCDH-ALPHA-C2;protocadherin alpha subfamily C, 2
hsa:29106;SCG3,SGIII;secretogranin III
hsa:8772;FADD,MORT1;Fas (TNFRSF6)-associated via death domain
hsa:161003;STOML3,Epb7.2l,SRO;stomatin (EPB72)-like 3
hsa:57185;NIPAL3,DJ462O23.2,NPAL3;NIPA-like domain containing 3
hsa:9381;OTOF,AUNB1,DFNB6,DFNB9,FER1L2,NSRD9;otoferlin
hsa:126133;ALDH16A1;aldehyde dehydrogenase 16 family, member A1
hsa:26064;RAI14,NORPEG,RAI13;retinoic acid induced 14
hsa:84947;SERAC1;serine active site containing 1
hsa:50717;DCAF8,H326,WDR42A;DDB1 and CUL4 associated factor 8
hsa:55165;CEP55,C10orf3,CT111,URCC6;centrosomal protein 55kDa
hsa:8498;RANBP3;RAN binding protein 3
hsa:7441;VPREB1,IGI,IGVPB,VPREB;pre-B lymphocyte 1
hsa:1258;CNGB1,CNCG2,CNCG3L,CNCG4,CNG4,CNGB1B,GAR1,GARP,RCNC2,RCNCb,RCNCbeta,RP45;cyclic nucleotide gated channel beta 1
hsa:79135;APOO,FAM121B;apolipoprotein O
hsa:51522;TMEM14C,C6orf53,MSTP073,NET26,bA421M1.6;transmembrane protein 14C
hsa:901;CCNG2;cyclin G2
hsa:131669;UROC1,HMFN0320;urocanate hydratase 1 (EC:4.2.1.49)
hsa:255104;TMCO4,RP5-1056L3.6;transmembrane and coiled-coil domains 4
hsa:23007;PLCH1,PLCL3;phospholipase C, eta 1 (EC:3.1.4.11)
hsa:388585;HES5,bHLHb38;hairy and enhancer of split 5 (Drosophila)
hsa:79980;DSN1,C20orf172,KNL3,MIS13,dJ469A13.2,hKNL-3;DSN1, MIND kinetochore complex component, homolog (S. cerevisiae)
hsa:254251;LCORL,MLR1;ligand dependent nuclear receptor corepressor-like
hsa:84722;PSRC1,DDA3,FP3214;proline/serine-rich coiled-coil 1
hsa:203069;R3HCC1;R3H domain and coiled-coil containing 1
hsa:140609;NEK7;NIMA-related kinase 7 (EC:2.7.11.1)
hsa:1384;CRAT,CAT1;carnitine O-acetyltransferase (EC:2.3.1.7)
hsa:5774;PTPN3,PTP-H1,PTPH1;protein tyrosine phosphatase, non-receptor type 3 (EC:3.1.3.48)
hsa:2302;FOXJ1,FKHL13,HFH-4,HFH4;forkhead box J1
hsa:171024;SYNPO2;synaptopodin 2
hsa:3936;LCP1,CP64,L-PLASTIN,LC64P,LPL,PLS2;lymphocyte cytosolic protein 1 (L-plastin)
hsa:4645;MYO5B;myosin VB
hsa:9276;COPB2,beta'-COP;coatomer protein complex, subunit beta 2 (beta prime)
hsa:51434;ANAPC7,APC7;anaphase promoting complex subunit 7
hsa:81550;TDRD3;tudor domain containing 3
hsa:5284;PIGR;polymeric immunoglobulin receptor
hsa:92579;G6PC3,SCN4,UGRP;glucose 6 phosphatase, catalytic, 3 (EC:3.1.3.9)
hsa:22908;SACM1L,SAC1;SAC1 suppressor of actin mutations 1-like (yeast)
hsa:64782;AEN,ISG20L1,pp12744;apoptosis enhancing nuclease
hsa:8539;API5,AAC-11,AAC11;apoptosis inhibitor 5
hsa:338376;IFNE,IFN-E,IFNE1,IFNT1,PRO655;interferon, epsilon
hsa:84260;TCHP,TpMs;trichoplein, keratin filament binding
hsa:93627;TBCK,TBCKL;TBC1 domain containing kinase
hsa:342538;NACA2,ANAC,NACAL;nascent polypeptide-associated complex alpha subunit 2
hsa:375686;SPATC1,SPATA15;spermatogenesis and centriole associated 1
hsa:80746;TSEN2,PCH2B,SEN2,SEN2L;tRNA splicing endonuclease 2 homolog (S. cerevisiae) (EC:3.1.27.9)
hsa:5333;PLCD1,NDNC3,PLC-III;phospholipase C, delta 1 (EC:3.1.4.11)
hsa:151963;MB21D2,C3orf59;Mab-21 domain containing 2
hsa:158046;NXNL2,C9orf121,RDCVF2;nucleoredoxin-like 2 (EC:1.8.1.8)
hsa:471;ATIC,AICAR,AICARFT,IMPCHASE,PURH;5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (EC:2.1.2.3 3.5.4.10)
hsa:57530;CGN;cingulin
hsa:5153;PDE1B,PDE1B1,PDES1B;phosphodiesterase 1B, calmodulin-dependent (EC:3.1.4.17)
hsa:80304;C2orf44;chromosome 2 open reading frame 44
hsa:441478;NRARP;NOTCH-regulated ankyrin repeat protein
hsa:30845;EHD3,PAST3;EH-domain containing 3
hsa:93408;MYL10,MYLC2PL,PLRLC;myosin, light chain 10, regulatory
hsa:57125;PLXDC1,TEM3,TEM7;plexin domain containing 1
hsa:64137;ABCG4,WHITE2;ATP-binding cassette, sub-family G (WHITE), member 4
hsa:670;BPHL,BPH-RP,MCNAA,VACVASE;biphenyl hydrolase-like (serine hydrolase)
hsa:65983;GRAMD3,NS3TP2;GRAM domain containing 3
hsa:23001;WDFY3,ALFY,ZFYVE25;WD repeat and FYVE domain containing 3
hsa:57707;TLDC1,KIAA1609;TBC/LysM-associated domain containing 1
hsa:84305;WIBG,PYM;within bgcn homolog (Drosophila)
hsa:10589;DRAP1,NC2-alpha;DR1-associated protein 1 (negative cofactor 2 alpha)
hsa:203245;NAIF1,C9orf90,RP11-379C10.2,bA379C10.2;nuclear apoptosis inducing factor 1
hsa:346007;EYS,C6orf178,C6orf179,C6orf180,EGFL10,EGFL11,RP25,SPAM,bA166P24.2,bA307F22.3,bA74E24.1,dJ1018A4.2,dJ22I17.2,dJ303F19.1;eyes shut homolog (Drosophila)
hsa:9766;;KIAA0247
hsa:5395;PMS2,HNPCC4,PMS2CL,PMSL2;PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
hsa:51164;DCTN4,DYN4,P62;dynactin 4 (p62)
hsa:64778;FNDC3B,FAD104,PRO4979,YVTM2421;fibronectin type III domain containing 3B
hsa:10797;MTHFD2,NMDMC;methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase (EC:3.5.4.9 1.5.1.15)
hsa:54549;SDK2;sidekick cell adhesion molecule 2
hsa:79187;FSD1,GLFND,MIR1;fibronectin type III and SPRY domain containing 1
hsa:2328;FMO3,FMOII,TMAU,dJ127D3.1;flavin containing monooxygenase 3 (EC:1.14.13.8 1.14.13.148)
hsa:55879;GABRQ,THETA;gamma-aminobutyric acid (GABA) A receptor, theta
hsa:57511;COG6,CDG2L,COD2;component of oligomeric golgi complex 6
hsa:55345;C4orf21;chromosome 4 open reading frame 21
hsa:5140;PDE3B,HcGIP1,cGIPDE1;phosphodiesterase 3B, cGMP-inhibited (EC:3.1.4.17)
hsa:117144;CATSPER1,CATSPER,SPGF7;cation channel, sperm associated 1
hsa:140767;NRSN1,VMP,p24;neurensin 1
hsa:9686;VGLL4,VGL-4;vestigial like 4 (Drosophila)
hsa:129807;NEU4;sialidase 4 (EC:3.2.1.18)
hsa:158584;FAAH2,AMDD;fatty acid amide hydrolase 2 (EC:3.5.1.99)
hsa:94241;TP53INP1,SIP,TP53DINP1,TP53INP1A,TP53INP1B,Teap,p53DINP1;tumor protein p53 inducible nuclear protein 1
hsa:7464;CORO2A,CLIPINB,IR10,WDR2;coronin, actin binding protein, 2A
hsa:10978;CLP1,HEAB,hClp1;cleavage and polyadenylation factor I subunit 1 (EC:2.7.1.78)
hsa:84248;FYTTD1,UIF;forty-two-three domain containing 1
hsa:54602;NDFIP2,N4WBP5A;Nedd4 family interacting protein 2
hsa:134510;UBLCP1,CPUB1;ubiquitin-like domain containing CTD phosphatase 1 (EC:3.1.3.16)
hsa:22895;RPH3A;rabphilin 3A homolog (mouse)
hsa:83716;CRISPLD2,CRISP11,LCRISP2;cysteine-rich secretory protein LCCL domain containing 2
hsa:201266;SLC39A11,C17orf26,ZIP11;solute carrier family 39 (metal ion transporter), member 11
hsa:1997;ELF1;E74-like factor 1 (ets domain transcription factor)
hsa:23130;ATG2A;autophagy related 2A
hsa:6542;SLC7A2,ATRC2,CAT2,HCAT2;solute carrier family 7 (cationic amino acid transporter, y+ system), member 2
hsa:389170;LEKR1;leucine, glutamate and lysine rich 1
hsa:9843;HEPH,CPL;hephaestin
hsa:79029;SPATA5L1;spermatogenesis associated 5-like 1
hsa:56971;CEACAM19,CEAL1;carcinoembryonic antigen-related cell adhesion molecule 19
hsa:6493;SIM2,HMC13F06,HMC29C01,SIM,bHLHe15;single-minded homolog 2 (Drosophila)
hsa:5689;PSMB1,HC5,PMSB1,PSC5;proteasome (prosome, macropain) subunit, beta type, 1 (EC:3.4.25.1)
hsa:8763;CD164,MGC-24,MUC-24,endolyn;CD164 molecule, sialomucin
hsa:55510;DDX43,CT13,HAGE;DEAD (Asp-Glu-Ala-Asp) box polypeptide 43 (EC:3.6.4.13)
hsa:57673;BEND3,KIAA1553,RP11-59I9.2;BEN domain containing 3
hsa:221178;SPATA13,ARHGEF29,ASEF2;spermatogenesis associated 13
hsa:201627;DENND6A,AFI1A,FAM116A;DENN/MADD domain containing 6A
hsa:28985;MCTS1,MCT-1,MCT1;malignant T cell amplified sequence 1
hsa:389072;PLEKHM3,DAPR,PLEKHM1L;pleckstrin homology domain containing, family M, member 3
hsa:145173;B3GALTL,B3GLCT,B3GTL,B3Glc-T,Gal-T,beta3Glc-T;beta 1,3-galactosyltransferase-like
hsa:150696;PROM2,PROML2;prominin 2
hsa:7264;TSTA3,FX,P35B,SDR4E1;tissue specific transplantation antigen P35B (EC:1.1.1.271)
hsa:25996;REXO2,REX2,RFN,SFN;REX2, RNA exonuclease 2 homolog (S. cerevisiae)
hsa:28969;BZW2,MST017,MSTP017;basic leucine zipper and W2 domains 2
hsa:57522;SRGAP1,ARHGAP13;SLIT-ROBO Rho GTPase activating protein 1
hsa:85461;TANC1,ROLSB,TANC;tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1
hsa:18;ABAT,GABA-AT,GABAT,NPD009;4-aminobutyrate aminotransferase (EC:2.6.1.19 2.6.1.22)
hsa:152137;CCDC50,C3orf6,DFNA44,YMER;coiled-coil domain containing 50
hsa:1207;CLNS1A,CLCI,CLNS1B,ICln;chloride channel, nucleotide-sensitive, 1A
hsa:9108;MTMR7;myotubularin related protein 7 (EC:3.1.3.-)
hsa:2835;GPR12,GPCR12,GPCR21;G protein-coupled receptor 12
hsa:1161;ERCC8,CKN1,CSA,UVSS2;excision repair cross-complementing rodent repair deficiency, complementation group 8
hsa:54662;TBC1D13;TBC1 domain family, member 13
hsa:6835;SURF2,SURF-2;surfeit 2
hsa:348807;CCDC37;coiled-coil domain containing 37
hsa:3002;GZMB,CCPI,CGL-1,CGL1,CSP-B,CSPB,CTLA1,CTSGL1,HLP,SECT;granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) (EC:3.4.21.79)
hsa:6191;RPS4X,CCG2,DXS306,RPS4,S4,SCAR,SCR10;ribosomal protein S4, X-linked
hsa:64377;CHST8,GALNAC4ST1,GalNAc4ST;carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8
hsa:9988;DMTF1,DMP1,DMTF,hDMP1;cyclin D binding myb-like transcription factor 1
hsa:1445;CSK;c-src tyrosine kinase (EC:2.7.10.2)
hsa:80380;PDCD1LG2,B7DC,Btdc,CD273,PD-L2,PDCD1L2,PDL2,bA574F11.2;programmed cell death 1 ligand 2
hsa:6428;SRSF3,SFRS3,SRp20;serine/arginine-rich splicing factor 3
hsa:79791;FBXO31,FBX14,FBXO14,Fbx31,pp2386;F-box protein 31
hsa:6429;SRSF4,SFRS4,SRP75;serine/arginine-rich splicing factor 4
hsa:8565;YARS,CMTDIC,TYRRS,YRS,YTS;tyrosyl-tRNA synthetase (EC:6.1.1.1)
hsa:10226;PLIN3,M6PRBP1,PP17,TIP47;perilipin 3
hsa:1844;DUSP2,PAC-1,PAC1;dual specificity phosphatase 2 (EC:3.1.3.16 3.1.3.48)
hsa:54413;NLGN3,HNL3;neuroligin 3
hsa:79735;TBC1D17;TBC1 domain family, member 17
hsa:2286;FKBP2,FKBP-13,PPIase;FK506 binding protein 2, 13kDa (EC:5.2.1.8)
hsa:84766;EFCAB4B,CRACR2A;EF-hand calcium binding domain 4B
hsa:54039;PCBP3,ALPHA-CP3;poly(rC) binding protein 3
hsa:7429;VIL1,D2S1471,VIL;villin 1
hsa:5796;PTPRK,R-PTP-kappa;protein tyrosine phosphatase, receptor type, K (EC:3.1.3.48)
hsa:25801;GCA,GCL;grancalcin, EF-hand calcium binding protein
hsa:55971;BAIAP2L1,IRTKS;BAI1-associated protein 2-like 1
hsa:2011;MARK2,EMK-1,EMK1,PAR-1,Par-1b,Par1b;MAP/microtubule affinity-regulating kinase 2 (EC:2.7.11.1 2.7.11.26)
hsa:5463;POU6F1,BRN5,MPOU,TCFB1;POU class 6 homeobox 1
hsa:7266;DNAJC7,DJ11,DJC7,TPR2,TTC2;DnaJ (Hsp40) homolog, subfamily C, member 7
hsa:137735;ABRA,STARS;actin-binding Rho activating protein
hsa:5350;PLN,CMD1P,CMH18,PLB;phospholamban
hsa:5706;PSMC6,CADP44,P44,SUG2,p42;proteasome (prosome, macropain) 26S subunit, ATPase, 6
hsa:10466;COG5,CDG2I,GOLTC1,GTC90;component of oligomeric golgi complex 5
hsa:202559;KHDRBS2,SLM-1,SLM1,bA535F17.1;KH domain containing, RNA binding, signal transduction associated 2
hsa:29851;ICOS,AILIM,CD278,CVID1;inducible T-cell co-stimulator
hsa:4580;MTX1,MTX,MTXN;metaxin 1
hsa:30812;SOX8;SRY (sex determining region Y)-box 8
hsa:8288;EPX,EPO,EPP,EPX-PEN;eosinophil peroxidase (EC:1.11.1.7)
hsa:55157;DARS2,ASPRS,LBSL,MT-ASPRS,RP3-383J4.2;aspartyl-tRNA synthetase 2, mitochondrial (EC:6.1.1.12)
hsa:8834;TMEM11,C17orf35,PM1,PMI;transmembrane protein 11
hsa:4810;NHS,CXN,SCML1;Nance-Horan syndrome (congenital cataracts and dental anomalies)
hsa:8125;ANP32A,C15orf1,HPPCn,I1PP2A,LANP,MAPM,PHAP1,PHAPI,PP32;acidic (leucine-rich) nuclear phosphoprotein 32 family, member A
hsa:64779;MTHFSD;methenyltetrahydrofolate synthetase domain containing
hsa:51744;CD244,2B4,NAIL,NKR2B4,Nmrk,SLAMF4;CD244 molecule, natural killer cell receptor 2B4
hsa:52;ACP1,HAAP;acid phosphatase 1, soluble (EC:3.1.3.2 3.1.3.48)
hsa:23348;DOCK9,ZIZ1,ZIZIMIN1;dedicator of cytokinesis 9
hsa:29842;TFCP2L1,CRTR1,LBP-9,LBP9;transcription factor CP2-like 1
hsa:57205;ATP10D,ATPVD;ATPase, class V, type 10D (EC:3.6.3.1)
hsa:79858;NEK11;NIMA-related kinase 11 (EC:2.7.11.1)
hsa:210;ALAD,ALADH,PBGS;aminolevulinate dehydratase (EC:4.2.1.24)
hsa:56951;C5orf15,KCT2;chromosome 5 open reading frame 15
hsa:161931;ADAD2,TENRL;adenosine deaminase domain containing 2
hsa:1944;EFNA3,EFL2,EPLG3,Ehk1-L,LERK3;ephrin-A3
hsa:64856;VWA1,WARP;von Willebrand factor A domain containing 1
hsa:54788;DNAJB12,DJ10;DnaJ (Hsp40) homolog, subfamily B, member 12
hsa:4289;MKLN1,TWA2;muskelin 1, intracellular mediator containing kelch motifs
hsa:154664;ABCA13;ATP-binding cassette, sub-family A (ABC1), member 13
hsa:147138;TMC8,EV2,EVER2,EVIN2;transmembrane channel-like 8
hsa:201626;PDE12,2'-PDE;phosphodiesterase 12
hsa:145508;CEP128,C14orf145,C14orf61,LEDP/132;centrosomal protein 128kDa
hsa:10227;MFSD10,TETRAN,TETTRAN;major facilitator superfamily domain containing 10
hsa:3274;HRH2,H2R;histamine receptor H2
hsa:5538;PPT1,CLN1,INCL,PPT;palmitoyl-protein thioesterase 1 (EC:3.1.2.22)
hsa:2000;ELF4,ELFR,MEF;E74-like factor 4 (ets domain transcription factor)
hsa:116449;CLNK,MIST;cytokine-dependent hematopoietic cell linker
hsa:4759;NEU2,SIAL2;sialidase 2 (cytosolic sialidase) (EC:3.2.1.18)
hsa:89832;CHRFAM7A,CHRNA7,CHRNA7-DR1,D-10;CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion
hsa:256227;STEAP1B;STEAP family member 1B
hsa:25950;RWDD3,RSUME;RWD domain containing 3
hsa:493869;GPX8,EPLA847,GPx-8,GSHPx-8,UNQ847;glutathione peroxidase 8 (putative) (EC:1.11.1.9)
hsa:11012;KLK11,PRSS20,TLSP;kallikrein-related peptidase 11
hsa:401115;C4orf48,CHR4_55;chromosome 4 open reading frame 48
hsa:11180;WDR6;WD repeat domain 6
hsa:6909;TBX2;T-box 2
hsa:54715;RBFOX1,2BP1,A2BP1,FOX-1,FOX1,HRNBP1;RNA binding protein, fox-1 homolog (C. elegans) 1
hsa:386617;KCTD8;potassium channel tetramerisation domain containing 8
hsa:135656;DPCR1,PBLT;diffuse panbronchiolitis critical region 1
hsa:10718;NRG3,HRG3,pro-NRG3;neuregulin 3
hsa:389903;CSAG3,CSAG3A,CT24.2;CSAG family, member 3
hsa:91801;ALKBH8,ABH8;alkB, alkylation repair homolog 8 (E. coli) (EC:2.1.1.229)
hsa:57528;KCTD16;potassium channel tetramerisation domain containing 16
hsa:137970;UNC5D,PRO34692,Unc5h4;unc-5 homolog D (C. elegans)
hsa:79073;TMEM109;transmembrane protein 109
hsa:124583;CANT1,DBQD,SCAN-1,SCAN1,SHAPY;calcium activated nucleotidase 1 (EC:3.6.1.6)
hsa:338917;VSX2,CHX10,HOX10,MCOP2,MCOPCB3,RET1;visual system homeobox 2
hsa:11322;TMC6,EV1,EVER1,EVIN1,LAK-4P;transmembrane channel-like 6
hsa:55066;PDPR,PDP3;pyruvate dehydrogenase phosphatase regulatory subunit (EC:1.5.8.4)
hsa:477;ATP1A2,FHM2,MHP2;ATPase, Na+/K+ transporting, alpha 2 polypeptide (EC:3.6.3.9)
hsa:22868;FASTKD2,KIAA0971;FAST kinase domains 2
hsa:731;C8A;complement component 8, alpha polypeptide
hsa:400954;EML6;echinoderm microtubule associated protein like 6
hsa:221472;FGD2,ZFYVE4;FYVE, RhoGEF and PH domain containing 2
hsa:5378;PMS1,HNPCC3,PMSL1,hPMS1;PMS1 postmeiotic segregation increased 1 (S. cerevisiae)
hsa:7913;DEK,D6S231E;DEK oncogene
hsa:57718;PPP4R4,KIAA1622,PP4R4;protein phosphatase 4, regulatory subunit 4
hsa:8761;PABPC4,APP-1,APP1,PABP4,iPABP;poly(A) binding protein, cytoplasmic 4 (inducible form)
hsa:5937;RBMS1,C2orf12,HCC-4,MSSP,MSSP-1,MSSP-2,MSSP-3,SCR2,YC1;RNA binding motif, single stranded interacting protein 1
hsa:219988;PATL1,Pat1b,hPat1b;protein associated with topoisomerase II homolog 1 (yeast)
hsa:11021;RAB35,H-ray,RAB1C,RAY;RAB35, member RAS oncogene family
hsa:2010;EMD,EDMD,LEMD5,STA;emerin
hsa:7275;TUB,rd5;tubby homolog (mouse)
hsa:55784;MCTP2;multiple C2 domains, transmembrane 2
hsa:9735;KNTC1,ROD;kinetochore associated 1
hsa:11198;SUPT16H,CDC68,FACTP140,SPT16/CDC68;suppressor of Ty 16 homolog (S. cerevisiae)
hsa:29078;NDUFAF4,C6orf66,HRPAP20,My013,bA22L21.1;NADH dehydrogenase (ubiquinone) complex I, assembly factor 4
hsa:51078;THAP4,PP238;THAP domain containing 4
hsa:57470;LRRC47;leucine rich repeat containing 47
hsa:221806;VWDE;von Willebrand factor D and EGF domains
hsa:10599;SLCO1B1,HBLRR,LST-1,LST1,OATP-C,OATP1B1,OATP2,OATPC,SLC21A6;solute carrier organic anion transporter family, member 1B1
hsa:23157;SEPT6,SEP2,SEPT2;septin 6
hsa:570;BAAT,BACAT,BAT;bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) (EC:2.3.1.65 3.1.2.2)
hsa:1315;COPB1,COPB;coatomer protein complex, subunit beta 1
hsa:283446;MYO1H;myosin IH
hsa:50813;COPS7A,CSN7A;COP9 signalosome subunit 7A
hsa:2108;ETFA,EMA,GA2,MADD;electron-transfer-flavoprotein, alpha polypeptide
hsa:55706;TMEM48,NDC1,NET3;transmembrane protein 48
hsa:26996;GPR160,GPCR1,GPCR150;G protein-coupled receptor 160
hsa:191;AHCY,SAHH,adoHcyase;adenosylhomocysteinase (EC:3.3.1.1)
hsa:57495;;KIAA1239
hsa:83417;FCRL4,CD307d,FCRH4,IGFP2,IRTA1;Fc receptor-like 4
hsa:64848;YTHDC2,CAHL;YTH domain containing 2 (EC:3.6.4.13)
hsa:23199;GSE1,KIAA0182;Gse1 coiled-coil protein
hsa:338579;ANKRD30BP3;ankyrin repeat domain 30B pseudogene 3
hsa:283033;LINC00841;long intergenic non-protein coding RNA 841
hsa:100506835;LINC00840;long intergenic non-protein coding RNA 840
hsa:55164;SHQ1,Shq1p;SHQ1, H/ACA ribonucleoprotein assembly factor
hsa:8905;AP1S2,MGC:1902,MRX59,MRXS21,MRXSF,SIGMA1B;adaptor-related protein complex 1, sigma 2 subunit
hsa:146850;PIK3R6,C17orf38,HsT41028,p84,p84_PIKAP,p87(PIKAP),p87PIKAP;phosphoinositide-3-kinase, regulatory subunit 6
hsa:414241;FAM35BP,FAM35B,bA38L15.1;family with sequence similarity 35, member A pseudogene
hsa:439965;FAM35DP,FAM35B2;family with sequence similarity 35, member A pseudogene
hsa:728643;HNRNPA1P33;heterogeneous nuclear ribonucleoprotein A1 pseudogene 33
hsa:100506215;PAXBP1-AS1,GCFC1-AS1;PAXBP1 antisense RNA 1
hsa:100126793;GHRLOS,GHRL-AS1,GHRLAS,NCRNA00068;ghrelin opposite strand/antisense RNA
hsa:392360;CTSL3P,CTSL3,HCTSL-s;cathepsin L family member 3, pseudogene
hsa:101180901;IPO11-LRRC70;IPO11-LRRC70 readthrough
hsa:643650;LINC00842;long intergenic non-protein coding RNA 842
hsa:6391;SDHC,CYB560,CYBL,PGL3,QPS1,SDH3;succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
hsa:79990;PLEKHH3;pleckstrin homology domain containing, family H (with MyTH4 domain) member 3
hsa:60468;BACH2,BTBD25;BTB and CNC homology 1, basic leucine zipper transcription factor 2
hsa:881;CCIN,BTBD20;calicin
hsa:83892;KCTD10,BTBD28,ULRO61,hBACURD3;potassium channel tetramerisation domain containing 10
hsa:8216;LZTR1,BTBD29,LZTR-1;leucine-zipper-like transcription regulator 1
hsa:8405;SPOP,BTBD32,TEF2;speckle-type POZ protein
hsa:80325;ABTB1,BPOZ,BTB3,BTBD21,EF1ABP;ankyrin repeat and BTB (POZ) domain containing 1
hsa:25998;IBTK,BTBD26,BTKI,RP1-93K22.1;inhibitor of Bruton agammaglobulinemia tyrosine kinase
hsa:54793;KCTD9,BTBD27;potassium channel tetramerisation domain containing 9
hsa:7126;TNFAIP1,B12,B61,BTBD34,EDP1,hBACURD2;tumor necrosis factor, alpha-induced protein 1 (endothelial)
hsa:100130370;;uncharacterized LOC100130370
hsa:339745;SPOPL,BTBD33;speckle-type POZ protein-like
hsa:100506733;FAM170B-AS1;FAM170B antisense RNA 1
hsa:54581;SCAND2P,SCAND2;SCAN domain containing 2 pseudogene
hsa:442421;PTGER4P2-CDK2AP2P2,PTGER4P2;PTGER4P2-CDK2AP2P2 readthrough transcribed pseudogene
hsa:445328;ARHGEF35,ARHGEF5L;Rho guanine nucleotide exchange factor (GEF) 35
hsa:60488;MRPS35,MDS023,MRP-S28,MRPS28;mitochondrial ribosomal protein S35
hsa:275;AMT,GCE,GCST,GCVT,NKH;aminomethyltransferase (EC:2.1.2.10)
hsa:54101;RIPK4,ANKK2,ANKRD3,DIK,NKRD3,PKK,PPS2,RIP4;receptor-interacting serine-threonine kinase 4 (EC:2.7.11.1)
hsa:92815;HIST3H2A;histone cluster 3, H2a
hsa:55168;MRPS18A,HumanS18b,MRP-S18-3,MRPS18-3,S18bmt;mitochondrial ribosomal protein S18A
hsa:197257;LDHD,DLD;lactate dehydrogenase D (EC:1.1.2.4)
hsa:92399;MRRF,MRFF,MTRRF,RRF;mitochondrial ribosome recycling factor
hsa:5096;PCCB;propionyl CoA carboxylase, beta polypeptide (EC:6.4.1.3)
hsa:57172;CAMK1G,CLICK3,CLICKIII,VWS1,dJ272L16.1;calcium/calmodulin-dependent protein kinase IG (EC:2.7.11.17)
hsa:55646;LYAR,ZC2HC2,ZLYAR;Ly1 antibody reactive
hsa:64756;ATPAF1,ATP11,ATP11p;ATP synthase mitochondrial F1 complex assembly factor 1
hsa:54995;OXSM,FASN2D,KASI,KS;3-oxoacyl-ACP synthase, mitochondrial (EC:2.3.1.41)
hsa:6359;CCL15,HCC-2,HMRP-2B,LKN-1,LKN1,MIP-1_delta,MIP-1D,MIP-5,MRP-2B,NCC-3,NCC3,SCYA15,SCYL3,SY15;chemokine (C-C motif) ligand 15
hsa:400658;;FLJ44313 protein
hsa:25915;NDUFAF3,2P1,C3orf60,E3-3;NADH dehydrogenase (ubiquinone) complex I, assembly factor 3
hsa:100506939;PRKG1-AS1;PRKG1 antisense RNA 1
hsa:650623;BEND3P3;BEN domain containing 3 pseudogene 3
hsa:29990;PILRB,FDFACT1,FDFACT2;paired immunoglobin-like type 2 receptor beta
hsa:23168;RTF1,GTL7,KIAA0252;Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)
hsa:79036;KXD1,C19orf50,KXDL,MST096,MSTP096;KxDL motif containing 1
hsa:1955;MEGF9,EGFL5;multiple EGF-like-domains 9
hsa:126432;RINL;Ras and Rab interactor-like
hsa:8513;LIPF,GL,HGL,HLAL;lipase, gastric (EC:3.1.1.3)
hsa:132160;PPM1M,PP2C-eta,PP2CE,PP2Ceta;protein phosphatase, Mg2+/Mn2+ dependent, 1M (EC:3.1.3.16)
hsa:23054;NCOA6,AIB3,ASC2,NRC,PRIP,RAP250,TRBP;nuclear receptor coactivator 6
hsa:55312;RFK,RIFK;riboflavin kinase (EC:2.7.1.26)
hsa:9786;Talpid3;KIAA0586
hsa:114299;PALM2,AKAP2;paralemmin 2
hsa:132;ADK,AK;adenosine kinase (EC:2.7.1.20)
hsa:4926;NUMA1,NUMA;nuclear mitotic apparatus protein 1
hsa:4594;MUT,MCM;methylmalonyl CoA mutase (EC:5.4.99.2)
hsa:23594;ORC6,ORC6L;origin recognition complex, subunit 6
hsa:10335;MRVI1,IRAG,JAW1L;murine retrovirus integration site 1 homolog
hsa:92106;OXNAD1;oxidoreductase NAD-binding domain containing 1
hsa:84275;SLC25A33,BMSC-MCP,PNC1;solute carrier family 25 (pyrimidine nucleotide carrier), member 33
hsa:118980;SFXN2;sideroflexin 2
hsa:5611;DNAJC3,ERdj6,HP58,P58,P58IPK,PRKRI;DnaJ (Hsp40) homolog, subfamily C, member 3
hsa:80031;SEMA6D;sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D
hsa:29907;SNX15,HSAF001435;sorting nexin 15
hsa:53616;ADAM22,ADAM_22,MDC2;ADAM metallopeptidase domain 22
hsa:23151;GRAMD4,DIP,dA59H18.1,dJ439F8.1;GRAM domain containing 4
hsa:5360;PLTP,BPIFE,HDLCQ9;phospholipid transfer protein
hsa:51199;NIN,SCKL7;ninein (GSK3B interacting protein)
hsa:57120;GOPC,CAL,FIG,GOPC1,PIST,dJ94G16.2;golgi-associated PDZ and coiled-coil motif containing
hsa:9647;PPM1F,CAMKP,CaMKPase,FEM-2,POPX2,hFEM-2;protein phosphatase, Mg2+/Mn2+ dependent, 1F (EC:3.1.3.16)
hsa:4678;NASP,FLB7527,PRO1999;nuclear autoantigenic sperm protein (histone-binding)
hsa:11211;FZD10,CD350,FZ-10,Fz10,FzE7,hFz10;frizzled family receptor 10
hsa:23034;SAMD4A,SAMD4,SMAUG,SMAUG1,SMG,SMGA;sterile alpha motif domain containing 4A
hsa:8749;ADAM18,ADAM27,tMDCIII;ADAM metallopeptidase domain 18
hsa:56890;MDM1;Mdm1 nuclear protein homolog (mouse)
hsa:152002;XXYLT1,C3orf21;xyloside xylosyltransferase 1
hsa:55118;CRTAC1,ASPIC,ASPIC1,CEP-68;cartilage acidic protein 1
hsa:3176;HNMT,HMT,HNMT-S1,HNMT-S2;histamine N-methyltransferase (EC:2.1.1.8)
hsa:196883;ADCY4,AC4;adenylate cyclase 4 (EC:4.6.1.1)
hsa:387597;ILDR2,C1orf32,RP4-782G3.2,dJ782G3.1;immunoglobulin-like domain containing receptor 2
hsa:84311;MRPL45,L45mt,MRP-L45;mitochondrial ribosomal protein L45
hsa:6625;SNRNP70,RNPU1Z,RPU1,SNRP70,Snp1,U1-70K,U170K,U1AP,U1RNP;small nuclear ribonucleoprotein 70kDa (U1)
hsa:3437;IFIT3,CIG-49,GARG-49,IFI60,IFIT4,IRG2,ISG60,P60,RIG-G;interferon-induced protein with tetratricopeptide repeats 3
hsa:145282;MIPOL1;mirror-image polydactyly 1
hsa:6883;TAF12,TAF2J,TAFII20;TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa
hsa:6505;SLC1A1,EAAC1,EAAT3;solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
hsa:831;CAST,BS-17;calpastatin
hsa:160364;CLEC12A,CLL-1,CLL1,DCAL-2,MICL;C-type lectin domain family 12, member A
hsa:58190;CTDSP1,NIF3,NLI-IF,NLIIF,SCP1;CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 (EC:3.1.3.16)
hsa:51295;ECSIT,SITPEC;ECSIT homolog (Drosophila)
hsa:7086;TKT,TK,TKT1;transketolase (EC:2.2.1.1)
hsa:221150;SKA3,C13orf3,RAMA1;spindle and kinetochore associated complex subunit 3
hsa:29086;BABAM1,C19orf62,MERIT40,NBA1;BRISC and BRCA1 A complex member 1
hsa:2140;EYA3;eyes absent homolog 3 (Drosophila) (EC:3.1.3.48)
hsa:51778;MYOZ2,C4orf5,CMH16,CS-1;myozenin 2
hsa:142891;SAMD8,SMSr;sterile alpha motif domain containing 8
hsa:10137;RBM12,HRIHFB2091,SWAN;RNA binding motif protein 12
hsa:51447;IP6K2,IHPK2,PIUS;inositol hexakisphosphate kinase 2 (EC:2.7.4.21)
hsa:10669;CGREF1,CGR11;cell growth regulator with EF-hand domain 1
hsa:1805;DPT,TRAMP;dermatopontin
hsa:23514;;KIAA0146
hsa:51143;DYNC1LI1,DNCLI1,LIC1;dynein, cytoplasmic 1, light intermediate chain 1
hsa:898;CCNE1,CCNE;cyclin E1
hsa:2766;GMPR,GMPR1;guanosine monophosphate reductase (EC:1.7.1.7)
hsa:6182;MRPL12,5c5-2,L12mt,MRP-L31/34,MRPL7,MRPL7/L12,RPML12;mitochondrial ribosomal protein L12
hsa:23500;DAAM2,dJ90A20A.1;dishevelled associated activator of morphogenesis 2
hsa:23344;ESYT1,FAM62A,MBC2;extended synaptotagmin-like protein 1
hsa:1893;ECM1;extracellular matrix protein 1
hsa:11100;HNRNPUL1,E1B-AP5,E1BAP5,HNRPUL1;heterogeneous nuclear ribonucleoprotein U-like 1
hsa:25960;GPR124,TEM5;G protein-coupled receptor 124
hsa:7818;DAP3,DAP-3,MRP-S29,MRPS29,bMRP-10;death associated protein 3
hsa:4702;NDUFA8,CI-19KD,CI-PGIV,PGIV;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa (EC:1.6.5.3 1.6.99.3)
hsa:11215;AKAP11,AKAP-11,AKAP220,PPP1R44,PRKA11;A kinase (PRKA) anchor protein 11
hsa:10691;GMEB1,P96PIF,PIF96;glucocorticoid modulatory element binding protein 1
hsa:63898;SH2D4A,PPP1R38,SH2A;SH2 domain containing 4A
hsa:84869;CBR4,SDR45C1;carbonyl reductase 4 (EC:1.1.1.-)
hsa:10576;CCT2,99D8.1,CCT-beta,CCTB,PRO1633,TCP-1-beta;chaperonin containing TCP1, subunit 2 (beta)
hsa:23523;CABIN1,CAIN,PPP3IN;calcineurin binding protein 1
hsa:51185;CRBN,MRT2,MRT2A;cereblon
hsa:122773;KLHDC1,MST025;kelch domain containing 1
hsa:55217;TMLHE,AUTSX6,BBOX2,TMLD,TMLH,TMLHED,XAP130;trimethyllysine hydroxylase, epsilon (EC:1.14.11.8)
hsa:81027;TUBB1;tubulin, beta 1 class VI
hsa:84456;L3MBTL3,MBT-1,MBT1,RP11-73O6.1;l(3)mbt-like 3 (Drosophila)
hsa:26003;GORASP2,GOLPH6,GRASP55,GRS2,p59;golgi reassembly stacking protein 2, 55kDa
hsa:1453;CSNK1D,CKIdelta,HCKID;casein kinase 1, delta (EC:2.7.11.1 2.7.11.26)
hsa:5511;PPP1R8,ARD-1,ARD1,NIPP-1,NIPP1,PRO2047;protein phosphatase 1, regulatory subunit 8
hsa:113235;SLC46A1,HCP1,PCFT;solute carrier family 46 (folate transporter), member 1
hsa:26577;PCOLCE2,PCPE2;procollagen C-endopeptidase enhancer 2
hsa:51807;TUBA8,TUBAL2;tubulin, alpha 8
hsa:254394;MCM9,C6orf61,MCMDC1,dJ329L24.1,dJ329L24.3;minichromosome maintenance complex component 9 (EC:3.6.4.12)
hsa:57715;SEMA4G;sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G
hsa:79660;PPP1R3B,GL,PPP1R4,PTG;protein phosphatase 1, regulatory subunit 3B
hsa:125170;SMCR7,MID49;Smith-Magenis syndrome chromosome region, candidate 7
hsa:51386;EIF3L,EIF3EIP,EIF3S11,EIF3S6IP,HSPC021,HSPC025,MSTP005;eukaryotic translation initiation factor 3, subunit L
hsa:149628;PYHIN1,IFIX,RP11-520H16.1;pyrin and HIN domain family, member 1
hsa:83439;TCF7L1,TCF-3,TCF3;transcription factor 7-like 1 (T-cell specific, HMG-box)
hsa:5068;REG3A,HIP,INGAP,PAP,PAP-H,PAP1,PBCGF,REG-III,REG3;regenerating islet-derived 3 alpha
hsa:10512;SEMA3C,SEMAE,SemE;sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
hsa:8237;USP11,UHX1;ubiquitin specific peptidase 11 (EC:3.4.19.12)
hsa:54507;ADAMTSL4,ECTOL2,TSRC1;ADAMTS-like 4
hsa:23062;GGA2,VEAR;golgi-associated, gamma adaptin ear containing, ARF binding protein 2
hsa:51377;UCHL5,CGI-70,INO80R,UCH-L5,UCH37;ubiquitin carboxyl-terminal hydrolase L5 (EC:3.4.19.12)
hsa:140465;MYL6B,MLC1SA;myosin, light chain 6B, alkali, smooth muscle and non-muscle
hsa:171558;PTCRA,PT-ALPHA,PTA;pre T-cell antigen receptor alpha
hsa:2047;EPHB1,ELK,EPHT2,Hek6,NET;EPH receptor B1 (EC:2.7.10.1)
hsa:51460;SFMBT1,RU1,SFMBT;Scm-like with four mbt domains 1
hsa:2237;FEN1,FEN-1,MF1,RAD2;flap structure-specific endonuclease 1
hsa:57407;NMRAL1,HSCARG,SDR48A1;NmrA-like family domain containing 1
hsa:114883;OSBPL9,ORP-9,ORP9;oxysterol binding protein-like 9
hsa:6385;SDC4,SYND4;syndecan 4
hsa:5898;RALA,RAL;v-ral simian leukemia viral oncogene homolog A (ras related)
hsa:29117;BRD7,BP75,CELTIX1,NAG4;bromodomain containing 7
hsa:84516;DCTN5;dynactin 5 (p25)
hsa:79152;FA2H,FAAH,FAH1,FAXDC1,SCS7,SPG35;fatty acid 2-hydroxylase
hsa:342510;CD300E,CD300LE,CLM-2,CLM2,CMRF35-A5,IREM-2,IREM2,PIgR-2,PIgR2;CD300e molecule
hsa:5525;PPP2R5A,B56A,PR61A;protein phosphatase 2, regulatory subunit B', alpha
hsa:346;APOC4,APO-CIV,APOC-IV;apolipoprotein C-IV
hsa:23345;SYNE1,8B,ARCA1,C6orf98,CPG2,EDMD4,MYNE1,Nesp1,SCAR8,dJ45H2.2;spectrin repeat containing, nuclear envelope 1
hsa:10290;SPEG,APEG-1,APEG1,BPEG,SPEGalpha,SPEGbeta;SPEG complex locus (EC:2.7.11.1)
hsa:53841;CDHR5,MU-PCDH,MUCDHL,MUPCDH;cadherin-related family member 5
hsa:989;SEPT7,CDC10,CDC3,NBLA02942,SEPT7A;septin 7
hsa:2769;GNA15,GNA16;guanine nucleotide binding protein (G protein), alpha 15 (Gq class)
hsa:10110;SGK2,H-SGK2,dJ138B7.2;serum/glucocorticoid regulated kinase 2 (EC:2.7.11.1)
hsa:64078;SLC28A3,CNT3;solute carrier family 28 (sodium-coupled nucleoside transporter), member 3
hsa:6936;GCFC2,C2orf3,DNABF,GCF,TCF9;GC-rich sequence DNA-binding factor 2
hsa:80824;DUSP16,MKP-7,MKP7;dual specificity phosphatase 16 (EC:3.1.3.16 3.1.3.48)
hsa:129285;PPP1R21,CCDC128,KLRAQ1;protein phosphatase 1, regulatory subunit 21
hsa:273;AMPH,AMPH1;amphiphysin
hsa:8034;SLC25A16,D10S105E,GDA,GDC,HGT.1,ML7,hML7;solute carrier family 25 (mitochondrial carrier;Graves disease autoantigen), member 16
hsa:5024;P2RX3,P2X3;purinergic receptor P2X, ligand-gated ion channel, 3
hsa:114294;LACTB,G24,MRPL56;lactamase, beta
hsa:10500;SEMA6C,SEMAY,m-SemaY,m-SemaY2;sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C
hsa:1936;EEF1D,EF-1D,EF1D,FP1047;eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)
hsa:51540;SCLY,SCL,hSCL;selenocysteine lyase (EC:4.4.1.16)
hsa:168507;PKD1L1,PRO19563;polycystic kidney disease 1 like 1
hsa:9689;BZW1,BZAP45,Nbla10236;basic leucine zipper and W2 domains 1
hsa:4793;NFKBIB,IKBB,TRIP9;nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
hsa:10588;MTHFS,HsT19268;5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase) (EC:6.3.3.2)
hsa:284119;PTRF,CAVIN,CAVIN1,CGL4,cavin-1;polymerase I and transcript release factor
hsa:114327;EFHC1,dJ304B14.2;EF-hand domain (C-terminal) containing 1
hsa:166614;DCLK2,CL2,CLICK-II,CLICK2,CLIK2,DCAMKL2,DCDC3,DCDC3B,DCK2;doublecortin-like kinase 2 (EC:2.7.11.1)
hsa:93185;IGSF8,CD316,CD81P3,EWI-2,EWI2,KCT-4,LIR-D1,PGRL;immunoglobulin superfamily, member 8
hsa:79646;PANK3;pantothenate kinase 3 (EC:2.7.1.33)
hsa:7016;TESK1;testis-specific kinase 1 (EC:2.7.12.1)
hsa:871;SERPINH1,AsTP3,CBP1,CBP2,HSP47,OI10,PPROM,RA-A47,SERPINH2,gp46;serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
hsa:6294;SAFB,HAP,HET,SAF-B1,SAFB1;scaffold attachment factor B
hsa:4303;FOXO4,AFX,AFX1,MLLT7;forkhead box O4
hsa:54825;CDHR2,PCDH24,PCLKC;cadherin-related family member 2
hsa:54438;GFOD1,ADG-90,C6orf114;glucose-fructose oxidoreductase domain containing 1
hsa:117;ADCYAP1R1,PAC1,PAC1R,PACAPR,PACAPRI;adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
hsa:60481;ELOVL5,HELO1,dJ483K16.1;ELOVL fatty acid elongase 5 (EC:2.3.1.199)
hsa:51646;YPEL5;yippee-like 5 (Drosophila)
hsa:131578;LRRC15,LIB;leucine rich repeat containing 15
hsa:514;ATP5E,ATPE,MC5DN3;ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit (EC:3.6.3.14)
hsa:124995;MRPL10,L10MT,MRP-L10,MRP-L8,MRPL8,RPML8;mitochondrial ribosomal protein L10
hsa:54848;ARHGEF38;Rho guanine nucleotide exchange factor (GEF) 38
hsa:6950;TCP1,CCT-alpha,CCT1,CCTa,D6S230E,TCP-1-alpha;t-complex 1
hsa:22800;RRAS2,TC21;related RAS viral (r-ras) oncogene homolog 2
hsa:9482;STX8,CARB;syntaxin 8
hsa:7079;TIMP4;TIMP metallopeptidase inhibitor 4
hsa:283927;NUDT7;nudix (nucleoside diphosphate linked moiety X)-type motif 7 (EC:3.6.1.-)
hsa:54829;ASPN,OS3,PLAP-1,PLAP1,SLRR1C;asporin
hsa:6574;SLC20A1,GLVR1,Glvr-1,PIT1,PiT-1;solute carrier family 20 (phosphate transporter), member 1
hsa:79695;GALNT12,CRCS1,GalNAc-T12;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (GalNAc-T12) (EC:2.4.1.41)
hsa:8802;SUCLG1,GALPHA,MTDPS9,SUCLA1;succinate-CoA ligase, alpha subunit (EC:6.2.1.4 6.2.1.5)
hsa:142680;SLC34A3,HHRH,NPTIIc;solute carrier family 34 (sodium phosphate), member 3
hsa:4713;NDUFB7,B18,CI-B18;NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa (EC:1.6.5.3 1.6.99.3)
hsa:1847;DUSP5,DUSP,HVH3;dual specificity phosphatase 5 (EC:3.1.3.16 3.1.3.48)
hsa:54857;GDPD2,GDE3,OBDPF;glycerophosphodiester phosphodiesterase domain containing 2 (EC:3.1.4.43)
hsa:84966;IGSF21;immunoglobin superfamily, member 21
hsa:622;BDH1,BDH,SDR9C1;3-hydroxybutyrate dehydrogenase, type 1 (EC:1.1.1.30)
hsa:285025;CCDC141,CAMDI;coiled-coil domain containing 141
hsa:3067;HDC;histidine decarboxylase (EC:4.1.1.22)
hsa:255520;ELMOD2,9830169G11Rik;ELMO/CED-12 domain containing 2
hsa:80274;SCUBE1;signal peptide, CUB domain, EGF-like 1
hsa:10105;PPIF,CYP3,CyP-M,Cyp-D,CypD;peptidylprolyl isomerase F (EC:5.2.1.8)
hsa:64577;ALDH8A1,ALDH12,DJ352A20.2;aldehyde dehydrogenase 8 family, member A1
hsa:56943;ENY2,e(y)2;enhancer of yellow 2 homolog (Drosophila)
hsa:5427;POLE2,DPE2;polymerase (DNA directed), epsilon 2, accessory subunit (EC:2.7.7.7)
hsa:9152;SLC6A5,GLYT-2,GLYT2,HKPX3,NET1;solute carrier family 6 (neurotransmitter transporter, glycine), member 5
hsa:90952;ESAM,W117m;endothelial cell adhesion molecule
hsa:285362;SUMF1,AAPA3037,FGE;sulfatase modifying factor 1 (EC:1.13.-.-)
hsa:2820;GPD2,GDH2,GPDM,mGPDH;glycerol-3-phosphate dehydrogenase 2 (mitochondrial) (EC:1.1.5.3)
hsa:79723;SUV39H2,KMT1B;suppressor of variegation 3-9 homolog 2 (Drosophila) (EC:2.1.1.43)
hsa:22809;ATF5,ATFX,HMFN0395;activating transcription factor 5
hsa:65110;UPF3A,HUPF3A,RENT3A,UPF3;UPF3 regulator of nonsense transcripts homolog A (yeast)
hsa:9493;KIF23,CHO1,KNSL5,MKLP-1,MKLP1;kinesin family member 23
hsa:54552;GNL3L;guanine nucleotide binding protein-like 3 (nucleolar)-like
hsa:642273;FAM110C;family with sequence similarity 110, member C
hsa:1750;DLX6;distal-less homeobox 6
hsa:200014;CC2D1B;coiled-coil and C2 domain containing 1B
hsa:165904;XIRP1,CMYA1,Xin;xin actin-binding repeat containing 1
hsa:57546;PDP2,PPM2C2;pyruvate dehyrogenase phosphatase catalytic subunit 2 (EC:3.1.3.43)
hsa:51102;MECR,CGI-63,FASN2B,NRBF1;mitochondrial trans-2-enoyl-CoA reductase (EC:1.3.1.38)
hsa:2543;GAGE1,CT4.1,GAGE-1;G antigen 1
hsa:221476;PI16,CRISP9,MSMBBP,PSPBP;peptidase inhibitor 16
hsa:1993;ELAVL2,HEL-N1,HELN1,HUB;ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B)
hsa:87769;GGACT,A2LD1;gamma-glutamylamine cyclotransferase (EC:2.3.2.4)
hsa:9367;RAB9A,RAB9;RAB9A, member RAS oncogene family
hsa:157638;FAM84B,BCMP101,NSE2;family with sequence similarity 84, member B
hsa:3120;HLA-DQB2,HLA-DQB1,HLA-DXB;major histocompatibility complex, class II, DQ beta 2
hsa:432;ASGR1,ASGPR,ASGPR1,CLEC4H1,HL-1;asialoglycoprotein receptor 1
hsa:51107;APH1A,6530402N02Rik,APH-1,APH-1A,CGI-78;anterior pharynx defective 1 homolog A (C. elegans)
hsa:29766;TMOD3,UTMOD;tropomodulin 3 (ubiquitous)
hsa:9649;RALGPS1,RALGEF2,RALGPS1A;Ral GEF with PH domain and SH3 binding motif 1
hsa:10417;SPON2,DIL-1,DIL1,M-SPONDIN,MINDIN;spondin 2, extracellular matrix protein
hsa:11132;CAPN10,CANP10,NIDDM1;calpain 10
hsa:284273;ZADH2;zinc binding alcohol dehydrogenase domain containing 2;K07119
hsa:57047;PLSCR2;phospholipid scramblase 2
hsa:50939;IMPG2,IPM200,RP56,SPACRCAN;interphotoreceptor matrix proteoglycan 2
hsa:53354;PANK1,PANK;pantothenate kinase 1 (EC:2.7.1.33)
hsa:202052;DNAJC18;DnaJ (Hsp40) homolog, subfamily C, member 18
hsa:5504;PPP1R2,IPP-2,IPP2;protein phosphatase 1, regulatory (inhibitor) subunit 2 (EC:3.1.3.16)
hsa:151827;LRRC34;leucine rich repeat containing 34
hsa:373509;USP50;ubiquitin specific peptidase 50
hsa:221154;MICU2,1110008L20Rik,EFHA1;mitochondrial calcium uptake 2
hsa:25771;TBC1D22A,C22orf4,HSC79E021;TBC1 domain family, member 22A
hsa:1395;CRHR2,CRF-RB,CRF2,CRFR2,HM-CRF;corticotropin releasing hormone receptor 2
hsa:65263;PYCRL;pyrroline-5-carboxylate reductase-like (EC:1.5.1.2)
hsa:6818;SULT1A3,HAST,HAST3,M-PST,ST1A3/ST1A4,ST1A5,STM,TL-PST;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1)
hsa:7324;UBE2E1,UBCH6;ubiquitin-conjugating enzyme E2E 1 (EC:6.3.2.19)
hsa:23499;MACF1,ABP620,ACF7,MACF,OFC4;microtubule-actin crosslinking factor 1
hsa:777;CACNA1E,BII,CACH6,CACNL1A6,Cav2.3;calcium channel, voltage-dependent, R type, alpha 1E subunit
hsa:1845;DUSP3,VHR;dual specificity phosphatase 3 (EC:3.1.3.16 3.1.3.48)
hsa:5013;OTX1;orthodenticle homeobox 1
hsa:64093;SMOC1,OAS;SPARC related modular calcium binding 1
hsa:64344;HIF3A,HIF-3A,IPAS,MOP7,PASD7,bHLHe17;hypoxia inducible factor 3, alpha subunit
hsa:51082;POLR1D,AC19,POLR1C,RPA16,RPA9,RPAC2,RPC16,RPO1-3,TCS2;polymerase (RNA) I polypeptide D, 16kDa
hsa:3706;ITPKA,IP3-3KA,IP3KA;inositol-trisphosphate 3-kinase A (EC:2.7.1.127)
hsa:8775;NAPA,SNAPA;N-ethylmaleimide-sensitive factor attachment protein, alpha
hsa:1973;EIF4A1,DDX2A,EIF-4A,EIF4A,eIF-4A-I,eIF4A-I;eukaryotic translation initiation factor 4A1 (EC:3.6.4.13)
hsa:55183;RIF1;RAP1 interacting factor homolog (yeast)
hsa:5232;PGK2,PGKB,PGKPS,dJ417L20.2;phosphoglycerate kinase 2 (EC:2.7.2.3)
hsa:1041;CDSN,D6S586E,HTSS,HTSS1,PSS,S;corneodesmosin
hsa:4719;NDUFS1,CI-75Kd,CI-75k,PRO1304;NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3)
hsa:5613;PRKX,PKX1;protein kinase, X-linked (EC:2.7.11.1)
hsa:51393;TRPV2,VRL,VRL-1,VRL1;transient receptor potential cation channel, subfamily V, member 2
hsa:5959;RDH5,9cRDH,HSD17B9,RDH1,SDR9C5;retinol dehydrogenase 5 (11-cis/9-cis) (EC:1.1.1.315)
hsa:140739;UBE2F,NCE2;ubiquitin-conjugating enzyme E2F (putative)
hsa:5646;PRSS3,MTG,PRSS4,T9,TRY3,TRY4;protease, serine, 3 (EC:3.4.21.4)
hsa:22930;RAB3GAP1,P130,RAB3GAP,RAB3GAP130,WARBM1;RAB3 GTPase activating protein subunit 1 (catalytic)
hsa:728911;CT45A2,CT45-2,CT45.2;cancer/testis antigen family 45, member A2
hsa:11243;PMF1;polyamine-modulated factor 1
hsa:3744;KCNA10,Kcn1,Kv1.8;potassium voltage-gated channel, shaker-related subfamily, member 10
hsa:784;CACNB3,CAB3,CACNLB3;calcium channel, voltage-dependent, beta 3 subunit
hsa:54749;EPDR1,EPDR,MERP-1,MERP1,UCC1;ependymin related protein 1 (zebrafish)
hsa:23286;WWC1,HBEBP3,HBEBP36,KIBRA;WW and C2 domain containing 1
hsa:9321;TRIP11,ACG1A,CEV14,GMAP-210,TRIP-11,TRIP230;thyroid hormone receptor interactor 11
hsa:6677;SPAM1,HYA1,HYAL1,HYAL3,HYAL5,PH-20,PH20,SPAG15;sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding) (EC:3.2.1.35)
hsa:396;ARHGDIA,GDIA1,RHOGDI,RHOGDI-1;Rho GDP dissociation inhibitor (GDI) alpha
hsa:8673;VAMP8,EDB,VAMP-8;vesicle-associated membrane protein 8
hsa:22929;SEPHS1,SELD,SPS,SPS1;selenophosphate synthetase 1 (EC:2.7.9.3)
hsa:2242;FES,FPS;feline sarcoma oncogene (EC:2.7.10.2)
hsa:221981;THSD7A;thrombospondin, type I, domain containing 7A
hsa:1660;DHX9,DDX9,LKP,NDH2,NDHII,RHA;DEAH (Asp-Glu-Ala-His) box polypeptide 9 (EC:3.6.4.13)
hsa:64786;TBC1D15,RAB7-GAP;TBC1 domain family, member 15 (EC:1.15.1.1)
hsa:5686;PSMA5,PSC5,ZETA;proteasome (prosome, macropain) subunit, alpha type, 5 (EC:3.4.25.1)
hsa:27319;BHLHE22,BHLHB5,Beta3,CAGL85,TNRC20;basic helix-loop-helix family, member e22
hsa:125061;AFMID,FKF,KF,KFA;arylformamidase (EC:3.5.1.9)
hsa:80018;NAA25,C12orf30,MDM20,NAP1;N(alpha)-acetyltransferase 25, NatB auxiliary subunit
hsa:9057;SLC7A6,LAT-2,LAT3,y+LAT-2;solute carrier family 7 (amino acid transporter light chain, y+L system), member 6
hsa:9156;EXO1,HEX1,hExoI;exonuclease 1
hsa:433;ASGR2,ASGP-R2,ASGPR2,CLEC4H2,HBXBP,HL-2;asialoglycoprotein receptor 2
hsa:6672;SP100,lysp100b;SP100 nuclear antigen
hsa:25945;PVRL3,CD113,CDW113,NECTIN-3,PPR3,PRR3,PVRR3;poliovirus receptor-related 3
hsa:23274;CLEC16A,Gop-1,KIAA0350;C-type lectin domain family 16, member A
hsa:64419;MTMR14,C3orf29;myotubularin related protein 14
hsa:5669;PSG1,B1G1,CD66f,DHFRP2,FL-NCA-1/2,PBG1,PS-beta-C/D,PS-beta-G-1,PSBG-1,PSBG1,PSG95,PSGGA,PSGIIA,SP1;pregnancy specific beta-1-glycoprotein 1
hsa:163486;DENND1B,C1ORF18,C1orf218,FAM31B;DENN/MADD domain containing 1B
hsa:171568;POLR3H,RPC22.9,RPC8;polymerase (RNA) III (DNA directed) polypeptide H (22.9kD) (EC:2.7.7.6)
hsa:51271;UBAP1,NAG20,UAP,UBAP,UBAP-1;ubiquitin associated protein 1
hsa:27109;ATP5S,ATPW,FB,HSU79253;ATP synthase, H+ transporting, mitochondrial Fo complex, subunit s (factor B) (EC:3.6.1.14)
hsa:11036;GTF2A1L,ALF;general transcription factor IIA, 1-like
hsa:375057;C1orf95;chromosome 1 open reading frame 95
hsa:9356;SLC22A6,HOAT1,OAT1,PAHT,ROAT1;solute carrier family 22 (organic anion transporter), member 6
hsa:94120;SYTL3,SLP3;synaptotagmin-like 3
hsa:3242;HPD,4-HPPD,4HPPD,GLOD3,HPPDASE,PPD;4-hydroxyphenylpyruvate dioxygenase (EC:1.13.11.27)
hsa:8909;ENDOU,P11,PP11,PRSS26;endonuclease, polyU-specific
hsa:2821;GPI,AMF,GNPI,NLK,PGI,PHI,SA-36,SA36;glucose-6-phosphate isomerase (EC:5.3.1.9)
hsa:27238;GPKOW,GPATC5,GPATCH5,Spp2,T54;G patch domain and KOW motifs
hsa:81704;DOCK8,MRD2,ZIR8;dedicator of cytokinesis 8
hsa:85407;NKD1,Naked1;naked cuticle homolog 1 (Drosophila)
hsa:22839;DLGAP4,DAP4,DLP4,RP5-977B1.6,SAPAP4;discs, large (Drosophila) homolog-associated protein 4
hsa:55192;DNAJC17;DnaJ (Hsp40) homolog, subfamily C, member 17
hsa:723790;HIST2H2AA4,H2A/R;histone cluster 2, H2aa4
hsa:2519;FUCA2,dJ20N2.5;fucosidase, alpha-L- 2, plasma (EC:3.2.1.51)
hsa:79934;ADCK4;aarF domain containing kinase 4
hsa:89848;FCHSD1,NWK2;FCH and double SH3 domains 1
hsa:6881;TAF10,TAF2A,TAF2H,TAFII30;TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa
hsa:6626;SNRPA,Mud1,U1-A,U1A;small nuclear ribonucleoprotein polypeptide A
hsa:6301;SARS,SERRS,SERS;seryl-tRNA synthetase (EC:6.1.1.11)
hsa:64849;SLC13A3,NADC3,SDCT2;solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3
hsa:8904;CPNE1,COPN1,CPN1;copine I
hsa:4117;MAK,RP62,dJ417M14.2;male germ cell-associated kinase (EC:2.7.11.22)
hsa:59283;CACNG8;calcium channel, voltage-dependent, gamma subunit 8
hsa:84976;DISP1,DISPA;dispatched homolog 1 (Drosophila)
hsa:114815;SORCS1,hSorCS;sortilin-related VPS10 domain containing receptor 1
hsa:348110;C15orf38;chromosome 15 open reading frame 38
hsa:440695;ETV3L;ets variant 3-like
hsa:479;ATP12A,ATP1AL1;ATPase, H+/K+ transporting, nongastric, alpha polypeptide (EC:3.6.3.10)
hsa:59338;PLEKHA1,TAPP1;pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
hsa:282809;POC1B,PIX1,TUWD12,WDR51B;POC1 centriolar protein homolog B (Chlamydomonas)
hsa:4141;MARS,METRS,MRS,MTRNS;methionyl-tRNA synthetase (EC:6.1.1.10)
hsa:83548;COG3,SEC34;component of oligomeric golgi complex 3
hsa:10746;MAP3K2,MEKK2,MEKK2B;mitogen-activated protein kinase kinase kinase 2 (EC:2.7.11.25)
hsa:79148;MMP28,EPILYSIN,MM28,MMP-28,MMP25;matrix metallopeptidase 28
hsa:4241;MFI2,CD228,MAP97,MTF1;antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5
hsa:286262;TPRN,C9orf75,DFNB79,RP11-350O14.7;taperin
hsa:7327;UBE2G2,UBC7;ubiquitin-conjugating enzyme E2G 2 (EC:6.3.2.19)
hsa:84824;FCRLA,FCRL,FCRL1,FCRLM1,FCRLX,FCRLb,FCRLc1,FCRLc2,FCRLd,FCRLe,FCRX,FREB;Fc receptor-like A
hsa:57191;VN1R1,V1RL1,VNR19I1,ZVNH1,ZVNR1;vomeronasal 1 receptor 1
hsa:4258;MGST2,GST2,MGST-II;microsomal glutathione S-transferase 2 (EC:2.5.1.18)
hsa:53826;FXYD6;FXYD domain containing ion transport regulator 6
hsa:64768;IPPK,C9orf12,INSP5K2,IP5K,IPK1,bA476B13.1;inositol 1,3,4,5,6-pentakisphosphate 2-kinase (EC:2.7.1.158)
hsa:9228;DLGAP2,DAP2,SAPAP2;discs, large (Drosophila) homolog-associated protein 2
hsa:55644;OSGEP,GCPL1,KAE1,OSGEP1,PRSMG1;O-sialoglycoprotein endopeptidase (EC:3.4.24.57)
hsa:84572;GNPTG,C16orf27,GNPTAG,LP2537,RJD9;N-acetylglucosamine-1-phosphate transferase, gamma subunit
hsa:51655;RASD1,AGS1,DEXRAS1,MGC:26290;RAS, dexamethasone-induced 1
hsa:138050;HGSNAT,HGNAT,MPS3C,TMEM76;heparan-alpha-glucosaminide N-acetyltransferase (EC:2.3.1.78)
hsa:496;ATP4B,ATP6B;ATPase, H+/K+ exchanging, beta polypeptide
hsa:23382;AHCYL2,ADOHCYASE3;adenosylhomocysteinase-like 2 (EC:3.3.1.1)
hsa:84818;IL17RC,IL17-RL,IL17RL;interleukin 17 receptor C
hsa:51247;PAIP2,PAIP2A;poly(A) binding protein interacting protein 2
hsa:3430;IFI35,IFP35;interferon-induced protein 35
hsa:116154;PHACTR3,C20orf101,H17739,SCAPIN1,SCAPININ;phosphatase and actin regulator 3
hsa:272;AMPD3;adenosine monophosphate deaminase 3 (EC:3.5.4.6)
hsa:81889;FAHD1,C16orf36,YISKL;fumarylacetoacetate hydrolase domain containing 1 (EC:3.7.1.5)
hsa:9754;STARD8,ARHGAP38,DLC3,STARTGAP3;StAR-related lipid transfer (START) domain containing 8
hsa:54949;SDHAF2,C11orf79,PGL2,SDH5;succinate dehydrogenase complex assembly factor 2
hsa:64710;NUCKS1,NUCKS;nuclear casein kinase and cyclin-dependent kinase substrate 1
hsa:64223;MLST8,GBL,GbetaL,LST8,POP3,WAT1;MTOR associated protein, LST8 homolog (S. cerevisiae)
hsa:5690;PSMB2,HC7-I;proteasome (prosome, macropain) subunit, beta type, 2 (EC:3.4.25.1)
hsa:3203;HOXA6,HOX1,HOX1.2,HOX1B;homeobox A6
hsa:84285;EIF1AD,haponin;eukaryotic translation initiation factor 1A domain containing
hsa:6821;SUOX;sulfite oxidase (EC:1.8.3.1)
hsa:125336;LOXHD1,DFNB77,LH2D1;lipoxygenase homology domains 1
hsa:9330;GTF3C3,TFIIIC102,TFIIICgamma,TFiiiC2-102;general transcription factor IIIC, polypeptide 3, 102kDa
hsa:9581;PREPL;prolyl endopeptidase-like (EC:3.4.21.-)
hsa:1491;CTH;cystathionase (cystathionine gamma-lyase) (EC:4.4.1.1)
hsa:23305;ACSL6,ACS2,FACL6,LACS_6,LACS2,LACS5;acyl-CoA synthetase long-chain family member 6 (EC:6.2.1.3)
hsa:25769;SLC24A2,NCKX2;solute carrier family 24 (sodium/potassium/calcium exchanger), member 2
hsa:84631;SLITRK2,CXorf2,SLITL1;SLIT and NTRK-like family, member 2
hsa:1104;RCC1,CHC1,RCC1-I,SNHG3-RCC1;regulator of chromosome condensation 1
hsa:9436;NCR2,CD336,LY95,NK-p44,NKP44,dJ149M18.1;natural cytotoxicity triggering receptor 2
hsa:54865;GPATCH4,GPATC4;G patch domain containing 4
hsa:9734;HDAC9,HD7,HD7b,HD9,HDAC,HDAC7,HDAC7B,HDAC9B,HDAC9FL,HDRP,MITR;histone deacetylase 9 (EC:3.5.1.98)
hsa:113;ADCY7,AC7;adenylate cyclase 7 (EC:4.6.1.1)
hsa:23047;PDS5B,APRIN,AS3,CG008;PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae)
hsa:79651;RHBDF2,RHBDL5,RHBDL6,TOC;rhomboid 5 homolog 2 (Drosophila)
hsa:9802;DAZAP2,PRTB;DAZ associated protein 2
hsa:4817;NIT1;nitrilase 1
hsa:7389;UROD,PCT,UPD;uroporphyrinogen decarboxylase (EC:4.1.1.37)
hsa:11196;SEC23IP,P125,P125A;SEC23 interacting protein
hsa:1145;CHRNE,ACHRE,CMS1D,CMS1E,CMS2A,FCCMS,SCCMS;cholinergic receptor, nicotinic, epsilon (muscle)
hsa:51181;DCXR,DCR,HCR2,HCRII,KIDCR,P34H,SDR20C1,XR;dicarbonyl/L-xylulose reductase (EC:1.1.1.10)
hsa:9529;BAG5,BAG-5;BCL2-associated athanogene 5
hsa:25764;HYPK,C15orf63;huntingtin interacting protein K
hsa:6799;SULT1A2,HAST4,P-PST,ST1A2,STP2,TSPST2;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 (EC:2.8.2.1)
hsa:56984;PSMG2,CLAST3,HCCA3,HsT1707,MDS003,PAC2,TNFSF5IP1;proteasome (prosome, macropain) assembly chaperone 2
hsa:221184;CPNE2,COPN2,CPN2;copine II
hsa:4668;NAGA,D22S674,GALB;N-acetylgalactosaminidase, alpha- (EC:3.2.1.49)
hsa:6434;TRA2B,Htra2-beta,SFRS10,SRFS10,TRA2-BETA,TRAN2B;transformer 2 beta homolog (Drosophila)
hsa:64100;ELSPBP1,E12,EDDM12,HE12;epididymal sperm binding protein 1
hsa:28998;MRPL13,L13,L13A,L13mt,RPL13,RPML13;mitochondrial ribosomal protein L13
hsa:83416;FCRL5,BXMAS1,CD307,CD307e,FCRH5,IRTA2,PRO820;Fc receptor-like 5
hsa:27111;SDCBP2,SITAC,SITAC18,ST-2;syndecan binding protein (syntenin) 2
hsa:113251;LARP4;La ribonucleoprotein domain family, member 4
hsa:63971;KIF13A,RBKIN,bA500C11.2;kinesin family member 13A
hsa:139760;GPR119,GPCR2;G protein-coupled receptor 119
hsa:83543;AIF1L,C9orf58,IBA2;allograft inflammatory factor 1-like
hsa:54474;KRT20,CD20,CK-20,CK20,K20,KRT21;keratin 20
hsa:57020;C16orf62;chromosome 16 open reading frame 62
hsa:84624;FNDC1,AGS8,FNDC2,MEL4B3,RP11-243O10.2,bA243O10.1,dJ322A24.1;fibronectin type III domain containing 1
hsa:55627;SMPD4,NET13,NSMASE-3,NSMASE3;sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3) (EC:3.1.4.12)
hsa:57446;NDRG3;NDRG family member 3
hsa:3195;TLX1,HOX11,TCL3;T-cell leukemia homeobox 1
hsa:8801;SUCLG2,GBETA;succinate-CoA ligase, GDP-forming, beta subunit (EC:6.2.1.4)
hsa:7258;TSPY1,CT78,DYS14,TSPY,pJA923;testis specific protein, Y-linked 1
hsa:91624;NEXN,CMH20,NELIN;nexilin (F actin binding protein)
hsa:55812;SPATA7,HSD-3.1,HSD3,LCA3;spermatogenesis associated 7
hsa:4998;ORC1,HSORC1,ORC1L,PARC1;origin recognition complex, subunit 1
hsa:27032;ATP2C1,ATP2C1A,BCPM,HHD,PMR1,SPCA1,hSPCA1;ATPase, Ca++ transporting, type 2C, member 1 (EC:3.6.3.8)
hsa:2961;GTF2E2,FE,TF2E2,TFIIE-B;general transcription factor IIE, polypeptide 2, beta 34kDa
hsa:8973;CHRNA6,CHNRA6;cholinergic receptor, nicotinic, alpha 6 (neuronal)
hsa:51601;LIPT1;lipoyltransferase 1 (EC:2.3.1.181)
hsa:5756;TWF1,A6,PTK9;twinfilin, actin-binding protein, homolog 1 (Drosophila)
hsa:5984;RFC4,A1,RFC37;replication factor C (activator 1) 4, 37kDa
hsa:10229;COQ7,CAT5,CLK-1,CLK1;coenzyme Q7 homolog, ubiquinone (yeast)
hsa:57055;DAZ2,pDP1678;deleted in azoospermia 2
hsa:51004;COQ6,CGI10,COQ10D6;coenzyme Q6 homolog, monooxygenase (S. cerevisiae)
hsa:8832;CD84,LY9B,SLAMF5,hCD84,mCD84;CD84 molecule
hsa:57551;TAOK1,KFC-B,MAP3K16,MARKK,PSK-2,PSK2,TAO1,hKFC-B,hTAOK1;TAO kinase 1 (EC:2.7.11.1)
hsa:133584;EGFLAM,AGRINL,AGRNL;EGF-like, fibronectin type III and laminin G domains
hsa:203111;C8orf47;chromosome 8 open reading frame 47
hsa:84639;IL1F10,FIL1-theta,IL-1HY2,IL-38,IL1-theta;interleukin 1 family, member 10 (theta)
hsa:50814;NSDHL,H105E3,SDR31E1,XAP104;NAD(P) dependent steroid dehydrogenase-like (EC:1.1.1.170)
hsa:51619;UBE2D4,HBUCE1;ubiquitin-conjugating enzyme E2D 4 (putative) (EC:6.3.2.19)
hsa:129138;ANKRD54,LIAR;ankyrin repeat domain 54
hsa:1769;DNAH8,ATPase,hdhc9;dynein, axonemal, heavy chain 8
hsa:80700;UBXN6,UBXD1,UBXDC2;UBX domain protein 6
hsa:270;AMPD1,MAD,MADA;adenosine monophosphate deaminase 1 (EC:3.5.4.6)
hsa:2487;FRZB,FRE,FRITZ,FRP-3,FRZB-1,FRZB-PEN,FRZB1,FZRB,OS1,SFRP3,SRFP3,hFIZ;frizzled-related protein
hsa:9551;ATP5J2,ATP5JL;ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2 (EC:3.6.1.14)
hsa:3739;KCNA4,HBK4,HK1,HPCN2,HUKII,KCNA4L,KCNA8,KV1.4,PCN2;potassium voltage-gated channel, shaker-related subfamily, member 4
hsa:84000;TMPRSS13,MSP,MSPL,MSPS,TMPRSS11;transmembrane protease, serine 13
hsa:64837;KLC2;kinesin light chain 2
hsa:92017;SNX29,A-388D4.1,RUNDC2A;sorting nexin 29
hsa:58477;SRPRB,APMCF1;signal recognition particle receptor, B subunit
hsa:51162;EGFL7,NEU1,RP11-251M1.2,VE-STATIN,ZNEU1;EGF-like-domain, multiple 7
hsa:64858;DCLRE1B,APOLLO,SNM1B,SNMIB;DNA cross-link repair 1B
hsa:26027;ACOT11,BFIT,STARD14,THEA,THEM1;acyl-CoA thioesterase 11 (EC:3.1.2.-)
hsa:56344;CABP5,CABP3;calcium binding protein 5
hsa:4097;MAFG,hMAF;v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian)
hsa:84545;MRPL43,bMRP36a;mitochondrial ribosomal protein L43
hsa:53358;SHC3,N-Shc,NSHC,RAI,SHCC;SHC (Src homology 2 domain containing) transforming protein 3
hsa:515;ATP5F1,PIG47;ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1
hsa:4065;LY75,CD205,CLEC13B,DEC-205,GP200-MR6,LY-75;lymphocyte antigen 75
hsa:148534;TMEM56;transmembrane protein 56
hsa:85300;ATCAY,BNIP-H,CLAC;ataxia, cerebellar, Cayman type
hsa:84660;CCDC62,CT109,ERAP75,TSP-NY;coiled-coil domain containing 62
hsa:10525;HYOU1,GRP-170,Grp170,HSP12A,ORP-150,ORP150;hypoxia up-regulated 1
hsa:9982;FGFBP1,FGF-BP,FGF-BP1,FGFBP,FGFBP-1,HBP17;fibroblast growth factor binding protein 1
hsa:6539;SLC6A12,BGT-1,BGT1,GAT2;solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12
hsa:951;CD37,GP52-40,TSPAN26;CD37 molecule
hsa:257068;PLCXD2;phosphatidylinositol-specific phospholipase C, X domain containing 2
hsa:283848;CES4A,CES6,CES8;carboxylesterase 4A
hsa:282679;AQP11,AQPX1;aquaporin 11
hsa:9936;CD302,BIMLEC,CLEC13A,DCL-1,DCL1;CD302 molecule
hsa:100506658;OCLN,BLCPMG;occludin (EC:2.1.1.67)
hsa:51742;ARID4B,BCAA,BRCAA1,RBBP1L1,RBP1L1,SAP180;AT rich interactive domain 4B (RBP1-like)
hsa:168400;DDX53,CAGE,CT26;DEAD (Asp-Glu-Ala-Asp) box polypeptide 53 (EC:3.6.4.13)
hsa:51371;POMP,C13orf12,PNAS-110,UMP1;proteasome maturation protein
hsa:27148;STK36,FU;serine/threonine kinase 36 (EC:2.7.11.1)
hsa:9435;CHST2,C6ST,GST-2,GST2,Gn6ST-1,glcNAc6ST-1;carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2
hsa:10124;ARL4A,ARL4;ADP-ribosylation factor-like 4A
hsa:6878;TAF6,MGC:8964,TAF(II)70,TAF(II)80,TAF2E,TAFII-70,TAFII-80,TAFII70,TAFII80,TAFII85;TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa
hsa:83990;BRIP1,BACH1,FANCJ,OF;BRCA1 interacting protein C-terminal helicase 1 (EC:3.6.4.13)
hsa:56257;MEPCE,BCDIN3;methylphosphate capping enzyme
hsa:5008;OSM;oncostatin M
hsa:2557;GABRA4;gamma-aminobutyric acid (GABA) A receptor, alpha 4
hsa:286205;SCAI,C9orf126,NET40;suppressor of cancer cell invasion
hsa:8087;FXR1,FXR1P;fragile X mental retardation, autosomal homolog 1
hsa:80224;NUBPL,C14orf127,IND1,huInd1;nucleotide binding protein-like
hsa:54913;RPP25;ribonuclease P/MRP 25kDa subunit (EC:3.1.26.5)
hsa:54874;FNBP1L,C1orf39,TOCA1;formin binding protein 1-like
hsa:253738;EBF3,COE3,EBF-3,O/E-2,OE-2;early B-cell factor 3
hsa:9887;SMG7,C1orf16,EST1C,SGA56M;smg-7 homolog, nonsense mediated mRNA decay factor (C. elegans) (EC:2.7.11.1)
hsa:84883;AIFM2,AMID,PRG3,RP11-367H5.2;apoptosis-inducing factor, mitochondrion-associated, 2
hsa:11118;BTN3A2,BT3.2,BT3.3,BTF4;butyrophilin, subfamily 3, member A2
hsa:54453;RIN2,MACS,RASSF4;Ras and Rab interactor 2
hsa:80223;RAB11FIP1,NOEL1A,RCP,rab11-FIP1;RAB11 family interacting protein 1 (class I)
hsa:389432;SAMD5,dJ875H10.1;sterile alpha motif domain containing 5
hsa:9150;CTDP1,CCFDN,FCP1;CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 (EC:3.1.3.16)
hsa:2184;FAH;fumarylacetoacetate hydrolase (fumarylacetoacetase) (EC:3.7.1.2)
hsa:3221;HOXC4,HOX3,HOX3E,cp19;homeobox C4
hsa:23583;SMUG1,FDG,HMUDG,UNG3;single-strand-selective monofunctional uracil-DNA glycosylase 1
hsa:93273;LEMD1,CT50,LEMP-1;LEM domain containing 1
hsa:902;CCNH,CAK,p34,p37;cyclin H
hsa:5778;PTPN7,BPTP-4,HEPTP,LC-PTP,LPTP,PTPNI;protein tyrosine phosphatase, non-receptor type 7 (EC:3.1.3.48)
hsa:24141;LAMP5,BAD-LAMP,BADLAMP,C20orf103,LAMP-5,UNC-43;lysosomal-associated membrane protein family, member 5
hsa:114112;TXNRD3,TGR,TR2,TRXR3;thioredoxin reductase 3 (EC:1.8.1.9)
hsa:50863;NTM,HNT,IGLON2,NTRI;neurotrimin
hsa:29098;RANGRF,HSPC236,MOG1,RANGNRF;RAN guanine nucleotide release factor
hsa:10436;EMG1,C2F,Grcc2f,NEP1;EMG1 nucleolar protein homolog (S. cerevisiae)
hsa:10321;CRISP3,Aeg2,CRISP-3,CRS3,SGP28,dJ442L6.3;cysteine-rich secretory protein 3
hsa:65264;UBE2Z,USE1;ubiquitin-conjugating enzyme E2Z (EC:6.3.2.19)
hsa:22920;KIFAP3,FLA3,KAP-1,KAP-3,KAP3,SMAP,Smg-GDS,dJ190I16.1;kinesin-associated protein 3
hsa:5567;PRKACB,PKACB;protein kinase, cAMP-dependent, catalytic, beta (EC:2.7.11.11)
hsa:6948;TCN2,D22S676,D22S750,II,TC,TC_II,TC-2,TC2,TCII;transcobalamin II
hsa:64106;NPFFR1,GPR147,NPFF1,NPFF1R1,OT7T022;neuropeptide FF receptor 1
hsa:23636;NUP62,IBSN,SNDI,p62;nucleoporin 62kDa
hsa:81793;TLR10,CD290;toll-like receptor 10
hsa:5569;PKIA,PRKACN1;protein kinase (cAMP-dependent, catalytic) inhibitor alpha
hsa:9013;TAF1C,MGC:39976,SL1,TAFI110,TAFI95;TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 110kDa
hsa:5985;RFC5,RFC36;replication factor C (activator 1) 5, 36.5kDa
hsa:27248;ERLEC1,C2orf30,CIM,CL24936,CL25084,XTP3-B,XTP3TPB;endoplasmic reticulum lectin 1
hsa:5164;PDK2,PDHK2,PDKII;pyruvate dehydrogenase kinase, isozyme 2 (EC:2.7.11.2)
hsa:9632;SEC24C;SEC24 family, member C (S. cerevisiae)
hsa:3737;KCNA2,HBK5,HK4,HUKIV,KV1.2,MK2,NGK1,RBK2;potassium voltage-gated channel, shaker-related subfamily, member 2
hsa:84817;TXNDC17,TRP14,TXNL5;thioredoxin domain containing 17
hsa:3993;LLGL2,HGL,LGL2;lethal giant larvae homolog 2 (Drosophila)
hsa:9444;QKI,Hqk,QK,QK1,QK3,hqkI;QKI, KH domain containing, RNA binding
hsa:2323;FLT3LG,FL,FLT3L;fms-related tyrosine kinase 3 ligand
hsa:930;CD19,B4,CVID3;CD19 molecule
hsa:79576;NKAP;NFKB activating protein
hsa:286676;ILDR1,DFNB42,ILDR1alpha,ILDR1alpha',ILDR1beta;immunoglobulin-like domain containing receptor 1
hsa:4074;M6PR,CD-MPR,MPR_46,MPR-46,MPR46,SMPR;mannose-6-phosphate receptor (cation dependent)
hsa:3188;HNRNPH2,FTP3,HNRPH',HNRPH2,hnRNPH';heterogeneous nuclear ribonucleoprotein H2 (H')
hsa:5435;POLR2F,HRBP14.4,POLRF,RPABC2,RPB14.4,RPB6;polymerase (RNA) II (DNA directed) polypeptide F (EC:2.7.7.6)
hsa:6439;SFTPB,PSP-B,SFTB3,SFTP3,SMDP1,SP-B;surfactant protein B
hsa:7112;TMPO,CMD1T,LAP2,LEMD4,PRO0868,TP;thymopoietin
hsa:9295;SRSF11,NET2,SFRS11,dJ677H15.2,p54;serine/arginine-rich splicing factor 11
hsa:100526832;PHOSPHO2-KLHL23;PHOSPHO2-KLHL23 readthrough
hsa:53981;CPSF2,CPSF100;cleavage and polyadenylation specific factor 2, 100kDa
hsa:23155;CLCC1,MCLC;chloride channel CLIC-like 1
hsa:187;APLNR,AGTRL1,APJ,APJR,HG11;apelin receptor
hsa:144406;WDR66;WD repeat domain 66
hsa:84547;PGBD1,HUCEP-4,SCAND4,dJ874C20.4;piggyBac transposable element derived 1
hsa:64753;CCDC136;coiled-coil domain containing 136
hsa:84930;MASTL,GREATWALL,GW,GWL,MAST-L,RP11-85G18.2,THC2,hGWL;microtubule associated serine/threonine kinase-like (EC:2.7.11.1)
hsa:80323;CCDC68,SE57-1;coiled-coil domain containing 68
hsa:973;CD79A,IGA,MB-1;CD79a molecule, immunoglobulin-associated alpha
hsa:2782;GNB1;guanine nucleotide binding protein (G protein), beta polypeptide 1
hsa:57863;CADM3,BIgR,IGSF4B,NECL1,Necl-1,TSLL1,synCAM3;cell adhesion molecule 3
hsa:50999;TMED5,CGI-100,p28;transmembrane emp24 protein transport domain containing 5
hsa:5606;MAP2K3,MAPKK3,MEK3,MKK3,PRKMK3,SAPKK-2,SAPKK2;mitogen-activated protein kinase kinase 3 (EC:2.7.12.2)
hsa:5298;PI4KB,NPIK,PI4K-BETA,PI4K92,PI4KBETA,PI4KIIIBETA,PIK4CB;phosphatidylinositol 4-kinase, catalytic, beta (EC:2.7.1.67)
hsa:90134;KCNH7,ERG3,HERG3,Kv11.3;potassium voltage-gated channel, subfamily H (eag-related), member 7
hsa:55544;RBM38,HSRNASEB,RNPC1,SEB4B,SEB4D,dJ800J21.2;RNA binding motif protein 38
hsa:27330;RPS6KA6,PP90RSK4,RSK4;ribosomal protein S6 kinase, 90kDa, polypeptide 6 (EC:2.7.11.1)
hsa:493856;CISD2,ERIS,Miner1,NAF-1,WFS2,ZCD2;CDGSH iron sulfur domain 2
hsa:50865;HEBP1,HBP,HEBP;heme binding protein 1
hsa:5707;PSMD1,P112,Rpn2,S1;proteasome (prosome, macropain) 26S subunit, non-ATPase, 1
hsa:51204;TACO1,CCDC44;translational activator of mitochondrially encoded cytochrome c oxidase I
hsa:23329;TBC1D30;TBC1 domain family, member 30
hsa:51263;MRPL30,L28MT,L30MT,MRP-L28,MRP-L30,MRPL28,MRPL28M,RPML28;mitochondrial ribosomal protein L30
hsa:833;CARS,CARS1,CYSRS,MGC:11246;cysteinyl-tRNA synthetase (EC:6.1.1.16)
hsa:53833;IL20RB,DIRS1,FNDC6,IL-20R2;interleukin 20 receptor beta
hsa:6156;RPL30,L30;ribosomal protein L30
hsa:81832;NETO1,BCTL1,BTCL1;neuropilin (NRP) and tolloid (TLL)-like 1
hsa:80712;ESX1,ESX1L,ESXR1;ESX homeobox 1
hsa:869;CBLN1;cerebellin 1 precursor
hsa:23241;PACS2,PACS-2,PACS1L;phosphofurin acidic cluster sorting protein 2
hsa:926;CD8B,CD8B1,LEU2,LY3,LYT3,P37;CD8b molecule
hsa:2794;GNL1,HSR1;guanine nucleotide binding protein-like 1
hsa:51126;NAA20,NAT3,NAT5,dJ1002M8.1;N(alpha)-acetyltransferase 20, NatB catalytic subunit (EC:2.3.1.88)
hsa:3141;HLCS,HCS;holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) (EC:6.3.4.10 6.3.4.11 6.3.4.15 6.3.4.9)
hsa:23708;GSPT2,ERF3B,GST2;G1 to S phase transition 2
hsa:27158;NDOR1,NR1,bA350O14.9;NADPH dependent diflavin oxidoreductase 1 (EC:1.6.-.-)
hsa:29890;RBM15B,HUMAGCGB,OTT3;RNA binding motif protein 15B
hsa:54536;EXOC6,EXOC6A,SEC15,SEC15L,SEC15L1,SEC15L3,Sec15p;exocyst complex component 6
hsa:55275;VPS53,HCCS1,hVps53L,pp13624;vacuolar protein sorting 53 homolog (S. cerevisiae)
hsa:284434;NWD1;NACHT and WD repeat domain containing 1
hsa:523;ATP6V1A,ATP6A1,ATP6V1A1,HO68,VA68,VPP2,Vma1;ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A (EC:3.6.3.14)
hsa:4084;MXD1,BHLHC58,MAD,MAD1;MAX dimerization protein 1
hsa:3017;HIST1H2BD,H2B.1B,H2B/b,H2BFB,HIRIP2,dJ221C16.6;histone cluster 1, H2bd
hsa:78995;C17orf53;chromosome 17 open reading frame 53
hsa:5132;PDC,MEKA,PHD,PhLOP,PhLP;phosducin
hsa:1734;DIO2,5DII,D2,DIOII,SelY,TXDI2;deiodinase, iodothyronine, type II (EC:1.97.1.10)
hsa:57486;NLN,AGTBP,EP24.16,MEP,MOP;neurolysin (metallopeptidase M3 family) (EC:3.4.24.16)
hsa:858;CAV2,CAV;caveolin 2
hsa:80760;ITIH5,ITI-HC5;inter-alpha-trypsin inhibitor heavy chain family, member 5
hsa:26289;AK5,AK6;adenylate kinase 5 (EC:2.7.4.3)
hsa:23164;MPRIP,M-RIP,MRIP,RHOIP3,RIP3,p116Rip;myosin phosphatase Rho interacting protein
hsa:4111;MAGEA12,CT1.12,MAGE12;melanoma antigen family A, 12
hsa:91949;COG7,CDG2E;component of oligomeric golgi complex 7
hsa:6718;AKR1D1,3o5bred,CBAS2,SRD5B1;aldo-keto reductase family 1, member D1 (EC:1.3.1.3)
hsa:10076;PTPRU,FMI,PCP-2,PTP,PTP-J,PTP-PI,PTP-RO,PTPPSI,PTPRO,PTPU2,R-PTP-PSI,R-PTP-U,hPTP-J;protein tyrosine phosphatase, receptor type, U (EC:3.1.3.48)
hsa:100528032;KLRC4-KLRK1;KLRC4-KLRK1 readthrough
hsa:51091;SEPSECS,LP,PCH2D,SLA,SLA/LP;Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase (EC:2.9.1.2)
hsa:1340;COX6B1,COX6B,COXG,COXVIb1;cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) (EC:1.9.3.1)
hsa:10330;CNPY2,HP10390,MSAP,TMEM4,ZSIG9;canopy 2 homolog (zebrafish)
hsa:80218;NAA50,MAK3,NAT13,NAT5,SAN,hNAT5,hSAN;N(alpha)-acetyltransferase 50, NatE catalytic subunit (EC:2.3.1.-)
hsa:4756;NEO1,IGDCC2,NGN;neogenin 1
hsa:3766;KCNJ10,BIRK-10,KCNJ13-PEN,KIR1.2,KIR4.1,SESAME;potassium inwardly-rectifying channel, subfamily J, member 10
hsa:23678;SGK3,CISK,SGK2,SGKL;serum/glucocorticoid regulated kinase family, member 3 (EC:2.7.11.1)
hsa:3812;KIR3DL2,CD158K,NKAT-4,NKAT4,NKAT4B,p140;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
hsa:130752;MDH1B,RP11-95H11;malate dehydrogenase 1B, NAD (soluble) (EC:1.1.1.-)
hsa:3628;INPP1;inositol polyphosphate-1-phosphatase (EC:3.1.3.57)
hsa:9703;BCOX,BCOX1,CT101;KIAA0100
hsa:8692;HYAL2,LUCA2;hyaluronoglucosaminidase 2 (EC:3.2.1.35)
hsa:501;ALDH7A1,ATQ1,EPD,PDE;aldehyde dehydrogenase 7 family, member A1 (EC:1.2.1.3 1.2.1.8 1.2.1.31)
hsa:940;CD28,Tp44;CD28 molecule
hsa:117283;IP6K3,IHPK3,INSP6K3;inositol hexakisphosphate kinase 3 (EC:2.7.4.21)
hsa:5550;PREP,PE,PEP;prolyl endopeptidase (EC:3.4.21.26)
hsa:25932;CLIC4,CLIC4L,H1,MTCLIC,huH1,p64H1;chloride intracellular channel 4
hsa:64895;PAPOLG;poly(A) polymerase gamma (EC:2.7.7.19)
hsa:11222;MRPL3,COXPD9,MRL3,RPML3;mitochondrial ribosomal protein L3
hsa:5588;PRKCQ,PRKCT,nPKC-theta;protein kinase C, theta (EC:2.7.11.13)
hsa:221078;NSUN6,4933414E04Rik,NOPD1;NOP2/Sun domain family, member 6
hsa:3081;HGD,AKU,HGO;homogentisate 1,2-dioxygenase (EC:1.13.11.5)
hsa:84445;LZTS2,LAPSER1;leucine zipper, putative tumor suppressor 2
hsa:57048;PLSCR3;phospholipid scramblase 3
hsa:9540;TP53I3,PIG3;tumor protein p53 inducible protein 3
hsa:51552;RAB14,FBP,RAB-14;RAB14, member RAS oncogene family
hsa:64332;NFKBIZ,IKBZ,INAP,MAIL;nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
hsa:345930;ECT2L,ARHGEF32,C6orf91,FBXO49,LFDH,dJ509I19.2,dJ509I19.3,dJ509I19.5;epithelial cell transforming sequence 2 oncogene-like
hsa:4848;CNOT2,CDC36,NOT2,NOT2H;CCR4-NOT transcription complex, subunit 2
hsa:152330;CNTN4,AXCAM,BIG-2;contactin 4
hsa:59345;GNB4;guanine nucleotide binding protein (G protein), beta polypeptide 4
hsa:29781;NCAPH2,CAPH2;non-SMC condensin II complex, subunit H2
hsa:9677;PPIP5K1,HISPPD2A,IP6K,IPS1,VIP1,hsVIP1;diphosphoinositol pentakisphosphate kinase 1 (EC:2.7.4.21 2.7.4.24)
hsa:79848;CSPP1,CSPP;centrosome and spindle pole associated protein 1
hsa:23026;MYO16,MYR8,Myo16b,NYAP3;myosin XVI
hsa:254102;EHBP1L1;EH domain binding protein 1-like 1
hsa:29085;PHPT1,CGI-202,HSPC141,PHP14,RP11-216L13.10,bA216L13.10;phosphohistidine phosphatase 1 (EC:3.1.3.-)
hsa:5082;PDCL,PhLP;phosducin-like
hsa:1123;CHN1,ARHGAP2,CHN,DURS2,NC,RHOGAP2;chimerin 1
hsa:51205;ACP6,ACPL1,LPAP,PACPL1;acid phosphatase 6, lysophosphatidic (EC:3.1.3.2)
hsa:30836;DNTTIP2,ERBP,FCF2,HSU15552,LPTS-RP2,TdIF2;deoxynucleotidyltransferase, terminal, interacting protein 2
hsa:6811;STX5,SED5,STX5A;syntaxin 5
hsa:414;ARSD,ASD;arylsulfatase D (EC:3.1.6.1)
hsa:11184;MAP4K1,HPK1;mitogen-activated protein kinase kinase kinase kinase 1 (EC:2.7.11.1)
hsa:80835;TAS1R1,GPR70,T1R1,TR1;taste receptor, type 1, member 1
hsa:5137;PDE1C,Hcam3;phosphodiesterase 1C, calmodulin-dependent 70kDa (EC:3.1.4.17)
hsa:6582;SLC22A2,OCT2;solute carrier family 22 (organic cation transporter), member 2
hsa:25896;INTS7,C1orf73,INT7;integrator complex subunit 7
hsa:134;ADORA1,RDC7;adenosine A1 receptor
hsa:26470;SEZ6L2,PSK-1;seizure related 6 homolog (mouse)-like 2
hsa:2653;GCSH,GCE,NKH;glycine cleavage system protein H (aminomethyl carrier)
hsa:5413;SEPT5,CDCREL,CDCREL-1,CDCREL1,H5,HCDCREL-1,PNUTL1;septin 5 (EC:3.1.5.1)
hsa:9569;GTF2IRD1,BEN,CREAM1,GTF3,MUSTRD1,RBAP2,WBS,WBSCR11,WBSCR12,hMusTRD1alpha1;GTF2I repeat domain containing 1
hsa:400;ARL1,ARFL1;ADP-ribosylation factor-like 1
hsa:55245;UQCC,BFZB,C20orf44,CBP3;ubiquinol-cytochrome c reductase complex chaperone
hsa:10450;PPIE,CYP-33,CYP33;peptidylprolyl isomerase E (cyclophilin E) (EC:5.2.1.8)
hsa:8729;GBF1,ARF1GEF;golgi brefeldin A resistant guanine nucleotide exchange factor 1
hsa:100533105;C8orf44-SGK3;C8orf44-SGK3 readthrough (EC:2.7.11.1)
hsa:6136;RPL12,L12;ribosomal protein L12
hsa:10312;TCIRG1,ATP6N1C,ATP6V0A3,Atp6i,OC-116kDa,OC116,OPTB1,Stv1,TIRC7,Vph1,a3;T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 (EC:3.6.3.6)
hsa:5549;PRELP,MST161,MSTP161,SLRR2A;proline/arginine-rich end leucine-rich repeat protein
hsa:5862;RAB2A,LHX,RAB2;RAB2A, member RAS oncogene family
hsa:29103;DNAJC15,DNAJD1,HSD18,MCJ;DnaJ (Hsp40) homolog, subfamily C, member 15
hsa:192683;SCAMP5;secretory carrier membrane protein 5
hsa:166012;CHST13,C4ST3;carbohydrate (chondroitin 4) sulfotransferase 13 (EC:2.8.2.5)
hsa:318;NUDT2,APAH1;nudix (nucleoside diphosphate linked moiety X)-type motif 2 (EC:3.6.1.17)
hsa:7786;MAP3K12,DLK,MEKK12,MUK,ZPK,ZPKP1;mitogen-activated protein kinase kinase kinase 12 (EC:2.7.11.25)
hsa:116328;C8orf34,VEST-1,VEST1;chromosome 8 open reading frame 34
hsa:5451;POU2F1,OCT1,OTF1,oct-1B;POU class 2 homeobox 1
hsa:159;ADSS,ADEH,ADSS_2;adenylosuccinate synthase (EC:6.3.4.4)
hsa:11149;BVES,HBVES,POP1,POPDC1;blood vessel epicardial substance
hsa:81831;NETO2,BTCL2,NEOT2;neuropilin (NRP) and tolloid (TLL)-like 2
hsa:147912;SIX5,BOR2,DMAHP;SIX homeobox 5
hsa:1211;CLTA,LCA;clathrin, light chain A
hsa:79751;SLC25A22,EIEE3,GC1,NET44;solute carrier family 25 (mitochondrial carrier: glutamate), member 22
hsa:140578;CHODL,C21orf68,MT75;chondrolectin
hsa:3300;DNAJB2,DSMA5,HSJ-1,HSJ1,HSPF3;DnaJ (Hsp40) homolog, subfamily B, member 2
hsa:3439;IFNA1,IFL,IFN,IFN-ALPHA,IFN-alphaD,IFNA13,IFNA@;interferon, alpha 1
hsa:51172;NAGPA,APAA,UCE;N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (EC:3.1.4.45)
hsa:79038;ZFYVE21,ZF21;zinc finger, FYVE domain containing 21
hsa:51727;CMPK1,CMK,CMPK,UMK,UMP-CMPK,UMPK;cytidine monophosphate (UMP-CMP) kinase 1, cytosolic (EC:2.7.4.14)
hsa:55920;RCC2,TD-60;regulator of chromosome condensation 2
hsa:10565;ARFGEF1,ARFGEP1,BIG1,P200;ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
hsa:23314;SATB2;SATB homeobox 2
hsa:4066;LYL1,bHLHa18;lymphoblastic leukemia derived sequence 1
hsa:1939;EIF2D,HCA56,LGTN;eukaryotic translation initiation factor 2D
hsa:51021;MRPS16,COXPD2,MRP-S16,RPMS16;mitochondrial ribosomal protein S16
hsa:11189;CELF3,BRUNOL1,CAGH4,ERDA4,TNRC4;CUGBP, Elav-like family member 3
hsa:401024;FSIP2;fibrous sheath interacting protein 2
hsa:57829;ZP4,ZBP,ZP1,ZPB,Zp-4;zona pellucida glycoprotein 4
hsa:25839;COG4,CDG2J,COD1;component of oligomeric golgi complex 4
hsa:9296;ATP6V1F,ATP6S14,VATF,Vma7;ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F (EC:3.6.3.14)
hsa:57135;DAZ4,pDP1680,pDP1681;deleted in azoospermia 4
hsa:57175;CORO1B,CORONIN-2;coronin, actin binding protein, 1B
hsa:84320;ACBD6;acyl-CoA binding domain containing 6
hsa:7991;TUSC3,D8S1992,M33,MRT22,MRT7,N33,OST3A;tumor suppressor candidate 3
hsa:5214;PFKP,PFK-C,PFKF;phosphofructokinase, platelet (EC:2.7.1.11)
hsa:56001;NXF2,CT39,TAPL-2;nuclear RNA export factor 2
hsa:4621;MYH3,HEMHC,MYHC-EMB,MYHSE1,SMHCE;myosin, heavy chain 3, skeletal muscle, embryonic
hsa:9562;MINPP1,HIPER1,MINPP2,MIPP;multiple inositol-polyphosphate phosphatase 1 (EC:3.1.3.62 3.1.3.80)
hsa:1639;DCTN1,DAP-150,DP-150,P135;dynactin 1
hsa:10552;ARPC1A,Arc40,SOP2Hs,SOP2L;actin related protein 2/3 complex, subunit 1A, 41kDa
hsa:2562;GABRB3,ECA5;gamma-aminobutyric acid (GABA) A receptor, beta 3
hsa:8988;HSPB3,DHMN2C,HMN2C,HSPL27;heat shock 27kDa protein 3
hsa:29935;RPA4,HSU24186;replication protein A4, 30kDa
hsa:29763;PACSIN3,SDPIII;protein kinase C and casein kinase substrate in neurons 3
hsa:170575;GIMAP1,HIMAP1,IMAP1,IMAP38;GTPase, IMAP family member 1
hsa:1382;CRABP2,CRABP-II,RBP6;cellular retinoic acid binding protein 2
hsa:5992;RFX4,NYD-SP10;regulatory factor X, 4 (influences HLA class II expression)
hsa:79814;AGMAT;agmatine ureohydrolase (agmatinase) (EC:3.5.3.11)
hsa:51231;VRK3;vaccinia related kinase 3 (EC:2.7.11.1)
hsa:200895;DHFRL1,DHFRP4;dihydrofolate reductase-like 1 (EC:1.5.1.3)
hsa:54205;CYCS,CYC,HCS,THC4;cytochrome c, somatic
hsa:126328;NDUFA11,B14.7,CI-B14.7;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa (EC:1.6.5.3)
hsa:55827;DCAF6,1200006M05Rik,ARCAP,IQWD1,MSTP055,NRIP,PC326;DDB1 and CUL4 associated factor 6
hsa:642;BLMH,BH,BMH;bleomycin hydrolase (EC:3.4.22.40)
hsa:53347;UBASH3A,CLIP4,STS-2,TULA,TULA-1;ubiquitin associated and SH3 domain containing A
hsa:4670;HNRNPM,CEAR,HNRNPM4,HNRPM,HNRPM4,HTGR1,NAGR1,hnRNP_M;heterogeneous nuclear ribonucleoprotein M
hsa:55258;THNSL2,SOFAT,THS2,TSH2;threonine synthase-like 2 (S. cerevisiae) (EC:4.2.3.-)
hsa:163589;TDRD5,RP11-427G13.1,TUDOR3;tudor domain containing 5
hsa:252839;TMEM9,TMEM9A;transmembrane protein 9
hsa:283298;OLFML1,UNQ564;olfactomedin-like 1
hsa:55036;CCDC40,CILD15;coiled-coil domain containing 40
hsa:5787;PTPRB,HPTP-BETA,HPTPB,PTPB,R-PTP-BETA,VEPTP;protein tyrosine phosphatase, receptor type, B (EC:3.1.3.48)
hsa:5203;PFDN4,C1,PFD4;prefoldin subunit 4
hsa:9812;DELE;KIAA0141
hsa:285755;PPIL6,RSPH12,bA425D10.6,dJ919F19.1;peptidylprolyl isomerase (cyclophilin)-like 6 (EC:5.2.1.8)
hsa:56899;ANKS1B,AIDA,AIDA-1,ANKS2,EB-1,EB1,cajalin-2;ankyrin repeat and sterile alpha motif domain containing 1B
hsa:84933;C8orf76;chromosome 8 open reading frame 76
hsa:64359;NXN,NRX,TRG-4;nucleoredoxin (EC:1.8.1.8)
hsa:10527;IPO7,Imp7,RANBP7;importin 7
hsa:11044;PAPD7,LAK-1,LAK1,POLK,POLS,TRF4,TRF4-1,TRF41,TUTASE5;PAP associated domain containing 7 (EC:2.7.7.7)
hsa:103910;MYL12B,MLC-B,MRLC2;myosin, light chain 12B, regulatory
hsa:7401;CLRN1,RP61,USH3,USH3A;clarin 1
hsa:1327;COX4I1,COX4,COX4-1,COXIV;cytochrome c oxidase subunit IV isoform 1 (EC:1.9.3.1)
hsa:58488;PCTP,PC-TP,STARD2;phosphatidylcholine transfer protein
hsa:131118;DNAJC19,PAM18,TIM14,TIMM14;DnaJ (Hsp40) homolog, subfamily C, member 19
hsa:91526;ANKRD44,PP6-ARS-B;ankyrin repeat domain 44
hsa:55717;WDR11,BRWD2,DR11,HH14,WDR15;WD repeat domain 11
hsa:6993;DYNLT1,CW-1,TCTEL1,tctex-1;dynein, light chain, Tctex-type 1
hsa:6276;S100A5,S100D;S100 calcium binding protein A5
hsa:100528062;ARMCX5-GPRASP2;ARMCX5-GPRASP2 readthrough
hsa:55972;SLC25A40,MCFP;solute carrier family 25, member 40
hsa:666;BOK,BCL2L9,BOKL;BCL2-related ovarian killer
hsa:7873;MANF,ARMET,ARP;mesencephalic astrocyte-derived neurotrophic factor
hsa:4001;LMNB1,ADLD,LMN,LMN2,LMNB;lamin B1
hsa:8496;PPFIBP1,L2,SGT2,hSGT2,hSgt2p;PTPRF interacting protein, binding protein 1 (liprin beta 1)
hsa:440574;MINOS1,C1orf151,MIO10;mitochondrial inner membrane organizing system 1
hsa:54832;VPS13C;vacuolar protein sorting 13 homolog C (S. cerevisiae)
hsa:29777;ABT1,hABT1;activator of basal transcription 1
hsa:64798;DEPTOR,DEP.6,DEPDC6;DEP domain containing MTOR-interacting protein
hsa:11026;LILRA3,CD85E,HM31,HM43,ILT6,LIR-4,LIR4,e3;leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3
hsa:83893;SPATA16,NYD-SP12,SPGF6;spermatogenesis associated 16
hsa:4704;NDUFA9,CC6,CI-39k,CI39k,NDUFS2L,SDR22E1;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa
hsa:3604;TNFRSF9,4-1BB,CD137,CDw137,ILA;tumor necrosis factor receptor superfamily, member 9
hsa:23025;UNC13A,Munc13-1;unc-13 homolog A (C. elegans)
hsa:25833;POU2F3,Epoc-1,OCT-11,OCT11,OTF-11,PLA-1,PLA1,Skn-1a;POU class 2 homeobox 3
hsa:51279;C1RL,C1RL1,C1RLP,C1r-LP,CLSPa;complement component 1, r subcomponent-like (EC:3.4.21.41)
hsa:55388;MCM10,CNA43,DNA43;minichromosome maintenance complex component 10
hsa:25999;CLIP3,CLIPR-59,CLIPR59,RSNL1;CAP-GLY domain containing linker protein 3
hsa:4099;MAG,GMA,S-MAG,SIGLEC-4A,SIGLEC4A;myelin associated glycoprotein
hsa:9758;FRMPD4,PDZD10,PDZK10;FERM and PDZ domain containing 4
hsa:6399;TRAPPC2,MIP2A,SEDL,SEDT,TRAPPC2P1,TRS20,ZNF547L,hYP38334;trafficking protein particle complex 2
hsa:286514;MAGEB18;melanoma antigen family B, 18
hsa:9993;DGCR2,DGS-C,IDD,LAN,SEZ-12;DiGeorge syndrome critical region gene 2
hsa:388551;CEACAM16,CEAL2,DFNA4B;carcinoembryonic antigen-related cell adhesion molecule 16
hsa:8209;C21orf33,ES1,GT335,HES1,KNPH,KNPI;chromosome 21 open reading frame 33
hsa:740;MRPL49,C11orf4,L49mt,MRP-L49,NOF,NOF1;mitochondrial ribosomal protein L49
hsa:5139;PDE3A,CGI-PDE,CGI-PDE_A,CGI-PDE-A;phosphodiesterase 3A, cGMP-inhibited (EC:3.1.4.17)
hsa:27343;POLL,BETAN,POLKAPPA;polymerase (DNA directed), lambda (EC:2.7.7.7)
hsa:8161;COIL,CLN80,p80-coilin;coilin
hsa:253714;MMS22L,C6orf167,dJ39B17.2;MMS22-like, DNA repair protein
hsa:1326;MAP3K8,COT,EST,ESTF,MEKK8,TPL2,Tpl-2,c-COT;mitogen-activated protein kinase kinase kinase 8 (EC:2.7.11.25)
hsa:57732;ZFYVE28,LST2,LYST2;zinc finger, FYVE domain containing 28
hsa:3360;HTR4,5-HT4,5-HT4R;5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
hsa:54963;UCKL1,UCK1-LIKE,UCK1L,URKL1;uridine-cytidine kinase 1-like 1 (EC:2.7.1.48)
hsa:5150;PDE7A,HCP1,PDE7;phosphodiesterase 7A (EC:3.1.4.17)
hsa:9915;ARNT2,bHLHe1;aryl-hydrocarbon receptor nuclear translocator 2
hsa:23076;RRP1B,KIAA0179,NNP1L,Nnp1,RRP1;ribosomal RNA processing 1 homolog B (S. cerevisiae)
hsa:9685;CLINT1,CLINT,ENTH,EPN4,EPNR;clathrin interactor 1
hsa:373863;DND1,RBMS4;dead end homolog 1 (zebrafish)
hsa:2535;FZD2,Fz2,fz-2,fzE2,hFz2;frizzled family receptor 2
hsa:64759;TNS3,TEM6,TENS1;tensin 3
hsa:1948;EFNB2,EPLG5,HTKL,Htk-L,LERK5;ephrin-B2
hsa:25853;DCAF12,CT102,KIAA1892,TCC52,WDR40A;DDB1 and CUL4 associated factor 12
hsa:51531;C9orf156,HSPC219,NAP1;chromosome 9 open reading frame 156
hsa:55156;ARMC1,Arcp;armadillo repeat containing 1
hsa:4291;MLF1;myeloid leukemia factor 1
hsa:7329;UBE2I,C358B7.1,P18,UBC9;ubiquitin-conjugating enzyme E2I (EC:6.3.2.19)
hsa:55604;LRRC16A,CARMIL,CARMIL1,CARMIL1a,LRRC16,dJ501N12.1,dJ501N12.5;leucine rich repeat containing 16A
hsa:5518;PPP2R1A,PP2A-Aalpha,PP2AAALPHA,PR65A;protein phosphatase 2, regulatory subunit A, alpha (EC:3.1.3.16)
hsa:51277;DNAJC27,RBJ,RabJS;DnaJ (Hsp40) homolog, subfamily C, member 27
hsa:64963;MRPS11,HCC-2;mitochondrial ribosomal protein S11
hsa:11221;DUSP10,MKP-5,MKP5;dual specificity phosphatase 10 (EC:3.1.3.16 3.1.3.48)
hsa:64342;HS1BP3,ETM2,HS1-BP3;HCLS1 binding protein 3
hsa:79955;PDZD7,PDZK7;PDZ domain containing 7
hsa:55556;ENOSF1,HSRTSBETA,RTS,TYMSAS;enolase superfamily member 1
hsa:84833;USMG5,DAPIT,HCVFTP2,bA792D24.4;up-regulated during skeletal muscle growth 5 homolog (mouse)
hsa:55735;DNAJC11,dJ126A5.1;DnaJ (Hsp40) homolog, subfamily C, member 11
hsa:25983;NGDN,C14orf120,LCP5,NGD,lpd-2;neuroguidin, EIF4E binding protein
hsa:23171;GPD1L,GPD1-L;glycerol-3-phosphate dehydrogenase 1-like (EC:1.1.1.8)
hsa:57054;DAZ3,pDP1679;deleted in azoospermia 3
hsa:9324;HMGN3,PNAS-25,TRIP7;high mobility group nucleosomal binding domain 3
hsa:54809;SAMD9,C7orf5,DRIF1,NFTC,OEF1,OEF2;sterile alpha motif domain containing 9
hsa:23767;FLRT3;fibronectin leucine rich transmembrane protein 3
hsa:65258;MPPE1,PGAP5;metallophosphoesterase 1 (EC:3.1.-.-)
hsa:57223;SMEK2,FLFL2,PP4R3B,PSY2,smk1;SMEK homolog 2, suppressor of mek1 (Dictyostelium)
hsa:4285;MIPEP,HMIP,MIP;mitochondrial intermediate peptidase (EC:3.4.24.59)
hsa:23536;ADAT1,HADAT1;adenosine deaminase, tRNA-specific 1
hsa:79056;PRRG4,PRGP4,TMG4;proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane)
hsa:774;CACNA1B,BIII,CACNL1A5,CACNN,Cav2.2;calcium channel, voltage-dependent, N type, alpha 1B subunit
hsa:219;ALDH1B1,ALDH5,ALDHX;aldehyde dehydrogenase 1 family, member B1 (EC:1.2.1.3)
hsa:7093;TLL2;tolloid-like 2
hsa:84958;SYTL1,JFC1,SLP1;synaptotagmin-like 1
hsa:10327;AKR1A1,ALDR1,ALR,ARM,DD3;aldo-keto reductase family 1, member A1 (aldehyde reductase) (EC:1.1.1.2)
hsa:5860;QDPR,DHPR,PKU2,SDR33C1;quinoid dihydropteridine reductase (EC:1.5.1.34)
hsa:7443;VRK1,PCH1,PCH1A;vaccinia related kinase 1 (EC:2.7.11.1)
hsa:79184;BRCC3,BRCC36,C6.1A,CXorf53;BRCA1/BRCA2-containing complex, subunit 3 (EC:3.1.2.15)
hsa:11254;SLC6A14,BMIQ11;solute carrier family 6 (amino acid transporter), member 14
hsa:25777;SUN2,UNC84B;Sad1 and UNC84 domain containing 2
hsa:326624;RAB37;RAB37, member RAS oncogene family
hsa:57106;NAT14,KLP1;N-acetyltransferase 14 (GCN5-related, putative)
hsa:6698;SPRR1A,SPRK;small proline-rich protein 1A
hsa:28977;MRPL42,L31MT,L42MT,MRP-L31,MRP-L42,MRP-S32,MRPL31,MRPS32,PTD007,RPML31,S32MT;mitochondrial ribosomal protein L42
hsa:3487;IGFBP4,BP-4,HT29-IGFBP,IBP4,IGFBP-4;insulin-like growth factor binding protein 4
hsa:94274;PPP1R14A,CPI-17,CPI17,PPP1INL;protein phosphatase 1, regulatory (inhibitor) subunit 14A
hsa:9455;HOMER2,ACPD,CPD,HOMER-2,VESL-2;homer homolog 2 (Drosophila)
hsa:55728;N4BP2,B3BP;NEDD4 binding protein 2
hsa:22876;INPP5F,MSTPO47,SAC2,hSAC2;inositol polyphosphate-5-phosphatase F (EC:3.1.3.-)
hsa:57560;IFT80,ATD2,WDR56;intraflagellar transport 80 homolog (Chlamydomonas)
hsa:1809;DPYSL3,CRMP-4,CRMP4,DRP-3,DRP3,LCRMP,ULIP,ULIP-1;dihydropyrimidinase-like 3
hsa:1510;CTSE,CATE;cathepsin E (EC:3.4.23.34)
hsa:10093;ARPC4,ARC20,P20-ARC;actin related protein 2/3 complex, subunit 4, 20kDa
hsa:26263;FBXO22,FBX22,FISTC1;F-box protein 22
hsa:55901;THSD1,TMTSP,UNQ3010;thrombospondin, type I, domain containing 1
hsa:91179;SCARF2,NSR1,SREC-II,SREC2,SRECRP-1,VDEGS;scavenger receptor class F, member 2
hsa:6900;CNTN2,AXT,TAG-1,TAX,TAX1;contactin 2 (axonal)
hsa:23253;ANKRD12,ANCO-2,ANCO1,GAC-1,Nbla00144;ankyrin repeat domain 12
hsa:83700;JAM3,JAM-2,JAM-3,JAM-C,JAMC;junctional adhesion molecule 3
hsa:91663;MYADM,SB135;myeloid-associated differentiation marker
hsa:51667;NUB1,BS4,NUB1L,NYREN18;negative regulator of ubiquitin-like proteins 1
hsa:116931;MED12L,NOPAR,TNRC11L,TRALP,TRALPUSH;mediator complex subunit 12-like
hsa:89845;ABCC10,EST182763,MRP7,SIMRP7;ATP-binding cassette, sub-family C (CFTR/MRP), member 10
hsa:57794;SUGP1,F23858,RBP,SF4;SURP and G patch domain containing 1
hsa:23544;SEZ6L;seizure related 6 homolog (mouse)-like
hsa:1513;CTSK,CTS02,CTSO,CTSO1,CTSO2,PKND,PYCD;cathepsin K (EC:3.4.22.38)
hsa:1523;CUX1,CASP,CDP,CDP/Cut,CDP1,COY1,CUTL1,CUX,Clox,Cux/CDP,GOLIM6,Nbla10317,p100,p110,p200,p75;cut-like homeobox 1
hsa:2886;GRB7;growth factor receptor-bound protein 7
hsa:259266;ASPM,ASP,Calmbp1,MCPH5;asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
hsa:5935;RBM3,IS1-RNPL,RNPL;RNA binding motif (RNP1, RRM) protein 3
hsa:79672;FN3KRP,FN3KL;fructosamine 3 kinase related protein
hsa:23261;CAMTA1,CANPMR;calmodulin binding transcription activator 1
hsa:7371;UCK2,TSA903,UK,UMPK;uridine-cytidine kinase 2 (EC:2.7.1.48)
hsa:54879;ST7L,FAM4B,ST7R,STLR;suppression of tumorigenicity 7 like
hsa:3443;IFNA6,IFN-alphaK;interferon, alpha 6
hsa:64901;RANBP17;RAN binding protein 17
hsa:3645;INSRR,IRR;insulin receptor-related receptor (EC:2.7.10.1)
hsa:25824;PRDX5,ACR1,AOEB166,B166,PLP,PMP20,PRDX6,PRXV;peroxiredoxin 5 (EC:1.11.1.15)
hsa:4144;MAT2A,MATA2,MATII,SAMS2;methionine adenosyltransferase II, alpha (EC:2.5.1.6)
hsa:26051;PPP1R16B,ANKRD4,TIMAP;protein phosphatase 1, regulatory subunit 16B
hsa:22849;CPEB3;cytoplasmic polyadenylation element binding protein 3
hsa:4161;MC5R,MC2;melanocortin 5 receptor
hsa:83857;TMTC1,OLF,TMTC1A;transmembrane and tetratricopeptide repeat containing 1
hsa:5618;PRLR,hPRLrI;prolactin receptor
hsa:54432;YIPF1,DJ167A19.1,FinGER1;Yip1 domain family, member 1
hsa:244;ANXA8L2,ANXA8,bA145E20.2;annexin A8-like 2
hsa:9091;PIGQ,GPI1,c407A10.1;phosphatidylinositol glycan anchor biosynthesis, class Q (EC:2.4.1.198)
hsa:55777;MBD5,MRD1;methyl-CpG binding domain protein 5
hsa:7029;TFDP2,DP2;transcription factor Dp-2 (E2F dimerization partner 2)
hsa:81025;GJA9,CX58,CX59,GJA10;gap junction protein, alpha 9, 59kDa
hsa:124997;WDR81,CAMRQ2;WD repeat domain 81
hsa:715;C1R;complement component 1, r subcomponent (EC:3.4.21.41)
hsa:10693;CCT6B,CCT-zeta-2,CCTZ-2,Cctz2,TCP-1-zeta-2,TSA303;chaperonin containing TCP1, subunit 6B (zeta 2)
hsa:55109;AGGF1,GPATC7,GPATCH7,HSU84971,HUS84971,VG5Q;angiogenic factor with G patch and FHA domains 1
hsa:8577;TMEFF1,C9orf2,CT120.1,H7365,TR-1;transmembrane protein with EGF-like and two follistatin-like domains 1
hsa:25782;RAB3GAP2,RAB3-GAP150,RAB3GAP150,WARBM2,p150;RAB3 GTPase activating protein subunit 2 (non-catalytic)
hsa:55605;KIF21A,CFEOM1,FEOM1,FEOM3A;kinesin family member 21A
hsa:7976;FZD3,Fz-3;frizzled family receptor 3
hsa:27244;SESN1,PA26,SEST1;sestrin 1
hsa:114803;MYSM1,2A-DUB,2ADUB,RP4-592A1.1;Myb-like, SWIRM and MPN domains 1 (EC:3.1.2.15)
hsa:4355;MPP2,DLG2;membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2)
hsa:517;ATP5G2,ATP5A;ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)
hsa:2805;GOT1,ASTQTL1,GIG18;glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) (EC:2.6.1.1)
hsa:80303;EFHD1,MST133,MSTP133,SWS2;EF-hand domain family, member D1
hsa:84106;PRAM1,PML-RAR,PRAM-1;PML-RARA regulated adaptor molecule 1
hsa:349565;NMNAT3,PNAT-3,PNAT3;nicotinamide nucleotide adenylyltransferase 3 (EC:2.7.7.1 2.7.7.18)
hsa:3257;HPS1,HPS;Hermansky-Pudlak syndrome 1
hsa:54732;TMED9,GMP25,HSGP25L2G,p25;transmembrane emp24 protein transport domain containing 9
hsa:1996;ELAVL4,HUD,PNEM;ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4
hsa:55340;GIMAP5,HIMAP3,IAN-5,IAN4,IAN4L1,IAN5,IMAP3,IROD;GTPase, IMAP family member 5
hsa:22955;SCMH1,Scml3;sex comb on midleg homolog 1 (Drosophila)
hsa:10573;MRPL28,MAAT1,p15;mitochondrial ribosomal protein L28
hsa:6728;SRP19;signal recognition particle 19kDa (EC:3.6.5.4)
hsa:27339;PRPF19,NMP200,PRP19,PSO4,SNEV,UBOX4,hPSO4;PRP19/PSO4 pre-mRNA processing factor 19 homolog (S. cerevisiae)
hsa:23162;MAPK8IP3,JIP3,JSAP1,SYD2,syd;mitogen-activated protein kinase 8 interacting protein 3
hsa:57186;RALGAPA2,AS250,C20orf74,bA287B20.1,dJ1049G11,dJ1049G11.4,p220;Ral GTPase activating protein, alpha subunit 2 (catalytic)
hsa:10379;IRF9,IRF-9,ISGF3,ISGF3G,p48;interferon regulatory factor 9
hsa:55759;WDR12,YTM1;WD repeat domain 12
hsa:23096;IQSEC2,BRAG1,MRX1;IQ motif and Sec7 domain 2
hsa:10655;DMRT2;doublesex and mab-3 related transcription factor 2
hsa:114987;WDR31;WD repeat domain 31
hsa:80333;KCNIP4,CALP,KCHIP4;Kv channel interacting protein 4
hsa:79442;LRRC2;leucine rich repeat containing 2
hsa:3052;HCCS,CCHL,MCOPS7;holocytochrome c synthase (EC:4.4.1.17)
hsa:57465;TBC1D24,FIME,TLDC6;TBC1 domain family, member 24
hsa:525;ATP6V1B1,ATP6B1,RTA1B,VATB,VMA2,VPP3;ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 (EC:3.6.3.14)
hsa:121214;SDR9C7,RDHS,SDR-O,SDRO;short chain dehydrogenase/reductase family 9C, member 7 (EC:1.1.1.-)
hsa:9652;TTC37,KIAA0372,Ski3;tetratricopeptide repeat domain 37
hsa:94031;HTRA3,Prsp,Tasp;HtrA serine peptidase 3
hsa:9133;CCNB2,HsT17299;cyclin B2
hsa:54014;BRWD1,C21orf107,N143,WDR9;bromodomain and WD repeat domain containing 1
hsa:8479;HIRIP3;HIRA interacting protein 3
hsa:4239;MFAP4;microfibrillar-associated protein 4
hsa:115201;ATG4A,APG4A,AUTL2;autophagy related 4A, cysteine peptidase
hsa:10923;SUB1,P15,PC4,p14;SUB1 homolog (S. cerevisiae)
hsa:55572;FOXRED1,H17;FAD-dependent oxidoreductase domain containing 1
hsa:7036;TFR2,HFE3,TFRC2;transferrin receptor 2
hsa:2595;GANC;glucosidase, alpha;neutral C (EC:3.2.1.20)
hsa:10483;SEC23B,CDA-II,CDAII,CDAN2,HEMPAS;Sec23 homolog B (S. cerevisiae)
hsa:285195;SLC9A9,AUTS16,NHE9;solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9
hsa:340900;EBLN1,EBLN-1;endogenous Bornavirus-like nucleoprotein 1
hsa:10562;OLFM4,GC1,GW112,OLM4,OlfD,UNQ362,bA209J19.1,hGC-1,hOLfD;olfactomedin 4
hsa:55269;PSPC1,PSP1;paraspeckle component 1
hsa:1193;CLIC2,CLIC2b,MRXS32,XAP121;chloride intracellular channel 2
hsa:51808;PHAX,RNUXA;phosphorylated adaptor for RNA export
hsa:4190;MDH1,MDH-s,MDHA,MGC:1375,MOR2;malate dehydrogenase 1, NAD (soluble) (EC:1.1.1.37 1.1.1.96)
hsa:26292;MYCBP,AMY-1;c-myc binding protein
hsa:92935;MARS2,MetRS,mtMetRS;methionyl-tRNA synthetase 2, mitochondrial (EC:6.1.1.10)
hsa:26298;EHF,ESE3,ESE3B,ESEJ;ets homologous factor
hsa:118672;PSTK,C10orf89;phosphoseryl-tRNA kinase (EC:2.7.1.164)
hsa:10999;SLC27A4,ACSVL4,FATP4,IPS;solute carrier family 27 (fatty acid transporter), member 4 (EC:6.2.1.-)
hsa:4043;LRPAP1,A2MRAP,A2RAP,HBP44,MRAP,RAP;low density lipoprotein receptor-related protein associated protein 1
hsa:4033;LRMP,JAW1;lymphoid-restricted membrane protein
hsa:1154;CISH,BACTS2,CIS,CIS-1,G18,SOCS;cytokine inducible SH2-containing protein
hsa:81532;MOB2,HCCA2;MOB kinase activator 2
hsa:6787;NEK4,NRK2,STK2,pp12301;NIMA-related kinase 4 (EC:2.7.11.1)
hsa:8190;MIA,CD-RAP;melanoma inhibitory activity
hsa:80714;PBX4;pre-B-cell leukemia homeobox 4
hsa:11040;PIM2;pim-2 oncogene (EC:2.7.11.1)
hsa:3821;KLRC1,CD159A,NKG2,NKG2A;killer cell lectin-like receptor subfamily C, member 1
hsa:89853;MVB12B,C9orf28,FAM125B;multivesicular body subunit 12B
hsa:54737;MPHOSPH8,HSMPP8,TWA3,mpp8;M-phase phosphoprotein 8 (EC:2.4.2.30)
hsa:10081;PDCD7,ES18,HES18;programmed cell death 7
hsa:2230;FDX1,ADX,FDX,LOH11CR1D;ferredoxin 1
hsa:9699;RIMS2,OBOE,RAB3IP3,RIM2;regulating synaptic membrane exocytosis 2
hsa:2878;GPX3,GPx-P,GSHPx-3,GSHPx-P;glutathione peroxidase 3 (plasma) (EC:1.11.1.9)
hsa:90411;MCFD2,F5F8D,F5F8D2,LMAN1IP,SDNSF;multiple coagulation factor deficiency 2
hsa:259173;ALS2CL,RN49018;ALS2 C-terminal like
hsa:29974;A1CF,ACF,ACF64,ACF65,APOBEC1CF,ASP;APOBEC1 complementation factor
hsa:50515;CHST11,C4ST,C4ST-1,C4ST1,HSA269537;carbohydrate (chondroitin 4) sulfotransferase 11 (EC:2.8.2.5)
hsa:11183;MAP4K5,GCKR,KHS,KHS1,MAPKKKK5;mitogen-activated protein kinase kinase kinase kinase 5 (EC:2.7.11.1)
hsa:283078;MKX,C10orf48,IFRX,IRXL1;mohawk homeobox
hsa:23682;RAB38,NY-MEL-1,rrGTPbp;RAB38, member RAS oncogene family
hsa:1804;DPP6,DPPX,VF2;dipeptidyl-peptidase 6
hsa:140803;TRPM6,CHAK2,HMGX,HOMG,HOMG1,HSH;transient receptor potential cation channel, subfamily M, member 6 (EC:2.7.11.1)
hsa:53916;RAB4B;RAB4B, member RAS oncogene family
hsa:79635;CCDC121;coiled-coil domain containing 121
hsa:754;PTTG1IP,C21orf1,C21orf3,PBF;pituitary tumor-transforming 1 interacting protein
hsa:399671;HEATR4;HEAT repeat containing 4
hsa:976;CD97,TM7LN1;CD97 molecule
hsa:26275;HIBCH,HIBYLCOAH;3-hydroxyisobutyryl-CoA hydrolase (EC:3.1.2.4)
hsa:122876;GPHB5,B5,GPB5,ZLUT1;glycoprotein hormone beta 5
hsa:170850;KCNG3,KV10.1,KV6.3;potassium voltage-gated channel, subfamily G, member 3
hsa:133396;IL31RA,CRL,CRL3,GLM-R,GLMR,GPL,IL-31RA,PLCA2,PRO21384,hGLM-R;interleukin 31 receptor A
hsa:3909;LAMA3,BM600,E170,LAMNA,LOCS,lama3a;laminin, alpha 3
hsa:51805;COQ3,DHHBMT,DHHBMTASE,UG0215E05,bA9819.1;coenzyme Q3 homolog, methyltransferase (S. cerevisiae) (EC:2.1.1.114 2.1.1.64 2.1.1.222)
hsa:6809;STX3,STX3A;syntaxin 3
hsa:54540;FAM193B,IRIZIO;family with sequence similarity 193, member B
hsa:84725;PLEKHA8,FAPP2;pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8
hsa:4886;NPY1R,NPY1-R,NPYR;neuropeptide Y receptor Y1
hsa:2677;GGCX,VKCFD1;gamma-glutamyl carboxylase (EC:4.1.1.90)
hsa:230;ALDOC,ALDC;aldolase C, fructose-bisphosphate (EC:4.1.2.13)
hsa:11030;RBPMS,HERMES;RNA binding protein with multiple splicing
hsa:4081;MAB21L1,CAGR1;mab-21-like 1 (C. elegans)
hsa:84263;HSDL2,C9orf99,SDR13C1;hydroxysteroid dehydrogenase like 2
hsa:51067;YARS2,MLASA2,MT-TYRRS,TYRRS;tyrosyl-tRNA synthetase 2, mitochondrial (EC:6.1.1.1)
hsa:2802;GOLGA3,GCP170,MEA-2;golgin A3
hsa:4905;NSF,SKD2;N-ethylmaleimide-sensitive factor (EC:3.6.4.6)
hsa:55844;PPP2R2D,MDS026;protein phosphatase 2, regulatory subunit B, delta
hsa:57669;EPB41L5,BE37,YMO1;erythrocyte membrane protein band 4.1 like 5
hsa:5126;PCSK2,NEC_2,NEC-2,NEC2,PC2,SPC2;proprotein convertase subtilisin/kexin type 2 (EC:3.4.21.94)
hsa:3710;ITPR3,IP3R,IP3R3;inositol 1,4,5-trisphosphate receptor, type 3
hsa:84153;RNASEH2C,AGS3,AYP1;ribonuclease H2, subunit C
hsa:54885;TBC1D8B;TBC1 domain family, member 8B (with GRAM domain)
hsa:255743;NPNT,EGFL6L,POEM;nephronectin
hsa:9054;NFS1,IscS,NIFS;NFS1 nitrogen fixation 1 homolog (S. cerevisiae) (EC:2.8.1.7)
hsa:114880;OSBPL6,ORP6;oxysterol binding protein-like 6
hsa:54757;FAM20A,AIGFS,FP2747;family with sequence similarity 20, member A
hsa:89874;SLC25A21,ODC,ODC1;solute carrier family 25 (mitochondrial oxoadipate carrier), member 21
hsa:84458;LCOR,MLR2;ligand dependent nuclear receptor corepressor
hsa:1301;COL11A1,CO11A1,COLL6,STL2;collagen, type XI, alpha 1
hsa:5684;PSMA3,HC8,PSC3;proteasome (prosome, macropain) subunit, alpha type, 3 (EC:3.4.25.1)
hsa:3609;ILF3,CBTF,DRBF,DRBP76,MMP4,MPHOSPH4,MPP4,NF-AT-90,NF110,NF110b,NF90,NF90a,NF90b,NFAR,NFAR-1,NFAR2,TCP110,TCP80;interleukin enhancer binding factor 3, 90kDa
hsa:92170;MTG1,GTP,GTPBP7,RP11-108K14.2;mitochondrial GTPase 1 homolog (S. cerevisiae)
hsa:11031;RAB31,Rab22B;RAB31, member RAS oncogene family
hsa:84955;NUDCD1,CML66,OVA66;NudC domain containing 1
hsa:5865;RAB3B;RAB3B, member RAS oncogene family
hsa:7203;CCT3,CCT-gamma,CCTG,PIG48,TCP-1-gamma,TRIC5;chaperonin containing TCP1, subunit 3 (gamma)
hsa:26098;C10orf137,EDRF1;chromosome 10 open reading frame 137
hsa:4924;NUCB1,CALNUC,NUC;nucleobindin 1
hsa:4301;MLLT4,AF6,RP3-431P23.3;myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila);translocated to, 4
hsa:30820;KCNIP1,KCHIP1,VABP;Kv channel interacting protein 1
hsa:56955;MEPE,OF45;matrix extracellular phosphoglycoprotein
hsa:521;ATP5I,ATP5K;ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E (EC:3.6.1.14)
hsa:112398;EGLN2,EIT6,HIF-PH1,HIFPH1,HPH-1,HPH-3,PHD1;egl nine homolog 2 (C. elegans) (EC:1.14.11.29)
hsa:79871;RPAP2,C1orf82;RNA polymerase II associated protein 2 (EC:3.1.3.16)
hsa:6291;SAA4,C-SAA,CSAA;serum amyloid A4, constitutive
hsa:339122;RAB43,RAB11B,RAB41;RAB43, member RAS oncogene family
hsa:105;ADARB2,ADAR3,RED2;adenosine deaminase, RNA-specific, B2
hsa:7965;AIMP2,JTV-1,JTV1,P38;aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
hsa:80852;GRIP2;glutamate receptor interacting protein 2
hsa:93107;KCNG4,KV6.3,KV6.4;potassium voltage-gated channel, subfamily G, member 4
hsa:51289;RXFP3,GPCR135,RLN3R1,RXFPR3,SALPR;relaxin/insulin-like family peptide receptor 3
hsa:55212;BBS7,BBS2L1;Bardet-Biedl syndrome 7
hsa:81556;VWA9,C15orf44;von Willebrand factor A domain containing 9
hsa:57558;USP35;ubiquitin specific peptidase 35 (EC:3.4.19.12)
hsa:5341;PLEK,P47;pleckstrin
hsa:254552;NUDT8;nudix (nucleoside diphosphate linked moiety X)-type motif 8
hsa:378708;APITD1,CENP-S,CENPS,FAAP16,MHF1;apoptosis-inducing, TAF9-like domain 1
hsa:51382;ATP6V1D,ATP6M,VATD,VMA8;ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D (EC:3.6.3.14)
hsa:7060;THBS4,TSP4;thrombospondin 4
hsa:221927;BRAT1,BAAT1,C7orf27,RMFSL;BRCA1-associated ATM activator 1
hsa:79803;HPS6,RP11-302K17.1;Hermansky-Pudlak syndrome 6
hsa:117583;PARD3B,ALS2CR19,PAR3B,PAR3L,PAR3LC,PAR3beta,Par3Lb;par-3 partitioning defective 3 homolog B (C. elegans)
hsa:55756;INTS9,CPSF2L,INT9,RC74;integrator complex subunit 9
hsa:51649;MRPS23,HSPC329,MRP-S23;mitochondrial ribosomal protein S23
hsa:402;ARL2,ARFL2;ADP-ribosylation factor-like 2
hsa:843;CASP10,ALPS2,FLICE2,MCH4;caspase 10, apoptosis-related cysteine peptidase (EC:3.4.22.63)
hsa:6443;SGCB,A3b,LGMD2E,SGC;sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)
hsa:10101;NUBP2,CFD1,NUBP1;nucleotide binding protein 2
hsa:51209;RAB9B,RAB9L,Rab-9L;RAB9B, member RAS oncogene family
hsa:254065;BRWD3,BRODL,MRX93;bromodomain and WD repeat domain containing 3
hsa:8533;COPS3,CSN3,SGN3;COP9 signalosome subunit 3
hsa:3234;HOXD8,HOX4,HOX4E,HOX5.4;homeobox D8
hsa:5800;PTPRO,GLEPP1,NPHS6,PTP-OC,PTP-U2,PTPROT,PTPU2,R-PTP-O;protein tyrosine phosphatase, receptor type, O (EC:3.1.3.48)
hsa:4498;MT1JP,MT1,MT1J,MT1NP,MTB;metallothionein 1J, pseudogene
hsa:5075;PAX1,HUP48;paired box 1
hsa:2785;GNG3;guanine nucleotide binding protein (G protein), gamma 3
hsa:493753;COA5,6330578E17Rik,C2orf64,Pet191;cytochrome c oxidase assembly factor 5
hsa:63926;ANKEF1,ANKRD5,dJ839B4.6;ankyrin repeat and EF-hand domain containing 1
hsa:1295;COL8A1,C3orf7;collagen, type VIII, alpha 1
hsa:29893;PSMC3IP,GT198,HOP2,HUMGT198A,ODG3,TBPIP;PSMC3 interacting protein
hsa:124056;NOXO1,P41NOX,P41NOXA,P41NOXB,P41NOXC,SH3PXD5,SNX28;NADPH oxidase organizer 1
hsa:11154;AP4S1,AP47B,CLA20,CLAPS4,CPSQ6,SPG52;adaptor-related protein complex 4, sigma 1 subunit
hsa:5136;PDE1A,CAM-PDE-1A,HCAM-1,HCAM1,HSPDE1A;phosphodiesterase 1A, calmodulin-dependent (EC:3.1.4.17)
hsa:57678;GPAM,GPAT,GPAT1;glycerol-3-phosphate acyltransferase, mitochondrial (EC:2.3.1.15)
hsa:23293;SMG6,C17orf31,EST1A,SMG-6,hSMG5/7a;smg-6 homolog, nonsense mediated mRNA decay factor (C. elegans) (EC:3.1.-.-)
hsa:729440;CCDC61;coiled-coil domain containing 61
hsa:1337;COX6A1,COX6A,COX6AL;cytochrome c oxidase subunit VIa polypeptide 1 (EC:1.9.3.1)
hsa:23214;XPO6,EXP6,RANBP20;exportin 6
hsa:10846;PDE10A,HSPDE10A;phosphodiesterase 10A (EC:3.1.4.35 3.1.4.17)
hsa:3590;IL11RA,CRSDA;interleukin 11 receptor, alpha
hsa:54499;TMCO1,HP10122,PCIA3,PNAS-136,RP11-466F5.7,TMCC4;transmembrane and coiled-coil domains 1
hsa:92960;PEX11G;peroxisomal biogenesis factor 11 gamma
hsa:23256;SCFD1,C14orf163,RA410,SLY1,SLY1P,STXBP1L2;sec1 family domain containing 1
hsa:339210;C17orf67;chromosome 17 open reading frame 67
hsa:80185;TTI2,C8orf41;TELO2 interacting protein 2
hsa:51606;ATP6V1H,MSTP042,NBP1,SFD,SFDalpha,SFDbeta,VMA13;ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H (EC:3.6.3.14)
hsa:1629;DBT,BCATE2,BCKAD-E2,BCKADE2,E2,E2B;dihydrolipoamide branched chain transacylase E2 (EC:2.3.1.168)
hsa:6400;SEL1L,PRO1063,SEL1-LIKE,SEL1L1;sel-1 suppressor of lin-12-like (C. elegans)
hsa:157680;VPS13B,CHS1,COH1;vacuolar protein sorting 13 homolog B (yeast)
hsa:56938;ARNTL2,BMAL2,CLIF,MOP9,PASD9,bHLHe6;aryl hydrocarbon receptor nuclear translocator-like 2
hsa:8941;CDK5R2,NCK5AI,P39,p39nck5ai;cyclin-dependent kinase 5, regulatory subunit 2 (p39)
hsa:5887;RAD23B,HHR23B,HR23B,P58;RAD23 homolog B (S. cerevisiae)
hsa:2977;GUCY1A2,GC-SA2,GUC1A2;guanylate cyclase 1, soluble, alpha 2 (EC:4.6.1.2)
hsa:23398;PPWD1;peptidylprolyl isomerase domain and WD repeat containing 1 (EC:5.2.1.8)
hsa:63973;NEUROG2,Atoh4,Math4A,NGN2,bHLHa8,ngn-2;neurogenin 2
hsa:60485;SAV1,SAV,WW45,WWP4;salvador homolog 1 (Drosophila)
hsa:6742;SSBP1,Mt-SSB,SOSS-B1,SSBP,mtSSB;single-stranded DNA binding protein 1, mitochondrial
hsa:9088;PKMYT1,MYT1;protein kinase, membrane associated tyrosine/threonine 1 (EC:2.7.11.1)
hsa:140890;SREK1,SFRS12,SRrp508,SRrp86;splicing regulatory glutamine/lysine-rich protein 1
hsa:51454;GULP1,CED-6,CED6,GULP;GULP, engulfment adaptor PTB domain containing 1
hsa:6788;STK3,KRS1,MST2;serine/threonine kinase 3 (EC:2.7.11.1)
hsa:29121;CLEC2D,CLAX,LLT1,OCIL;C-type lectin domain family 2, member D
hsa:84081;NSRP1,CCDC55,HSPC095,NSrp70;nuclear speckle splicing regulatory protein 1
hsa:22874;PLEKHA6,PEPP-3,PEPP3;pleckstrin homology domain containing, family A member 6
hsa:56884;FSTL5;follistatin-like 5
hsa:2036;EPB41L1,4.1N,MRD11;erythrocyte membrane protein band 4.1-like 1
hsa:30817;EMR2,CD312;egf-like module containing, mucin-like, hormone receptor-like 2
hsa:1188;CLCNKB,CLCKB,ClC-K2,ClC-Kb;chloride channel, voltage-sensitive Kb
hsa:4357;MPST,MST,TST2;mercaptopyruvate sulfurtransferase (EC:2.8.1.2)
hsa:79003;MIS12,2510025F08Rik,KNTC2AP,MTW1,hMis12;MIS12, MIND kinetochore complex component, homolog (S. pombe)
hsa:151393;RMDN2,FAM82A,FAM82A1,PRO34163,PYST9371,RMD-2,RMD2,RMD4;regulator of microtubule dynamics 2
hsa:1743;DLST,DLTS;dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) (EC:2.3.1.61)
hsa:79825;EFCC1,C3orf73,CCDC48;EF-hand and coiled-coil domain containing 1
hsa:64207;IRF2BPL,C14orf4,EAP1;interferon regulatory factor 2 binding protein-like
hsa:56996;SLC12A9,CCC6,CIP1,WO3.3,hCCC6;solute carrier family 12 (potassium/chloride transporters), member 9
hsa:11273;ATXN2L,A2D,A2LG,A2LP,A2RP;ataxin 2-like
hsa:25904;CNOT10;CCR4-NOT transcription complex, subunit 10
hsa:284252;KCTD1,C18orf5;potassium channel tetramerisation domain containing 1
hsa:5695;PSMB7,Z;proteasome (prosome, macropain) subunit, beta type, 7 (EC:3.4.25.1)
hsa:2210;FCGR1B,CD64b,IGFRB;Fc fragment of IgG, high affinity Ib, receptor (CD64)
hsa:6536;SLC6A9,GLYT1;solute carrier family 6 (neurotransmitter transporter, glycine), member 9
hsa:253980;KCTD13,PDIP1,POLDIP1,hBACURD1;potassium channel tetramerisation domain containing 13
hsa:84952;CGNL1,JACOP;cingulin-like 1
hsa:23428;SLC7A8,LAT2,LPI-PC1;solute carrier family 7 (amino acid transporter light chain, L system), member 8
hsa:51070;NOSIP;nitric oxide synthase interacting protein
hsa:55683;KANSL3,KIAA1310,NSL3,Rcd1;KAT8 regulatory NSL complex subunit 3
hsa:8491;MAP4K3,GLK,MAPKKKK3,MEKKK_3,MEKKK3,RAB8IPL1;mitogen-activated protein kinase kinase kinase kinase 3 (EC:2.7.11.1)
hsa:55177;RMDN3,FAM82A2,FAM82C,RMD-3,RMD3,ptpip51;regulator of microtubule dynamics 3
hsa:4782;NFIC,CTF,CTF5,NF-I,NFI;nuclear factor I/C (CCAAT-binding transcription factor)
hsa:345651;ACTBL2,ACT;actin, beta-like 2
hsa:54928;IMPAD1,GPAPP,IMP_3,IMP-3,IMPA3;inositol monophosphatase domain containing 1 (EC:3.1.3.7 3.1.3.25)
hsa:112770;C1orf85,NCU-G1;chromosome 1 open reading frame 85
hsa:114897;C1QTNF1,CTRP1,GIP,ZSIG37;C1q and tumor necrosis factor related protein 1
hsa:10914;PAPOLA,PAP;poly(A) polymerase alpha (EC:2.7.7.19)
hsa:5454;POU3F2,BRN2,N-Oct3,OCT7,OTF-7,OTF7,POUF3,brn-2,oct-7;POU class 3 homeobox 2
hsa:10965;ACOT2,CTE-IA,CTE1A,MTE1,PTE2,PTE2A,ZAP128;acyl-CoA thioesterase 2 (EC:3.1.2.2)
hsa:3761;KCNJ4,HIR,HIRK2,HRK1,IRK-3,IRK3,Kir2.3;potassium inwardly-rectifying channel, subfamily J, member 4
hsa:54498;SMOX,C20orf16,PAO,PAO-1,PAOH1,SMO;spermine oxidase (EC:1.5.3.16)
hsa:10265;IRX5,HMMS,IRX-2a,IRXB2;iroquois homeobox 5
hsa:1053;CEBPE,C/EBP-epsilon,CRP1;CCAAT/enhancer binding protein (C/EBP), epsilon
hsa:94134;ARHGAP12;Rho GTPase activating protein 12
hsa:419;ART3,ARTC3;ADP-ribosyltransferase 3 (EC:2.4.2.31)
hsa:79892;MCMBP,C10orf119,MCM-BP;minichromosome maintenance complex binding protein
hsa:7220;TRPC1,HTRP-1,TRP1;transient receptor potential cation channel, subfamily C, member 1
hsa:56896;DPYSL5,CRAM,CRMP-5,CRMP5,Ulip6;dihydropyrimidinase-like 5
hsa:90480;GADD45GIP1,CKBBP2,CRIF1,PLINP,PLINP-1,PRG6,Plinp1;growth arrest and DNA-damage-inducible, gamma interacting protein 1
hsa:84233;TMEM126A,OPA7;transmembrane protein 126A
hsa:7366;UGT2B15,HLUG4,UDPGT_2B8,UDPGT2B15,UDPGTH3,UGT2B8;UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17)
hsa:26233;FBXL6,FBL6,FBL6A,PP14630;F-box and leucine-rich repeat protein 6
hsa:4640;MYO1A,BBMI,DFNA48,MIHC,MYHL;myosin IA
hsa:79412;KREMEN2,KRM2;kringle containing transmembrane protein 2
hsa:92797;HELB,hDHB;helicase (DNA) B (EC:3.6.4.12)
hsa:29980;DONSON,B17,C21orf60,C2TA;downstream neighbor of SON
hsa:54463;FAM134B,JK-1,JK1;family with sequence similarity 134, member B
hsa:81892;SLIRP,C14orf156,DC50,PD04872;SRA stem-loop interacting RNA binding protein
hsa:4249;MGAT5,GNT-V,GNT-VA;mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase (EC:2.4.1.155)
hsa:10075;HUWE1,ARF-BP1,HECTH9,HSPC272,Ib772,LASU1,MULE,URE-B1,UREB1;HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase
hsa:83546;RTBDN;retbindin
hsa:136288;C7orf57;chromosome 7 open reading frame 57
hsa:7201;TRHR,TRH-R;thyrotropin-releasing hormone receptor
hsa:5775;PTPN4,MEG,PTPMEG,PTPMEG1;protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) (EC:3.1.3.48)
hsa:55907;CMAS,CSS;cytidine monophosphate N-acetylneuraminic acid synthetase (EC:2.7.7.43)
hsa:127495;LRRC39;leucine rich repeat containing 39
hsa:79714;CCDC51;coiled-coil domain containing 51
hsa:84665;MYPN,MYOP;myopalladin
hsa:4059;BCAM,AU,CD239,LU,MSK19;basal cell adhesion molecule (Lutheran blood group)
hsa:374875;HSD11B1L,11-DH3,11-beta-HSD3,HSD3,SCDR10,SCDR10B,SDR26C2;hydroxysteroid (11-beta) dehydrogenase 1-like (EC:1.1.1.-)
hsa:1663;DDX11,CHL1,CHLR1,KRG2,WABS;DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 (EC:3.6.4.13)
hsa:64772;ENGASE;endo-beta-N-acetylglucosaminidase (EC:3.2.1.96)
hsa:57535;EIG121;KIAA1324
hsa:4121;MAN1A1,HUMM3,HUMM9,MAN9;mannosidase, alpha, class 1A, member 1 (EC:3.2.1.113)
hsa:7347;UCHL3,UCH-L3;ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase) (EC:3.4.19.12)
hsa:51116;MRPS2,MRP-S2,S2mt;mitochondrial ribosomal protein S2
hsa:403313;PPAPDC2,PDP1,PSDP,bA6J24.6;phosphatidic acid phosphatase type 2 domain containing 2
hsa:166824;RASSF6;Ras association (RalGDS/AF-6) domain family member 6
hsa:369;ARAF,A-RAF,ARAF1,PKS2,RAFA1;v-raf murine sarcoma 3611 viral oncogene homolog (EC:2.7.11.1)
hsa:50700;RDH8,PRRDH,SDR28C2;retinol dehydrogenase 8 (all-trans) (EC:1.1.1.300)
hsa:341277;OVCH2,OVTN;ovochymase 2 (gene/pseudogene) (EC:3.4.21.120)
hsa:84823;LMNB2,LAMB2,LMN2;lamin B2
hsa:5570;PKIB,PRKACN2;protein kinase (cAMP-dependent, catalytic) inhibitor beta
hsa:79809;TTC21B,ATD4,IFT139,JBTS11,NPHP12,THM1;tetratricopeptide repeat domain 21B
hsa:3763;KCNJ6,BIR1,GIRK-2,GIRK2,KATP-2,KATP2,KCNJ7,KIR3.2,hiGIRK2;potassium inwardly-rectifying channel, subfamily J, member 6
hsa:4308;TRPM1,CSNB1C,LTRPC1,MLSN1;transient receptor potential cation channel, subfamily M, member 1
hsa:6576;SLC25A1,CTP,SEA,SLC20A3;solute carrier family 25 (mitochondrial carrier;citrate transporter), member 1
hsa:144321;GLIPR1L2;GLI pathogenesis-related 1 like 2
hsa:782;CACNB1,CAB1,CACNLB1,CCHLB1;calcium channel, voltage-dependent, beta 1 subunit
hsa:125972;CALR3,CMH19,CRT2,CT93;calreticulin 3
hsa:154075;SAMD3;sterile alpha motif domain containing 3
hsa:2538;G6PC,G6PC1,G6PT,GSD1,GSD1a;glucose-6-phosphatase, catalytic subunit (EC:3.1.3.9)
hsa:22978;NT5C2,GMP,NT5B,PNT5,cN-II;5'-nucleotidase, cytosolic II (EC:3.1.3.5)
hsa:95681;CEP41,JBTS15,TSGA14;centrosomal protein 41kDa
hsa:51599;LSR,ILDR3,LISCH7;lipolysis stimulated lipoprotein receptor
hsa:9466;IL27RA,CRL1,IL-27RA,IL27R,TCCR,WSX1,zcytor1;interleukin 27 receptor, alpha
hsa:79924;ADM2,AM2,dJ579N16.4;adrenomedullin 2
hsa:5425;POLD2;polymerase (DNA directed), delta 2, accessory subunit (EC:2.7.7.7)
hsa:342371;ATXN1L,BOAT,BOAT1;ataxin 1-like
hsa:23431;AP4E1,CPSQ4,SPG51;adaptor-related protein complex 4, epsilon 1 subunit
hsa:9665;LKAP,MARF1,PPP1R34;KIAA0430
hsa:23315;SLC9A8,NHE-8,NHE8;solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8
hsa:26207;PITPNC1,M-RDGB-beta,MRDGBbeta,RDGB-BETA,RDGBB,RDGBB1;phosphatidylinositol transfer protein, cytoplasmic 1
hsa:64641;EBF2,COE2,EBF-2,O/E-3,OE-3;early B-cell factor 2
hsa:7381;UQCRB,QCR7,QP-C,QPC,UQBC,UQBP,UQCR6,UQPC;ubiquinol-cytochrome c reductase binding protein (EC:1.10.2.2)
hsa:30833;NT5C,DNT,DNT1,P5N2,PN-I,PN-II,UMPH2,cdN,dNT-1;5', 3'-nucleotidase, cytosolic (EC:3.1.3.5)
hsa:158038;LINGO2,LERN3,LRRN6C;leucine rich repeat and Ig domain containing 2
hsa:25804;LSM4,GRP,YER112W;LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae)
hsa:55357;TBC1D2,PARIS-1,PARIS1,TBC1D2A;TBC1 domain family, member 2
hsa:29957;SLC25A24,APC1,SCAMC-1;solute carrier family 25 (mitochondrial carrier;phosphate carrier), member 24
hsa:23786;BCL2L13,BCL-RAMBO,Bcl2-L-13,MIL1;BCL2-like 13 (apoptosis facilitator)
hsa:2567;GABRG3;gamma-aminobutyric acid (GABA) A receptor, gamma 3
hsa:3373;HYAL1,HYAL-1,LUCA1,NAT6;hyaluronoglucosaminidase 1 (EC:3.2.1.35)
hsa:3773;KCNJ16,BIR9,KIR5.1;potassium inwardly-rectifying channel, subfamily J, member 16
hsa:157506;RDH10,SDR16C4;retinol dehydrogenase 10 (all-trans) (EC:1.1.1.300)
hsa:25943;C20orf194;chromosome 20 open reading frame 194
hsa:94240;EPSTI1,BRESI1;epithelial stromal interaction 1 (breast)
hsa:10942;PRSS21,ESP-1,ESP1,TEST1,TESTISIN;protease, serine, 21 (testisin)
hsa:64834;ELOVL1,Ssc1;ELOVL fatty acid elongase 1 (EC:2.3.1.199)
hsa:10717;AP4B1,BETA-4,CPSQ5,SPG47;adaptor-related protein complex 4, beta 1 subunit
hsa:2002;ELK1;ELK1, member of ETS oncogene family
hsa:55858;TMEM165,CDG2K,FT27,GDT1,TMPT27,TPARL;transmembrane protein 165
hsa:57505;AARS2,AARSL,COXPD8,MT-ALARS,MTALARS;alanyl-tRNA synthetase 2, mitochondrial (EC:6.1.1.7)
hsa:115557;ARHGEF25,GEFT,p63RhoGEF;Rho guanine nucleotide exchange factor (GEF) 25
hsa:55143;CDCA8,BOR,BOREALIN,DasraB,MESRGP;cell division cycle associated 8
hsa:84679;SLC9A7,NHE-7,NHE7,SLC9A6;solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7
hsa:132789;GNPDA2,GNP2,SB52;glucosamine-6-phosphate deaminase 2 (EC:3.5.99.6)
hsa:56995;TULP4,TUSP;tubby like protein 4
hsa:23002;DAAM1;dishevelled associated activator of morphogenesis 1
hsa:10011;SRA1,SRA,SRAP,STRAA1,pp7684;steroid receptor RNA activator 1
hsa:8891;EIF2B3,EIF-2B,EIF2Bgamma;eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa
hsa:63928;CHP2;calcineurin-like EF-hand protein 2
hsa:266722;HS6ST3,HS6ST-3;heparan sulfate 6-O-sulfotransferase 3 (EC:2.8.2.-)
hsa:65062;TMEM237,ALS2CR4,JBTS14;transmembrane protein 237
hsa:84466;MEGF10,EMARDD;multiple EGF-like-domains 10
hsa:51363;CHST15,BRAG,GALNAC4S-6ST,RP11-47G11.1;carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 (EC:2.8.2.33)
hsa:83640;FAM103A1,C15orf18,HsT19360,RAM;family with sequence similarity 103, member A1
hsa:10633;RASL10A,RRP22;RAS-like, family 10, member A
hsa:5878;RAB5C,L1880,RAB5CL,RAB5L,RABL;RAB5C, member RAS oncogene family
hsa:123803;NTAN1,PNAA,PNAD;N-terminal asparagine amidase
hsa:11253;MAN1B1,ERMAN1,MANA-ER,MRT15;mannosidase, alpha, class 1B, member 1 (EC:3.2.1.113)
hsa:26092;TOR1AIP1,LAP1,LAP1B;torsin A interacting protein 1
hsa:140688;C20orf112,C20orf113,dJ1184F4.2,dJ1184F4.4;chromosome 20 open reading frame 112
hsa:85417;CCNB3;cyclin B3
hsa:64398;MPP5,PALS1;membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5)
hsa:3760;KCNJ3,GIRK1,KGA,KIR3.1;potassium inwardly-rectifying channel, subfamily J, member 3
hsa:201191;SAMD14;sterile alpha motif domain containing 14
hsa:84689;MS4A14,MS4A16,NYD-SP21;membrane-spanning 4-domains, subfamily A, member 14
hsa:27037;TRMT2A,HTF9C;tRNA methyltransferase 2 homolog A (S. cerevisiae)
hsa:286826;LIN9,BARA,BARPsv,Lin-9,TGS,TGS1,TGS2;lin-9 homolog (C. elegans)
hsa:4257;MGST1,GST12,MGST,MGST-I;microsomal glutathione S-transferase 1 (EC:2.5.1.18)
hsa:81570;CLPB,HSP78,SKD3;ClpB caseinolytic peptidase B homolog (E. coli)
hsa:1212;CLTB,LCB;clathrin, light chain B
hsa:129607;CMPK2,TMPK2,TYKi,UMP-CMPK2;cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial (EC:2.7.4.14)
hsa:5452;POU2F2,OCT2,OTF2,Oct-2;POU class 2 homeobox 2
hsa:80146;UXS1,SDR6E1,UGD;UDP-glucuronate decarboxylase 1 (EC:4.1.1.35)
hsa:84332;DYDC2;DPY30 domain containing 2
hsa:1215;CMA1,CYH,MCT1,chymase;chymase 1, mast cell (EC:3.4.21.39)
hsa:55610;CCDC132;coiled-coil domain containing 132
hsa:165721;DNAJB8,DJ6;DnaJ (Hsp40) homolog, subfamily B, member 8
hsa:79443;FYCO1,CATC2,RUFY3,ZFYVE7;FYVE and coiled-coil domain containing 1
hsa:65061;CDK15,ALS2CR7,PFTAIRE2,PFTK2;cyclin-dependent kinase 15 (EC:2.7.11.22)
hsa:10517;FBXW10,Fbw10,HREP,SM25H2,SM2SH2,C17orf1,C17orf1A;F-box and WD repeat domain containing 10
hsa:114789;SLC25A25,MCSC,PCSCL,RP11-395P17.4,SCAMC-2;solute carrier family 25 (mitochondrial carrier;phosphate carrier), member 25
hsa:27159;CHIA,AMCASE,CHIT2,TSA1902;chitinase, acidic (EC:3.2.1.14)
hsa:84303;CHCHD6,CHCM1,PPP1R23;coiled-coil-helix-coiled-coil-helix domain containing 6
hsa:9070;ASH2L,ASH2,ASH2L1,ASH2L2,Bre2;ash2 (absent, small, or homeotic)-like (Drosophila)
hsa:55334;SLC39A9,ZIP-9,ZIP9;solute carrier family 39 (zinc transporter), member 9
hsa:55997;CFC1,CFC1B,CRYPTIC,DTGA2,HTX2;cripto, FRL-1, cryptic family 1
hsa:83987;CCDC8,3M3,PPP1R20,p90;coiled-coil domain containing 8
hsa:6286;S100P,MIG9;S100 calcium binding protein P
hsa:822;CAPG,AFCP,MCP;capping protein (actin filament), gelsolin-like
hsa:8690;JRKL,HHMJG;jerky homolog-like (mouse)
hsa:3563;IL3RA,CD123,IL3R,IL3RAY,IL3RX,IL3RY,hIL-3Ra;interleukin 3 receptor, alpha (low affinity)
hsa:64151;NCAPG,CAPG,CHCG,NY-MEL-3;non-SMC condensin I complex, subunit G
hsa:51138;COPS4,CSN4;COP9 signalosome subunit 4
hsa:56917;MEIS3,MRG2;Meis homeobox 3
hsa:23187;PHLDB1,LL5A;pleckstrin homology-like domain, family B, member 1
hsa:57147;SCYL3,PACE-1,PACE1;SCY1-like 3 (S. cerevisiae)
hsa:126119;JOSD2;Josephin domain containing 2 (EC:3.4.19.12)
hsa:25929;GEMIN5,GEMIN-5;gem (nuclear organelle) associated protein 5
hsa:1186;CLCN7,CLC-7,CLC7,OPTA2,OPTB4,PPP1R63;chloride channel, voltage-sensitive 7
hsa:55626;AMBRA1,DCAF3,WDR94;autophagy/beclin-1 regulator 1
hsa:5110;PCMT1,PIMT;protein-L-isoaspartate (D-aspartate) O-methyltransferase (EC:2.1.1.77)
hsa:57569;ARHGAP20,RARHOGAP;Rho GTPase activating protein 20
hsa:11123;RCAN3,DSCR1L2,MCIP3,RCN3,hRCN3;RCAN family member 3
hsa:7263;TST,RDS;thiosulfate sulfurtransferase (rhodanese) (EC:2.8.1.1)
hsa:9883;POM121,P145,POM121A;POM121 transmembrane nucleoporin
hsa:954;ENTPD2,CD39L1,NTPDase-2;ectonucleoside triphosphate diphosphohydrolase 2 (EC:3.6.1.-)
hsa:10811;NOXA1,NY-CO-31,SDCCAG31,p51NOX;NADPH oxidase activator 1
hsa:1535;CYBA,p22-PHOX;cytochrome b-245, alpha polypeptide
hsa:2569;GABRR1;gamma-aminobutyric acid (GABA) A receptor, rho 1
hsa:1653;DDX1,DBP-RB,UKVH5d;DEAD (Asp-Glu-Ala-Asp) box helicase 1 (EC:3.6.4.13)
hsa:64784;CRTC3,TORC-3,TORC3;CREB regulated transcription coactivator 3
hsa:8711;TNK1;tyrosine kinase, non-receptor, 1 (EC:2.7.10.2)
hsa:25979;DHRS7B,SDR32C1;dehydrogenase/reductase (SDR family) member 7B (EC:1.1.-.-)
hsa:259307;IL4I1,FIG1,LAAO,LAO;interleukin 4 induced 1 (EC:1.4.3.2)
hsa:9577;BRE,BRCC4,BRCC45;brain and reproductive organ-expressed (TNFRSF1A modulator)
hsa:50640;PNPLA8,IPLA2(GAMMA),IPLA2-2,IPLA2G,iPLA2gamma;patatin-like phospholipase domain containing 8 (EC:3.1.1.5)
hsa:1656;DDX6,HLR2,P54,RCK;DEAD (Asp-Glu-Ala-Asp) box helicase 6 (EC:3.6.4.13)
hsa:64174;DPEP2,MBD2;dipeptidase 2 (EC:3.4.13.19)
hsa:22877;MLXIP,MIR,MONDOA,bHLHe36;MLX interacting protein
hsa:3231;HOXD1,HOX4,HOX4G,Hox-4.7;homeobox D1
hsa:8500;PPFIA1,LIP.1,LIP1,LIPRIN;protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1
hsa:2298;FOXD4,FKHL9,FOXD4A,FREAC-5,FREAC5;forkhead box D4
hsa:2957;GTF2A1,TF2A1,TFIIA,TFIIA-42,TFIIAL;general transcription factor IIA, 1, 19/37kDa
hsa:51115;RMDN1,FAM82B,RMD-1,RMD1;regulator of microtubule dynamics 1
hsa:390598;SKOR1,CORL1,FUSSEL15,LBXCOR1;SKI family transcriptional corepressor 1
hsa:9832;JAKMIP2,JAMIP2,NECC1;janus kinase and microtubule interacting protein 2
hsa:407039;MIR33A,MIR33,MIRN33,MIRN33A,hsa-mir-33,hsa-mir-33a,miR-33,miRNA33A;microRNA 33a
hsa:594;BCKDHB,E1B,dJ279A18.1;branched chain keto acid dehydrogenase E1, beta polypeptide (EC:1.2.4.4)
hsa:9135;RABEP1,RAB5EP,RABPT5;rabaptin, RAB GTPase binding effector protein 1
hsa:9902;MRC2,CD280,CLEC13E,ENDO180,UPARAP;mannose receptor, C type 2
hsa:137492;VPS37A,HCRP1,PQBP2,SPG53;vacuolar protein sorting 37 homolog A (S. cerevisiae)
hsa:5010;CLDN11,OSP,OTM;claudin 11
hsa:2674;GFRA1,GDNFR,GDNFRA,GFR-ALPHA-1,RET1L,RETL1,TRNR1;GDNF family receptor alpha 1
hsa:374569;ASPG,C14orf76,GPA/WT;asparaginase homolog (S. cerevisiae) (EC:3.1.1.5 3.1.1.47 3.5.1.1)
hsa:157567;ANKRD46,ANK-S,GENX-115279;ankyrin repeat domain 46
hsa:9351;SLC9A3R2,E3KARP,NHE3RF2,NHERF-2,NHERF2,OCTS2,SIP-1,SIP1,TKA-1;solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2
hsa:4761;NEUROD2,NDRF,bHLHa1;neuronal differentiation 2
hsa:54431;DNAJC10,ERdj5,JPDI,MTHr,PDIA19;DnaJ (Hsp40) homolog, subfamily C, member 10
hsa:80314;EPC1,Epl1;enhancer of polycomb homolog 1 (Drosophila)
hsa:6752;SSTR2;somatostatin receptor 2
hsa:80227;PAAF1,PAAF,Rpn14,WDR71;proteasomal ATPase-associated factor 1
hsa:56287;GKN1,AMP18,BRICD1,CA11,FOV,foveolin;gastrokine 1
hsa:5498;PPOX,PPO,V290M,VP;protoporphyrinogen oxidase (EC:1.3.3.4)
hsa:10699;CORIN,ATC2,CRN,Lrp4,PEE5,TMPRSS10;corin, serine peptidase
hsa:7042;TGFB2,LDS4,TGF-beta2;transforming growth factor, beta 2
hsa:8065;CUL5,VACM-1,VACM1;cullin 5
hsa:84519;ACRBP,CT23,OY-TES-1,SP32;acrosin binding protein
hsa:81605;URM1,C9orf74;ubiquitin related modifier 1
hsa:1908;EDN3,ET-3,ET3,HSCR4,PPET3,WS4B;endothelin 3
hsa:56302;TRPV5,CAT2,ECAC1,OTRPC3;transient receptor potential cation channel, subfamily V, member 5
hsa:92211;CDHR1,CORD15,PCDH21,PRCAD,RP65;cadherin-related family member 1
hsa:55773;TBC1D23,NS4ATP1;TBC1 domain family, member 23
hsa:55220;KLHDC8A;kelch domain containing 8A
hsa:6181;RPLP2,D11S2243E,LP2,P2,RPP2;ribosomal protein, large, P2
hsa:54543;TOMM7,TOM7;translocase of outer mitochondrial membrane 7 homolog (yeast)
hsa:81608;FIP1L1,Rhe,hFip1;FIP1 like 1 (S. cerevisiae)
hsa:84174;SLA2,C20orf156,MARS,SLAP-2,SLAP2;Src-like-adaptor 2
hsa:5818;PVRL1,CD111,CLPED1,ED4,HIgR,HVEC,OFC7,PRR,PRR1,PVRR,PVRR1,SK-12,nectin-1;poliovirus receptor-related 1 (herpesvirus entry mediator C)
hsa:5297;PI4KA,PI4K-ALPHA,PIK4CA,pi4K230;phosphatidylinositol 4-kinase, catalytic, alpha (EC:2.7.1.67)
hsa:2059;EPS8;epidermal growth factor receptor pathway substrate 8
hsa:51171;HSD17B14,DHRS10,SDR47C1,retSDR3;hydroxysteroid (17-beta) dehydrogenase 14
hsa:287;ANK2,ANK-2,LQT4,brank-2;ankyrin 2, neuronal
hsa:7100;TLR5,SLEB1,TIL3;toll-like receptor 5
hsa:152926;PPM1K,BDP,PP2Ckappa,PP2Cm,PTMP,UG0882E07;protein phosphatase, Mg2+/Mn2+ dependent, 1K (EC:3.1.3.16)
hsa:85406;DNAJC14,DNAJ,DRIP78,HDJ3,LIP6;DnaJ (Hsp40) homolog, subfamily C, member 14
hsa:4887;NPY2R,NPY2-R;neuropeptide Y receptor Y2
hsa:9146;HGS,HRS;hepatocyte growth factor-regulated tyrosine kinase substrate
hsa:11314;CD300A,CLM-8,CMRF-35-H9,CMRF-35H,CMRF35-H,CMRF35-H9,CMRF35H,CMRF35H9,IGSF12,IRC1,IRC1/IRC2,IRC2,IRp60;CD300a molecule
hsa:80331;DNAJC5,CLN4,CLN4B,CSP,DNAJC5A,NCL;DnaJ (Hsp40) homolog, subfamily C, member 5
hsa:10628;TXNIP,EST01027,HHCPA78,THIF,VDUP1;thioredoxin interacting protein
hsa:57337;SENP7;SUMO1/sentrin specific peptidase 7 (EC:3.4.22.68)
hsa:1263;PLK3,CNK,FNK,PRK;polo-like kinase 3 (EC:2.7.11.21)
hsa:55074;OXR1,TLDC3;oxidation resistance 1
hsa:3978;LIG1;ligase I, DNA, ATP-dependent (EC:6.5.1.1)
hsa:10657;KHDRBS1,Sam68,p62,p68;KH domain containing, RNA binding, signal transduction associated 1
hsa:140469;MYO3B;myosin IIIB (EC:2.7.11.1)
hsa:26127;FGFR1OP2,HSPC123-like,WIT3.0;FGFR1 oncogene partner 2
hsa:283234;CCDC88B,BRLZ,CCDC88,HKRP3,gipie;coiled-coil domain containing 88B
hsa:64112;MOAP1,MAP-1,PNMA4;modulator of apoptosis 1
hsa:158800;RHOXF1,OTEX,PEPP1;Rhox homeobox family, member 1
hsa:9702;CEP57,MVA2,PIG8,TSP57;centrosomal protein 57kDa
hsa:3428;IFI16,IFNGIP1,PYHIN2;interferon, gamma-inducible protein 16
hsa:7942;TFEB,ALPHATFEB,BHLHE35,TCFEB;transcription factor EB
hsa:55770;EXOC2,SEC5,SEC5L1,Sec5p;exocyst complex component 2
hsa:26019;UPF2,HUPF2,RENT2,smg-3;UPF2 regulator of nonsense transcripts homolog (yeast)
hsa:92483;LDHAL6B,LDH6B,LDHAL6,LDHL;lactate dehydrogenase A-like 6B (EC:1.1.1.27)
hsa:1618;DAZL,DAZH,DAZL1,DAZLA,SPGYLA;deleted in azoospermia-like
hsa:5725;PTBP1,HNRNP-I,HNRNPI,HNRPI,PTB,PTB-1,PTB-T,PTB2,PTB3,PTB4,pPTB;polypyrimidine tract binding protein 1
hsa:10398;MYL9,LC20,MLC-2C,MLC2,MRLC1,MYRL2;myosin, light chain 9, regulatory
hsa:6853;SYN1,SYN1a,SYN1b,SYNI;synapsin I
hsa:2182;ACSL4,ACS4,FACL4,LACS4,MRX63,MRX68;acyl-CoA synthetase long-chain family member 4 (EC:6.2.1.3)
hsa:221424;LRRC73,C6orf154;leucine rich repeat containing 73
hsa:401190;RGS7BP,R7BP;regulator of G-protein signaling 7 binding protein
hsa:10204;NUTF2,NTF2,PP15;nuclear transport factor 2
hsa:5664;PSEN2,AD3L,AD4,CMD1V,PS2,STM2;presenilin 2 (Alzheimer disease 4)
hsa:54902;TTC19,2010204O13Rik;tetratricopeptide repeat domain 19
hsa:91754;NEK9,NERCC,NERCC1,Nek8;NIMA-related kinase 9 (EC:2.7.11.1)
hsa:58524;DMRT3,DMRTA3;doublesex and mab-3 related transcription factor 3
hsa:51571;FAM49B,L1;family with sequence similarity 49, member B
hsa:164312;LRRN4,C20orf75,NLRR-4,NLRR4,dJ1056H1.1;leucine rich repeat neuronal 4
hsa:2173;FABP7,B-FABP,BLBP,FABPB,MRG;fatty acid binding protein 7, brain
hsa:79781;IQCA1,4930465P12Rik,IQCA;IQ motif containing with AAA domain 1
hsa:3433;IFIT2,G10P2,GARG-39,IFI-54,IFI-54K,IFI54,IFIT-2,ISG-54_K,ISG-54K,ISG54,P54,cig42;interferon-induced protein with tetratricopeptide repeats 2
hsa:54973;CPSF3L,CPSF73L,INT11,INTS11,RC-68,RC68;cleavage and polyadenylation specific factor 3-like (EC:3.1.27.-)
hsa:3361;HTR5A,5-HT5A;5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled
hsa:714;C1QC,C1Q-C,C1QG;complement component 1, q subcomponent, C chain
hsa:5918;RARRES1,TIG1;retinoic acid receptor responder (tazarotene induced) 1
hsa:55876;GSDMB,GSDML,PRO2521;gasdermin B
hsa:85450;ITPRIP,DANGER,KIAA1754,bA127L20,bA127L20.2;inositol 1,4,5-trisphosphate receptor interacting protein
hsa:51490;C9orf114,CENP-32,HSPC109;chromosome 9 open reading frame 114
hsa:10769;PLK2,SNK,hPlk2,hSNK;polo-like kinase 2 (EC:2.7.11.21)
hsa:913;CD1E,CD1A,R2;CD1e molecule
hsa:10878;CFHR3,CFHL3,DOWN16,FHR-3,FHR3,HLF4;complement factor H-related 3
hsa:1178;CLC,GAL10,Gal-10,LGALS10,LGALS10A,LPPL_HUMAN;Charcot-Leyden crystal protein (EC:3.1.1.5)
hsa:59352;LGR6,GPCR,VTS20631;leucine-rich repeat containing G protein-coupled receptor 6
hsa:2589;GALNT1,GALNAC-T1;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1) (EC:2.4.1.41)
hsa:3217;HOXB7,HHO.C1,HOX2,HOX2C,Hox-2.3;homeobox B7
hsa:6388;SDF2;stromal cell-derived factor 2
hsa:51129;ANGPTL4,ANGPTL2,ARP4,FIAF,HFARP,NL2,PGAR,pp1158;angiopoietin-like 4
hsa:7216;TRO,MAGE-d3,MAGED3;trophinin
hsa:56667;MUC13,DRCC1,MUC-13;mucin 13, cell surface associated
hsa:3394;IRF8,H-ICSBP,ICSBP,ICSBP1,IRF-8;interferon regulatory factor 8
hsa:91862;MARVELD3,MARVD3,MRVLDC3;MARVEL domain containing 3
hsa:3654;IRAK1,IRAK,pelle;interleukin-1 receptor-associated kinase 1 (EC:2.7.11.1)
hsa:6894;TARBP1,TRM3,TRP-185,TRP185;TAR (HIV-1) RNA binding protein 1
hsa:57826;RAP2C;RAP2C, member of RAS oncogene family
hsa:3937;LCP2,SLP-76,SLP76;lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
hsa:5083;PAX9,STHAG3;paired box 9
hsa:1819;DRG2;developmentally regulated GTP binding protein 2;K06944
hsa:6263;RYR3;ryanodine receptor 3
hsa:26084;ARHGEF26,CSGEF,HMFN1864,SGEF;Rho guanine nucleotide exchange factor (GEF) 26
hsa:57127;RHBG,SLC42A2;Rh family, B glycoprotein (gene/pseudogene)
hsa:3562;IL3,IL-3,MCGF,MULTI-CSF;interleukin 3 (colony-stimulating factor, multiple)
hsa:166379;BBS12,C4orf24;Bardet-Biedl syndrome 12
hsa:10617;STAMBP,AMSH;STAM binding protein (EC:3.1.2.15)
hsa:5125;PCSK5,PC5,PC6,PC6A,SPC6;proprotein convertase subtilisin/kexin type 5 (EC:3.4.21.-)
hsa:8660;IRS2,IRS-2;insulin receptor substrate 2
hsa:158326;FREM1,BNAR,C9orf143,C9orf145,C9orf154,MOTA,TILRR,TRIGNO2;FRAS1 related extracellular matrix 1
hsa:63876;PKNOX2,PREP2;PBX/knotted 1 homeobox 2
hsa:129531;MITD1;MIT, microtubule interacting and transport, domain containing 1
hsa:6856;SYPL1,H-SP1,SYPL;synaptophysin-like 1
hsa:7357;UGCG,GCS,GLCT1;UDP-glucose ceramide glucosyltransferase (EC:2.4.1.80)
hsa:6660;SOX5,L-SOX5;SRY (sex determining region Y)-box 5
hsa:3489;IGFBP6,IBP6;insulin-like growth factor binding protein 6
hsa:721;C4B,C4B1,C4B12,C4B2,C4B3,C4B5,C4BD,C4F,CH,CO4,CPAMD3;complement component 4B (Chido blood group)
hsa:57835;SLC4A5,NBC4;solute carrier family 4, sodium bicarbonate cotransporter, member 5
hsa:7023;TFAP4,AP-4,bHLHc41;transcription factor AP-4 (activating enhancer binding protein 4)
hsa:55801;IL26,AK155,IL-26;interleukin 26
hsa:10148;EBI3,IL-27B,IL27B;Epstein-Barr virus induced 3
hsa:83480;PUS3,2610020J05Rik;pseudouridylate synthase 3 (EC:5.4.99.45)
hsa:5981;RFC1,A1,MHCBFB,PO-GA,RECC1,RFC,RFC140;replication factor C (activator 1) 1, 145kDa
hsa:219743;TYSND1,NET41;trypsin domain containing 1
hsa:167153;PAPD4,GLD2;PAP associated domain containing 4 (EC:2.7.7.19)
hsa:7180;CRISP2,CRISP-2,CT36,GAPDL5,TPX1,TSP1;cysteine-rich secretory protein 2
hsa:54518;APBB1IP,INAG1,PREL1,RARP1,RIAM;amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein
hsa:10690;FUT9,Fuc-TIX;fucosyltransferase 9 (alpha (1,3) fucosyltransferase) (EC:2.4.1.152)
hsa:6598;SMARCB1,BAF47,INI1,MRD15,RDT,RTPS1,SNF5,SNF5L1,Sfh1p,Snr1,hSNFS;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
hsa:55254;TMEM39A;transmembrane protein 39A
hsa:161198;CLEC14A,C14orf27,CEG1,EGFR-5;C-type lectin domain family 14, member A
hsa:23545;ATP6V0A2,A2,ARCL,ARCL2A,ATP6A2,ATP6N1D,J6B7,RTF,STV1,TJ6,TJ6M,TJ6S,VPH1,WSS;ATPase, H+ transporting, lysosomal V0 subunit a2 (EC:3.6.3.6)
hsa:84223;IQCG;IQ motif containing G
hsa:80036;TRPM3,GON-2,LTRPC3,MLSN2;transient receptor potential cation channel, subfamily M, member 3
hsa:5495;PPM1B,PP2C-beta-X,PP2CB,PP2CBETA,PPC2BETAX;protein phosphatase, Mg2+/Mn2+ dependent, 1B (EC:3.1.3.16)
hsa:254268;AKNAD1,C1orf62;AKNA domain containing 1
hsa:5106;PCK2,PEPCK,PEPCK-M,PEPCK2;phosphoenolpyruvate carboxykinase 2 (mitochondrial) (EC:4.1.1.32)
hsa:10518;CIB2,DFNB48,KIP2,USH1J;calcium and integrin binding family member 2
hsa:4321;MMP12,HME,ME,MME,MMP-12;matrix metallopeptidase 12 (macrophage elastase) (EC:3.4.24.65)
hsa:7805;LAPTM5,CLAST6;lysosomal protein transmembrane 5
hsa:920;CD4,CD4mut;CD4 molecule
hsa:80149;ZC3H12A,MCPIP,MCPIP1,RP3-423B22.1,dJ423B22.1;zinc finger CCCH-type containing 12A
hsa:54;ACP5,SPENCDI,TRAP;acid phosphatase 5, tartrate resistant (EC:3.1.3.2)
hsa:5175;PECAM1,CD31,CD31/EndoCAM,GPIIA',PECA1,PECAM-1,endoCAM;platelet/endothelial cell adhesion molecule 1
hsa:353324;SPATA12,SRG5;spermatogenesis associated 12
hsa:6575;SLC20A2,GLVR-2,GLVR2,IBGC3,MLVAR,PIT-2,PIT2,RAM1;solute carrier family 20 (phosphate transporter), member 2
hsa:271;AMPD2;adenosine monophosphate deaminase 2 (EC:3.5.4.6)
hsa:6372;CXCL6,CKA-3,GCP-2,GCP2,SCYB6;chemokine (C-X-C motif) ligand 6
hsa:58472;SQRDL,PRO1975;sulfide quinone reductase-like (yeast)
hsa:4751;NEK2,HsPK21,NEK2A,NLK1;NIMA-related kinase 2 (EC:2.7.11.1)
hsa:84292;WDR83,MORG1;WD repeat domain 83
hsa:80222;TARS2,TARSL1,thrRS;threonyl-tRNA synthetase 2, mitochondrial (putative) (EC:6.1.1.3)
hsa:2999;GZMH,CCP-X,CGL-2,CSP-C,CTLA1,CTSGL2;granzyme H (cathepsin G-like 2, protein h-CCPX)
hsa:864;RUNX3,AML2,CBFA3,PEBP2aC;runt-related transcription factor 3
hsa:10043;TOM1;target of myb1 (chicken)
hsa:719;C3AR1,AZ3B,C3AR,HNFAG09;complement component 3a receptor 1
hsa:4216;MAP3K4,MAPKKK4,MEKK4,MTK1,PRO0412;mitogen-activated protein kinase kinase kinase 4 (EC:2.7.11.25)
hsa:11034;DSTN,ACTDP,ADF,bA462D18.2;destrin (actin depolymerizing factor)
hsa:10225;CD96,TACTILE;CD96 molecule
hsa:7074;TIAM1;T-cell lymphoma invasion and metastasis 1
hsa:25788;RAD54B,RDH54;RAD54 homolog B (S. cerevisiae)
hsa:51527;GSKIP,C14orf129;GSK3B interacting protein
hsa:7283;TUBG1,GCP-1,TUBG,TUBGCP1;tubulin, gamma 1
hsa:8433;UTF1;undifferentiated embryonic cell transcription factor 1
hsa:27035;NOX1,GP91-2,MOX1,NOH-1,NOH1;NADPH oxidase 1
hsa:23607;CD2AP,CMS;CD2-associated protein
hsa:6570;SLC18A1,CGAT,VAT1,VMAT1;solute carrier family 18 (vesicular monoamine), member 1
hsa:408;ARRB1,ARB1,ARR1;arrestin, beta 1
hsa:91;ACVR1B,ACTRIB,ACVRLK4,ALK4,SKR2;activin A receptor, type IB (EC:2.7.11.30)
hsa:1302;COL11A2,DFNA13,DFNB53,FBCG2,HKE5,PARP,STL3;collagen, type XI, alpha 2
hsa:7138;TNNT1,ANM,NEM5,STNT,TNT,TNTS;troponin T type 1 (skeletal, slow)
hsa:8682;PEA15,HMAT1,HUMMAT1H,MAT1,MAT1H,PEA-15,PED;phosphoprotein enriched in astrocytes 15
hsa:117286;CIB3,KIP3;calcium and integrin binding family member 3
hsa:113791;PIK3IP1,HGFL,hHGFL(S);phosphoinositide-3-kinase interacting protein 1
hsa:2290;FOXG1,BF1,BF2,FHKL3,FKH2,FKHL1,FKHL2,FKHL3,FKHL4,FOXG1A,FOXG1B,FOXG1C,HBF-1,HBF-2,HBF-3,HBF-G2,HBF2,HFK1,HFK2,HFK3,KHL2,QIN;forkhead box G1
hsa:2570;GABRR2;gamma-aminobutyric acid (GABA) A receptor, rho 2
hsa:644943;RASSF10;Ras association (RalGDS/AF-6) domain family (N-terminal) member 10
hsa:6455;SH3GL1,CNSA1,EEN,SH3D2B,SH3P8;SH3-domain GRB2-like 1
hsa:1643;DDB2,DDBB,UV-DDB2;damage-specific DNA binding protein 2, 48kDa
hsa:134957;STXBP5,LGL3,LLGL3,Nbla04300;syntaxin binding protein 5 (tomosyn)
hsa:5023;P2RX1,P2X1;purinergic receptor P2X, ligand-gated ion channel, 1
hsa:10561;IFI44,MTAP44,TLDC5,p44;interferon-induced protein 44
hsa:26353;HSPB8,CMT2L,DHMN2,E2IG1,H11,HMN2,HMN2A,HSP22;heat shock 22kDa protein 8
hsa:1757;SARDH,BPR-2,DMGDHL1,SAR,SARD,SDH;sarcosine dehydrogenase (EC:1.5.8.3)
hsa:6888;TALDO1,TAL,TAL-H,TALDOR,TALH;transaldolase 1 (EC:2.2.1.2)
hsa:10899;JTB,HJTB,HSPC222,PAR,hJT;jumping translocation breakpoint
hsa:821;CANX,CNX,IP90,P90;calnexin
hsa:25793;FBXO7,FBX,FBX07,FBX7,PARK15,PKPS;F-box protein 7
hsa:50514;DEC1,CTS9;deleted in esophageal cancer 1
hsa:84515;MCM8,C20orf154,REC,dJ967N21.5;minichromosome maintenance complex component 8 (EC:3.6.4.12)
hsa:6304;SATB1;SATB homeobox 1
hsa:146556;C16orf89;chromosome 16 open reading frame 89
hsa:407030;MIR30B,MIRN30B;microRNA 30b
hsa:406911;MIR125B1,MIRN125B1;microRNA 125b-1
hsa:406933;MIR141,MIRN141;microRNA 141
hsa:406971;MIR195,MIRN195,miRNA195;microRNA 195
hsa:407027;MIR301A,MIRN301,MIRN301A;microRNA 301a
hsa:643332;ECRP;ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) pseudogene
hsa:442892;MIR148B,MIRN148B,mir-148b;microRNA 148b
hsa:442890;MIR133B,MIRN133B,miRNA133B,mir-133b;microRNA 133b
hsa:574443;MIR490,MIRN490,hsa-mir-490,miR-490;microRNA 490
hsa:406954;MIR181A2,MIRN181A,MIRN181A2,hsa-mir-181a-2;microRNA 181a-2
hsa:4327;MMP19,MMP18,RASI-1;matrix metallopeptidase 19
hsa:9709;HERPUD1,HERP,Mif1,SUP;homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1
hsa:5859;QARS,GLNRS,PRO2195;glutaminyl-tRNA synthetase (EC:6.1.1.18)
hsa:347741;OTOP3;otopetrin 3
hsa:112950;MED8,ARC32;mediator complex subunit 8
hsa:391003;PRAMEF18;PRAME family member 18
hsa:100113407;TMEM170B;transmembrane protein 170B
hsa:23038;WDTC1,ADP,DCAF9;WD and tetratricopeptide repeats 1
hsa:79072;FASTKD3;FAST kinase domains 3
hsa:200197;TMEM51-AS1,C1orf126,RP1-21O18.2;TMEM51 antisense RNA 1
hsa:1174;AP1S1,AP19,CLAPS1,MEDNIK,SIGMA1A,WUGSC:H_DJ0747G18.2;adaptor-related protein complex 1, sigma 1 subunit
hsa:9060;PAPSS2,ATPSK2,BCYM4,SK2;3'-phosphoadenosine 5'-phosphosulfate synthase 2 (EC:2.7.1.25 2.7.7.4)
hsa:197322;ACSF3;acyl-CoA synthetase family member 3
hsa:60684;TRAPPC11,C4orf41,FOIGR,GRY;trafficking protein particle complex 11
hsa:25914;RTTN;rotatin
hsa:6511;SLC1A6,EAAT4;solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6
hsa:317772;HIST2H2AB,H2AB;histone cluster 2, H2ab
hsa:8526;DGKE,DAGK5,DAGK6,DGK,NPHS7;diacylglycerol kinase, epsilon 64kDa (EC:2.7.1.107)
hsa:283596;SNHG10,C14orf62,LINC00063,NCRNA00063;small nucleolar RNA host gene 10 (non-protein coding)
hsa:6013;RLN1,H1,H1RLX,RLXH1,bA12D24.3.1,bA12D24.3.2;relaxin 1
hsa:55329;MNS1,SPATA40;meiosis-specific nuclear structural 1
hsa:3249;HPN,TMPRSS1;hepsin (EC:3.4.21.106)
hsa:390231;TRIM77,TRIM77P;tripartite motif containing 77
hsa:150365;MEI1,SPATA38;meiosis inhibitor 1
hsa:644890;MEIG1,SPATA39,bA2K17.3;meiosis expressed gene 1 homolog (mouse)
hsa:136227;COL26A1,EMI6,EMID2,EMU2,SH2B;collagen, type XXVI, alpha 1
hsa:988;CDC5L,CDC5,CDC5-LIKE,CEF1,PCDC5RP,dJ319D22.1;cell division cycle 5-like
hsa:283232;TMEM80;transmembrane protein 80
hsa:994;CDC25B;cell division cycle 25B (EC:3.1.3.48)
hsa:51362;CDC40,EHB3,PRP17,PRPF17;cell division cycle 40
hsa:699;BUB1,BUB1A,BUB1L,hBUB1;BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1)
hsa:993;CDC25A,CDC25A2;cell division cycle 25A (EC:3.1.3.48)
hsa:11140;CDC37,P50CDC37;cell division cycle 37
hsa:23281;MTUS2,CAZIP,ICIS,KIAA0774,TIP150;microtubule associated tumor suppressor candidate 2
hsa:9184;BUB3,BUB3L,hBUB3;BUB3 mitotic checkpoint protein
hsa:8555;CDC14B,CDC14B3,Cdc14B1,Cdc14B2,hCDC14B;cell division cycle 14B (EC:3.1.3.16 3.1.3.48)
hsa:5499;PPP1CA,PP-1A,PP1A,PP1alpha,PPP1A;protein phosphatase 1, catalytic subunit, alpha isozyme (EC:3.1.3.16)
hsa:283106;CSNK2A3,CSNK2A1P;casein kinase 2, alpha 3 polypeptide
hsa:8556;CDC14A,cdc14,hCDC14;cell division cycle 14A (EC:3.1.3.16 3.1.3.48)
hsa:166979;CDC20B;cell division cycle 20B
hsa:1063;CENPF,CENF,PRO1779,hcp-1;centromere protein F, 350/400kDa
hsa:8697;CDC23,ANAPC8,APC8,CUT23;cell division cycle 23
hsa:6810;STX4,STX4A,p35-2;syntaxin 4
hsa:8318;CDC45,CDC45L,CDC45L2,PORC-PI-1;cell division cycle 45
hsa:168448;CDC14C,CDC14B2,CDC14Bretro;cell division cycle 14C
hsa:55331;ACER3,APHC,PHCA;alkaline ceramidase 3 (EC:3.5.1.23)
hsa:55909;BIN3;bridging integrator 3
hsa:4720;NDUFS2,CI-49;NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3)
hsa:10659;CELF2,BRUNOL3,CUGBP2,ETR-3,ETR3,NAPOR;CUGBP, Elav-like family member 2
hsa:8021;NUP214,CAIN,CAN,D9S46E,N214;nucleoporin 214kDa
hsa:57148;RALGAPB,KIAA1219,RalGAPbeta,dJ1100H13.1;Ral GTPase activating protein, beta subunit (non-catalytic)
hsa:421;ARVCF;armadillo repeat gene deleted in velocardiofacial syndrome
hsa:23308;ICOSLG,B7-H2,B7H2,B7RP-1,B7RP1,CD275,GL50,ICOS-L,ICOSL,LICOS;inducible T-cell co-stimulator ligand
hsa:134359;POC5,C5orf37;POC5 centriolar protein homolog (Chlamydomonas)
hsa:54716;SLC6A20,SIT1,XT3,Xtrp3;solute carrier family 6 (proline IMINO transporter), member 20
hsa:2537;IFI6,6-16,FAM14C,G1P3,IFI-6-16,IFI616;interferon, alpha-inducible protein 6
hsa:9966;TNFSF15,TL1,TL1A,VEGI,VEGI192A;tumor necrosis factor (ligand) superfamily, member 15
hsa:23229;ARHGEF9,COLLYBISTIN,EIEE8,HPEM-2,PEM-2,PEM2;Cdc42 guanine nucleotide exchange factor (GEF) 9
hsa:925;CD8A,CD8,Leu2,MAL,p32;CD8a molecule
hsa:4706;NDUFAB1,ACP,FASN2A,SDAP;NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8kDa
hsa:9731;CEP104,GlyBP,KIAA0562;centrosomal protein 104kDa
hsa:5253;PHF2,CENP-35,GRC5,JHDM1E;PHD finger protein 2
hsa:6712;SPTBN2,GTRAP41,SCA5;spectrin, beta, non-erythrocytic 2
hsa:2826;CCR10,GPR2;chemokine (C-C motif) receptor 10
hsa:84795;PYROXD2,C10orf33,FP3420;pyridine nucleotide-disulphide oxidoreductase domain 2
hsa:80155;NAA15,Ga19,NARG1,NATH,TBDN100;N(alpha)-acetyltransferase 15, NatA auxiliary subunit
hsa:2828;GPR4;G protein-coupled receptor 4
hsa:129787;TMEM18;transmembrane protein 18
hsa:389118;CDHR4,CDH29,PRO34300;cadherin-related family member 4
hsa:10529;NEBL,LASP2,LNEBL;nebulette
hsa:5169;ENPP3,B10,CD203c,NPP3,PD-IBETA,PDNP3;ectonucleotide pyrophosphatase/phosphodiesterase 3 (EC:3.1.4.1 3.6.1.9)
hsa:51495;PTPLAD1,B-IND1,HACD3,HSPC121;protein tyrosine phosphatase-like A domain containing 1 (EC:4.2.1.134)
hsa:10566;AKAP3,AKAP110,CT82,FSP95,PRKA3,SOB1;A kinase (PRKA) anchor protein 3
hsa:4147;MATN2;matrilin 2
hsa:8618;CADPS,CADPS1,CAPS,CAPS1;Ca++-dependent secretion activator
hsa:10724;MGEA5,MEA5,NCOAT,OGA;meningioma expressed antigen 5 (hyaluronidase) (EC:2.3.1.48 3.2.1.169)
hsa:27348;TOR1B,DQ1;torsin family 1, member B (torsin B)
hsa:66008;TRAK2,ALS2CR3,CALS-C,GRIF-1,GRIF1,MILT2,OIP98;trafficking protein, kinesin binding 2
hsa:57017;COQ9,C16orf49,COQ10D5;coenzyme Q9 homolog (S. cerevisiae)
hsa:57419;SLC24A3,NCKX3;solute carrier family 24 (sodium/potassium/calcium exchanger), member 3
hsa:314;AOC2,DAO2,RAO;amine oxidase, copper containing 2 (retina-specific) (EC:1.4.3.21)
hsa:284521;OR2L13,OR2L14;olfactory receptor, family 2, subfamily L, member 13
hsa:26133;TRPC4AP,C20orf188,TRRP4AP,TRUSS;transient receptor potential cation channel, subfamily C, member 4 associated protein
hsa:283652;SLC24A5,JSX,NCKX5,SHEP4;solute carrier family 24, member 5
hsa:27324;TOX3,CAGF9,TNRC9;TOX high mobility group box family member 3
hsa:111;ADCY5,AC5,FDFM;adenylate cyclase 5 (EC:4.6.1.1)
hsa:64132;XYLT2,PXYLT2,XT-II,XT2,xylT-II;xylosyltransferase II (EC:2.4.2.26)
hsa:81566;CSRNP2,C12orf2,C12orf22,FAM130A1,PPP1R72,TAIP-12;cysteine-serine-rich nuclear protein 2
hsa:124093;CCDC78,C16orf25,CNM4,JFP10;coiled-coil domain containing 78
hsa:27334;P2RY10,P2Y10;purinergic receptor P2Y, G-protein coupled, 10
hsa:8614;STC2,STC-2,STCRP;stanniocalcin 2
hsa:8698;S1PR4,EDG6,LPC1,S1P4,SLP4;sphingosine-1-phosphate receptor 4
hsa:2304;FOXE1,FKHL15,FOXE2,HFKH4,HFKL5,TITF2,TTF-2,TTF2;forkhead box E1 (thyroid transcription factor 2)
hsa:5288;PIK3C2G,PI3K-C2GAMMA;phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma (EC:2.7.1.154)
hsa:55435;AP1AR,2C18,C4orf16,GBAR,gamma-BAR;adaptor-related protein complex 1 associated regulatory protein
hsa:4188;MDFI,I-MF,I-mfa;MyoD family inhibitor
hsa:2859;GPR35;G protein-coupled receptor 35
hsa:122769;LRR1,4-1BBLRR,LRR-1,PPIL5;leucine rich repeat protein 1
hsa:9187;SLC24A1,CSNB1D,HsT17412,NCKX,NCKX1,RODX;solute carrier family 24 (sodium/potassium/calcium exchanger), member 1
hsa:80781;COL18A1,KNO,KNO1,KS;collagen, type XVIII, alpha 1
hsa:79953;SYNDIG1,C20orf39,DSPC2,IFITMD5,TMEM90B;synapse differentiation inducing 1
hsa:81492;RSPH6A,RSHL1,RSP4,RSP6,RSPH4B;radial spoke head 6 homolog A (Chlamydomonas)
hsa:23746;AIPL1,AIPL2,LCA4;aryl hydrocarbon receptor interacting protein-like 1
hsa:23239;PHLPP1,PHLPP,PLEKHE1,SCOP;PH domain and leucine rich repeat protein phosphatase 1 (EC:3.1.3.16)
hsa:3911;LAMA5;laminin, alpha 5
hsa:376132;LRRC10,HRLRRP,LRRC10A;leucine rich repeat containing 10
hsa:10692;RRH;retinal pigment epithelium-derived rhodopsin homolog
hsa:3429;IFI27,FAM14D,ISG12,ISG12A,P27;interferon, alpha-inducible protein 27
hsa:5218;CDK14,PFTAIRE1,PFTK1;cyclin-dependent kinase 14 (EC:2.7.11.22)
hsa:10663;CXCR6,BONZO,CD186,STRL33,TYMSTR;chemokine (C-X-C motif) receptor 6
hsa:8326;FZD9,CD349,FZD3;frizzled family receptor 9
hsa:2691;GHRH,GHRF,GRF,INN;growth hormone releasing hormone
hsa:9547;CXCL14,BMAC,BRAK,KEC,KS1,MIP-2g,MIP2G,NJAC,SCYB14;chemokine (C-X-C motif) ligand 14
hsa:9394;HS6ST1,HH15,HS6ST;heparan sulfate 6-O-sulfotransferase 1 (EC:2.8.2.-)
hsa:348932;SLC6A18,Xtrp2;solute carrier family 6, member 18
hsa:6902;TBCA;tubulin folding cofactor A
hsa:2181;ACSL3,ACS3,FACL3,PRO2194;acyl-CoA synthetase long-chain family member 3 (EC:6.2.1.3)
hsa:8940;TOP3B;topoisomerase (DNA) III beta (EC:5.99.1.2)
hsa:8745;ADAM23,MDC3;ADAM metallopeptidase domain 23
hsa:6846;XCL2,SCM-1b,SCM1B,SCYC2;chemokine (C motif) ligand 2
hsa:23208;SYT11,SYT12,sytXI;synaptotagmin XI
hsa:827;CAPN6,CANPX,CAPNX,CalpM,DJ914P14.1;calpain 6
hsa:284403;WDR62,C19orf14,MCPH2;WD repeat domain 62
hsa:607;BCL9,LGS;B-cell CLL/lymphoma 9
hsa:57194;ATP10A,ATP10C,ATPVA,ATPVC;ATPase, class V, type 10A (EC:3.6.3.1)
hsa:57586;SYT13;synaptotagmin XIII
hsa:10095;ARPC1B,ARC41,p40-ARC,p41-ARC;actin related protein 2/3 complex, subunit 1B, 41kDa
hsa:8416;ANXA9,ANX31;annexin A9
hsa:1105;CHD1;chromodomain helicase DNA binding protein 1 (EC:3.6.4.12)
hsa:127623;OR2B11;olfactory receptor, family 2, subfamily B, member 11
hsa:129450;TYW5,C2orf60,hTYW5;tRNA-yW synthesizing protein 5
hsa:10351;ABCA8;ATP-binding cassette, sub-family A (ABC1), member 8
hsa:395;ARHGAP6,RHOGAP6,RHOGAPX-1;Rho GTPase activating protein 6
hsa:20;ABCA2,ABC2;ATP-binding cassette, sub-family A (ABC1), member 2
hsa:7107;GPR137B,TM7SF1;G protein-coupled receptor 137B
hsa:56983;POGLUT1,C3orf9,CLP46,KDELCL1,KTELC1,MDSRP,Rumi,hCLP46;protein O-glucosyltransferase 1
hsa:80067;DCAF17,C2orf37;DDB1 and CUL4 associated factor 17
hsa:23198;PSME4,PA200;proteasome (prosome, macropain) activator subunit 4
hsa:84934;C12orf52,RITA;chromosome 12 open reading frame 52
hsa:30010;NXPH1,NPH1;neurexophilin 1
hsa:23336;SYNM,DMN,SYN;synemin, intermediate filament protein
hsa:23190;UBXN4,UBXD2,UBXDC1,erasin;UBX domain protein 4
hsa:8822;FGF17,FGF-13;fibroblast growth factor 17
hsa:346562;GNAT3,GDCA;guanine nucleotide binding protein, alpha transducing 3
hsa:81542;TMX1,PDIA11,TMX,TXNDC,TXNDC1;thioredoxin-related transmembrane protein 1
hsa:79155;TNIP2,ABIN2,FLIP1,KLIP;TNFAIP3 interacting protein 2
hsa:123872;DNAAF1,CILD13,LRRC50,ODA7;dynein, axonemal, assembly factor 1
hsa:9672;SDC3,SDCN,SYND3;syndecan 3
hsa:9669;EIF5B,IF2;eukaryotic translation initiation factor 5B
hsa:374868;ATP9B,ATPASEP,ATPIIB,NEO1L,hMMR1;ATPase, class II, type 9B (EC:3.6.3.1)
hsa:116512;MRGPRD,MRGD,TGR7;MAS-related GPR, member D
hsa:80117;ARL14,ARF7;ADP-ribosylation factor-like 14
hsa:9051;PSTPIP1,CD2BP1,CD2BP1L,CD2BP1S,H-PIP,PAPAS,PSTPIP;proline-serine-threonine phosphatase interacting protein 1
hsa:8928;FOXH1,FAST-1,FAST1;forkhead box H1
hsa:9334;B4GALT5,B4Gal-T5,BETA4-GALT-IV,beta4Gal-T5,beta4GalT-V,gt-V;UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5 (EC:2.4.1.38)
hsa:7009;TMBIM6,BAXI1,BI-1,TEGT;transmembrane BAX inhibitor motif containing 6
hsa:11145;PLA2G16,AdPLA,H-REV107-1,HRASLS3,HREV107,HREV107-1,HREV107-3,HRSL3;phospholipase A2, group XVI (EC:3.1.1.4 3.1.1.32)
hsa:25805;BAMBI,NMA;BMP and activin membrane-bound inhibitor homolog (Xenopus laevis)
hsa:11041;B3GNT1,B3GN-T1,B3GNT6,BETA3GNTI,iGAT,iGNT;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 (EC:2.4.1.149)
hsa:2218;FKTN,CMD1X,FCMD,LGMD2M,MDDGA4,MDDGB4,MDDGC4;fukutin
hsa:221044;UCMA,C10orf49,GRP;upper zone of growth plate and cartilage matrix associated
hsa:2580;GAK,DNAJ26,DNAJC26;cyclin G associated kinase (EC:2.7.11.1)
hsa:9363;RAB33A,RabS10;RAB33A, member RAS oncogene family
hsa:8665;EIF3F,EIF3S5,eIF3-p47;eukaryotic translation initiation factor 3, subunit F (EC:3.4.19.12)
hsa:7484;WNT9B,WNT14B,WNT15;wingless-type MMTV integration site family, member 9B
hsa:84080;ENKD1,C16orf48,DAKV6410;enkurin domain containing 1
hsa:10123;ARL4C,ARL7,LAK;ADP-ribosylation factor-like 4C
hsa:27199;OXGR1,GPR80,GPR99,P2RY15,P2Y15;oxoglutarate (alpha-ketoglutarate) receptor 1
hsa:6375;XCL1,ATAC,LPTN,LTN,SCM-1,SCM-1a,SCM1,SCM1A,SCYC1;chemokine (C motif) ligand 1
hsa:84530;SRRM4,KIAA1853,MU-MB-2.76,nSR100;serine/arginine repetitive matrix 4
hsa:157753;TMEM74,NET36;transmembrane protein 74
hsa:10079;ATP9A,ATPIIA;ATPase, class II, type 9A (EC:3.6.3.1)
hsa:2676;GFRA3;GDNF family receptor alpha 3
hsa:55081;IFT57,ESRRBL1,HIPPI,MHS4R2;intraflagellar transport 57 homolog (Chlamydomonas)
hsa:83873;GPR61,BALGR,GPCR3;G protein-coupled receptor 61
hsa:9421;HAND1,Hxt,Thing1,bHLHa27,eHand;heart and neural crest derivatives expressed 1
hsa:123041;SLC24A4,NCKX4,SHEP6,SLC24A2;solute carrier family 24 (sodium/potassium/calcium exchanger), member 4
hsa:23643;LY96,ESOP-1,MD-2,MD2,ly-96;lymphocyte antigen 96
hsa:23242;COBL;cordon-bleu WH2 repeat protein
hsa:5565;PRKAB2;protein kinase, AMP-activated, beta 2 non-catalytic subunit
hsa:3448;IFNA14,IFN-alphaH,LEIF2H;interferon, alpha 14
hsa:8553;BHLHE40,BHLHB2,DEC1,HLHB2,SHARP-2,STRA13,Stra14;basic helix-loop-helix family, member e40
hsa:8987;STBD1,GENEX3414;starch binding domain 1
hsa:53829;P2RY13,GPCR1,GPR86,GPR94,P2Y13,SP174;purinergic receptor P2Y, G-protein coupled, 13
hsa:143425;SYT9;synaptotagmin IX
hsa:9878;TOX4,C14orf92,KIAA0737,LCP1,MIG7;TOX high mobility group box family member 4
hsa:8797;TNFRSF10A,APO2,CD261,DR4,TRAILR-1,TRAILR1;tumor necrosis factor receptor superfamily, member 10a
hsa:54812;AFTPH,Nbla10388;aftiphilin
hsa:5442;POLRMT,APOLMT,MTRNAP,MTRPOL,h-mtRPOL;polymerase (RNA) mitochondrial (DNA directed) (EC:2.7.7.6)
hsa:4878;NPPA,ANF,ANP,ATFB6,CDD-ANF,PND;natriuretic peptide A
hsa:3840;KPNA4,IPOA3,QIP1,SRP3;karyopherin alpha 4 (importin alpha 3)
hsa:11249;NXPH2,NPH2;neurexophilin 2
hsa:10888;GPR83,GIR,GPR72;G protein-coupled receptor 83
hsa:199800;ADM5,AM5,C19orf76;adrenomedullin 5 (putative)
hsa:9061;PAPSS1,ATPSK1,PAPSS,SK1;3'-phosphoadenosine 5'-phosphosulfate synthase 1 (EC:2.7.1.25 2.7.7.4)
hsa:3451;IFNA17,IFN-alphaI,IFNA,INFA,LEIF2C1;interferon, alpha 17
hsa:576;BAI2;brain-specific angiogenesis inhibitor 2
hsa:8574;AKR7A2,AFAR,AFAR1,AFB1-AR1,AKR7;aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) (EC:1.1.1.n11)
hsa:27201;GPR78;G protein-coupled receptor 78
hsa:27242;TNFRSF21,BM-018,CD358,DR6;tumor necrosis factor receptor superfamily, member 21
hsa:5623;PSPN,PSP;persephin
hsa:55693;KDM4D,JMJD2D;lysine (K)-specific demethylase 4D
hsa:340485;ACER2,ALKCDase2,ASAH3L;alkaline ceramidase 2 (EC:3.5.1.23)
hsa:8704;B4GALT2,B4Gal-T2,B4Gal-T3,beta4Gal-T2;UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 (EC:2.4.1.22 2.4.1.90 2.4.1.38)
hsa:284297;SSC5D;scavenger receptor cysteine rich domain containing (5 domains)
hsa:6801;STRN,SG2NA;striatin, calmodulin binding protein
hsa:84879;MFSD2A,MFSD2;major facilitator superfamily domain containing 2A
hsa:575;BAI1,GDAIF;brain-specific angiogenesis inhibitor 1
hsa:51272;BET1L,BET1L1,GOLIM3,GS15,HSPC197;Bet1 golgi vesicular membrane trafficking protein-like
hsa:255928;SYT14,SCAR11,sytXIV;synaptotagmin XIV
hsa:7476;WNT7A;wingless-type MMTV integration site family, member 7A
hsa:23633;KPNA6,IPOA7,KPNA7;karyopherin alpha 6 (importin alpha 7)
hsa:723961;INS-IGF2,INSIGF;INS-IGF2 readthrough
hsa:10964;IFI44L,C1orf29;interferon-induced protein 44-like
hsa:92558;CCDC64,BICDR-1,H_267D11.1;coiled-coil domain containing 64
hsa:4185;ADAM11,MDC;ADAM metallopeptidase domain 11
hsa:23541;SEC14L2,C22orf6,SPF,TAP,TAP1;SEC14-like 2 (S. cerevisiae)
hsa:2306;FOXD2,FKHL17,FREAC-9,FREAC9;forkhead box D2
hsa:27197;GPR82;G protein-coupled receptor 82
hsa:10960;LMAN2,C5orf8,GP36B,VIP36;lectin, mannose-binding 2
hsa:7475;WNT6;wingless-type MMTV integration site family, member 6
hsa:29984;RHOD,ARHD,RHOHP1,RHOM,Rho;ras homolog family member D
hsa:9248;GPR50,H9,Mel1c;G protein-coupled receptor 50
hsa:137695;TMEM68;transmembrane protein 68
hsa:9901;SRGAP3,ARHGAP14,MEGAP,SRGAP2,WRP;SLIT-ROBO Rho GTPase activating protein 3
hsa:5276;SERPINI2,MEPI,PANCPIN,PI14,TSA2004;serpin peptidase inhibitor, clade I (pancpin), member 2
hsa:51754;TMEM8B,C9orf127,NAG-5,NGX6,RP11-112J3.10;transmembrane protein 8B
hsa:23380;SRGAP2,ARHGAP34,FNBP2,SRGAP2A,SRGAP3;SLIT-ROBO Rho GTPase activating protein 2
hsa:6666;SOX12,SOX22;SRY (sex determining region Y)-box 12
hsa:28987;NOB1,ART-4,MST158,NOB1P,PSMD8BP1;NIN1/RPN12 binding protein 1 homolog (S. cerevisiae)
hsa:9826;ARHGEF11,GTRAP48,PDZ-RHOGEF;Rho guanine nucleotide exchange factor (GEF) 11
hsa:5876;RABGGTB,GGTB;Rab geranylgeranyltransferase, beta subunit (EC:2.5.1.60)
hsa:10602;CDC42EP3,BORG2,CEP3,UB1;CDC42 effector protein (Rho GTPase binding) 3
hsa:148229;ATP8B3,ATPIK;ATPase, aminophospholipid transporter, class I, type 8B, member 3 (EC:3.6.3.1)
hsa:8793;TNFRSF10D,CD264,DCR2,TRAIL-R4,TRAILR4,TRUNDD;tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
hsa:9136;RRP9,RNU3IP2,U3-55K;ribosomal RNA processing 9, small subunit (SSU) processome component, homolog (yeast)
hsa:5715;PSMD9,Rpn4,p27;proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
hsa:11216;AKAP10,AKAP-10,D-AKAP-2,D-AKAP2,PRKA10;A kinase (PRKA) anchor protein 10
hsa:10494;STK25,SOK1,YSK1;serine/threonine kinase 25 (EC:2.7.11.1)
hsa:26;ABP1,ABP,AOC1,DAO,DAO1,KAO;amiloride binding protein 1 (amine oxidase (copper-containing)) (EC:1.4.3.22)
hsa:4209;MEF2D;myocyte enhancer factor 2D
hsa:79959;CEP76,C18orf9,HsT1705;centrosomal protein 76kDa
hsa:5709;PSMD3,P58,RPN3,S3,TSTA2;proteasome (prosome, macropain) 26S subunit, non-ATPase, 3
hsa:5717;PSMD11,Rpn6,S9,p44.5;proteasome (prosome, macropain) 26S subunit, non-ATPase, 11
hsa:2827;GPR3,ACCA;G protein-coupled receptor 3
hsa:9096;TBX18;T-box 18
hsa:79895;ATP8B4,ATPIM;ATPase, class I, type 8B, member 4 (EC:3.6.3.1)
hsa:5296;PIK3R2,MPPH,P85B,p85,p85-BETA;phosphoinositide-3-kinase, regulatory subunit 2 (beta)
hsa:285848;PNPLA1,ARCI10,dJ50J22.1;patatin-like phospholipase domain containing 1
hsa:7780;SLC30A2,PP12488,TNZD,ZNT2,ZnT-2;solute carrier family 30 (zinc transporter), member 2
hsa:996;CDC27,ANAPC3,APC3,CDC27Hs,D0S1430E,D17S978E,HNUC,NUC2;cell division cycle 27
hsa:997;CDC34,E2-CDC34,UBC3,UBCH3,UBE2R1;cell division cycle 34 (EC:6.3.2.19)
hsa:643418;LIPN,ARCI8,LI4,LIPL4,bA186O14.3;lipase, family member N
hsa:8881;CDC16,ANAPC6,APC6,CUT9;cell division cycle 16
hsa:492;ATP2B3,PMCA3,PMCA3a,SCAX1;ATPase, Ca++ transporting, plasma membrane 3 (EC:3.6.3.8)
hsa:203260;CCDC107,PSEC0222;coiled-coil domain containing 107
hsa:7373;COL14A1,UND;collagen, type XIV, alpha 1
hsa:140689;CBLN4,CBLNL1;cerebellin 4 precursor
hsa:387914;SHISA2,C13orf13,PRO28631,TMEM46,WGAR9166,bA398O19.2,hShisa;shisa homolog 2 (Xenopus laevis)
hsa:100293534;C4B_2;complement component 4B (Chido blood group), copy 2
hsa:140825;NEURL2,C20orf163,OZZ,Ozz-E3;neuralized homolog 2 (Drosophila)
hsa:4430;MYO1B,myr1;myosin IB
hsa:374403;TBC1D10C,CARABIN,EPI64C;TBC1 domain family, member 10C
hsa:10128;LRPPRC,CLONE-23970,GP130,LRP130,LSFC;leucine-rich pentatricopeptide repeat containing
hsa:59286;UBL5,HUB1;ubiquitin-like 5
hsa:26033;ATRNL1,ALP,bA338L11.1,bA454H24.1;attractin-like 1
hsa:56987;BBX,ARTC1,HBP2,HSPC339,MDS001;bobby sox homolog (Drosophila)
hsa:23316;CUX2,CDP2,CUTL2;cut-like homeobox 2
hsa:7384;UQCRC1,D3S3191,QCR1,UQCR1;ubiquinol-cytochrome c reductase core protein I (EC:1.10.2.2)
hsa:441425;ANKRD20A3;ankyrin repeat domain 20 family, member A3
hsa:6727;SRP14,ALURBP;signal recognition particle 14kDa (homologous Alu RNA binding protein)
hsa:728747;ANKRD20A4;ankyrin repeat domain 20 family, member A4
hsa:9398;CD101,EWI-101,IGSF2,V7;CD101 molecule
hsa:55135;WRAP53,DKCB3,TCAB1,WDR79;WD repeat containing, antisense to TP53
hsa:9869;SETDB1,ESET,H3-K9-HMTase4,KG1T,KMT1E,TDRD21;SET domain, bifurcated 1 (EC:2.1.1.43)
hsa:27030;MLH3,HNPCC7;mutL homolog 3 (E. coli)
hsa:3930;LBR,DHCR14B,LMN2R,PHA,TDRD18;lamin B receptor
hsa:54714;CNGB3,ACHM1,ACHM3,RMCH;cyclic nucleotide gated channel beta 3
hsa:10285;SMNDC1,SMNR,SPF30,TDRD16C;survival motor neuron domain containing 1
hsa:2812;GP1BB,BDPLT1,BS,CD42C,GPIBB;glycoprotein Ib (platelet), beta polypeptide
hsa:343066;AADACL4;arylacetamide deacetylase-like 4
hsa:574434;MIR410,MIRN410,hsa-mir-410;microRNA 410
hsa:664616;MIR487B,MIRN487B;microRNA 487b
hsa:55571;CNOT11,C2orf29;CCR4-NOT transcription complex, subunit 11
hsa:23511;NUP188,KIAA0169,hNup188;nucleoporin 188kDa
hsa:399814;C10orf120,bA318C4.1;chromosome 10 open reading frame 120
hsa:400831;C20orf202;chromosome 20 open reading frame 202
hsa:813;CALU;calumenin
hsa:64579;NDST4,NDST-4,NHSST4;N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4 (EC:2.8.2.8)
hsa:11188;NISCH,I-1,IR1,IRAS,hIRAS;nischarin
hsa:53822;FXYD7;FXYD domain containing ion transport regulator 7
hsa:4325;MMP16,C8orf57,MMP-X2,MT-MMP2,MT-MMP3,MT3-MMP;matrix metallopeptidase 16 (membrane-inserted) (EC:3.4.24.-)
hsa:10897;YIF1A,54TM,FinGER7,YIF1,YIF1P;Yip1 interacting factor homolog A (S. cerevisiae)
hsa:8320;EOMES,TBR2;eomesodermin
hsa:611;OPN1SW,BCP,BOP,CBT;opsin 1 (cone pigments), short-wave-sensitive
hsa:145376;PPP1R36,C14orf50;protein phosphatase 1, regulatory subunit 36
hsa:10815;CPLX1,CPX-I,CPX1;complexin 1
hsa:27302;BMP10;bone morphogenetic protein 10
hsa:126123;IZUMO2,C19orf41,PLAL6978,PRO21961,SCRL;IZUMO family member 2
hsa:3981;LIG4;ligase IV, DNA, ATP-dependent (EC:6.5.1.1)
hsa:161145;TMEM229B,C14orf83;transmembrane protein 229B
hsa:9283;GPR37L1,ET(B)R-LP-2,ETBR-LP-2;G protein-coupled receptor 37 like 1
hsa:9362;CPNE6,N-COPINE;copine VI (neuronal)
hsa:6363;CCL19,CKb11,ELC,MIP-3b,MIP3B,SCYA19;chemokine (C-C motif) ligand 19
hsa:27297;CRCP,CGRP-RCP,CGRPRCP,RCP,RCP9;CGRP receptor component
hsa:4902;NRTN,NTN;neurturin
hsa:5819;PVRL2,CD112,HVEB,PRR2,PVRR2;poliovirus receptor-related 2 (herpesvirus entry mediator B)
hsa:85465;EPT1,SELI,SEPI;ethanolaminephosphotransferase 1 (CDP-ethanolamine-specific) (EC:2.7.8.1)
hsa:56923;NMUR2,FM-4,FM4,NMU-R2,NMU2R,TGR-1,TGR1;neuromedin U receptor 2
hsa:84692;CCDC54,NYD-SP17,SP17;coiled-coil domain containing 54
hsa:10040;TOM1L1,OK/KNS-CL.3,SRCASM;target of myb1 (chicken)-like 1
hsa:9026;HIP1R,HIP12,HIP3,ILWEQ;huntingtin interacting protein 1 related
hsa:2962;GTF2F1,BTF4,RAP74,TF2F1,TFIIF;general transcription factor IIF, polypeptide 1, 74kDa
hsa:10636;RGS14;regulator of G-protein signaling 14
hsa:6911;TBX6;T-box 6
hsa:57161;PELI2;pellino E3 ubiquitin protein ligase family member 2
hsa:752;FMNL1,C17orf1,C17orf1B,FHOD4,FMNL,KW-13;formin-like 1
hsa:10579;TACC2,AZU-1,ECTACC;transforming, acidic coiled-coil containing protein 2
hsa:5152;PDE9A,HSPDE9A2;phosphodiesterase 9A (EC:3.1.4.35)
hsa:7481;WNT11,HWNT11;wingless-type MMTV integration site family, member 11
hsa:5738;PTGFRN,CD315,CD9P-1,EWI-F,FPRP,SMAP-6;prostaglandin F2 receptor inhibitor
hsa:2029;ENSA,ARPP-19e;endosulfine alpha
hsa:11133;KPTN,2E4;kaptin (actin binding protein)
hsa:57452;GALNT16,GALNACT16,GALNTL1,GalNAc-T16;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 (EC:2.4.1.41)
hsa:11130;ZWINT,HZwint-1,KNTC2AP,ZWINT1;ZW10 interactor, kinetochore protein
hsa:64407;RGS18,RGS13;regulator of G-protein signaling 18
hsa:3625;INHBB;inhibin, beta B
hsa:113177;IZUMO4,C19orf36,IMAGE:4215339;IZUMO family member 4
hsa:374378;GALNT18,GALNT15,GALNTL4,GalNAc-T15,GalNAc-T18;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 18 (EC:2.4.1.41)
hsa:6368;CCL23,CK-BETA-8,CKb8,Ckb-8,Ckb-8-1,MIP-3,MIP3,MPIF-1,SCYA23;chemokine (C-C motif) ligand 23
hsa:9751;SNPH,bA314N13.5;syntaphilin
hsa:7482;WNT2B,WNT13,XWNT2;wingless-type MMTV integration site family, member 2B
hsa:56270;WDR45B,WDR45L,WIPI-3,WIPI3;WD repeat domain 45B
hsa:92745;SLC38A5,JM24,SN2,SNAT5,pp7194;solute carrier family 38, member 5
hsa:10465;PPIH,CYP-20,CYPH,SnuCyp-20,USA-CYP;peptidylprolyl isomerase H (cyclophilin H) (EC:5.2.1.8)
hsa:84221;SPATC1L,C21orf56;spermatogenesis and centriole associated 1-like
hsa:317701;VN1R2,V1RL2;vomeronasal 1 receptor 2
hsa:665;BNIP3L,BNIP3a,NIX;BCL2/adenovirus E1B 19kDa interacting protein 3-like
hsa:753;LDLRAD4,C18orf1;low density lipoprotein receptor class A domain containing 4
hsa:23351;KHNYN,KIAA0323;KH and NYN domain containing
hsa:10613;ERLIN1,C10orf69,Erlin-1,KE04,KEO4,SPFH1;ER lipid raft associated 1
hsa:51117;COQ4,CGI-92;coenzyme Q4 homolog (S. cerevisiae)
hsa:9158;FIBP,FGFIBP,FIBP-1;fibroblast growth factor (acidic) intracellular binding protein
hsa:63917;GALNT11;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11) (EC:2.4.1.41)
hsa:27190;IL17B,IL-17B,IL-20,NIRF,ZCYTO7;interleukin 17B
hsa:56936;CCDC177,C14orf162,PLPL;coiled-coil domain containing 177
hsa:26290;GALNT8,GALNAC-T8;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8) (EC:2.4.1.41)
hsa:2853;GPR31,12-HETER,HETER,HETER1;G protein-coupled receptor 31
hsa:8786;RGS11,RS11;regulator of G-protein signaling 11
hsa:83550;GPR101,GPCR6;G protein-coupled receptor 101
hsa:83551;TAAR8,GPR102,TA5,TAR5,TRAR5,TaR-5,TaR-8;trace amine associated receptor 8
hsa:955;ENTPD6,CD39L2,IL-6SAG,IL6ST2,NTPDase-6,dJ738P15.3;ectonucleoside triphosphate diphosphohydrolase 6 (putative) (EC:3.6.1.6)
hsa:8456;FOXN1,FKHL20,RONU,WHN;forkhead box N1
hsa:10656;KHDRBS3,Etle,SALP,SLM-2,SLM2,T-STAR,TSTAR,etoile;KH domain containing, RNA binding, signal transduction associated 3
hsa:790;CAD;carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (EC:2.1.3.2 3.5.2.3 6.3.5.5)
hsa:144233;BCDIN3D;BCDIN3 domain containing (EC:2.1.1.-)
hsa:6004;RGS16,A28-RGS14,A28-RGS14P,RGS-R;regulator of G-protein signaling 16
hsa:23564;DDAH2,DDAH,DDAHII,G6a,NG30;dimethylarginine dimethylaminohydrolase 2 (EC:3.5.3.18)
hsa:2359;FPR3,FML2_HUMAN,FMLPY,FPRH1,FPRH2,FPRL2,RMLP-R-I;formyl peptide receptor 3
hsa:388753;COA6,C1orf31;cytochrome c oxidase assembly factor 6 homolog (S. cerevisiae)
hsa:5116;PCNT,KEN,MOPD2,PCN,PCNT2,PCNTB,PCTN2,SCKL4;pericentrin
hsa:10174;SORBS3,SCAM-1,SCAM1,SH3D4;sorbin and SH3 domain containing 3
hsa:84265;POLR3GL,RPC32HOM,flj32422;polymerase (RNA) III (DNA directed) polypeptide G (32kD)-like
hsa:200424;TET3;tet methylcytosine dioxygenase 3 (EC:1.14.11.n2)
hsa:22824;HSPA4L,APG-1,HSPH3,Osp94;heat shock 70kDa protein 4-like
hsa:2845;GPR22;G protein-coupled receptor 22
hsa:643008;SMIM5,C17orf109,PP12104;small integral membrane protein 5
hsa:4211;MEIS1;Meis homeobox 1
hsa:11081;KERA,CNA2,SLRR2B;keratocan
hsa:83715;ESPN,DFNB36;espin
hsa:441911;OR10J3,OR1-25,OR10J3P;olfactory receptor, family 10, subfamily J, member 3
hsa:201229;LYRM9,C17orf108;LYR motif containing 9
hsa:10623;POLR3C,RPC3,RPC62;polymerase (RNA) III (DNA directed) polypeptide C (62kD)
hsa:143098;MPP7;membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7)
hsa:8811;GALR2,GALNR2;galanin receptor 2
hsa:54932;EXD3,mut-7;exonuclease 3'-5' domain containing 3
hsa:54959;ODAM,APIN;odontogenic, ameloblast asssociated
hsa:9683;N4BP1;NEDD4 binding protein 1
hsa:10297;APC2,APCL;adenomatosis polyposis coli 2
hsa:3641;INSL4,EPIL,PLACENTIN;insulin-like 4 (placenta)
hsa:10427;SEC24B,SEC24;SEC24 family, member B (S. cerevisiae)
hsa:26256;CABYR,CABYRa,CABYRc,CABYRc/d,CABYRe,CBP86,CT88,FSP-2,FSP2;calcium binding tyrosine-(Y)-phosphorylation regulated
hsa:100130933;SMIM6,C17orf110;small integral membrane protein 6
hsa:7456;WIPF1,PRPL-2,WASPIP,WIP;WAS/WASL interacting protein family, member 1
hsa:85445;CNTNAP4,CASPR4;contactin associated protein-like 4
hsa:51287;COA4,CHCHD8,CMC3,E2IG2;cytochrome c oxidase assembly factor 4 homolog (S. cerevisiae)
hsa:9287;TAAR2,GPR58;trace amine associated receptor 2
hsa:3177;SLC29A2,DER12,ENT2,HNP36;solute carrier family 29 (nucleoside transporters), member 2
hsa:8823;FGF16,FGF-16;fibroblast growth factor 16
hsa:55840;EAF2,BM040,TRAITS,U19;ELL associated factor 2
hsa:144455;E2F7;E2F transcription factor 7
hsa:9524;TECR,GPSN2,MRT14,SC2,TER;trans-2,3-enoyl-CoA reductase (EC:1.3.1.93)
hsa:6555;SLC10A2,ASBT,IBAT,ISBT,NTCP2,PBAM;solute carrier family 10 (sodium/bile acid cotransporter family), member 2
hsa:83606;GUCD1,C22orf13,LLN4;guanylyl cyclase domain containing 1
hsa:348654;GEN1,Gen;Gen endonuclease homolog 1 (Drosophila)
hsa:1475;CSTA,AREI,STF1,STFA;cystatin A (stefin A)
hsa:6001;RGS10;regulator of G-protein signaling 10
hsa:9651;PLCH2,PLC-eta2,PLCL4,PLCeta2;phospholipase C, eta 2 (EC:3.1.4.11)
hsa:644672;CLDN25;claudin 25
hsa:93210;PGAP3,AGLA546,CAB2,PER1,PERLD1,PP1498;post-GPI attachment to proteins 3
hsa:392138;OR2A25,OR2A24P,OR2A25P,OR2A27;olfactory receptor, family 2, subfamily A, member 25
hsa:140706;CCM2L,C20orf160,dJ310O13.5;cerebral cavernous malformation 2-like
hsa:27177;IL36B,FIL1,FIL1-(ETA),FIL1H,FILI-(ETA),IL-1F8,IL-1H2,IL1-ETA,IL1F8,IL1H2;interleukin 36, beta
hsa:662;BNIP1,NIP1,SEC20,TRG-8;BCL2/adenovirus E1B 19kDa interacting protein 1
hsa:5612;PRKRIR,DAP4,P52rIPK,THAP0,THAP12;protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor)
hsa:10841;FTCD,LCHC1;formiminotransferase cyclodeaminase (EC:2.1.2.5 4.3.1.4)
hsa:10474;TADA3,ADA3,NGG1,TADA3L,hADA3;transcriptional adaptor 3
hsa:727936;GXYLT2,GLT8D4;glucoside xylosyltransferase 2
hsa:283985;FADS6;fatty acid desaturase 6 (EC:1.14.19.-)
hsa:25928;SOSTDC1,ECTODIN,USAG1;sclerostin domain containing 1
hsa:3182;HNRNPAB,ABBP1,HNRPAB;heterogeneous nuclear ribonucleoprotein A/B
hsa:23768;FLRT2;fibronectin leucine rich transmembrane protein 2
hsa:651;BMP3,BMP-3A;bone morphogenetic protein 3
hsa:9570;GOSR2,Bos1,EPM6,GS27;golgi SNAP receptor complex member 2
hsa:92703;TMEM183A,C1orf37;transmembrane protein 183A
hsa:221443;OARD1,C6orf130,TARG1,dJ34B21.3;O-acyl-ADP-ribose deacylase 1
hsa:10488;CREB3,LUMAN,LZIP;cAMP responsive element binding protein 3
hsa:51643;TMBIM4,GAAP,LFG4,S1R,ZPRO;transmembrane BAX inhibitor motif containing 4;K06890
hsa:6584;SLC22A5,CDSP,OCTN2,OCTN2VT;solute carrier family 22 (organic cation/carnitine transporter), member 5
hsa:390321;OR6C1,OST267;olfactory receptor, family 6, subfamily C, member 1
hsa:283987;HID1,C17orf28,DMC1,HID-1;HID1 domain containing
hsa:9605;VPS9D1,ATP-BL,C16orf7;VPS9 domain containing 1
hsa:10622;POLR3G,RPC32,RPC7;polymerase (RNA) III (DNA directed) polypeptide G (32kD)
hsa:128338;DRAM2,PRO180,RP5-1180E21.1,TMEM77,WWFQ154;DNA-damage regulated autophagy modulator 2
hsa:6585;SLIT1,MEGF4,SLIL1,SLIT-1,SLIT3;slit homolog 1 (Drosophila)
hsa:55664;CDC37L1,CDC37B,HARC;cell division cycle 37-like 1
hsa:126433;FBXO27,FBG5,Fbx27;F-box protein 27
hsa:2825;GPR1;G protein-coupled receptor 1
hsa:23417;MLYCD,MCD;malonyl-CoA decarboxylase (EC:4.1.1.9)
hsa:140732;SUN5,SPAG4L,TSARG4,dJ726C3.1;Sad1 and UNC84 domain containing 5
hsa:474354;LRRC18,UNQ933,UNQ9338,VKGE9338;leucine rich repeat containing 18
hsa:55308;DDX19A,DDX19-DDX19L,DDX19L;DEAD (Asp-Glu-Ala-Asp) box polypeptide 19A (EC:3.6.4.13)
hsa:80764;THAP7;THAP domain containing 7
hsa:1112;FOXN3,C14orf116,CHES1,PRO1635;forkhead box N3
hsa:83850;ESYT3,CHR3SYT,E-Syt3,FAM62C;extended synaptotagmin-like protein 3
hsa:85019;TMEM241,C18orf45,hVVT;transmembrane protein 241
hsa:3211;HOXB1,HCFP3,HOX2,HOX2I,Hox-2.9;homeobox B1
hsa:51111;SUV420H1,CGI85,KMT5B;suppressor of variegation 4-20 homolog 1 (Drosophila) (EC:2.1.1.43)
hsa:390058;OR51B6,HOR5'Beta6;olfactory receptor, family 51, subfamily B, member 6
hsa:80326;WNT10A,OODD,SSPS,STHAG4;wingless-type MMTV integration site family, member 10A
hsa:10641;NPRL2,NPR2,NPR2L,TUSC4;nitrogen permease regulator-like 2 (S. cerevisiae)
hsa:55471;NDUFAF7,C2orf56,MidA;NADH dehydrogenase (ubiquinone) complex I, assembly factor 7
hsa:147872;CCDC155,KASH5;coiled-coil domain containing 155 (EC:3.1.3.48)
hsa:83660;TLN2,ILWEQ;talin 2
hsa:3250;HPR,A-259H10.2,HP;haptoglobin-related protein
hsa:5995;RGR,RP44;retinal G protein coupled receptor
hsa:10272;FSTL3,FLRG,FSRP;follistatin-like 3 (secreted glycoprotein)
hsa:8153;RND2,ARHN,RHO7,RhoN;Rho family GTPase 2
hsa:127255;LRRIQ3,LRRC44;leucine-rich repeats and IQ motif containing 3
hsa:4142;MAS1,MAS;MAS1 oncogene
hsa:8287;USP9Y,DFFRY,SPGFY2;ubiquitin specific peptidase 9, Y-linked (EC:3.4.19.12)
hsa:5737;PTGFR,FP;prostaglandin F receptor (FP)
hsa:147495;APCDD1,B7323,DRAPC1,HHS,HTS;adenomatosis polyposis coli down-regulated 1
hsa:50855;PARD6A,PAR-6A,PAR6,PAR6C,PAR6alpha,TAX40,TIP-40;par-6 partitioning defective 6 homolog alpha (C. elegans)
hsa:140856;SCP2D1,C20orf79,HSD22,dJ1068E13.2;SCP2 sterol-binding domain containing 1
hsa:9675;TTI1,KIAA0406,smg-10;TELO2 interacting protein 1
hsa:27230;SERP1,RAMP4;stress-associated endoplasmic reticulum protein 1
hsa:56253;CRTAM,CD355;cytotoxic and regulatory T cell molecule
hsa:128710;SLX4IP,C20orf94,bA204H22.1,bA254M13.1,dJ1099D15.3;SLX4 interacting protein
hsa:3447;IFNA13;interferon, alpha 13
hsa:388125;C2CD4B,FAM148B,NLF2;C2 calcium-dependent domain containing 4B
hsa:11045;UPK1A,TSPAN21,UP1A,UPIA,UPKA;uroplakin 1A
hsa:6002;RGS12;regulator of G-protein signaling 12
hsa:414918;DENND6B,AFI1B,FAM116B;DENN/MADD domain containing 6B
hsa:5792;PTPRF,LAR;protein tyrosine phosphatase, receptor type, F (EC:3.1.3.48)
hsa:51384;WNT16;wingless-type MMTV integration site family, member 16
hsa:131474;CHCHD4,MIA40,TIMM40;coiled-coil-helix-coiled-coil-helix domain containing 4
hsa:22871;NLGN1,NL1;neuroligin 1
hsa:128486;FITM2,C20orf142,Fit2,dJ881L22.2;fat storage-inducing transmembrane protein 2
hsa:134860;TAAR9,TA3,TAR3,TAR9,TRAR3;trace amine associated receptor 9 (gene/pseudogene)
hsa:1534;CYB561,CYB561A1,FRRS2;cytochrome b561
hsa:6867;TACC1,Ga55;transforming, acidic coiled-coil containing protein 1
hsa:3178;HNRNPA1,HNRPA1,HNRPA1L3,hnRNP_A1,hnRNP-A1;heterogeneous nuclear ribonucleoprotein A1
hsa:6366;CCL21,6Ckine,CKb9,ECL,SCYA21,SLC,TCA4;chemokine (C-C motif) ligand 21
hsa:9079;LDB2,CLIM1,LDB1;LIM domain binding 2
hsa:222962;SLC29A4,ENT4,PMAT;solute carrier family 29 (nucleoside transporters), member 4
hsa:117248;GALNT15,GALNT13,GALNT7,GALNTL2,PIH5;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 (EC:2.4.1.41)
hsa:146713;RBFOX3,FOX-3,FOX3,HRNBP3,NEUN;RNA binding protein, fox-1 homolog (C. elegans) 3
hsa:221908;PPP1R35,C7orf47;protein phosphatase 1, regulatory subunit 35
hsa:89876;MAATS1,AAT1,AAT1alpha,C3orf15,SPATA26;MYCBP-associated, testis expressed 1
hsa:5470;PPEF2,PPP7CB;protein phosphatase, EF-hand calcium binding domain 2 (EC:3.1.3.16)
hsa:23741;EID1,C15orf3,CRI1,EID-1,IRO45620,PTD014,RBP21;EP300 interacting inhibitor of differentiation 1
hsa:8535;CBX4,NBP16,PC2;chromobox homolog 4
hsa:9326;ZNHIT3,TRIP3;zinc finger, HIT-type containing 3
hsa:27189;IL17C,CX2,IL-17C,IL-21;interleukin 17C
hsa:11122;PTPRT,RPTPrho;protein tyrosine phosphatase, receptor type, T (EC:3.1.3.48)
hsa:246175;CNOT6L,CCR4b;CCR4-NOT transcription complex, subunit 6-like
hsa:8870;IER3,DIF-2,DIF2,GLY96,IEX-1,IEX-1L,IEX1,PRG1;immediate early response 3
hsa:319100;TAAR6,RP11-295F4.3,TA4,TAR4,TAR6,TRAR4,taR-4,taR-6;trace amine associated receptor 6
hsa:79086;SMIM7,C19orf42;small integral membrane protein 7
hsa:170384;FUT11;fucosyltransferase 11 (alpha (1,3) fucosyltransferase)
hsa:100272147;CMC4,C6.1B,MTCP1,MTCP1B,MTCP1NB,p8,p8MTCP1;C-x(9)-C motif containing 4 homolog (S. cerevisiae)
hsa:6512;SLC1A7,AAAT,EAAT5;solute carrier family 1 (glutamate transporter), member 7
hsa:10300;KATNB1,KAT;katanin p80 (WD repeat containing) subunit B 1
hsa:58476;TP53INP2,C20orf110,DOR,PINH,dJ1181N3.1;tumor protein p53 inducible nuclear protein 2
hsa:2843;GPR20;G protein-coupled receptor 20
hsa:256076;COL6A5,COL29A1,VWA4;collagen, type VI, alpha 5
hsa:139425;DCAF8L1,WDR42B;DDB1 and CUL4 associated factor 8-like 1
hsa:117177;RAB3IP,RABIN3;RAB3A interacting protein
hsa:80195;TMEM254,C10orf57,bA369J21.6;transmembrane protein 254
hsa:116511;MAS1L,MAS-L,MRG,dJ994E9.2;MAS1 oncogene-like
hsa:9145;SYNGR1;synaptogyrin 1
hsa:10201;NME6,IPIA-ALPHA,NDK_6,NM23-H6;NME/NM23 nucleoside diphosphate kinase 6 (EC:2.7.4.6)
hsa:8986;RPS6KA4,MSK2,RSK-B;ribosomal protein S6 kinase, 90kDa, polypeptide 4 (EC:2.7.11.1)
hsa:123016;TTC8,BBS8,RP51;tetratricopeptide repeat domain 8
hsa:9068;ANGPTL1,ANG3,ANGPT3,ARP1,AngY,UNQ162,dJ595C2.2;angiopoietin-like 1
hsa:51208;CLDN18,SFTA5,SFTPJ;claudin 18
hsa:11318;GPR182,7TMR,ADMR,AM-R,AMR,G10D,gamrh,hrhAMR;G protein-coupled receptor 182
hsa:256236;NAPSB,NAP1L,NAP2,NAPB,NAPSBP;napsin B aspartic peptidase, pseudogene
hsa:26080;FAM230C,LINC00281,NCRNA00281;family with sequence similarity 230, member C
hsa:338739;CSTF3-AS1;CSTF3 antisense RNA 1 (head to head)
hsa:10737;RFPL3S,NCRNA00005,RFPL3-AS,RFPL3-AS1,RFPL3ANT,RFPL3AS,dJ149A16.3;RFPL3 antisense
hsa:1780;DYNC1I1,DNCI1,DNCIC1;dynein, cytoplasmic 1, intermediate chain 1
hsa:438;ASMT,ASMTY,HIOMT,HIOMTY;acetylserotonin O-methyltransferase (EC:2.1.1.4)
hsa:1758;DMP1,ARHP,ARHR,DMP-1;dentin matrix acidic phosphoprotein 1
hsa:283999;TMEM235,ARGM1;transmembrane protein 235
hsa:4758;NEU1,NANH,NEU,SIAL1;sialidase 1 (lysosomal sialidase) (EC:3.2.1.18)
hsa:23197;FAF2,ETEA,UBXD8,UBXN3B;Fas associated factor family member 2
hsa:6523;SLC5A1,D22S675,NAGT,SGLT1;solute carrier family 5 (sodium/glucose cotransporter), member 1
hsa:6722;SRF,MCM1;serum response factor (c-fos serum response element-binding transcription factor)
hsa:10156;RASA4,CAPRI,GAPL;RAS p21 protein activator 4
hsa:3623;INHA;inhibin, alpha
hsa:6692;SPINT1,HAI,HAI1,MANSC2;serine peptidase inhibitor, Kunitz type 1
hsa:1870;E2F2,E2F-2;E2F transcription factor 2
hsa:4685;NCAM2,NCAM21;neural cell adhesion molecule 2
hsa:7494;XBP1,TREB5,XBP-1,XBP2;X-box binding protein 1
hsa:93974;ATPIF1,ATPI,ATPIP,IP;ATPase inhibitory factor 1
hsa:55315;SLC29A3,ENT3,HCLAP,HJCD,PHID;solute carrier family 29 (nucleoside transporters), member 3
hsa:8867;SYNJ1,INPP5G;synaptojanin 1 (EC:3.1.3.36)
hsa:55206;SBNO1,MOP3,Sno;strawberry notch homolog 1 (Drosophila)
hsa:5338;PLD2;phospholipase D2 (EC:3.1.4.4)
hsa:6996;TDG;thymine-DNA glycosylase (EC:3.2.2.29)
hsa:10154;PLXNC1,CD232,PLXN-C1,VESPR;plexin C1
hsa:1676;DFFA,DFF-45,DFF1,ICAD;DNA fragmentation factor, 45kDa, alpha polypeptide
hsa:8477;GPR65,TDAG8,hTDAG8;G protein-coupled receptor 65
hsa:9437;NCR1,CD335,LY94,NK-p46,NKP46;natural cytotoxicity triggering receptor 1
hsa:2120;ETV6,TEL,TEL/ABL;ets variant 6
hsa:8440;NCK2,GRB4,NCKbeta;NCK adaptor protein 2
hsa:8534;CHST1,C6ST,GST-1,KS6ST,KSGal6ST,KSST;carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 (EC:2.8.2.21)
hsa:3775;KCNK1,DPK,HOHO,K2P1,K2p1.1,KCNO1,TWIK-1,TWIK1;potassium channel, subfamily K, member 1
hsa:6638;SNRPN,HCERN3,PWCR,RT-LI,SM-D,SMN,SNRNP-N,SNURF-SNRPN,sm-N;small nuclear ribonucleoprotein polypeptide N
hsa:683;BST1,CD157;bone marrow stromal cell antigen 1 (EC:3.2.2.5)
hsa:10521;DDX17,P72,RH70;DEAD (Asp-Glu-Ala-Asp) box helicase 17 (EC:3.6.4.13)
hsa:93099;DMKN,UNQ729,ZD52F10;dermokine
hsa:57154;SMURF1;SMAD specific E3 ubiquitin protein ligase 1
hsa:4881;NPR1,ANPRA,ANPa,GUC2A,GUCY2A,NPRA;natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) (EC:4.6.1.2)
hsa:4697;NDUFA4,CI-9k,CI-MLRQ,MLRQ;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa (EC:1.6.5.3 1.6.99.3)
hsa:729230;CCR2,CC-CKR-2,CCR-2,CCR2A,CCR2B,CD192,CKR2,CKR2A,CKR2B,CMKBR2,MCP-1-R;chemokine (C-C motif) receptor 2
hsa:50604;IL20,IL-20,IL10D,ZCYTO10;interleukin 20
hsa:9545;RAB3D,D2-2,GOV,RAB16,RAD3D;RAB3D, member RAS oncogene family
hsa:30837;SOCS7,NAP4,NCKAP4;suppressor of cytokine signaling 7
hsa:5617;PRL;prolactin
hsa:53836;GPR87,GPR95,KPG_002;G protein-coupled receptor 87
hsa:127833;SYT2,SytII;synaptotagmin II
hsa:1240;CMKLR1,CHEMERINR,ChemR23,DEZ,RVER1;chemokine-like receptor 1
hsa:8857;FCGBP,FC(GAMMA)BP;Fc fragment of IgG binding protein
hsa:4919;ROR1,NTRKR1,dJ537F10.1;receptor tyrosine kinase-like orphan receptor 1 (EC:2.7.10.1)
hsa:53630;BCMO1,BCDO,BCDO1,BCMO,BCO,BCO1;beta-carotene 15,15'-monooxygenase 1 (EC:1.14.99.36)
hsa:7200;TRH;thyrotropin-releasing hormone
hsa:9267;CYTH1,B2-1,CYTOHESIN-1,D17S811E,PSCD1,SEC7;cytohesin 1
hsa:253430;IPMK;inositol polyphosphate multikinase (EC:2.7.1.151)
hsa:3292;HSD17B1,EDH17B2,EDHB17,HSD17,SDR28C1;hydroxysteroid (17-beta) dehydrogenase 1 (EC:1.1.1.62)
hsa:1729;DIAPH1,DFNA1,DIA1,DRF1,LFHL1,hDIA1;diaphanous homolog 1 (Drosophila)
hsa:5481;PPID,CYP-40,CYPD;peptidylprolyl isomerase D (EC:5.2.1.8)
hsa:3790;KCNS3,KV9.3;potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3
hsa:832;CAPZB,CAPB,CAPPB,CAPZ;capping protein (actin filament) muscle Z-line, beta
hsa:9235;IL32,IL-32alpha,IL-32beta,IL-32delta,IL-32gamma,NK4,TAIF,TAIFa,TAIFb,TAIFc,TAIFd;interleukin 32
hsa:50940;PDE11A,PPNAD2;phosphodiesterase 11A (EC:3.1.4.35 3.1.4.17)
hsa:11319;ECD,GCR2,HSGT1;ecdysoneless homolog (Drosophila)
hsa:3769;KCNJ13,KIR1.4,KIR7.1,LCA16,SVD;potassium inwardly-rectifying channel, subfamily J, member 13
hsa:4838;NODAL,HTX5;nodal growth differentiation factor
hsa:2495;FTH1,FHC,FTH,FTHL6,PIG15,PLIF;ferritin, heavy polypeptide 1 (EC:1.16.3.1)
hsa:57152;SLURP1,ANUP,ARS,ArsB,LY6LS,MDM;secreted LY6/PLAUR domain containing 1
hsa:114899;C1QTNF3,C1ATNF3,CORCS,CORS,CORS-26,CORS26,CTRP3;C1q and tumor necrosis factor related protein 3 (EC:5.1.99.4)
hsa:201633;TIGIT,VSIG9,VSTM3,WUCAM;T cell immunoreceptor with Ig and ITIM domains
hsa:9823;ARMCX2,ALEX2;armadillo repeat containing, X-linked 2
hsa:7857;SCG2,CHGC,EM66,SN,SgII;secretogranin II
hsa:387129;NPSR1,ASRT2,GPR154,GPRA,NPSR,PGR14,VRR1;neuropeptide S receptor 1
hsa:84166;NLRC5,CLR16.1,NOD27,NOD4;NLR family, CARD domain containing 5
hsa:23385;NCSTN,APH2;nicastrin
hsa:9963;SLC23A1,SLC23A2,SVCT1,YSPL3;solute carrier family 23 (nucleobase transporters), member 1
hsa:405;ARNT,HIF-1-beta,HIF-1beta,HIF1-beta,HIF1B,HIF1BETA,TANGO,bHLHe2;aryl hydrocarbon receptor nuclear translocator
hsa:57153;SLC44A2,CTL2,PP1292;solute carrier family 44, member 2
hsa:5295;PIK3R1,GRB1,p85,p85-ALPHA;phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
hsa:8912;CACNA1H,CACNA1HB,Cav3.2,ECA6,EIG6;calcium channel, voltage-dependent, T type, alpha 1H subunit
hsa:5445;PON2;paraoxonase 2 (EC:3.1.1.2 3.1.1.81)
hsa:10952;SEC61B;Sec61 beta subunit
hsa:79861;TUBAL3;tubulin, alpha-like 3
hsa:55512;SMPD3,NSMASE2;sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) (EC:3.1.4.12)
hsa:10100;TSPAN2,NET3,TSN2,TSPAN-2;tetraspanin 2
hsa:4068;SH2D1A,DSHP,EBVS,IMD5,LYP,MTCP1,SAP,SAP/SH2D1A,XLP,XLPD;SH2 domain containing 1A
hsa:22909;FAN1,KIAA1018,KMIN,MTMR15;FANCD2/FANCI-associated nuclease 1 (EC:3.1.4.1)
hsa:10725;NFAT5,NF-AT5,NFATL1,NFATZ,OREBP,TONEBP;nuclear factor of activated T-cells 5, tonicity-responsive
hsa:2555;GABRA2;gamma-aminobutyric acid (GABA) A receptor, alpha 2
hsa:337867;UBAC2,PHGDHL1;UBA domain containing 2
hsa:155;ADRB3,BETA3AR;adrenoceptor beta 3
hsa:29927;SEC61A1,HSEC61,SEC61,SEC61A;Sec61 alpha 1 subunit (S. cerevisiae)
hsa:815;CAMK2A,CAMKA;calcium/calmodulin-dependent protein kinase II alpha (EC:2.7.11.17)
hsa:166929;SGMS2,SMS2;sphingomyelin synthase 2 (EC:2.7.8.27)
hsa:140885;SIRPA,BIT,CD172A,MFR,MYD-1,P84,PTPNS1,SHPS1,SIRP;signal-regulatory protein alpha (EC:3.1.3.48)
hsa:23149;FCHO1;FCH domain only 1
hsa:4482;MSRA,PMSR;methionine sulfoxide reductase A (EC:1.8.4.11)
hsa:10551;AGR2,AG2,GOB-4,HAG-2,PDIA17,XAG-2;anterior gradient 2 homolog (Xenopus laevis)
hsa:5726;TAS2R38,PTC,T2R38,T2R61;taste receptor, type 2, member 38
hsa:55697;VAC14,ArPIKfyve,TAX1BP2,TRX;Vac14 homolog (S. cerevisiae)
hsa:54407;SLC38A2,ATA2,PRO1068,SAT2,SNAT2;solute carrier family 38, member 2
hsa:3684;ITGAM,CD11B,CR3A,MAC-1,MAC1A,MO1A,SLEB6;integrin, alpha M (complement component 3 receptor 3 subunit)
hsa:116448;OLIG1,BHLHB6,BHLHE21;oligodendrocyte transcription factor 1
hsa:55349;CHDH;choline dehydrogenase (EC:1.1.99.1)
hsa:6943;TCF21,POD1,bHLHa23;transcription factor 21
hsa:79671;NLRX1,CLR11.3,DLNB26,NOD26,NOD5,NOD9;NLR family member X1
hsa:143662;MUC15,MUC-15,PAS3,PASIII;mucin 15, cell surface associated
hsa:85004;RERG;RAS-like, estrogen-regulated, growth inhibitor
hsa:388323;GLTPD2;glycolipid transfer protein domain containing 2
hsa:27092;CACNG4;calcium channel, voltage-dependent, gamma subunit 4
hsa:55614;KIF16B,C20orf23,KISC20ORF,SNX23;kinesin family member 16B
hsa:10117;ENAM,ADAI,AI1C,AIH2;enamelin
hsa:8643;PTCH2,PTC2;patched 2
hsa:1982;EIF4G2,AAG1,DAP5,NAT1,P97;eukaryotic translation initiation factor 4 gamma, 2
hsa:5551;PRF1,FLH2,HPLH2,P1,PFN1,PFP;perforin 1 (pore forming protein)
hsa:23620;NTSR2,NTR2;neurotensin receptor 2
hsa:1454;CSNK1E,CKIepsilon,HCKIE;casein kinase 1, epsilon (EC:2.7.11.1)
hsa:4808;NHLH2,HEN2,NSCL2,bHLHa34;nescient helix loop helix 2
hsa:2740;GLP1R;glucagon-like peptide 1 receptor
hsa:2119;ETV5,ERM;ets variant 5
hsa:3577;CXCR1,C-C,C-C-CKR-1,CD128,CD181,CDw128a,CKR-1,CMKAR1,IL8R1,IL8RA,IL8RBA;chemokine (C-X-C motif) receptor 1
hsa:4040;LRP6,ADCAD2;low density lipoprotein receptor-related protein 6
hsa:80762;NDFIP1,N4WBP5;Nedd4 family interacting protein 1
hsa:54577;UGT1A7,UDPGT,UDPGT_1-7,UGT-1G,UGT1-07,UGT1.7,UGT1G;UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17)
hsa:1822;ATN1,B37,D12S755E,DRPLA,HRS,NOD;atrophin 1
hsa:5346;PLIN1,FPLD4,PERI,PLIN;perilipin 1
hsa:5034;P4HB,DSI,ERBA2L,GIT,P4Hbeta,PDI,PDIA1,PHDB,PO4DB,PO4HB,PROHB;prolyl 4-hydroxylase, beta polypeptide (EC:5.3.4.1)
hsa:3364;HUS1,hHUS1;HUS1 checkpoint homolog (S. pombe)
hsa:3777;KCNK3,K2p3.1,OAT1,TASK,TASK-1,TBAK1;potassium channel, subfamily K, member 3
hsa:153562;MARVELD2,DFNB49,MARVD2,MRVLDC2,Tric;MARVEL domain containing 2
hsa:2547;XRCC6,CTC75,CTCBF,G22P1,KU70,ML8,TLAA;X-ray repair complementing defective repair in Chinese hamster cells 6
hsa:9426;CDY2A,CDY,CDY2;chromodomain protein, Y-linked, 2A (EC:2.3.1.48)
hsa:2701;GJA4,CX37;gap junction protein, alpha 4, 37kDa
hsa:5817;PVR,CD155,HVED,NECL5,Necl-5,PVS,TAGE4;poliovirus receptor
hsa:1969;EPHA2,ARCC2,CTPA,CTPP1,ECK;EPH receptor A2 (EC:2.7.10.1)
hsa:4860;PNP,NP,PRO1837,PUNP;purine nucleoside phosphorylase (EC:2.4.2.1)
hsa:9722;NOS1AP,6330408P19Rik,CAPON;nitric oxide synthase 1 (neuronal) adaptor protein
hsa:3087;HHEX,HEX,HMPH,HOX11L-PEN,PRH,PRHX;hematopoietically expressed homeobox
hsa:8557;TCAP,CMD1N,LGMD2G,T-cap,TELE,telethonin;titin-cap
hsa:1638;DCT,TRP-2,TYRP2;dopachrome tautomerase (EC:5.3.3.12)
hsa:4935;GPR143,NYS6,OA1;G protein-coupled receptor 143
hsa:10800;CYSLTR1,CYSLT1,CYSLT1R,CYSLTR,HG55,HMTMF81;cysteinyl leukotriene receptor 1
hsa:79989;TTC26,DYF13,dyf-13;tetratricopeptide repeat domain 26
hsa:23017;FAIM2,LFG,LFG2,NGP35,NMP35,TMBIM2;Fas apoptotic inhibitory molecule 2
hsa:54328;GPR173,SREB3;G protein-coupled receptor 173
hsa:343;AQP8,AQP-8;aquaporin 8
hsa:83985;SPNS1,HSpin1,LAT,PP2030,SPIN1,SPINL,nrs;spinster homolog 1 (Drosophila)
hsa:24146;CLDN15;claudin 15
hsa:29949;IL19,IL-10C,MDA1,NG.1,ZMDA1;interleukin 19
hsa:6515;SLC2A3,GLUT3;solute carrier family 2 (facilitated glucose transporter), member 3
hsa:164633;CABP7,CALN2;calcium binding protein 7
hsa:5540;PPYR1,NPY4-R,NPY4R,PP1,Y4;pancreatic polypeptide receptor 1
hsa:10220;GDF11,BMP-11,BMP11;growth differentiation factor 11
hsa:2767;GNA11,GNA-11;guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
hsa:3115;HLA-DPB1,DPB1,HLA-DP,HLA-DP1B,HLA-DPB;major histocompatibility complex, class II, DP beta 1
hsa:722;C4BPA,C4BP,PRP;complement component 4 binding protein, alpha
hsa:2864;FFAR1,FFA1R,GPCR40,GPR40;free fatty acid receptor 1
hsa:253012;HEPACAM2,MIKI;HEPACAM family member 2
hsa:6907;TBL1X,EBI,SMAP55,TBL1;transducin (beta)-like 1X-linked
hsa:54578;UGT1A6,GNT1,HLUGP,HLUGP1,UDPGT,UDPGT_1-6,UGT1,UGT1A6S,UGT1F;UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17)
hsa:23467;NPTXR,NPR;neuronal pentraxin receptor
hsa:9568;GABBR2,GABABR2,GPR51,GPRC3B,HG20,HRIHFB2099;gamma-aminobutyric acid (GABA) B receptor, 2
hsa:221421;RSPH9,C6orf206,CILD12,MRPS18AL1;radial spoke head 9 homolog (Chlamydomonas)
hsa:116337;PANX3,PX3;pannexin 3
hsa:1140;CHRNB1,ACHRB,CHRNB,CMS1D,CMS2A,SCCMS;cholinergic receptor, nicotinic, beta 1 (muscle)
hsa:57498;KIDINS220,ARMS;kinase D-interacting substrate, 220kDa
hsa:825;CAPN3,CANP3,CANPL3,LGMD2,LGMD2A,nCL-1,p94;calpain 3, (p94) (EC:3.4.22.54)
hsa:56998;CTNNBIP1,ICAT;catenin, beta interacting protein 1
hsa:10603;SH2B2,APS;SH2B adaptor protein 2
hsa:1573;CYP2J2,CPJ2;cytochrome P450, family 2, subfamily J, polypeptide 2 (EC:1.14.14.1)
hsa:5141;PDE4A,DPDE2,PDE4,PDE46;phosphodiesterase 4A, cAMP-specific (EC:3.1.4.17)
hsa:9080;CLDN9;claudin 9
hsa:1311;COMP,EDM1,EPD1,MED,PSACH,THBS5;cartilage oligomeric matrix protein
hsa:6278;S100A7,PSOR1,S100A7c;S100 calcium binding protein A7
hsa:374907;B3GNT8,B3GALT7,BGALT15,beta3Gn-T8;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8
hsa:29028;ATAD2,ANCCA,PRO2000;ATPase family, AAA domain containing 2 (EC:3.6.1.3)
hsa:11231;SEC63,DNAJC23,ERdj2,PRO2507,SEC63L;SEC63 homolog (S. cerevisiae)
hsa:317;APAF1,APAF-1,CED4;apoptotic peptidase activating factor 1
hsa:23683;PRKD3,EPK2,PKC-NU,PKD3,PRKCN,nPKC-NU;protein kinase D3 (EC:2.7.11.13)
hsa:1028;CDKN1C,BWCR,BWS,KIP2,WBS,p57,p57Kip2;cyclin-dependent kinase inhibitor 1C (p57, Kip2)
hsa:8809;IL18R1,CD218a,CDw218a,IL-1Rrp,IL18RA,IL1RRP;interleukin 18 receptor 1
hsa:55617;TASP1,C20orf13,dJ585I14.2;taspase, threonine aspartase, 1 (EC:3.4.25.-)
hsa:10333;TLR6,CD286;toll-like receptor 6
hsa:4610;MYCL1,LMYC,MYCL,bHLHe38;v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian)
hsa:56301;SLC7A10,HASC-1,asc-1;solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10
hsa:942;CD86,B7-2,B7.2,B70,CD28LG2,LAB72;CD86 molecule
hsa:1233;CCR4,CC-CKR-4,CD194,CKR4,CMKBR4,ChemR13,HGCN:14099,K5-5;chemokine (C-C motif) receptor 4
hsa:3977;LIFR,CD118,LIF-R,SJS2,STWS,SWS;leukemia inhibitory factor receptor alpha
hsa:9656;MDC1,NFBD1;mediator of DNA-damage checkpoint 1
hsa:4880;NPPC,CNP,CNP2;natriuretic peptide C
hsa:54798;DCHS2,CDH27,CDHJ,CDHR7,PCDH23,PCDHJ;dachsous 2 (Drosophila)
hsa:26121;PRPF31,NY-BR-99,PRP31,RP11;PRP31 pre-mRNA processing factor 31 homolog (S. cerevisiae)
hsa:1848;DUSP6,MKP3,PYST1;dual specificity phosphatase 6 (EC:3.1.3.16 3.1.3.48)
hsa:8620;NPFF,FMRFAL;neuropeptide FF-amide peptide precursor
hsa:10014;HDAC5,HD5,NY-CO-9;histone deacetylase 5 (EC:3.5.1.98)
hsa:5138;PDE2A,CGS-PDE,PDE2A1,PED2A4,cGSPDE;phosphodiesterase 2A, cGMP-stimulated (EC:3.1.4.17)
hsa:80279;CDK5RAP3,C53,HSF-27,IC53,LZAP,MST016,OK/SW-cl.114;CDK5 regulatory subunit associated protein 3
hsa:261726;TIPRL,TIP,TIP41,dJ69E11.3;TIP41, TOR signaling pathway regulator-like (S. cerevisiae)
hsa:9894;TELO2,CLK2,TEL2;TEL2, telomere maintenance 2, homolog (S. cerevisiae)
hsa:26574;AATF,CHE-1,CHE1,DED;apoptosis antagonizing transcription factor
hsa:54329;GPR85,SREB,SREB2;G protein-coupled receptor 85
hsa:5923;RASGRF1,CDC25,CDC25L,GNRP,GRF1,GRF55,H-GRF55,PP13187,ras-GRF1;Ras protein-specific guanine nucleotide-releasing factor 1
hsa:90459;ERI1,3'HEXO,HEXO,THEX1;exoribonuclease 1
hsa:6339;SCNN1D,ENaCd,ENaCdelta,SCNED,dNaCh;sodium channel, non-voltage-gated 1, delta subunit
hsa:5179;PENK;proenkephalin
hsa:9638;FEZ1;fasciculation and elongation protein zeta 1 (zygin I)
hsa:57571;CARNS1,ATPGD1;carnosine synthase 1 (EC:6.3.2.11)
hsa:10808;HSPH1,HSP105,HSP105A,HSP105B,NY-CO-25;heat shock 105kDa/110kDa protein 1
hsa:388015;RTL1,MART1,Mar1,PEG11;retrotransposon-like 1
hsa:10277;UBE4B,E4,HDNB1,UBOX3,UFD2,UFD2A;ubiquitination factor E4B
hsa:54878;DPP8,DP8,DPRP1,MSTP141;dipeptidyl-peptidase 8 (EC:3.4.14.5)
hsa:23394;ADNP,ADNP1;activity-dependent neuroprotector homeobox
hsa:2048;EPHB2,CAPB,DRT,EK5,EPHT3,ERK,Hek5,PCBC,Tyro5;EPH receptor B2 (EC:2.7.10.1)
hsa:9175;MAP3K13,LZK,MEKK13,MLK;mitogen-activated protein kinase kinase kinase 13 (EC:2.7.11.25)
hsa:26285;CLDN17;claudin 17
hsa:65109;UPF3B,HUPF3B,MRXS14,RENT3B,UPF3X;UPF3 regulator of nonsense transcripts homolog B (yeast)
hsa:4920;ROR2,BDB,BDB1,NTRKR2;receptor tyrosine kinase-like orphan receptor 2 (EC:2.7.10.1)
hsa:8997;KALRN,ARHGEF24,CHD5,CHDS5,DUET,DUO,HAPIP,TRAD;kalirin, RhoGEF kinase (EC:2.7.11.1)
hsa:1548;CYP2A6,CPA6,CYP2A,CYP2A3,CYPIIA6,P450C2A,P450PB;cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1)
hsa:10686;CLDN16,HOMG3,PCLN1;claudin 16
hsa:6451;SH3BGRL,SH3BGR;SH3 domain binding glutamic acid-rich protein like
hsa:65125;WNK1,HSAN2,HSN2,KDP,PRKWNK1,PSK,p65;WNK lysine deficient protein kinase 1 (EC:2.7.11.1)
hsa:4718;NDUFC2,B14.5b,CI-B14.5b,HLC-1,NADHDH2;NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa
hsa:5620;PRM2,CT94.2;protamine 2
hsa:1723;DHODH,DHOdehase,POADS,URA1;dihydroorotate dehydrogenase (quinone) (EC:1.3.5.2)
hsa:374786;EFCAB5;EF-hand calcium binding domain 5
hsa:51305;KCNK9,K2p9.1,KT3.2,TASK-3,TASK3;potassium channel, subfamily K, member 9
hsa:567;B2M;beta-2-microglobulin
hsa:9056;SLC7A7,LAT3,LPI,MOP-2,Y+LAT1,y+LAT-1;solute carrier family 7 (amino acid transporter light chain, y+L system), member 7
hsa:8893;EIF2B5,CACH,CLE,EIF-2B,EIF2Bepsilon,LVWM;eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
hsa:127700;OSCP1,C1orf102,NOR1;organic solute carrier partner 1
hsa:5601;MAPK9,JNK-55,JNK2,JNK2A,JNK2ALPHA,JNK2B,JNK2BETA,PRKM9,SAPK,SAPK1a,p54a,p54aSAPK;mitogen-activated protein kinase 9 (EC:2.7.11.24)
hsa:100431172;KLRF2,NKp65;killer cell lectin-like receptor subfamily F, member 2
hsa:866;SERPINA6,CBG;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
hsa:2660;MSTN,GDF8,MSLHP;myostatin
hsa:2115;ETV1,ER81;ets variant 1
hsa:6871;TADA2A,ADA2,ADA2A,TADA2L,hADA2;transcriptional adaptor 2A
hsa:9333;TGM5,TGASE5,TGASEX,TGM6,TGMX,TGX;transglutaminase 5 (EC:2.3.2.13)
hsa:6003;RGS13;regulator of G-protein signaling 13
hsa:6583;SLC22A4,OCTN1;solute carrier family 22 (organic cation/ergothioneine transporter), member 4
hsa:55272;IMP3,BRMS2,C15orf12,MRPS4;IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast)
hsa:6007;RHD,CD240D,DIIIc,RH,RH30,RHCED,RHDVA(TT),RHDel,RHPII,RHXIII,Rh4,RhDCw,RhII,RhK562-II,RhPI;Rh blood group, D antigen
hsa:2949;GSTM5,GSTM5-5,GTM5;glutathione S-transferase mu 5 (EC:2.5.1.18)
hsa:6578;SLCO2A1,MATR1,OATP2A1,PGT,PHOAR2,SLC21A2;solute carrier organic anion transporter family, member 2A1
hsa:6283;S100A12,CAAF1,CAGC,CGRP,ENRAGE,MRP-6,MRP6,p6;S100 calcium binding protein A12
hsa:5366;PMAIP1,APR,NOXA;phorbol-12-myristate-13-acetate-induced protein 1
hsa:55630;SLC39A4,AEZ,AWMS2,ZIP4;solute carrier family 39 (zinc transporter), member 4
hsa:6927;HNF1A,HNF-1A,HNF1,IDDM20,LFB1,MODY3,TCF-1,TCF1;HNF1 homeobox A
hsa:11082;ESM1,endocan;endothelial cell-specific molecule 1
hsa:286077;FAM83H,AI3;family with sequence similarity 83, member H
hsa:222642;TSPO2,BZRPL1;translocator protein 2
hsa:200010;SLC5A9,SGLT4;solute carrier family 5 (sodium/glucose cotransporter), member 9
hsa:4595;MUTYH,CYP2C,MYH;mutY homolog (E. coli) (EC:3.2.2.-)
hsa:7096;TLR1,CD281,TIL,TIL._LPRS5,rsc786;toll-like receptor 1
hsa:56912;IFT46,C11orf2,C11orf60;intraflagellar transport 46 homolog (Chlamydomonas)
hsa:10620;ARID3B,BDP,DRIL2;AT rich interactive domain 3B (BRIGHT-like)
hsa:23133;PHF8,JHDM1F,MRXSSD,ZNF422;PHD finger protein 8 (EC:1.14.11.27)
hsa:56670;SUCNR1,GPR91;succinate receptor 1
hsa:411;ARSB,ASB,G4S,MPS6;arylsulfatase B (EC:3.1.6.12)
hsa:29997;GLTSCR2,PICT-1,PICT1;glioma tumor suppressor candidate region gene 2
hsa:91039;DPP9,DP9,DPLP9,DPRP-2,DPRP2;dipeptidyl-peptidase 9 (EC:3.4.14.5)
hsa:3140;MR1,HLALS;major histocompatibility complex, class I-related
hsa:2856;GPR33;G protein-coupled receptor 33 (gene/pseudogene)
hsa:249;ALPL,AP-TNAP,APTNAP,HOPS,TNAP,TNSALP;alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1)
hsa:285590;SH3PXD2B,FAD49,FTHS,HOFI,KIAA1295,TKS4,TSK4;SH3 and PX domains 2B
hsa:968;CD68,GP110,LAMP4,SCARD1;CD68 molecule
hsa:728458;OPN1MW2,GOP;opsin 1 (cone pigments), medium-wave-sensitive 2
hsa:9123;SLC16A3,MCT_3,MCT_4,MCT-3,MCT-4,MCT3,MCT4;solute carrier family 16, member 3 (monocarboxylic acid transporter 4)
hsa:991;CDC20,CDC20A,bA276H19.3,p55CDC;cell division cycle 20
hsa:8817;FGF18,FGF-18,ZFGF5;fibroblast growth factor 18
hsa:1558;CYP2C8,CPC8,CYPIIC8,MP-12/MP-20;cytochrome P450, family 2, subfamily C, polypeptide 8 (EC:1.14.14.1)
hsa:9670;IPO13,IMP13,KAP13,LGL2,RANBP13;importin 13
hsa:2356;FPGS;folylpolyglutamate synthase (EC:6.3.2.17)
hsa:11156;PTP4A3,PRL-3,PRL-R,PRL3;protein tyrosine phosphatase type IVA, member 3 (EC:3.1.3.48)
hsa:382;ARF6;ADP-ribosylation factor 6
hsa:8601;RGS20,RGSZ1,ZGAP1;regulator of G-protein signaling 20
hsa:23057;NMNAT2,C1orf15,PNAT2;nicotinamide nucleotide adenylyltransferase 2 (EC:2.7.7.1 2.7.7.18)
hsa:3284;HSD3B2,HSD3B,HSDB,SDR11E2;hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (EC:1.1.1.145 5.3.3.1)
hsa:1796;DOK1,P62DOK;docking protein 1, 62kDa (downstream of tyrosine kinase 1)
hsa:51747;LUC7L3,CRA,CREAP-1,CROP,LUC7A,OA48-18,hLuc7A;LUC7-like 3 (S. cerevisiae)
hsa:3658;IREB2,ACO3,IRP2,IRP2AD;iron-responsive element binding protein 2
hsa:49861;CLDN20;claudin 20
hsa:221391;OPN5,GPR136,PGR12,TMEM13;opsin 5
hsa:26018;LRIG1,LIG-1,LIG1;leucine-rich repeats and immunoglobulin-like domains 1
hsa:7369;UMOD,ADMCKD2,FJHN,HNFJ,HNFJ1,MCKD2,THGP,THP;uromodulin
hsa:6495;SIX1,BOS3,DFNA23,TIP39;SIX homeobox 1
hsa:360;AQP3,AQP-3,GIL;aquaporin 3 (Gill blood group)
hsa:1435;CSF1,CSF-1,MCSF;colony stimulating factor 1 (macrophage) (EC:2.7.10.1)
hsa:259289;TAS2R43,T2R43,T2R52;taste receptor, type 2, member 43
hsa:4205;MEF2A,ADCAD1,RSRFC4,RSRFC9,mef2;myocyte enhancer factor 2A
hsa:5143;PDE4C,DPDE1;phosphodiesterase 4C, cAMP-specific (EC:3.1.4.17)
hsa:92086;GGTLC1,GGTL6,GGTLA3,GGTLA4,dJ831C21.1,dJ831C21.2;gamma-glutamyltransferase light chain 1 (EC:2.3.2.2)
hsa:5099;PCDH7,BH-Pcdh,BHPCDH;protocadherin 7
hsa:7517;XRCC3,CMM6;X-ray repair complementing defective repair in Chinese hamster cells 3
hsa:403;ARL3,ARFL3;ADP-ribosylation factor-like 3
hsa:10858;CYP46A1,CP46,CYP46;cytochrome P450, family 46, subfamily A, polypeptide 1 (EC:1.14.13.98)
hsa:9342;SNAP29,CEDNIK,SNAP-29;synaptosomal-associated protein, 29kDa
hsa:9688;NUP93,NIC96;nucleoporin 93kDa
hsa:2001;ELF5,ESE2;E74-like factor 5 (ets domain transcription factor)
hsa:254956;MORN5,C9orf113,C9orf18;MORN repeat containing 5
hsa:10526;IPO8,RANBP8;importin 8
hsa:947;CD34;CD34 molecule
hsa:282996;RBM20;RNA binding motif protein 20
hsa:169026;SLC30A8,ZNT8,ZnT-8;solute carrier family 30 (zinc transporter), member 8
hsa:83444;INO80B,HMGA1L4,HMGIYL4,IES2,PAP-1BP,PAPA-1,ZNHIT4,hIes2;INO80 complex subunit B
hsa:24137;KIF4A,KIF4,KIF4G1;kinesin family member 4A
hsa:1787;TRDMT1,DMNT2,DNMT2,MHSAIIP,PUMET,RNMT1;tRNA aspartic acid methyltransferase 1 (EC:2.1.1.204)
hsa:3280;HES1,HES-1,HHL,HRY,bHLHb39;hairy and enhancer of split 1, (Drosophila)
hsa:9479;MAPK8IP1,IB1,JIP-1,JIP1,PRKM8IP;mitogen-activated protein kinase 8 interacting protein 1
hsa:8170;SLC14A2,HUT2,UT-A2,UT2,UTA,UTR,hUT-A6;solute carrier family 14 (urea transporter), member 2
hsa:4256;MGP,MGLAP,NTI;matrix Gla protein
hsa:1059;CENPB;centromere protein B, 80kDa
hsa:83844;USP26;ubiquitin specific peptidase 26 (EC:3.4.19.12)
hsa:4923;NTSR1,NTR;neurotensin receptor 1 (high affinity)
hsa:79017;GGCT,C7orf24,CRF21,GCTG,GGC;gamma-glutamylcyclotransferase (EC:2.3.2.4)
hsa:10486;CAP2;CAP, adenylate cyclase-associated protein, 2 (yeast)
hsa:23209;MLC1,LVM,MLC,VL;megalencephalic leukoencephalopathy with subcortical cysts 1
hsa:6997;TDGF1,CR,CRGF,CRIPTO;teratocarcinoma-derived growth factor 1
hsa:53827;FXYD5,DYSAD,IWU1,KCT1,OIT2,PRO6241,RIC;FXYD domain containing ion transport regulator 5
hsa:83872;HMCN1,ARMD1,FBLN6,FIBL-6,FIBL6;hemicentin 1
hsa:56649;TMPRSS4,CAPH2,MT-SP2,TMPRSS3;transmembrane protease, serine 4
hsa:4320;MMP11,SL-3,ST3,STMY3;matrix metallopeptidase 11 (stromelysin 3) (EC:3.4.24.-)
hsa:2081;ERN1,IRE1,IRE1P,IRE1a,hIRE1p;endoplasmic reticulum to nucleus signaling 1 (EC:2.7.11.1)
hsa:26471;NUPR1,COM1,P8;nuclear protein, transcriptional regulator, 1
hsa:84280;BTBD10,GMRP-1,GMRP1;BTB (POZ) domain containing 10
hsa:919;CD247,CD3-ZETA,CD3H,CD3Q,CD3Z,T3Z,TCRZ;CD247 molecule
hsa:7905;REEP5,C5orf18,D5S346,DP1,TB2,YOP1;receptor accessory protein 5
hsa:57817;HAMP,HEPC,HFE2B,LEAP1,PLTR;hepcidin antimicrobial peptide
hsa:340371;NRBP2,TRG16,pp9320;nuclear receptor binding protein 2
hsa:390594;KBTBD13,HCG1645727,NEM6;kelch repeat and BTB (POZ) domain containing 13
hsa:9069;CLDN12;claudin 12
hsa:241;ALOX5AP,FLAP;arachidonate 5-lipoxygenase-activating protein
hsa:5619;PRM1,CT94.1,P1;protamine 1
hsa:1910;EDNRB,ABCDS,ET-B,ET-BR,ETB,ETBR,ETRB,HSCR,HSCR2,WS4A;endothelin receptor type B
hsa:1527;TEX28,CXorf2,TEX28P1,TEX28P2,fTEX;testis expressed 28
hsa:10572;SIVA1,CD27BP,SIVA,Siva-1,Siva-2;SIVA1, apoptosis-inducing factor
hsa:23378;RRP8,KIAA0409;ribosomal RNA processing 8, methyltransferase, homolog (yeast)
hsa:10403;NDC80,HEC,HEC1,HsHec1,KNTC2,TID3,hsNDC80;NDC80 kinetochore complex component
hsa:56898;BDH2,DHRS6,EFA6R,PRO20933,SDR15C1,UCPA-OR,UNQ6308;3-hydroxybutyrate dehydrogenase, type 2 (EC:1.1.1.30)
hsa:256435;ST6GALNAC3,PRO7177,SIAT7C,ST6GALNACIII,STY;ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3
hsa:442117;GALNTL6,GALNT17;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 (EC:2.4.1.41)
hsa:4060;LUM,LDC,SLRR2D;lumican
hsa:9247;GCM2,GCMB,hGCMb;glial cells missing homolog 2 (Drosophila)
hsa:27063;ANKRD1,ALRP,C-193,CARP,CVARP,MCARP,bA320F15.2;ankyrin repeat domain 1 (cardiac muscle)
hsa:444;ASPH,AAH,BAH,CASQ2BP1,HAAH,JCTN,junctin;aspartate beta-hydroxylase (EC:1.14.11.16)
hsa:405754;ERVFRD-1,ERVFRDE1,GLLL6191,HERV-FRD,HERV-W/FRD,UNQ6191,envFRD;endogenous retrovirus group FRD, member 1
hsa:23670;TMEM2;transmembrane protein 2
hsa:375;ARF1;ADP-ribosylation factor 1
hsa:146225;CMTM2,CKLFSF2;CKLF-like MARVEL transmembrane domain containing 2
hsa:54741;LEPROT,LEPR,OB-RGRP,OBRGRP,VPS55;leptin receptor overlapping transcript
hsa:220004;PPP1R32,C11orf66,IIIG9;protein phosphatase 1, regulatory subunit 32
hsa:11065;UBE2C,UBCH10,dJ447F3.2;ubiquitin-conjugating enzyme E2C (EC:6.3.2.19)
hsa:1109;AKR1C4,3-alpha-HSD,C11,CDR,CHDR,DD-4,DD4,HAKRA;aldo-keto reductase family 1, member C4 (EC:1.1.1.225 1.1.1.50)
hsa:55233;MOB1A,C2orf6,MATS1,MOB1,MOBK1B,MOBKL1B,Mob4B;MOB kinase activator 1A
hsa:608;TNFRSF17,BCM,BCMA,CD269;tumor necrosis factor receptor superfamily, member 17
hsa:8840;WISP1,CCN4,WISP1c,WISP1i,WISP1tc;WNT1 inducible signaling pathway protein 1
hsa:8013;NR4A3,CHN,CSMF,MINOR,NOR1,TEC;nuclear receptor subfamily 4, group A, member 3
hsa:9475;ROCK2,ROCK-II;Rho-associated, coiled-coil containing protein kinase 2 (EC:2.7.11.1)
hsa:63892;THADA,GITA;thyroid adenoma associated
hsa:54414;SIAE,AIS6,CSE-C,CSEC,LSE,YSG2;sialic acid acetylesterase (EC:3.1.1.53)
hsa:80177;MYCT1,MTLC;myc target 1
hsa:1230;CCR1,CD191,CKR-1,CKR1,CMKBR1,HM145,MIP1aR,SCYAR1;chemokine (C-C motif) receptor 1
hsa:9038;TAAR5,PNR,RP11-295F4.5;trace amine associated receptor 5
hsa:119504;ANAPC16,APC16,C10orf104,CENP-27,MSAG,bA570G20.3;anaphase promoting complex subunit 16
hsa:2239;GPC4,K-glypican;glypican 4
hsa:4967;OGDH,AKGDH,E1k,OGDC;oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) (EC:1.2.4.2)
hsa:284352;PPP1R37,LRRC68;protein phosphatase 1, regulatory subunit 37
hsa:23165;NUP205,C7orf14;nucleoporin 205kDa
hsa:4267;CD99,HBA71,MIC2,MIC2X,MIC2Y,MSK5X;CD99 molecule
hsa:9266;CYTH2,ARNO,CTS18,CTS18.1,PSCD2,PSCD2L,SEC7L,Sec7p-L,Sec7p-like;cytohesin 2
hsa:7013;TERF1,PIN2,TRBF1,TRF,TRF1,hTRF1-AS,t-TRF1;telomeric repeat binding factor (NIMA-interacting) 1
hsa:5893;RAD52;RAD52 homolog (S. cerevisiae)
hsa:161253;REM2;RAS (RAD and GEM)-like GTP binding 2
hsa:3635;INPP5D,SHIP,SHIP-1,SHIP1,SIP-145,hp51CN;inositol polyphosphate-5-phosphatase, 145kDa (EC:3.1.3.86)
hsa:54440;SASH3,753P9,CXorf9,HACS2,SH3D6C,SLY;SAM and SH3 domain containing 3
hsa:203427;SLC25A43;solute carrier family 25, member 43
hsa:23582;CCNDBP1,DIP1,GCIP,HHM;cyclin D-type binding-protein 1
hsa:55288;RHOT1,ARHT1,MIRO-1,MIRO1;ras homolog family member T1
hsa:127124;ATP6V1G3,ATP6G3,Vma10;ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 (EC:3.6.3.14)
hsa:108;ADCY2,AC2,HBAC2;adenylate cyclase 2 (brain) (EC:4.6.1.1)
hsa:6573;SLC19A1,CHMD,FOLT,IFC1,REFC,RFC1;solute carrier family 19 (folate transporter), member 1
hsa:7423;VEGFB,VEGFL,VRF;vascular endothelial growth factor B
hsa:6098;ROS1,MCF3,ROS,c-ros-1;c-ros oncogene 1, receptor tyrosine kinase (EC:2.7.10.1)
hsa:5919;RARRES2,HP10433,TIG2;retinoic acid receptor responder (tazarotene induced) 2
hsa:153;ADRB1,ADRB1R,B1AR,BETA1AR,RHR;adrenoceptor beta 1
hsa:8826;IQGAP1,HUMORFA01,SAR1,p195;IQ motif containing GTPase activating protein 1
hsa:132884;EVC2,LBN;Ellis van Creveld syndrome 2
hsa:8876;VNN1,HDLCQ8,Tiff66;vanin 1 (EC:3.5.1.92)
hsa:197;AHSG,A2HS,AHS,FETUA,HSGA;alpha-2-HS-glycoprotein
hsa:5320;PLA2G2A,MOM1,PLA2,PLA2B,PLA2L,PLA2S,PLAS1,sPLA2;phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4)
hsa:4585;MUC4,ASGP,HSA276359,MUC-4;mucin 4, cell surface associated
hsa:2249;FGF4,HBGF-4,HST,HST-1,HSTF1,K-FGF,KFGF;fibroblast growth factor 4
hsa:9073;CLDN8;claudin 8
hsa:25794;FSCN2,RFSN,RP30;fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus)
hsa:3796;KIF2A,HK2,KIF2;kinesin heavy chain member 2A
hsa:3442;IFNA5,IFN-alpha-5,IFN-alphaG,INA5,INFA5,leIF_G;interferon, alpha 5
hsa:55332;DRAM1,DRAM;DNA-damage regulated autophagy modulator 1
hsa:83595;SOX7;SRY (sex determining region Y)-box 7
hsa:680;BRS3;bombesin-like receptor 3
hsa:26045;LRRTM2;leucine rich repeat transmembrane neuronal 2
hsa:8501;SLC43A1,LAT3,PB39,POV1,R00504;solute carrier family 43, member 1
hsa:6497;SKI,SGS,SKV;v-ski sarcoma viral oncogene homolog (avian)
hsa:8884;SLC5A6,SMVT;solute carrier family 5 (sodium-dependent vitamin transporter), member 6
hsa:81788;NUAK2,SNARK;NUAK family, SNF1-like kinase, 2 (EC:2.7.11.1)
hsa:221092;HNRNPUL2,HNRPUL2,SAF-A2;heterogeneous nuclear ribonucleoprotein U-like 2
hsa:4684;NCAM1,CD56,MSK39,NCAM;neural cell adhesion molecule 1 (EC:2.7.11.1)
hsa:27120;DKKL1,CT34,SGY,SGY-1,SGY1;dickkopf-like 1
hsa:3299;HSF4,CTM;heat shock transcription factor 4
hsa:2879;GPX4,GPx-4,GSHPx-4,MCSP,PHGPx,snGPx,snPHGPx;glutathione peroxidase 4 (EC:1.11.1.12)
hsa:55748;CNDP2,CN2,CPGL,HsT2298,PEPA;CNDP dipeptidase 2 (metallopeptidase M20 family) (EC:3.4.13.18)
hsa:6457;SH3GL3,CNSA3,EEN-2B-L3,EEN-B2,HsT19371,SH3D2C,SH3P13;SH3-domain GRB2-like 3
hsa:9265;CYTH3,ARNO3,GRP1,PSCD3;cytohesin 3
hsa:55568;GALNT10,GALNACT10,PPGALNACT10,PPGANTASE10;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) (EC:2.4.1.41)
hsa:100287171;WASH1,FAM39E,WASH;WAS protein family homolog 1
hsa:5078;PAX4,KPD,MODY9;paired box 4
hsa:6422;SFRP1,FRP,FRP-1,FRP1,FrzA,SARP2;secreted frizzled-related protein 1
hsa:9208;LRRFIP1,FLAP-1,FLAP1,FLIIAP1,GCF-2,GCF2,HUFI-1,TRIP;leucine rich repeat (in FLII) interacting protein 1
hsa:9542;NRG2,DON1,HRG2,NTAK;neuregulin 2
hsa:57016;AKR1B10,AKR1B11,AKR1B12,ALDRLn,ARL-1,ARL1,HIS,HSI;aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2)
hsa:100506049;LRRC72;leucine rich repeat containing 72
hsa:4212;MEIS2,HsT18361,MRG1;Meis homeobox 2
hsa:3113;HLA-DPA1,DP(W3),DP(W4),HLA-DP1A,HLADP,HLASB,PLT1;major histocompatibility complex, class II, DP alpha 1
hsa:3092;HIP1,ILWEQ;huntingtin interacting protein 1
hsa:51676;ASB2,ASB-2;ankyrin repeat and SOCS box containing 2
hsa:83463;MXD3,BHLHC13,MAD3,MYX;MAX dimerization protein 3
hsa:6367;CCL22,ABCD-1,DC/B-CK,MDC,SCYA22,STCP-1;chemokine (C-C motif) ligand 22
hsa:182;JAG1,AGS,AHD,AWS,CD339,HJ1,JAGL1;jagged 1
hsa:5789;PTPRD,HPTP,HPTPD,HPTPDELTA,PTPD,RPTPDELTA;protein tyrosine phosphatase, receptor type, D (EC:3.1.3.48)
hsa:8202;NCOA3,ACTR,AIB-1,AIB1,CAGH16,CTG26,KAT13B,RAC3,SRC-3,SRC3,TNRC14,TNRC16,TRAM-1,bHLHe42,pCIP;nuclear receptor coactivator 3 (EC:2.3.1.48)
hsa:23221;RHOBTB2,DBC2;Rho-related BTB domain containing 2
hsa:2201;FBN2,CCA,DA9;fibrillin 2
hsa:144100;PLEKHA7;pleckstrin homology domain containing, family A member 7
hsa:1834;DSPP,DFNA39,DGI1,DMP3,DPP,DSP,DTDP2;dentin sialophosphoprotein
hsa:10975;UQCR11,0710008D09Rik,QCR10,UQCR;ubiquinol-cytochrome c reductase, complex III subunit XI
hsa:9681;DEPDC5,DEP.5;DEP domain containing 5
hsa:55851;PSENEN,MSTP064,PEN-2,PEN2;presenilin enhancer 2 homolog (C. elegans)
hsa:11124;FAF1,HFAF1s,UBXD12,UBXN3A,hFAF1;Fas (TNFRSF6) associated factor 1
hsa:221037;JMJD1C,RP11-10C13.2,TRIP8;jumonji domain containing 1C
hsa:252995;FNDC5,FRCP2;fibronectin type III domain containing 5
hsa:53831;GPR84,EX33,GPCR4;G protein-coupled receptor 84
hsa:11113;CIT,CRIK,STK21;citron (rho-interacting, serine/threonine kinase 21) (EC:2.7.11.1)
hsa:92304;SCGB3A1,HIN-1,HIN1,LU105,PnSP-2,UGRP2;secretoglobin, family 3A, member 1
hsa:23389;MED13L,PROSIT240,THRAP2,TRAP240L;mediator complex subunit 13-like
hsa:10215;OLIG2,BHLHB1,OLIGO2,PRKCBP2,RACK17,bHLHe19;oligodendrocyte lineage transcription factor 2
hsa:80757;TMEM121,hole;transmembrane protein 121
hsa:51192;CKLF,C32,CKLF1,CKLF2,CKLF3,CKLF4,UCK-1;chemokine-like factor
hsa:8872;CDC123,C10orf7,D123;cell division cycle 123
hsa:5583;PRKCH,PKC-L,PKCL,PRKCL,nPKC-eta;protein kinase C, eta (EC:2.7.11.13)
hsa:5087;PBX1;pre-B-cell leukemia homeobox 1
hsa:4775;NFATC3,NFAT4,NFATX;nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
hsa:26959;HBP1;HMG-box transcription factor 1
hsa:344167;FOXI3;forkhead box I3
hsa:1647;GADD45A,DDIT1,GADD45;growth arrest and DNA-damage-inducible, alpha
hsa:2348;FOLR1,FBP,FOLR;folate receptor 1 (adult)
hsa:23562;CLDN14,DFNB29;claudin 14
hsa:5909;RAP1GAP,RAP1GA1,RAP1GAP1,RAP1GAPII,RAPGAP;RAP1 GTPase activating protein
hsa:9245;GCNT3,C2/4GnT,C24GNT,C2GNT2,C2GNTM,GNTM;glucosaminyl (N-acetyl) transferase 3, mucin type (EC:2.4.1.102 2.4.1.150)
hsa:11240;PADI2,PAD-H19,PAD2,PDI2;peptidyl arginine deiminase, type II (EC:3.5.3.15)
hsa:57190;SEPN1,CFTD,MDRS1,RSMD1,RSS,SELN;selenoprotein N, 1
hsa:1717;DHCR7,SLOS;7-dehydrocholesterol reductase (EC:1.3.1.21)
hsa:6445;SGCG,A4,DAGA4,DMDA,DMDA1,LGMD2C,MAM,SCARMD2,SCG3,TYPE;sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
hsa:6556;SLC11A1,LSH,NRAMP,NRAMP1;solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1
hsa:165324;UBXN2A,UBXD4;UBX domain protein 2A
hsa:9014;TAF1B,MGC:9349,RAF1B,RAFI63,SL1,TAFI63;TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa
hsa:8471;IRS4,IRS-4,PY160;insulin receptor substrate 4
hsa:116840;CNTROB,LIP8;centrobin, centrosomal BRCA2 interacting protein
hsa:80025;PANK2,C20orf48,HARP,HSS,NBIA1,PKAN;pantothenate kinase 2 (EC:2.7.1.33)
hsa:30000;TNPO2,IPO3,KPNB2B,TRN2;transportin 2
hsa:64421;DCLRE1C,A-SCID,DCLREC1C,RS-SCID,SCIDA,SNM1C,hSNM1C;DNA cross-link repair 1C
hsa:152559;PAQR3,RKTG;progestin and adipoQ receptor family member III
hsa:114614;MIR155HG,BIC,MIRHG2,NCRNA00172;MIR155 host gene (non-protein coding)
hsa:406944;MIR153-1,MIRN153-1;microRNA 153-1
hsa:80350;LPAL2,APOA2,APOAL,APOARGC,RP11-72O9.2;lipoprotein, Lp(a)-like 2, pseudogene
hsa:406982;MIR20A,MIR20,MIRN20,MIRN20A,hsa-mir-20,hsa-mir-20a,miR-20,miRNA20A;microRNA 20a
hsa:407053;MIR96,DFNA50,MIRN96,hsa-mir-96,miR-96,miRNA96;microRNA 96
hsa:406901;MIR107,MIRN107,miR-107;microRNA 107
hsa:693165;MIR580,MIRN580,hsa-mir-580;microRNA 580
hsa:283131;NEAT1,LINC00084,NCRNA00084,TncRNA;nuclear paraspeckle assembly transcript 1 (non-protein coding)
hsa:693190;MIR605,MIRN605,hsa-mir-605;microRNA 605
hsa:693120;MIR33B,MIRN33B,hsa-mir-33b;microRNA 33b
hsa:84740;AFAP1-AS1,AFAP1-AS,AFAP1AS;AFAP1 antisense RNA 1
hsa:50861;STMN3,SCLIP;stathmin-like 3
hsa:57403;RAB22A;RAB22A, member RAS oncogene family
hsa:440712;C1orf186;chromosome 1 open reading frame 186
hsa:64405;CDH22,C20orf25,dJ998H6.1;cadherin 22, type 2
hsa:64409;WBSCR17,GALNT16,GALNT20,GALNTL3;Williams-Beuren syndrome chromosome region 17 (EC:2.4.1.41)
hsa:222584;FAM83B,C6orf143;family with sequence similarity 83, member B
hsa:474382;H2AFB1,H2A.Bbd;H2A histone family, member B1
hsa:23759;PPIL2,CYC4,CYP60,Cyp-60,UBOX7,hCyP-60;peptidylprolyl isomerase (cyclophilin)-like 2 (EC:5.2.1.8)
hsa:80341;BPIFB2,BPIL1,C20orf184,LPLUNC2,RYSR,dJ726C3.2;BPI fold containing family B, member 2
hsa:84630;TTBK1,BDTK;tau tubulin kinase 1 (EC:2.7.11.1)
hsa:85235;HIST1H2AH,H2A/S,H2AFALii,H2AH,dJ86C11.1;histone cluster 1, H2ah
hsa:353133;LCE1C,LEP3;late cornified envelope 1C
hsa:135293;PM20D2,ACY1L2,bA63L7.3;peptidase M20 domain containing 2
hsa:353140;LCE2C,LEP11;late cornified envelope 2C
hsa:353141;LCE2D,LEP12,SPRL1A;late cornified envelope 2D
hsa:353145;LCE3E,LEP17;late cornified envelope 3E
hsa:253635;GPATCH11,CCDC75,CENP-Y,CENPY;G patch domain containing 11
hsa:6711;SPTBN1,ELF,SPTB2,betaSpII;spectrin, beta, non-erythrocytic 1
hsa:341883;LRRC9;leucine rich repeat containing 9
hsa:284402;SCGB2B2,SCGB4A2,SCGBL;secretoglobin, family 2B, member 2
hsa:136371;ASB10;ankyrin repeat and SOCS box containing 10
hsa:140458;ASB5,ASB-5;ankyrin repeat and SOCS box containing 5
hsa:51322;WAC,BM-016,PRO1741,Wwp4;WW domain containing adaptor with coiled-coil
hsa:26115;TANC2,ROLSA,rols;tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2
hsa:113612;CYP2U1,P450TEC,SPG49,SPG56;cytochrome P450, family 2, subfamily U, polypeptide 1 (EC:1.14.14.1)
hsa:140460;ASB7;ankyrin repeat and SOCS box containing 7
hsa:79754;ASB13;ankyrin repeat and SOCS box containing 13
hsa:92591;ASB16;ankyrin repeat and SOCS box containing 16
hsa:57082;CASC5,AF15Q14,CT29,D40,KNL1,PPP1R55,hKNL-1,hSpc105;cancer susceptibility candidate 5
hsa:170487;ACTL10,C20orf134,dJ63M2.2;actin-like 10
hsa:57680;CHD8,AUTS18,HELSNF1;chromodomain helicase DNA binding protein 8 (EC:3.6.4.12)
hsa:728404;AGAP8,CTGLF5;ArfGAP with GTPase domain, ankyrin repeat and PH domain 8
hsa:200159;C1orf100;chromosome 1 open reading frame 100
hsa:140459;ASB6;ankyrin repeat and SOCS box containing 6
hsa:400757;C1orf141;chromosome 1 open reading frame 141
hsa:140461;ASB8;ankyrin repeat and SOCS box containing 8
hsa:115795;FANCD2OS,C3orf24;FANCD2 opposite strand
hsa:352999;C6orf58;chromosome 6 open reading frame 58
hsa:142689;ASB12;ankyrin repeat and SOCS box containing 12
hsa:404552;SCGB1D4;secretoglobin, family 1D, member 4
hsa:445577;C9orf129,bA165J3.3;chromosome 9 open reading frame 129
hsa:100506385;;uncharacterized LOC100506385
hsa:7062;TCHH,THH,THL,TRHY;trichohyalin
hsa:26249;KLHL3,PHA2D;kelch-like family member 3
hsa:200008;CDCP2;CUB domain containing protein 2
hsa:90293;KLHL13,BKLHD2,KIAA1309;kelch-like family member 13
hsa:51575;ESF1,ABTAP,C20orf6,bA526K24.1;ESF1, nucleolar pre-rRNA processing protein, homolog (S. cerevisiae)
hsa:448834;KPRP,C1orf45;keratinocyte proline-rich protein
hsa:27252;KLHL20,KHLHX,KLEIP,KLHLX,RP3-383J4.3;kelch-like family member 20
hsa:317719;KLHL10,SPGF11;kelch-like family member 10
hsa:11275;KLHL2,ABP-KELCH,MAV,MAYVEN;kelch-like family member 2
hsa:55175;KLHL11;kelch-like family member 11
hsa:84861;KLHL22,KELCHL;kelch-like family member 22
hsa:339451;KLHL17,RP11-54O7.6;kelch-like family member 17
hsa:10625;IVNS1ABP,FLARA3,HSPC068,KLHL39,ND1,NS-1,NS1-BP,NS1BP;influenza virus NS1A binding protein
hsa:9903;KLHL21;kelch-like family member 21
hsa:440193;CCDC88C,DAPLE,HKRP2,KIAA1509;coiled-coil domain containing 88C
hsa:151230;KLHL23,DITHP;kelch-like family member 23
hsa:56062;KLHL4,DKELCHL,KHL4;kelch-like family member 4
hsa:59349;KLHL12,C3IP1,DKIR,hDKIR;kelch-like family member 12
hsa:115024;NT5C3B,NT5C3L;5'-nucleotidase, cytosolic IIIB (EC:3.1.3.5)
hsa:57565;KLHL14;kelch-like family member 14
hsa:89857;KLHL6;kelch-like family member 6
hsa:3652;IPP,KLHL27;intracisternal A particle-promoted polypeptide
hsa:55958;KLHL9;kelch-like family member 9
hsa:57563;KLHL8;kelch-like family member 8
hsa:51497;NELFCD,NELF-C,NELF-D,TH1,TH1L;negative elongation factor complex member C/D
hsa:80006;TRAPPC13,C5orf44;trafficking protein particle complex 13
hsa:57626;KLHL1,MRP2;kelch-like family member 1
hsa:51088;KLHL5;kelch-like family member 5
hsa:55975;KLHL7,KLHL6,SBBI26;kelch-like family member 7
hsa:388595;TMEM82;transmembrane protein 82
hsa:83860;TAF3,TAF140,TAFII-140,TAFII140;TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa
hsa:128506;OCSTAMP,C20orf123,OC-STAMP,dJ257E24.3;osteoclast stimulatory transmembrane protein
hsa:7936;NELFE,D6S45,NELF-E,RD,RDBP,RDP;negative elongation factor complex member E
hsa:644019;CBWD6;COBW domain containing 6
hsa:401551;WDR38;WD repeat domain 38
hsa:7391;USF1,FCHL,FCHL1,HYPLIP1,MLTF,MLTFI,UEF,bHLHb11;upstream transcription factor 1
hsa:23276;KLHL18;kelch-like family member 18
hsa:618;BCYRN1,BC200,BC200a,LINC00004,NCRNA00004;brain cytoplasmic RNA 1
hsa:100507246;SNHG16,ncRAN;small nucleolar RNA host gene 16 (non-protein coding)
hsa:23557;SNAPIN,BLOC1S7,SNAPAP;SNAP-associated protein
hsa:27315;PGAP2,CWH43-N,FRAG1;post-GPI attachment to proteins 2
hsa:3094;HINT1,HINT,NMAN,PKCI-1,PRKCNH1;histidine triad nucleotide binding protein 1
hsa:10712;FAM189B,C1orf2,COTE1;family with sequence similarity 189, member B
hsa:6506;SLC1A2,EAAT2,GLT-1;solute carrier family 1 (glial high affinity glutamate transporter), member 2
hsa:54623;PAF1,F23149_1,PD2;Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae)
hsa:25851;TECPR1;tectonin beta-propeller repeat containing 1
hsa:85440;DOCK7,ZIR2;dedicator of cytokinesis 7
hsa:23432;GPR161,RE2;G protein-coupled receptor 161
hsa:146909;KIF18B;kinesin family member 18B
hsa:11245;GPR176,HB-954;G protein-coupled receptor 176
hsa:57582;KCNT1,EIEE14,ENFL5,KCa4.1,SLACK,bA100C15.2;potassium channel, subfamily T, member 1
hsa:10575;CCT4,CCT-DELTA,Cctd,SRB;chaperonin containing TCP1, subunit 4 (delta)
hsa:7409;VAV1,VAV;vav 1 guanine nucleotide exchange factor
hsa:51053;GMNN,Gem;geminin, DNA replication inhibitor
hsa:90850;ZNF598;zinc finger protein 598
hsa:4778;NFE2,NF-E2,p45;nuclear factor (erythroid-derived 2), 45kDa
hsa:55283;MCOLN3,TRP-ML3,TRPML3;mucolipin 3
hsa:55559;HAUS7,UCHL5IP,UIP1;HAUS augmin-like complex, subunit 7
hsa:80347;COASY,DPCK,NBP,PPAT,UKR1,pOV-2;CoA synthase (EC:2.7.7.3 2.7.1.24)
hsa:1894;ECT2,ARHGEF31;epithelial cell transforming sequence 2 oncogene
hsa:2848;GPR25;G protein-coupled receptor 25
hsa:55582;KIF27;kinesin family member 27
hsa:2593;GAMT,PIG2,TP53I2;guanidinoacetate N-methyltransferase (EC:2.1.1.2)
hsa:55718;POLR3E,RPC5,SIN;polymerase (RNA) III (DNA directed) polypeptide E (80kD)
hsa:1903;S1PR3,EDG-3,EDG3,LPB3,S1P3;sphingosine-1-phosphate receptor 3
hsa:2819;GPD1,GPD-C,GPDH-C,HTGTI;glycerol-3-phosphate dehydrogenase 1 (soluble) (EC:1.1.1.8)
hsa:84803;AGPAT9,AGPAT8,GPAT3,LPAAT-theta,MAG1;1-acylglycerol-3-phosphate O-acyltransferase 9 (EC:2.3.1.15)
hsa:4892;NRAP,N-RAP;nebulin-related anchoring protein
hsa:55914;ERBB2IP,ERBIN,LAP2;erbb2 interacting protein
hsa:23218;NBEAL2,BDPLT4,GPS;neurobeachin-like 2
hsa:55032;SLC35A5;solute carrier family 35, member A5
hsa:9814;SFI1,PISD,hSfi1p;Sfi1 homolog, spindle assembly associated (yeast)
hsa:3035;HARS,HRS,USH3B;histidyl-tRNA synthetase (EC:6.1.1.21)
hsa:85413;SLC22A16,CT2,FLIPT2,OAT6,OCT6,OKB1,dJ261K5.1;solute carrier family 22 (organic cation/carnitine transporter), member 16
hsa:29986;SLC39A2,6A1,ETI-1,ZIP-2,ZIP2;solute carrier family 39 (zinc transporter), member 2
hsa:2015;EMR1,TM7LN3;egf-like module containing, mucin-like, hormone receptor-like 1
hsa:7008;TEF;thyrotrophic embryonic factor
hsa:23526;HMHA1,ARHGAP45,HA-1,HLA-HA1;histocompatibility (minor) HA-1
hsa:10611;PDLIM5,ENH,ENH1,LIM;PDZ and LIM domain 5
hsa:200373;PCDP1;primary ciliary dyskinesia protein 1
hsa:6813;STXBP2,FHL5,Hunc18b,MUNC18-2,UNC18-2,UNC18B,pp10122;syntaxin binding protein 2
hsa:79170;PRR15L,ATAD4;proline rich 15-like
hsa:1917;EEF1A2,EEF1AL,EF-1-alpha-2,EF1A,HS1,STN,STNL;eukaryotic translation elongation factor 1 alpha 2
hsa:2246;FGF1,AFGF,ECGF,ECGF-beta,ECGFA,ECGFB,FGF-1,FGF-alpha,FGFA,GLIO703,HBGF-1,HBGF1;fibroblast growth factor 1 (acidic)
hsa:5196;PF4,CXCL4,PF-4,SCYB4;platelet factor 4
hsa:51400;PPME1,PME-1;protein phosphatase methylesterase 1 (EC:3.1.1.89)
hsa:2967;GTF2H3,BTF2,P34,TFB4,TFIIH;general transcription factor IIH, polypeptide 3, 34kDa
hsa:220074;LRTOMT,DFNB63,LRRC51;leucine rich transmembrane and 0-methyltransferase domain containing (EC:2.1.1.6)
hsa:492307;C8orf22;chromosome 8 open reading frame 22
hsa:4192;MDK,ARAP,MK,NEGF2;midkine (neurite growth-promoting factor 2)
hsa:834;CASP1,ICE,IL1BC,P45;caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36)
hsa:26099;SZRD1,C1orf144;SUZ RNA binding domain containing 1
hsa:5872;RAB13;RAB13, member RAS oncogene family
hsa:3034;HAL,HIS,HSTD;histidine ammonia-lyase (EC:4.3.1.3)
hsa:24150;TP53TG3,P53TG3,TP53TG3A;TP53 target 3
hsa:2854;GPR32,RVDR1;G protein-coupled receptor 32
hsa:143686;SESN3,SEST3;sestrin 3
hsa:51103;NDUFAF1,CGI65,CIA30;NADH dehydrogenase (ubiquinone) complex I, assembly factor 1
hsa:5272;SERPINB9,CAP-3,CAP3,PI-9,PI9;serpin peptidase inhibitor, clade B (ovalbumin), member 9
hsa:2844;GPR21;G protein-coupled receptor 21
hsa:83539;CHST9,GALNAC4ST-2;carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9
hsa:55847;CISD1,C10orf70,ZCD1,mitoNEET;CDGSH iron sulfur domain 1
hsa:5955;RCN2,E6BP,ERC-55,ERC55,TCBP49;reticulocalbin 2, EF-hand calcium binding domain
hsa:765;CA6,CA-VI,GUSTIN;carbonic anhydrase VI (EC:4.2.1.1)
hsa:9194;SLC16A7,MCT2;solute carrier family 16, member 7 (monocarboxylic acid transporter 2)
hsa:653567;TMEM236,FAM23A,FAM23B,bA162I21.2,bA16O1.2;transmembrane protein 236
hsa:1183;CLCN4,CLC4,ClC-4,ClC-4A;chloride channel, voltage-sensitive 4
hsa:85358;SHANK3,DEL22q13.3,PROSAP2,PSAP2,SCZD15,SPANK-2;SH3 and multiple ankyrin repeat domains 3
hsa:64105;CENPK,AF5alpha,CENP-K,P33,Solt;centromere protein K
hsa:23443;SLC35A3;solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3
hsa:56913;C1GALT1,C1GALT,T-synthase;core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 (EC:2.4.1.122)
hsa:4171;MCM2,BM28,CCNL1,CDCL1,D3S3194,MITOTIN,cdc19;minichromosome maintenance complex component 2 (EC:3.6.4.12)
hsa:4760;NEUROD1,BETA2,BHF-1,MODY6,NEUROD,bHLHa3;neuronal differentiation 1
hsa:79582;SPAG16,PF20,WDR29;sperm associated antigen 16
hsa:112939;NACC1,BEND8,BTBD14B,BTBD30,NAC-1,NAC1;nucleus accumbens associated 1, BEN and BTB (POZ) domain containing
hsa:80230;RUFY1,RABIP4,ZFYVE12;RUN and FYVE domain containing 1
hsa:10139;ARFRP1,ARL18,ARP,Arp1;ADP-ribosylation factor related protein 1
hsa:57409;MIF4GD,AD023,MIFD,SLIP1;MIF4G domain containing
hsa:126393;HSPB6,Hsp20;heat shock protein, alpha-crystallin-related, B6
hsa:64092;SAMSN1,HACS1,NASH1,SASH2,SH3D6B,SLy2;SAM domain, SH3 domain and nuclear localization signals 1
hsa:1397;CRIP2,CRIP,CRP2,ESP1;cysteine-rich protein 2
hsa:8550;MAPKAPK5,MAPKAP-K5,MK-5,MK5,PRAK;mitogen-activated protein kinase-activated protein kinase 5 (EC:2.7.11.1)
hsa:400258;C14orf180,C14orf77,NRAC;chromosome 14 open reading frame 180
hsa:79733;E2F8,E2F-8;E2F transcription factor 8
hsa:22808;MRAS,M-RAs,R-RAS3,RRAS3;muscle RAS oncogene homolog
hsa:2689;GH2,GH-V,GHL,GHV,hGH-V;growth hormone 2
hsa:121227;LRIG3,LIG3;leucine-rich repeats and immunoglobulin-like domains 3
hsa:1954;MEGF8,C19orf49,CRPT2,EGFL4,SBP1;multiple EGF-like-domains 8
hsa:84688;C9orf24,CBE1,NYD-SP22,SMRP1,bA573M23.4;chromosome 9 open reading frame 24
hsa:89781;HPS4,LE;Hermansky-Pudlak syndrome 4
hsa:28514;DLL1,DELTA1,DL1,Delta;delta-like 1 (Drosophila)
hsa:2797;GNRH2,GnRH-II,LH-RHII;gonadotropin-releasing hormone 2
hsa:100129669;IZUMO3,C9orf134,bA20A20.1;IZUMO family member 3
hsa:1386;ATF2,CRE-BP1,CREB2,HB16,TREB7;activating transcription factor 2
hsa:8916;HERC3;HECT and RLD domain containing E3 ubiquitin protein ligase 3
hsa:3400;ID4,IDB4,bHLHb27;inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
hsa:50512;PODXL2,EG,PODLX2;podocalyxin-like 2
hsa:100130613;CXorf64;chromosome X open reading frame 64
hsa:126969;SLC44A3,CTL3;solute carrier family 44, member 3
hsa:2314;FLII,FLI,FLIL,Fli1;flightless I homolog (Drosophila)
hsa:10844;TUBGCP2,GCP-2,GCP2,Grip103,SPBC97,Spc97p,h103p,hGCP2,hSpc97;tubulin, gamma complex associated protein 2
hsa:2165;F13B,FXIIIB;coagulation factor XIII, B polypeptide (EC:2.3.2.13)
hsa:284439;SLC25A42;solute carrier family 25, member 42
hsa:51555;PEX5L,PEX5R,PEX5RP,PXR2,PXR2B,TRIP8b;peroxisomal biogenesis factor 5-like
hsa:10922;FASTK,FAST;Fas-activated serine/threonine kinase (EC:2.7.11.8)
hsa:720;C4A,C4,C4A2,C4A3,C4A4,C4A6,C4AD,C4S,CO4,CPAMD2,RG;complement component 4A (Rodgers blood group)
hsa:9728;SECISBP2L,SBP2L,SLAN;SECIS binding protein 2-like
hsa:5080;PAX6,AN,AN2,D11S812E,MGDA,WAGR;paired box 6
hsa:6354;CCL7,FIC,MARC,MCP-3,MCP3,NC28,SCYA6,SCYA7;chemokine (C-C motif) ligand 7
hsa:79623;GALNT14,GALNT15,GalNac-T10,GalNac-T14;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) (EC:2.4.1.41)
hsa:84649;DGAT2,ARAT,GS1999FULL;diacylglycerol O-acyltransferase 2 (EC:2.3.1.20 2.3.1.76)
hsa:29104;N6AMT1,C21orf127,HEMK2,MTQ2,N6AMT;N-6 adenine-specific DNA methyltransferase 1 (putative) (EC:2.1.1.72)
hsa:4440;MSI1;musashi RNA-binding protein 1
hsa:29988;SLC2A8,GLUT8,GLUTX1;solute carrier family 2 (facilitated glucose transporter), member 8
hsa:23046;KIF21B;kinesin family member 21B
hsa:114757;CYGB,HGB,STAP;cytoglobin
hsa:22806;IKZF3,AIO,AIOLOS,ZNFN1A3;IKAROS family zinc finger 3 (Aiolos)
hsa:122481;AK7;adenylate kinase 7 (EC:2.7.4.3)
hsa:4643;MYO1E,FSGS6,HuncM-IC,MYO1C;myosin IE
hsa:5998;RGS3,C2PA,RGP3;regulator of G-protein signaling 3
hsa:2982;GUCY1A3,GC-SA3,GUC1A3,GUCA3,GUCSA3,GUCY1A1;guanylate cyclase 1, soluble, alpha 3 (EC:4.6.1.2)
hsa:51156;SERPINA10,PZI,ZPI;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10
hsa:81501;DCSTAMP,FIND,TM7SF4,hDC-STAMP;dendrocyte expressed seven transmembrane protein
hsa:3175;ONECUT1,HNF-6,HNF6,HNF6A;one cut homeobox 1
hsa:5291;PIK3CB,P110BETA,PI3K,PI3KBETA,PIK3C1;phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta (EC:2.7.1.153)
hsa:83636;C19orf12,NBIA3;chromosome 19 open reading frame 12
hsa:122786;FRMD6,C14orf31,EX1,Willin,c14_5320;FERM domain containing 6
hsa:8490;RGS5,MST092,MST106,MST129,MSTP032,MSTP092,MSTP106,MSTP129;regulator of G-protein signaling 5
hsa:5545;PRB4,Po;proline-rich protein BstNI subfamily 4
hsa:441273;SPDYE2,SPDYB2-L1;speedy homolog E2 (Xenopus laevis)
hsa:7273;TTN,CMD1G,CMH9,CMPD4,EOMFC,HMERF,LGMD2J,MYLK5,TMD;titin (EC:2.7.11.1)
hsa:399473;SPRED3,Eve-3,spred-3;sprouty-related, EVH1 domain containing 3
hsa:90527;DUOXA1,NIP,NUMBIP,mol;dual oxidase maturation factor 1
hsa:7247;TSN,BCLF-1,C3PO,RCHF1,REHF-1,TBRBP,TRSLN;translin
hsa:9033;PKD2L1,PCL,PKD2L,PKDL,TRPP3;polycystic kidney disease 2-like 1
hsa:8677;STX10,SYN10,hsyn10;syntaxin 10
hsa:10016;PDCD6,ALG-2,PEF1B;programmed cell death 6
hsa:10471;PFDN6,H2-KE2,HKE2,KE-2,PFD6;prefoldin subunit 6
hsa:27173;SLC39A1,ZIP1,ZIRTL;solute carrier family 39 (zinc transporter), member 1
hsa:56916;SMARCAD1,ADERM,ETL1,HEL1;SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 (EC:3.6.4.12)
hsa:51191;HERC5,CEB1,CEBP1;HECT and RLD domain containing E3 ubiquitin protein ligase 5
hsa:27433;TOR2A,TORP1;torsin family 2, member A
hsa:6717;SRI,CP-22,CP22,SCN,V19;sorcin
hsa:8924;HERC2,D15F37S1,SHEP1,jdf2,p528;HECT and RLD domain containing E3 ubiquitin protein ligase 2
hsa:7711;ZNF155,pHZ-96;zinc finger protein 155
hsa:4791;NFKB2,H2TF1,LYT-10,LYT10,NF-kB2,p105,p52;nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
hsa:8930;MBD4,MED1;methyl-CpG binding domain protein 4
hsa:114049;WBSCR22,HASJ4442,HUSSY-3,MERM1,PP3381,WBMT;Williams Beuren syndrome chromosome region 22
hsa:728239;MAGED4,MAGE-E1,MAGE1,MAGEE1;melanoma antigen family D, 4
hsa:8913;CACNA1G,Ca(V)T.1,Cav3.1,NBR13;calcium channel, voltage-dependent, T type, alpha 1G subunit
hsa:353139;LCE2A,LEP9;late cornified envelope 2A
hsa:22843;PPM1E,CaMKP-N,POPX1,PP2CH,caMKN;protein phosphatase, Mg2+/Mn2+ dependent, 1E (EC:3.1.3.16)
hsa:4048;LTA4H;leukotriene A4 hydrolase (EC:3.3.2.6)
hsa:63978;PRDM14,PFM11;PR domain containing 14
hsa:8569;MKNK1,MNK1;MAP kinase interacting serine/threonine kinase 1 (EC:2.7.11.1)
hsa:51246;SHISA5,SCOTIN;shisa homolog 5 (Xenopus laevis)
hsa:7574;ZNF26,KOX20;zinc finger protein 26
hsa:22852;ANKRD26,THC2,bA145E8.1;ankyrin repeat domain 26
hsa:4437;MSH3,DUP,MRP1;mutS homolog 3 (E. coli)
hsa:55667;DENND4C,C9orf55,C9orf55B,bA513M16.3;DENN/MADD domain containing 4C
hsa:11160;ERLIN2,C8orf2,Erlin-2,NET32,SPFH2,SPG18;ER lipid raft associated 2
hsa:10933;MORF4L1,Eaf3,HsT17725,MEAF3,MORFRG15,MRG15,S863-6;mortality factor 4 like 1
hsa:90678;LRSAM1,CMT2P,RIFLE,TAL;leucine rich repeat and sterile alpha motif containing 1
hsa:23262;PPIP5K2,HISPPD1,IP7K2,VIP2;diphosphoinositol pentakisphosphate kinase 2 (EC:2.7.4.21 2.7.4.24)
hsa:89;ACTN3;actinin, alpha 3
hsa:56341;PRMT8,HRMT1L3,HRMT1L4;protein arginine methyltransferase 8 (EC:2.1.1.-)
hsa:9829;DNAJC6,DJC6;DnaJ (Hsp40) homolog, subfamily C, member 6 (EC:3.1.3.48)
hsa:6548;SLC9A1,APNH,NHE-1,NHE1;solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
hsa:5962;RDX,DFNB24;radixin
hsa:6019;RLN2,H2,H2-RLX,RLXH2,bA12D24.1.1,bA12D24.1.2;relaxin 2
hsa:653550;TP53TG3C,TP53TG3;TP53 target 3C
hsa:129080;EMID1,EMI5,EMU1;EMI domain containing 1
hsa:6433;SFSWAP,SFRS8,SWAP;splicing factor, suppressor of white-apricot homolog (Drosophila)
hsa:64769;MEAF6,C1orf149,CENP-28,EAF6,NY-SAR-91;MYST/Esa1-associated factor 6
hsa:4232;MEST,PEG1;mesoderm specific transcript
hsa:255324;EPGN,ALGV3072,EPG,PRO9904;epithelial mitogen
hsa:10460;TACC3,ERIC-1,ERIC1;transforming, acidic coiled-coil containing protein 3
hsa:755;C21orf2,YF5/A2;chromosome 21 open reading frame 2
hsa:10540;DCTN2,DCTN50,DYNAMITIN,RBP50;dynactin 2 (p50)
hsa:80142;PTGES2,C9orf15,GBF-1,GBF1,PGES2,mPGES-2;prostaglandin E synthase 2 (EC:5.3.99.3)
hsa:6693;SPN,CD43,GALGP,GPL115,LSN;sialophorin
hsa:6484;ST3GAL4,CGS23,NANTA3,SAT3,SIAT4,SIAT4C,ST3GalIV,STZ;ST3 beta-galactoside alpha-2,3-sialyltransferase 4 (EC:2.4.99.4)
hsa:80131;LRRC8E;leucine rich repeat containing 8 family, member E
hsa:778;CACNA1F,AIED,COD3,COD4,CORDX,CORDX3,CSNB2,CSNB2A,CSNBX2,Cav1.4,JM8,JMC8,OA2;calcium channel, voltage-dependent, L type, alpha 1F subunit
hsa:162989;DEDD2,FLAME-3;death effector domain containing 2
hsa:8048;CSRP3,CLP,CMD1M,CMH12,CRP3,LMO4,MLP;cysteine and glycine-rich protein 3 (cardiac LIM protein)
hsa:65108;MARCKSL1,F52,MACMARCKS,MLP,MLP1,MRP;MARCKS-like 1
hsa:11060;WWP2,AIP2,WWp2-like;WW domain containing E3 ubiquitin protein ligase 2
hsa:56937;PMEPA1,STAG1,TMEPAI;prostate transmembrane protein, androgen induced 1
hsa:9125;RQCD1,CNOT9,CT129,RCD-1,RCD1;RCD1 required for cell differentiation1 homolog (S. pombe)
hsa:9576;SPAG6,Repro-SA-1,pf16;sperm associated antigen 6
hsa:9100;USP10,UBPO;ubiquitin specific peptidase 10 (EC:3.4.19.12)
hsa:11162;NUDT6,ASFGF2,FGF-AS,FGF2AS,GFG-1,GFG1;nudix (nucleoside diphosphate linked moiety X)-type motif 6
hsa:3764;KCNJ8,KIR6.1,uKATP-1;potassium inwardly-rectifying channel, subfamily J, member 8
hsa:8603;FAM193A,C4orf8;family with sequence similarity 193, member A
hsa:9113;LATS1,WARTS,wts;LATS, large tumor suppressor, homolog 1 (Drosophila) (EC:2.7.11.1)
hsa:29978;UBQLN2,ALS15,CHAP1,DSK2,N4BP4,PLIC2;ubiquilin 2
hsa:10758;TRAF3IP2,ACT1,C6orf2,C6orf4,C6orf5,C6orf6,CIKS,PSORS13;TRAF3 interacting protein 2
hsa:9497;SLC4A7,NBC2,NBC3,NBCN1,SBC2,SLC4A6;solute carrier family 4, sodium bicarbonate cotransporter, member 7
hsa:259291;TAS2R45,GPR59,T2R45,ZG24P;taste receptor, type 2, member 45
hsa:5869;RAB5B;RAB5B, member RAS oncogene family
hsa:729355;TP53TG3B;TP53 target 3B
hsa:729264;TP53TG3D;TP53 target 3D
hsa:23216;TBC1D1,TBC,TBC1;TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1
hsa:23189;KANK1,ANKRD15,CPSQ2,KANK;KN motif and ankyrin repeat domains 1
hsa:3421;IDH3G,H-IDHG;isocitrate dehydrogenase 3 (NAD+) gamma (EC:1.1.1.41)
hsa:140690;CTCFL,BORIS,CT27,CTCF-T,HMGB1L1,dJ579F20.2;CCCTC-binding factor (zinc finger protein)-like
hsa:5216;PFN1,ALS18;profilin 1
hsa:28234;SLCO1B3,HBLRR,LST-2,LST-3TM13,LST3,OATP-8,OATP1B3,OATP8,SLC21A8;solute carrier organic anion transporter family, member 1B3
hsa:56164;STK31,SGK396,TDRD8;serine/threonine kinase 31 (EC:2.7.11.1)
hsa:7846;TUBA1A,B-ALPHA-1,LIS3,TUBA3;tubulin, alpha 1a
hsa:3187;HNRNPH1,HNRPH,HNRPH1,hnRNPH;heterogeneous nuclear ribonucleoprotein H1 (H)
hsa:159989;CCDC67;coiled-coil domain containing 67
hsa:57572;DOCK6,AOS2,ZIR1;dedicator of cytokinesis 6
hsa:113263;GLCCI1,FAM117C,GCTR,GIG18,TSSN1;glucocorticoid induced transcript 1
hsa:11269;DDX19B,DBP5,DDX19,RNAh;DEAD (Asp-Glu-Ala-Asp) box polypeptide 19B (EC:3.6.4.13)
hsa:6014;RIT2,RIBA,RIN,ROC2;Ras-like without CAAX 2
hsa:10072;DPP3,DPPIII;dipeptidyl-peptidase 3 (EC:3.4.14.4)
hsa:80343;SEL1L2,C20orf50;sel-1 suppressor of lin-12-like 2 (C. elegans);K07126
hsa:90410;IFT20;intraflagellar transport 20 homolog (Chlamydomonas)
hsa:22873;DZIP1,DZIP,DZIPt1;DAZ interacting protein 1
hsa:51692;CPSF3,CPSF-73,CPSF73;cleavage and polyadenylation specific factor 3, 73kDa
hsa:23787;MTCH1,CGI-64,PIG60,PSAP,SLC25A49;mitochondrial carrier 1
hsa:10730;YME1L1,FTSH,MEG4,PAMP,YME1L;YME1-like 1 (S. cerevisiae)
hsa:134145;FAM173B,JS-2;family with sequence similarity 173, member B
hsa:6487;ST3GAL3,EIEE15,MRT12,SIAT6,ST3GALII,ST3GalIII,ST3N;ST3 beta-galactoside alpha-2,3-sialyltransferase 3 (EC:2.4.99.6)
hsa:29126;CD274,B7-H,B7H1,PD-L1,PDCD1L1,PDCD1LG1,PDL1;CD274 molecule
hsa:8638;OASL,OASLd,TRIP-14,TRIP14,p59_OASL,p59-OASL,p59OASL;2'-5'-oligoadenylate synthetase-like
hsa:8835;SOCS2,CIS2,Cish2,SOCS-2,SSI-2,SSI2,STATI2;suppressor of cytokine signaling 2
hsa:3543;IGLL1,14.1,AGM2,CD179b,IGL1,IGL5,IGLJ14.1,IGLL,IGO,IGVPB,VPREB2;immunoglobulin lambda-like polypeptide 1
hsa:10238;DCAF7,AN11,HAN11,SWAN-1,WDR68;DDB1 and CUL4 associated factor 7
hsa:27243;CHMP2A,BC-2,BC2,CHMP2,VPS2,VPS2A;charged multivesicular body protein 2A
hsa:10941;UGT2A1;UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus (EC:2.4.1.17)
hsa:9833;MELK,HPK38;maternal embryonic leucine zipper kinase (EC:2.7.11.1 2.7.10.2)
hsa:57720;GPR107,GCDRP,LUSTR1,RP11-88G17,bA138E2.2;G protein-coupled receptor 107
hsa:4118;MAL;mal, T-cell differentiation protein
hsa:117581;TWIST2,DERMO1,FFDD3,SETLSS,bHLHa39;twist basic helix-loop-helix transcription factor 2
hsa:388389;CCDC103,CILD17,PR46b,SMH;coiled-coil domain containing 103
hsa:64764;CREB3L2,BBF2H7;cAMP responsive element binding protein 3-like 2
hsa:51479;ANKFY1,ANKHZN,BTBD23,ZFYVE14;ankyrin repeat and FYVE domain containing 1
hsa:728255;KRTAP1-4,KAP1.4,KRTAP1.4;keratin associated protein 1-4
hsa:25776;CBY1,C22orf2,CBY,HS508I15A,PGEA1,PIGEA-14,PIGEA14,arb1;chibby homolog 1 (Drosophila)
hsa:55284;UBE2W,UBC-16,UBC16;ubiquitin-conjugating enzyme E2W (putative) (EC:6.3.2.19)
hsa:776;CACNA1D,CACH3,CACN4,CACNL1A2,CCHL1A2,Cav1.3,SANDD;calcium channel, voltage-dependent, L type, alpha 1D subunit
hsa:51594;NBAS,NAG,SOPH;neuroblastoma amplified sequence
hsa:8710;SERPINB7,MEGSIN,TP55;serpin peptidase inhibitor, clade B (ovalbumin), member 7
hsa:3560;IL2RB,CD122,IL15RB,P70-75;interleukin 2 receptor, beta
hsa:29079;MED4,ARC36,DRIP36,HSPC126,TRAP36,VDRIP;mediator complex subunit 4
hsa:57338;JPH3,CAGL237,HDL2,JP-3,JP3,TNRC22;junctophilin 3
hsa:2914;GRM4,GPRC1D,MGLUR4,mGlu4;glutamate receptor, metabotropic 4
hsa:1776;DNASE1L3,DHP2,DNAS1L3,LSD,SLEB16;deoxyribonuclease I-like 3 (EC:3.1.21.-)
hsa:5886;RAD23A,HHR23A,HR23A;RAD23 homolog A (S. cerevisiae)
hsa:84033;OBSCN,ARHGEF30,UNC89;obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF (EC:2.7.11.1)
hsa:10231;RCAN2,CSP2,DSCR1L1,MCIP2,RCN2,ZAKI-4,ZAKI4;regulator of calcineurin 2
hsa:7332;UBE2L3,E2-F1,L-UBC,UBCH7,UbcM4;ubiquitin-conjugating enzyme E2L 3 (EC:6.3.2.19)
hsa:730249;IRG1;immunoresponsive 1 homolog (mouse)
hsa:7296;TXNRD1,GRIM-12,TR,TR1,TRXR1,TXNR;thioredoxin reductase 1 (EC:1.8.1.9)
hsa:9043;SPAG9,CT89,HLC-6,HLC4,JIP-4,JIP4,JLP,PHET,PIG6;sperm associated antigen 9
hsa:257177;C1orf192;chromosome 1 open reading frame 192
hsa:100996939;PYURF,PREY;PIGY upstream reading frame
hsa:1452;CSNK1A1,CK1,CK1a,CKIa,HLCDGP1,PRO2975;casein kinase 1, alpha 1 (EC:2.7.11.1)
hsa:1272;CNTN1,F3,GP135;contactin 1
hsa:8195;MKKS,BBS6,HMCS,KMS,MKS;McKusick-Kaufman syndrome
hsa:79139;DERL1,DER-1,DER1;derlin 1
hsa:282991;BLOC1S2,BLOS2,RP11-316M21.4;biogenesis of lysosomal organelles complex-1, subunit 2
hsa:6581;SLC22A3,EMT,EMTH,OCT3;solute carrier family 22 (extraneuronal monoamine transporter), member 3
hsa:6999;TDO2,TDO,TO,TPH2,TRPO;tryptophan 2,3-dioxygenase (EC:1.13.11.11)
hsa:2838;GPR15,BOB;G protein-coupled receptor 15
hsa:29843;SENP1,SuPr-2;SUMO1/sentrin specific peptidase 1 (EC:3.4.22.68)
hsa:8725;URI1,C19orf2,NNX3,PPP1R19,RMP,URI;URI1, prefoldin-like chaperone
hsa:2151;F2RL2,PAR-3,PAR3;coagulation factor II (thrombin) receptor-like 2
hsa:84300;MNF1,C6orf125,Cbp6,M19,bA6B20.2;mitochondrial nucleoid factor 1 (EC:2.7.4.21)
hsa:11020;IFT27,RABL4,RAYL;intraflagellar transport 27 homolog (Chlamydomonas)
hsa:10269;ZMPSTE24,FACE-1,FACE1,HGPS,PRO1,STE24,Ste24p;zinc metallopeptidase STE24 (EC:3.4.24.84)
hsa:25803;SPDEF,PDEF,RP11-375E1__A.3,bA375E1.3;SAM pointed domain containing ets transcription factor
hsa:80125;CCDC33,CT61;coiled-coil domain containing 33
hsa:58529;MYOZ1,CS-2,FATZ,MYOZ;myozenin 1
hsa:27344;PCSK1N,PROSAAS,SAAS;proprotein convertase subtilisin/kexin type 1 inhibitor
hsa:55908;C19orf80,ANGPTL8,PRO1185,PVPA599,RIFL,TD26;chromosome 19 open reading frame 80
hsa:54494;C11orf71;chromosome 11 open reading frame 71
hsa:54883;CWC25,CCDC49;CWC25 spliceosome-associated protein homolog (S. cerevisiae)
hsa:2107;ETF1,D5S1995,ERF,ERF1,RF1,SUP45L1,TB3-1;eukaryotic translation termination factor 1
hsa:10412;NSA2,CDK105,HCL-G1,HCLG1,HUSSY29,TINP1;NSA2 ribosome biogenesis homolog (S. cerevisiae)
hsa:87178;PNPT1,COXPD13,DFNB70,OLD35,PNPASE,old-35;polyribonucleotide nucleotidyltransferase 1 (EC:2.7.7.8)
hsa:347541;MAGEB5,CT3.3,MAGE-B5;melanoma antigen family B, 5
hsa:10402;ST3GAL6,SIAT10,ST3GALVI;ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (EC:2.4.99.-)
hsa:23185;LARP4B,KIAA0217,LARP5;La ribonucleoprotein domain family, member 4B
hsa:2054;STX2,EPIM,EPM,STX2A,STX2B,STX2C;syntaxin 2
hsa:89869;PLCZ1,NYD-SP27,PLC-zeta-1,PLCzeta;phospholipase C, zeta 1 (EC:3.1.4.11)
hsa:8800;PEX11A,PEX11-ALPHA,PMP28,hsPEX11p;peroxisomal biogenesis factor 11 alpha
hsa:2770;GNAI1,Gi;guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
hsa:6134;RPL10,AUTSX5,DXS648,DXS648E,L10,NOV,QM;ribosomal protein L10
hsa:3157;HMGCS1,HMGCS;3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) (EC:2.3.3.10)
hsa:84892;GTDC2,AGO61,C3orf39,MDDGA8;glycosyltransferase-like domain containing 2 (EC:2.4.1.255)
hsa:7075;TIE1,JTK14,TIE;tyrosine kinase with immunoglobulin-like and EGF-like domains 1 (EC:2.7.10.1)
hsa:84206;MEX3B,MEX-3B,RKHD3,RNF195;mex-3 homolog B (C. elegans)
hsa:4063;LY9,CD229,SLAMF3,hly9,mLY9;lymphocyte antigen 9
hsa:8409;UXT,ART-27,STAP1;ubiquitously-expressed, prefoldin-like chaperone
hsa:693178;MIR593,MIRN593,hsa-mir-593;microRNA 593
hsa:100302263;MIR1908,MIRN1908,hsa-mir-1908;microRNA 1908
hsa:406919;MIR130A,MIRN130A,miRNA130A;microRNA 130a
hsa:406910;MIR125A,MIRN125A,miRNA125A;microRNA 125a
hsa:406929;MIR138-1,MIRN138-1;microRNA 138-1
hsa:406946;MIR154,MIRN154;microRNA 154
hsa:406968;MIR193A,MIRN193,MIRN193A;microRNA 193a
hsa:406985;MIR200C,MIRN200C;microRNA 200c
hsa:100302135;MIR320C1,MIR320C-1,MIRN320C1,hsa-mir-320c-1;microRNA 320c-1
hsa:494324;MIR375,MIRN375,hsa-mir-375,miRNA375;microRNA 375
hsa:574032;MIR20B,MIRN20B,hsa-mir-20b;microRNA 20b
hsa:100126335;MIR543,MIRN543,hsa-mir-543;microRNA 543
hsa:574413;MIR409,MIRN409,hsa-mir-409;microRNA 409
hsa:574469;MIR519B,MIRN519B;microRNA 519b
hsa:406885;MIRLET7C,LET7C,MIRNLET7C,hsa-let-7c,let-7c;microRNA let-7c
hsa:574478;MIR524,MIRN524,hsa-mir-524;microRNA 524
hsa:406886;MIRLET7D,LET7D,MIRNLET7D,hsa-let-7d,let-7d;microRNA let-7d
hsa:407010;MIR23A,MIRN23A,hsa-mir-23a,miRNA23A;microRNA 23a
hsa:407018;MIR27A,MIR27,MIRN27A;microRNA 27a
hsa:407036;MIR32,MIRN32,hsa-mir-32,miR-32,miRNA32;microRNA 32
hsa:406892;MIR100,MIRN100,miR-100;microRNA 100
hsa:574507;MIR504,MIRN504,hsa-mir-504;microRNA 504
hsa:406972;MIR196A1,MIRN196-1,MIRN196A1;microRNA 196a-1
hsa:406955;MIR181B1,MIRN181B1;microRNA 181b-1
hsa:406963;MIR187,MIRN187,miR-187,miRNA187;microRNA 187
hsa:25994;HIGD1A,HIG1,RCF1a;HIG1 hypoxia inducible domain family, member 1A
hsa:1605;DAG1,156DAG,A3a,AGRNR,DAG,MDDGC7,MDDGC9;dystroglycan 1 (dystrophin-associated glycoprotein 1)
hsa:85236;HIST1H2BK,H2B/S,H2BFAiii,H2BFT,H2BK;histone cluster 1, H2bk
hsa:90673;PPP1R3E;protein phosphatase 1, regulatory subunit 3E
hsa:7469;NELFA,NELF-A,WHSC2;negative elongation factor complex member A
hsa:54768;HYDIN,CILD5,HYDIN1,HYDIN2,PPP1R31;HYDIN, axonemal central pair apparatus protein
hsa:345193;LRIT3,CSNB1F,FIGLER4;leucine-rich repeat, immunoglobulin-like and transmembrane domains 3
hsa:128312;HIST3H2BB,H2Bb;histone cluster 3, H2bb
hsa:55065;SLC52A1,GPCR42,GPR172B,PAR2,RBFVD,RFT1,RFVT1,hRFT1;solute carrier family 52, riboflavin transporter, member 1
hsa:8970;HIST1H2BJ,H2B/r,H2BFR,H2BJ;histone cluster 1, H2bj
hsa:6419;SETMAR,HsMar1,METNASE,Mar1;SET domain and mariner transposase fusion gene (EC:2.1.1.43)
hsa:192286;HIGD2A,RCF1b;HIG1 hypoxia inducible domain family, member 2A
hsa:8425;LTBP4,ARCL1C,LTBP-4,LTBP4L,LTBP4S;latent transforming growth factor beta binding protein 4
hsa:25920;NELFB,COBRA1,NELF-B;negative elongation factor complex member B
hsa:285343;TCAIM,C3orf23,TOAG-1,TOAG1;T cell activation inhibitor, mitochondrial
hsa:4218;RAB8A,MEL,RAB8;RAB8A, member RAS oncogene family
hsa:3508;IGHMBP2,CATF1,HCSA,HMN6,SMARD1,SMUBP2,ZFAND7;immunoglobulin mu binding protein 2 (EC:3.6.4.13 3.6.4.12)
hsa:11073;TOPBP1,TOP2BP1;topoisomerase (DNA) II binding protein 1
hsa:3397;ID1,ID,bHLHb24;inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
hsa:1287;COL4A5,ASLN,ATS,CA54;collagen, type IV, alpha 5
hsa:2072;ERCC4,ERCC11,RAD1,XPF;excision repair cross-complementing rodent repair deficiency, complementation group 4
hsa:157855;KCNU1,KCNMC1,KCa5,KCa5.1,Kcnma3,Slo3;potassium channel, subfamily U, member 1
hsa:7066;THPO,MGDF,MKCSF,ML,MPLLG,THCYT1,TPO;thrombopoietin
hsa:54862;CC2D1A,FREUD-1,Freud-1/Aki1,MRT3;coiled-coil and C2 domain containing 1A
hsa:11213;IRAK3,ASRT5,IRAKM;interleukin-1 receptor-associated kinase 3 (EC:2.7.11.1)
hsa:527;ATP6V0C,ATP6C,ATP6L,ATPL,VATL,VPPC,Vma3;ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c (EC:3.6.3.14)
hsa:4646;MYO6,DFNA22,DFNB37;myosin VI
hsa:55968;NSFL1C,P47,UBX1,UBXD10,UBXN2C,dJ776F14.1;NSFL1 (p97) cofactor (p47)
hsa:9255;AIMP1,EMAP2,EMAPII,HLD3,SCYE1,p43;aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
hsa:2632;GBE1,APBD,GBE,GSD4;glucan (1,4-alpha-), branching enzyme 1 (EC:2.4.1.18)
hsa:329;BIRC2,API1,HIAP2,Hiap-2,MIHB,RNF48,c-IAP1,cIAP1;baculoviral IAP repeat containing 2
hsa:624;BDKRB2,B2R,BK-2,BK2,BKR2,BRB2;bradykinin receptor B2
hsa:1271;CNTFR;ciliary neurotrophic factor receptor
hsa:55740;ENAH,ENA,MENA,NDPP1;enabled homolog (Drosophila)
hsa:3854;KRT6B,CK-6B,CK6B,K6B,KRTL1,PC2;keratin 6B
hsa:10643;IGF2BP3,CT98,IMP-3,IMP3,KOC1,VICKZ3;insulin-like growth factor 2 mRNA binding protein 3
hsa:58484;NLRC4,CARD12,CLAN,CLAN1,CLANA,CLANB,CLANC,CLAND,CLR2.1,IPAF;NLR family, CARD domain containing 4
hsa:3190;HNRNPK,CSBP,HNRPK,TUNP;heterogeneous nuclear ribonucleoprotein K
hsa:112744;IL17F,CANDF6,IL-17F,ML-1,ML1;interleukin 17F
hsa:379;ARL4D,ARF4L,ARL6;ADP-ribosylation factor-like 4D
hsa:5420;PODXL,Gp200,PC,PCLP,PCLP-1;podocalyxin-like
hsa:6328;SCN3A,NAC3,Nav1.3;sodium channel, voltage-gated, type III, alpha subunit
hsa:3431;SP110,IFI41,IFI75,IPR1,VODI;SP110 nuclear body protein
hsa:4041;LRP5,BMND1,EVR1,EVR4,HBM,LR3,LRP7,OPPG,OPS,OPTA1,VBCH2;low density lipoprotein receptor-related protein 5
hsa:64783;RBM15,OTT,OTT1,SPEN;RNA binding motif protein 15
hsa:57695;USP37;ubiquitin specific peptidase 37 (EC:3.4.19.12)
hsa:387715;ARMS2,ARMD8;age-related maculopathy susceptibility 2
hsa:84525;HOPX,CAMEO,HOD,HOP,LAGY,NECC1,OB1,SMAP31,TOTO;HOP homeobox
hsa:23521;RPL13A,L13A,TSTA1;ribosomal protein L13a
hsa:9972;NUP153,HNUP153,N153;nucleoporin 153kDa
hsa:84245;MRI1,MRDI,MTNA,Ypr118w;methylthioribose-1-phosphate isomerase homolog (S. cerevisiae) (EC:5.3.1.23)
hsa:10752;CHL1,CALL,L1CAM2;cell adhesion molecule with homology to L1CAM (close homolog of L1)
hsa:2206;MS4A2,APY,ATOPY,FCER1B,FCERI,IGEL,IGER,IGHER,MS4A1;membrane-spanning 4-domains, subfamily A, member 2
hsa:57761;TRIB3,C20orf97,NIPK,SINK,SKIP3,TRB3;tribbles homolog 3 (Drosophila)
hsa:10856;RUVBL2,ECP51,INO80J,REPTIN,RVB2,TIH2,TIP48,TIP49B;RuvB-like 2 (E. coli) (EC:3.6.4.12)
hsa:3484;IGFBP1,AFBP,IBP1,IGF-BP25,PP12,hIGFBP-1;insulin-like growth factor binding protein 1
hsa:81888;HYI,HT036;hydroxypyruvate isomerase (putative) (EC:5.3.1.22)
hsa:51256;TBC1D7,PIG51,TBC7,dJ257A7.3;TBC1 domain family, member 7
hsa:6653;SORL1,C11orf32,LR11,LRP9,SORLA,SorLA-1,gp250;sortilin-related receptor, L(DLR class) A repeats containing
hsa:1478;CSTF2,CstF-64;cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa
hsa:9448;MAP4K4,FLH21957,HGK,MEKKK4,NIK;mitogen-activated protein kinase kinase kinase kinase 4 (EC:2.7.11.1)
hsa:4602;MYB,Cmyb,c-myb,c-myb_CDS,efg;v-myb myeloblastosis viral oncogene homolog (avian)
hsa:25855;BRMS1;breast cancer metastasis suppressor 1
hsa:9138;ARHGEF1,GEF1,LBCL2,LSC,P115-RHOGEF,SUB1.5;Rho guanine nucleotide exchange factor (GEF) 1
hsa:51592;TRIM33,ECTO,PTC7,RFG7,TF1G,TIF1G,TIF1GAMMA,TIFGAMMA;tripartite motif containing 33
hsa:5245;PHB,PHB1;prohibitin
hsa:5154;PDGFA,PDGF-A,PDGF1;platelet-derived growth factor alpha polypeptide
hsa:64902;AGXT2,AGT2,DAIBAT;alanine--glyoxylate aminotransferase 2 (EC:2.6.1.44 2.6.1.40)
hsa:3811;KIR3DL1,CD158E1,KIR,KIR3DL1/S1,NKAT3,NKB1,NKB1B;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
hsa:3026;HABP2,FSAP,HABP,HGFAL,PHBP;hyaluronan binding protein 2
hsa:4688;NCF2,NCF-2,NOXA2,P67-PHOX,P67PHOX;neutrophil cytosolic factor 2
hsa:84632;AFAP1L2,KIAA1914,XB130;actin filament associated protein 1-like 2
hsa:374;AREG,AR,CRDGF,SDGF;amphiregulin
hsa:57414;RHBDD2,NPD007,RHBDL7;rhomboid domain containing 2
hsa:1051;CEBPB,C/EBP-beta,CRP2,IL6DBP,LAP,NF-IL6,TCF5;CCAAT/enhancer binding protein (C/EBP), beta
hsa:156;ADRBK1,BARK1,BETA-ARK1,GRK2;adrenergic, beta, receptor kinase 1 (EC:2.7.11.15)
hsa:23328;SASH1,SH3D6A,dJ323M4,dJ323M4.1;SAM and SH3 domain containing 1
hsa:54461;FBXW5,Fbw5;F-box and WD repeat domain containing 5
hsa:3263;HPX,HX;hemopexin (EC:3.2.1.35)
hsa:57650;CIP2A,p90;KIAA1524
hsa:10131;TRAP1,HSP_75,HSP75,HSP90L,TRAP-1;TNF receptor-associated protein 1
hsa:1579;CYP4A11,CP4Y,CYP4A2,CYP4AII;cytochrome P450, family 4, subfamily A, polypeptide 11 (EC:1.14.15.3)
hsa:399967;PATE2,C11orf38,PATE-M,UNQ3112;prostate and testis expressed 2
hsa:7045;TGFBI,BIGH3,CDB1,CDG2,CDGG1,CSD,CSD1,CSD2,CSD3,EBMD,LCD1;transforming growth factor, beta-induced, 68kDa
hsa:7041;TGFB1I1,ARA55,HIC-5,HIC5,TSC-5;transforming growth factor beta 1 induced transcript 1
hsa:7917;BAG6,BAG-6,BAT3,D6S52E,G3;BCL2-associated athanogene 6
hsa:7050;TGIF1,HPE4,TGIF;TGFB-induced factor homeobox 1
hsa:3566;IL4R,CD124,IL-4RA,IL4RA;interleukin 4 receptor
hsa:57149;LYRM1,A211C6.1;LYR motif containing 1
hsa:6586;SLIT3,MEGF5,SLIL2,SLIT1,Slit-3,slit2;slit homolog 3 (Drosophila)
hsa:160065;PATE1,PATE;prostate and testis expressed 1
hsa:7166;TPH1,TPRH,TRPH,TPH;tryptophan hydroxylase 1 (EC:1.14.16.4)
hsa:7849;PAX8;paired box 8
hsa:10762;NUP50,NPAP60,NPAP60L;nucleoporin 50kDa
hsa:7316;UBC,HMG20;ubiquitin C
hsa:1158;CKM,CKMM,M-CK;creatine kinase, muscle (EC:2.7.3.2)
hsa:9846;GAB2;GRB2-associated binding protein 2
hsa:7128;TNFAIP3,A20,OTUD7C,TNFA1P2;tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12)
hsa:27101;CACYBP,GIG5,RP1-102G20.6,S100A6BP,SIP;calcyclin binding protein
hsa:2170;FABP3,FABP11,H-FABP,M-FABP,MDGI,O-FABP;fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)
hsa:2252;FGF7,HBGF-7,KGF;fibroblast growth factor 7
hsa:4299;AFF1,AF4,MLLT2,PBM1;AF4/FMR2 family, member 1
hsa:3074;HEXB,ENC-1AS;hexosaminidase B (beta polypeptide) (EC:3.2.1.52)
hsa:3381;IBSP,BNSP,BSP,BSP-II,SP-II;integrin-binding sialoprotein
hsa:4620;MYH2,MYH2A,MYHSA2,MYHas8,MyHC-2A,MyHC-IIa;myosin, heavy chain 2, skeletal muscle, adult
hsa:1901;S1PR1,CD363,CHEDG1,D1S3362,ECGF1,EDG-1,EDG1,S1P1;sphingosine-1-phosphate receptor 1
hsa:9476;NAPSA,KAP,Kdap,NAP1,NAPA,SNAPA;napsin A aspartic peptidase
hsa:6609;SMPD1,ASM,ASMASE,NPD;sphingomyelin phosphodiesterase 1, acid lysosomal (EC:3.1.4.12)
hsa:7248;TSC1,LAM,TSC;tuberous sclerosis 1
hsa:3297;HSF1,HSTF1;heat shock transcription factor 1
hsa:5901;RAN,ARA24,Gsp1,TC4;RAN, member RAS oncogene family
hsa:5608;MAP2K6,MAPKK6,MEK6,MKK6,PRKMK6,SAPKK-3,SAPKK3;mitogen-activated protein kinase kinase 6 (EC:2.7.12.2)
hsa:83475;DOHH,HLRC1,hDOHH;deoxyhypusine hydroxylase/monooxygenase (EC:1.14.99.29)
hsa:8521;GCM1,GCMA,hGCMa;glial cells missing homolog 1 (Drosophila)
hsa:8454;CUL1;cullin 1
hsa:101;ADAM8,CD156,MS2;ADAM metallopeptidase domain 8 (EC:3.4.24.-)
hsa:2938;GSTA1,GST2,GSTA1-1,GTH1;glutathione S-transferase alpha 1 (EC:2.5.1.18)
hsa:23326;USP22,USP3L;ubiquitin specific peptidase 22 (EC:3.4.19.12)
hsa:928;CD9,BTCC-1,DRAP-27,MIC3,MRP-1,TSPAN-29,TSPAN29;CD9 molecule
hsa:3803;KIR2DL2,CD158B1,CD158b,NKAT6,p58.2;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
hsa:3198;HOXA1,BSAS,HOX1,HOX1F;homeobox A1
hsa:1084;CEACAM3,CD66D,CEA,CGM1,W264,W282;carcinoembryonic antigen-related cell adhesion molecule 3
hsa:7498;XDH,XO,XOR;xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2)
hsa:474381;H2AFB2,H2A.Bbd;H2A histone family, member B2
hsa:368;ABCC6,ABC34,ARA,EST349056,GACI2,MLP1,MOAT-E,MOATE,MRP6,PXE,PXE1,URG7;ATP-binding cassette, sub-family C (CFTR/MRP), member 6
hsa:54097;FAM3B,2-21,C21orf11,C21orf76,ORF9,PANDER;family with sequence similarity 3, member B
hsa:54505;DHX29,DDX29;DEAH (Asp-Glu-Ala-His) box polypeptide 29 (EC:3.6.4.13)
hsa:22875;ENPP4,NPP4;ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative) (EC:3.1.-.-)
hsa:10755;GIPC1,C19orf3,GIPC,GLUT1CBP,Hs.6454,IIP-1,NIP,RGS19IP1,SEMCAP,SYNECTIIN,SYNECTIN,TIP-2;GIPC PDZ domain containing family, member 1
hsa:26085;KLK13,KLK-L4,KLKL4;kallikrein-related peptidase 13
hsa:79039;DDX54,DP97;DEAD (Asp-Glu-Ala-Asp) box polypeptide 54 (EC:3.6.4.13)
hsa:6886;TAL1,SCL,TCL5,bHLHa17,tal-1;T-cell acute lymphocytic leukemia 1
hsa:2891;GRIA2,GLUR2,GLURB,GluA2,GluR-K2,HBGR2;glutamate receptor, ionotropic, AMPA 2
hsa:9563;H6PD,CORTRD1,G6PDH,GDH;hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) (EC:1.1.1.47 3.1.1.31)
hsa:4552;MTRR,MSR,cblE;5-methyltetrahydrofolate-homocysteine methyltransferase reductase (EC:1.16.1.8)
hsa:55636;CHD7,HH5,IS3,KAL5;chromodomain helicase DNA binding protein 7 (EC:3.6.4.12)
hsa:5813;PURA,PUR-ALPHA,PUR1,PURALPHA;purine-rich element binding protein A
hsa:10009;ZBTB33,ZNF-kaiso,ZNF348;zinc finger and BTB domain containing 33
hsa:54511;HMGCLL1,bA418P12.1,er-cHL;3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1 (EC:4.1.3.4)
hsa:1655;DDX5,G17P1,HLR1,HUMP68,p68;DEAD (Asp-Glu-Ala-Asp) box helicase 5 (EC:3.6.4.13)
hsa:55832;CAND1,TIP120,TIP120A;cullin-associated and neddylation-dissociated 1
hsa:70;ACTC1,ACTC,ASD5,CMD1R,CMH11,LVNC4;actin, alpha, cardiac muscle 1
hsa:338322;NLRP10,CLR11.1,NALP10,NOD8,PAN5,PYNOD;NLR family, pyrin domain containing 10
hsa:7538;ZFP36,G0S24,GOS24,NUP475,RNF162A,TIS11,TTP,zfp-36;ZFP36 ring finger protein
hsa:10714;POLD3,P66,P68;polymerase (DNA-directed), delta 3, accessory subunit
hsa:57534;MIB1,DIP-1,DIP1,LVNC7,MIB,ZZANK2,ZZZ6;mindbomb E3 ubiquitin protein ligase 1
hsa:7483;WNT9A,WNT14;wingless-type MMTV integration site family, member 9A
hsa:5770;PTPN1,PTP1B;protein tyrosine phosphatase, non-receptor type 1 (EC:3.1.3.48)
hsa:7832;BTG2,PC3,TIS21;BTG family, member 2
hsa:10859;LILRB1,CD85,CD85J,ILT-2,ILT2,LIR-1,LIR1,MIR-7,MIR7;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
hsa:6288;SAA1,PIG4,SAA,SAA2,TP53I4;serum amyloid A1
hsa:389;RHOC,ARH9,ARHC,H9,RHOH9;ras homolog family member C
hsa:3903;LAIR1,CD305,LAIR-1;leukocyte-associated immunoglobulin-like receptor 1
hsa:641;BLM,BS,RECQ2,RECQL2,RECQL3;Bloom syndrome, RecQ helicase-like (EC:3.6.4.12)
hsa:2916;GRM6,CSNB1B,GPRC1F,MGLUR6,mGlu6;glutamate receptor, metabotropic 6
hsa:9315;NREP,C5orf13,D4S114,P311,PRO1873,PTZ17,SEZ17;neuronal regeneration related protein
hsa:1577;CYP3A5,CP35,CYPIIIA5,P450PCN3,PCN3;cytochrome P450, family 3, subfamily A, polypeptide 5 (EC:1.14.14.1)
hsa:957;ENTPD5,CD39L4,NTPDase-5,PCPH;ectonucleoside triphosphate diphosphohydrolase 5 (EC:3.6.1.6 3.6.1.42)
hsa:338;APOB,FLDB,LDLCQ4;apolipoprotein B (including Ag(x) antigen)
hsa:399968;PATE4,PATE-B;prostate and testis expressed 4
hsa:4898;NRD1,hNRD1,hNRD2;nardilysin (N-arginine dibasic convertase) (EC:3.4.24.61)
hsa:8644;AKR1C3,DD3,DDX,HA1753,HAKRB,HAKRe,HSD17B5,PGFS,hluPGFS;aldo-keto reductase family 1, member C3 (EC:1.1.1.213 1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112)
hsa:3899;AFF3,LAF4,MLLT2-like;AF4/FMR2 family, member 3
hsa:10468;FST,FS;follistatin
hsa:5076;PAX2,PAPRS;paired box 2
hsa:8322;FZD4,CD344,EVR1,FEVR,FZD4S,Fz-4,Fz4,FzE4,GPCR,hFz4;frizzled family receptor 4
hsa:8836;GGH,GH;gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) (EC:3.4.19.9)
hsa:2736;GLI2,HPE9,THP1,THP2;GLI family zinc finger 2
hsa:204851;HIPK1,Myak,Nbak2;homeodomain interacting protein kinase 1 (EC:2.7.11.1)
hsa:6336;SCN10A,Nav1.8,PN3,SNS,hPN3;sodium channel, voltage-gated, type X, alpha subunit
hsa:56648;EIF5A2,EIF-5A2,eIF5AII;eukaryotic translation initiation factor 5A2
hsa:2857;GPR34;G protein-coupled receptor 34
hsa:89766;UMODL1;uromodulin-like 1
hsa:384;ARG2;arginase, type II (EC:3.5.3.1)
hsa:2066;ERBB4,HER4,p180erbB4;v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) (EC:2.7.10.1)
hsa:8372;HYAL3,HYAL-3,LUCA-3,LUCA3;hyaluronoglucosaminidase 3 (EC:3.2.1.35)
hsa:11284;PNKP,EIEE10,MCSZ,PNK;polynucleotide kinase 3'-phosphatase (EC:2.7.1.78 3.1.3.32)
hsa:3491;CYR61,CCN1,GIG1,IGFBP10;cysteine-rich, angiogenic inducer, 61
hsa:57514;ARHGAP31,AOS1,CDGAP;Rho GTPase activating protein 31
hsa:3351;HTR1B,5-HT1B,5-HT1DB,HTR1D2,HTR1DB,S12;5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
hsa:90627;STARD13,ARHGAP37,DLC2,GT650,LINC00464;StAR-related lipid transfer (START) domain containing 13
hsa:3587;IL10RA,CD210,CD210a,CDW210A,HIL-10R,IL-10R1,IL10R;interleukin 10 receptor, alpha
hsa:48;ACO1,ACONS,IREB1,IREBP,IREBP1,IRP1;aconitase 1, soluble (EC:4.2.1.3)
hsa:206338;AQPEP,APQ,LVRN;laeverin
hsa:11033;ADAP1,CENTA1,GCS1L,p42IP4;ArfGAP with dual PH domains 1
hsa:8525;DGKZ,DAGK5,DAGK6,DGK-ZETA,hDGKzeta;diacylglycerol kinase, zeta (EC:2.7.1.107)
hsa:1366;CLDN7,CEPTRL2,CLDN-7,CPETRL2,Hs.84359,claudin-1;claudin 7
hsa:9337;CNOT8,CAF1,CALIF,POP2,hCAF1;CCR4-NOT transcription complex, subunit 8
hsa:10902;BRD8,SMAP,SMAP2,p120;bromodomain containing 8
hsa:6879;TAF7,TAF2F,TAFII55;TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa
hsa:1725;DHPS,DHS,DS,MIG13;deoxyhypusine synthase (EC:2.5.1.46)
hsa:23019;CNOT1,CDC39,NOT1,NOT1H;CCR4-NOT transcription complex, subunit 1
hsa:3454;IFNAR1,AVP,IFN-alpha-REC,IFNAR,IFNBR,IFRC;interferon (alpha, beta and omega) receptor 1
hsa:7018;TF,PRO1557,PRO2086,TFQTL1;transferrin
hsa:8607;RUVBL1,ECP54,INO80H,NMP238,PONTIN,Pontin52,RVB1,TIH1,TIP49,TIP49A;RuvB-like 1 (E. coli) (EC:3.6.4.12)
hsa:6011;GRK1,GPRK1,RHOK,RK;G protein-coupled receptor kinase 1 (EC:2.7.11.14)
hsa:1434;CSE1L,CAS,CSE1,XPO2;CSE1 chromosome segregation 1-like (yeast)
hsa:11155;LDB3,CMD1C,CYPHER,LDB3Z1,LDB3Z4,LVNC3,ORACLE,PDLIM6,ZASP;LIM domain binding 3
hsa:23566;LPAR3,EDG7,Edg-7,GPCR,HOFNH30,LP-A3,LPA3,RP4-678I3;lysophosphatidic acid receptor 3
hsa:7531;YWHAE,14-3-3E,KCIP-1,MDCR,MDS;tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide
hsa:10522;DEAF1,NUDR,SPN,ZMYND5;DEAF1 transcription factor
hsa:1022;CDK7,CAK1,CDKN7,HCAK,MO15,STK1,p39MO15;cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22)
hsa:23136;EPB41L3,4.1B,DAL-1,DAL1;erythrocyte membrane protein band 4.1-like 3
hsa:200942;KLHDC8B;kelch domain containing 8B
hsa:1200;TPP1,CLN2,LPIC,TPP-1;tripeptidyl peptidase I (EC:3.4.14.9)
hsa:6464;SHC1,SHC,SHCA;SHC (Src homology 2 domain containing) transforming protein 1
hsa:6926;TBX3,TBX3-ISO,UMS,XHL;T-box 3
hsa:838;CASP5,ICE(rel)III,ICEREL-III,ICH-3;caspase 5, apoptosis-related cysteine peptidase (EC:3.4.22.58)
hsa:54861;SNRK,HSNFRK;SNF related kinase (EC:2.7.11.1)
hsa:1476;CSTB,CST6,EPM1,EPM1A,PME,STFB,ULD;cystatin B (stefin B)
hsa:23067;SETD1B,KMT2G,Set1B;SET domain containing 1B (EC:2.1.1.43)
hsa:7704;ZBTB16,PLZF,ZNF145;zinc finger and BTB domain containing 16
hsa:27129;HSPB7,cvHSP;heat shock 27kDa protein family, member 7 (cardiovascular)
hsa:2130;EWSR1,EWS,bK984G1.4;Ewing sarcoma breakpoint region 1
hsa:38;ACAT1,ACAT,MAT,T2,THIL;acetyl-CoA acetyltransferase 1 (EC:2.3.1.9)
hsa:220134;SKA1,C18orf24;spindle and kinetochore associated complex subunit 1
hsa:25816;TNFAIP8,GG2-1,MDC-3.13,SCC-S2,SCCS2;tumor necrosis factor, alpha-induced protein 8
hsa:5464;PPA1,IOPPP,PP,PP1,SID6-8061;pyrophosphatase (inorganic) 1 (EC:3.6.1.1)
hsa:5020;OXT,OT,OT-NPI,OXT-NPI;oxytocin/neurophysin I prepropeptide
hsa:8086;AAAS,AAA,AAASb,ADRACALA,ADRACALIN,ALADIN;achalasia, adrenocortical insufficiency, alacrimia
hsa:5522;PPP2R2C,B55-GAMMA,IMYPNO,IMYPNO1,PR52,PR55G;protein phosphatase 2, regulatory subunit B, gamma (EC:3.1.3.16)
hsa:4671;NAIP,BIRC1,NLRB1,psiNAIP;NLR family, apoptosis inhibitory protein
hsa:1984;EIF5A,EIF-5A,EIF5A1,eIF5AI;eukaryotic translation initiation factor 5A
hsa:9478;CABP1,CALBRAIN,HCALB_BR;calcium binding protein 1
hsa:23600;AMACR,AMACRD,CBAS4,RACE,RM;alpha-methylacyl-CoA racemase (EC:5.1.99.4)
hsa:121340;SP7,OI11,OI12,OSX,osterix;Sp7 transcription factor
hsa:1180;CLCN1,CLC1;chloride channel, voltage-sensitive 1
hsa:7187;TRAF3,CAP-1,CAP1,CD40bp,CRAF1,IIAE5,LAP1;TNF receptor-associated factor 3
hsa:121278;TPH2,ADHD7,NTPH;tryptophan hydroxylase 2 (EC:1.14.16.4)
hsa:81621;KAZALD1,BONO1,FKSG28,FKSG40,IGFBP-rP10;Kazal-type serine peptidase inhibitor domain 1
hsa:9365;KL;klotho (EC:3.2.1.31)
hsa:5593;PRKG2,PRKGR2,cGKII;protein kinase, cGMP-dependent, type II (EC:2.7.11.12)
hsa:10645;CAMKK2,CAMKK,CAMKKB;calcium/calmodulin-dependent protein kinase kinase 2, beta (EC:2.7.11.17)
hsa:8408;ULK1,ATG1,ATG1A,UNC51,Unc51.1,hATG1;unc-51-like kinase 1 (C. elegans) (EC:2.7.11.1)
hsa:80736;SLC44A4,C6orf29,CTL4,NG22;solute carrier family 44, member 4
hsa:6517;SLC2A4,GLUT4;solute carrier family 2 (facilitated glucose transporter), member 4
hsa:392;ARHGAP1,CDC42GAP,RHOGAP,RHOGAP1,p50rhoGAP;Rho GTPase activating protein 1
hsa:6500;SKP1,EMC19,OCP-II,OCP2,SKP1A,TCEB1L,p19A;S-phase kinase-associated protein 1 (EC:3.1.1.3)
hsa:7049;TGFBR3,BGCAN,betaglycan;transforming growth factor, beta receptor III
hsa:406998;MIR216A,MIR216,MIRN216,MIRN216A,miRNA216,mir-216;microRNA 216a
hsa:407007;MIR222,MIRN222,miRNA222,mir-222;microRNA 222
hsa:693218;MIR633,MIRN633,hsa-mir-633;microRNA 633
hsa:7012;TERC,DKCA1,PFBMFT2,SCARNA19,TR,TRC3,hTR;telomerase RNA component
hsa:3044;HBBP1;hemoglobin, beta pseudogene 1
hsa:100126321;MIR922,MIRN922,hsa-mir-922;microRNA 922
hsa:574453;MIR495,MIRN495,hsa-mir-495;microRNA 495
hsa:574466;MIR519C,MIRN519C;microRNA 519c
hsa:574493;MIR520H,MIRN520H;microRNA 520h
hsa:406958;MIR182,MIRN182,miRNA182;microRNA 182
hsa:407975;MIR17HG,C13orf25,FGLDS2,LINC00048,MIHG1,MIRH1,MIRHG1,NCRNA00048,miR-17-92;miR-17-92 cluster host gene (non-protein coding)
hsa:406957;MIR181C,MIRN181C,mir-181c;microRNA 181c
hsa:100913187;APOBEC3A_B;APOBEC3A and APOBEC3B deletion hybrid
hsa:729678;LINC00847;long intergenic non-protein coding RNA 847
hsa:149018;LELP1;late cornified envelope-like proline-rich 1
hsa:29919;C18orf8,HsT2591,MIC1,Mic-1;chromosome 18 open reading frame 8
hsa:64919;BCL11B,ATL1-alpha,ATL1-beta,ATL1-delta,ATL1-gamma,CTIP-2,CTIP2,RIT1,ZNF856B,hRIT1-alpha;B-cell CLL/lymphoma 11B (zinc finger protein)
hsa:388633;LDLRAD1;low density lipoprotein receptor class A domain containing 1
hsa:222698;NKAPL,C6orf194,bA424I5.1;NFKB activating protein-like
hsa:130951;M1AP,C2orf65,D6Mm5e,SPATA37;meiosis 1 associated protein
hsa:126410;CYP4F22,ARCI5,INLNE,LI3;cytochrome P450, family 4, subfamily F, polypeptide 22
hsa:10767;HBS1L,EF-1a,ERFS,HBS1,HSPC276;HBS1-like (S. cerevisiae)
hsa:8969;HIST1H2AG,H2A.1b,H2A/p,H2AFP,H2AG,pH2A/f;histone cluster 1, H2ag
hsa:25941;TPGS2,C18orf10,L17,PGs2;tubulin polyglutamylase complex subunit 2
hsa:137964;AGPAT6,1-AGPAT_6,LPAAT-zeta,LPAATZ,TSARG7;1-acylglycerol-3-phosphate O-acyltransferase 6 (EC:2.3.1.15)
hsa:56895;AGPAT4,1-AGPAT4,LPAAT-delta,dJ473J16.2;1-acylglycerol-3-phosphate O-acyltransferase 4 (EC:2.3.1.51)
hsa:10554;AGPAT1,1-AGPAT1,G15,LPAAT-alpha,LPAATA;1-acylglycerol-3-phosphate O-acyltransferase 1 (EC:2.3.1.51)
hsa:11039;SMA4,SMA3,b55C20.2;glucuronidase, beta pseudogene
hsa:100124700;HOTAIR,HOXAS,HOXC-AS4,HOXC11-AS1,NCRNA00072;HOX transcript antisense RNA
hsa:85458;DIXDC1,CCD1;DIX domain containing 1
hsa:54149;C21orf91,C21orf14,C21orf38,CSSG1,EURL,YG81;chromosome 21 open reading frame 91
hsa:3268;AGFG2,HRBL,RABR;ArfGAP with FG repeats 2
hsa:197358;NLRC3,CLR16.2,NOD3;NLR family, CARD domain containing 3
hsa:64718;UNKL,C16orf28,ZC3H5L,ZC3HDC5L;unkempt homolog (Drosophila)-like
hsa:91304;TMEM259,ASBABP1,C19orf6,MBRL,MEMBRALIN,R32184_3;transmembrane protein 259
hsa:347689;SOX2-OT,NCRNA00043,SOX2OT;SOX2 overlapping transcript (non-protein coding)
hsa:441951;ZFAS1,C20orf199,HSUP1,HSUP2,NCRNA00275,ZNFX1-AS1;ZNFX1 antisense RNA 1
hsa:6290;SAA3P,SAA3;serum amyloid A3 pseudogene
hsa:100529239;RPS10-NUDT3;RPS10-NUDT3 readthrough
hsa:100529063;BCL2L2-PABPN1;BCL2L2-PABPN1 readthrough
hsa:100529241;HSPE1-MOB4,HSPE1-PHOCN;HSPE1-MOB4 readthrough
hsa:9919;SEC16A,KIAA0310,RP11-413M3.10,SEC16L,p250;SEC16 homolog A (S. cerevisiae) (EC:3.1.3.36)
hsa:693175;MIR590,MIRN590,hsa-mir-590;microRNA 590
hsa:400550;FENDRR,FOXF1-AS1,TCONS_00024240,lincFOXF1;FOXF1 adjacent non-coding developmental regulatory RNA
hsa:7503;XIST,DXS1089,DXS399E,LINC00001,NCRNA00001,SXI1,swd66;X inactive specific transcript (non-protein coding)
hsa:353500;BMP8A;bone morphogenetic protein 8a
hsa:388649;C1orf146,RP11-163M2.4;chromosome 1 open reading frame 146
hsa:337876;CHSY3,CHSY2,CSS3;chondroitin sulfate synthase 3 (EC:2.4.1.175 2.4.1.226)
hsa:349075;ZNF713;zinc finger protein 713
hsa:26112;CCDC69;coiled-coil domain containing 69
hsa:56165;TDRD1,CT41.1;tudor domain containing 1
hsa:57418;WDR18,Ipi3,R32184_1;WD repeat domain 18
hsa:56949;XAB2,HCNP,HCRN,NTC90,SYF1;XPA binding protein 2
hsa:51704;GPRC5B,RAIG-2,RAIG2;G protein-coupled receptor, family C, group 5, member B
hsa:317703;VN1R4,V1RL4;vomeronasal 1 receptor 4
hsa:51042;ZNF593,ZT86;zinc finger protein 593
hsa:23191;CYFIP1,P140SRA-1,SHYC,SRA1;cytoplasmic FMR1 interacting protein 1
hsa:54620;FBXL19,Fbl19,JHDM1C;F-box and leucine-rich repeat protein 19
hsa:79628;SH3TC2,CMT4C,MNMN;SH3 domain and tetratricopeptide repeats 2
hsa:141;ADPRH,ARH1;ADP-ribosylarginine hydrolase (EC:3.2.2.19)
hsa:11108;PRDM4,PFM1;PR domain containing 4
hsa:84627;ZNF469,BCS;zinc finger protein 469
hsa:168544;ZNF467,EZI,Zfp467;zinc finger protein 467
hsa:144983;HNRNPA1L2;heterogeneous nuclear ribonucleoprotein A1-like 2
hsa:84900;RNFT2,TMEM118;ring finger protein, transmembrane 2
hsa:7644;ZNF91,HPF7,HTF10;zinc finger protein 91
hsa:147948;ZNF582;zinc finger protein 582
hsa:780776;TVP23A,FAM18A,YDR084C;trans-golgi network vesicle protein 23 homolog A (S. cerevisiae)
hsa:57683;ZDBF2;zinc finger, DBF-type containing 2
hsa:79624;C6orf211;chromosome 6 open reading frame 211
hsa:56907;SPIRE1,Spir-1;spire homolog 1 (Drosophila)
hsa:7142;TNP2,TP2;transition protein 2 (during histone to protamine replacement)
hsa:646603;C4orf51;chromosome 4 open reading frame 51
hsa:29940;DSE,DSEP,DSEPI,SART-2,SART2;dermatan sulfate epimerase (EC:5.1.3.19)
hsa:2868;GRK4,GPRK2L,GPRK4,GRK4a,IT11;G protein-coupled receptor kinase 4 (EC:2.7.11.16)
hsa:3838;KPNA2,IPOA1,QIP2,RCH1,SRP1alpha;karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
hsa:23355;VPS8,KIAA0804;vacuolar protein sorting 8 homolog (S. cerevisiae)
hsa:51260;PBDC1,CXorf26;polysaccharide biosynthesis domain containing 1
hsa:9260;PDLIM7,LMP1,LMP3;PDZ and LIM domain 7 (enigma)
hsa:203523;ZNF449,ZSCAN19;zinc finger protein 449
hsa:64170;CARD9,CANDF2,hCARD9;caspase recruitment domain family, member 9
hsa:8350;HIST1H3A,H3/A,H3FA;histone cluster 1, H3a
hsa:6721;SREBF2,SREBP2,bHLHd2;sterol regulatory element binding transcription factor 2
hsa:10849;CD3EAP,ASE-1,ASE1,CAST,PAF49;CD3e molecule, epsilon associated protein
hsa:23078;VWA8,KIAA0564;von Willebrand factor A domain containing 8
hsa:8648;NCOA1,F-SRC-1,KAT13A,RIP160,SRC1,bHLHe42,bHLHe74;nuclear receptor coactivator 1 (EC:2.3.1.48)
hsa:51193;ZNF639,6230400O18Rik,ANC-2H01,ANC_2H01,ZASC1;zinc finger protein 639
hsa:374946;DRAXIN,AGPA3119,C1orf187,UNQ3119,neucrin;dorsal inhibitory axon guidance protein
hsa:254359;ZDHHC24;zinc finger, DHHC-type containing 24
hsa:1031;CDKN2C,INK4C,p18,p18-INK4C;cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
hsa:80139;ZNF703,ZEPPO1,ZNF503L,ZPO1;zinc finger protein 703
hsa:5596;MAPK4,ERK-4,ERK3,Erk4,MAPK_4,PRKM4,p63MAPK;mitogen-activated protein kinase 4 (EC:2.7.11.24)
hsa:9520;NPEPPS,AAP-S,MP100,PSA;aminopeptidase puromycin sensitive (EC:3.4.11.14)
hsa:7840;ALMS1,ALSS;Alstrom syndrome 1
hsa:84376;HOOK3,HK3;hook homolog 3 (Drosophila)
hsa:57537;SORCS2;sortilin-related VPS10 domain containing receptor 2
hsa:3398;ID2,GIG8,ID2A,ID2H,bHLHb26;inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
hsa:8935;SKAP2,PRAP,RA70,SAPS,SCAP2,SKAP-HOM,SKAP55R;src kinase associated phosphoprotein 2
hsa:136051;ZNF786;zinc finger protein 786
hsa:283518;KCNRG,DLTET;potassium channel regulator
hsa:148156;ZNF558;zinc finger protein 558
hsa:9560;CCL4L1,AT744.2,CCL4L,LAG-1,LAG1,SCYA4L;chemokine (C-C motif) ligand 4-like 1
hsa:10426;TUBGCP3,GCP3,SPBC98,Spc98p;tubulin, gamma complex associated protein 3
hsa:8352;HIST1H3C,H3.1,H3/c,H3FC;histone cluster 1, H3c
hsa:131540;ZDHHC19,DHHC19;zinc finger, DHHC-type containing 19
hsa:23087;TRIM35,HLS5,MAIR;tripartite motif containing 35
hsa:10793;ZNF273,HZF9;zinc finger protein 273
hsa:11016;ATF7,ATFA;activating transcription factor 7
hsa:148268;ZNF570;zinc finger protein 570
hsa:56157;TEX13A;testis expressed 13A
hsa:1393;CRHBP,CRF-BP,CRFBP;corticotropin releasing hormone binding protein
hsa:8353;HIST1H3E,H3.1,H3/d,H3FD;histone cluster 1, H3e
hsa:10668;CGRRF1,CGR19,RNF197;cell growth regulator with ring finger domain 1
hsa:84331;FAM195A,C16orf14,c349E10.1;family with sequence similarity 195, member A
hsa:23762;OSBP2,ORP-4,ORP4,OSBPL1,OSBPL4;oxysterol binding protein 2
hsa:8354;HIST1H3I,H3.f,H3/f,H3FF;histone cluster 1, H3i
hsa:10794;ZNF460,HZF8,ZNF272;zinc finger protein 460
hsa:338440;ANO9,PIG5,TMEM16J,TP53I5;anoctamin 9
hsa:283820;NOMO2,Nomo,PM5;NODAL modulator 2
hsa:55114;ARHGAP17,MST066,MST110,MSTP038,MSTP066,MSTP110,NADRIN,PP367,PP4534,RICH1,RICH1B,WBP15;Rho GTPase activating protein 17
hsa:80206;FHOD3,FHOS2,Formactin2;formin homology 2 domain containing 3
hsa:27040;LAT,LAT1,pp36;linker for activation of T cells
hsa:49854;ZBTB21,ZNF295;zinc finger and BTB domain containing 21
hsa:56123;PCDHB13,PCDH-BETA13;protocadherin beta 13
hsa:5319;PLA2G1B,PLA2,PLA2A,PPLA2;phospholipase A2, group IB (pancreas) (EC:3.1.1.4)
hsa:93;ACVR2B,ACTRIIB,ActR-IIB,HTX4;activin A receptor, type IIB (EC:2.7.11.30)
hsa:26258;BLOC1S6,HPS9,PA,PALLID,PLDN;biogenesis of lysosomal organelles complex-1, subunit 6, pallidin
hsa:8355;HIST1H3G,H3/h,H3FH;histone cluster 1, H3g
hsa:1298;COL9A2,DJ39G22.4,EDM2,MED,STL5;collagen, type IX, alpha 2
hsa:687;KLF9,BTEB,BTEB1;Kruppel-like factor 9
hsa:6754;SSTR4,SS-4-R,SS4-R,SS4R;somatostatin receptor 4
hsa:56122;PCDHB14,PCDH-BETA14;protocadherin beta 14
hsa:90827;ZNF479,KR19;zinc finger protein 479
hsa:4277;MICB,PERB11.2;MHC class I polypeptide-related sequence B
hsa:149461;CLDN19,HOMG5;claudin 19
hsa:11107;PRDM5,BCS2,PFM2;PR domain containing 5
hsa:391475;DYTN;dystrotelin
hsa:8356;HIST1H3J,H3/j,H3FJ;histone cluster 1, H3j
hsa:8738;CRADD,MRT34,RAIDD;CASP2 and RIPK1 domain containing adaptor with death domain
hsa:11258;DCTN3,DCTN-22,DCTN22;dynactin 3 (p22)
hsa:1503;CTPS1,CTPS;CTP synthase 1 (EC:6.3.4.2)
hsa:221395;GPR116,KPG_001;G protein-coupled receptor 116
hsa:148103;ZNF599;zinc finger protein 599
hsa:56121;PCDHB15,PCDH-BETA15;protocadherin beta 15
hsa:7556;ZNF10,KOX1;zinc finger protein 10
hsa:729201;SPACA5B;sperm acrosome associated 5B (EC:3.2.1.17)
hsa:3642;INSM1,IA-1,IA1;insulinoma-associated 1
hsa:6820;SULT2B1,HSST2;sulfotransferase family, cytosolic, 2B, member 1 (EC:2.8.2.2)
hsa:386653;IL31,IL-31;interleukin 31
hsa:6169;RPL38,L38;ribosomal protein L38
hsa:83259;PCDH11Y,PCDH-PC,PCDH22,PCDHY;protocadherin 11 Y-linked
hsa:9139;CBFA2T2,EHT,MTGR1,ZMYND3,p85;core-binding factor, runt domain, alpha subunit 2;translocated to, 2
hsa:56477;CCL28,CCK1,MEC,SCYA28;chemokine (C-C motif) ligand 28
hsa:7681;MKRN3,D15S9,RNF63,ZFP127,ZNF127;makorin ring finger protein 3
hsa:347734;SLC35B2,PAPST1,SLL,UGTrel4;solute carrier family 35, member B2
hsa:113419;TEX261,TEG-261;testis expressed 261
hsa:255877;BCL6B,BAZF,ZBTB28,ZNF62;B-cell CLL/lymphoma 6, member B
hsa:8358;HIST1H3B,H3/l,H3FL;histone cluster 1, H3b
hsa:51466;EVL,RNB6;Enah/Vasp-like
hsa:6143;RPL19,L19;ribosomal protein L19
hsa:10894;LYVE1,CRSBP-1,HAR,LYVE-1,XLKD1;lymphatic vessel endothelial hyaluronan receptor 1
hsa:158511;CSAG1,CSAGE,CT24.1;chondrosarcoma associated gene 1
hsa:162239;ZFP1,ZNF475;ZFP1 zinc finger protein
hsa:56914;OTOR,FDP,MIAL,MIAL1;otoraplin
hsa:100133171;SPANXB2,SPANX,SPANXB;SPANX family, member B2
hsa:8359;HIST1H4A,H4FA;histone cluster 1, H4a
hsa:10002;NR2E3,ESCS,PNR,RNR,RP37,rd7;nuclear receptor subfamily 2, group E, member 3
hsa:7769;ZNF226;zinc finger protein 226
hsa:23144;ZC3H3,ZC3HDC3;zinc finger CCCH-type containing 3
hsa:245915;DEFB112,DEFB-12;defensin, beta 112
hsa:2016;EMX1;empty spiracles homeobox 1
hsa:378925;RNF148;ring finger protein 148
hsa:4929;NR4A2,HZF-3,NOT,NURR1,RNR1,TINUR;nuclear receptor subfamily 4, group A, member 2
hsa:23386;NUDCD3,NudCL;NudC domain containing 3
hsa:3001;GZMA,CTLA3,HFSP;granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) (EC:3.4.21.78)
hsa:85302;FBF1,Alb,FBF-1;Fas (TNFRSF6) binding factor 1
hsa:387990;TOMM20L,UNQ9438;translocase of outer mitochondrial membrane 20 homolog (yeast)-like
hsa:5582;PRKCG,PKC-gamma,PKCC,PKCG,SCA14;protein kinase C, gamma (EC:2.7.11.13)
hsa:8360;HIST1H4D,H4/b,H4FB,dJ221C16.9;histone cluster 1, H4d
hsa:339;APOBEC1,APOBEC-1,BEDP,CDAR1,HEPR;apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
hsa:4007;PRICKLE3,LMO6;prickle homolog 3 (Drosophila)
hsa:148066;ZNRF4,RNF204,SPERIZIN,Ssrzf1,spzn;zinc and ring finger 4
hsa:245928;DEFB114,DEFB-14;defensin, beta 114
hsa:8683;SRSF9,SFRS9,SRp30c;serine/arginine-rich splicing factor 9
hsa:51035;UBXN1,2B28,SAKS1,UBXD10;UBX domain protein 1
hsa:55182;RNF220,C1orf164;ring finger protein 220
hsa:171489;SPANXE,SPANX-E;SPANX family, member E
hsa:8361;HIST1H4F,H4,H4/c,H4FC;histone cluster 1, H4f
hsa:253461;ZBTB38,CIBZ,ZNF921;zinc finger and BTB domain containing 38
hsa:221823;PRPS1L1,PRPS1,PRPS3,PRPSL,PRS-III;phosphoribosyl pyrophosphate synthetase 1-like 1 (EC:2.7.6.1)
hsa:54923;LIME1,LIME,LP8067,dJ583P15.4;Lck interacting transmembrane adaptor 1
hsa:79598;CEP97,2810403B08Rik,LRRIQ2;centrosomal protein 97kDa
hsa:29074;MRPL18,L18mt,MRP-L18;mitochondrial ribosomal protein L18
hsa:7561;ZNF14,GIOT-4,KOX6;zinc finger protein 14
hsa:79018;GID4,C17orf39,VID24;GID complex subunit 4, VID24 homolog (S. cerevisiae)
hsa:8362;HIST1H4K,H4/d,H4F2iii,H4FD,dJ160A22.1;histone cluster 1, H4k
hsa:388567;ZNF749;zinc finger protein 749
hsa:64663;SPANXC,C,CT11.3,CTp11,SPANX-C;SPANX family, member C
hsa:8445;DYRK2;dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (EC:2.7.12.1)
hsa:79894;ZNF672;zinc finger protein 672
hsa:9559;VPS26A,HB58,Hbeta58,PEP8A,VPS26;vacuolar protein sorting 26 homolog A (S. pombe)
hsa:90441;ZNF622,ZPR9;zinc finger protein 622
hsa:1187;CLCNKA,CLCK1,ClC-K1,hClC-Ka;chloride channel, voltage-sensitive Ka
hsa:84962;AJUBA,JUB;ajuba LIM protein
hsa:7181;NR2C1,TR2;nuclear receptor subfamily 2, group C, member 1
hsa:390637;GDPGP1,C15orf58,VTC2;GDP-D-glucose phosphorylase 1 (EC:2.7.7.78)
hsa:64224;HERPUD2;HERPUD family member 2
hsa:342897;NCCRP1,FBXO50,NCCRP-1;non-specific cytotoxic cell receptor protein 1 homolog (zebrafish)
hsa:8363;HIST1H4J,H4/e,H4F2iv,H4FE,dJ160A22.2;histone cluster 1, H4j
hsa:55659;ZNF416;zinc finger protein 416
hsa:80004;ESRP2,RBM35B;epithelial splicing regulatory protein 2
hsa:8364;HIST1H4C,H4/g,H4FG,dJ221C16.1;histone cluster 1, H4c
hsa:64430;PCNXL4,C14orf135,FBP2;pecanex-like 4 (Drosophila)
hsa:56950;SMYD2,HSKM-B,KMT3C,ZMYND14;SET and MYND domain containing 2 (EC:2.1.1.43)
hsa:7733;ZNF180,HHZ168;zinc finger protein 180
hsa:27133;KCNH5,EAG2,H-EAG2,Kv10.2;potassium voltage-gated channel, subfamily H (eag-related), member 5
hsa:8365;HIST1H4H,H4/h,H4FH;histone cluster 1, H4h
hsa:2960;GTF2E1,FE,TF2E1,TFIIE-A;general transcription factor IIE, polypeptide 1, alpha 56kDa
hsa:387640;SKIDA1,C10orf140,DLN-1;SKI/DACH domain containing 1
hsa:54954;FAM120C,CXorf17,ORF34;family with sequence similarity 120C
hsa:5480;PPIC,CYPC;peptidylprolyl isomerase C (cyclophilin C) (EC:5.2.1.8)
hsa:8805;TRIM24,PTC6,RNF82,TF1A,TIF1,TIF1A,TIF1ALPHA,hTIF1;tripartite motif containing 24
hsa:8366;HIST1H4B,H4/I,H4FI;histone cluster 1, H4b
hsa:79724;ZNF768;zinc finger protein 768
hsa:2671;GFER,ALR,ERV1,HERV1,HPO,HPO1,HPO2,HSS;growth factor, augmenter of liver regeneration (EC:1.8.3.2)
hsa:7763;ZFAND5,ZA20D2,ZFAND5A,ZNF216;zinc finger, AN1-type domain 5
hsa:1974;EIF4A2,BM-010,DDX2B,EIF4A,EIF4F,eIF-4A-II,eIF4A-II;eukaryotic translation initiation factor 4A2 (EC:3.6.4.13)
hsa:9534;ZNF254,BMZF-5,HD-ZNF1,ZNF539,ZNF91L;zinc finger protein 254
hsa:23528;ZNF281,ZBP-99,ZNP-99;zinc finger protein 281
hsa:55422;ZNF331,RITA,ZNF361,ZNF463;zinc finger protein 331
hsa:8367;HIST1H4E,H4/j,H4FJ;histone cluster 1, H4e
hsa:284390;ZNF763,ZNF,ZNF440L;zinc finger protein 763
hsa:343930;MSGN1,MSOG;mesogenin 1
hsa:26036;ZNF451,COASTER,dJ417I1.1;zinc finger protein 451
hsa:80818;ZNF436,ZNF,Zfp46;zinc finger protein 436
hsa:9849;ZNF518A,ZNF518;zinc finger protein 518A
hsa:1070;CETN3,CEN3;centrin, EF-hand protein, 3
hsa:8368;HIST1H4L,H4.k,H4/k,H4FK;histone cluster 1, H4l
hsa:23354;HAUS5,KIAA0841,dgt5;HAUS augmin-like complex, subunit 5
hsa:9507;ADAMTS4,ADAMTS-2,ADAMTS-4,ADMP-1;ADAM metallopeptidase with thrombospondin type 1 motif, 4 (EC:3.4.24.82)
hsa:8369;HIST1H4G,H4/l,H4FL;histone cluster 1, H4g
hsa:8110;DPF3,CERD4;D4, zinc and double PHD fingers, family 3
hsa:26043;UBXN7,UBXD7;UBX domain protein 7
hsa:9601;PDIA4,ERP70,ERP72,ERp-72;protein disulfide isomerase family A, member 4 (EC:5.3.4.1)
hsa:554313;HIST2H4B,H4/o;histone cluster 2, H4b
hsa:54439;RBM27,ARRS1,Psc1,ZC3H18;RNA binding motif protein 27
hsa:166785;MMAA,cblA;methylmalonic aciduria (cobalamin deficiency) cblA type
hsa:431705;ASTL;astacin-like metallo-endopeptidase (M12 family) (EC:3.4.24.21)
hsa:4053;LTBP2,C14orf141,GLC3D,LTBP3,MSPKA,MSTP031,WMS3;latent transforming growth factor beta binding protein 2
hsa:23279;NUP160;nucleoporin 160kDa
hsa:100008586;GAGE12F;G antigen 12F
hsa:55666;NPLOC4,NPL4;nuclear protein localization 4 homolog (S. cerevisiae)
hsa:83637;ZMIZ2,NET27,TRAFIP20,ZIMP7,hZIMP7;zinc finger, MIZ-type containing 2
hsa:257629;ANKS4B,HARP;ankyrin repeat and sterile alpha motif domain containing 4B
hsa:51015;ISOC1;isochorismatase domain containing 1
hsa:26266;SLC13A4,SUT-1,SUT1;solute carrier family 13 (sodium/sulfate symporters), member 4
hsa:168374;ZNF92,HPF12,HTF12,TF12;zinc finger protein 92
hsa:152485;ZNF827;zinc finger protein 827
hsa:10782;ZNF274,HFB101,ZF2,ZKSCAN19,ZSCAN51;zinc finger protein 274
hsa:84709;MGARP,C4orf49,CESP-1,HUMMR,OSAP;mitochondria-localized glutamic acid-rich protein
hsa:116412;ZNF837;zinc finger protein 837
hsa:4124;MAN2A1,GOLIM7,MANA2,MANII;mannosidase, alpha, class 2A, member 1 (EC:3.2.1.114)
hsa:23024;PDZRN3,LNX3,SEMACAP3;PDZ domain containing ring finger 3
hsa:138715;ARID3C;AT rich interactive domain 3C (BRIGHT-like)
hsa:58531;PRM3;protamine 3
hsa:6128;RPL6,L6,SHUJUN-2,TAXREB107,TXREB1;ribosomal protein L6
hsa:25797;QPCT,GCT,QC,sQC;glutaminyl-peptide cyclotransferase (EC:2.3.2.5)
hsa:7691;ZNF132,pHZ-12;zinc finger protein 132
hsa:9487;PIGL,CHIME;phosphatidylinositol glycan anchor biosynthesis, class L (EC:3.5.1.89)
hsa:285671;RNF180;ring finger protein 180
hsa:23732;FRRS1L,C9orf4,CG-6,CG6;ferric-chelate reductase 1-like
hsa:255313;CT47A11,CT47.11;cancer/testis antigen family 47, member A11
hsa:1010;CDH12,CDHB;cadherin 12, type 2 (N-cadherin 2)
hsa:283600;SLC25A47,C14orf68,HDMCP;solute carrier family 25, member 47
hsa:333932;HIST2H3A,H3/n,H3/o;histone cluster 2, H3a
hsa:84295;PHF6,BFLS,BORJ,CENP-31;PHD finger protein 6
hsa:285533;RNF175;ring finger protein 175
hsa:10084;PQBP1,MRX55,MRXS3,MRXS8,NPW38,RENS1,SHS;polyglutamine binding protein 1
hsa:119016;AGAP4,CTGLF1,MRIP2;ArfGAP with GTPase domain, ankyrin repeat and PH domain 4
hsa:56985;ADPRM,C17orf48,NBLA03831;ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent (EC:3.6.1.13 3.6.1.16 3.6.1.53)
hsa:10130;PDIA6,ERP5,P5,TXNDC7;protein disulfide isomerase family A, member 6 (EC:5.3.4.1)
hsa:134492;NUDCD2;NudC domain containing 2
hsa:7637;ZNF84,HPF2;zinc finger protein 84
hsa:402117;VWC2L;von Willebrand factor C domain containing protein 2-like
hsa:728036;CT47A10,CT47,CT47.10;cancer/testis antigen family 47, member A10
hsa:57292;KIR2DL5A,CD158F,KIR2DL5,KIR2DL5.1,KIR2DL5.3,KIR2DL5B;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
hsa:25924;MYRIP,SLAC2-C,SLAC2C;myosin VIIA and Rab interacting protein
hsa:23040;MYT1L,NZF1,ZC2HC4B;myelin transcription factor 1-like
hsa:220441;RNF152;ring finger protein 152
hsa:3047;HBG1,HBGA,HBGR,HSGGL1;hemoglobin, gamma A
hsa:4951;OCM2,OCM;oncomodulin 2
hsa:286827;TRIM59,MRF1,RNF104,TRIM57,TSBF1;tripartite motif containing 59
hsa:3716;JAK1,JAK1A,JAK1B,JTK3;Janus kinase 1 (EC:2.7.10.2)
hsa:658;BMPR1B,ALK-6,ALK6,CDw293;bone morphogenetic protein receptor, type IB (EC:2.7.11.30)
hsa:6519;SLC3A1,ATR1,CSNU1,D2H,NBAT,RBAT;solute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 1
hsa:729447;GAGE2A,CT4.2,GAGE-2,GAGE-2A,GAGE2;G antigen 2A
hsa:51202;DDX47,E4-DBP,HQ0256,MSTP162,RRP3;DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 (EC:3.6.4.13)
hsa:728042;CT47A9,CT47.9;cancer/testis antigen family 47, member A9
hsa:1404;HAPLN1,CRTL1;hyaluronan and proteoglycan link protein 1
hsa:3048;HBG2,TNCY;hemoglobin, gamma G
hsa:10753;CAPN9,GC36,nCL-4;calpain 9 (EC:3.4.22.-)
hsa:59348;ZNF350,ZBRK1,ZFQR;zinc finger protein 350
hsa:168850;ZNF800;zinc finger protein 800
hsa:9202;ZMYM4,CDIR,MYM,ZNF198L3,ZNF262;zinc finger, MYM-type 4
hsa:7779;SLC30A1,ZNT1,ZRC1;solute carrier family 30 (zinc transporter), member 1
hsa:79149;ZSCAN5A,ZNF495,ZSCAN5;zinc finger and SCAN domain containing 5A
hsa:27338;UBE2S,E2-EPF,E2EPF,EPF5;ubiquitin-conjugating enzyme E2S (EC:6.3.2.19)
hsa:219578;ZNF804B;zinc finger protein 804B
hsa:29128;UHRF1,ICBP90,Np95,RNF106,hNP95,hUHRF1;ubiquitin-like with PHD and ring finger domains 1 (EC:6.3.2.19)
hsa:7043;TGFB3,ARVD,TGF-beta3;transforming growth factor, beta 3
hsa:11136;SLC7A9,BAT1,CSNU3;solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9
hsa:728049;CT47A8,CT47.8;cancer/testis antigen family 47, member A8
hsa:26009;ZZZ3,ATAC1;zinc finger, ZZ-type containing 3
hsa:978;CDA,CDD;cytidine deaminase (EC:3.5.4.5)
hsa:84838;ZNF496,NIZP1,ZFP496,ZKSCAN17,ZSCAN49;zinc finger protein 496
hsa:10472;ZBTB18,C2H2-171,RP58,TAZ-1,ZNF238;zinc finger and BTB domain containing 18
hsa:56254;RNF20,BRE1,BRE1A,hBRE1;ring finger protein 20, E3 ubiquitin protein ligase
hsa:7553;ZNF7,HF.16,KOX4,zf30;zinc finger protein 7
hsa:386684;KRTAP12-4,KRTAP12.4;keratin associated protein 12-4
hsa:3799;KIF5B,KINH,KNS,KNS1,UKHC;kinesin family member 5B
hsa:6920;TCEA3,TFIIS,TFIIS.H;transcription elongation factor A (SII), 3
hsa:79891;ZNF671;zinc finger protein 671
hsa:91978;TPGS1,C19orf20,GTRGEO22,PGs1;tubulin polyglutamylase complex subunit 1
hsa:51538;ZCCHC17,HSPC251,PS1D,RP11-266K22.1,pNO40;zinc finger, CCHC domain containing 17
hsa:541465;CT45A6,CT45-6,CT45.6;cancer/testis antigen family 45, member A6
hsa:161424;NOP9,C14orf21;NOP9 nucleolar protein
hsa:5318;PKP2,ARVD9;plakophilin 2
hsa:391013;PLA2G2C;phospholipase A2, group IIC (EC:3.1.1.4)
hsa:10026;PIGK,GPI8;phosphatidylinositol glycan anchor biosynthesis, class K (EC:3.-.-.-)
hsa:9204;ZMYM6,Buster2,MYM,ZNF198L4,ZNF258;zinc finger, MYM-type 6
hsa:11344;TWF2,A6RP,A6r,PTK9L;twinfilin, actin-binding protein, homolog 2 (Drosophila)
hsa:3730;KAL1,ADMLX,HH1,HHA,KAL,KALIG-1,KMS,WFDC19;Kallmann syndrome 1 sequence
hsa:9154;SLC28A1,CNT1,HCNT1;solute carrier family 28 (sodium-coupled nucleoside transporter), member 1
hsa:163115;ZNF781;zinc finger protein 781
hsa:153527;ZMAT2,Ptg-12,Snu23,hSNU23;zinc finger, matrin-type 2
hsa:4090;SMAD5,DWFC,JV5-1,MADH5;SMAD family member 5
hsa:51673;TPPP3,p20,p25gamma;tubulin polymerization-promoting protein family member 3
hsa:548596;CKMT1A,CKMT1;creatine kinase, mitochondrial 1A (EC:2.7.3.2)
hsa:57533;TBC1D14;TBC1 domain family, member 14
hsa:51499;TRIAP1,MDM35,P53CSV,WF-1;TP53 regulated inhibitor of apoptosis 1
hsa:317761;C14orf39,Six6os1;chromosome 14 open reading frame 39
hsa:653282;CT47A7,CT47.7;cancer/testis antigen family 47, member A7
hsa:7525;YES1,HsT441,P61-YES,Yes,c-yes;v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 (EC:2.7.10.2)
hsa:3622;ING2,ING1L,p33ING2;inhibitor of growth family, member 2
hsa:80863;PRRT1,C6orf31,DSPD1,IFITMD7,NG5;proline-rich transmembrane protein 1
hsa:81029;WNT5B;wingless-type MMTV integration site family, member 5B
hsa:115196;ZNF554;zinc finger protein 554
hsa:2893;GRIA4,GLUR4,GLUR4C,GLURD,GluA4;glutamate receptor, ionotropic, AMPA 4
hsa:1387;CREBBP,CBP,KAT3A,RSTS;CREB binding protein (EC:2.3.1.48)
hsa:728062;CT47A6,CT47.6;cancer/testis antigen family 47, member A6
hsa:114991;ZNF618,FP13169,NEDD10;zinc finger protein 618
hsa:23613;ZMYND8,PRKCBP1,PRO2893,RACK7;zinc finger, MYND-type containing 8
hsa:26974;ZNF285,ZNF285A;zinc finger protein 285
hsa:200350;FOXD4L1,FOXD5,bA395L14.1;forkhead box D4-like 1
hsa:6096;RORB,NR1F2,ROR-BETA,RZR-BETA,RZRB,bA133M9.1;RAR-related orphan receptor B
hsa:90075;ZNF30,KOX28;zinc finger protein 30
hsa:10861;SLC26A1,EDM4,SAT-1,SAT1;solute carrier family 26 (sulfate transporter), member 1
hsa:54904;WHSC1L1,NSD3,pp14328;Wolf-Hirschhorn syndrome candidate 1-like 1 (EC:2.1.1.43)
hsa:7589;ZSCAN21,NY-REN-21,ZNF38,Zipro1;zinc finger and SCAN domain containing 21
hsa:728072;CT47A5,CT47.5;cancer/testis antigen family 47, member A5
hsa:125950;RAVER1;ribonucleoprotein, PTB-binding 1
hsa:1414;CRYBB1,CATCN3;crystallin, beta B1
hsa:377047;PRSS45,TESSP5;protease, serine, 45 (EC:3.4.21.-)
hsa:1877;E4F1,E4F;E4F transcription factor 1
hsa:1107;CHD3,Mi-2a,Mi2-ALPHA,ZFH;chromodomain helicase DNA binding protein 3 (EC:3.6.4.12)
hsa:55889;GOLGA6B,GOLGA,GOLGA6D;golgin A6 family, member B
hsa:308;ANXA5,ANX5,ENX2,PP4,RPRGL3;annexin A5
hsa:377677;CA13,CAXIII;carbonic anhydrase XIII (EC:4.2.1.1)
hsa:199777;ZNF626;zinc finger protein 626
hsa:728075;CT47A4,CT47.4;cancer/testis antigen family 47, member A4
hsa:79788;ZNF665,ZFP160L;zinc finger protein 665
hsa:8407;TAGLN2,HA1756;transgelin 2
hsa:387680;FAM21A,bA56A21.1;family with sequence similarity 21, member A
hsa:6701;SPRR2B;small proline-rich protein 2B
hsa:339229;OXLD1,C17orf90;oxidoreductase-like domain containing 1
hsa:26061;HACL1,2-HPCL,HPCL,HPCL2,PHYH2;2-hydroxyacyl-CoA lyase 1
hsa:359710;BPIFB3,C20orf185,LPLUNC3,RYA3,dJ726C3.4;BPI fold containing family B, member 3
hsa:6940;ZNF354A,EZNF,HKL1,KID-1,KID1,TCF17;zinc finger protein 354A
hsa:26017;FAM32A,OTAG-12,OTAG12;family with sequence similarity 32, member A
hsa:9694;EMC2,KIAA0103,TTC35;ER membrane protein complex subunit 2
hsa:117584;RFFL,CARP-2,CARP2,FRING,RIFIFYLIN,RNF189,RNF34L;ring finger and FYVE-like domain containing E3 ubiquitin protein ligase
hsa:55079;FEZF2,FEZ,FEZL,TOF,ZFP312,ZNF312;FEZ family zinc finger 2
hsa:10107;TRIM10,HERF1,RFB30,RNF9;tripartite motif containing 10
hsa:440585;FAM183A;family with sequence similarity 183, member A
hsa:26519;TIMM10,TIM10,TIM10A;translocase of inner mitochondrial membrane 10 homolog (yeast)
hsa:285971;ZNF775;zinc finger protein 775
hsa:1497;CTNS,CTNS-LSB,PQLC4;cystinosin, lysosomal cystine transporter
hsa:728082;CT47A3,CT47.3;cancer/testis antigen family 47, member A3
hsa:150356;CHADL,SLRR4B;chondroadherin-like
hsa:84878;ZBTB45,ZNF499;zinc finger and BTB domain containing 45
hsa:8637;EIF4EBP3,4E-BP3,4EBP3;eukaryotic translation initiation factor 4E binding protein 3
hsa:65012;SLC26A10;solute carrier family 26, member 10
hsa:1146;CHRNG,ACHRG;cholinergic receptor, nicotinic, gamma (muscle)
hsa:54756;IL17RD,IL-17RD,IL17RLM,SEF;interleukin 17 receptor D
hsa:26011;TENM4,Doc4,ODZ4,TNM4,Ten-M4;teneurin transmembrane protein 4
hsa:8120;AP3B2,NAPTB;adaptor-related protein complex 3, beta 2 subunit
hsa:64949;MRPS26,C20orf193,GI008,MRP-S13,MRP-S26,MRPS13,NY-BR-87,RPMS13,dJ534B8.3;mitochondrial ribosomal protein S26
hsa:57659;ZBTB4,KAISO-L1,ZNF903;zinc finger and BTB domain containing 4
hsa:728090;CT47A2,CT47.2;cancer/testis antigen family 47, member A2
hsa:51222;ZNF219,ZFP219;zinc finger protein 219
hsa:55722;CEP72;centrosomal protein 72kDa
hsa:121536;AEBP2;AE binding protein 2
hsa:22846;VASH1,KIAA1036;vasohibin 1
hsa:7597;ZBTB25,C14orf51,KUP,ZNF46;zinc finger and BTB domain containing 25
hsa:388021;TMEM179,C14orf90,TMEM179A;transmembrane protein 179
hsa:54546;RNF186,RP11-91K11.1;ring finger protein 186
hsa:375757;SWI5,C9orf119,bA395P17.9;SWI5 recombination repair homolog (yeast)
hsa:162333;MARCH10,MARCH-X,RNF190;membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase
hsa:54799;MBTD1,SA49P01;mbt domain containing 1
hsa:9640;ZNF592,CAMOS,SCAR5;zinc finger protein 592
hsa:5048;PAFAH1B1,LIS1,LIS2,MDCR,MDS,PAFAH;platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) (EC:3.1.1.47)
hsa:197021;LCTL,KLG,KLPH;lactase-like
hsa:199704;ZNF585A;zinc finger protein 585A
hsa:728096;CT47A1,CT47.1;cancer/testis antigen family 47, member A1
hsa:6015;RING1,RING1A,RNF1;ring finger protein 1
hsa:57590;WDFY1,FENS-1,WDF1,ZFYVE17;WD repeat and FYVE domain containing 1
hsa:51234;EMC4,PIG17,TMEM85;ER membrane protein complex subunit 4
hsa:170261;ZCCHC12,PNMA7A,SIZN,SIZN1;zinc finger, CCHC domain containing 12
hsa:6715;SRD5A1,S5AR_1;steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) (EC:1.3.1.22)
hsa:1007;CDH9;cadherin 9, type 2 (T1-cadherin)
hsa:7762;ZNF215,BAZ-2,BAZ2,ZKSCAN11,ZSCAN43;zinc finger protein 215
hsa:96459;FNIP1;folliculin interacting protein 1
hsa:7692;ZNF133,ZNF150,pHZ-13,pHZ-66;zinc finger protein 133
hsa:146434;ZNF597;zinc finger protein 597
hsa:51529;ANAPC11,APC11,Apc11p;anaphase promoting complex subunit 11
hsa:54838;WBP1L,C10orf26,OPA1L,OPAL1;WW domain binding protein 1-like
hsa:84085;FBXO30,Fbx30;F-box protein 30
hsa:767;CA8,CA-VIII,CALS,CAMRQ3,CARP;carbonic anhydrase VIII (EC:4.2.1.1)
hsa:8927;BSN,ZNF231;bassoon presynaptic cytomatrix protein
hsa:64499;TPSB2,TPS2,tryptaseB,tryptaseC;tryptase beta 2 (gene/pseudogene) (EC:3.4.21.59)
hsa:2687;GGT5,GGT-REL,GGTLA1;gamma-glutamyltransferase 5 (EC:2.3.2.2 3.4.19.13 3.4.19.14)
hsa:4908;NTF3,HDNF,NGF-2,NGF2,NT3;neurotrophin 3
hsa:53917;RAB24;RAB24, member RAS oncogene family
hsa:2937;GSS,GSHS;glutathione synthetase (EC:6.3.2.3)
hsa:3850;KRT3,CK3,K3;keratin 3
hsa:114798;SLITRK1,LRRC12,RP11-395N17.1,TTM;SLIT and NTRK-like family, member 1
hsa:7673;ZNF222;zinc finger protein 222
hsa:51427;ZNF107,Y8,ZFD25,ZNF588,smap-7;zinc finger protein 107
hsa:84851;TRIM52,RNF102;tripartite motif containing 52
hsa:23390;ZDHHC17,HIP14,HIP3,HYPH;zinc finger, DHHC-type containing 17
hsa:387032;ZKSCAN4,P1P373C6,ZNF307,ZNF427,ZSCAN36,p373c6.1;zinc finger with KRAB and SCAN domains 4
hsa:201625;DNAH12,DHC3,DLP12,DNAH12L,DNAH7L,DNAHC12,DNAHC3,DNHD2,HDHC3,HL-19,HL19;dynein, axonemal, heavy chain 12
hsa:56851;EMC7,C11orf3,C15orf24,ORF1-FL1;ER membrane protein complex subunit 7
hsa:290;ANPEP,APN,CD13,GP150,LAP1,P150,PEPN;alanyl (membrane) aminopeptidase (EC:3.4.11.2)
hsa:28951;TRIB2,C5FW,GS3955,TRB2;tribbles homolog 2 (Drosophila)
hsa:9310;ZNF235,ANF270,HZF6,ZFP93,ZNF270;zinc finger protein 235
hsa:7566;ZNF18,HDSG1,KOX11,ZKSCAN6,ZNF535,ZSCAN38,Zfp535;zinc finger protein 18
hsa:7745;ZKSCAN8,LD5-1,ZNF192,ZSCAN40;zinc finger with KRAB and SCAN domains 8
hsa:387778;SPDYC,RINGOC,Ringo2;speedy homolog C (Xenopus laevis)
hsa:26175;TMEM251,C14orf109;transmembrane protein 251
hsa:36;ACADSB,2-MEBCAD,ACAD7,SBCAD;acyl-CoA dehydrogenase, short/branched chain (EC:1.3.8.5)
hsa:170690;ADAMTS16,ADAMTS16s;ADAM metallopeptidase with thrombospondin type 1 motif, 16
hsa:57449;PLEKHG5,DSMA4,GEF720,Syx,Tech;pleckstrin homology domain containing, family G (with RhoGef domain) member 5
hsa:4666;NACA,NACA1;nascent polypeptide-associated complex alpha subunit (EC:5.3.99.3)
hsa:2672;GFI1,GFI-1,GFI1A,SCN2,ZNF163;growth factor independent 1 transcription repressor
hsa:10723;SLC12A7,KCC4;solute carrier family 12 (potassium/chloride transporters), member 7
hsa:55274;PHF10,BAF45A,XAP135;PHD finger protein 10
hsa:440153;OR11H12;olfactory receptor, family 11, subfamily H, member 12
hsa:55041;PLEKHB2,EVT2;pleckstrin homology domain containing, family B (evectins) member 2
hsa:9921;RNF10,RIE2;ring finger protein 10
hsa:163033;ZNF579;zinc finger protein 579
hsa:733;C8G,C8C;complement component 8, gamma polypeptide
hsa:4632;MYL1,MLC1F,MLC3F;myosin, light chain 1, alkali;skeletal, fast
hsa:11095;ADAMTS8,ADAM-TS8,METH2;ADAM metallopeptidase with thrombospondin type 1 motif, 8
hsa:56990;CDC42SE2,SPEC2;CDC42 small effector 2
hsa:284312;ZSCAN1,MZF-1,ZNF915;zinc finger and SCAN domain containing 1
hsa:53405;CLIC5,MST130,MSTP130;chloride intracellular channel 5
hsa:151636;DTX3L,BBAP;deltex 3-like (Drosophila)
hsa:58496;LY6G5B,C6orf19,G5b;lymphocyte antigen 6 complex, locus G5B
hsa:730394;GTF2H2D;general transcription factor IIH, polypeptide 2D
hsa:5032;P2RY11,P2Y11;purinergic receptor P2Y, G-protein coupled, 11
hsa:338761;C1QL4,C1QTNF11,CTRP11;complement component 1, q subcomponent-like 4
hsa:26584;DUX1;double homeobox 1
hsa:134218;DNAJC21,DNAJA5,GS3,JJJ1;DnaJ (Hsp40) homolog, subfamily C, member 21
hsa:57604;C8orf79;KIAA1456
hsa:23051;ZHX3,TIX1;zinc fingers and homeoboxes 3
hsa:6194;RPS6,S6;ribosomal protein S6
hsa:84902;CEP89,CCDC123;centrosomal protein 89kDa
hsa:386677;KRTAP10-1,KAP10.1,KAP18-1,KAP18.1,KRTAP10.1,KRTAP18-1,KRTAP18.1;keratin associated protein 10-1
hsa:9355;LHX2,LH2,hLhx2;LIM homeobox 2
hsa:6345;SRL;sarcalumenin
hsa:54345;SOX18,HLTS;SRY (sex determining region Y)-box 18
hsa:10172;ZNF256,BMZF-3,BMZF3;zinc finger protein 256
hsa:4496;MT1H,MT-0,MT-1H,MT-IH,MT1;metallothionein 1H
hsa:51329;ARL6IP4,SFRS20,SR-25,SRp25,SRrp37;ADP-ribosylation-like factor 6 interacting protein 4
hsa:5740;PTGIS,CYP8,CYP8A1,PGIS,PTGI;prostaglandin I2 (prostacyclin) synthase (EC:5.3.99.4)
hsa:201514;ZNF584;zinc finger protein 584
hsa:441525;SPANXN4,CT11.9;SPANX family, member N4
hsa:51276;ZNF571;zinc finger protein 571
hsa:152518;NFXL1,HOZFP,URCC5;nuclear transcription factor, X-box binding-like 1
hsa:2971;GTF3A,AP2,TFIIIA;general transcription factor IIIA
hsa:7775;ZNF232,ZSCAN11;zinc finger protein 232
hsa:11337;GABARAP,ATG8A,GABARAP-a,MM46;GABA(A) receptor-associated protein
hsa:9830;TRIM14;tripartite motif containing 14
hsa:51533;PHF7,HSPC045,HSPC226,NYD-SP6;PHD finger protein 7
hsa:402381;SOHLH1,C9orf157,NOHLH,SPATA27,TEB2,bA100C15.3,bHLHe80;spermatogenesis and oogenesis specific basic helix-loop-helix 1
hsa:100137047;JMJD7;jumonji domain containing 7 (EC:3.1.1.4)
hsa:343990;KIAA1211L,C2orf55;KIAA1211-like
hsa:3021;H3F3B,H3.3B;H3 histone, family 3B (H3.3B)
hsa:7776;ZNF236,ZNF236A,ZNF236B;zinc finger protein 236
hsa:8748;ADAM20;ADAM metallopeptidase domain 20
hsa:23519;ANP32D,PP32R2;acidic (leucine-rich) nuclear phosphoprotein 32 family, member D
hsa:7753;ZNF202,ZKSCAN10,ZSCAN42;zinc finger protein 202
hsa:28989;NTMT1,AD-003,C9orf32,HOMT1A,METTL11A,NRMT,NTM1A;N-terminal Xaa-Pro-Lys N-methyltransferase 1 (EC:2.1.1.244)
hsa:390927;ZNF793;zinc finger protein 793
hsa:147;ADRA1B,ADRA1,ALPHA1BAR;adrenoceptor alpha 1B
hsa:259296;TAS2R50,T2R50,T2R51,TAS2R51;taste receptor, type 2, member 50
hsa:26994;RNF11,SID1669;ring finger protein 11
hsa:9473;THEMIS2,C1orf38,ICB-1;thymocyte selection associated family member 2
hsa:401251;SAPCD1,C6orf26,NG23;suppressor APC domain containing 1
hsa:4166;CHST6,MCDC1;carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6
hsa:60676;PAPPA2,PAPP-A2,PAPP-E,PAPPE,PLAC3;pappalysin 2
hsa:6834;SURF1;surfeit 1 (EC:1.9.3.1)
hsa:55075;UACA,NUCLING;uveal autoantigen with coiled-coil domains and ankyrin repeats
hsa:222484;LNX2,PDZRN1;ligand of numb-protein X 2
hsa:342132;ZNF774;zinc finger protein 774
hsa:284361;EMC10,C19orf63,HSM1,HSS1,INM02;ER membrane protein complex subunit 10
hsa:27141;CIDEB;cell death-inducing DFFA-like effector b
hsa:5229;PGGT1B,BGGI,GGTI;protein geranylgeranyltransferase type I, beta subunit (EC:2.5.1.59)
hsa:353088;ZNF429;zinc finger protein 429
hsa:158234;TRMT10B,RG9MTD3,RP11-3J10.9,bA3J10.9;tRNA methyltransferase 10 homolog B (S. cerevisiae)
hsa:57343;ZNF304;zinc finger protein 304
hsa:7551;ZNF3,A8-51,HF.12,KOX25,PP838,Zfp113;zinc finger protein 3
hsa:84684;INSM2,IA-6,IA6,mlt1;insulinoma-associated 2
hsa:56097;PCDHGC5,PCDH-GAMMA-C5;protocadherin gamma subfamily C, 5
hsa:400591;C17orf102;chromosome 17 open reading frame 102
hsa:339327;ZNF546,ZNF49;zinc finger protein 546
hsa:280;AMY2B,AMY2;amylase, alpha 2B (pancreatic) (EC:3.2.1.1)
hsa:56098;PCDHGC4,PCDH-GAMMA-C4;protocadherin gamma subfamily C, 4
hsa:399949;C11orf88;chromosome 11 open reading frame 88
hsa:29911;HOOK2,HK2;hook homolog 2 (Drosophila)
hsa:51274;KLF3,BKLF;Kruppel-like factor 3 (basic)
hsa:2817;GPC1,glypican;glypican 1
hsa:952;CD38,T10;CD38 molecule (EC:3.2.2.5)
hsa:79840;NHEJ1,XLF;nonhomologous end-joining factor 1
hsa:23321;TRIM2,RNF86;tripartite motif containing 2
hsa:56154;TEX15,CT42;testis expressed 15
hsa:79175;ZNF343,dJ734P14.5;zinc finger protein 343
hsa:163071;ZNF114;zinc finger protein 114
hsa:54541;DDIT4,Dig2,REDD-1,REDD1;DNA-damage-inducible transcript 4
hsa:85378;TUBGCP6,GCP-6,GCP6,MCCRP,MCPHCR;tubulin, gamma complex associated protein 6
hsa:7706;TRIM25,EFP,RNF147,Z147,ZNF147;tripartite motif containing 25 (EC:6.3.2.19 6.3.2.n3)
hsa:22954;TRIM32,BBS11,HT2A,LGMD2H,TATIP;tripartite motif containing 32
hsa:162962;ZNF836;zinc finger protein 836
hsa:246184;CDC26,ANAPC12,APC12,C9orf17;cell division cycle 26
hsa:54659;UGT1A3,UDPGT,UDPGT_1-3,UGT-1C,UGT1-03,UGT1.3,UGT1C;UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17)
hsa:6038;RNASE4,RNS4;ribonuclease, RNase A family, 4 (EC:3.1.27.-)
hsa:54816;ZNF280D,SUHW4,ZNF634;zinc finger protein 280D
hsa:113540;CMTM1,CKLFH,CKLFH1,CKLFSF1;CKLF-like MARVEL transmembrane domain containing 1
hsa:56100;PCDHGB6,PCDH-GAMMA-B6;protocadherin gamma subfamily B, 6
hsa:25974;MMACHC,RP11-291L19.3,cblC;methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria
hsa:140596;DEFB104A,BD-4,DEFB-4,DEFB104,DEFB4,hBD-4;defensin, beta 104A
hsa:55611;OTUB1,OTB1,OTU1;OTU domain, ubiquitin aldehyde binding 1 (EC:3.4.19.12)
hsa:11096;ADAMTS5,ADAM-TS_11,ADAM-TS_5,ADAM-TS5,ADAMTS-11,ADAMTS-5,ADAMTS11,ADMP-2;ADAM metallopeptidase with thrombospondin type 1 motif, 5
hsa:390443;RNASE9,HEL128,h461;ribonuclease, RNase A family, 9 (non-active)
hsa:10787;NCKAP1,HEM2,NAP1,NAP125;NCK-associated protein 1
hsa:164832;LONRF2,RNF192;LON peptidase N-terminal domain and ring finger 2
hsa:56101;PCDHGB5,PCDH-GAMMA-B5;protocadherin gamma subfamily B, 5
hsa:135892;TRIM50,TRIM50A;tripartite motif containing 50
hsa:284459;HKR1,ZNF875;HKR1, GLI-Kruppel zinc finger family member
hsa:84614;ZBTB37,D430004I08Rik,ZNF908;zinc finger and BTB domain containing 37
hsa:56922;MCCC1,MCC-B,MCCA;methylcrotonoyl-CoA carboxylase 1 (alpha) (EC:6.4.1.4)
hsa:81539;SLC38A1,ATA1,NAT2,SAT1,SNAT1;solute carrier family 38, member 1
hsa:50626;CYHR1,CHRP;cysteine/histidine-rich 1
hsa:122183;PRR20A,PRR20;proline rich 20A
hsa:7516;XRCC2;X-ray repair complementing defective repair in Chinese hamster cells 2
hsa:56102;PCDHGB3,PCDH-GAMMA-B3;protocadherin gamma subfamily B, 3
hsa:64324;NSD1,ARA267,KMT3B,SOTOS,SOTOS1,STO;nuclear receptor binding SET domain protein 1 (EC:2.1.1.43)
hsa:729233;PRR20B;proline rich 20B
hsa:56103;PCDHGB2,PCDH-GAMMA-B2;protocadherin gamma subfamily B, 2
hsa:125476;INO80C,C18orf37,IES6,hIes6;INO80 complex subunit C
hsa:201243;C17orf74;chromosome 17 open reading frame 74
hsa:126070;ZNF440;zinc finger protein 440
hsa:55069;TMEM248,C7orf42;transmembrane protein 248
hsa:2528;FUT6,FCT3A,FT1A,Fuc-TVI,FucT-VI;fucosyltransferase 6 (alpha (1,3) fucosyltransferase) (EC:2.4.1.65)
hsa:79960;PHF17,JADE1;PHD finger protein 17
hsa:51084;CRYL1,GDH,lambda-CRY;crystallin, lambda 1 (EC:1.1.1.45)
hsa:729240;PRR20C;proline rich 20C
hsa:1466;CSRP2,CRP2,LMO5,SmLIM;cysteine and glycine-rich protein 2
hsa:11339;OIP5,5730547N13Rik,CT86,LINT-25,MIS18B,MIS18beta,hMIS18beta;Opa interacting protein 5
hsa:56104;PCDHGB1,PCDH-GAMMA-B1;protocadherin gamma subfamily B, 1
hsa:375593;TRIM73,TRIM50B;tripartite motif containing 73
hsa:83650;SLC35G5,AMAC,AMAC1L2;solute carrier family 35, member G5
hsa:55330;BLOC1S4,BCAS4L,CNO;biogenesis of lysosomal organelles complex-1, subunit 4, cappuccino
hsa:146845;WDR16,WDRPUH;WD repeat domain 16
hsa:729246;PRR20D;proline rich 20D
hsa:30834;ZNRD1,HTEX-6,Rpa12,TEX6,hZR14,tctex-6;zinc ribbon domain containing 1 (EC:2.7.7.6)
hsa:55900;ZNF302,HSD16,MST154,MSTP154,ZNF135L,ZNF140L,ZNF327;zinc finger protein 302
hsa:56105;PCDHGA11,PCDH-GAMMA-A11;protocadherin gamma subfamily A, 11
hsa:2116;ETV2,ER71,ETSRP71;ets variant 2
hsa:54836;BSPRY;B-box and SPRY domain containing
hsa:9967;THRAP3,TRAP150;thyroid hormone receptor associated protein 3
hsa:350383;GPR142,PGR2;G protein-coupled receptor 142
hsa:1806;DPYD,DHP,DHPDHASE,DPD;dihydropyrimidine dehydrogenase (EC:1.3.1.2)
hsa:729250;PRR20E;proline rich 20E
hsa:7571;ZNF23,KOX16,ZNF359,ZNF612,Zfp612;zinc finger protein 23
hsa:124912;SPACA3,1700025M08Rik,ALLP17,CT54,LYC3,LYZL3,SLLP1;sperm acrosome associated 3
hsa:5510;PPP1R7,SDS22;protein phosphatase 1, regulatory subunit 7
hsa:283431;GAS2L3,G2L3;growth arrest-specific 2 like 3
hsa:56106;PCDHGA10,PCDH-GAMMA-A10;protocadherin gamma subfamily A, 10
hsa:122651;RNASE11,C14orf6;ribonuclease, RNase A family, 11 (non-active)
hsa:80095;ZNF606,ZNF328;zinc finger protein 606
hsa:81559;TRIM11,BIA1,RNF92;tripartite motif containing 11
hsa:55015;PRPF39;PRP39 pre-mRNA processing factor 39 homolog (S. cerevisiae)
hsa:2890;GRIA1,GLUH1,GLUR1,GLURA,GluA1,HBGR1;glutamate receptor, ionotropic, AMPA 1
hsa:3059;HCLS1,CTTNL,HS1;hematopoietic cell-specific Lyn substrate 1
hsa:353345;GPR141,PGR13;G protein-coupled receptor 141
hsa:221656;KDM1B,AOF1,C6orf193,LSD2,bA204B7.3,dJ298J15.2;lysine (K)-specific demethylase 1B
hsa:147741;ZNF560;zinc finger protein 560
hsa:9510;ADAMTS1,C3-C5,METH1;ADAM metallopeptidase with thrombospondin type 1 motif, 1
hsa:3446;IFNA10,IFN-alphaC;interferon, alpha 10
hsa:23710;GABARAPL1,APG8-LIKE,APG8L,ATG8,ATG8B,ATG8L,GEC1;GABA(A) receptor-associated protein like 1
hsa:56107;PCDHGA9,PCDH-GAMMA-A9;protocadherin gamma subfamily A, 9
hsa:286234;SPATA31E1,C9orf79,FAM75E1;SPATA31 subfamily E, member 1
hsa:84872;ZC3H10,ZC3HDC10;zinc finger CCCH-type containing 10
hsa:5324;PLAG1,PSA,SGPA,ZNF912;pleiomorphic adenoma gene 1
hsa:8888;MCM3AP,GANP,MAP80,SAC3;minichromosome maintenance complex component 3 associated protein
hsa:10090;UST,2OST;uronyl-2-sulfotransferase
hsa:219749;ZNF25,KOX19,Zfp9;zinc finger protein 25
hsa:56108;PCDHGA7,PCDH-GAMMA-A7;protocadherin gamma subfamily A, 7
hsa:1117;CHI3L2,YKL-39,YKL39;chitinase 3-like 2
hsa:222967;RSPH10B;radial spoke head 10 homolog B (Chlamydomonas)
hsa:440021;KRTAP5-2,KRTAP5-8,KRTAP5.2;keratin associated protein 5-2
hsa:8882;ZNF259,ZPR1;zinc finger protein 259
hsa:23300;ATMIN,ASCIZ,ZNF822;ATM interactor
hsa:56109;PCDHGA6,PCDH-GAMMA-A6;protocadherin gamma subfamily A, 6
hsa:8187;ZNF239,HOK-2,MOK2;zinc finger protein 239
hsa:26149;ZNF658;zinc finger protein 658
hsa:84874;ZNF514;zinc finger protein 514
hsa:5189;PEX1,PBD1A,PBD1B,ZWS,ZWS1;peroxisomal biogenesis factor 1
hsa:9877;ZC3H11A,ZC3HDC11A;zinc finger CCCH-type containing 11A
hsa:6597;SMARCA4,BAF190,BAF190A,BRG1,MRD16,RTPS2,SNF2,SNF2L4,SNF2LB,SWI2,hSNF2b;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
hsa:153768;PRELID2;PRELI domain containing 2
hsa:23302;WSCD1;WSC domain containing 1
hsa:56110;PCDHGA5,CDH-GAMMA-A5,ME3,PCDH-GAMMA-A5;protocadherin gamma subfamily A, 5
hsa:282808;RAB40AL,MRXSMP,RAR2,RLGP;RAB40A, member RAS oncogene family-like
hsa:5306;PITPNA,PI-TPalpha,PITPN,VIB1A;phosphatidylinositol transfer protein, alpha
hsa:126731;CCSAP,C1orf96,CSAP;centriole, cilia and spindle-associated protein
hsa:5190;PEX6,PAF-2,PAF2,PBD4A,PDB4B,PXAAA1;peroxisomal biogenesis factor 6
hsa:26031;OSBPL3,ORP-3,ORP3,OSBP3;oxysterol binding protein-like 3
hsa:79711;IPO4,Imp4;importin 4
hsa:27154;BRPF3;bromodomain and PHD finger containing, 3
hsa:56111;PCDHGA4,PCDH-GAMMA-A4;protocadherin gamma subfamily A, 4
hsa:7083;TK1,TK2;thymidine kinase 1, soluble (EC:2.7.1.21)
hsa:84186;ZCCHC7,AIR1,RP11-397D12.1;zinc finger, CCHC domain containing 7
hsa:64771;C6orf106,FP852,dJ391O22.4;chromosome 6 open reading frame 106
hsa:56112;PCDHGA3,PCDH-GAMMA-A3;protocadherin gamma subfamily A, 3
hsa:90871;C9orf123;chromosome 9 open reading frame 123
hsa:50804;MYEF2,HsT18564,MEF-2,MST156,MSTP156;myelin expression factor 2
hsa:503618;DEFB104B,BD-4,DEFB-4,hBD-4;defensin, beta 104B
hsa:1549;CYP2A7,CPA7,CPAD,CYP2A,CYPIIA7,P450-IIA4;cytochrome P450, family 2, subfamily A, polypeptide 7 (EC:1.14.14.1)
hsa:9447;AIM2,PYHIN4;absent in melanoma 2
hsa:51816;CECR1,ADA2,ADGF,IDGFL;cat eye syndrome chromosome region, candidate 1 (EC:3.5.4.4)
hsa:51385;ZNF589,SZF1;zinc finger protein 589
hsa:56113;PCDHGA2,PCDH-GAMMA-A2;protocadherin gamma subfamily A, 2
hsa:79836;LONRF3,RNF127;LON peptidase N-terminal domain and ring finger 3
hsa:22890;ZBTB1,ZNF909;zinc finger and BTB domain containing 1
hsa:84936;ZFYVE19,MPFYVE;zinc finger, FYVE domain containing 19
hsa:55852;TEX2,HT008,TMEM96;testis expressed 2
hsa:55860;ACTR10,ACTR11,Arp11,HARP11;actin-related protein 10 homolog (S. cerevisiae)
hsa:9700;ESPL1,ESP1,SEPA;extra spindle pole bodies homolog 1 (S. cerevisiae) (EC:3.4.22.49)
hsa:119385;AGAP11;ankyrin repeat and GTPase domain Arf GTPase activating protein 11
hsa:10863;ADAM28,ADAM_28,ADAM23,MDC-L,MDC-Lm,MDC-Ls,MDCL,eMDC_II,eMDCII;ADAM metallopeptidase domain 28
hsa:7712;ZNF157,HZF22;zinc finger protein 157
hsa:342357;ZKSCAN2,ZNF694,ZSCAN31,ZSCAN34;zinc finger with KRAB and SCAN domains 2
hsa:1374;CPT1A,CPT1,CPT1-L,L-CPT1;carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21)
hsa:64375;IKZF4,EOS,ZNFN1A4;IKAROS family zinc finger 4 (Eos)
hsa:730;C7;complement component 7
hsa:945;CD33,SIGLEC-3,SIGLEC3,p67;CD33 molecule
hsa:375748;ERCC6L2,C9orf102,RAD26L,SR278;excision repair cross-complementing rodent repair deficiency, complementation group 6-like 2
hsa:124961;ZFP3,ZNF752;ZFP3 zinc finger protein
hsa:504180;DEFB105B;defensin, beta 105B
hsa:25791;NGEF,ARHGEF27,EPHEXIN;neuronal guanine nucleotide exchange factor
hsa:57336;ZNF287,ZKSCAN13,ZSCAN45;zinc finger protein 287
hsa:2006;ELN,SVAS,WBS,WS;elastin
hsa:123688;AGPHD1;aminoglycoside phosphotransferase domain containing 1 (EC:2.7.1.81)
hsa:84447;SYVN1,DER3,HRD1;synovial apoptosis inhibitor 1, synoviolin (EC:6.3.2.-)
hsa:64146;PDF;peptide deformylase (mitochondrial) (EC:3.5.1.88)
hsa:401036;ASB18,ASB-18;ankyrin repeat and SOCS box containing 18
hsa:245909;DEFB106A,BD-6,DEFB-6,DEFB106;defensin, beta 106A
hsa:4481;MSR1,CD204,SCARA1,SR-A,SRA,phSR1,phSR2;macrophage scavenger receptor 1
hsa:146198;ZFP90,NK10,ZNF756;ZFP90 zinc finger protein
hsa:388569;ZNF324B;zinc finger protein 324B
hsa:285636;C5orf51;chromosome 5 open reading frame 51
hsa:285268;ZNF621;zinc finger protein 621
hsa:54914;FOCAD,KIAA1797;focadhesin
hsa:51306;FAM13B,ARHGAP49,C5orf5,FAM13B1,KHCHP,N61;family with sequence similarity 13, member B
hsa:114904;C1QTNF6,CTFP6,CTRP6,ZACRP6;C1q and tumor necrosis factor related protein 6
hsa:59336;PRDM13,MU-MB-20.220,PFM10;PR domain containing 13
hsa:94039;ZNF101,HZF12;zinc finger protein 101
hsa:434;ASIP,AGSW,AGTI,AGTIL,ASP,SHEP9;agouti signaling protein
hsa:503841;DEFB106B;defensin, beta 106B
hsa:79230;ZNF557;zinc finger protein 557
hsa:64770;CCDC14;coiled-coil domain containing 14
hsa:7743;ZNF189;zinc finger protein 189
hsa:54495;TMX3,PDIA13,TXNDC10;thioredoxin-related transmembrane protein 3 (EC:5.3.4.1)
hsa:79937;CNTNAP3,CASPR3,CNTNAP3A,RP11-138L21.1,RP11-290L7.1;contactin associated protein-like 3
hsa:4125;MAN2B1,LAMAN,MANB;mannosidase, alpha, class 2B, member 1 (EC:3.2.1.24)
hsa:127544;RNF19B,IBRDC3,NKLAM;ring finger protein 19B
hsa:1592;CYP26A1,CP26,CYP26,P450RAI,P450RAI1;cytochrome P450, family 26, subfamily A, polypeptide 1 (EC:1.14.-.-)
hsa:55149;MTPAP,PAPD1,SPAX4;mitochondrial poly(A) polymerase (EC:2.7.7.19)
hsa:55888;ZKSCAN7,ZFP,ZNF167,ZNF448,ZNF64,ZSCAN39;zinc finger with KRAB and SCAN domains 7
hsa:79096;C11orf49;chromosome 11 open reading frame 49
hsa:25888;ZNF473,HZFP100,ZN473;zinc finger protein 473
hsa:9223;MAGI1,AIP-3,AIP3,BAIAP1,BAP-1,BAP1,MAGI-1,TNRC19,WWP3;membrane associated guanylate kinase, WW and PDZ domain containing 1
hsa:27300;ZNF544;zinc finger protein 544
hsa:64096;GFRA4;GDNF family receptor alpha 4
hsa:126069;ZNF491;zinc finger protein 491
hsa:63977;PRDM15,C21orf83,PFM15,ZNF298;PR domain containing 15
hsa:245910;DEFB107A,BD-7,DEFB-7,DEFB107;defensin, beta 107A
hsa:374879;ZNF699,hang;zinc finger protein 699
hsa:51330;TNFRSF12A,CD266,FN14,TWEAKR;tumor necrosis factor receptor superfamily, member 12A
hsa:440730;TRIM67,TNL;tripartite motif containing 67
hsa:7156;TOP3A,TOP3;topoisomerase (DNA) III alpha (EC:5.99.1.2)
hsa:353274;ZNF445,ZKSCAN15,ZNF168,ZSCAN47;zinc finger protein 445
hsa:51105;PHF20L1,TDRD20B;PHD finger protein 20-like 1
hsa:122704;MRPL52;mitochondrial ribosomal protein L52
hsa:51734;MSRB1,SELR,SELX,SEPX1,SepR;methionine sulfoxide reductase B1 (EC:1.8.4.-)
hsa:7547;ZIC3,HTX,HTX1,VACTERLX,ZNF203;Zic family member 3
hsa:57539;WDR35,CED2;WD repeat domain 35
hsa:11338;U2AF2,U2AF65;U2 small nuclear RNA auxiliary factor 2
hsa:56127;PCDHB9,PCDH-BETA9,PCDH3H;protocadherin beta 9
hsa:50835;TAS2R9,T2R9,TRB6;taste receptor, type 2, member 9
hsa:23303;KIF13B,GAKIN;kinesin family member 13B
hsa:257397;TAB3,MAP3K7IP3,NAP1;TGF-beta activated kinase 1/MAP3K7 binding protein 3
hsa:503614;DEFB107B,HsT21816;defensin, beta 107B
hsa:22998;LIMCH1,LIMCH1A,LMO7B;LIM and calponin homology domains 1
hsa:8335;HIST1H2AB,H2A/m,H2AFM;histone cluster 1, H2ab
hsa:3239;HOXD13,BDE,BDSD,HOX4I,SPD;homeobox D13
hsa:116115;ZNF526;zinc finger protein 526
hsa:10542;LAMTOR5,HBXIP,XIP;late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
hsa:2738;GLI4,HKR4,ZNF928;GLI family zinc finger 4
hsa:9230;RAB11B,H-YPT3;RAB11B, member RAS oncogene family
hsa:7025;NR2F1,COUP-TFI,EAR-3,EAR3,ERBAL3,NR2F2,SVP44,TCFCOUP1,TFCOUP1;nuclear receptor subfamily 2, group F, member 1
hsa:1657;DMXL1;Dmx-like 1
hsa:10738;RFPL3;ret finger protein-like 3
hsa:219793;TBATA,C10orf27,spatial;thymus, brain and testes associated
hsa:51809;GALNT7,GALNAC-T7,GalNAcT7;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) (EC:2.4.1.41)
hsa:1593;CYP27A1,CP27,CTX,CYP27;cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15)
hsa:25921;ZDHHC5,DHHC5,ZNF375;zinc finger, DHHC-type containing 5
hsa:490;ATP2B1,PMCA1,PMCA1kb;ATPase, Ca++ transporting, plasma membrane 1 (EC:3.6.3.8)
hsa:86614;HSFY1,HSF2L,HSFY;heat shock transcription factor, Y-linked 1
hsa:1131;CHRM3,EGBRS,HM3;cholinergic receptor, muscarinic 3
hsa:9496;TBX4,SPS;T-box 4
hsa:56547;MMP26;matrix metallopeptidase 26 (EC:3.4.24.1)
hsa:51621;KLF13,BTEB3,FKLF2,NSLP1,RFLAT-1,RFLAT1;Kruppel-like factor 13
hsa:147807;ZNF524;zinc finger protein 524
hsa:134637;ADAT2,DEADC1,TAD2,dJ20N2,dJ20N2.1;adenosine deaminase, tRNA-specific 2
hsa:57541;ZNF398,P51,P71,ZER6;zinc finger protein 398
hsa:221188;GPR114,PGR27;G protein-coupled receptor 114
hsa:2968;GTF2H4,P52,TFB2,TFIIH;general transcription factor IIH, polypeptide 4, 52kDa
hsa:55845;BRK1,C3orf10,MDS027,hHBrk1;BRICK1, SCAR/WAVE actin-nucleating complex subunit
hsa:51725;FBXO40,FBX40;F-box protein 40
hsa:728661;SLC35E2B,SLC35E2;solute carrier family 35, member E2B
hsa:79830;ZMYM1,MYM,RP11-181E22.4;zinc finger, MYM-type 1
hsa:219287;AMER2,FAM123A;APC membrane recruitment protein 2
hsa:219990;PLAC1L,TMEM122;placenta-specific 1-like
hsa:51428;DDX41,ABS;DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 (EC:3.6.4.13)
hsa:8078;USP5,ISOT;ubiquitin specific peptidase 5 (isopeptidase T) (EC:3.4.19.12)
hsa:9553;MRPL33,C2orf1,L33mt,MRP-L33,RPL33L;mitochondrial ribosomal protein L33
hsa:11179;ZNF277,NRIF4,ZNF277P;zinc finger protein 277
hsa:85364;ZCCHC3,C20orf99;zinc finger, CCHC domain containing 3
hsa:442038;SULT1C3,ST1C3;sulfotransferase family, cytosolic, 1C, member 3 (EC:2.8.2.2)
hsa:83659;TEKT1;tektin 1
hsa:199746;U2AF1L4,U2AF1-RS3,U2AF1L3,U2AF1L3V1,U2AF1RS3,U2af26;U2 small nuclear RNA auxiliary factor 1-like 4
hsa:374928;ZNF773,ZNF419B;zinc finger protein 773
hsa:5193;PEX12,PAF-3,PBD3A;peroxisomal biogenesis factor 12
hsa:9081;PRY,PRY1,PTPN13LY;PTPN13-like, Y-linked
hsa:93978;CLEC6A,CLEC4N,CLECSF10;C-type lectin domain family 6, member A
hsa:84273;NOA1,C4orf14,hAtNOS1,hNOA1,mAtNOS1;nitric oxide associated 1
hsa:50859;SPOCK3,HSAJ1454,TES-3,TICN3;sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3
hsa:25917;THUMPD3;THUMP domain containing 3
hsa:54988;ACSM5;acyl-CoA synthetase medium-chain family member 5 (EC:6.2.1.2)
hsa:373;TRIM23,ARD1,ARFD1,RNF46;tripartite motif containing 23
hsa:6759;SSX4,CT5.4;synovial sarcoma, X breakpoint 4
hsa:55632;G2E3,KIAA1333,PHF7B;G2/M-phase specific E3 ubiquitin protein ligase
hsa:389874;ZCCHC13,CNBP2,ZNF9L;zinc finger, CCHC domain containing 13
hsa:84662;GLIS2,NKL,NPHP7;GLIS family zinc finger 2
hsa:116988;AGAP3,AGAP-3,CENTG3,CRAG,MRIP-1,cnt-g3;ArfGAP with GTPase domain, ankyrin repeat and PH domain 3
hsa:54925;ZSCAN32,ZNF434;zinc finger and SCAN domain containing 32
hsa:11177;BAZ1A,ACF1,WALp1,WCRF180,hACF1;bromodomain adjacent to zinc finger domain, 1A
hsa:285672;SREK1IP1,P18SRP,SFRS12IP1;SREK1-interacting protein 1
hsa:146059;CDAN1,CDA1,CDAI,DLT,PRO1295;codanin 1
hsa:5988;RFPL1,RNF78;ret finger protein-like 1
hsa:146542;ZNF688;zinc finger protein 688
hsa:56135;PCDHAC1,PCDH-ALPHA-C1;protocadherin alpha subfamily C, 1
hsa:10578;GNLY,519,D2S69E,LAG-2,LAG2,NKG5,TLA519;granulysin
hsa:84124;ZNF394,ZKSCAN14,ZSCAN46;zinc finger protein 394
hsa:374308;PTCHD3,PTR;patched domain containing 3
hsa:137075;CLDN23,CLDNL,hCG1646163;claudin 23
hsa:388591;RNF207,C1orf188;ring finger protein 207
hsa:171490;SPANXF1;SPANX family, member F1
hsa:29944;PNMA3,MA3,MA5;paraneoplastic Ma antigen 3
hsa:8510;MMP23B,MIFR,MIFR-1,MMP22,MMP23A;matrix metallopeptidase 23B
hsa:57606;SLAIN2,KIAA1458;SLAIN motif family, member 2
hsa:56136;PCDHA13,CNR5,CNRN5,CNRS5,CRNR5,PCDH-ALPHA13;protocadherin alpha 13
hsa:55823;VPS11,END1,PEP5,RNF108,hVPS11;vacuolar protein sorting 11 homolog (S. cerevisiae)
hsa:27181;SIGLEC8,SAF2,SIGLEC-8,SIGLEC8L;sialic acid binding Ig-like lectin 8
hsa:10224;ZNF443,ZK1;zinc finger protein 443
hsa:90655;TGIF2LY,TGIFLY;TGFB-induced factor homeobox 2-like, Y-linked
hsa:9085;CDY1,CDY,CDY1A;chromodomain protein, Y-linked, 1 (EC:2.3.1.48)
hsa:386683;KRTAP12-3,KRTAP12.3;keratin associated protein 12-3
hsa:56137;PCDHA12,PCDH-ALPHA12;protocadherin alpha 12
hsa:4547;MTTP,ABL,MTP;microsomal triglyceride transfer protein
hsa:3890;KRT84,HB4,KRTHB4;keratin 84
hsa:9512;PMPCB,Beta-MPP,MPP11,MPPB,MPPP52,P-52;peptidase (mitochondrial processing) beta (EC:3.4.24.64)
hsa:29760;BLNK,AGM4,BASH,BLNK-S,LY57,SLP-65,SLP65,bca;B-cell linker
hsa:100131439;CD300LD,CD300D,CLM-4,CMRF35-A4,CMRF35A4;CD300 molecule-like family member d
hsa:5557;PRIM1,p49;primase, DNA, polypeptide 1 (49kDa) (EC:2.7.7.-)
hsa:56900;TMEM167B,C1orf119;transmembrane protein 167B
hsa:4360;MRC1,CD206,CLEC13D,CLEC13DL,MMR,MRC1L1,bA541I19.1;mannose receptor, C type 1
hsa:7716;VEZF1,DB1,ZNF161;vascular endothelial zinc finger 1
hsa:56138;PCDHA11,CNR7,CNRN7,CNRS7,CRNR7,PCDH-ALPHA11;protocadherin alpha 11
hsa:115111;SLC26A7,SUT2;solute carrier family 26, member 7
hsa:11176;BAZ2A,TIP5,WALp3;bromodomain adjacent to zinc finger domain, 2A
hsa:79031;PDCL3,HTPHLP,PHLP2A,PHLP3,VIAF,VIAF1;phosducin-like 3
hsa:55829;VIMP,ADO15,SBBI8,SELS,SEPS1;VCP-interacting membrane protein
hsa:87;ACTN1;actinin, alpha 1
hsa:6664;SOX11;SRY (sex determining region Y)-box 11
hsa:54069;MIS18A,B28,C21orf45,C21orf46,FASP1,MIS18alpha,hMis18alpha;MIS18 kinetochore protein homolog A (S. pombe)
hsa:25862;USP49;ubiquitin specific peptidase 49 (EC:3.4.19.12)
hsa:170692;ADAMTS18,ADAMTS21,KNO2;ADAM metallopeptidase with thrombospondin type 1 motif, 18
hsa:56139;PCDHA10,CNR8,CNRN8,CNRS8,CRNR8,PCDH-ALPHA10;protocadherin alpha 10
hsa:51317;PHF21A,BHC80;PHD finger protein 21A
hsa:79369;B3GNT4,B3GN-T4,beta3Gn-T4;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4
hsa:51714;SELT;selenoprotein T
hsa:56140;PCDHA8,PCDH-ALPHA8;protocadherin alpha 8
hsa:3012;HIST1H2AE,H2A.1,H2A.2,H2A/a,H2AFA;histone cluster 1, H2ae
hsa:56889;TM9SF3,EP70-P-iso,SMBP;transmembrane 9 superfamily member 3
hsa:55552;ZNF823,HSZFP36;zinc finger protein 823
hsa:55738;ARFGAP1,ARF1GAP,HRIHFB2281;ADP-ribosylation factor GTPase activating protein 1
hsa:56141;PCDHA7,CNR4,CNRN4,CNRS4,CRNR4,PCDH-ALPHA7;protocadherin alpha 7
hsa:26165;SPATA31A7,C9orf36A,FAM75A7;SPATA31 subfamily A, member 7
hsa:7772;ZNF229;zinc finger protein 229
hsa:25842;ASF1A,CGI-98,CIA,HSPC146;ASF1 anti-silencing function 1 homolog A (S. cerevisiae)
hsa:152687;ZNF595;zinc finger protein 595
hsa:56142;PCDHA6,CNR2,CNRN2,CNRS2,CRNR2,PCDH-ALPHA6;protocadherin alpha 6
hsa:6671;SP4,HF1B,SPR-1;Sp4 transcription factor
hsa:84276;NICN1;nicolin 1
hsa:51029;DESI2,C1orf121,DESI,DESI1,DeSI-2,FAM152A,PNAS-4,PPPDE1;desumoylating isopeptidase 2
hsa:159119;HSFY2,HSF2L,HSFY;heat shock transcription factor, Y linked 2
hsa:8175;SF3A2,PRP11,PRPF11,SAP62,SF3a66;splicing factor 3a, subunit 2, 66kDa
hsa:340719;NANOS1,NOS1;nanos homolog 1 (Drosophila)
hsa:56143;PCDHA5,CNR6,CNRN6,CNRS6,CRNR6,PCDH-ALPHA5;protocadherin alpha 5
hsa:7549;ZNF2,A1-5,ZNF661,Zfp661;zinc finger protein 2
hsa:3018;HIST1H2BB,H2B.1,H2B/f,H2BFF;histone cluster 1, H2bb
hsa:140862;ISM1,C20orf82,ISM,Isthmin,bA149I18.1,dJ1077I2.1;isthmin 1 homolog (zebrafish)
hsa:147686;ZNF418;zinc finger protein 418
hsa:7364;UGT2B7,UDPGT_2B9,UDPGT2B7,UDPGTH2,UGT2B9;UDP glucuronosyltransferase 2 family, polypeptide B7 (EC:2.4.1.17)
hsa:2935;GSPT1,551G9.2,ETF3A,GST1,eRF3a;G1 to S phase transition 1
hsa:23071;ERP44,PDIA10,TXNDC4;endoplasmic reticulum protein 44
hsa:56144;PCDHA4,CNR1,CNRN1,CRNR1,PCDH-ALPHA4;protocadherin alpha 4
hsa:64211;LHX5;LIM homeobox 5
hsa:9682;KDM4A,JHDM3A,JMJD2,JMJD2A,TDRD14A;lysine (K)-specific demethylase 4A (EC:1.14.11.-)
hsa:10479;SLC9A6,MRSA,NHE6;solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6
hsa:57654;UVSSA,KIAA1530,UVSS3;UV-stimulated scaffold protein A
hsa:53335;BCL11A,BCL11A-L,BCL11A-S,BCL11A-XL,BCL11a-M,CTIP1,EVI9,HBFQTL5,ZNF856;B-cell CLL/lymphoma 11A (zinc finger protein)
hsa:9986;RCE1,FACE2,RCE1A,RCE1B;RCE1 homolog, prenyl protein protease (S. cerevisiae) (EC:3.4.22.-)
hsa:53349;ZFYVE1,DFCP1,TAFF1,ZNFN2A1;zinc finger, FYVE domain containing 1
hsa:5359;PLSCR1,MMTRA1B;phospholipid scramblase 1
hsa:374768;SPEM1,C17orf83;spermatid maturation 1
hsa:1106;CHD2;chromodomain helicase DNA binding protein 2 (EC:3.6.4.12)
hsa:429;ASCL1,ASH1,HASH1,MASH1,bHLHa46;achaete-scute complex homolog 1 (Drosophila)
hsa:6650;SOLH,CAPN15;small optic lobes homolog (Drosophila)
hsa:220972;MARCH8,MARCH-VIII,MIR,RNF178,c-MIR;membrane-associated ring finger (C3HC4) 8, E3 ubiquitin protein ligase
hsa:344558;SH3RF3,POSH2,SH3MD4;SH3 domain containing ring finger 3
hsa:55803;ADAP2,CENTA2,HSA272195,cent-b;ArfGAP with dual PH domains 2
hsa:3029;HAGH,GLO2,GLX2,GLXII,HAGH1;hydroxyacylglutathione hydrolase (EC:3.1.2.6)
hsa:79142;PHF23,hJUNE-1b;PHD finger protein 23
hsa:155185;AMZ1;archaelysin family metallopeptidase 1
hsa:114881;OSBPL7,ORP7;oxysterol binding protein-like 7
hsa:129881;CCDC173,C2orf77;coiled-coil domain containing 173
hsa:100101629;GAGE8,CT4.8,GAGE-8;G antigen 8
hsa:9885;OSBPL2,ORP-2,ORP2;oxysterol binding protein-like 2
hsa:143244;EIF5AL1,EIF5AP1,bA342M3.3;eukaryotic translation initiation factor 5A-like 1
hsa:441531;PGAM4,PGAM-B,PGAM1,PGAM3,dJ1000K24.1;phosphoglycerate mutase family member 4 (EC:3.1.3.13 5.4.2.1 5.4.2.4)
hsa:128209;KLF17,ZNF393,Zfp393;Kruppel-like factor 17
hsa:51136;RNFT1;ring finger protein, transmembrane 1
hsa:5660;PSAP,GLBA,SAP1;prosaposin
hsa:1830;DSG3,CDHF6,PVA;desmoglein 3
hsa:6601;SMARCC2,BAF170,CRACC2,Rsc8;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2
hsa:5036;PA2G4,EBP1,HG4-1,p38-2G4;proliferation-associated 2G4, 38kDa
hsa:55521;TRIM36,HAPRIN,RBCC728,RNF98;tripartite motif containing 36
hsa:57733;GBA3,CBGL1,GLUC,KLrP;glucosidase, beta, acid 3 (cytosolic) (EC:3.2.1.21)
hsa:643246;MAP1LC3B2,ATG8G;microtubule-associated protein 1 light chain 3 beta 2
hsa:10916;MAGED2,11B6,BCG1,HCA10,JCL-1,MAGE-D2,MAGED;melanoma antigen family D, 2
hsa:5687;PSMA6,IOTA,PROS27,p27K;proteasome (prosome, macropain) subunit, alpha type, 6 (EC:3.4.25.1)
hsa:23495;TNFRSF13B,CD267,CVID,CVID2,TACI,TNFRSF14B;tumor necrosis factor receptor superfamily, member 13B
hsa:84083;ZRANB3,4933425L19Rik,AH2;zinc finger, RAN-binding domain containing 3
hsa:51230;PHF20,C20orf104,GLEA2,HCA58,NZF,TDRD20A,TZP;PHD finger protein 20
hsa:10801;SEPT9,AF17q25,MSF,MSF1,NAPB,PNUTL4,SINT1,SeptD1;septin 9
hsa:2209;FCGR1A,CD64,CD64A,FCRI,IGFR1;Fc fragment of IgG, high affinity Ia, receptor (CD64)
hsa:7554;ZNF8,HF.18,Zfp128;zinc finger protein 8
hsa:90381;TICRR,C15orf42,SLD3,Treslin;TOPBP1-interacting checkpoint and replication regulator
hsa:728294;D2HGDH,D2HGD;D-2-hydroxyglutarate dehydrogenase (EC:1.1.99.-)
hsa:3954;LETM1;leucine zipper-EF-hand containing transmembrane protein 1
hsa:340385;ZNF517;zinc finger protein 517
hsa:25792;CIZ1,LSFR1,NP94,ZNF356;CDKN1A interacting zinc finger protein 1
hsa:7542;ZFPL1,D11S750,MCG4;zinc finger protein-like 1
hsa:442247;RFPL4B,RNF211;ret finger protein-like 4B
hsa:53353;LRP1B,LRP-DIT,LRPDIT;low density lipoprotein receptor-related protein 1B
hsa:51361;HOOK1,HK1;hook homolog 1 (Drosophila)
hsa:65003;MRPL11,L11MT,MRP-L11;mitochondrial ribosomal protein L11
hsa:340277;FAM221A,C7orf46;family with sequence similarity 221, member A
hsa:60509;AGBL5;ATP/GTP binding protein-like 5
hsa:388677;NOTCH2NL,N2N;notch 2 N-terminal like
hsa:400165;C13orf35;chromosome 13 open reading frame 35
hsa:79441;HAUS3,C4orf15,IT1,dgt3;HAUS augmin-like complex, subunit 3
hsa:503582;ARGFX;arginine-fifty homeobox
hsa:9200;PTPLA,CAP,HACD1;protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A (EC:4.2.1.134)
hsa:23277;CLUH,CLU1,KIAA0664;clustered mitochondria (cluA/CLU1) homolog
hsa:11236;RNF139,HRCA1,RCA1,TRC8;ring finger protein 139
hsa:8974;P4HA2;prolyl 4-hydroxylase, alpha polypeptide II (EC:1.14.11.2)
hsa:392392;OR1K1,hg99;olfactory receptor, family 1, subfamily K, member 1
hsa:50614;GALNT9,GALNAC-T9;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) (EC:2.4.1.41)
hsa:84871;AGBL4,CCP6;ATP/GTP binding protein-like 4
hsa:26993;AKAP8L,HA95,HAP95,NAKAP,NAKAP95;A kinase (PRKA) anchor protein 8-like
hsa:83746;L3MBTL2,H-l(3)mbt-l,L3MBT;l(3)mbt-like 2 (Drosophila)
hsa:414059;TBC1D3B,PRC17,TBC1D3I;TBC1 domain family, member 3B
hsa:7633;ZNF79,pT7;zinc finger protein 79
hsa:139285;AMER1,FAM123B,OSCS,WTX;APC membrane recruitment protein 1
hsa:57187;THOC2,CXorf3,THO2,dJ506G2.1,hTREX120;THO complex 2
hsa:54657;UGT1A4,HUG-BR2,UDPGT,UDPGT_1-4,UGT-1D,UGT1-04,UGT1.4,UGT1D;UDP glucuronosyltransferase 1 family, polypeptide A4 (EC:2.4.1.17)
hsa:5692;PSMB4,HN3,HsN3,PROS-26,PROS26;proteasome (prosome, macropain) subunit, beta type, 4 (EC:3.4.25.1)
hsa:26058;GIGYF2,GYF2,PARK11,PERQ2,PERQ3,TNRC15;GRB10 interacting GYF protein 2
hsa:91694;LONRF1,RNF191;LON peptidase N-terminal domain and ring finger 1
hsa:3054;HCFC1,CFF,HCF-1,HCF1,HFC1,MRX3,VCAF;host cell factor C1 (VP16-accessory protein)
hsa:653140;FAM228A,C2orf84;family with sequence similarity 228, member A
hsa:50862;RNF141,ZFP26,ZNF230;ring finger protein 141
hsa:113622;ADPRHL1,ARH2;ADP-ribosylhydrolase like 1
hsa:26517;TIMM13,TIM13,TIM13B,TIMM13A,TIMM13B,ppv1;translocase of inner mitochondrial membrane 13 homolog (yeast)
hsa:29058;TMEM230,C20orf30,HSPC274,dJ1116H23.2.1;transmembrane protein 230
hsa:140032;RPS4Y2,RPS4Y2P;ribosomal protein S4, Y-linked 2
hsa:84448;ABLIM2;actin binding LIM protein family, member 2
hsa:284346;ZNF575;zinc finger protein 575
hsa:360203;GLT6D1,GLTDC1,GT6M7;glycosyltransferase 6 domain containing 1 (EC:2.4.1.-)
hsa:54979;HRASLS2,PLA1/2-2;HRAS-like suppressor 2
hsa:9710;;KIAA0355
hsa:7932;OR2H2,FAT11,OLFR2,OLFR42B,OR2H3,dJ271M21.2,hs6M1-12;olfactory receptor, family 2, subfamily H, member 2
hsa:79739;TTLL7,RP5-836J3.2;tubulin tyrosine ligase-like family, member 7
hsa:3078;CFHR1,CFHL,CFHL1,CFHL1P,CFHR1P,FHR1,H36-1,H36-2,HFL1,HFL2;complement factor H-related 1
hsa:6607;SMN2,BCD541,C-BCD541,GEMIN1,SMNC,TDRD16B;survival of motor neuron 2, centromeric
hsa:7629;ZNF76,D6S229E,ZNF523,Zfp523;zinc finger protein 76
hsa:5831;PYCR1,ARCL2B,ARCL3B,P5C,P5CR,PIG45,PP222,PRO3,PYCR;pyrroline-5-carboxylate reductase 1 (EC:1.5.1.2)
hsa:401612;SLC25A53,MCART6;solute carrier family 25, member 53
hsa:57507;ZNF608,NY-REN-36;zinc finger protein 608
hsa:224;ALDH3A2,ALDH10,FALDH,SLS;aldehyde dehydrogenase 3 family, member A2 (EC:1.2.1.3)
hsa:53842;CLDN22,CLDN21;claudin 22
hsa:10560;SLC19A2,TC1,THMD1,THT1,THTR1,TRMA;solute carrier family 19 (thiamine transporter), member 2
hsa:79866;BORA,C13orf34;bora, aurora kinase A activator
hsa:163175;LGI4,LGIL3;leucine-rich repeat LGI family, member 4
hsa:55954;ZMAT5,SNRNP20;zinc finger, matrin-type 5
hsa:113146;AHNAK2,C14orf78;AHNAK nucleoprotein 2
hsa:8357;HIST1H3H,H3/k,H3F1K,H3FK;histone cluster 1, H3h
hsa:3955;LFNG,SCDO3;LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase (EC:2.4.1.222)
hsa:147808;ZNF784;zinc finger protein 784
hsa:653499;LGALS7B,GAL7,Gal-7,HKL-14,LGALS7,PI7;lectin, galactoside-binding, soluble, 7B
hsa:7150;TOP1,TOPI;topoisomerase (DNA) I (EC:5.99.1.2)
hsa:259215;LY6G6F,C6orf21,G6f,LY6G6D,NG32;lymphocyte antigen 6 complex, locus G6F
hsa:54993;ZSCAN2,ZFP29,ZNF854;zinc finger and SCAN domain containing 2
hsa:27086;FOXP1,12CC4,QRF1,hFKH1B;forkhead box P1
hsa:6499;SKIV2L,170A,DDX13,HLP,SKI2,SKI2W,SKIV2,THES2;superkiller viralicidic activity 2-like (S. cerevisiae)
hsa:5326;PLAGL2,ZNF900;pleiomorphic adenoma gene-like 2
hsa:152098;ZCWPW2,ZCW2;zinc finger, CW type with PWWP domain 2
hsa:2491;CENPI,CENP-I,FSHPRH1,LRPR1,Mis6;centromere protein I
hsa:79081;C11orf48;chromosome 11 open reading frame 48
hsa:196528;ARID2,BAF200,p200;AT rich interactive domain 2 (ARID, RFX-like)
hsa:9708;PCDHGA8,PCDH-GAMMA-A8;protocadherin gamma subfamily A, 8
hsa:643394;SPINK9,LEKTI2;serine peptidase inhibitor, Kazal type 9
hsa:11116;FGFR1OP,FOP;FGFR1 oncogene partner
hsa:343071;PRAMEF10,RP5-845O24.7;PRAME family member 10
hsa:54458;PRR13,TXR1;proline rich 13
hsa:8568;RRP1,D21S2056E,NNP-1,NOP52,RRP1A;ribosomal RNA processing 1 homolog (S. cerevisiae)
hsa:116113;FOXP4,hFKHLA;forkhead box P4
hsa:11074;TRIM31,C6orf13,HCG1,HCGI,RNF;tripartite motif containing 31
hsa:5307;PITX1,BFT,CCF,LBNBG,POTX,PTX1;paired-like homeodomain 1
hsa:23352;UBR4,RBAF600,ZUBR1,p600;ubiquitin protein ligase E3 component n-recognin 4
hsa:81578;COL21A1,COLA1L,dJ682J15.1,dJ708F5.1;collagen, type XXI, alpha 1
hsa:55009;C19orf24;chromosome 19 open reading frame 24
hsa:3482;IGF2R,CD222,CIMPR,M6P-R,MPR1,MPRI;insulin-like growth factor 2 receptor
hsa:3860;KRT13,CK13,K13;keratin 13
hsa:147923;ZNF420,APAK;zinc finger protein 420
hsa:203569;PAGE2,CT16.4,GAGEC2,GAGEE2,PAGE-2;P antigen family, member 2 (prostate associated)
hsa:80108;ZFP2,ZNF751;ZFP2 zinc finger protein
hsa:7862;BRPF1,BR140;bromodomain and PHD finger containing, 1
hsa:338755;OR2AG2,OR11-76,OR2AG2P;olfactory receptor, family 2, subfamily AG, member 2
hsa:26048;ZNF500,ZKSCAN18,ZSCAN50;zinc finger protein 500
hsa:56978;PRDM8,PFM5;PR domain containing 8
hsa:64064;OXCT2,SCOTT;3-oxoacid CoA transferase 2 (EC:2.8.3.5)
hsa:84302;TMEM246,C9orf125;transmembrane protein 246
hsa:4641;MYO1C,MMI-beta,MMIb,NMI,myr2;myosin IC
hsa:57827;C6orf47,D6S53E,G4,NG34;chromosome 6 open reading frame 47
hsa:10765;KDM5B,CT31,JARID1B,PLU-1,PLU1,PUT1,RBBP2H1A;lysine (K)-specific demethylase 5B
hsa:148213;ZNF681;zinc finger protein 681
hsa:54764;ZRANB1,TRABID;zinc finger, RAN-binding domain containing 1 (EC:3.4.19.12)
hsa:55731;FAM222B,C17orf63;family with sequence similarity 222, member B
hsa:122809;SOCS4,SOCS7;suppressor of cytokine signaling 4
hsa:1379;CR1L;complement component (3b/4b) receptor 1-like
hsa:574028;CLLU1;chronic lymphocytic leukemia up-regulated 1
hsa:147660;ZNF578;zinc finger protein 578
hsa:54859;ELP6,C3orf75,TMEM103;elongator acetyltransferase complex subunit 6
hsa:51523;CXXC5,CF5,RINF,WID;CXXC finger protein 5
hsa:169841;ZNF169;zinc finger protein 169
hsa:6561;SLC13A1,NAS1,NaSi-1;solute carrier family 13 (sodium/sulfate symporters), member 1
hsa:23367;LARP1,LARP;La ribonucleoprotein domain family, member 1
hsa:91703;ACY3,ACY-3,HCBP1;aspartoacylase (aminocyclase) 3 (EC:3.5.1.15)
hsa:378108;TRIM74,TRIM50C;tripartite motif containing 74
hsa:460;ASTN1,ASTN;astrotactin 1
hsa:4224;MEP1A,PPHA;meprin A, alpha (PABA peptide hydrolase) (EC:3.4.24.18)
hsa:84101;USP44;ubiquitin specific peptidase 44 (EC:3.4.19.12)
hsa:51016;EMC9,C14orf122,FAM158A;ER membrane protein complex subunit 9
hsa:7006;TEC,PSCTK4;tec protein tyrosine kinase (EC:2.7.10.2)
hsa:7710;ZNF154,pHZ-92;zinc finger protein 154
hsa:4495;MT1G,MT1,MT1K;metallothionein 1G
hsa:55764;IFT122,CED,CED1,SPG,WDR10,WDR10p,WDR140;intraflagellar transport 122 homolog (Chlamydomonas)
hsa:100129885;SCXA,SCX,bHLHa41;scleraxis homolog A (mouse)
hsa:154386;C6orf195,RP11-145H9.2,bA145H9.2;chromosome 6 open reading frame 195
hsa:79054;TRPM8,LTRPC6,TRPP8;transient receptor potential cation channel, subfamily M, member 8
hsa:653543;DUX4L7;double homeobox 4 like 7
hsa:23430;TPSD1,MCP7-LIKE,MCP7L1,MMCP-7L;tryptase delta 1 (EC:3.4.21.59)
hsa:29995;LMCD1;LIM and cysteine-rich domains 1
hsa:56956;LHX9;LIM homeobox 9
hsa:29803;REPIN1,AP4,RIP60,ZNF464,Zfp464;replication initiator 1
hsa:6614;SIGLEC1,CD169,SIGLEC-1,SN,dJ1009E24.1;sialic acid binding Ig-like lectin 1, sialoadhesin
hsa:140766;ADAMTS14;ADAM metallopeptidase with thrombospondin type 1 motif, 14
hsa:6716;SRD5A2;steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) (EC:1.3.1.22)
hsa:728410;DUX4L2,DUX4;double homeobox 4 like 2
hsa:440077;ZNF705A;zinc finger protein 705A
hsa:5053;PAH,PH,PKU,PKU1;phenylalanine hydroxylase (EC:1.14.16.1)
hsa:28964;GIT1;G protein-coupled receptor kinase interacting ArfGAP 1
hsa:162967;ZNF320,ZFPL;zinc finger protein 320
hsa:83482;SCRT1,SCRT,ZNF898;scratch homolog 1, zinc finger protein (Drosophila)
hsa:64844;MARCH7,AXO,AXOT,MARCH-VII,RNF177;membrane-associated ring finger (C3HC4) 7, E3 ubiquitin protein ligase
hsa:766;CA7,CAVII;carbonic anhydrase VII (EC:4.2.1.1)
hsa:80737;VWA7,C6orf27,G7c,NG37;von Willebrand factor A domain containing 7
hsa:6144;RPL21,L21;ribosomal protein L21 (EC:3.6.5.3)
hsa:91120;ZNF682,BC39498_3;zinc finger protein 682
hsa:55320;MIS18BP1,C14orf106,HSA242977,KNL2,M18BP1;MIS18 binding protein 1
hsa:9034;CCRL2,CKRX,CRAM,CRAM-A,CRAM-B,HCR;chemokine (C-C motif) receptor-like 2
hsa:94104;PAXBP1,BM020,C21orf66,FSAP105,GCFC,GCFC1;PAX3 and PAX7 binding protein 1
hsa:90594;ZNF439;zinc finger protein 439
hsa:3301;DNAJA1,DJ-2,DjA1,HDJ2,HSDJ,HSJ2,HSPF4,NEDD7,hDJ-2;DnaJ (Hsp40) homolog, subfamily A, member 1
hsa:53840;TRIM34,IFP1,RNF21;tripartite motif containing 34
hsa:9489;PGS1;phosphatidylglycerophosphate synthase 1 (EC:2.7.8.5)
hsa:26747;NUFIP1,NUFIP,bA540M5.1;nuclear fragile X mental retardation protein interacting protein 1
hsa:340156;MYLK4,SgK085;myosin light chain kinase family, member 4 (EC:2.7.11.1)
hsa:79944;L2HGDH,C14orf160;L-2-hydroxyglutarate dehydrogenase (EC:1.1.99.2)
hsa:200312;RNF215;ring finger protein 215
hsa:401250;MCCD1;mitochondrial coiled-coil domain 1
hsa:25858;TEX40,C11orf20;testis expressed 40
hsa:161882;ZFPM1,FOG,FOG1,ZC2HC11A,ZNF408,ZNF89A;zinc finger protein, FOG family member 1
hsa:1411;CRYBA1,CRYB1;crystallin, beta A1
hsa:55734;ZFP64,ZNF338;ZFP64 zinc finger protein
hsa:6100;RP9,PAP-1;retinitis pigmentosa 9 (autosomal dominant)
hsa:27107;ZBTB11,ZNF-U69274,ZNF913;zinc finger and BTB domain containing 11
hsa:23517;SKIV2L2,Dob1,KIAA0052,Mtr4,fSAP118;superkiller viralicidic activity 2-like 2 (S. cerevisiae) (EC:3.6.4.13)
hsa:58509;CACTIN,C19orf29,NY-REN-24,fSAPc;cactin, spliceosome C complex subunit
hsa:653784;MZT2A,FAM128A,MOZART2A;mitotic spindle organizing protein 2A
hsa:4122;MAN2A2,MANA2X;mannosidase, alpha, class 2A, member 2 (EC:3.2.1.114)
hsa:3682;ITGAE,CD103,HUMINAE;integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1;alpha polypeptide)
hsa:25800;SLC39A6,LIV-1;solute carrier family 39 (zinc transporter), member 6
hsa:79974;CPED1,C7orf58;cadherin-like and PC-esterase domain containing 1
hsa:6919;TCEA2,TFIIS;transcription elongation factor A (SII), 2
hsa:221294;NT5DC1,C6orf200,LP2642,NT5C2L1;5'-nucleotidase domain containing 1
hsa:58492;ZNF77,pT1;zinc finger protein 77
hsa:11283;CYP4F8,CPF8,CYPIVF8;cytochrome P450, family 4, subfamily F, polypeptide 8 (EC:1.14.14.1)
hsa:158431;ZNF782;zinc finger protein 782
hsa:29942;PURG,PURG-A,PURG-B;purine-rich element binding protein G
hsa:54467;ANKIB1;ankyrin repeat and IBR domain containing 1
hsa:55184;DZANK1,ANKRD64,C20orf12,C20orf84,bA189K21.1,bA189K21.8,dJ568F9.2;double zinc ribbon and ankyrin repeat domains 1
hsa:3818;KLKB1,KLK3,PPK;kallikrein B, plasma (Fletcher factor) 1 (EC:3.4.21.34)
hsa:6018;RLF,ZN-15L,ZNF292L;rearranged L-myc fusion
hsa:440093;H3F3C,H3.5;H3 histone, family 3C
hsa:11173;ADAMTS7,ADAM-TS_7,ADAM-TS7,ADAMTS-7;ADAM metallopeptidase with thrombospondin type 1 motif, 7 (EC:3.4.24.-)
hsa:2026;ENO2,NSE;enolase 2 (gamma, neuronal) (EC:4.2.1.11)
hsa:90780;PYGO2,1190004M21Rik;pygopus homolog 2 (Drosophila)
hsa:7579;ZSCAN20,KOX29,ZFP-31,ZNF31,ZNF360;zinc finger and SCAN domain containing 20
hsa:254225;RNF169;ring finger protein 169
hsa:94239;H2AFV,H2AV;H2A histone family, member V
hsa:29994;BAZ2B,WALp4;bromodomain adjacent to zinc finger domain, 2B
hsa:147929;ZNF565;zinc finger protein 565
hsa:25913;POT1,HPOT1;protection of telomeres 1
hsa:23598;PATZ1,MAZR,PATZ,RIAZ,ZBTB19,ZNF278,ZSG,dJ400N23;POZ (BTB) and AT hook containing zinc finger 1
hsa:7703;PCGF2,MEL-18,RNF110,ZNF144;polycomb group ring finger 2
hsa:7343;UBTF,NOR-90,UBF,UBF-1,UBF1;upstream binding transcription factor, RNA polymerase I
hsa:23211;ZC3H4,C19orf7;zinc finger CCCH-type containing 4
hsa:6764;ST5,DENND2B,HTS1,p126;suppression of tumorigenicity 5
hsa:5903;RANBP2,ANE1,IIAE3,NUP358,TRP1,TRP2;RAN binding protein 2 (EC:5.2.1.8)
hsa:22885;ABLIM3;actin binding LIM protein family, member 3
hsa:284306;ZNF547;zinc finger protein 547
hsa:27229;TUBGCP4,76P,GCP-4,GCP4,h76p,hGCP4,hGrip76;tubulin, gamma complex associated protein 4
hsa:97;ACYP1,ACYPE;acylphosphatase 1, erythrocyte (common) type (EC:3.6.1.7)
hsa:656;BMP8B,BMP8,OP2;bone morphogenetic protein 8b
hsa:22803;XRN2;5'-3' exoribonuclease 2 (EC:3.1.13.-)
hsa:781;CACNA2D1,CACNA2,CACNL2A,CCHL2A,MHS3;calcium channel, voltage-dependent, alpha 2/delta subunit 1
hsa:284349;ZNF283,HZF41;zinc finger protein 283
hsa:6483;ST3GAL2,Gal-NAc6S,SIAT4B,ST3GALII,ST3GalA.2;ST3 beta-galactoside alpha-2,3-sialyltransferase 2 (EC:2.4.99.4)
hsa:6147;RPL23A,L23A,MDA20;ribosomal protein L23a
hsa:4948;OCA2,BEY,BEY1,BEY2,BOCA,D15S12,EYCL,EYCL2,EYCL3,HCL3,P,PED,SHEP1;oculocutaneous albinism II
hsa:1415;CRYBB2,CCA2,CRYB2,CRYB2A,D22S665;crystallin, beta B2
hsa:3240;HP,BP,HP2ALPHA2,HPA1S;haptoglobin
hsa:81706;PPP1R14C,CPI17-like,KEPI,NY-BR-81;protein phosphatase 1, regulatory (inhibitor) subunit 14C
hsa:4661;MYT1,C20orf36,MTF1,MYTI,PLPB1,ZC2HC4A;myelin transcription factor 1
hsa:54769;DIRAS2,Di-Ras2;DIRAS family, GTP-binding RAS-like 2
hsa:30819;KCNIP2,KCHIP2;Kv channel interacting protein 2
hsa:55776;SAYSD1,C6orf64;SAYSVFN motif domain containing 1
hsa:2574;GAGE2C,CT4.2,GAGE-2,GAGE-2C,GAGE2;G antigen 2C
hsa:646892;SH2D7;SH2 domain containing 7
hsa:55663;ZNF446,ZKSCAN20,ZSCAN30,ZSCAN52;zinc finger protein 446
hsa:116028;RMI2,BLAP18,C16orf75;RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae)
hsa:5172;SLC26A4,DFNB4,EVA,PDS,TDH2B;solute carrier family 26, member 4
hsa:79000;AUNIP,AIBP,C1orf135;aurora kinase A and ninein interacting protein
hsa:147687;ZNF417;zinc finger protein 417
hsa:85301;COL27A1;collagen, type XXVII, alpha 1
hsa:56999;ADAMTS9;ADAM metallopeptidase with thrombospondin type 1 motif, 9
hsa:23567;ZNF346,JAZ,Zfp346;zinc finger protein 346
hsa:1840;DTX1,hDx-1;deltex homolog 1 (Drosophila)
hsa:222696;ZSCAN23,ZNF390,ZNF453,dJ29K1.3,dJ29K1.3.1;zinc finger and SCAN domain containing 23
hsa:5830;PEX5,PBD2A,PBD2B,PTS1-BP,PTS1R,PXR1;peroxisomal biogenesis factor 5
hsa:162979;ZNF296,ZFP296,ZNF342;zinc finger protein 296
hsa:2928;GSC2,GSCL;goosecoid homeobox 2
hsa:56204;FAM214A,KIAA1370;family with sequence similarity 214, member A
hsa:140883;ZNF280B,5'OY11.1,D87009.C22.3,SUHW2,ZNF279,ZNF632;zinc finger protein 280B
hsa:7584;ZNF35,HF.10,HF10,Zfp105;zinc finger protein 35
hsa:4077;NBR1,1A1-3B,M17S2;neighbor of BRCA1 gene 1
hsa:348327;ZNF530;zinc finger protein 530
hsa:10683;DLL3,SCDO1;delta-like 3 (Drosophila)
hsa:123624;AGBL1;ATP/GTP binding protein-like 1
hsa:400581;GRAPL;GRB2-related adaptor protein-like
hsa:163227;ZNF100;zinc finger protein 100
hsa:4490;MT1B,MT1,MT1Q,MTP;metallothionein 1B
hsa:219595;FOLH1B,FOLH2,FOLHP,GCP3,GCPIII,PSM,PSMA-LIKE,PSMAL;folate hydrolase 1B
hsa:22898;DENND3;DENN/MADD domain containing 3
hsa:10168;ZNF197,D3S1363E,P18,VHLaK,ZKSCAN9,ZNF166,ZNF20,ZSCAN41;zinc finger protein 197
hsa:146057;TTBK2,SCA11,TTBK;tau tubulin kinase 2 (EC:2.7.11.1)
hsa:2966;GTF2H2,BTF2,BTF2P44,T-BTF2P44,TFIIH,p44;general transcription factor IIH, polypeptide 2, 44kDa
hsa:10850;CCL27,ALP,CTACK,CTAK,ESKINE,ILC,PESKY,SCYA27;chemokine (C-C motif) ligand 27
hsa:146310;RNF151;ring finger protein 151
hsa:388558;ZNF808;zinc finger protein 808
hsa:80045;GPR157;G protein-coupled receptor 157
hsa:27143;PALD1,KIAA1274,PALD;phosphatase domain containing, paladin 1
hsa:253935;ANGPTL5;angiopoietin-like 5
hsa:57211;GPR126,APG1,DREG,PS1TP2,VIGR;G protein-coupled receptor 126
hsa:5932;RBBP8,COM1,CTIP,JWDS,RIM,SAE2,SCKL2;retinoblastoma binding protein 8
hsa:163059;ZNF433;zinc finger protein 433
hsa:23475;QPRT,QPRTase;quinolinate phosphoribosyltransferase (EC:2.4.2.19)
hsa:3104;ZBTB48,HKR3,ZNF855,pp9964;zinc finger and BTB domain containing 48
hsa:414325;DEFB103A,BD-3,DEFB-3,DEFB103,DEFB3,HBD3,HBP-3,HBP3,hBD-3;defensin, beta 103A
hsa:246100;CTAG1A,ESO1,LAGE2A;cancer/testis antigen 1A
hsa:285753;CEP57L1,C6orf182,bA487F23.2,cep57R;centrosomal protein 57kDa-like 1
hsa:164395;TTLL9,C20orf125,dJ310O13.1;tubulin tyrosine ligase-like family, member 9
hsa:10063;COX17;cytochrome c oxidase assembly homolog 17 (yeast)
hsa:130013;ACMSD;aminocarboxymuconate semialdehyde decarboxylase (EC:4.1.1.45)
hsa:51074;APIP,APIP2,CGI29,MMRP19,dJ179L10.2,hAPIP;APAF1 interacting protein (EC:4.2.1.109)
hsa:254887;ZDHHC23,NIDD;zinc finger, DHHC-type containing 23
hsa:30832;ZNF354C,KID3;zinc finger protein 354C
hsa:27043;PELP1,HMX3,MNAR,P160;proline, glutamate and leucine rich protein 1
hsa:58533;SNX6,MSTP010,TFAF2;sorting nexin 6
hsa:25885;POLR1A,A190,RPA1,RPA194,RPO1-4,RPO14;polymerase (RNA) I polypeptide A, 194kDa (EC:2.7.7.6)
hsa:7565;ZNF17,HPF3,KOX10;zinc finger protein 17
hsa:7627;ZNF75A;zinc finger protein 75a
hsa:657;BMPR1A,10q23del,ACVRLK3,ALK3,CD292,SKR5;bone morphogenetic protein receptor, type IA (EC:2.7.11.30)
hsa:129025;ZNF280A,3'OY11.1,SUHW1,ZNF280,ZNF636;zinc finger protein 280A
hsa:8448;DOC2A,Doc2;double C2-like domains, alpha
hsa:255394;TCP11L2;t-complex 11, testis-specific-like 2
hsa:26108;PYGO1;pygopus homolog 1 (Drosophila)
hsa:284110;GSDMA,GSDM,GSDM1;gasdermin A
hsa:9768;NS5ATP9,OEATC,OEATC-1,OEATC1,PAF,PAF15,p15(PAF),p15/PAF,p15PAF;KIAA0101
hsa:4214;MAP3K1,MAPKKK1,MEKK,MEKK_1,MEKK1,SRXY6;mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase (EC:2.7.11.25)
hsa:55072;RNF31,HOIP,ZIBRA;ring finger protein 31
hsa:10060;ABCC9,ABC37,ATFB12,CANTU,CMD1O,SUR2;ATP-binding cassette, sub-family C (CFTR/MRP), member 9
hsa:387718;TEX36,C10orf122,bA383C5.1;testis expressed 36
hsa:56980;PRDM10,PFM7;PR domain containing 10
hsa:81786;TRIM7,GNIP,RNF90;tripartite motif containing 7
hsa:57616;TSHZ3,TSH3,ZNF537;teashirt zinc finger homeobox 3
hsa:116843;SLC18B1,C6orf192,dJ55C23.6;solute carrier family 18, subfamily B, member 1
hsa:65249;ZSWIM4;zinc finger, SWIM-type containing 4
hsa:2801;GOLGA2,GM130;golgin A2
hsa:79690;GAL3ST4,GAL3ST-4;galactose-3-O-sulfotransferase 4
hsa:6726;SRP9,ALURBP;signal recognition particle 9kDa
hsa:9459;ARHGEF6,COOL2,Cool-2,MRX46,PIXA,alpha-PIX,alphaPIX;Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6
hsa:6349;CCL3L1,464.2,D17S1718,G0S19-2,LD78,LD78BETA,MIP1AP,SCYA3L,SCYA3L1;chemokine (C-C motif) ligand 3-like 1
hsa:79009;DDX50,GU2,GUB,RH-II/GuB,mcdrh;DEAD (Asp-Glu-Ala-Asp) box polypeptide 50 (EC:3.6.4.13)
hsa:23132;RAD54L2,ARIP4,HSPC325,SRISNF2L;RAD54-like 2 (S. cerevisiae) (EC:3.6.4.12)
hsa:120534;ARL14EP,ARF7EP,C11orf46,dJ299F11.1;ADP-ribosylation factor-like 14 effector protein
hsa:3007;HIST1H1D,H1.3,H1D,H1F3,H1s-2;histone cluster 1, H1d
hsa:126;ADH1C,ADH3;alcohol dehydrogenase 1C (class I), gamma polypeptide (EC:1.1.1.1)
hsa:114026;ZIM3,ZNF657;zinc finger, imprinted 3
hsa:50854;C6orf48,D6S57,G8;chromosome 6 open reading frame 48
hsa:341116;MS4A10,CD20L7,MS4A9;membrane-spanning 4-domains, subfamily A, member 10
hsa:56928;SPPL2B,IMP-4,IMP4,PSH4,PSL1;signal peptide peptidase like 2B (EC:3.4.23.-)
hsa:23361;ZNF629,ZNF,ZNF65;zinc finger protein 629
hsa:995;CDC25C,CDC25,PPP1R60;cell division cycle 25C (EC:3.1.3.48)
hsa:284076;TTLL6,TTL.6;tubulin tyrosine ligase-like family, member 6
hsa:342909;ZNF284,ZNF284L;zinc finger protein 284
hsa:162966;ZNF600,KR-ZNF1;zinc finger protein 600
hsa:144124;OR10A5,JCG6,OR10A1,OR11-403;olfactory receptor, family 10, subfamily A, member 5
hsa:3097;HIVEP2,HIV-EP2,MBP-2,MIBP1,SHN2,ZAS2,ZNF40B;human immunodeficiency virus type I enhancer binding protein 2
hsa:22854;NTNG1,Lmnt1;netrin G1
hsa:340595;ZCCHC16,Mar4,Mart4;zinc finger, CCHC domain containing 16
hsa:223082;ZNRF2,RNF202;zinc and ring finger 2
hsa:8572;PDLIM4,RIL;PDZ and LIM domain 4
hsa:54576;UGT1A8,UDPGT,UDPGT_1-8,UGT-1H,UGT1-08,UGT1.8,UGT1A8S,UGT1H;UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17)
hsa:152756;FAM218A,C4orf39;family with sequence similarity 218, member A
hsa:91894;C11orf52;chromosome 11 open reading frame 52
hsa:3009;HIST1H1B,H1,H1.5,H1B,H1F5,H1s-3;histone cluster 1, H1b
hsa:7869;SEMA3B,LUCA-1,SEMA5,SEMAA,SemA,semaV;sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
hsa:55270;NUDT15,MTH2,RP11-90M2.1;nudix (nucleoside diphosphate linked moiety X)-type motif 15 (EC:3.6.1.55)
hsa:728113;ANXA8L1,ANXA8,bA301J7.3;annexin A8-like 1
hsa:6284;S100A13;S100 calcium binding protein A13
hsa:763;CA5A,CA5,CAV,CAVA;carbonic anhydrase VA, mitochondrial (EC:4.2.1.1)
hsa:7705;ZNF146,OZF;zinc finger protein 146
hsa:170691;ADAMTS17;ADAM metallopeptidase with thrombospondin type 1 motif, 17
hsa:22921;MSRB2,CBS-1,CBS1,MSRB,PILB;methionine sulfoxide reductase B2
hsa:26156;RSL1D1,CSIG,PBK1,UTP30;ribosomal L1 domain containing 1
hsa:134187;POU5F2,SPRM-1;POU domain class 5, transcription factor 2
hsa:221357;GSTA5;glutathione S-transferase alpha 5 (EC:2.5.1.18)
hsa:4975;OMP;olfactory marker protein
hsa:11193;WBP4,FBP21;WW domain binding protein 4
hsa:81603;TRIM8,GERP,RNF27;tripartite motif containing 8
hsa:55148;UBR7,C14orf130;ubiquitin protein ligase E3 component n-recognin 7 (putative)
hsa:4716;NDUFB10,PDSW;NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa
hsa:391253;SPINT4,C20orf137,SPINT3,dJ601O1.1;serine peptidase inhibitor, Kunitz type 4
hsa:3096;HIVEP1,CIRIP,CRYBP1,MBP-1,PRDII-BF1,Schnurri-1,ZAS1,ZNF40,ZNF40A;human immunodeficiency virus type I enhancer binding protein 1
hsa:90799;CEP95,CCDC45;centrosomal protein 95kDa
hsa:79844;ZDHHC11,ZNF399;zinc finger, DHHC-type containing 11
hsa:112849;L3HYPDH,C14orf149;L-3-hydroxyproline dehydratase (trans-) (EC:4.2.1.77)
hsa:6346;CCL1,I-309,P500,SCYA1,SISe,TCA3;chemokine (C-C motif) ligand 1
hsa:9284;NPIP,morpheus;nuclear pore complex interacting protein
hsa:23650;TRIM29,ATDC;tripartite motif containing 29
hsa:148479;PHF13,PHF5,SPOC1;PHD finger protein 13
hsa:63943;FKBPL,DIR1,NG7,WISP39;FK506 binding protein like
hsa:162993;ZNF846;zinc finger protein 846
hsa:55216;C11orf57;chromosome 11 open reading frame 57
hsa:9923;ZBTB40,ZNF923;zinc finger and BTB domain containing 40
hsa:1005;CDH7,CDH7L1;cadherin 7, type 2
hsa:92312;MEX3A,MEX-3A,RKHD4;mex-3 homolog A (C. elegans)
hsa:126208;ZNF787,TIP20;zinc finger protein 787
hsa:127;ADH4,ADH-2;alcohol dehydrogenase 4 (class II), pi polypeptide (EC:1.1.1.1)
hsa:984;CDK11B,CDC2L1,CDK11,CDK11-p110,CDK11-p46,CDK11-p58,CLK-1,PK58,p58,p58CDC2L1,p58CLK-1;cyclin-dependent kinase 11B (EC:2.7.11.22)
hsa:201475;RAB12;RAB12, member RAS oncogene family
hsa:55139;ANKZF1,ZNF744;ankyrin repeat and zinc finger domain containing 1
hsa:171392;ZNF675,TBZF,TIZ;zinc finger protein 675
hsa:85021;REPS1,RALBP1;RALBP1 associated Eps domain containing 1
hsa:653423;SPAG11A,EDDM2A,HE2;sperm associated antigen 11A
hsa:23324;MAN2B2;mannosidase, alpha, class 2B, member 2 (EC:3.2.1.24)
hsa:22938;SNW1,Bx42,NCOA-62,PRPF45,Prp45,SKIIP,SKIP;SNW domain containing 1
hsa:30968;STOML2,SLP-2;stomatin (EPB72)-like 2
hsa:9645;MICAL2,MICAL-2,MICAL2PV1,MICAL2PV2;microtubule associated monoxygenase, calponin and LIM domain containing 2
hsa:8994;LIMD1;LIM domains containing 1
hsa:55692;LUC7L,LUC7B1,Luc7,SR+89,hLuc7B1;LUC7-like (S. cerevisiae)
hsa:23135;KDM6B,JMJD3;lysine (K)-specific demethylase 6B
hsa:129868;TRIM43,TRIM43A;tripartite motif containing 43
hsa:254827;NAALADL2;N-acetylated alpha-linked acidic dipeptidase-like 2 (EC:3.4.17.21)
hsa:93349;SP140L;SP140 nuclear body protein-like
hsa:255101;CCDC108;coiled-coil domain containing 108
hsa:22918;CD93,C1QR1,C1qR(P),C1qRP,CDw93,ECSM3,MXRA4,dJ737E23.1;CD93 molecule
hsa:653121;ZBTB8A,BOZF1,ZBTB8,ZNF916A;zinc finger and BTB domain containing 8A
hsa:257160;RNF214;ring finger protein 214
hsa:55905;RNF114,PSORS12,ZNF313;ring finger protein 114
hsa:55854;ZC3H15,HT010,LEREPO4,MSTP012;zinc finger CCCH-type containing 15
hsa:340252;ZNF680;zinc finger protein 680
hsa:54600;UGT1A9,HLUGP4,LUGP4,UDPGT,UDPGT_1-9,UGT-1I,UGT1-09,UGT1-9,UGT1.9,UGT1AI,UGT1I;UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17)
hsa:5438;POLR2I,RPB9,hRPB14.5;polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa (EC:2.7.7.6)
hsa:11266;DUSP12,DUSP1,YVH1;dual specificity phosphatase 12 (EC:3.1.3.16 3.1.3.48)
hsa:25832;NBPF14,DJ328E19.C1.1,NBPF;neuroblastoma breakpoint family, member 14
hsa:64763;ZNF574,FP972;zinc finger protein 574
hsa:4626;MYH8,MyHC-peri,MyHC-pn,gtMHC-F;myosin, heavy chain 8, skeletal muscle, perinatal
hsa:27127;SMC1B,SMC1BETA,SMC1L2,bK268H5,bK268H5.5;structural maintenance of chromosomes 1B
hsa:54934;KANSL2,C12orf41,NSL2;KAT8 regulatory NSL complex subunit 2
hsa:132625;ZFP42,REX1,ZNF754;ZFP42 zinc finger protein
hsa:10519;CIB1,CIB,KIP,KIP1,SIP2-28;calcium and integrin binding 1 (calmyrin)
hsa:92235;DUSP27;dual specificity phosphatase 27 (putative)
hsa:64327;LMBR1,ACHP,C7orf2,DIF14,PPD2,TPT;limb region 1 homolog (mouse)
hsa:23291;FBXW11,BTRC2,BTRCP2,FBW1B,FBXW1B,Fbw11,Hos;F-box and WD repeat domain containing 11
hsa:6414;SEPP1,SELP,SeP;selenoprotein P, plasma, 1
hsa:7294;TXK,BTKL,PSCTK5,PTK4,RLK,TKL;TXK tyrosine kinase (EC:2.7.10.2)
hsa:80032;ZNF556;zinc finger protein 556
hsa:7227;TRPS1,GC79,LGCR;trichorhinophalangeal syndrome I
hsa:79818;ZNF552;zinc finger protein 552
hsa:2892;GRIA3,GLUR-C,GLUR-K3,GLUR3,GLURC,GluA3,MRX94;glutamate receptor, ionotropic, AMPA 3
hsa:163049;ZNF791;zinc finger protein 791
hsa:80731;THSD7B;thrombospondin, type I, domain containing 7B
hsa:3050;HBZ;hemoglobin, zeta
hsa:83903;GSG2,HASPIN;germ cell associated 2 (haspin) (EC:2.7.11.1)
hsa:284254;DYNAP,C18orf26;dynactin associated protein
hsa:28316;CDH20,CDH7L3,Cdh7;cadherin 20, type 2
hsa:55106;SLFN12,SLFN3;schlafen family member 12
hsa:644591;PPIAL4G,BX284650.5;peptidylprolyl isomerase A (cyclophilin A)-like 4G (EC:5.2.1.8)
hsa:7728;ZNF175,OTK18;zinc finger protein 175
hsa:50618;ITSN2,PRO2015,SH3D1B,SH3P18,SWA,SWAP;intersectin 2
hsa:22915;MMRN1,ECM,EMILIN4,GPIa*,MMRN;multimerin 1
hsa:9931;HELZ,DHRC,DRHC,HUMORF5;helicase with zinc finger
hsa:84449;ZNF333;zinc finger protein 333
hsa:282969;FUOM,C10orf125,FUCU,FucM;fucose mutarotase (EC:5.1.3.n2)
hsa:553128;KIR2DL5B,KIR2DL5,KIR2DL5.2,KIR2DLX;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5B
hsa:138065;RNF183;ring finger protein 183
hsa:128;ADH5,ADH-3,ADHX,FALDH,FDH,GSH-FDH,GSNOR;alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284)
hsa:7182;NR2C2,TAK1,TR2R1,TR4,hTAK1;nuclear receptor subfamily 2, group C, member 2
hsa:23612;PHLDA3,TIH1;pleckstrin homology-like domain, family A, member 3
hsa:338821;SLCO1B7,LST-3,LST-3TM12,LST3,SLC21A21;solute carrier organic anion transporter family, member 1B7 (non-functional)
hsa:91523;PCED1B,FAM113B;PC-esterase domain containing 1B
hsa:51545;ZNF581;zinc finger protein 581
hsa:402682;UFSP1,UFSP;UFM1-specific peptidase 1 (non-functional)
hsa:23113;CUL9,H7AP1,PARC,RP3-330M21.2;cullin 9
hsa:6157;RPL27A,L27A;ribosomal protein L27a
hsa:7699;ZNF140,pHZ-39;zinc finger protein 140
hsa:27072;VPS41,HVPS41,HVSP41,hVps41p;vacuolar protein sorting 41 homolog (S. cerevisiae)
hsa:56731;SLC2A4RG,GEF,HDBP-1,HDBP1,Si-1-2,Si-1-2-19;SLC2A4 regulator
hsa:22893;BAHD1;bromo adjacent homology domain containing 1
hsa:221504;ZBTB9,ZNF919;zinc finger and BTB domain containing 9
hsa:57567;ZNF319,ZFP319;zinc finger protein 319
hsa:51131;PHF11,APY,BCAP,IGEL,IGER,IGHER,NY-REN-34,NYREN34;PHD finger protein 11
hsa:93663;ARHGAP18,MacGAP,SENEX,bA307O14.2;Rho GTPase activating protein 18
hsa:79873;NUDT18,MTH3;nudix (nucleoside diphosphate linked moiety X)-type motif 18 (EC:3.6.1.-)
hsa:132001;TAMM41,C3orf31,RAM41,TAM41;TAM41, mitochondrial translocator assembly and maintenance protein, homolog (S. cerevisiae)
hsa:154214;RNF217,C6orf172,IBRDC1,dJ84N20.1;ring finger protein 217
hsa:23469;PHF3;PHD finger protein 3
hsa:10365;KLF2,LKLF;Kruppel-like factor 2 (lung)
hsa:64925;CCDC71;coiled-coil domain containing 71
hsa:64145;ZFYVE20,Rabenosyn-5;zinc finger, FYVE domain containing 20
hsa:51255;RNF181;ring finger protein 181
hsa:7287;TULP1,LCA15,RP14,TUBL1;tubby like protein 1
hsa:8706;B3GALNT1,B3GALT3,GLCT3,GLOB,Gb4Cer,P,P1,beta3Gal-T3,galT3;beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) (EC:2.4.1.79)
hsa:83887;TTLL2,C6orf104,NYD-TSPG,dJ366N23.3;tubulin tyrosine ligase-like family, member 2
hsa:7386;UQCRFS1,RIP1,RIS1,RISP,UQCR5;ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 (EC:1.10.2.2)
hsa:57553;MICAL3,MICAL-3;microtubule associated monoxygenase, calponin and LIM domain containing 3
hsa:79594;MUL1,C1orf166,GIDE,MAPL,MULAN,RNF218,RP11-401M16.2;mitochondrial E3 ubiquitin protein ligase 1
hsa:23626;SPO11,CT35;SPO11 meiotic protein covalently bound to DSB homolog (S. cerevisiae)
hsa:100131137;BSPH1,BSP1,ELSPBP2;binder of sperm protein homolog 1
hsa:10898;CPSF4,CPSF30,NAR,NEB1;cleavage and polyadenylation specific factor 4, 30kDa
hsa:10407;SPAG11B,EDDM2B,EP2,EP2C,EP2D,HE2,HE2C,SPAG11;sperm associated antigen 11B
hsa:5108;PCM1,PTC4;pericentriolar material 1
hsa:5376;PMP22,CMT1A,CMT1E,DSS,GAS-3,HMSNIA,HNPP,Sp110;peripheral myelin protein 22
hsa:202309;GAPT,C5orf29;GRB2-binding adaptor protein, transmembrane
hsa:27033;ZBTB32,FAXF,FAZF,Rog,TZFP,ZNF538;zinc finger and BTB domain containing 32
hsa:84904;ARHGEF39,C9orf100,RP11-331F9.7;Rho guanine nucleotide exchange factor (GEF) 39
hsa:1836;SLC26A2,D5S1708,DTD,DTDST,EDM4,MST153,MSTP157;solute carrier family 26 (sulfate transporter), member 2
hsa:10536;LEPREL2,GRCB,HSU47926,P3H3;leprecan-like 2 (EC:1.14.11.7)
hsa:10459;MAD2L2,MAD2B,POLZ2,REV7;MAD2 mitotic arrest deficient-like 2 (yeast)
hsa:54956;PARP16,ARTD15,C15orf30,pART15;poly (ADP-ribose) polymerase family, member 16 (EC:2.4.2.31)
hsa:23119;HIC2,HRG22,ZBTB30,ZNF907;hypermethylated in cancer 2
hsa:51567;TDP2,AD022,EAP2,EAPII,TTRAP,dJ30M3.3,hTDP2;tyrosyl-DNA phosphodiesterase 2 (EC:3.1.4.-)
hsa:11174;ADAMTS6,ADAM-TS_6,ADAM-TS6,ADAMTS-6;ADAM metallopeptidase with thrombospondin type 1 motif, 6
hsa:399;RHOH,ARHH,TTF;ras homolog family member H
hsa:284369;SIGLECL1,C19orf75,SIGLEC23P,SIGLECP7;SIGLEC family like 1
hsa:635;BHMT,BHMT1;betaine--homocysteine S-methyltransferase (EC:2.1.1.5)
hsa:54970;TTC12,TPARM;tetratricopeptide repeat domain 12
hsa:84759;PCGF1,2010002K04Rik,NSPC1,RNF3A-2,RNF68;polycomb group ring finger 1
hsa:116225;ZMYND19,MIZIP,RP11-48C7.4;zinc finger, MYND-type containing 19
hsa:54556;ING3,Eaf4,ING2,MEAF4,p47ING3;inhibitor of growth family, member 3
hsa:23660;ZKSCAN5,ZFP95,ZNF914,ZSCAN37;zinc finger with KRAB and SCAN domains 5
hsa:4302;MLLT6,AF17;myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila);translocated to, 6
hsa:10280;SIGMAR1,ALS16,OPRS1,SR-BP1,SRBP;sigma non-opioid intracellular receptor 1
hsa:56126;PCDHB10,PCDH-BETA10,PCHB10;protocadherin beta 10
hsa:3820;KLRB1,CD161,CLEC5B,NKR,NKR-P1,NKR-P1A,NKRP1A,hNKR-P1A;killer cell lectin-like receptor subfamily B, member 1
hsa:245939;DEFB128,DEFB-28,DEFB28,hBD-28;defensin, beta 128
hsa:100506084;ARL17B,ARL17,ARL17A;ADP-ribosylation factor-like 17B
hsa:91607;SLFN11,SLFN8/9;schlafen family member 11
hsa:85438;CABS1,C4orf35,CLPH,NYD-SP26;calcium-binding protein, spermatid-specific 1
hsa:169792;GLIS3,ZNF515;GLIS family zinc finger 3
hsa:123263;MTFMT,COXPD15,FMT1;mitochondrial methionyl-tRNA formyltransferase (EC:2.1.2.9)
hsa:10621;POLR3F,RPC39,RPC6;polymerase (RNA) III (DNA directed) polypeptide F, 39 kDa
hsa:4946;OAZ1,AZI,OAZ;ornithine decarboxylase antizyme 1
hsa:51364;ZMYND10,BLU,FLU;zinc finger, MYND-type containing 10
hsa:5325;PLAGL1,LOT1,ZAC,ZAC1;pleiomorphic adenoma gene-like 1
hsa:79084;WDR77,MEP-50,MEP50,Nbla10071,RP11-552M11.3,p44,p44/Mep50;WD repeat domain 77
hsa:56124;PCDHB12,PCDH-BETA12;protocadherin beta 12
hsa:6665;SOX15,SOX20,SOX26,SOX27;SRY (sex determining region Y)-box 15
hsa:150383;CDPF1,C22orf40;cysteine-rich, DPF motif domain containing 1
hsa:8968;HIST1H3F,H3/i,H3FI;histone cluster 1, H3f
hsa:6132;RPL8,L8;ribosomal protein L8
hsa:3024;HIST1H1A,H1.1,H1A,H1F1,HIST1;histone cluster 1, H1a
hsa:10293;TRAIP,RNF206,TRIP;TRAF interacting protein
hsa:1305;COL13A1,COLXIIIA1;collagen, type XIII, alpha 1
hsa:3233;HOXD4,HHO.C13,HOX-5.1,HOX4,HOX4B,Hox-4.2;homeobox D4
hsa:90317;ZNF616;zinc finger protein 616
hsa:6746;SSR2,TLAP,TRAP-BETA,TRAPB;signal sequence receptor, beta (translocon-associated protein beta)
hsa:1807;DPYS,DHP,DHPase;dihydropyrimidinase (EC:3.5.2.2)
hsa:5896;RAG1,RAG-1,RNF74;recombination activating gene 1
hsa:285440;CYP4V2,BCD,CYP4AH1;cytochrome P450, family 4, subfamily V, polypeptide 2
hsa:51056;LAP3,LAP,LAPEP,PEPS;leucine aminopeptidase 3 (EC:3.4.11.5 3.4.11.1)
hsa:54575;UGT1A10,UDPGT,UGT-1J,UGT1-10,UGT1.10,UGT1J;UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17)
hsa:10439;OLFM1,AMY,NOE1,NOELIN1,OlfA;olfactomedin 1
hsa:6130;RPL7A,L7A,SURF3,TRUP;ribosomal protein L7a
hsa:84437;MSANTD4,KIAA1826;Myb/SANT-like DNA-binding domain containing 4 with coiled-coils
hsa:5832;ALDH18A1,ARCL3A,GSAS,P5CS,PYCS;aldehyde dehydrogenase 18 family, member A1 (EC:1.2.1.41 2.7.2.11)
hsa:80332;ADAM33,C20orf153,DJ964F7.1;ADAM metallopeptidase domain 33
hsa:64087;MCCC2,MCCB;methylcrotonoyl-CoA carboxylase 2 (beta) (EC:6.4.1.4)
hsa:2623;GATA1,ERYF1,GATA-1,GF-1,GF1,NFE1,XLANP,XLTDA,XLTT;GATA binding protein 1 (globin transcription factor 1)
hsa:6176;RPLP1,LP1,P1,RPP1;ribosomal protein, large, P1
hsa:442862;PRY2,PTPN13LY2;PTPN13-like, Y-linked 2
hsa:126017;ZNF813;zinc finger protein 813
hsa:114034;TOE1;target of EGR1, member 1 (nuclear)
hsa:286380;FOXD4L3,FOXD4L2,FOXD6;forkhead box D4-like 3
hsa:374286;CDRT1,C170RF1,C17ORF1,C17ORF1A,FBXW10B,FBXW10P1,HREP,SM25H2;CMT1A duplicated region transcript 1
hsa:9935;MAFB,KRML,MCTO;v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)
hsa:92283;ZNF461,GIOT-1,GIOT1;zinc finger protein 461
hsa:116844;LRG1,HMFT1766,LRG;leucine-rich alpha-2-glycoprotein 1
hsa:387264;KRTAP5-1,KRN1L,KRTAP5.1;keratin associated protein 5-1
hsa:51337;THEM6,C8orf55,DSCD75;thioesterase superfamily member 6
hsa:642265;SPATA31A2,FAM75A2;SPATA31 subfamily A, member 2
hsa:473;RERE,ARG,ARP,ATN1L,DNB1;arginine-glutamic acid dipeptide (RE) repeats
hsa:92822;ZNF276,CENP-Z,CENPZ,ZFP276,ZNF477;zinc finger protein 276
hsa:644;BLVRA,BLVR,BVR,BVRA;biliverdin reductase A (EC:1.3.1.24)
hsa:63925;ZNF335,MCPH10,NIF-1,NIF1,NIF2;zinc finger protein 335
hsa:376940;ZC3H6,ZC3HDC6;zinc finger CCCH-type containing 6
hsa:494118;SPANXN1,CT11.6;SPANX family, member N1
hsa:3813;KIR3DS1,CD158E2,KIR-123FM,KIR-G1,NKAT10;killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
hsa:84108;PCGF6,MBLR,RNF134;polycomb group ring finger 6
hsa:51550;CINP;cyclin-dependent kinase 2 interacting protein
hsa:403314;APOBEC4,C1orf169;apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 4 (putative)
hsa:51341;ZBTB7A,FBI-1,FBI1,LRF,ZBTB7,ZNF857A,pokemon;zinc finger and BTB domain containing 7A
hsa:85416;ZIC5;Zic family member 5
hsa:7539;ZFP37,ZNF906;ZFP37 zinc finger protein
hsa:2199;FBLN2;fibulin 2
hsa:340665;CYP26C1,FFDD4;cytochrome P450, family 26, subfamily C, polypeptide 1
hsa:163223;ZNF676;zinc finger protein 676
hsa:169044;COL22A1;collagen, type XXII, alpha 1
hsa:64412;GZF1,ZBTB23,ZNF336;GDNF-inducible zinc finger protein 1
hsa:146167;SLC38A8;solute carrier family 38, member 8
hsa:2028;ENPEP,APA,CD249,gp160;glutamyl aminopeptidase (aminopeptidase A) (EC:3.4.11.7)
hsa:57504;MTA3;metastasis associated 1 family, member 3
hsa:9668;ZNF432;zinc finger protein 432
hsa:84622;ZNF594;zinc finger protein 594
hsa:85441;HELZ2,PDIP-1,PRIC285;helicase with zinc finger 2, transcriptional coactivator
hsa:88745;RRP36,C6orf153,dJ20C7.4;ribosomal RNA processing 36 homolog (S. cerevisiae)
hsa:169270;ZNF596;zinc finger protein 596 (EC:2.1.1.43)
hsa:35;ACADS,ACAD3,SCAD;acyl-CoA dehydrogenase, C-2 to C-3 short chain (EC:1.3.8.1)
hsa:6941;TCF19,SC1,SC1-1;transcription factor 19
hsa:25820;ARIH1,ARI,HARI,HHARI,UBCH7BP;ariadne homolog, ubiquitin-conjugating enzyme E2 binding protein, 1 (Drosophila)
hsa:114335;CGB1;chorionic gonadotropin, beta polypeptide 1
hsa:79012;CAMKV,1G5,VACAMKL;CaM kinase-like vesicle-associated
hsa:642843;CPSF4L;cleavage and polyadenylation specific factor 4-like
hsa:389852;SPACA5,LYC5,LYZL5,SLLP2,UNQ6288,dJ54B20.3;sperm acrosome associated 5 (EC:3.2.1.17)
hsa:10239;AP3S2,AP3S3,sigma3b;adaptor-related protein complex 3, sigma 2 subunit
hsa:93550;ZFAND4,ANUBL1;zinc finger, AN1-type domain 4
hsa:64841;GNPNAT1,GNPNAT,Gpnat1;glucosamine-phosphate N-acetyltransferase 1 (EC:2.3.1.4)
hsa:84264;HAGHL;hydroxyacylglutathione hydrolase-like (EC:3.1.2.6)
hsa:10616;RBCK1,C20orf18,HOIL-1,HOIL1,RBCK2,RNF54,UBCE7IP3,XAP3,XAP4,ZRANB4;RanBP-type and C3HC4-type zinc finger containing 1
hsa:79596;RNF219,C13orf7;ring finger protein 219
hsa:54875;CNTLN,C9orf101,C9orf39,RP11-340N12.1,bA340N12.1;centlein, centrosomal protein
hsa:23246;BOP1;block of proliferation 1
hsa:5799;PTPRN2,IA-2beta,IAR,ICAAR,PTPRP,R-PTP-N2;protein tyrosine phosphatase, receptor type, N polypeptide 2 (EC:3.1.3.48)
hsa:79991;OBFC1,AAF-44,AAF44,RP11-541N10.2,RPA-32,STN1,bA541N10.2;oligonucleotide/oligosaccharide-binding fold containing 1
hsa:8687;KRT38,HA8,KRTHA8,hHa8;keratin 38
hsa:196951;FAM227B,C15orf33;family with sequence similarity 227, member B
hsa:6133;RPL9,L9,NPC-A-16;ribosomal protein L9
hsa:90338;ZNF160,F11,HKr18,HZF5,KR18;zinc finger protein 160
hsa:55247;NEIL3,FGP2,FPG2,NEI3,hFPG2,hNEI3;nei endonuclease VIII-like 3 (E. coli) (EC:4.2.99.18)
hsa:84240;ZCCHC9,PPP1R41;zinc finger, CCHC domain containing 9
hsa:7621;ZNF70,Cos17;zinc finger protein 70
hsa:343472;BARHL2;BarH-like homeobox 2
hsa:197370;NSMCE1,NSE1;non-SMC element 1 homolog (S. cerevisiae)
hsa:401262;CRIP3,TLP,TLP-A,bA480N24.2;cysteine-rich protein 3
hsa:55084;SOBP,JXC1,MRAMS;sine oculis binding protein homolog (Drosophila)
hsa:55142;HAUS2,C15orf25,CEP27,HsT17025;HAUS augmin-like complex, subunit 2
hsa:169693;TMEM252,C9orf71,RP11-274B18.1;transmembrane protein 252
hsa:79744;ZNF419,ZNF419A;zinc finger protein 419
hsa:29063;ZCCHC4,HSPC052;zinc finger, CCHC domain containing 4
hsa:23060;ZNF609;zinc finger protein 609
hsa:3824;KLRD1,CD94;killer cell lectin-like receptor subfamily D, member 1
hsa:55870;ASH1L,ASH1,ASH1L1,KMT2H;ash1 (absent, small, or homeotic)-like (Drosophila) (EC:2.1.1.43)
hsa:5251;PHEX,HPDR,HPDR1,HYP,HYP1,LXHR,PEX,XLH;phosphate regulating endopeptidase homolog, X-linked
hsa:84287;ZDHHC16,APH2;zinc finger, DHHC-type containing 16
hsa:7592;ZNF41,MRX89;zinc finger protein 41
hsa:6596;HLTF,HIP116,HIP116A,HLTF1,RNF80,SMARCA3,SNF2L3,ZBU1;helicase-like transcription factor
hsa:27231;NMRK2,ITGB1BP3,MIBP,NRK2;nicotinamide riboside kinase 2 (EC:2.7.1.22 2.7.1.173)
hsa:55159;RFWD3,RNF201;ring finger and WD repeat domain 3
hsa:79050;NOC4L,NET49,NOC4,UTP19;nucleolar complex associated 4 homolog (S. cerevisiae)
hsa:80345;ZSCAN16,ZNF392,ZNF435,dJ265C24.3;zinc finger and SCAN domain containing 16
hsa:65986;ZBTB10,RINZF;zinc finger and BTB domain containing 10
hsa:8370;HIST2H4A,FO108,H4,H4/n,H4F2,H4FN,HIST2H4;histone cluster 2, H4a
hsa:1363;CPE;carboxypeptidase E (EC:3.4.17.10)
hsa:64968;MRPS6,C21orf101,MRP-S6,RPMS6,S6mt;mitochondrial ribosomal protein S6
hsa:153364;MBLAC2;metallo-beta-lactamase domain containing 2
hsa:2628;GATM,AGAT,AT;glycine amidinotransferase (L-arginine:glycine amidinotransferase) (EC:2.1.4.1)
hsa:79027;ZNF655,VIK,VIK-1;zinc finger protein 655
hsa:9586;CREB5,CRE-BPA;cAMP responsive element binding protein 5
hsa:23731;TMEM245,C9orf5,CG-2,CG2;transmembrane protein 245
hsa:1749;DLX5,SHFM1D;distal-less homeobox 5
hsa:149076;ZNF362,RN,lin-29;zinc finger protein 362
hsa:79684;MSANTD2,C11orf61;Myb/SANT-like DNA-binding domain containing 2
hsa:28976;ACAD9,NPD002;acyl-CoA dehydrogenase family, member 9
hsa:285613;RELL2,C5orf16;RELT-like 2
hsa:9409;PEX16,PBD8A,PBD8B;peroxisomal biogenesis factor 16
hsa:6637;SNRPG,SMG,Sm-G;small nuclear ribonucleoprotein polypeptide G
hsa:6355;CCL8,HC14,MCP-2,MCP2,SCYA10,SCYA8;chemokine (C-C motif) ligand 8
hsa:6202;RPS8,S8;ribosomal protein S8
hsa:57570;TRMT5,KIAA1393,TRM5;tRNA methyltransferase 5 homolog (S. cerevisiae) (EC:2.1.1.228)
hsa:57728;WDR19,ATD5,CED4,DYF-2,IFT144,NPHP13,ORF26,Oseg6,PWDMP;WD repeat domain 19
hsa:169834;ZNF883;zinc finger protein 883
hsa:90203;SNX21,C20orf161,PP3993,SNX-L,dJ337O18.4;sorting nexin family member 21
hsa:1153;CIRBP,CIRP;cold inducible RNA binding protein
hsa:645037;GAGE2B,GAGE-2B;G antigen 2B
hsa:1464;CSPG4,HMW-MAA,MCSP,MCSPG,MEL-CSPG,MSK16,NG2;chondroitin sulfate proteoglycan 4
hsa:93145;OLFM2,NOE2,NOELIN2,NOELIN2_V1,OlfC;olfactomedin 2
hsa:140612;ZFP28,mkr5;ZFP28 zinc finger protein
hsa:118490;MSS51,ZMYND17;MSS51 mitochondrial translational activator
hsa:10580;SORBS1,CAP,FLAF2,R85FL,SH3D5,SH3P12,SORB1;sorbin and SH3 domain containing 1
hsa:9867;PJA2,Neurodap1,RNF131;praja ring finger 2, E3 ubiquitin protein ligase (EC:6.3.2.-)
hsa:8658;TNKS,ARTD5,PARP-5a,PARP5A,PARPL,TIN1,TINF1,TNKS1,pART5;tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase (EC:2.4.2.30)
hsa:118424;UBE2J2,NCUBE-2,NCUBE2,PRO2121;ubiquitin-conjugating enzyme E2, J2 (EC:6.3.2.19)
hsa:143279;HECTD2;HECT domain containing E3 ubiquitin protein ligase 2 (EC:6.3.2.-)
hsa:1504;CTRB1,CTRB;chymotrypsinogen B1 (EC:3.4.21.1)
hsa:9092;SART1,Ara1,HOMS1,SART1259,SNRNP110,Snu66;squamous cell carcinoma antigen recognized by T cells
hsa:1828;DSG1,CDHF4,DG1,DSG,PPKS1,SPPK1;desmoglein 1
hsa:79034;C7orf26;chromosome 7 open reading frame 26
hsa:58530;LY6G6D,C6orf23,G6D,LY6-D,MEGT1,NG25;lymphocyte antigen 6 complex, locus G6D
hsa:55205;ZNF532;zinc finger protein 532
hsa:147841;SPC24,SPBC24;SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae)
hsa:7994;KAT6A,MOZ,MYST3,RUNXBP2,ZC2HC6A,ZNF220;K(lysine) acetyltransferase 6A (EC:2.3.1.48)
hsa:8844;KSR1,KSR,RSU2;kinase suppressor of ras 1
hsa:130507;UBR3,ZNF650;ubiquitin protein ligase E3 component n-recognin 3 (putative) (EC:6.3.2.-)
hsa:10467;ZNHIT1,CG1I,ZNFN4A1;zinc finger, HIT-type containing 1
hsa:255403;ZNF718;zinc finger protein 718
hsa:26525;IL36RN,FIL1,FIL1(DELTA),FIL1D,IL1F5,IL1HY1,IL1L1,IL1RP3,IL36RA,PSORP;interleukin 36 receptor antagonist
hsa:6196;RPS6KA2,HU-2,MAPKAPK1C,RSK,RSK3,S6K-alpha,S6K-alpha2,p90-RSK3,pp90RSK3;ribosomal protein S6 kinase, 90kDa, polypeptide 2 (EC:2.7.11.1)
hsa:57484;RNF150;ring finger protein 150
hsa:26154;ABCA12,ARCI4A,ARCI4B,ICR2B,LI2;ATP-binding cassette, sub-family A (ABC1), member 12
hsa:10425;ARIH2,ARI2,TRIAD1;ariadne homolog 2 (Drosophila)
hsa:5983;RFC3,RFC38;replication factor C (activator 1) 3, 38kDa
hsa:11164;NUDT5,YSA1,YSA1H,hYSAH1;nudix (nucleoside diphosphate linked moiety X)-type motif 5 (EC:3.6.1.13 3.6.1.58)
hsa:83540;NUF2,CDCA1,CT106,NUF2R;NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae)
hsa:341392;ACSM4;acyl-CoA synthetase medium-chain family member 4 (EC:6.2.1.2)
hsa:9227;LRAT,LCA14;lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) (EC:2.3.1.135)
hsa:10049;DNAJB6,DJ4,DnaJ,HHDJ1,HSJ-2,HSJ2,LGMD1E,MRJ,MSJ-1;DnaJ (Hsp40) homolog, subfamily B, member 6
hsa:4012;LNPEP,CAP,IRAP,P-LAP,PLAP;leucyl/cystinyl aminopeptidase (EC:3.4.11.3)
hsa:7314;UBB,RPS27A,UBA52,UBC;ubiquitin B
hsa:54542;RC3H2,MNAB,RNF164;ring finger and CCCH-type domains 2
hsa:23549;DNPEP,ASPEP,DAP;aspartyl aminopeptidase (EC:3.4.11.21)
hsa:10464;PIBF1,C13orf24,CEP90,PIBF,RP11-505F3.1;progesterone immunomodulatory binding factor 1
hsa:57592;ZNF687;zinc finger protein 687
hsa:1160;CKMT2,SMTCK;creatine kinase, mitochondrial 2 (sarcomeric) (EC:2.7.3.2)
hsa:7581;ZNF33A,KOX2,KOX31,KOX5,NF11A,ZNF11,ZNF11A,ZNF33,ZZAPK;zinc finger protein 33A
hsa:1811;SLC26A3,CLD,DRA;solute carrier family 26, member 3
hsa:148266;ZNF569,ZAP1,ZNF;zinc finger protein 569
hsa:64792;RABL5;RAB, member RAS oncogene family-like 5
hsa:221060;C10orf111,bA455B2.4;chromosome 10 open reading frame 111
hsa:7569;ZNF182,HHZ150,KOX14,ZNF21,Zfp182;zinc finger protein 182
hsa:283551;C14orf182;chromosome 14 open reading frame 182
hsa:54811;ZNF562;zinc finger protein 562
hsa:125988;C19orf70,P117,QIL1;chromosome 19 open reading frame 70
hsa:10600;USP16,UBP-M;ubiquitin specific peptidase 16 (EC:3.4.19.12)
hsa:347240;KIF24,C9orf48,bA571F15.4;kinesin family member 24
hsa:11238;CA5B,CA-VB;carbonic anhydrase VB, mitochondrial (EC:4.2.1.1)
hsa:7768;ZNF225;zinc finger protein 225
hsa:339345;NANOS2,NOS2;nanos homolog 2 (Drosophila)
hsa:344191;EVX2,EVX-2;even-skipped homeobox 2
hsa:126068;ZNF441;zinc finger protein 441
hsa:81794;ADAMTS10,ADAM-TS10,WMS,WMS1;ADAM metallopeptidase with thrombospondin type 1 motif, 10
hsa:285203;EOGT,AER61,C3orf64,EOGT1;EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase (EC:2.4.1.255)
hsa:9781;RNF144A,RNF144,UBCE7IP4;ring finger protein 144A
hsa:10331;B3GNT3,B3GAL-T8,B3GN-T3,B3GNT-3,HP10328,TMEM3,beta3Gn-T3;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
hsa:161725;OTUD7A,C15orf16,C16ORF15,CEZANNE2,OTUD7;OTU domain containing 7A (EC:3.4.19.12)
hsa:3751;KCND2,KV4.2,RK5;potassium voltage-gated channel, Shal-related subfamily, member 2
hsa:51310;SLC22A17,24p3R,BOCT,BOIT,NGALR,NGALR2,NGALR3,hBOIT;solute carrier family 22, member 17
hsa:7448;VTN,V75,VN,VNT;vitronectin
hsa:65010;SLC26A6;solute carrier family 26, member 6
hsa:6783;SULT1E1,EST,EST-1,ST1E1,STE;sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4)
hsa:164022;PPIAL4A,COAS2,PPIAL4;peptidylprolyl isomerase A (cyclophilin A)-like 4A (EC:5.2.1.8)
hsa:51299;NRN1,NRN,dJ380B8.2;neuritin 1
hsa:9220;TIAF1,MAJN,SPR210;TGFB1-induced anti-apoptotic factor 1
hsa:6942;TCF20,AR1,SPBP;transcription factor 20 (AR1)
hsa:6193;RPS5,S5;ribosomal protein S5
hsa:10744;PTTG2;pituitary tumor-transforming 2
hsa:57649;PHF12,PF1;PHD finger protein 12
hsa:8767;RIPK2,CARD3,CARDIAK,CCK,GIG30,RICK,RIP2;receptor-interacting serine-threonine kinase 2 (EC:2.7.11.1 2.7.10.2)
hsa:9854;C2CD2L,TMEM24;C2CD2-like
hsa:340260;UNCX,UNCX4.1;UNC homeobox
hsa:140467;ZNF358,ZFEND;zinc finger protein 358
hsa:7586;ZKSCAN1,9130423L19Rik,KOX18,PHZ-37,ZNF139,ZNF36,ZSCAN33;zinc finger with KRAB and SCAN domains 1
hsa:26251;KCNG2,KCNF2,KV6.2;potassium voltage-gated channel, subfamily G, member 2
hsa:2009;EML1,ELP79,EMAP,EMAPL,HuEMAP;echinoderm microtubule associated protein like 1
hsa:4978;OPCML,IGLON1,OBCAM,OPCM;opioid binding protein/cell adhesion molecule-like
hsa:1303;COL12A1,BA209D8.1,COL12A1L,DJ234P15.1;collagen, type XII, alpha 1
hsa:57684;ZBTB26,ZNF481,bioref;zinc finger and BTB domain containing 26
hsa:89970;RSPRY1;ring finger and SPRY domain containing 1
hsa:92162;TMEM88;transmembrane protein 88
hsa:3554;IL1R1,CD121A,D2S1473,IL-1R-alpha,IL1R,IL1RA,P80;interleukin 1 receptor, type I
hsa:23416;KCNH3,BEC1,ELK2,Kv12.2;potassium voltage-gated channel, subfamily H (eag-related), member 3
hsa:3444;IFNA7,IFN-alphaJ,IFNA-J;interferon, alpha 7
hsa:6228;RPS23,S23;ribosomal protein S23
hsa:57600;FNIP2,FNIPL,MAPO1;folliculin interacting protein 2
hsa:345222;MSANTD1,C4orf44;Myb/SANT-like DNA-binding domain containing 1
hsa:257202;GPX6,GPX5p,GPXP3,GPx-6,GSHPx-6,dJ1186N24,dJ1186N24.1;glutathione peroxidase 6 (olfactory) (EC:1.11.1.9)
hsa:7700;ZNF141,D4S90,pHZ-44;zinc finger protein 141
hsa:326625;MMAB,ATR,cblB,cob;methylmalonic aciduria (cobalamin deficiency) cblB type (EC:2.5.1.17)
hsa:5566;PRKACA,PKACA;protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11)
hsa:390667;PTX4,C16orf38;pentraxin 4, long
hsa:91661;ZNF765;zinc finger protein 765
hsa:54796;BNC2,BSN2;basonuclin 2
hsa:3912;LAMB1,CLM;laminin, beta 1
hsa:5226;PGD,6PGD;phosphogluconate dehydrogenase (EC:1.1.1.44)
hsa:1824;DSC2,ARVD11,CDHF2,DG2,DGII/III,DSC3;desmocollin 2
hsa:79943;ZNF696;zinc finger protein 696
hsa:115123;MARCH3,MARCH-III,RNF173;membrane-associated ring finger (C3HC4) 3, E3 ubiquitin protein ligase
hsa:79683;ZDHHC14,NEW1CP;zinc finger, DHHC-type containing 14
hsa:342926;ZNF677;zinc finger protein 677
hsa:90321;ZNF766;zinc finger protein 766
hsa:147700;KLC3,KLC2,KLC2L,KLCt,KNS2B;kinesin light chain 3
hsa:6461;SHB,RP11-3J10.8,bA3J10.2;Src homology 2 domain containing adaptor protein B
hsa:60386;SLC25A19,DNC,MCPHA,MUP1,THMD3,THMD4,TPC;solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19
hsa:114088;TRIM9,RNF91,SPRING;tripartite motif containing 9
hsa:81926;ABHD17A,C19orf27,FAM108A1;abhydrolase domain containing 17A
hsa:389058;SP5;Sp5 transcription factor
hsa:64761;PARP12,ARTD12,MST109,MSTP109,ZC3H1,ZC3HDC1;poly (ADP-ribose) polymerase family, member 12 (EC:2.4.2.30)
hsa:91107;TRIM47,GOA,RNF100;tripartite motif containing 47
hsa:3804;KIR2DL3,CD158B2,CD158b,GL183,KIR-023GB,KIR-K7b,KIR-K7c,KIRCL23,NKAT,NKAT2,NKAT2A,NKAT2B,p58;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
hsa:221895;JAZF1,TIP27,ZNF802;JAZF zinc finger 1
hsa:4647;MYO7A,DFNA11,DFNB2,MYOVIIA,MYU7A,NSRD2,USH1B;myosin VIIA
hsa:26152;ZNF337;zinc finger protein 337
hsa:341568;OR8S1;olfactory receptor, family 8, subfamily S, member 1
hsa:55366;LGR4,GPR48;leucine-rich repeat containing G protein-coupled receptor 4
hsa:797;CALCB,CALC2,CGRP-II,CGRP2;calcitonin-related polypeptide beta
hsa:84436;ZNF528;zinc finger protein 528
hsa:165;AEBP1,ACLP;AE binding protein 1
hsa:158586;ZXDB,ZNF905,dJ83L6.1;zinc finger, X-linked, duplicated B
hsa:51528;JKAMP,C14orf100,HSPC213,HSPC327,JAMP;JNK1/MAPK8-associated membrane protein
hsa:4736;RPL10A,Csa-19,L10A,NEDD6;ribosomal protein L10a (EC:3.6.5.3)
hsa:653437;AQP12B,INSSA3;aquaporin 12B
hsa:30014;SPANXA1,CT11.1,NAP-X,SPAN-Xa,SPAN-Xb,SPANX;sperm protein associated with the nucleus, X-linked, family member A1
hsa:7552;ZNF711,CMPX1,MRX97,ZNF4,ZNF5,ZNF6,Zfp711,dJ75N13.1;zinc finger protein 711
hsa:83740;H2AFB3,H2ABBD,H2AFB;H2A histone family, member B3
hsa:56957;OTUD7B,CEZANNE,ZA20D1;OTU domain containing 7B (EC:3.4.19.12)
hsa:23338;PHF15,JADE2;PHD finger protein 15
hsa:7582;ZNF33B,KOX2,KOX31,ZNF11B;zinc finger protein 33B
hsa:285989;ZNF789;zinc finger protein 789
hsa:6218;RPS17,DBA4,RPS17L,RPS17L1,RPS17L2,S17;ribosomal protein S17
hsa:440307;TTLL13;tubulin tyrosine ligase-like family, member 13
hsa:728695;SPANXB1,B1,CT11.2,SPANX-B,SPANXB;SPANX family, member B1
hsa:7567;ZNF19,KOX12;zinc finger protein 19
hsa:2063;NR2F6,EAR-2,EAR2,ERBAL2;nuclear receptor subfamily 2, group F, member 6
hsa:283337;ZNF740,Zfp740;zinc finger protein 740
hsa:388610;TRNP1,C1orf225,TNRP;TMF1-regulated nuclear protein 1
hsa:8754;ADAM9,CORD9,MCMP,MDC9,Mltng;ADAM metallopeptidase domain 9
hsa:378950;RBMY1E;RNA binding motif protein, Y-linked, family 1, member E
hsa:85463;ZC3H12C,MCPIP3;zinc finger CCCH-type containing 12C
hsa:79673;ZNF329;zinc finger protein 329
hsa:162699;TCEB3C,HsT829,TCEB3L2;transcription elongation factor B polypeptide 3C (elongin A3)
hsa:7564;ZNF16,HZF1,KOX9;zinc finger protein 16
hsa:339976;TRIML1,RNF209;tripartite motif family-like 1
hsa:90874;ZNF697;zinc finger protein 697
hsa:58515;SELK,HSPC297;selenoprotein K
hsa:2295;FOXF2,FKHL6,FREAC-2,FREAC2;forkhead box F2
hsa:7580;ZNF32,KOX30;zinc finger protein 32
hsa:378949;RBMY1D;RNA binding motif protein, Y-linked, family 1, member D
hsa:51061;TXNDC11,EFP1;thioredoxin domain containing 11
hsa:7638;ZNF221;zinc finger protein 221
hsa:1261;CNGA3,ACHM2,CCNC1,CCNCa,CCNCalpha,CNCG3,CNG3;cyclic nucleotide gated channel alpha 3
hsa:7392;USF2,FIP,bHLHb12;upstream transcription factor 2, c-fos interacting
hsa:64843;ISL2;ISL LIM homeobox 2
hsa:283576;ZDHHC22,C14orf59;zinc finger, DHHC-type containing 22
hsa:4478;MSN;moesin
hsa:64062;RBM26,ARRS2,C13orf10,RP11-255E21.1,SE70-2,ZC3H17;RNA binding motif protein 26
hsa:5542;PRB1,PM,PMF,PMS,PRB1L,PRB1M;proline-rich protein BstNI subfamily 1
hsa:762;CA4,CAIV,Car4,RP17;carbonic anhydrase IV (EC:4.2.1.1)
hsa:22869;ZNF510;zinc finger protein 510
hsa:124602;KIF19,KIF19A;kinesin family member 19
hsa:196403;DTX3,RNF154;deltex homolog 3 (Drosophila)
hsa:55277;FGGY;FGGY carbohydrate kinase domain containing (EC:2.7.1.16)
hsa:23287;AGTPBP1,CCP1,NNA1;ATP/GTP binding protein 1
hsa:131096;KCNH8,ELK,ELK1,Kv12.1,elk3;potassium voltage-gated channel, subfamily H (eag-related), member 8
hsa:55893;ZNF395,HDBP-2,HDBP2,HDRF-2,PBF,PRF-1,PRF1,Si-1-8-14;zinc finger protein 395
hsa:6207;RPS13,S13;ribosomal protein S13 (EC:3.6.5.3)
hsa:85437;ZCRB1,MADP-1,MADP1,RBM36,SNRNP31,ZCCHC19;zinc finger CCHC-type and RNA binding motif 1
hsa:338599;DUPD1,DUSP27,FMDSP;dual specificity phosphatase and pro isomerase domain containing 1 (EC:3.1.3.16 3.1.3.48)
hsa:26472;PPP1R14B,PHI-1,PLCB3N,PNG,SOM172;protein phosphatase 1, regulatory (inhibitor) subunit 14B
hsa:63951;DMRTA1,DMO,DMRT4;DMRT-like family A1
hsa:118738;ZNF488;zinc finger protein 488
hsa:55531;ELMOD1;ELMO/CED-12 domain containing 1
hsa:2274;FHL2,AAG11,DRAL,FHL-2,SLIM-3,SLIM3;four and a half LIM domains 2
hsa:131375;LYZL4,1810009N24Rik,LYC4;lysozyme-like 4
hsa:80723;SLC35G2,TMEM22;solute carrier family 35, member G2
hsa:89870;TRIM15,RNF93,ZNF178,ZNFB7;tripartite motif containing 15
hsa:130;ADH6,ADH-5;alcohol dehydrogenase 6 (class V) (EC:1.1.1.1)
hsa:394263;MUC21,C6orf205,KMQK697,MUC-21,bCX31G15.2;mucin 21, cell surface associated
hsa:84922;FIZ1,ZNF798;FLT3-interacting zinc finger 1
hsa:27153;ZNF777;zinc finger protein 777
hsa:2584;GALK1,GALK,GK1;galactokinase 1 (EC:2.7.1.6)
hsa:444882;IGFL4;IGF-like family member 4
hsa:4351;MPI,CDG1B,PMI,PMI1;mannose phosphate isomerase (EC:5.3.1.8)
hsa:10946;SF3A3,PRP9,PRPF9,SAP61,SF3a60;splicing factor 3a, subunit 3, 60kDa
hsa:79589;RNF128,GRAIL;ring finger protein 128, E3 ubiquitin protein ligase (EC:6.3.2.-)
hsa:123811;FOPNL,C16orf63,FOR20,PHSECRG2;FGFR1OP N-terminal like
hsa:1176;AP3S1,CLAPS3,Sigma3A;adaptor-related protein complex 3, sigma 1 subunit
hsa:80895;ILKAP,ILKAP2,ILKAP3,PP2C-DELTA;integrin-linked kinase-associated serine/threonine phosphatase (EC:3.1.3.16)
hsa:79088;ZNF426;zinc finger protein 426
hsa:3892;KRT86,HB6,Hb1,KRTHB1,KRTHB6,MNX,hHb6;keratin 86
hsa:353513;VCY1B,BPY1B;variable charge, Y-linked 1B
hsa:54827;NXPE4,C11orf33,FAM55D;neurexophilin and PC-esterase domain family, member 4
hsa:10816;SPINT3,HKIB9;serine peptidase inhibitor, Kunitz type, 3
hsa:23587;ELP5,C17orf81,DERP6,MST071,MSTP071;elongator acetyltransferase complex subunit 5
hsa:55714;TENM3,ODZ3,TNM3,Ten-m3;teneurin transmembrane protein 3
hsa:139716;GAB3;GRB2-associated binding protein 3
hsa:6118;RPA2,REPA2,RPA32;replication protein A2, 32kDa
hsa:117579;RLN3,H3,RXN3,ZINS4,insl7;relaxin 3
hsa:6201;RPS7,DBA8,S7;ribosomal protein S7 (EC:3.6.5.3)
hsa:3614;IMPDH1,IMPD,IMPD1,LCA11,RP10,sWSS2608;IMP (inosine 5'-monophosphate) dehydrogenase 1 (EC:1.1.1.205)
hsa:7773;ZNF230,FDZF2;zinc finger protein 230
hsa:125150;ZSWIM7,SWS1;zinc finger, SWIM-type containing 7
hsa:8630;HSD17B6,HSE,RODH,SDR9C6;hydroxysteroid (17-beta) dehydrogenase 6 (EC:1.1.1.62 1.1.1.239 1.1.1.105)
hsa:4501;MT1X,MT-1l,MT1;metallothionein 1X
hsa:205147;AMER3,FAM123C;APC membrane recruitment protein 3
hsa:5197;PF4V1,CXCL4L1,CXCL4V1,PF4-ALT,PF4A,SCYB4V1;platelet factor 4 variant 1
hsa:54978;SLC35F6,ANT2BP,C2orf18,TANGO9;solute carrier family 35, member F6
hsa:154288;KHDC3L,C6orf221,ECAT1,HYDM2;KH domain containing 3-like, subcortical maternal complex member
hsa:4154;MBNL1,EXP,EXP35,EXP40,EXP42,MBNL;muscleblind-like splicing regulator 1
hsa:728712;SPANXA2,CT11.1,SPANX,SPANX-A,SPANXA;SPANX family, member A2
hsa:2649;NR6A1,GCNF,GCNF1,NR61,RTR;nuclear receptor subfamily 6, group A, member 1
hsa:54819;ZCCHC10;zinc finger, CCHC domain containing 10
hsa:6203;RPS9,S9;ribosomal protein S9
hsa:25906;ANAPC15,APC15,C11orf51;anaphase promoting complex subunit 15
hsa:4520;MTF1,MTF-1,ZRF;metal-regulatory transcription factor 1
hsa:203054;ADCK5;aarF domain containing kinase 5
hsa:56156;TEX13B,TGC3B,TSGA5;testis expressed 13B
hsa:126375;ZNF792;zinc finger protein 792
hsa:7038;TG,AITD3,TGN;thyroglobulin
hsa:56888;KCMF1,DEBT91,FIGC,PCMF,ZZZ1;potassium channel modulatory factor 1 (EC:6.3.2.-)
hsa:284307;ZIK1,ZNF762;zinc finger protein interacting with K protein 1
hsa:7761;ZNF214,BAZ-1,BAZ1;zinc finger protein 214
hsa:54845;ESRP1,RBM35A,RMB35A;epithelial splicing regulatory protein 1
hsa:85015;USP45;ubiquitin specific peptidase 45 (EC:3.4.19.12)
hsa:3983;ABLIM1,ABLIM,LIMAB1,LIMATIN,abLIM-1;actin binding LIM protein 1
hsa:5437;POLR2H,RPABC3,RPB17,RPB8,hsRPB8;polymerase (RNA) II (DNA directed) polypeptide H (EC:2.7.7.6)
hsa:440068;CARD17,INCA;caspase recruitment domain family, member 17
hsa:7766;ZNF223;zinc finger protein 223
hsa:84691;FAM71F1,FAM137A,NYD-SP18;family with sequence similarity 71, member F1
hsa:7770;ZNF227;zinc finger protein 227
hsa:65065;NBEAL1,A530083I02Rik,ALS2CR16,ALS2CR17;neurobeachin-like 1
hsa:653659;TMEM183B,C1orf37-DUP;transmembrane protein 183B
hsa:157313;CDCA2,Repo-Man;cell division cycle associated 2
hsa:6668;SP2;Sp2 transcription factor
hsa:7267;TTC3,DCRR1,RNF105,TPRDIII;tetratricopeptide repeat domain 3
hsa:53832;IL20RA,IL-20R1,ZCYTOR7;interleukin 20 receptor, alpha
hsa:7756;ZNF207;zinc finger protein 207
hsa:140628;GATA5,bB379O24.1;GATA binding protein 5
hsa:2959;GTF2B,TF2B,TFIIB;general transcription factor IIB
hsa:84289;ING5,p28ING5;inhibitor of growth family, member 5
hsa:81858;SHARPIN,SIPL1;SHANK-associated RH domain interactor
hsa:113246;C12orf57,C10,GRCC10;chromosome 12 open reading frame 57
hsa:10626;TRIM16,EBBP;tripartite motif containing 16
hsa:22880;MORC2,ZCW3,ZCWCC1;MORC family CW-type zinc finger 2
hsa:58527;ABRACL,C6orf115,Costars,HSPC280,PRO2013;ABRA C-terminal like
hsa:83642;SELO;selenoprotein O
hsa:55819;RNF130,G1RZFP,GOLIATH,GP;ring finger protein 130
hsa:245908;DEFB105A,BD-5,DEFB-5,DEFB105;defensin, beta 105A
hsa:348262;FAM195B;family with sequence similarity 195, member B
hsa:54708;MARCH5,MARCH-V,MITOL,RNF153;membrane-associated ring finger (C3HC4) 5
hsa:57621;ZBTB2,ZNF437;zinc finger and BTB domain containing 2
hsa:374355;CCDC172,C10orf96;coiled-coil domain containing 172
hsa:6206;RPS12,S12;ribosomal protein S12
hsa:56829;ZC3HAV1,ARTD13,FLB6421,PARP13,ZAP,ZC3H2,ZC3HDC2;zinc finger CCCH-type, antiviral 1
hsa:25897;RNF19A,DORFIN,RNF19;ring finger protein 19A, E3 ubiquitin protein ligase
hsa:135114;HINT3,HINT4;histidine triad nucleotide binding protein 3 (EC:3.-.-.-)
hsa:10926;DBF4,ASK,CHIF,DBF4A,ZDBF1;DBF4 homolog (S. cerevisiae)
hsa:163081;ZNF567;zinc finger protein 567
hsa:6274;S100A3,S100E;S100 calcium binding protein A3
hsa:57184;FAM219B,C15orf17;family with sequence similarity 219, member B
hsa:353142;LCE3A,LEP13;late cornified envelope 3A
hsa:8735;MYH13,MyHC-eo;myosin, heavy chain 13, skeletal muscle
hsa:168433;RNF133;ring finger protein 133
hsa:93979;CPA5;carboxypeptidase A5 (EC:3.4.17.1)
hsa:163087;ZNF383;zinc finger protein 383
hsa:161176;SYNE3,C14orf49,NET53,Nesp3;spectrin repeat containing, nuclear envelope family member 3
hsa:23625;FAM89B,MTVR1;family with sequence similarity 89, member B
hsa:347051;SLC10A5,P5;solute carrier family 10 (sodium/bile acid cotransporter family), member 5
hsa:22807;IKZF2,ANF1A2,HELIOS,ZNF1A2,ZNFN1A2;IKAROS family zinc finger 2 (Helios)
hsa:400935;IL17REL;interleukin 17 receptor E-like
hsa:341;APOC1;apolipoprotein C-I
hsa:148;ADRA1A,ADRA1C,ADRA1L1,ALPHA1AAR;adrenoceptor alpha 1A
hsa:9774;BCLAF1,BTF,bK211L9.1;BCL2-associated transcription factor 1
hsa:9215;LARGE,MDC1D,MDDGA6,MDDGB6;like-glycosyltransferase
hsa:9402;GRAP2,GADS,GRAP-2,GRB2L,GRBLG,GRID,GRPL,GrbX,Grf40,Mona,P38;GRB2-related adaptor protein 2
hsa:26520;TIMM9,TIM9,TIM9A;translocase of inner mitochondrial membrane 9 homolog (yeast)
hsa:85460;ZNF518B;zinc finger protein 518B
hsa:113835;ZNF257,BMZF-4,BMZF4;zinc finger protein 257
hsa:1149;CIDEA,CIDE-A;cell death-inducing DFFA-like effector a
hsa:55769;ZNF83,HPF1,ZNF816B;zinc finger protein 83
hsa:10160;FARP1,CDEP,PLEKHC2,PPP1R75;FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)
hsa:79973;ZNF442;zinc finger protein 442
hsa:26589;MRPL46,C15orf4,LIECG2,P2ECSL;mitochondrial ribosomal protein L46
hsa:7297;TYK2,JTK1;tyrosine kinase 2 (EC:2.7.10.2)
hsa:9896;FIG4,ALS11,CMT4J,KIAA0274,SAC3,dJ249I4.1;FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae)
hsa:253175;CDY1B,CDY;chromodomain protein, Y-linked, 1B (EC:2.3.1.48)
hsa:8639;AOC3,HPAO,SSAO,VAP-1,VAP1;amine oxidase, copper containing 3 (vascular adhesion protein 1) (EC:1.4.3.21)
hsa:7690;ZNF131,ZBTB35,pHZ-10;zinc finger protein 131
hsa:441430;ANKRD20A2;ankyrin repeat domain 20 family, member A2
hsa:346673;STRA8;stimulated by retinoic acid 8
hsa:9169;SCAF11,CASP11,SFRS2IP,SIP1,SRRP129,SRSF2IP;SR-related CTD-associated factor 11
hsa:26025;PCDHGA12,CDH21,FIB3,PCDH-GAMMA-A12;protocadherin gamma subfamily A, 12
hsa:10206;TRIM13,CAR,DLEU5,LEU5,RFP2,RNF77;tripartite motif containing 13
hsa:23036;ZNF292,Nbla00365,ZFP292,ZN-16,Zn-15,bA393I2.3;zinc finger protein 292
hsa:100125288;ZGLP1,GATAD3,GLP-1,GLP1;zinc finger, GATA-like protein 1
hsa:387332;TBPL2,TBP2,TRF3;TATA box binding protein like 2
hsa:51752;ERAP1,A-LAP,ALAP,APPILS,ARTS-1,ARTS1,ERAAP,ERAAP1,PILS-AP,PILSAP;endoplasmic reticulum aminopeptidase 1
hsa:51474;LIMA1,EPLIN,SREBP3;LIM domain and actin binding 1
hsa:112;ADCY6,AC6;adenylate cyclase 6 (EC:4.6.1.1)
hsa:79845;RNF122;ring finger protein 122
hsa:91768;CABLES1,CABL1,CABLES,HsT2563,IK3-1;Cdk5 and Abl enzyme substrate 1
hsa:8641;PCDHGB4,CDH20,FIB2,PCDH-GAMMA-B4;protocadherin gamma subfamily B, 4
hsa:8566;PDXK,C21orf124,C21orf97,PKH,PNK;pyridoxal (pyridoxine, vitamin B6) kinase (EC:2.7.1.35)
hsa:58525;WIZ,ZNF803;widely interspaced zinc finger motifs
hsa:221191;PRSS54,KLKBL4;protease, serine, 54
hsa:9037;SEMA5A,SEMAF,semF;sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
hsa:6833;ABCC8,ABC36,HHF1,HI,HRINS,MRP8,PHHI,SUR,SUR1,SUR1delta2,TNDM2;ATP-binding cassette, sub-family C (CFTR/MRP), member 8
hsa:51351;ZNF117,H-plk,HPF9;zinc finger protein 117
hsa:2577;GAGE5,CT4.5;G antigen 5
hsa:79132;DHX58,D11LGP2,D11lgp2e,LGP2,RLR-3;DEXH (Asp-Glu-X-His) box polypeptide 58 (EC:3.6.4.13)
hsa:6468;FBXW4,DAC,FBW4,FBWD4,SHFM3,SHSF3;F-box and WD repeat domain containing 4
hsa:81844;TRIM56,RNF109;tripartite motif containing 56
hsa:23152;CIC;capicua transcriptional repressor
hsa:59335;PRDM12,PFM9;PR domain containing 12
hsa:2578;GAGE6,CT4.6;G antigen 6
hsa:114900;C1QTNF4,CTRP4,ZACRP4;C1q and tumor necrosis factor related protein 4
hsa:84503;ZNF527;zinc finger protein 527
hsa:57573;ZNF471,ERP1,Z1971;zinc finger protein 471
hsa:2175;FANCA,FA,FA-H,FA1,FAA,FACA,FAH,FANCH;Fanconi anemia, complementation group A
hsa:345079;SOWAHB,ANKRD56;sosondowah ankyrin repeat domain family member B
hsa:5927;KDM5A,JARID1A,RBBP-2,RBBP2,RBP2;lysine (K)-specific demethylase 5A
hsa:6299;SALL1,HSAL1,Sal-1,TBS,ZNF794;sal-like 1 (Drosophila)
hsa:254173;TTLL10,TTLL5;tubulin tyrosine ligase-like family, member 10 (EC:6.-.-.-)
hsa:145858;C15orf32;chromosome 15 open reading frame 32
hsa:50636;ANO7,D-TMPP,DTMPP,IPCA-5,IPCA5,NGEP,PCANAP5,PCANAP5L,TMEM16G;anoctamin 7
hsa:29916;SNX11;sorting nexin 11
hsa:55319;TMA16,C4orf43;translation machinery associated 16 homolog (S. cerevisiae)
hsa:114770;PGLYRP2,HMFT0141,PGLYRPL,PGRP-L,PGRPL,TAGL-like,tagL,tagL-alpha,tagl-beta;peptidoglycan recognition protein 2 (EC:3.5.1.28)
hsa:51430;SUCO,C1orf9,CH1,OPT,SLP1;SUN domain containing ossification factor
hsa:3174;HNF4G,NR2A2,NR2A3;hepatocyte nuclear factor 4, gamma
hsa:6917;TCEA1,GTF2S,SII,TCEA,TF2S,TFIIS;transcription elongation factor A (SII), 1
hsa:140606;SELM,SEPM;selenoprotein M
hsa:162394;SLFN5;schlafen family member 5
hsa:1360;CPB1,CPB,PASP,PCPB;carboxypeptidase B1 (tissue) (EC:3.4.17.2)
hsa:29923;HILPDA,C7orf68,HIG-2,HIG2;hypoxia inducible lipid droplet-associated
hsa:391365;SULT6B1;sulfotransferase family, cytosolic, 6B, member 1
hsa:7226;TRPM2,EREG1,KNP3,LTRPC2,NUDT9H,NUDT9L1,TRPC7;transient receptor potential cation channel, subfamily M, member 2 (EC:3.6.1.13)
hsa:5558;PRIM2,PRIM2A,p58;primase, DNA, polypeptide 2 (58kDa) (EC:2.7.7.-)
hsa:8647;ABCB11,ABC16,BRIC2,BSEP,PFIC-2,PFIC2,PGY4,SPGP;ATP-binding cassette, sub-family B (MDR/TAP), member 11
hsa:4600;MX2,MXB;myxovirus (influenza virus) resistance 2 (mouse)
hsa:55093;WDYHV1,C8orf32;WDYHV motif containing 1
hsa:4947;OAZ2,AZ2;ornithine decarboxylase antizyme 2
hsa:23452;ANGPTL2,ARP2,HARP;angiopoietin-like 2
hsa:93323;HAUS8,DGT4,HICE1,NY-SAR-48;HAUS augmin-like complex, subunit 8
hsa:151112;ZSWIM2,MEX,ZZZ2;zinc finger, SWIM-type containing 2
hsa:11163;NUDT4,DIPP2,DIPP2alpha,DIPP2beta;nudix (nucleoside diphosphate linked moiety X)-type motif 4 (EC:3.6.1.52)
hsa:114791;TUBGCP5,GCP5;tubulin, gamma complex associated protein 5
hsa:6651;SON,BASS1,C21orf50,DBP-5,NREBP,SON3;SON DNA binding protein
hsa:7741;ZSCAN26,SRE-ZBP,ZNF187;zinc finger and SCAN domain containing 26
hsa:54941;RNF125,TRAC-1,TRAC1;ring finger protein 125, E3 ubiquitin protein ligase
hsa:4487;MSX1,ECTD3,HOX7,HYD1,STHAG1;msh homeobox 1
hsa:9403;SEP15;15 kDa selenoprotein
hsa:3598;IL13RA2,CD213A2,CT19,IL-13R,IL13BP;interleukin 13 receptor, alpha 2
hsa:8294;HIST1H4I,H4/m,H4FM,H4M;histone cluster 1, H4i
hsa:7545;ZIC1,ZIC,ZNF201;Zic family member 1
hsa:646;BNC1,BNC,BSN1,HsT19447;basonuclin 1
hsa:654483;BOLA2B,BOLA2;bolA homolog 2B (E. coli)
hsa:1058;CENPA,CENP-A,CenH3;centromere protein A
hsa:100131827;ZNF717,X17,ZNF838;zinc finger protein 717
hsa:114822;RHPN1,ODF5,RHOPHILIN,RHPN;rhophilin, Rho GTPase binding protein 1
hsa:11086;ADAM29,CT73,svph1;ADAM metallopeptidase domain 29
hsa:25946;ZNF385A,HZF,RZF,ZFP385,ZNF385;zinc finger protein 385A
hsa:90288;EFCAB12,C3orf25;EF-hand calcium binding domain 12
hsa:9313;MMP20,AI2A2,MMP-20;matrix metallopeptidase 20
hsa:7791;ZYX,ESP-2,HED-2;zyxin
hsa:148930;KNCN,Kino,L5;kinocilin
hsa:54455;FBXO42,Fbx42,JFK;F-box protein 42
hsa:6480;ST6GAL1,SIAT1,ST6GalI,ST6N;ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 (EC:2.4.99.1)
hsa:79850;FAM57A,CT120;family with sequence similarity 57, member A
hsa:284695;ZNF326,ZAN75,ZIRD,Zfp326,dJ871E2.1;zinc finger protein 326
hsa:83902;KRTAP17-1,KAP17.1,KRTAP16.1,KRTAP17.1;keratin associated protein 17-1
hsa:3236;HOXD10,HOX4,HOX4D,HOX4E,Hox-4.4;homeobox D10
hsa:55027;HEATR3,SYO1;HEAT repeat containing 3
hsa:414189;AGAP6,CTGLF3,bA324H6.1;ArfGAP with GTPase domain, ankyrin repeat and PH domain 6
hsa:5161;PDHA2,PDHAL;pyruvate dehydrogenase (lipoamide) alpha 2 (EC:1.2.4.1)
hsa:386676;KRTAP10-9,KAP10.9,KAP18.9,KRTAP18-9;keratin associated protein 10-9
hsa:259282;BOD1L1,BOD1L,FAM44A;biorientation of chromosomes in cell division 1-like 1
hsa:80778;ZNF34,KOX32;zinc finger protein 34
hsa:171019;ADAMTS19;ADAM metallopeptidase with thrombospondin type 1 motif, 19
hsa:64320;RNF25,AO7;ring finger protein 25
hsa:22838;RNF44;ring finger protein 44
hsa:58495;OVOL2,EUROIMAGE566589,ZNF339;ovo-like 2 (Drosophila)
hsa:115330;GPR146,PGR8;G protein-coupled receptor 146
hsa:27239;GPR162,A-2,GRCA;G protein-coupled receptor 162
hsa:64428;NARFL,HPRN,IOP1,LET1L,PRN;nuclear prelamin A recognition factor-like
hsa:353;APRT,AMP,APRTD;adenine phosphoribosyltransferase (EC:2.4.2.7)
hsa:342908;ZNF404;zinc finger protein 404
hsa:80216;ALPK1,8430410J10Rik,LAK;alpha-kinase 1
hsa:51121;RPL26L1,RPL26P1;ribosomal protein L26-like 1
hsa:11316;COPE,epsilon-COP;coatomer protein complex, subunit epsilon
hsa:641654;HEPN1;hepatocellular carcinoma, down-regulated 1
hsa:64167;ERAP2,L-RAP,LRAP;endoplasmic reticulum aminopeptidase 2 (EC:3.4.11.-)
hsa:26012;NSMF,HH9,NELF;NMDA receptor synaptonuclear signaling and neuronal migration factor
hsa:57198;ATP8B2,ATPID;ATPase, aminophospholipid transporter, class I, type 8B, member 2 (EC:3.6.3.1)
hsa:29925;GMPPB;GDP-mannose pyrophosphorylase B (EC:2.7.7.13)
hsa:7693;ZNF134,pHZ-15;zinc finger protein 134
hsa:118472;ZNF511;zinc finger protein 511
hsa:51530;ZC3HC1,1110054L24Rik,NIPA;zinc finger, C3HC-type containing 1
hsa:64429;ZDHHC6,ZNF376;zinc finger, DHHC-type containing 6
hsa:23742;NPAP1,C15orf2;nuclear pore associated protein 1
hsa:3127;HLA-DRB5,HLA-DRB;major histocompatibility complex, class II, DR beta 5
hsa:118427;OLFM3,NOE3,NOELIN3,NOELIN3_V1,NOELIN3_V2,NOELIN3_V3,NOELIN3_V4,NOELIN3_V5,NOELIN3_V6,OPTIMEDIN;olfactomedin 3
hsa:7334;UBE2N,UBC13,UbcH-ben,UbcH13;ubiquitin-conjugating enzyme E2N (EC:6.3.2.19)
hsa:84905;ZNF341;zinc finger protein 341
hsa:9618;TRAF4,CART1,MLN62,RNF83;TNF receptor-associated factor 4
hsa:130106;CIB4,KIP4;calcium and integrin binding family member 4
hsa:5590;PRKCZ,PKC-ZETA,PKC2;protein kinase C, zeta (EC:2.7.11.13)
hsa:112752;IFT43,C14orf179,CED3;intraflagellar transport 43 homolog (Chlamydomonas)
hsa:55904;MLL5,HDCMC04P,KMT2E;myeloid/lymphoid or mixed-lineage leukemia 5 (trithorax homolog, Drosophila) (EC:2.1.1.43)
hsa:25893;TRIM58,BIA2;tripartite motif containing 58
hsa:2658;GDF2,BMP-9,BMP9;growth differentiation factor 2
hsa:57093;TRIM49,RNF18,TRIM49A,TRIM49L2;tripartite motif containing 49
hsa:114826;SMYD4,ZMYND21;SET and MYND domain containing 4
hsa:146395;GSG1L,PRO19651;GSG1-like
hsa:84937;ZNRF1,NIN283;zinc and ring finger 1, E3 ubiquitin protein ligase
hsa:167465;ZNF366,DCSCRIPT;zinc finger protein 366
hsa:6222;RPS18,D6S218E,HKE3,KE-3,KE3,S18;ribosomal protein S18
hsa:169714;QSOX2,QSCN6L1,SOXN;quiescin Q6 sulfhydryl oxidase 2 (EC:1.8.3.2)
hsa:8985;PLOD3,LH3;procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (EC:1.14.11.4)
hsa:728118;NUTM2A,FAM22A;NUT family member 2A
hsa:93624;TADA2B,ADA2(beta),ADA2B;transcriptional adaptor 2B
hsa:5166;PDK4;pyruvate dehydrogenase kinase, isozyme 4 (EC:2.7.11.2)
hsa:140432;RNF113B,RNF161,ZNF183L1,bA10G5.1;ring finger protein 113B
hsa:51802;ASIC5,ACCN5,HINAC,INAC;acid-sensing (proton-gated) ion channel family member 5
hsa:54863;TOR4A,C9orf167;torsin family 4, member A
hsa:5702;PSMC3,TBP1;proteasome (prosome, macropain) 26S subunit, ATPase, 3
hsa:503835;DUXA;double homeobox A
hsa:3859;KRT12,K12;keratin 12
hsa:23360;FNBP4,FBP30;formin binding protein 4
hsa:7555;CNBP,CNBP1,DM2,PROMM,RNF163,ZCCHC22,ZNF9;CCHC-type zinc finger, nucleic acid binding protein
hsa:54981;NMRK1,C9orf95,NRK1,bA235O14.2;nicotinamide riboside kinase 1 (EC:2.7.1.22 2.7.1.173)
hsa:64403;CDH24,CDH11L;cadherin 24, type 2
hsa:8634;RTCA,RPC,RTC1,RTCD1;RNA 3'-terminal phosphate cyclase (EC:6.5.1.4)
hsa:29928;TIMM22,TEX4,TIM22;translocase of inner mitochondrial membrane 22 homolog (yeast)
hsa:22882;ZHX2,AFR1,RAF;zinc fingers and homeoboxes 2
hsa:90987;ZNF251;zinc finger protein 251
hsa:286075;ZNF707;zinc finger protein 707
hsa:613211;DEFB134;defensin, beta 134
hsa:51281;ANKMY1,ZMYND13;ankyrin repeat and MYND domain containing 1
hsa:5858;PZP,CPAMD6;pregnancy-zone protein
hsa:5195;PEX14,NAPP2,PBD13A,Pex14p,dJ734G22.2;peroxisomal biogenesis factor 14
hsa:51020;HDDC2,C6orf74,NS5ATP2,dJ167O5.2;HD domain containing 2
hsa:100130958;SYCE1L,MRP2;synaptonemal complex central element protein 1-like
hsa:133923;ZNF474;zinc finger protein 474
hsa:9745;ZNF536;zinc finger protein 536
hsa:138307;LCN8,EP17,LCN5;lipocalin 8
hsa:400506;KNOP1,101F10.1,C16orf88,FAM191A,TSG118;lysine-rich nucleolar protein 1
hsa:400673;VMAC;vimentin-type intermediate filament associated coiled-coil protein
hsa:57335;ZNF286A,ZNF286;zinc finger protein 286A
hsa:150280;HORMAD2;HORMA domain containing 2
hsa:391723;HELT,HCM1228,HESL,Mgn,bHLHb44;helt bHLH transcription factor
hsa:51062;ATL1,AD-FSP,FSP1,GBP3,HSN1D,SPG3,SPG3A,atlastin1;atlastin GTPase 1
hsa:342618;SLFN14;schlafen family member 14
hsa:29933;GPR132,G2A;G protein-coupled receptor 132
hsa:1635;DCTD;dCMP deaminase (EC:3.5.4.12)
hsa:403341;ZBTB34,RP11-106H5.1,ZNF918;zinc finger and BTB domain containing 34
hsa:197131;UBR1,JBS;ubiquitin protein ligase E3 component n-recognin 1
hsa:283742;FAM98B;family with sequence similarity 98, member B
hsa:91942;NDUFAF2,B17.2L,MMTN,NDUFA12L,mimitin;NADH dehydrogenase (ubiquinone) complex I, assembly factor 2
hsa:1396;CRIP1,CRHP,CRIP,CRP-1,CRP1;cysteine-rich protein 1 (intestinal)
hsa:23322;RPGRIP1L,CORS3,FTM,JBTS7,MKS5,NPHP8;RPGRIP1-like
hsa:84885;ZDHHC12,ZNF400;zinc finger, DHHC-type containing 12
hsa:170959;ZNF431;zinc finger protein 431
hsa:139562;OTUD6A,DUBA2,HSHIN6;OTU domain containing 6A
hsa:8329;HIST1H2AI,H2A/c,H2AFC;histone cluster 1, H2ai
hsa:4855;NOTCH4,INT3,NOTCH3;notch 4
hsa:441520;CT45A4,CT45-4,CT45.4;cancer/testis antigen family 45, member A4
hsa:57643;ZSWIM5;zinc finger, SWIM-type containing 5
hsa:84792;FAM220A,C7orf70,SIPAR;family with sequence similarity 220, member A
hsa:414062;CCL3L3,464.2,D17S1718,LD78,LD78BETA,SCYA3L,SCYA3L1;chemokine (C-C motif) ligand 3-like 3
hsa:11278;KLF12,AP-2rep,AP2REP;Kruppel-like factor 12
hsa:54877;ZCCHC2,C18orf49;zinc finger, CCHC domain containing 2
hsa:158399;ZNF483,ZKSCAN16,ZSCAN48;zinc finger protein 483
hsa:284406;ZFP82,ZNF545;ZFP82 zinc finger protein
hsa:8330;HIST1H2AK,H2A/d,H2AFD;histone cluster 1, H2ak
hsa:1294;COL7A1,EBD1,EBDCT,EBR1;collagen, type VII, alpha 1
hsa:24149;ZNF318,TZF,ZFP318;zinc finger protein 318
hsa:7915;ALDH5A1,SSADH,SSDH;aldehyde dehydrogenase 5 family, member A1 (EC:1.2.1.24)
hsa:8332;HIST1H2AL,H2A.i,H2A/i,H2AFI,dJ193B12.9;histone cluster 1, H2al
hsa:440023;KRTAP5-6,KRTAP5.6;keratin associated protein 5-6
hsa:55111;PLEKHJ1,GNRPX;pleckstrin homology domain containing, family J member 1
hsa:27006;FGF22;fibroblast growth factor 22
hsa:7205;TRIP6,OIP-1,OIP1,TRIP-6,TRIP6i2,ZRP-1;thyroid hormone receptor interactor 6
hsa:148979;GLIS1;GLIS family zinc finger 1
hsa:79755;ZNF750,ZFP750;zinc finger protein 750
hsa:28960;DCPS,HINT-5,HSL1;decapping enzyme, scavenger (EC:3.6.1.59)
hsa:5037;PEBP1,HCNP,HCNPpp,PBP,PEBP,PEBP-1,RKIP;phosphatidylethanolamine binding protein 1
hsa:23371;TENC1,C1-TEN,C1TEN,TNS2;tensin like C1 domain containing phosphatase (tensin 2)
hsa:90957;DHX57,DDX57;DEAH (Asp-Glu-Ala-Asp/His) box polypeptide 57 (EC:3.6.4.13)
hsa:2563;GABRD,EIG10,EJM7,GEFSP5;gamma-aminobutyric acid (GABA) A receptor, delta
hsa:5479;PPIB,CYP-S1,CYPB,OI9,SCYLP;peptidylprolyl isomerase B (cyclophilin B) (EC:5.2.1.8)
hsa:643226;GRXCR2;glutaredoxin, cysteine rich 2
hsa:771;CA12,CAXII,HsT18816;carbonic anhydrase XII (EC:4.2.1.1)
hsa:8334;HIST1H2AC,H2A/l,H2AFL,dJ221C16.4;histone cluster 1, H2ac
hsa:1855;DVL1,DVL,DVL1L1;dishevelled, dsh homolog 1 (Drosophila)
hsa:144108;SPTY2D1;SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)
hsa:56242;ZNF253,BMZF-1,BMZF1,ZNF411;zinc finger protein 253
hsa:55355;HJURP,FAKTS,URLC9,hFLEG1;Holliday junction recognition protein
hsa:678;ZFP36L2,BRF2,ERF-2,ERF2,RNF162C,TIS11D;ZFP36 ring finger protein-like 2
hsa:57146;TMEM159,PROMETHIN;transmembrane protein 159
hsa:4801;NFYB,CBF-A,CBF-B,HAP3,NF-YB;nuclear transcription factor Y, beta
hsa:9752;PCDHA9,PCDH-ALPHA9;protocadherin alpha 9
hsa:201299;RDM1,RAD52B;RAD52 motif 1
hsa:4234;METTL1,C12orf1,TRM8,TRMT8,YDL201w;methyltransferase like 1 (EC:2.1.1.33)
hsa:346157;ZNF391,dJ153G14.3;zinc finger protein 391
hsa:4796;TONSL,IKBR,NFKBIL2;tonsoku-like, DNA repair protein
hsa:220869;CBWD5,DC36;COBW domain containing 5
hsa:90423;ATP6V1E2,ATP6E1,ATP6EL2,ATP6V1EL2,VMA4;ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2
hsa:54985;HCFC1R1,HPIP;host cell factor C1 regulator 1 (XPO1 dependent)
hsa:8336;HIST1H2AM,H2A.1,H2A/n,H2AFN,dJ193B12.1;histone cluster 1, H2am
hsa:388566;ZNF470,CZF-1;zinc finger protein 470
hsa:6122;RPL3,ASC-1,L3,TARBP-B;ribosomal protein L3
hsa:55279;ZNF654;zinc finger protein 654
hsa:126961;HIST2H3C,H3,H3.2,H3/M,H3F2,H3FM,H3FN;histone cluster 2, H3c
hsa:7562;ZNF708,KOX8,ZNF15,ZNF15L1;zinc finger protein 708
hsa:25865;PRKD2,PKD2,nPKC-D2;protein kinase D2 (EC:2.7.11.13)
hsa:115939;TSR3,C16orf42;TSR3, 20S rRNA accumulation, homolog (S. cerevisiae)
hsa:23039;XPO7,EXP7,RANBP16;exportin 7
hsa:10615;SPAG5,DEEPEST,MAP126,hMAP126;sperm associated antigen 5
hsa:60682;SMAP1,SMAP-1;small ArfGAP 1
hsa:84675;TRIM55,MURF-2,RNF29,muRF2;tripartite motif containing 55
hsa:168620;BHLHA15,BHLHB8,MIST1;basic helix-loop-helix family, member a15
hsa:54994;GID8,C20orf11,TWA1;GID complex subunit 8 homolog (S. cerevisiae)
hsa:54887;UHRF1BP1,C6orf107,ICBP90,dJ349A12.1;UHRF1 binding protein 1
hsa:196477;CCER1,C12orf12;coiled-coil glutamate-rich protein 1
hsa:8338;HIST2H2AC,H2A,H2A-GL101,H2A/q,H2AFQ;histone cluster 2, H2ac
hsa:343702;XKR7,C20orf159,dJ310O13.4;XK, Kell blood group complex subunit-related family, member 7
hsa:6526;SLC5A3,SMIT,SMIT1,SMIT2;solute carrier family 5 (sodium/myo-inositol cotransporter), member 3
hsa:135644;TRIM40,RNF35;tripartite motif containing 40
hsa:79159;NOL12,Nop25,dJ37E16.7;nucleolar protein 12
hsa:55705;IPO9,Imp9;importin 9
hsa:4792;NFKBIA,IKBA,MAD-3,NFKBI;nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
hsa:255631;COL24A1;collagen, type XXIV, alpha 1
hsa:163051;ZNF709;zinc finger protein 709
hsa:22850;ADNP2,ZNF508;ADNP homeobox 2
hsa:115653;KIR3DL3,CD158Z,KIR3DL7,KIR44,KIRC1;killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3
hsa:360023;ZBTB41,FRBZ1,RP11-469L3.1,ZNF924;zinc finger and BTB domain containing 41
hsa:163859;SDE2,C1orf55,RP4-671D7.1,dJ671D7.1;SDE2 telomere maintenance homolog (S. pombe)
hsa:283358;B4GALNT3;beta-1,4-N-acetyl-galactosaminyl transferase 3 (EC:2.4.1.244)
hsa:1201;CLN3,BTS,JNCL;ceroid-lipofuscinosis, neuronal 3
hsa:57232;ZNF630,dJ54B20.2;zinc finger protein 630
hsa:9541;CIR1,CIR;corepressor interacting with RBPJ, 1
hsa:50628;GEMIN4,HC56,HCAP1,HHRF-1,p97;gem (nuclear organelle) associated protein 4
hsa:80774;LIMD2;LIM domain containing 2
hsa:389643;NUGGC,C8orf80,SLIP-GC;nuclear GTPase, germinal center associated
hsa:83759;RBM4B,RBM30,RBM4L,ZCCHC15,ZCCHC21B,ZCRB3B;RNA binding motif protein 4B
hsa:221527;ZBTB12,Bat9,C6orf46,D6S59E,G10,NG35;zinc finger and BTB domain containing 12
hsa:8843;HCAR3,GPR109B,HCA3,HM74,PUMAG,Puma-g;hydroxycarboxylic acid receptor 3
hsa:23174;ZCCHC14,BDG-29,BDG29;zinc finger, CCHC domain containing 14
hsa:5223;PGAM1,PGAM-B,PGAMA;phosphoglycerate mutase 1 (brain) (EC:3.1.3.13 5.4.2.1 5.4.2.4)
hsa:54815;GATAD2A,p66alpha;GATA zinc finger domain containing 2A
hsa:729428;GAGE12B,GAGE-12B;G antigen 12B
hsa:645432;ARRDC5;arrestin domain containing 5
hsa:23530;NNT,GCCD4;nicotinamide nucleotide transhydrogenase (EC:1.6.1.2)
hsa:728932;GPR89C;G protein-coupled receptor 89C
hsa:5827;PXMP2,PMP22;peroxisomal membrane protein 2, 22kDa
hsa:56603;CYP26B1,CYP26A2,P450RAI-2,P450RAI2,RHFCA;cytochrome P450, family 26, subfamily B, polypeptide 1
hsa:4105;MAGEA6,CT1.6,MAGE-3b,MAGE3B,MAGE6;melanoma antigen family A, 6
hsa:339883;C3orf35,APRG1;chromosome 3 open reading frame 35
hsa:203068;TUBB,M40,OK/SW-cl.56,TUBB1,TUBB5;tubulin, beta class I
hsa:51123;ZNF706,PNAS-106,PNAS-113;zinc finger protein 706
hsa:203238;CCDC171,C9orf93,bA536D16.1,bA778P13.1;coiled-coil domain containing 171
hsa:10732;TCFL5,CHA,E2BP-1,Figlb,bHLHe82;transcription factor-like 5 (basic helix-loop-helix)
hsa:8427;ZNF282,HUB1;zinc finger protein 282
hsa:120939;TMEM52B,C12orf59;transmembrane protein 52B
hsa:646174;C16orf90;chromosome 16 open reading frame 90
hsa:58493;INIP,C9orf80,HSPC043,MISE,SOSSC,SSBIP1,hSSBIP1;INTS3 and NABP interacting protein
hsa:10980;COPS6,CSN6,MOV34-34KD;COP9 signalosome subunit 6
hsa:84693;MCEE,GLOD2;methylmalonyl CoA epimerase (EC:5.1.99.1)
hsa:2549;GAB1;GRB2-associated binding protein 1
hsa:83538;TTC25;tetratricopeptide repeat domain 25
hsa:10085;EDIL3,DEL1;EGF-like repeats and discoidin I-like domains 3
hsa:5211;PFKL,PFK-B;phosphofructokinase, liver (EC:2.7.1.11)
hsa:2923;PDIA3,ER60,ERp57,ERp60,ERp61,GRP57,GRP58,HsT17083,P58,PI-PLC;protein disulfide isomerase family A, member 3 (EC:5.3.4.1)
hsa:131405;TRIM71,LIN-41,LIN41;tripartite motif containing 71, E3 ubiquitin protein ligase
hsa:54808;DYM,DMC,SMC;dymeclin
hsa:257101;ZNF683;zinc finger protein 683
hsa:57451;TENM2,ODZ2,TEN-M2,TNM2;teneurin transmembrane protein 2
hsa:65123;INTS3,C1orf193,C1orf60,INT3,SOSS-A;integrator complex subunit 3
hsa:26749;GAGE2E,GAGE-2E,GAGE8;G antigen 2E
hsa:4591;TRIM37,MUL,POB1,TEF3;tripartite motif containing 37
hsa:375567;VWC2,PSST739,UNQ739;von Willebrand factor C domain containing 2
hsa:9840;TESPA1,KIAA0748;thymocyte expressed, positive selection associated 1
hsa:166655;TRIM60,RNF129,RNF33;tripartite motif containing 60
hsa:4839;NOP2,NOL1,NOP120,NSUN1,p120;NOP2 nucleolar protein
hsa:153222;CREBRF,C5orf41,LRF;CREB3 regulatory factor
hsa:7544;ZFY,ZNF911;zinc finger protein, Y-linked
hsa:114971;PTPMT1,DUSP23,MOSP,PLIP;protein tyrosine phosphatase, mitochondrial 1 (EC:3.1.3.16 3.1.3.48 3.1.3.27)
hsa:440163;RNASE13;ribonuclease, RNase A family, 13 (non-active)
hsa:201516;ZSCAN4,ZNF494;zinc finger and SCAN domain containing 4
hsa:90233;ZNF551;zinc finger protein 551
hsa:441376;AARD,C8orf85;alanine and arginine rich domain containing protein
hsa:117245;HRASLS5,HRLP5,HRSL5,RLP1,iNAT;HRAS-like suppressor family, member 5
hsa:400224;PLEKHD1,UPF0639;pleckstrin homology domain containing, family D (with coiled-coil domains) member 1
hsa:100287284;MANSC4;MANSC domain containing 4
hsa:83448;PUS7L;pseudouridylate synthase 7 homolog (S. cerevisiae)-like (EC:5.4.99.-)
hsa:162514;TRPV3,OLMS,VRL3;transient receptor potential cation channel, subfamily V, member 3
hsa:51132;RLIM,NY-REN-43,RNF12;ring finger protein, LIM domain interacting
hsa:60437;CDH26,VR20;cadherin 26
hsa:133015;PACRGL,C4orf28;PARK2 co-regulated-like
hsa:6139;RPL17,L17,PD-1,RPL23;ribosomal protein L17
hsa:57140;RNPEPL1;arginyl aminopeptidase (aminopeptidase B)-like 1
hsa:113179;ADAT3,FWP005,MST121,MSTP121,S863-5,TAD3;adenosine deaminase, tRNA-specific 3
hsa:162968;ZNF497;zinc finger protein 497
hsa:284058;KANSL1,CENP-36,KDVS,KIAA1267,MSL1v1,NSL1,hMSL1v1;KAT8 regulatory NSL complex subunit 1
hsa:8747;ADAM21,ADAM_21,ADAM31;ADAM metallopeptidase domain 21
hsa:3266;ERAS,HRAS2,HRASP;ES cell expressed Ras
hsa:56265;CPXM1,CPX1,CPXM;carboxypeptidase X (M14 family), member 1 (EC:3.4.17.10)
hsa:10295;BCKDK,BCKDKD,BDK;branched chain ketoacid dehydrogenase kinase (EC:2.7.11.4)
hsa:9094;UNC119,HRG4,POC7,POC7A;unc-119 homolog (C. elegans)
hsa:135112;NCOA7,ERAP140,ESNA1,Nbla00052,Nbla10993,TLDC4,dJ187J11.3;nuclear receptor coactivator 7
hsa:653192;TRIM43B;tripartite motif containing 43B
hsa:54585;LZTFL1,BBS17;leucine zipper transcription factor-like 1
hsa:9767;PHF16,JADE3;PHD finger protein 16
hsa:9063;PIAS2,ARIP3,DIP,MIZ,MIZ1,PIASX,PIASX-ALPHA,PIASX-BETA,SIZ2,ZMIZ4;protein inhibitor of activated STAT, 2
hsa:124404;SEPT12,SPGF10;septin 12
hsa:284391;ZNF844;zinc finger protein 844
hsa:387638;C10orf113,bA165O3.1;chromosome 10 open reading frame 113
hsa:10193;RNF41,FLRF,NRDP1;ring finger protein 41 (EC:6.3.2.-)
hsa:221400;TDRD6,CT41.2,NY-CO-45,SPATA36,TDR2,bA446F17.4;tudor domain containing 6
hsa:57679;ALS2,ALS2CR6,ALSJ,IAHSP,PLSJ;amyotrophic lateral sclerosis 2 (juvenile)
hsa:5875;RABGGTA,PTAR3;Rab geranylgeranyltransferase, alpha subunit (EC:2.5.1.60)
hsa:11037;STON1,SALF,SBLF,STN1,STNB1;stonin 1
hsa:6046;BRD2,D6S113E,FSH,FSRG1,NAT,RING3,RNF3;bromodomain containing 2
hsa:389523;GATSL1;GATS protein-like 1
hsa:27166;PRELID1,PRELI,PX19,SBBI12;PRELI domain containing 1
hsa:729438;GATSL2;GATS protein-like 2
hsa:340069;FAM170A,ZNFD;family with sequence similarity 170, member A
hsa:148281;SYT6,sytVI;synaptotagmin VI
hsa:142678;MIB2,ZZANK1,ZZZ5;mindbomb E3 ubiquitin protein ligase 2
hsa:124857;WFIKKN2,GASP-1,WFDC20B,WFIKKNRP,hGASP-1;WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2
hsa:57402;S100A14,BCMP84,S100A15;S100 calcium binding protein A14
hsa:150209;AIFM3,AIFL;apoptosis-inducing factor, mitochondrion-associated, 3
hsa:401145;CCSER1,FAM190A;coiled-coil serine-rich protein 1
hsa:55146;ZDHHC4,ZNF374;zinc finger, DHHC-type containing 4
hsa:5908;RAP1B,K-REV,RAL1B;RAP1B, member of RAS oncogene family
hsa:93474;ZNF670;zinc finger protein 670
hsa:147407;SLC25A52,MCART2;solute carrier family 25, member 52
hsa:8773;SNAP23,HsT17016,SNAP-23,SNAP23A,SNAP23B;synaptosomal-associated protein, 23kDa
hsa:57655;GRAMD1A,KIAA1533;GRAM domain containing 1A
hsa:151649;PP2D1,C3orf48;protein phosphatase 2C-like domain containing 1
hsa:10213;PSMD14,PAD1,POH1,RPN11;proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 (EC:3.1.2.15)
hsa:619189;SERINC4;serine incorporator 4
hsa:375298;CERKL,RP26;ceramide kinase-like
hsa:84243;ZDHHC18,DHHC-18,DHHC18;zinc finger, DHHC-type containing 18
hsa:55421;C17orf85,ELG,HSA277841;chromosome 17 open reading frame 85
hsa:27065;NSG1,D4S234,D4S234E,NEEP21,P21;neuron specific gene family member 1
hsa:55629;PNRC2;proline-rich nuclear receptor coactivator 2
hsa:115286;SLC25A26,SAMC;solute carrier family 25 (S-adenosylmethionine carrier), member 26
hsa:65243;ZFP69B,RP11-656D10.1,ZKSCAN23B,ZNF643,ZSCAN54B;ZFP69 zinc finger protein B
hsa:100288695;LIMS3L;LIM and senescent cell antigen-like domains 3-like
hsa:7757;ZNF208,PMIDP,ZNF95;zinc finger protein 208
hsa:8609;KLF7,UKLF;Kruppel-like factor 7 (ubiquitous)
hsa:84915;FAM222A,C12orf34;family with sequence similarity 222, member A
hsa:283847;CCDC79;coiled-coil domain containing 79
hsa:163255;ZNF540,Nbla10512;zinc finger protein 540
hsa:64754;SMYD3,KMT3E,ZMYND1,ZNFN3A1,bA74P14.1;SET and MYND domain containing 3 (EC:2.1.1.43)
hsa:129804;FBLN7,TM14;fibulin 7
hsa:158135;TTLL11,C9orf20,bA244O19.1;tubulin tyrosine ligase-like family, member 11
hsa:160622;GRASP,TAMALIN;GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein
hsa:9975;NR1D2,BD73,EAR-1R,RVR;nuclear receptor subfamily 1, group D, member 2
hsa:9148;NEURL,NEURL1,RNF67,bA416N2.1,neu,neu-1;neuralized homolog (Drosophila)
hsa:51148;CERCAM,CEECAM1,GLT25D3;cerebral endothelial cell adhesion molecule
hsa:55298;RNF121;ring finger protein 121
hsa:23704;KCNE4,MIRP3;potassium voltage-gated channel, Isk-related family, member 4
hsa:54477;PLEKHA5,PEPP-2,PEPP2;pleckstrin homology domain containing, family A member 5
hsa:143570;XRRA1;X-ray radiation resistance associated 1
hsa:345778;MTX3;metaxin 3
hsa:79752;ZFAND1;zinc finger, AN1-type domain 1;K07059
hsa:55037;PTCD3;pentatricopeptide repeat domain 3
hsa:57060;PCBP4,CBP,LIP4,MCG10;poly(rC) binding protein 4
hsa:117166;WFIKKN1,C16orf12,RJD2,WFDC20A,WFIKKN;WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1
hsa:7576;ZNF28,KOX24;zinc finger protein 28
hsa:149954;BPIFB4,C20orf186,LPLUNC4,RY2G5,dJ726C3.5;BPI fold containing family B, member 4
hsa:6142;RPL18A,L18A;ribosomal protein L18a
hsa:4784;NFIX,MRSHSS,NF1A,SOTOS2;nuclear factor I/X (CCAAT-binding transcription factor)
hsa:100127889;C10orf131,bA690P14.3;chromosome 10 open reading frame 131
hsa:339559;ZFP69,RP11-656D10.2,ZFP69A,ZKSCAN23A,ZNF642,ZSCAN54A;ZFP69 zinc finger protein
hsa:728116;ZBTB8B,RP1-27O5.1,ZNF916B;zinc finger and BTB domain containing 8B
hsa:8796;SCEL;sciellin
hsa:55703;POLR3B,C128,HLD8,RPC2;polymerase (RNA) III (DNA directed) polypeptide B (EC:2.7.7.6)
hsa:57786;RBAK,ZNF769;RB-associated KRAB zinc finger
hsa:54860;MS4A12,Ms4a10;membrane-spanning 4-domains, subfamily A, member 12
hsa:5866;RAB3IL1,GRAB;RAB3A interacting protein (rabin3)-like 1
hsa:391712;TRIM61,RNF35;tripartite motif containing 61
hsa:23098;SARM1,MyD88-5,SAMD2,SARM;sterile alpha and TIR motif containing 1
hsa:3792;KEL,CD238,ECE3;Kell blood group, metallo-endopeptidase (EC:3.4.24.-)
hsa:388588;SMIM1;small integral membrane protein 1
hsa:728395;TSPY4,TSPY10,TSPY8;testis specific protein, Y-linked 4
hsa:55006;TRMT61B;tRNA methyltransferase 61 homolog B (S. cerevisiae) (EC:2.1.1.220)
hsa:6138;RPL15,EC45,L15,RPL10,RPLY10,RPYL10;ribosomal protein L15
hsa:10773;ZBTB6,ZID,ZNF482;zinc finger and BTB domain containing 6
hsa:3700;ITIH4,GP120,H4P,IHRP,ITI-HC4,ITIHL1,PK-120,PK120;inter-alpha-trypsin inhibitor heavy chain family, member 4
hsa:29780;PARVB,CGI-56;parvin, beta
hsa:221833;SP8,BTD;Sp8 transcription factor
hsa:164668;APOBEC3H,ARP10;apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
hsa:54482;TRMT13,CCDC76;tRNA methyltransferase 13 homolog (S. cerevisiae)
hsa:252884;ZNF396,ZSCAN14;zinc finger protein 396
hsa:9907;AP5Z1,KIAA0415,SPG48,zeta;adaptor-related protein complex 5, zeta 1 subunit
hsa:6432;SRSF7,9G8,AAG3,SFRS7;serine/arginine-rich splicing factor 7
hsa:219957;OR9Q2,OR9Q2P;olfactory receptor, family 9, subfamily Q, member 2
hsa:140809;SRXN1,C20orf139,Npn3,SRX,SRX1;sulfiredoxin 1 (EC:1.8.98.2)
hsa:728361;OVOL3;ovo-like 3 (Drosophila)
hsa:340152;ZC3H12D,C6orf95,MCPIP4,TFL,dJ281H8.1,p34;zinc finger CCCH-type containing 12D
hsa:55795;PCID2,F10;PCI domain containing 2
hsa:79872;CBLL1,HAKAI,RNF188;Cbl proto-oncogene, E3 ubiquitin protein ligase-like 1
hsa:10102;TSFM,EFTS,EFTSMT;Ts translation elongation factor, mitochondrial
hsa:282974;STK32C,PKE,RP11-140A10.1,YANK3;serine/threonine kinase 32C (EC:2.7.11.1)
hsa:811;CALR,CRT,RO,SSA,cC1qR;calreticulin
hsa:55741;EDEM2,C20orf31,C20orf49,bA4204.1;ER degradation enhancer, mannosidase alpha-like 2
hsa:93134;ZNF561;zinc finger protein 561
hsa:26150;RIBC2,C22orf11;RIB43A domain with coiled-coils 2
hsa:84077;C3orf20;chromosome 3 open reading frame 20
hsa:171482;FAM9A,TEX39A;family with sequence similarity 9, member A
hsa:2530;FUT8;fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (EC:2.4.1.68)
hsa:5877;RABIF,MSS4,RASGFR3,RASGRF3;RAB interacting factor
hsa:2091;FBL,FIB,FLRN,RNU3IP1;fibrillarin
hsa:56975;FAM20C,DMP-4,DMP4,GEF-CK,RNS;family with sequence similarity 20, member C (EC:2.7.11.1)
hsa:23676;SMPX,DFNX4;small muscle protein, X-linked
hsa:8128;ST8SIA2,HsT19690,SIAT8B,ST8SIA-II,STX;ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
hsa:51283;BFAR,BAR,RNF47;bifunctional apoptosis regulator
hsa:2899;GRIK3,EAA5,GLR7,GLUR7,GluK3,GluR7a;glutamate receptor, ionotropic, kainate 3
hsa:79228;THOC6,WDR58,fSAP35;THO complex 6 homolog (Drosophila)
hsa:137835;TMEM71;transmembrane protein 71
hsa:23304;UBR2,C6orf133,RP3-392M17.3,bA49A4.1,dJ242G1.1,dJ392M17.3;ubiquitin protein ligase E3 component n-recognin 2
hsa:9787;DLGAP5,DLG7,HURP;discs, large (Drosophila) homolog-associated protein 5
hsa:26232;FBXO2,FBG1,FBX2,Fbs1,NFB42,OCP1;F-box protein 2
hsa:8854;ALDH1A2,RALDH(II),RALDH2,RALDH2-T;aldehyde dehydrogenase 1 family, member A2 (EC:1.2.1.36)
hsa:221710;SMIM13,C6orf228;small integral membrane protein 13
hsa:158158;RASEF,RAB45;RAS and EF-hand domain containing
hsa:342892;ZNF850,ZNF850P;zinc finger protein 850
hsa:84281;C2orf88,smAKAP;chromosome 2 open reading frame 88
hsa:6173;RPL36A,L36A,L44L,MIG6,RPL44;ribosomal protein L36a
hsa:84419;C15orf48,FOAP-11,NMES1;chromosome 15 open reading frame 48
hsa:50674;NEUROG3,Atoh5,Math4B,NGN-3,bHLHa7,ngn3;neurogenin 3
hsa:5017;OVOL1,HOVO1;ovo-like 1(Drosophila)
hsa:374899;ZNF829;zinc finger protein 829
hsa:8351;HIST1H3D,H3/b,H3FB;histone cluster 1, H3d
hsa:738;VPS51,ANG2,ANG3,C11orf2,C11orf3,FFR;vacuolar protein sorting 51 homolog (S. cerevisiae)
hsa:1008;CDH10;cadherin 10, type 2 (T2-cadherin)
hsa:283767;GOLGA6L1;golgin A6 family-like 1
hsa:127540;HMGB4,dJ1007G16.5;high mobility group box 4
hsa:201895;SMIM14,C4orf34;small integral membrane protein 14
hsa:4799;NFX1,NFX2;nuclear transcription factor, X-box binding 1 (EC:6.3.2.-)
hsa:79691;QTRTD1;queuine tRNA-ribosyltransferase domain containing 1 (EC:2.4.2.29)
hsa:54839;LRRC49;leucine rich repeat containing 49
hsa:1795;DOCK3,MOCA,PBP;dedicator of cytokinesis 3
hsa:7593;MZF1,MZF-1,MZF1B,ZFP98,ZNF42,ZSCAN6;myeloid zinc finger 1
hsa:153769;SH3RF2,HEPP1,POSHER,PPP1R39,RNF158;SH3 domain containing ring finger 2
hsa:169200;TMEM64;transmembrane protein 64
hsa:128553;TSHZ2,C20orf17,OVC10-2,TSH2,ZABC2,ZNF218;teashirt zinc finger homeobox 2
hsa:116984;ARAP2,CENTD1,PARX;ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2
hsa:2197;FAU,FAU1,Fub1,Fubi,MNSFbeta,RPS30,S30,asr1;Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed
hsa:7044;LEFTY2,EBAF,LEFTA,LEFTYA,TGFB4;left-right determination factor 2
hsa:138716;RPP25L,C9orf23,bA296L22.5;ribonuclease P/MRP 25kDa subunit-like
hsa:10726;NUDC,HNUDC,MNUDC,NPD011;nuclear distribution C homolog (A. nidulans)
hsa:81602;CDADC1,NYD-SP15,bA103J18.1;cytidine and dCMP deaminase domain containing 1
hsa:29906;ST8SIA5,SIAT8E,ST8SiaV;ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 (EC:2.4.99.-)
hsa:283991;UBALD2,FAM100B;UBA-like domain containing 2
hsa:90576;ZNF799,HIT-40,ZNF842;zinc finger protein 799
hsa:55504;TNFRSF19,TAJ,TAJ-alpha,TRADE,TROY;tumor necrosis factor receptor superfamily, member 19
hsa:80169;CTC1,AAF-132,AAF132,C17orf68,CRMCC,tmp494178;CTS telomere maintenance complex component 1
hsa:55565;ZNF821;zinc finger protein 821
hsa:339263;C17orf51;chromosome 17 open reading frame 51
hsa:79644;SRD5A3,CDG1P,CDG1Q,KRIZI,SRD5A2L,SRD5A2L1;steroid 5 alpha-reductase 3 (EC:1.3.1.22 1.3.1.94)
hsa:1943;EFNA2,ELF-1,EPLG6,HEK7-L,LERK-6,LERK6;ephrin-A2
hsa:133688;UGT3A1;UDP glycosyltransferase 3 family, polypeptide A1 (EC:2.4.1.17)
hsa:8050;PDHX,DLDBP,E3BP,OPDX,PDX1,proX;pyruvate dehydrogenase complex, component X
hsa:100128569;C19orf71;chromosome 19 open reading frame 71
hsa:64859;NABP1,OBFC2A,SOSS-B2,SSB2;nucleic acid binding protein 1
hsa:9653;HS2ST1,dJ604K5.2;heparan sulfate 2-O-sulfotransferase 1 (EC:2.8.2.-)
hsa:200523;TEX37,C2orf51,TSC21;testis expressed 37
hsa:642658;SCXB,bHLHa48;scleraxis homolog B (mouse)
hsa:8543;LMO4;LIM domain only 4
hsa:137682;NDUFAF6,C8orf38;NADH dehydrogenase (ubiquinone) complex I, assembly factor 6
hsa:84364;ARFGAP2,IRZ,NBLA10535,ZFP289,ZNF289;ADP-ribosylation factor GTPase activating protein 2
hsa:220992;ZNF485;zinc finger protein 485
hsa:653464;SRGAP2C,SRGAP2P1;SLIT-ROBO Rho GTPase activating protein 2C
hsa:51124;IER3IP1,MEDS,PRO2309;immediate early response 3 interacting protein 1
hsa:84225;ZMYND15;zinc finger, MYND-type containing 15
hsa:79750;ZNF385D,ZNF659;zinc finger protein 385D
hsa:2903;GRIN2A,EPND,GluN2A,NMDAR2A,NR2A;glutamate receptor, ionotropic, N-methyl D-aspartate 2A
hsa:54936;ADPRHL2,ARH3;ADP-ribosylhydrolase like 2 (EC:3.2.1.143)
hsa:84911;ZNF382,KS1;zinc finger protein 382
hsa:3987;LIMS1,PINCH,PINCH-1,PINCH1;LIM and senescent cell antigen-like domains 1
hsa:2647;BLOC1S1,BLOS1,GCN5L1,MICoA,RT14;biogenesis of lysosomal organelles complex-1, subunit 1
hsa:286464;CHDC2,CXorf59;calponin homology domain containing 2
hsa:338596;ST8SIA6,SIA8F,SIAT8F,ST8SIA-VI;ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 (EC:2.4.99.-)
hsa:54065;SMIM11,C21orf51,FAM165B;small integral membrane protein 11
hsa:345274;SLC10A6,SOAT;solute carrier family 10 (sodium/bile acid cotransporter family), member 6
hsa:967;CD63,LAMP-3,ME491,MLA1,OMA81H,TSPAN30;CD63 molecule
hsa:23765;IL17RA,CANDF5,CD217,CDw217,IL-17RA,IL17R,hIL-17R;interleukin 17 receptor A
hsa:23429;RYBP,AAP1,DEDAF,YEAF1;RING1 and YY1 binding protein
hsa:100130311;C17orf107;chromosome 17 open reading frame 107
hsa:84450;ZNF512;zinc finger protein 512
hsa:390110;ACCSL;1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)-like
hsa:51604;PIGT,NDAP;phosphatidylinositol glycan anchor biosynthesis, class T
hsa:85377;MICALL1,MICAL-L1,MIRAB13;MICAL-like 1
hsa:79581;SLC52A2,BVVLS2,D15Ertd747e,GPCR41,GPR172A,PAR1,RFT3,RFVT2,hRFT3;solute carrier family 52, riboflavin transporter, member 2
hsa:25898;RCHY1,ARNIP,CHIMP,PIRH2,PIRH2E,PIRH2F,PRO1996,RNF199,ZNF363,hARNIP;ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase
hsa:8546;AP3B1,ADTB3,ADTB3A,HPS,HPS2,PE;adaptor-related protein complex 3, beta 1 subunit
hsa:116534;MRGPRE,GPR167,MRGE;MAS-related GPR, member E
hsa:2217;FCGRT,FCRN,alpha-chain;Fc fragment of IgG, receptor, transporter, alpha
hsa:5264;PHYH,LN1,LNAP1,PAHX,PHYH1,RD;phytanoyl-CoA 2-hydroxylase (EC:1.14.11.18)
hsa:149041;RC3H1,RNF198,ROQUIN;ring finger and CCCH-type domains 1
hsa:8022;LHX3,CPHD3,LIM3,M2-LHX3;LIM homeobox 3
hsa:167227;DCP2,NUDT20;DCP2 decapping enzyme homolog (S. cerevisiae) (EC:3.6.1.62)
hsa:259197;NCR3,1C7,CD337,LY117,MALS,NKp30;natural cytotoxicity triggering receptor 3
hsa:153339;TMEM167A,TMEM167;transmembrane protein 167A
hsa:79701;OGFOD3,C17orf101;2-oxoglutarate and iron-dependent oxygenase domain containing 3
hsa:116987;AGAP1,AGAP-1,CENTG2,GGAP1,cnt-g2;ArfGAP with GTPase domain, ankyrin repeat and PH domain 1
hsa:338645;LUZP2,KFSP2566,PRO6246;leucine zipper protein 2
hsa:4091;SMAD6,AOVD2,HsT17432,MADH6,MADH7;SMAD family member 6
hsa:51066;SSUH2,C3orf32,SSU-2,fls485;ssu-2 homolog (C. elegans)
hsa:862;RUNX1T1,AML1T1,CBFA2T1,CDR,ETO,MTG8,ZMYND2;runt-related transcription factor 1;translocated to, 1 (cyclin D-related);K10053 runt-related transcription factor 1;translocated to, 1
hsa:8241;RBM10,DXS8237E,GPATC9,GPATCH9,S1-1,TARPS,ZRANB5;RNA binding motif protein 10
hsa:401207;C5orf63,YDR286C;chromosome 5 open reading frame 63
hsa:7771;ZFP112,ZNF112,ZNF228;zinc finger protein 112 homolog (mouse)
hsa:170689;ADAMTS15;ADAM metallopeptidase with thrombospondin type 1 motif, 15
hsa:54758;KLHDC4;kelch domain containing 4
hsa:89122;TRIM4,RNF87;tripartite motif containing 4
hsa:133121;ENPP6,NPP6;ectonucleotide pyrophosphatase/phosphodiesterase 6 (EC:3.1.4.38)
hsa:100287428;PNMA6C;paraneoplastic Ma antigen family member 6C
hsa:389384;C6orf222;chromosome 6 open reading frame 222
hsa:136647;MPLKIP,ABHS,C7orf11,ORF20;M-phase specific PLK1 interacting protein
hsa:9373;PLAA,DOA1,PLA2P,PLAP;phospholipase A2-activating protein
hsa:55967;NDUFA12,B17.2,DAP13;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12
hsa:3712;IVD,ACAD2;isovaleryl-CoA dehydrogenase (EC:1.3.8.4)
hsa:54807;ZNF586;zinc finger protein 586
hsa:146857;SLFN13,SLFN10;schlafen family member 13
hsa:54496;PRMT7;protein arginine methyltransferase 7 (EC:2.1.1.125 2.1.1.126)
hsa:283933;ZNF843;zinc finger protein 843
hsa:1296;COL8A2,FECD,FECD1,PPCD,PPCD2;collagen, type VIII, alpha 2
hsa:440829;SHISA8,C22orf17,Orf26;shisa homolog 8 (Xenopus laevis)
hsa:389860;PAGE2B,CT16.5,GAGEE3,PAGE-2B;P antigen family, member 2B
hsa:65982;ZSCAN18,ZNF447;zinc finger and SCAN domain containing 18
hsa:54784;ALKBH4,ABH4;alkB, alkylation repair homolog 4 (E. coli)
hsa:644353;ZCCHC18,PNMA7B,SIZN2;zinc finger, CCHC domain containing 18
hsa:9142;TMEM257,CXorf1;transmembrane protein 257
hsa:131601;TPRA1,GPR175,TMEM227,TPRA40;transmembrane protein, adipocyte asscociated 1
hsa:120406;NXPE2,FAM55B;neurexophilin and PC-esterase domain family, member 2
hsa:1465;CSRP1,CRP,CRP1,CSRP,CYRP,D1S181E;cysteine and glycine-rich protein 1
hsa:169436;C9orf96,RP11-244N20.8,SgK071,Sk521;chromosome 9 open reading frame 96
hsa:80267;EDEM3,C1orf22;ER degradation enhancer, mannosidase alpha-like 3 (EC:3.2.1.113)
hsa:116443;GRIN3A,GluN3A,NMDAR-L,NR3A;glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
hsa:116986;AGAP2,CENTG1,GGAP2,PIKE;ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
hsa:3006;HIST1H1C,H1.2,H1C,H1F2,H1s-1;histone cluster 1, H1c
hsa:10138;YAF2;YY1 associated factor 2
hsa:727866;FAM156B,TMEM29B;family with sequence similarity 156, member B
hsa:4175;MCM6,MCG40308,Mis5,P105MCM;minichromosome maintenance complex component 6 (EC:3.6.4.12)
hsa:29886;SNX8,Mvp1;sorting nexin 8
hsa:22872;SEC31A,ABP125,ABP130,HSPC334,SEC31L1;SEC31 homolog A (S. cerevisiae)
hsa:1992;SERPINB1,EI,ELANH2,LEI,M/NEI,MNEI,PI-2,PI2;serpin peptidase inhibitor, clade B (ovalbumin), member 1
hsa:8328;GFI1B;growth factor independent 1B transcription repressor
hsa:27090;ST6GALNAC4,IV,SIAT3-C,SIAT3C,SIAT7-D,SIAT7D,ST6GALNACIV,ST6GalNAc;ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 (EC:2.4.99.7)
hsa:23506;GLTSCR1L,KIAA0240;GLTSCR1-like
hsa:548313;SSX4B,CT5.4;synovial sarcoma, X breakpoint 4B
hsa:4712;NDUFB6,B17,CI;NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa (EC:1.6.5.3 1.6.99.3)
hsa:389114;ZNF662;zinc finger protein 662
hsa:29934;SNX12;sorting nexin 12
hsa:11120;BTN2A1,BK14H9.1,BT2.1,BTF1,DJ3E1.1;butyrophilin, subfamily 2, member A1
hsa:400720;ZNF772;zinc finger protein 772
hsa:90120;C9orf69,bA83N9.1;chromosome 9 open reading frame 69
hsa:84266;ALKBH7,ABH7,SPATA11,UNQ6002;alkB, alkylation repair homolog 7 (E. coli)
hsa:56848;SPHK2,SK_2,SK-2,SPK_2,SPK-2;sphingosine kinase 2 (EC:2.7.1.91)
hsa:84107;ZIC4;Zic family member 4
hsa:64098;PARVG;parvin, gamma
hsa:642517;AGAP9,AGAP-9,CTGLF6,bA301J7.2;ArfGAP with GTPase domain, ankyrin repeat and PH domain 9
hsa:8790;FPGT,GFPP;fucose-1-phosphate guanylyltransferase (EC:2.7.7.30)
hsa:1960;EGR3,EGR-3,PILOT;early growth response 3
hsa:27291;R3HCC1L,C10orf28,GIDRP86,GIDRP88,PSORT;R3H domain and coiled-coil containing 1-like
hsa:146664;MGAT5B,GnT-IX,GnT-VB;mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B (EC:2.4.1.155)
hsa:26503;SLC17A5,AST,ISSD,NSD,SD,SIALIN,SIASD,SLD;solute carrier family 17 (anion/sugar transporter), member 5
hsa:165829;GPR156,GABABL,PGR28;G protein-coupled receptor 156
hsa:7570;ZNF22,HKR-T1,KOX15,ZNF422,Zfp422;zinc finger protein 22
hsa:285267;ZNF619;zinc finger protein 619
hsa:25852;ARMC8,GID5,HSPC056,VID28;armadillo repeat containing 8
hsa:51735;RAPGEF6,KIA001LB,PDZ-GEF2,PDZGEF2,RA-GEF-2,RAGEF2;Rap guanine nucleotide exchange factor (GEF) 6
hsa:8224;SYN3;synapsin III
hsa:199990;C1orf86,FAAP20,FP7162;chromosome 1 open reading frame 86
hsa:79008;SLX1B,GIYD2;SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae)
hsa:55196;C12orf35;KIAA1551
hsa:118813;ZFYVE27,PROTRUDIN,RP11-459F3.2,SPG33;zinc finger, FYVE domain containing 27
hsa:11331;PHB2,BAP,BCAP37,Bap37,PNAS-141,REA,p22;prohibitin 2
hsa:140290;TCP10L,C21orf77,TCP10A-2;t-complex 10-like
hsa:84765;ZNF577;zinc finger protein 577
hsa:653604;HIST2H3D;histone cluster 2, H3d
hsa:127281;FAM213B,C1orf93;family with sequence similarity 213, member B (EC:1.11.1.20)
hsa:23533;PIK3R5,F730038I15Rik,FOAP-2,P101-PI3K,p101;phosphoinositide-3-kinase, regulatory subunit 5
hsa:1506;CTRL,CTRL1;chymotrypsin-like (EC:3.4.21.-)
hsa:729384;TRIM49D2P,TRIM48L1,TRIM49L,TRIM49L1;tripartite motif containing 49D2, pseudogene
hsa:51237;MZB1,MEDA-7,PACAP,pERp1;marginal zone B and B1 cell-specific protein
hsa:100101467;ZSCAN30,ZNF397OS,ZNF917;zinc finger and SCAN domain containing 30
hsa:338879;RNASE10,RNASE9;ribonuclease, RNase A family, 10 (non-active)
hsa:55026;TMEM255A,FAM70A;transmembrane protein 255A
hsa:154881;KCTD7,CLN14,EPM3;potassium channel tetramerisation domain containing 7
hsa:23099;ZBTB43,ZBTB22B,ZNF-X,ZNF297B;zinc finger and BTB domain containing 43
hsa:55432;YOD1,DUBA8,OTUD2,PRO0907;YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae) (EC:3.4.19.12)
hsa:2901;GRIK5,EAA2,GRIK2,GluK5,KA2;glutamate receptor, ionotropic, kainate 5
hsa:55744;COA1,C7orf44,MITRAC15;cytochrome c oxidase assembly factor 1 homolog (S. cerevisiae)
hsa:100131378;C11orf91;chromosome 11 open reading frame 91
hsa:10385;BTN2A2,BT2.2,BTF2;butyrophilin, subfamily 2, member A2
hsa:28956;LAMTOR2,ENDAP,HSPC003,MAPBPIP,MAPKSP1AP,ROBLD3,Ragulator2,p14;late endosomal/lysosomal adaptor, MAPK and MTOR activator 2
hsa:7748;ZNF195,HRF1,ZNFP104;zinc finger protein 195
hsa:8492;PRSS12,BSSP-3,BSSP3,MRT1;protease, serine, 12 (neurotrypsin, motopsin)
hsa:377630;USP17L2,DUB-3,DUB3,USP17;ubiquitin specific peptidase 17-like family member 2 (EC:3.4.19.12)
hsa:10308;ZNF267,HZF2;zinc finger protein 267
hsa:9780;PIEZO1,FAM38A,Mib;piezo-type mechanosensitive ion channel component 1
hsa:4237;MFAP2,MAGP,MAGP-1,MAGP1;microfibrillar-associated protein 2
hsa:9753;ZSCAN12,ZFP96,ZNF29K1,ZNF305,ZNF96,dJ29K1.2;zinc finger and SCAN domain containing 12
hsa:3786;KCNQ3,BFNC2,EBN2,KV7.3;potassium voltage-gated channel, KQT-like subfamily, member 3
hsa:25861;DFNB31,CIP98,USH2D,WHRN,WI;deafness, autosomal recessive 31
hsa:5433;POLR2D,HSRBP4,HSRPB4,RBP4,RPB16;polymerase (RNA) II (DNA directed) polypeptide D (EC:2.7.7.6)
hsa:8470;SORBS2,ARGBP2,PRO0618;sorbin and SH3 domain containing 2
hsa:283489;CHAMP1,C13orf8,CAMP,CHAMP,ZNF828;chromosome alignment maintaining phosphoprotein 1
hsa:117854;TRIM6,RNF89;tripartite motif containing 6
hsa:202374;STK32A,YANK1;serine/threonine kinase 32A (EC:2.7.11.1)
hsa:401934;RNF223;ring finger protein 223
hsa:130733;TMEM178A,TMEM178;transmembrane protein 178A
hsa:404281;YY2,ZNF631;YY2 transcription factor
hsa:26049;FAM169A,SLAP75;family with sequence similarity 169, member A
hsa:10531;PITRM1,MP1,PreP;pitrilysin metallopeptidase 1;K06972
hsa:282890;ZNF311,zf31;zinc finger protein 311
hsa:100506422;;putative deoxyuridine 5'-triphosphate nucleotidohydrolase-like protein FLJ16323
hsa:284266;SIGLEC15,CD33L3,HsT1361,SIGLEC-15;sialic acid binding Ig-like lectin 15
hsa:55959;SULF2,HSULF-2;sulfatase 2
hsa:81847;RNF146,RP3-351K20.1,dJ351K20.1;ring finger protein 146
hsa:80164;;putative uncharacterized protein FLJ22184
hsa:11075;STMN2,SCG10,SCGN10;stathmin-like 2
hsa:115908;CTHRC1;collagen triple helix repeat containing 1
hsa:51046;ST8SIA3,SIAT8C,ST8SiaIII;ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3
hsa:100506650;C17orf112;chromosome 17 open reading frame 112
hsa:1781;DYNC1I2,DNCI2,IC2;dynein, cytoplasmic 1, intermediate chain 2
hsa:113457;TUBA3D,H2-ALPHA;tubulin, alpha 3d
hsa:55352;COPRS,C17orf79,COPR5,HSA272196,TTP1;coordinator of PRMT5, differentiation stimulator
hsa:64780;MICAL1,MICAL,MICAL-1,NICAL;microtubule associated monoxygenase, calponin and LIM domain containing 1
hsa:2624;GATA2,DCML,MONOMAC,NFE1B;GATA binding protein 2
hsa:6307;MSMO1,DESP4,ERG25,SC4MOL;methylsterol monooxygenase 1 (EC:1.14.13.72)
hsa:374462;PTPRQ,DFNB84,DFNB84A,PTPGMC1,R-PTP-Q;protein tyrosine phosphatase, receptor type, Q (EC:3.1.3.48)
hsa:26521;TIMM8B,DDP2,TIM8B;translocase of inner mitochondrial membrane 8 homolog B (yeast)
hsa:60685;ZFAND3,TEX27;zinc finger, AN1-type domain 3
hsa:23131;GPATCH8,GPATC8,KIAA0553;G patch domain containing 8
hsa:26168;SENP3,SMT3IP1,SSP3,Ulp1;SUMO1/sentrin/SMT3 specific peptidase 3 (EC:3.4.22.68)
hsa:29057;FAM156A,PRO0659,TMEM29;family with sequence similarity 156, member A
hsa:6199;RPS6KB2,KLS,P70-beta,P70-beta-1,P70-beta-2,S6K-beta2,S6K2,SRK,STK14B,p70(S6K)-beta,p70S6Kb;ribosomal protein S6 kinase, 70kDa, polypeptide 2 (EC:2.7.11.1)
hsa:148418;SAMD13,RP11-376N17.1;sterile alpha motif domain containing 13
hsa:100820829;MYZAP,GCOM1,Gup,Gup1,Gup2,MYOZAP;myocardial zonula adherens protein
hsa:2936;GSR;glutathione reductase (EC:1.8.1.7)
hsa:23424;TDRD7,CATC4,PCTAIRE2BP,RP11-508D10.1,TRAP;tudor domain containing 7
hsa:9501;RPH3AL,NOC2;rabphilin 3A-like (without C2 domains)
hsa:51043;ZBTB7B,THPOK,ZBTB15,ZFP-67,ZFP67,ZNF857B,c-KROX,hcKROX;zinc finger and BTB domain containing 7B
hsa:163050;ZNF564;zinc finger protein 564
hsa:389493;NUPR1L;nuclear protein, transcriptional regulator, 1-like
hsa:7162;TPBG,5T4,5T4AG,M6P1;trophoblast glycoprotein
hsa:64773;PCED1A,C20orf81,FAM113A,bA12M19.1;PC-esterase domain containing 1A
hsa:2104;ESRRG,ERR3,ERRgamma,NR3B3;estrogen-related receptor gamma
hsa:23569;PADI4,PAD,PAD4,PADI5,PDI4,PDI5;peptidyl arginine deiminase, type IV (EC:3.5.3.15)
hsa:1358;CPA2;carboxypeptidase A2 (pancreatic) (EC:3.4.17.15)
hsa:2906;GRIN2D,EB11,GluN2D,NMDAR2D,NR2D;glutamate receptor, ionotropic, N-methyl D-aspartate 2D
hsa:85446;ZFHX2,ZFH-5,ZNF409;zinc finger homeobox 2
hsa:10005;ACOT8,HNAACTE,PTE-1,PTE-2,PTE1,PTE2,hACTE-III,hTE;acyl-CoA thioesterase 8 (EC:3.1.2.27)
hsa:57711;ZNF529;zinc finger protein 529
hsa:130162;CLHC1,C2orf63;clathrin heavy chain linker domain containing 1
hsa:10781;ZNF266,HZF1;zinc finger protein 266
hsa:115703;ARHGAP33,NOMA-GAP,SNX26,TCGAP;Rho GTPase activating protein 33
hsa:375611;SLC26A5,DFNB61,PRES;solute carrier family 26, member 5 (prestin)
hsa:100462983;MTRNR2L3,HN3;MT-RNR2-like 3
hsa:392307;FAM221B,C9orf128;family with sequence similarity 221, member B
hsa:1016;CDH18,CDH14,CDH14L,CDH24;cadherin 18, type 2
hsa:55163;PNPO,PDXPO;pyridoxamine 5'-phosphate oxidase (EC:1.4.3.5)
hsa:84282;RNF135,MMFD,REUL,Riplet;ring finger protein 135
hsa:30813;VSX1,CAASDS,KTCN,KTCN1,PPCD,PPD,RINX;visual system homeobox 1
hsa:100287205;USP17L12;ubiquitin specific peptidase 17-like family member 12 (EC:3.4.19.12)
hsa:10520;ZNF211,C2H2-25,CH2H2-25,ZNF-25,ZNFC25;zinc finger protein 211
hsa:55064;SPATA6L,C9orf68,bA6J24.2;spermatogenesis associated 6-like
hsa:114884;OSBPL10,ORP10,OSBP9;oxysterol binding protein-like 10
hsa:100287178;USP17L11;ubiquitin specific peptidase 17-like family member 11 (EC:3.4.19.12)
hsa:124402;UBALD1,FAM100A;UBA-like domain containing 1
hsa:81614;NIPA2;non imprinted in Prader-Willi/Angelman syndrome 2
hsa:100287238;USP17L13;ubiquitin specific peptidase 17-like family member 13 (EC:3.4.19.12)
hsa:64762;GAREM,C18orf11,FAM59A,Gm944;GRB2 associated, regulator of MAPK1
hsa:112817;HOGA1,C10orf65,DHDPS2,DHDPSL,HP3,NPL2;4-hydroxy-2-oxoglutarate aldolase 1 (EC:4.1.3.16)
hsa:7165;TPD52L2,D54;tumor protein D52-like 2
hsa:100463285;MTRNR2L4,HN4;MT-RNR2-like 4
hsa:643965;TMEM88B;transmembrane protein 88B
hsa:283638;CEP170B,CEP170R,FAM68C,KIAA0284;centrosomal protein 170B
hsa:11270;NRM,NRM29;nurim (nuclear envelope membrane protein)
hsa:85508;SCRT2,ZNF898B;scratch homolog 2, zinc finger protein (Drosophila)
hsa:10838;ZNF275;zinc finger protein 275
hsa:338557;FFAR4,BMIQ10,GPR120,GPR129,GT01,O3FAR1,PGR4;free fatty acid receptor 4
hsa:2946;GSTM2,GST4,GSTM,GSTM2-2,GTHMUS;glutathione S-transferase mu 2 (muscle) (EC:2.5.1.18)
hsa:388564;TMEM238;transmembrane protein 238
hsa:100287327;USP17L17;ubiquitin specific peptidase 17-like family member 17 (EC:3.4.19.12)
hsa:4026;LPP;LIM domain containing preferred translocation partner in lipoma
hsa:57464;STRIP2,FAM40B,FAR11B;striatin interacting protein 2
hsa:1907;EDN2,ET2,PPET2;endothelin 2
hsa:195827;AAED1,C9orf21;AhpC/TSA antioxidant enzyme domain containing 1
hsa:80208;SPG11,KIAA1840;spastic paraplegia 11 (autosomal recessive)
hsa:4306;NR3C2,MCR,MLR,MR,NR3C2VIT;nuclear receptor subfamily 3, group C, member 2
hsa:79947;DHDDS,CIT,CPT,DS,HDS,RP59;dehydrodolichyl diphosphate synthase
hsa:168417;ZNF679;zinc finger protein 679
hsa:653641;GOLGA6C;golgin A6 family, member C
hsa:80298;MTERFD3,mTERF2,mTERFL;MTERF domain containing 3
hsa:55621;TRMT1,TRM1;tRNA methyltransferase 1 homolog (S. cerevisiae) (EC:2.1.1.216)
hsa:100131244;ANKRD63;ankyrin repeat domain 63
hsa:54462;CCSER2,FAM190B,Gcap14,KIAA1128,bA486O22.1;coiled-coil serine-rich protein 2
hsa:57178;ZMIZ1,MIZ,RAI17,TRAFIP10,ZIMP10,hZIMP10;zinc finger, MIZ-type containing 1
hsa:9278;ZBTB22,BING1,ZBTB22A,ZNF297,ZNF297A,fru,fruitless;zinc finger and BTB domain containing 22
hsa:117145;THEM4,CTMP;thioesterase superfamily member 4 (EC:3.1.2.2)
hsa:727857;BHLHA9,BHLHF42;basic helix-loop-helix family, member a9
hsa:23318;ZCCHC11,PAPD3,TUT4;zinc finger, CCHC domain containing 11 (EC:2.7.7.52)
hsa:10675;CSPG5,NGC;chondroitin sulfate proteoglycan 5 (neuroglycan C)
hsa:342184;FMN1,FMN,LD;formin 1
hsa:860;RUNX2,AML3,CBFA1,CCD,CCD1,CLCD,OSF-2,OSF2,PEA2aA,PEBP2A1,PEBP2A2,PEBP2aA,PEBP2aA1;runt-related transcription factor 2
hsa:441457;NUTMG,FAM22G;NUT family member 2G
hsa:157695;C8orf42,Inm01,Tdrp;chromosome 8 open reading frame 42
hsa:619279;ZNF704,Gig1;zinc finger protein 704
hsa:29965;CDIP1,C16orf5,CDIP,I1,LITAFL;cell death-inducing p53 target 1
hsa:291;SLC25A4,AAC1,ANT,ANT1,PEO2,PEO3,T1;solute carrier family 25 (mitochondrial carrier;adenine nucleotide translocator), member 4
hsa:64426;SUDS3,SAP45,SDS3;suppressor of defective silencing 3 homolog (S. cerevisiae)
hsa:79649;MAP7D3;MAP7 domain containing 3
hsa:100287364;USP17L18;ubiquitin specific peptidase 17-like family member 18 (EC:3.4.19.12)
hsa:54478;FAM64A,CATS,RCS1;family with sequence similarity 64, member A
hsa:3158;HMGCS2;3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) (EC:2.3.3.10)
hsa:23090;ZNF423,Ebfaz,JBTS19,NPHP14,OAZ,Roaz,ZFP423,Zfp104;zinc finger protein 423
hsa:2027;ENO3,GSD13,MSE;enolase 3 (beta, muscle) (EC:4.2.1.11)
hsa:63934;ZNF667,MIPU1;zinc finger protein 667
hsa:94121;SYTL4,SLP4;synaptotagmin-like 4
hsa:1208;CLPS;colipase, pancreatic
hsa:83986;ITFG3,C16orf9,gs19;integrin alpha FG-GAP repeat containing 3
hsa:100287404;USP17L19;ubiquitin specific peptidase 17-like family member 19 (EC:3.4.19.12)
hsa:643155;SMIM15,C5orf43;small integral membrane protein 15
hsa:80174;DBF4B,ASKL1,CHIFB,DRF1,ZDBF1B;DBF4 homolog B (S. cerevisiae)
hsa:100505503;RPS17L;ribosomal protein S17-like
hsa:3069;HDLBP,HBP,PRO2900,VGL;high density lipoprotein binding protein
hsa:100287441;USP17L20;ubiquitin specific peptidase 17-like family member 20 (EC:3.4.19.12)
hsa:144165;PRICKLE1,EPM1B,RILP;prickle homolog 1 (Drosophila)
hsa:254863;TMEM256,C17orf61;transmembrane protein 256
hsa:22841;RAB11FIP2,Rab11-FIP2,nRip11;RAB11 family interacting protein 2 (class I)
hsa:100287478;USP17L21;ubiquitin specific peptidase 17-like family member 21 (EC:3.4.19.12)
hsa:146894;CD300LG,CLM-9,CLM9,NEPMUCIN,TREM-4,TREM4;CD300 molecule-like family member g
hsa:389289;ANXA2R,AX2R,AXIIR,C5orf39;annexin A2 receptor
hsa:2905;GRIN2C,GluN2C,NMDAR2C,NR2C;glutamate receptor, ionotropic, N-methyl D-aspartate 2C
hsa:160365;CLECL1,DCAL-1,DCAL1;C-type lectin-like 1
hsa:3295;HSD17B4,DBP,MFE-2,MPF-2,PRLTS1,SDR8C1;hydroxysteroid (17-beta) dehydrogenase 4 (EC:4.2.1.107 4.2.1.119 1.1.1.n12)
hsa:7322;UBE2D2,E2(17)KB2,PUBC1,UBC4,UBC4/5,UBCH5B;ubiquitin-conjugating enzyme E2D 2 (EC:6.3.2.19)
hsa:4150;MAZ,PUR1,Pur-1,SAF-1,SAF-2,SAF-3,ZF87,ZNF801,Zif87;MYC-associated zinc finger protein (purine-binding transcription factor)
hsa:7594;ZNF43,HTF6,KOX27,ZNF39L1;zinc finger protein 43
hsa:7188;TRAF5,MGC:39780,RNF84;TNF receptor-associated factor 5
hsa:89801;PPP1R3F,HB2E,R3F;protein phosphatase 1, regulatory subunit 3F
hsa:100287513;USP17L22;ubiquitin specific peptidase 17-like family member 22 (EC:3.4.19.12)
hsa:57110;HRASLS,A-C1,H-REV107,HRASLS1,HRSL1,HSD28;HRAS-like suppressor
hsa:8242;KDM5C,DXS1272E,JARID1C,MRXJ,MRXSCJ,MRXSJ,SMCX,XE169;lysine (K)-specific demethylase 5C
hsa:2103;ESRRB,DFNB35,ERR2,ERRb,ESRL2,NR3B2;estrogen-related receptor beta
hsa:95;ACY1,ACY-1,ACY1D;aminoacylase 1 (EC:3.5.1.14)
hsa:147658;ZNF534,KRBO3;zinc finger protein 534
hsa:100287226;ZNF729;zinc finger protein 729
hsa:55223;TRIM62,DEAR1;tripartite motif containing 62
hsa:2900;GRIK4,EAA1,GRIK,GluK4,KA1;glutamate receptor, ionotropic, kainate 4
hsa:642612;TRIM49C,TRIM49L2;tripartite motif containing 49C
hsa:81856;ZNF611;zinc finger protein 611
hsa:493829;TRIM72,MG53;tripartite motif containing 72
hsa:7903;ST8SIA4,PST,PST1,SIAT8D,ST8SIA-IV;ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 (EC:2.4.99.-)
hsa:54765;TRIM44,DIPB,HSA249128,MC7;tripartite motif containing 44
hsa:57159;TRIM54,MURF,MURF-3,RNF30,muRF3;tripartite motif containing 54
hsa:9143;SYNGR3;synaptogyrin 3
hsa:63933;MCUR1,C6orf79,CCDC90A;mitochondrial calcium uniporter regulator 1
hsa:8542;APOL1,APO-L,APOL,APOL-I,FSGS4;apolipoprotein L, 1
hsa:80319;CXXC4,IDAX;CXXC finger protein 4
hsa:84964;ALKBH6,ABH6;alkB, alkylation repair homolog 6 (E. coli) (EC:3.4.22.17)
hsa:3275;PRMT2,HRMT1L1;protein arginine methyltransferase 2 (EC:2.1.1.125)
hsa:22859;LPHN1,CIRL1,CL1,LEC2;latrophilin 1
hsa:2895;GRID2,GluD2;glutamate receptor, ionotropic, delta 2
hsa:1641;DCX,DBCN,DC,LISX,SCLH,XLIS;doublecortin
hsa:84913;ATOH8,HATH6,bHLHa21;atonal homolog 8 (Drosophila)
hsa:23559;WBP1,WBP-1;WW domain binding protein 1
hsa:653643;GOLGA6D;golgin A6 family, member D
hsa:643836;ZFP62,ZET,ZNF755;ZFP62 zinc finger protein
hsa:114804;RNF157;ring finger protein 157
hsa:8453;CUL2;cullin 2
hsa:55328;RNLS,C10orf59,RENALASE;renalase, FAD-dependent amine oxidase
hsa:2258;FGF13,FGF-13,FGF2,FHF-2,FHF2;fibroblast growth factor 13
hsa:10194;TSHZ1,CAA,NY-CO-33,SDCCAG33,TSH1;teashirt zinc finger homeobox 1
hsa:8260;NAA10,ARD1,ARD1A,DXS707,NATD,TE2;N(alpha)-acetyltransferase 10, NatA catalytic subunit (EC:2.3.1.88)
hsa:8504;PEX3,PBD10A,TRG18;peroxisomal biogenesis factor 3
hsa:25925;ZNF521,EHZF,Evi3;zinc finger protein 521
hsa:3159;HMGA1,HMG-R,HMGA1A,HMGIY;high mobility group AT-hook 1
hsa:80352;RNF39,HZF,HZFW,LIRF;ring finger protein 39
hsa:1144;CHRND,ACHRD,CMS2A,FCCMS,SCCMS;cholinergic receptor, nicotinic, delta (muscle)
hsa:51174;TUBD1,TUBD;tubulin, delta 1
hsa:387104;SOGA3,C6orf174,dJ403A15.3;SOGA family member 3
hsa:124936;CYB5D2;cytochrome b5 domain containing 2
hsa:55745;AP5M1,C14orf108,MUDENG,Mu5,MuD;adaptor-related protein complex 5, mu 1 subunit
hsa:79822;ARHGAP28;Rho GTPase activating protein 28
hsa:80129;CCDC170,C6orf97,bA282P11.1;coiled-coil domain containing 170
hsa:2972;BRF1,BRF,BRF-1,GTF3B,TAF3B2,TAF3C,TAFIII90,TF3B90,TFIIIB90,hBRF;BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae)
hsa:90485;ZNF835,BC37295_3;zinc finger protein 835
hsa:969;CD69,AIM,BL-AC/P26,CLEC2C,EA1,GP32/28,MLR-3;CD69 molecule
hsa:51304;ZDHHC3,DHHC-3,GODZ,ZNF373;zinc finger, DHHC-type containing 3
hsa:27132;CPNE7;copine VII
hsa:79101;TAF1D,JOSD3,RAFI41,TAF(I)41,TAFI41;TATA box binding protein (TBP)-associated factor, RNA polymerase I, D, 41kDa
hsa:6646;SOAT1,ACACT,ACAT,ACAT-1,ACAT1,SOAT,STAT;sterol O-acyltransferase 1 (EC:2.3.1.26)
hsa:168667;BMPER,CRIM3,CV-2,CV2;BMP binding endothelial regulator
hsa:2790;GNG10;guanine nucleotide binding protein (G protein), gamma 10
hsa:90507;SCRN2,Ses2;secernin 2
hsa:64374;SIL1,BAP,MSS,ULG5;SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae)
hsa:57473;ZNF512B,GM632;zinc finger protein 512B
hsa:79740;ZBBX;zinc finger, B-box domain containing
hsa:404220;C6orf201,dJ1013A10.5;chromosome 6 open reading frame 201
hsa:91392;ZNF502;zinc finger protein 502
hsa:728340;GTF2H2C;general transcription factor IIH, polypeptide 2C
hsa:414060;TBC1D3C,TBC1D3D;TBC1 domain family, member 3C
hsa:79841;AGBL2;ATP/GTP binding protein-like 2
hsa:100506164;HSFX1,LW-1;heat shock transcription factor family, X linked 1
hsa:55501;CHST12,C4S-2,C4ST-2,C4ST2;carbohydrate (chondroitin 4) sulfotransferase 12 (EC:2.8.2.5)
hsa:7799;PRDM2,HUMHOXY1,KMT8,MTB-ZF,RIZ,RIZ1,RIZ2;PR domain containing 2, with ZNF domain (EC:2.1.1.43)
hsa:27332;ZNF638,NP220,ZFML,Zfp638;zinc finger protein 638
hsa:387804;VSTM5,C11orf90;V-set and transmembrane domain containing 5
hsa:353288;KRT26,CK26,K25IRS2,K26,KRT25B;keratin 26
hsa:389075;RESP18;regulated endocrine-specific protein 18
hsa:100130086;HSFX2;heat shock transcription factor family, X linked 2
hsa:57113;TRPC7,TRP7;transient receptor potential cation channel, subfamily C, member 7
hsa:5533;PPP3CC,CALNA3,CNA3,PP2Bgamma;protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16)
hsa:64376;IKZF5,PEGASUS,ZNFN1A5;IKAROS family zinc finger 5 (Pegasus)
hsa:2317;FLNB,ABP-278,ABP-280,AOI,FH1,FLN-B,FLN1L,LRS1,SCT,TABP,TAP;filamin B, beta
hsa:127665;ZNF648;zinc finger protein 648
hsa:728386;USP17L5;ubiquitin specific peptidase 17-like family member 5 (EC:3.4.19.12)
hsa:122060;SLAIN1,C13orf32;SLAIN motif family, member 1
hsa:23309;SIN3B;SIN3 transcription regulator homolog B (yeast)
hsa:7739;ZNF185;zinc finger protein 185 (LIM domain)
hsa:392188;USP17L8,USP17L10;ubiquitin specific peptidase 17-like family member 8 (EC:3.4.19.12)
hsa:201292;TRIM65,4732463G12Rik;tripartite motif containing 65
hsa:10189;ALYREF,ALY,ALY/REF,BEF,REF,THOC4;Aly/REF export factor
hsa:51660;MPC1,BRP44L,MPYCD,dJ68L15.3;mitochondrial pyruvate carrier 1
hsa:6239;RREB1,FINB,HNT,LZ321,RREB-1,Zep-1;ras responsive element binding protein 1
hsa:3071;NCKAP1L,HEM1;NCK-associated protein 1-like
hsa:7738;ZNF184;zinc finger protein 184
hsa:3118;HLA-DQA2,DX-ALPHA,HLA-DXA;major histocompatibility complex, class II, DQ alpha 2
hsa:91833;WDR20,DMR;WD repeat domain 20
hsa:55786;ZNF415;zinc finger protein 415
hsa:5277;PIGA,GPI3,MCAHS2,PIG-A;phosphatidylinositol glycan anchor biosynthesis, class A (EC:2.4.1.198)
hsa:645402;USP17L4;ubiquitin specific peptidase 17-like family member 4
hsa:147837;ZNF563;zinc finger protein 563
hsa:59271;EVA1C,B18,B19,C21orf63,C21orf64,FAM176C,SUE21;eva-1 homolog C (C. elegans)
hsa:4337;MOCS1,MIG11,MOCOD;molybdenum cofactor synthesis 1 (EC:4.1.99.18)
hsa:81555;YIPF5,FinGER5,SB140,SMAP-5,SMAP5,YIP1A;Yip1 domain family, member 5
hsa:100288413;ERVMER34-1;endogenous retrovirus group MER34, member 1
hsa:79697;C14orf169,MAPJD,NO66,ROX;chromosome 14 open reading frame 169 (EC:1.14.11.27)
hsa:79719;AAGAB,KPPP1,PPKP1,PPKP1A,p34;alpha- and gamma-adaptin binding protein
hsa:55628;ZNF407;zinc finger protein 407
hsa:56852;RAD18,RNF73;RAD18 homolog (S. cerevisiae)
hsa:9899;SV2B,HsT19680;synaptic vesicle glycoprotein 2B
hsa:8295;TRRAP,PAF350/400,PAF400,STAF40,TR-AP,Tra1;transformation/transcription domain-associated protein
hsa:84705;GTPBP3,GTPBG3,MSS1,MTGP1,THDF1;GTP binding protein 3 (mitochondrial)
hsa:100130274;CCDC166;coiled-coil domain containing 166
hsa:284996;RNF149,DNAPTP2;ring finger protein 149
hsa:7084;TK2,MTDPS2,MTTK;thymidine kinase 2, mitochondrial (EC:2.7.1.21)
hsa:339804;C2orf74;chromosome 2 open reading frame 74
hsa:51365;PLA1A,PS-PLA1,PSPLA1;phospholipase A1 member A (EC:3.1.1.-)
hsa:728403;TSPY8;testis specific protein, Y-linked 8
hsa:151246;SGOL2,SGO2,TRIPIN;shugoshin-like 2 (S. pombe)
hsa:3851;KRT4,CK-4,CK4,CYK4,K4;keratin 4
hsa:140894;CNBD2,C20orf152,CNMPD1,dJ954P9.1;cyclic nucleotide binding domain containing 2
hsa:286144;TRIQK,C8orf83,PRO0845,UPF0599;triple QxxK/R motif containing
hsa:6440;SFTPC,BRICD6,PSP-C,SFTP2,SMDP2,SP-C;surfactant protein C
hsa:79777;ACBD4;acyl-CoA binding domain containing 4
hsa:1800;DPEP1,MBD1,MDP,RDP;dipeptidase 1 (renal) (EC:3.4.13.19)
hsa:55033;FKBP14,EDSKMH,FKBP22,IPBP12;FK506 binding protein 14, 22 kDa (EC:5.2.1.8)
hsa:10178;TENM1,ODZ1,ODZ3,TEN-M1,TNM,TNM1;teneurin transmembrane protein 1
hsa:51161;C3orf18,G20;chromosome 3 open reading frame 18
hsa:22829;NLGN4Y;neuroligin 4, Y-linked
hsa:10528;NOP56,NOL5A,SCA36;NOP56 ribonucleoprotein
hsa:100463482;MTRNR2L6,HN6;MT-RNR2-like 6
hsa:4094;MAF,CCA4,c-MAF;v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)
hsa:387338;NSUN4,RP4-603I14.2,SHTAP;NOP2/Sun domain family, member 4
hsa:161357;MDGA2,MAMDC1,c14_5286;MAM domain containing glycosylphosphatidylinositol anchor 2
hsa:375484;SIMC1,C5orf25,OOMA1;SUMO-interacting motifs containing 1
hsa:2303;FOXC2,FKHL14,LD,MFH-1,MFH1;forkhead box C2 (MFH-1, mesenchyme forkhead 1)
hsa:118;ADD1,ADDA;adducin 1 (alpha)
hsa:54677;CROT,COT;carnitine O-octanoyltransferase (EC:2.3.1.137)
hsa:100288485;MTRNR2L7,HN7;MT-RNR2-like 7
hsa:127435;PODN,PCAN,SLRR5A;podocan
hsa:83693;HSDL1,SDR12C3;hydroxysteroid dehydrogenase like 1
hsa:8148;TAF15,Npl3,RBP56,TAF2N,TAFII68;TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
hsa:1468;SLC25A10,DIC;solute carrier family 25 (mitochondrial carrier;dicarboxylate transporter), member 10
hsa:92999;ZBTB47,ZNF651;zinc finger and BTB domain containing 47
hsa:3267;AGFG1,HRB,RAB,RIP;ArfGAP with FG repeats 1
hsa:100506736;SLFN12L;schlafen family member 12-like
hsa:2898;GRIK2,EAA4,GLR6,GLUK6,GLUR6,GluK2,MRT6;glutamate receptor, ionotropic, kainate 2
hsa:55906;ZC4H2,HCA127,KIAA1166;zinc finger, C4H2 domain containing
hsa:79446;WDR25,C14orf67;WD repeat domain 25
hsa:25942;SIN3A;SIN3 transcription regulator homolog A (yeast)
hsa:2058;EPRS,EARS,GLUPRORS,PARS,QARS,QPRS;glutamyl-prolyl-tRNA synthetase (EC:6.1.1.15 6.1.1.17)
hsa:10501;SEMA6B,SEM-SEMA-Y,SEMA-VIB,SEMAN,semaZ;sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B
hsa:100129842;ZNF737,ZNF102;zinc finger protein 737
hsa:51079;NDUFA13,B16.6,CDA016,GRIM-19,GRIM19;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
hsa:79710;MORC4,ZCW4,ZCWCC2,dJ75H8.2;MORC family CW-type zinc finger 4
hsa:29993;PACSIN1,SDPI;protein kinase C and casein kinase substrate in neurons 1
hsa:116985;ARAP1,CENTD2;ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
hsa:255809;C19orf38,HIDE1;chromosome 19 open reading frame 38
hsa:2894;GRID1,GluD1;glutamate receptor, ionotropic, delta 1
hsa:78989;COLEC11,3MC2,CL-K1-I,CL-K1-II,CL-K1-IIa,CL-K1-IIb,CLK1;collectin sub-family member 11
hsa:114879;OSBPL5,OBPH1,ORP5;oxysterol binding protein-like 5
hsa:55454;CSGALNACT2,CHGN2,GALNACT-2,GALNACT2;chondroitin sulfate N-acetylgalactosaminyltransferase 2 (EC:2.4.1.174)
hsa:23237;ARC,Arg3.1;activity-regulated cytoskeleton-associated protein
hsa:6923;TCEB2,ELOB,SIII;transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B)
hsa:5236;PGM1,CDG1T,GSD14;phosphoglucomutase 1 (EC:5.4.2.2)
hsa:340393;TMEM249,C8ORFK29;transmembrane protein 249
hsa:84699;CREB3L3,CREB-H,CREBH;cAMP responsive element binding protein 3-like 3
hsa:84333;PCGF5,RNF159;polycomb group ring finger 5
hsa:58494;JAM2,C21orf43,CD322,JAM-B,JAMB,PRO245,VE-JAM,VEJAM;junctional adhesion molecule 2
hsa:85369;STRIP1,FAM40A,FAR11A;striatin interacting protein 1
hsa:167691;LCA5,C6orf152;Leber congenital amaurosis 5
hsa:440515;ZNF506;zinc finger protein 506
hsa:51444;RNF138,HSD-4,NARF,STRIN,hNARF;ring finger protein 138, E3 ubiquitin protein ligase
hsa:5440;POLR2K,ABC10-alpha,RPABC4,RPB10alpha,RPB12,RPB7.0,hRPB7.0,hsRPB10a;polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa (EC:2.7.7.6)
hsa:7643;ZNF90,HTF9;zinc finger protein 90
hsa:79102;RNF26;ring finger protein 26
hsa:84203;TXNDC2,SPTRX,SPTRX1;thioredoxin domain containing 2 (spermatozoa)
hsa:2012;EMP1,CL-20,EMP-1,TMP;epithelial membrane protein 1
hsa:9093;DNAJA3,HCA57,TID1,hTID-1;DnaJ (Hsp40) homolog, subfamily A, member 3
hsa:6050;RNH1,RAI,RNH;ribonuclease/angiogenin inhibitor 1
hsa:8853;ASAP2,AMAP2,CENTB3,DDEF2,PAG3,PAP,Pap-alpha,SHAG1;ArfGAP with SH3 domain, ankyrin repeat and PH domain 2
hsa:196527;ANO6,BDPLT7,SCTS,TMEM16F;anoctamin 6
hsa:254427;PROSER2,C10orf47;proline and serine-rich protein 2
hsa:100533106;ZHX1-C8ORF76;ZHX1-C8ORF76 readthrough
hsa:197407;ZNF48,ZNF553;zinc finger protein 48
hsa:85007;AGXT2L2,PHLU;alanine-glyoxylate aminotransferase 2-like 2 (EC:4.2.3.134)
hsa:10121;ACTR1A,ARP1,CTRN1;ARP1 actin-related protein 1 homolog A, centractin alpha (yeast)
hsa:64147;KIF9;kinesin family member 9
hsa:197259;MLKL;mixed lineage kinase domain-like
hsa:203259;FAM219A,C9orf25,bA573M23.5;family with sequence similarity 219, member A
hsa:284323;ZNF780A,ZNF780;zinc finger protein 780A
hsa:57139;RGL3;ral guanine nucleotide dissociation stimulator-like 3
hsa:221074;SLC39A12,LZT-Hs8,ZIP-12,bA570F3.1;solute carrier family 39 (zinc transporter), member 12
hsa:10475;TRIM38,RNF15,RORET;tripartite motif containing 38
hsa:388536;ZNF790;zinc finger protein 790
hsa:84747;UNC119B,POC7B;unc-119 homolog B (C. elegans)
hsa:54801;HAUS6,Dgt6,FAM29A;HAUS augmin-like complex, subunit 6
hsa:83394;PITPNM3,CORD5,NIR1,RDGBA3;PITPNM family member 3
hsa:152006;RNF38;ring finger protein 38
hsa:55762;ZNF701;zinc finger protein 701
hsa:55670;PEX26,PBD7A,PBD7B,PEX26M1T,Pex26pM1T;peroxisomal biogenesis factor 26
hsa:89782;LMLN,GP63,INV,IX14,MSP;leishmanolysin-like (metallopeptidase M8 family) (EC:3.4.24.36)
hsa:283297;OR10A4,JCG5,OR10A4P;olfactory receptor, family 10, subfamily A, member 4
hsa:2533;FYB,ADAP,PRO0823,SLAP-130;FYN binding protein
hsa:3516;RBPJ,AOS3,CBF1,IGKJRB,IGKJRB1,KBF2,RBP-J,RBPJK,RBPSUH,SUH,csl;recombination signal binding protein for immunoglobulin kappa J region
hsa:7718;ZNF165,CT53,LD65,ZSCAN7;zinc finger protein 165
hsa:441250;TYW1B,LINC00069,NCRNA00069,RSAFD2;tRNA-yW synthesizing protein 1 homolog B (S. cerevisiae)
hsa:100130519;TMEM221;transmembrane protein 221
hsa:338707;B4GALNT4;beta-1,4-N-acetyl-galactosaminyl transferase 4 (EC:2.4.1.244)
hsa:389762;SPATA31D3,FAM75D3;SPATA31 subfamily D, member 3
hsa:11085;ADAM30,svph4;ADAM metallopeptidase domain 30
hsa:84667;HES7,SCDO4,bHLHb37;hairy and enhancer of split 7 (Drosophila)
hsa:285349;ZNF660;zinc finger protein 660
hsa:8082;SSPN,DAGA5,KRAG,NSPN,SPN1,SPN2;sarcospan
hsa:84527;ZNF559,NBLA00121;zinc finger protein 559
hsa:10384;BTN3A3,BTF3;butyrophilin, subfamily 3, member A3
hsa:127933;UHMK1,KIS,KIST,P-CIP2;U2AF homology motif (UHM) kinase 1 (EC:2.7.11.1)
hsa:26140;TTLL3,HOTTL;tubulin tyrosine ligase-like family, member 3
hsa:219654;ZCCHC24,C10orf56;zinc finger, CCHC domain containing 24
hsa:54503;ZDHHC13,HIP14L,HIP3RP;zinc finger, DHHC-type containing 13
hsa:4010;LMX1B,LMX1.2,NPS1;LIM homeobox transcription factor 1, beta
hsa:387712;ENO4,AC023283.3,C10orf134;enolase family member 4
hsa:91445;RNF185;ring finger protein 185
hsa:10346;TRIM22,GPSTAF50,RNF94,STAF50;tripartite motif containing 22
hsa:54814;QPCTL,gQC;glutaminyl-peptide cyclotransferase-like (EC:2.3.2.5)
hsa:2662;GDF10,BMP-3b,BMP3B;growth differentiation factor 10
hsa:389541;LAMTOR4,C7orf59;late endosomal/lysosomal adaptor, MAPK and MTOR activator 4
hsa:130749;CPO;carboxypeptidase O (EC:3.4.17.-)
hsa:100132396;ZNF705B;zinc finger protein 705B
hsa:5334;PLCL1,PLCE,PLCL,PLDL1,PRIP;phospholipase C-like 1
hsa:9813;EFCAB14,KIAA0494,RP11-8J9.3;EF-hand calcium binding domain 14
hsa:23077;MYCBP2,PAM;MYC binding protein 2, E3 ubiquitin protein ligase
hsa:9205;ZMYM5,HSPC050,MYM,ZNF198L1,ZNF237;zinc finger, MYM-type 5
hsa:55609;ZNF280C,SUHW3,ZNF633;zinc finger protein 280C
hsa:619208;FAM229B,C6orf225;family with sequence similarity 229, member B
hsa:84864;MINA,MDIG,MINA53,NO52,ROX;MYC induced nuclear antigen
hsa:6489;ST8SIA1,GD3S,SIAT8,SIAT8-A,SIAT8A,ST8SiaI;ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 (EC:2.4.99.8)
hsa:91775;NXPE3,FAM55C,MST115;neurexophilin and PC-esterase domain family, member 3
hsa:50937;CDON,CDO,CDON1,HPE11,ORCAM;cell adhesion associated, oncogene regulated
hsa:221496;LEMD2,NET25,dJ482C21.1;LEM domain containing 2
hsa:78987;CRELD1,AVSD2,CIRRIN;cysteine-rich with EGF-like domains 1
hsa:57799;RAB40C,RARL,RASL8C;RAB40C, member RAS oncogene family
hsa:80755;AARSD1;alanyl-tRNA synthetase domain containing 1;K07050
hsa:57150;SMIM8,C6orf162,dJ102H19.2;small integral membrane protein 8
hsa:54897;CASZ1,CAS11,CST,SRG,ZNF693,dJ734G22.1;castor zinc finger 1
hsa:56931;DUS3L,DUS3;dihydrouridine synthase 3-like (S. cerevisiae)
hsa:10418;SPON1,f-spondin;spondin 1, extracellular matrix protein
hsa:91056;AP5B1,AP-5,PP1030;adaptor-related protein complex 5, beta 1 subunit
hsa:11062;DUS4L,DUS4,PP35;dihydrouridine synthase 4-like (S. cerevisiae)
hsa:2040;STOM,BND7,EPB7,EPB72;stomatin
hsa:161436;EML5,EMAP-2;echinoderm microtubule associated protein like 5
hsa:374872;C19orf35;chromosome 19 open reading frame 35
hsa:166793;ZBTB49,ZNF509;zinc finger and BTB domain containing 49
hsa:22834;ZNF652;zinc finger protein 652
hsa:26229;B3GAT3,GLCATI;beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) (EC:2.4.1.135)
hsa:4802;NFYC,CBF-C,CBFC,H1TF2A,HAP5,HSM,NF-YC;nuclear transcription factor Y, gamma
hsa:63915;BLOC1S5,MU,MUTED;biogenesis of lysosomal organelles complex-1, subunit 5, muted
hsa:8027;STAM,STAM-1,STAM1;signal transducing adaptor molecule (SH3 domain and ITAM motif) 1
hsa:1392;CRH,CRF;corticotropin releasing hormone
hsa:10772;SRSF10,FUSIP1,FUSIP2,NSSR,SFRS13,SFRS13A,SRp38,SRrp40,TASR,TASR1,TASR2;serine/arginine-rich splicing factor 10
hsa:23126;POGZ,SUHW5,ZNF280E,ZNF635,ZNF635m;pogo transposable element with ZNF domain
hsa:388336;SHISA6;shisa homolog 6 (Xenopus laevis)
hsa:388701;C1orf189;chromosome 1 open reading frame 189
hsa:51728;POLR3K,C11,C11-RNP3,RPC10,RPC11,RPC12.5,hRPC11;polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa
hsa:57719;ANO8,KIAA1623,TMEM16H;anoctamin 8
hsa:730291;ZNF735;zinc finger protein 735
hsa:23563;CHST5,I-GlcNAc-6-ST,I-GlcNAc6ST,glcNAc6ST-3,gn6st-3,hIGn6ST;carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5
hsa:79759;ZNF668;zinc finger protein 668
hsa:55051;NRDE2,C14orf102;NRDE-2, necessary for RNA interference, domain containing
hsa:6482;ST3GAL1,Gal-NAc6S,SIAT4A,SIATFL,ST3GalA,ST3GalA.1,ST3GalIA,ST3GalIA,1,ST3O;ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (EC:2.4.99.4)
hsa:8649;LAMTOR3,MAP2K1IP1,MAPBP,MAPKSP1,MP1,PRO0633,Ragulator3;late endosomal/lysosomal adaptor, MAPK and MTOR activator 3
hsa:7101;NR2E1,TLL,TLX,XTLL;nuclear receptor subfamily 2, group E, member 1
hsa:2897;GRIK1,EAA3,EEA3,GLR5,GLUR5,GluK1;glutamate receptor, ionotropic, kainate 1
hsa:221301;FAM26D,C6orf78;family with sequence similarity 26, member D
hsa:51374;ATRAID,APR--3,APR-3,APR3,C2orf28,PRO240,p18;all-trans retinoic acid-induced differentiation factor
hsa:391123;VSIG8;V-set and immunoglobulin domain containing 8
hsa:100132463;CLDN24,CLDN21;claudin 24
hsa:253832;ZDHHC20;zinc finger, DHHC-type containing 20
hsa:2551;GABPA,E4TF1-60,E4TF1A,NFT2,NRF2,NRF2A,RCH04A07;GA binding protein transcription factor, alpha subunit 60kDa
hsa:8875;VNN2,FOAP-4,GPI-80;vanin 2 (EC:3.5.1.92)
hsa:23263;MCF2L,ARHGEF14,DBS,OST;MCF.2 cell line derived transforming sequence-like
hsa:283579;C14orf178;chromosome 14 open reading frame 178
hsa:57628;DPP10,DPL2,DPPY,DPRP3;dipeptidyl-peptidase 10 (non-functional)
hsa:10739;RFPL2,RNF79;ret finger protein-like 2
hsa:124;ADH1A,ADH1;alcohol dehydrogenase 1A (class I), alpha polypeptide (EC:1.1.1.1)
hsa:285555;STPG2,C4orf37;sperm-tail PG-rich repeat containing 2
hsa:199221;DZIP1L,DZIP2;DAZ interacting protein 1-like
hsa:284486;THEM5;thioesterase superfamily member 5 (EC:3.1.2.2)
hsa:64397;ZFP106,SH3BP3,ZNF106,ZNF474;zinc finger protein 106 homolog (mouse)
hsa:100506888;TCEB3CL2;transcription elongation factor B polypeptide 3C-like 2
hsa:55326;AGPAT5,1AGPAT5,LPAATE;1-acylglycerol-3-phosphate O-acyltransferase 5 (EC:2.3.1.51)
hsa:79698;ZMAT4;zinc finger, matrin-type 4
hsa:80264;ZNF430;zinc finger protein 430
hsa:84992;PIGY,PIG-Y;phosphatidylinositol glycan anchor biosynthesis, class Y
hsa:5571;PRKAG1,AMPKG;protein kinase, AMP-activated, gamma 1 non-catalytic subunit
hsa:10505;SEMA4F,M-SEMA,PRO2353,S4F,SEMAM,SEMAW,m-Sema-M;sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F
hsa:92912;UBE2Q2;ubiquitin-conjugating enzyme E2Q family member 2 (EC:6.3.2.19)
hsa:282618;IFNL1,IL-29,IL29;interferon, lambda 1
hsa:6827;SUPT4H1,SPT4,SPT4H,SUPT4H;suppressor of Ty 4 homolog 1 (S. cerevisiae)
hsa:84298;LLPH,C12orf31,hLLP;LLP homolog, long-term synaptic facilitation (Aplysia)
hsa:116444;GRIN3B,GluN3B,NR3B;glutamate receptor, ionotropic, N-methyl-D-aspartate 3B
hsa:10930;APOBEC2,ARCD1,ARP1;apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2
hsa:84309;NUDT16L1,SDOS;nudix (nucleoside diphosphate linked moiety X)-type motif 16-like 1
hsa:7919;DDX39B,BAT1,D6S81E,UAP56;DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B (EC:3.6.4.13)
hsa:84197;SGK196;protein kinase-like protein SgK196
hsa:60680;CELF5,BRUNOL-5,BRUNOL5,CELF-5;CUGBP, Elav-like family member 5
hsa:4522;MTHFD1,MTHFC,MTHFD;methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase (EC:1.5.1.5 6.3.4.3 3.5.4.9)
hsa:644538;SMIM10,CXorf69;small integral membrane protein 10
hsa:7278;TUBA3C,TUBA2,bA408E5.3;tubulin, alpha 3c
hsa:27351;DESI1,D15Wsu75e,DESI2,DJ347H13.4,DeSI-1,FAM152B,PPPDE2;desumoylating isopeptidase 1
hsa:197320;ZNF778;zinc finger protein 778
hsa:5524;PPP2R4,PP2A,PR53,PTPA;protein phosphatase 2A activator, regulatory subunit 4 (EC:5.2.1.8)
hsa:55128;TRIM68,GC109,RNF137,SS-56,SS56;tripartite motif containing 68
hsa:1359;CPA3,MC-CPA;carboxypeptidase A3 (mast cell) (EC:3.4.17.1)
hsa:100463486;MTRNR2L8,HN8;MT-RNR2-like 8
hsa:84690;SPATA22,NYD-SP20,NYDSP20;spermatogenesis associated 22
hsa:158506;ZNF645,HAKAIL;zinc finger protein 645
hsa:84671;ZNF347,ZNF1111;zinc finger protein 347
hsa:6476;SI;sucrase-isomaltase (alpha-glucosidase) (EC:3.2.1.10 3.2.1.48)
hsa:100507679;MUC22,PBMUCL1;mucin 22
hsa:100132963;SMIM9,CXorf68;small integral membrane protein 9
hsa:84767;TRIM51,SPRYD5,TRIM51A;tripartite motif-containing 51
hsa:10877;CFHR4,CFHL4,FHR-4,FHR4;complement factor H-related 4
hsa:6689;SPIB,SPI-B;Spi-B transcription factor (Spi-1/PU.1 related)
hsa:7132;TNFRSF1A,CD120a,FPF,MS5,TBP1,TNF-R,TNF-R-I,TNF-R55,TNFAR,TNFR1,TNFR1-d2,TNFR55,TNFR60,p55,p55-R,p60;tumor necrosis factor receptor superfamily, member 1A
hsa:9519;TBPL1,MGC:8389,MGC:9620,STUD,TLF,TLP,TRF2;TBP-like 1
hsa:1357;CPA1,CPA;carboxypeptidase A1 (pancreatic) (EC:3.4.17.1)
hsa:64744;SMAP2,RP1-228H13.3,SMAP1L;small ArfGAP2
hsa:7918;GPANK1,ANKRD59,BAT4,D6S54E,G5,GPATCH10;G patch domain and ankyrin repeats 1
hsa:23515;MORC3,NXP2,ZCW5,ZCWCC3;MORC family CW-type zinc finger 3
hsa:5407;PNLIPRP1,PLRP1;pancreatic lipase-related protein 1 (EC:3.1.1.3)
hsa:389766;C9orf153,bA507D14.1;chromosome 9 open reading frame 153
hsa:100288520;USP17L15;ubiquitin specific peptidase 17-like family member 15 (EC:3.4.19.12)
hsa:8323;FZD6,FZ-6,FZ6,HFZ6,NDNC10;frizzled family receptor 6
hsa:9666;DZIP3,PPP1R66,UURF2,hRUL138;DAZ interacting protein 3, zinc finger
hsa:100128731;OST4;oligosaccharyltransferase 4 homolog (S. cerevisiae)
hsa:157869;SBSPON,C8orf84,RPESP;somatomedin B and thrombospondin, type 1 domain containing
hsa:65251;ZNF649;zinc finger protein 649
hsa:4477;MSMB,HPC13,IGBF,MSP,MSPB,PN44,PRPS,PSP,PSP-94,PSP57,PSP94;microseminoprotein, beta-
hsa:55351;STK32B,HSA250839,STK32,STKG6,YANK2;serine/threonine kinase 32B (EC:2.7.11.1)
hsa:57547;ZNF624;zinc finger protein 624
hsa:642629;SPATA31A4,FAM75A4;SPATA31 subfamily A, member 4
hsa:6478;SIAH2,hSiah2;siah E3 ubiquitin protein ligase 2 (EC:6.3.2.-)
hsa:79931;TNIP3,ABIN-3,LIND;TNFAIP3 interacting protein 3
hsa:92595;ZNF764;zinc finger protein 764
hsa:388523;ZNF728;zinc finger protein 728
hsa:55289;ACOXL;acyl-CoA oxidase-like
hsa:5052;PRDX1,MSP23,NKEF-A,NKEFA,PAG,PAGA,PAGB,PRX1,PRXI,TDPX2;peroxiredoxin 1 (EC:1.11.1.15)
hsa:139804;RBMXL3,CXorf55;RNA binding motif protein, X-linked-like 3
hsa:348013;TMEM255B,FAM70B;transmembrane protein 255B
hsa:27301;APEX2,APE2,APEXL2,XTH2;APEX nuclease (apurinic/apyrimidinic endonuclease) 2 (EC:4.2.99.18)
hsa:100132929;FAM25B,FAM25A,FAM25C,FAM25G,bA144G6.8;family with sequence similarity 25, member B
hsa:6258;RXRG,NR2B3,RXRC;retinoid X receptor, gamma
hsa:55290;BRF2,BRFU,TFIIIB50;BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like
hsa:54492;NEURL1B,NEURL3,hNeur2,neur2;neuralized homolog 1B (Drosophila) (EC:6.3.2.-)
hsa:100463488;MTRNR2L10,HN10;MT-RNR2-like 10
hsa:84133;ZNRF3,BK747E2.3,RNF203;zinc and ring finger 3
hsa:22856;CHSY1,CHSY,CSS1,ChSy-1,TPBS;chondroitin sulfate synthase 1 (EC:2.4.1.175 2.4.1.226)
hsa:92014;SLC25A51,CG7943,MCART1;solute carrier family 25, member 51
hsa:92597;MOB1B,MATS2,MOB4A,MOBKL1A;MOB kinase activator 1B
hsa:138151;NACC2,BEND9,BTBD14,BTBD14A,BTBD31;NACC family member 2, BEN and BTB (POZ) domain containing
hsa:9779;TBC1D5;TBC1 domain family, member 5
hsa:29954;POMT2,LGMD2N,MDDGA2,MDDGB2,MDDGC2;protein-O-mannosyltransferase 2 (EC:2.4.1.109)
hsa:120237;DBX1;developing brain homeobox 1
hsa:3998;LMAN1,ERGIC-53,ERGIC53,F5F8D,FMFD1,MCFD1,MR60,gp58;lectin, mannose-binding, 1
hsa:254528;MEIOB,C16orf73,gs129;meiosis specific with OB domains
hsa:63827;BCAN,BEHAB,CSPG7;brevican
hsa:51232;CRIM1,CRIM-1,S52;cysteine rich transmembrane BMP regulator 1 (chordin-like)
hsa:51200;CPA4,CPA3;carboxypeptidase A4
hsa:54849;DEF8;differentially expressed in FDCP 8 homolog (mouse)
hsa:729;C6;complement component 6
hsa:257144;GCSAM,GCAT2,GCET2,HGAL;germinal center-associated, signaling and motility
hsa:253827;MSRB3,DFNB74;methionine sulfoxide reductase B3 (EC:1.8.4.-)
hsa:10067;SCAMP3,C1orf3;secretory carrier membrane protein 3
hsa:641372;ACOT6,C14orf42,c14_5530;acyl-CoA thioesterase 6 (EC:3.1.2.2)
hsa:83852;SETDB2,C13orf4,CLLD8,CLLL8,KMT1F;SET domain, bifurcated 2 (EC:2.1.1.43)
hsa:150946;GAREML,FAM59B;GRB2 associated, regulator of MAPK1-like
hsa:5162;PDHB,PDHBD,PDHE1-B,PHE1B;pyruvate dehydrogenase (lipoamide) beta (EC:1.2.4.1)
hsa:5222;PGA5,PGA3,PGA4;pepsinogen 5, group I (pepsinogen A) (EC:3.4.23.1)
hsa:5188;PET112,PET112L;PET112 homolog (yeast)
hsa:22931;RAB18,RAB18LI1,WARBM3;RAB18, member RAS oncogene family
hsa:27299;ADAMDEC1,M12.219;ADAM-like, decysin 1
hsa:646851;FAM227A;family with sequence similarity 227, member A
hsa:2288;FKBP4,FKBP51,FKBP52,FKBP59,HBI,Hsp56,PPIase,p52;FK506 binding protein 4, 59kDa (EC:5.2.1.8)
hsa:50807;ASAP1,AMAP1,CENTB4,DDEF1,PAG2,PAP,ZG14P;ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
hsa:387103;CENPW,C6orf173,CUG2;centromere protein W
hsa:115;ADCY9,AC9;adenylate cyclase 9 (EC:4.6.1.1)
hsa:493901;RNASE12;ribonuclease, RNase A family, 12 (non-active)
hsa:79133;NDUFAF5,C20orf7,bA526K24.2,dJ842G6.1;NADH dehydrogenase (ubiquinone) complex I, assembly factor 5
hsa:150572;SMYD1,BOP,KMT3D,ZMYND18,ZMYND22;SET and MYND domain containing 1
hsa:79807;GSTCD;glutathione S-transferase, C-terminal domain containing
hsa:645142;PPIAL4D;peptidylprolyl isomerase A (cyclophilin A)-like 4D (EC:5.2.1.8)
hsa:6249;CLIP1,CLIP,CLIP-170,CLIP170,CYLN1,RSN;CAP-GLY domain containing linker protein 1
hsa:6882;TAF11,MGC:15243,TAF2I,TAFII28;TAF11 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 28kDa
hsa:121601;ANO4,TMEM16D;anoctamin 4
hsa:128611;ZNF831,C20orf174,dJ492J12.1;zinc finger protein 831
hsa:6289;SAA2;serum amyloid A2
hsa:284904;SEC14L4,TAP3;SEC14-like 4 (S. cerevisiae)
hsa:653505;PPIAL4B,COAS-2;peptidylprolyl isomerase A (cyclophilin A)-like 4B (EC:5.2.1.8)
hsa:51433;ANAPC5,APC5;anaphase promoting complex subunit 5
hsa:8386;OR1D5,C17orf2,OR17-2,OR17-30,OR17-31;olfactory receptor, family 1, subfamily D, member 5
hsa:352909;DNAAF3,C19orf51,CILD2,DAB1,PCD,PF22;dynein, axonemal, assembly factor 3
hsa:130916;MTERFD2,MTERF4;MTERF domain containing 2
hsa:25981;DNAH1,DNAHC1,HDHC7,HL-11,HL11,XLHSRF-1;dynein, axonemal, heavy chain 1
hsa:4795;NFKBIL1,IKBL,LST1,NFKBIL;nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
hsa:3588;IL10RB,CDW210B,CRF2-4,CRFB4,D21S58,D21S66,IL-10R2;interleukin 10 receptor, beta
hsa:11261;CHP1,CHP,SLC9A1BP,Sid470p,p22,p24;calcineurin-like EF-hand protein 1
hsa:149603;RNF187,RACO-1,RACO1;ring finger protein 187
hsa:9343;EFTUD2,MFDGA,MFDM,Snrp116,Snu114,U5-116KD;elongation factor Tu GTP binding domain containing 2
hsa:80896;NPL,C112,C1orf13,NAL,NPL1;N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) (EC:4.1.3.3)
hsa:7173;TPO,MSA,TDH2A,TPX;thyroid peroxidase (EC:1.11.1.8)
hsa:51537;MTFP1,MTP18;mitochondrial fission process 1
hsa:11043;MID2,FXY2,RNF60,TRIM1;midline 2
hsa:6358;CCL14,CC-1,CC-3,CKB1,HCC-1,HCC-1(1-74),HCC-1/HCC-3,HCC-3,MCIF,NCC-2,NCC2,SCYA14,SCYL2,SY14;chemokine (C-C motif) ligand 14
hsa:54522;ANKRD16;ankyrin repeat domain 16
hsa:414328;IDNK,C9orf103,bA522I20.2;idnK, gluconokinase homolog (E. coli) (EC:2.7.1.12)
hsa:653268;AGAP7,CTGLF4,bA109G10.1;ArfGAP with GTPase domain, ankyrin repeat and PH domain 7
hsa:140691;TRIM69,HSD34,RNF36,Trif;tripartite motif containing 69
hsa:9831;ZNF623;zinc finger protein 623
hsa:6230;RPS25,S25;ribosomal protein S25
hsa:730051;ZNF814;zinc finger protein 814
hsa:176;ACAN,AGC1,AGCAN,CSPG1,CSPGCP,MSK16,SEDK;aggrecan
hsa:25758;KIAA1549L,C11orf41,C11orf69,G2;KIAA1549-like
hsa:863;CBFA2T3,ETO2,MTG16,MTGR2,ZMYND4;core-binding factor, runt domain, alpha subunit 2;translocated to, 3
hsa:5788;PTPRC,B220,CD45,CD45R,GP180,L-CA,LCA,LY5,T200;protein tyrosine phosphatase, receptor type, C (EC:3.1.3.48)
hsa:353355;ZNF233;zinc finger protein 233
hsa:7940;LST1,B144,D6S49E,LST-1;leukocyte specific transcript 1
hsa:26060;APPL1,APPL,DIP13alpha;adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
hsa:23117;NPIPL3,KIAA0220L;nuclear pore complex interacting protein-like 3
hsa:2877;GPX2,GI-GPx,GPRP,GPRP-2,GPx-2,GPx-GI,GSHPX-GI,GSHPx-2;glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9)
hsa:317749;DHRS4L2,SDR25C3;dehydrogenase/reductase (SDR family) member 4 like 2
hsa:196500;PIANP,C12orf53,PANP,leda-1;PILR alpha associated neural protein
hsa:57332;CBX8,PC3,RC1;chromobox homolog 8
hsa:9611;NCOR1,N-CoR,N-CoR1,TRAC1,hN-CoR;nuclear receptor corepressor 1
hsa:84330;ZNF414,ZFP414;zinc finger protein 414
hsa:287015;TRIM42,PPP1R40;tripartite motif containing 42
hsa:9374;PPT2,C6orf8,G14,PPT-2;palmitoyl-protein thioesterase 2 (EC:3.1.2.22)
hsa:55317;AP5S1,C20orf29;adaptor-related protein complex 5, sigma 1 subunit
hsa:55193;PBRM1,BAF180,PB1;polybromo 1
hsa:25988;HINFP,HiNF-P,MIZF,ZNF743;histone H4 transcription factor
hsa:83695;RHNO1,C12orf32,RHINO;RAD9-HUS1-RAD1 interacting nuclear orphan 1
hsa:4005;LMO2,RBTN2,RBTNL1,RHOM2,TTG2;LIM domain only 2 (rhombotin-like 1)
hsa:5829;PXN;paxillin
hsa:10314;LANCL1,GPR69A,p40;LanC lantibiotic synthetase component C-like 1 (bacterial)
hsa:6897;TARS,ThrRS;threonyl-tRNA synthetase (EC:6.1.1.3)
hsa:10299;MARCH6,DOA10,MARCH-VI,RNF176,TEB4;membrane-associated ring finger (C3HC4) 6, E3 ubiquitin protein ligase (EC:6.3.2.-)
hsa:10961;ERP29,C12orf8,ERp28,ERp31,PDI-DB,PDIA9;endoplasmic reticulum protein 29
hsa:2195;FAT1,CDHF7,CDHR8,FAT,ME5,hFat1;FAT tumor suppressor homolog 1 (Drosophila)
hsa:28999;KLF15,KKLF;Kruppel-like factor 15
hsa:55809;TRERF1,BCAR2,HSA277276,RAPA,RP1-139D8.5,TReP-132,dJ139D8.5;transcriptional regulating factor 1
hsa:728276;CLEC19A;C-type lectin domain family 19, member A
hsa:10982;MAPRE2,EB1,EB2,RP1;microtubule-associated protein, RP/EB family, member 2
hsa:83744;ZNF484,BA526D8.4;zinc finger protein 484
hsa:79776;ZFHX4,ZFH4,ZHF4;zinc finger homeobox 4
hsa:54332;GDAP1,CMT4,CMT4A,CMTRIA;ganglioside induced differentiation associated protein 1
hsa:729288;ZNF286B,ZNF286C,ZNF286L,ZNF590;zinc finger protein 286B
hsa:9815;GIT2,CAT-2,CAT2;G protein-coupled receptor kinase interacting ArfGAP 2
hsa:91664;ZNF845;zinc finger protein 845
hsa:55657;ZNF692,AREBP,Zfp692;zinc finger protein 692
hsa:79772;MCTP1;multiple C2 domains, transmembrane 1
hsa:284371;ZNF841;zinc finger protein 841
hsa:54538;ROBO4,ECSM4,MRB;roundabout, axon guidance receptor, homolog 4 (Drosophila)
hsa:2692;GHRHR,GHRFR,GRFR,IGHD1B;growth hormone releasing hormone receptor
hsa:159091;FAM122C;family with sequence similarity 122C
hsa:5194;PEX13,NALD,PBD11A,PBD11B,ZWS;peroxisomal biogenesis factor 13
hsa:93166;PRDM6;PR domain containing 6 (EC:2.1.1.43)
hsa:10537;UBD,FAT10,GABBR1,UBD-3;ubiquitin D
hsa:23491;CES3,ES31;carboxylesterase 3 (EC:3.1.1.1)
hsa:267;AMFR,GP78,RNF45;autocrine motility factor receptor, E3 ubiquitin protein ligase (EC:6.3.2.19)
hsa:26583;DUX2;double homeobox 2
hsa:346171;ZFP57,C6orf40,TNDM1,ZNF698,bA145L22,bA145L22.2;ZFP57 zinc finger protein
hsa:10284;SAP18,2HOR0202,SAP18P;Sin3A-associated protein, 18kDa
hsa:5165;PDK3;pyruvate dehydrogenase kinase, isozyme 3 (EC:2.7.11.2)
hsa:10432;RBM14,COAA,PSP2,SIP,SYTIP1,TMEM137;RNA binding motif protein 14
hsa:80821;DDHD1,PA-PLA1,PAPLA1,SPG28;DDHD domain containing 1
hsa:647042;GOLGA6L10;golgin A6 family-like 10
hsa:64799;IQCH,NYDSP5;IQ motif containing H
hsa:80204;FBXO11,FBX11,PRMT9,UBR6,VIT1;F-box protein 11
hsa:5157;PDGFRL,PDGRL,PRLTS;platelet-derived growth factor receptor-like
hsa:389396;GLYATL3,C6orf140,bA28H17.2;glycine-N-acyltransferase-like 3 (EC:2.3.1.-)
hsa:6232;RPS27,MPS-1,MPS1,S27;ribosomal protein S27
hsa:126231;ZNF573;zinc finger protein 573
hsa:84909;C9orf3,AOPEP,AP-O,APO,C90RF3,ONPEP;chromosome 9 open reading frame 3
hsa:309;ANXA6,ANX6,CBP68;annexin A6
hsa:1961;EGR4,NGFI-C,NGFIC,PAT133;early growth response 4
hsa:390245;KDM4E,JMJD2E,KDM4DL;lysine (K)-specific demethylase 4E
hsa:51321;AMZ2;archaelysin family metallopeptidase 2
hsa:5931;RBBP7,RbAp46;retinoblastoma binding protein 7
hsa:125893;ZNF816,ZNF816A;zinc finger protein 816
hsa:9236;CCPG1,CPR8;cell cycle progression 1
hsa:653548;DUX4L3;double homeobox 4 like 3
hsa:252969;NEIL2,NEH2,NEI2;nei endonuclease VIII-like 2 (E. coli) (EC:4.2.99.18)
hsa:57474;ZNF490;zinc finger protein 490
hsa:9214;FAIM3,FCMR,TOSO;Fas apoptotic inhibitory molecule 3
hsa:55616;ASAP3,ACAP4,CENTB6,DDEFL1,UPLC1;ArfGAP with SH3 domain, ankyrin repeat and PH domain 3
hsa:55892;MYNN,OSZF,ZBTB31,ZNF902;myoneurin
hsa:146705;ENTHD2,C17orf56;ENTH domain containing 2
hsa:3975;LHX1,LIM-1,LIM1;LIM homeobox 1
hsa:641339;ZNF674,MRX92,ZNF673B;zinc finger protein 674
hsa:253650;ANKRD18A;ankyrin repeat domain 18A
hsa:57623;ZFAT,AITD3,ZFAT1,ZNF406;zinc finger and AT hook domain containing
hsa:10288;LILRB2,CD85D,ILT4,LILRA6,LIR-2,LIR2,MIR-10,MIR10;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
hsa:29110;TBK1,NAK,T2K;TANK-binding kinase 1 (EC:2.7.11.1)
hsa:91283;MSANTD3,C9orf30;Myb/SANT-like DNA-binding domain containing 3
hsa:987;LRBA,BGL,CDC4L,CVID8,LAB300,LBA;LPS-responsive vesicle trafficking, beach and anchor containing
hsa:10133;OPTN,ALS12,FIP2,GLC1E,HIP7,HYPL,NRP,TFIIIA-INTP;optineurin
hsa:10713;USP39,65K,HSPC332,SAD1,SNRNP65;ubiquitin specific peptidase 39
hsa:126129;CPT1C,CATL1,CPT1-B,CPT1P,CPTI-B,CPTIC;carnitine palmitoyltransferase 1C (EC:2.3.1.21)
hsa:390928;PAPL;iron/zinc purple acid phosphatase-like protein (EC:3.1.3.2)
hsa:8467;SMARCA5,ISWI,SNF2H,WCRF135,hISWI,hSNF2H;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
hsa:23093;TTLL5,KIAA0998,STAMP;tubulin tyrosine ligase-like family, member 5
hsa:25829;TMEM184B,C22orf5,FM08,HS5O6A;transmembrane protein 184B
hsa:83932;SPRTN,C1orf124,DDDL1880,DVC1,PRO4323,Spartan,dJ876B10.3;SprT-like N-terminal domain
hsa:163590;TOR1AIP2,IFRG15,LULL1,NET9,RP11-12M5.5;torsin A interacting protein 2
hsa:729431;GAGE12E,GAGE-12B;G antigen 12E
hsa:57116;ZNF695,RP11-551G24.1,SBZF3;zinc finger protein 695
hsa:246243;RNASEH1,H1RNA,RNH1;ribonuclease H1 (EC:3.1.26.4)
hsa:79670;ZCCHC6,PAPD6;zinc finger, CCHC domain containing 6 (EC:2.7.7.52)
hsa:9277;WDR46,BING4,C6orf11,FP221,UTP7;WD repeat domain 46
hsa:1237;CCR8,CC-CKR-8,CCR-8,CDw198,CKRL1,CMKBR8,CMKBRL2,CY6,GPRCY6,TER1;chemokine (C-C motif) receptor 8
hsa:154313;C6orf165,dJ382I10.1;chromosome 6 open reading frame 165
hsa:374654;KIF7,ACLS,HLS2,JBTS12,UNQ340;kinesin family member 7
hsa:285190;RGPD4,RGP4;RANBP2-like and GRIP domain containing 4
hsa:5174;PDZK1,CAP70,CLAMP,NHERF-3,NHERF3,PDZD1;PDZ domain containing 1
hsa:84140;FAM161A,RP28;family with sequence similarity 161, member A
hsa:381;ARF5;ADP-ribosylation factor 5
hsa:339318;ZNF181,HHZ181;zinc finger protein 181
hsa:286151;FBXO43,EMI2,ERP1,FBX43;F-box protein 43
hsa:222546;RFX6,MTFS,RFXDC1,dJ955L16.1;regulatory factor X, 6
hsa:896;CCND3;cyclin D3
hsa:84514;GHDC,D11LGP1,LGP1;GH3 domain containing
hsa:10939;AFG3L2,SCA28,SPAX5;AFG3 ATPase family member 3-like 2 (S. cerevisiae)
hsa:100507170;CT47A12,CT47,CT47.12;cancer/testis antigen family 47, member A12
hsa:8226;HDHD1,DXF68S1E,FAM16AX,GS1,HDHD1A;haloacid dehalogenase-like hydrolase domain containing 1
hsa:389658;FAM150A,UNQ9433;family with sequence similarity 150, member A
hsa:9654;TTLL4;tubulin tyrosine ligase-like family, member 4
hsa:7957;EPM2A,EPM2,MELF;epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EC:3.1.3.16 3.1.3.48)
hsa:5936;RBM4,LARK,RBM4A,ZCCHC21,ZCRB3A;RNA binding motif protein 4
hsa:57708;MIER1,ER1,MI-ER1,hMI-ER1;mesoderm induction early response 1 homolog (Xenopus laevis)
hsa:5701;PSMC2,MSS1,Nbla10058,S7;proteasome (prosome, macropain) 26S subunit, ATPase, 2
hsa:8934;RAB7L1,RAB7L;RAB7, member RAS oncogene family-like 1
hsa:90933;TRIM41,RINCK;tripartite motif containing 41
hsa:7439;BEST1,ARB,BEST,BMD,RP50,TU15B,VMD2;bestrophin 1
hsa:84676;TRIM63,IRF,MURF1,MURF2,RNF28,SMRZ;tripartite motif containing 63, E3 ubiquitin protein ligase
hsa:23066;CAND2,TIP120B,Tp120b;cullin-associated and neddylation-dissociated 2 (putative)
hsa:11165;NUDT3,DIPP,DIPP-1,DIPP1;nudix (nucleoside diphosphate linked moiety X)-type motif 3 (EC:3.6.1.52)
hsa:390790;ARL5C,ARL12;ADP-ribosylation factor-like 5C
hsa:100129128;KHDC1L;KH homology domain containing 1-like
hsa:5134;PDCD2,RP8,ZMYND7;programmed cell death 2
hsa:50808;AK3,AK3L1,AK6,AKL3L,AKL3L1,FIX;adenylate kinase 3 (EC:2.7.4.10)
hsa:8218;CLTCL1,CHC22,CLH22,CLTCL,CLTD;clathrin, heavy chain-like 1
hsa:23032;USP33,VDU1;ubiquitin specific peptidase 33 (EC:3.4.19.12)
hsa:80864;EGFL8,C6orf8,NG3;EGF-like-domain, multiple 8
hsa:9712;USP6NL,RNTRE,TRE2NL;USP6 N-terminal like
hsa:23464;GCAT,KBL;glycine C-acetyltransferase (EC:2.3.1.29)
hsa:51031;GLOD4,C17orf25,HC71;glyoxalase domain containing 4
hsa:340481;ZDHHC21,9130404H11Rik,DHHC-21,DHHC21,DNZ1,HSPC097;zinc finger, DHHC-type containing 21 (EC:2.3.1.-)
hsa:7626;ZNF75D,D8C6,ZKSCAN24,ZNF75,ZNF82,ZSCAN28;zinc finger protein 75D
hsa:55004;LAMTOR1,C11orf59,PDRO,Ragulator1,p18,p27RF-Rho;late endosomal/lysosomal adaptor, MAPK and MTOR activator 1
hsa:79753;SNIP1,PMRED;Smad nuclear interacting protein 1
hsa:643904;RNF222;ring finger protein 222
hsa:5184;PEPD,PROLIDASE;peptidase D (EC:3.4.13.9)
hsa:9910;RABGAP1L,HHL,TBC1D18;RAB GTPase activating protein 1-like
hsa:55503;TRPV6,ABP/ZF,CAT1,CATL,ECAC2,HSA277909,LP6728,ZFAB;transient receptor potential cation channel, subfamily V, member 6
hsa:11262;SP140,LYSP100,LYSP100-A,LYSP100-B;SP140 nuclear body protein
hsa:116447;TOP1MT;topoisomerase (DNA) I, mitochondrial (EC:5.99.1.2)
hsa:57677;ZFP14,ZNF531;ZFP14 zinc finger protein
hsa:7123;CLEC3B,TN,TNA;C-type lectin domain family 3, member B
hsa:92949;ADAMTSL1,ADAMTSL-1,ADAMTSR1,C9orf94,PUNCTIN;ADAMTS-like 1
hsa:1821;DRP2;dystrophin related protein 2
hsa:9662;CEP135,CEP4,KIAA0635,MCPH8;centrosomal protein 135kDa
hsa:4931;NVL;nuclear VCP-like
hsa:9705;ST18,ZC2HC10,ZNF387;suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein)
hsa:148823;GCSAML,C1orf150;germinal center-associated, signaling and motility-like
hsa:23384;SPECC1L,CYTSA,OBLFC1;sperm antigen with calponin homology and coiled-coil domains 1-like
hsa:344805;TMPRSS7;transmembrane protease, serine 7
hsa:23457;ABCB9,EST122234,TAPL;ATP-binding cassette, sub-family B (MDR/TAP), member 9
hsa:10947;AP3M2,AP47B,CLA20,P47B;adaptor-related protein complex 3, mu 2 subunit
hsa:2862;MLNR,GPR38,MTLR1;motilin receptor
hsa:10612;TRIM3,BERP,HAC1,RNF22,RNF97;tripartite motif containing 3
hsa:6383;SDC2,CD362,HSPG,HSPG1,SYND2;syndecan 2
hsa:1368;CPM;carboxypeptidase M (EC:3.4.17.12)
hsa:90589;ZNF625;zinc finger protein 625
hsa:3675;ITGA3,CD49C,GAP-B3,GAPB3,ILNEB,MSK18,VCA-2,VL3A,VLA3a;integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
hsa:54751;FBLIM1,CAL,FBLP-1,FBLP1;filamin binding LIM protein 1
hsa:10044;SH2D3C,CHAT,NSP3,PRO34088;SH2 domain containing 3C
hsa:80263;TRIM45,RNF99;tripartite motif containing 45
hsa:1482;NKX2-5,CHNG5,CSX,CSX1,HLHS2,NKX2.5,NKX2E,NKX4-1,VSD3;NK2 homeobox 5
hsa:10921;RNPS1,E5.1;RNA binding protein S1, serine-rich domain
hsa:94059;LENG9;leukocyte receptor cluster (LRC) member 9
hsa:124923;SGK494;uncharacterized serine/threonine-protein kinase SgK494 (EC:2.7.11.1)
hsa:1748;DLX4,BP1,DLX7,DLX8,DLX9;distal-less homeobox 4
hsa:389610;XKR5,HARL2754,UNQ2754,XRG5A,XRG5BM;XK, Kell blood group complex subunit-related family, member 5
hsa:5523;PPP2R3A,PPP2R3,PR130,PR72;protein phosphatase 2, regulatory subunit B'', alpha (EC:3.1.3.16)
hsa:23788;MTCH2,MIMP,SLC25A50;mitochondrial carrier 2
hsa:440435;GPR179,CSNB1E,GPR158L,GPR158L1;G protein-coupled receptor 179
hsa:445;ASS1,ASS,CTLN1;argininosuccinate synthase 1 (EC:6.3.4.5)
hsa:284309;ZNF776;zinc finger protein 776
hsa:2744;GLS,AAD20,GAC,GAM,GLS1,KGA;glutaminase (EC:3.5.1.2)
hsa:122042;RXFP2,GPR106,GREAT,INSL3R,LGR8,LGR8.1,RXFPR2;relaxin/insulin-like family peptide receptor 2
hsa:50511;SYCP3,COR1,SCP3,SPGF4;synaptonemal complex protein 3
hsa:23635;SSBP2,HSPC116,SOSS-B2;single-stranded DNA binding protein 2
hsa:7750;ZMYM2,FIM,MYM,RAMP,SCLL,ZNF198;zinc finger, MYM-type 2
hsa:84619;ZGPAT,GPATC6,GPATCH6,KIAA1847,ZC3H9,ZC3HDC9,ZIP;zinc finger, CCCH-type with G patch domain
hsa:183;AGT,ANHU,SERPINA8;angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
hsa:1485;CTAG1B,CT6.1,CTAG,CTAG1,ESO1,LAGE-2,LAGE2B,NY-ESO-1;cancer/testis antigen 1B
hsa:3459;IFNGR1,CD119,IFNGR;interferon gamma receptor 1
hsa:90550;MCU,C10orf42,CCDC109A;mitochondrial calcium uniporter
hsa:28982;FLVCR1,AXPC1,FLVCR,MFSD7B,PCA,PCARP;feline leukemia virus subgroup C cellular receptor 1
hsa:54940;OCIAD1,ASRIJ,OCIA,TPA018;OCIA domain containing 1
hsa:4126;MANBA,MANB1;mannosidase, beta A, lysosomal (EC:3.2.1.25)
hsa:10733;PLK4,SAK,STK18;polo-like kinase 4 (EC:2.7.11.21)
hsa:84893;FBXO18,FBH1,Fbx18;F-box protein, helicase, 18 (EC:3.6.4.12)
hsa:9053;MAP7,E-MAP-115,EMAP115;microtubule-associated protein 7
hsa:7568;ZNF20,KOX13;zinc finger protein 20
hsa:81931;ZNF93,HPF34,HTF34,TF34,ZNF505;zinc finger protein 93
hsa:221692;PHACTR1,RPEL,RPEL1,dJ257A7.2;phosphatase and actin regulator 1
hsa:2865;FFAR3,FFA3R,GPR41;free fatty acid receptor 3
hsa:253639;ZNF620;zinc finger protein 620
hsa:116369;SLC26A8,TAT1;solute carrier family 26, member 8
hsa:140831;ZSWIM3,C20orf164;zinc finger, SWIM-type containing 3
hsa:7572;ZNF24,KOX17,RSG-A,ZNF191,ZSCAN3,Zfp191;zinc finger protein 24
hsa:54840;APTX,AOA,AOA1,AXA1,EAOH,EOAHA,FHA-HIT;aprataxin
hsa:553115;PEF1,ABP32,PEF1A;penta-EF-hand domain containing 1
hsa:79831;KDM8,JMJD5;lysine (K)-specific demethylase 8 (EC:1.14.11.27)
hsa:5913;RAPSN,RAPSYN,RNF205;receptor-associated protein of the synapse
hsa:51686;OAZ3,AZ3,OAZ-t,TISP15;ornithine decarboxylase antizyme 3
hsa:146433;IL34,C16orf77,IL-34;interleukin 34
hsa:51375;SNX7;sorting nexin 7
hsa:2956;MSH6,GTBP,HNPCC5,HSAP;mutS homolog 6 (E. coli)
hsa:4008;LMO7,FBX20,FBXO20,LOMP;LIM domain 7
hsa:11094;CACFD1,C9orf7,D9S2135,FLOWER;calcium channel flower domain containing 1
hsa:25850;ZNF345,HZF10;zinc finger protein 345
hsa:83552;MFRP,MCOP5,NNO2,RD6;membrane frizzled-related protein
hsa:64102;TNMD,BRICD4,CHM1L,TEM;tenomodulin
hsa:149095;DCST1;DC-STAMP domain containing 1
hsa:10771;ZMYND11,BRAM1,BS69;zinc finger, MYND-type containing 11
hsa:7094;TLN1,ILWEQ,TLN;talin 1
hsa:7225;TRPC6,FSGS2,TRP6;transient receptor potential cation channel, subfamily C, member 6
hsa:1463;NCAN,CSPG3;neurocan
hsa:60312;AFAP1,AFAP,AFAP-110,AFAP110;actin filament associated protein 1
hsa:78997;GDAP1L1,dJ881L22.1,dJ995J12.1.1;ganglioside induced differentiation associated protein 1-like 1
hsa:55679;LIMS2,PINCH-2,PINCH2;LIM and senescent cell antigen-like domains 2
hsa:729330;OC90,PLA2L;otoconin 90
hsa:55016;MARCH1,MARCH-I,RNF171;membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase
hsa:92979;MARCH9,MARCH-IX,RNF179;membrane-associated ring finger (C3HC4) 9
hsa:112479;ERI2,EXOD1;ERI1 exoribonuclease family member 2 (EC:3.1.-.-)
hsa:2257;FGF12,FGF12B,FHF1;fibroblast growth factor 12
hsa:391104;VHLL,VHLP,VLP;von Hippel-Lindau tumor suppressor-like
hsa:10086;HHLA1,PLA2L;HERV-H LTR-associating 1
hsa:163702;IFNLR1,CRF2/12,IFNLR,IL-28R1,IL28RA,LICR2;interferon, lambda receptor 1
hsa:2005;ELK4,SAP1;ELK4, ETS-domain protein (SRF accessory protein 1)
hsa:10342;TFG,HMSNP,SPG57,TF6,TRKT3;TRK-fused gene
hsa:147694;ZNF548;zinc finger protein 548
hsa:8447;DOC2B,DOC2BL;double C2-like domains, beta
hsa:84173;ELMOD3,LST3,RBED1,RBM29;ELMO/CED-12 domain containing 3
hsa:89941;RHOT2,ARHT2,C16orf39,MIRO-2,MIRO2,RASL;ras homolog family member T2 (EC:3.6.5.-)
hsa:7639;ZNF85,HPF4,HTF1;zinc finger protein 85
hsa:5317;PKP1,B6P;plakophilin 1 (ectodermal dysplasia/skin fragility syndrome)
hsa:65980;BRD9,LAVS3040,PRO9856;bromodomain containing 9
hsa:388512;CLEC17A;C-type lectin domain family 17, member A
hsa:8325;FZD8,FZ-8,hFZ8;frizzled family receptor 8
hsa:9727;RAB11FIP3,CART1,Rab11-FIP3;RAB11 family interacting protein 3 (class II) (EC:2.7.4.6)
hsa:8936;WASF1,SCAR1,WAVE,WAVE1;WAS protein family, member 1
hsa:1594;CYP27B1,CP2B,CYP1,CYP1alpha,CYP27B,P450c1,PDDR,VDD1,VDDR,VDDRI,VDR;cytochrome P450, family 27, subfamily B, polypeptide 1 (EC:1.14.13.13)
hsa:6189;RPS3A,FTE1,MFTL,S3A;ribosomal protein S3A
hsa:124401;ANKS3;ankyrin repeat and sterile alpha motif domain containing 3
hsa:148254;ZNF555;zinc finger protein 555
hsa:57101;ANO2,C12orf3,TMEM16B;anoctamin 2
hsa:80128;TRIM46,GENEY,TRIFIC;tripartite motif containing 46
hsa:9084;VCY,BPY1,VCY1,VCY1A;variable charge, Y-linked
hsa:57091;CASS4,C20orf32,CAS4,HEFL,HEPL;Cas scaffolding protein family member 4
hsa:5693;PSMB5,LMPX,MB1,X;proteasome (prosome, macropain) subunit, beta type, 5 (EC:3.4.25.1)
hsa:84146;ZNF644,BM-005,MYP21,NatF,ZEP-2;zinc finger protein 644
hsa:5861;RAB1A,RAB1,YPT1;RAB1A, member RAS oncogene family
hsa:115749;C12orf56;chromosome 12 open reading frame 56
hsa:55818;KDM3A,JHDM2A,JHMD2A,JMJD1,JMJD1A,TSGA;lysine (K)-specific demethylase 3A
hsa:64852;TUT1,PAPD2,RBM21,STARPAP,TUTase;terminal uridylyl transferase 1, U6 snRNA-specific (EC:2.7.7.19 2.7.7.52)
hsa:55713;ZNF334;zinc finger protein 334
hsa:378884;NHLRC1,EPM2A,EPM2B,MALIN,bA204B7.2;NHL repeat containing 1
hsa:344561;GPR148,BTR,PGR6;G protein-coupled receptor 148
hsa:84532;ACSS1,ACAS2L,ACECS1,AceCS2L;acyl-CoA synthetase short-chain family member 1 (EC:6.2.1.1)
hsa:728912;NBPF24;neuroblastoma breakpoint family, member 24
hsa:407977;TNFSF12-TNFSF13,TWE-PRIL;TNFSF12-TNFSF13 readthrough
hsa:7746;ZSCAN9,PRD51,ZNF193;zinc finger and SCAN domain containing 9
hsa:10948;STARD3,CAB1,MLN64,es64;StAR-related lipid transfer (START) domain containing 3
hsa:84321;THOC3,TEX1;THO complex 3
hsa:81631;MAP1LC3B,ATG8F,LC3B,MAP1A/1BLC3,MAP1LC3B-a;microtubule-associated protein 1 light chain 3 beta
hsa:55613;MTMR8;myotubularin related protein 8 (EC:3.1.3.-)
hsa:23163;GGA3;golgi-associated, gamma adaptin ear containing, ARF binding protein 3
hsa:11143;KAT7,HBO1,HBOA,MYST2,ZC2HC7;K(lysine) acetyltransferase 7 (EC:2.3.1.48)
hsa:10127;ZNF263,FPM315,ZKSCAN12,ZSCAN44;zinc finger protein 263
hsa:342931;RFPL4A,RFPL4,RNF210;ret finger protein-like 4A
hsa:6906;SERPINA7,TBG;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7
hsa:387521;TMEM189,KUA;transmembrane protein 189
hsa:27031;NPHP3,MKS7,NPH3,RHPD;nephronophthisis 3 (adolescent)
hsa:56413;LTB4R2,BLT2,BLTR2,JULF2,KPG_004,LTB4-R_2,LTB4-R2,NOP9;leukotriene B4 receptor 2
hsa:4331;MNAT1,CAP35,MAT1,RNF66,TFB3;menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis)
hsa:22827;PUF60,FIR,RoBPI,SIAHBP1;poly-U binding splicing factor 60KDa
hsa:57862;ZNF410,APA-1,APA1;zinc finger protein 410
hsa:55652;SLC48A1,HRG-1,HRG1,hHRG-1;solute carrier family 48 (heme transporter), member 1
hsa:9678;PHF14;PHD finger protein 14
hsa:55502;HES6,HES-6,bHLHb41,bHLHc23;hairy and enhancer of split 6 (Drosophila)
hsa:286;ANK1,ANK,SPH1,SPH2;ankyrin 1, erythrocytic
hsa:79657;RPAP3;RNA polymerase II associated protein 3
hsa:155061;ZNF746,PARIS;zinc finger protein 746
hsa:118611;C10orf90,FATS,bA422P15.2;chromosome 10 open reading frame 90
hsa:23332;CLASP1,MAST1;cytoplasmic linker associated protein 1
hsa:100462977;MTRNR2L1,HN1;MT-RNR2-like 1
hsa:5145;PDE6A,CGPR-A,PDEA,RP43;phosphodiesterase 6A, cGMP-specific, rod, alpha (EC:3.1.4.35)
hsa:80150;ASRGL1,ALP,ALP1,CRASH;asparaginase like 1 (EC:3.5.1.1 3.4.19.5)
hsa:3872;KRT17,K17,PC,PC2,PCHC1;keratin 17
hsa:79035;NABP2,OBFC2B,SOSS-B1,SSB1,hSSB1;nucleic acid binding protein 2
hsa:53343;NUDT9,NUDT10;nudix (nucleoside diphosphate linked moiety X)-type motif 9 (EC:3.6.1.13)
hsa:100128927;ZBTB42,ZNF925;zinc finger and BTB domain containing 42
hsa:51008;ASCC1,ASC1p50,p50;activating signal cointegrator 1 complex subunit 1
hsa:1815;DRD4,D4DR;dopamine receptor D4
hsa:55796;MBNL3,CHCR,MBLX,MBLX39,MBXL;muscleblind-like splicing regulator 3
hsa:29964;PRICKLE4,C6orf49,OBTP,OEBT,TOMM6;prickle homolog 4 (Drosophila)
hsa:113189;CHST14,ATCS,D4ST1,HNK1ST;carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14 (EC:2.8.2.35)
hsa:1002;CDH4,CAD4,RCAD;cadherin 4, type 1, R-cadherin (retinal)
hsa:4004;LMO1,RBTN1,RHOM1,TTG1;LIM domain only 1 (rhombotin 1)
hsa:8531;YBX3,CSDA,CSDA1,DBPA,ZONAB;Y box binding protein 3
hsa:8879;SGPL1,S1PL,SPL;sphingosine-1-phosphate lyase 1 (EC:4.1.2.27)
hsa:51072;MEMO1,C2orf4,MEMO,NS5ATP7;mediator of cell motility 1;K06990
hsa:132158;GLYCTK,HBEBP2,HBEBP4,HBeAgBP4A;glycerate kinase (EC:2.7.1.31)
hsa:441521;CT45A5,CT45.5,CT455;cancer/testis antigen family 45, member A5
hsa:100132406;NBPF10,AB6,AG1,NBPF9;neuroblastoma breakpoint family, member 10
hsa:94234;FOXQ1,HFH1;forkhead box Q1
hsa:389421;LIN28B,CSDD2;lin-28 homolog B (C. elegans)
hsa:4939;OAS2;2'-5'-oligoadenylate synthetase 2, 69/71kDa (EC:2.7.7.-)
hsa:25976;TIPARP,ARTD14,PARP7,pART14;TCDD-inducible poly(ADP-ribose) polymerase (EC:2.4.2.30)
hsa:84217;ZMYND12;zinc finger, MYND-type containing 12
hsa:646486;FABP12;fatty acid binding protein 12
hsa:91975;ZNF300;zinc finger protein 300
hsa:55778;ZNF839,C14orf131;zinc finger protein 839
hsa:100289635;ZNF605;zinc finger protein 605
hsa:51773;RSF1,HBXAP,RSF-1,XAP8,p325;remodeling and spacing factor 1
hsa:51058;ZNF691,Zfp691;zinc finger protein 691
hsa:23220;DTX4,RNF155;deltex homolog 4 (Drosophila)
hsa:2615;LRRC32,D11S833E,GARP;leucine rich repeat containing 32
hsa:9738;CCP110,CP110,Cep110;centriolar coiled coil protein 110kDa
hsa:10869;USP19,ZMYND9;ubiquitin specific peptidase 19 (EC:3.4.19.12)
hsa:389761;SPATA31D4,FAM75D4;SPATA31 subfamily D, member 4
hsa:643161;FAM25A,FAM25B,FAM25C,FAM25G,bA96C23.5;family with sequence similarity 25, member A
hsa:585;BBS4;Bardet-Biedl syndrome 4
hsa:5146;PDE6C,ACHM5,COD4,PDEA2;phosphodiesterase 6C, cGMP-specific, cone, alpha prime (EC:3.1.4.35)
hsa:3720;JARID2,JMJ;jumonji, AT rich interactive domain 2
hsa:386746;MRGPRG,GPR169,MRGG;MAS-related GPR, member G
hsa:374655;ZNF710;zinc finger protein 710
hsa:11285;B4GALT7,XGALT1,XGPT1;xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (EC:2.4.1.133)
hsa:57143;ADCK1;aarF domain containing kinase 1
hsa:90637;ZFAND2A,AIRAP;zinc finger, AN1-type domain 2A
hsa:23200;ATP11B,ATPIF,ATPIR;ATPase, class VI, type 11B (EC:3.6.3.1)
hsa:3679;ITGA7;integrin, alpha 7
hsa:3416;IDE,INSULYSIN;insulin-degrading enzyme (EC:3.4.24.56)
hsa:55775;TDP1;tyrosyl-DNA phosphodiesterase 1 (EC:3.1.4.-)
hsa:439;ASNA1,ARSA-I,ARSA1,ASNA-I,GET3,TRC40,hASNA-I;arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) (EC:3.6.3.16)
hsa:51710;ZNF44,GIOT-2,KOX7,ZNF,ZNF504,ZNF55,ZNF58;zinc finger protein 44
hsa:5187;PER1,PER,RIGUI,hPER;period circadian clock 1
hsa:162655;ZNF519,HsT2362;zinc finger protein 519
hsa:23312;DMXL2,RC3;Dmx-like 2
hsa:125919;ZNF543;zinc finger protein 543
hsa:284546;C1orf185;chromosome 1 open reading frame 185
hsa:203430;ZCCHC5,Mar3,Mart3,ZHC5;zinc finger, CCHC domain containing 5
hsa:80097;MZT2B,FAM128B,MOZART2B;mitotic spindle organizing protein 2B
hsa:23426;GRIP1,GRIP;glutamate receptor interacting protein 1
hsa:57805;DBC-1,DBC1,NET35,p30_DBC,p30DBC;KIAA1967
hsa:5705;PSMC5,S8,SUG-1,SUG1,TBP10,TRIP1,p45,p45/SUG;proteasome (prosome, macropain) 26S subunit, ATPase, 5
hsa:6496;SIX3,HPE2;SIX homeobox 3
hsa:85363;TRIM5,RNF88,TRIM5alpha;tripartite motif containing 5
hsa:6541;SLC7A1,ATRC1,CAT-1,ERR,HCAT1,REC1L;solute carrier family 7 (cationic amino acid transporter, y+ system), member 1
hsa:115106;HAUS1,CCDC5,HEI-C,HEIC,HsT1461;HAUS augmin-like complex, subunit 1
hsa:100507290;ZNF865;zinc finger protein 865
hsa:79908;BTNL8;butyrophilin-like 8
hsa:912;CD1D,CD1A,R3;CD1d molecule
hsa:7760;ZNF213,CR53,ZKSCAN21,ZSCAN53;zinc finger protein 213
hsa:57631;LRCH2,dA204F4.4;leucine-rich repeats and calponin homology (CH) domain containing 2
hsa:5191;PEX7,PBD9B,PTS2R,RCDP1,RD;peroxisomal biogenesis factor 7
hsa:23363;OBSL1;obscurin-like 1 (EC:2.7.11.18)
hsa:5127;CDK16,PCTAIRE,PCTAIRE1,PCTGAIRE,PCTK1;cyclin-dependent kinase 16 (EC:2.7.11.22)
hsa:57088;PLSCR4,TRA1;phospholipid scramblase 4
hsa:84914;ZNF587,ZF6;zinc finger protein 587
hsa:84858;ZNF503,NOLZ-1,NOLZ1;zinc finger protein 503
hsa:7625;ZNF74,COS52,ZFP520,ZNF520,hZNF7;zinc finger protein 74
hsa:9404;LPXN,LDPL;leupaxin
hsa:4189;DNAJB9,ERdj4,MDG-1,MDG1,MST049,MSTP049;DnaJ (Hsp40) homolog, subfamily B, member 9
hsa:645811;CCDC154,C16orf29;coiled-coil domain containing 154
hsa:11131;CAPN11,calpain11;calpain 11
hsa:440;ASNS,TS11;asparagine synthetase (glutamine-hydrolyzing) (EC:6.3.5.4)
hsa:10241;CALCOCO2,NDP52;calcium binding and coiled-coil domain 2
hsa:1362;CPD,GP180;carboxypeptidase D (EC:3.4.17.22)
hsa:100293516;ZNF587B;zinc finger protein 587B
hsa:399664;MEX3D,MEX-3D,MEX3,OK/SW-cl.4,RKHD1,RNF193,TINO;mex-3 homolog D (C. elegans)
hsa:84987;COX14,C12orf62;cytochrome c oxidase assembly homolog 14 (S. cerevisiae)
hsa:136;ADORA2B,ADORA2;adenosine A2b receptor
hsa:2178;FANCE,FACE,FAE;Fanconi anemia, complementation group E
hsa:258;AMBN;ameloblastin (enamel matrix protein)
hsa:23516;SLC39A14,LZT-Hs4,NET34,ZIP14,cig19;solute carrier family 39 (zinc transporter), member 14
hsa:285367;RPUSD3;RNA pseudouridylate synthase domain containing 3
hsa:10533;ATG7,APG7-LIKE,APG7L,GSA7;autophagy related 7
hsa:51763;INPP5K,PPS,SKIP;inositol polyphosphate-5-phosphatase K (EC:3.1.3.56)
hsa:9925;ZBTB5;zinc finger and BTB domain containing 5
hsa:9648;GCC2,GCC185,RANBP2L4,REN53;GRIP and coiled-coil domain containing 2
hsa:47;ACLY,ACL,ATPCL,CLATP;ATP citrate lyase (EC:2.3.3.8)
hsa:55596;ZCCHC8;zinc finger, CCHC domain containing 8
hsa:342933;ZSCAN5B,ZNF371,ZNF495B;zinc finger and SCAN domain containing 5B
hsa:6560;SLC12A4,KCC1;solute carrier family 12 (potassium/chloride transporters), member 4
hsa:23081;KDM4C,GASC1,JHDM3C,JMJD2C,TDRD14C,bA146B14.1;lysine (K)-specific demethylase 4C (EC:1.14.11.-)
hsa:9325;TRIP4,ASC-1,ASC1,HsT17391;thyroid hormone receptor interactor 4
hsa:79954;NOL10,PQBP5;nucleolar protein 10
hsa:548593;SLX1A,GIYD1;SLX1 structure-specific endonuclease subunit homolog A (S. cerevisiae)
hsa:132660;LIN54,CXCDC1,JC8.6,MIP120;lin-54 homolog (C. elegans)
hsa:1380;CR2,C3DR,CD21,CR,CVID7,SLEB9;complement component (3d/Epstein Barr virus) receptor 2
hsa:4781;NFIB,CTF,HMGIC/NFIB,NF-I/B,NF1-B,NFI-B,NFI-RED,NFIB2,NFIB3;nuclear factor I/B
hsa:8193;DPF1,BAF45b,NEUD4,neuro-d4;D4, zinc and double PHD fingers family 1
hsa:9506;PAGE4,CT16.7,GAGE-9,GAGEC1,JM-27,PAGE-1,PAGE-4;P antigen family, member 4 (prostate associated)
hsa:29953;TRHDE,PAP-II,PGPEP2,TRH-DE;thyrotropin-releasing hormone degrading enzyme (EC:3.4.19.6)
hsa:5128;CDK17,PCTAIRE2,PCTK2;cyclin-dependent kinase 17 (EC:2.7.11.22)
hsa:5696;PSMB8,ALDD,D6S216,D6S216E,JMP,LMP7,NKJO,PSMB5i,RING10;proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) (EC:3.4.25.1)
hsa:7675;ZNF121,D19S204,ZHC32,ZNF20;zinc finger protein 121
hsa:4152;MBD1,CXXC3,PCM1,RFT;methyl-CpG binding domain protein 1
hsa:171017;ZNF384,CAGH1,CAGH1A,CIZ,ERDA2,NMP4,NP,TNRC1;zinc finger protein 384
hsa:63891;RNF123,KPC1;ring finger protein 123
hsa:6975;TECTB;tectorin beta
hsa:115426;UHRF2,NIRF,RNF107,URF2;ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase
hsa:284040;CDRT4;CMT1A duplicated region transcript 4
hsa:5602;MAPK10,JNK3,JNK3A,PRKM10,SAPK1b,p493F12,p54bSAPK;mitogen-activated protein kinase 10 (EC:2.7.11.24)
hsa:15;AANAT,DSPS,SNAT;aralkylamine N-acetyltransferase (EC:2.3.1.87)
hsa:55379;LRRC59,p34;leucine rich repeat containing 59
hsa:51547;SIRT7,SIR2L7;sirtuin 7
hsa:1345;COX6C;cytochrome c oxidase subunit VIc (EC:1.9.3.1)
hsa:653149;NBPF6;neuroblastoma breakpoint family, member 6
hsa:8693;GALNT4,GALNAC-T4,GALNACT4;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4) (EC:2.4.1.41)
hsa:442194;OR10C1,OR10C1P,OR10C2,OR6-31,hs6M1-17;olfactory receptor, family 10, subfamily C, member 1
hsa:7732;RNF112,BFP,ZNF179;ring finger protein 112
hsa:10142;AKAP9,AKAP-9,AKAP350,AKAP450,CG-NAP,HYPERION,LQT11,MU-RMS-40.16A,PPP1R45,PRKA9,YOTIAO;A kinase (PRKA) anchor protein (yotiao) 9
hsa:1823;DSC1,CDHF1,DG2/DG3;desmocollin 1
hsa:10912;GADD45G,CR6,DDIT2,GADD45gamma,GRP17;growth arrest and DNA-damage-inducible, gamma
hsa:8975;USP13,ISOT3,IsoT-3;ubiquitin specific peptidase 13 (isopeptidase T-3) (EC:3.4.19.12)
hsa:25875;LETMD1,1110019O13Rik,HCCR-1,HCCR-2,HCCR1,HCRR-2;LETM1 domain containing 1
hsa:59350;RXFP1,LGR7,RXFPR1;relaxin/insulin-like family peptide receptor 1
hsa:200030;NBPF11;neuroblastoma breakpoint family, member 11
hsa:6017;RLBP1,CRALBP;retinaldehyde binding protein 1
hsa:79650;USB1,C16orf57,HVSL1,Mpn1,PN,hUsb1;U6 snRNA biogenesis 1
hsa:441061;MARCH11,MARCH-XI;membrane-associated ring finger (C3HC4) 11 (EC:6.3.2.-)
hsa:55593;OTUD5,DUBA;OTU domain containing 5 (EC:3.4.19.12)
hsa:64326;RFWD2,COP1,RNF200;ring finger and WD repeat domain 2, E3 ubiquitin protein ligase
hsa:91869;RFT1,CDG1N;RFT1 homolog (S. cerevisiae)
hsa:823;CAPN1,CANP,CANP1,CANPL1,muCANP,muCL;calpain 1, (mu/I) large subunit (EC:3.4.22.52)
hsa:84307;ZNF397,ZNF47,ZSCAN15;zinc finger protein 397
hsa:2275;FHL3,SLIM2;four and a half LIM domains 3
hsa:84524;ZC3H8,Fliz1,ZC3HDC8;zinc finger CCCH-type containing 8
hsa:1185;CLCN6,CLC-6;chloride channel, voltage-sensitive 6
hsa:654502;IQCJ;IQ motif containing J
hsa:7634;ZNF80,pT17;zinc finger protein 80
hsa:3316;HSPB2,HSP27,Hs.78846,LOH11CR1K,MKBP;heat shock 27kDa protein 2
hsa:3313;HSPA9,CSA,GRP-75,GRP75,HSPA9B,MOT,MOT2,MTHSP75,PBP74;heat shock 70kDa protein 9 (mortalin)
hsa:6509;SLC1A4,ASCT1,SATT;solute carrier family 1 (glutamate/neutral amino acid transporter), member 4
hsa:146183;OTOA,CT108,DFNB22;otoancorin
hsa:22823;MTF2,M96,PCL2,RP5-976O13.1,TDRD19A,dJ976O13.2;metal response element binding transcription factor 2
hsa:633;BGN,DSPG1,PG-S1,PGI,SLRR1A;biglycan
hsa:117608;ZNF354B,KID2;zinc finger protein 354B
hsa:59269;HIVEP3,KBP-1,KBP1,KRC,SHN3,Schnurri-3,ZAS3,ZNF40C;human immunodeficiency virus type I enhancer binding protein 3
hsa:56605;ERO1LB;ERO1-like beta (S. cerevisiae)
hsa:25874;MPC2,BRP44;mitochondrial pyruvate carrier 2
hsa:9798;IST1,OLC1,KIAA0174;increased sodium tolerance 1 homolog (yeast)
hsa:7789;ZXDA,ZNF896;zinc finger, X-linked, duplicated A
hsa:10120;ACTR1B,ARP1B,CTRN2,PC3;ARP1 actin-related protein 1 homolog B, centractin beta (yeast)
hsa:623;BDKRB1,B1BKR,B1R,BKB1R,BKR1,BRADYB1;bradykinin receptor B1
hsa:6778;STAT6,D12S1644,IL-4-STAT,STAT6B,STAT6C;signal transducer and activator of transcription 6, interleukin-4 induced
hsa:494470;RNF165,ARKL2;ring finger protein 165
hsa:162963;ZNF610;zinc finger protein 610
hsa:128674;PROKR2,GPR73L1,GPR73b,GPRg2,HH3,KAL3,PKR2,dJ680N4.3;prokineticin receptor 2
hsa:54476;RNF216,TRIAD3,U7I1,UBCE7IP1,ZIN;ring finger protein 216;K11976 TRIAD3;E3 ubiquitin-protein ligase RNF216 [EC:6.3.2.19]
hsa:7170;TPM3,CFTD,NEM1,OK/SW-cl.5,TM-5,TM3,TM30,TM30nm,TM5,TPMsk3,TRK,hTM5,hscp30;tropomyosin 3
hsa:158866;ZDHHC15,MRX91;zinc finger, DHHC-type containing 15
hsa:5676;PSG7,PSBG-7,PSG1,PSGGA;pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene)
hsa:51320;MEX3C,MEX-3C,RKHD2,RNF194;mex-3 homolog C (C. elegans)
hsa:7702;ZNF143,SBF,STAF,pHZ-1;zinc finger protein 143
hsa:80320;SP6,EPFN,EPIPROFIN,KLF14;Sp6 transcription factor
hsa:9045;RPL14,CAG-ISL-7,CTG-B33,L14,RL14,hRL14;ribosomal protein L14
hsa:50508;NOX3,GP91-3,MOX-2;NADPH oxidase 3
hsa:64975;MRPL41,BMRP,MRP-L27,MRPL27,RPML27;mitochondrial ribosomal protein L41
hsa:5626;PROP1,CPHD2,PROP-1;PROP paired-like homeobox 1
hsa:389151;PRR23B;proline rich 23B
hsa:1646;AKR1C2,AKR1C-pseudo,BABP,DD,DD2,DDH2,HAKRD,HBAB,MCDR2,SRXY8;aldo-keto reductase family 1, member C2 (EC:1.1.1.213 1.3.1.20)
hsa:79882;ZC3H14,MSUT-2,NY-REN-37,SUT2,UKp68;zinc finger CCCH-type containing 14
hsa:60436;TGIF2;TGFB-induced factor homeobox 2
hsa:83549;UCK1,URK1;uridine-cytidine kinase 1 (EC:2.7.1.48)
hsa:11097;NUPL2,CG1,NLP-1,NLP_1,hCG1;nucleoporin like 2
hsa:6101;RP1,DCDC4A,ORP1;retinitis pigmentosa 1 (autosomal dominant)
hsa:27130;INVS,INV,NPH2,NPHP2;inversin
hsa:83464;APH1B,APH-1B,PRO1328,PSFL,TAAV688;anterior pharynx defective 1 homolog B (C. elegans)
hsa:128876;FAM83C,C20orf128,dJ614O4.7;family with sequence similarity 83, member C
hsa:84066;TEX35,C1orf49,TSC24;testis expressed 35
hsa:2045;EPHA7,EHK3,HEK11;EPH receptor A7 (EC:2.7.10.1)
hsa:139735;ZFP92,ZNF897;ZFP92 zinc finger protein
hsa:55014;STX17;syntaxin 17
hsa:950;SCARB2,AMRF,CD36L2,EPM4,HLGP85,LGP85,LIMP-2,LIMPII,SR-BII;scavenger receptor class B, member 2
hsa:653509;SFTPA1,COLEC4,PSAP,PSP-A,PSPA,SFTP1,SFTPA1B,SP-A,SP-A1,SPA,SPA1;surfactant protein A1
hsa:10906;TRAFD1,FLN29;TRAF-type zinc finger domain containing 1
hsa:3732;CD82,4F9,C33,GR15,IA4,KAI1,R2,SAR2,ST6,TSPAN27;CD82 molecule
hsa:4897;NRCAM;neuronal cell adhesion molecule
hsa:83707;TRPT1;tRNA phosphotransferase 1 (EC:2.7.1.160)
hsa:51100;SH3GLB1,Bif-1,PPP1R70,dJ612B15.2;SH3-domain GRB2-like endophilin B1
hsa:1006;CDH8,Nbla04261;cadherin 8, type 2
hsa:4828;NMB;neuromedin B
hsa:115548;FCHO2;FCH domain only 2
hsa:55687;TRMU,MTO2,MTU1,TRMT,TRMT1,TRNT1;tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase (EC:2.1.1.61)
hsa:9604;RNF14,ARA54,HFB30,TRIAD2;ring finger protein 14
hsa:6633;SNRPD2,SMD2,SNRPD1,Sm-D2;small nuclear ribonucleoprotein D2 polypeptide 16.5kDa
hsa:90204;ZSWIM1,C20orf162;zinc finger, SWIM-type containing 1
hsa:322;APBB1,FE65,MGC:9072,RIR;amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
hsa:10313;RTN3,ASYIP,HAP,NSPL2,NSPLII,RTN3-A1;reticulon 3
hsa:79899;PRR5L,PROTOR2;proline rich 5 like
hsa:6507;SLC1A3,EA6,EAAT1,GLAST,GLAST1;solute carrier family 1 (glial high affinity glutamate transporter), member 3
hsa:8740;TNFSF14,CD258,HVEML,LIGHT,LTg,TR2;tumor necrosis factor (ligand) superfamily, member 14
hsa:7543;ZFX,ZNF926;zinc finger protein, X-linked
hsa:55011;PIH1D1,NOP17;PIH1 domain containing 1
hsa:9376;SLC22A8,OAT3;solute carrier family 22 (organic anion transporter), member 8
hsa:8570;KHSRP,FBP2,FUBP2,KSRP;KH-type splicing regulatory protein
hsa:113201;CASC4,H63;cancer susceptibility candidate 4
hsa:128229;TSACC,C1orf182,RP11-443G18.5,SIP,SSTK-IP;TSSK6 activating co-chaperone
hsa:7328;UBE2H,E2-20K,GID3,UBC8,UBCH,UBCH2;ubiquitin-conjugating enzyme E2H (EC:6.3.2.19)
hsa:57057;TBX20,ASD4;T-box 20
hsa:5073;PARN,DAN;poly(A)-specific ribonuclease (EC:3.1.13.4)
hsa:3785;KCNQ2,BFNC,BFNS1,EBN,EBN1,EIEE7,ENB1,HNSPC,KCNA11,KV7.2,KVEBN1;potassium voltage-gated channel, KQT-like subfamily, member 2
hsa:654254;ZNF732;zinc finger protein 732
hsa:10367;MICU1,CALC,CBARA1,EFHA3;mitochondrial calcium uptake 1
hsa:147657;ZNF480;zinc finger protein 480
hsa:23053;ZSWIM8,KIAA0913;zinc finger, SWIM-type containing 8
hsa:2039;EPB49,DMT;erythrocyte membrane protein band 4.9 (dematin)
hsa:136259;KLF14,BTEB5;Kruppel-like factor 14
hsa:1378;CR1,C3BR,C4BR,CD35,KN;complement component (3b/4b) receptor 1 (Knops blood group)
hsa:4485;MST1,D3F15S2,DNF15S2,HGFL,MSP,NF15S2;macrophage stimulating 1 (hepatocyte growth factor-like)
hsa:55930;MYO5C;myosin VC
hsa:55129;ANO10,SCAR10,TMEM16K;anoctamin 10
hsa:79663;HSPBAP1,PASS1;HSPB (heat shock 27kDa) associated protein 1
hsa:6760;SS18,SSXT,SYT;synovial sarcoma translocation, chromosome 18
hsa:3866;KRT15,CK15,K15,K1CO;keratin 15
hsa:23170;TTLL12,dJ526I14.2;tubulin tyrosine ligase-like family, member 12
hsa:64219;PJA1,PRAJA1,RNF70;praja ring finger 1, E3 ubiquitin protein ligase
hsa:933;CD22,SIGLEC-2,SIGLEC2;CD22 molecule
hsa:729747;ZNF878;zinc finger protein 878
hsa:440026;TMEM41B;transmembrane protein 41B
hsa:131870;NUDT16;nudix (nucleoside diphosphate linked moiety X)-type motif 16 (EC:3.6.1.62)
hsa:3490;IGFBP7,AGM,FSTL2,IBP-7,IGFBP-7,IGFBP-7v,IGFBPRP1,MAC25,PSF,RAMSVPS,TAF;insulin-like growth factor binding protein 7
hsa:57037;ANKMY2,ZMYND20;ankyrin repeat and MYND domain containing 2
hsa:729092;AGAP5,CTGLF2;ArfGAP with GTPase domain, ankyrin repeat and PH domain 5
hsa:8482;SEMA7A,CD108,CDw108,H-SEMA-K1,H-Sema-L,JMH,SEMAK1,SEMAL;semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group)
hsa:728492;SERF1B,FAM2B,H4F5C;small EDRK-rich factor 1B (centromeric)
hsa:388630;TRABD2B,TIKI2;TraB domain containing 2B
hsa:55831;EMC3,POB,TMEM111;ER membrane protein complex subunit 3
hsa:5784;PTPN14,PEZ,PTP36;protein tyrosine phosphatase, non-receptor type 14 (EC:3.1.3.48)
hsa:6338;SCNN1B,BESC1,ENaCb,ENaCbeta,SCNEB;sodium channel, non-voltage-gated 1, beta subunit
hsa:60490;PPCDC;phosphopantothenoylcysteine decarboxylase (EC:4.1.1.36)
hsa:116039;OSR2;odd-skipped related 2 (Drosophila)
hsa:9880;ZBTB39,ZNF922;zinc finger and BTB domain containing 39
hsa:3049;HBQ1;hemoglobin, theta 1
hsa:57579;FAM135A,KIAA1411;family with sequence similarity 135, member A
hsa:100132399;GAGE12D,GAGE-12B;G antigen 12D
hsa:3488;IGFBP5,IBP5;insulin-like growth factor binding protein 5
hsa:729665;CCDC175,C14orf38,c14_5395;coiled-coil domain containing 175
hsa:89887;ZNF628,ZEC,Zfp628;zinc finger protein 628
hsa:28511;NKIRAS2,KBRAS2,kappaB-Ras2;NFKB inhibitor interacting Ras-like 2
hsa:100129792;CCDC152,CH5400;coiled-coil domain containing 152
hsa:10196;PRMT3,HRMT1L3;protein arginine methyltransferase 3
hsa:10780;ZNF234,HZF4,ZNF269;zinc finger protein 234
hsa:139212;PIH1D3,CXorf41,NYSAR97;PIH1 domain containing 3
hsa:9535;GMFG,GMF-GAMMA;glia maturation factor, gamma
hsa:55154;MSTO1,MST;misato homolog 1 (Drosophila)
hsa:582;BBS1,BBS2L2;Bardet-Biedl syndrome 1
hsa:23409;SIRT4,SIR2L4;sirtuin 4
hsa:390980;ZNF805;zinc finger protein 805
hsa:7923;HSD17B8,D6S2245E,FABG,FABGL,H2-KE6,HKE6,KE6,RING2,SDR30C1,dJ1033B10.9;hydroxysteroid (17-beta) dehydrogenase 8 (EC:1.1.1.62 1.1.1.239)
hsa:728229;TMEM191B;transmembrane protein 191B
hsa:54997;TESC,CHP3,TSC;tescalcin
hsa:93587;TRMT10A,RG9MTD2,TRM10;tRNA methyltransferase 10 homolog A (S. cerevisiae)
hsa:349149;GJC3,CX29,CX30.2,CX31.3,GJE1;gap junction protein, gamma 3, 30.2kDa
hsa:10055;SAE1,AOS1,HSPC140,SUA1,UBLE1A;SUMO1 activating enzyme subunit 1
hsa:65055;REEP1,C2orf23,HMN5B,SPG31;receptor accessory protein 1
hsa:285676;ZNF454;zinc finger protein 454
hsa:26086;GPSM1,AGS3;G-protein signaling modulator 1
hsa:347688;TUBB8,bA631M21.2;tubulin, beta 8 class VIII
hsa:116254;GINM1,C6orf72,dJ12G14.2;glycoprotein integral membrane 1
hsa:11281;POU6F2,RPF-1,WT5,WTSL;POU class 6 homeobox 2
hsa:57447;NDRG2,SYLD;NDRG family member 2
hsa:4085;MAD2L1,HSMAD2,MAD2;MAD2 mitotic arrest deficient-like 1 (yeast)
hsa:255967;PAN3;PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) (EC:3.1.13.4)
hsa:5192;PEX10,NALD,PBD6A,PBD6B,RNF69;peroxisomal biogenesis factor 10
hsa:5003;SLC22A18AS,BWR1B,BWSCR1B,ORCTL2S,SLC22A1LS,p27-BWR1B;solute carrier family 22 (organic cation transporter), member 18 antisense
hsa:27247;NFU1,HIRIP,HIRIP5,MMDS1,NIFUC,Nfu,NifU;NFU1 iron-sulfur cluster scaffold homolog (S. cerevisiae)
hsa:953;ENTPD1,ATPDase,CD39,NTPDase-1;ectonucleoside triphosphate diphosphohydrolase 1 (EC:3.6.1.5)
hsa:100287144;USP17L10;ubiquitin specific peptidase 17-like family member 10
hsa:64118;DUS1L,DUS1,PP3111;dihydrouridine synthase 1-like (S. cerevisiae)
hsa:201501;ZBTB7C,APM-1,APM1,ZBTB36,ZNF857C;zinc finger and BTB domain containing 7C
hsa:56155;TEX14,CT113;testis expressed 14
hsa:10328;EMC8,C16orf2,C16orf4,COX4NB,FAM158B,NOC4;ER membrane protein complex subunit 8
hsa:4904;YBX1,BP-8,CSDA2,CSDB,DBPB,MDR-NF1,NSEP-1,NSEP1,YB-1,YB1;Y box binding protein 1
hsa:27136;MORC1,CT33,MORC,ZCW6;MORC family CW-type zinc finger 1
hsa:162;AP1B1,ADTB1,AP105A,BAM22,CLAPB2;adaptor-related protein complex 1, beta 1 subunit
hsa:5336;PLCG2,APLAID,FCAS3;phospholipase C, gamma 2 (phosphatidylinositol-specific) (EC:3.1.4.11)
hsa:91966;CXorf40A,CXorf40,EOLA1;chromosome X open reading frame 40A
hsa:55696;RBM22,Cwc2,ZC3H16,fSAP47;RNA binding motif protein 22
hsa:37;ACADVL,ACAD6,LCACD,VLCAD;acyl-CoA dehydrogenase, very long chain (EC:1.3.8.9)
hsa:144717;FAM109A,IPIP27A,SES1;family with sequence similarity 109, member A
hsa:10212;DDX39A,BAT1,BAT1L,DDX39,DDXL,URH49;DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A (EC:3.6.4.13)
hsa:9616;RNF7,CKBBP1,ROC2,SAG;ring finger protein 7
hsa:130557;ZNF513,HMFT0656,RP58;zinc finger protein 513
hsa:100303755;PET117;PET117 homolog (S. cerevisiae)
hsa:4439;MSH5,G7,MUTSH5,NG23;mutS homolog 5 (E. coli)
hsa:64283;ARHGEF28,RGNEF,RIP2,p190RHOGEF;Rho guanine nucleotide exchange factor (GEF) 28
hsa:11217;AKAP2,AKAP-2,AKAPKL,PRKA2;A kinase (PRKA) anchor protein 2
hsa:643382;TMEM253,C14orf176,C14orf95,NCRNA00220;transmembrane protein 253
hsa:140710;SOGA1,C20orf117,KIAA0889,SOGA;suppressor of glucose, autophagy associated 1
hsa:57509;MTUS1,ATBP,ATIP,ICIS,MP44,MTSG1;microtubule associated tumor suppressor 1
hsa:27246;RNF115,BCA2,ZNF364;ring finger protein 115
hsa:7071;KLF10,EGRA,TIEG,TIEG1;Kruppel-like factor 10
hsa:388561;ZNF761,ZNF468;zinc finger protein 761
hsa:80724;ACAD10;acyl-CoA dehydrogenase family, member 10
hsa:5441;POLR2L,RBP10,RPABC5,RPB10,RPB10beta,RPB7.6,hRPB7.6;polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa (EC:2.7.7.6)
hsa:26038;CHD5,CHD-5;chromodomain helicase DNA binding protein 5 (EC:3.6.4.12)
hsa:5997;RGS2,G0S8;regulator of G-protein signaling 2, 24kDa
hsa:401067;IQCF3;IQ motif containing F3
hsa:80742;PRR3,CAT56;proline rich 3
hsa:200728;TMEM17;transmembrane protein 17
hsa:55969;C20orf24,RIP5;chromosome 20 open reading frame 24
hsa:5351;PLOD1,EDS6,LH,LH1,LLH,PLOD;procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 (EC:1.14.11.4)
hsa:22985;ACIN1,ACINUS,ACN,fSAP152;apoptotic chromatin condensation inducer 1
hsa:7485;WRB,CHD5;tryptophan rich basic protein
hsa:200576;PIKFYVE,CFD,FAB1,PIP5K,PIP5K3,ZFYVE29;phosphoinositide kinase, FYVE finger containing (EC:2.7.1.150)
hsa:56163;RNF17,Mmip-2,SPATA23,TDRD4;ring finger protein 17
hsa:3241;HPCAL1,BDR1,HLP2,VILIP-3;hippocalcin-like 1
hsa:55282;LRRC36,RORBP70,XLHSRF2;leucine rich repeat containing 36
hsa:163131;ZNF780B,ZNF779;zinc finger protein 780B
hsa:149465;WDR65,VWS2;WD repeat domain 65
hsa:7265;TTC1,TPR1;tetratricopeptide repeat domain 1
hsa:5205;ATP8B1,ATPIC,BRIC,FIC1,ICP1,PFIC,PFIC1;ATPase, aminophospholipid transporter, class I, type 8B, member 1 (EC:3.6.3.1)
hsa:2947;GSTM3,GST5,GSTB,GSTM3-3,GTM3;glutathione S-transferase mu 3 (brain) (EC:2.5.1.18)
hsa:2017;CTTN,EMS1;cortactin
hsa:100463289;MTRNR2L5,HN5;MT-RNR2-like 5
hsa:58500;ZNF250,ZFP647,ZNF647;zinc finger protein 250
hsa:400830;DEFB132,DEFB32,UNQ827;defensin, beta 132
hsa:440073;IQSEC3;IQ motif and Sec7 domain 3
hsa:23052;ENDOD1;endonuclease domain containing 1
hsa:80196;RNF34,CARP-1,CARP1,RFI,RIF,RIFF,hRFI;ring finger protein 34, E3 ubiquitin protein ligase (EC:6.3.2.-)
hsa:26046;LTN1,C21orf10,C21orf98,RNF160,ZNF294;listerin E3 ubiquitin protein ligase 1
hsa:9555;H2AFY,H2A.y,H2A/y,H2AF12M,H2AFJ,MACROH2A1.1,mH2A1,macroH2A1.2;H2A histone family, member Y
hsa:23178;PASK,PASKIN,STK37;PAS domain containing serine/threonine kinase (EC:2.7.11.1)
hsa:647286;RD3L,TDRD9-AS1,TDRD9AS1;retinal degeneration 3-like
hsa:10210;TOPORS,LUN,P53BP3,RP31,TP53BPL;topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase
hsa:402569;KPNA7;karyopherin alpha 7 (importin alpha 8)
hsa:246777;SPESP1,ESP,SP-ESP;sperm equatorial segment protein 1
hsa:55256;ADI1,APL1,ARD,Fe-ARD,MTCBP1,Ni-ARD,SIPL;acireductone dioxygenase 1 (EC:1.13.11.54)
hsa:11237;RNF24,G1L;ring finger protein 24
hsa:121441;NEDD1,GCP-WD,TUBGCP7;neural precursor cell expressed, developmentally down-regulated 1
hsa:22835;ZFP30,ZNF745;ZFP30 zinc finger protein
hsa:91227;GGTLC2,GGTL4;gamma-glutamyltransferase light chain 2
hsa:284485;RIIAD1,C1orf230,NCRNA00166;regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1
hsa:431707;LHX8,LHX7;LIM homeobox 8
hsa:4927;NUP88;nucleoporin 88kDa
hsa:90736;FAM104B,CXorf44;family with sequence similarity 104, member B
hsa:54753;ZNF853;zinc finger protein 853
hsa:283807;FBXL22,Fbl22;F-box and leucine-rich repeat protein 22 (EC:3.4.19.12)
hsa:140545;RNF32,FKSG33,HSD15;ring finger protein 32
hsa:23619;ZIM2,ZNF656;zinc finger, imprinted 2
hsa:6342;SCP2,NLTP,NSL-TP,SCP-2,SCP-CHI,SCP-X,SCPX;sterol carrier protein 2 (EC:2.3.1.176)
hsa:6928;HNF1B,FJHN,HNF-1B,HNF1beta,HNF2,HPC11,LF-B3,LFB3,MODY5,TCF-2,TCF2,VHNF1;HNF1 homeobox B
hsa:728194;RSPH10B2;radial spoke head 10 homolog B2 (Chlamydomonas)
hsa:5603;MAPK13,MAPK_13,MAPK-13,PRKM13,SAPK4,p38delta;mitogen-activated protein kinase 13 (EC:2.7.11.24)
hsa:713;C1QB;complement component 1, q subcomponent, B chain
hsa:637;BID,FP497;BH3 interacting domain death agonist
hsa:257218;SHPRH,bA545I5.2;SNF2 histone linker PHD RING helicase, E3 ubiquitin protein ligase
hsa:5026;P2RX5,LRH-1,P2X5,P2X5R;purinergic receptor P2X, ligand-gated ion channel, 5
hsa:9508;ADAMTS3,ADAMTS-4;ADAM metallopeptidase with thrombospondin type 1 motif, 3 (EC:3.4.24.-)
hsa:144348;ZNF664,ZFOC1,ZNF176;zinc finger protein 664
hsa:645051;GAGE13,GAGE12A;G antigen 13
hsa:26286;ARFGAP3,ARFGAP1;ADP-ribosylation factor GTPase activating protein 3
hsa:81624;DIAPH3,AN,AUNA1,DIA2,DRF3,NSDAN,diap3,mDia2;diaphanous homolog 3 (Drosophila)
hsa:3718;JAK3,JAK-3,JAK3_HUMAN,JAKL,L-JAK,LJAK;Janus kinase 3 (EC:2.7.10.2)
hsa:8622;PDE8B,ADSD,PPNAD3;phosphodiesterase 8B (EC:3.1.4.17)
hsa:8028;MLLT10,AF10;myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila);translocated to, 10
hsa:57688;ZSWIM6;zinc finger, SWIM-type containing 6
hsa:347733;TUBB2B,PMGYSA,bA506K6.1;tubulin, beta 2B class IIb
hsa:1259;CNGA1,CNCG,CNCG1,CNG-1,CNG1,RCNC1,RCNCa,RCNCalpha,RP49;cyclic nucleotide gated channel alpha 1
hsa:5095;PCCA;propionyl CoA carboxylase, alpha polypeptide (EC:6.4.1.3)
hsa:115560;ZNF501,ZNF,ZNF52;zinc finger protein 501
hsa:4435;CITED1,MSG1;Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1
hsa:55848;PLGRKT,C9orf46,MDS030,PLG-RKT,Plg-R(KT);plasminogen receptor, C-terminal lysine transmembrane protein
hsa:5824;PEX19,D1S2223E,HK33,PBD12A,PMP1,PMPI,PXF,PXMP1;peroxisomal biogenesis factor 19
hsa:50484;RRM2B,MTDPS8A,MTDPS8B,P53R2;ribonucleotide reductase M2 B (TP53 inducible) (EC:1.17.4.1)
hsa:498;ATP5A1,ATP5A,ATP5AL2,ATPM,MOM2,OMR,ORM,hATP1;ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle
hsa:22847;ZNF507;zinc finger protein 507
hsa:29914;UBIAD1,RP4-796F18.1,SCCD,TERE1;UbiA prenyltransferase domain containing 1
hsa:8654;PDE5A,CGB-PDE,CN5A,PDE5;phosphodiesterase 5A, cGMP-specific (EC:3.1.4.35)
hsa:25841;ABTB2,BTBD22;ankyrin repeat and BTB (POZ) domain containing 2
hsa:2867;FFAR2,FFA2R,GPR43;free fatty acid receptor 2
hsa:27249;MMADHC,C2orf25,CL25022,cblD;methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria
hsa:5925;RB1,OSRC,RB,p105-Rb,pRb,pp110;retinoblastoma 1
hsa:392465;GLOD5;glyoxalase domain containing 5
hsa:647219;ASCL5,bHLHa47;achaete-scute complex homolog 5 (Drosophila)
hsa:317671;RFESD;Rieske (Fe-S) domain containing
hsa:10671;DCTN6,WS-3,WS3,p27;dynactin 6
hsa:8874;ARHGEF7,BETA-PIX,COOL-1,COOL1,Nbla10314,P50,P50BP,P85,P85COOL1,P85SPR,PAK3,PIXB;Rho guanine nucleotide exchange factor (GEF) 7
hsa:83460;EMC6,TMEM93;ER membrane protein complex subunit 6
hsa:5411;PNN,DRS,DRSP,SDK3,memA;pinin, desmosome associated protein
hsa:79364;ZXDC,ZXDL;ZXD family zinc finger C
hsa:23743;BHMT2;betaine--homocysteine S-methyltransferase 2 (EC:2.1.1.5)
hsa:58191;CXCL16,CXCLG16,SR-PSOX,SRPSOX;chemokine (C-X-C motif) ligand 16
hsa:27295;PDLIM3,ALP;PDZ and LIM domain 3
hsa:11146;GLMN,FAP,FAP48,FAP68,FKBPAP,GLML,GVM,VMGLOM;glomulin, FKBP associated protein
hsa:728957;ZNF705D,ZNF705C;zinc finger protein 705D
hsa:2253;FGF8,AIGF,FGF-8,HBGF-8,HH6,KAL6;fibroblast growth factor 8 (androgen-induced)
hsa:51127;TRIM17,RBCC,RNF16,terf;tripartite motif containing 17
hsa:55709;KBTBD4,BKLHD4,HSPC252;kelch repeat and BTB (POZ) domain containing 4
hsa:256051;ZNF549;zinc finger protein 549
hsa:63924;CIDEC,CIDE-3,CIDE3,FSP27;cell death-inducing DFFA-like effector c
hsa:84187;TMEM164,bB360B22.3;transmembrane protein 164
hsa:85451;UNK,ZC3H5,ZC3HDC5;unkempt homolog (Drosophila)
hsa:57118;CAMK1D,CKLiK,CaM-K1,CaMKID;calcium/calmodulin-dependent protein kinase ID (EC:2.7.11.17)
hsa:26147;PHF19,MTF2L1,PCL3,TDRD19B;PHD finger protein 19
hsa:7587;ZNF37A,KOX21,ZNF37;zinc finger protein 37A
hsa:54881;TEX10,Ipi1,bA208F1.2;testis expressed 10
hsa:387694;SH2D4B;SH2 domain containing 4B
hsa:840;CASP7,CASP-7,CMH-1,ICE-LAP3,LICE2,MCH3;caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60)
hsa:7916;PRRC2A,BAT2,D6S51,D6S51E,G2;proline-rich coiled-coil 2A
hsa:22853;LMTK2,AATYK2,BREK,KPI-2,KPI2,LMR2,cprk;lemur tyrosine kinase 2 (EC:2.7.11.1)
hsa:157777;MCMDC2,C8orf45;minichromosome maintenance domain containing 2
hsa:256987;SERINC5,C5orf12,TPO1;serine incorporator 5
hsa:220202;ATOH7,Math5,bHLHa13;atonal homolog 7 (Drosophila)
hsa:93986;FOXP2,CAGH44,SPCH1,TNRC10;forkhead box P2
hsa:284257;BOD1L2,BOD1P,FAM44C;biorientation of chromosomes in cell division 1-like 2
hsa:204;AK2,ADK2,AK_2;adenylate kinase 2 (EC:2.7.4.3)
hsa:65250;C5orf42,JBTS17;chromosome 5 open reading frame 42
hsa:392617;ELFN1,PPP1R28;extracellular leucine-rich repeat and fibronectin type III domain containing 1
hsa:79725;THAP9;THAP domain containing 9
hsa:3294;HSD17B2,EDH17B2,HSD17,SDR9C2;hydroxysteroid (17-beta) dehydrogenase 2 (EC:1.1.1.62 1.1.1.239)
hsa:400713;ZNF880;zinc finger protein 880
hsa:11083;DIDO1,BYE1,C20orf158,DATF-1,DATF1,DIDO2,DIDO3,DIO-1,DIO1,dJ885L7.8;death inducer-obliterator 1
hsa:9841;ZBTB24,BIF1,ICF2,PATZ2,ZNF450;zinc finger and BTB domain containing 24
hsa:145814;PGPEP1L;pyroglutamyl-peptidase I-like (EC:3.4.19.-)
hsa:5292;PIM1,PIM;pim-1 oncogene (EC:2.7.11.1)
hsa:1013;CDH15,CDH14,CDH3,CDHM,MCAD,MRD3;cadherin 15, type 1, M-cadherin (myotubule)
hsa:5553;PRG2,BMPG,MBP,MBP1;proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
hsa:79679;VTCN1,B7-H4,B7H4,B7S1,B7X,B7h.5,PRO1291,VCTN1;V-set domain containing T cell activation inhibitor 1
hsa:347344;ZNF81,HFZ20,MRX45,dJ54B20.6;zinc finger protein 81
hsa:84517;ACTRT3,ARP-T3,ARPM1;actin-related protein T3
hsa:392197;USP17L7;ubiquitin specific peptidase 17-like family member 7
hsa:91612;CHURC1,C14orf52,chch;churchill domain containing 1
hsa:7222;TRPC3,TRP3;transient receptor potential cation channel, subfamily C, member 3
hsa:135250;RAET1E,LETAL,N2DL-4,NKG2DL4,RAET1E2,RL-4,ULBP4,bA350J20.7;retinoic acid early transcript 1E
hsa:57117;INTS12,INT12,PHF22;integrator complex subunit 12
hsa:8463;TEAD2,ETF,TEAD-2,TEF-4,TEF4;TEA domain family member 2
hsa:140807;KRT72,K6IRS2,K6irs,KRT6,KRT6IRS2;keratin 72
hsa:23595;ORC3,LAT,LATHEO,ORC3L;origin recognition complex, subunit 3
hsa:49855;SCAPER,ZNF291,Zfp291;S-phase cyclin A-associated protein in the ER
hsa:284417;TMEM150B,TMEM224;transmembrane protein 150B
hsa:374897;SBSN,UNQ698;suprabasin
hsa:59307;SIGIRR,TIR8;single immunoglobulin and toll-interleukin 1 receptor (TIR) domain
hsa:79797;ZNF408;zinc finger protein 408
hsa:223075;CCDC129;coiled-coil domain containing 129
hsa:201232;SLC16A13,MCT13;solute carrier family 16, member 13 (monocarboxylic acid transporter 13)
hsa:200931;SLC51A,OSTA,OSTalpha;solute carrier family 51, alpha subunit
hsa:3856;KRT8,CARD2,CK-8,CK8,CYK8,K2C8,K8,KO;keratin 8
hsa:57804;POLD4,POLDS,p12;polymerase (DNA-directed), delta 4, accessory subunit
hsa:90196;SYS1,C20orf169,dJ453C12.4,dJ453C12.4.1;SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae)
hsa:7375;USP4,UNP,Unph;ubiquitin specific peptidase 4 (proto-oncogene) (EC:3.4.19.12)
hsa:647589;ANHX;anomalous homeobox
hsa:158219;TTC39B,C9orf52;tetratricopeptide repeat domain 39B
hsa:29967;LRP12,ST7;low density lipoprotein receptor-related protein 12
hsa:7596;ZNF45,KOX5,ZNF13;zinc finger protein 45
hsa:3980;LIG3,LIG2;ligase III, DNA, ATP-dependent (EC:6.5.1.1)
hsa:441234;ZNF716;zinc finger protein 716
hsa:6921;TCEB1,SIII,eloC;transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C)
hsa:1737;DLAT,DLTA,PDC-E2,PDCE2;dihydrolipoamide S-acetyltransferase (EC:2.3.1.12)
hsa:63976;PRDM16,MEL1,PFM13;PR domain containing 16
hsa:8567;MADD,DENN,IG20,RAB3GEP;MAP-kinase activating death domain
hsa:2321;FLT1,FLT,FLT-1,VEGFR-1,VEGFR1;fms-related tyrosine kinase 1 (EC:2.7.10.1)
hsa:79886;CAAP1,C9orf82,CAAP,RP11-337A23.1;caspase activity and apoptosis inhibitor 1
hsa:55620;STAP2,BKS;signal transducing adaptor family member 2
hsa:6737;TRIM21,RNF81,RO52,SSA,SSA1;tripartite motif containing 21
hsa:389827;TMEM8C,TMEM226;transmembrane protein 8C
hsa:259249;MRGPRX1,GPCR,MRGX1,SNSR4;MAS-related GPR, member X1
hsa:55117;SLC6A15,NTT73,SBAT1,V7-3,hv7-3;solute carrier family 6 (neutral amino acid transporter), member 15
hsa:9197;SLC33A1,ACATN,AT-1,AT1,CCHLND,SPG42;solute carrier family 33 (acetyl-CoA transporter), member 1
hsa:727800;RNF208;ring finger protein 208
hsa:9866;TRIM66,C11orf29,TIF1D,TIF1DELTA;tripartite motif containing 66
hsa:57104;PNPLA2,1110001C14Rik,ATGL,PEDF-R,TTS-2.2,TTS2,iPLA2zeta;patatin-like phospholipase domain containing 2 (EC:3.1.1.3)
hsa:23365;ARHGEF12,LARG,PRO2792;Rho guanine nucleotide exchange factor (GEF) 12
hsa:79585;CORO7,0610011B16Rik,CRN7,POD1;coronin 7
hsa:5977;DPF2,REQ,UBID4,ubi-d4;D4, zinc and double PHD fingers family 2
hsa:9793;CKAP5,CHTOG,MSPS,TOG,TOGp,ch-TOG;cytoskeleton associated protein 5
hsa:340554;ZC3H12B,CXorf32,MCPIP2;zinc finger CCCH-type containing 12B
hsa:342945;ZSCAN22,HKR2,ZNF50;zinc finger and SCAN domain containing 22
hsa:339324;ZNF260,OZRF1,PEX1,ZFP260;zinc finger protein 260
hsa:114876;OSBPL1A,ORP-1,ORP1,OSBPL1B;oxysterol binding protein-like 1A
hsa:54207;KCNK10,K2p10.1,TREK-2,TREK2;potassium channel, subfamily K, member 10
hsa:440738;MAP1LC3C,ATG8J,LC3C;microtubule-associated protein 1 light chain 3 gamma
hsa:1015;CDH17,CDH16,HPT-1,HPT1;cadherin 17, LI cadherin (liver-intestine)
hsa:7695;ZNF136,pHZ-20;zinc finger protein 136
hsa:338809;C12orf74;chromosome 12 open reading frame 74
hsa:55857;PLK1S1,C20orf19,Kiz,Kizuna,NCRNA00153;polo-like kinase 1 substrate 1
hsa:140685;ZBTB46,BTBD4,BZEL,RINZF,ZNF340,dJ583P15.7,dJ583P15.8;zinc finger and BTB domain containing 46
hsa:26509;MYOF,FER1L3;myoferlin
hsa:6954;TCP11,D6S230E,FPPR;t-complex 11, testis-specific
hsa:10452;TOMM40,C19orf1,D19S1177E,PER-EC1,PEREC1,TOM40;translocase of outer mitochondrial membrane 40 homolog (yeast)
hsa:6137;RPL13,BBC1,D16S444E,D16S44E,L13;ribosomal protein L13 (EC:3.6.5.3)
hsa:6738;TROVE2,RO60,RORNP,SSA2;TROVE domain family, member 2
hsa:5000;ORC4,ORC4L,ORC4P;origin recognition complex, subunit 4
hsa:7844;RNF103,HKF-1,KF-1,KF1,ZFP-103,ZFP103;ring finger protein 103
hsa:390243;FOLR4,Folbp3;folate receptor 4, delta (putative)
hsa:1014;CDH16;cadherin 16, KSP-cadherin
hsa:79689;STEAP4,STAMP2,TIARP,TNFAIP9;STEAP family member 4
hsa:128408;BHLHE23,BETA4,BHLHB4,bA305P22.3;basic helix-loop-helix family, member e23
hsa:253782;CERS6,CERS5,LASS6;ceramide synthase 6
hsa:10270;AKAP8,AKAP_95,AKAP-8,AKAP-95,AKAP95;A kinase (PRKA) anchor protein 8
hsa:126520;PLK5,PLK-5,PLK5P,SgK384ps;polo-like kinase 5 (EC:2.7.11.21)
hsa:7353;UFD1L,UFD1;ubiquitin fusion degradation 1 like (yeast)
hsa:10336;PCGF3,DONG1,RNF3,RNF3A;polycomb group ring finger 3
hsa:57282;SLC4A10,NBCn2,NCBE;solute carrier family 4, sodium bicarbonate transporter, member 10
hsa:1285;COL4A3;collagen, type IV, alpha 3 (Goodpasture antigen)
hsa:9810;RNF40,BRE1B,RBP95,STARING;ring finger protein 40, E3 ubiquitin protein ligase (EC:6.3.2.-)
hsa:7652;ZNF99,C19orf9,F8281;zinc finger protein 99
hsa:25809;TTLL1,C22orf7,HS323M22B;tubulin tyrosine ligase-like family, member 1
hsa:24;ABCA4,ABC10,ABCR,ARMD2,CORD3,FFM,RMP,RP19,STGD,STGD1;ATP-binding cassette, sub-family A (ABC1), member 4
hsa:153830;RNF145;ring finger protein 145
hsa:11244;ZHX1;zinc fingers and homeoboxes 1
hsa:140730;RIMS4,C20orf190,RIM_4,RIM-4,RIM4,RIM4-gamma,RIM4gamma;regulating synaptic membrane exocytosis 4
hsa:10954;PDIA5,PDIR;protein disulfide isomerase family A, member 5 (EC:5.3.4.1)
hsa:130617;ZFAND2B,AIRAPL;zinc finger, AN1-type domain 2B
hsa:26468;LHX6,LHX6.1;LIM homeobox 6
hsa:50616;IL22,IL-21,IL-22,IL-D110,IL-TIF,ILTIF,TIFIL-23,TIFa,zcyto18;interleukin 22
hsa:123720;WHAMM,WHDC1;WAS protein homolog associated with actin, golgi membranes and microtubules
hsa:3485;IGFBP2,IBP2,IGF-BP53;insulin-like growth factor binding protein 2, 36kDa
hsa:5921;RASA1,CM-AVM,CMAVM,GAP,PKWS,RASA,RASGAP,p120GAP,p120RASGAP;RAS p21 protein activator (GTPase activating protein) 1
hsa:51012;SLMO2,C20orf45,PRELID3B,dJ543J19.5;slowmo homolog 2 (Drosophila)
hsa:140456;ASB11;ankyrin repeat and SOCS box containing 11
hsa:8851;CDK5R1,CDK5P35,CDK5R,NCK5A,p23,p25,p35,p35nck5a;cyclin-dependent kinase 5, regulatory subunit 1 (p35)
hsa:100310812;SPDYE2L;WBSCR19-like protein 3
hsa:7755;ZNF205,RhitH,ZNF210,Zfp13;zinc finger protein 205
hsa:100505591;LRRC3C;leucine rich repeat containing 3C
hsa:81669;CCNL2,ANIA-6B,CCNM,HCLA-ISO,HLA-ISO,PCEE,SB138;cyclin L2
hsa:132430;PABPC4L;poly(A) binding protein, cytoplasmic 4-like
hsa:57661;PHRF1,RNF221;PHD and ring finger domains 1
hsa:7988;ZNF212,C2H2-150,ZNF182,ZNFC150;zinc finger protein 212
hsa:390940;PINLYP;phospholipase A2 inhibitor and LY6/PLAUR domain containing
hsa:51025;PAM16,MAGMAS,TIM16,TIMM16;presequence translocase-associated motor 16 homolog (S. cerevisiae)
hsa:55695;NSUN5,NOL1,NOL1R,NSUN5A,WBSCR20,WBSCR20A,p120;NOP2/Sun domain family, member 5
hsa:8898;MTMR2,CMT4B,CMT4B1;myotubularin related protein 2
hsa:115677;NOSTRIN,DaIP2;nitric oxide synthase trafficker
hsa:6124;RPL4,L4;ribosomal protein L4
hsa:22992;KDM2A,CXXC8,FBL11,FBL7,FBXL11,JHDM1A,LILINA;lysine (K)-specific demethylase 2A (EC:1.14.11.27)
hsa:285381;DPH3,DELGIP,DELGIP1,DESR1,DPH3A,KTI11,ZCSL2;DPH3, KTI11 homolog (S. cerevisiae)
hsa:10180;RBM6,3G2,DEF-3,DEF3,HLC-11,NY-LU-12,g16;RNA binding motif protein 6
hsa:10904;BLCAP,BC10;bladder cancer associated protein
hsa:8581;LY6D,E48,Ly-6D;lymphocyte antigen 6 complex, locus D
hsa:643596;RNF224;ring finger protein 224
hsa:55676;SLC30A6,MST103,MSTP103,ZNT6;solute carrier family 30 (zinc transporter), member 6
hsa:84650;EBPL,EBRP;emopamil binding protein-like
hsa:729648;ZNF812;zinc finger protein 812
hsa:81034;SLC25A32,MFT,MFTC;solute carrier family 25 (mitochondrial folate carrier), member 32
hsa:150921;TCF23,OUT,TCF-23,bHLHa24;transcription factor 23
hsa:1716;DGUOK,MTDPS3,dGK;deoxyguanosine kinase (EC:2.7.1.113)
hsa:64218;SEMA4A,CORD10,RP35,SEMAB,SEMB;sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A
hsa:79641;ROGDI,KTZS;rogdi homolog (Drosophila)
hsa:10567;RABAC1,PRA1,PRAF1,YIP3;Rab acceptor 1 (prenylated)
hsa:4741;NEFM,NEF3,NF-M,NFM;neurofilament, medium polypeptide
hsa:7737;RNF113A,Cwc24,RNF113,ZNF183;ring finger protein 113A
hsa:387882;C12orf75,AGD3,OCC-1,OCC1;chromosome 12 open reading frame 75
hsa:3181;HNRNPA2B1,HNRNPA2,HNRNPB1,HNRPA2,HNRPA2B1,HNRPB1,RNPA2,SNRPB1;heterogeneous nuclear ribonucleoprotein A2/B1
hsa:57822;GRHL3,SOM,TFCP2L4;grainyhead-like 3 (Drosophila)
hsa:84268;RPAIN,HRIP,RIP;RPA interacting protein
hsa:1581;CYP7A1,CP7A,CYP7,CYPVII;cytochrome P450, family 7, subfamily A, polypeptide 1 (EC:1.14.13.17)
hsa:908;CCT6A,CCT-zeta,CCT-zeta-1,CCT6,Cctz,HTR3,MoDP-2,TCP-1-zeta,TCP20,TCPZ,TTCP20;chaperonin containing TCP1, subunit 6A (zeta 1)
hsa:83871;RAB34,RAB39,RAH;RAB34, member RAS oncogene family
hsa:79692;ZNF322,HCG12,ZNF322A,ZNF388,ZNF489;zinc finger protein 322
hsa:128387;TATDN3;TatD DNase domain containing 3
hsa:51130;ASB3,ASB-3;ankyrin repeat and SOCS box containing 3
hsa:64089;SNX16;sorting nexin 16
hsa:5933;RBL1,CP107,PRB1,p107;retinoblastoma-like 1 (p107)
hsa:8462;KLF11,FKLF,FKLF1,MODY7,TIEG2,Tieg3;Kruppel-like factor 11
hsa:29800;ZDHHC1,C16orf1,HSU90653,ZNF377;zinc finger, DHHC-type containing 1
hsa:58516;FAM60A,C12orf14,TERA;family with sequence similarity 60, member A
hsa:8464;SUPT3H,SPT3,SPT3L;suppressor of Ty 3 homolog (S. cerevisiae)
hsa:64094;SMOC2,DTDP1,MST117,MSTP117,MSTP140,SMAP2,bA270C4A.1,bA37D8.1,dJ421D16.1;SPARC related modular calcium binding 2
hsa:170482;CLEC4C,BDCA2,CD303,CLECSF11,CLECSF7,DLEC,HECL,PRO34150;C-type lectin domain family 4, member C
hsa:7767;ZNF224,BMZF-2,BMZF2,KOX22,ZNF255,ZNF27;zinc finger protein 224
hsa:79862;ZNF669;zinc finger protein 669
hsa:350;APOH,B2G1,B2GP1,BG;apolipoprotein H (beta-2-glycoprotein I)
hsa:26494;OR8G1,HSTPCR25,OR8G1P,TPCR25;olfactory receptor, family 8, subfamily G, member 1
hsa:51333;ZNF771,DSC43;zinc finger protein 771
hsa:2214;FCGR3A,CD16,CD16A,FCG3,FCGR3,FCGRIII,FCR-10,FCRIII,FCRIIIA,IGFR3;Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
hsa:9406;ZRANB2,ZIS,ZIS1,ZIS2,ZNF265;zinc finger, RAN-binding domain containing 2
hsa:29066;ZC3H7A,ZC3H7,ZC3HDC7;zinc finger CCCH-type containing 7A
hsa:8309;ACOX2,BCOX,BRCACOX,BRCOX,THCCox;acyl-CoA oxidase 2, branched chain (EC:1.17.99.3)
hsa:54210;TREM1,CD354,TREM-1;triggering receptor expressed on myeloid cells 1
hsa:80335;WDR82,MST107,MSTP107,PRO2730,PRO34047,SWD2,TMEM113,WDR82A;WD repeat domain 82
hsa:2254;FGF9,GAF,HBFG-9,SYNS3;fibroblast growth factor 9 (glia-activating factor)
hsa:7433;VIPR1,HVR1,II,PACAP-R-2,PACAP-R2,RDC1,V1RG,VAPC1,VIP-R-1,VIPR,VIRG,VPAC1,VPAC1R,VPCAP1R;vasoactive intestinal peptide receptor 1
hsa:5833;PCYT2,ET;phosphate cytidylyltransferase 2, ethanolamine (EC:2.7.7.14)
hsa:7168;TPM1,C15orf13,CMD1Y,CMH3,HTM-alpha,TMSA;tropomyosin 1 (alpha)
hsa:5098;PCDHGC3,PC43,PCDH-GAMMA-C3,PCDH2;protocadherin gamma subfamily C, 3
hsa:51314;NME8,CILD6,NM23-H8,SPTRX2,TXNDC3,sptrx-2;NME/NM23 family member 8
hsa:7067;THRA,AR7,CHNG6,EAR7,ERB-T-1,ERBA,ERBA1,NR1A1,THRA1,THRA2,c-ERBA-1;thyroid hormone receptor, alpha
hsa:9509;ADAMTS2,ADAM-TS2,ADAMTS-2,ADAMTS-3,NPI,PC_I-NP,PCI-NP,PCINP,PCPNI,PNPI;ADAM metallopeptidase with thrombospondin type 1 motif, 2 (EC:3.4.24.14)
hsa:55250;ELP2,SHINC-2,STATIP1,StIP;elongator acetyltransferase complex subunit 2
hsa:3269;HRH1,H1-R,hisH1;histamine receptor H1
hsa:100134934;TEN1,C17orf106;TEN1 telomerase capping complex subunit homolog (S. cerevisiae)
hsa:51157;ZNF580;zinc finger protein 580
hsa:653048;XAGE1C,CT12.1,CT12.1C,CTP9,GAGED2;X antigen family, member 1C
hsa:51631;LUC7L2,CGI-74,LUC7B2;LUC7-like 2 (S. cerevisiae)
hsa:404037;HAPLN4,BRAL2;hyaluronan and proteoglycan link protein 4
hsa:126306;JSRP1,JP-45,JP45;junctional sarcoplasmic reticulum protein 1
hsa:124245;ZC3H18,NHN1;zinc finger CCCH-type containing 18
hsa:285679;C5orf60;chromosome 5 open reading frame 60
hsa:425054;VCX3B,VCX-C,VCXC;variable charge, X-linked 3B
hsa:2023;ENO1,ENO1L1,MPB1,NNE,PPH;enolase 1, (alpha) (EC:4.2.1.11)
hsa:54469;ZFAND6,AWP1,ZA20D3,ZFAND5B;zinc finger, AN1-type domain 6
hsa:139105;BEND2,CXorf20;BEN domain containing 2
hsa:29801;ZDHHC8,DHHC8,ZDHHCL1,ZNF378;zinc finger, DHHC-type containing 8
hsa:6533;SLC6A6,TAUT;solute carrier family 6 (neurotransmitter transporter, taurine), member 6
hsa:100506564;THEGL;theg spermatid protein-like
hsa:55010;PARPBP,AROM,C12orf48,PARI;PARP1 binding protein
hsa:50489;CD207,CLEC4K;CD207 molecule, langerin
hsa:9630;GNA14;guanine nucleotide binding protein (G protein), alpha 14
hsa:9439;MED23,ARC130,CRSP130,CRSP133,CRSP3,DRIP130,MRT18,SUR-2,SUR2;mediator complex subunit 23
hsa:5160;PDHA1,PDHA,PDHCE1A,PHE1A;pyruvate dehydrogenase (lipoamide) alpha 1 (EC:1.2.4.1)
hsa:79567;FAM65A;family with sequence similarity 65, member A
hsa:100507588;TGFBR3L,TGFR-3L;transforming growth factor, beta receptor III-like
hsa:4831;NME2,NDKB,NDPK-B,NDPKB,NM23-H2,NM23B,PUF;NME/NM23 nucleoside diphosphate kinase 2 (EC:2.7.4.6 2.7.13.3)
hsa:221687;RNF182;ring finger protein 182
hsa:51201;ZDHHC2,DHHC2,ZNF372;zinc finger, DHHC-type containing 2
hsa:93611;FBXO44,FBG3,FBX30,FBX6A,Fbx44,Fbxo6a;F-box protein 44
hsa:116143;WDR92;WD repeat domain 92
hsa:8943;AP3D1,ADTD,hBLVR;adaptor-related protein complex 3, delta 1 subunit
hsa:3638;INSIG1,CL-6,CL6;insulin induced gene 1
hsa:84720;PIGO,HPMRS2,RP11-182N22.4;phosphatidylinositol glycan anchor biosynthesis, class O
hsa:389730;SPATA31A6,FAM75A6;SPATA31 subfamily A, member 6
hsa:10524;KAT5,ESA1,HTATIP,HTATIP1,PLIP,TIP,TIP60,ZC2HC5,cPLA2;K(lysine) acetyltransferase 5 (EC:2.3.1.48)
hsa:9344;TAOK2,MAP3K17,PSK,PSK1,PSK1-BETA,TAO1,TAO2;TAO kinase 2 (EC:2.7.11.1)
hsa:11128;POLR3A,ADDH,HLD7,RPC1,RPC155,hRPC155;polymerase (RNA) III (DNA directed) polypeptide A, 155kDa (EC:2.7.7.6)
hsa:9965;FGF19;fibroblast growth factor 19
hsa:7091;TLE4,BCE-1,BCE1,E(spI),ESG,ESG4,GRG4;transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila)
hsa:80005;DOCK5;dedicator of cytokinesis 5
hsa:55739;CARKD,LP3298;carbohydrate kinase domain containing (EC:4.2.1.93)
hsa:4515;MTCP1,P13MTCP1,p8MTCP1;mature T-cell proliferation 1
hsa:134288;TMEM174;transmembrane protein 174
hsa:2934;GSN,ADF,AGEL;gelsolin
hsa:401285;TCP10L2,bA517H2.3;t-complex 10-like 2
hsa:112401;BIRC8,ILP-2,ILP2,hILP2;baculoviral IAP repeat containing 8
hsa:130120;REG3G,LPPM429,PAP_IB,PAP-1B,PAP1B,PAPIB,REG-III,UNQ429;regenerating islet-derived 3 gamma
hsa:146050;ZSCAN29,ZNF690,Zfp690;zinc finger and SCAN domain containing 29
hsa:79949;PLEKHS1,C10orf81,HEL185,bA211N11.2;pleckstrin homology domain containing, family S member 1
hsa:145553;MDP1,FN6PASE,MDP-1;magnesium-dependent phosphatase 1 (EC:3.1.3.48)
hsa:389763;SPATA31D1,FAM75D1;SPATA31 subfamily D, member 1
hsa:7259;TSPYL1,TSPYL;TSPY-like 1
hsa:54989;ZNF770,PRO1914;zinc finger protein 770
hsa:2043;EPHA4,HEK8,SEK,TYRO1;EPH receptor A4 (EC:2.7.10.1)
hsa:100037417;DDTL;D-dopachrome tautomerase-like (EC:4.1.1.-)
hsa:64943;NT5DC2;5'-nucleotidase domain containing 2 (EC:3.1.3.5)
hsa:3551;IKBKB,IKK-beta,IKK2,IKKB,NFKBIKB;inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10)
hsa:6334;SCN8A,CERIII,CIAT,EIEE13,MED,NaCh6,Nav1.6,PN4;sodium channel, voltage gated, type VIII, alpha subunit
hsa:9659;PDE4DIP,CMYA2,MMGL;phosphodiesterase 4D interacting protein
hsa:6303;SAT1,DC21,KFSD,KFSDX,SAT,SSAT,SSAT-1;spermidine/spermine N1-acetyltransferase 1 (EC:2.3.1.57)
hsa:5699;PSMB10,LMP10,MECL1,beta2i;proteasome (prosome, macropain) subunit, beta type, 10 (EC:3.4.25.1)
hsa:344787;ZNF860;zinc finger protein 860
hsa:80144;FRAS1;Fraser syndrome 1
hsa:163183;SYNE4,C19orf46,Nesp4;spectrin repeat containing, nuclear envelope family member 4
hsa:27180;SIGLEC9,CD329,CDw329,FOAP-9,OBBP-LIKE,siglec-9;sialic acid binding Ig-like lectin 9
hsa:6059;ABCE1,ABC38,OABP,RLI,RNASEL1,RNASELI,RNS4I;ATP-binding cassette, sub-family E (OABP), member 1
hsa:22888;UBOX5,RNF37,UBCE7IP5,UIP5;U-box domain containing 5
hsa:284443;ZNF493;zinc finger protein 493
hsa:9582;APOBEC3B,APOBEC1L,ARCD3,ARP4,DJ742C19.2,PHRBNL,bK150C2.2;apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
hsa:55825;PECR,DCRRP,HPDHASE,HSA250303,PVIARL,SDR29C1,TERP;peroxisomal trans-2-enoyl-CoA reductase (EC:1.3.1.38)
hsa:5592;PRKG1,1,PKG,PRKG1B,PRKGR1B,cGK,cGK_1,cGK1,cGKI,cGKI-BETA,cGKI-alpha;protein kinase, cGMP-dependent, type I (EC:2.7.11.12)
hsa:1632;ECI1,DCI;enoyl-CoA delta isomerase 1 (EC:5.3.3.8)
hsa:54437;SEMA5B,SEMAG,SemG;sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B
hsa:90649;ZNF486,KRBO2;zinc finger protein 486
hsa:100885848;PTGES3L;prostaglandin E synthase 3 (cytosolic)-like
hsa:10111;RAD50,NBSLD,RAD502,hRad50;RAD50 homolog (S. cerevisiae)
hsa:10806;SDCCAG8,BBS16,CCCAP,CCCAP_SLSN7,NPHP10,NY-CO-8,SLSN7,hCCCAP;serologically defined colon cancer antigen 8
hsa:118471;PRAP1,PRO1195,RP11-122K13.6,UPA;proline-rich acidic protein 1
hsa:4172;MCM3,HCC5,P1-MCM3,P1.h,RLFB;minichromosome maintenance complex component 3 (EC:3.6.4.12)
hsa:221302;ZUFSP,C6orf113,dJ412I7.3;zinc finger with UFM1-specific peptidase domain
hsa:64924;SLC30A5,ZNT5,ZNTL1,ZTL1,ZnT-5;solute carrier family 30 (zinc transporter), member 5
hsa:57706;DENND1A,FAM31A,KIAA1608,RP11-230L22.3;DENN/MADD domain containing 1A
hsa:645073;GAGE12G,AL4,CT4.7,GAGE-12G,RP11-959H17.6;G antigen 12G
hsa:8771;TNFRSF6B,DCR3,DJ583P15.1.1,M68,M68E,TR6;tumor necrosis factor receptor superfamily, member 6b, decoy
hsa:123;PLIN2,ADFP,ADRP;perilipin 2
hsa:7709;ZBTB17,MIZ-1,ZNF151,ZNF60,pHZ-67;zinc finger and BTB domain containing 17
hsa:27306;HPGDS,GSTS,GSTS1-1,PGD2,PGDS;hematopoietic prostaglandin D synthase (EC:2.5.1.18 5.3.99.2)
hsa:5916;RARG,NR1B3,RARC;retinoic acid receptor, gamma
hsa:9422;ZNF264;zinc finger protein 264
hsa:51588;PIAS4,PIASY,Piasg,ZMIZ6;protein inhibitor of activated STAT, 4
hsa:4038;LRP4,CLSS,LRP-4,LRP10,MEGF7,SOST2;low density lipoprotein receptor-related protein 4
hsa:729408;GAGE2D,CT4.8,GAGE-2D,GAGE-8,GAGE8;G antigen 2D
hsa:55839;CENPN,BM039,C16orf60,CENP-N,ICEN32;centromere protein N
hsa:131;ADH7,ADH4;alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide (EC:1.1.1.1)
hsa:81887;LAS1L,dJ475B7.2;LAS1-like (S. cerevisiae)
hsa:375346;TMEM110;transmembrane protein 110
hsa:729442;GAGE12H,RP11-959H17.7;G antigen 12H
hsa:7001;PRDX2,NKEF-B,NKEFB,PRP,PRX2,PRXII,PTX1,TDPX1,TPX1,TSA;peroxiredoxin 2 (EC:1.11.1.15)
hsa:5575;PRKAR1B,PRKAR1;protein kinase, cAMP-dependent, regulatory, type I, beta (EC:2.7.11.1)
hsa:9742;IFT140,MZSDS,WDTC2,c305C8.4,c380F5.1,gs114;intraflagellar transport 140 homolog (Chlamydomonas)
hsa:56099;PCDHGB7,ME6,PCDH-GAMMA-B7;protocadherin gamma subfamily B, 7
hsa:7249;TSC2,LAM,TSC4;tuberous sclerosis 2
hsa:152992;TRMT44,C4orf23,METTL19,TRM44;tRNA methyltransferase 44 homolog (S. cerevisiae) (EC:2.1.1.211)
hsa:195828;ZNF367,CDC14B,ZFF29;zinc finger protein 367
hsa:5713;PSMD7,MOV34,P40,Rpn8,S12;proteasome (prosome, macropain) 26S subunit, non-ATPase, 7
hsa:651746;ANKRD33B;ankyrin repeat domain 33B
hsa:4942;OAT,GACR,HOGA,OATASE,OKT;ornithine aminotransferase (EC:2.6.1.13)
hsa:22933;SIRT2,SIR2,SIR2L,SIR2L2;sirtuin 2 (EC:3.5.1.-)
hsa:729422;GAGE12C,GAGE-12B;G antigen 12C
hsa:5716;PSMD10,dJ889N15.2,p28,p28(GANK);proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
hsa:154791;C7orf55,FMC1;chromosome 7 open reading frame 55
hsa:7727;ZNF174,ZSCAN8;zinc finger protein 174
hsa:9209;LRRFIP2,HUFI-2;leucine rich repeat (in FLII) interacting protein 2
hsa:360226;PRSS41,TESSP1;protease, serine, 41 (EC:3.4.21.-)
hsa:29118;DDX25,GRTH;DEAD (Asp-Glu-Ala-Asp) box helicase 25 (EC:3.6.4.13)
hsa:6892;TAPBP,NGS17,TAPA,TPN,TPSN;TAP binding protein (tapasin)
hsa:6396;SEC13,D3S1231E,SEC13L1,SEC13R,npp-20;SEC13 homolog (S. cerevisiae)
hsa:339390;CLEC4G,DTTR431,LP2698,LSECtin,UNQ431;C-type lectin domain family 4, member G
hsa:25799;ZNF324,ZF5128,ZNF324A;zinc finger protein 324
hsa:115992;RNF166;ring finger protein 166
hsa:441056;DUX4L4;double homeobox 4 like 4
hsa:2833;CXCR3,CD182,CD183,CKR-L2,CMKAR3,GPR9,IP10-R,Mig-R,MigR;chemokine (C-X-C motif) receptor 3
hsa:100131801;PET100,C19orf79;PET100 homolog (S. cerevisiae)
hsa:148206;ZNF714;zinc finger protein 714
hsa:442319;ZNF727;zinc finger protein 727
hsa:54778;RNF111,ARK;ring finger protein 111 (EC:6.3.2.-)
hsa:645961;SPATA31C2,FAM75C2;SPATA31 subfamily C, member 2
hsa:58491;ZNF71,EZFIT;zinc finger protein 71
hsa:8915;BCL10,CARMEN,CIPER,CLAP,c-E10,mE10;B-cell CLL/lymphoma 10
hsa:55625;ZDHHC7,DHHC7,SERZ-B,SERZ1,ZNF370;zinc finger, DHHC-type containing 7
hsa:284370;ZNF615;zinc finger protein 615
hsa:6472;SHMT2,GLYA,SHMT;serine hydroxymethyltransferase 2 (mitochondrial) (EC:2.1.2.1)
hsa:5519;PPP2R1B,PP2A-Abeta,PR65B;protein phosphatase 2, regulatory subunit A, beta (EC:3.1.3.16)
hsa:79178;THTPA,THTP,THTPASE;thiamine triphosphatase (EC:3.6.1.28)
hsa:100529215;ZNF559-ZNF177;ZNF559-ZNF177 readthrough
hsa:126299;ZNF428,C19orf37,Zfp428;zinc finger protein 428
hsa:51360;MBTPS2,BRESEK,IFAP,KFSDX,S2P;membrane-bound transcription factor peptidase, site 2 (EC:3.4.24.85)
hsa:23512;SUZ12,CHET9,JJAZ1;suppressor of zeste 12 homolog (Drosophila)
hsa:149281;METTL11B,C1orf184,HOMT1B,NTM1B;methyltransferase like 11B (EC:2.1.1.244)
hsa:51114;ZDHHC9,CGI89,CXorf11,DHHC9,MMSA1,MRXSZ,ZDHHC10,ZNF379,ZNF380;zinc finger, DHHC-type containing 9
hsa:51106;TFB1M,CGI75,mtTFB,mtTFB1;transcription factor B1, mitochondrial (EC:2.1.1.-)
hsa:10262;SF3B4,AFD1,Hsh49,SAP49,SF3b49;splicing factor 3b, subunit 4, 49kDa
hsa:463;ZFHX3,ATBF1,ATBT,ZNF927;zinc finger homeobox 3
hsa:4654;MYOD1,MYF3,MYOD,PUM,bHLHc1;myogenic differentiation 1
hsa:79898;ZNF613;zinc finger protein 613
hsa:5066;PAM,PAL,PHM;peptidylglycine alpha-amidating monooxygenase (EC:1.14.17.3 4.3.2.5)
hsa:112495;GTF3C6,C6orf51,TFIIIC35,bA397G5.3;general transcription factor IIIC, polypeptide 6, alpha 35kDa
hsa:83940;TATDN1;TatD DNase domain containing 1
hsa:7730;ZNF177,PIGX;zinc finger protein 177
hsa:26137;ZBTB20,DPZF,HOF,ODA-8S,ZNF288;zinc finger and BTB domain containing 20
hsa:60675;PROK2,BV8,HH4,KAL4,MIT1,PK2;prokineticin 2
hsa:116540;MRPL53,L53MT;mitochondrial ribosomal protein L53
hsa:5836;PYGL,GSD6;phosphorylase, glycogen, liver (EC:2.4.1.1)
hsa:100134444;KCNJ18,KIR2.6,TTPP2;potassium inwardly-rectifying channel, subfamily J, member 18
hsa:8728;ADAM19,MADDAM,MLTNB;ADAM metallopeptidase domain 19
hsa:8532;CPZ;carboxypeptidase Z
hsa:389549;FEZF1,FEZ,ZNF312B;FEZ family zinc finger 1
hsa:5158;PDE6B,CSNB3,CSNBAD2,PDEB,RP40,rd1;phosphodiesterase 6B, cGMP-specific, rod, beta (EC:3.1.4.35)
hsa:100288801;FRG2C;FSHD region gene 2 family, member C
hsa:3705;ITPK1,ITRPK1;inositol-tetrakisphosphate 1-kinase (EC:2.7.1.134 2.7.1.159)
hsa:81567;TXNDC5,ENDOPDI,ERP46,HCC-2,PDIA15,STRF8,UNQ364;thioredoxin domain containing 5 (endoplasmic reticulum)
hsa:10855;HPSE,HPA,HPA1,HPR1,HPSE1,HSE1;heparanase (EC:3.2.1.166)
hsa:81627;TRMT1L,C1orf25,MST070,TRM1L,bG120K12.3;tRNA methyltransferase 1 homolog (S. cerevisiae)-like
hsa:145482;PTGR2,PGR2,ZADH1;prostaglandin reductase 2 (EC:1.3.1.48)
hsa:441452;SPATA31C1,FAM75C1,SPATA31C2;SPATA31 subfamily C, member 1
hsa:55869;HDAC8,CDLS5,HD8,HDACL1,MRXS6,RPD3,WTS;histone deacetylase 8 (EC:3.5.1.98)
hsa:676;BRDT,BRD6,CT9;bromodomain, testis-specific
hsa:284654;RSPO1,CRISTIN3,RSPO;R-spondin 1
hsa:7033;TFF3,ITF,P1B,TFI;trefoil factor 3 (intestinal)
hsa:130497;OSR1,ODD;odd-skipped related 1 (Drosophila)
hsa:27164;SALL3,ZNF796;sal-like 3 (Drosophila)
hsa:644054;FAM25C,FAM25A,FAM25B,FAM25G,bA164N7.4;family with sequence similarity 25, member C
hsa:23527;ACAP2,CENTB2,CNT-B2;ArfGAP with coiled-coil, ankyrin repeat and PH domains 2
hsa:126295;ZNF57,ZNF424;zinc finger protein 57
hsa:11035;RIPK3,RIP3;receptor-interacting serine-threonine kinase 3 (EC:2.7.11.1)
hsa:8312;AXIN1,AXIN,PPP1R49;axin 1
hsa:89790;SIGLEC10,PRO940,SIGLEC-10,SLG2;sialic acid binding Ig-like lectin 10
hsa:11001;SLC27A2,ACSVL1,FACVL1,FATP2,HsT17226,VLACS,VLCS,hFACVL1;solute carrier family 27 (fatty acid transporter), member 2 (EC:6.2.1.3)
hsa:283310;OTOGL,C12orf64,DFNB84B;otogelin-like
hsa:3020;H3F3A,H3.3A,H3F3;H3 histone, family 3A
hsa:23608;MKRN1,RNF61;makorin ring finger protein 1
hsa:84079;ANKRD27,VARP;ankyrin repeat domain 27 (VPS9 domain)
hsa:7095;SEC62,Dtrp1,HTP1,TLOC1,TP-1;SEC62 homolog (S. cerevisiae)
hsa:6932;TCF7,TCF-1;transcription factor 7 (T-cell specific, HMG-box)
hsa:7089;TLE2,ESG,ESG2,GRG2;transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila)
hsa:155054;ZNF425;zinc finger protein 425
hsa:84460;ZMAT1;zinc finger, matrin-type 1
hsa:100533177;KRTAP29-1,KAP29.2;keratin associated protein 29-1
hsa:55063;ZCWPW1,ZCW1;zinc finger, CW type with PWWP domain 1
hsa:100507421;TMEM178B;transmembrane protein 178B
hsa:283417;DPY19L2,SPATA34,SPGF9;dpy-19-like 2 (C. elegans)
hsa:9181;ARHGEF2,GEF,GEF-H1,GEFH1,LFP40,P40;Rho/Rac guanine nucleotide exchange factor (GEF) 2
hsa:7694;ZNF135,ZNF61,ZNF78L1,pHZ-17,pT3;zinc finger protein 135
hsa:115584;SLC5A11,KST1,RKST1,SGLT6,SMIT2;solute carrier family 5 (sodium/glucose cotransporter), member 11
hsa:253769;WDR27;WD repeat domain 27
hsa:7678;ZNF124,HZF-16,HZF16,ZK7;zinc finger protein 124
hsa:55038;CDCA4,HEPP,SEI-3/HEPP;cell division cycle associated 4
hsa:100133093;FAM25G,FAM25A,FAM25B,FAM25C,bA301J7.4;family with sequence similarity 25, member G
hsa:79400;NOX5;NADPH oxidase, EF-hand calcium binding domain 5
hsa:119391;GSTO2,GSTO_2-2,bA127L20.1;glutathione S-transferase omega 2 (EC:2.5.1.18 1.8.5.1 1.20.4.2)
hsa:153129;SLC38A9;solute carrier family 38, member 9
hsa:146540;ZNF785;zinc finger protein 785
hsa:3691;ITGB4,CD104;integrin, beta 4
hsa:642636;RAD21L1,RAD21L,dJ545L17.2;RAD21-like 1 (S. pombe)
hsa:4957;ODF2,CT134,ODF2/1,ODF2/2,ODF84;outer dense fiber of sperm tails 2
hsa:166336;PRICKLE2,EPM5;prickle homolog 2 (Drosophila)
hsa:4850;CNOT4,CLONE243,NOT4,NOT4H;CCR4-NOT transcription complex, subunit 4
hsa:443;ASPA,ACY2,ASP;aspartoacylase (EC:3.5.1.15)
hsa:9317;PTER,HPHRP,RPR-1;phosphotriesterase related
hsa:7546;ZIC2,HPE5;Zic family member 2
hsa:26097;CHTOP,C1orf77,FL-SRAG,FOP,RP1-178F15.2,SRAG,SRAG-3,SRAG-5,pp7704;chromatin target of PRMT1
hsa:89978;ATPBD4;ATP binding domain 4
hsa:284525;SLC9C2,RP3-436N22.2,SLC9A11;solute carrier family 9, member C2 (putative)
hsa:90113;VWA5B2;von Willebrand factor A domain containing 5B2
hsa:5694;PSMB6,DELTA,LMPY,Y;proteasome (prosome, macropain) subunit, beta type, 6 (EC:3.4.25.1)
hsa:4521;NUDT1,MTH1;nudix (nucleoside diphosphate linked moiety X)-type motif 1 (EC:3.6.1.55 3.6.1.56)
hsa:5605;MAP2K2,MAPKK2,MEK2,MKK2,PRKMK2;mitogen-activated protein kinase kinase 2 (EC:2.7.12.2)
hsa:80317;ZKSCAN3,ZF47,ZFP306,ZNF306,ZNF309,ZSCAN13,ZSCAN35,Zfp47,dJ874C20.1,dJ874C20.1.,zfp-47;zinc finger with KRAB and SCAN domains 3
hsa:23258;DENND5A,RAB6IP1;DENN/MADD domain containing 5A
hsa:54606;DDX56,DDX21,DDX26,NOH61;DEAD (Asp-Glu-Ala-Asp) box helicase 56 (EC:3.6.4.13)
hsa:5300;PIN1,DOD,UBL5;peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (EC:5.2.1.8)
hsa:10419;PRMT5,HRMT1L5,IBP72,JBP1,SKB1,SKB1Hs;protein arginine methyltransferase 5 (EC:2.1.1.125)
hsa:64400;AKTIP,FT1,FTS;AKT interacting protein
hsa:9203;ZMYM3,DXS6673E,MYM,XFIM,ZNF198L2,ZNF261;zinc finger, MYM-type 3
hsa:84775;ZNF607;zinc finger protein 607
hsa:345462;ZNF879,DKFZp686E2433;zinc finger protein 879
hsa:54930;HAUS4,C14orf94;HAUS augmin-like complex, subunit 4
hsa:9020;MAP3K14,FTDCR1B,HS,HSNIK,NIK;mitogen-activated protein kinase kinase kinase 14 (EC:2.7.11.25)
hsa:2281;FKBP1B,FKBP12.6,FKBP1L,OTK4,PKBP1L,PPIase;FK506 binding protein 1B, 12.6 kDa (EC:5.2.1.8)
hsa:138009;DCAF4L2,WDR21C;DDB1 and CUL4 associated factor 4-like 2
hsa:79365;BHLHE41,BHLHB3,DEC2,SHARP1,hDEC2;basic helix-loop-helix family, member e41
hsa:9744;ACAP1,CENTB1;ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
hsa:9960;USP3,SIH003,UBP;ubiquitin specific peptidase 3 (EC:3.4.19.12)
hsa:96626;LIMS3,PINCH-3;LIM and senescent cell antigen-like domains 3
hsa:2771;GNAI2,GIP,GNAI2B,H_LUCA15.1,H_LUCA16.1;guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
hsa:5151;PDE8A,HsT19550;phosphodiesterase 8A (EC:3.1.4.17)
hsa:92285;ZNF585B,SZFP41;zinc finger protein 585B
hsa:8290;HIST3H3,H3.4,H3/g,H3FT,H3t;histone cluster 3, H3
hsa:400359;C15orf53;chromosome 15 open reading frame 53
hsa:6652;SORD,SORD1;sorbitol dehydrogenase (EC:1.1.1.14)
hsa:1238;CCBP2,CCR10,CCR9,CMKBR9,D6,hD6;chemokine binding protein 2
hsa:54464;XRN1,SEP1;5'-3' exoribonuclease 1
hsa:124872;B4GALNT2,B4GALT,GALGT2;beta-1,4-N-acetyl-galactosaminyl transferase 2 (EC:2.4.1.-)
hsa:54937;SOHLH2,SPATA28,TEB1,bHLHe81;spermatogenesis and oogenesis specific basic helix-loop-helix 2
hsa:27;ABL2,ABLL,ARG;v-abl Abelson murine leukemia viral oncogene homolog 2 (EC:2.7.10.2)
hsa:192111;PGAM5,BXLBV68;phosphoglycerate mutase family member 5 (EC:3.1.3.16)
hsa:344022;NOTO;notochord homeobox
hsa:388946;TMEM247;transmembrane protein 247
hsa:79188;TMEM43,ARVC5,ARVD5,LUMA;transmembrane protein 43
hsa:54968;TMEM70,MC5DN2;transmembrane protein 70
hsa:116983;ACAP3,CENTB5;ArfGAP with coiled-coil, ankyrin repeat and PH domains 3
hsa:54888;NSUN2,MISU,MRT5,SAKI,TRM4;NOP2/Sun RNA methyltransferase family, member 2 (EC:2.1.1.203)
hsa:390748;PABPN1L,PABPNL1,ePABP2;poly(A) binding protein, nuclear 1-like (cytoplasmic)
hsa:84924;ZNF566;zinc finger protein 566
hsa:50810;HDGFRP3,HDGF-2,HDGF2,HRP-3;hepatoma-derived growth factor, related protein 3
hsa:57126;CD177,HNA-2a,HNA2A,NB1,NB1_GP,PRV-1,PRV1;CD177 molecule
hsa:6494;SIPA1,SPA1;signal-induced proliferation-associated 1
hsa:115019;SLC26A9;solute carrier family 26, member 9
hsa:5093;PCBP1,HNRPE1,HNRPX,hnRNP-E1,hnRNP-X;poly(rC) binding protein 1
hsa:836;CASP3,CPP32,CPP32B,SCA-1;caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56)
hsa:147949;ZNF583;zinc finger protein 583
hsa:83959;SLC4A11,BTR1,CDPD1,CHED2,NABC1,dJ794I6.2;solute carrier family 4, sodium borate transporter, member 11
hsa:3066;HDAC2,HD2,RPD3,YAF1;histone deacetylase 2 (EC:3.5.1.98)
hsa:7752;ZNF200;zinc finger protein 200
hsa:256223;CDRT15L2;CMT1A duplicated region transcript 15-like 2
hsa:100506742;CASP12,CASP-12,CASP12P1;caspase 12 (gene/pseudogene)
hsa:5704;PSMC4,MIP224,RPT3,S6,TBP-7,TBP7;proteasome (prosome, macropain) 26S subunit, ATPase, 4
hsa:158880;USP51;ubiquitin specific peptidase 51 (EC:3.4.19.12)
hsa:11274;USP18,ISG43,UBP43;ubiquitin specific peptidase 18
hsa:81790;RNF170,SNAX1;ring finger protein 170
hsa:342977;NANOS3,NANOS1L,NOS3;nanos homolog 3 (Drosophila)
hsa:84329;HVCN1,HV1,VSOP;hydrogen voltage-gated channel 1
hsa:9782;MATR3,MPD2,VCPDM;matrin 3
hsa:115950;ZNF653,E430039K05Rik,ZIP67;zinc finger protein 653
hsa:26580;BSCL2,GNG3LG,HMN5,SPG17;Berardinelli-Seip congenital lipodystrophy 2 (seipin)
hsa:57538;ALPK3,MAK,MIDORI;alpha-kinase 3
hsa:57693;ZNF317;zinc finger protein 317
hsa:79595;SAP130;Sin3A-associated protein, 130kDa (EC:3.2.1.3)
hsa:2823;GPM6A,GPM6,M6A;glycoprotein M6A
hsa:80110;ZNF614;zinc finger protein 614
hsa:92340;C17orf72;chromosome 17 open reading frame 72
hsa:23118;TAB2,CHTD2,MAP3K7IP2;TGF-beta activated kinase 1/MAP3K7 binding protein 2
hsa:7185;TRAF1,EBI6,MGC:10353;TNF receptor-associated factor 1
hsa:1528;CYB5A,CYB5,MCB5;cytochrome b5 type A (microsomal)
hsa:125206;SLC5A10,SGLT-5,SGLT5;solute carrier family 5 (sodium/glucose cotransporter), member 10
hsa:400950;C2orf91;chromosome 2 open reading frame 91
hsa:4093;SMAD9,MADH6,MADH9,SMAD8,SMAD8A,SMAD8B;SMAD family member 9
hsa:64236;PDLIM2,MYSTIQUE,SLIM;PDZ and LIM domain 2 (mystique)
hsa:80114;BICC1,BICC,CYSRD;bicaudal C homolog 1 (Drosophila)
hsa:8850;KAT2B,CAF,P,P/CAF,PCAF;K(lysine) acetyltransferase 2B (EC:2.3.1.48)
hsa:79177;ZNF576;zinc finger protein 576
hsa:9290;GPR55;G protein-coupled receptor 55
hsa:51280;GOLM1,C9orf155,GOLPH2,GP73,PSEC0257,bA379P1.3;golgi membrane protein 1
hsa:10482;NXF1,MEX67,TAP;nuclear RNA export factor 1
hsa:400746;NCMAP,C1orf130,MP11;noncompact myelin associated protein
hsa:56910;STARD7,GTT1;StAR-related lipid transfer (START) domain containing 7
hsa:4240;MFGE8,BA46,EDIL1,HMFG,HsT19888,MFG-E8,MFGM,OAcGD3S,SED1,SPAG10,hP47;milk fat globule-EGF factor 8 protein
hsa:3556;IL1RAP,C3orf13,IL-1RAcP,IL1R3;interleukin 1 receptor accessory protein
hsa:11119;BTN3A1,BT3.1,BTF5,CD277;butyrophilin, subfamily 3, member A1
hsa:10219;KLRG1,2F1,CLEC15A,MAFA,MAFA-2F1,MAFA-L,MAFA-LIKE;killer cell lectin-like receptor subfamily G, member 1
hsa:121274;ZNF641;zinc finger protein 641
hsa:1054;CEBPG,GPE1BP,IG/EBP-1;CCAAT/enhancer binding protein (C/EBP), gamma
hsa:6535;SLC6A8,CRT,CRTR,CT1;solute carrier family 6 (neurotransmitter transporter, creatine), member 8
hsa:1137;CHRNA4,BFNC,EBN,EBN1,NACHR,NACHRA4,NACRA4;cholinergic receptor, nicotinic, alpha 4 (neuronal)
hsa:100529261;CHURC1-FNTB;CHURC1-FNTB readthrough
hsa:84126;ATRIP;ATR interacting protein
hsa:6631;SNRPC,U1C,Yhc1;small nuclear ribonucleoprotein polypeptide C
hsa:7511;XPNPEP1,APP1,SAMP,XPNPEP,XPNPEPL,XPNPEPL1;X-prolyl aminopeptidase (aminopeptidase P) 1, soluble (EC:3.4.11.9)
hsa:4067;LYN,JTK8,p53Lyn,p56Lyn;v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2)
hsa:4340;MOG,MOGIG2,NRCLP7;myelin oligodendrocyte glycoprotein
hsa:55198;APPL2,DIP13B;adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2
hsa:529;ATP6V1E1,ATP6E,ATP6E2,ATP6V1E,P31,Vma4;ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 (EC:3.6.3.14)
hsa:51645;PPIL1,CYPL1,PPIase,hCyPX;peptidylprolyl isomerase (cyclophilin)-like 1 (EC:5.2.1.8)
hsa:4542;MYO1F;myosin IF
hsa:23415;KCNH4,BEC2,ELK1,Kv12.3;potassium voltage-gated channel, subfamily H (eag-related), member 4
hsa:100131980;ZNF705G;zinc finger protein 705G
hsa:646799;ZAR1L,ZAR2;zygote arrest 1-like
hsa:55086;CXorf57;chromosome X open reading frame 57
hsa:51086;TNNI3K,CARK;TNNI3 interacting kinase (EC:2.7.11.1)
hsa:6490;PMEL,D12S53E,ME20,ME20-M,ME20M,P1,P100,PMEL17,SI,SIL,SILV,gp100;premelanosome protein
hsa:57209;ZNF248,bA162G10.3;zinc finger protein 248
hsa:2710;GK,GK1,GKD;glycerol kinase (EC:2.7.1.30)
hsa:4916;NTRK3,TRKC,gp145(trkC);neurotrophic tyrosine kinase, receptor, type 3 (EC:2.7.10.1)
hsa:51501;C11orf73,HSPC179,Hikeshi,L7RN6,OPI10;chromosome 11 open reading frame 73
hsa:127396;ZNF684;zinc finger protein 684
hsa:9127;P2RX6,P2RXL1,P2X6,P2XM;purinergic receptor P2X, ligand-gated ion channel, 6
hsa:53919;SLCO1C1,OATP-F,OATP1,OATP14,OATP1C1,OATPF,OATPRP5,SLC21A14;solute carrier organic anion transporter family, member 1C1
hsa:112885;PHF21B,BHC80L,PHF4;PHD finger protein 21B
hsa:220929;ZNF438,bA330O11.1;zinc finger protein 438
hsa:2830;GPR6;G protein-coupled receptor 6
hsa:1889;ECE1,ECE;endothelin converting enzyme 1 (EC:3.4.24.71)
hsa:100506012;PPP5D1;PPP5 tetratricopeptide repeat domain containing 1
hsa:155066;ATP6V0E2,ATP6V0E2L,C7orf32;ATPase, H+ transporting V0 subunit e2
hsa:7559;ZNF12,GIOT-3,HZF11,KOX3,ZNF325;zinc finger protein 12
hsa:283;ANG,ALS9,HEL168,RNASE4,RNASE5;angiogenin, ribonuclease, RNase A family, 5 (EC:3.1.27.-)
hsa:100271715;ARHGEF33;Rho guanine nucleotide exchange factor (GEF) 33
hsa:57574;MARCH4,MARCH-IV,RNF174;membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase
hsa:9521;EEF1E1,AIMP3,P18;eukaryotic translation elongation factor 1 epsilon 1
hsa:255488;RNF144B,IBRDC2,PIR2,bA528A10.3,p53RFP;ring finger protein 144B
hsa:57798;GATAD1,CMD2B,ODAG,RG083M05.2;GATA zinc finger domain containing 1
hsa:6049;RNF6;ring finger protein (C3H2C3 type) 6
hsa:201181;ZNF385C;zinc finger protein 385C
hsa:55684;RABL6,C9orf86,PARF,RBEL1,pp8875;RAB, member RAS oncogene family-like 6
hsa:51109;RDH11,ARSDR1,CGI82,HCBP12,MDT1,PSDR1,RALR1,SCALD,SDR7C1;retinol dehydrogenase 11 (all-trans/9-cis/11-cis) (EC:1.1.1.300)
hsa:441509;GLRA4;glycine receptor, alpha 4
hsa:374383;NCR3LG1,B7-H6,B7H6,DKFZp686O24166;natural killer cell cytotoxicity receptor 3 ligand 1
hsa:10661;KLF1,EKLF,HBFQTL6,INLU;Kruppel-like factor 1 (erythroid)
hsa:123264;SLC51B,OSTB,OSTBETA;solute carrier family 51, beta subunit
hsa:84190;METTL25,C12orf26;methyltransferase like 25
hsa:25939;SAMHD1,CHBL2,DCIP,HDDC1,MOP-5,SBBI88;SAM domain and HD domain 1
hsa:55311;ZNF444,EZF-2,EZF2,ZSCAN17;zinc finger protein 444
hsa:199692;ZNF627;zinc finger protein 627
hsa:440275;EIF2AK4,GCN2;eukaryotic translation initiation factor 2 alpha kinase 4 (EC:2.7.11.1)
hsa:9188;DDX21,GUA,GURDB,RH-II/GU,RH-II/GuA;DEAD (Asp-Glu-Ala-Asp) box helicase 21 (EC:3.6.4.13)
hsa:91543;RSAD2,2510004L01Rik,cig33,cig5,vig1;radical S-adenosyl methionine domain containing 2
hsa:80829;ZFP91,DMS-8,DSM-8,PZF,ZFP-91,ZNF757;ZFP91 zinc finger protein
hsa:55170;PRMT6,HRMT1L6;protein arginine methyltransferase 6 (EC:2.1.1.125)
hsa:65220;NADK,dJ283E3.1;NAD kinase (EC:2.7.1.23)
hsa:79897;RPP21,C6orf135,CAT60;ribonuclease P/MRP 21kDa subunit (EC:3.1.26.5)
hsa:3483;IGFALS,ALS;insulin-like growth factor binding protein, acid labile subunit
hsa:646754;TRIM64C;tripartite motif containing 64C
hsa:85409;NKD2,Naked2;naked cuticle homolog 2 (Drosophila)
hsa:57176;VARS2,G7a,VARS2L,VARSL;valyl-tRNA synthetase 2, mitochondrial (EC:6.1.1.9)
hsa:5029;P2RY2,HP2U,P2RU1,P2U,P2U1,P2UR,P2Y2,P2Y2R;purinergic receptor P2Y, G-protein coupled, 2
hsa:653598;PPIAL4C,COAS-2;peptidylprolyl isomerase A (cyclophilin A)-like 4C (EC:5.2.1.8)
hsa:124989;EFCAB13,C17orf57;EF-hand calcium binding domain 13
hsa:728262;FAM157A;family with sequence similarity 157, member A
hsa:1735;DIO3,5DIII,D3,DIOIII,TXDI3;deiodinase, iodothyronine, type III (EC:1.97.1.11)
hsa:323;APBB2,FE65L,FE65L1;amyloid beta (A4) precursor protein-binding, family B, member 2
hsa:139422;MAGEB10;melanoma antigen family B, 10
hsa:286053;NSMCE2,C8orf36,MMS21,NSE2,ZMIZ7;non-SMC element 2, MMS21 homolog (S. cerevisiae)
hsa:100131390;SP9,ZNF990;Sp9 transcription factor
hsa:11117;EMILIN1,EMI,EMILIN,gp115;elastin microfibril interfacer 1
hsa:8073;PTP4A2,HH13,HH7-2,HU-PP-1,OV-1,PRL-2,PRL2,PTP4A,PTPCAAX2,ptp-IV1a,ptp-IV1b;protein tyrosine phosphatase type IVA, member 2 (EC:3.1.3.48)
hsa:79842;ZBTB3;zinc finger and BTB domain containing 3
hsa:10438;C1D,LRP1,SUN-CoR,SUNCOR,hC1D;C1D nuclear receptor corepressor
hsa:646643;SBK2,SGK069;SH3-binding domain kinase family, member 2 (EC:2.7.11.1)
hsa:137209;ZNF572;zinc finger protein 572
hsa:119587;CPXM2,CPX2,UNQ676;carboxypeptidase X (M14 family), member 2
hsa:28513;CDH19,CDH7,CDH7L2;cadherin 19, type 2
hsa:9938;ARHGAP25,KAIA0053;Rho GTPase activating protein 25
hsa:200232;FAM209A,C20orf106,dJ1153D9.3;family with sequence similarity 209, member A
hsa:7804;LRP8,APOER2,HSZ75190,LRP-8,MCI1;low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
hsa:5129;CDK18,PCTAIRE,PCTAIRE3,PCTK3;cyclin-dependent kinase 18 (EC:2.7.11.22)
hsa:57545;CC2D2A,JBTS9,MKS6;coiled-coil and C2 domain containing 2A
hsa:728927;ZNF736;zinc finger protein 736
hsa:286223;C9orf47,C9orf108,bA791O21.3;chromosome 9 open reading frame 47
hsa:200909;HTR3D,5HT3D;5-hydroxytryptamine (serotonin) receptor 3D, ionotropic
hsa:3832;KIF11,EG5,HKSP,KNSL1,MCLMR,TRIP5;kinesin family member 11
hsa:79901;CYBRD1,CYB561A2,DCYTB,FRRS3;cytochrome b reductase 1
hsa:2037;EPB41L2,4.1-G,4.1G;erythrocyte membrane protein band 4.1-like 2
hsa:57526;PCDH19,EFMR,EIEE9;protocadherin 19
hsa:6550;SLC9A3,NHE3;solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
hsa:175;AGA,AGU,ASRG,GA;aspartylglucosaminidase (EC:3.5.1.26)
hsa:1129;CHRM2,HM2;cholinergic receptor, muscarinic 2
hsa:10000;AKT3,MPPH,PKB-GAMMA,PKBG,PRKBG,RAC-PK-gamma,RAC-gamma,STK-2;v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (EC:2.7.11.1)
hsa:1182;CLCN3,CLC3,ClC-3;chloride channel, voltage-sensitive 3
hsa:406984;MIR200B,MIRN200B;microRNA 200b
hsa:406890;MIRLET7G,LET7G,MIRNLET7G,hsa-let-7g;microRNA let-7g
hsa:406907;MIR124-1,MIR124A,MIR124A1,MIRN124-1,MIRN124A1;microRNA 124-1
hsa:406969;MIR194-1,MIRN194-1;microRNA 194-1
hsa:693122;MIR421,MIRN421,hsa-mir-421;microRNA 421
hsa:55384;MEG3,FP504,GTL2,LINC00023,NCRNA00023,PRO0518,PRO2160,prebp1;maternally expressed 3 (non-protein coding)
hsa:406979;MIR19A,MIRN19A,hsa-mir-19a,miR-19a,miRNA19A;microRNA 19a
hsa:574452;MIR494,MIRN494,hsa-mir-494;microRNA 494
hsa:574455;MIR193B,MIRN193B;microRNA 193b
hsa:574460;MIR498,MIRN498,hsa-mir-498;microRNA 498
hsa:693124;MIR532,MIRN532,hsa-mir-532;microRNA 532
hsa:407032;MIR30C2,MIRN30C2;microRNA 30c-2
hsa:406902;MIR10A,MIRN10A,hsa-mir-10a,miRNA10A,mir-10a;microRNA 10a
hsa:222950;NYAP1,C7orf51,KIAA1486L;neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1
hsa:1731;SEPT1,DIFF6,LARP,PNUTL3,SEP1;septin 1 (EC:3.1.5.1)
hsa:1538;CYLC1,CYCL1;cylicin, basic protein of sperm head cytoskeleton 1
hsa:29920;PYCR2,P5CR2;pyrroline-5-carboxylate reductase family, member 2 (EC:1.5.1.2)
hsa:100129385;C9orf92,Em:AL513424.1;chromosome 9 open reading frame 92
hsa:9358;ITGBL1,OSCP,TIED;integrin, beta-like 1 (with EGF-like repeat domains)
hsa:1184;CLCN5,CLC5,CLCK2,ClC-5,DENTS,NPHL1,NPHL2,XLRH,XRN,hCIC-K2;chloride channel, voltage-sensitive 5
hsa:653308;ASAH2B,ASAH2C,ASAH2L,bA449O16.3;N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2B
hsa:126006;PCP2,GPSM4;Purkinje cell protein 2
hsa:54920;DUS2L,DUS2,SMM1,URLC8;dihydrouridine synthase 2-like, SMM1 homolog (S. cerevisiae)
hsa:388697;HRNR,FLG3,S100A16,S100a18;hornerin
hsa:64121;RRAGC,GTR2,RAGC,TIB929;Ras-related GTP binding C
hsa:79664;NARG2,BRCC1;NMDA receptor regulated 2
hsa:51319;RSRC1,SFRS21,SRrp53;arginine/serine-rich coiled-coil 1
hsa:7155;TOP2B,TOPIIB,top2beta;topoisomerase (DNA) II beta 180kDa (EC:5.99.1.3)
hsa:3013;HIST1H2AD,H2A.3,H2A/g,H2AFG;histone cluster 1, H2ad
hsa:11277;TREX1,AGS1,CRV,DRN3,HERNS;three prime repair exonuclease 1 (EC:3.1.11.2)
hsa:90060;CCDC120;coiled-coil domain containing 120
hsa:100310846;ANKRD61;ankyrin repeat domain 61
hsa:653145;ANXA8,ANX8;annexin A8
hsa:54931;TRMT10C,HNYA,MRPP1,RG9MTD1;tRNA methyltransferase 10 homolog C (S. cerevisiae)
hsa:55005;RMND1,C6orf96,COXPD11,RMD1,bA351K16,bA351K16.3;required for meiotic nuclear division 1 homolog (S. cerevisiae)
hsa:80194;TMEM134;transmembrane protein 134
hsa:4747;NEFL,CMT1F,CMT2E,NF-L,NF68,NFL;neurofilament, light polypeptide
hsa:8723;SNX4,ATG24B;sorting nexin 4
hsa:30814;PLA2G2E,GIIE_sPLA2,sPLA2-IIE;phospholipase A2, group IIE (EC:3.1.1.4)
hsa:23609;MKRN2,RNF62;makorin ring finger protein 2
hsa:5900;RALGDS,RGDS,RGF,RalGEF;ral guanine nucleotide dissociation stimulator
hsa:27430;MAT2B,MAT-II,MATIIbeta,Nbla02999,SDR23E1,TGR;methionine adenosyltransferase II, beta (EC:2.5.1.6)
hsa:23264;ZC3H7B,RoXaN;zinc finger CCCH-type containing 7B
hsa:9861;PSMD6,Rpn7,S10,SGA-113M,p42A,p44S10;proteasome (prosome, macropain) 26S subunit, non-ATPase, 6
hsa:55711;FAR2,MLSTD1,SDR10E2;fatty acyl CoA reductase 2 (EC:1.2.1.n2)
hsa:25980;AAR2,C20orf4;AAR2 splicing factor homolog (S. cerevisiae)
hsa:728489;DNLZ,C9orf151,HEP,TIMM15,ZIM17,bA413M3.2;DNL-type zinc finger
hsa:5891;MOK,RAGE,RAGE-1,RAGE1;MOK protein kinase (EC:2.7.11.22)
hsa:440689;HIST2H2BF;histone cluster 2, H2bf
hsa:23065;EMC1,KIAA0090,RP1-43E13.1;ER membrane protein complex subunit 1
hsa:158787;RIBC1,2610028I09Rik;RIB43A domain with coiled-coils 1
hsa:6691;SPINK2,HUSI-II;serine peptidase inhibitor, Kazal type 2 (acrosin-trypsin inhibitor)
hsa:55656;INTS8,C8orf52,INT8;integrator complex subunit 8
hsa:221091;LRRN4CL;LRRN4 C-terminal like
hsa:3376;IARS,IARS1,ILERS,ILRS,IRS,PRO0785;isoleucyl-tRNA synthetase (EC:6.1.1.5)
hsa:81545;FBXO38,Fbx38,MOKA;F-box protein 38
hsa:1826;DSCAM,CHD2-42,CHD2-52;Down syndrome cell adhesion molecule
hsa:63974;NEUROD6,Atoh2,MATH2,Math-2,NEX1M,Nex1,bHLHa2;neuronal differentiation 6
hsa:51308;REEP2,C5orf19,SGC32445;receptor accessory protein 2
hsa:5207;PFKFB1,F6PK,HL2K,PFRX;6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 (EC:2.7.1.105 3.1.3.46)
hsa:79583;TMEM231,ALYE870,JBTS20,PRO1886;transmembrane protein 231
hsa:7697;ZNF138,pHZ-32;zinc finger protein 138
hsa:11223;MST1L,BRF-1,D1F15S1A,MSPL-7,MSPL7,MST1P9,MSTP7,MSTP9;macrophage stimulating 1-like
hsa:22818;COPZ1,COPZ,HSPC181,zeta-COP,zeta1-COP;coatomer protein complex, subunit zeta 1
hsa:115509;ZNF689,TIPUH1;zinc finger protein 689
hsa:388325;SCIMP,C17orf87,UNQ5783;SLP adaptor and CSK interacting membrane protein
hsa:125058;TBC1D16;TBC1 domain family, member 16
hsa:80210;ARMC9,ARM,KU-MEL-1;armadillo repeat containing 9
hsa:154141;MBOAT1,1,LPEAT1,LPLAT,LPLAT_1,LPSAT,OACT1,dJ434O11.1;membrane bound O-acyltransferase domain containing 1 (EC:2.3.1.n6)
hsa:90592;ZNF700;zinc finger protein 700
hsa:5521;PPP2R2B,B55BETA,PP2AB55BETA,PP2ABBETA,PP2APR55B,PP2APR55BETA,PR2AB55BETA,PR2ABBETA,PR2APR55BETA,PR52B,PR55-BETA,PR55BETA,SCA12;protein phosphatase 2, regulatory subunit B, beta (EC:3.1.3.16)
hsa:27304;MOCS3,UBA4;molybdenum cofactor synthesis 3 (EC:2.7.7.80 2.8.1.11)
hsa:340205;TREML1,GLTL1825,PRO3438,TLT-1,TLT1,dJ238O23.3;triggering receptor expressed on myeloid cells-like 1
hsa:5409;PNMT,PENT,PNMTase;phenylethanolamine N-methyltransferase (EC:2.1.1.28)
hsa:2709;GJB5,CX31.1;gap junction protein, beta 5, 31.1kDa
hsa:7701;ZNF142,pHZ-49;zinc finger protein 142
hsa:9937;DCLRE1A,PSO2,SNM1,SNM1A;DNA cross-link repair 1A
hsa:27202;C5AR2,C5L2,GPF77,GPR77;complement component 5a receptor 2
hsa:10203;CALCRL,CGRPR,CRLR;calcitonin receptor-like
hsa:10868;USP20,LSFR3A,VDU2,hVDU2;ubiquitin specific peptidase 20 (EC:3.4.19.12)
hsa:3758;KCNJ1,KIR1.1,ROMK,ROMK1;potassium inwardly-rectifying channel, subfamily J, member 1
hsa:10444;ZER1,C9orf60,ZYG,ZYG11BL;zyg-11 related, cell cycle regulator
hsa:5269;SERPINB6,CAP,DFNB91,MSTP057,PI-6,PI6,PTI,SPI3;serpin peptidase inhibitor, clade B (ovalbumin), member 6
hsa:347252;IGFBPL1,IGFBP-RP4,IGFBPRP4,bA113O24.1;insulin-like growth factor binding protein-like 1
hsa:9427;ECEL1,DA5D,DINE,ECEX,XCE;endothelin converting enzyme-like 1
hsa:3708;ITPR1,INSP3R1,IP3R,IP3R1,SCA15,SCA16,SCA29;inositol 1,4,5-trisphosphate receptor, type 1
hsa:53947;A4GALT,A14GALT,A4GALT1,Gb3S,P(k),P1,P1PK,PK;alpha 1,4-galactosyltransferase (EC:2.4.1.228)
hsa:54084;TSPEAR,C21orf29,DFNB98,TSP-EAR;thrombospondin-type laminin G domain and EAR repeats
hsa:3770;KCNJ14,IRK4,KIR2.4;potassium inwardly-rectifying channel, subfamily J, member 14
hsa:286128;ZFP41,ZNF753,zfp-41;ZFP41 zinc finger protein
hsa:3772;KCNJ15,IRKK,KIR1.3,KIR4.2;potassium inwardly-rectifying channel, subfamily J, member 15
hsa:84989;JMJD1C-AS1;JMJD1C antisense RNA 1
hsa:100271873;AIRN,AIR,IGF2R-AS,IGF2R-AS1,IGF2RAS,NCRNA00088;antisense of IGF2R non-protein coding RNA
hsa:644168;DRGX,DRG11,PRRXL1;dorsal root ganglia homeobox
hsa:124944;C17orf49,BAP18,HEPIS;chromosome 17 open reading frame 49
hsa:3780;KCNN1,KCa2.1,SK1,SKCA1,hSK1;potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
hsa:388799;FAM209B,C20orf107,dJ1153D9.4;family with sequence similarity 209, member B
hsa:728130;NUTM2D,FAM22D;NUT family member 2D
hsa:1998;ELF2,EU32,NERF,NERF-1A,NERF-1B,NERF-1a,b,NERF-2;E74-like factor 2 (ets domain transcription factor)
hsa:441168;FAM26F,C6orf187,dJ93H18.5;family with sequence similarity 26, member F
hsa:349334;FOXD4L4,FOXD4b,bA460E7.2;forkhead box D4-like 4
hsa:653427;FOXD4L5,bA15J10.2;forkhead box D4-like 5
hsa:653404;FOXD4L6;forkhead box D4-like 6
hsa:442425;FOXB2,bA159H20.4;forkhead box B2
hsa:2583;B4GALNT1,GALGT,GALNACT,GalNAc-T;beta-1,4-N-acetyl-galactosaminyl transferase 1 (EC:2.4.1.92)
hsa:23603;CORO1C,HCRNN4;coronin, actin binding protein, 1C
hsa:55726;ASUN,C12orf11,GCT1,Mat89Bb,NET48,SPATA30;asunder, spermatogenesis regulator
hsa:51026;GOLT1B,GCT2,GOT1,GOT1B,YMR292W;golgi transport 1B
hsa:54627;MAP10,KIAA1383,MTR120;microtubule-associated protein 10
hsa:406966;MIR191,MIRN191,miR-191;microRNA 191
hsa:100422842;MIR3074;microRNA 3074
hsa:494337;MIR425,MIRN425,hsa-mir-425;microRNA 425
hsa:3619;INCENP;inner centromere protein antigens 135/155kDa
hsa:647135;SRGAP2B,SRGAP2L,SRGAP2P2;SLIT-ROBO Rho GTPase activating protein 2B
hsa:51574;LARP7,ALAZS,PIP7S;La ribonucleoprotein domain family, member 7
hsa:2976;GTF3C2,TFIIIC-BETA,TFIIIC110;general transcription factor IIIC, polypeptide 2, beta 110kDa
hsa:3382;ICA1,ICA69,ICAp69;islet cell autoantigen 1, 69kDa
hsa:55152;DALRD3;DALR anticodon binding domain containing 3
hsa:118461;C10orf71;chromosome 10 open reading frame 71
hsa:5394;EXOSC10,PM-Scl,PM/Scl-100,PMSCL,PMSCL2,RRP6,Rrp6p,p2,p3,p4;exosome component 10
hsa:84657;LINC00852,C3orf42,GHRL-AS2,GHRLOS2,NAG73;long intergenic non-protein coding RNA 852
hsa:100874253;LINC00853,PDZK1IP1-AS1,ncRNA-a4;long intergenic non-protein coding RNA 853
hsa:171022;LINC00035,ABHD11-AS1,NCRNA00035,WBSCR26;long intergenic non-protein coding RNA 35
hsa:100874261;LINC00854,TMEM106A-AS1;long intergenic non-protein coding RNA 854
hsa:440757;LINC00851,DZANK1-AS1;long intergenic non-protein coding RNA 851
hsa:1419;CRYGB,CRYG2;crystallin, gamma B
hsa:5271;SERPINB8,CAP2,PI8;serpin peptidase inhibitor, clade B (ovalbumin), member 8
hsa:8481;OFD1,71-7A,CXorf5,JBTS10,RP23,SGBS2;oral-facial-digital syndrome 1
hsa:6236;RRAD,RAD,RAD1,REM3;Ras-related associated with diabetes
hsa:5473;PPBP,B-TG1,Beta-TG,CTAP-III,CTAP3,CTAPIII,CXCL7,LA-PF4,LDGF,MDGF,NAP-2,PBP,SCYB7,TC1,TC2,TGB,TGB1,THBGB,THBGB1;pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
hsa:5672;PSG4,PSG9;pregnancy specific beta-1-glycoprotein 4
hsa:1420;CRYGC,CCL,CRYG3;crystallin, gamma C
hsa:113444;SMIM12,C1orf212;small integral membrane protein 12
hsa:1427;CRYGS,CRYG8;crystallin, gamma S
hsa:145226;RDH12,LCA13,LCA3,RP53,SDR7C2;retinol dehydrogenase 12 (all-trans/9-cis/11-cis) (EC:1.1.1.-)
hsa:1412;CRYBA2;crystallin, beta A2
hsa:5293;PIK3CD,P110DELTA,PI3K,p110D;phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (EC:2.7.1.153)
hsa:1429;CRYZ;crystallin, zeta (quinone reductase) (EC:1.6.5.5)
hsa:3594;IL12RB1,CD212,IL-12R-BETA1,IL12RB;interleukin 12 receptor, beta 1
hsa:1428;CRYM,DFNA40,THBP;crystallin, mu (EC:1.5.1.25)
hsa:1418;CRYGA,CRY-g-A,CRYG1,CRYG5;crystallin, gamma A
hsa:28;ABO,A3GALNT,A3GALT1,GTB,NAGAT;ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase;transferase B, alpha 1-3-galactosyltransferase) (EC:2.4.1.37 2.4.1.40)
hsa:64478;CSMD1,PPP1R24;CUB and Sushi multiple domains 1
hsa:6687;SPG7,CAR,CMAR,PGN,SPG5C;spastic paraplegia 7 (pure and complicated autosomal recessive)
hsa:317762;CCDC85C;coiled-coil domain containing 85C
hsa:83449;PMFBP1;polyamine modulated factor 1 binding protein 1
hsa:2208;FCER2,BLAST-2,CD23,CD23A,CLEC4J,FCE2,IGEBF;Fc fragment of IgE, low affinity II, receptor for (CD23)
hsa:91355;LRP5L;low density lipoprotein receptor-related protein 5-like
hsa:152405;C3orf30,TSCPA;chromosome 3 open reading frame 30
hsa:10587;TXNRD2,SELZ,TR,TR-BETA,TR3,TRXR2;thioredoxin reductase 2 (EC:1.8.1.9)
hsa:2902;GRIN1,GluN1,MRD8,NMDA1,NMDAR1,NR1;glutamate receptor, ionotropic, N-methyl D-aspartate 1
hsa:54471;SMCR7L,HSU79252,MID51,MIEF1,dJ1104E15.3;Smith-Magenis syndrome chromosome region, candidate 7-like
hsa:149986;LSM14B,C20orf40,FAM61B,LSM13,RAP55B,bA11M20.3;LSM14B, SCD6 homolog B (S. cerevisiae)
hsa:9083;BPY2,BPY2A,VCY2,VCY2A;basic charge, Y-linked, 2
hsa:55894;DEFB103B,BD-3,DEFB103,DEFB3,HBD3,HBP3;defensin, beta 103B
hsa:22907;DHX30,DDX30,RETCOR;DEAH (Asp-Glu-Ala-His) box polypeptide 30 (EC:3.6.4.13)
hsa:5358;PLS3,T-plastin;plastin 3
hsa:6840;SVIL;supervillin
hsa:7145;TNS1,MST091,MST122,MST127,MSTP122,MSTP127,MXRA6,TNS;tensin 1
hsa:442867;BPY2B,VCY2B;basic charge, Y-linked, 2B
hsa:442868;BPY2C,VCY2C;basic charge, Y-linked, 2C
hsa:51406;NOL7,C6orf90,PQBP3,RARG-1,dJ223E5.2;nucleolar protein 7, 27kDa
hsa:8573;CASK,CAGH39,CAMGUK,CMG,FGS4,LIN2,MICPCH,MRXSNA,TNRC8;calcium/calmodulin-dependent serine protein kinase (MAGUK family) (EC:2.7.11.1)
hsa:4925;NUCB2,NEFA;nucleobindin 2
hsa:1964;EIF1AX,EIF1A,EIF1AP1,EIF4C,eIF-1A,eIF-4C;eukaryotic translation initiation factor 1A, X-linked
hsa:80024;SLC24A6,NCKX6,NCLX;solute carrier family 24 (sodium/lithium/calcium exchanger), member 6
hsa:79161;TMEM243,C7orf23,MM-TRAG;transmembrane protein 243, mitochondrial
hsa:5260;PHKG1,PHKG;phosphorylase kinase, gamma 1 (muscle) (EC:2.7.11.1 2.7.11.19 2.7.11.26)
hsa:128240;APOA1BP,AIBP,YJEFN1;apolipoprotein A-I binding protein (EC:5.1.99.6)
hsa:5261;PHKG2,GSD9C;phosphorylase kinase, gamma 2 (testis) (EC:2.7.11.19)
hsa:6675;UAP1,AGX,AGX1,AGX2,SPAG2;UDP-N-acetylglucosamine pyrophosphorylase 1 (EC:2.7.7.23 2.7.7.83)
hsa:55347;ABHD10;abhydrolase domain containing 10 (EC:3.1.1.93)
hsa:203228;C9orf72,ALSFTD,FTDALS;chromosome 9 open reading frame 72
hsa:2232;FDXR,ADXR;ferredoxin reductase (EC:1.18.1.6)
hsa:51128;SAR1B,ANDD,CMRD,GTBPB,SARA2;SAR1 homolog B (S. cerevisiae)
hsa:92421;CHMP4C,SNF7-3,Shax3,VPS32C;charged multivesicular body protein 4C
hsa:81696;OR5V1,6M1-21,hs6M1-21;olfactory receptor, family 5, subfamily V, member 1
hsa:652;BMP4,BMP2B,BMP2B1,MCOPS6,OFC11,ZYME;bone morphogenetic protein 4
hsa:4245;MGAT1,GLCNAC-TI,GLCT1,GLYT1,GNT-1,GNT-I,MGAT;mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.101)
hsa:2678;GGT1,CD224,D22S672,D22S732,GGT,GGT_1,GTG;gamma-glutamyltransferase 1 (EC:2.3.2.2 3.4.19.13 3.4.19.14)
hsa:1667;DEFA1,DEF1,DEFA2,HNP-1,HP-1,HP1,MRS;defensin, alpha 1
hsa:8856;NR1I2,BXR,ONR1,PAR,PAR1,PAR2,PARq,PRR,PXR,SAR,SXR;nuclear receptor subfamily 1, group I, member 2
hsa:4170;MCL1,BCL2L3,EAT,MCL1-ES,MCL1L,MCL1S,Mcl-1,TM,bcl2-L-3,mcl1/EAT;myeloid cell leukemia sequence 1 (BCL2-related)
hsa:10798;OR5I1,HSOlf1,OLF1;olfactory receptor, family 5, subfamily I, member 1
hsa:1278;COL1A2,OI4;collagen, type I, alpha 2
hsa:64805;P2RY12,ADPG-R,BDPLT8,HORK3,P2T(AC),P2Y(12)R,P2Y(AC),P2Y(ADP),P2Y(cyc),P2Y12,SP1999;purinergic receptor P2Y, G-protein coupled, 12
hsa:219960;OR10Q1,OR11-233;olfactory receptor, family 10, subfamily Q, member 1
hsa:3767;KCNJ11,BIR,HHF2,IKATP,KIR6.2,PHHI,TNDM3;potassium inwardly-rectifying channel, subfamily J, member 11
hsa:8277;TKTL1,TKR,TKT2;transketolase-like 1 (EC:2.2.1.1)
hsa:26686;OR4E2,OR14-42;olfactory receptor, family 4, subfamily E, member 2
hsa:1394;CRHR1,CRF-R,CRF-R-1,CRF-R1,CRF1,CRFR-1,CRFR1,CRH-R-1,CRH-R1,CRH-R1h,CRHR,CRHR1L,CRHR1f;corticotropin releasing hormone receptor 1
hsa:11152;WDR45,NBIA4,WDRX1,WIPI-4,WIPI4;WD repeat domain 45
hsa:1470;CST2;cystatin SA
hsa:79473;OR52N1,OR11-61;olfactory receptor, family 52, subfamily N, member 1
hsa:26189;OR1A2,OR17-6;olfactory receptor, family 1, subfamily A, member 2
hsa:2346;FOLH1,FGCP,FOLH,GCP2,GCPII,NAALAD1,NAALAdase,PSM,PSMA,mGCP;folate hydrolase (prostate-specific membrane antigen) 1 (EC:3.4.17.21)
hsa:166;AES,AES-1,AES-2,ESP1,GRG,GRG5,TLE5;amino-terminal enhancer of split
hsa:23327;NEDD4L,NEDD4-2,NEDD4.2,RSP5,hNEDD4-2;neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase (EC:6.3.2.-)
hsa:81469;OR2G3,OR1-33;olfactory receptor, family 2, subfamily G, member 3
hsa:28968;SLC6A16,NTT5;solute carrier family 6, member 16
hsa:4123;MAN2C1,MAN6A8,MANA,MANA1;mannosidase, alpha, class 2C, member 1 (EC:3.2.1.24)
hsa:26707;OR2J2,OR6-19,OR6-8,OR6.3.8,ORL684,dJ80I19.4,hs6M1-6;olfactory receptor, family 2, subfamily J, member 2
hsa:3929;LBP,BPIFD2;lipopolysaccharide binding protein
hsa:4345;CD200,MOX1,MOX2,MRC,OX-2;CD200 molecule
hsa:81470;OR2G2,OR1-32;olfactory receptor, family 2, subfamily G, member 2
hsa:213;ALB,PRO0883,PRO0903,PRO1341;albumin
hsa:2158;F9,FIX,HEMB,P19,PTC,THPH8;coagulation factor IX (EC:3.4.21.22)
hsa:4868;NPHS1,CNF,NPHN,nephrin;nephrosis 1, congenital, Finnish type (nephrin)
hsa:347;APOD;apolipoprotein D
hsa:8655;DYNLL1,DLC1,DLC8,DNCL1,DNCLC1,LC8,LC8a,PIN,hdlc1;dynein, light chain, LC8-type 1
hsa:79345;OR51B2,HOR5'Beta3,OR51B1P;olfactory receptor, family 51, subfamily B, member 2
hsa:84570;COL25A1,AMY,CLAC,CLAC-P,CLACP;collagen, type XXV, alpha 1
hsa:4690;NCK1,NCK,NCKalpha,nck-1;NCK adaptor protein 1
hsa:2911;GRM1,GPRC1A,GRM1A,MGLUR1,MGLUR1A,SCAR13,mGlu1;glutamate receptor, metabotropic 1
hsa:1471;CST3,ARMD11;cystatin C
hsa:127066;OR14C36,OR5BF1;olfactory receptor, family 14, subfamily C, member 36
hsa:219453;OR8K5,OR11-174;olfactory receptor, family 8, subfamily K, member 5
hsa:388468;POTEC,A26B2,CT104.6,POTE-18,POTE18;POTE ankyrin domain family, member C
hsa:138803;OR13C3,OR37G,OR9-8;olfactory receptor, family 13, subfamily C, member 3
hsa:138804;OR13C4,HSHTPCRX17,HTPCRX17,OR2K1,OR37F,OR9-7;olfactory receptor, family 13, subfamily C, member 4
hsa:4335;MNT,MAD6,MXD6,ROX,bHLHd3;MNT, MAX dimerization protein
hsa:11197;WIF1,WIF-1;WNT inhibitory factor 1
hsa:81309;OR4C15,OR11-127,OR11-134;olfactory receptor, family 4, subfamily C, member 15
hsa:4992;OR1F1,OLFMF,OR16-36,OR16-37,OR16-88,OR16-89,OR16-90,OR1F10,OR1F13P,OR1F4,OR1F5,OR1F6,OR1F7,OR1F8,OR1F9,OR3-145,ORL1023;olfactory receptor, family 1, subfamily F, member 1
hsa:2995;GYPC,CD236,CD236R,GE,GPC,GPD,GYPD,PAS-2,PAS-2';glycophorin C (Gerbich blood group)
hsa:672;BRCA1,BRCAI,BRCC1,BROVCA1,IRIS,PNCA4,PPP1R53,PSCP,RNF53;breast cancer 1, early onset
hsa:2532;DARC,CCBP1,CD234,Dfy,FY,GPD,GpFy,WBCQ1;Duffy blood group, chemokine receptor
hsa:64399;HHIP,HIP;hedgehog interacting protein
hsa:219447;OR5AS1,OR11-168;olfactory receptor, family 5, subfamily AS, member 1
hsa:2875;GPT,AAT1,ALT1,GPT1;glutamic-pyruvate transaminase (alanine aminotransferase) (EC:2.6.1.2)
hsa:219875;OR4D5,OR11-276;olfactory receptor, family 4, subfamily D, member 5
hsa:2271;FH,HLRCC,LRCC,MCL,MCUL1;fumarate hydratase (EC:4.2.1.2)
hsa:341799;OR6S1,OR14-37,OR6S1Q;olfactory receptor, family 6, subfamily S, member 1
hsa:138883;OR1N1,OR1-26,OR1N3,OR9-22;olfactory receptor, family 1, subfamily N, member 1
hsa:114781;BTBD9,dJ322I12.1;BTB (POZ) domain containing 9
hsa:2746;GLUD1,GDH,GDH1,GLUD;glutamate dehydrogenase 1 (EC:1.4.1.3)
hsa:3655;ITGA6,CD49f,ITGA6B,VLA-6;integrin, alpha 6
hsa:81168;OR8J3,OR11-173;olfactory receptor, family 8, subfamily J, member 3
hsa:158131;OR1Q1,HSTPCR106,OR1Q2,OR1Q3,OR9-25,OR9-A,OST226,OST226OR9-A,TPCR106;olfactory receptor, family 1, subfamily Q, member 1
hsa:1536;CYBB,AMCBX2,CGD,GP91-1,GP91-PHOX,GP91PHOX,NOX2,p91-PHOX;cytochrome b-245, beta polypeptide
hsa:79026;AHNAK,AHNAKRS;AHNAK nucleoprotein
hsa:27241;BBS9,B1,C18,D1,PTHB1;Bardet-Biedl syndrome 9
hsa:150483;TEKT4;tektin 4
hsa:1457;CSNK2A1,CK2A1,CKII;casein kinase 2, alpha 1 polypeptide (EC:2.7.11.1)
hsa:162998;OR7D2,HTPCRH03,OR19-10,OR19-4;olfactory receptor, family 7, subfamily D, member 2
hsa:190;NR0B1,AHC,AHCH,AHX,DAX-1,DAX1,DSS,GTD,HHG,NROB1,SRXY2;nuclear receptor subfamily 0, group B, member 1
hsa:81327;OR4A16,OR11-117,OR4A16Q;olfactory receptor, family 4, subfamily A, member 16
hsa:9958;USP15,UNPH-2,UNPH4;ubiquitin specific peptidase 15 (EC:3.4.19.12)
hsa:10329;TMEM5,HP10481,MDDGA10;transmembrane protein 5
hsa:10581;IFITM2,1-8D,DSPA2c;interferon induced transmembrane protein 2
hsa:9950;GOLGA5,GOLIM5,RFG5,ret-II;golgin A5
hsa:81328;OR4A15,OR11-118;olfactory receptor, family 4, subfamily A, member 15
hsa:83855;KLF16,BTEB4,DRRF,NSLP2;Kruppel-like factor 16
hsa:27347;STK39,DCHT,PASK,SPAK;serine threonine kinase 39 (EC:2.7.11.1)
hsa:80776;B9D2,ICIS-1,MKS10,MKSR2;B9 protein domain 2
hsa:170302;ARX,CT121,EIEE1,ISSX,MRX29,MRX32,MRX33,MRX36,MRX38,MRX43,MRX54,MRX76,MRX87,MRXS1,PRTS;aristaless related homeobox
hsa:79865;TREML2,C6orf76,TLT-2,TLT2,dJ238O23.1;triggering receptor expressed on myeloid cells-like 2
hsa:7134;TNNC1,CMD1Z,CMH13,TN-C,TNC,TNNC;troponin C type 1 (slow)
hsa:2582;GALE,SDR1E1;UDP-galactose-4-epimerase (EC:5.1.3.2)
hsa:10252;SPRY1,hSPRY1;sprouty homolog 1, antagonist of FGF signaling (Drosophila)
hsa:65018;PINK1,BRPK,PARK6;PTEN induced putative kinase 1 (EC:2.7.11.1)
hsa:81;ACTN4,ACTININ-4,FSGS,FSGS1;actinin, alpha 4
hsa:5894;RAF1,CRAF,NS5,Raf-1,c-Raf;v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1)
hsa:4618;MYF6,CNM3,MRF4,bHLHc4,myf-6;myogenic factor 6 (herculin)
hsa:23418;CRB1,LCA8,RP12;crumbs homolog 1 (Drosophila)
hsa:8604;SLC25A12,AGC1,ARALAR;solute carrier family 25 (aspartate/glutamate carrier), member 12
hsa:259;AMBP,A1M,EDC1,HCP,HI30,IATIL,ITI,ITIL,ITILC,UTI;alpha-1-microglobulin/bikunin precursor
hsa:81399;OR4F16,OR1-1,OR7-21;olfactory receptor, family 4, subfamily F, member 16
hsa:442184;OR2B3,6M1-1,OR2B3P,OR6-14,OR6-4;olfactory receptor, family 2, subfamily B, member 3
hsa:3423;IDS,MPS2,SIDS;iduronate 2-sulfatase (EC:3.1.6.13)
hsa:219959;OR1S1,OR11-232,OST034;olfactory receptor, family 1, subfamily S, member 1
hsa:4601;MXI1,MAD2,MXD2,MXI,bHLHc11;MAX interactor 1, dimerization protein
hsa:1009;CDH11,CAD11,CDHOB,OB,OSF-4;cadherin 11, type 2, OB-cadherin (osteoblast)
hsa:6204;RPS10,DBA9,S10;ribosomal protein S10
hsa:81442;OR6N2,OR1-23;olfactory receptor, family 6, subfamily N, member 2
hsa:5077;PAX3,CDHS,HUP2,WS1,WS3;paired box 3
hsa:154810;AMOTL1,JEAP;angiomotin like 1
hsa:219958;OR1S2,OR11-231;olfactory receptor, family 1, subfamily S, member 2
hsa:81448;OR6K2,OR1-17;olfactory receptor, family 6, subfamily K, member 2
hsa:1139;CHRNA7,CHRNA7-2,NACHRA7;cholinergic receptor, nicotinic, alpha 7 (neuronal)
hsa:5956;OPN1LW,CBBM,CBP,COD5,RCP,ROP;opsin 1 (cone pigments), long-wave-sensitive
hsa:5028;P2RY1,P2Y1;purinergic receptor P2Y, G-protein coupled, 1
hsa:3352;HTR1D,5-HT1D,HT1DA,HTR1DA,HTRL,RDC4;5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled
hsa:2324;FLT4,FLT41,LMPH1A,PCL,VEGFR3;fms-related tyrosine kinase 4 (EC:2.7.10.1)
hsa:92292;GLYATL1,GATF-C,GNAT;glycine-N-acyltransferase-like 1 (EC:2.3.1.68)
hsa:219954;OR9I1,OR11-228;olfactory receptor, family 9, subfamily I, member 1
hsa:3358;HTR2C,5-HT2C,5-HTR2C,HTR1C;5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
hsa:127068;OR2T34;olfactory receptor, family 2, subfamily T, member 34
hsa:121364;OR10A7,OR12-6;olfactory receptor, family 10, subfamily A, member 7
hsa:26658;OR7C2,CIT-HSP-87M17,OR19-18,OR7C3;olfactory receptor, family 7, subfamily C, member 2
hsa:277;AMY1B,AMY1;amylase, alpha 1B (salivary) (EC:3.2.1.1)
hsa:278;AMY1C,AMY1;amylase, alpha 1C (salivary) (EC:3.2.1.1)
hsa:3122;HLA-DRA,HLA-DRA1,MLRW;major histocompatibility complex, class II, DR alpha
hsa:3692;EIF6,CAB,EIF3A,ITGB4BP,b(2)gcn,eIF-6,p27(BBP),p27BBP;eukaryotic translation initiation factor 6 (EC:3.6.5.3)
hsa:819;CAMLG,CAML;calcium modulating ligand
hsa:135946;OR6B1,OR7-3,OR7-9;olfactory receptor, family 6, subfamily B, member 1
hsa:2920;CXCL2,CINC-2a,GRO2,GROb,MGSA-b,MIP-2a,MIP2,MIP2A,SCYB2;chemokine (C-X-C motif) ligand 2
hsa:1442;CSH1,CS-1,CSA,CSMT,PL,hCS-A;chorionic somatomammotropin hormone 1 (placental lactogen)
hsa:219484;OR5M8,OR11-194;olfactory receptor, family 5, subfamily M, member 8
hsa:125;ADH1B,ADH2;alcohol dehydrogenase 1B (class I), beta polypeptide (EC:1.1.1.1)
hsa:26716;OR2H1,6M1-16,HS6M1-16,OLFR42A-9004-14,OR2H6,OR2H8,OR6-2,dJ994E9.4;olfactory receptor, family 2, subfamily H, member 1
hsa:6521;SLC4A1,AE1,BND3,CD233,DI,EMPB3,EPB3,FR,RTA1A,SW,WD,WD1,WR;solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)
hsa:1181;CLCN2,CIC-2,CLC2,ECA2,ECA3,EGI11,EGI3,EGMA,EJM6,EJM8,clC-2;chloride channel, voltage-sensitive 2
hsa:81797;OR12D3,hs6M1-27;olfactory receptor, family 12, subfamily D, member 3
hsa:55733;HHAT,MART2,SKI1,Skn;hedgehog acyltransferase
hsa:2783;GNB2;guanine nucleotide binding protein (G protein), beta polypeptide 2
hsa:283189;OR9G4,OR11-216;olfactory receptor, family 9, subfamily G, member 4
hsa:8714;ABCC3,ABC31,EST90757,MLP2,MOAT-D,MRP3,cMOAT2;ATP-binding cassette, sub-family C (CFTR/MRP), member 3
hsa:1896;EDA,ECTD1,ED1,ED1-A1,ED1-A2,EDA1,EDA2,HED,HED1,ODT1,STHAGX1,XHED,XLHED;ectodysplasin A
hsa:1075;CTSC,CPPI,DPP-I,DPP1,DPPI,HMS,JP,JPD,PALS,PDON1,PLS;cathepsin C (EC:3.4.14.1)
hsa:8838;WISP3,CCN6,LIBC,PPAC,PPD;WNT1 inducible signaling pathway protein 3
hsa:6324;SCN1B,GEFSP1;sodium channel, voltage-gated, type I, beta subunit
hsa:2815;GP9,CD42a,GPIX;glycoprotein IX (platelet)
hsa:3028;HSD17B10,17b-HSD10,ABAD,CAMR,DUPXp11.22,ERAB,HADH2,HCD2,MHBD,MRPP2,MRX17,MRX31,MRXS10,SCHAD,SDR5C1;hydroxysteroid (17-beta) dehydrogenase 10 (EC:1.1.1.35 1.1.1.178)
hsa:120892;LRRK2,AURA17,DARDARIN,PARK8,RIPK7,ROCO2;leucine-rich repeat kinase 2 (EC:2.7.11.1)
hsa:10825;NEU3,SIAL3;sialidase 3 (membrane sialidase) (EC:3.2.1.18)
hsa:55690;PACS1,MRD17;phosphofurin acidic cluster sorting protein 1
hsa:341152;OR2AT4,OR11-265;olfactory receptor, family 2, subfamily AT, member 4
hsa:1654;DDX3X,DBX,DDX14,DDX3,HLP2;DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked (EC:3.6.4.13)
hsa:84246;MED10,NUT2,TRG20;mediator complex subunit 10
hsa:343169;OR6F1,OR1-34,OR1-38,OST731;olfactory receptor, family 6, subfamily F, member 1
hsa:403239;OR2T27;olfactory receptor, family 2, subfamily T, member 27
hsa:276;AMY1A,AMY1;amylase, alpha 1A (salivary) (EC:3.2.1.1)
hsa:5994;RFXAP;regulatory factor X-associated protein
hsa:6915;TBXA2R,BDPLT13,TXA2-R;thromboxane A2 receptor
hsa:403244;OR2T35;olfactory receptor, family 2, subfamily T, member 35
hsa:346528;OR2A1;olfactory receptor, family 2, subfamily A, member 1
hsa:306;ANXA3,ANX3;annexin A3 (EC:3.1.4.43)
hsa:5873;RAB27A,GS2,HsT18676,RAB27,RAM;RAB27A, member RAS oncogene family
hsa:9956;HS3ST2,30ST2,3OST2;heparan sulfate (glucosamine) 3-O-sulfotransferase 2 (EC:2.8.2.29)
hsa:390067;OR52H1,OR11-41,OR11-45;olfactory receptor, family 52, subfamily H, member 1
hsa:486;FXYD2,ATP1G1,HOMG2;FXYD domain containing ion transport regulator 2
hsa:6187;RPS2,LLREP3,S2;ribosomal protein S2
hsa:11127;KIF3A,FLA10,KLP-20;kinesin family member 3A
hsa:7024;TFCP2,LBP1C,LSF,LSF1D,SEF,TFCP2C;transcription factor CP2
hsa:6277;S100A6,2A9,5B10,CABP,CACY,PRA;S100 calcium binding protein A6
hsa:2596;GAP43,B-50,PP46;growth associated protein 43
hsa:81318;OR4A5,OR11-111;olfactory receptor, family 4, subfamily A, member 5
hsa:1991;ELANE,ELA2,GE,HLE,HNE,NE,PMN-E,SCN1;elastase, neutrophil expressed (EC:3.4.21.37)
hsa:2592;GALT;galactose-1-phosphate uridylyltransferase (EC:2.7.7.12)
hsa:571;BACH1,BACH-1;BTB and CNC homology 1, basic leucine zipper transcription factor 1
hsa:3603;IL16,LCF,NIL16,PRIL16,prIL-16;interleukin 16
hsa:3417;IDH1,IDCD,IDH,IDP,IDPC,PICD;isocitrate dehydrogenase 1 (NADP+), soluble (EC:1.1.1.42)
hsa:3621;ING1,p24ING1c,p33,p33ING1,p33ING1b,p47,p47ING1a;inhibitor of growth family, member 1
hsa:8671;SLC4A4,HNBC1,KNBC,NBC1,NBC2,NBCe1-A,SLC4A5,hhNMC,pNBC;solute carrier family 4, sodium bicarbonate cotransporter, member 4
hsa:7352;UCP3,SLC25A9;uncoupling protein 3 (mitochondrial, proton carrier)
hsa:9526;MPDU1,CDGIF,HBEBP2BPA,Lec35,My008,PP3958,PQLC5,SL15;mannose-P-dolichol utilization defect 1
hsa:634;CEACAM1,BGP,BGP1,BGPI;carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
hsa:85439;STON2,STN2,STNB,STNB2;stonin 2
hsa:5345;SERPINF2,A2AP,AAP,ALPHA-2-PI,API,PLI;serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
hsa:7133;TNFRSF1B,CD120b,TBPII,TNF-R-II,TNF-R75,TNFBR,TNFR1B,TNFR2,TNFR80,p75,p75TNFR;tumor necrosis factor receptor superfamily, member 1B
hsa:83452;RAB33B;RAB33B, member RAS oncogene family
hsa:10492;SYNCRIP,GRY-RBP,GRYRBP,HNRPQ1,NSAP1,PP68,hnRNP-Q;synaptotagmin binding, cytoplasmic RNA interacting protein
hsa:283092;OR4C13;olfactory receptor, family 4, subfamily C, member 13
hsa:6749;SSRP1,FACT,FACT80,T160;structure specific recognition protein 1
hsa:7399;USH2A,RP39,US2,USH2,dJ1111A8.1;Usher syndrome 2A (autosomal recessive, mild)
hsa:3817;KLK2,KLK2A2,hGK-1,hK2;kallikrein-related peptidase 2 (EC:3.4.21.35)
hsa:79165;LENG1;leukocyte receptor cluster (LRC) member 1
hsa:81851;KRTAP1-1,HB2A,KAP1.1,KAP1.1A,KAP1.1B,KAP1.6,KAP1.7,KRTAP1.1,KRTAP1A,hKAP1.7;keratin associated protein 1-1
hsa:3479;IGF1,IGF-I,IGF1A,IGFI;insulin-like growth factor 1 (somatomedin C)
hsa:6772;STAT1,CANDF7,ISGF-3,STAT91;signal transducer and activator of transcription 1, 91kDa
hsa:3852;KRT5,CK5,DDD,EBS2,K5,KRT5A;keratin 5
hsa:5167;ENPP1,ARHR2,M6S1,NPP1,NPPS,PC-1,PCA1,PDNP1;ectonucleotide pyrophosphatase/phosphodiesterase 1 (EC:3.1.4.1 3.6.1.9)
hsa:55755;CDK5RAP2,C48,Cep215,MCPH3;CDK5 regulatory subunit associated protein 2
hsa:466;ATF1,EWS-ATF1,FUS/ATF-1,TREB36;activating transcription factor 1
hsa:23553;HYAL4,CSHY;hyaluronoglucosaminidase 4 (EC:3.2.1.35)
hsa:5133;PDCD1,CD279,PD-1,PD1,SLEB2,hPD-1,hPD-l;programmed cell death 1
hsa:8862;APLN,APEL,XNPEP2;apelin
hsa:10165;SLC25A13,ARALAR2,CITRIN,CTLN2;solute carrier family 25 (aspartate/glutamate carrier), member 13
hsa:6934;TCF7L2,TCF-4,TCF4;transcription factor 7-like 2 (T-cell specific, HMG-box)
hsa:55749;CCAR1,RP11-437A18.1;cell division cycle and apoptosis regulator 1
hsa:7372;UMPS,OPRT;uridine monophosphate synthetase (EC:2.4.2.10 4.1.1.23)
hsa:1832;DSP,DP,DPI,DPII;desmoplakin
hsa:3670;ISL1,ISLET1,Isl-1;ISL LIM homeobox 1
hsa:57136;APMAP,BSCv,C20orf3;adipocyte plasma membrane associated protein
hsa:219477;OR8J1,OR11-183;olfactory receptor, family 8, subfamily J, member 1
hsa:793;CALB1,CALB;calbindin 1, 28kDa
hsa:30061;SLC40A1,FPN1,HFE4,IREG1,MST079,MTP1,SLC11A3;solute carrier family 40 (iron-regulated transporter), member 1
hsa:3156;HMGCR,LDLCQ3;3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34)
hsa:2318;FLNC,ABP-280,ABP280A,ABPA,ABPL,FLN2,MFM5,MPD4;filamin C, gamma
hsa:22926;ATF6,ATF6A;activating transcription factor 6
hsa:5469;MED1,CRSP1,CRSP200,DRIP205,DRIP230,PBP,PPARBP,PPARGBP,RB18A,TRAP220,TRIP2;mediator complex subunit 1
hsa:8590;OR6A2,I7,OR11-55,OR6A1,OR6A2P;olfactory receptor, family 6, subfamily A, member 2
hsa:2670;GFAP;glial fibrillary acidic protein
hsa:3908;LAMA2,LAMM;laminin, alpha 2
hsa:26648;OR7E24,HSHT2,OR19-8,OR7E24P,OR7E24Q;olfactory receptor, family 7, subfamily E, member 24
hsa:9412;MED21,SRB7,SURB7,hSrb7;mediator complex subunit 21
hsa:283093;OR4C12,OR11-259;olfactory receptor, family 4, subfamily C, member 12
hsa:147007;TMEM199,C17orf32;transmembrane protein 199
hsa:211;ALAS1,ALAS,ALAS3,ALASH,MIG4;aminolevulinate, delta-, synthase 1 (EC:2.3.1.37)
hsa:11169;WDHD1,AND-1,CHTF4,CTF4;WD repeat and HMG-box DNA binding protein 1
hsa:27183;VPS4A,SKD1,SKD1A,SKD2,VPS4,VPS4-1;vacuolar protein sorting 4 homolog A (S. cerevisiae) (EC:3.6.4.6)
hsa:114836;SLAMF6,CD352,KALI,KALIb,Ly108,NTB-A,NTBA,SF2000;SLAM family member 6
hsa:3714;JAG2,HJ2,SER2;jagged 2
hsa:5961;PRPH2,AOFMD,AVMD,CACD2,DS,PRPH,RDS,RP7,TSPAN22,rd2;peripherin 2 (retinal degeneration, slow)
hsa:10013;HDAC6,HD6;histone deacetylase 6 (EC:3.5.1.98)
hsa:10135;NAMPT,1110035O14Rik,PBEF,PBEF1,VF,VISFATIN;nicotinamide phosphoribosyltransferase (EC:2.4.2.12)
hsa:6628;SNRPB,COD,SNRPB1,Sm-B/B',SmB/B',SmB/SmB',snRNP-B;small nuclear ribonucleoprotein polypeptides B and B1
hsa:390054;OR52A5,OR11-33;olfactory receptor, family 52, subfamily A, member 5
hsa:2052;EPHX1,EPHX,EPOX,HYL1,MEH;epoxide hydrolase 1, microsomal (xenobiotic) (EC:3.3.2.9)
hsa:403253;OR4A47,OR11-113;olfactory receptor, family 4, subfamily A, member 47
hsa:4907;NT5E,CD73,E5NT,NT,NT5,NTE,eN,eNT;5'-nucleotidase, ecto (CD73) (EC:3.1.3.5)
hsa:143496;OR52B4,OR11-3;olfactory receptor, family 52, subfamily B, member 4
hsa:3948;LDHC,CT32,LDH3,LDHX;lactate dehydrogenase C (EC:1.1.1.27)
hsa:9424;KCNK6,K2p6.1,KCNK8,TOSS,TWIK-2,TWIK2;potassium channel, subfamily K, member 6
hsa:27121;DKK4,DKK-4;dickkopf homolog 4 (Xenopus laevis)
hsa:9371;KIF3B,FLA8,HH0048,KLP-11;kinesin family member 3B (EC:3.6.4.4)
hsa:9282;MED14,CRSP150,CRSP2,CSRP,CXorf4,DRIP150,EXLM1,RGR1,TRAP170;mediator complex subunit 14
hsa:6373;CXCL11,H174,I-TAC,IP-9,IP9,SCYB11,SCYB9B,b-R1;chemokine (C-X-C motif) ligand 11
hsa:10350;ABCA9,EST640918;ATP-binding cassette, sub-family A (ABC1), member 9
hsa:1609;DGKQ,DAGK,DAGK4,DAGK7;diacylglycerol kinase, theta 110kDa (EC:2.7.1.107)
hsa:7486;WRN,RECQ3,RECQL2,RECQL3;Werner syndrome, RecQ helicase-like (EC:3.6.4.12)
hsa:6310;ATXN1,ATX1,D6S504E,SCA1;ataxin 1
hsa:10803;CCR9,CC-CKR-9,CDw199,GPR-9-6,GPR28;chemokine (C-C motif) receptor 9
hsa:33;ACADL,ACAD4,LCAD;acyl-CoA dehydrogenase, long chain (EC:1.3.8.8)
hsa:81848;SPRY4;sprouty homolog 4 (Drosophila)
hsa:5294;PIK3CG,PI3CG,PI3K,PI3Kgamma,PIK3;phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma (EC:2.7.11.1 2.7.1.153)
hsa:2332;FMR1,FMRP,FRAXA,POF,POF1;fragile X mental retardation 1
hsa:6390;SDHB,CWS2,IP,PGL4,SDH,SDH1,SDH2,SDHIP;succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (EC:1.3.5.1)
hsa:26737;OR1L1,HG23,OR1L2,OR9-27,OR9-C;olfactory receptor, family 1, subfamily L, member 1
hsa:6850;SYK,p72-Syk;spleen tyrosine kinase (EC:2.7.10.2)
hsa:54820;NDE1,HOM-TES-87,LIS4,NUDE,NUDE1;nudE nuclear distribution E homolog 1 (A. nidulans)
hsa:392390;OR1L6,HG16,OR1L7,OR9-30;olfactory receptor, family 1, subfamily L, member 6
hsa:285659;OR2V2,OR2V3,OST713;olfactory receptor, family 2, subfamily V, member 2
hsa:1512;CTSH,ACC-4,ACC-5,CPSB,minichain;cathepsin H (EC:3.4.22.16)
hsa:10332;CLEC4M,CD209L,CD299,DC-SIGN2,DC-SIGNR,DCSIGNR,HP10347,L-SIGN,LSIGN;C-type lectin domain family 4, member M
hsa:1559;CYP2C9,CPC9,CYP2C,CYP2C10,CYPIIC9,P450IIC9;cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80)
hsa:347169;OR1B1,OR9-26,OR9-B;olfactory receptor, family 1, subfamily B, member 1
hsa:219952;OR6Q1,OR11-226;olfactory receptor, family 6, subfamily Q, member 1
hsa:6337;SCNN1A,BESC2,ENaCa,ENaCalpha,SCNEA,SCNN1;sodium channel, non-voltage-gated 1 alpha subunit
hsa:56;ACRV1,D11S4365,SP-10,SPACA2;acrosomal vesicle protein 1
hsa:1244;ABCC2,ABC30,CMOAT,DJS,MRP2,cMRP;ATP-binding cassette, sub-family C (CFTR/MRP), member 2
hsa:1308;COL17A1,BA16H23.2,BP180,BPA-2,BPAG2,LAD-1;collagen, type XVII, alpha 1
hsa:51022;GLRX2,CGI-133,GRX2;glutaredoxin 2
hsa:3798;KIF5A,D12S1889,MY050,NKHC,SPG10;kinesin family member 5A
hsa:54331;GNG2;guanine nucleotide binding protein (G protein), gamma 2
hsa:347168;OR1J1,OR9-18,hg32;olfactory receptor, family 1, subfamily J, member 1
hsa:10150;MBNL2,MBLL,MBLL39,PRO2032;muscleblind-like splicing regulator 2
hsa:23460;ABCA6,EST155051;ATP-binding cassette, sub-family A (ABC1), member 6
hsa:84417;C2orf40,ECRG4;chromosome 2 open reading frame 40
hsa:26219;OR1J4,HSHTPCRX01,HTPCRX01,OR9-21;olfactory receptor, family 1, subfamily J, member 4
hsa:5468;PPARG,CIMT1,GLM1,NR1C3,PPARG1,PPARG2,PPARgamma;peroxisome proliferator-activated receptor gamma
hsa:1361;CPB2,CPU,PCPB,TAFI;carboxypeptidase B2 (plasma) (EC:3.4.17.20)
hsa:56606;SLC2A9,GLUT9,GLUTX,UAQTL2,URATv1;solute carrier family 2 (facilitated glucose transporter), member 9
hsa:51517;NCKIPSD,AF3P21,DIP,DIP1,ORF1,SPIN90,WASLBP,WISH;NCK interacting protein with SH3 domain
hsa:1281;COL3A1,EDS4A;collagen, type III, alpha 1
hsa:8932;MBD2,DMTase,NY-CO-41;methyl-CpG binding domain protein 2
hsa:729920;ISPD,MDDGA7,Nip;isoprenoid synthase domain containing (EC:2.7.7.-)
hsa:2542;SLC37A4,G6PT1,G6PT2,G6PT3,GSD1b,GSD1c,GSD1d,TRG-19,TRG19;solute carrier family 37 (glucose-6-phosphate transporter), member 4
hsa:119774;OR52K2,OR11-7;olfactory receptor, family 52, subfamily K, member 2
hsa:138881;OR1L8,OR9-24;olfactory receptor, family 1, subfamily L, member 8
hsa:366;AQP9,AQP-9,HsT17287,SSC1;aquaporin 9
hsa:118460;EXOSC6,EAP4,MTR3,Mtr3p,hMtr3p,p11;exosome component 6
hsa:10614;HEXIM1,CLP1,EDG1,HIS1,MAQ1;hexamethylene bis-acetamide inducible 1
hsa:9536;PTGES,MGST-IV,MGST1-L1,MGST1L1,MPGES,PGES,PIG12,PP102,PP1294,TP53I12,mPGES-1;prostaglandin E synthase (EC:5.3.99.3)
hsa:151;ADRA2B,ADRA2L1,ADRA2RL1,ADRARL1,ALPHA2BAR,alpha-2BAR;adrenoceptor alpha 2B
hsa:1730;DIAPH2,DIA,DIA2,DRF2,POF,POF2;diaphanous homolog 2 (Drosophila)
hsa:125963;OR1M1,OR19-5,OR19-6;olfactory receptor, family 1, subfamily M, member 1
hsa:8387;OR1E1,HGM071,OR13-66,OR17-2,OR17-32,OR1E5,OR1E6,OR1E8P,OR1E9P,OST547;olfactory receptor, family 1, subfamily E, member 1
hsa:7007;TECTA,DFNA12,DFNA8,DFNB21;tectorin alpha
hsa:138882;OR1N2,OR9-23;olfactory receptor, family 1, subfamily N, member 2
hsa:2921;CXCL3,CINC-2b,GRO3,GROg,MIP-2b,MIP2B,SCYB3;chemokine (C-X-C motif) ligand 3
hsa:26532;OR10H3;olfactory receptor, family 10, subfamily H, member 3
hsa:150;ADRA2A,ADRA2,ADRA2R,ADRAR,ALPHA2AAR,ZNF32;adrenoceptor alpha 2A
hsa:10397;NDRG1,CAP43,CMT4D,DRG-1,DRG1,GC4,HMSNL,NDR1,NMSL,PROXY1,RIT42,RTP,TARG1,TDD5;N-myc downstream regulated 1
hsa:9927;MFN2,CMT2A,CMT2A2,CPRP1,HSG,MARF;mitofusin 2
hsa:119772;OR52M1,OR11-11,OR52M1P,OR52M3P;olfactory receptor, family 52, subfamily M, member 1
hsa:9991;PTBP3,ROD1;polypyrimidine tract binding protein 3
hsa:113746;ODF3,CT135,SHIPPO1,TISP50,hSHIPPO;outer dense fiber of sperm tails 3
hsa:4598;MVK,LRBP,MK,MVLK,POROK3;mevalonate kinase (EC:2.7.1.36)
hsa:341276;OR10A2,OR10A2P,OR11-82,OR11-86,OST363;olfactory receptor, family 10, subfamily A, member 2
hsa:3046;HBE1,HBE;hemoglobin, epsilon 1
hsa:2887;GRB10,GRB-IR,Grb-10,IRBP,MEG1,RSS;growth factor receptor-bound protein 10
hsa:185;AGTR1,AG2S,AGTR1A,AGTR1B,AT1,AT1AR,AT1B,AT1BR,AT1R,AT2R1,AT2R1A,AT2R1B,HAT1R;angiotensin II receptor, type 1
hsa:143502;OR52I2,OR11-12;olfactory receptor, family 52, subfamily I, member 2
hsa:390093;OR10A6,OR11-96;olfactory receptor, family 10, subfamily A, member 6
hsa:343171;OR2W3,OR2W3P,OR2W8P,OST718;olfactory receptor, family 2, subfamily W, member 3
hsa:1565;CYP2D6,CPD6,CYP2D,CYP2D7AP,CYP2D7BP,CYP2D7P2,CYP2D8P2,CYP2DL1,CYPIID6,P450-DB1,P450C2D,P450DB1;cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1)
hsa:4634;MYL3,CMH8,MLC1SB,MLC1V,VLC1;myosin, light chain 3, alkali;ventricular, skeletal, slow
hsa:4633;MYL2,CMH10,MLC2;myosin, light chain 2, regulatory, cardiac, slow
hsa:390264;OR10G4,OR11-278;olfactory receptor, family 10, subfamily G, member 4
hsa:910;CD1B,CD1,CD1A,R1;CD1b molecule
hsa:435;ASL,ASAL;argininosuccinate lyase (EC:4.3.2.1)
hsa:9124;PDLIM1,CLIM1,CLP-36,CLP36,hCLIM1;PDZ and LIM domain 1
hsa:390265;OR10G7,OR11-283;olfactory receptor, family 10, subfamily G, member 7
hsa:51028;VPS36,C13orf9,EAP45;vacuolar protein sorting 36 homolog (S. cerevisiae)
hsa:126792;B3GALT6,beta3GalT6;UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6 (EC:2.4.1.134)
hsa:6295;SAG,RP47,S-AG;S-antigen;retina and pineal gland (arrestin)
hsa:120775;OR2D3,OR11-89;olfactory receptor, family 2, subfamily D, member 3
hsa:7167;TPI1,TIM,TPI;triosephosphate isomerase 1 (EC:5.3.1.1)
hsa:338751;OR52L1,OR11-50;olfactory receptor, family 52, subfamily L, member 1
hsa:219869;OR10G8,OR11-274,OR11-282;olfactory receptor, family 10, subfamily G, member 8
hsa:54512;EXOSC4,RRP41,RRP41A,Rrp41p,SKI6,Ski6p,hRrp41p,p12A;exosome component 4
hsa:317754;POTED,A26B3,ANKRD21,CT104.1,POTE,POTE-21,POTE21;POTE ankyrin domain family, member D
hsa:2683;B4GALT1,B4GAL-T1,CDG2D,GGTB2,GT1,GTB,beta4Gal-T1;UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (EC:2.4.1.22 2.4.1.90 2.4.1.38)
hsa:5270;SERPINE2,GDN,GDNPF,PI-7,PI7,PN-1,PN1,PNI;serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
hsa:135948;OR2F2,OR7-1;olfactory receptor, family 2, subfamily F, member 2
hsa:55167;MSL2,MSL-2,MSL2L1,RNF184;male-specific lethal 2 homolog (Drosophila)
hsa:6663;SOX10,DOM,PCWH,WS2E,WS4,WS4C;SRY (sex determining region Y)-box 10
hsa:914;CD2,LFA-2,SRBC,T11;CD2 molecule
hsa:2747;GLUD2,GDH2,GLUDP1;glutamate dehydrogenase 2 (EC:1.4.1.3)
hsa:9469;CHST3,C6ST,C6ST1,HSD;carbohydrate (chondroitin 6) sulfotransferase 3 (EC:2.8.2.17)
hsa:55145;THAP1,DYT6;THAP domain containing, apoptosis associated protein 1
hsa:3898;LAD1,LadA;ladinin 1
hsa:22919;MAPRE1,EB1;microtubule-associated protein, RP/EB family, member 1
hsa:100507436;MICA,MIC-A,PERB11.1;MHC class I polypeptide-related sequence A
hsa:4776;NFATC4,NF-ATc4,NFAT3;nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
hsa:126541;OR10H4,OR19-28;olfactory receptor, family 10, subfamily H, member 4
hsa:3214;HOXB4,HOX-2.6,HOX2,HOX2F;homeobox B4
hsa:2033;EP300,KAT3B,RSTS2,p300;E1A binding protein p300 (EC:2.3.1.48)
hsa:11235;PDCD10,CCM3,TFAR15;programmed cell death 10
hsa:284433;OR10H5,OR19-25,OR19-26;olfactory receptor, family 10, subfamily H, member 5
hsa:390201;OR10V1,OR11-256;olfactory receptor, family 10, subfamily V, member 1
hsa:339287;MSL1,MSL-1,hMSL1;male-specific lethal 1 homolog (Drosophila)
hsa:2155;F7,SPCA;coagulation factor VII (serum prothrombin conversion accelerator) (EC:3.4.21.21)
hsa:6281;S100A10,42C,ANX2L,ANX2LG,CAL1L,CLP11,Ca[1],GP11,P11,p10;S100 calcium binding protein A10
hsa:5724;PTAFR,PAFR;platelet-activating factor receptor
hsa:23481;PES1,PES;pescadillo ribosomal biogenesis factor 1
hsa:390261;OR6M1,OR11-271;olfactory receptor, family 6, subfamily M, member 1
hsa:127062;OR2M3,OR1-54,OR2M3P,OR2M6,OST003;olfactory receptor, family 2, subfamily M, member 3
hsa:348938;NIPAL4,ARCI6,ICHTHYIN,ICHYN;NIPA-like domain containing 4
hsa:5393;EXOSC9,PM/Scl-75,PMSCL1,RRP45,Rrp45p,p5,p6;exosome component 9 (EC:3.1.13.-)
hsa:3356;HTR2A,5-HT2A,HTR2;5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
hsa:2822;GPLD1,GPIPLD,GPIPLDM,PIGPLD,PIGPLD1;glycosylphosphatidylinositol specific phospholipase D1 (EC:3.1.4.50)
hsa:3215;HOXB5,HHO.C10,HOX2,HOX2A,HU-1,Hox2.1;homeobox B5
hsa:23089;PEG10,EDR,HB-1,MEF3L,Mar2,Mart2,RGAG3;paternally expressed 10
hsa:431704;RGS21;regulator of G-protein signaling 21
hsa:127385;OR10J5,OR1-28;olfactory receptor, family 10, subfamily J, member 5
hsa:391196;OR2M7,OR1-58;olfactory receptor, family 2, subfamily M, member 7
hsa:390648;OR4F6,OR15-15,OR4F12;olfactory receptor, family 4, subfamily F, member 6
hsa:57559;STAMBPL1,ALMalpha,AMSH-FP,AMSH-LP,bA399O19.2;STAM binding protein-like 1 (EC:3.1.2.15)
hsa:4155;MBP;myelin basic protein
hsa:410;ARSA,MLD;arylsulfatase A (EC:3.1.6.8)
hsa:3425;IDUA,IDA,MPS1;iduronidase, alpha-L- (EC:3.2.1.76)
hsa:5373;PMM2,CDG1,CDG1a,CDGS,PMI,PMI1,PMM_2;phosphomannomutase 2 (EC:5.4.2.8)
hsa:127064;OR2T12,OR1-57;olfactory receptor, family 2, subfamily T, member 12
hsa:401427;OR2A7,HSDJ0798C17,OR2A21;olfactory receptor, family 2, subfamily A, member 7
hsa:242;ALOX12B,12R-LOX,ARCI2;arachidonate 12-lipoxygenase, 12R type (EC:1.13.11.-)
hsa:127069;OR2T10,OR1-64;olfactory receptor, family 2, subfamily T, member 10
hsa:56681;SAR1A,SAR1,SARA1,Sara,masra2;SAR1 homolog A (S. cerevisiae)
hsa:26245;OR2M4,HSHTPCRX18,HTPCRX18,OR1-55,OST710,TPCR100;olfactory receptor, family 2, subfamily M, member 4
hsa:23186;RCOR1,COREST,RCOR;REST corepressor 1
hsa:9048;ARTN,ENOVIN,EVN,NBN;artemin
hsa:26339;OR5K1,HSHTPCRX10,HTPCRX10,OR3-8;olfactory receptor, family 5, subfamily K, member 1
hsa:3148;HMGB2,HMG2;high mobility group box 2
hsa:1613;DAPK3,ZIP,ZIPK;death-associated protein kinase 3 (EC:2.7.11.1)
hsa:8484;GALR3;galanin receptor 3
hsa:343406;OR10R2,OR1-8,OR10R2Q;olfactory receptor, family 10, subfamily R, member 2
hsa:391195;OR2T33,OR1-56;olfactory receptor, family 2, subfamily T, member 33
hsa:427;ASAH1,AC,ACDase,ASAH,PHP,PHP32,SMAPME;N-acylsphingosine amidohydrolase (acid ceramidase) 1 (EC:3.5.1.23)
hsa:219482;OR5M3,OR11-191;olfactory receptor, family 5, subfamily M, member 3
hsa:391109;OR10K1,OR1-6;olfactory receptor, family 10, subfamily K, member 1
hsa:127074;OR2T4,OR1-60,OR2T4Q;olfactory receptor, family 2, subfamily T, member 4
hsa:2703;GJA8,CAE,CAE1,CX50,CZP1,MP70;gap junction protein, alpha 8, 50kDa
hsa:10454;TAB1,3'-Tab1,MAP3K7IP1;TGF-beta activated kinase 1/MAP3K7 binding protein 1
hsa:219873;OR10S1,OR11-279;olfactory receptor, family 10, subfamily S, member 1
hsa:401993;OR2T5,OR1-62;olfactory receptor, family 2, subfamily T, member 5
hsa:5465;PPARA,NR1C1,PPAR,PPARalpha,hPPAR;peroxisome proliferator-activated receptor alpha
hsa:23108;RAP1GAP2,GARNL4,RAP1GA3;RAP1 GTPase activating protein 2
hsa:1586;CYP17A1,CPT7,CYP17,P450C17,S17AH;cytochrome P450, family 17, subfamily A, polypeptide 1 (EC:1.14.99.9)
hsa:63929;XPNPEP3,APP3,NPHPL1;X-prolyl aminopeptidase (aminopeptidase P) 3, putative (EC:3.4.11.9)
hsa:6580;SLC22A1,HOCT1,OCT1,oct1_cds;solute carrier family 22 (organic cation transporter), member 1
hsa:128360;OR10T2,OR1-3;olfactory receptor, family 10, subfamily T, member 2
hsa:1728;NQO1,DHQU,DIA4,DTD,NMOR1,NMORI,QR1;NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2)
hsa:125958;OR7D4,OR19-7,OR19-B,OR19B,OR7D4P,hg105;olfactory receptor, family 7, subfamily D, member 4
hsa:5364;PLXNB1,PLEXIN-B1,PLXN5,SEP;plexin B1
hsa:467;ATF3;activating transcription factor 3
hsa:391107;OR10K2,OR1-4;olfactory receptor, family 10, subfamily K, member 2
hsa:284383;OR2Z1,OR19-4,OR2Z2;olfactory receptor, family 2, subfamily Z, member 1
hsa:5354;PLP1,HLD1,MMPL,PLP,PLP/DM20,PMD,SPG2;proteolipid protein 1
hsa:2993;GYPA,CD235a,GPA,GPErik,GPSAT,HGpMiV,HGpMiXI,HGpSta(C),MN,MNS,PAS-2;glycophorin A (MNS blood group)
hsa:10058;ABCB6,ABC,ABC14,LAN,MCOPCB7,MTABC3,PRP,umat;ATP-binding cassette, sub-family B (MDR/TAP), member 6
hsa:26248;OR2K2,HSHTPCRH06,HTPCRH06,OR2AN1P,OR2AR1P;olfactory receptor, family 2, subfamily K, member 2
hsa:4018;LPA,AK38,APOA,LP;lipoprotein, Lp(a) (EC:3.4.21.-)
hsa:127077;OR2T11,OR2T11Q;olfactory receptor, family 2, subfamily T, member 11
hsa:50848;F11R,CD321,JAM,JAM1,JAMA,JCAM,KAT,PAM-1;F11 receptor
hsa:6647;SOD1,ALS,ALS1,IPOA,SOD,hSod1,homodimer;superoxide dismutase 1, soluble (EC:1.15.1.1)
hsa:128367;OR10X1,OR1-13,OR1-14,OR10X1P;olfactory receptor, family 10, subfamily X, member 1
hsa:219438;OR5D18,OR11-143;olfactory receptor, family 5, subfamily D, member 18
hsa:256144;OR4C3,OR11-98;olfactory receptor, family 4, subfamily C, member 3
hsa:8910;SGCE,DYT11,ESG;sarcoglycan, epsilon
hsa:3985;LIMK2;LIM domain kinase 2 (EC:2.7.11.1)
hsa:7054;TH,DYT14,DYT5b,TYH;tyrosine hydroxylase (EC:1.14.16.2)
hsa:119180;LYZL2;lysozyme-like 2 (EC:3.2.1.17)
hsa:6449;SGTA,SGT,alphaSGT,hSGT;small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha
hsa:10927;SPIN1,SPIN;spindlin 1
hsa:11093;ADAMTS13,13,ADAM-TS,ADAM-TS13,ADAMTS-13,C9orf8,TTP,VWFCP,vWF-CP;ADAM metallopeptidase with thrombospondin type 1 motif, 13 (EC:3.4.24.87)
hsa:2200;FBN1,ACMICD,ECTOL1,FBN,GPHYSD2,MASS,MFS1,OCTD,SGS,SSKS,WMS,WMS2;fibrillin 1
hsa:3547;IGSF1,CHTE,IGCD1,IGDC1,INHBP,PGSF2,p120;immunoglobulin superfamily, member 1
hsa:1270;CNTF,HCNTF;ciliary neurotrophic factor
hsa:219981;OR5A2;olfactory receptor, family 5, subfamily A, member 2
hsa:128368;OR10Z1,OR1-15;olfactory receptor, family 10, subfamily Z, member 1
hsa:219432;OR4C6,OR11-138;olfactory receptor, family 4, subfamily C, member 6
hsa:3216;HOXB6,HOX2,HOX2B,HU-2,Hox-2.2;homeobox B6
hsa:818;CAMK2G,CAMK,CAMK-II,CAMKG;calcium/calmodulin-dependent protein kinase II gamma (EC:2.7.11.17)
hsa:11025;LILRB3,CD85A,HL9,ILT-5,ILT5,LILRA6,LIR-3,LIR3,PIRB;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3
hsa:390442;OR11H4,OR14-36;olfactory receptor, family 11, subfamily H, member 4
hsa:3835;KIF22,A-328A3.2,KID,KNSL4,OBP,OBP-1,OBP-2,SEMDJL2;kinesin family member 22
hsa:9518;GDF15,GDF-15,MIC-1,MIC1,NAG-1,PDF,PLAB,PTGFB;growth differentiation factor 15
hsa:3822;KLRC2,CD159c,NKG2-C,NKG2C;killer cell lectin-like receptor subfamily C, member 2
hsa:7407;VARS,G7A,VARS1,VARS2;valyl-tRNA synthetase (EC:6.1.1.9)
hsa:284532;OR14A16,OR5AT1;olfactory receptor, family 14, subfamily A, member 16
hsa:5885;RAD21,CDLS4,HR21,HRAD21,MCD1,NXP1,SCC1,hHR21;RAD21 homolog (S. pombe)
hsa:390197;OR4D10,OR11-251,OR4D10P,OST711;olfactory receptor, family 4, subfamily D, member 10
hsa:122748;OR11H6;olfactory receptor, family 11, subfamily H, member 6
hsa:9075;CLDN2;claudin 2
hsa:25978;CHMP2B,ALS17,CHMP2.5,DMT1,VPS2-2,VPS2B;charged multivesicular body protein 2B
hsa:286362;OR13C9,OR37L,OR9-13;olfactory receptor, family 13, subfamily C, member 9
hsa:79647;AKIRIN1,C1orf108,RP11-781D11.2,STRF2;akirin 1
hsa:392376;OR13C2,OR37K;olfactory receptor, family 13, subfamily C, member 2
hsa:1759;DNM1,DNM;dynamin 1 (EC:3.6.5.5)
hsa:54386;TERF2IP,DRIP5,RAP1;telomeric repeat binding factor 2, interacting protein
hsa:596;BCL2,Bcl-2,PPP1R50;B-cell CLL/lymphoma 2
hsa:4261;CIITA,C2TA,CIITAIV,MHC2TA,NLRA;class II, major histocompatibility complex, transactivator
hsa:1602;DACH1,DACH;dachshund homolog 1 (Drosophila)
hsa:5266;PI3,ESI,SKALP,WAP3,WFDC14,cementoin;peptidase inhibitor 3, skin-derived
hsa:4086;SMAD1,BSP-1,BSP1,JV4-1,JV41,MADH1,MADR1;SMAD family member 1
hsa:138799;OR13C5,OR9-11;olfactory receptor, family 13, subfamily C, member 5
hsa:390037;OR52I1,OR11-13;olfactory receptor, family 52, subfamily I, member 1
hsa:390142;OR5D13;olfactory receptor, family 5, subfamily D, member 13
hsa:219983;OR4D6,OR11-250;olfactory receptor, family 4, subfamily D, member 6
hsa:8284;KDM5D,HY,HYA,JARID1D,SMCY;lysine (K)-specific demethylase 5D
hsa:57007;CXCR7,CMKOR1,CXC-R7,CXCR-7,GPR159,RDC-1,RDC1;chemokine (C-X-C motif) receptor 7
hsa:390148;OR5W2,OR5W2P,OR5W3P;olfactory receptor, family 5, subfamily W, member 2
hsa:390038;OR51D1,OR11-14,OR51D1Q;olfactory receptor, family 51, subfamily D, member 1
hsa:286365;OR13D1,OR9-15;olfactory receptor, family 13, subfamily D, member 1
hsa:4359;MPZ,CHM,CMT1,CMT1B,CMT2I,CMT2J,CMT4E,CMTDI3,CMTDID,DSS,HMSNIB,MPP,P0;myelin protein zero
hsa:6678;SPARC,ON;secreted protein, acidic, cysteine-rich (osteonectin)
hsa:5547;PRCP,HUMPCP,PCP;prolylcarboxypeptidase (angiotensinase C) (EC:3.4.16.2)
hsa:2796;GNRH1,GNRH,GRH,HH12,LHRH,LNRH;gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
hsa:390883;OR7G3,OST085;olfactory receptor, family 7, subfamily G, member 3
hsa:138805;OR13F1,OR9-6;olfactory receptor, family 13, subfamily F, member 1
hsa:390199;OR4D9,OR11-253;olfactory receptor, family 4, subfamily D, member 9
hsa:3612;IMPA1,IMP,IMPA;inositol(myo)-1(or 4)-monophosphatase 1 (EC:3.1.3.25)
hsa:552;AVPR1A,AVPR_V1a,AVPR1,V1aR;arginine vasopressin receptor 1A
hsa:1179;CLCA1,CACC,CACC1,CLCRG1,CaCC-1,GOB5,hCLCA1,hCaCC-1;chloride channel accessory 1
hsa:10001;MED6,NY-REN-28;mediator complex subunit 6
hsa:347468;OR13H1,ORX1;olfactory receptor, family 13, subfamily H, member 1
hsa:55576;STAB2,FEEL2,FELE-2,FELL2,FEX2,HARE;stabilin 2
hsa:261734;NPHP4,POC10,SLSN4;nephronophthisis 4
hsa:7515;XRCC1,RCC;X-ray repair complementing defective repair in Chinese hamster cells 1
hsa:391190;OR2L8;olfactory receptor, family 2, subfamily L, member 8
hsa:1019;CDK4,CMM3,PSK-J3;cyclin-dependent kinase 4 (EC:2.7.11.22)
hsa:1108;CHD4,Mi-2b,Mi2-BETA;chromodomain helicase DNA binding protein 4 (EC:3.6.4.12)
hsa:8200;GDF5,BDA1C,BMP14,CDMP1,LAP4,OS5,SYNS2;growth differentiation factor 5
hsa:4173;MCM4,CDC21,CDC54,NKCD,NKGCD,P1-CDC21,hCdc21;minichromosome maintenance complex component 4 (EC:3.6.4.12)
hsa:282763;OR51B5,HOR5'Beta5,OR11-37;olfactory receptor, family 51, subfamily B, member 5
hsa:5313;PKLR,PK1,PKL,PKR,PKRL,RPK;pyruvate kinase, liver and RBC (EC:2.7.1.40)
hsa:122740;OR4K14,OR14-18,OR14-22;olfactory receptor, family 4, subfamily K, member 14
hsa:392309;OR13J1,OR9-2;olfactory receptor, family 13, subfamily J, member 1
hsa:586;BCAT1,BCATC,BCT1,ECA39,MECA39,PNAS121,PP18;branched chain amino-acid transaminase 1, cytosolic (EC:2.6.1.42)
hsa:390081;OR52E4,OR11-55;olfactory receptor, family 52, subfamily E, member 4
hsa:7541;ZBTB14,ZF5,ZFP-161,ZFP-5,ZFP161,ZNF478;zinc finger and BTB domain containing 14
hsa:9895;TECPR2,KIAA0329,SPG49;tectonin beta-propeller repeat containing 2
hsa:4692;NDN,HsT16328,PWCR;necdin, melanoma antigen (MAGE) family member
hsa:4993;OR2C1,OLFmf3,OR2C2P;olfactory receptor, family 2, subfamily C, member 1
hsa:390433;OR4K13,OR14-27;olfactory receptor, family 4, subfamily K, member 13
hsa:390078;OR52E6,OR11-58;olfactory receptor, family 52, subfamily E, member 6
hsa:55835;CENPJ,BM032,CENP-J,CPAP,LAP,LIP1,MCPH6,SASS4,SCKL4,Sas-4;centromere protein J
hsa:390436;OR4K17,OR14-29;olfactory receptor, family 4, subfamily K, member 17
hsa:390079;OR52E8,OR11-54;olfactory receptor, family 52, subfamily E, member 8
hsa:10943;MSL3,MSL3L1;male-specific lethal 3 homolog (Drosophila)
hsa:7444;VRK2;vaccinia related kinase 2 (EC:2.7.11.1)
hsa:816;CAMK2B,CAM2,CAMK2,CAMKB;calcium/calmodulin-dependent protein kinase II beta (EC:2.7.11.17)
hsa:391191;OR2AK2,OR1-47,OR2AK1P;olfactory receptor, family 2, subfamily AK, member 2
hsa:8635;RNASET2,RNASE6PL,bA514O12.3;ribonuclease T2 (EC:3.1.27.1)
hsa:119695;OR52R1,OR11-22;olfactory receptor, family 52, subfamily R, member 1
hsa:133;ADM,AM;adrenomedullin
hsa:6571;SLC18A2,SVAT,SVMT,VAT2,VMAT2;solute carrier family 18 (vesicular monoamine), member 2
hsa:2852;GPER,CEPR,CMKRL2,DRY12,FEG-1,GPCR-Br,GPR30,LERGU,LERGU2,LyGPR;G protein-coupled estrogen receptor 1
hsa:5645;PRSS2,TRY2,TRY8,TRYP2;protease, serine, 2 (trypsin 2) (EC:3.4.21.4)
hsa:3651;PDX1,GSF,IDX-1,IPF1,IUF1,MODY4,PDX-1,STF-1;pancreatic and duodenal homeobox 1
hsa:4486;MST1R,CD136,CDw136,PTK8,RON;macrophage stimulating 1 receptor (c-met-related tyrosine kinase) (EC:2.7.10.1)
hsa:130075;OR9A4;olfactory receptor, family 9, subfamily A, member 4
hsa:26692;OR2W1,hs6M1-15;olfactory receptor, family 2, subfamily W, member 1
hsa:5530;PPP3CA,CALN,CALNA,CALNA1,CCN1,CNA1,PPP2B;protein phosphatase 3, catalytic subunit, alpha isozyme (EC:3.1.3.16)
hsa:122742;OR4L1,OR14-28,OR4L2P;olfactory receptor, family 4, subfamily L, member 1
hsa:23347;SMCHD1;structural maintenance of chromosomes flexible hinge domain containing 1
hsa:1376;CPT2,CPT1,CPTASE,IIAE4;carnitine palmitoyltransferase 2 (EC:2.3.1.21)
hsa:80271;ITPKC,IP3-3KC,IP3KC;inositol-trisphosphate 3-kinase C (EC:2.7.1.127)
hsa:2517;FUCA1,FUCA;fucosidase, alpha-L- 1, tissue (EC:3.2.1.51)
hsa:134083;OR2Y1,OR5-2;olfactory receptor, family 2, subfamily Y, member 1
hsa:1072;CFL1,CFL;cofilin 1 (non-muscle)
hsa:390077;OR52N2,OR11-57;olfactory receptor, family 52, subfamily N, member 2
hsa:54795;TRPM4,PFHB1B,TRPM4B;transient receptor potential cation channel, subfamily M, member 4
hsa:5118;PCOLCE,PCPE,PCPE-1,PCPE1;procollagen C-endopeptidase enhancer
hsa:26529;OR12D2,DJ994E9.8,HS6M1-20;olfactory receptor, family 12, subfamily D, member 2
hsa:135924;OR9A2;olfactory receptor, family 9, subfamily A, member 2
hsa:5122;PCSK1,BMIQ12,NEC1,PC1,PC3,SPC3;proprotein convertase subtilisin/kexin type 1 (EC:3.4.21.93)
hsa:9610;RIN1;Ras and Rab interactor 1
hsa:10735;STAG2,SA-2,SA2,SCC3B,bA517O1.1;stromal antigen 2
hsa:1390;CREM,CREM-2,ICER,hCREM-2;cAMP responsive element modulator
hsa:402317;OR2A42;olfactory receptor, family 2, subfamily A, member 42
hsa:121130;OR10P1,OR10P1P,OR10P2P,OR10P3P,OR12-7,OST701;olfactory receptor, family 10, subfamily P, member 1
hsa:3880;KRT19,CK19,K19,K1CS;keratin 19
hsa:135941;OR2A14,OR2A14P,OR2A6,OST182;olfactory receptor, family 2, subfamily A, member 14
hsa:361;AQP4,HMIWC2,MIWC;aquaporin 4
hsa:286530;P2RY8,P2Y8;purinergic receptor P2Y, G-protein coupled, 8
hsa:112802;KRT71,K6IRS1,KRT6IRS,KRT6IRS1;keratin 71
hsa:81565;NDEL1,EOPA,MITAP1,NUDEL;nudE nuclear distribution E homolog (A. nidulans)-like 1
hsa:6102;RP2,DELXp11.3,NM23-H10,NME10,TBCCD2,XRP2;retinitis pigmentosa 2 (X-linked recessive)
hsa:89910;UBE3B;ubiquitin protein ligase E3B (EC:6.3.2.-)
hsa:10294;DNAJA2,CPR3,DJ3,DJA2,DNAJ,DNJ3,HIRIP4,PRO3015,RDJ2;DnaJ (Hsp40) homolog, subfamily A, member 2
hsa:122953;JDP2,JUNDM2;Jun dimerization protein 2
hsa:59341;TRPV4,CMT2C,HMSN2C,OTRPC4,SMAL,SPSMA,SSQTL1,TRP12,VRL2,VROAC;transient receptor potential cation channel, subfamily V, member 4
hsa:2244;FGB;fibrinogen beta chain
hsa:3906;LALBA;lactalbumin, alpha- (EC:2.4.1.22)
hsa:157769;FAM91A1;family with sequence similarity 91, member A1
hsa:1406;CRX,CORD2,CRD,LCA7,OTX3;cone-rod homeobox
hsa:55634;KRBOX4,ZNF673;KRAB box domain containing 4
hsa:6331;SCN5A,CDCD2,CMD1E,CMPD2,HB1,HB2,HBBD,HH1,ICCD,IVF,LQT3,Nav1.5,PFHB1,SSS1,VF1;sodium channel, voltage-gated, type V, alpha subunit
hsa:3354;HTR1E,5-HT1E;5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled
hsa:2832;NPBWR2,GPR8;neuropeptides B/W receptor 2
hsa:3326;HSP90AB1,D6S182,HSP84,HSP90B,HSPC2,HSPCB;heat shock protein 90kDa alpha (cytosolic), class B member 1
hsa:81472;OR2C3,OR2C4,OR2C5P,OST742;olfactory receptor, family 2, subfamily C, member 3
hsa:29071;C1GALT1C1,C1GALT2,C38H2-L1,COSMC,MST143,TNPS;C1GALT1-specific chaperone 1
hsa:6282;S100A11,MLN70,S100C;S100 calcium binding protein A11
hsa:84313;VPS25,DERP9,EAP20,FAP20;vacuolar protein sorting 25 homolog (S. cerevisiae)
hsa:2171;FABP5,E-FABP,EFABP,KFABP,PA-FABP,PAFABP;fatty acid binding protein 5 (psoriasis-associated)
hsa:10208;USPL1,C13orf22,D13S106E,RP11-121O19.1,bA121O19.1;ubiquitin specific peptidase like 1
hsa:6442;SGCA,50-DAG,A2,ADL,DAG2,DMDA2,LGMD2D,SCARMD1,adhalin;sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)
hsa:120787;OR52W1,OR11-71,OR52W1P;olfactory receptor, family 52, subfamily W, member 1
hsa:6709;SPTAN1,EIEE5,NEAS,SPTA2;spectrin, alpha, non-erythrocytic 1
hsa:51142;CHCHD2,C7orf17;coiled-coil-helix-coiled-coil-helix domain containing 2
hsa:26188;OR1C1,HSTPCR27,OR1-42,OR1.5.10,ORL211,TPCR27;olfactory receptor, family 1, subfamily C, member 1
hsa:2259;FGF14,FGF-14,FHF-4,FHF4,SCA27;fibroblast growth factor 14
hsa:390429;OR4N2,OR14-13,OR14-8;olfactory receptor, family 4, subfamily N, member 2
hsa:695;BTK,AGMX1,AT,ATK,BPK,IMD1,PSCTK1,XLA;Bruton agammaglobulinemia tyrosine kinase (EC:2.7.10.2)
hsa:120066;OR5P3,JCG1;olfactory receptor, family 5, subfamily P, member 3
hsa:6792;CDKL5,EIEE2,ISSX,STK9;cyclin-dependent kinase-like 5 (EC:2.7.11.22)
hsa:160851;DGKH,DGKeta;diacylglycerol kinase, eta (EC:2.7.1.107)
hsa:3098;HK1,HK1-ta,HK1-tb,HK1-tc,HKI,HXK1;hexokinase 1 (EC:2.7.1.1)
hsa:81693;AMN,PRO1028,amnionless;amnion associated transmembrane protein
hsa:3053;SERPIND1,D22S673,HC2,HCF2,HCII,HLS2,LS2,THPH10;serpin peptidase inhibitor, clade D (heparin cofactor), member 1
hsa:390437;OR4N5;olfactory receptor, family 4, subfamily N, member 5
hsa:196335;OR56B4,OR11-67;olfactory receptor, family 56, subfamily B, member 4
hsa:10749;KIF1C,LTXS1;kinesin family member 1C
hsa:256148;OR4S1,OR11-100;olfactory receptor, family 4, subfamily S, member 1
hsa:79158;GNPTAB,GNPTA,ICD;N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits (EC:2.7.8.17)
hsa:5308;PITX2,ARP1,Brx1,IDG2,IGDS,IGDS2,IHG2,IRID2,Otlx2,PTX2,RGS,RIEG,RIEG1,RS;paired-like homeodomain 2
hsa:57165;GJC2,CX46.6,Cx47,GJA12,HLD2,LMPH1C,PMLDAR,SPG44;gap junction protein, gamma 2, 47kDa
hsa:390113;OR4X1,OR11-104;olfactory receptor, family 4, subfamily X, member 1
hsa:26533;OR10G3,OR14-40;olfactory receptor, family 10, subfamily G, member 3
hsa:11151;CORO1A,CLABP,CLIPINA,HCORO1,TACO,p57;coronin, actin binding protein, 1A
hsa:119764;OR4X2,OR11-105;olfactory receptor, family 4, subfamily X, member 2
hsa:4009;LMX1A,LMX1,LMX1.1;LIM homeobox transcription factor 1, alpha
hsa:128371;OR6K6,OR1-21;olfactory receptor, family 6, subfamily K, member 6
hsa:580;BARD1;BRCA1 associated RING domain 1
hsa:3107;HLA-C,D6S204,HLA-JY3,HLC-C,PSORS1;major histocompatibility complex, class I, C
hsa:10021;HCN4,SSS2;hyperpolarization activated cyclic nucleotide-gated potassium channel 4
hsa:219982;OR5A1,OR11-249,OR5A1P,OST181;olfactory receptor, family 5, subfamily A, member 1
hsa:390064;OR51I2,OR11-38;olfactory receptor, family 51, subfamily I, member 2
hsa:390195;OR5AN1,OR11-244;olfactory receptor, family 5, subfamily AN, member 1
hsa:390271;OR8B3,OR11-311;olfactory receptor, family 8, subfamily B, member 3
hsa:390066;OR52D1,OR11-43;olfactory receptor, family 52, subfamily D, member 1
hsa:9499;MYOT,LGMD1,LGMD1A,TTID;myotilin
hsa:219493;OR5AR1,OR11-209;olfactory receptor, family 5, subfamily AR, member 1
hsa:113278;SLC52A3,BVVLS,BVVLS1,C20orf54,RFT2,RFVT3,bA371L19.1,hRFT2;solute carrier family 52, riboflavin transporter, member 3
hsa:23259;DDHD2,SAMWD1,SPG54;DDHD domain containing 2
hsa:390445;OR5AU1,OR14-38;olfactory receptor, family 5, subfamily AU, member 1
hsa:219874;OR6T1,OR11-277;olfactory receptor, family 6, subfamily T, member 1
hsa:6231;RPS26,DBA10,S26;ribosomal protein S26
hsa:5562;PRKAA1,AMPK,AMPKa1;protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31)
hsa:4987;OPRL1,KOR-3,NOCIR,OOR,ORL1;opiate receptor-like 1
hsa:9;NAT1,AAC1,MNAT,NAT-1,NATI;N-acetyltransferase 1 (arylamine N-acetyltransferase) (EC:2.3.1.5)
hsa:7046;TGFBR1,AAT5,ACVRLK4,ALK-5,ALK5,LDS1A,LDS2A,MSSE,SKR4,TGFR-1;transforming growth factor, beta receptor 1 (EC:2.7.11.30)
hsa:390063;OR51I1;olfactory receptor, family 51, subfamily I, member 1
hsa:390260;OR6X1,OR11-270;olfactory receptor, family 6, subfamily X, member 1
hsa:64789;EXO5,C1orf176,DEM1,Exo_V,hExo5;exonuclease 5
hsa:27253;PCDH17,PCDH68,PCH68;protocadherin 17
hsa:4200;ME2,ODS1;malic enzyme 2, NAD(+)-dependent, mitochondrial (EC:1.1.1.38)
hsa:391112;OR6Y1,OR1-11,OR6Y2;olfactory receptor, family 6, subfamily Y, member 1
hsa:119765;OR4B1,OR11-106,OST208;olfactory receptor, family 4, subfamily B, member 1
hsa:1446;CSN1S1,CASA,CSN1;casein alpha s1
hsa:342372;PKD1L3;polycystic kidney disease 1-like 3
hsa:2990;GUSB,BG,MPS7;glucuronidase, beta (EC:3.2.1.31)
hsa:5309;PITX3,CTPP4,PTX3;paired-like homeodomain 3
hsa:10658;CELF1,BRUNOL2,CUG-BP,CUGBP,CUGBP1,EDEN-BP,NAB50,NAPOR,hNab50;CUGBP, Elav-like family member 1
hsa:4015;LOX;lysyl oxidase (EC:1.4.3.13)
hsa:10795;ZNF268,HZF3;zinc finger protein 268
hsa:1583;CYP11A1,CYP11A,CYPXIA1,P450SCC;cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6)
hsa:80310;PDGFD,IEGF,SCDGF-B,SCDGFB;platelet derived growth factor D
hsa:26013;L3MBTL1,H-L(3)MBT,L3MBTL,ZC2HC3,dJ138B7.3;l(3)mbt-like 1 (Drosophila)
hsa:7051;TGM1,ARCI1,ICR2,KTG,LI,LI1,TGASE,TGK;transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) (EC:2.3.2.13)
hsa:3399;ID3,HEIR-1,bHLHb25;inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
hsa:390892;OR7A10,BC85395_3,OR19-18;olfactory receptor, family 7, subfamily A, member 10
hsa:2652;OPN1MW,CBBM,CBD,COD5,GCP,GOP,OPN1MW1;opsin 1 (cone pigments), medium-wave-sensitive
hsa:219436;OR5D14,OR11-141,OR11-150;olfactory receptor, family 5, subfamily D, member 14
hsa:9970;NR1I3,CAR,CAR1,MB67;nuclear receptor subfamily 1, group I, member 3
hsa:5104;SERPINA5,PAI-3,PAI3,PCI,PCI-B,PLANH3,PROCI;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
hsa:1803;DPP4,ADABP,ADCP2,CD26,DPPIV,TP103;dipeptidyl-peptidase 4 (EC:3.4.14.5)
hsa:9588;PRDX6,1-Cys,AOP2,NSGPx,PRX,aiPLA2,p29;peroxiredoxin 6 (EC:1.11.1.9 1.11.1.15)
hsa:4352;MPL,C-MPL,CD110,MPLV,THCYT2,TPOR;myeloproliferative leukemia virus oncogene
hsa:9862;MED24,ARC100,CRSP100,CRSP4,DRIP100,THRAP4,TRAP100;mediator complex subunit 24
hsa:2215;FCGR3B,CD16,CD16b,FCG3,FCGR3,FCR-10,FCRIII,FCRIIIb;Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
hsa:8547;FCN3,FCNH,HAKA1;ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen)
hsa:402135;OR5K2,OR3-9;olfactory receptor, family 5, subfamily K, member 2
hsa:390882;OR7G2,OR19-6,OST260;olfactory receptor, family 7, subfamily G, member 2
hsa:2213;FCGR2B,CD32,CD32B,FCG2,FCGR2,IGFR2;Fc fragment of IgG, low affinity IIb, receptor (CD32)
hsa:6567;SLC16A2,AHDS,DXS128,DXS128E,MCT_7,MCT_8,MCT7,MCT8,MRX22,XPCT;solute carrier family 16, member 2 (thyroid hormone transporter)
hsa:847;CAT;catalase (EC:1.11.1.6)
hsa:219437;OR5L1,OR11-151,OST262;olfactory receptor, family 5, subfamily L, member 1
hsa:390275;OR8A1,OR11-318,OST025;olfactory receptor, family 8, subfamily A, member 1
hsa:26538;OR10H2;olfactory receptor, family 10, subfamily H, member 2
hsa:51510;CHMP5,C9orf83,HSPC177,PNAS-2,SNF7DC2,Vps60;charged multivesicular body protein 5
hsa:51160;VPS28;vacuolar protein sorting 28 homolog (S. cerevisiae)
hsa:51176;LEF1,LEF-1,TCF10,TCF1ALPHA,TCF7L3;lymphoid enhancer-binding factor 1
hsa:26338;OR5L2,HSHTPCRX16,HTPCRX16,OR11-153;olfactory receptor, family 5, subfamily L, member 2
hsa:219858;OR8B12,OR11-317;olfactory receptor, family 8, subfamily B, member 12
hsa:7077;TIMP2,CSC-21K;TIMP metallopeptidase inhibitor 2
hsa:125962;OR7G1,OR19-15,OR19-8,OR7G1P;olfactory receptor, family 7, subfamily G, member 1
hsa:8029;CUBN,IFCR,MGA1,gp280;cubilin (intrinsic factor-cobalamin receptor)
hsa:64072;CDH23,CDHR23,USH1D,DFNB12;cadherin-related 23
hsa:390168;OR5M1,OR11-208,OST050;olfactory receptor, family 5, subfamily M, member 1
hsa:283162;OR8B4,OR11-315,OR8B4P;olfactory receptor, family 8, subfamily B, member 4
hsa:2888;GRB14;growth factor receptor-bound protein 14
hsa:60482;SLC5A7,CHT,CHT1,HMN7A,hCHT;solute carrier family 5 (choline transporter), member 7
hsa:390167;OR5M10,OR11-207;olfactory receptor, family 5, subfamily M, member 10
hsa:338662;OR8D4,OR11-275;olfactory receptor, family 8, subfamily D, member 4
hsa:26539;OR10H1;olfactory receptor, family 10, subfamily H, member 1
hsa:65009;NDRG4,BDM1,SMAP-8,SMAP8;NDRG family member 4
hsa:64284;RAB17;RAB17, member RAS oncogene family
hsa:219865;OR8G5,OR11-298,OR8G5P,OR8G6;olfactory receptor, family 8, subfamily G, member 5
hsa:7707;ZNF148,BERF-1,BFCOL1,HT-BETA,ZBP-89,ZFP148,pHZ-52;zinc finger protein 148
hsa:26740;OR1J2,HG152,HSA5,OR1J3,OR1J5,OR9-19,OST044;olfactory receptor, family 1, subfamily J, member 2
hsa:4744;NEFH,NFH;neurofilament, heavy polypeptide
hsa:2534;FYN,SLK,SYN,p59-FYN;FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2)
hsa:219469;OR8H1,OR11-180;olfactory receptor, family 8, subfamily H, member 1
hsa:79092;CARD14,BIMP2,CARMA2,PRP,PSORS2,PSS1;caspase recruitment domain family, member 14
hsa:346517;OR6V1,GPR138;olfactory receptor, family 6, subfamily V, member 1
hsa:390151;OR8H2,OR11-171;olfactory receptor, family 8, subfamily H, member 2
hsa:390162;OR5M9,OR11-190;olfactory receptor, family 5, subfamily M, member 9
hsa:27020;NPTN,GP55,GP65,SDFR1,SDR1,np55,np65;neuroplastin
hsa:55966;AJAP1,MOT8,RP3-426F10.1,SHREW-1,SHREW1;adherens junctions associated protein 1
hsa:5884;RAD17,CCYC,HRAD17,R24L,RAD17SP,RAD24;RAD17 homolog (S. pombe)
hsa:219479;OR5R1,OR11-185,OR5R1P;olfactory receptor, family 5, subfamily R, member 1
hsa:390152;OR8H3,OR11-172;olfactory receptor, family 8, subfamily H, member 3
hsa:26492;OR8G2,HSTPCR120,OR8G2P,OR8G4,ORL206,ORL486,TPCR120;olfactory receptor, family 8, subfamily G, member 2
hsa:10349;ABCA10,EST698739;ATP-binding cassette, sub-family A (ABC1), member 10
hsa:1514;CTSL1,CATL,CTSL,MEP;cathepsin L1 (EC:3.4.22.15)
hsa:94233;OPN4,MOP;opsin 4
hsa:6744;SSFA2,CS-1,CS1,KRAP,SPAG13;sperm specific antigen 2
hsa:91147;TMEM67,JBTS6,MECKELIN,MKS3,NPHP11,TNEM67;transmembrane protein 67
hsa:9946;CRYZL1,4P11,QOH-1;crystallin, zeta (quinone reductase)-like 1
hsa:1644;DDC,AADC;dopa decarboxylase (aromatic L-amino acid decarboxylase) (EC:4.1.1.28)
hsa:390155;OR5T1,OR11-179,OR5T1P;olfactory receptor, family 5, subfamily T, member 1
hsa:219473;OR8K3,OR11-181;olfactory receptor, family 8, subfamily K, member 3
hsa:79295;OR5H6,OR3-11;olfactory receptor, family 5, subfamily H, member 6
hsa:10594;PRPF8,HPRP8,PRP8,PRPC8,RP13;PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae)
hsa:51010;EXOSC3,PCH1B,RP11-3J10.8,RRP40,Rrp40p,bA3J10.7,hRrp-40,p10;exosome component 3
hsa:4625;MYH7,CMD1S,CMH1,MPD1,MYHCB,SPMD,SPMM;myosin, heavy chain 7, cardiac muscle, beta
hsa:2162;F13A1,F13A;coagulation factor XIII, A1 polypeptide (EC:2.3.2.13)
hsa:85480;TSLP;thymic stromal lymphopoietin
hsa:219464;OR5T2,OR11-177;olfactory receptor, family 5, subfamily T, member 2
hsa:27303;RBMS3;RNA binding motif, single stranded interacting protein 3
hsa:26211;OR2F1,OLF3,OR14-60,OR2F3,OR2F3P,OR2F4,OR2F5,OR7-139,OR7-140;olfactory receptor, family 2, subfamily F, member 1
hsa:8106;PABPN1,OPMD,PAB2,PABII,PABP-2,PABP2;poly(A) binding protein, nuclear 1
hsa:4991;OR1D2,OLFR1,OR17-4;olfactory receptor, family 1, subfamily D, member 2
hsa:390154;OR5T3,OR11-178,OR5T3Q;olfactory receptor, family 5, subfamily T, member 3
hsa:79310;OR5H2,OR3-10;olfactory receptor, family 5, subfamily H, member 2
hsa:4994;OR3A1,OLFRA03,OR17-40,OR17-82,OR40;olfactory receptor, family 3, subfamily A, member 1
hsa:4914;NTRK1,MTC,TRK,TRK1,TRKA,Trk-A,p140-TrkA;neurotrophic tyrosine kinase, receptor, type 1 (EC:2.7.10.1)
hsa:5870;RAB6A,RAB6;RAB6A, member RAS oncogene family
hsa:119687;OR51A7,OR11-27;olfactory receptor, family 51, subfamily A, member 7
hsa:10253;SPRY2,hSPRY2;sprouty homolog 2 (Drosophila)
hsa:79317;OR4K5,OR14-16;olfactory receptor, family 4, subfamily K, member 5
hsa:4199;ME1,HUMNDME,MES;malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40)
hsa:26333;OR7A17,BC85395_4,HTPCRX19;olfactory receptor, family 7, subfamily A, member 17
hsa:26476;OR10J1,HGMP07J,HSHGMP07J;olfactory receptor, family 10, subfamily J, member 1
hsa:5555;PRH2,PIF-S,PRH1,PRP-1/PRP-2,Pr,db-s,pa,pr1/Pr2;proline-rich protein HaeIII subfamily 2
hsa:59344;ALOXE3,ARCI3,E-LOX,eLOX3;arachidonate lipoxygenase 3 (EC:1.13.11.-)
hsa:2768;GNA12,NNX3,RMP,gep;guanine nucleotide binding protein (G protein) alpha 12
hsa:10054;UBA2,ARX,SAE2;ubiquitin-like modifier activating enzyme 2
hsa:4607;MYBPC3,CMH4,FHC,MYBP-C;myosin binding protein C, cardiac
hsa:51339;DACT1,DAPPER,DAPPER1,DPR1,FRODO,HDPR1,THYEX3;dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis)
hsa:6870;TACR3,HH11,NK-3R,NK3R,NKR,TAC3RL;tachykinin receptor 3
hsa:26696;OR2T1,OR1-25;olfactory receptor, family 2, subfamily T, member 1
hsa:780;DDR1,CAK,CD167,DDR,EDDR1,HGK2,MCK10,NEP,NTRK4,PTK3,PTK3A,RTK6,TRKE;discoidin domain receptor tyrosine kinase 1 (EC:2.7.10.1)
hsa:8036;SHOC2,SIAA0862,SOC2,SUR8;soc-2 suppressor of clear homolog (C. elegans)
hsa:3753;KCNE1,ISK,JLNS,JLNS2,LQT2/5,LQT5,MinK;potassium voltage-gated channel, Isk-related family, member 1
hsa:9607;CARTPT,CART;CART prepropeptide
hsa:119694;OR51F2,OR11-23;olfactory receptor, family 51, subfamily F, member 2
hsa:3933;LCN1,PMFA,TLC,TP,VEGP;lipocalin 1
hsa:6520;SLC3A2,4F2,4F2HC,4T2HC,CD98,CD98HC,MDU1,NACAE;solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2
hsa:8702;B4GALT4,B4Gal-T4,beta4Gal-T4;UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4 (EC:2.4.1.90 2.4.1.275)
hsa:4835;NQO2,DHQV,DIA6,NMOR2,QR2;NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2)
hsa:959;CD40LG,CD154,CD40L,HIGM1,IGM,IMD3,T-BAM,TNFSF5,TRAP,gp39,hCD40L;CD40 ligand
hsa:2272;FHIT,AP3Aase,FRA3B;fragile histidine triad (EC:3.6.1.29)
hsa:1690;COCH,COCH-5B2,COCH5B2,DFNA9,DFNA31;coagulation factor C homolog, cochlin (Limulus polyphemus)
hsa:364;AQP7,AQP7L,AQP9,AQPap,GLYCQTL;aquaporin 7
hsa:119682;OR51L1,OR11-31;olfactory receptor, family 51, subfamily L, member 1
hsa:81127;OR4K15,OR14-20,OR4K15Q;olfactory receptor, family 4, subfamily K, member 15
hsa:2735;GLI1,GLI;GLI family zinc finger 1
hsa:2395;FXN,CyaY,FA,FARR,FRDA,X25;frataxin (EC:1.16.3.1)
hsa:441933;OR13G1,OR1-37;olfactory receptor, family 13, subfamily G, member 1
hsa:892;CCNC,CycC;cyclin C
hsa:79541;OR2A4,OR2A10;olfactory receptor, family 2, subfamily A, member 4
hsa:60495;HPSE2,HPA2,HPR2,UFS,UFS1;heparanase 2
hsa:8841;HDAC3,HD3,RPD3,RPD3-2;histone deacetylase 3 (EC:3.5.1.98)
hsa:279;AMY2A,AMY2,AMY2B,PA;amylase, alpha 2A (pancreatic) (EC:3.2.1.1)
hsa:55122;AKIRIN2,C6orf166,FBI1,dJ486L4.2;akirin 2
hsa:26659;OR7A5,HTPCR2;olfactory receptor, family 7, subfamily A, member 5
hsa:4281;MID1,BBBG1,FXY,GBBB1,MIDIN,OGS1,OS,OSX,RNF59,TRIM18,XPRF,ZNFXY;midline 1 (Opitz/BBB syndrome)
hsa:79290;OR13A1;olfactory receptor, family 13, subfamily A, member 1
hsa:9453;GGPS1,GGPPS,GGPPS1;geranylgeranyl diphosphate synthase 1 (EC:2.5.1.1 2.5.1.10 2.5.1.29)
hsa:538;ATP7A,DSMAX,MK,MNK,SMAX3;ATPase, Cu++ transporting, alpha polypeptide (EC:3.6.3.4)
hsa:119692;OR51S1,OR11-24;olfactory receptor, family 51, subfamily S, member 1
hsa:401665;OR51T1,OR11-26;olfactory receptor, family 51, subfamily T, member 1
hsa:8517;IKBKG,AMCBX1,FIP-3,FIP3,Fip3p,IKK-gamma,IP,IP1,IP2,IPD2,NEMO,ZC2HC9;inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
hsa:4824;NKX3-1,BAPX2,NKX3,NKX3.1,NKX3A;NK3 homeobox 1
hsa:1621;DBH,DBM;dopamine beta-hydroxylase (dopamine beta-monooxygenase) (EC:1.14.17.1)
hsa:7980;TFPI2,PP5,REF1,TFPI-2;tissue factor pathway inhibitor 2
hsa:140;ADORA3,A3AR,AD026,bA552M11.5;adenosine A3 receptor
hsa:54776;PPP1R12C,LENG3,MBS85,p84,p85;protein phosphatase 1, regulatory subunit 12C
hsa:79608;RIC3,AYST720,PRO1385;resistance to inhibitors of cholinesterase 3 homolog (C. elegans)
hsa:51003;MED31,3110004H13Rik,Soh1;mediator complex subunit 31
hsa:79168;LILRA6,CD85b,ILT5,ILT8,LILRB3,LILRB6;leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6
hsa:4624;MYH6,ASD3,CMD1EE,CMH14,MYHC,MYHCA,SSS3,alpha-MHC;myosin, heavy chain 6, cardiac muscle, alpha
hsa:55526;DHTKD1,AMOXAD,CMT2Q;dehydrogenase E1 and transketolase domain containing 1 (EC:1.2.4.2)
hsa:64423;INF2,C14orf151,C14orf173,CMTDIE,FSGS5,pp9484;inverted formin, FH2 and WH2 domain containing
hsa:610;HCN2,BCNG-2,BCNG2,HAC-1;hyperpolarization activated cyclic nucleotide-gated potassium channel 2
hsa:9827;RGP1,KIAA0258;RGP1 retrograde golgi transport homolog (S. cerevisiae)
hsa:2776;GNAQ,G-ALPHA-q,GAQ;guanine nucleotide binding protein (G protein), q polypeptide
hsa:8929;PHOX2B,NBLST2,NBPhox,PMX2B;paired-like homeobox 2b
hsa:84634;KISS1R,AXOR12,GPR54,HH8,HOT7T175,KISS-1R;KISS1 receptor
hsa:390174;OR9G1,OR9G5;olfactory receptor, family 9, subfamily G, member 1
hsa:5025;P2RX4,P2X4,P2X4R;purinergic receptor P2X, ligand-gated ion channel, 4
hsa:51652;CHMP3,NEDF,VPS24;charged multivesicular body protein 3
hsa:25837;RAB26,V46133;RAB26, member RAS oncogene family
hsa:8925;HERC1,p532,p619;HECT and RLD domain containing E3 ubiquitin protein ligase family member 1
hsa:23086;EXPH5,SLAC2-B,SLAC2B;exophilin 5
hsa:8989;TRPA1,ANKTM1,FEPS;transient receptor potential cation channel, subfamily A, member 1
hsa:388228;SBK1,SBK;SH3-binding domain kinase 1 (EC:2.7.11.1)
hsa:6327;SCN2B;sodium channel, voltage-gated, type II, beta subunit
hsa:6323;SCN1A,EIEE6,FEB3,FEB3A,FHM3,GEFSP2,HBSCI,NAC1,Nav1.1,SCN1,SMEI;sodium channel, voltage-gated, type I, alpha subunit
hsa:946;SIGLEC6,CD327,CD33L,CD33L1,CD33L2,CDW327,OBBP1;sialic acid binding Ig-like lectin 6
hsa:8794;TNFRSF10C,CD263,DCR1,DCR1-TNFR,LIT,TRAIL-R3,TRAILR3,TRID;tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
hsa:91582;RPS19BP1,AROS,S19BP,dJ1104E15.4;ribosomal protein S19 binding protein 1
hsa:201254;STRA13,CENP-X,FAAP10,MHF2;stimulated by retinoic acid 13
hsa:3164;NR4A1,GFRP1,HMR,N10,NAK-1,NGFIB,NP10,NUR77,TR3;nuclear receptor subfamily 4, group A, member 1
hsa:8675;STX16,SYN16;syntaxin 16
hsa:50488;MINK1,B55,MAP4K6,MINK,YSK2,ZC3,hMINK,hMINKbeta;misshapen-like kinase 1 (EC:2.7.11.1)
hsa:338674;OR5F1,OR11-10;olfactory receptor, family 5, subfamily F, member 1
hsa:5768;QSOX1,Q6,QSCN6;quiescin Q6 sulfhydryl oxidase 1 (EC:1.8.3.2)
hsa:4644;MYO5A,GS1,MYH12,MYO5,MYR12;myosin VA (heavy chain 12, myoxin)
hsa:1627;DBN1,D0S117E;drebrin 1
hsa:10666;CD226,DNAM-1,DNAM1,PTA1,TLiSA1;CD226 molecule
hsa:6916;TBXAS1,BDPLT14,CYP5,CYP5A1,GHOSAL,THAS,TS,TXAS,TXS;thromboxane A synthase 1 (platelet) (EC:5.3.99.5)
hsa:390157;OR8K1,OR11-182,OR8N1P;olfactory receptor, family 8, subfamily K, member 1
hsa:8383;OR1A1,OR17-7;olfactory receptor, family 1, subfamily A, member 1
hsa:8788;DLK1,DLK,DLK-1,Delta1,FA1,PREF1,Pref-1,ZOG,pG2;delta-like 1 homolog (Drosophila)
hsa:1232;CCR3,CC-CKR-3,CD193,CKR3,CMKBR3;chemokine (C-C motif) receptor 3
hsa:5009;OTC,OCTD;ornithine carbamoyltransferase (EC:2.1.3.3)
hsa:147409;DSG4,CDGF13,CDHF13,LAH;desmoglein 4
hsa:120796;OR56A1,OR11-75;olfactory receptor, family 56, subfamily A, member 1
hsa:8392;OR3A3,OR17-137,OR17-16,OR17-201,OR3A6,OR3A7,OR3A8P;olfactory receptor, family 3, subfamily A, member 3
hsa:120776;OR2D2,OR11-610,OR2D1,hg27;olfactory receptor, family 2, subfamily D, member 2
hsa:150678;MYEOV2;myeloma overexpressed 2
hsa:282770;OR10AG1,OR11-160;olfactory receptor, family 10, subfamily AG, member 1
hsa:54901;CDKAL1;CDK5 regulatory subunit associated protein 1-like 1
hsa:2597;GAPDH,G3PD,GAPD;glyceraldehyde-3-phosphate dehydrogenase (EC:1.2.1.12)
hsa:11309;SLCO2B1,OATP-B,OATP2B1,OATPB,SLC21A9;solute carrier organic anion transporter family, member 2B1
hsa:387748;OR56B1,OR11-65,OR56B1P;olfactory receptor, family 56, subfamily B, member 1
hsa:65268;WNK2,NY-CO-43,P/OKcl.13,PRKWNK2,SDCCAG43;WNK lysine deficient protein kinase 2 (EC:2.7.11.1)
hsa:29969;MDFIC,HIC;MyoD family inhibitor domain containing
hsa:53637;S1PR5,EDG8,Edg-8,S1P5,SPPR-1,SPPR-2;sphingosine-1-phosphate receptor 5
hsa:282775;OR5J2,OR11-266;olfactory receptor, family 5, subfamily J, member 2
hsa:56475;RPRM,REPRIMO;reprimo, TP53 dependent G2 arrest mediator candidate
hsa:1191;CLU,APO-J,APOJ,CLI,CLU1,CLU2,KUB1,NA1/NA2,SGP-2,SGP2,SP-40,TRPM-2,TRPM2;clusterin
hsa:10672;GNA13,G13;guanine nucleotide binding protein (G protein), alpha 13
hsa:79339;OR51B4,HOR5'Beta1;olfactory receptor, family 51, subfamily B, member 4
hsa:79334;OR11H2,C14orf15,OR11H2P,OR11H8P;olfactory receptor, family 11, subfamily H, member 2
hsa:143903;LAYN;layilin
hsa:7345;UCHL1,PARK5,PGP_9.5,PGP9.5,PGP95,Uch-L1;ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) (EC:3.4.19.12)
hsa:29082;CHMP4A,C14orf123,CHMP4,CHMP4B,HSPC134,SHAX2,SNF7,SNF7-1,VPS32-1,VPS32A;charged multivesicular body protein 4A
hsa:79042;TSEN34,LENG5,PCH2C,SEN34,SEN34L;tRNA splicing endonuclease 34 homolog (S. cerevisiae) (EC:3.1.27.9)
hsa:1134;CHRNA1,ACHRA,ACHRD,CHRNA,CMS2A,FCCMS,SCCMS;cholinergic receptor, nicotinic, alpha 1 (muscle)
hsa:1511;CTSG,CATG,CG;cathepsin G (EC:3.4.21.20)
hsa:144125;OR2AG1,OR11-79,OR2AG3;olfactory receptor, family 2, subfamily AG, member 1
hsa:359;AQP2,AQP-CD,WCH-CD;aquaporin 2 (collecting duct)
hsa:341418;OR6C4,OR12-10;olfactory receptor, family 6, subfamily C, member 4
hsa:712;C1QA;complement component 1, q subcomponent, A chain
hsa:835;CASP2,CASP-2,ICH1,NEDD-2,NEDD2,PPP1R57;caspase 2, apoptosis-related cysteine peptidase (EC:3.4.22.55)
hsa:5337;PLD1;phospholipase D1, phosphatidylcholine-specific (EC:3.1.4.4)
hsa:23175;LPIN1,PAP1;lipin 1 (EC:3.1.3.4)
hsa:22974;TPX2,C20orf1,C20orf2,DIL-2,DIL2,FLS353,GD:C20orf1,HCA519,HCTP4,REPP86,p100;TPX2, microtubule-associated, homolog (Xenopus laevis)
hsa:284;ANGPT1,AGP1,AGPT,ANG1;angiopoietin 1
hsa:56915;EXOSC5,RRP41B,RRP46,Rrp46p,hRrp46p,p12B;exosome component 5
hsa:8858;PROZ,PZ;protein Z, vitamin K-dependent plasma glycoprotein
hsa:375318;AQP12A,AQP-12,AQP12,AQPX2;aquaporin 12A
hsa:51297;BPIFA1,LUNX,NASG,PLUNC,SPLUNC1,SPURT,bA49G10.5;BPI fold containing family A, member 1
hsa:2811;GP1BA,BDPLT1,BDPLT3,BSS,CD42B,CD42b-alpha,DBPLT3,GP1B,GPIbA,VWDP;glycoprotein Ib (platelet), alpha polypeptide
hsa:390144;OR5D16,OR11-154;olfactory receptor, family 5, subfamily D, member 16
hsa:1029;CDKN2A,ARF,CDK4I,CDKN2,CMM2,INK4,INK4A,MLM,MTS-1,MTS1,P14,P14ARF,P16,P16-INK4A,P16INK4,P16INK4A,P19,P19ARF,TP16;cyclin-dependent kinase inhibitor 2A
hsa:119679;OR52J3,OR11-32;olfactory receptor, family 52, subfamily J, member 3
hsa:8575;PRKRA,DYT16,PACT,RAX;protein kinase, interferon-inducible double stranded RNA dependent activator
hsa:2581;GALC;galactosylceramidase (EC:3.2.1.46)
hsa:2629;GBA,GBA1,GCB,GLUC;glucosidase, beta, acid (EC:3.2.1.45)
hsa:3567;IL5,EDF,IL-5,TRF;interleukin 5 (colony-stimulating factor, eosinophil)
hsa:26682;OR4F4,OLA-7501,OR4F18;olfactory receptor, family 4, subfamily F, member 4
hsa:9943;OXSR1,OSR1;oxidative-stress responsive 1 (EC:2.7.11.1)
hsa:26664;OR7C1,CIT-HSP-146E8,HSTPCR86P,OR19-5,OR7C4,TPCR86;olfactory receptor, family 7, subfamily C, member 1
hsa:219428;OR4C16,OR11-135;olfactory receptor, family 4, subfamily C, member 16
hsa:390036;OR52K1,OR11-8;olfactory receptor, family 52, subfamily K, member 1
hsa:6188;RPS3,S3;ribosomal protein S3
hsa:390059;OR51M1,HOR5'Beta7,OR11-40;olfactory receptor, family 51, subfamily M, member 1
hsa:441670;OR4M1,OR14-7;olfactory receptor, family 4, subfamily M, member 1
hsa:4330;MN1,MGCR,MGCR1,MGCR1-PEN,dJ353E16.2;meningioma (disrupted in balanced translocation) 1
hsa:390072;OR52N4,OR11-64;olfactory receptor, family 52, subfamily N, member 4
hsa:85379;;KIAA1671
hsa:81466;OR2L5,OR2L11,OR2L5P;olfactory receptor, family 2, subfamily L, member 5
hsa:219431;OR4S2,OR11-137,OR4S2P,OST725;olfactory receptor, family 4, subfamily S, member 2
hsa:26683;OR4F3;olfactory receptor, family 4, subfamily F, member 3
hsa:390431;OR4K2,OR14-15;olfactory receptor, family 4, subfamily K, member 2
hsa:26212;OR2B6,OR2B1,OR2B1P,OR2B5,OR2B6P,OR5-40,OR5-41,OR6-31,dJ408B20.2;olfactory receptor, family 2, subfamily B, member 6
hsa:340980;OR52B6,OR11-47;olfactory receptor, family 52, subfamily B, member 6
hsa:121129;OR2AP1,OR2AP1P;olfactory receptor, family 2, subfamily AP, member 1
hsa:4986;OPRK1,KOR,OPRK;opioid receptor, kappa 1
hsa:3782;KCNN3,KCa2.3,SK3,SKCA3,hSK3;potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
hsa:2694;GIF,IF,IFMH,INF,TCN3;gastric intrinsic factor (vitamin B synthesis)
hsa:283111;OR51V1,OR11-36,OR51A12;olfactory receptor, family 51, subfamily V, member 1
hsa:9636;ISG15,G1P2,IFI15,IP17,UCRP,hUCRP;ISG15 ubiquitin-like modifier
hsa:283159;OR8D1,JCG9,OR8D3,OST004,PDJ9J14;olfactory receptor, family 8, subfamily D, member 1
hsa:27113;BBC3,JFY-1,JFY1,PUMA;BCL2 binding component 3
hsa:4830;NME1,AWD,GAAD,NB,NBS,NDKA,NDPK-A,NDPKA,NM23,NM23-H1;NME/NM23 nucleoside diphosphate kinase 1 (EC:2.7.4.6)
hsa:283160;OR8D2,JCG2;olfactory receptor, family 8, subfamily D, member 2
hsa:7535;ZAP70,SRK,STCD,STD,TZK,ZAP-70;zeta-chain (TCR) associated protein kinase 70kDa (EC:2.7.10.2)
hsa:7004;TEAD4,EFTR-2,RTEF1,TCF13L1,TEF-3,TEF3,TEFR-1,hRTEF-1B;TEA domain family member 4
hsa:10163;WASF2,IMD2,SCAR2,WASF4,WAVE2,dJ393P12.2;WAS protein family, member 2
hsa:3308;HSPA4,APG-2,HS24/P52,HSPH2,RY,hsp70,hsp70RY;heat shock 70kDa protein 4
hsa:2745;GLRX,GRX,GRX1;glutaredoxin (thioltransferase) (EC:1.8.4.1)
hsa:10401;PIAS3,ZMIZ5;protein inhibitor of activated STAT, 3
hsa:390439;OR11G2,OR14-34;olfactory receptor, family 11, subfamily G, member 2
hsa:81285;OR51E2,OR51E3P,OR52A2,PSGR;olfactory receptor, family 51, subfamily E, member 2
hsa:7841;MOGS,CDG2B,CWH41,DER7,GCS1;mannosyl-oligosaccharide glucosidase (EC:3.2.1.106)
hsa:390075;OR52N5,OR11-62,OR52N5Q;olfactory receptor, family 52, subfamily N, member 5
hsa:9498;SLC4A8,NBC3,NDCBE;solute carrier family 4, sodium bicarbonate cotransporter, member 8
hsa:11320;MGAT4A,GNT-IV,GNT-IVA,GnT-4a;mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A (EC:2.4.1.145)
hsa:23122;CLASP2;cytoplasmic linker associated protein 2
hsa:79643;CHMP6,VPS20;charged multivesicular body protein 6
hsa:79544;OR4K1,OR14-19;olfactory receptor, family 4, subfamily K, member 1
hsa:390538;OR4M2,OR15-3;olfactory receptor, family 4, subfamily M, member 2
hsa:3033;HADH,HAD,HADH1,HADHSC,HCDH,HHF4,MSCHAD,SCHAD;hydroxyacyl-CoA dehydrogenase (EC:1.1.1.35)
hsa:57045;TWSG1,TSG;twisted gastrulation homolog 1 (Drosophila)
hsa:283694;OR4N4,OR15-1,OR15-5;olfactory receptor, family 4, subfamily N, member 4
hsa:11267;SNF8,Dot3,EAP30,VPS22;SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae)
hsa:3552;IL1A,IL-1A,IL1,IL1-ALPHA,IL1F1;interleukin 1, alpha
hsa:8625;RFXANK,ANKRA1,BLS,F14150_1,RFX-B;regulatory factor X-associated ankyrin-containing protein
hsa:353497;POLN,POL4P;polymerase (DNA directed) nu (EC:2.7.7.7)
hsa:7428;VHL,HRCA1,RCA1,VHL1,pVHL;von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
hsa:6311;ATXN2,ASL13,ATX2,SCA2,TNRC13;ataxin 2
hsa:10569;SLU7,9G8,hSlu7;SLU7 splicing factor homolog (S. cerevisiae)
hsa:23030;KDM4B,JMJD2B,TDRD14B;lysine (K)-specific demethylase 4B
hsa:56300;IL36G,IL-1F9,IL-1H1,IL-1RP2,IL1E,IL1F9,IL1H1,IL1RP2;interleukin 36, gamma
hsa:58499;ZNF462,Zfp462;zinc finger protein 462
hsa:8291;DYSF,FER1L1,LGMD2B,MMD1;dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive)
hsa:390649;OR4F15;olfactory receptor, family 4, subfamily F, member 15
hsa:64757;MARC1,MOSC1;mitochondrial amidoxime reducing component 1
hsa:442191;OR14J1,OR5U1,OR6-25,bA150A6.4,hs6M1-28;olfactory receptor, family 14, subfamily J, member 1
hsa:7293;TNFRSF4,ACT35,CD134,OX40,TXGP1L;tumor necrosis factor receptor superfamily, member 4
hsa:3984;LIMK1,LIMK,LIMK-1;LIM domain kinase 1 (EC:2.7.11.1)
hsa:330;BIRC3,AIP1,API2,CIAP2,HAIP1,HIAP1,MALT2,MIHC,RNF49,c-IAP2;baculoviral IAP repeat containing 3
hsa:4995;OR3A2,OLFRA04,OR17-14,OR17-228,OR228;olfactory receptor, family 3, subfamily A, member 2
hsa:11340;EXOSC8,CIP3,EAP2,OIP2,RP11-421P11.3,RRP43,Rrp43p,bA421P11.3,p9;exosome component 8 (EC:3.1.13.-)
hsa:390191;OR5B12,OR11-241,OR5B12P,OR5B16,OST743;olfactory receptor, family 5, subfamily B, member 12
hsa:11076;TPPP,TPPP/p25,TPPP1,p24,p25,p25alpha;tubulin polymerization promoting protein
hsa:8842;PROM1,AC133,CD133,CORD12,MCDR2,PROML1,RP41,STGD4;prominin 1
hsa:3199;HOXA2,HOX1K;homeobox A2
hsa:9159;PCSK7,LPC,PC7,PC8,SPC7;proprotein convertase subtilisin/kexin type 7 (EC:3.4.21.-)
hsa:708;C1QBP,GC1QBP,HABP1,SF2p32,gC1Q-R,gC1qR,p32;complement component 1, q subcomponent binding protein
hsa:4656;MYOG,MYF4,bHLHc3,myf-4;myogenin (myogenic factor 4)
hsa:6357;CCL13,CKb10,MCP-4,NCC-1,NCC1,SCYA13,SCYL1;chemokine (C-C motif) ligand 13
hsa:1356;CP,CP-2;ceruloplasmin (ferroxidase) (EC:1.16.3.1)
hsa:7436;VLDLR,CARMQ1,CHRMQ1,VLDLRCH;very low density lipoprotein receptor
hsa:362;AQP5,AQP-5;aquaporin 5
hsa:4915;NTRK2,GP145-TrkB,TRKB,trk-B;neurotrophic tyrosine kinase, receptor, type 2 (EC:2.7.10.1)
hsa:6714;SRC,ASV,SRC1,c-SRC,p60-Src;v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (EC:2.7.10.2)
hsa:219429;OR4C11,OR11-136,OR4C11P;olfactory receptor, family 4, subfamily C, member 11
hsa:2280;FKBP1A,FKBP-12,FKBP-1A,FKBP1,FKBP12,PKC12,PKCI2,PPIASE;FK506 binding protein 1A, 12kDa (EC:5.2.1.8)
hsa:51266;CLEC1B,1810061I13Rik,CLEC2,CLEC2B,PRO1384,QDED721;C-type lectin domain family 1, member B
hsa:5993;RFX5;regulatory factor X, 5 (influences HLA class II expression)
hsa:282617;IFNL3,IL-28B,IL28B,IL28C;interferon, lambda 3
hsa:11342;RNF13,RZF;ring finger protein 13
hsa:2353;FOS,AP-1,C-FOS,p55;FBJ murine osteosarcoma viral oncogene homolog
hsa:9332;CD163,M130,MM130;CD163 molecule
hsa:5573;PRKAR1A,ACRDYS1,ADOHR,CAR,CNC,CNC1,PKR1,PPNAD1,PRKAR1,TSE1;protein kinase, cAMP-dependent, regulatory, type I, alpha (EC:2.7.11.1)
hsa:10410;IFITM3,1-8U,DSPA2b,IP15;interferon induced transmembrane protein 3
hsa:51;ACOX1,ACOX,PALMCOX,SCOX;acyl-CoA oxidase 1, palmitoyl (EC:1.3.3.6)
hsa:5644;PRSS1,TRP1,TRY1,TRY4,TRYP1;protease, serine, 1 (trypsin 1) (EC:3.4.21.4)
hsa:8795;TNFRSF10B,CD262,DR5,KILLER,KILLER/DR5,TRAIL-R2,TRAILR2,TRICK2,TRICK2A,TRICK2B,TRICKB,ZTNFR9;tumor necrosis factor receptor superfamily, member 10b
hsa:6404;SELPLG,CD162,CLA,PSGL-1,PSGL1;selectin P ligand
hsa:2688;GH1,GH,GH-N,GHN,IGHD1B,hGH-N;growth hormone 1
hsa:81697;OR2B2,OR2B2Q,OR2B9,OR6-1,dJ193B12.4,hs6M1-10;olfactory receptor, family 2, subfamily B, member 2
hsa:128866;CHMP4B,C20orf178,CHMP4A,CTPP3,SNF7,SNF7-2,Shax1,VPS32B,Vps32-2,dJ553F4.4;charged multivesicular body protein 4B
hsa:5467;PPARD,FAAR,NR1C2,NUC1,NUCI,NUCII,PPARB;peroxisome proliferator-activated receptor delta
hsa:6223;RPS19,DBA,DBA1,S19;ribosomal protein S19
hsa:26735;OR1L3,OR9-28,OR9-D;olfactory receptor, family 1, subfamily L, member 3
hsa:944;TNFSF8,CD153,CD30L,CD30LG;tumor necrosis factor (ligand) superfamily, member 8
hsa:3040;HBA2,HBH;hemoglobin, alpha 2
hsa:254973;OR1L4,OR1L5,OR9-29,OR9-E,OST046;olfactory receptor, family 1, subfamily L, member 4
hsa:6477;SIAH1,SIAH1A;siah E3 ubiquitin protein ligase 1 (EC:6.3.2.-)
hsa:403273;OR5H14;olfactory receptor, family 5, subfamily H, member 14
hsa:948;CD36,BDPLT10,CHDS7,FAT,GP3B,GP4,GPIV,PASIV,SCARB3;CD36 molecule (thrombospondin receptor)
hsa:643;CXCR5,BLR1,CD185,MDR15;chemokine (C-X-C motif) receptor 5
hsa:79324;OR51G1,OR11-29,OR51G3P;olfactory receptor, family 51, subfamily G, member 1
hsa:81282;OR51G2,OR11-28;olfactory receptor, family 51, subfamily G, member 2
hsa:5033;P4HA1,P4HA;prolyl 4-hydroxylase, alpha polypeptide I (EC:1.14.11.2)
hsa:1282;COL4A1,HANAC,ICH,POREN1,arresten;collagen, type IV, alpha 1
hsa:2030;SLC29A1,ENT1;solute carrier family 29 (nucleoside transporters), member 1
hsa:29775;CARD10,BIMP1,CARMA3;caspase recruitment domain family, member 10
hsa:27232;GNMT;glycine N-methyltransferase (EC:2.1.1.20)
hsa:83939;EIF2A,EIF-2A,MST089,MSTP004,MSTP089;eukaryotic translation initiation factor 2A, 65kDa
hsa:57094;CPA6,CPAH,ETL5,FEB11;carboxypeptidase A6 (EC:3.4.17.1)
hsa:81061;OR11H1,OR22-1;olfactory receptor, family 11, subfamily H, member 1
hsa:50846;DHH,GDXYM,HHG-3,SRXY7;desert hedgehog
hsa:389090;OR6B2,OR2-1,OR6B2P;olfactory receptor, family 6, subfamily B, member 2
hsa:79813;EHMT1,EUHMTASE1,Eu-HMTase1,FP13812,GLP,GLP1,KMT1D,bA188C12.1;euchromatic histone-lysine N-methyltransferase 1 (EC:2.1.1.43)
hsa:316;AOX1,AO,AOH1;aldehyde oxidase 1 (EC:1.2.3.1)
hsa:7020;TFAP2A,AP-2,AP-2alpha,AP2TF,BOFS,TFAP2;transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
hsa:90362;FAM110B,C8orf72;family with sequence similarity 110, member B
hsa:5428;POLG,MDP1,MIRAS,MTDPS4A,MTDPS4B,PEO,POLG1,POLGA,SANDO,SCAE;polymerase (DNA directed), gamma (EC:2.7.7.7)
hsa:3371;TNC,150-225,GMEM,GP,HXB,JI,TN,TN-C;tenascin C
hsa:5021;OXTR,OT-R;oxytocin receptor
hsa:817;CAMK2D,CAMKD;calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17)
hsa:11009;IL24,C49A,FISP,IL10B,MDA7,MOB5,ST16;interleukin 24
hsa:337;APOA4;apolipoprotein A-IV
hsa:9530;BAG4,BAG-4,SODD;BCL2-associated athanogene 4
hsa:1727;CYB5R3,B5R,DIA1;cytochrome b5 reductase 3 (EC:1.6.2.2)
hsa:8431;NR0B2,SHP,SHP1;nuclear receptor subfamily 0, group B, member 2
hsa:442361;OR2A2,OR2A17P,OR2A2P,OR7-11,OST008;olfactory receptor, family 2, subfamily A, member 2
hsa:5330;PLCB2;phospholipase C, beta 2 (EC:3.1.4.11)
hsa:10216;PRG4,CACP,HAPO,JCAP,MSF,SZP,bG174L6.2;proteoglycan 4
hsa:9695;EDEM1,EDEM;ER degradation enhancer, mannosidase alpha-like 1
hsa:375790;AGRN;agrin
hsa:81850;KRTAP1-3,KAP1.2,KAP1.3,KAP1.6,KAP1.8A,KAP1.8B,KAP1.9,KRTAP1.3;keratin associated protein 1-3
hsa:441639;OR9K2,OR12-2;olfactory receptor, family 9, subfamily K, member 2
hsa:55367;PIDD,LRDD;p53-induced death domain protein
hsa:23476;BRD4,CAP,HUNK1,HUNKI,MCAP;bromodomain containing 4 (EC:3.1.1.31)
hsa:8495;PPFIBP2,Cclp1;PTPRF interacting protein, binding protein 2 (liprin beta 2)
hsa:150681;OR6B3,OR6B3P,OR6B3Q;olfactory receptor, family 6, subfamily B, member 3
hsa:3248;HPGD,15-PGDH,PGDH,PGDH1,PHOAR1,SDR36C1;hydroxyprostaglandin dehydrogenase 15-(NAD) (EC:1.1.1.141)
hsa:9848;MFAP3L,NYD-sp9;microfibrillar-associated protein 3-like
hsa:57396;CLK4;CDC-like kinase 4 (EC:2.7.12.1)
hsa:346525;OR2A12,OR2A12P,OR2A16P;olfactory receptor, family 2, subfamily A, member 12
hsa:55743;CHFR,RNF116,RNF196;checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
hsa:124538;OR4D2,BC2009,OR17-24;olfactory receptor, family 4, subfamily D, member 2
hsa:121275;OR10AD1,OR10AD1P,OR12-1;olfactory receptor, family 10, subfamily AD, member 1
hsa:51421;AMOTL2,LCCP;angiomotin like 2
hsa:3283;HSD3B1,3BETAHSD,HSD3B,HSDB3,HSDB3A,I,SDR11E1;hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (EC:1.1.1.145 5.3.3.1)
hsa:114780;PKD1L2,PC1L2;polycystic kidney disease 1-like 2
hsa:587;BCAT2,BCAM,BCATM,BCT2,PP18;branched chain amino-acid transaminase 2, mitochondrial (EC:2.6.1.42)
hsa:84628;NTNG2,LHLL9381,Lmnt2,NTNG1,bA479K20.1;netrin G2
hsa:91010;FMNL3,FHOD3,WBP-3,WBP3;formin-like 3
hsa:53342;IL17D,IL-17D,IL-22,IL-27,IL27;interleukin 17D
hsa:128366;OR6P1;olfactory receptor, family 6, subfamily P, member 1
hsa:389434;IYD,C6orf71,DEHAL1,TDH4,dJ422F24.1;iodotyrosine deiodinase (EC:1.22.1.1)
hsa:5055;SERPINB2,HsT1201,PAI,PAI-2,PAI2,PLANH2;serpin peptidase inhibitor, clade B (ovalbumin), member 2
hsa:1163;CKS1B,CKS1,PNAS-16,PNAS-18,ckshs1;CDC28 protein kinase regulatory subunit 1B
hsa:401992;OR2T2,OR1-43,OR2T2P;olfactory receptor, family 2, subfamily T, member 2
hsa:4023;LPL,HDLCQ11,LIPD;lipoprotein lipase (EC:3.1.1.34)
hsa:5144;PDE4D,ACRDYS2,DPDE3,HSPDE4D,PDE43,PDE4DN2,STRK1;phosphodiesterase 4D, cAMP-specific (EC:3.1.4.17)
hsa:4613;MYCN,MODED,N-myc,NMYC,ODED,bHLHe37;v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)
hsa:6611;SMS,MRSR,SPMSY,SRS,SpS;spermine synthase (EC:2.5.1.22)
hsa:3745;KCNB1,DRK1,KV2.1,h-DRK1;potassium voltage-gated channel, Shab-related subfamily, member 1
hsa:5950;RBP4;retinol binding protein 4, plasma
hsa:240;ALOX5,5-LO,5-LOX,5LPG,LOG5;arachidonate 5-lipoxygenase (EC:1.13.11.34)
hsa:49;ACR;acrosin (EC:3.4.21.10)
hsa:80704;SLC19A3,BBGD,THMD2,THTR2;solute carrier family 19, member 3
hsa:5777;PTPN6,HCP,HCPH,HPTP1C,PTP-1C,SH-PTP1,SHP-1,SHP-1L,SHP1;protein tyrosine phosphatase, non-receptor type 6 (EC:3.1.3.48)
hsa:23538;OR52A1,HPFH1OR;olfactory receptor, family 52, subfamily A, member 1
hsa:2287;FKBP3,FKBP-25,FKBP-3,FKBP25,PPIase;FK506 binding protein 3, 25kDa (EC:5.2.1.8)
hsa:3126;HLA-DRB4,DR-4,DR4,DRB4,HLA-DR4B;major histocompatibility complex, class II, DR beta 4
hsa:8877;SPHK1,SPHK;sphingosine kinase 1 (EC:2.7.1.91)
hsa:4143;MAT1A,MAT,MATA1,SAMS,SAMS1;methionine adenosyltransferase I, alpha (EC:2.5.1.6)
hsa:6326;SCN2A,BFIC3,BFIS3,BFNIS,EIEE11,HBA,HBSCI,HBSCII,NAC2,Na(v)1.2,Nav1.2,SCN2A1,SCN2A2;sodium channel, voltage-gated, type II, alpha subunit
hsa:3315;HSPB1,CMT2F,HMN2B,HS.76067,HSP27,HSP28,Hsp25,SRP27;heat shock 27kDa protein 1
hsa:1495;CTNNA1,CAP102;catenin (cadherin-associated protein), alpha 1, 102kDa
hsa:3958;LGALS3,CBP35,GAL3,GALBP,GALIG,L31,LGALS2,MAC2;lectin, galactoside-binding, soluble, 3
hsa:3779;KCNMB1,BKbeta1,K(VCA)beta,SLO-BETA,hbeta1,hslo-beta,k(VCA)beta-1,slo-beta-1;potassium large conductance calcium-activated channel, subfamily M, beta member 1
hsa:3778;KCNMA1,BKTM,KCa1.1,MaxiK,SAKCA,SLO,SLO-ALPHA,SLO1,bA205K10.1,mSLO1;potassium large conductance calcium-activated channel, subfamily M, alpha member 1
hsa:10695;CNPY3,CAG4A,ERDA5,PRAT4A,TNRC5;canopy 3 homolog (zebrafish)
hsa:8778;SIGLEC5,CD170,CD33L2,OB-BP2,OBBP2,SIGLEC-5;sialic acid binding Ig-like lectin 5
hsa:5230;PGK1,MIG10,PGKA;phosphoglycerate kinase 1 (EC:2.7.2.3)
hsa:390083;OR56A3,OR56A2P,OR56A3P,OR56A6;olfactory receptor, family 56, subfamily A, member 3
hsa:26496;OR10A3,HSHTPCRX12,HTPCRX12;olfactory receptor, family 10, subfamily A, member 3
hsa:773;CACNA1A,APCA,BI,CACNL1A4,CAV2.1,EA2,FHM,HPCA,MHP,MHP1,SCA6;calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
hsa:3426;CFI,AHUS3,C3BINA,C3b-INA,FI,IF,KAF;complement factor I (EC:3.4.21.45)
hsa:54903;MKS1,BBS13,MES,MKS,POC12;Meckel syndrome, type 1
hsa:131450;CD200R1,CD200R,HCRTR2,MOX2R,OX2R;CD200 receptor 1
hsa:489;ATP2A3,SERCA3;ATPase, Ca++ transporting, ubiquitous (EC:3.6.3.8)
hsa:147372;CCBE1;collagen and calcium binding EGF domains 1
hsa:1277;COL1A1,OI4;collagen, type I, alpha 1
hsa:22894;DIS3,EXOSC11,KIAA1008,RP11-342J4.3,RRP44,bA555G22.1,dis3p;DIS3 mitotic control homolog (S. cerevisiae)
hsa:1854;DUT,dUTPase;deoxyuridine triphosphatase (EC:3.6.1.23)
hsa:390190;OR5B2,OR11-240,OST073;olfactory receptor, family 5, subfamily B, member 2
hsa:8315;BRAP,BRAP2,IMP,RNF52;BRCA1 associated protein
hsa:84062;DTNBP1,BLOC1S8,DBND,HPS7,My031,SDY;dystrobrevin binding protein 1
hsa:56656;OR2S2,OR37A,OST715;olfactory receptor, family 2, subfamily S, member 2
hsa:3452;IFNA21,IFN-alphaI,LeIF_F,leIF-F;interferon, alpha 21
hsa:775;CACNA1C,CACH2,CACN2,CACNL1A1,CCHL1A1,CaV1.2,LQT8,TS;calcium channel, voltage-dependent, L type, alpha 1C subunit
hsa:1299;COL9A3,DJ885L7.4.1,EDM3,IDD,MED;collagen, type IX, alpha 3
hsa:547;KIF1A,ATSV,C2orf20,HSN2C,MRD9,SPG30,UNC104;kinesin family member 1A
hsa:1269;CNR2,CB-2,CB2,CX5;cannabinoid receptor 2 (macrophage)
hsa:30009;TBX21,T-PET,T-bet,TBET,TBLYM;T-box 21
hsa:5805;PTS,PTPS;6-pyruvoyltetrahydropterin synthase (EC:4.2.3.12)
hsa:10381;TUBB3,CDCBM,CFEOM3A,TUBB4,beta-4;tubulin, beta 3 class III
hsa:2139;EYA2,EAB1;eyes absent homolog 2 (Drosophila) (EC:3.1.3.48)
hsa:1192;CLIC1,G6,NCC27;chloride intracellular channel 1
hsa:119;ADD2,ADDB;adducin 2 (beta)
hsa:84894;LINGO1,LERN1,LRRN6A,UNQ201;leucine rich repeat and Ig domain containing 1
hsa:10630;PDPN,AGGRUS,GP36,GP40,Gp38,HT1A-1,OTS8,PA2.26,T1A,T1A-2;podoplanin
hsa:26531;OR11A1,OR11A2,dJ994E9.6,hs6M1-18;olfactory receptor, family 11, subfamily A, member 1
hsa:93649;MYOCD,MYCD;myocardin
hsa:51218;GLRX5,C14orf87,FLB4739,GRX5,PR01238,PRO1238;glutaredoxin 5
hsa:255725;OR52B2,OR11-70;olfactory receptor, family 52, subfamily B, member 2
hsa:23016;EXOSC7,EAP1,RRP42,Rrp42p,hRrp42p,p8;exosome component 7 (EC:3.1.13.-)
hsa:9994;CASP8AP2,CED-4,FLASH,RIP25;caspase 8 associated protein 2
hsa:1398;CRK,CRKII,p38;v-crk sarcoma virus CT10 oncogene homolog (avian)
hsa:3925;STMN1,C1orf215,LAP18,Lag,OP18,PP17,PP19,PR22,SMN;stathmin 1
hsa:4087;SMAD2,JV18,JV18-1,MADH2,MADR2,hMAD-2,hSMAD2;SMAD family member 2
hsa:84181;CHD6,CHD5,RIGB;chromodomain helicase DNA binding protein 6 (EC:3.6.4.12)
hsa:441669;OR4Q3,C14orf13,HSA6,OR14-3,OR4Q4,c14_5008;olfactory receptor, family 4, subfamily Q, member 3
hsa:441608;OR5B3,OR11-239,OR5B13,OST129;olfactory receptor, family 5, subfamily B, member 3
hsa:27178;IL37,FIL1,FIL1(ZETA),FIL1Z,IL-1F7,IL-1H,IL-1H4,IL-1RP1,IL-37,IL1F7,IL1H4,IL1RP1;interleukin 37
hsa:6103;RPGR,COD1,CORDX1,CRD,PCDX,RP15,RP3,XLRP3,orf15;retinitis pigmentosa GTPase regulator
hsa:217;ALDH2,ALDH-E2,ALDHI,ALDM;aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3)
hsa:5734;PTGER4,EP4,EP4R;prostaglandin E receptor 4 (subtype EP4)
hsa:219965;OR5B17,OR11-237,OR5B20P;olfactory receptor, family 5, subfamily B, member 17
hsa:1364;CLDN4,CPE-R,CPER,CPETR,CPETR1,WBSCR8,hCPE-R;claudin 4
hsa:81341;OR10W1,OR10W1P,OR10W1Q,OR11-236,UNQ6469;olfactory receptor, family 10, subfamily W, member 1
hsa:407006;MIR221,MIRN221,miRNA221,mir-221;microRNA 221
hsa:378938;MALAT1,HCN,LINC00047,MALAT-1,NCRNA00047,NEAT2,PRO2853;metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
hsa:407003;MIR219-2,MIRN219-2;microRNA 219-2
hsa:406904;MIR1-1,MIRN1-1,hsa-mir-1-1,miRNA1-1;microRNA 1-1
hsa:732253;TDRG1,LINC00532;testis development related 1 (non-protein coding)
hsa:406881;MIRLET7A1,LET7A1,MIRNLET7A1,let-7a-1;microRNA let-7a-1
hsa:145624;PAR1,D15S227E;Prader-Willi/Angelman region-1
hsa:407004;MIR22,MIRN22,hsa-mir-22,miR-22;microRNA 22
hsa:27161;AGO2,EIF2C2,Q10;argonaute RISC catalytic component 2
hsa:9271;PIWIL1,HIWI,MIWI,PIWI;piwi-like RNA-mediated gene silencing 1
hsa:26523;AGO1,EIF2C,EIF2C1,GERP95,Q99;argonaute RISC catalytic component 1
hsa:440822;PIWIL3,HIWI3;piwi-like RNA-mediated gene silencing 3
hsa:143689;PIWIL4,HIWI2,MIWI2;piwi-like RNA-mediated gene silencing 4
hsa:100996712;SRGAP2D;SLIT-ROBO Rho GTPase activating protein 2D
hsa:55124;PIWIL2,CT80,HILI,PIWIL1L,mili;piwi-like RNA-mediated gene silencing 2
hsa:100996928;C7orf55-LUC7L2;C7orf55-LUC7L2 readthrough
hsa:192669;AGO3,EIF2C3;argonaute RISC catalytic component 3
hsa:728978;UNC5B-AS1;UNC5B antisense RNA 1
hsa:647012;YY1P2;YY1 transcription factor pseudogene 2
hsa:283050;ZMIZ1-AS1;ZMIZ1 antisense RNA 1
hsa:100132987;LINC00856;long intergenic non-protein coding RNA 856
hsa:439990;LINC00857;long intergenic non-protein coding RNA 857
hsa:170425;LINC00858;long intergenic non-protein coding RNA 858
hsa:100128292;DLG5-AS1;DLG5 antisense RNA 1
hsa:100507331;ZSWIM8-AS1;ZSWIM8 antisense RNA 1
hsa:63940;GPSM3,AGS4,C6orf9,G18,G18.1a,G18.1b,G18.2,NG1;G-protein signaling modulator 3
hsa:283254;HARBI1,C11orf77;harbinger transposase derived 1 (EC:3.1.-.-)
hsa:57674;RNF213,ALO17,C17orf27,KIAA1618,MYMY2,MYSTR,NET57;ring finger protein 213
hsa:285116;AHCTF1P1,AHCTF1P,ELYS-like;AT hook containing transcription factor 1 pseudogene 1
hsa:440311;;glioma tumor suppressor candidate region gene 2 pseudogene
hsa:120146;TRIM64,C11orf28,TRIM64A;tripartite motif containing 64
hsa:1417;CRYBB3,CATCN2,CRYB3;crystallin, beta B3
hsa:60673;C12orf44,ATG101;chromosome 12 open reading frame 44
hsa:139189;DGKK;diacylglycerol kinase, kappa (EC:2.7.1.107)
hsa:9776;ATG13,KIAA0652,PARATARG8;autophagy related 13
hsa:6944;VPS72,CFL1,Swc2,TCFL1,YL-1,YL1;vacuolar protein sorting 72 homolog (S. cerevisiae)
hsa:93973;ACTR8,ARP8,INO80N,hArp8;ARP8 actin-related protein 8 homolog (yeast)
hsa:9414;TJP2,C9DUPq21.11,DFNA51,DUP9q21.11,X104,ZO2;tight junction protein 2
hsa:10974;ADIRF,AFRO,APM2,C10orf116,apM-2;adipogenesis regulatory factor
hsa:887;CCKBR,CCK-B,CCK2R,GASR;cholecystokinin B receptor
hsa:22794;CASC3,BTZ,MLN51;cancer susceptibility candidate 3
hsa:8452;CUL3,CUL-3,PHA2E;cullin 3
hsa:84142;FAM175A,ABRA1,CCDC98;family with sequence similarity 175, member A
hsa:11091;WDR5,BIG-3,SWD3;WD repeat domain 5
hsa:55643;BTBD2;BTB (POZ) domain containing 2
hsa:79971;WLS,C1orf139,EVI,GPR177,MRP,mig-14;wntless homolog (Drosophila)
hsa:84073;MYCBPAP,AMAP-1,AMAP1;MYCBP associated protein
hsa:10274;STAG1,SA1,SCC3A;stromal antigen 1
hsa:80152;CENPT,C16orf56,CENP-T;centromere protein T
hsa:3920;LAMP2,CD107b,LAMP-2,LAMPB,LGP110;lysosomal-associated membrane protein 2
hsa:27019;DNAI1,CILD1,DIC1,ICS,ICS1,PCD;dynein, axonemal, intermediate chain 1
hsa:3055;HCK,JTK9,p59Hck,p61Hck;hemopoietic cell kinase (EC:2.7.10.2)
hsa:10539;GLRX3,GLRX4,GRX3,GRX4,PICOT,TXNL2,TXNL3;glutaredoxin 3
hsa:11232;POLG2,HP55,MTPOLB,PEOA4,POLB,POLG-BETA,POLGB;polymerase (DNA directed), gamma 2, accessory subunit (EC:2.7.7.7)
hsa:1912;PHC2,EDR2,HPH2,PH2;polyhomeotic homolog 2 (Drosophila)
hsa:2176;FANCC,FA3,FAC,FACC;Fanconi anemia, complementation group C
hsa:6198;RPS6KB1,PS6K,S6K,S6K-beta-1,S6K1,STK14A,p70_S6KA,p70(S6K)-alpha,p70-S6K,p70-alpha;ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1)
hsa:7335;UBE2V1,CIR1,CROC-1,CROC1,UBE2V,UEV-1,UEV1,UEV1A;ubiquitin-conjugating enzyme E2 variant 1
hsa:8091;HMGA2,BABL,HMGI-C,HMGIC,LIPO,STQTL9;high mobility group AT-hook 2
hsa:11161;C14orf1,ERG28,NET51;chromosome 14 open reading frame 1
hsa:2803;GOLGA4,GCP2,GOLG,MU-RMS-40.18,p230;golgin A4
hsa:10598;AHSA1,AHA1,C14orf3,p38;AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast)
hsa:5063;PAK3,CDKN1A,MRX30,MRX47,OPHN3,PAK3beta,bPAK,hPAK3;p21 protein (Cdc42/Rac)-activated kinase 3 (EC:2.7.11.1)
hsa:6048;RNF5,RING5,RMA1;ring finger protein 5, E3 ubiquitin protein ligase
hsa:83723;FAM57B;family with sequence similarity 57, member B
hsa:7175;TPR;translocated promoter region, nuclear basket protein
hsa:55120;FANCL,FAAP43,PHF9,POG;Fanconi anemia, complementation group L
hsa:101180976;IFNL4,IFNAN;interferon, lambda 4 (gene/pseudogene)
hsa:6045;RNF2,BAP-1,BAP1,DING,HIPI3,RING1B,RING2;ring finger protein 2 (EC:6.3.2.-)
hsa:29844;TFPT,FB1,INO80F,amida;TCF3 (E2A) fusion partner (in childhood Leukemia)
hsa:3273;HRG,HPRG,HRGP,THPH11;histidine-rich glycoprotein
hsa:4534;MTM1,CNM,MTMX,XLMTM;myotubularin 1 (EC:3.1.3.64)
hsa:6117;RPA1,HSSB,MST075,REPA1,RF-A,RP-A,RPA70;replication protein A1, 70kDa
hsa:642446;TRIM64B;tripartite motif containing 64B
hsa:5584;PRKCI,DXS1179E,PKCI,nPKC-iota;protein kinase C, iota (EC:2.7.11.13)
hsa:55742;PARVA,CH-ILKBP,MXRA2;parvin, alpha
hsa:5828;PEX2,PAF1,PBD5A,PBD5B,PMP3,PMP35,PXMP3,RNF72,ZWS3;peroxisomal biogenesis factor 2
hsa:83942;TSSK1B,SPOGA4,STK22D,TSK1,TSSK1;testis-specific serine kinase 1B (EC:2.7.11.1)
hsa:5685;PSMA4,HC9,HsT17706,PSC9;proteasome (prosome, macropain) subunit, alpha type, 4 (EC:3.4.25.1)
hsa:2665;GDI2,RABGDIB;GDP dissociation inhibitor 2
hsa:9939;RBM8A,BOV-1A,BOV-1B,BOV-1C,C1DELq21.1,DEL1q21.1,MDS014,RBM8,RBM8B,TAR,Y14,ZNRP,ZRNP1;RNA binding motif protein 8A
hsa:9040;UBE2M,UBC-RS2,UBC12,hUbc12;ubiquitin-conjugating enzyme E2M (EC:6.3.2.19)
hsa:84557;MAP1LC3A,ATG8E,LC3,LC3A,MAP1ALC3,MAP1BLC3;microtubule-associated protein 1 light chain 3 alpha
hsa:89891;WDR34,DIC5,bA216B9.3;WD repeat domain 34
hsa:9978;RBX1,BA554C12.1,RNF75,ROC1;ring-box 1, E3 ubiquitin protein ligase
hsa:5929;RBBP5,RBQ3,SWD1;retinoblastoma binding protein 5
hsa:356;FASLG,ALPS1B,APT1LG1,APTL,CD178,CD95-L,CD95L,FASL,TNFSF6;Fas ligand (TNF superfamily, member 6)
hsa:9525;VPS4B,SKD1,SKD1B,VPS4-2;vacuolar protein sorting 4 homolog B (S. cerevisiae) (EC:3.6.4.6)
hsa:30827;CXXC1,2410002I16Rik,5830420C16Rik,CFP1,CGBP,HsT2645,PCCX1,PHF18,SPP1,ZCGPC1,hCGBP;CXXC finger protein 1
hsa:5867;RAB4A,HRES-1/RAB4,RAB4;RAB4A, member RAS oncogene family
hsa:64446;DNAI2,CILD9,DIC2;dynein, axonemal, intermediate chain 2
hsa:51720;UIMC1,RAP80,X2HRIP110;ubiquitin interaction motif containing 1
hsa:7336;UBE2V2,DDVIT1,DDVit-1,EDAF-1,EDPF-1,EDPF1,MMS2,UEV-2,UEV2;ubiquitin-conjugating enzyme E2 variant 2
hsa:83875;BCO2,B-DIOX-II,BCDO2;beta-carotene oxygenase 2 (EC:1.13.11.71)
hsa:10020;GNE,DMRV,GLCNE,IBM2,NM,Uae1;glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (EC:2.7.1.60 3.2.1.183)
hsa:113878;DTX2,RNF58;deltex homolog 2 (Drosophila)
hsa:4798;NFRKB,INO80G;nuclear factor related to kappaB binding protein
hsa:2342;FNTB,FPTB;farnesyltransferase, CAAX box, beta (EC:2.5.1.58)
hsa:9775;EIF4A3,DDX48,NMP265,NUK34,eIF4AIII;eukaryotic translation initiation factor 4A3 (EC:3.6.4.13)
hsa:5754;PTK7,CCK-4,CCK4;protein tyrosine kinase 7 (EC:2.7.10.1)
hsa:638;BIK,BIP1,BP4,NBK;BCL2-interacting killer (apoptosis-inducing)
hsa:4140;MARK3,CTAK1,KP78,PAR1A,Par-1a;MAP/microtubule affinity-regulating kinase 3 (EC:2.7.11.1)
hsa:151987;PPP4R2,PP4R2;protein phosphatase 4, regulatory subunit 2
hsa:84733;CBX2,CDCA6,M33,SRXY5;chromobox homolog 2
hsa:84967;LSM10,MST074,MSTP074;LSM10, U7 small nuclear RNA associated
hsa:4361;MRE11A,ATLD,HNGS1,MRE11,MRE11B;MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
hsa:6602;SMARCD1,BAF60A,CRACD1,Rsc6p;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1
hsa:8668;EIF3I,EIF3S2,PRO2242,TRIP-1,TRIP1,eIF3-beta,eIF3-p36;eukaryotic translation initiation factor 3, subunit I
hsa:55655;NLRP2,CLR19.9,NALP2,NBS1,PAN1,PYPAF2;NLR family, pyrin domain containing 2
hsa:3831;KLC1,KLC,KNS2,KNS2A;kinesin light chain 1
hsa:22906;TRAK1,MILT1,OIP106;trafficking protein, kinesin binding 1
hsa:654;BMP6,VGR,VGR1;bone morphogenetic protein 6
hsa:9726;ZNF646;zinc finger protein 646
hsa:4116;MAGOH,MAGOH1,MAGOHA;mago-nashi homolog, proliferation-associated (Drosophila)
hsa:64328;XPO4,exp4;exportin 4
hsa:51013;EXOSC1,CGI-108,CSL4,Csl4p,SKI4,Ski4p,hCsl4p,p13;exosome component 1
hsa:10188;TNK2,ACK,ACK-1,ACK1,p21cdc42Hs;tyrosine kinase, non-receptor, 2 (EC:2.7.11.1 2.7.10.2)
hsa:80012;PHC3,EDR3,HPH3;polyhomeotic homolog 3 (Drosophila)
hsa:5119;CHMP1A,CHMP1,PCH8,PCOLN3,PRSM1,VPS46-1,VPS46A;charged multivesicular body protein 1A
hsa:8766;RAB11A,YL8;RAB11A, member RAS oncogene family
hsa:1911;PHC1,EDR1,HPH1,RAE28;polyhomeotic homolog 1 (Drosophila)
hsa:6256;RXRA,NR2B1;retinoid X receptor, alpha
hsa:79778;MICALL2,JRAB,MICAL-L2;MICAL-like 2
hsa:1962;EHHADH,ECHD,L-PBE,LBFP,LBP,PBFE;enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase (EC:1.1.1.35 5.3.3.8 4.2.1.17)
hsa:79720;VPS37B;vacuolar protein sorting 37 homolog B (S. cerevisiae)
hsa:57132;CHMP1B,C10orf2,C18-ORF2,C18orf2,CHMP1.5,Vps46-2,Vps46B,hVps46-2;charged multivesicular body protein 1B
hsa:10458;BAIAP2,BAP2,FLAF3,IRSP53;BAI1-associated protein 2
hsa:160762;CCDC63,ODA5;coiled-coil domain containing 63
hsa:1286;COL4A4,CA44;collagen, type IV, alpha 4
hsa:2516;NR5A1,AD4BP,ELP,FTZ1,FTZF1,POF7,SF-1,SF1,SPGF8,SRXY3;nuclear receptor subfamily 5, group A, member 1
hsa:140462;ASB9;ankyrin repeat and SOCS box containing 9
hsa:8139;GAN,GAN1,KLHL16;gigaxonin
hsa:79819;WDR78,DIC4;WD repeat domain 78
hsa:5810;RAD1,HRAD1,REC1;RAD1 homolog (S. pombe) (EC:3.1.11.2)
hsa:3728;JUP,ARVD12,CTNNG,DP3,DPIII,PDGB,PKGB;junction plakoglobin
hsa:5516;PPP2CB,PP2Abeta,PP2CB;protein phosphatase 2, catalytic subunit, beta isozyme (EC:3.1.3.16)
hsa:983;CDK1,CDC2,CDC28A,P34CDC2;cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22)
hsa:5753;PTK6,BRK;protein tyrosine kinase 6 (EC:2.7.10.2)
hsa:1152;CKB,B-CK,CKBB;creatine kinase, brain (EC:2.7.3.2)
hsa:56158;TEX12;testis expressed 12
hsa:8669;EIF3J,EIF3S1,eIF3-alpha,eIF3-p35;eukaryotic translation initiation factor 3, subunit J
hsa:1288;COL4A6,CXDELq22.3,DELXq22.3;collagen, type IV, alpha 6
hsa:25843;MOB4,2C4D,MOB1,MOB3,MOBKL3,PHOCN,PREI3;MOB family member 4, phocein
hsa:163126;EID2,CRI2,EID-2;EP300 interacting inhibitor of differentiation 2
hsa:8507;ENC1,CCL28,ENC-1,KLHL35,KLHL37,NRPB,PIG10,TP53I10;ectodermal-neural cortex 1 (with BTB domain)
hsa:54894;RNF43,RNF124,URCC;ring finger protein 43
hsa:126820;WDR63,DIC3,NYD-SP29,RP11-507C22.2;WD repeat domain 63
hsa:9039;UBA3,UBE1C,hUBA3;ubiquitin-like modifier activating enzyme 3
hsa:1808;DPYSL2,CRMP-2,CRMP2,DHPRP2,DRP-2,DRP2,N2A3,ULIP-2,ULIP2;dihydropyrimidinase-like 2
hsa:593;BCKDHA,BCKDE1A,MSU,MSUD1,OVD1A;branched chain keto acid dehydrogenase E1, alpha polypeptide (EC:1.2.4.4)
hsa:3043;HBB,CD113t-C,beta-globin;hemoglobin, beta
hsa:56288;PARD3,ASIP,Baz,PAR3,PAR3alpha,PARD-3,PARD3A,SE2-5L16,SE2-5LT1,SE2-5T2;par-3 partitioning defective 3 homolog (C. elegans)
hsa:26271;FBXO5,EMI1,FBX5,Fbxo31;F-box protein 5
hsa:9322;TRIP10,CIP4,HSTP,STOT,STP;thyroid hormone receptor interactor 10
hsa:100859930;HEIH,LINC-HEIH,LINC00848,lncRNA-HEIH;highly expressed in hepatocellular carcinoma long non-coding RNA
hsa:100132594;PGAM1P5;phosphoglycerate mutase 1 pseudogene 5
hsa:100874241;STARD13-AS,STARD13-AS2;STARD13 antisense RNA
hsa:644962;;TNRC18P1
hsa:199857;ALG14;ALG14, UDP-N-acetylglucosaminyltransferase subunit
hsa:25880;TMEM186,C16orf51;transmembrane protein 186
hsa:29880;ALG5,RP11-421P11.2,bA421P11.2;ALG5, dolichyl-phosphate beta-glucosyltransferase (EC:2.4.1.117)
hsa:79868;ALG13,CDG1S,CXorf45,GLT28D1,MDS031,TDRD13,YGL047W;ALG13, UDP-N-acetylglucosaminyltransferase subunit (EC:2.4.1.141)
hsa:283571;PROX2,PROX-2;prospero homeobox 2
hsa:54742;LY6K,CT97,HSJ001348,ly-6K;lymphocyte antigen 6 complex, locus K
hsa:9211;LGI1,ADLTE,ADPAEF,ADPEAF,EPITEMPIN,EPT,ETL1,IB1099;leucine-rich, glioma inactivated 1
hsa:1024;CDK8,K35;cyclin-dependent kinase 8 (EC:2.7.11.23 2.7.11.22)
hsa:8739;HRK,DP5,HARAKIRI;harakiri, BCL2 interacting protein (contains only BH3 domain)
hsa:54919;HEATR2,CILD18;HEAT repeat containing 2
hsa:26001;RNF167,5730408C10Rik,RING105;ring finger protein 167
hsa:282973;JAKMIP3,C10orf14,C10orf39,Jamip3,NECC2,bA140A10.5;Janus kinase and microtubule interacting protein 3
hsa:2631;GBAS,NIPSNAP2;glioblastoma amplified sequence
hsa:171389;NLRP6,AVR,CLR11.4,NALP6,NAVR,NAVR/AVR,PAN3,PYPAF5;NLR family, pyrin domain containing 6
hsa:118487;CHCHD1,C10orf34,C2360;coiled-coil-helix-coiled-coil-helix domain containing 1
hsa:23639;LRRC6,CILD19,LRTP,TSLRP;leucine rich repeat containing 6
hsa:8508;NIPSNAP1;nipsnap homolog 1 (C. elegans)
hsa:93233;CCDC114,CILD20;coiled-coil domain containing 114
hsa:3861;KRT14,CK14,EBS3,EBS4,K14,NFJ;keratin 14
hsa:83938;C10orf11;chromosome 10 open reading frame 11
hsa:3090;HIC1,ZBTB29,ZNF901,hic-1;hypermethylated in cancer 1
hsa:6247;RS1,RS,XLRS1;retinoschisin 1
hsa:5332;PLCB4,ARCND2,PI-PLC;phospholipase C, beta 4 (EC:3.1.4.11)
hsa:9620;CELSR1,CDHF9,FMI2,HFMI2,ME2;cadherin, EGF LAG seven-pass G-type receptor 1
hsa:10324;KLHL41,KBTBD10,Krp1,SARCOSIN;kelch-like family member 41
hsa:377007;KLHL30;kelch-like family member 30
hsa:54800;KLHL24,DRE1,KRIP6;kelch-like family member 24
hsa:85365;ALG2,CDGIi,NET38,hALPG2;ALG2, alpha-1,3/1,6-mannosyltransferase (EC:2.4.1.132 2.4.1.257)
hsa:57542;KLHL42,Ctb9,KLHDC5;kelch-like family member 42
hsa:56052;ALG1,CDG1K,HMAT1,HMT-1,HMT1,MT-1,Mat-1,hMat-1;ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase (EC:2.4.1.142)
hsa:2992;GYG1,GSD15,GYG;glycogenin 1 (EC:2.4.1.186)
hsa:8908;GYG2,GN-2,GN2;glycogenin 2 (EC:2.4.1.186)
hsa:131377;KLHL40,KBTBD5,SRYP;kelch-like family member 40
hsa:137902;PXDNL,PMR1,PRM1,VPO2;peroxidasin homolog (Drosophila)-like (EC:1.11.1.7)
hsa:79712;GTDC1,Hmat-Xa,mat-Xa;glycosyltransferase-like domain containing 1
hsa:644974;ALG1L2;ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase-like 2
hsa:200810;ALG1L,ALG1L1;ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase-like
hsa:114818;KLHL29,KBTBD9;kelch-like family member 29
hsa:51372;TMA7,CCDC72;translation machinery associated 7 homolog (S. cerevisiae)
hsa:340359;KLHL38,C8ORFK36;kelch-like family member 38
hsa:440138;ALG11,CDG1P,GT8;ALG11, alpha-1,2-mannosyltransferase (EC:2.4.1.131)
hsa:64410;KLHL25,ENC-2,ENC2;kelch-like family member 25
hsa:55295;KLHL26;kelch-like family member 26
hsa:283212;KLHL35;kelch-like family member 35
hsa:56911;MAP3K7CL,C21orf7,HC21ORF7,TAK1L,TAKL,TAKL-1,TAKL-2,TAKL-4;MAP3K7 C-terminal like
hsa:1951;CELSR3,CDHF11,EGFL1,FMI1,HFMI1,MEGF2,RESDA1;cadherin, EGF LAG seven-pass G-type receptor 3
hsa:123103;KLHL33;kelch-like family member 33
hsa:257240;KLHL34;kelch-like family member 34
hsa:54813;KLHL28,BTBD5;kelch-like family member 28
hsa:114792;KLHL32,BKLHD5,KIAA1900,UG0030H05,dJ21F7.1;kelch-like family member 32
hsa:79786;KLHL36,C16orf44;kelch-like family member 36
hsa:120586;OR8I2,OR11-170;olfactory receptor, family 8, subfamily I, member 2
hsa:1952;CELSR2,CDHF10,EGFL2,Flamingo1,MEGF3;cadherin, EGF LAG seven-pass G-type receptor 2
hsa:64745;METTL17,METT11D1;methyltransferase like 17
hsa:2773;GNAI3,87U6,ARCND1;guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
hsa:728655;HULC,LINC00078,NCRNA00078;highly up-regulated in liver cancer long non-coding RNA
hsa:554279;LINC00862,C1orf98,SMIM16;long intergenic non-protein coding RNA 862
hsa:5657;PRTN3,ACPA,AGP7,C-ANCA,CANCA,MBN,MBT,NP-4,NP4,P29,PR-3,PR3;proteinase 3 (EC:3.4.21.76)
hsa:2590;GALNT2,GalNAc-T2;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) (EC:2.4.1.41)
hsa:6297;SALL2,HSAL2,Sal-2,ZNF795,p150(Sal2);sal-like 2 (Drosophila)
hsa:4322;MMP13,CLG3,MANDP1;matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-)
hsa:4628;MYH10,NMMHC-IIB,NMMHCB;myosin, heavy chain 10, non-muscle
hsa:2889;RAPGEF1,C3G,GRF2;Rap guanine nucleotide exchange factor (GEF) 1
hsa:2512;FTL,NBIA3;ferritin, light polypeptide
hsa:83706;FERMT3,KIND3,MIG-2,MIG2B,UNC112C,URP2,URP2SF;fermitin family member 3
hsa:51284;TLR7,TLR7-like;toll-like receptor 7
hsa:4255;MGMT;O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63)
hsa:4882;NPR2,AMDM,ANPRB,ANPb,GUC2B,GUCY2B,NPRB,NPRBi;natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) (EC:4.6.1.2)
hsa:57599;WDR48,P80,UAF1;WD repeat domain 48
hsa:6241;RRM2,R2,RR2,RR2M;ribonucleotide reductase M2 (EC:1.17.4.1)
hsa:6272;SORT1,Gp95,LDLCQ6,NT3;sortilin 1
hsa:2319;FLOT2,ECS-1,ECS1,ESA,ESA1,M17S1;flotillin 2
hsa:3014;H2AFX,H2A.X,H2A/X,H2AX;H2A histone family, member X
hsa:79666;PLEKHF2,PHAFIN2,ZFYVE18;pleckstrin homology domain containing, family F (with FYVE domain) member 2
hsa:29952;DPP7,DPP2,DPPII,QPP;dipeptidyl-peptidase 7 (EC:3.4.14.2)
hsa:9388;LIPG,EDL,EL,PRO719;lipase, endothelial (EC:3.1.1.3)
hsa:4780;NFE2L2,NRF2;nuclear factor (erythroid-derived 2)-like 2
hsa:5971;RELB,I-REL,IREL,REL-B;v-rel reticuloendotheliosis viral oncogene homolog B
hsa:597;BCL2A1,ACC-1,ACC-2,BCL2L5,BFL1,GRS,HBPA1;BCL2-related protein A1
hsa:1012;CDH13,CDHH,P105;cadherin 13, H-cadherin (heart) (EC:3.6.1.3)
hsa:3559;IL2RA,CD25,IDDM10,IL2R,TCGFR;interleukin 2 receptor, alpha
hsa:3569;IL6,BSF2,HGF,HSF,IFNB2,IL-6;interleukin 6 (interferon, beta 2)
hsa:4350;MPG,AAG,ADPG,APNG,CRA36.1,MDG,Mid1,PIG11,PIG16,anpg;N-methylpurine-DNA glycosylase (EC:3.2.2.21)
hsa:56623;INPP5E,CORS1,CPD4,JBTS1,MORMS,PPI5PIV;inositol polyphosphate-5-phosphatase, 72 kDa (EC:3.1.3.36)
hsa:3757;KCNH2,ERG1,HERG,HERG1,Kv11.1,LQT2,SQT1;potassium voltage-gated channel, subfamily H (eag-related), member 2
hsa:10971;YWHAQ,14-3-3,1C5,HS1;tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide
hsa:7186;TRAF2,MGC:45012,TRAP,TRAP3;TNF receptor-associated factor 2
hsa:3837;KPNB1,IMB1,IPO1,IPOB,Impnb,NTF97;karyopherin (importin) beta 1
hsa:3077;HFE,HFE1,HH,HLA-H,MVCD7,TFQTL2;hemochromatosis
hsa:3293;HSD17B3,EDH17B3,SDR12C2;hydroxysteroid (17-beta) dehydrogenase 3 (EC:1.1.1.64)
hsa:4627;MYH9,BDPLT6,DFNA17,EPSTS,FTNS,MHA,NMHC-II-A,NMMHC-IIA,NMMHCA;myosin, heavy chain 9, non-muscle
hsa:10392;NOD1,CARD4,CLR7.1,NLRC1;nucleotide-binding oligomerization domain containing 1
hsa:6452;SH3BP2,3BP-2,3BP2,CRBM,CRPM;SH3-domain binding protein 2
hsa:9099;USP2,UBP41,USP9;ubiquitin specific peptidase 2 (EC:3.4.19.12)
hsa:231;AKR1B1,ADR,ALDR1,ALR2,AR;aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21)
hsa:64750;SMURF2;SMAD specific E3 ubiquitin protein ligase 2
hsa:6845;VAMP7,SYBL1,TI-VAMP,TIVAMP,VAMP-7;vesicle-associated membrane protein 7
hsa:358;AQP1,AQP-CHIP,CHIP28,CO;aquaporin 1 (Colton blood group)
hsa:5733;PTGER3,EP3,EP3-I,EP3-II,EP3-III,EP3-IV,EP3e,PGE2-R;prostaglandin E receptor 3 (subtype EP3)
hsa:2737;GLI3,ACLS,GCPS,GLI3-190,GLI3FL,PAP-A,PAPA,PAPA1,PAPB,PHS,PPDIV;GLI family zinc finger 3
hsa:84152;PPP1R1B,DARPP-32,DARPP32;protein phosphatase 1, regulatory (inhibitor) subunit 1B (EC:3.1.3.16)
hsa:573;BAG1,BAG-1,HAP,RAP46;BCL2-associated athanogene
hsa:6688;SPI1,OF,PU.1,SFPI1,SPI-1,SPI-A;spleen focus forming virus (SFFV) proviral integration oncogene spi1
hsa:8030;CCDC6,D10S170,H4,PTC,TPC,TST1;coiled-coil domain containing 6
hsa:1525;CXADR,CAR,CAR4/6,HCAR;coxsackie virus and adenovirus receptor
hsa:3290;HSD11B1,11-DH,11-beta-HSD1,CORTRD2,HDL,HSD11,HSD11B,HSD11L,SDR26C1;hydroxysteroid (11-beta) dehydrogenase 1 (EC:1.1.1.146)
hsa:6793;STK10,LOK,PRO2729;serine/threonine kinase 10 (EC:2.7.11.1)
hsa:81857;MED25,ACID1,ARC92,CMT2B2,P78,PTOV2;mediator complex subunit 25
hsa:5888;RAD51,BRCC5,HRAD51,HsRad51,HsT16930,MRMV2,RAD51A,RECA;RAD51 homolog (S. cerevisiae)
hsa:3608;ILF2,NF45,PRO3063;interleukin enhancer binding factor 2
hsa:79957;PAQR6;progestin and adipoQ receptor family member VI
hsa:5520;PPP2R2A,B55A,B55ALPHA,PR52A,PR55A;protein phosphatase 2, regulatory subunit B, alpha (EC:3.1.3.16)
hsa:81792;ADAMTS12,PRO4389;ADAM metallopeptidase with thrombospondin type 1 motif, 12
hsa:2764;GMFB,GMF;glia maturation factor, beta
hsa:1742;DLG4,PSD95,SAP-90,SAP90;discs, large homolog 4 (Drosophila)
hsa:55600;ITLN1,HL-1,HL1,INTL,ITLN,LFR,hIntL,omentin;intelectin 1 (galactofuranose binding)
hsa:2263;FGFR2,BBDS,BEK,BFR-1,CD332,CEK3,CFD1,ECT1,JWS,K-SAM,KGFR,TK14,TK25;fibroblast growth factor receptor 2 (EC:2.7.10.1)
hsa:3039;HBA1,CD31,HBH;hemoglobin, alpha 1
hsa:58504;ARHGAP22,RhoGAP2,RhoGap22;Rho GTPase activating protein 22
hsa:55584;CHRNA9,HSA243342,NACHRA9;cholinergic receptor, nicotinic, alpha 9 (neuronal)
hsa:8390;OR1G1,OR17-130,OR17-209,OR1G2;olfactory receptor, family 1, subfamily G, member 1
hsa:11200;CHEK2,CDS1,CHK2,HuCds1,LFS2,PP1425,RAD53,hCds1;checkpoint kinase 2 (EC:2.7.11.1)
hsa:958;CD40,Bp50,CDW40,TNFRSF5,p50;CD40 molecule, TNF receptor superfamily member 5
hsa:9984;THOC1,HPR1,P84,P84N5;THO complex 1
hsa:335;APOA1;apolipoprotein A-I
hsa:5914;RARA,NR1B1,RAR;retinoic acid receptor, alpha
hsa:30835;CD209,CDSIGN,CLEC4L,DC-SIGN,DC-SIGN1;CD209 molecule
hsa:7014;TERF2,TRBF2,TRF2;telomeric repeat binding factor 2
hsa:10970;CKAP4,CLIMP-63,ERGIC-63,p63;cytoskeleton-associated protein 4
hsa:1143;CHRNB4;cholinergic receptor, nicotinic, beta 4 (neuronal)
hsa:4162;MCAM,CD146,MUC18;melanoma cell adhesion molecule
hsa:2912;GRM2,GLUR2,GPRC1B,MGLUR2,mGlu2;glutamate receptor, metabotropic 2
hsa:345;APOC3,APOCIII,HALP2;apolipoprotein C-III
hsa:4072;EPCAM,DIAR5,EGP-2,EGP314,EGP40,ESA,HNPCC8,KS1/4,KSA,M4S1,MIC18,MK-1,TACSTD1,TROP1;epithelial cell adhesion molecule
hsa:79969;ATAT1,C6orf134,MEC17,Nbla00487,TAT;alpha tubulin acetyltransferase 1 (EC:2.3.1.108)
hsa:22897;CEP164,NPHP15;centrosomal protein 164kDa
hsa:84868;HAVCR2,HAVcr-2,KIM-3,TIM3,TIMD-3,TIMD3,Tim-3;hepatitis A virus cellular receptor 2
hsa:29894;CPSF1,CPSF160,HSU37012,P/cl.18;cleavage and polyadenylation specific factor 1, 160kDa
hsa:1773;DNASE1,DNL1,DRNI;deoxyribonuclease I (EC:3.1.21.1)
hsa:2648;KAT2A,GCN5,GCN5L2,PCAF-b,hGCN5;K(lysine) acetyltransferase 2A (EC:2.3.1.48)
hsa:4057;LTF,GIG12,HLF2,LF;lactotransferrin
hsa:24145;PANX1,MRS1,PX1,UNQ2529;pannexin 1
hsa:59067;IL21,IL-21,Za11;interleukin 21
hsa:326;AIRE,AIRE1,APECED,APS1,APSI,PGA1;autoimmune regulator
hsa:3689;ITGB2,CD18,LAD,LCAMB,LFA-1,MAC-1,MF17,MFI7;integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
hsa:961;CD47,IAP,MER6,OA3;CD47 molecule
hsa:2650;GCNT1,C2GNT,C2GNT-L,C2GNT1,G6NT,NACGT2,NAGCT2;glucosaminyl (N-acetyl) transferase 1, core 2 (EC:2.4.1.102)
hsa:51257;MARCH2,MARCH-II,RNF172;membrane-associated ring finger (C3HC4) 2, E3 ubiquitin protein ligase (EC:6.3.2.-)
hsa:54361;WNT4,SERKAL,WNT-4;wingless-type MMTV integration site family, member 4
hsa:3725;JUN,AP-1,AP1,c-Jun;jun proto-oncogene
hsa:2273;FHL1,FHL-1,FHL1A,FHL1B,FLH1A,KYOT,SLIM,SLIM-1,SLIM1,SLIMMER,XMPMA;four and a half LIM domains 1
hsa:3597;IL13RA1,CD213A1,IL-13Ra,NR4;interleukin 13 receptor, alpha 1
hsa:3784;KCNQ1,ATFB1,ATFB3,JLNS1,KCNA8,KCNA9,KVLQT1,Kv1.9,Kv7.1,LQT,LQT1,RWS,SQT2,WRS;potassium voltage-gated channel, KQT-like subfamily, member 1
hsa:208;AKT2,HIHGHH,PKBB,PKBBETA,PRKBB,RAC-BETA;v-akt murine thymoma viral oncogene homolog 2 (EC:2.7.11.1)
hsa:1138;CHRNA5,LNCR2;cholinergic receptor, nicotinic, alpha 5 (neuronal)
hsa:4811;NID1,NID;nidogen 1
hsa:115004;MB21D1,C6orf150,cGAS,h-cGAS;Mab-21 domain containing 1
hsa:9928;KIF14;kinesin family member 14
hsa:84444;DOT1L,DOT1,KMT4;DOT1-like, histone H3 methyltransferase (S. cerevisiae) (EC:2.1.1.43)
hsa:9820;CUL7,KIAA0076,dJ20C7.5;cullin 7
hsa:5727;PTCH1,BCNS,HPE7,NBCCS,PTC,PTC1,PTCH,PTCH11;patched 1
hsa:6335;SCN9A,ETHA,FEB3B,GEFSP7,NE-NA,NENA,Nav1.7,PN1,SFNP;sodium channel, voltage-gated, type IX, alpha subunit
hsa:2079;ERH,DROER;enhancer of rudimentary homolog (Drosophila)
hsa:51691;NAA38,LSM8;N(alpha)-acetyltransferase 38, NatC auxiliary subunit
hsa:26191;PTPN22,LYP,LYP1,LYP2,PEP,PTPN8;protein tyrosine phosphatase, non-receptor type 22 (lymphoid) (EC:3.1.3.48)
hsa:23008;KLHDC10,slim;kelch domain containing 10
hsa:54472;TOLLIP,IL-1RAcPIP;toll interacting protein
hsa:9112;MTA1;metastasis associated 1
hsa:4210;MEFV,FMF,MEF,TRIM20;Mediterranean fever
hsa:2055;CLN8,C8orf61,EPMR;ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
hsa:387082;SUMO4,IDDM5,SMT3H4,SUMO-4,dJ281H8.4;SMT3 suppressor of mif two 3 homolog 4 (S. cerevisiae)
hsa:5429;POLH,RAD30,RAD30A,XP-V,XPV;polymerase (DNA directed), eta (EC:2.7.7.7)
hsa:3842;TNPO1,IPO2,KPNB2,MIP,MIP1,TRN;transportin 1
hsa:1852;DUSP9,MKP-4,MKP4;dual specificity phosphatase 9 (EC:3.1.3.16 3.1.3.48)
hsa:57634;EP400,CAGH32,P400,TNRC12;E1A binding protein p400
hsa:54927;CHCHD3,MINOS3,PPP1R22;coiled-coil-helix-coiled-coil-helix domain containing 3
hsa:6557;SLC12A1,BSC1,NKCC2;solute carrier family 12 (sodium/potassium/chloride transporters), member 1
hsa:5663;PSEN1,AD3,FAD,PS-1,PS1,S182;presenilin 1 (EC:3.4.23.-)
hsa:8140;SLC7A5,4F2LC,CD98,D16S469E,E16,LAT1,MPE16,hLAT1;solute carrier family 7 (amino acid transporter light chain, L system), member 5
hsa:6360;CCL16,CKb12,HCC-4,ILINCK,LCC-1,LEC,LMC,Mtn-1,NCC-4,NCC4,SCYA16,SCYL4;chemokine (C-C motif) ligand 16
hsa:9828;ARHGEF17,P164RHOGEF,TEM4,p164-RhoGEF;Rho guanine nucleotide exchange factor (GEF) 17
hsa:22924;MAPRE3,EB3,EBF3,EBF3-S,RP3;microtubule-associated protein, RP/EB family, member 3
hsa:5599;MAPK8,JNK,JNK-46,JNK1,JNK1A2,JNK21B1/2,PRKM8,SAPK1,SAPK1c;mitogen-activated protein kinase 8 (EC:2.7.11.24)
hsa:26259;FBXW8,FBW6,FBW8,FBX29,FBXO29,FBXW6;F-box and WD repeat domain containing 8
hsa:8411;EEA1,MST105,MSTP105,ZFYVE2;early endosome antigen 1
hsa:54739;XAF1,BIRC4BP,HSXIAPAF1,XIAPAF1;XIAP associated factor 1
hsa:112476;PRRT2,BFIC2,BFIS2,DSPB3,DYT10,EKD1,ICCA,IFITMD1,PKC;proline-rich transmembrane protein 2
hsa:7508;XPC,RAD4,XP3,XPCC;xeroderma pigmentosum, complementation group C
hsa:3605;IL17A,CTLA8,IL-17,IL-17A,IL17;interleukin 17A
hsa:84269;CHCHD5,C2orf9,MIC14;coiled-coil-helix-coiled-coil-helix domain containing 5
hsa:2896;GRN,CLN11,GEP,GP88,PCDGF,PEPI,PGRN;granulin
hsa:5147;PDE6D,PDED;phosphodiesterase 6D, cGMP-specific, rod, delta (EC:3.1.4.17)
hsa:57492;ARID1B,6A3-5,BAF250B,BRIGHT,DAN15,ELD/OSA1,MRD12,OSA2,P250R;AT rich interactive domain 1B (SWI1-like)
hsa:1441;CSF3R,CD114,GCSFR;colony stimulating factor 3 receptor (granulocyte)
hsa:100132285;KIR2DS2,183ActI,CD158J,CD158b,NKAT5,cl-49;killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
hsa:3574;IL7,IL-7;interleukin 7
hsa:9311;ASIC3,ACCN3,DRASIC,SLNAC1,TNaC1;acid-sensing (proton-gated) ion channel 3
hsa:1048;CEACAM5,CD66e,CEA;carcinoembryonic antigen-related cell adhesion molecule 5
hsa:1136;CHRNA3,LNCR2,NACHRA3,PAOD2;cholinergic receptor, nicotinic, alpha 3 (neuronal)
hsa:6616;SNAP25,RIC-4,RIC4,SEC9,SNAP,SNAP-25,bA416N4.2,dJ1068F16.2;synaptosomal-associated protein, 25kDa
hsa:5742;PTGS1,COX1,COX3,PCOX1,PES-1,PGG/HS,PGHS-1,PGHS1,PHS1,PTGHS;prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1)
hsa:30818;KCNIP3,CSEN,DREAM,KCHIP3;Kv channel interacting protein 3, calsenilin
hsa:112399;EGLN3,HIFP4H3,HIFPH3,PHD3;egl nine homolog 3 (C. elegans) (EC:1.14.11.29)
hsa:8505;PARG,PARG99;poly (ADP-ribose) glycohydrolase (EC:3.2.1.143)
hsa:7068;THRB,C-ERBA-2,C-ERBA-BETA,ERBA2,GRTH,NR1A2,PRTH,THR1,THRB1,THRB2;thyroid hormone receptor, beta
hsa:9730;VPRBP,DCAF1;Vpr (HIV-1) binding protein
hsa:56034;PDGFC,FALLOTEIN,SCDGF;platelet derived growth factor C
hsa:1798;DPAGT1,ALG7,CDG-Ij,CDG1J,CMSTA2,D11S366,DGPT,DPAGT,DPAGT2,G1PT,GPT,UAGT,UGAT;dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) (EC:2.7.8.15)
hsa:2202;EFEMP1,DHRD,DRAD,FBLN3,FBNL,FIBL-3,MLVT,MTLV,S1-5;EGF containing fibulin-like extracellular matrix protein 1
hsa:706;TSPO,BPBS,BZRP,DBI,IBP,MBR,PBR,PBS,PKBS,PTBR,mDRC,pk18;translocator protein (18kDa)
hsa:4016;LOXL1,LOL,LOXL;lysyl oxidase-like 1
hsa:64581;CLEC7A,BGR,CANDF4,CLECSF12,DECTIN1;C-type lectin domain family 7, member A
hsa:5047;PAEP,GD,GdA,GdF,GdS,PAEG,PEP,PP14;progestagen-associated endometrial protein
hsa:23064;SETX,ALS4,AOA2,SCAR1,bA479K20.2;senataxin (EC:3.6.1.-)
hsa:4314;MMP3,CHDS6,MMP-3,SL-1,STMY,STMY1,STR1;matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17)
hsa:4049;LTA,LT,TNFB,TNFSF1;lymphotoxin alpha (TNF superfamily, member 1)
hsa:9457;FHL5,ACT,RP3-393D12.2,dJ393D12.2;four and a half LIM domains 5
hsa:6347;CCL2,GDCF-2,HC11,HSMCR30,MCAF,MCP-1,MCP1,SCYA2,SMC-CF;chemokine (C-C motif) ligand 2
hsa:2113;ETS1,ETS-1,EWSR2;v-ets erythroblastosis virus E26 oncogene homolog 1 (avian)
hsa:3738;KCNA3,HGK5,HLK3,HPCN3,HUKIII,KV1.3,MK3,PCN3;potassium voltage-gated channel, shaker-related subfamily, member 3
hsa:2882;GPX7,CL683,GPX6,GPx-7,GSHPx-7,NPGPx;glutathione peroxidase 7 (EC:1.11.1.9)
hsa:5915;RARB,HAP,NR1B2,RRB2;retinoic acid receptor, beta
hsa:55704;CCDC88A,APE,GIRDIN,GIV,GRDN,HkRP1,KIAA1212;coiled-coil domain containing 88A
hsa:374900;ZNF568;zinc finger protein 568
hsa:11335;CBX3,HECH,HP1-GAMMA,HP1Hs-gamma;chromobox homolog 3
hsa:540;ATP7B,PWD,WC1,WD,WND;ATPase, Cu++ transporting, beta polypeptide (EC:3.6.3.4)
hsa:1543;CYP1A1,AHH,AHRR,CP11,CYP1,P1-450,P450-C,P450DX;cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1)
hsa:1488;CTBP2;C-terminal binding protein 2
hsa:11345;GABARAPL2,ATG8,ATG8C,GATE-16,GATE16,GEF-2,GEF2;GABA(A) receptor-associated protein-like 2
hsa:148022;TICAM1,IIAE6,MyD88-3,PRVTIRB,TICAM-1,TRIF;toll-like receptor adaptor molecule 1
hsa:23774;BRD1,BRL,BRPF1,BRPF2;bromodomain containing 1
hsa:4092;SMAD7,CRCS3,MADH7,MADH8;SMAD family member 7
hsa:9275;BCL7B;B-cell CLL/lymphoma 7B
hsa:2289;FKBP5,AIG6,FKBP51,FKBP54,P54,PPIase,Ptg-10;FK506 binding protein 5 (EC:5.2.1.8)
hsa:684;BST2,CD317,TETHERIN;bone marrow stromal cell antigen 2
hsa:4913;NTHL1,NTH1,OCTS3;nth endonuclease III-like 1 (E. coli) (EC:4.2.99.18)
hsa:128637;TBC1D20,C20orf140;TBC1 domain family, member 20
hsa:4488;MSX2,CRS2,FPP,HOX8,MSH,PFM,PFM1;msh homeobox 2
hsa:10631;POSTN,OSF-2,OSF2,PDLPOSTN,PN,RP11-412K4.1,periostin;periostin, osteoblast specific factor
hsa:9516;LITAF,PIG7,SIMPLE,TP53I7;lipopolysaccharide-induced TNF factor
hsa:8516;ITGA8;integrin, alpha 8
hsa:54898;ELOVL2,SSC2;ELOVL fatty acid elongase 2 (EC:2.3.1.199)
hsa:2885;GRB2,ASH,EGFRBP-GRB2,Grb3-3,MST084,MSTP084,NCKAP2;growth factor receptor-bound protein 2
hsa:90417;KNSTRN,C15orf23,SKAP,TRAF4AF1;kinetochore-localized astrin/SPAG5 binding protein
hsa:4952;OCRL,INPP5F,LOCR,NPHL2,OCRL-1,OCRL1;oculocerebrorenal syndrome of Lowe (EC:3.1.3.36)
hsa:84735;CNDP1,CN1,CPGL2,HsT2308;carnosine dipeptidase 1 (metallopeptidase M20 family) (EC:3.4.13.20)
hsa:8289;ARID1A,B120,BAF250,BAF250a,BM029,C1orf4,ELD,MRD14,OSA1,P270,SMARCF1,hELD,hOSA1;AT rich interactive domain 1A (SWI-like)
hsa:5972;REN,HNFJ2;renin (EC:3.4.23.15)
hsa:6855;SYP,MRXSYP;synaptophysin
hsa:563;AZGP1,ZA2G,ZAG;alpha-2-glycoprotein 1, zinc-binding
hsa:30001;ERO1L,ERO1-alpha,ERO1A;ERO1-like (S. cerevisiae)
hsa:2212;FCGR2A,CD32,CD32A,CDw32,FCG2,FCGR2,FCGR2A1,FcGR,IGFR2;Fc fragment of IgG, low affinity IIa, receptor (CD32)
hsa:8061;FOSL1,FRA,FRA1,fra-1;FOS-like antigen 1
hsa:104;ADARB1,ADAR2,DRABA2,DRADA2,RED1;adenosine deaminase, RNA-specific, B1
hsa:2810;SFN,YWHAS;stratifin
hsa:3741;KCNA5,ATFB7,HCK1,HK2,HPCN1,KV1.5,PCN1;potassium voltage-gated channel, shaker-related subfamily, member 5
hsa:63967;CLSPN;claspin
hsa:7292;TNFSF4,CD134L,CD252,GP34,OX-40L,OX4OL,TXGP1;tumor necrosis factor (ligand) superfamily, member 4
hsa:8451;CUL4A;cullin 4A
hsa:6623;SNCG,BCSG1,SR;synuclein, gamma (breast cancer-specific protein 1)
hsa:11255;HRH3,GPCR97,HH3R;histamine receptor H3
hsa:493;ATP2B4,ATP2B2,MXRA1,PMCA4,PMCA4b,PMCA4x;ATPase, Ca++ transporting, plasma membrane 4 (EC:3.6.3.8)
hsa:891;CCNB1,CCNB;cyclin B1
hsa:5156;PDGFRA,CD140A,PDGFR-2,PDGFR2,RHEPDGFRA;platelet-derived growth factor receptor, alpha polypeptide (EC:2.7.10.1)
hsa:4050;LTB,TNFC,TNFSF3,p33;lymphotoxin beta (TNF superfamily, member 3)
hsa:29947;DNMT3L;DNA (cytosine-5-)-methyltransferase 3-like
hsa:6317;SERPINB3,HsT1196,SCC,SCCA-1,SCCA-PD,SCCA1,T4-A;serpin peptidase inhibitor, clade B (ovalbumin), member 3
hsa:659;BMPR2,BMPR-II,BMPR3,BMR2,BRK-3,PPH1,T-ALK;bone morphogenetic protein receptor, type II (serine/threonine kinase) (EC:2.7.11.30)
hsa:57724;EPG5,HEEW1,KIAA1632,VICIS,hEPG5;ectopic P-granules autophagy protein 5 homolog (C. elegans)
hsa:729873;TBC1D3,PRC17,TBC1D3A,TBC1D3F;TBC1 domain family, member 3
hsa:7076;TIMP1,CLGI,EPA,EPO,HCI,TIMP;TIMP metallopeptidase inhibitor 1
hsa:5581;PRKCE,PKCE,nPKC-epsilon;protein kinase C, epsilon (EC:2.7.11.13)
hsa:6770;STAR,STARD1;steroidogenic acute regulatory protein
hsa:8878;SQSTM1,A170,OSIL,PDB3,ZIP3,p60,p62,p62B;sequestosome 1
hsa:5654;HTRA1,ARMD7,CARASIL,HtrA,L56,ORF480,PRSS11;HtrA serine peptidase 1 (EC:3.4.21.-)
hsa:5978;REST,NRSF,XBR;RE1-silencing transcription factor
hsa:23461;ABCA5,ABC13,EST90625;ATP-binding cassette, sub-family A (ABC1), member 5
hsa:23373;CRTC1,MECT1,TORC-1,TORC1,WAMTP1;CREB regulated transcription coactivator 1
hsa:1413;CRYBA4,MCOPCT4;crystallin, beta A4
hsa:5340;PLG;plasminogen (EC:3.4.21.7)
hsa:3229;HOXC13,ECTD9,HOX3,HOX3G;homeobox C13
hsa:10555;AGPAT2,1-AGPAT2,BSCL,BSCL1,LPAAB,LPAAT-beta;1-acylglycerol-3-phosphate O-acyltransferase 2 (EC:2.3.1.51)
hsa:6392;SDHD,CBT1,CII-4,CWS3,PGL,PGL1,QPs3,SDH4,cybS;succinate dehydrogenase complex, subunit D, integral membrane protein
hsa:9201;DCLK1,CL1,CLICK1,DCAMKL1,DCDC3A,DCLK;doublecortin-like kinase 1 (EC:2.7.11.1)
hsa:3265;HRAS,C-BAS/HAS,C-H-RAS,C-HA-RAS1,CTLO,H-RASIDX,HAMSV,HRAS1,K-RAS,N-RAS,RASH1;v-Ha-ras Harvey rat sarcoma viral oncogene homolog
hsa:393;ARHGAP4,C1,RGC1,RhoGAP4,SrGAP4,p115;Rho GTPase activating protein 4
hsa:57491;AHRR,AHH,AHHR,bHLHe77;aryl-hydrocarbon receptor repressor
hsa:331;XIAP,API3,BIRC4,IAP-3,ILP1,MIHA,XLP2,hIAP-3,hIAP3;X-linked inhibitor of apoptosis
hsa:353238;PADI6,hPADVI;peptidyl arginine deiminase, type VI (EC:3.5.3.15)
hsa:7764;ZNF217,ZABC1;zinc finger protein 217
hsa:1003;CDH5,7B4,CD144;cadherin 5, type 2 (vascular endothelium)
hsa:7398;USP1,UBP;ubiquitin specific peptidase 1 (EC:3.4.19.12)
hsa:3674;ITGA2B,BDPLT2,CD41,CD41B,GP2B,GPIIb,GT,GTA,HPA3;integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
hsa:4363;ABCC1,ABC29,ABCC,GS-X,MRP,MRP1;ATP-binding cassette, sub-family C (CFTR/MRP), member 1
hsa:9892;SNAP91,AP180,CALM;synaptosomal-associated protein, 91kDa
hsa:554;AVPR2,ADHR,DI1,DIR,DIR3,NDI,V2R;arginine vasopressin receptor 2
hsa:11315;PARK7,DJ-1,DJ1;parkinson protein 7
hsa:8848;TSC22D1,Ptg-2,TGFB1I4,TSC22;TSC22 domain family, member 1
hsa:7356;SCGB1A1,CC10,CC16,CCPBP,CCSP,UGB,UP-1,UP1;secretoglobin, family 1A, member 1 (uteroglobin)
hsa:118429;ANTXR2,CMG-2,CMG2,HFS,ISH,JHF;anthrax toxin receptor 2
hsa:355;FAS,ALPS1A,APO-1,APT1,CD95,FAS1,FASTM,TNFRSF6;Fas (TNF receptor superfamily, member 6)
hsa:2702;GJA5,ATFB11,CX40;gap junction protein, alpha 5, 40kDa
hsa:26035;GLCE,HSEPI;glucuronic acid epimerase (EC:5.1.3.17)
hsa:2296;FOXC1,ARA,FKHL7,FREAC-3,FREAC3,IGDA,IHG1,IRID1,RIEG3;forkhead box C1
hsa:57818;G6PC2,IGRP;glucose-6-phosphatase, catalytic, 2 (EC:3.1.3.9)
hsa:7867;MAPKAPK3,3PK,MAPKAP-K3,MAPKAP3,MAPKAPK-3,MK-3;mitogen-activated protein kinase-activated protein kinase 3 (EC:2.7.11.1)
hsa:1508;CTSB,APPS,CPSB;cathepsin B (EC:3.4.22.1)
hsa:7507;XPA,XP1,XPAC;xeroderma pigmentosum, complementation group A
hsa:151126;ZNF385B,ZFN533,ZNF533;zinc finger protein 385B
hsa:51150;SDF4,Cab45,SDF-4;stromal cell derived factor 4
hsa:229;ALDOB,ALDB,ALDO2;aldolase B, fructose-bisphosphate (EC:4.1.2.13)
hsa:9463;PICK1,PICK,PRKCABP;protein interacting with PRKCA 1
hsa:4507;MTAP,BDMF,DMSFH,DMSMFH,LGMBF,MSAP,c86fus;methylthioadenosine phosphorylase (EC:2.4.2.28)
hsa:84678;KDM2B,CXXC2,FBXL10,Fbl10,JHDM1B,PCCX2;lysine (K)-specific demethylase 2B (EC:1.14.11.27)
hsa:6441;SFTPD,COLEC7,PSP-D,SFTP4,SP-D;surfactant protein D
hsa:10810;WASF3,Brush-1,SCAR3,WAVE3;WAS protein family, member 3
hsa:56652;C10orf2,ATXN8,IOSCA,MTDPS7,PEO,PEO1,PEOA3,SANDO,SCA8,TWINL;chromosome 10 open reading frame 2 (EC:3.6.4.12)
hsa:10211;FLOT1;flotillin 1
hsa:1890;TYMP,ECGF,ECGF1,MEDPS1,MNGIE,MTDPS1,PDECGF,TP,hPD-ECGF;thymidine phosphorylase (EC:2.4.2.4)
hsa:8038;ADAM12,MCMP,MCMPMltna,MLTN,MLTNA;ADAM metallopeptidase domain 12
hsa:2;A2M,A2MD,CPAMD5,FWP007,S863-7;alpha-2-macroglobulin
hsa:25836;NIPBL,CDLS,CDLS1,IDN3,IDN3-B,Scc2;Nipped-B homolog (Drosophila)
hsa:7070;THY1,CD90;Thy-1 cell surface antigen
hsa:85414;SLC45A3,IPCA-2,IPCA-6,IPCA-8,IPCA6,PCANAP2,PCANAP6,PCANAP8,PRST;solute carrier family 45, member 3
hsa:5743;PTGS2,COX-2,COX2,GRIPGHS,PGG/HS,PGHS-2,PHS-2,hCox-2;prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1)
hsa:10875;FGL2,T49,pT49;fibrinogen-like 2
hsa:7174;TPP2,TPP-2;tripeptidyl peptidase II (EC:3.4.14.10)
hsa:79145;CHCHD7,COX23;coiled-coil-helix-coiled-coil-helix domain containing 7
hsa:5906;RAP1A,KREV-1,KREV1,RAP1,SMGP21;RAP1A, member of RAS oncogene family
hsa:26040;SETBP1,SEB;SET binding protein 1
hsa:79661;NEIL1,FPG1,NEI1,hFPG1;nei endonuclease VIII-like 1 (E. coli) (EC:4.2.99.18)
hsa:10728;PTGES3,P23,TEBP,cPGES;prostaglandin E synthase 3 (cytosolic) (EC:5.3.99.3)
hsa:9446;GSTO1,GSTO_1-1,GSTTLp28,P28,SPG-R;glutathione S-transferase omega 1 (EC:2.5.1.18 1.8.5.1 1.20.4.2)
hsa:820;CAMP,CAP-18,CAP18,CRAMP,FALL-39,FALL39,LL37;cathelicidin antimicrobial peptide
hsa:9971;NR1H4,BAR,FXR,HRR-1,HRR1,RIP14;nuclear receptor subfamily 1, group H, member 4
hsa:51548;SIRT6,SIR2L6;sirtuin 6 (EC:2.4.2.31)
hsa:84433;CARD11,BIMP3,CARMA1;caspase recruitment domain family, member 11
hsa:196;AHR,bHLHe76;aryl hydrocarbon receptor
hsa:6804;STX1A,HPC-1,P35-1,STX1,SYN1A;syntaxin 1A (brain)
hsa:4739;NEDD9,CAS-L,CAS2,CASL,CASS2,HEF1;neural precursor cell expressed, developmentally down-regulated 9
hsa:5027;P2RX7,P2X7;purinergic receptor P2X, ligand-gated ion channel, 7
hsa:5069;PAPPA,ASBABP2,DIPLA1,IGFBP-4ase,PAPA,PAPP-A,PAPPA1;pregnancy-associated plasma protein A, pappalysin 1 (EC:3.4.24.79)
hsa:53340;SPA17,CT22,SP17,SP17-1;sperm autoantigenic protein 17
hsa:3688;ITGB1,CD29,FNRB,GPIIA,MDF2,MSK12,VLA-BETA,VLAB;integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
hsa:145957;NRG4,HRG4;neuregulin 4
hsa:5347;PLK1,PLK,STPK13;polo-like kinase 1 (EC:2.7.11.21)
hsa:972;CD74,DHLAG,HLADG,II,Ia-GAMMA;CD74 molecule, major histocompatibility complex, class II invariant chain
hsa:6351;CCL4,ACT2,AT744.1,G-26,HC21,LAG-1,LAG1,MIP-1-beta,MIP1B,MIP1B1,SCYA2,SCYA4;chemokine (C-C motif) ligand 4
hsa:3953;LEPR,CD295,LEP-R,LEPRD,OB-R,OBR;leptin receptor
hsa:54882;ANKHD1,MASK,VBARP;ankyrin repeat and KH domain containing 1
hsa:81876;RAB1B;RAB1B, member RAS oncogene family
hsa:4176;MCM7,CDC47,MCM2,P1.1-MCM3,P1CDC47,P85MCM,PNAS146;minichromosome maintenance complex component 7 (EC:3.6.4.12)
hsa:27436;EML4,C2orf2,ELP120,EMAP-4,EMAPL4,ROPP120;echinoderm microtubule associated protein like 4
hsa:57412;AS3MT,CYT19;arsenic (+3 oxidation state) methyltransferase (EC:2.1.1.137)
hsa:9968;MED12,ARC240,CAGH45,FGS1,HOPA,MED12S,OKS,OPA1,TNRC11,TRAP230;mediator complex subunit 12
hsa:7189;TRAF6,MGC:3310,RNF85;TNF receptor-associated factor 6, E3 ubiquitin protein ligase
hsa:9173;IL1RL1,DER4,FIT-1,IL33R,ST2,ST2L,ST2V,T1;interleukin 1 receptor-like 1
hsa:1978;EIF4EBP1,4E-BP1,4EBP1,BP-1,PHAS-I;eukaryotic translation initiation factor 4E binding protein 1
hsa:3015;H2AFZ,H2A.z,H2A/z,H2AZ;H2A histone family, member Z
hsa:9126;SMC3,BAM,BMH,CDLS3,CSPG6,HCAP,SMC3L1;structural maintenance of chromosomes 3
hsa:3596;IL13,ALRH,BHR1,IL-13,P600;interleukin 13
hsa:1103;CHAT,CHOACTASE,CMS1A,CMS1A2;choline O-acetyltransferase (EC:2.3.1.6)
hsa:344838;PAQR9;progestin and adipoQ receptor family member IX
hsa:6514;SLC2A2,GLUT2;solute carrier family 2 (facilitated glucose transporter), member 2
hsa:56244;BTNL2,BTL-II,HSBLMHC1,SS2;butyrophilin-like 2 (MHC class II associated)
hsa:3676;ITGA4,CD49D,IA4;integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
hsa:3915;LAMC1,LAMB2;laminin, gamma 1 (formerly LAMB2)
hsa:668;FOXL2,BPES,BPES1,PFRK,PINTO,POF3;forkhead box L2
hsa:2313;FLI1,EWSR2,SIC-1;Friend leukemia virus integration 1
hsa:794;CALB2,CAB29,CAL2,CR;calbindin 2
hsa:1968;EIF2S3,EIF2,EIF2G,EIF2gamma,eIF-2gA;eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa
hsa:675;BRCA2,BRCC2,BROVCA2,FACD,FAD,FAD1,FANCB,FANCD,FANCD1,GLM3,PNCA2;breast cancer 2, early onset
hsa:2774;GNAL;guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type
hsa:3565;IL4,BCGF-1,BCGF1,BSF-1,BSF1,IL-4;interleukin 4
hsa:7021;TFAP2B,AP-2B,AP2-B;transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
hsa:23543;RBFOX2,FOX2,Fox-2,HNRBP2,HRNBP2,RBM9,RTA,dJ106I20.3,fxh;RNA binding protein, fox-1 homolog (C. elegans) 2
hsa:1460;CSNK2B,CK2B,CK2N,CSK2B,G5A;casein kinase 2, beta polypeptide (EC:2.7.11.1)
hsa:8743;TNFSF10,APO2L,Apo-2L,CD253,TL2,TRAIL;tumor necrosis factor (ligand) superfamily, member 10
hsa:328;APEX1,APE,APE1,APEN,APEX,APX,HAP1,REF1;APEX nuclease (multifunctional DNA repair enzyme) 1 (EC:4.2.99.18)
hsa:6356;CCL11,SCYA11;chemokine (C-C motif) ligand 11
hsa:1440;CSF3,C17orf33,CSF3OS,GCSF,G-CSF;colony stimulating factor 3 (granulocyte)
hsa:55698;RADIL,RASIP2;Ras association and DIL domains
hsa:1520;CTSS;cathepsin S (EC:3.4.22.27)
hsa:3662;IRF4,LSIRF,MUM1,NF-EM5;interferon regulatory factor 4
hsa:9590;AKAP12,AKAP250,SSeCKS;A kinase (PRKA) anchor protein 12
hsa:200894;ARL13B,ARL2L1,JBTS8;ADP-ribosylation factor-like 13B
hsa:1046;CDX4;caudal type homeobox 4
hsa:80228;ORAI2,C7orf19,CBCIP2,MEM142B,TMEM142B;ORAI calcium release-activated calcium modulator 2
hsa:8737;RIPK1,RIP,RIP1;receptor (TNFRSF)-interacting serine-threonine kinase 1 (EC:2.7.11.1)
hsa:246778;IL27,IL-27,IL-27A,IL27A,IL27p28,IL30,p28;interleukin 27
hsa:51561;IL23A,IL-23,IL-23A,IL23P19,P19,SGRF;interleukin 23, alpha subunit p19
hsa:1493;CTLA4,CD,CD152,CELIAC3,CTLA-4,GRD4,GSE,IDDM12;cytotoxic T-lymphocyte-associated protein 4
hsa:25953;PNKD,BRP17,DYT8,FPD1,KIPP1184,MR-1,MR1,PDC,PKND1,TAHCCP2;paroxysmal nonkinesigenic dyskinesia (EC:3.1.2.6)
hsa:9217;VAPB,ALS8,VAMP-B,VAP-B;VAMP (vesicle-associated membrane protein)-associated protein B and C
hsa:51514;DTL,CDT2,DCAF2,L2DTL,RAMP;denticleless E3 ubiquitin protein ligase homolog (Drosophila)
hsa:6794;STK11,LKB1,PJS,hLKB1;serine/threonine kinase 11 (EC:2.7.11.1)
hsa:2022;ENG,CD105,END,HHT1,ORW,ORW1;endoglin
hsa:3570;IL6R,CD126,IL-6R-1,IL-6RA,IL6Q,IL6RA,IL6RQ,gp80;interleukin 6 receptor
hsa:599;BCL2L2,BCL-W,BCL2-L-2,BCLW,PPP1R51;BCL2-like 2
hsa:64411;ARAP3,CENTD3,DRAG1;ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
hsa:9748;SLK,LOSK,STK2,bA16H23.1,se20-9;STE20-like kinase (EC:2.7.11.1)
hsa:841;CASP8,ALPS2B,CAP4,Casp-8,FLICE,MACH,MCH5;caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61)
hsa:8243;SMC1A,CDLS2,DXS423E,SB1.8,SMC1,SMC1L1,SMC1alpha,SMCB;structural maintenance of chromosomes 1A
hsa:22861;NLRP1,CARD7,CLR17.1,DEFCAP,DEFCAP-L/S,NAC,NALP1,PP1044,SLEV1,VAMAS1;NLR family, pyrin domain containing 1
hsa:6016;RIT1,RIBB,RIT,ROC1;Ras-like without CAAX 1
hsa:3575;IL7R,CD127,CDW127,IL-7R-alpha,IL7RA,ILRA;interleukin 7 receptor
hsa:10987;COPS5,CSN5,JAB1,MOV-34,SGN5;COP9 signalosome subunit 5
hsa:960;CD44,CDW44,CSPG8,ECMR-III,HCELL,HUTCH-I,IN,LHR,MC56,MDU2,MDU3,MIC4,Pgp1;CD44 molecule (Indian blood group)
hsa:23405;DICER1,DCR1,Dicer,HERNA,MNG1;dicer 1, ribonuclease type III (EC:3.1.26.-)
hsa:27434;POLM,Pol_Mu,Tdt-N;polymerase (DNA directed), mu (EC:2.7.7.7)
hsa:79648;MCPH1,BRIT1,MCT;microcephalin 1
hsa:1829;DSG2,ARVC10,ARVD10,CDHF5,CMD1BB,HDGC;desmoglein 2
hsa:1740;DLG2,PPP1R58,PSD-93,PSD93,chapsyn-110;discs, large homolog 2 (Drosophila)
hsa:10642;IGF2BP1,CRD-BP,CRDBP,IMP-1,IMP1,VICKZ1,ZBP1;insulin-like growth factor 2 mRNA binding protein 1
hsa:3350;HTR1A,5-HT-1A,5-HT1A,5HT1a,ADRB2RL1,ADRBRL1,G-21,PFMCD;5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
hsa:22994;AZI1,AZ1,Cep131,ZA1;5-azacytidine induced 1
hsa:407009;MIR224,MIRN224,miRNA224;microRNA 224
hsa:407011;MIR23B,MIRN23B,hsa-mir-23b,miRNA23B;microRNA 23b
hsa:100302129;MIR1915,MIRN1915,hsa-mir-1915;microRNA 1915
hsa:407028;MIR302A,MIRN302,MIRN302A,hsa-mir-302;microRNA 302a
hsa:442912;MIR367,MIRN367,hsa-mir-367;microRNA 367
hsa:407012;MIR24-1,MIR189,MIRN24-1,miR-24-1,miRNA24-1;microRNA 24-1
hsa:407040;MIR34A,MIRN34A,miRNA34A,mir-34;microRNA 34a
hsa:701;BUB1B,BUB1beta,BUBR1,Bub1A,MAD3L,MVA1,SSK1,hBUBR1;BUB1 mitotic checkpoint serine/threonine kinase B (EC:2.7.11.1)
hsa:1175;AP2S1,AP17,AP17-DELTA,CLAPS2,HHC3;adaptor-related protein complex 2, sigma 1 subunit
hsa:6635;SNRPE,B-raf,HYPT11,SME,Sm-E;small nuclear ribonucleoprotein polypeptide E
hsa:5424;POLD1,CDC2,CRCS10,POLD;polymerase (DNA directed), delta 1, catalytic subunit (EC:2.7.7.7)
hsa:152007;GLIPR2,C9orf19,GAPR-1,GAPR1;GLI pathogenesis-related 2
hsa:57459;GATAD2B,MRD18,P66beta,RP11-216N14.6,p68;GATA zinc finger domain containing 2B
hsa:4246;SCGB2A1,LPHC,LPNC,MGB2,UGB3;secretoglobin, family 2A, member 1
hsa:442186;OR2J3,6M1-3,C3HEXS,HS6M1-3,OR6-16,OR6-6,OR6.3.6,ORL671;olfactory receptor, family 2, subfamily J, member 3
hsa:92667;MGME1,C20orf72,DDK1,MTDPS11,bA504H3.4;mitochondrial genome maintenance exonuclease 1
hsa:4750;NEK1,NY-REN-55,SRPS2,SRPS2A;NIMA-related kinase 1 (EC:2.7.11.1)
hsa:79659;DYNC2H1,ATD3,DHC1b,DHC2,DNCH2,DYH1B,SRPS2B,hdhc11;dynein, cytoplasmic 2, heavy chain 1
hsa:10647;SCGB1D2,LIPB,LPHB,LPNB;secretoglobin, family 1D, member 2
hsa:4222;MEOX1,KFS2,MOX1;mesenchyme homeobox 1
hsa:10648;SCGB1D1,LIPA,LPHA,LPNA;secretoglobin, family 1D, member 1
hsa:29887;SNX10,OPTB8;sorting nexin 10
hsa:123096;SLC25A29,C14orf69,CACL,ORNT3;solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29
hsa:8313;AXIN2,AXIL,ODCRCS;axin 2
hsa:6540;SLC6A13,GAT-2,GAT2,GAT3;solute carrier family 6 (neurotransmitter transporter, GABA), member 13
hsa:401265;KLHL31,BKLHD6,KBTBD1,KLHL,bA345L23.2;kelch-like family member 31
hsa:728780;ANKDD1B;ankyrin repeat and death domain containing 1B
hsa:406999;MIR217,MIRN217,mir-217;microRNA 217
hsa:100130231;LINC00861;long intergenic non-protein coding RNA 861
hsa:100128885;;uncharacterized LOC100128885
hsa:6166;RPL36AL,RPL36A;ribosomal protein L36a-like
hsa:3827;KNG1,BDK,BK,KNG;kininogen 1
hsa:55151;TMEM38B,C9orf87,D4Ertd89e,OI14,TRIC-B,TRICB,bA219P18.1;transmembrane protein 38B
hsa:2778;GNAS,AHO,C20orf45,GNAS1,GPSA,GSA,GSP,NESP,PHP1A,PHP1B,PHP1C,POH;GNAS complex locus
hsa:1325;CORT,CST-14,CST-17,CST-29;cortistatin
hsa:441294;CTAGE15,CTAGE15P;CTAGE family, member 15
hsa:23331;TTC28,TPRBK;tetratricopeptide repeat domain 28
hsa:805;CALM2,CAMII,PHKD,PHKD2;calmodulin 2 (phosphorylase kinase, delta) (EC:2.7.11.19)
hsa:808;CALM3,PHKD,PHKD3;calmodulin 3 (phosphorylase kinase, delta) (EC:2.7.11.19)
hsa:203074;PRSS55,T-SP1,UNQ9391;protease, serine, 55
hsa:885;CCK;cholecystokinin
hsa:4338;MOCS2,MCBPE,MOCO1,MOCO1-A,MOCO1-B,MOCS2A,MOCS2B,MPTS;molybdenum cofactor synthesis 2 (EC:2.8.1.12)
hsa:727;C5,C5a,C5b,CPAMD4;complement component 5
hsa:100287639;;methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase pseudogene
hsa:10740;RFPL1S,NCRNA00006,RFPL1-AS,RFPL1-AS1,RFPL1AS;RFPL1 antisense RNA 1
hsa:4681;NBL1,D1S1733E,DAN,DAND1,NB,NO3;neuroblastoma 1, DAN family BMP antagonist
hsa:6866;TAC3,HH10,NKB,NKNB,PRO1155,ZNEUROK1;tachykinin 3
hsa:7280;TUBB2A,TUBB,TUBB2,dJ40E16.7;tubulin, beta 2A class IIa
hsa:283869;NPW,L8,L8C,PPL8,PPNPW;neuropeptide W
hsa:93183;PIGM,GPI-MT-I;phosphatidylinositol glycan anchor biosynthesis, class M (EC:2.4.1.-)
hsa:129293;TRABD2A,C2orf89,TIKI1;TraB domain containing 2A
hsa:79087;ALG12,CDG1G,ECM39,PP14673,hALG12;ALG12, alpha-1,6-mannosyltransferase (EC:2.4.1.260)
hsa:51738;GHRL,MTLRP;ghrelin/obestatin prepropeptide
hsa:55917;CTTNBP2NL;CTTNBP2 N-terminal like
hsa:84617;TUBB6,HsT1601,TUBB-5;tubulin, beta 6 class V
hsa:9350;CER1,DAND4;cerberus 1, DAN family BMP antagonist
hsa:10195;ALG3,CDG1D,CDGS4,D16Ertd36e,NOT56L,Not56;ALG3, alpha-1,3- mannosyltransferase (EC:2.4.1.258)
hsa:256933;NPB,L7,PPL7,PPNPB;neuropeptide B
hsa:80235;PIGZ,GPI-MT-IV,PIG-Z,SMP3;phosphatidylinositol glycan anchor biosynthesis, class Z
hsa:6863;TAC1,Hs.2563,NK2,NKNA,NPK,TAC2;tachykinin, precursor 1
hsa:4922;NTS,NMN-125,NN,NT,NT/N,NTS1;neurotensin
hsa:57701;NCKAP5L,KIAA1602;NCK-associated protein 5-like
hsa:2922;GRP,BN,GRP-10,preproGRP,proGRP;gastrin-releasing peptide
hsa:4295;MLN;motilin
hsa:199699;DAND5,CER2,CERL2,CKTSF1B3,COCO,CRL2,DANTE,GREM3,SP1;DAN domain family member 5, BMP antagonist
hsa:5170;PDPK1,PDK1,PDPK2,PRO0461;3-phosphoinositide dependent protein kinase-1 (EC:2.7.11.1)
hsa:10022;INSL5,PRO182,UNQ156;insulin-like 5
hsa:79796;ALG9,CDG1L,DIBD1,LOH11CR1J;ALG9, alpha-1,2-mannosyltransferase (EC:2.4.1.259 2.4.1.261)
hsa:10585;POMT1,LGMD2K,MDDGA1,MDDGB1,MDDGC1,RT;protein-O-mannosyltransferase 1 (EC:2.4.1.109)
hsa:594857;NPS;neuropeptide S
hsa:10874;NMU;neuromedin U
hsa:55650;PIGV,GPI-MT-II,HPMRS1,PIG-V;phosphatidylinositol glycan anchor biosynthesis, class V
hsa:9488;PIGB,GPI-MT-III,PIG-B;phosphatidylinositol glycan anchor biosynthesis, class B
hsa:129521;NMS;neuromedin S
hsa:644068;RPS14P3,RPS14_1_16;ribosomal protein S14 pseudogene 3
hsa:643711;;platelet-activating factor acetylhydrolase IB subunit beta pseudogene
hsa:170960;ZNF721;zinc finger protein 721
hsa:79961;DENND2D;DENN/MADD domain containing 2D
hsa:84224;NBPF3,AE2;neuroblastoma breakpoint family, member 3
hsa:783;CACNB2,CACNLB2,CAVB2,MYSB;calcium channel, voltage-dependent, beta 2 subunit
hsa:4436;MSH2,COCA1,FCC1,HNPCC,HNPCC1,LCFS2;mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)
hsa:64755;C16orf58,RUS;chromosome 16 open reading frame 58
hsa:201725;C4orf46;chromosome 4 open reading frame 46
hsa:23295;MGRN1,RNF156;mahogunin ring finger 1, E3 ubiquitin protein ligase (EC:6.3.2.-)
hsa:1763;DNA2,DNA2L,hDNA2;DNA replication helicase 2 homolog (yeast) (EC:3.6.4.12)
hsa:348793;WDR53;WD repeat domain 53
hsa:645958;RPS18P9,RPS18_6_767;ribosomal protein S18 pseudogene 9
hsa:101241902;;chromosome 4 open reading frame 46 pseudogene
hsa:11191;PTENP1,PTEN-rs,PTEN2,PTENpg1,PTH2,psiPTEN;phosphatase and tensin homolog pseudogene 1
hsa:148545;NBPF4;neuroblastoma breakpoint family, member 4
hsa:27085;MTBP,MDM2BP;Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa
hsa:56924;PAK6,PAK5;p21 protein (Cdc42/Rac)-activated kinase 6 (EC:2.7.11.1)
hsa:57513;CASKIN2,ANKS5B;CASK interacting protein 2
hsa:6208;RPS14,EMTB,S14;ribosomal protein S14
hsa:55830;GLT8D1,MSTP139;glycosyltransferase 8 domain containing 1
hsa:10144;FAM13A,ARHGAP48,FAM13A1;family with sequence similarity 13, member A
hsa:189;AGXT,AGT,AGT1,AGXT1,PH1,SPAT,SPT,TLH6;alanine-glyoxylate aminotransferase (EC:2.6.1.44 2.6.1.51)
hsa:6238;RRBP1,ES/130,ES130,RRp,hES;ribosome binding protein 1
hsa:2524;FUT2,B12QTL1,SE,SEC2,Se2,sej;fucosyltransferase 2 (secretor status included) (EC:2.4.1.69)
hsa:79586;CHPF,CHSY2,CSS2;chondroitin polymerizing factor (EC:2.4.1.175 2.4.1.226)
hsa:23228;PLCL2,PLCE2;phospholipase C-like 2
hsa:221545;C6orf136;chromosome 6 open reading frame 136
hsa:51750;RTEL1,C20orf41,NHL,RTEL,bK3184A7.3;regulator of telomere elongation helicase 1 (EC:3.6.4.12)
hsa:7884;SLBP,HBP;stem-loop binding protein
hsa:3895;KTN1,CG1,KNT,MU-RMS-40.19;kinectin 1 (kinesin receptor)
hsa:10202;DHRS2,HEP27,SDR25C1;dehydrogenase/reductase (SDR family) member 2
hsa:4705;NDUFA10,CI-42KD,CI-42k;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa (EC:1.6.5.3 1.6.99.3)
hsa:65083;NOL6,NRAP,UTP22,bA311H10.1;nucleolar protein 6 (RNA-associated)
hsa:8813;DPM1,CDGIE,MPDS;dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit (EC:2.4.1.83)
hsa:64388;GREM2,CKTSF1B2,DAND3,PRDC;gremlin 2, DAN family BMP antagonist
hsa:54344;DPM3,CDG1O;dolichyl-phosphate mannosyltransferase polypeptide 3 (EC:2.4.1.83)
hsa:26585;GREM1,CKTSF1B1,DAND2,DRM,GREMLIN,IHG-2;gremlin 1, DAN family BMP antagonist
hsa:8818;DPM2,CDG1U;dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit (EC:2.4.1.83)
hsa:729930;;chromosome 11 open reading frame 74 pseudogene
hsa:101243545;;uncharacterized LOC101243545
hsa:392452;;mitochondrial fission factor pseudogene
hsa:81894;SLC25A28,MFRN2,MRS3/4,MRS4L;solute carrier family 25 (mitochondrial iron transporter), member 28
hsa:7512;XPNPEP2,APP2;X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound (EC:3.4.11.9)
hsa:3135;HLA-G,MHC-G;major histocompatibility complex, class I, G
hsa:8398;PLA2G6,CaI-PLA2,GVI,INAD1,IPLA2-VIA,NBIA2,NBIA2A,NBIA2B,PARK14,PLA2,PNPLA9,iPLA2,iPLA2beta;phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4)
hsa:8600;TNFSF11,CD254,ODF,OPGL,OPTB2,RANKL,TRANCE,hRANKL2,sOdf;tumor necrosis factor (ligand) superfamily, member 11
hsa:84666;RETNLB,FIZZ1,FIZZ2,HXCP2,RELM-beta,RELMb,RELMbeta,XCP2;resistin like beta
hsa:92140;MTDH,3D3,AEG-1,AEG1,LYRIC,LYRIC/3D3;metadherin
hsa:55107;ANO1,DOG1,ORAOV2,TAOS2,TMEM16A;anoctamin 1, calcium activated chloride channel
hsa:83943;IMMP2L,IMP2,IMP2-LIKE;IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae)
hsa:1668;DEFA3,DEF3,HNP-3,HNP3,HP-3,HP3;defensin, alpha 3, neutrophil-specific
hsa:79727;LIN28A,CSDD1,LIN-28,LIN28,ZCCHC1,lin-28A;lin-28 homolog A (C. elegans)
hsa:4842;NOS1,IHPS1,N-NOS,NC-NOS,NOS,bNOS,nNOS;nitric oxide synthase 1 (neuronal) (EC:1.14.13.39)
hsa:1052;CEBPD,C/EBP-delta,CELF,CRP3,NF-IL6-beta;CCAAT/enhancer binding protein (C/EBP), delta
hsa:5536;PPP5C,PP5,PPP5,PPT;protein phosphatase 5, catalytic subunit (EC:3.1.3.16)
hsa:9474;ATG5,APG5,APG5-LIKE,APG5L,ASP,hAPG5;autophagy related 5
hsa:6382;SDC1,CD138,SDC,SYND1,syndecan;syndecan 1
hsa:4615;MYD88,MYD88D;myeloid differentiation primary response 88
hsa:23705;CADM1,BL2,IGSF4,IGSF4A,NECL2,Necl-2,RA175,ST17,SYNCAM,TSLC1,sTSLC-1,sgIGSF,synCAM1;cell adhesion molecule 1
hsa:324;APC,BTPS2,DP2,DP2.5,DP3,GS,PPP1R46;adenomatous polyposis coli
hsa:481;ATP1B1,ATP1B;ATPase, Na+/K+ transporting, beta 1 polypeptide
hsa:5321;PLA2G4A,PLA2G4,cPLA2-alpha;phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4)
hsa:5728;PTEN,10q23del,BZS,CWS1,DEC,GLM2,MHAM,MMAC1,PTEN1,TEP1;phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48)
hsa:5624;PROC,APC,PC,PROC1,THPH3,THPH4;protein C (inactivator of coagulation factors Va and VIIIa) (EC:3.4.21.69)
hsa:3600;IL15,IL-15;interleukin 15
hsa:8085;MLL2,AAD10,ALR,CAGL114,KABUK1,KMS,KMT2D,MLL4,TNRC21;myeloid/lymphoid or mixed-lineage leukemia 2 (EC:2.1.1.43)
hsa:6731;SRP72,BMFF;signal recognition particle 72kDa
hsa:6777;STAT5B,STAT5;signal transducer and activator of transcription 5B
hsa:2064;ERBB2,CD340,HER-2,HER-2/neu,HER2,MLN_19,NEU,NGL,TKR1;v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (EC:2.7.10.1)
hsa:3593;IL12B,CLMF,CLMF2,IL-12B,NKSF,NKSF2;interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)
hsa:23404;EXOSC2,RRP4,Rrp4p,hRrp4p,p7;exosome component 2
hsa:462;SERPINC1,AT3,AT3D,ATIII,THPH7;serpin peptidase inhibitor, clade C (antithrombin), member 1
hsa:6271;S100A1,S100,S100-alpha,S100A;S100 calcium binding protein A1
hsa:6403;SELP,CD62,CD62P,GMP140,GRMP,LECAM3,PADGEM,PSEL;selectin P (granule membrane protein 140kDa, antigen CD62)
hsa:3643;INSR,CD220,HHF5;insulin receptor (EC:2.7.10.1)
hsa:5163;PDK1;pyruvate dehydrogenase kinase, isozyme 1 (EC:2.7.11.2)
hsa:3206;HOXA10,HOX1,HOX1.8,HOX1H,PL;homeobox A10
hsa:57144;PAK7,PAK5;p21 protein (Cdc42/Rac)-activated kinase 7 (EC:2.7.11.1)
hsa:51203;NUSAP1,ANKT,BM037,LNP,NUSAP,PRO0310p1,Q0310,SAPL;nucleolar and spindle associated protein 1
hsa:5924;RASGRF2,GRF2,RAS-GRF2;Ras protein-specific guanine nucleotide-releasing factor 2
hsa:169522;KCNV2,KV11.1,Kv8.2,RCD3B;potassium channel, subfamily V, member 2
hsa:91752;ZNF804A,C2orf10;zinc finger protein 804A
hsa:9378;NRXN1,Hs.22998,PTHSL2,SCZD17;neurexin 1
hsa:3108;HLA-DMA,D6S222E,DMA,HLADM,RING6;major histocompatibility complex, class II, DM alpha
hsa:688;KLF5,BTEB2,CKLF,IKLF;Kruppel-like factor 5 (intestinal)
hsa:3630;INS,IDDM2,ILPR,IRDN,MODY10;insulin
hsa:1636;ACE,ACE1,CD143,DCP,DCP1,ICH,MVCD3;angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1)
hsa:6812;STXBP1,MUNC18-1,NSEC1,P67,RBSEC1,UNC18;syntaxin binding protein 1
hsa:55658;RNF126;ring finger protein 126
hsa:6261;RYR1,CCO,MHS,MHS1,RYDR,RYR,RYR-1,SKRR;ryanodine receptor 1 (skeletal)
hsa:10161;LPAR6,ARWH1,LAH3,P2RY5,P2Y5;lysophosphatidic acid receptor 6
hsa:3125;HLA-DRB3,HLA-DR3B;major histocompatibility complex, class II, DR beta 3
hsa:1316;KLF6,BCD1,CBA1,COPEB,CPBP,GBF,PAC1,ST12,ZF9;Kruppel-like factor 6
hsa:1349;COX7B,APLCC;cytochrome c oxidase subunit VIIb (EC:1.9.3.1)
hsa:5045;FURIN,FUR,PACE,PCSK3,SPC1;furin (paired basic amino acid cleaving enzyme) (EC:3.4.21.75)
hsa:4691;NCL,C23;nucleolin
hsa:56658;TRIM39,RNF23,TFP,TRIM39B;tripartite motif containing 39
hsa:25987;TSKU,E2IG4,LRRC54,TSK;tsukushi, small leucine rich proteoglycan
hsa:22914;KLRK1,CD314,D12S2489E,KLR,NKG2-D,NKG2D;killer cell lectin-like receptor subfamily K, member 1
hsa:57379;AICDA,AID,ARP2,CDA2,HIGM2;activation-induced cytidine deaminase (EC:3.5.4.5)
hsa:23408;SIRT5,SIR2L5;sirtuin 5
hsa:255022;CALHM1,FAM26C;calcium homeostasis modulator 1
hsa:55715;DOK4;docking protein 4
hsa:6885;MAP3K7,MEKK7,TAK1,TGF1a;mitogen-activated protein kinase kinase kinase 7 (EC:2.7.11.25)
hsa:94025;MUC16,CA125;mucin 16, cell surface associated
hsa:4133;MAP2,MAP2A,MAP2B,MAP2C;microtubule-associated protein 2
hsa:222229;LRWD1,CENP-33,ORCA;leucine-rich repeats and WD repeat domain containing 1
hsa:150094;SIK1,MSK,SIK,SNF1LK;salt-inducible kinase 1 (EC:2.7.11.1)
hsa:51741;WWOX,D16S432E,FOR,FRA16D,HHCMA56,PRO0128,SDR41C1,WOX1;WW domain containing oxidoreductase (EC:1.1.1.-)
hsa:10523;CHERP,DAN16,SCAF6,SRA1;calcium homeostasis endoplasmic reticulum protein
hsa:2706;GJB2,CX26,DFNA3,DFNA3A,DFNB1,DFNB1A,HID,KID,NSRD1,PPK;gap junction protein, beta 2, 26kDa
hsa:2050;EPHB4,HTK,MYK1,TYRO11;EPH receptor B4 (EC:2.7.10.1)
hsa:41;ASIC1,ACCN2,ASIC,BNaC2;acid-sensing (proton-gated) ion channel 1
hsa:1234;CCR5,CC-CKR-5,CCCKR5,CCR-5,CD195,CKR-5,CKR5,CMKBR5,IDDM22;chemokine (C-C motif) receptor 5 (gene/pseudogene)
hsa:3749;KCNC4,C1orf30,HKSHIIIC,KSHIIIC,KV3.4;potassium voltage-gated channel, Shaw-related subfamily, member 4
hsa:11004;KIF2C,KNSL6,MCAK;kinesin family member 2C
hsa:26276;VPS33B;vacuolar protein sorting 33 homolog B (yeast)
hsa:1859;DYRK1A,DYRK,DYRK1,HP86,MNB,MNBH,MRD7;dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (EC:2.7.12.1)
hsa:3606;IL18,IGIF,IL-18,IL-1g,IL1F4;interleukin 18 (interferon-gamma-inducing factor)
hsa:28958;COA3,CCDC56,MITRAC12;cytochrome c oxidase assembly factor 3
hsa:54106;TLR9,CD289;toll-like receptor 9
hsa:1116;CHI3L1,ASRT7,CGP-39,GP-39,GP39,HC-gp39,HCGP-3P,YKL-40,YKL40,YYL-40,hCGP-39;chitinase 3-like 1 (cartilage glycoprotein-39)
hsa:5252;PHF1,MTF2L2,PCL1,PHF2,TDRD19C;PHD finger protein 1
hsa:238;ALK,CD246,NBLST3;anaplastic lymphoma receptor tyrosine kinase (EC:2.7.10.1)
hsa:929;CD14;CD14 molecule
hsa:5897;RAG2,RAG-2;recombination activating gene 2
hsa:9122;SLC16A4,MCT4,MCT5;solute carrier family 16, member 4 (monocarboxylic acid transporter 5)
hsa:8792;TNFRSF11A,CD265,FEO,LOH18CR1,ODFR,OFE,OPTB7,OSTS,PDB2,RANK,TRANCER;tumor necrosis factor receptor superfamily, member 11a, NFKB activator
hsa:6895;TARBP2,LOQS,TRBP,TRBP1,TRBP2;TAR (HIV-1) RNA binding protein 2
hsa:79705;LRRK1,RIPK6,Roco1;leucine-rich repeat kinase 1 (EC:2.7.11.1)
hsa:11214;AKAP13,AKAP-13,AKAP-Lbc,ARHGEF13,BRX,HA-3,Ht31,LBC,PRKA13,PROTO-LB,PROTO-LBC,c-lbc,p47;A kinase (PRKA) anchor protein 13
hsa:94;ACVRL1,ACVRLK1,ALK-1,ALK1,HHT,HHT2,ORW2,SKR3,TSR-I;activin A receptor type II-like 1 (EC:2.7.11.30)
hsa:5868;RAB5A,RAB5;RAB5A, member RAS oncogene family
hsa:80311;KLHL15;kelch-like family member 15
hsa:2520;GAST,GAS;gastrin
hsa:3133;HLA-E,EA1.2,EA2.1,HLA-6.2,MHC,QA1;major histocompatibility complex, class I, E
hsa:22863;ATG14,ATG14L,BARKOR,KIAA0831;autophagy related 14
hsa:23534;TNPO3,IPO12,MTR10A,TRN-SR,TRN-SR2,TRNSR;transportin 3
hsa:3693;ITGB5;integrin, beta 5
hsa:79071;ELOVL6,FACE,FAE,LCE;ELOVL fatty acid elongase 6 (EC:2.3.1.199)
hsa:120227;CYP2R1;cytochrome P450, family 2, subfamily R, polypeptide 1 (EC:1.14.13.159)
hsa:5159;PDGFRB,CD140B,IBGC4,JTK12,PDGFR,PDGFR-1,PDGFR1;platelet-derived growth factor receptor, beta polypeptide (EC:2.7.10.1)
hsa:27350;APOBEC3C,A3C,APOBEC1L,ARDC2,ARDC4,ARP5,PBI,bK150C2.3;apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
hsa:1159;CKMT1B,CKMT,CKMT1,UMTCK;creatine kinase, mitochondrial 1B (EC:2.7.3.2)
hsa:1062;CENPE,CENP-E,KIF10,PPP1R61;centromere protein E, 312kDa
hsa:51534;VTA1,C6orf55,DRG-1,DRG1,LIP5,My012,SBP1;Vps20-associated 1 homolog (S. cerevisiae)
hsa:7026;NR2F2,ARP1,COUPTFB,COUPTFII,NF-E3,NR2F1,SVP40,TFCOUP2;nuclear receptor subfamily 2, group F, member 2
hsa:6376;CX3CL1,ABCD-3,C3Xkine,CXC3,CXC3C,NTN,NTT,SCYD1,fractalkine,neurotactin;chemokine (C-X3-C motif) ligand 1
hsa:9429;ABCG2,ABC15,ABCP,BCRP,BCRP1,BMDP,CD338,CDw338,EST157481,GOUT1,MRX,MXR,MXR1,UAQTL1;ATP-binding cassette, sub-family G (WHITE), member 2
hsa:7078;TIMP3,HSMRK222,K222,K222TA2,SFD;TIMP metallopeptidase inhibitor 3
hsa:3475;IFRD1,PC4,TIS7;interferon-related developmental regulator 1
hsa:6498;SKIL,SNO,SnoA,SnoI,SnoN;SKI-like oncogene
hsa:949;SCARB1,CD36L1,CLA-1,CLA1,HDLQTL6,SR-BI,SRB1;scavenger receptor class B, member 1
hsa:3339;HSPG2,HSPG,PLC,PRCAN,SJA,SJS,SJS1;heparan sulfate proteoglycan 2
hsa:1585;CYP11B2,ALDOS,CPN2,CYP11B,CYP11BL,CYPXIB2,P-450C18,P450C18,P450aldo;cytochrome P450, family 11, subfamily B, polypeptide 2 (EC:1.14.15.4 1.14.15.5)
hsa:10963;STIP1,HOP,IEF-SSP-3521,P60,STI1,STI1L;stress-induced-phosphoprotein 1
hsa:8727;CTNNAL1,CLLP,alpha-CATU;catenin (cadherin-associated protein), alpha-like 1
hsa:5328;PLAU,ATF,BDPLT5,QPD,UPA,URK,u-PA;plasminogen activator, urokinase (EC:3.4.21.73)
hsa:26973;CHORDC1,CHP1;cysteine and histidine-rich domain (CHORD) containing 1
hsa:2266;FGG;fibrinogen gamma chain
hsa:3868;KRT16,CK16,FNEPPK,K16,K1CP,KRT16A,NEPPK;keratin 16
hsa:7122;CLDN5,AWAL,BEC1,CPETRL1,TMVCF;claudin 5
hsa:9140;ATG12,APG12,APG12L,FBR93,HAPG12;autophagy related 12
hsa:51144;HSD17B12,KAR,SDR12C1;hydroxysteroid (17-beta) dehydrogenase 12 (EC:1.1.1.62)
hsa:2952;GSTT1;glutathione S-transferase theta 1 (EC:2.5.1.18)
hsa:10743;RAI1,SMCR,SMS;retinoic acid induced 1
hsa:1671;DEFA6,DEF6,HD-6;defensin, alpha 6, Paneth cell-specific
hsa:1421;CRYGD,CACA,CCA3,CCP,CRYG4,cry-g-D;crystallin, gamma D
hsa:6352;CCL5,D17S136E,RANTES,SCYA5,SISd,TCP228;chemokine (C-C motif) ligand 5
hsa:6700;SPRR2A;small proline-rich protein 2A
hsa:10456;HAX1,HCLSBP1,HS1BP1,SCN3;HCLS1 associated protein X-1
hsa:5304;PIP,GCDFP-15,GCDFP15,GPIP4;prolactin-induced protein
hsa:7030;TFE3,RCCP2,RCCX1,TFEA,bHLHe33;transcription factor binding to IGHM enhancer 3
hsa:558;AXL,JTK11,UFO;AXL receptor tyrosine kinase (EC:2.7.10.1)
hsa:1050;CEBPA,C/EBP-alpha,CEBP;CCAAT/enhancer binding protein (C/EBP), alpha
hsa:2160;F11,FXI;coagulation factor XI (EC:3.4.21.27)
hsa:5801;PTPRR,EC-PTP,PCPTP1,PTP-SL,PTPBR7,PTPRQ;protein tyrosine phosphatase, receptor type, R (EC:3.1.3.48)
hsa:8815;BANF1,BAF,BCRP1,D14S1460,NGPS;barrier to autointegration factor 1
hsa:4928;NUP98,ADIR2,NUP196,NUP96;nucleoporin 98kDa
hsa:1438;CSF2RA,CD116,CDw116,CSF2R,CSF2RAX,CSF2RAY,CSF2RX,CSF2RY,GM-CSF-R-alpha,GMCSFR,GMR,SMDP4;colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
hsa:6502;SKP2,FBL1,FBXL1,FLB1,p45;S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
hsa:6781;STC1,STC;stanniocalcin 1
hsa:3213;HOXB3,HOX2,HOX2G,Hox-2.7;homeobox B3
hsa:6462;SHBG,ABP,SBP,TEBG;sex hormone-binding globulin
hsa:1778;DYNC1H1,DHC1,DHC1a,DNCH1,DNCL,DNECL,DYHC,Dnchc1,HL-3,p22;dynein, cytoplasmic 1, heavy chain 1
hsa:3939;LDHA,GSD11,LDH1,LDHM;lactate dehydrogenase A (EC:1.1.1.27)
hsa:2255;FGF10;fibroblast growth factor 10
hsa:5711;PSMD5,S5B;proteasome (prosome, macropain) 26S subunit, non-ATPase, 5
hsa:3440;IFNA2,IFN-alphaA,IFNA,IFNA2B,INFA2;interferon, alpha 2
hsa:3320;HSP90AA1,EL52,HSP86,HSP89A,HSP90A,HSP90N,HSPC1,HSPCA,HSPCAL1,HSPCAL4,HSPN,Hsp89,Hsp90,LAP2;heat shock protein 90kDa alpha (cytosolic), class A member 1
hsa:1994;ELAVL1,ELAV1,HUR,Hua,MelG;ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)
hsa:63895;PIEZO2,C18orf30,C18orf58,FAM38B,FAM38B2,HsT748,HsT771;piezo-type mechanosensitive ion channel component 2
hsa:29095;ORMDL2,MST095,MSTP095,adoplin-2;ORM1-like 2 (S. cerevisiae)
hsa:3119;HLA-DQB1,CELIAC1,HLA-DQB,IDDM1;major histocompatibility complex, class II, DQ beta 1
hsa:7040;TGFB1,CED,DPD1,LAP,TGFB,TGFbeta;transforming growth factor, beta 1
hsa:115352;FCRL3,CD307c,FCRH3,IFGP3,IRTA3,SPAP2;Fc receptor-like 3
hsa:100287932;TIMM23,TIM23;translocase of inner mitochondrial membrane 23 homolog (yeast)
hsa:7979;SHFM1,DSS1,ECD,SEM1,SHFD1,SHSF1,Shfdg1;split hand/foot malformation (ectrodactyly) type 1
hsa:1846;DUSP4,HVH2,MKP-2,MKP2,TYP;dual specificity phosphatase 4 (EC:3.1.3.16 3.1.3.48)
hsa:25827;FBXL2,FBL2,FBL3;F-box and leucine-rich repeat protein 2
hsa:5213;PFKM,GSD7,PFK-1,PFK1,PFKA,PFKX;phosphofructokinase, muscle (EC:2.7.1.11)
hsa:10635;RAD51AP1,PIR51;RAD51 associated protein 1
hsa:3931;LCAT;lecithin-cholesterol acyltransferase (EC:2.3.1.43)
hsa:7417;VDAC2,POR;voltage-dependent anion channel 2
hsa:121504;HIST4H4,H4/p;histone cluster 4, H4
hsa:9219;MTA2,MTA1L1,PID;metastasis associated 1 family, member 2
hsa:6525;SMTN;smoothelin
hsa:875;CBS,HIP4;cystathionine-beta-synthase (EC:4.2.1.22)
hsa:8480;RAE1,MIG14,MRNP41,Mnrp41,dJ481F12.3,dJ800J21.1;RAE1 RNA export 1 homolog (S. pombe)
hsa:1977;EIF4E,AUTS19,CBP,EIF4E1,EIF4EL1,EIF4F;eukaryotic translation initiation factor 4E
hsa:11052;CPSF6,CFIM,CFIM68,HPBRII-4,HPBRII-7;cleavage and polyadenylation specific factor 6, 68kDa
hsa:3418;IDH2,D2HGA2,ICD-M,IDH,IDHM,IDP,IDPM,mNADP-IDH;isocitrate dehydrogenase 2 (NADP+), mitochondrial (EC:1.1.1.42)
hsa:8829;NRP1,BDCA4,CD304,NP1,NRP,VEGF165R;neuropilin 1
hsa:27250;PDCD4,H731;programmed cell death 4 (neoplastic transformation inhibitor)
hsa:226;ALDOA,ALDA,GSD12;aldolase A, fructose-bisphosphate (EC:4.1.2.13)
hsa:3921;RPSA,37LRP,67LR,LAMBR,LAMR1,LBP,LBP/p40,LRP,LRP/LR,NEM/1CHD4,SA,lamR,p40;ribosomal protein SA
hsa:7056;THBD,AHUS6,BDCA3,CD141,THPH12,THRM,TM;thrombomodulin
hsa:6657;SOX2,ANOP3,MCOPS3;SRY (sex determining region Y)-box 2
hsa:26986;PABPC1,PAB1,PABP,PABP1,PABPC2,PABPL1;poly(A) binding protein, cytoplasmic 1
hsa:102;ADAM10,AD10,CD156c,HsT18717,MADM,kuz;ADAM metallopeptidase domain 10 (EC:3.4.24.81)
hsa:1869;E2F1,E2F-1,RBAP1,RBBP3,RBP3;E2F transcription factor 1
hsa:3111;HLA-DOA,HLA-DNA,HLA-DZA,HLADZ;major histocompatibility complex, class II, DO alpha
hsa:2661;GDF9;growth differentiation factor 9
hsa:57787;MARK4,MARK4L,MARK4S,MARKL1,MARKL1L;MAP/microtubule affinity-regulating kinase 4 (EC:2.7.11.1)
hsa:29119;CTNNA3,VR22;catenin (cadherin-associated protein), alpha 3
hsa:2308;FOXO1,FKH1,FKHR,FOXO1A;forkhead box O1
hsa:6513;SLC2A1,DYT17,DYT18,DYT9,EIG12,GLUT,GLUT1,GLUT1DS,PED;solute carrier family 2 (facilitated glucose transporter), member 1
hsa:3620;IDO1,IDO,IDO-1,INDO;indoleamine 2,3-dioxygenase 1 (EC:1.13.11.52)
hsa:4311;MME,CALLA,CD10,NEP,SFE;membrane metallo-endopeptidase (EC:3.4.24.11)
hsa:10112;KIF20A,MKLP2,RAB6KIFL;kinesin family member 20A
hsa:9856;DYLX2,DYX2;KIAA0319
hsa:3601;IL15RA,CD215;interleukin 15 receptor, alpha
hsa:219623;TMEM26;transmembrane protein 26
hsa:6869;TACR1,NK1R,NKIR,SPR,TAC1R;tachykinin receptor 1
hsa:51654;CDK5RAP1,C20orf34,C42,CDK5RAP1.3,CDK5RAP1.4,CGI-05,HSPC167;CDK5 regulatory subunit associated protein 1
hsa:581;BAX,BCL2L4;BCL2-associated X protein
hsa:10371;SEMA3A,COLL1,Hsema-I,Hsema-III,SEMA1,SEMAD,SEMAIII,SEMAL,SemD,coll-1;sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
hsa:1118;CHIT1,CHI3,CHIT,CHITD;chitinase 1 (chitotriosidase) (EC:3.2.1.14)
hsa:22899;ARHGEF15,ARGEF15,E5,Ephexin5,Vsm-RhoGEF;Rho guanine nucleotide exchange factor (GEF) 15
hsa:3805;KIR2DL4,CD158D,G9P,KIR103,KIR103AS;killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
hsa:4599;MX1,IFI-78K,IFI78,MX,MxA;myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse)
hsa:8894;EIF2S2,EIF2,EIF2B,EIF2beta,PPP1R67,eIF-2-beta;eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa
hsa:135138;PACRG,GLUP,HAK005771,PARK2CRG,RP3-495O10.2;PARK2 co-regulated
hsa:8742;TNFSF12,APO3L,DR3LG,TWEAK;tumor necrosis factor (ligand) superfamily, member 12
hsa:3976;LIF,CDF,DIA,HILDA,MLPLI;leukemia inhibitory factor
hsa:11168;PSIP1,DFS70,LEDGF,PAIP,PSIP2,p52,p75;PC4 and SFRS1 interacting protein 1
hsa:3759;KCNJ2,ATFB9,HHBIRK1,HHIRK1,IRK1,KIR2.1,LQT7,SQT3;potassium inwardly-rectifying channel, subfamily J, member 2
hsa:51473;DCDC2,DCDC2A,RU2,RU2S;doublecortin domain containing 2
hsa:7130;TNFAIP6,TSG-6,TSG6;tumor necrosis factor, alpha-induced protein 6
hsa:10140;TOB1,APRO6,PIG49,TOB,TROB,TROB1;transducer of ERBB2, 1
hsa:468;ATF4,CREB-2,CREB2,TAXREB67,TXREB;activating transcription factor 4 (tax-responsive enhancer element B67)
hsa:10400;PEMT,PEAMT,PEMPT,PEMT2,PNMT;phosphatidylethanolamine N-methyltransferase (EC:2.1.1.17 2.1.1.71)
hsa:4149;MAX,bHLHd4;MYC associated factor X
hsa:1545;CYP1B1,CP1B,CYPIB1,GLC3A,P4501B1;cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1)
hsa:1155;TBCB,CG22,CKAP1,CKAPI;tubulin folding cofactor B
hsa:302;ANXA2,ANX2,ANX2L4,CAL1H,LIP2,LPC2,LPC2D,P36,PAP-IV;annexin A2
hsa:10409;BASP1,CAP-23,CAP23,NAP-22,NAP22;brain abundant, membrane attached signal protein 1
hsa:54567;DLL4,hdelta2;delta-like 4 (Drosophila)
hsa:27327;TNRC6A,CAGH26,GW1,GW182,TNRC6;trinucleotide repeat containing 6A
hsa:7169;TPM2,AMCD1,DA1,DA2B,NEM4,TMSB;tropomyosin 2 (beta)
hsa:6868;ADAM17,ADAM18,CD156B,CSVP,NISBD,TACE;ADAM metallopeptidase domain 17 (EC:3.4.24.86)
hsa:83737;ITCH,AIF4,AIP4,NAPP1,dJ468O1.1;itchy E3 ubiquitin protein ligase
hsa:64714;PDIA2,PDA2,PDI,PDIP,PDIR;protein disulfide isomerase family A, member 2 (EC:5.3.4.1)
hsa:7272;TTK,CT96,ESK,MPH1,MPS1,MPS1L1,PYT;TTK protein kinase (EC:2.7.12.1)
hsa:4353;MPO;myeloperoxidase (EC:1.11.2.2)
hsa:57703;CWC22,EIF4GL,NCM,fSAPb;CWC22 spliceosome-associated protein homolog (S. cerevisiae)
hsa:5287;PIK3C2B,C2-PI3K;phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta (EC:2.7.1.154)
hsa:1672;DEFB1,BD1,DEFB-1,DEFB101,HBD1;defensin, beta 1
hsa:348;APOE,AD2,LDLCQ5,LPG;apolipoprotein E
hsa:6532;SLC6A4,5-HTT,5-HTTLPR,5HTT,HTT,OCD1,SERT,SERT1,hSERT;solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
hsa:10159;ATP6AP2,APT6M8-9,ATP6IP2,ATP6M8-9,ELDF10,M8-9,MRXE,MSTP009,XMRE;ATPase, H+ transporting, lysosomal accessory protein 2
hsa:966;CD59,16.3A5,1F5,EJ16,EJ30,EL32,G344,HRF-20,HRF20,MAC-IP,MACIF,MEM43,MIC11,MIN1,MIN2,MIN3,MIRL,MSK21,p18-20;CD59 molecule, complement regulatory protein
hsa:57502;NLGN4X,ASPGX2,AUTSX2,HLNX,HNL4X,HNLX,NLGN,NLGN4;neuroligin 4, X-linked
hsa:5111;PCNA;proliferating cell nuclear antigen
hsa:4297;MLL,ALL-1,CXXC7,HRX,HTRX1,KMT2A,MLL/GAS7,MLL1A,TET1-MLL,TRX1,WDSTS;myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) (EC:2.1.1.43)
hsa:84708;LNX1,LNX,MPDZ,PDZRN2;ligand of numb-protein X 1, E3 ubiquitin protein ligase (EC:6.3.2.19)
hsa:3752;KCND3,KCND3L,KCND3S,KSHIVB,KV4.3;potassium voltage-gated channel, Shal-related subfamily, member 3
hsa:56172;ANKH,ANK,CCAL2,CMDJ,CPPDD,HANK,MANK;ankylosis, progressive homolog (mouse)
hsa:7419;VDAC3,HD-VDAC3,VDAC-3;voltage-dependent anion channel 3
hsa:545;ATR,FCTCS,FRP1,MEC1,SCKL,SCKL1;ataxia telangiectasia and Rad3 related (EC:2.7.11.1)
hsa:1080;CFTR,ABC35,ABCC7,CF,CFTR/MRP,MRP7,TNR-CFTR,dJ760C5.1;cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)
hsa:64395;GMCL1,BTBD13,GCL,GCL1,SPATA29;germ cell-less, spermatogenesis associated 1
hsa:6037;RNASE3,ECP,RNS3;ribonuclease, RNase A family, 3 (EC:3.1.27.-)
hsa:6606;SMN1,BCD541,GEMIN1,SMA,SMA1,SMA2,SMA3,SMA4,SMA@,SMN,SMNT,T-BCD541,TDRD16A;survival of motor neuron 1, telomeric
hsa:8317;CDC7,CDC7L1,HsCDC7,Hsk1,huCDC7;cell division cycle 7 (EC:2.7.11.1)
hsa:10197;PSME3,Ki,PA28-gamma,PA28G,PA28gamma,REG-GAMMA;proteasome (prosome, macropain) activator subunit 3 (PA28 gamma;Ki)
hsa:4137;MAPT,DDPAC,FTDP-17,MAPTL,MSTD,MTBT1,MTBT2,PPND,TAU;microtubule-associated protein tau
hsa:2150;F2RL1,GPR11,PAR2;coagulation factor II (thrombin) receptor-like 1
hsa:203859;ANO5,GDD1,LGMD2L,TMEM16E;anoctamin 5
hsa:8239;USP9X,DFFRX,FAF,FAM;ubiquitin specific peptidase 9, X-linked (EC:3.4.19.12)
hsa:103;ADAR,ADAR1,AGS6,DRADA,DSH,DSRAD,G1P1,IFI-4,IFI4,K88DSRBP,P136;adenosine deaminase, RNA-specific
hsa:3927;LASP1,Lasp-1,MLN50;LIM and SH3 protein 1
hsa:2277;FIGF,VEGF-D,VEGFD;c-fos induced growth factor (vascular endothelial growth factor D)
hsa:56147;PCDHA1,PCDH-ALPHA1;protocadherin alpha 1
hsa:4683;NBN,AT-V1,AT-V2,ATV,NBS,NBS1,P95;nibrin
hsa:4653;MYOC,GLC1A,GPOA,JOAG,JOAG1,TIGR,myocilin;myocilin, trabecular meshwork inducible glucocorticoid response
hsa:6386;SDCBP,MDA-9,ST1,SYCL,TACIP18;syndecan binding protein (syntenin)
hsa:3169;FOXA1,HNF3A,TCF3A;forkhead box A1
hsa:8726;EED,HEED,WAIT1;embryonic ectoderm development
hsa:10181;RBM5,G15,LUCA15,RMB5;RNA binding motif protein 5
hsa:10059;DNM1L,DLP1,DRP1,DVLP,DYMPLE,DYNIV-11,EMPF,HDYNIV,VPS1;dynamin 1-like (EC:3.6.5.5)
hsa:1777;DNASE2,DNASE2A,DNL,DNL2;deoxyribonuclease II, lysosomal (EC:3.1.22.1)
hsa:2641;GCG,GLP1,GLP2,GRPP;glucagon
hsa:990;CDC6,CDC18L,HsCDC18,HsCDC6;cell division cycle 6
hsa:200186;CRTC2,TORC-2,TORC2;CREB regulated transcription coactivator 2
hsa:1816;DRD5,DBDR,DRD1B,DRD1L2;dopamine receptor D5
hsa:3099;HK2,HKII,HXK2;hexokinase 2 (EC:2.7.1.1)
hsa:2693;GHSR;growth hormone secretagogue receptor
hsa:5514;PPP1R10,CAT53,FB19,PNUTS,PP1R10,R111,p99;protein phosphatase 1, regulatory subunit 10
hsa:941;CD80,B7,B7-1,B7.1,BB1,CD28LG,CD28LG1,LAB7;CD80 molecule
hsa:6708;SPTA1,EL2,HPP,HS3,SPH3,SPTA;spectrin, alpha, erythrocytic 1 (elliptocytosis 2)
hsa:121256;TMEM132D,MOLT;transmembrane protein 132D
hsa:1030;CDKN2B,CDK4I,INK4B,MTS2,P15,TP15,p15INK4b;cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
hsa:4286;MITF,CMM8,MI,WS2,WS2A,bHLHe32;microphthalmia-associated transcription factor
hsa:4288;MKI67,KIA;antigen identified by monoclonal antibody Ki-67
hsa:5587;PRKD1,PKC-MU,PKCM,PKD,PRKCM;protein kinase D1 (EC:2.7.11.13)
hsa:5881;RAC3;ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
hsa:6531;SLC6A3,DAT,DAT1,PKDYS;solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
hsa:1147;CHUK,IKBKA,IKK-alpha,IKK1,IKKA,NFKBIKA,TCF16;conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10)
hsa:26136;TES,TESS,TESS-2;testis derived transcript (3 LIM domains)
hsa:12;SERPINA3,AACT,ACT,GIG25;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
hsa:977;CD151,GP27,MER2,PETA-3,RAPH,SFA1,TSPAN24;CD151 molecule (Raph blood group)
hsa:26047;CNTNAP2,AUTS15,CASPR2,CDFE,NRXN4,PTHSL1;contactin associated protein-like 2
hsa:4999;ORC2,ORC2L;origin recognition complex, subunit 2
hsa:2729;GCLC,GCL,GCS,GLCL,GLCLC;glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2)
hsa:2944;GSTM1,GST1,GSTM1-1,GSTM1a-1a,GSTM1b-1b,GTH4,GTM1,H-B,MU,MU-1;glutathione S-transferase mu 1 (EC:2.5.1.18)
hsa:57381;RHOJ,ARHJ,RASL7B,TC10B,TCL;ras homolog family member J
hsa:7148;TNXB,EDS3,HXBL,TENX,TN-X,TNX,TNXB1,TNXB2,TNXBS,XB,XBS;tenascin XB
hsa:200316;APOBEC3F,ARP8,BK150C2.4.MRNA,KA6;apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
hsa:8945;BTRC,BETA-TRCP,FBW1A,FBXW1,FBXW1A,FWD1,bTrCP,bTrCP1,betaTrCP;beta-transducin repeat containing E3 ubiquitin protein ligase
hsa:4225;MEP1B;meprin A, beta (EC:3.4.24.63)
hsa:1044;CDX1;caudal type homeobox 1
hsa:94101;ORMDL1;ORM1-like 1 (S. cerevisiae)
hsa:11252;PACSIN2,SDPII;protein kinase C and casein kinase substrate in neurons 2
hsa:56925;LXN,ECI,TCI;latexin
hsa:2260;FGFR1,BFGFR,CD331,CEK,FGFBR,FGFR-1,FLG,FLT-2,FLT2,HBGFR,HH2,KAL2,N-SAM,OGD,bFGF-R-1;fibroblast growth factor receptor 1 (EC:2.7.10.1)
hsa:4973;OLR1,CLEC8A,LOX1,LOXIN,SCARE1,SLOX1;oxidized low density lipoprotein (lectin-like) receptor 1
hsa:2152;F3,CD142,TF,TFA;coagulation factor III (thromboplastin, tissue factor)
hsa:5426;POLE,CRCS12,POLE1;polymerase (DNA directed), epsilon, catalytic subunit (EC:2.7.7.7)
hsa:55244;SLC47A1,MATE1;solute carrier family 47, member 1
hsa:5928;RBBP4,NURF55,RBAP48;retinoblastoma binding protein 4
hsa:409;ARRB2,ARB2,ARR2,BARR2;arrestin, beta 2
hsa:9131;AIFM1,AIF,CMTX4,COWCK,COXPD6,PDCD8;apoptosis-inducing factor, mitochondrion-associated, 1
hsa:801;CALM1,CALML2,CAMI,CPVT4,DD132,PHKD,caM;calmodulin 1 (phosphorylase kinase, delta) (EC:2.7.11.19)
hsa:6642;SNX1,HsT17379,VPS5;sorting nexin 1
hsa:710;SERPING1,C1IN,C1INH,C1NH,HAE1,HAE2;serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
hsa:4738;NEDD8,NEDD-8;neural precursor cell expressed, developmentally down-regulated 8
hsa:9258;MFHAS1,LRRC65,MASL1;malignant fibrous histiocytoma amplified sequence 1
hsa:939;CD27,S152,T14,TNFRSF7,Tp55;CD27 molecule
hsa:5781;PTPN11,BPTP3,CFC,NS1,PTP-1D,PTP2C,SH-PTP2,SH-PTP3,SHP2;protein tyrosine phosphatase, non-receptor type 11 (EC:3.1.3.48)
hsa:5732;PTGER2,EP2;prostaglandin E receptor 2 (subtype EP2), 53kDa
hsa:7518;XRCC4;X-ray repair complementing defective repair in Chinese hamster cells 4
hsa:2626;GATA4,ASD2,VSD1;GATA binding protein 4
hsa:90737;PAGE5,CT16,CT16.1,CT16.2,GAGEE1,PAGE-5;P antigen family, member 5 (prostate associated)
hsa:6522;SLC4A2,AE2,BND3L,EPB3L1,HKB3,NBND3;solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1)
hsa:1213;CLTC,CHC,CHC17,CLH-17,CLTCL2,Hc;clathrin, heavy chain (Hc)
hsa:7184;HSP90B1,ECGP,GP96,GRP94,TRA1;heat shock protein 90kDa beta (Grp94), member 1
hsa:4790;NFKB1,EBP-1,KBF1,NF-kB1,NF-kappa-B,NF-kappaB,NFKB-p105,NFKB-p50,NFkappaB,p105,p50;nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
hsa:546;ATRX,ATR2,JMS,MRXHF1,RAD54,RAD54L,SFM1,SHS,XH2,XNP,ZNF-HX;alpha thalassemia/mental retardation syndrome X-linked (EC:3.6.4.12)
hsa:6374;CXCL5,ENA-78,SCYB5;chemokine (C-X-C motif) ligand 5
hsa:8301;PICALM,CALM,CLTH,LAP;phosphatidylinositol binding clathrin assembly protein
hsa:4745;NELL1,IDH3GL,NRP1;NEL-like 1 (chicken)
hsa:246;ALOX15,15-LOX-1,15LOX-1;arachidonate 15-lipoxygenase (EC:1.13.11.33)
hsa:10910;SUGT1,SGT1;SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae)
hsa:23479;ISCU,2310020H20Rik,HML,ISU2,NIFU,NIFUN,hnifU;iron-sulfur cluster scaffold homolog (E. coli)
hsa:23095;KIF1B,CMT2,CMT2A,CMT2A1,HMSNII,KLP,NBLST1;kinesin family member 1B
hsa:8404;SPARCL1,PIG33,SC1;SPARC-like 1 (hevin)
hsa:2695;GIP;gastric inhibitory polypeptide
hsa:6615;SNAI1,SLUGH2,SNA,SNAH,SNAIL,SNAIL1,dJ710H13.1;snail homolog 1 (Drosophila)
hsa:6135;RPL11,DBA7,GIG34,L11;ribosomal protein L11
hsa:3673;ITGA2,BR,CD49B,GPIa,HPA-5,VLA-2,VLAA2;integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
hsa:5423;POLB;polymerase (DNA directed), beta (EC:2.7.7.7)
hsa:2322;FLT3,CD135,FLK-2,FLK2,STK1;fms-related tyrosine kinase 3 (EC:2.7.10.1)
hsa:10592;SMC2,CAP-E,CAPE,SMC-2,SMC2L1;structural maintenance of chromosomes 2
hsa:84464;SLX4,BTBD12,FANCP,MUS312;SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae)
hsa:57591;MKL1,BSAC,MAL,MRTF-A;megakaryoblastic leukemia (translocation) 1
hsa:5049;PAFAH1B2;platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa) (EC:3.1.1.47)
hsa:51647;FAM96B,MIP18;family with sequence similarity 96, member B
hsa:3661;IRF3;interferon regulatory factor 3
hsa:4899;NRF1,ALPHA-PAL;nuclear respiratory factor 1
hsa:5071;PARK2,AR-JP,LPRS2,PDJ,PRKN;parkinson protein 2, E3 ubiquitin protein ligase (parkin)
hsa:79923;NANOG;Nanog homeobox
hsa:29127;RACGAP1,CYK4,HsCYK-4,ID-GAP,MgcRacGAP;Rac GTPase activating protein 1
hsa:51206;GP6,BDPLT11,GPIV,GPVI;glycoprotein VI (platelet)
hsa:5335;PLCG1,NCKAP3,PLC-II,PLC1,PLC148,PLCgamma1;phospholipase C, gamma 1 (EC:3.1.4.11)
hsa:9132;KCNQ4,DFNA2,DFNA2A,KV7.4;potassium voltage-gated channel, KQT-like subfamily, member 4
hsa:79915;ATAD5,C17orf41,ELG1,FRAG1;ATPase family, AAA domain containing 5
hsa:10461;MERTK,MER,RP38,c-mer;c-mer proto-oncogene tyrosine kinase (EC:2.7.10.1)
hsa:3690;ITGB3,BDPLT2,CD61,GP3A,GPIIIa,GT;integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
hsa:6318;SERPINB4,LEUPIN,PI11,SCCA-2,SCCA1,SCCA2;serpin peptidase inhibitor, clade B (ovalbumin), member 4
hsa:292;SLC25A5,2F1,AAC2,ANT2,T2,T3;solute carrier family 25 (mitochondrial carrier;adenine nucleotide translocator), member 5
hsa:266;AMELY,AMGL,AMGY;amelogenin, Y-linked
hsa:2908;NR3C1,GCCR,GCR,GR,GRL;nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
hsa:2741;GLRA1,HKPX1,STHE;glycine receptor, alpha 1
hsa:10413;YAP1,YAP,YAP2,YAP65,YKI;Yes-associated protein 1
hsa:11279;KLF8,BKLF3,ZNF741;Kruppel-like factor 8
hsa:22900;CARD8,CARDINAL,DACAR,DAKAR,NDPP,NDPP1,TUCAN;caspase recruitment domain family, member 8
hsa:54822;TRPM7,ALSPDC,CHAK,CHAK1,LTRPC7,TRP-PLIK;transient receptor potential cation channel, subfamily M, member 7 (EC:2.7.11.1)
hsa:1490;CTGF,CCN2,HCS24,IGFBP8,NOV2;connective tissue growth factor
hsa:8293;SERF1A,4F5,FAM2A,H4F5,SERF1,SMAM1;small EDRK-rich factor 1A (telomeric)
hsa:7035;TFPI,EPI,LACI,TFI,TFPI1;tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
hsa:7299;TYR,CMM8,OCA1A,OCAIA,SHEP3;tyrosinase (EC:1.14.18.1)
hsa:7039;TGFA,TFGA;transforming growth factor, alpha
hsa:4982;TNFRSF11B,OCIF,OPG,TR1;tumor necrosis factor receptor superfamily, member 11b
hsa:7422;VEGFA,MVCD1,VEGF,VPF;vascular endothelial growth factor A
hsa:7871;SLMAP,SLAP;sarcolemma associated protein
hsa:23028;KDM1A,AOF2,BHC110,KDM1,LSD1;lysine (K)-specific demethylase 1A
hsa:135;ADORA2A,ADORA2,RDC8,hA2aR;adenosine A2a receptor
hsa:2997;GYS1,GSY,GYS;glycogen synthase 1 (muscle) (EC:2.4.1.11)
hsa:6559;SLC12A3,NCC,NCCT,TSC;solute carrier family 12 (sodium/chloride transporters), member 3
hsa:650;BMP2,BDA2,BMP2A;bone morphogenetic protein 2
hsa:6473;SHOX,GCFX,PHOG,SHOXY,SS;short stature homeobox
hsa:1871;E2F3,E2F-3;E2F transcription factor 3
hsa:8549;LGR5,FEX,GPR49,GPR67,GRP49,HG38;leucine-rich repeat containing G protein-coupled receptor 5
hsa:10006;ABI1,ABI-1,ABLBP4,E3B1,NAP1BP,SSH3BP,SSH3BP1;abl-interactor 1
hsa:23414;ZFPM2,DIH3,FOG2,ZC2HC11B,ZNF89B,hFOG-2;zinc finger protein, FOG family member 2
hsa:9696;CROCC,ROLT;ciliary rootlet coiled-coil, rootletin
hsa:3205;HOXA9,ABD-B,HOX1,HOX1.7,HOX1G;homeobox A9
hsa:476;ATP1A1;ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9)
hsa:9784;SNX17;sorting nexin 17
hsa:7057;THBS1,THBS,THBS-1,TSP,TSP-1,TSP1;thrombospondin 1
hsa:3853;KRT6A,CK6A,CK6C,CK6D,K6A,K6C,K6D,KRT6C,KRT6D;keratin 6A
hsa:6566;SLC16A1,HHF7,MCT,MCT1;solute carrier family 16, member 1 (monocarboxylic acid transporter 1)
hsa:81622;UNC93B1,IIAE1,UNC93,UNC93B,Unc-93B1;unc-93 homolog B1 (C. elegans)
hsa:6624;FSCN1,FAN1,HSN,SNL,p55;fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus)
hsa:11079;RER1;RER1 retention in endoplasmic reticulum 1 homolog (S. cerevisiae)
hsa:694;BTG1;B-cell translocation gene 1, anti-proliferative
hsa:10318;TNIP1,ABIN-1,NAF1,VAN,nip40-1;TNFAIP3 interacting protein 1
hsa:3747;KCNC2,KV3.2;potassium voltage-gated channel, Shaw-related subfamily, member 2
hsa:5371;PML,MYL,PP8675,RNF71,TRIM19;promyelocytic leukemia
hsa:58487;CREBZF,SMILE,ZF;CREB/ATF bZIP transcription factor
hsa:30851;TAX1BP3,TIP-1;Tax1 (human T-cell leukemia virus type I) binding protein 3
hsa:3329;HSPD1,CPN60,GROEL,HLD4,HSP-60,HSP60,HSP65,HuCHA60,SPG13;heat shock 60kDa protein 1 (chaperonin)
hsa:7532;YWHAG,14-3-3GAMMA;tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide
hsa:2625;GATA3,HDR,HDRS;GATA binding protein 3
hsa:285489;DOK7,C4orf25,CMS1B;docking protein 7
hsa:2309;FOXO3,AF6q21,FKHRL1,FKHRL1P2,FOXO2,FOXO3A;forkhead box O3
hsa:3084;NRG1,ARIA,GGF,GGF2,HGL,HRG,HRG1,HRGA,MST131,NDF,SMDF;neuregulin 1
hsa:114882;OSBPL8,MST120,MSTP120,ORP8,OSBP10;oxysterol binding protein-like 8
hsa:51135;IRAK4,IPD1,IRAK-4,NY-REN-64,REN64;interleukin-1 receptor-associated kinase 4 (EC:2.7.11.1)
hsa:6530;SLC6A2,NAT1,NET,NET1,SLC6A5;solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
hsa:4852;NPY,PYY4;neuropeptide Y
hsa:1785;DNM2,CMT2M,CMTDI1,CMTDIB,DI-CMTB,DYN2,DYNII;dynamin 2 (EC:3.6.5.5)
hsa:64127;NOD2,ACUG,BLAU,CARD15,CD,CLR16.3,IBD1,NLRC2,NOD2B,PSORAS1;nucleotide-binding oligomerization domain containing 2
hsa:943;TNFRSF8,CD30,D1S166E,Ki-1;tumor necrosis factor receptor superfamily, member 8
hsa:6730;SRP68;signal recognition particle 68kDa
hsa:3814;KISS1,HH13,KiSS-1;KiSS-1 metastasis-suppressor
hsa:6908;TBP,GTF2D,GTF2D1,HDL4,SCA17,TFIID;TATA box binding protein
hsa:4017;LOXL2,LOR2,WS9-14;lysyl oxidase-like 2 (EC:1.4.3.-)
hsa:1026;CDKN1A,CAP20,CDKN1,CIP1,MDA-6,P21,SDI1,WAF1,p21CIP1;cyclin-dependent kinase inhibitor 1A (p21, Cip1)
hsa:1439;CSF2RB,CD131,CDw131,IL3RB,IL5RB,SMDP5;colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
hsa:9557;CHD1L,ALC1,CHDL;chromodomain helicase DNA binding protein 1-like (EC:3.6.4.12)
hsa:759;CA1,CA-I,CAB,Car1;carbonic anhydrase I (EC:4.2.1.1)
hsa:32;ACACB,ACC2,ACCB,HACC275;acetyl-CoA carboxylase beta (EC:6.4.1.2 6.3.4.14)
hsa:4582;MUC1,CA_15-3,CD227,EMA,H23AG,KL-6,MAM6,MUC-1,MUC-1/SEC,MUC-1/X,MUC1/ZD,PEM,PEMT,PUM;mucin 1, cell surface associated
hsa:81671;VMP1,EPG3,TANGO5,TMEM49;vacuole membrane protein 1
hsa:619373;MBOAT4,GOAT,OACT4;membrane bound O-acyltransferase domain containing 4 (EC:2.3.1.-)
hsa:1499;CTNNB1,CTNNB,MRD19,armadillo;catenin (cadherin-associated protein), beta 1, 88kDa
hsa:7298;TYMS,HST422,TMS,TS;thymidylate synthetase (EC:2.1.1.45)
hsa:5627;PROS1,PROS,PS21,PS22,PS23,PS24,PS25,PSA,THPH5,THPH6;protein S (alpha)
hsa:1371;CPOX,CPO,CPX,HCP;coproporphyrinogen oxidase (EC:1.3.3.3)
hsa:6361;CCL17,A-152E5.3,ABCD-2,SCYA17,TARC;chemokine (C-C motif) ligand 17
hsa:682;BSG,5F7,CD147,EMMPRIN,M6,OK,TCSF;basigin (Ok blood group)
hsa:22925;PLA2R1,CLEC13C,PLA2-R,PLA2G1R,PLA2IR,PLA2R;phospholipase A2 receptor 1, 180kDa
hsa:859;CAV3,LGMD1C,LQT9,VIP-21,VIP21;caveolin 3
hsa:64946;CENPH;centromere protein H
hsa:5526;PPP2R5B,B56B,PR61B;protein phosphatase 2, regulatory subunit B', beta
hsa:288;ANK3,ANKYRIN-G;ankyrin 3, node of Ranvier (ankyrin G)
hsa:80339;PNPLA3,ADPN,C22orf20,iPLA(2)epsilon;patatin-like phospholipase domain containing 3 (EC:3.1.1.3)
hsa:3717;JAK2,JTK10,THCYT3;Janus kinase 2 (EC:2.7.10.2)
hsa:2915;GRM5,GPRC1E,MGLUR5,mGlu5;glutamate receptor, metabotropic 5
hsa:34;ACADM,ACAD1,MCAD,MCADH;acyl-CoA dehydrogenase, C-4 to C-12 straight chain (EC:1.3.8.7)
hsa:3065;HDAC1,GON-10,HD1,RPD3,RPD3L1;histone deacetylase 1 (EC:3.5.1.98)
hsa:5746;PTH2R,PTHR2;parathyroid hormone 2 receptor
hsa:1584;CYP11B1,CPN1,CYP11B,FHI,P450C11;cytochrome P450, family 11, subfamily B, polypeptide 1 (EC:1.14.15.4)
hsa:6910;TBX5,HOS;T-box 5
hsa:10563;CXCL13,ANGIE,ANGIE2,BCA-1,BCA1,BLC,BLR1L,SCYB13;chemokine (C-X-C motif) ligand 13
hsa:6741;SSB,LARP3,La;Sjogren syndrome antigen B (autoantigen La)
hsa:5892;RAD51D,BROVCA4,R51H3,RAD51L3,TRAD;RAD51 homolog D (S. cerevisiae)
hsa:590;BCHE,CHE1,E1;butyrylcholinesterase (EC:3.1.1.8)
hsa:200315;APOBEC3A,ARP3,PHRBN,bK150C2.1;apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
hsa:199713;NLRP7,CLR19.4,HYDM,NALP7,NOD12,PAN7,PYPAF3;NLR family, pyrin domain containing 7
hsa:3875;KRT18,CYK18,K18;keratin 18
hsa:80312;TET1,CXXC6,LCX,bA119F7.1;tet methylcytosine dioxygenase 1 (EC:1.14.11.n2)
hsa:6348;CCL3,G0S19-1,LD78ALPHA,MIP-1-alpha,MIP1A,SCYA3;chemokine (C-C motif) ligand 3
hsa:4282;MIF,GIF,GLIF,MMIF;macrophage migration inhibitory factor (glycosylation-inhibiting factor) (EC:5.3.3.12 5.3.2.1)
hsa:1113;CHGA,CGA;chromogranin A (parathyroid secretory protein 1)
hsa:81620;CDT1,DUP,RIS2;chromatin licensing and DNA replication factor 1
hsa:4283;CXCL9,CMK,Humig,MIG,SCYB9,crg-10;chemokine (C-X-C motif) ligand 9
hsa:904;CCNT1,CCNT,CYCT1,HIVE1;cyclin T1
hsa:2305;FOXM1,FKHL16,FOXM1B,HFH-11,HFH11,HNF-3,INS-1,MPHOSPH2,MPP-2,MPP2,PIG29,TGT3,TRIDENT;forkhead box M1
hsa:5478;PPIA,CYPA,CYPH;peptidylprolyl isomerase A (cyclophilin A) (EC:5.2.1.8)
hsa:64210;MMS19,MET18,MMS19L,hMMS19;MMS19 nucleotide excision repair homolog (S. cerevisiae)
hsa:5460;POU5F1,OCT3,OCT4,OTF-3,OTF3,OTF4,Oct-3,Oct-4;POU class 5 homeobox 1
hsa:10155;TRIM28,KAP1,RNF96,TF1B,TIF1B;tripartite motif containing 28
hsa:6285;S100B,NEF,S100,S100-B,S100beta;S100 calcium binding protein B
hsa:23284;LPHN3,CIRL3,LEC3;latrophilin 3
hsa:3362;HTR6,5-HT6,5-HT6R;5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled
hsa:8437;RASAL1,RASAL;RAS protein activator like 1 (GAP1 like)
hsa:9021;SOCS3,ATOD4,CIS3,Cish3,SOCS-3,SSI-3,SSI3;suppressor of cytokine signaling 3
hsa:5168;ENPP2,ATX,ATX-X,AUTOTAXIN,LysoPLD,NPP2,PD-IALPHA,PDNP2;ectonucleotide pyrophosphatase/phosphodiesterase 2 (EC:3.1.4.39)
hsa:3678;ITGA5,CD49e,FNRA,VLA5A;integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
hsa:1843;DUSP1,CL100,HVH1,MKP-1,MKP1,PTPN10;dual specificity phosphatase 1 (EC:3.1.3.16 3.1.3.48)
hsa:26548;ITGB1BP2,CHORDC3,ITGB1BP,MELUSIN;integrin beta 1 binding protein (melusin) 2
hsa:3685;ITGAV,CD51,MSK8,VNRA,VTNR;integrin, alpha V
hsa:51657;STYXL1,DUSP24,MK-STYX;serine/threonine/tyrosine interacting-like 1
hsa:3664;IRF6,LPS,OFC6,PIT,PPS,PPS1,VWS,VWS1;interferon regulatory factor 6
hsa:5327;PLAT,T-PA,TPA;plasminogen activator, tissue (EC:3.4.21.68)
hsa:572;BAD,BBC2,BCL2L8;BCL2-associated agonist of cell death
hsa:154;ADRB2,ADRB2R,ADRBR,B2AR,BAR,BETA2AR;adrenoceptor beta 2, surface
hsa:4254;KITLG,FPH2,KL-1,Kitl,MGF,SCF,SF,SHEP7;KIT ligand
hsa:916;CD3E,T3E,TCRE;CD3e molecule, epsilon (CD3-TCR complex)
hsa:23411;SIRT1,SIR2L1;sirtuin 1
hsa:2357;FPR1,FMLP,FPR;formyl peptide receptor 1
hsa:639;PRDM1,BLIMP1,PRDI-BF1;PR domain containing 1, with ZNF domain
hsa:3746;KCNC1,KV3.1,KV4,NGK2;potassium voltage-gated channel, Shaw-related subfamily, member 1
hsa:2034;EPAS1,ECYT4,HIF2A,HLF,MOP2,PASD2,bHLHe73;endothelial PAS domain protein 1
hsa:79001;VKORC1,EDTP308,IMAGE3455200,MST134,MST576,VKCFD2,VKOR;vitamin K epoxide reductase complex, subunit 1 (EC:1.1.4.1)
hsa:64682;ANAPC1,APC1,MCPR,TSG24;anaphase promoting complex subunit 1
hsa:5100;PCDH8,ARCADLIN,PAPC;protocadherin 8
hsa:3486;IGFBP3,BP-53,IBP3;insulin-like growth factor binding protein 3
hsa:1950;EGF,HOMG4,URG;epidermal growth factor
hsa:3932;LCK,LSK,YT16,p56lck,pp58lck;lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2)
hsa:9844;ELMO1,CED-12,CED12,ELMO-1;engulfment and cell motility 1
hsa:332;BIRC5,API4,EPR-1;baculoviral IAP repeat containing 5
hsa:4316;MMP7,MMP-7,MPSL1,PUMP-1;matrix metallopeptidase 7 (matrilysin, uterine) (EC:3.4.24.23)
hsa:5803;PTPRZ1,HPTPZ,HPTPzeta,PTP-ZETA,PTP18,PTPRZ,PTPZ,R-PTP-zeta-2,RPTPB,RPTPbeta,phosphacan;protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (EC:3.1.3.48)
hsa:2739;GLO1,GLOD1,GLYI;glyoxalase I (EC:4.4.1.5)
hsa:285;ANGPT2,AGPT2,ANG2;angiopoietin 2
hsa:91252;SLC39A13;solute carrier family 39 (zinc transporter), member 13
hsa:3146;HMGB1,HMG1,HMG3,SBP-1;high mobility group box 1
hsa:7157;TP53,BCC7,LFS1,P53,TRP53;tumor protein p53
hsa:6510;SLC1A5,AAAT,ASCT2,ATBO,M7V1,M7VS1,R16,RDRC;solute carrier family 1 (neutral amino acid transporter), member 5
hsa:7454;WAS,IMD2,SCNX,THC,THC1,WASP;Wiskott-Aldrich syndrome
hsa:3110;MNX1,HB9,HLXB9,HOXHB9,SCRA1;motor neuron and pancreas homeobox 1
hsa:729238;SFTPA2,COLEC5,PSAP,PSP-A,PSPA,SFTP1,SFTPA2B,SP-A,SPA2,SPAII;surfactant protein A2
hsa:219771;CCNY,C10orf9,CBCP1,CCNX,CFP1;cyclin Y
hsa:867;CBL,C-CBL,CBL2,FRA11B,NSLL,RNF55;Cbl proto-oncogene, E3 ubiquitin protein ligase
hsa:146802;SLC47A2,MATE2,MATE2-B,MATE2-K,MATE2K;solute carrier family 47, member 2
hsa:57103;C12orf5,FR2BP,TIGAR;chromosome 12 open reading frame 5 (EC:3.1.3.46)
hsa:7098;TLR3,CD283,IIAE2;toll-like receptor 3
hsa:27342;RABGEF1,RABEX5,rabex-5;RAB guanine nucleotide exchange factor (GEF) 1
hsa:2638;GC,DBP,DBP/GC,GRD3,VDBG,VDBP;group-specific component (vitamin D binding protein) (EC:6.4.-.-)
hsa:351;APP,AAA,ABETA,ABPP,AD1,APPI,CTFgamma,CVAP,PN-II,PN2;amyloid beta (A4) precursor protein
hsa:114885;OSBPL11,ORP-11,ORP11,OSBP12,TCCCIA00292;oxysterol binding protein-like 11
hsa:6387;CXCL12,IRH,PBSF,SCYB12,SDF1,SDF1A,SDF1B,TLSF,TPAR1;chemokine (C-X-C motif) ligand 12
hsa:165918;RNF168,hRNF168;ring finger protein 168, E3 ubiquitin protein ligase
hsa:19;ABCA1,ABC-1,ABC1,CERP,HDLDT1,TGD;ATP-binding cassette, sub-family A (ABC1), member 1
hsa:846;CASR,CAR,EIG8,FHH,FIH,GPRC2A,HHC,HHC1,NSHPT,PCAR1;calcium-sensing receptor
hsa:6006;RHCE,CD240CE,RH,RH30A,RHC,RHE,RHIXB,RHPI,Rh4,RhIVb(J),RhVI,RhVIII;Rh blood group, CcEe antigens
hsa:10406;WFDC2,EDDM4,HE4,WAP5,dJ461P17.6;WAP four-disulfide core domain 2
hsa:1983;EIF5,EIF-5,EIF-5A;eukaryotic translation initiation factor 5
hsa:83988;NCALD;neurocalcin delta
hsa:2073;ERCC5,COFS3,ERCM2,UVDR,XPG,XPGC;excision repair cross-complementing rodent repair deficiency, complementation group 5
hsa:1082;CGB,CGB3,CGB5,CGB7,CGB8,hCGB;chorionic gonadotropin, beta polypeptide
hsa:1045;CDX2,CDX-3,CDX3;caudal type homeobox 2
hsa:6362;CCL18,AMAC-1,AMAC1,CKb7,DC-CK1,DCCK1,MIP-4,PARC,SCYA18;chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
hsa:1025;CDK9,C-2k,CDC2L4,CTK1,PITALRE,TAK;cyclin-dependent kinase 9 (EC:2.7.11.23 2.7.11.22)
hsa:7306;TYRP1,CAS2,CATB,GP75,OCA3,TRP,TRP1,TYRP,b-PROTEIN;tyrosinase-related protein 1 (EC:1.14.18.-)
hsa:4356;MPP3,DLG3;membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)
hsa:57506;MAVS,CARDIF,IPS-1,IPS1,VISA;mitochondrial antiviral signaling protein
hsa:3965;LGALS9,HUAT,LGALS9A;lectin, galactoside-binding, soluble, 9
hsa:4076;CAPRIN1,GPIAP1,GPIP137,M11S1,RNG105,p137GPI;cell cycle associated protein 1
hsa:9025;RNF8,hRNF8;ring finger protein 8, E3 ubiquitin protein ligase (EC:6.3.2.-)
hsa:3112;HLA-DOB,DOB;major histocompatibility complex, class II, DO beta
hsa:8976;WASL,N-WASP,NWASP;Wiskott-Aldrich syndrome-like
hsa:9589;WTAP;Wilms tumor 1 associated protein
hsa:7010;TEK,CD202B,TIE-2,TIE2,VMCM,VMCM1;TEK tyrosine kinase, endothelial (EC:2.7.10.1)
hsa:3117;HLA-DQA1,CD,CELIAC1,DQ-A1,GSE,HLA-DQA;major histocompatibility complex, class II, DQ alpha 1
hsa:1814;DRD3,D3DR,ETM1,FET1;dopamine receptor D3
hsa:9451;EIF2AK3,PEK,PERK,WRS;eukaryotic translation initiation factor 2-alpha kinase 3 (EC:2.7.11.1)
hsa:6656;SOX1;SRY (sex determining region Y)-box 1
hsa:3845;KRAS,C-K-RAS,K-RAS2A,K-RAS2B,K-RAS4A,K-RAS4B,KI-RAS,KRAS1,KRAS2,NS,NS3,RASK2;v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
hsa:26279;PLA2G2D,PLA2IID,SPLASH,sPLA2-IID,sPLA2S;phospholipase A2, group IID (EC:3.1.1.4)
hsa:10209;EIF1,A121,EIF-1,EIF1A,ISO1,SUI1;eukaryotic translation initiation factor 1
hsa:58508;MLL3,HALR,KMT2C;myeloid/lymphoid or mixed-lineage leukemia 3 (EC:2.1.1.43)
hsa:7251;TSG101,TSG10,VPS23;tumor susceptibility gene 101
hsa:4804;NGFR,CD271,Gp80-LNGFR,TNFRSF16,p75(NTR),p75NTR;nerve growth factor receptor
hsa:84876;ORAI1,CRACM1,ORAT1,TMEM142A;ORAI calcium release-activated calcium modulator 1
hsa:90;ACVR1,ACTRI,ACVR1A,ACVRLK2,ALK2,FOP,SKR1,TSRI;activin A receptor, type I (EC:2.7.11.30)
hsa:8554;PIAS1,DDXBP1,GBP,GU/RH-II,ZMIZ3;protein inhibitor of activated STAT, 1
hsa:63894;VIPAS39,C14orf133,SPE-39,SPE39,VIPAR,VPS16B,hSPE-39;VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog
hsa:7153;TOP2A,TOP2,TP2A;topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3)
hsa:673;BRAF,B-RAF1,BRAF1,NS7,RAFB1;v-raf murine sarcoma viral oncogene homolog B1 (EC:2.7.11.1)
hsa:1235;CCR6,BN-1,C-C_CKR-6,CC-CKR-6,CCR-6,CD196,CKR-L3,CKRL3,CMKBR6,DCR2,DRY6,GPR29,GPRCY4,STRL22;chemokine (C-C motif) receptor 6
hsa:6097;RORC,NR1F3,RORG,RZR-GAMMA,RZRG,TOR;RAR-related orphan receptor C
hsa:1788;DNMT3A,DNMT3A2,M.HsaIIIA;DNA (cytosine-5-)-methyltransferase 3 alpha (EC:2.1.1.37)
hsa:2065;ERBB3,ErbB-3,HER3,LCCS2,MDA-BF-1,c-erbB-3,c-erbB3,erbB3-S,p180-ErbB3,p45-sErbB3,p85-sErbB3;v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (EC:2.7.10.1)
hsa:79447;PAGR1,C16orf53,GAS,PA1;PAXIP1 associated glutamate-rich protein 1
hsa:79834;PEAK1,SGK269;NKF3 kinase family member (EC:2.7.10.2)
hsa:26748;GAGE12I,AL4,CT4.7,GAGE-7B,GAGE7B;G antigen 12I
hsa:3762;KCNJ5,CIR,GIRK4,KATP1,KIR3.4,LQT13;potassium inwardly-rectifying channel, subfamily J, member 5
hsa:1289;COL5A1;collagen, type V, alpha 1
hsa:388;RHOB,ARH6,ARHB,MST081,MSTP081,RHOH6;ras homolog family member B
hsa:1612;DAPK1,DAPK;death-associated protein kinase 1 (EC:2.7.11.1)
hsa:9110;MTMR4,FYVE-DSP2,ZFYVE11;myotubularin related protein 4 (EC:3.1.3.48)
hsa:2161;F12,HAE3,HAEX,HAF;coagulation factor XII (Hageman factor) (EC:3.4.21.38)
hsa:6125;RPL5,DBA6,L5;ribosomal protein L5
hsa:94103;ORMDL3;ORM1-like 3 (S. cerevisiae)
hsa:6280;S100A9,60B8AG,CAGB,CFAG,CGLB,L1AG,LIAG,MAC387,MIF,MRP14,NIF,P14;S100 calcium binding protein A9
hsa:51196;PLCE1,NPHS3,PLCE,PPLC;phospholipase C, epsilon 1 (EC:3.1.4.11)
hsa:27314;RAB30;RAB30, member RAS oncogene family
hsa:161582;DYX1C1,DYX1,DYXC1,EKN1,RD;dyslexia susceptibility 1 candidate 1
hsa:6659;SOX4,EVI16;SRY (sex determining region Y)-box 4
hsa:1385;CREB1,CREB;cAMP responsive element binding protein 1
hsa:1540;CYLD,BRSS,CDMT,CYLD1,CYLDI,EAC,MFT,MFT1,SBS,TEM,USPL2;cylindromatosis (turban tumor syndrome) (EC:3.4.19.12)
hsa:57167;SALL4,DRRS,HSAL4,ZNF797,dJ1112F19.1;sal-like 4 (Drosophila)
hsa:143384;CACUL1,C10orf46,CAC1;CDK2-associated, cullin domain 1
hsa:54583;EGLN1,C1orf12,ECYT3,HIF-PH2,HIFPH2,HPH-2,HPH2,PHD2,SM20,ZMYND6;egl nine homolog 1 (C. elegans) (EC:1.14.11.29)
hsa:4833;NME4,NDPK-D,NM23H4,nm23-H4;NME/NM23 nucleoside diphosphate kinase 4 (EC:2.7.4.6)
hsa:7416;VDAC1,PORIN,VDAC-1;voltage-dependent anion channel 1
hsa:1789;DNMT3B,ICF,ICF1,M.HsaIIIB;DNA (cytosine-5-)-methyltransferase 3 beta (EC:2.1.1.37)
hsa:26234;FBXL5,FBL4,FBL5,FLR1;F-box and leucine-rich repeat protein 5
hsa:5176;SERPINF1,EPC-1,OI12,OI6,PEDF;serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
hsa:2633;GBP1;guanylate binding protein 1, interferon-inducible
hsa:3109;HLA-DMB,D6S221E,RING7;major histocompatibility complex, class II, DM beta
hsa:2149;F2R,CF2R,HTR,PAR-1,PAR1,TR;coagulation factor II (thrombin) receptor
hsa:4312;MMP1,CLG,CLGN;matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7)
hsa:5610;EIF2AK2,EIF2AK1,PKR,PRKR;eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1 2.7.10.2)
hsa:255738;PCSK9,FH3,HCHOLA3,LDLCQ1,NARC-1,NARC1,PC9;proprotein convertase subtilisin/kexin type 9
hsa:6773;STAT2,ISGF-3,P113,STAT113;signal transducer and activator of transcription 2, 113kDa
hsa:9788;MTSS1,MIM,MIMA,MIMB;metastasis suppressor 1
hsa:2316;FLNA,ABP-280,ABPX,CVD1,FLN,FLN-A,FLN1,FMD,MNS,NHBP,OPD,OPD1,OPD2,XLVD,XMVD;filamin A, alpha
hsa:79140;CCDC28B,RP4-622L5.5;coiled-coil domain containing 28B
hsa:29090;TIMM21,C18orf55,TIM21;translocase of inner mitochondrial membrane 21 homolog (yeast)
hsa:100133941;CD24,CD24A;CD24 molecule
hsa:389692;MAFA,RIPE3b1,hMafA;v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian)
hsa:1524;CX3CR1,CCRL1,CMKBRL1,CMKDR1,GPR13,GPRV28,V28;chemokine (C-X3-C motif) receptor 1
hsa:51422;PRKAG2,AAKG,AAKG2,CMH6,H91620p,WPWS;protein kinase, AMP-activated, gamma 2 non-catalytic subunit
hsa:653361;NCF1,NCF1A,NOXO2,SH3PXD1A,p47phox;neutrophil cytosolic factor 1
hsa:4815;NINJ2;ninjurin 2
hsa:5329;PLAUR,CD87,U-PAR,UPAR,URKR;plasminogen activator, urokinase receptor
hsa:998;CDC42,CDC42Hs,G25K;cell division cycle 42
hsa:5228;PGF,D12S1900,PGFL,PLGF,PlGF-2,SHGC-10760;placental growth factor
hsa:8000;PSCA,PRO232;prostate stem cell antigen
hsa:11190;CEP250,C-NAP1,CEP2,CNAP1;centrosomal protein 250kDa
hsa:9757;MLL4,HRX2,KMT2B,MLL2,TRX2,WBP7;myeloid/lymphoid or mixed-lineage leukemia 4 (EC:2.1.1.43)
hsa:55125;CEP192,PPP1R62;centrosomal protein 192kDa
hsa:55723;ASF1B,CIA-II;ASF1 anti-silencing function 1 homolog B (S. cerevisiae)
hsa:2057;EPOR,EPO-R;erythropoietin receptor
hsa:140564;APOBEC3D,APOBEC3DE,APOBEC3E,ARP6;apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D
hsa:121665;SPPL3,IMP2,MDHV1887,PRO4332,PSH1,PSL4;signal peptide peptidase like 3
hsa:1874;E2F4,E2F-4;E2F transcription factor 4, p107/p130-binding
hsa:55054;ATG16L1,APG16L,ATG16A,ATG16L,IBD10,WDR30;autophagy related 16-like 1 (S. cerevisiae)
hsa:267012;DAOA,G72,LG72,SG72;D-amino acid oxidase activator
hsa:1756;DMD,BMD,CMD3B,DXS142,DXS164,DXS206,DXS230,DXS239,DXS268,DXS269,DXS270,DXS272;dystrophin
hsa:4233;MET,AUTS9,HGFR,RCCP2,c-Met;met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1)
hsa:5515;PPP2CA,PP2Ac,PP2CA,PP2Calpha,RP-C;protein phosphatase 2, catalytic subunit, alpha isozyme (EC:3.1.3.16)
hsa:4194;MDM4,HDMX,MDMX,MRP1;Mdm4 p53 binding protein homolog (mouse)
hsa:442920;MIR196B,MIRN196B,miR-196b,miRNA196B;microRNA 196b
hsa:406922;MIR133A1,MIRN133A1;microRNA 133a-1
hsa:406921;MIR132,MIRN132,miRNA132;microRNA 132
hsa:406925;MIR135A1,MIRN135-1,MIRN135A1;microRNA 135a-1
hsa:406928;MIR137,MIRN137,miR-137;microRNA 137
hsa:406934;MIR142,MIRN142;microRNA 142
hsa:406900;MIR106B,MIRN106B;microRNA 106b
hsa:50652;PCA3,DD3,NCRNA00019;prostate cancer antigen 3 (non-protein coding)
hsa:442916;MIR371A,MIR371,MIRN371,hsa-mir-371,hsa-mir-371a;microRNA 371a
hsa:442915;MIR370,MIRN370,hsa-mir-370;microRNA 370
hsa:442917;MIR372,MIRN372,hsa-mir-372;microRNA 372
hsa:442918;MIR373,MIRN373,hsa-mir-373,miRNA373;microRNA 373
hsa:406952;MIR17,MIR17-5p,MIR91,MIRN17,MIRN91,hsa-mir-17,miR-17,miR17-3p,miRNA17,miRNA91;microRNA 17
hsa:494327;MIR378A,MIR378,MIRN378,hsa-mir-378,hsa-mir-378a,miRNA378;microRNA 378a
hsa:407021;MIR29A,MIRN29,MIRN29A,hsa-mir-29,hsa-mir-29a,miRNA29A;microRNA 29a
hsa:407054;MIR98,MIRN98,hsa-mir-98,miR-98;microRNA 98
hsa:406893;MIR101-1,MIRN101-1;microRNA 101-1
hsa:406990;MIR208A,MIR208,MIRN208,MIRN208A,hsa-mir-208a,miRNA208;microRNA 208a
hsa:406931;MIR139,MIR139-3p,MIRN139;microRNA 139
hsa:406903;MIR10B,MIRN10B,hsa-mir-10b,miRNA10B,mir-10b;microRNA 10b
hsa:406986;MIR203,MIRN203,miR-203,miRNA203;microRNA 203
hsa:406994;MIR212,MIRN212,mir-212;microRNA 212
hsa:406996;MIR214,MIRN214,miRNA214,mir-214;microRNA 214
hsa:101243544;CSB-PGBD3,CPFP;Cockayne syndrome B-piggyBac fusion protein
hsa:151903;CCDC12;coiled-coil domain containing 12
hsa:55554;KLK15,ACO,HSRNASPH;kallikrein-related peptidase 15
hsa:2074;ERCC6,ARMD5,CKN2,COFS,COFS1,CSB,RAD26,UVSS1;excision repair cross-complementing rodent repair deficiency, complementation group 6
hsa:84215;ZNF541;zinc finger protein 541
hsa:9456;HOMER1,HOMER,HOMER1A,HOMER1B,HOMER1C,SYN47,Ves-1;homer homolog 1 (Drosophila)
hsa:23236;PLCB1,EIEE12,PI-PLC,PLC-154,PLC-I,PLC154,PLCB1A,PLCB1B;phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11)
hsa:55661;DDX27,DRS1,Drs1p,PP3241,RHLP,dJ686N3.1;DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 (EC:3.6.4.13)
hsa:100996569;NAMA;non-protein coding RNA, associated with MAP kinase pathway and growth arrest
hsa:119710;C11orf74,HEPIS;chromosome 11 open reading frame 74
hsa:79709;COLGALT1,GLT25D1;collagen beta(1-O)galactosyltransferase 1 (EC:2.4.1.50)
hsa:10826;FAXDC2,C5orf4;fatty acid hydroxylase domain containing 2
hsa:2134;EXTL1,EXTL;exostosin-like glycosyltransferase 1 (EC:2.4.1.224)
hsa:267004;PGBD3;piggyBac transposable element derived 3
hsa:5697;PYY,PYY-I,PYY1;peptide YY
hsa:56947;MFF,C2orf33,GL004;mitochondrial fission factor
hsa:257313;UTS2B,U2B,URP,UTS2D;urotensin 2B
hsa:23127;COLGALT2,C1orf17,GLT25D2;collagen beta(1-O)galactosyltransferase 2 (EC:2.4.1.50)
hsa:5539;PPY,PNP;pancreatic polypeptide
hsa:4035;LRP1,A2MR,APOER,APR,CD91,IGFBP3R,LRP,LRP1A,TGFBR5;low density lipoprotein receptor-related protein 1
hsa:2185;PTK2B,CADTK,CAKB,FADK2,FAK2,PKB,PTK,PYK2,RAFTK;protein tyrosine kinase 2 beta (EC:2.7.10.2)
hsa:79053;ALG8,CDG1H;ALG8, alpha-1,3-glucosyltransferase (EC:2.4.1.265)
hsa:7403;KDM6A,KABUK2,UTX,bA386N14.2;lysine (K)-specific demethylase 6A
hsa:7432;VIP,PHM27;vasoactive intestinal peptide
hsa:114131;UCN3,SCP,SPC,UCNIII;urocortin 3
hsa:2132;EXT2,SOTV;exostosin glycosyltransferase 2 (EC:2.4.1.225 2.4.1.224)
hsa:10911;UTS2,PRO1068,U-II,UCN2,UII;urotensin 2
hsa:29929;ALG6,CDG1C;ALG6, alpha-1,3-glucosyltransferase (EC:2.4.1.267)
hsa:5834;PYGB,GPBB;phosphorylase, glycogen;brain (EC:2.4.1.1)
hsa:6309;SC5D,ERG3,S5DES,SC5DL;sterol-C5-desaturase (EC:1.14.21.6)
hsa:551;AVP,ADH,ARVP,AVP-NPII,AVRP,VP;arginine vasopressin
hsa:162972;ZNF550;zinc finger protein 550
hsa:64111;NPVF,C7orf9,RFRP;neuropeptide VF precursor
hsa:63982;ANO3,C11orf25,DYT23,DYT24,TMEM16C;anoctamin 3
hsa:340307;CTAGE6,CTAGE6P;CTAGE family, member 6
hsa:7349;UCN,UI,UROC;urocortin
hsa:6343;SCT;secretin
hsa:90226;UCN2,SRP,UCN-II,UCNI,UR,URP;urocortin 2
hsa:171023;ASXL1,BOPS,MDS;additional sex combs like 1 (Drosophila)
hsa:8233;ZRSR2,U2AF1-RS2,U2AF1L2,U2AF1RS2,URP;zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2
hsa:116;ADCYAP1,PACAP;adenylate cyclase activating polypeptide 1 (pituitary)
hsa:144245;ALG10B,ALG10,KCR1;ALG10B, alpha-1,2-glucosyltransferase (EC:2.4.1.256)
hsa:345643;MCIDAS,IDAS,MCI,MCIN;multiciliate differentiation and DNA synthesis associated cell cycle protein
hsa:347148;QRFP,26RFa,P518;pyroglutamylated RFamide peptide
hsa:2131;EXT1,EXT,LGCR,LGS,TRPS2,TTV;exostosin glycosyltransferase 1 (EC:2.4.1.225 2.4.1.224)
hsa:2135;EXTL2,EXTR2;exostosin-like glycosyltransferase 2 (EC:2.4.1.223)
hsa:83661;MS4A8,4SPAN4,CD20L5,MS4A4,MS4A8B;membrane-spanning 4-domains, subfamily A, member 8
hsa:84920;ALG10,ALG10A,DIE2,KCR1;ALG10, alpha-1,2-glucosyltransferase (EC:2.4.1.256)
hsa:1314;COPA,HEP-COP;coatomer protein complex, subunit alpha
hsa:51388;NIP7,HSPC031,KD93;NIP7, nucleolar pre-rRNA processing protein
hsa:5744;PTHLH,BDE2,HHM,PLP,PTHR,PTHRP;parathyroid hormone-like hormone
hsa:63035;BCORL1,BCoR-L1,CXorf10;BCL6 corepressor-like 1
hsa:2137;EXTL3,BOTV,EXTR1,REGR,RPR;exostosin-like glycosyltransferase 3 (EC:2.4.1.223)
hsa:728218;LINC00864;long intergenic non-protein coding RNA 864
hsa:643529;LINC00865;long intergenic non-protein coding RNA 865
hsa:728190;NUTM2A-AS1,FAM22A-AS1;NUTM2A antisense RNA 1
hsa:81839;VANGL1,KITENIN,LPP2,STB2,STBM2;VANGL planar cell polarity protein 1
hsa:27152;INTU,INT,PDZD6,PDZK6;inturned planar cell polarity protein
hsa:4193;MDM2,ACTFS,HDMX,hdm2;MDM2 oncogene, E3 ubiquitin protein ligase
hsa:80199;FUZ,FY,NTD;fuzzy planar cell polarity protein
hsa:23513;SCRIB,CRIB1,SCRB1,SCRIB1,Vartul;scribbled planar cell polarity protein
hsa:54961;SSH3,SSH3L;slingshot protein phosphatase 3 (EC:3.1.3.16 3.1.3.48)
hsa:5631;PRPS1,ARTS,CMTX5,DFN2,DFNX1,PPRibP,PRS-I,PRSI;phosphoribosyl pyrophosphate synthetase 1 (EC:2.7.6.1)
hsa:57216;VANGL2,LPP1,LTAP,STB1,STBM,STBM1;VANGL planar cell polarity protein 2
hsa:92345;NAF1;nuclear assembly factor 1 ribonucleoprotein
hsa:85464;SSH2,SSH-2;slingshot protein phosphatase 2 (EC:3.1.3.16 3.1.3.48)
hsa:100289388;;uncharacterized LOC100289388
hsa:1650;DDOST,AGER1,CDG1R,OKSWcl45,OST,OST48,WBP1;dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic) (EC:2.4.99.18)
hsa:80816;ASXL3,KIAA1713;additional sex combs like 3 (Drosophila)
hsa:58505;OSTC;oligosaccharyltransferase complex subunit (non-catalytic)
hsa:9658;ZNF516,HsT287;zinc finger protein 516
hsa:6185;RPN2,RIBIIR,RPN-II,RPNII,SWP1;ribophorin II (EC:2.4.99.18)
hsa:51251;NT5C3A,NT5C3,P5'N-1,P5N-1,PN-I,POMP,PSN1,UMPH,UMPH1,cN-III,hUMP1,p36;5'-nucleotidase, cytosolic IIIA (EC:3.1.3.5)
hsa:6184;RPN1,OST1,RBPH1;ribophorin I (EC:2.4.99.18)
hsa:3703;STT3A,ITM1,STT3-A,TMC;STT3A, subunit of the oligosaccharyltransferase complex (catalytic) (EC:2.4.99.18)
hsa:201595;STT3B,SIMP,STT3-B;STT3B, subunit of the oligosaccharyltransferase complex (catalytic) (EC:2.4.99.18)
hsa:6170;RPL39,L39,RPL39P42,RPL39_23_1806;ribosomal protein L39
hsa:8701;DNAH11,CILD7,DNAHBL,DNAHC11,DNHBL,DPL11;dynein, axonemal, heavy chain 11
hsa:645745;MT1HL1,MT1P2;metallothionein 1H-like 1
hsa:9761;MLEC,KIAA0152;malectin
hsa:399939;TRIM49D1,TRIM49D,TRIM49D1P,TRIM49DP;tripartite motif containing 49D1
hsa:1603;DAD1,OST2;defender against cell death 1 (EC:2.4.99.18)
hsa:442459;XRCC6P5;X-ray repair complementing defective repair in Chinese hamster cells 6 pseudogene 5
hsa:338069;ST7-OT4,NCRNA00042,ST7OT4;ST7 overlapping transcript 4
hsa:100874362;HOXB-AS1;HOXB cluster antisense RNA 1
hsa:79782;LRRC31;leucine rich repeat containing 31
hsa:10018;BCL2L11,BAM,BIM,BOD;BCL2-like 11 (apoptosis facilitator)
hsa:5074;PAWR,PAR4,Par-4;PRKC, apoptosis, WT1, regulator
hsa:339500;ZNF678;zinc finger protein 678
hsa:10291;SF3A1,PRP21,PRPF21,SAP114,SF3A120;splicing factor 3a, subunit 1, 120kDa
hsa:7307;U2AF1,FP793,RN,RNU2AF1,U2AF35,U2AFBP;U2 small nuclear RNA auxiliary factor 1
hsa:7490;WT1,AWT1,EWS-WT1,GUD,NPHS4,WAGR,WIT-2,WT33;Wilms tumor 1
hsa:8529;CYP4F2,CPF2;cytochrome P450, family 4, subfamily F, polypeptide 2 (EC:1.14.13.30)
hsa:90333;ZNF468;zinc finger protein 468
hsa:127550;A3GALT2,A3GALT2P,IGBS3S;alpha 1,3-galactosyltransferase 2
hsa:6427;SRSF2,PR264,SC-35,SC35,SFRS2,SFRS2A,SRp30b;serine/arginine-rich splicing factor 2
hsa:54880;BCOR,ANOP2,MAA2,MCOPS2;BCL6 corepressor
hsa:7536;SF1,BBP,D11S636,MBBP,ZCCHC25,ZFM1,ZNF162;splicing factor 1
hsa:6235;RPS29,S29;ribosomal protein S29
hsa:23451;SF3B1,Hsh155,MDS,PRP10,PRPF10,SAP155,SF3b155;splicing factor 3b, subunit 1, 155kDa
hsa:7473;WNT3,INT4;wingless-type MMTV integration site family, member 3
hsa:7528;YY1,DELTA,INO80S,NF-E1,UCRBP,YIN-YANG-1;YY1 transcription factor
hsa:91662;NLRP12,CLR19.3,FCAS2,NALP12,PAN6,PYPAF7,RNO,RNO2;NLR family, pyrin domain containing 12
hsa:221785;ZSCAN25,ZNF498;zinc finger and SCAN domain containing 25
hsa:285498;RNF212,ZHP3;ring finger protein 212
hsa:23601;CLEC5A,CLECSF5,MDL-1,MDL1;C-type lectin domain family 5, member A
hsa:192670;AGO4,EIF2C4;argonaute RISC catalytic component 4
hsa:195814;SDR16C5,RDH#2,RDH-E2,RDHE2;short chain dehydrogenase/reductase family 16C, member 5 (EC:1.1.1.105)
hsa:64288;ZSCAN31,ZNF20-Lp,ZNF310P,ZNF323,dJ874C20.2;zinc finger and SCAN domain containing 31
hsa:3312;HSPA8,HSC54,HSC70,HSC71,HSP71,HSP73,HSPA10,LAP1,NIP71;heat shock 70kDa protein 8
hsa:84304;NUDT22;nudix (nucleoside diphosphate linked moiety X)-type motif 22
hsa:746;TMEM258,C11orf10;transmembrane protein 258
hsa:9732;DOCK4;dedicator of cytokinesis 4
hsa:92342;METTL18,AsTP2,C1orf156,HPM1;methyltransferase like 18
hsa:55750;AGK,CATC5,MTDPS10,MULK;acylglycerol kinase (EC:2.7.1.107 2.7.1.94)
hsa:55937;APOM,G3a,HSPC336,NG20,apo-M;apolipoprotein M
hsa:79823;CAMKMT,C2orf34,CLNMT,CaM_KMT,Cam,KMT;calmodulin-lysine N-methyltransferase (EC:2.1.1.60)
hsa:23192;ATG4B,APG4B,AUTL1;autophagy related 4B, cysteine peptidase
hsa:5362;PLXNA2,OCT,PLXN2;plexin A2
hsa:389690;MROH5;maestro heat-like repeat family member 5
hsa:503542;SPRN,SHADOO,SHO,bA108K14.1;shadow of prion protein homolog (zebrafish)
hsa:3303;HSPA1A,HSP70-1,HSP70-1A,HSP70I,HSP72,HSPA1;heat shock 70kDa protein 1A
hsa:154661;RUNDC3B,RPIB9,RPIP9;RUN domain containing 3B
hsa:83874;TBC1D10A,EPI64,TBC1D10,dJ130H16.1,dJ130H16.2;TBC1 domain family, member 10A
hsa:57690;TNRC6C;trinucleotide repeat containing 6C
hsa:57615;ZNF492,ZNF115;zinc finger protein 492
hsa:3304;HSPA1B,HSP70-1B,HSP70-2;heat shock 70kDa protein 1B
hsa:148198;ZNF98,F7175,ZNF739;zinc finger protein 98
hsa:845;CASQ2,PDIB2;calsequestrin 2 (cardiac muscle)
hsa:1837;DTNA,D18S892E,DRP3,DTN,DTN-A,LVNC1;dystrobrevin, alpha
hsa:89758;C6orf7;chromosome 6 open reading frame 7
hsa:9244;CRLF1,CISS,CISS1,CLF,CLF-1,NR6,zcytor5;cytokine receptor-like factor 1
hsa:5871;MAP4K2,BL44,GCK,RAB8IP;mitogen-activated protein kinase kinase kinase kinase 2 (EC:2.7.11.1)
hsa:79091;METTL22,C16orf68;methyltransferase like 22
hsa:5331;PLCB3;phospholipase C, beta 3 (phosphatidylinositol-specific) (EC:3.1.4.11)
hsa:253982;ASPHD1;aspartate beta-hydroxylase domain containing 1
hsa:79609;METTL21D,C14orf138,VCP-KMT;methyltransferase like 21D
hsa:340351;AGBL3;ATP/GTP binding protein-like 3
hsa:5578;PRKCA,AAG6,PKC-alpha,PKCA,PRKACA;protein kinase C, alpha (EC:2.7.11.13)
hsa:151194;METTL21A,FAM119A,HCA557b;methyltransferase like 21A
hsa:85002;FAM86B1;family with sequence similarity 86, member B1
hsa:164781;DAW1,ODA16,WDR69;dynein assembly factor with WDR repeat domains 1
hsa:203100;HTRA4;HtrA serine peptidase 4
hsa:27010;TPK1,HTPK1,PP20,THMD5;thiamin pyrophosphokinase 1 (EC:2.7.6.2)
hsa:284013;VMO1,ERGA6350,PRO21055;vitelline membrane outer layer 1 homolog (chicken)
hsa:22944;KIN,BTCD,KIN17;KIN, antigenic determinant of recA protein homolog (mouse)
hsa:6257;RXRB,DAUDI6,H-2RIIBP,NR2B2,RCoR-1;retinoid X receptor, beta
hsa:11104;KATNA1;katanin p60 (ATPase containing) subunit A 1 (EC:3.6.4.3)
hsa:375612;LHFPL3,LHFPL4;lipoma HMGIC fusion partner-like 3
hsa:388650;FAM69A;family with sequence similarity 69, member A
hsa:284565;NBPF15,AB14;neuroblastoma breakpoint family, member 15
hsa:79058;ASPSCR1,ASPCR1,ASPL,ASPS,RCC17,TUG,UBXD9,UBXN9;alveolar soft part sarcoma chromosome region, candidate 1
hsa:7415;VCP,ALS14,IBMPFD,TERA,p97;valosin containing protein (EC:3.6.4.6)
hsa:124512;METTL23,C17orf95;methyltransferase like 23
hsa:100631383;FAM47E-STBD1;FAM47E-STBD1 readthrough
hsa:677;ZFP36L1,BRF1,Berg36,ERF-1,ERF1,RNF162B,TIS11B,cMG1;ZFP36 ring finger protein-like 1
hsa:5528;PPP2R5D,B56D;protein phosphatase 2, regulatory subunit B', delta
hsa:282616;IFNL2,IL-28A,IL28A;interferon, lambda 2
hsa:79783;C7orf10,DERP13,ORF19;chromosome 7 open reading frame 10
hsa:2675;GFRA2,GDNFRB,NRTNR-ALPHA,NTNRA,RETL2,TRNR2;GDNF family receptor alpha 2
hsa:25895;METTL21B,FAM119B;methyltransferase like 21B
hsa:8646;CHRD;chordin
hsa:5529;PPP2R5E;protein phosphatase 2, regulatory subunit B', epsilon isoform
hsa:57689;LRRC4C,NGL-1,NGL1;leucine rich repeat containing 4C
hsa:1981;EIF4G1,EIF-4G1,EIF4F,EIF4G,EIF4GI,P220,PARK18;eukaryotic translation initiation factor 4 gamma, 1
hsa:5683;PSMA2,HC3,MU,PMSA2,PSC2;proteasome (prosome, macropain) subunit, alpha type, 2 (EC:3.4.25.1)
hsa:57698;;KIAA1598
hsa:55199;FAM86C1,FAM86C;family with sequence similarity 86, member C1
hsa:196541;METTL21C,C13orf39;methyltransferase like 21C
hsa:64065;PERP,KCP1,KRTCAP1,PIGPC1,RP3-496H19.1,THW,dJ496H19.1;PERP, TP53 apoptosis effector
hsa:10345;TRDN,TDN,TRISK;triadin
hsa:100128590;SLC8A1-AS1;SLC8A1 antisense RNA 1
hsa:100302166;MIR1322,MIRN1322,hsa-mir-1322;microRNA 1322
hsa:100506686;IQCH-AS1;IQCH antisense RNA 1
hsa:100506409;ELOVL2-AS1;ELOVL2 antisense RNA 1
hsa:400110;ANKRD20A19P;ankyrin repeat domain 20 family, member A19, pseudogene
hsa:284294;;uncharacterized LOC284294
hsa:100048912;CDKN2B-AS1,ANRIL,CDKN2B-AS,CDKN2BAS,NCRNA00089,p15AS;CDKN2B antisense RNA 1
hsa:100506497;;uncharacterized LOC100506497
hsa:339524;;uncharacterized LOC339524
hsa:100505795;;uncharacterized LOC100505795
hsa:339529;;uncharacterized LOC339529
hsa:100506810;;uncharacterized LOC100506810
hsa:100616384;MIR548AC;microRNA 548ac
hsa:440034;DKFZp686K1684;uncharacterized LOC440034
hsa:100532746;PPT2-EGFL8;PPT2-EGFL8 readthrough
hsa:100131089;;uncharacterized LOC100131089
hsa:284900;TTC28-AS1,TTC28-AS,TTC28AS,dJ353E16.2;TTC28 antisense RNA 1
hsa:26801;SNORD48,RNU48,U48;small nucleolar RNA, C/D box 48
hsa:100302267;MIR2054,hsa-mir-2054;microRNA 2054
hsa:693196;MIR611,MIRN611,hsa-mir-611;microRNA 611
hsa:100270679;;uncharacterized LOC100270679
hsa:100505718;;uncharacterized LOC100505718
hsa:401324;;uncharacterized LOC401324
hsa:728409;C21orf54;chromosome 21 open reading frame 54
hsa:100507377;;uncharacterized LOC100507377
hsa:386593;CHKB-CPT1B,CHKL-CPT1B;CHKB-CPT1B readthrough (non-protein coding)
hsa:399948;C11orf92;chromosome 11 open reading frame 92
hsa:100885778;NALCN-AS1;NALCN antisense RNA 1
hsa:100287616;LOXL1-AS1;LOXL1 antisense RNA 1
hsa:148824;GCSAML-AS1;GCSAML antisense RNA 1
hsa:338588;LINC00705;long intergenic non-protein coding RNA 705
hsa:64002;PCGEM1,LINC00071,NCRNA00071;PCGEM1, prostate-specific transcript (non-protein coding)
hsa:553103;;uncharacterized LOC553103
hsa:100505702;;uncharacterized LOC100505702
hsa:100216001;LINC00704;long intergenic non-protein coding RNA 704
hsa:285830;HLA-F-AS1;HLA-F antisense RNA 1
hsa:100507346;;uncharacterized LOC100507346
hsa:100505696;SH3BP5-AS1;SH3BP5 antisense RNA 1
hsa:285965;EPHA1-AS1;EPHA1 antisense RNA 1
hsa:100874151;LINC00381;long intergenic non-protein coding RNA 381
hsa:100507389;;uncharacterized LOC100507389
hsa:285441;;uncharacterized LOC285441
hsa:100132354;;uncharacterized LOC100132354
hsa:100616329;MIR4700;microRNA 4700
hsa:100507401;LRP4-AS1;LRP4 antisense RNA 1
hsa:388906;;opioid growth factor receptor pseudogene
hsa:140828;LINC00261,C20orf56,NCRNA00261,bA216C10.1,dJ788L20.2;long intergenic non-protein coding RNA 261
hsa:100289178;GNG12-AS1;GNG12 antisense RNA 1
hsa:100379251;NPPA-AS1,NPPA-AS,NPPAAS;NPPA antisense RNA 1
hsa:100303453;TSNAX-DISC1;TSNAX-DISC1 readthrough
hsa:100422970;MIR1273D;microRNA 1273d
hsa:100128714;;uncharacterized LOC100128714
hsa:692233;SNORD117,U83;small nucleolar RNA, C/D box 117
hsa:100302150;MIR1296,MIRN1296,hsa-mir-1296;microRNA 1296
hsa:100128081;JAZF1-AS1;JAZF1 antisense RNA 1
hsa:100506697;LINC00327,NCRNA00327;long intergenic non-protein coding RNA 327
hsa:339894;;uncharacterized LOC339894
hsa:344887;;NmrA-like family domain containing 1 pseudogene
hsa:100422918;MIR3167;microRNA 3167
hsa:100873065;;uncharacterized LOC100873065
hsa:643749;TRAF3IP2-AS1,C6UAS,C6orf3,NCRNA00248,TRAF3IP2-AS2;TRAF3IP2 antisense RNA 1
hsa:100874167;LINC00423;long intergenic non-protein coding RNA 423
hsa:401022;HOXD-AS1;HOXD cluster antisense RNA 1
hsa:400957;FLJ16341;uncharacterized LOC400957
hsa:646736;;uncharacterized LOC646736
hsa:100131060;;uncharacterized LOC100131060
hsa:643714;;uncharacterized LOC643714
hsa:643542;;uncharacterized LOC643542
hsa:154442;BVES-AS1,C6orf112,bA99L11.2;BVES antisense RNA 1
hsa:400765;MIR137HG;MIR137 host gene (non-protein coding)
hsa:729852;;uncharacterized LOC729852
hsa:100631378;;uncharacterized 100631378
hsa:100128977;MAPT-AS1;MAPT antisense RNA 1
hsa:285696;;uncharacterized LOC285696
hsa:100131825;;uncharacterized LOC100131825
hsa:100652759;PRICKLE2-AS1;PRICKLE2 antisense RNA 1
hsa:154092;;uncharacterized LOC154092
hsa:2630;GBAP1,GBAP;glucosidase, beta, acid pseudogene 1
hsa:352961;HCG26,3.8-1,NCRNA00191,bCX205D4.4,bPG181B23.4;HLA complex group 26 (non-protein coding)
hsa:100506023;;uncharacterized LOC100506023
hsa:23766;GABARAPL3,ATG8D;GABA(A) receptors associated protein like 3, pseudogene
hsa:100532732;MSH5-SAPCD1,MSH5-C6orf26;MSH5-SAPCD1 readthrough (non-protein coding)
hsa:100852409;NEGR1-IT1;NEGR1 intronic transcript 1 (non-protein coding)
hsa:51214;IGF2-AS,IGF2-AS1,IGF2AS,PEG8;IGF2 antisense RNA
hsa:100874128;LINC00333,NCRNA00333;long intergenic non-protein coding RNA 333
hsa:339789;LINC00299,C2orf46,NCRNA00299;long intergenic non-protein coding RNA 299
hsa:643339;;uncharacterized LOC643339
hsa:338864;LINC00347;long intergenic non-protein coding RNA 347
hsa:100874222;RNF219-AS1,POU4F1-AS1;RNF219 antisense RNA 1
hsa:100506393;;uncharacterized LOC100506393
hsa:100289211;LINC00624;long intergenic non-protein coding RNA 624
hsa:727896;;cysteine and histidine-rich domain (CHORD) containing 1 pseudogene
hsa:220980;TMEM72-AS1;TMEM72 antisense RNA 1
hsa:10984;KCNQ1OT1,KCNQ1-AS2,KCNQ10T1,KvDMR1,KvLQT1-AS,LIT1,NCRNA00012;KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
hsa:100505566;LINC00578;long intergenic non-protein coding RNA 578
hsa:100379224;;uncharacterized LOC100379224
hsa:100144597;;uncharacterized LOC100144597
hsa:100874095;ADIPOQ-AS1;ADIPOQ antisense RNA 1
hsa:100507118;;uncharacterized LOC100507118
hsa:100506834;;uncharacterized LOC100506834
hsa:100302133;MIR1287,MIRN1287,hsa-mir-1287;microRNA 1287
hsa:646982;LINC00598,TTL;long intergenic non-protein coding RNA 598
hsa:100874028;SGOL1-AS1;SGOL1 antisense RNA 1
hsa:414351;LINC00229,C22orf10,NCRNA00229,dJ474I12.C22.2;long intergenic non-protein coding RNA 229
hsa:100847084;MIR548AP;microRNA 548ap
hsa:100874037;CADM2-AS2;CADM2 antisense RNA 2
hsa:100533107;RTEL1-TNFRSF6B;RTEL1-TNFRSF6B readthrough (non-protein coding)
hsa:378832;COL18A1-AS1,C21orf123,NCRNA00175,PRED80;COL18A1 antisense RNA 1
hsa:254100;;uncharacterized LOC254100
hsa:441389;FLJ35282;uncharacterized LOC441389
hsa:100144596;LINC00029,C20orf51,NCRNA00029;long intergenic non-protein coding RNA 29
hsa:645323;LINC00461;long intergenic non-protein coding RNA 461
hsa:100507098;ADAMTS9-AS2;ADAMTS9 antisense RNA 2
hsa:644714;LIMD1-AS1;LIMD1 antisense RNA 1
hsa:257000;TINCR,LINC00036,NCRNA00036,PLAC2;tissue differentiation-inducing non-protein coding RNA
hsa:149773;APCDD1L-AS1;APCDD1L antisense RNA 1 (head to head)
hsa:100294362;;uncharacterized LOC100294362
hsa:646576;HHIP-AS1;HHIP antisense RNA 1
hsa:339975;;uncharacterized LOC339975
hsa:728723;ZBED3-AS1;ZBED3 antisense RNA 1
hsa:151300;LINC00608;long intergenic non-protein coding RNA 608
hsa:692089;SNORD19,HBII-108;small nucleolar RNA, C/D box 19
hsa:497258;BDNF-AS,ANTI-BDNF,BDNF,BDNF-AS1,BDNFOS,NCRNA00049;BDNF antisense RNA
hsa:284260;;uncharacterized LOC284260
hsa:100533975;SLMO2-ATP5E;SLMO2-ATP5E readthrough
hsa:84546;SNORD35B,RNU35B,U35B;small nucleolar RNA, C/D box 35B
hsa:157273;;uncharacterized LOC157273
hsa:100861552;LINC00558;long intergenic non-protein coding RNA 558
hsa:391051;UOX,UOXP,URICASE;urate oxidase, pseudogene
hsa:441355;FLJ39080;uncharacterized LOC441355
hsa:677775;SCARNA5,U87;small Cajal body-specific RNA 5
hsa:3;A2MP1,A2MP;alpha-2-macroglobulin pseudogene 1
hsa:100873762;RNU6-53;RNA, U6 small nuclear 53
hsa:732275;;uncharacterized LOC732275
hsa:100130197;EFCAB14-AS1,KIAA0494-AS1;EFCAB14 antisense RNA 1
hsa:100532737;ATP6V1G2-DDX39B;ATP6V1G2-DDX39B readthrough (non-protein coding)
hsa:414764;HCG23,dJ1077I5.3;HLA complex group 23 (non-protein coding)
hsa:100287944;;uncharacterized LOC100287944
hsa:100506172;;uncharacterized LOC100506172
hsa:100505933;;uncharacterized LOC100505933
hsa:441108;C5orf56;chromosome 5 open reading frame 56
hsa:3137;HLA-J,CDA12,D6S203,HLA-59,HLA-CDA12;major histocompatibility complex, class I, J (pseudogene)
hsa:727677;;uncharacterized LOC727677
hsa:100507443;;uncharacterized LOC100507443
hsa:100529262;MIA-RAB4B;MIA-RAB4B readthrough
hsa:100874059;LINC00297,NCRNA00297;long intergenic non-protein coding RNA 297
hsa:147081;CRHR1-IT1,C17orf69;CRHR1 intronic transcript 1 (non-protein coding)
hsa:100874251;KIRREL3-AS2;KIRREL3 antisense RNA 2
hsa:100505783;;uncharacterized LOC100505783
hsa:645206;LINC00693;long intergenic non-protein coding RNA 693
hsa:400955;FLJ30838;uncharacterized LOC400955
hsa:100529264;RAB4B-EGLN2,RERT-lncRNA;RAB4B-EGLN2 readthrough (non-protein coding)
hsa:285375;LINC00620;long intergenic non-protein coding RNA 620
hsa:285780;LY86-AS1,LY86-AS,LY86AS;LY86 antisense RNA 1
hsa:285626;;uncharacterized LOC285626
hsa:100288077;WTAPP1;Wilms tumor 1 associated protein pseudogene 1
hsa:1601;DAB2,DOC-2,DOC2;Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
hsa:136263;SSMEM1,C7orf45;serine-rich single-pass membrane protein 1
hsa:23275;POFUT2,C21orf80,FUT13;protein O-fucosyltransferase 2 (EC:2.4.1.221)
hsa:1600;DAB1;Dab, reelin signal transducer, homolog 1 (Drosophila)
hsa:23196;FAM120A,C9orf10,DNAPTP1,DNAPTP5,OSSA;family with sequence similarity 120A
hsa:653781;POTEJ,POTE2beta;POTE ankyrin domain family, member J
hsa:23509;POFUT1,FUT12,O-FUT,O-Fuc-T,O-FucT-1;protein O-fucosyltransferase 1 (EC:2.4.1.221)
hsa:80308;FLAD1,FAD1,FADS,RP11-307C12.7;flavin adenine dinucleotide synthetase 1 (EC:2.7.7.2)
hsa:389203;SMIM20,C4orf52;small integral membrane protein 20
hsa:132228;LSMEM2,C3orf45;leucine-rich single-pass membrane protein 2
hsa:100499483;CCDC180,BDAG1,C9orf174,KIAA1529;coiled-coil domain containing 180
hsa:91689;SMDT1,C22orf32,DDDD,dJ186O1.1;single-pass membrane protein with aspartate-rich tail 1
hsa:57493;HEG1,HEG,MST112,MSTP112;heart development protein with EGF-like domains 1
hsa:10282;BET1,HBET1;Bet1 golgi vesicular membrane trafficking protein
hsa:1738;DLD,DLDD,DLDH,E3,GCSL,LAD,PHE3;dihydrolipoamide dehydrogenase (EC:1.8.1.4)
hsa:54916;TMEM260,C14orf101;transmembrane protein 260
hsa:286006;LSMEM1,C7orf53;leucine-rich single-pass membrane protein 1
hsa:114926;SMIM19,C8orf40;small integral membrane protein 19
hsa:221477;C6orf89,BRAP;chromosome 6 open reading frame 89
hsa:100128054;PLCE1-AS1;PLCE1 antisense RNA 1
hsa:54209;TREM2,TREM-2,Trem2a,Trem2b,Trem2c;triggering receptor expressed on myeloid cells 2
hsa:9002;F2RL3,PAR4;coagulation factor II (thrombin) receptor-like 3
hsa:6591;SNAI2,SLUG,SLUGH1,SNAIL2,WS2D;snail homolog 2 (Drosophila)
hsa:9415;FADS2,D6D,DES6,FADSD6,LLCDL2,SLL0262,TU13;fatty acid desaturase 2 (EC:1.14.19.-)
hsa:7080;NKX2-1,BCH,BHC,NK-2,NKX2.1,NKX2A,TEBP,TITF1,TTF-1,TTF1;NK2 homeobox 1
hsa:604;BCL6,BCL5,BCL6A,LAZ3,ZBTB27,ZNF51;B-cell CLL/lymphoma 6
hsa:7159;TP53BP2,53BP2,ASPP2,BBP,P53BP2,PPP1R13A;tumor protein p53 binding protein, 2
hsa:10664;CTCF;CCCTC-binding factor (zinc finger protein)
hsa:6648;SOD2,IPOB,MNSOD,MVCD6;superoxide dismutase 2, mitochondrial (EC:1.15.1.1)
hsa:30011;SH3KBP1,CD2BP3,CIN85,GIG10,HSB-1,HSB1,MIG18;SH3-domain kinase binding protein 1
hsa:5739;PTGIR,IP,PRIPR;prostaglandin I2 (prostacyclin) receptor (IP)
hsa:7276;TTR,CTS,CTS1,HsT2651,PALB,TBPA;transthyretin
hsa:4669;NAGLU,MPS-IIIB,MPS3B,NAG,UFHSD;N-acetylglucosaminidase, alpha (EC:3.2.1.50)
hsa:2690;GHR,GHBP;growth hormone receptor
hsa:301;ANXA1,ANX1,LPC1;annexin A1
hsa:7253;TSHR,CHNG1,LGR3,hTSHR-I;thyroid stimulating hormone receptor
hsa:5443;POMC,ACTH,CLIP,LPH,MSH,NPP,POC;proopiomelanocortin
hsa:613;BCR,ALL,BCR1,CML,D22S11,D22S662,PHL;breakpoint cluster region (EC:2.7.11.1)
hsa:1462;VCAN,CSPG2,ERVR,GHAP,PG-M,WGN,WGN1;versican
hsa:6469;SHH,HHG1,HLP3,HPE3,MCOPCB5,SMMCI,TPT,TPTPS;sonic hedgehog
hsa:57580;PREX1,P-REX1;phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
hsa:3579;CXCR2,CD182,CDw128b,CMKAR2,IL8R2,IL8RA,IL8RB;chemokine (C-X-C motif) receptor 2
hsa:51343;FZR1,CDC20C,CDH1,FZR,FZR2,HCDH,HCDH1;fizzy/cell division cycle 20 related 1 (Drosophila)
hsa:9897;SPG8;KIAA0196
hsa:55353;LAPTM4B,LAPTM4beta,LC27;lysosomal protein transmembrane 4 beta
hsa:2627;GATA6;GATA binding protein 6
hsa:1128;CHRM1,HM1,M1,M1R;cholinergic receptor, muscarinic 1
hsa:6421;SFPQ,POMP100,PSF;splicing factor proline/glutamine-rich
hsa:5980;REV3L,POLZ,REV3;REV3-like, polymerase (DNA directed), zeta, catalytic subunit (EC:2.7.7.7)
hsa:7468;WHSC1,MMSET,NSD2,REIIBP,TRX5,WHS;Wolf-Hirschhorn syndrome candidate 1 (EC:2.1.1.43)
hsa:50964;SOST,CDD,VBCH;sclerostin
hsa:1909;EDNRA,ET-A,ETA,ETA-R,ETAR,ETRA,hET-AR;endothelin receptor type A
hsa:4854;NOTCH3,CADASIL,CASIL;notch 3
hsa:6774;STAT3,APRF,HIES;signal transducer and activator of transcription 3 (acute-phase response factor)
hsa:1674;DES,CSM1,CSM2;desmin
hsa:84148;KAT8,MOF,MYST1,ZC2HC8,hMOF;K(lysine) acetyltransferase 8 (EC:2.3.1.48)
hsa:4000;LMNA,CDCD1,CDDC,CMD1A,CMT2B1,EMD2,FPL,FPLD,FPLD2,HGPS,IDC,LDP1,LFP,LGMD1B,LMN1,LMNC,LMNL1,PRO1;lamin A/C
hsa:2705;GJB1,CMTX,CMTX1,CX32;gap junction protein, beta 1, 32kDa
hsa:149233;IL23R;interleukin 23 receptor
hsa:23358;USP24;ubiquitin specific peptidase 24 (EC:3.4.19.12)
hsa:7037;TFRC,CD71,T9,TFR,TFR1,TR,TRFR,p90;transferrin receptor (p90, CD71)
hsa:23435;TARDBP,ALS10,TDP-43;TAR DNA binding protein
hsa:2521;FUS,ALS6,ETM4,FUS1,HNRNPP2,POMP75,TLS;fused in sarcoma
hsa:3060;HCRT,NRCLP1,OX,PPOX;hypocretin (orexin) neuropeptide precursor
hsa:4609;MYC,MRTL,bHLHe39,c-Myc;v-myc myelocytomatosis viral oncogene homolog (avian)
hsa:1280;COL2A1,ANFH,AOM,COL11A3,SEDC;collagen, type II, alpha 1
hsa:6456;SH3GL2,CNSA2,EEN-B1,SH3D2A,SH3P4;SH3-domain GRB2-like 2
hsa:4070;TACSTD2,EGP-1,EGP1,GA733-1,GA7331,GP50,M1S1,TROP2;tumor-associated calcium signal transducer 2
hsa:3105;HLA-A,HLAA;major histocompatibility complex, class I, A
hsa:114907;FBXO32,Fbx32,MAFbx;F-box protein 32
hsa:23586;DDX58,RIG-I,RIGI,RLR-1;DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 (EC:3.6.4.13)
hsa:7465;WEE1,WEE1A,WEE1hu;WEE1 homolog (S. pombe) (EC:2.7.10.2)
hsa:25973;PARS2,MT-PRORS;prolyl-tRNA synthetase 2, mitochondrial (putative) (EC:6.1.1.15)
hsa:11343;MGLL,HU-K5,HUK5,MAGL,MGL;monoglyceride lipase (EC:3.1.1.23)
hsa:6546;SLC8A1,NCX1;solute carrier family 8 (sodium/calcium exchanger), member 1
hsa:50485;SMARCAL1,HARP,HHARP;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
hsa:1407;CRY1,PHLL1;cryptochrome 1 (photolyase-like)
hsa:23421;ITGB3BP,CENP-R,CENPR,HSU37139,NRIF3,TAP20;integrin beta 3 binding protein (beta3-endonexin)
hsa:1673;DEFB4A,BD-2,DEFB-2,DEFB102,DEFB2,DEFB4,HBD-2,SAP1;defensin, beta 4A
hsa:4879;NPPB,BNP;natriuretic peptide B
hsa:8828;NRP2,NP2,NPN2,PRO2714,VEGF165R2;neuropilin 2
hsa:8503;PIK3R3,p55,p55-GAMMA;phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
hsa:6340;SCNN1G,BESC3,ENaCg,ENaCgamma,PHA1,SCNEG;sodium channel, non-voltage-gated 1, gamma subunit
hsa:5178;PEG3,PW1,ZKSCAN22,ZNF904,ZSCAN24;paternally expressed 3
hsa:307;ANXA4,ANX4,PIG28,ZAP36;annexin A4
hsa:3627;CXCL10,C7,IFI10,INP10,IP-10,SCYB10,crg-2,gIP-10,mob-1;chemokine (C-X-C motif) ligand 10
hsa:4292;MLH1,COCA2,FCC2,HNPCC,HNPCC2,hMLH1;mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)
hsa:83879;CDCA7,JPO1;cell division cycle associated 7
hsa:1553;CYP2A13,CPAD,CYP2A,CYPIIA13;cytochrome P450, family 2, subfamily A, polypeptide 13 (EC:1.14.14.1)
hsa:64760;FAM160B2,RAI16;family with sequence similarity 160, member B2
hsa:5930;RBBP6,MY038,P2P-R,PACT,RBQ-1,SNAMA;retinoblastoma binding protein 6
hsa:9531;BAG3,BAG-3,BIS,CAIR-1;BCL2-associated athanogene 3
hsa:2243;FGA,Fib2;fibrinogen alpha chain
hsa:4659;PPP1R12A,M130,MBS,MYPT1;protein phosphatase 1, regulatory subunit 12A
hsa:3667;IRS1,HIRS-1;insulin receptor substrate 1
hsa:5500;PPP1CB,PP-1B,PP1B,PP1beta,PPP1CD;protein phosphatase 1, catalytic subunit, beta isozyme (EC:3.1.3.16 3.1.3.53)
hsa:1634;DCN,CSCD,DSPG2,PG40,PGII,PGS2,SLRR1B;decorin
hsa:90529;STPG1,C1orf201,MAPO2;sperm-tail PG-rich repeat containing 1
hsa:6389;SDHA,CMD1GG,FP,PGL5,SDH1,SDH2,SDHF;succinate dehydrogenase complex, subunit A, flavoprotein (Fp) (EC:1.3.5.1)
hsa:4088;SMAD3,HSPC193,HsT17436,JV15-2,LDS1C,LDS3,MADH3;SMAD family member 3
hsa:10395;DLC1,ARHGAP7,HP,STARD12,p122-RhoGAP;deleted in liver cancer 1
hsa:5771;PTPN2,PTN2,PTPT,TC-PTP,TCELLPTP,TCPTP;protein tyrosine phosphatase, non-receptor type 2 (EC:3.1.3.48)
hsa:9121;SLC16A5,MCT5,MCT6;solute carrier family 16, member 5 (monocarboxylic acid transporter 6)
hsa:7410;VAV2,VAV-2;vav 2 guanine nucleotide exchange factor
hsa:2146;EZH2,ENX-1,ENX1,EZH1,KMT6,KMT6A,WVS2;enhancer of zeste homolog 2 (Drosophila) (EC:2.1.1.43)
hsa:9619;ABCG1,ABC8,WHITE1;ATP-binding cassette, sub-family G (WHITE), member 1
hsa:64083;GOLPH3,GOPP1,GPP34,MIDAS;golgi phosphoprotein 3 (coat-protein)
hsa:58985;IL22RA1,CRF2-9,IL22R,IL22R1;interleukin 22 receptor, alpha 1
hsa:9261;MAPKAPK2,MAPKAP-K2,MK-2,MK2;mitogen-activated protein kinase-activated protein kinase 2 (EC:2.7.11.1)
hsa:203547;VMA21,MEAX,XMEA;VMA21 vacuolar H+-ATPase homolog (S. cerevisiae)
hsa:7124;TNF,DIF,TNF-alpha,TNFA,TNFSF2;tumor necrosis factor
hsa:133522;PPARGC1B,ERRL1,PERC,PGC-1(beta),PGC1B;peroxisome proliferator-activated receptor gamma, coactivator 1 beta
hsa:7471;WNT1,INT1;wingless-type MMTV integration site family, member 1
hsa:3106;HLA-B,AS,HLAB,SPDA1;major histocompatibility complex, class I, B
hsa:2264;FGFR4,CD334,JTK2,TKF;fibroblast growth factor receptor 4 (EC:2.7.10.1)
hsa:1410;CRYAB,CRYA2,CTPP2,HSPB5;crystallin, alpha B
hsa:2494;NR5A2,B1F,B1F2,CPF,FTF,FTZ-F1,FTZ-F1beta,LRH-1,LRH1,hB1F-2;nuclear receptor subfamily 5, group A, member 2
hsa:57510;XPO5,exp5;exportin 5
hsa:5241;PGR,NR3C3,PR;progesterone receptor
hsa:3990;LIPC,HDLCQ12,HL,HTGL,LIPH;lipase, hepatic (EC:3.1.1.3)
hsa:4985;OPRD1,OPRD;opioid receptor, delta 1
hsa:79621;RNASEH2B,AGS2,DLEU8;ribonuclease H2, subunit B
hsa:6736;SRY,SRXX1,SRXY1,TDF,TDY;sex determining region Y
hsa:206358;SLC36A1,Dct1,LYAAT1,PAT1,TRAMD3;solute carrier family 36 (proton/amino acid symporter), member 1
hsa:2157;F8,AHF,DXS1253E,F8B,F8C,FVIII,HEMA;coagulation factor VIII, procoagulant component
hsa:9212;AURKB,AIK2,AIM-1,AIM1,ARK2,AurB,IPL1,PPP1R48,STK12,STK5,aurkb-sv1,aurkb-sv2;aurora kinase B (EC:2.7.11.1)
hsa:116835;HSPA12B,C20orf60,dJ1009E24.2;heat shock 70kD protein 12B
hsa:64321;SOX17,VUR3;SRY (sex determining region Y)-box 17
hsa:22;ABCB7,ABC7,ASAT,Atm1p,EST140535;ATP-binding cassette, sub-family B (MDR/TAP), member 7
hsa:2492;FSHR,FSHRO,LGR1,ODG1;follicle stimulating hormone receptor
hsa:1001;CDH3,CDHP,HJMD,PCAD;cadherin 3, type 1, P-cadherin (placental)
hsa:60681;FKBP10,FKBP65,OI11,OI6,PPIASE,hFKBP65;FK506 binding protein 10, 65 kDa (EC:5.2.1.8)
hsa:90865;IL33,C9orf26,DVS27,IL1F11,NF-HEV,NFEHEV,RP11-575C20.2;interleukin 33
hsa:5798;PTPRN,IA-2,IA-2/PTP,IA2,ICA512,R-PTP-N;protein tyrosine phosphatase, receptor type, N (EC:3.1.3.48)
hsa:8626;TP63,AIS,B(p51A),B(p51B),EEC3,KET,LMS,NBP,OFC8,RHS,SHFM4,TP53CP,TP53L,TP73L,p40,p51,p53CP,p63,p73H,p73L;tumor protein p63
hsa:1718;DHCR24,DCE,Nbla03646,SELADIN1,seladin-1;24-dehydrocholesterol reductase (EC:1.3.1.72)
hsa:861;RUNX1,AML1,AML1-EVI-1,AMLCR1,CBFA2,EVI-1,PEBP2aB;runt-related transcription factor 1
hsa:3848;KRT1,CK1,EHK,EHK1,EPPK,K1,KRT1A,NEPPK;keratin 1
hsa:100;ADA;adenosine deaminase (EC:3.5.4.4)
hsa:768;CA9,CAIX,MN;carbonic anhydrase IX (EC:4.2.1.1)
hsa:5604;MAP2K1,MAPKK1,MEK1,MKK1,PRKMK1;mitogen-activated protein kinase kinase 1 (EC:2.7.12.2)
hsa:1831;TSC22D3,DIP,DSIPI,GILZ,TSC-22R,hDIP;TSC22 domain family, member 3
hsa:6720;SREBF1,SREBP-1c,SREBP1,bHLHd1;sterol regulatory element binding transcription factor 1
hsa:84290;CAPNS2;calpain, small subunit 2
hsa:116519;APOA5,APOAV,RAP3;apolipoprotein A-V
hsa:3713;IVL;involucrin
hsa:7048;TGFBR2,AAT3,FAA3,LDS1B,LDS2B,MFS2,RIIC,TAAD2,TGFR-2,TGFbeta-RII;transforming growth factor, beta receptor II (70/80kDa) (EC:2.7.11.30)
hsa:6564;SLC15A1,HPECT1,HPEPT1,PEPT1;solute carrier family 15 (oligopeptide transporter), member 1
hsa:4543;MTNR1A,MEL-1A-R,MT1;melatonin receptor 1A
hsa:216;ALDH1A1,ALDC,ALDH-E1,ALDH1,ALDH11,PUMB1,RALDH1;aldehyde dehydrogenase 1 family, member A1 (EC:1.2.1.36)
hsa:3586;IL10,CSIF,GVHDS,IL-10,IL10A,TGIF;interleukin 10
hsa:6604;SMARCD3,BAF60C,CRACD3,Rsc6p;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
hsa:2335;FN1,CIG,ED-B,FINC,FN,FNZ,GFND,GFND2,LETS,MSF;fibronectin 1
hsa:1036;CDO1;cysteine dioxygenase, type I (EC:1.13.11.20)
hsa:8996;NOL3,ARC,FCM,MYP,NOP,NOP30;nucleolar protein 3 (apoptosis repressor with CARD domain)
hsa:3704;ITPA,C20orf37,HLC14-06-P,dJ794I6.3;inosine triphosphatase (nucleoside triphosphate pyrophosphatase) (EC:3.6.1.19)
hsa:2122;MECOM,AML1-EVI-1,EVI1,MDS1,MDS1-EVI1,PRDM3;MDS1 and EVI1 complex locus
hsa:9270;ITGB1BP1,ICAP-1A,ICAP-1B,ICAP-1alpha,ICAP1,ICAP1A,ICAP1B;integrin beta 1 binding protein 1
hsa:10062;NR1H3,LXR-a,LXRA,RLD-1;nuclear receptor subfamily 1, group H, member 3
hsa:890;CCNA2,CCN1,CCNA;cyclin A2
hsa:3934;LCN2,24p3,MSFI,NGAL;lipocalin 2
hsa:2869;GRK5,GPRK5;G protein-coupled receptor kinase 5 (EC:2.7.11.16)
hsa:64699;TMPRSS3,DFNB10,DFNB8,ECHOS1,TADG12;transmembrane protease, serine 3 (EC:3.4.21.-)
hsa:10276;NET1,ARHGEF8,NET1A;neuroepithelial cell transforming 1
hsa:3553;IL1B,IL-1,IL1-BETA,IL1F2;interleukin 1, beta
hsa:1610;DAO,DAAO,DAMOX,OXDA;D-amino-acid oxidase (EC:1.4.3.3)
hsa:7291;TWIST1,ACS3,BPES2,BPES3,CRS1,SCS,TWIST,bHLHa38;twist basic helix-loop-helix transcription factor 1
hsa:8741;TNFSF13,APRIL,CD256,TALL-2,TALL2,TRDL-1,ZTNF2;tumor necrosis factor (ligand) superfamily, member 13
hsa:999;CDH1,Arc-1,CD324,CDHE,ECAD,LCAM,UVO;cadherin 1, type 1, E-cadherin (epithelial)
hsa:5444;PON1,ESA,MVCD5,PON;paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81)
hsa:23420;NOMO1,Nomo,PM5;NODAL modulator 1
hsa:3375;IAPP,DAP,IAP;islet amyloid polypeptide
hsa:8493;PPM1D,PP2C-DELTA,WIP1;protein phosphatase, Mg2+/Mn2+ dependent, 1D (EC:3.1.3.16)
hsa:4069;LYZ,LZM;lysozyme (EC:3.2.1.17)
hsa:9314;KLF4,EZF,GKLF;Kruppel-like factor 4 (gut)
hsa:4318;MMP9,CLG4B,GELB,MANDP2,MMP-9;matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35)
hsa:5747;PTK2,FADK,FAK,FAK1,FRNK,PPP1R71,p125FAK,pp125FAK;protein tyrosine kinase 2 (EC:2.7.10.2)
hsa:5730;PTGDS,L-PGDS,LPGDS,PDS,PGD2,PGDS,PGDS2;prostaglandin D2 synthase 21kDa (brain) (EC:5.3.99.2)
hsa:3659;IRF1,IRF-1,MAR;interferon regulatory factor 1
hsa:54658;UGT1A1,BILIQTL1,GNT1,HUG-BR1,UDPGT,UDPGT_1-1,UGT1,UGT1A;UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17)
hsa:4938;OAS1,IFI-4,OIAS,OIASI;2'-5'-oligoadenylate synthetase 1, 40/46kDa (EC:2.7.7.-)
hsa:9572;NR1D1,EAR1,THRA1,THRAL,ear-1,hRev;nuclear receptor subfamily 1, group D, member 1
hsa:1965;EIF2S1,EIF-2,EIF-2A,EIF-2alpha,EIF2,EIF2A;eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
hsa:3032;HADHB,ECHB,MTPB,TP-BETA;hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit (EC:2.3.1.16)
hsa:83998;REG4,GISP,REG-IV,RELP;regenerating islet-derived family, member 4
hsa:6093;ROCK1,P160ROCK,ROCK-I;Rho-associated, coiled-coil containing protein kinase 1 (EC:2.7.11.1)
hsa:4153;MBL2,COLEC1,HSMBPC,MBL,MBL2D,MBP,MBP-C,MBP1,MBPD;mannose-binding lectin (protein C) 2, soluble
hsa:6405;SEMA3F,SEMA-IV,SEMA4,SEMAK;sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
hsa:27185;DISC1,C1orf136,SCZD9;disrupted in schizophrenia 1
hsa:4851;NOTCH1,TAN1,hN1;notch 1
hsa:2166;FAAH,FAAH-1;fatty acid amide hydrolase (EC:3.5.1.99)
hsa:1432;MAPK14,CSBP,CSBP1,CSBP2,CSPB1,EXIP,Mxi2,PRKM14,PRKM15,RK,SAPK2A,p38,p38ALPHA;mitogen-activated protein kinase 14 (EC:2.7.11.24)
hsa:2205;FCER1A,FCE1A,FcERI;Fc fragment of IgE, high affinity I, receptor for;alpha polypeptide
hsa:6670;SP3,SPR2;Sp3 transcription factor
hsa:1557;CYP2C19,CPCJ,CYP2C,P450C2C,P450IIC19;cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80)
hsa:2056;EPO,EP,MVCD2;erythropoietin
hsa:2700;GJA3,CX46,CZP3;gap junction protein, alpha 3, 46kDa
hsa:2194;FASN,FAS,OA-519,SDR27X1;fatty acid synthase (EC:2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 3.1.2.14 1.3.1.10 4.2.1.59 1.1.1.100)
hsa:214;ALCAM,CD166,MEMD;activated leukocyte cell adhesion molecule
hsa:9076;CLDN1,CLD1,ILVASC,SEMP1;claudin 1
hsa:64794;DDX31,PPP1R25;DEAD (Asp-Glu-Ala-Asp) box polypeptide 31 (EC:3.6.4.13)
hsa:5268;SERPINB5,PI5,maspin;serpin peptidase inhibitor, clade B (ovalbumin), member 5
hsa:7137;TNNI3,CMD1FF,CMD2A,CMH7,RCM1,TNNC1,cTnI;troponin I type 3 (cardiac)
hsa:3309;HSPA5,BIP,GRP78,MIF2;heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
hsa:27022;FOXD3,AIS1,Genesis,HFH2,VAMAS2;forkhead box D3
hsa:58480;RHOU,ARHU,CDC42L1,DJ646B12.2,WRCH1,fJ646B12.2,hG28K;ras homolog family member U
hsa:2561;GABRB2;gamma-aminobutyric acid (GABA) A receptor, beta 2
hsa:4869;NPM1,B23,NPM;nucleophosmin (nucleolar phosphoprotein B23, numatrin)
hsa:219699;UNC5B,UNC5H2,p53RDL1;unc-5 homolog B (C. elegans)
hsa:390;RND3,ARHE,Rho8,RhoE,memB;Rho family GTPase 3
hsa:5641;LGMN,AEP,LGMN1,PRSC1;legumain (EC:3.4.22.34)
hsa:1071;CETP,BPIFF,HDLCQ10;cholesteryl ester transfer protein, plasma
hsa:6929;TCF3,E2A,E47,ITF1,TCF-3,VDIR,bHLHb21;transcription factor 3
hsa:27429;HTRA2,OMI,PARK13,PRSS25;HtrA serine peptidase 2 (EC:3.4.21.108)
hsa:3956;LGALS1,GAL1,GBP;lectin, galactoside-binding, soluble, 1
hsa:221458;KIF6,C6orf102,dJ1043E3.1,dJ137F1.4,dJ188D3.1;kinesin family member 6
hsa:84687;PPP1R9B,PPP1R6,PPP1R9,SPINO,Spn;protein phosphatase 1, regulatory subunit 9B
hsa:7097;TLR2,CD282,TIL4;toll-like receptor 2
hsa:8314;BAP1,HUCEP-13,TPDS,UCHL2;BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (EC:3.4.19.12)
hsa:29123;ANKRD11,ANCO-1,ANCO1,LZ16,T13;ankyrin repeat domain 11
hsa:632;BGLAP,BGP,OC;bone gamma-carboxyglutamate (gla) protein
hsa:10125;RASGRP1,CALDAG-GEFI,CALDAG-GEFII,RASGRP,V,hRasGRP1;RAS guanyl releasing protein 1 (calcium and DAG-regulated)
hsa:4763;NF1,NFNS,VRNF,WSS;neurofibromin 1
hsa:10320;IKZF1,Hs.54452,IK1,IKAROS,LYF1,PRO0758,ZNFN1A1,hIk-1;IKAROS family zinc finger 1 (Ikaros)
hsa:9575;CLOCK,KAT13D,bHLHe8;clock circadian regulator (EC:2.3.1.48)
hsa:4160;MC4R;melanocortin 4 receptor
hsa:865;CBFB,PEBP2B;core-binding factor, beta subunit
hsa:27125;AFF4,AF5Q31,MCEF;AF4/FMR2 family, member 4
hsa:2707;GJB3,CX31,DFNA2,DFNA2B,EKV;gap junction protein, beta 3, 31kDa
hsa:85359;DGCR6L;DiGeorge syndrome critical region gene 6-like
hsa:51366;UBR5,DD5,EDD,EDD1,HYD;ubiquitin protein ligase E3 component n-recognin 5
hsa:64135;IFIH1,Hlcd,IDDM19,MDA-5,MDA5,RLR-2;interferon induced with helicase C domain 1 (EC:3.6.4.13)
hsa:4803;NGF,Beta-NGF,HSAN5,NGFB;nerve growth factor (beta polypeptide)
hsa:27067;STAU2,39K2,39K3;staufen, RNA binding protein, homolog 2 (Drosophila)
hsa:2068;ERCC2,COFS2,EM9,TTD,XPD;excision repair cross-complementing rodent repair deficiency, complementation group 2 (EC:3.6.4.12)
hsa:857;CAV1,BSCL3,CGL3,MSTP085,VIP21,CAV;caveolin 1, caveolae protein, 22kDa
hsa:81607;PVRL4,EDSS1,LNIR,PRR4,nectin-4;poliovirus receptor-related 4
hsa:6425;SFRP5,SARP3;secreted frizzled-related protein 5
hsa:1555;CYP2B6,CPB6,CYP2B,CYP2B7,CYP2B7P,CYPIIB6,EFVM,IIB1,P450;cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1)
hsa:54434;SSH1,SSH1L;slingshot protein phosphatase 1 (EC:3.1.3.16 3.1.3.48)
hsa:6608;SMO,FZD11,Gx,SMOH;smoothened, frizzled family receptor
hsa:3458;IFNG,IFG,IFI;interferon, gamma
hsa:2919;CXCL1,FSP,GRO1,GROa,MGSA,MGSA-a,NAP-3,SCYB1;chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
hsa:354;KLK3,APS,KLK2A1,PSA,hK3;kallikrein-related peptidase 3 (EC:3.4.21.77)
hsa:3557;IL1RN,DIRA,ICIL-1RA,IL-1RN,IL-1ra,IL-1ra3,IL1F3,IL1RA,IRAP,MVCD4;interleukin 1 receptor antagonist
hsa:10370;CITED2,ASD8,MRG-1,MRG1,P35SRJ,VSD2;Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
hsa:5311;PKD2,APKD2,PC2,PKD4,Pc-2,TRPP2;polycystic kidney disease 2 (autosomal dominant)
hsa:1236;CCR7,BLR2,CD197,CDw197,CMKBR7,EBI1;chemokine (C-C motif) receptor 7
hsa:13;AADAC,CES5A1,DAC;arylacetamide deacetylase (EC:3.1.1.3)
hsa:353376;TICAM2,MyD88-4,TICAM-2,TIRAP3,TIRP,TRAM;toll-like receptor adaptor molecule 2
hsa:2167;FABP4,A-FABP,AFABP,ALBP,aP2;fatty acid binding protein 4, adipocyte
hsa:54806;AHI1,AHI-1,JBTS3,ORF1,dJ71N10.1;Abelson helper integration site 1
hsa:5883;RAD9A,RAD9;RAD9 homolog A (S. pombe) (EC:3.1.11.2)
hsa:8536;CAMK1,CAMKI;calcium/calmodulin-dependent protein kinase I (EC:2.7.11.17)
hsa:1000;CDH2,CD325,CDHN,CDw325,NCAD;cadherin 2, type 1, N-cadherin (neuronal)
hsa:1572;CYP2F1,C2F1,CYP2F;cytochrome P450, family 2, subfamily F, polypeptide 1 (EC:1.14.14.1)
hsa:9361;LONP1,LON,LONP,LonHS,PIM1,PRSS15,hLON;lon peptidase 1, mitochondrial
hsa:627;BDNF,ANON2,BULN2;brain-derived neurotrophic factor
hsa:2100;ESR2,ER-BETA,ESR-BETA,ESRB,ESTRB,Erb,NR3A2;estrogen receptor 2 (ER beta)
hsa:9564;BCAR1,CAS,CAS1,CASS1,CRKAS,P130Cas;breast cancer anti-estrogen resistance 1
hsa:3756;KCNH1,EAG,EAG1,Kv10.1,h-eag;potassium voltage-gated channel, subfamily H (eag-related), member 1
hsa:3162;HMOX1,HMOX1D,HO-1,HSP32,bK286B10;heme oxygenase (decycling) 1 (EC:1.14.99.3)
hsa:2697;GJA1,AVSD3,CX43,DFNB38,GJAL,HLHS1,HSS,ODDD;gap junction protein, alpha 1, 43kDa
hsa:728;C5AR1,C5A,C5AR,C5R1,CD88;complement component 5a receptor 1
hsa:1906;EDN1,ET1,HDLCQ7,PPET1;endothelin 1
hsa:84159;ARID5B,DESRT,MRF-2,MRF2;AT rich interactive domain 5B (MRF1-like)
hsa:7424;VEGFC,Flt4-L,VRP;vascular endothelial growth factor C
hsa:5290;PIK3CA,CLOVE,CWS5,MCAP,MCM,MCMTC,PI3K,p110-alpha;phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153)
hsa:84891;ZSCAN10,ZNF206;zinc finger and SCAN domain containing 10
hsa:2876;GPX1,GPXD,GSHPX1;glutathione peroxidase 1 (EC:1.11.1.9)
hsa:1746;DLX2,TES-1,TES1;distal-less homeobox 2
hsa:3123;HLA-DRB1,DRB1,DRw10,HLA-DR1B,HLA-DRB,SS1;major histocompatibility complex, class II, DR beta 1
hsa:9622;KLK4,AI2A1,ARM1,EMSP,EMSP1,KLK-L1,PRSS17,PSTS,kallikrein;kallikrein-related peptidase 4
hsa:3640;INSL3,RLF,RLNL,ley-I-L;insulin-like 3 (Leydig cell)
hsa:84432;PROK1,EGVEGF,PK1,PRK1;prokineticin 1
hsa:26065;LSM14A,C19orf13,FAM61A,RAP55,RAP55A;LSM14A, SCD6 homolog A (S. cerevisiae)
hsa:3680;ITGA9,ALPHA-RLC,ITGA4L,RLC;integrin, alpha 9
hsa:5698;PSMB9,LMP2,PSMB6i,RING12,beta1i;proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) (EC:3.4.25.1)
hsa:7442;TRPV1,VR1;transient receptor potential cation channel, subfamily V, member 1
hsa:23547;LILRA4,CD85g,ILT7;leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4
hsa:4217;MAP3K5,ASK1,MAPKKK5,MEKK5;mitogen-activated protein kinase kinase kinase 5 (EC:2.7.11.25)
hsa:51119;SBDS,SDS,SWDS;Shwachman-Bodian-Diamond syndrome
hsa:9024;BRSK2,C11orf7,PEN11B,SAD1,STK29;BR serine/threonine kinase 2 (EC:2.7.11.1 2.7.11.26)
hsa:9031;BAZ1B,WBSCR10,WBSCR9,WSTF;bromodomain adjacent to zinc finger domain, 1B (EC:2.7.10.2)
hsa:1312;COMT;catechol-O-methyltransferase (EC:2.1.1.6)
hsa:177;AGER,RAGE;advanced glycosylation end product-specific receptor
hsa:6446;SGK1,SGK;serum/glucocorticoid regulated kinase 1 (EC:2.7.11.1)
hsa:5531;PPP4C,PP4,PP4C,PPH3,PPP4,PPX;protein phosphatase 4, catalytic subunit (EC:3.1.3.16)
hsa:3359;HTR3A,5-HT-3,5-HT3A,5-HT3R,5HT3R,HTR3;5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
hsa:23;ABCF1,ABC27,ABC50;ATP-binding cassette, sub-family F (GCN20), member 1
hsa:11013;TMSB15A,TMSB15,TMSB15B,TMSL8,TMSNB,Tb15,TbNB;thymosin beta 15a
hsa:50943;FOXP3,AIID,DIETER,IPEX,PIDX,XPID;forkhead box P3
hsa:114548;NLRP3,AGTAVPRL,AII,AVP,C1orf7,CIAS1,CLR1.1,FCAS,FCU,MWS,NALP3,PYPAF1;NLR family, pyrin domain containing 3
hsa:26090;ABHD12,ABHD12A,BEM46L2,C20orf22,PHARC,dJ965G21.2;abhydrolase domain containing 12 (EC:3.1.1.23)
hsa:143503;OR51E1,D-GPCR,GPR136,GPR164,OR51E1P,OR52A3P,POGR,PSGR2;olfactory receptor, family 51, subfamily E, member 1
hsa:9612;NCOR2,CTG26,N-CoR2,SMAP270,SMRT,SMRTE,SMRTE-tau,TNRC14,TRAC,TRAC-1,TRAC1;nuclear receptor corepressor 2
hsa:89884;LHX4,CPHD4;LIM homeobox 4
hsa:10747;MASP2,MAP19,MASP-2,MASP1P1,sMAP;mannan-binding lectin serine peptidase 2 (EC:3.4.21.104)
hsa:4940;OAS3,p100;2'-5'-oligoadenylate synthetase 3, 100kDa
hsa:10015;PDCD6IP,AIP1,ALIX,DRIP4,HP95;programmed cell death 6 interacting protein
hsa:1604;CD55,CR,CROM,DAF,TC;CD55 molecule, decay accelerating factor for complement (Cromer blood group)
hsa:9794;MAML1,Mam-1,Mam1;mastermind-like 1 (Drosophila)
hsa:10344;CCL26,IMAC,MIP-4a,MIP-4alpha,SCYA26,TSC-1;chemokine (C-C motif) ligand 26
hsa:3383;ICAM1,BB2,CD54,P3.58;intercellular adhesion molecule 1
hsa:1268;CNR1,CANN6,CB-R,CB1,CB1A,CB1K5,CB1R,CNR;cannabinoid receptor 1 (brain)
hsa:1902;LPAR1,EDG2,GPR26,Gpcr26,LPA1,Mrec1.3,VZG1,edg-2,rec.1.3,vzg-1;lysophosphatidic acid receptor 1
hsa:4502;MT2A,MT2;metallothionein 2A
hsa:7472;WNT2,INT1L1,IRP;wingless-type MMTV integration site family member 2
hsa:6768;ST14,HAI,MT-SP1,MTSP1,PRSS14,SNC19,TADG15,TMPRSS14;suppression of tumorigenicity 14 (colon carcinoma) (EC:3.4.21.109)
hsa:3952;LEP,LEPD,OB,OBS;leptin
hsa:3791;KDR,CD309,FLK1,VEGFR,VEGFR2;kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1)
hsa:23410;SIRT3,SIR2L3;sirtuin 3
hsa:2668;GDNF,ATF1,ATF2,HFB1-GDNF,HSCR3;glial cell derived neurotrophic factor
hsa:4846;NOS3,ECNOS,eNOS;nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39)
hsa:56979;PRDM9,MEISETZ,MSBP3,PFM6,PRMD9,ZNF899;PR domain containing 9 (EC:2.1.1.43)
hsa:6695;SPOCK1,SPOCK,TESTICAN,TIC1;sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1
hsa:2645;GCK,FGQTL3,GK,GLK,HHF3,HK4,HKIV,HXKP,LGLK,MODY2;glucokinase (hexokinase 4) (EC:2.7.1.2)
hsa:4853;NOTCH2,AGS2,HJCYS,hN2;notch 2
hsa:4548;MTR,MS,cblG;5-methyltetrahydrofolate-homocysteine methyltransferase (EC:2.1.1.13)
hsa:6662;SOX9,CMD1,CMPD1,SRA1;SRY (sex determining region Y)-box 9
hsa:8214;DGCR6;DiGeorge syndrome critical region gene 6
hsa:6612;SUMO3,SMT3A,SMT3H1,SUMO-3,Smt3B;SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae)
hsa:116085;SLC22A12,OAT4L,RST,URAT1;solute carrier family 22 (organic anion/urate transporter), member 12
hsa:8519;IFITM1,9-27,CD225,DSPA2a,IFI17,LEU13;interferon induced transmembrane protein 1
hsa:842;CASP9,APAF-3,APAF3,CASPASE-9c,ICE-LAP6,MCH6,PPP1R56;caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62)
hsa:10644;IGF2BP2,IMP-2,IMP2,VICKZ2,p62;insulin-like growth factor 2 mRNA binding protein 2
hsa:29881;NPC1L1,NPC11L1;NPC1-like 1
hsa:3172;HNF4A,HNF4,HNF4a7,HNF4a8,HNF4a9,HNF4alpha,MODY,MODY1,NR2A1,NR2A21,TCF,TCF14;hepatocyte nuclear factor 4, alpha
hsa:4204;MECP2,AUTSX3,MRX16,MRX79,MRXS13,MRXSL,PPMX,RS,RTS,RTT;methyl CpG binding protein 2 (Rett syndrome)
hsa:718;C3,AHUS5,ARMD9,ASP,C3a,C3b,CPAMD1;complement component 3 (EC:3.4.21.43)
hsa:1317;SLC31A1,COPT1,CTR1;solute carrier family 31 (copper transporters), member 1
hsa:1736;DKC1,CBF5,DKC,DKCX,NAP57,NOLA4,XAP101;dyskeratosis congenita 1, dyskerin
hsa:7421;VDR,NR1I1;vitamin D (1,25- dihydroxyvitamin D3) receptor
hsa:595;CCND1,BCL1,D11S287E,PRAD1,U21B31;cyclin D1
hsa:114609;TIRAP,BACTS1,Mal,MyD88-2,wyatt;toll-interleukin 1 receptor (TIR) domain containing adaptor protein
hsa:4221;MEN1,MEAI,SCG2;multiple endocrine neoplasia I
hsa:7474;WNT5A,hWNT5A;wingless-type MMTV integration site family, member 5A
hsa:648;BMI1,FLVI2/BMI1,PCGF4,RNF51;BMI1 polycomb ring finger oncogene
hsa:6925;TCF4,E2-2,ITF-2,ITF2,PTHS,SEF-2,SEF2,SEF2-1,SEF2-1A,SEF2-1B,TCF-4,bHLHb19;transcription factor 4
hsa:5579;PRKCB,PKC-beta,PKCB,PRKCB1,PRKCB2;protein kinase C, beta (EC:2.7.11.13)
hsa:6195;RPS6KA1,HU-1,MAPKAPK1A,RSK,RSK1;ribosomal protein S6 kinase, 90kDa, polypeptide 1 (EC:2.7.11.1)
hsa:814;CAMK4,CaMK_IV,CaMK-GR,IV,caMK;calcium/calmodulin-dependent protein kinase IV (EC:2.7.11.17)
hsa:29116;MYLIP,IDOL,MIR;myosin regulatory light chain interacting protein (EC:6.3.2.-)
hsa:207;AKT1,AKT,CWS6,PKB,PKB-ALPHA,PRKBA,RAC,RAC-ALPHA;v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1)
hsa:23020;SNRNP200,ASCC3L1,BRR2,HELIC2,RP33,U5-200KD;small nuclear ribonucleoprotein 200kDa (U5) (EC:3.6.4.13)
hsa:54890;ALKBH5,ABH5,OFOXD,OFOXD1;alkB, alkylation repair homolog 5 (E. coli)
hsa:5315;PKM,CTHBP,OIP3,PK3,PKM2,TCB,THBP1;pyruvate kinase, muscle (EC:2.7.1.40)
hsa:3558;IL2,IL-2,TCGF,lymphokine;interleukin 2
hsa:29108;PYCARD,ASC,CARD5,TMS,TMS-1,TMS1;PYD and CARD domain containing
hsa:2078;ERG,erg-3,p55;v-ets erythroblastosis virus E26 oncogene homolog (avian)
hsa:9370;ADIPOQ,ACDC,ACRP30,ADIPQTL1,ADPN,APM-1,APM1,GBP28;adiponectin, C1Q and collagen domain containing
hsa:2925;GRPR;gastrin-releasing peptide receptor
hsa:57111;RAB25,CATX-8,RAB11C;RAB25, member RAS oncogene family
hsa:3735;KARS,CMTRIB,KARS1,KARS2,KRS;lysyl-tRNA synthetase (EC:6.1.1.6)
hsa:1958;EGR1,AT225,G0S30,KROX-24,NGFI-A,TIS8,ZIF-268,ZNF225;early growth response 1
hsa:9407;TMPRSS11D,HAT;transmembrane protease, serine 11D
hsa:1571;CYP2E1,CPE1,CYP2E,P450-J,P450C2E;cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7)
hsa:5155;PDGFB,PDGF-2,PDGF2,SIS,SSV,c-sis;platelet-derived growth factor beta polypeptide
hsa:8473;OGT,HRNT1,O-GLCNAC;O-linked N-acetylglucosamine (GlcNAc) transferase (EC:2.4.1.255)
hsa:2798;GNRHR,GNRHR1,GRHR,HH7,LHRHR,LRHR;gonadotropin-releasing hormone receptor
hsa:79068;FTO;fat mass and obesity associated
hsa:9961;MVP,LRP,VAULT1;major vault protein
hsa:10891;PPARGC1A,LEM6,PGC-1(alpha),PGC-1v,PGC1,PGC1A,PPARGC1;peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
hsa:9241;NOG,SYM1,SYNS1;noggin
hsa:7295;TXN,TRDX,TRX,TRX1;thioredoxin
hsa:4319;MMP10,SL-2,STMY2;matrix metallopeptidase 10 (stromelysin 2) (EC:3.4.24.22)
hsa:54790;TET2,KIAA1546,MDS;tet methylcytosine dioxygenase 2 (EC:1.14.11.n2)
hsa:796;CALCA,CALC1,CGRP,CGRP-I,CGRP1,CT,KC;calcitonin-related polypeptide alpha
hsa:4893;NRAS,ALPS4,N-ras,NRAS1,NS6;neuroblastoma RAS viral (v-ras) oncogene homolog
hsa:10146;G3BP1,G3BP,HDH-VIII;GTPase activating protein (SH3 domain) binding protein 1 (EC:3.6.4.13 3.6.4.12)
hsa:5920;RARRES3,HRASLS4,HRSL4,PLA1/2-3,RIG1,TIG3;retinoic acid receptor responder (tazarotene induced) 3
hsa:91574;C12orf65,COXPD7,SPG55;chromosome 12 open reading frame 65
hsa:6041;RNASEL,PRCA1,RNS4;ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) (EC:3.1.26.- 3.1.27.-)
hsa:3062;HCRTR2,OX2R;hypocretin (orexin) receptor 2
hsa:8784;TNFRSF18,AITR,CD357,GITR,GITR-D;tumor necrosis factor receptor superfamily, member 18
hsa:7099;TLR4,ARMD10,CD284,TLR-4,TOLL;toll-like receptor 4
hsa:1576;CYP3A4,CP33,CP34,CYP3A,CYP3A3,CYPIIIA3,CYPIIIA4,HLP,NF-25,P450C3,P450PCN1;cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157)
hsa:3810;KIR2DS5,CD158G,NKAT9;killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
hsa:174;AFP,FETA,HPAFP;alpha-fetoprotein
hsa:8863;PER3,GIG13;period circadian clock 3
hsa:1825;DSC3,CDHF3,DSC,DSC1,DSC2,DSC4,HT-CP;desmocollin 3
hsa:81494;CFHR5,CFHL5,CFHR5D,FHR-5,FHR5;complement factor H-related 5
hsa:1500;CTNND1,CAS,CTNND,P120CAS,P120CTN,p120,p120(CAS),p120(CTN);catenin (cadherin-associated protein), delta 1
hsa:4771;NF2,ACN,BANF,SCH;neurofibromin 2 (merlin)
hsa:1474;CST6;cystatin E/M
hsa:340061;TMEM173,ERIS,MITA,MPYS,NET23,STING;transmembrane protein 173
hsa:7376;NR1H2,LXR-b,LXRB,NER,NER-I,RIP15,UNR;nuclear receptor subfamily 1, group H, member 2
hsa:4089;SMAD4,DPC4,JIP,MADH4,MYHRS;SMAD family member 4
hsa:7003;TEAD1,AA,NTEF-1,REF1,TCF-13,TCF13,TEAD-1,TEF-1;TEA domain family member 1 (SV40 transcriptional enhancer factor)
hsa:23522;KAT6B,GTPTS,MORF,MOZ2,MYST4,ZC2HC6B,qkf,querkopf;K(lysine) acetyltransferase 6B (EC:2.3.1.48)
hsa:181;AGRP,AGRT,ART,ASIP2;agouti related protein homolog (mouse)
hsa:7450;VWF,F8VWF,VWD;von Willebrand factor
hsa:6095;RORA,NR1F1,ROR1,ROR2,ROR3,RZR-ALPHA,RZRA;RAR-related orphan receptor A
hsa:10802;SEC24A;SEC24 family, member A (S. cerevisiae)
hsa:6401;SELE,CD62E,ELAM,ELAM1,ESEL,LECAM2;selectin E
hsa:2950;GSTP1,DFN7,FAEES3,GST3,GSTP,PI;glutathione S-transferase pi 1 (EC:2.5.1.18)
hsa:9595;CYTIP,B3-1,CASP,CYBR,CYTHIP,HE,PSCDBP;cytohesin 1 interacting protein
hsa:6314;ATXN7,ADCAII,OPCA3,SCA7;ataxin 7
hsa:7430;EZR,CVIL,CVL,VIL2;ezrin
hsa:4976;OPA1,MGM1,NPG,NTG,largeG;optic atrophy 1 (autosomal dominant) (EC:3.6.5.5)
hsa:4179;CD46,AHUS2,MCP,MIC10,TLX,TRA2.10;CD46 molecule, complement regulatory protein
hsa:8115;TCL1A,TCL1;T-cell leukemia/lymphoma 1A
hsa:1021;CDK6,PLSTIRE;cyclin-dependent kinase 6 (EC:2.7.11.22)
hsa:5649;RELN,LIS2,PRO1598,RL;reelin
hsa:5806;PTX3,TNFAIP5,TSG-14;pentraxin 3, long
hsa:7534;YWHAZ,14-3-3-zeta,KCIP-1,YWHAD;tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
hsa:10232;MSLN,MPF,SMRP;mesothelin
hsa:6240;RRM1,R1,RIR1,RR1;ribonucleotide reductase M1 (EC:1.17.4.1)
hsa:79172;CENPO,CENP-O,ICEN-36,MCM21R;centromere protein O
hsa:1020;CDK5,PSSALRE;cyclin-dependent kinase 5 (EC:2.7.11.22)
hsa:55662;HIF1AN,FIH1;hypoxia inducible factor 1, alpha subunit inhibitor (EC:1.14.11.30 1.14.11.n4)
hsa:3075;CFH,AHUS1,AMBP1,ARMD4,ARMS1,CFHL3,FH,FHL1,HF,HF1,HF2,HUS;complement factor H (EC:4.2.1.2)
hsa:3938;LCT,LAC,LPH,LPH1;lactase (EC:3.2.1.108 3.2.1.62)
hsa:5591;PRKDC,DNA-PKcs,DNAPK,DNPK1,HYRC,HYRC1,XRCC7,p350;protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1)
hsa:29102;DROSHA,ETOHI2,HSA242976,RANSE3L,RN3,RNASE3L,RNASEN;drosha, ribonuclease type III (EC:3.1.26.3)
hsa:8450;CUL4B,MRXHF2,MRXS15,MRXSC,SFM2;cullin 4B
hsa:10;NAT2,AAC2,NAT-2,PNAT;N-acetyltransferase 2 (arylamine N-acetyltransferase) (EC:2.3.1.5)
hsa:3456;IFNB1,IFB,IFF,IFNB;interferon, beta 1, fibroblast
hsa:1081;CGA,CG-ALPHA,FSHA,GPHA1,GPHa,HCG,LHA,TSHA;glycoprotein hormones, alpha polypeptide
hsa:10901;DHRS4,CR,NRDR,PHCR,PSCD,SCAD-SRL,SDR-SRL,SDR25C1,SDR25C2;dehydrogenase/reductase (SDR family) member 4 (EC:1.1.1.184)
hsa:388581;FAM132A,C1QDC2,C1QTNF12,CTRP12;family with sequence similarity 132, member A
hsa:7350;UCP1,SLC25A7,UCP;uncoupling protein 1 (mitochondrial, proton carrier)
hsa:9368;SLC9A3R1,EBP50,NHERF,NHERF-1,NHERF1,NPHLOP2;solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
hsa:5007;OSBP,OSBP1;oxysterol binding protein
hsa:60489;APOBEC3G,ARCD,ARP-9,ARP9,CEM-15,CEM15,bK150C2.7,dJ494G10.1;apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (EC:3.5.4.14)
hsa:9369;NRXN3,C14orf60;neurexin 3
hsa:6154;RPL26,DBA11,L26;ribosomal protein L26
hsa:4113;MAGEB2,CT3.2,DAM6,MAGE-XP-2;melanoma antigen family B, 2
hsa:3145;HMBS,PBG-D,PBGD,PORC,UPS;hydroxymethylbilane synthase (EC:2.5.1.61)
hsa:1938;EEF2,EEF-2,EF-2,EF2;eukaryotic translation elongation factor 2
hsa:3687;ITGAX,CD11C,SLEB6;integrin, alpha X (complement component 3 receptor 4 subunit)
hsa:9177;HTR3B,5-HT3B;5-hydroxytryptamine (serotonin) receptor 3B, ionotropic
hsa:79682;MLF1IP,CENP50,CENPU,CENPU50,KLIP1,PBIP1;MLF1 interacting protein
hsa:7514;XPO1,CRM1,emb,exp1;exportin 1 (CRM1 homolog, yeast)
hsa:931;MS4A1,B1,Bp35,CD20,CVID5,LEU-16,MS4A2,S7;membrane-spanning 4-domains, subfamily A, member 1
hsa:8837;CFLAR,CASH,CASP8AP1,CLARP,Casper,FLAME,FLAME-1,FLAME1,FLIP,I-FLICE,MRIT,c-FLIP,c-FLIPL,c-FLIPR,c-FLIPS;CASP8 and FADD-like apoptosis regulator
hsa:387;RHOA,ARH12,ARHA,RHO12,RHOH12;ras homolog family member A
hsa:2488;FSHB;follicle stimulating hormone, beta polypeptide
hsa:2153;F5,FVL,PCCF,RPRGL1,THPH2;coagulation factor V (proaccelerin, labile factor)
hsa:5580;PRKCD,MAY1,PKCD,nPKC-delta;protein kinase C, delta (EC:2.7.10.2 2.7.11.13)
hsa:1591;CYP24A1,CP24,CYP24,HCAI,P450-CC24;cytochrome P450, family 24, subfamily A, polypeptide 1 (EC:1.14.13.126)
hsa:11186;RASSF1,123F2,NORE2A,RASSF1A,RDA32,REH3P21;Ras association (RalGDS/AF-6) domain family member 1
hsa:4862;NPAS2,MOP4,PASD4,bHLHe9;neuronal PAS domain protein 2
hsa:55788;LMBRD1,C6orf209,LMBD1,MAHCF,NESI;LMBR1 domain containing 1
hsa:7852;CXCR4,CD184,D2S201E,FB22,HM89,HSY3RR,LAP3,LCR1,LESTR,NPY3R,NPYR,NPYRL,NPYY3R,WHIM;chemokine (C-X-C motif) receptor 4
hsa:5648;MASP1,3MC1,CRARF,CRARF1,MAP1,MASP,MASP3,MAp44,PRSS5,RaRF;mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) (EC:3.4.21.-)
hsa:1017;CDK2,p33(CDK2);cyclin-dependent kinase 2 (EC:2.7.11.22)
hsa:79444;BIRC7,KIAP,LIVIN,ML-IAP,MLIAP,RNF50;baculoviral IAP repeat containing 7
hsa:25;ABL1,ABL,JTK7,bcr/abl,c-ABL,p150,v-abl;c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2)
hsa:10919;EHMT2,BAT8,C6orf30,G9A,GAT8,KMT1C,NG36;euchromatic histone-lysine N-methyltransferase 2 (EC:2.1.1.43)
hsa:58;ACTA1,ACTA,ASMA,CFTD,CFTD1,CFTDM,MPFD,NEM1,NEM2,NEM3;actin, alpha 1, skeletal muscle
hsa:285335;SLC9C1,NHE,SLC9A10,sperm-NHE;solute carrier family 9, subfamily C (Na+-transporting carboxylic acid decarboxylase), member 1
hsa:717;C2,CO2;complement component 2 (EC:3.4.21.43)
hsa:5058;PAK1,PAKalpha;p21 protein (Cdc42/Rac)-activated kinase 1 (EC:2.7.11.1)
hsa:345611;IRGM,IFI1,IRGM1,LRG-47,LRG47;immunity-related GTPase family, M
hsa:6047;RNF4,SLX5,SNURF;ring finger protein 4
hsa:6010;RHO,CSNBAD1,OPN2,RP4;rhodopsin
hsa:4157;MC1R,CMM5,MSH-R,SHEP2;melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
hsa:2018;EMX2;empty spiracles homeobox 2
hsa:56616;DIABLO,DFNA64,DIABLO-S,SMAC,SMAC3;diablo, IAP-binding mitochondrial protein
hsa:1745;DLX1;distal-less homeobox 1
hsa:8744;TNFSF9,4-1BB-L,CD137L;tumor necrosis factor (ligand) superfamily, member 9
hsa:10481;HOXB13,PSGD;homeobox B13
hsa:7341;SUMO1,DAP1,GMP1,OFC10,PIC1,SENP2,SMT3,SMT3C,SMT3H3,UBL1;SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae)
hsa:8864;PER2,FASPS;period circadian clock 2
hsa:84171;LOXL4,LOXC;lysyl oxidase-like 4
hsa:7139;TNNT2,CMH2,CMPD2,LVNC6,RCM3,TnTC,cTnT;troponin T type 2 (cardiac)
hsa:3624;INHBA,EDF,FRP;inhibin, beta A
hsa:56729;RETN,ADSF,FIZZ3,RETN1,RSTN,XCP1;resistin
hsa:1956;EGFR,ERBB,ERBB1,HER1,PIG61,mENA;epidermal growth factor receptor (EC:2.7.10.1)
hsa:4772;NFATC1,NF-ATC,NFAT2,NFATc;nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
hsa:3091;HIF1A,HIF-1A,HIF-1alpha,HIF1,HIF1-ALPHA,MOP1,PASD8,bHLHe78;hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
hsa:5786;PTPRA,HEPTP,HLPR,HPTPA,HPTPalpha,LRP,PTPA,PTPRL2,R-PTP-alpha,RPTPA;protein tyrosine phosphatase, receptor type, A (EC:3.1.3.48)
hsa:8678;BECN1,ATG6,VPS30,beclin1;beclin 1, autophagy related
hsa:9817;KEAP1,INrf2,KLHL19;kelch-like ECH-associated protein 1
hsa:5595;MAPK3,ERK-1,ERK1,ERT2,HS44KDAP,HUMKER1A,P44ERK1,P44MAPK,PRKM3,p44-ERK1,p44-MAPK;mitogen-activated protein kinase 3 (EC:2.7.11.24)
hsa:26985;AP3M1;adaptor-related protein complex 3, mu 1 subunit
hsa:4968;OGG1,HMMH,HOGG1,MUTM,OGH1;8-oxoguanine DNA glycosylase (EC:4.2.99.18)
hsa:3663;IRF5,SLEB10;interferon regulatory factor 5
hsa:3276;PRMT1,ANM1,HCP1,HRMT1L2,IR1B4;protein arginine methyltransferase 1 (EC:2.1.1.125)
hsa:80381;CD276,4Ig-B7-H3,B7-H3,B7H3,B7RP-2;CD276 molecule
hsa:478;ATP1A3,AHC2,DYT12,RDP;ATPase, Na+/K+ transporting, alpha 3 polypeptide (EC:3.6.3.9)
hsa:55249;YY1AP1,HCCA1,HCCA2,YAP,YY1AP;YY1 associated protein 1
hsa:5563;PRKAA2,AMPK,AMPK2,AMPKa2,PRKAA;protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31)
hsa:2932;GSK3B;glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26)
hsa:3809;KIR2DS4,CD158I,KIR1D,KIR412,KKA3,NKAT8;killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
hsa:6558;SLC12A2,BSC,BSC2,NKCC1;solute carrier family 12 (sodium/potassium/chloride transporters), member 2
hsa:2312;FLG,ATOD2;filaggrin
hsa:1589;CYP21A2,CA21H,CAH1,CPS1,CYP21,CYP21B,P450c21B;cytochrome P450, family 21, subfamily A, polypeptide 2 (EC:1.14.99.10)
hsa:655;BMP7,OP-1;bone morphogenetic protein 7
hsa:10544;PROCR,CCCA,CCD41,CD201,EPCR;protein C receptor, endothelial
hsa:6776;STAT5A,MGF,STAT5;signal transducer and activator of transcription 5A
hsa:27329;ANGPTL3,ANG-5,ANGPT5,ANL3,FHBL2;angiopoietin-like 3
hsa:3945;LDHB,LDH-B,LDH-H,LDHBD,TRG-5;lactate dehydrogenase B (EC:1.1.1.27)
hsa:7874;USP7,HAUSP,TEF1;ubiquitin specific peptidase 7 (herpes virus-associated) (EC:3.4.19.12)
hsa:488;ATP2A2,ATP2B,DAR,DD,SERCA2;ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (EC:3.6.3.8)
hsa:1111;CHEK1,CHK1;checkpoint kinase 1 (EC:2.7.11.1)
hsa:401541;CENPP,CENP-P;centromere protein P
hsa:5265;SERPINA1,A1A,A1AT,AAT,PI,PI1,PRO2275,alpha1AT;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
hsa:9074;CLDN6;claudin 6
hsa:3082;HGF,DFNB39,F-TCF,HGFB,HPTA,SF;hepatocyte growth factor (hepapoietin A;scatter factor)
hsa:8074;FGF23,ADHR,FGFN,HPDR2,HYPF,PHPTC;fibroblast growth factor 23
hsa:10399;GNB2L1,Gnb2-rs1,H12.3,HLC-7,PIG21,RACK1;guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
hsa:2147;F2,PT,RPRGL2,THPH1;coagulation factor II (thrombin) (EC:3.4.21.5)
hsa:747;DAGLA,C11orf11,DAGL(ALPHA),DAGLALPHA,NSDDR;diacylglycerol lipase, alpha (EC:3.1.1.-)
hsa:4499;MT1M,MT-1M,MT-IM,MT1,MT1K;metallothionein 1M
hsa:4843;NOS2,HEP-NOS,INOS,NOS,NOS2A;nitric oxide synthase 2, inducible (EC:1.14.13.39)
hsa:406;ARNTL,BMAL1,BMAL1c,JAP3,MOP3,PASD3,TIC,bHLHe5;aryl hydrocarbon receptor nuclear translocator-like
hsa:1369;CPN1,CPN,SCPN;carboxypeptidase N, polypeptide 1 (EC:3.4.17.3)
hsa:7015;TERT,DKCA2,DKCB4,EST2,PFBMFT1,TCS1,TP2,TRT,hEST2,hTRT;telomerase reverse transcriptase (EC:2.7.7.49)
hsa:5430;POLR2A,POLR2,POLRA,RPB1,RPBh1,RPO2,RPOL2,RpIILS,hRPB220,hsRPB1;polymerase (RNA) II (DNA directed) polypeptide A, 220kDa (EC:2.7.7.6 2.7.7.48)
hsa:21;ABCA3,ABC-C,ABC3,EST111653,LBM180,SMDP3;ATP-binding cassette, sub-family A (ABC1), member 3
hsa:27123;DKK2,DKK-2;dickkopf 2 homolog (Xenopus laevis)
hsa:2114;ETS2,ETS2IT1;v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)
hsa:1409;CRYAA,CRYA1,HSPB4;crystallin, alpha A
hsa:3949;LDLR,FH,FHC,LDLCQ2;low density lipoprotein receptor
hsa:50486;G0S2,RP1-28O10.2;G0/G1switch 2
hsa:11218;DDX20,DP103,GEMIN3;DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 (EC:3.6.4.13)
hsa:29948;OSGIN1,BDGI,OKL38;oxidative stress induced growth inhibitor 1
hsa:367;AR,AIS,DHTR,HUMARA,HYSP1,KD,NR3C4,SBMA,SMAX1,TFM;androgen receptor
hsa:26762;HAVCR1,HAVCR,HAVCR-1,KIM-1,KIM1,TIM,TIM-1,TIM1,TIMD-1,TIMD1;hepatitis A virus cellular receptor 1
hsa:6622;SNCA,NACP,PARK1,PARK4,PD1;synuclein, alpha (non A4 component of amyloid precursor)
hsa:22943;DKK1,DKK-1,SK;dickkopf 1 homolog (Xenopus laevis)
hsa:598;BCL2L1,BCL-XL/S,BCL2L,BCLX,BCLXL,BCLXS,Bcl-X,PPP1R52,bcl-xL,bcl-xS;BCL2-like 1
hsa:3149;HMGB3,HMG-2a,HMG-4,HMG2A,HMG4;high mobility group box 3
hsa:1813;DRD2,D2DR,D2R;dopamine receptor D2
hsa:3973;LHCGR,HHG,LCGR,LGR2,LH/CG-R,LH/CGR,LHR,LHRHR,LSH-R,ULG5;luteinizing hormone/choriogonadotropin receptor
hsa:8165;AKAP1,AKAP,AKAP121,AKAP149,AKAP84,D-AKAP1,PPP1R43,PRKA1,SAKAP84,TDRD17;A kinase (PRKA) anchor protein 1
hsa:1786;DNMT1,AIM,CXXC9,DNMT,HSN1E,MCMT;DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37)
hsa:1959;EGR2,AT591,CMT1D,CMT4E,KROX20;early growth response 2
hsa:7466;WFS1,WFRS,WFS,WFSL,DFNA6,DFNA14,DFNA38;Wolfram syndrome 1 (wolframin)
hsa:5594;MAPK1,ERK,ERK2,ERT1,MAPK2,P42MAPK,PRKM1,PRKM2,p38,p40,p41,p41mapk;mitogen-activated protein kinase 1 (EC:2.7.11.24)
hsa:3481;IGF2,C11orf43,IGF-II,PP9974;insulin-like growth factor 2 (somatomedin A)
hsa:5015;OTX2,CPHD6,MCOPS5;orthodenticle homeobox 2
hsa:7941;PLA2G7,LDL-PLA2,LP-PLA2,PAFAD,PAFAH;phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (EC:3.1.1.47)
hsa:6197;RPS6KA3,CLS,HU-3,ISPK-1,MAPKAPK1B,MRX19,RSK,RSK2,S6K-alpha3,p90-RSK2,pp90RSK2;ribosomal protein S6 kinase, 90kDa, polypeptide 3 (EC:2.7.11.1)
hsa:3992;FADS1,D5D,FADS6,FADSD5,LLCDL1,TU12;fatty acid desaturase 1 (EC:1.14.19.-)
hsa:7431;VIM;vimentin
hsa:8633;UNC5C,UNC5H3;unc-5 homolog C (C. elegans)
hsa:6418;SET,2PP2A,I2PP2A,IGAAD,IPP2A2,PHAPII,TAF-I,TAF-IBETA;SET nuclear oncogene
hsa:6817;SULT1A1,HAST1/HAST2,P-PST,PST,ST1A1,ST1A3,STP,STP1,TSPST1;sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1)
hsa:10848;PPP1R13L,IASPP,NKIP1,RAI,RAI4;protein phosphatase 1, regulatory subunit 13 like
hsa:760;CA2,CA-II,CAC,CAII,Car2;carbonic anhydrase II (EC:4.2.1.1)
hsa:472;ATM,AT1,ATA,ATC,ATD,ATDC,ATE,TEL1,TELO1;ataxia telangiectasia mutated (EC:2.7.11.1)
hsa:387893;SETD8,KMT5A,PR-Set7,SET07,SET8;SET domain containing (lysine methyltransferase) 8 (EC:2.1.1.43)
hsa:2643;GCH1,DYT14,DYT5,DYT5a,GCH,GTP-CH-1,GTPCH1,HPABH4B;GTP cyclohydrolase 1 (EC:3.5.4.16)
hsa:5976;UPF1,HUPF1,NORF1,RENT1,pNORF1,smg-2;UPF1 regulator of nonsense transcripts homolog (yeast)
hsa:166968;MIER3;mesoderm induction early response 1, family member 3
hsa:6426;SRSF1,ASF,SF2,SF2p33,SFRS1,SRp30a;serine/arginine-rich splicing factor 1
hsa:6262;RYR2,ARVC2,ARVD2,RYR-2,RyR,VTSIP;ryanodine receptor 2 (cardiac)
hsa:93129;ORAI3,TMEM142C;ORAI calcium release-activated calcium modulator 3
hsa:6319;SCD,FADS5,MSTP008,SCD1,SCDOS;stearoyl-CoA desaturase (delta-9-desaturase) (EC:1.14.19.1)
hsa:2350;FOLR2,BETA-HFR,FBP,FBP/PL-1,FR-BETA,FR-P3;folate receptor 2 (fetal)
hsa:5764;PTN,HARP,HBGF8,HBNF,NEGF1;pleiotrophin
hsa:4174;MCM5,CDC46,P1-CDC46;minichromosome maintenance complex component 5 (EC:3.6.4.12)
hsa:201163;FLCN,BHD,FLCL;folliculin
hsa:23368;PPP1R13B,ASPP1,p53BP2-like,p85;protein phosphatase 1, regulatory subunit 13B
hsa:578;BAK1,BAK,BAK-LIKE,BCL2L7,CDN1;BCL2-antagonist/killer 1
hsa:2099;ESR1,ER,ESR,ESRA,Era,NR3A1;estrogen receptor 1
hsa:79577;CDC73,C1orf28,HPTJT,HRPT2,HYX;cell division cycle 73
hsa:6790;AURKA,AIK,ARK1,AURA,AURORA2,BTAK,PPP1R47,STK15,STK6,STK7;aurora kinase A (EC:2.7.11.1)
hsa:7019;TFAM,MTTF1,MTTFA,TCF6,TCF6L1,TCF6L2,TCF6L3;transcription factor A, mitochondrial
hsa:3858;KRT10,BCIE,BIE,CK10,EHK,K10,KPP;keratin 10
hsa:3972;LHB,CGB4,LSH-B,hLHB;luteinizing hormone beta polypeptide
hsa:142;PARP1,ADPRT,ADPRT_1,ADPRT1,ARTD1,PARP,PARP-1,PPOL,pADPRT-1;poly (ADP-ribose) polymerase 1 (EC:2.4.2.30)
hsa:284217;LAMA1,LAMA,S-LAM-alpha;laminin, alpha 1
hsa:4313;MMP2,CLG4,CLG4A,MMP-II,MONA,TBE-1;matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24)
hsa:474;ATOH1,ATH1,HATH1,MATH-1,bHLHa14;atonal homolog 1 (Drosophila)
hsa:1616;DAXX,BING2,DAP6,EAP1;death-domain associated protein
hsa:2118;ETV4,E1A-F,E1AF,PEA3,PEAS3;ets variant 4
hsa:25970;SH2B1,PSM,SH2B;SH2B adaptor protein 1
hsa:4489;MT1A,MT1,MT1S,MTC;metallothionein 1A
hsa:6696;SPP1,BNSP,BSPI,ETA-1,OPN;secreted phosphoprotein 1
hsa:51147;ING4,my036,p29ING4;inhibitor of growth family, member 4
hsa:80184;CEP290,3H11Ag,BBS14,CT87,JBTS5,LCA10,MKS4,NPHP6,POC3,SLSN6,rd16;centrosomal protein 290kDa
hsa:84441;MAML2,MAM-3,MAM2,MAM3,MLL-MAML2;mastermind-like 2 (Drosophila)
hsa:7161;TP73,P73;tumor protein p73
hsa:4524;MTHFR;methylenetetrahydrofolate reductase (NAD(P)H) (EC:1.5.1.20)
hsa:4052;LTBP1;latent transforming growth factor beta binding protein 1
hsa:57084;SLC17A6,DNPI,VGLUT2;solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6
hsa:55294;FBXW7,AGO,CDC4,FBW6,FBW7,FBX30,FBXO30,FBXW6,SEL-10,SEL10,hAgo,hCdc4;F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
hsa:6750;SST,SMST;somatostatin
hsa:24138;IFIT5,P58,RI58;interferon-induced protein with tetratricopeptide repeats 5
hsa:6369;CCL24,Ckb-6,MPIF-2,MPIF2,SCYA24;chemokine (C-C motif) ligand 24
hsa:9839;ZEB2,HSPC082,SIP-1,SIP1,SMADIP1,ZFHX1B;zinc finger E-box binding homeobox 2
hsa:348980;HCN1,BCNG-1,BCNG1,HAC-2;hyperpolarization activated cyclic nucleotide-gated potassium channel 1
hsa:6159;RPL29,HIP,HUMRPL29,L29,RPL29P10,RPL29_3_370;ribosomal protein L29
hsa:23621;BACE1,ASP2,BACE,HSPC104;beta-site APP-cleaving enzyme 1 (EC:3.4.23.46)
hsa:2720;GLB1,EBP,ELNR1,MPS4B;galactosidase, beta 1 (EC:3.2.1.23)
hsa:6786;STIM1,D11S4896E,GOK,STIM1L;stromal interaction molecule 1
hsa:340273;ABCB5,ABCB5alpha,ABCB5beta,EST422562;ATP-binding cassette, sub-family B (MDR/TAP), member 5
hsa:4988;OPRM1,LMOR,M-OR-1,MOP,MOR,MOR1,OPRM;opioid receptor, mu 1
hsa:161742;SPRED1,NFLS,hSpred1,spred-1;sprouty-related, EVH1 domain containing 1
hsa:6613;SUMO2,HSMT3,SMT3B,SMT3H2,SUMO3,Smt3A;SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae)
hsa:84231;TRAF7,RFWD1,RNF119;TNF receptor-associated factor 7, E3 ubiquitin protein ligase
hsa:6822;SULT2A1,DHEA-ST,DHEAS,HST,ST2,ST2A1,ST2A3,STD,hSTa;sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 (EC:2.8.2.14)
hsa:269;AMHR2,AMHR,MISR2,MISRII,MRII;anti-Mullerian hormone receptor, type II (EC:2.7.11.30)
hsa:5741;PTH,PTH1;parathyroid hormone
hsa:55885;LMO3,RBTN3,RBTNL2,RHOM3,Rhom-3;LIM domain only 3 (rhombotin-like 2)
hsa:222236;NAPEPLD,FMP30,NAPE-PLD;N-acyl phosphatidylethanolamine phospholipase D (EC:3.1.4.54)
hsa:91937;TIMD4,SMUCKLER,TIM4;T-cell immunoglobulin and mucin domain containing 4
hsa:1827;RCAN1,ADAPT78,CSP1,DSC1,DSCR1,MCIP1,RCN1;regulator of calcineurin 1
hsa:7337;UBE3A,ANCR,AS,E6-AP,EPVE6AP,HPVE6A;ubiquitin protein ligase E3A (EC:6.3.2.19)
hsa:64393;ZMAT3,PAG608,WIG-1,WIG1;zinc finger, matrin-type 3
hsa:1588;CYP19A1,ARO,ARO1,CPV1,CYAR,CYP19,CYPXIX,P-450AROM;cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1)
hsa:2159;F10,FX,FXA;coagulation factor X (EC:3.4.21.6)
hsa:60;ACTB,BRWS1,PS1TP5BP1;actin, beta
hsa:5621;PRNP,ASCR,AltPrP,CD230,CJD,GSS,KURU,PRIP,PrP,PrP27-30,PrP33-35C,PrPc,p27-30;prion protein
hsa:7178;TPT1,HRF,TCTP,p02;tumor protein, translationally-controlled 1
hsa:3815;KIT,C-Kit,CD117,PBT,SCFR;v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1)
hsa:383;ARG1;arginase, liver (EC:3.5.3.1)
hsa:3959;LGALS3BP,90K,BTBD17B,MAC-2-BP,TANGO10B;lectin, galactoside-binding, soluble, 3 binding protein
hsa:2904;GRIN2B,GluN2B,MRD6,NMDAR2B,NR2B,hNR3;glutamate receptor, ionotropic, N-methyl D-aspartate 2B
hsa:10763;NES;nestin
hsa:221120;ALKBH3,ABH3,DEPC-1,DEPC1,PCA1;alkB, alkylation repair homolog 3 (E. coli)
hsa:2053;EPHX2,CEH,SEH;epoxide hydrolase 2, cytoplasmic (EC:3.3.2.10 3.1.3.76)
hsa:3665;IRF7,IRF-7H,IRF7A;interferon regulatory factor 7
hsa:7052;TGM2,G-ALPHA-h,GNAH,TG2,TGC;transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) (EC:2.3.2.13)
hsa:1509;CTSD,CLN10,CPSD;cathepsin D (EC:3.4.23.5)
hsa:5225;PGC,PEPC,PGII;progastricsin (pepsinogen C) (EC:3.4.23.3)
hsa:10804;GJB6,CX30,DFNA3,DFNA3B,DFNB1B,ECTD2,ED2,EDH,HED,HED2;gap junction protein, beta 6, 30kDa
hsa:5979;RET,CDHF12,CDHR16,HSCR1,MEN2A,MEN2B,MTC1,PTC,RET-ELE1,RET51;ret proto-oncogene (EC:2.7.10.1)
hsa:6899;TBX1,CAFS,CTHM,DGCR,DGS,DORV,TBX1C,TGA,VCFS;T-box 1
hsa:3964;LGALS8,Gal-8,PCTA-1,PCTA1,Po66-CBP;lectin, galactoside-binding, soluble, 8
hsa:89780;WNT3A;wingless-type MMTV integration site family, member 3A
hsa:10221;TRIB1,C8FW,GIG2,SKIP1,TRB1;tribbles homolog 1 (Drosophila)
hsa:1642;DDB1,DDBA,UV-DDB1,XAP1,XPCE,XPE,XPE-BF;damage-specific DNA binding protein 1, 127kDa
hsa:55166;CENPQ,C6orf139,CENP-Q;centromere protein Q
hsa:6364;CCL20,CKb4,LARC,MIP-3-alpha,MIP-3a,MIP3A,SCYA20,ST38;chemokine (C-C motif) ligand 20
hsa:7113;TMPRSS2,PP9284,PRSS10;transmembrane protease, serine 2 (EC:3.4.21.-)
hsa:2539;G6PD,G6PD1;glucose-6-phosphate dehydrogenase (EC:1.1.1.49)
hsa:8651;SOCS1,CIS1,CISH1,JAB,SOCS-1,SSI-1,SSI1,TIP3;suppressor of cytokine signaling 1
hsa:837;CASP4,ICE(rel)II,ICEREL-II,ICH-2,Mih1/TX,TX;caspase 4, apoptosis-related cysteine peptidase (EC:3.4.22.57)
hsa:57119;EPPIN,CT71,CT72,SPINLW1,WAP7,WFDC7,dJ461P17.2;epididymal peptidase inhibitor
hsa:59272;ACE2,ACEH;angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 (EC:3.4.17.23)
hsa:2784;GNB3;guanine nucleotide binding protein (G protein), beta polypeptide 3
hsa:6667;SP1;Sp1 transcription factor
hsa:5054;SERPINE1,PAI,PAI-1,PAI1,PLANH1;serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
hsa:2719;GPC3,DGSX,GTR2-2,MXR7,OCI-5,SDYS,SGB,SGBS,SGBS1;glypican 3
hsa:6901;TAZ,BTHS,CMD3A,EFE,EFE2,G4.5,LVNCX,Taz1;tafazzin
hsa:4773;NFATC2,NFAT1,NFATP;nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
hsa:7412;VCAM1,CD106,INCAM-100;vascular cell adhesion molecule 1
hsa:7204;TRIO,ARHGEF23,tgat;trio Rho guanine nucleotide exchange factor (EC:2.7.11.1)
hsa:71;ACTG1,ACT,ACTG,BRWS2,DFNA20,DFNA26;actin, gamma 1
hsa:11199;ANXA10,ANX14;annexin A10
hsa:6406;SEMG1,CT103,SEMG,SGI,dJ172H20.2;semenogelin I
hsa:7158;TP53BP1,53BP1,p202;tumor protein p53 binding protein 1
hsa:5970;RELA,NFKB3,p65;v-rel reticuloendotheliosis viral oncogene homolog A (avian)
hsa:3897;L1CAM,CAML1,CD171,HSAS,HSAS1,MASA,MIC5,N-CAM-L1,N-CAML1,NCAM-L1,S10,SPG1;L1 cell adhesion molecule
hsa:2261;FGFR3,ACH,CD333,CEK2,HSFGFR3EX,JTK4;fibroblast growth factor receptor 3 (EC:2.7.10.1)
hsa:9294;S1PR2,AGR16,EDG-5,EDG5,Gpcr13,H218,LPB2,S1P2;sphingosine-1-phosphate receptor 2
hsa:5501;PPP1CC,PP-1G,PP1C,PPP1G;protein phosphatase 1, catalytic subunit, gamma isozyme (EC:3.1.3.16)
hsa:27445;PCLO,ACZ;piccolo presynaptic cytomatrix protein
hsa:9641;IKBKE,IKK-E,IKK-i,IKKE,IKKI;inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon (EC:2.7.11.10)
hsa:4323;MMP14,1,MMP-14,MMP-X1,MT-MMP,MT-MMP_1,MT1-MMP,MT1MMP,MTMMP1;matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80)
hsa:80243;PREX2,6230420N16Rik,DEP.2,DEPDC2,P-REX2;phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2
hsa:1401;CRP,PTX1;C-reactive protein, pentraxin-related
hsa:55737;VPS35,MEM3,PARK17;vacuolar protein sorting 35 homolog (S. cerevisiae)
hsa:3576;IL8,CXCL8,GCP-1,GCP1,LECT,LUCT,LYNAP,MDNCF,MONAP,NAF,NAP-1,NAP1;interleukin 8
hsa:10673;TNFSF13B,BAFF,BLYS,CD257,DTL,TALL-1,TALL1,THANK,TNFSF20,ZTNF4;tumor necrosis factor (ligand) superfamily, member 13b
hsa:6862;T,TFT;T, brachyury homolog (mouse)
hsa:7321;UBE2D1,E2(17)KB1,SFT,UBC4/5,UBCH5,UBCH5A;ubiquitin-conjugating enzyme E2D 1 (EC:6.3.2.19)
hsa:113130;CDCA5,SORORIN;cell division cycle associated 5
hsa:3611;ILK,ILK-2,P59;integrin-linked kinase (EC:2.7.11.1)
hsa:3061;HCRTR1,OX1R;hypocretin (orexin) receptor 1
hsa:3434;IFIT1,C56,G10P1,IFI-56,IFI-56K,IFI56,IFIT-1,IFNAI1,ISG56,P56,RNM561;interferon-induced protein with tetratricopeptide repeats 1
hsa:5243;ABCB1,ABC20,CD243,CLCS,GP170,MDR1,P-GP,PGY1;ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44)
hsa:6402;SELL,CD62L,LAM1,LECAM1,LEU8,LNHR,LSEL,LYAM1,PLNHR,TQ1;selectin L
hsa:29904;EEF2K,HSU93850,eEF-2K;eukaryotic elongation factor-2 kinase (EC:2.7.11.20)
hsa:23468;CBX5,HP1,HP1A;chromobox homolog 5
hsa:2067;ERCC1,COFS4,RAD10,UV20;excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)
hsa:7032;TFF2,SML1,SP;trefoil factor 2
hsa:10451;VAV3;vav 3 guanine nucleotide exchange factor
hsa:6649;SOD3,EC-SOD;superoxide dismutase 3, extracellular (EC:1.15.1.1)
hsa:3480;IGF1R,CD221,IGFIR,IGFR,JTK13;insulin-like growth factor 1 receptor (EC:2.7.10.1)
hsa:5598;MAPK7,BMK1,ERK4,ERK5,PRKM7;mitogen-activated protein kinase 7 (EC:2.7.11.24)
hsa:1649;DDIT3,CEBPZ,CHOP,CHOP-10,CHOP10,GADD153;DNA-damage-inducible transcript 3
hsa:4128;MAOA,MAO-A;monoamine oxidase A (EC:1.4.3.4)
hsa:55230;USP40;ubiquitin specific peptidase 40 (EC:3.4.19.12)
hsa:1408;CRY2,HCRY2,PHLL2;cryptochrome 2 (photolyase-like)
hsa:6935;ZEB1,AREB6,BZP,DELTAEF1,FECD6,NIL2A,PPCD3,TCF8,ZFHEP,ZFHX1A;zinc finger E-box binding homeobox 1
hsa:3064;HTT,HD,IT15;huntingtin
hsa:5879;RAC1,Rac-1,TC-25,p21-Rac1;ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
hsa:5609;MAP2K7,Jnkk2,MAPKK7,MKK7,PRKMK7,SAPKK-4,SAPKK4;mitogen-activated protein kinase kinase 7 (EC:2.7.12.2)
hsa:6610;SMPD2,ISC1,NSMASE,NSMASE1;sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase) (EC:3.1.4.12)
hsa:57406;ABHD6;abhydrolase domain containing 6 (EC:3.1.1.23)
hsa:7480;WNT10B,SHFM6,WNT-12;wingless-type MMTV integration site family, member 10B
hsa:6775;STAT4,SLEB11;signal transducer and activator of transcription 4
hsa:7351;UCP2,BMIQ4,SLC25A8,UCPH;uncoupling protein 2 (mitochondrial, proton carrier)
hsa:4148;MATN3,DIPOA,EDM5,HOA,OADIP,OS2;matrilin 3
hsa:539;ATP5O,ATPO,OSCP;ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (EC:3.6.3.14)
hsa:1027;CDKN1B,CDKN4,KIP1,MEN1B,MEN4,P27KIP1;cyclin-dependent kinase inhibitor 1B (p27, Kip1)
hsa:3549;IHH,BDA1,HHG2;indian hedgehog
hsa:8900;CCNA1;cyclin A1
hsa:3037;HAS2;hyaluronan synthase 2 (EC:2.4.1.212)
hsa:629;CFB,AHUS4,BF,BFD,CFAB,FB,FBI12,GBG,H2-Bf,PBF2;complement factor B (EC:3.4.21.47)
hsa:2475;MTOR,FRAP,FRAP1,FRAP2,RAFT1,RAPT1;mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1)
hsa:2247;FGF2,BFGF,FGF-2,FGFB,HBGF-2;fibroblast growth factor 2 (basic)
hsa:3589;IL11,AGIF,IL-11;interleukin 11
hsa:2913;GRM3,GLUR3,GPRC1C,MGLUR3,mGlu3;glutamate receptor, metabotropic 3
hsa:406906;MIR122,MIR122A,MIRN122,MIRN122A,hsa-mir-122,miRNA122,miRNA122A;microRNA 122
hsa:406909;MIR124-3,MIRN124-3,MIRN124A3;microRNA 124-3
hsa:406932;MIR140,MIRN140,miRNA140;microRNA 140
hsa:406936;MIR144,MIRN144;microRNA 144
hsa:406935;MIR143,MIRN143;microRNA 143
hsa:406937;MIR145,MIRN145,miR-145,miRNA145;microRNA 145
hsa:407046;MIR9-1,MIRN9-1,hsa-mir-9-1,miRNA9-1;microRNA 9-1
hsa:406913;MIR126,MIRN126,miRNA126;microRNA 126
hsa:406938;MIR146A,MIRN146,MIRN146A,miR-146a,miRNA146A;microRNA 146a
hsa:406941;MIR149,MIRN149;microRNA 149
hsa:406942;MIR150,MIRN150,miRNA150;microRNA 150
hsa:693223;MIR638,MIRN638,hsa-mir-638;microRNA 638
hsa:283120;H19,ASM,ASM1,BWS,D11S813E,LINC00008,NCRNA00008,PRO2605,WT2;H19, imprinted maternally expressed transcript (non-protein coding)
hsa:406989;MIR206,MIRN206,miRNA206;microRNA 206
hsa:406947;MIR155,MIRN155,miRNA155;microRNA 155
hsa:723778;MIR650,MIRN650,hsa-mir-650;microRNA 650
hsa:724033;MIR663A,MIR663,MIRN663,hsa-mir-663,hsa-mir-663a;microRNA 663a
hsa:407041;MIR34B,MIRN34B,miRNA34B;microRNA 34b
hsa:407042;MIR34C,MIRN34C,miRNA34C;microRNA 34c
hsa:406920;MIR130B,MIRN130B,mir-130b;microRNA 130b
hsa:664617;MIR542,MIRN542,hsa-mir-542;microRNA 542
hsa:100302203;MIR1271,MIRN1271,hsa-mir-1271;microRNA 1271
hsa:100033819;MIR675,MIRN675,hsa-mir-675;microRNA 675
hsa:494336;MIR424,MIR322,MIRN424,hsa-mir-424,miRNA424;microRNA 424
hsa:619554;MIR486,MIRN486,hsa-mir-486;microRNA 486
hsa:406884;MIRLET7B,LET7B,MIRNLET7B,hsa-let-7b,let-7b;microRNA let-7b
hsa:406948;MIR15A,MIRN15A,hsa-mir-15a,miRNA15A;microRNA 15a
hsa:100302187;MIR1297,MIRN1297,hsa-mir-1297;microRNA 1297
hsa:406991;MIR21,MIRN21,hsa-mir-21,miR-21,miRNA21;microRNA 21
hsa:406950;MIR16-1,MIRN16-1,miRNA16-1;microRNA 16-1
hsa:407035;MIR31,MIRN31,hsa-mir-31,miR-31;microRNA 31
hsa:407050;MIR93,MIRN9,MIRN93,hsa-mir-93,miR-93;microRNA 93
hsa:574501;MIR499A,MIR499,MIRN499,hsa-mir-499a;microRNA 499a
hsa:574506;MIR503,MIRN503,hsa-mir-503;microRNA 503
hsa:407043;MIR7-1,MIRN7-1,hsa-mir-7-1,mir-7-1;microRNA 7-1
hsa:406899;MIR106A,MIRN106A,mir-106;microRNA 106a
hsa:406959;MIR183,MIRN183,miR-183,miRNA183;microRNA 183
hsa:406976;MIR199A1,MIR-199-s,MIRN199A1;microRNA 199a-1
hsa:406973;MIR196A2,MIRN196-2,MIRN196A2;microRNA 196a-2
hsa:406992;MIR210,MIRN210,mir-210;microRNA 210
hsa:406988;MIR205,MIRN205;microRNA 205
hsa:406995;MIR181A1,MIR213,MIRN181A1,MIRN213,hsa-mir-181a-1,mir-213;microRNA 181a-1
hsa:728558;ENTPD1-AS1;ENTPD1 antisense RNA 1
hsa:9762;LZTS3,PROSAPIP1,RP5-1187M17.10;leucine zipper, putative tumor suppressor family member 3
hsa:4558;TRNF,MT-TF,MTTF;tRNA-Phe
hsa:4549;RNR1,MTRNR1,MT-RNR1;s-rRNA
hsa:4577;TRNV,MTTV,MT-TV;tRNA-Val
hsa:4550;RNR2,MTRNR2,MT-RNR2;l-rRNA
hsa:4567;TRNL1,MTTL1,MT-TL1;tRNA-Leu
hsa:4535;ND1,MTND1,MT-ND1;NADH dehydrogenase, subunit 1 (complex I)
hsa:4565;TRNI,MTTI,MT-TI;tRNA-Ile
hsa:4572;TRNQ,MTTQ,MT-TQ;tRNA-Gln
hsa:4569;TRNM,MTTM,MT-TM;tRNA-Met
hsa:4536;ND2,MTND2,MT-ND2;MTND2
hsa:4578;TRNW,MTTW,MT-TW;tRNA-Trp
hsa:4553;TRNA,MTTA,MT-TA;tRNA-Ala
hsa:4570;TRNN,MTTN,MT-TN;tRNA-Asn
hsa:4511;TRNC,MTTC,MT-TC;tRNA-Cys
hsa:4579;TRNY,MTTY,MT-TY;tRNA-Tyr
hsa:4512;COX1,COI,MTCO1,MT-CO1;cytochrome c oxidase subunit I
hsa:4574;TRNS1,MTTS1,MT-TS1;tRNA-Ser
hsa:4555;TRND,MTTD,MT-TD;tRNA-Asp
hsa:4513;COX2,COII,MTCO2,MT-CO2;cytochrome c oxidase subunit II
hsa:4566;TRNK,MTTK,MT-TK,MERRF;tRNA-Lys
hsa:4509;ATP8,ATPase8,MTATP8,MT-ATP8;ATP synthase F0 subunit 8
hsa:4508;ATP6,ATPase6,MTATP6,MT-ATP6,RP;ATP synthase F0 subunit 6
hsa:4514;COX3,COIII,MTCO3,MT-CO3;cytochrome c oxidase III
hsa:4563;TRNG,MTTG,MT-TG;tRNA-Gly
hsa:4537;ND3,MTND3,MT-ND3;NADH dehydrogenase, subunit 3 (complex I)
hsa:4573;TRNR,MTTR,MT-TR;tRNA-Arg
hsa:4539;ND4L,MTND4L,MT-ND4L;NADH dehydrogenase, subunit 4L (complex I)
hsa:4538;ND4,MTND4,MT-ND4;NADH dehydrogenase, subunit 4 (complex I)
hsa:4564;TRNH,MTTH,MT-TH;tRNA-His
hsa:4575;TRNS2,MTTS2,MT-TS2;tRNA-Ser
hsa:4568;TRNL2,MTTL2,MT-TL2;tRNA-Leu
hsa:4540;ND5,MTND5,MT-ND5;NADH dehydrogenase, subunit 5 (complex I)
hsa:4541;ND6,MTND6,MT-ND6;NADH dehydrogenase, subunit 6 (complex I)
hsa:4556;TRNE,MTTE,MT-TE;tRNA-Glu
hsa:4519;CYTB,MTCYB,MT-CYB;cytochrome b
hsa:4576;TRNT,MTTT,MT-TT;tRNA-Thr
hsa:4571;TRNP,MTTP,MT-TP;tRNA-Pro
